"reads_downloaded_1_1","mapped_read_count_1_1","auc_1_1","bigwig_file_1_1","gdc_cases.case_id_1_1","gdc_file_id_1_1","gdc_updated_datetime_1_1","gdc_file_name_1_1","gdc_submitter_id_1_1","gdc_file_size_1_1","gdc_platform_1_1","gdc_md5sum_1_1","gdc_data_format_1_1","gdc_center.code_1_1","gdc_center.name_1_1","gdc_center.short_name_1_1","gdc_center.center_id_1_1","gdc_center.namespace_1_1","gdc_metadata_files.updated_datetime.analysis_1_1","gdc_metadata_files.created_datetime.analysis_1_1","gdc_metadata_files.file_name.analysis_1_1","gdc_metadata_files.md5sum.analysis_1_1","gdc_metadata_files.file_id.analysis_1_1","gdc_metadata_files.file_size.analysis_1_1","gdc_metadata_files.updated_datetime.experiment_1_1","gdc_metadata_files.file_name.experiment_1_1","gdc_metadata_files.md5sum.experiment_1_1","gdc_metadata_files.file_id.experiment_1_1","gdc_metadata_files.file_size.experiment_1_1","gdc_metadata_files.updated_datetime.run_1_1","gdc_metadata_files.file_name.run_1_1","gdc_metadata_files.md5sum.run_1_1","gdc_metadata_files.file_id.run_1_1","gdc_metadata_files.file_size.run_1_1","gdc_cases.updated_datetime_1_1","gdc_cases.submitter_id_1_1","gdc_cases.demographic.updated_datetime_1_1","gdc_cases.demographic.gender_1_1","gdc_cases.demographic.submitter_id_1_1","gdc_cases.demographic.year_of_birth_1_1","gdc_cases.demographic.race_1_1","gdc_cases.demographic.demographic_id_1_1","gdc_cases.demographic.ethnicity_1_1","gdc_cases.demographic.year_of_death_1_1","gdc_cases.project.name_1_1","gdc_cases.project.primary_site_1_1","gdc_cases.project.project_id_1_1","gdc_cases.tissue_source_site.project_1_1","gdc_cases.tissue_source_site.bcr_id_1_1","gdc_cases.tissue_source_site.code_1_1","gdc_cases.tissue_source_site.tissue_source_site_id_1_1","gdc_cases.tissue_source_site.name_1_1","gdc_cases.diagnoses.classification_of_tumor_1_1","gdc_cases.diagnoses.primary_diagnosis_1_1","gdc_cases.diagnoses.submitter_id_1_1","gdc_cases.diagnoses.tumor_stage_1_1","gdc_cases.diagnoses.age_at_diagnosis_1_1","gdc_cases.diagnoses.vital_status_1_1","gdc_cases.diagnoses.morphology_1_1","gdc_cases.diagnoses.days_to_death_1_1","gdc_cases.diagnoses.days_to_last_follow_up_1_1","gdc_cases.diagnoses.diagnosis_id_1_1","gdc_cases.diagnoses.tissue_or_organ_of_origin_1_1","gdc_cases.diagnoses.days_to_birth_1_1","gdc_cases.diagnoses.treatments.submitter_id_1_1","gdc_cases.diagnoses.treatments.treatment_id_1_1","gdc_cases.samples.sample_type_id_1_1","gdc_cases.samples.oct_embedded_1_1","gdc_cases.samples.submitter_id_1_1","gdc_cases.samples.intermediate_dimension_1_1","gdc_cases.samples.sample_id_1_1","gdc_cases.samples.is_ffpe_1_1","gdc_cases.samples.pathology_report_uuid_1_1","gdc_cases.samples.sample_type_1_1","gdc_cases.samples.shortest_dimension_1_1","gdc_cases.samples.days_to_collection_1_1","gdc_cases.samples.initial_weight_1_1","gdc_cases.samples.longest_dimension_1_1","gdc_cases.samples.portions.creation_datetime_1_1","gdc_cases.samples.portions.portion_number_1_1","gdc_cases.samples.portions.weight_1_1","gdc_cases.samples.portions.submitter_id_1_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_1","gdc_cases.samples.portions.slides_percent_tumor_nuclei_2","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_monocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_normal_cells_1","gdc_cases.samples.portions.slides_percent_normal_cells_2","gdc_cases.samples.portions.slides_percent_stromal_cells_1","gdc_cases.samples.portions.slides_percent_stromal_cells_2","gdc_cases.samples.portions.slides_updated_datetime_1","gdc_cases.samples.portions.slides_updated_datetime_2","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_1","gdc_cases.samples.portions.slides_percent_lymphocyte_infiltration_2","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_1","gdc_cases.samples.portions.slides_percent_neutrophil_infiltration_2","gdc_cases.samples.portions.slides_section_location_1","gdc_cases.samples.portions.slides_section_location_2","gdc_cases.samples.portions.slides_percent_necrosis_1","gdc_cases.samples.portions.slides_percent_necrosis_2","gdc_cases.samples.portions.slides_slide_id_1","gdc_cases.samples.portions.slides_slide_id_2","gdc_cases.samples.portions.slides_submitter_id_1","gdc_cases.samples.portions.slides_submitter_id_2","gdc_cases.samples.portions.slides_percent_tumor_cells_1","gdc_cases.samples.portions.slides_percent_tumor_cells_2","gdc_cases.samples.portions.portion_id_1_1","gdc_cases.samples.portions.analytes.analyte_type_1_1","gdc_cases.samples.portions.analytes.submitter_id_1_1","gdc_cases.samples.portions.analytes.analyte_id_1_1","gdc_cases.samples.portions.analytes.a260_a280_ratio_1_1","gdc_cases.samples.portions.analytes.concentration_1_1","gdc_cases.samples.portions.analytes.spectrophotometer_method_1_1","gdc_cases.samples.portions.analytes.analyte_type_id_1_1","gdc_cases.samples.portions.analytes.aliquots.source_center_1_1","gdc_cases.samples.portions.analytes.aliquots.submitter_id_1_1","gdc_cases.samples.portions.analytes.aliquots.aliquot_id_1_1","gdc_cases.samples.portions.analytes.aliquots.concentration_1_1","gdc_cases.exposures.cigarettes_per_day_1_1","gdc_cases.exposures.weight_1_1","gdc_cases.exposures.bmi_1_1","gdc_cases.exposures.height_1_1","gdc_cases.exposures.exposure_id_1_1","gdc_cases.exposures.submitter_id_1_1","cgc_filename_1_1","cgc_file_upload_date_1_1","cgc_file_last_modified_date_1_1","cgc_file_submitter_id_1_1","cgc_file_sample_1_1","cgc_file_data_subtype_1_1","cgc_file_size_1_1","cgc_file_access_level_1_1","cgc_file_platform_1_1","cgc_file_investigation_1_1","cgc_file_experimental_strategy_1_1","cgc_file_data_type_1_1","cgc_file_aliquot_1_1","cgc_file_data_submitting_center_1_1","cgc_file_file_id_1_1","cgc_file_case_1_1","cgc_file_disease_type_1_1","cgc_file_data_format_1_1","cgc_file_portion_1_1","cgc_file_published_date_1_1","cgc_file_analyte_1_1","cgc_sample_country_of_sample_procurement_1_1","cgc_sample_is_ffpe_1_1","cgc_sample_sample_type_code_1_1","cgc_sample_shortest_dimension_1_1","cgc_sample_sample_type_1_1","cgc_sample_tissue_source_site_1_1","cgc_sample_days_to_collection_1_1","cgc_sample_portion_1_1","cgc_sample_intermediate_dimension_1_1","cgc_sample_tissue_source_site_code_1_1","cgc_sample_file_1_1","cgc_sample_initial_weight_1_1","cgc_sample_id_1_1","cgc_sample_longest_dimension_1_1","cgc_case_drug_therapy_1_1","cgc_case_program_1_1","cgc_case_year_of_diagnosis_1_1","cgc_case_new_tumor_event_1_1","cgc_case_primary_therapy_outcome_success_1_1","cgc_case_tumor_status_1_1","cgc_case_sample_1_1","cgc_case_age_at_diagnosis_1_1","cgc_case_file_1_1","cgc_case_vital_status_1_1","cgc_case_days_to_death_1_1","cgc_case_id_1_1","cgc_case_ethnicity_1_1","cgc_case_follow_up_1_1","cgc_case_new_tumor_event_after_initial_treatment_1_1","cgc_case_days_to_last_follow_up_1_1","cgc_case_prior_diagnosis_1_1","cgc_case_primary_site_1_1","cgc_case_icd_o3site_1_1","cgc_case_pathologic_n_1_1","cgc_case_histological_diagnosis_1_1","cgc_case_performance_status_score_ecog_1_1","cgc_case_performance_status_score_timing_1_1","cgc_case_clinical_stage_1_1","cgc_case_pathologic_stage_1_1","cgc_case_performance_status_score_karnofsky_1_1","cgc_case_pathologic_t_1_1","cgc_case_icd_o3histology_1_1","cgc_case_gender_1_1","cgc_case_icd10_1_1","cgc_case_batch_number_1_1","cgc_case_clinical_m_1_1","cgc_case_radiation_therapy_1_1","cgc_case_race_1_1","cgc_case_clinical_t_1_1","cgc_portion_portion_number_1_1","cgc_portion_weight_1_1","cgc_portion_slide_1_1","cgc_portion_analyte_1_1","cgc_portion_file_1_1","cgc_portion_id_1_1","cgc_slide_percent_tumor_nuclei_1_1","cgc_slide_percent_normal_cells_1_1","cgc_slide_percent_monocyte_infiltration_1_1","cgc_slide_percent_lymphocyte_infiltration_1_1","cgc_slide_percent_stromal_cells_1_1","cgc_slide_section_location_1_1","cgc_slide_percent_necrosis_1_1","cgc_slide_percent_neutrophil_infiltration_1_1","cgc_slide_id_1_1","cgc_slide_percent_tumor_cells_1_1","cgc_drug_therapy_drug_name_1_1","cgc_drug_therapy_pharmaceutical_therapy_type_1_1","cgc_drug_therapy_id_1_1","cgc_radiation_therapy_id_1_1","cgc_radiation_therapy_radiation_type_1_1","cgc_radiation_therapy_radiation_therapy_site_1_1","cgc_follow_up_new_tumor_event_1_1","cgc_follow_up_new_tumor_event_after_initial_treatment_1_1","cgc_follow_up_days_to_last_follow_up_1_1","cgc_follow_up_tumor_status_1_1","cgc_follow_up_vital_status_1_1","cgc_follow_up_days_to_death_1_1","cgc_follow_up_id_1_1","xml_bcr_patient_barcode_1_1","xml_additional_studies_1_1","xml_tissue_source_site_1_1","xml_patient_id_1_1","xml_informed_consent_verified_1_1","xml_icd_o_3_site_1_1","xml_icd_o_3_histology_1_1","xml_icd_10_1_1","xml_tissue_prospective_collection_indicator_1_1","xml_tissue_retrospective_collection_indicator_1_1","xml_days_to_birth_1_1","xml_gender_1_1","xml_race_list_1_1","xml_ethnicity_1_1","xml_other_dx_1_1","xml_history_of_neoadjuvant_treatment_1_1","xml_vital_status_1_1","xml_days_to_last_followup_1_1","xml_days_to_death_1_1","xml_radiation_therapy_1_1","xml_postoperative_rx_tx_1_1","xml_person_neoplasm_cancer_status_1_1","xml_has_new_tumor_events_information_1_1","xml_day_of_form_completion_1_1","xml_month_of_form_completion_1_1","xml_year_of_form_completion_1_1","xml_has_follow_ups_information_1_1","xml_has_drugs_information_1_1","xml_has_radiations_information_1_1","xml_primary_pathology_days_to_initial_pathologic_diagnosis_1_1","xml_primary_pathology_age_at_initial_pathologic_diagnosis_1_1","xml_primary_pathology_year_of_initial_pathologic_diagnosis_1_1","xml_tumor_tissue_site_1_1","xml_histological_type_1_1","xml_anatomic_neoplasm_subdivision_1_1","xml_days_to_initial_pathologic_diagnosis_1_1","xml_age_at_initial_pathologic_diagnosis_1_1","xml_year_of_initial_pathologic_diagnosis_1_1","xml_initial_pathologic_diagnosis_method_1_1","xml_primary_lymph_node_presentation_assessment_1_1","xml_lymph_node_examined_count_1_1","xml_number_of_lymphnodes_positive_by_he_1_1","xml_neoplasm_histologic_grade_1_1","xml_residual_tumor_1_1","xml_tobacco_smoking_history_1_1","xml_stopped_smoking_year_1_1","xml_number_pack_years_smoked_1_1","xml_targeted_molecular_therapy_1_1","xml_primary_therapy_outcome_success_1_1","xml_stage_event_system_version_1_1","xml_stage_event_clinical_stage_1_1","xml_stage_event_pathologic_stage_1_1","xml_stage_event_tnm_categories_1_1","xml_kras_gene_analysis_performed_1_1","xml_karnofsky_performance_score_1_1","xml_eastern_cancer_oncology_group_1_1","xml_performance_status_scale_timing_1_1","xml_laterality_1_1","xml_menopause_status_1_1","xml_anatomic_neoplasm_subdivisions_1_1","xml_breast_carcinoma_surgical_procedure_name_1_1","xml_breast_carcinoma_progesterone_receptor_status_1_1","xml_margin_status_1_1","xml_breast_carcinoma_estrogen_receptor_status_1_1","xml_diagnosis_1_1"
157198940,152072770,7255445239,"7826AE44-B03A-4528-9CB5-7421E592AE36.bw","00ad0ffe-2105-4829-a495-1c2aceb5bb31","7826ae44-b03a-4528-9cb5-7421e592ae36","2016-08-09T13:11:01.488828-05:00","UNCID_2186138.359ed529-c947-47f9-8119-78f2fd038ee5.121102_UNC12-SN629_0235_AC13F5ACXX_5_CGATGT.tar.gz","da62cebb-2fb2-428e-83a6-26034b608d66",6931944698,"Illumina HiSeq","bccac38c65034247deb35d86dddd7497","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:29:24.131200-05:00","2016-05-03T11:00:24.444360-05:00","da62cebb-2fb2-428e-83a6-26034b608d66_analysis.xml","bfff0f7a5aa66bb274db11bbc8d48548","244bcfef-8686-478b-80b2-d1184ba29b86",2124,"2016-09-29T20:02:27.767945-05:00","da62cebb-2fb2-428e-83a6-26034b608d66_experiment.xml","d5220e107d991ce99d202547a6d67250","5e9b9eae-dd4f-4ff5-85f9-b8ecb3417ebf",2431,"2016-09-29T23:47:59.329007-05:00","da62cebb-2fb2-428e-83a6-26034b608d66_run.xml","686a8c2ea99db208d055156543e6822c","ea3ace26-972c-4914-80dd-4535a0f0a91d",354,"2016-09-08T12:13:14.490998-05:00","TCGA-EK-A2R9","2016-09-02T18:58:25.107660-05:00","female","TCGA-EK-A2R9_demographic",1953,"white","af32f229-cdc6-5bc3-9d4b-0987d2cb8e3c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2R9_diagnosis","not reported",21242,"alive","8072/3",NA,4,"fd210f0b-cf9d-5763-8559-b012ccb21855","c53.9",-21242,"TCGA-EK-A2R9_treatment","d4baa31f-8c1f-5333-afcd-836816fd1a2a","01","false","TCGA-EK-A2R9-01A",NA,"7efd873d-8165-40f8-a07d-69cfd68a491e",FALSE,"05E84255-196B-424A-B317-9A4D2072BD5D","Primary Tumor",NA,230,100,NA,1315785600,"11",30,"TCGA-EK-A2R9-01A-11",65,NA,0,NA,50,NA,7,NA,"2016-09-08T12:13:14.490998-05:00",NA,10,NA,0,NA,"TOP",NA,3,NA,"a082eb54-ee55-46e9-8ab2-0e40f2a3bc6c",NA,"TCGA-EK-A2R9-01A-01-TS1",NA,40,NA,"31858d24-d726-4a77-a0f0-6f1b835d2593","RNA","TCGA-EK-A2R9-01A-11R","f745f40e-49c6-4bc8-8485-f881004e8578",1.88,0.16,"UV Spec","R","23","TCGA-EK-A2R9-01A-11R-A18M-07","359ed529-c947-47f9-8119-78f2fd038ee5",0.16,NA,185,70.4923030025911,162,"57820282-4905-50e2-8a15-718fdae604a2","TCGA-EK-A2R9_exposure","UNCID_2186138.359ed529-c947-47f9-8119-78f2fd038ee5.121102_UNC12-SN629_0235_AC13F5ACXX_5_CGATGT.tar.gz","2013-09-16T01:36:04.000Z","2013-09-16T01:56:01.000Z","DA62CEBB-2FB2-428E-83A6-26034B608D66","7EFD873D-8165-40F8-A07D-69CFD68A491E","Unaligned reads",6931944698,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","359ED529-C947-47F9-8119-78F2FD038EE5","University of North Carolina","56607555e4b0b37b3d98f726","00AD0FFE-2105-4829-A495-1C2ACEB5BB31","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","31858D24-D726-4A77-A0F0-6F1B835D2593","2013-09-16T01:56:01.000Z","F745F40E-49C6-4BC8-8485-F881004E8578","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",230,"31858D24-D726-4A77-A0F0-6F1B835D2593",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.58CD44F1-118D-4675-A3F8-0F28F8F98EF9.txt",100,"TCGA-EK-A2R9-01A",NA,NA,"TCGA",2011,NA,NA,"WITH TUMOR","996AD494-90B1-4AC7-9339-DD4ACF5AF472",58,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.58CD44F1-118D-4675-A3F8-0F28F8F98EF9.txt","Alive",NA,"TCGA-EK-A2R9","NOT HISPANIC OR LATINO","B7035727-5282-454B-AC18-BA317E344D00",NA,4,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"A082EB54-EE55-46E9-8AB2-0E40F2A3BC6C","F745F40E-49C6-4BC8-8485-F881004E8578","TCGA-EK-A2R9-01A-11R-A18L-13_mirna.bam.bai","TCGA-EK-A2R9-01A-11",65,50,0,10,7,"TOP",3,0,"TCGA-EK-A2R9-01A-01-TS1",40,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2R9-F58255_NTE-1",NA,4,NA,"Alive",NA,"TCGA-EK-A2R9-F58255","TCGA-EK-A2R9",NA,"EK","A2R9","YES","C53.9","8072/3","C53.9","NO","YES",-21242,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",4,NA,NA,NA,"WITH TUMOR","NO",7,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,58,2011,"Other method, specify:","YES",14,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,"T1b1N0",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
178111436,174931391,8345896768,"0DC2197B-2FEA-48EB-953E-8E44E1933757.bw","00bca18c-b3d4-45a3-8f19-034cc40449a4","0dc2197b-2fea-48eb-953e-8e44e1933757","2016-08-09T13:17:43.762157-05:00","UNCID_2186360.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.121102_UNC12-SN629_0235_AC13F5ACXX_1_GTGAAA.tar.gz","1f575bee-e6b5-4a37-b1f9-9c849f28fd3a",8195556667,"Illumina HiSeq","654a04ea4040b3260cf4ecd24833f962","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:36:54.263884-05:00","2016-05-03T11:00:24.456168-05:00","1f575bee-e6b5-4a37-b1f9-9c849f28fd3a_analysis.xml","8ade9a499c0f93525e70ead58a428aeb","98f4a3f2-04bb-463c-8396-3831ecbfa817",2124,"2016-09-29T21:01:34.537774-05:00","1f575bee-e6b5-4a37-b1f9-9c849f28fd3a_experiment.xml","71868be0b8d140105cc2422d4a8232a3","82f87936-f400-4cae-bfcc-6139eff06cca",2431,"2016-09-30T00:11:17.562267-05:00","1f575bee-e6b5-4a37-b1f9-9c849f28fd3a_run.xml","daaf7070b576363ccb2434815d27e3e0","f87e1fd5-a702-42ab-91d0-09e44835f349",354,"2016-09-08T11:43:11.706998-05:00","TCGA-C5-A2LV","2016-09-02T18:57:50.478931-05:00","female","TCGA-C5-A2LV_demographic",1967,"black or african american","2aeaaba9-ad2a-5c7c-a798-0498efdc3c92","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LV_diagnosis","not reported",13447,"alive","8070/3",NA,2234,"d4254940-bb96-5847-a213-2410e13310c3","c53.9",-13447,"TCGA-C5-A2LV_treatment","f0395060-60d2-54cc-bac5-c48006627c6c","01","false","TCGA-C5-A2LV-01A",NA,"cbad0c55-915a-4f65-b040-57111ead3bde",FALSE,"7D80B4D1-8480-4C06-9067-CF78DA3EBA69","Primary Tumor",NA,3016,160,NA,1314144000,"11",30,"TCGA-C5-A2LV-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T11:43:11.706998-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"f88df6d2-142e-44f0-959a-ad145751b047",NA,"TCGA-C5-A2LV-01A-01-TS1",NA,100,NA,"0e5925e0-2d6b-424c-bea5-9f2da1285e6e","RNA","TCGA-C5-A2LV-01A-11R","211cff70-d798-42ec-b5f6-073715b47107",1.84,0.18,"UV Spec","R","23","TCGA-C5-A2LV-01A-11R-A18M-07","a6a4630e-3d28-4a38-8c9f-29fc0c7b380a",0.18,0.876712328767123,84,30.8539944903581,165,"cbd3e300-7c14-58e8-afd6-222a89ce0f12","TCGA-C5-A2LV_exposure","UNCID_2186360.a6a4630e-3d28-4a38-8c9f-29fc0c7b380a.121102_UNC12-SN629_0235_AC13F5ACXX_1_GTGAAA.tar.gz","2013-09-16T06:06:04.000Z","2013-09-16T06:33:01.000Z","1F575BEE-E6B5-4A37-B1F9-9C849F28FD3A","CBAD0C55-915A-4F65-B040-57111EAD3BDE","Unaligned reads",8195556667,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A6A4630E-3D28-4A38-8C9F-29FC0C7B380A","University of North Carolina","564a3faee4b0298dd2c9c756","00BCA18C-B3D4-45A3-8F19-034CC40449A4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0E5925E0-2D6B-424C-BEA5-9F2DA1285E6E","2013-09-16T06:33:01.000Z","211CFF70-D798-42EC-B5F6-073715B47107","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3016,"0E5925E0-2D6B-424C-BEA5-9F2DA1285E6E",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.7BB3C290-D76B-4013-B020-527ADA351E3F.txt",160,"TCGA-C5-A2LV-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","CBAD0C55-915A-4F65-B040-57111EAD3BDE",36,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.7BB3C290-D76B-4013-B020-527ADA351E3F.txt","Alive",NA,"TCGA-C5-A2LV","NOT HISPANIC OR LATINO","4D0B1FD4-34D1-4EA4-B203-50106BF6D4EA",NA,2234,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Other","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",179,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"F88DF6D2-142E-44F0-959A-AD145751B047","211CFF70-D798-42EC-B5F6-073715B47107","568ca2acff10814c04ea071c0203e6d4.bam","TCGA-C5-A2LV-01A-11",85,0,0,0,0,"TOP",0,0,"TCGA-C5-A2LV-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,NA,"NO",2234,"TUMOR FREE","Alive",NA,"TCGA-C5-A2LV-F21292","TCGA-C5-A2LV",NA,"C5","A2LV","YES","C53.9","8070/3","C53.9","NO","YES",-13447,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",2234,NA,NA,NA,"TUMOR FREE","NO",8,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,36,2003,"Biopsy (cervical / CT-guided / Other)","YES",49,1,"G3",NA,2,NA,16,NA,NA,"1995",6,NA,"T1bN1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
134057648,129705604,6182401352,"87ABB098-8C1E-4677-8C31-48B71EFE41C7.bw","010a807f-9dc0-4e14-9533-dcf478f3d947","87abb098-8c1e-4677-8c31-48b71efe41c7","2016-08-26T00:17:05.693786-05:00","UNCID_2553107.7a1a71ad-c117-4091-bc20-88617bcb99d9.140408_UNC11-SN627_0351_AC3KY3ACXX_1_ACAGTG.tar.gz","e6f8564f-8e73-4ba3-8d5b-1d09d9aeec79",5860502450,"Illumina HiSeq","71df5e1a2ba9a3b1a0ebbb68b85028fd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:36:36.076801-05:00","2016-05-03T11:54:19.908545-05:00","e6f8564f-8e73-4ba3-8d5b-1d09d9aeec79_analysis.xml","e50a453e0924bc1110145a5fb78ead31","7355d36f-8d96-49a1-9308-58f3b98464ae",2124,"2016-08-13T10:02:50.999068-05:00","e6f8564f-8e73-4ba3-8d5b-1d09d9aeec79_experiment.xml","27645f9a63c8734811c42c7dc076da15","d495d1a2-abb1-4c0b-8d90-44719c1b1b73",2628,"2016-09-29T17:32:22.180779-05:00","e6f8564f-8e73-4ba3-8d5b-1d09d9aeec79_run.xml","14948315ec19ff0a8fde601c87134e2a","006f639e-dd6c-420e-ac7f-050cf1fb60ce",354,"2016-09-08T11:32:03.724079-05:00","TCGA-C5-A902","2016-09-02T19:01:12.122865-05:00","female","TCGA-C5-A902_demographic",1973,"black or african american","36961d5e-acde-52e1-a714-81594ce0e169","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A902_diagnosis","not reported",12959,"alive","8070/3",NA,149,"6ff110b4-edc3-5886-8581-534892896812","c53.9",-12959,"TCGA-C5-A902_treatment","ce9bbbb6-2d6d-5cb9-8ef6-fb9d28deabd7","01","false","TCGA-C5-A902-01A",NA,"1210c62c-d95d-473d-b088-afd93cc366d5",FALSE,"72D0C467-BF42-45A3-B472-00652B7B1705","Primary Tumor",NA,1829,70,NA,1388361600,"11",30,"TCGA-C5-A902-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:32:03.724079-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"40d7b9bd-2204-4813-b06a-df10681d3158",NA,"TCGA-C5-A902-01A-01-TS1",NA,80,NA,"6055e73f-bd64-4e0f-b2db-59fd8d8d0010","RNA","TCGA-C5-A902-01A-11R","8202ac9c-bd11-49b4-a1e1-be41d3bede36",1.85,0.15,"UV Spec","R","23","TCGA-C5-A902-01A-11R-A37O-07","7a1a71ad-c117-4091-bc20-88617bcb99d9",0.15,1.15068493150685,83,26.4930256312043,177,"15fe5a4f-4f61-5bdb-81d8-7968786b932f","TCGA-C5-A902_exposure","UNCID_2553107.7a1a71ad-c117-4091-bc20-88617bcb99d9.140408_UNC11-SN627_0351_AC3KY3ACXX_1_ACAGTG.tar.gz","2014-07-30T23:51:04.000Z","2014-07-31T00:13:22.000Z","E6F8564F-8E73-4BA3-8D5B-1D09D9AEEC79","1210C62C-D95D-473D-B088-AFD93CC366D5","Unaligned reads",5860502450,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7A1A71AD-C117-4091-BC20-88617BCB99D9","University of North Carolina","564a3998e4b0298dd2c7d3b8","010A807F-9DC0-4E14-9533-DCF478F3D947","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6055E73F-BD64-4E0F-B2DB-59FD8D8D0010","2014-07-31T00:13:22.000Z","8202AC9C-BD11-49B4-A1E1-BE41D3BEDE36","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1829,"6055E73F-BD64-4E0F-B2DB-59FD8D8D0010",NA,"C5","UNCID_2414840.7a1a71ad-c117-4091-bc20-88617bcb99d9.sorted_genome_alignments.bam.bai",70,"TCGA-C5-A902-01A",NA,"ED865073-B057-42DB-9EA8-5D0B20B591E9","TCGA",2008,"TCGA-C5-A902_NTE-1",NA,"TUMOR FREE","A7501451-AF5B-4148-A984-0B3F88D2C487",35,"nationwidechildrens.org_clinical.TCGA-C5-A902.xml","Alive",NA,"TCGA-C5-A902","NOT HISPANIC OR LATINO","0B1BD269-1F6C-4B54-8BB6-88BABFDC5FCC","NO",149,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"C4B76701-9082-42BA-87D5-96455F6099C8","BLACK OR AFRICAN AMERICAN",NA,11,30,"40D7B9BD-2204-4813-B06A-DF10681D3158","9BC3F583-C7B8-4C38-8DC5-E4430642F618","UNCID_2414840.7a1a71ad-c117-4091-bc20-88617bcb99d9.sorted_genome_alignments.bam.bai","TCGA-C5-A902-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-C5-A902-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-C5-A902-D58629","TCGA-C5-A902-R58631","Internal","Primary Tumor Field","TCGA-C5-A902-F66734_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A902-F66734","TCGA-C5-A902",NA,"C5","A902","YES","C53.9","8070/3","C53.9","NO","YES",-12959,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",149,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2008,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,2,NA,21,NA,NA,"2009",8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
94560068,93670395,4476084377,"EC0154E7-7A27-4535-83AE-6B379E99A93C.bw","03804f9b-df7c-462c-8984-8eb3a5ed4999","ec0154e7-7a27-4535-83ae-6b379e99a93c","2016-08-09T14:41:08.788873-05:00","UNCID_2654367.8cdfa086-9681-4b94-98c7-855d713cd877.141010_UNC12-SN629_0394_AC5FTUACXX_6_ACTGAT.tar.gz","a0d37019-a84a-41ad-bfcc-50568c6e0926",3979292679,"Illumina HiSeq","1610de36881484020fe6fb264efe37fc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:41:03.652103-05:00","2016-05-03T12:08:10.829131-05:00","a0d37019-a84a-41ad-bfcc-50568c6e0926_analysis.xml","b45225a6873bcf363de5aca9f6bbba8f","2baa5a7c-0848-47c9-8e89-00515752c40c",2124,"2016-09-29T17:51:12.876704-05:00","a0d37019-a84a-41ad-bfcc-50568c6e0926_experiment.xml","fdb5f5d8692a575001e6ecfe36d5d316","0c6cf251-689b-4714-9b76-b916caedb74e",2628,"2016-09-29T23:40:30.279925-05:00","a0d37019-a84a-41ad-bfcc-50568c6e0926_run.xml","a277589ee535ae5837c0148110a3e760","e587b857-477b-45dc-8efd-0375c2ea612a",354,"2016-09-08T12:14:28.271755-05:00","TCGA-VS-A9V2","2016-09-02T18:54:37.207725-05:00","female","TCGA-VS-A9V2_demographic",1984,"white","a03cb2dd-1400-5517-b448-76b309ca0982","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V2_diagnosis","not reported",10637,"alive","8070/3",NA,555,"5a362adb-4fce-5a3c-934a-4cd2f24bb123","c53.9",-10637,"TCGA-VS-A9V2_treatment","780f73ae-67e5-59ca-9e1f-b814a81d55cc","01","false","TCGA-VS-A9V2-01A",NA,"80c5ed15-bee5-4d36-b8fa-06dc70ab42e9",FALSE,"0D5FE178-46D8-41A5-BA54-E9746F3D2B4C","Primary Tumor",NA,119,40,NA,1390953600,"11",30,"TCGA-VS-A9V2-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:14:28.271755-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"84bb47f0-6ecc-4c57-bbff-7a833624e45e",NA,"TCGA-VS-A9V2-01A-01-TS1",NA,100,NA,"e7da819e-8da7-4d43-a4b2-995247eae924","RNA","TCGA-VS-A9V2-01A-11R","eeedb2bd-63a9-405f-9cbc-a0899d2b22be",1.88,0.16,"UV Spec","R","23","TCGA-VS-A9V2-01A-11R-A42T-07","8cdfa086-9681-4b94-98c7-855d713cd877",0.16,NA,49,20.1347797501644,156,"dc960776-8281-5f9d-97ba-677cb22ad161","TCGA-VS-A9V2_exposure","UNCID_2654367.8cdfa086-9681-4b94-98c7-855d713cd877.141010_UNC12-SN629_0394_AC5FTUACXX_6_ACTGAT.tar.gz","2014-11-05T00:51:04.000Z","2014-11-05T01:03:29.000Z","A0D37019-A84A-41AD-BFCC-50568C6E0926","80C5ED15-BEE5-4D36-B8FA-06DC70AB42E9","Unaligned reads",3979292679,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8CDFA086-9681-4B94-98C7-855D713CD877","University of North Carolina","56607427e4b0b37b3d98e75e","03804F9B-DF7C-462C-8984-8EB3A5ED4999","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E7DA819E-8DA7-4D43-A4B2-995247EAE924","2014-11-05T01:03:29.000Z","EEEDB2BD-63A9-405F-9CBC-A0899D2B22BE","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",119,"E7DA819E-8DA7-4D43-A4B2-995247EAE924",NA,"VS","0637151f53553467d8d8d815af33a9db.bam.bai",40,"TCGA-VS-A9V2-01A",NA,NA,"TCGA",2013,"TCGA-VS-A9V2_NTE-1","Complete Remission/Response","TUMOR FREE","D6B3BD61-45C1-456E-874C-B3F60E1305A0",29,"nationwidechildrens.org_clinical.TCGA-VS-A9V2.xml","Alive",NA,"TCGA-VS-A9V2",NA,"ADF66038-E257-40F9-9A32-91F618B48CF2","NO",237,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b","8070/3","FEMALE","C53.9",420,NA,"6CCF4683-024E-4970-8E95-0F658529E1BB","WHITE",NA,11,30,"84BB47F0-6ECC-4C57-BBFF-7A833624E45E","EEEDB2BD-63A9-405F-9CBC-A0899D2B22BE","0637151f53553467d8d8d815af33a9db.bam.bai","TCGA-VS-A9V2-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-VS-A9V2-01A-01-TS1",100,NA,NA,NA,"TCGA-VS-A9V2-R64587","External","Regional site","TCGA-VS-A9V2-F70886_NTE-1","NO",555,"TUMOR FREE","Alive",NA,"TCGA-VS-A9V2-F70886","TCGA-VS-A9V2",NA,"VS","A9V2","YES","C53.9","8070/3","C53.9","NO","YES",-10637,"FEMALE","WHITE",NA,"No","No","Alive",237,NA,NA,NA,"TUMOR FREE","YES",5,9,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,29,2013,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1bN0MX",NA,NA,1,"Preoperative",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
130387170,129315426,6150676434,"78F79407-D49F-4FA2-B09F-0665C502827C.bw","03c3fe57-ae85-4e45-9657-c3182ab5e124","78f79407-d49f-4fa2-b09f-0665c502827c","2016-08-09T13:57:32.655434-05:00","UNCID_2187319.5a7840e4-48ef-4d10-8709-c963b6b4c25a.120917_UNC11-SN627_0251_AC119PACXX_5_GGCTAC.tar.gz","dd206905-b294-4b19-9691-96235502949d",5322160229,"Illumina HiSeq","e4fc2e3b3c8e34fc7f92c2614cc041a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:01:49.296520-05:00","2016-05-03T11:02:00.425419-05:00","dd206905-b294-4b19-9691-96235502949d_analysis.xml","bfd4eb674c48debaa3cbc55792c524d3","38c39558-8815-4128-9127-5e2af633b6af",2124,"2016-09-30T00:15:24.508089-05:00","dd206905-b294-4b19-9691-96235502949d_experiment.xml","6c1406cb4de940598a390b2319a3aed1","fb1fc8fe-8626-4ba3-b699-ebd489319880",2431,"2016-09-29T20:33:34.956896-05:00","dd206905-b294-4b19-9691-96235502949d_run.xml","48cb8fad55a6db6336c9cae48ccda4d4","71801361-4b25-4c04-8326-48f9c32cf092",354,"2016-09-08T11:23:35.197682-05:00","TCGA-C5-A1BL","2016-09-02T18:56:45.577157-05:00","female","TCGA-C5-A1BL_demographic",1962,"white","96b82d67-5320-5e7a-8fa2-17e5eee24dd2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BL_diagnosis","not reported",11723,"alive","8070/3",NA,5271,"4b397f7a-b947-5a5a-a4f8-661ebc197498","c53.9",-11723,"TCGA-C5-A1BL_treatment","14576170-26db-5f41-bf74-32438259c4b6","01","true","TCGA-C5-A1BL-01A",NA,"4bf03dc9-3776-43f7-b5f8-31e993f59f63",FALSE,"C3312E18-832F-4126-8E9E-F829128F7530","Primary Tumor",NA,5950,150,NA,1296172800,"11",30,"TCGA-C5-A1BL-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:23:35.197682-05:00",NA,60,NA,20,NA,"TOP",NA,10,NA,"c800c102-9c54-4715-84f0-76d2e768aead",NA,"TCGA-C5-A1BL-01A-01-TS1",NA,70,NA,"485fa04d-40e5-47d0-a5fb-b802a841561c","RNA","TCGA-C5-A1BL-01A-11R","a7b9d412-d435-4f73-b411-87c7e1fc3eee",1.83,0.16,"UV Spec","R","23","TCGA-C5-A1BL-01A-11R-A13Y-07","5a7840e4-48ef-4d10-8709-c963b6b4c25a",0.16,0.657534246575342,78,27.6360544217687,168,"ffc51674-04b8-5fc3-973b-4fef4541ba0b","TCGA-C5-A1BL_exposure","UNCID_2187319.5a7840e4-48ef-4d10-8709-c963b6b4c25a.120917_UNC11-SN627_0251_AC119PACXX_5_GGCTAC.tar.gz","2013-09-17T07:31:04.000Z","2013-09-17T07:45:01.000Z","DD206905-B294-4B19-9691-96235502949D","4BF03DC9-3776-43F7-B5F8-31E993F59F63","Unaligned reads",5322160229,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5A7840E4-48EF-4D10-8709-C963B6B4C25A","University of North Carolina","5660748ce4b0b37b3d98ece2","03C3FE57-AE85-4E45-9657-C3182AB5E124","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","485FA04D-40E5-47D0-A5FB-B802A841561C","2013-09-17T07:45:01.000Z","A7B9D412-D435-4F73-B411-87C7E1FC3EEE","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",5950,"485FA04D-40E5-47D0-A5FB-B802A841561C",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BB6DD49D-01BA-4049-828A-8CA7BE399418.txt",150,"TCGA-C5-A1BL-01A",NA,NA,"TCGA",1994,NA,NA,"TUMOR FREE","58CC3290-B576-42AB-BADE-FE213BCB14B2",32,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BB6DD49D-01BA-4049-828A-8CA7BE399418.txt","Alive",NA,"TCGA-C5-A1BL","NOT HISPANIC OR LATINO","CA8E905D-4DA3-48CC-9AA4-2F6D8B4F6506",NA,5271,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB",NA,NA,NA,"8070/3","FEMALE","C53.9",114,NA,"225EF00D-8677-491D-B1DE-F3BF21C6C291","WHITE",NA,11,30,"C800C102-9C54-4715-84F0-76D2E768AEAD","A7B9D412-D435-4F73-B411-87C7E1FC3EEE","STOPS_p_TCGA_b101_114_SNP_N_GenomeWideSNP_6_C11_771720.tangent.copynumber.data.txt","TCGA-C5-A1BL-01A-11",70,0,20,60,20,"TOP",10,20,"TCGA-C5-A1BL-01A-01-TS1",70,NA,NA,NA,"TCGA-C5-A1BL-R21294","COMBINATION","Primary Tumor Field",NA,"NO",5271,"TUMOR FREE","Alive",NA,"TCGA-C5-A1BL-F20916","TCGA-C5-A1BL",NA,"C5","A1BL","YES","C53.9","8070/3","C53.9","NO","YES",-11723,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",5271,NA,NA,NA,"TUMOR FREE","NO",24,1,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,32,1994,"Biopsy (cervical / CT-guided / Other)","YES",25,1,"G2",NA,4,1988,12,NA,NA,"1988",6,NA,NA,NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
135505590,131051760,6252530355,"03E81178-E971-4E91-8BED-D8273EA1425C.bw","05026179-b1da-411e-a286-89727b1ae380","03e81178-e971-4e91-8bed-d8273ea1425c","2016-09-29T17:37:59.023507-05:00","UNCID_2520223.9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a.140417_UNC13-SN749_0343_BC41HBACXX_3_TTAGGC.tar.gz","800185ca-e976-4d33-abdc-e2f793c8c7a2",6016022240,"Illumina HiSeq","6669e2bb8f5fb41bdf0db7806d8ea8bf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:40:50.035308-05:00","2016-05-03T11:51:27.516015-05:00","800185ca-e976-4d33-abdc-e2f793c8c7a2_analysis.xml","58cafcd637d5f8c207c33057afa386eb","2b86c2ff-11bd-438f-bfb7-3e8da9dd343f",2124,"2016-08-30T02:17:16.707207-05:00","800185ca-e976-4d33-abdc-e2f793c8c7a2_experiment.xml","2417045eb3f9c036bf253894136715ff","e4dfc36b-12b9-4a88-ac7a-c45a56033130",2628,"2016-09-29T20:34:52.824181-05:00","800185ca-e976-4d33-abdc-e2f793c8c7a2_run.xml","b656017a3bad4234f8930dd0397d3158","7249e1b2-4193-47c3-b86e-1a5bd4eae50e",354,"2016-09-08T13:13:49.227383-05:00","TCGA-VS-A8EH","2016-09-02T19:01:05.246078-05:00","female","TCGA-VS-A8EH_demographic",1956,"not reported","16866248-c027-5708-b40b-09b0f00d0212","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EH_diagnosis","not reported",20728,"alive","8070/3",NA,986,"67a93274-f534-538d-8d19-9f4bef947b64","c53.9",-20728,"TCGA-VS-A8EH_treatment","5db7cf21-eaa5-536b-b890-7798e801fa9b","01","false","TCGA-VS-A8EH-01A",NA,"cc7d1f35-2c07-42dc-b2b0-98d404dfaba8",FALSE,"0CC29204-715D-465B-8F93-7DE27B85FD5F","Primary Tumor",NA,507,80,NA,1384819200,"11",30,"TCGA-VS-A8EH-01A-11",85,NA,0,NA,0,NA,15,NA,"2016-09-08T13:13:49.227383-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"0af8f3f0-0df4-4bdc-8294-fb56fa233c34",NA,"TCGA-VS-A8EH-01A-01-TS1",NA,85,NA,"04565d45-d0e6-4778-81db-6ee7a4061c66","RNA","TCGA-VS-A8EH-01A-11R","e6665c27-a692-4c16-b382-5d802d204808",1.9,0.17,"UV Spec","R","23","TCGA-VS-A8EH-01A-11R-A36F-07","9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a",0.17,0.164383561643836,44,17.8506227433162,157,"2ec73f82-facb-5e86-b1b9-02e9d326dd05","TCGA-VS-A8EH_exposure","UNCID_2520223.9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a.140417_UNC13-SN749_0343_BC41HBACXX_3_TTAGGC.tar.gz","2014-07-10T01:07:05.000Z","2014-07-10T01:33:18.000Z","800185CA-E976-4D33-ABDC-E2F793C8C7A2","CC7D1F35-2C07-42DC-B2B0-98D404DFABA8","Unaligned reads",6016022240,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9B04A1E0-7CCD-4695-AC3F-DF8B3B320F5A","University of North Carolina","5660750ae4b018727fe9fabd","05026179-B1DA-411E-A286-89727B1AE380","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","04565D45-D0E6-4778-81DB-6EE7A4061C66","2014-07-10T01:33:18.000Z","E6665C27-A692-4C16-B382-5D802D204808","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",507,"04565D45-D0E6-4778-81DB-6EE7A4061C66",NA,"VS","UNCID_2520223.9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a.140417_UNC13-SN749_0343_BC41HBACXX_3_TTAGGC.tar.gz",80,"TCGA-VS-A8EH-01A",NA,"6AA03F28-F6A9-444D-86FF-1E86AA069F1A","TCGA",2012,"TCGA-VS-A8EH_NTE-1","Complete Remission/Response","TUMOR FREE","CC7D1F35-2C07-42DC-B2B0-98D404DFABA8",56,"nationwidechildrens.org_clinical.TCGA-VS-A8EH.xml","Alive",NA,"TCGA-VS-A8EH",NA,"AA6EFE09-6544-4806-87D5-23DC2F0563F5","NO",615,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",373,NA,"D467909F-CCFB-4181-A323-FB1240171606",NA,NA,11,30,"0AF8F3F0-0DF4-4BDC-8294-FB56FA233C34","E6665C27-A692-4C16-B382-5D802D204808","UNCID_2520223.9b04a1e0-7ccd-4695-ac3f-df8b3b320f5a.140417_UNC13-SN749_0343_BC41HBACXX_3_TTAGGC.tar.gz","TCGA-VS-A8EH-01A-11",85,0,0,5,15,"TOP",0,0,"TCGA-VS-A8EH-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-VS-A8EH-D62772","TCGA-VS-A8EH-R61981","Internal","Primary Tumor Field","TCGA-VS-A8EH-F70875_NTE-1","NO",986,"TUMOR FREE","Alive",NA,"TCGA-VS-A8EH-F70875","TCGA-VS-A8EH",NA,"VS","A8EH","YES","C53.9","8070/3","C53.9","NO","YES",-20728,"FEMALE",NA,NA,"No","No","Alive",615,NA,NA,NA,"TUMOR FREE","YES",22,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,56,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,3,NA,"Complete Remission/Response","2009",16,NA,"T3bNXM0",NA,NA,2,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
150947066,140033211,6665958596,"62FCAEFF-16D8-4019-84B6-18EC3A88BC32.bw","0809ba8b-4ab6-4f43-934c-c1ccbc014a7e","62fcaeff-16d8-4019-84b6-18ec3a88bc32","2016-08-31T10:39:18.443231-05:00","UNCID_2186967.1e176d9d-dba9-4d41-946e-05b7f35eba64.121002_UNC11-SN627_0254_AC0WP5ACXX_3_GTCCGC.tar.gz","29507bea-bf84-4b4e-902b-e7e42d70ca31",6500212897,"Illumina HiSeq","cb6b6b10dc52905b1e80f69cb791d970","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:18:34.358691-05:00","2016-05-03T11:01:14.476120-05:00","29507bea-bf84-4b4e-902b-e7e42d70ca31_analysis.xml","a5d161815f5fc59412c8a2b660d7e8e0","1d827619-0bd2-401d-96f2-81971a0c5461",2124,"2016-10-07T15:49:00.787146-05:00","29507bea-bf84-4b4e-902b-e7e42d70ca31_experiment.xml","ac71e7762f98a29f79989a285c043c23","1a59f9cc-8c0d-4062-ac89-5604fdee262f",2431,"2016-09-29T21:52:08.280623-05:00","29507bea-bf84-4b4e-902b-e7e42d70ca31_run.xml","8e080800b47bf58fcf2e58c322767c0f","a26cf949-0dd2-47bd-9c9d-2a39116b1ca4",354,"2016-09-08T11:46:33.415726-05:00","TCGA-EK-A2PK","2016-09-02T18:58:17.651725-05:00","female","TCGA-EK-A2PK_demographic",1963,"white","f7618533-cee2-549e-85ad-3fbec96b0bc6","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2PK_diagnosis","not reported",15939,"alive","8072/3",NA,12,"0652422a-31c1-5594-96ba-07ac17e230db","c53.9",-15939,"TCGA-EK-A2PK_treatment","b859c43c-d3b0-5cfe-8e38-e59bc6b1688f","01","false","TCGA-EK-A2PK-01A",NA,"5f613800-55df-497f-a544-5b12cb9446ce",FALSE,"F447FFBB-73CD-404F-A078-A894079F30C2","Primary Tumor",NA,2043,110,NA,1314144000,"11",30,"TCGA-EK-A2PK-01A-11",90,NA,0,NA,0,NA,6,NA,"2016-09-08T11:46:33.415726-05:00",NA,4,NA,0,NA,"TOP",NA,1,NA,"ca1c2135-1c36-4a95-83b7-686649ed3512",NA,"TCGA-EK-A2PK-01A-01-TS1",NA,93,NA,"c519ac88-b5d6-468d-8914-4745902a50f8","RNA","TCGA-EK-A2PK-01A-11R","60490163-3e2f-44fb-b0ad-bf4e441304d6",1.81,0.18,"UV Spec","R","23","TCGA-EK-A2PK-01A-11R-A18M-07","1e176d9d-dba9-4d41-946e-05b7f35eba64",0.18,NA,94,33.7050449998207,167,"b0ec3431-d31c-5175-b6a1-cff10b97798a","TCGA-EK-A2PK_exposure","UNCID_2186967.1e176d9d-dba9-4d41-946e-05b7f35eba64.121002_UNC11-SN627_0254_AC0WP5ACXX_3_GTCCGC.tar.gz","2013-09-16T07:26:05.000Z","2013-09-16T20:18:02.000Z","29507BEA-BF84-4B4E-902B-E7E42D70CA31","5F613800-55DF-497F-A544-5B12CB9446CE","Unaligned reads",6500212897,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1E176D9D-DBA9-4D41-946E-05B7F35EBA64","University of North Carolina","564a3f68e4b0ef12181bb878","0809BA8B-4AB6-4F43-934C-C1CCBC014A7E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C519AC88-B5D6-468D-8914-4745902A50F8","2013-09-16T20:18:02.000Z","60490163-3E2F-44FB-B0AD-BF4E441304D6","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2043,"C519AC88-B5D6-468D-8914-4745902A50F8",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.580103D7-9873-4F83-857F-4D46A9DD24A2.txt",110,"TCGA-EK-A2PK-01A",NA,NA,"TCGA",2006,NA,NA,NA,"8AC65E67-E498-4771-B362-A76C57BB5895",43,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.580103D7-9873-4F83-857F-4D46A9DD24A2.txt","Alive",NA,"TCGA-EK-A2PK","NOT HISPANIC OR LATINO","C9644300-5774-4259-ACD7-7D1559F58796",NA,0,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,NA,"8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"CA1C2135-1C36-4A95-83B7-686649ED3512","70B5259D-1DE5-47F5-B2B3-41321305C842","TCGA-EK-A2PK-01A-11R-A18L-13_mirna.bam.bai","TCGA-EK-A2PK-01A-11",90,0,0,4,6,"TOP",1,0,"TCGA-EK-A2PK-01A-01-TS1",93,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2PK-F58250_NTE-1",NA,12,NA,"Alive",NA,"TCGA-EK-A2PK-F58250","TCGA-EK-A2PK",NA,"EK","A2PK","YES","C53.9","8072/3","C53.9","NO","YES",-15939,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,"TUMOR FREE","NO",8,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2006,"Other method, specify:","YES",35,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,1,"Preoperative",NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
160128448,157023240,7495007780,"722C1284-5983-4CC1-B19C-214C2DE6F8A6.bw","085df27c-9bc2-425a-9a49-547d692ea028","722c1284-5983-4cc1-b19c-214c2de6f8a6","2016-08-09T13:13:50.299059-05:00","UNCID_2186805.f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa.121009_UNC16-SN851_0187_AD15RRACXX_7_AGTTCC.tar.gz","b97d823c-1c07-45ac-9555-0cd415bb17fe",7057717823,"Illumina HiSeq","a040e884ebe3dfdb0b299481ea809c2c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:04:51.307371-05:00","2016-05-03T11:01:14.469334-05:00","b97d823c-1c07-45ac-9555-0cd415bb17fe_analysis.xml","56bb035c86fba03304fd1c38a7f18d07","3abd654a-e2f7-4010-9691-311d08cc07ad",2124,"2016-09-30T00:05:49.181576-05:00","b97d823c-1c07-45ac-9555-0cd415bb17fe_experiment.xml","08c924d2f9ef354f7643e97eea629173","f51d7fbb-3283-4338-9467-d751758bbcad",2431,"2016-09-29T19:21:15.583928-05:00","b97d823c-1c07-45ac-9555-0cd415bb17fe_run.xml","e28cdea876a59343de056103d184abf2","4516ee31-0435-4c47-867a-23a1569d6f67",354,"2016-09-08T11:31:13.587738-05:00","TCGA-C5-A3HF","2016-09-02T18:58:41.061496-05:00","female","TCGA-C5-A3HF_demographic",1972,"white","5de43394-6b20-5df3-a006-2bd0c3113169","not hispanic or latino",1997,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A3HF_diagnosis","not reported",9115,"dead","8482/3",543,NA,"5555b3bb-e286-5f2c-bac6-e687e432f9e3","c53.9",-9115,"TCGA-C5-A3HF_treatment","51052346-47af-579b-968f-2b017e8798c7","01","true","TCGA-C5-A3HF-01A",NA,"79c43439-bc01-4033-85fa-3191a79277c6",FALSE,"BDC1F089-937D-4812-9EF6-259A00FEAB80","Primary Tumor",NA,5464,110,NA,1323907200,"11",30,"TCGA-C5-A3HF-01A-11",65,NA,2,NA,15,NA,0,NA,"2016-09-08T11:31:13.587738-05:00",NA,15,NA,0,NA,"TOP",NA,5,NA,"f8fd7a86-1359-40a5-b35f-7708c20eb2a7",NA,"TCGA-C5-A3HF-01A-01-TSA",NA,80,NA,"7bef2bb4-a751-4d1d-82a7-0ab99f3583da","RNA","TCGA-C5-A3HF-01A-11R","10e08967-0230-46f4-a21f-34491a0d65a1",1.76,0.17,"UV Spec","R","23","TCGA-C5-A3HF-01A-11R-A213-07","f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa",0.17,0.493150684931507,NA,NA,NA,"8415dc0f-589e-5371-b466-8e506a07b671","TCGA-C5-A3HF_exposure","UNCID_2186805.f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa.121009_UNC16-SN851_0187_AD15RRACXX_7_AGTTCC.tar.gz","2013-09-16T15:16:05.000Z","2013-09-16T15:48:01.000Z","B97D823C-1C07-45AC-9555-0CD415BB17FE","79C43439-BC01-4033-85FA-3191A79277C6","Unaligned reads",7057717823,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F426F6C4-BB1F-4CE4-A770-7B5FCC4408FA","University of North Carolina","564a3adee4b093830b691869","085DF27C-9BC2-425A-9A49-547D692EA028","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7BEF2BB4-A751-4D1D-82A7-0AB99F3583DA","2013-09-16T15:48:01.000Z","10E08967-0230-46F4-A21F-34491A0D65A1","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",5464,"7BEF2BB4-A751-4D1D-82A7-0AB99F3583DA",NA,"C5","nationwidechildrens.org_biospecimen.TCGA-C5-A3HF.xml",110,"TCGA-C5-A3HF-01A",NA,NA,"TCGA",1996,NA,NA,"WITH TUMOR","8EF5E6DB-2FBD-4D96-846E-7708C085E72C",24,"1dab620ce7fd12477460b29c94ac03fd.bam","Dead",543,"TCGA-C5-A3HF","NOT HISPANIC OR LATINO","10EA26AD-B1EF-4B7A-8EDE-CA543994E994",NA,NA,"No","Cervix","C53.9",NA,"Mucinous Adenocarcinoma of Endocervical Type",NA,NA,"Stage IB2",NA,NA,NA,"8482/3","FEMALE","C53.9",200,NA,"F2985061-C716-475E-A0F3-929708760102","WHITE",NA,11,30,"F8FD7A86-1359-40A5-B35F-7708C20EB2A7","307FE9F9-6382-40C4-B25B-7B0327119065","UNCID_1662828.f426f6c4-bb1f-4ce4-a770-7b5fcc4408fa.sorted_genome_alignments.bam.bai","TCGA-C5-A3HF-01A-11",65,15,2,15,0,"TOP",5,0,"TCGA-C5-A3HF-01A-01-TSA",80,NA,NA,NA,"TCGA-C5-A3HF-R30757","COMBINATION","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",543,"TCGA-C5-A3HF-F30756","TCGA-C5-A3HF",NA,"C5","A3HF","YES","C53.9","8482/3","C53.9","NO","YES",-9115,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,543,NA,NA,"WITH TUMOR","NO",16,4,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,24,1996,"Biopsy (cervical / CT-guided / Other)","YES",32,11,"G2",NA,2,NA,9,NA,NA,"1995",8,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
149671542,147661437,7051032357,"54E42A64-B350-4A94-8FED-C9BC1872660E.bw","085fb6d8-6265-484e-9307-8292386714b7","54e42a64-b350-4a94-8fed-c9bc1872660e","2016-08-09T13:56:19.406980-05:00","UNCID_2186964.44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476.121002_UNC11-SN627_0254_AC0WP5ACXX_6_ACTGAT.tar.gz","bfec0cdc-428b-4f32-b178-da19160038fc",6245698718,"Illumina HiSeq","b324b94b85b57a64275e657cdab92e8c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:11:47.444776-05:00","2016-05-03T11:01:14.476120-05:00","bfec0cdc-428b-4f32-b178-da19160038fc_analysis.xml","6df9c0e6ffc80906a68bb34a0ec9ff2b","1960cf1d-45fb-4095-8570-fda79674d1e0",2124,"2016-08-13T04:50:14.378462-05:00","bfec0cdc-428b-4f32-b178-da19160038fc_experiment.xml","eb49dc3fc80d1786ca61d219cddd0cbc","bc4a32d5-05cd-427c-b05e-951ef2847f4f",2431,"2016-09-29T17:32:36.949593-05:00","bfec0cdc-428b-4f32-b178-da19160038fc_run.xml","cd0fd9871eea7b7d5c1ad412edd3e993","009522f3-36c2-4942-93ff-13a841b6572e",354,"2016-09-08T12:07:05.805808-05:00","TCGA-EK-A2PM","2016-09-02T18:58:23.459997-05:00","female","TCGA-EK-A2PM_demographic",1927,"white","0bc4d5aa-95da-5213-9a6a-a9416aab0752","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2PM_diagnosis","not reported",29747,"alive","8071/3",NA,18,"eccad583-6ae1-53db-923f-c7ce5527bfca","c53.9",-29747,"TCGA-EK-A2PM_treatment","cf9d6827-cdf1-569e-85c4-f313106e7c02","01","false","TCGA-EK-A2PM-01A",NA,"2e7f29fb-97de-4ee0-bca7-6a51c4c3e5cf",FALSE,"B1AB121F-E75E-4AE1-9C9A-16076A3B7879","Primary Tumor",NA,1199,100,NA,1314144000,"11",30,"TCGA-EK-A2PM-01A-11",96,NA,0,NA,0,NA,5,NA,"2016-09-08T12:07:05.805808-05:00",NA,1,NA,0,NA,"TOP",NA,15,NA,"f38f22d1-cddb-4bfe-8bb6-2b8654ebf21a",NA,"TCGA-EK-A2PM-01A-01-TS1",NA,80,NA,"27c5d8d1-b991-4b21-a2fc-d9fba47e559b","RNA","TCGA-EK-A2PM-01A-11R","6c8c5c36-42a4-4bef-875c-cba4d2d38c26",1.86,0.17,"UV Spec","R","23","TCGA-EK-A2PM-01A-11R-A18M-07","44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476",0.17,NA,51,20.6904945433892,157,"a6ee64ad-3442-5640-87cc-94ef6c555488","TCGA-EK-A2PM_exposure","UNCID_2186964.44a2f3dd-bf3d-4b8f-9b34-d1eb228e5476.121002_UNC11-SN627_0254_AC0WP5ACXX_6_ACTGAT.tar.gz","2013-09-16T07:16:03.000Z","2013-09-16T20:07:02.000Z","BFEC0CDC-428B-4F32-B178-DA19160038FC","2E7F29FB-97DE-4EE0-BCA7-6A51C4C3E5CF","Unaligned reads",6245698718,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","44A2F3DD-BF3D-4B8F-9B34-D1EB228E5476","University of North Carolina","566073ebe4b0b37b3d98e3fa","085FB6D8-6265-484E-9307-8292386714B7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","27C5D8D1-B991-4B21-A2FC-D9FBA47E559B","2013-09-16T20:07:02.000Z","6C8C5C36-42A4-4BEF-875C-CBA4D2D38C26","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1199,"27C5D8D1-B991-4B21-A2FC-D9FBA47E559B",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.62C8376A-9A66-4499-A4E3-E7C0102B5EB4.txt",100,"TCGA-EK-A2PM-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","B62127DC-8526-4099-AFC3-BE2E295C7DEE",81,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.62C8376A-9A66-4499-A4E3-E7C0102B5EB4.txt","Alive",NA,"TCGA-EK-A2PM",NA,"51ECDB55-6CE0-4614-8E9B-0593B8E7DAFE",NA,0,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIB",NA,NA,NA,"8071/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"F38F22D1-CDDB-4BFE-8BB6-2B8654EBF21A","6C8C5C36-42A4-4BEF-875C-CBA4D2D38C26","TCGA-EK-A2PM-01A-11R-A18L-13_mirna.bam","TCGA-EK-A2PM-01A-11",96,0,0,1,5,"TOP",15,0,"TCGA-EK-A2PM-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2PM-F58253_NTE-1",NA,18,NA,"Alive",NA,"TCGA-EK-A2PM-F58253","TCGA-EK-A2PM",NA,"EK","A2PM","YES","C53.9","8071/3","C53.9","NO","YES",-29747,"FEMALE","WHITE",NA,"No","No","Alive",0,NA,NA,NA,"WITH TUMOR","NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,81,2008,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",13,NA,NA,NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
123941646,121301665,5789613598,"53062969-D209-490B-9C9B-5D297625E2AE.bw","08a52bcf-d2e9-497b-938a-4660c332e914","53062969-d209-490b-9c9b-5d297625e2ae","2016-08-05T02:56:19.849526-05:00","UNCID_2187249.a1ff456d-7a22-4200-a429-c2a41e5c3e04.120921_UNC16-SN851_0181_AD14JFACXX_7_GGCTAC.tar.gz","f59d22cf-1670-4207-8454-6e74bdec2083",5192955216,"Illumina HiSeq","2327cc2f02812ed475f9608fc22d01e6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:00:40.813880-05:00","2016-05-03T11:02:00.403413-05:00","f59d22cf-1670-4207-8454-6e74bdec2083_analysis.xml","9892fbc30d49f73dc7afd9db811c715a","1266fea9-dcd5-4c07-88cd-c4ad3f580d78",2124,"2016-09-29T18:46:16.892715-05:00","f59d22cf-1670-4207-8454-6e74bdec2083_experiment.xml","90e7c59e781ae37d16fb7bf3101c4d76","2f03bebd-879c-4734-9618-f79333acde4b",2431,"2016-09-29T22:36:47.250225-05:00","f59d22cf-1670-4207-8454-6e74bdec2083_run.xml","a74c1e0a5db55bc897c9536e81335fb3","bdec618f-3978-4080-a821-15ad327776f4",354,"2016-09-08T11:55:31.168390-05:00","TCGA-C5-A1MP","2016-09-02T18:57:21.665111-05:00","female","TCGA-C5-A1MP_demographic",1975,"black or african american","ce2165d5-7e2c-5ddd-bf11-eb6e9419161c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MP_diagnosis","not reported",12692,"alive","8070/3",NA,109,"6297d9a4-843e-5a28-afaf-f731bd2b5974","c53.9",-12692,"TCGA-C5-A1MP_treatment","ecb73f9f-9491-5852-a15c-af05f2fa4bb2","01","true","TCGA-C5-A1MP-01A",NA,"73ff6bac-f086-4cf5-a5cb-c3b4a8d28e55",FALSE,"AA5A1858-A926-4CCE-BC1C-1F1E964EAA96","Primary Tumor",NA,747,100,NA,1301356800,"11",30,"TCGA-C5-A1MP-01A-11",85,NA,20,NA,0,NA,15,NA,"2016-09-08T11:55:31.168390-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"05ee4790-0ce6-4d8f-be68-c81249e80204",NA,"TCGA-C5-A1MP-01A-01-TSA",NA,85,NA,"398a0c24-5bbf-4a45-9e9c-5cbe75457f30","RNA","TCGA-C5-A1MP-01A-11R","b3d59841-4198-444d-88bf-20bc7c230895",1.8,0.16,"UV Spec","R","23","TCGA-C5-A1MP-01A-11R-A14Y-07","a1ff456d-7a22-4200-a429-c2a41e5c3e04",0.16,NA,NA,NA,NA,"d884f27b-e6d6-5ab5-a964-2d9a37cfdded","TCGA-C5-A1MP_exposure","UNCID_2187249.a1ff456d-7a22-4200-a429-c2a41e5c3e04.120921_UNC16-SN851_0181_AD14JFACXX_7_GGCTAC.tar.gz","2013-09-17T04:56:05.000Z","2013-09-17T05:10:02.000Z","F59D22CF-1670-4207-8454-6E74BDEC2083","73FF6BAC-F086-4CF5-A5CB-C3B4A8D28E55","Unaligned reads",5192955216,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A1FF456D-7A22-4200-A429-C2A41E5C3E04","University of North Carolina","564a4043e4b0298dd2c9f780","08A52BCF-D2E9-497B-938A-4660C332E914","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","398A0C24-5BBF-4A45-9E9C-5CBE75457F30","2013-09-17T05:10:02.000Z","B3D59841-4198-444D-88BF-20BC7C230895","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",747,"398A0C24-5BBF-4A45-9E9C-5CBE75457F30",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.42E384BE-242F-4BBB-87B1-FAF9D49D8C3D.txt",100,"TCGA-C5-A1MP-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","73FF6BAC-F086-4CF5-A5CB-C3B4A8D28E55",34,"nationwidechildrens.org_clinical.TCGA-C5-A1MP.xml","Alive",NA,"TCGA-C5-A1MP","NOT HISPANIC OR LATINO","79CD330E-9771-4D9D-AC39-4DAD789CC2D7",NA,109,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",127,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"05EE4790-0CE6-4D8F-BE68-C81249E80204","DCD506D0-9A97-42D2-A441-8E5A77B856A3","TCGA-C5-A1MP-01A-11R-A14X-13_mirna.bam","TCGA-C5-A1MP-01A-11",85,0,20,40,15,"TOP",0,20,"TCGA-C5-A1MP-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-C5-A1MP-F57086_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A1MP-F57086","TCGA-C5-A1MP",NA,"C5","A1MP","YES","C53.9","8070/3","C53.9","NO","YES",-12692,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",109,NA,NA,NA,"TUMOR FREE","NO",21,10,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,34,2009,"Biopsy (cervical / CT-guided / Other)","YES",54,6,"G3",NA,1,NA,NA,NA,NA,"1995",8,NA,"T1b2N1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
169261628,167239839,7983143665,"B710293C-41D3-4A2E-8104-5402F91DD859.bw","09329a53-d58d-4480-95d8-32043e40de6e","b710293c-41d3-4a2e-8104-5402f91dd859","2016-08-09T13:14:14.748245-05:00","UNCID_2186798.3337929b-5381-41ae-88f2-b6dbeb17f088.121009_UNC16-SN851_0187_AD15RRACXX_8_ATCACG.tar.gz","dee5260c-3de9-4a92-9a7c-d13da6dc688e",7494869904,"Illumina HiSeq","6e0d1846e7eeb79a2f6c2af5a9ddafaf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:03:09.973120-05:00","2016-05-03T11:01:14.469334-05:00","dee5260c-3de9-4a92-9a7c-d13da6dc688e_analysis.xml","bbc55f17a0c193ed62a80919248403a1","13fba5e9-ddcf-4ab4-9895-083947cf61ed",2124,"2016-08-27T19:40:32.811380-05:00","dee5260c-3de9-4a92-9a7c-d13da6dc688e_experiment.xml","d3fec576a2fc5a8f201cb09497489995","b07b2901-1108-4231-9b8b-17d12eb9ab59",2431,"2016-09-29T19:40:03.234412-05:00","dee5260c-3de9-4a92-9a7c-d13da6dc688e_run.xml","1d06668223503d9e5402658db4f41d80","50bdad24-d07d-476a-a5c0-bd770f25693c",354,"2016-09-08T12:34:16.253471-05:00","TCGA-C5-A3HL","2016-09-02T18:58:41.877974-05:00","female","TCGA-C5-A3HL_demographic",1931,"white","b350ccb9-8c21-5711-a089-185231120096","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A3HL_diagnosis","not reported",27963,"alive","8071/3",NA,621,"56da3e8e-32ec-5463-9a81-fa49476ae77c","c53.9",-27963,"TCGA-C5-A3HL_treatment","0425c5f9-6ee5-584e-9b3a-e3ef68d2ffa2","01","true","TCGA-C5-A3HL-01A",NA,"2a3cc87b-b120-49ec-93e6-8bddbae5c97c",FALSE,"0A258AD5-AE6C-4866-AE39-78C29DB89CAF","Primary Tumor",NA,1519,160,NA,1323734400,"11",30,"TCGA-C5-A3HL-01A-11",75,NA,0,NA,0,NA,15,NA,"2016-09-08T12:34:16.253471-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"04fc55f1-a576-49f3-ab45-5c760f56b38e",NA,"TCGA-C5-A3HL-01A-01-TS1",NA,85,NA,"e2944dde-beb6-4a11-bd0b-406b8d70adf2","RNA","TCGA-C5-A3HL-01A-11R","6ab70d7d-929d-4224-8b30-87d7504f4fa8",1.8,0.17,"UV Spec","R","23","TCGA-C5-A3HL-01A-11R-A213-07","3337929b-5381-41ae-88f2-b6dbeb17f088",0.17,NA,NA,NA,NA,"f142d75a-ec6f-5026-ab0b-e834d339b5e1","TCGA-C5-A3HL_exposure","UNCID_2186798.3337929b-5381-41ae-88f2-b6dbeb17f088.121009_UNC16-SN851_0187_AD15RRACXX_8_ATCACG.tar.gz","2013-09-16T15:46:05.000Z","2013-09-16T16:31:02.000Z","DEE5260C-3DE9-4A92-9A7C-D13DA6DC688E","2A3CC87B-B120-49EC-93E6-8BDDBAE5C97C","Unaligned reads",7494869904,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3337929B-5381-41AE-88F2-B6DBEB17F088","University of North Carolina","5660746fe4b0b37b3d98eb40","09329A53-D58D-4480-95D8-32043E40DE6E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E2944DDE-BEB6-4A11-BD0B-406B8D70ADF2","2013-09-16T16:31:02.000Z","6AB70D7D-929D-4224-8B30-87D7504F4FA8","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1519,"E2944DDE-BEB6-4A11-BD0B-406B8D70ADF2",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.7DA4AAC5-2CE9-49F6-A3AA-DBD843C5CF20.txt",160,"TCGA-C5-A3HL-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","794BB890-8431-4860-A6D9-B310918E0B1D",76,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.7DA4AAC5-2CE9-49F6-A3AA-DBD843C5CF20.txt","Alive",NA,"TCGA-C5-A3HL","NOT HISPANIC OR LATINO","A672B669-F75D-4D53-B1A8-3B30C6F47608",NA,621,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8071/3","FEMALE","C53.9",200,NA,"F244E340-522A-4933-8D92-0677BBEF4E37","WHITE",NA,11,30,"04FC55F1-A576-49F3-AB45-5C760F56B38E","85BF2FFB-7617-43B8-B7AE-1C5FF35774A6","UNCID_1662513.3337929b-5381-41ae-88f2-b6dbeb17f088.sorted_genome_alignments.bam","TCGA-C5-A3HL-01A-11",75,0,0,0,15,"TOP",0,0,"TCGA-C5-A3HL-01A-01-TS1",85,NA,NA,NA,"TCGA-C5-A3HL-R30842","EXTERNAL BEAM","Primary Tumor Field","TCGA-C5-A3HL-F47688_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A3HL-F47688","TCGA-C5-A3HL",NA,"C5","A3HL","YES","C53.9","8071/3","C53.9","NO","YES",-27963,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",621,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,76,2007,"Biopsy (cervical / CT-guided / Other)","YES",21,0,"G2",NA,1,NA,NA,NA,NA,"1995",8,NA,"T1b2N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
84952644,83910681,4008086243,"73CB1D05-7AE4-457D-B4EF-25AC5C1F2132.bw","0acd1e47-1099-469b-a6d4-e00db47f57a9","73cb1d05-7ae4-457d-b4ef-25ac5c1f2132","2016-08-05T07:36:33.354724-05:00","UNCID_2654375.48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834.141010_UNC12-SN629_0395_BC5FVEACXX_3_CTTGTA.tar.gz","92ef07d6-60af-42c7-8f73-9cffa6c5f4d9",3265343923,"Illumina HiSeq","e962f39cb3c41417e67725b4ccccf413","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:07:16.400833-05:00","2016-05-03T12:08:10.830175-05:00","92ef07d6-60af-42c7-8f73-9cffa6c5f4d9_analysis.xml","00429c075e8f3a7436a1813b3c19c4e6","f6054c49-cff6-4731-8031-23daeb0c3d86",2124,"2016-09-29T22:53:50.021536-05:00","92ef07d6-60af-42c7-8f73-9cffa6c5f4d9_experiment.xml","9119484b113b8ed1b7ee6f0259141403","c89971b4-7be5-4486-8fa3-f78a891be98d",2628,"2016-09-29T18:48:28.539425-05:00","92ef07d6-60af-42c7-8f73-9cffa6c5f4d9_run.xml","6f1573ae87907445946544b767b108c5","3066acd2-ccd1-4f4f-a049-d56581e81c54",354,"2016-09-08T10:31:41.424803-05:00","TCGA-ZJ-AAXF","2016-09-02T18:54:44.389527-05:00","female","TCGA-ZJ-AAXF_demographic",1948,"not reported","3223f628-c693-57a8-82e7-0b94b051a096","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXF_diagnosis","not reported",22709,"alive","8071/3",NA,0,"4197ccb2-d5a5-5f45-a84d-76b3166aa195","c53.9",-22709,"TCGA-ZJ-AAXF_treatment","dbd81487-3f21-5b2a-b438-820036fb815c","01","true","TCGA-ZJ-AAXF-01A",NA,"40ce7fb9-623d-4972-9031-e5e777e6f7d8",FALSE,"DB279590-B849-44D4-B781-BA72CE72C427","Primary Tumor",NA,1264,270,NA,1396569600,"31",30,"TCGA-ZJ-AAXF-01A-31",80,NA,20,NA,0,NA,15,NA,"2016-09-08T10:31:41.424803-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"fc540020-dee4-49ae-ba83-c070e7498a17",NA,"TCGA-ZJ-AAXF-01A-03-TSC",NA,80,NA,"76012afe-10b4-4e0d-9d89-22419f47dc01","RNA","TCGA-ZJ-AAXF-01A-31R","3052676f-ab4a-41ce-8853-27eddb8499e6",1.83,0.15,"UV Spec","R","23","TCGA-ZJ-AAXF-01A-31R-A42T-07","48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834",0.15,NA,NA,NA,NA,"5f7cdb2e-c2ef-508f-991f-524dda5aab74","TCGA-ZJ-AAXF_exposure","UNCID_2654375.48e0ecf3-3c7a-4d6a-b77c-51f3c65e4834.141010_UNC12-SN629_0395_BC5FVEACXX_3_CTTGTA.tar.gz","2014-11-05T04:27:04.000Z","2014-11-05T04:39:32.000Z","92EF07D6-60AF-42C7-8F73-9CFFA6C5F4D9","40CE7FB9-623D-4972-9031-E5E777E6F7D8","Unaligned reads",3265343923,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","48E0ECF3-3C7A-4D6A-B77C-51F3C65E4834","University of North Carolina","564a3d4ae4b08c5d86921d1b","0ACD1E47-1099-469B-A6D4-E00DB47F57A9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","76012AFE-10B4-4E0D-9D89-22419F47DC01","2014-11-05T04:39:32.000Z","3052676F-AB4A-41CE-8853-27EDDB8499E6","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1264,"76012AFE-10B4-4E0D-9D89-22419F47DC01",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.AFA27E8B-A438-4D1A-9344-6E760E7A890F.txt",270,"TCGA-ZJ-AAXF-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXF_NTE-1",NA,NA,"CC50CF9F-0C1B-437E-9931-B4C3F8309E12",62,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXF.xml","Alive",NA,"TCGA-ZJ-AAXF",NA,NA,NA,0,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8071/3","FEMALE","C53.9",420,NA,NA,NA,NA,31,30,"FC540020-DEE4-49AE-BA83-C070E7498A17","B8E02471-ED98-4AE8-AD73-FF1D8CA6C931","TCGA-ZJ-AAXF-01A-31R-A42V-13_mirna.bam.bai","TCGA-ZJ-AAXF-01A-31",80,0,20,40,15,"TOP",5,20,"TCGA-ZJ-AAXF-01A-03-TSC",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXF",NA,"ZJ","AAXF","YES","C53.9","8071/3","C53.9","NO","YES",-22709,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",28,1,2015,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,62,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"2009",13,NA,"T2bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
135818436,133537901,6372323709,"B055A70B-3003-47CB-BDAA-6378C000BF24.bw","0bd52d75-5113-4ef1-bc75-509f59eaef2b","b055a70b-3003-47cb-bdaa-6378c000bf24","2016-08-09T14:01:35.832116-05:00","UNCID_2169003.40eb69ac-5c96-42c7-adfc-877580c58cc5.130611_UNC15-SN850_0312_BC265JACXX_1_AGTCAA.tar.gz","3de85a5a-a3ec-4070-af79-4ab5700f6657",6034243102,"Illumina HiSeq","6847f84b1338d60f69dd36a01294d3d0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:18:56.011155-05:00","2016-05-03T11:06:28.634130-05:00","3de85a5a-a3ec-4070-af79-4ab5700f6657_analysis.xml","f8324189f5b705f134495efa4d1ce90a","8de8ad31-5d4e-4a2f-94af-008118bf0143",2123,"2016-09-29T20:06:15.999912-05:00","3de85a5a-a3ec-4070-af79-4ab5700f6657_experiment.xml","2ddb1df3454542376b484bdb1487ba1f","60e82142-04ef-4e18-a929-234f96d29245",2431,"2016-09-29T20:05:59.891917-05:00","3de85a5a-a3ec-4070-af79-4ab5700f6657_run.xml","5263caf7a721dd2d03e4944efa69dc0a","60c024a5-c1dc-477a-b386-9b3f54159030",354,"2016-09-08T11:31:48.666403-05:00","TCGA-JW-A5VG","2016-09-02T19:00:01.018059-05:00","female","TCGA-JW-A5VG_demographic",1977,"american indian or alaska native","ecbb10ce-232f-5de0-a294-4083cd5980db","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VG_diagnosis","not reported",13109,"alive","8070/3",NA,834,"2bd137c4-c7c9-52c3-8967-4be673bfc6a2","c53.9",-13109,"TCGA-JW-A5VG_treatment","83d7bb47-125e-59f1-b733-b71870d47c3e","01","false","TCGA-JW-A5VG-01A",NA,"b6979d87-1888-46d4-bceb-767c5a0b71b9",FALSE,"679E2EDC-A950-49A4-AC1A-9472CCB3447D","Primary Tumor",NA,342,40,NA,1362528000,"11",10,"TCGA-JW-A5VG-01A-11",95,NA,20,NA,0,NA,5,NA,"2016-09-08T11:31:48.666403-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"bf832b16-dd31-4e92-93e8-5d0bf2e619e3",NA,"TCGA-JW-A5VG-01A-01-TS1",NA,95,NA,"a36de57d-2315-4bc3-93bf-69ec4f51063b","RNA","TCGA-JW-A5VG-01A-11R","a646d9b8-9be6-4f97-b34a-97fc6c86c340",1.8,0.16,"UV Spec","R","23","TCGA-JW-A5VG-01A-11R-A28H-07","40eb69ac-5c96-42c7-adfc-877580c58cc5",0.16,NA,110,44.0634513699728,158,"e1dd2bfa-c7ad-5eb3-b658-0f180075e8c4","TCGA-JW-A5VG_exposure","UNCID_2169003.40eb69ac-5c96-42c7-adfc-877580c58cc5.130611_UNC15-SN850_0312_BC265JACXX_1_AGTCAA.tar.gz","2013-09-20T04:46:05.000Z","2013-09-20T05:05:01.000Z","3DE85A5A-A3EC-4070-AF79-4AB5700F6657","B6979D87-1888-46D4-BCEB-767C5A0B71B9","Unaligned reads",6034243102,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","40EB69AC-5C96-42C7-ADFC-877580C58CC5","University of North Carolina","564a3b51e4b0ef12181a69e2","0BD52D75-5113-4EF1-BC75-509F59EAEF2B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A36DE57D-2315-4BC3-93BF-69EC4F51063B","2013-09-20T05:05:01.000Z","A646D9B8-9BE6-4F97-B34A-97FC6C86C340","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",342,"A36DE57D-2315-4BC3-93BF-69EC4F51063B",NA,"JW","a97e4cc4d969b7fd99ce5d338dad538d.bam",40,"TCGA-JW-A5VG-01A",NA,"907266E1-5423-4E3C-9C72-00B915F1BE87","TCGA",2012,"TCGA-JW-A5VG_NTE-1","Complete Remission/Response","TUMOR FREE","B6979D87-1888-46D4-BCEB-767C5A0B71B9",35,"nationwidechildrens.org_clinical.TCGA-JW-A5VG.xml","Alive",NA,"TCGA-JW-A5VG","HISPANIC OR LATINO","5C399796-349F-4BA8-AF35-2C6823C498CE","NO",439,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIA",NA,NA,"T2a","8070/3","FEMALE","C53.9",297,NA,"CFCCCA45-538F-44C5-BC85-40F00F243EA3","AMERICAN INDIAN OR ALASKA NATIVE",NA,11,10,"BF832B16-DD31-4E92-93E8-5D0BF2E619E3","E2CF600B-8E0F-4528-BB64-0D8F7A137651","a97e4cc4d969b7fd99ce5d338dad538d.bam","TCGA-JW-A5VG-01A-11",95,0,20,40,5,"TOP",0,20,"TCGA-JW-A5VG-01A-01-TS1",95,"Cisplatin","Chemotherapy","TCGA-JW-A5VG-D58206","TCGA-JW-A5VG-R58207","External","Regional site","TCGA-JW-A5VG-F58243_NTE-1","NO",834,"TUMOR FREE","Alive",NA,"TCGA-JW-A5VG-F58243","TCGA-JW-A5VG",NA,"JW","A5VG","YES","C53.9","8070/3","C53.9","NO","YES",-13109,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Alive",439,NA,NA,NA,"TUMOR FREE","YES",3,6,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",10,NA,"T2aNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
117152630,115707610,5522315382,"46C3A870-E37A-42CB-8C0C-6ACACEAC1ADC.bw","0c6bb7dc-45a6-4190-a7c9-b080d49fd58a","46c3a870-e37a-42cb-8c0c-6acaceac1adc","2016-08-05T11:03:27.404492-05:00","UNCID_2169018.687d43fb-fb87-464d-a661-697889b99aed.130606_UNC9-SN296_0373_BD28T1ACXX_4_CTTGTA.tar.gz","e610be74-ca8a-4de7-97b8-889cd1e384b9",5692789557,"Illumina HiSeq","d37067c4d578c70cd5b511b0df0f4858","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:36:15.999575-05:00","2016-05-03T11:06:28.633852-05:00","e610be74-ca8a-4de7-97b8-889cd1e384b9_analysis.xml","51e03af855965276b13bec6e5b7acbc5","e2ec93c3-92c7-46c7-ac08-5c5d86ef36a7",2121,"2016-08-13T08:50:17.883104-05:00","e610be74-ca8a-4de7-97b8-889cd1e384b9_experiment.xml","da8cc90d0c350fa48fcbc64bf2527bcd","748a138b-6860-4818-97ee-482b7e2f8198",2431,"2016-09-29T21:28:18.854425-05:00","e610be74-ca8a-4de7-97b8-889cd1e384b9_run.xml","3a2da4f7cd1d280f94c22979a5adbf9b","93ba7872-dd16-4324-8b88-abcfac7ddff4",354,"2016-09-08T12:13:44.911234-05:00","TCGA-EA-A5ZF","2016-09-02T18:59:52.805274-05:00","female","TCGA-EA-A5ZF_demographic",1956,"asian","8f30d834-da5d-5583-80a0-0175bdec9262","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A5ZF_diagnosis","not reported",20506,"alive","8070/3",NA,828,"b3e4ef30-84ee-59b0-9e17-54e5849aae83","c53.9",-20506,"TCGA-EA-A5ZF_treatment","1088ef74-30d1-51f8-8e16-39a658791b48","01","true","TCGA-EA-A5ZF-01A",NA,"42c9c212-0d69-4ef3-8e63-0964f6f7b6df",FALSE,"B4189C9E-2244-4C36-AABB-00B57F9540FF","Primary Tumor",NA,100,1060,NA,1363651200,"11",30,"TCGA-EA-A5ZF-01A-11",90,NA,0,NA,10,NA,10,NA,"2016-09-08T12:13:44.911234-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"a051d680-81b7-4ae7-a94c-aa14eb39c985",NA,"TCGA-EA-A5ZF-01A-01-TSA",NA,80,NA,"fab217a5-afbc-4960-b803-7201e61a4331","RNA","TCGA-EA-A5ZF-01A-11R","e73d5a83-9c96-4857-90ee-4857b5063072",1.92,0.16,"UV Spec","R","23","TCGA-EA-A5ZF-01A-11R-A28H-07","687d43fb-fb87-464d-a661-697889b99aed",0.16,NA,51,22.3674400245603,151,"8642025f-e1c9-51dd-8a8e-6324d661fb8b","TCGA-EA-A5ZF_exposure","UNCID_2169018.687d43fb-fb87-464d-a661-697889b99aed.130606_UNC9-SN296_0373_BD28T1ACXX_4_CTTGTA.tar.gz","2013-09-20T03:46:05.000Z","2013-09-20T04:02:02.000Z","E610BE74-CA8A-4DE7-97B8-889CD1E384B9","42C9C212-0D69-4EF3-8E63-0964F6F7B6DF","Unaligned reads",5692789557,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","687D43FB-FB87-464D-A661-697889B99AED","University of North Carolina","564a3cdfe4b093830b69bd22","0C6BB7DC-45A6-4190-A7C9-B080D49FD58A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FAB217A5-AFBC-4960-B803-7201E61A4331","2013-09-20T04:02:02.000Z","E73D5A83-9C96-4857-90EE-4857B5063072","Vietnam","NO",1,NA,"Primary Tumor","Asterand",100,"FAB217A5-AFBC-4960-B803-7201E61A4331",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A2E4E986-D906-4AF4-B9E8-A14D9B8F9F07.txt",1060,"TCGA-EA-A5ZF-01A",NA,NA,"TCGA",2012,"TCGA-EA-A5ZF_NTE-1","Complete Remission/Response","TUMOR FREE","AD361505-6106-4AAB-A671-5157B72B4C3F",56,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A2E4E986-D906-4AF4-B9E8-A14D9B8F9F07.txt","Alive",NA,"TCGA-EA-A5ZF","NOT HISPANIC OR LATINO","9B580ED5-35E3-4FB2-8A16-AF9AAC22A06B","NO",26,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",297,NA,NA,"ASIAN",NA,11,30,"A051D680-81B7-4AE7-A94C-AA14EB39C985","CDBDC1F7-D843-4D5C-A677-E68DA5C9B2B7","33316aa3d72207fca24e7bdd0fb726e6.bam.bai","TCGA-EA-A5ZF-01A-11",90,10,0,0,10,"TOP",0,0,"TCGA-EA-A5ZF-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,"TCGA-EA-A5ZF-F70910_NTE-1","NO",828,"WITH TUMOR","Alive",NA,"TCGA-EA-A5ZF-F70910","TCGA-EA-A5ZF",NA,"EA","A5ZF","YES","C53.9","8070/3","C53.9","YES","NO",-20506,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",26,NA,NA,NA,"TUMOR FREE","YES",24,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,56,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1NXM0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
91910852,90082938,4298619041,"E8E6270E-F26D-4F2E-A63E-7885BDE05FDB.bw","0e137272-a21c-4c5e-bfd1-a774b339a753","e8e6270e-f26d-4f2e-a63e-7885bde05fdb","2016-08-26T22:44:20.918124-05:00","UNCID_2324816.74b2fff7-243f-4eb5-9c67-2ab77b3ca059.131016_UNC15-SN850_0333_AC2MBAACXX_4_TAGCTT.tar.gz","7666be99-286f-4262-9036-8745fe0eaf59",4318322646,"Illumina HiSeq","a63df9daf880c384c1883206ff9dfd8a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:54.049557-05:00","2016-05-03T11:30:43.421347-05:00","7666be99-286f-4262-9036-8745fe0eaf59_analysis.xml","8c1563c40168b14754f019ee9233d6ed","74cf7a75-70c0-404f-b393-70a0d37273c3",2124,"2016-10-07T16:28:11.638594-05:00","7666be99-286f-4262-9036-8745fe0eaf59_experiment.xml","7fc3bdee6b1dca9d78b86c565c8c69df","8f310339-e0c7-44d0-9390-1b4f112df3d5",2628,"2016-09-29T23:23:10.715896-05:00","7666be99-286f-4262-9036-8745fe0eaf59_run.xml","c6d9f890b7250c25e777197a00efbc6f","daadae06-0f5f-4a67-873b-9860259a391f",354,"2016-09-08T11:33:23.228724-05:00","TCGA-R2-A69V","2016-09-02T19:00:54.164860-05:00","female","TCGA-R2-A69V_demographic",1969,"white","c9b1d856-da03-58bb-8daa-1434762a5a2f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","R2","46a2169c-40b2-51d3-b295-0e94b72033c7","CHI-Penrose Colorado","not reported","c53.9","TCGA-R2-A69V_diagnosis","not reported",15479,"alive","8072/3",NA,596,"03fc617e-e11b-5719-b8b2-e90134e93f01","c53.9",-15479,"TCGA-R2-A69V_treatment","51f91bfb-6d5e-5640-a213-ea7ffa90a5d0","01","false","TCGA-R2-A69V-01A",NA,"a48d2173-fe97-4fea-8f4e-ba81b5f6a833",FALSE,"13EE4EE8-9C51-4EBC-9562-7233A148810B","Primary Tumor",NA,548,780,NA,1368057600,"11",30,"TCGA-R2-A69V-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T11:33:23.228724-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"4e119910-a26e-49e4-b32a-2f415f7c1d4c",NA,"TCGA-R2-A69V-01A-01-TS1",NA,60,NA,"0c9552fe-4846-4e47-90a7-dc1b12b3f2a9","RNA","TCGA-R2-A69V-01A-11R","24661923-822e-4bd8-80a8-4b0ec31a0f9f",1.96,0.17,"UV Spec","R","23","TCGA-R2-A69V-01A-11R-A32P-07","74b2fff7-243f-4eb5-9c67-2ab77b3ca059",0.17,NA,116,47.0607326869244,157,"66583d1c-cad5-56b1-8913-75597ddcf13b","TCGA-R2-A69V_exposure","UNCID_2324816.74b2fff7-243f-4eb5-9c67-2ab77b3ca059.131016_UNC15-SN850_0333_AC2MBAACXX_4_TAGCTT.tar.gz","2014-01-18T22:26:04.000Z","2014-01-18T22:40:03.000Z","7666BE99-286F-4262-9036-8745FE0EAF59","A48D2173-FE97-4FEA-8F4E-BA81B5F6A833","Unaligned reads",4318322646,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","74B2FFF7-243F-4EB5-9C67-2AB77B3CA059","University of North Carolina","564a3f15e4b093830b6a71a8","0E137272-A21C-4C5E-BFD1-A774B339A753","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0C9552FE-4846-4E47-90A7-DC1B12B3F2A9","2014-01-18T22:40:03.000Z","24661923-822E-4BD8-80A8-4B0EC31A0F9F","United States","NO",1,NA,"Primary Tumor","CHI-Penrose Colorado",548,"0C9552FE-4846-4E47-90A7-DC1B12B3F2A9",NA,"R2","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C070ECB0-DB6E-46BD-8B6F-80795F0B65E2.txt",780,"TCGA-R2-A69V-01A",NA,"20E60A9F-1F04-4860-9614-D90A6622C0AC","TCGA",2011,"TCGA-R2-A69V_NTE-1","Complete Remission/Response","TUMOR FREE","A48D2173-FE97-4FEA-8F4E-BA81B5F6A833",42,"nationwidechildrens.org_biospecimen.TCGA-R2-A69V.xml","Alive",NA,"TCGA-R2-A69V","NOT HISPANIC OR LATINO",NA,"NO",596,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8072/3","FEMALE","C53.9",335,NA,"4496D2C3-D5F4-41A7-ACDD-AA986353770B","WHITE",NA,11,30,"4E119910-A26E-49E4-B32A-2F415F7C1D4C","51BD94DD-A377-47D5-97FD-2BE329DB24BE","THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_D07_1367192.CEL","TCGA-R2-A69V-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-R2-A69V-01A-01-TS1",60,"Cisplatin-xrt","Chemotherapy","TCGA-R2-A69V-D58931","TCGA-R2-A69V-R58932","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-R2-A69V",NA,"R2","A69V","YES","C53.9","8072/3","C53.9","YES","NO",-15479,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",596,NA,NA,NA,"TUMOR FREE","YES",15,7,2013,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",18,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
89619306,88031773,4204977354,"C4A5EBA2-9091-4D12-BDC8-B84B122022B9.bw","0e7f79cd-d188-42ea-bf96-4ba9e9b8606b","c4a5eba2-9091-4d12-bdc8-b84b122022b9","2016-08-26T09:05:37.767840-05:00","UNCID_2553074.b52d5d7a-3104-4d2a-a36b-aa9ac75e341d.140521_UNC11-SN627_0359_BC4E01ACXX_8_GTGGCC.tar.gz","8629100c-e39a-4523-b758-328bcd6130c6",3546498572,"Illumina HiSeq","fe41fc38e463f4c6954c8489824ea383","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:25:44.262119-05:00","2016-05-03T11:54:19.885282-05:00","8629100c-e39a-4523-b758-328bcd6130c6_analysis.xml","07723dd72930fdf00610be1495e07af9","47e1acd1-679b-4669-ad68-7e416f12423a",2124,"2016-10-07T17:25:18.594304-05:00","8629100c-e39a-4523-b758-328bcd6130c6_experiment.xml","32ef42f3b9bcca727b6cc1232772505c","62e1fd3f-c8a8-4d35-a6f9-be5d5b5f00e9",2628,"2016-09-29T22:21:55.482710-05:00","8629100c-e39a-4523-b758-328bcd6130c6_run.xml","d17fe4d35e63079ac6a02a26592415f4","b4acafae-393d-45d8-837d-038c3f561916",354,"2016-09-08T12:40:54.717999-05:00","TCGA-VS-A94Y","2016-09-02T18:54:07.331445-05:00","female","TCGA-VS-A94Y_demographic",1963,"white","cc326f2d-2b74-56ad-a2ae-6c557c7449a6","not reported",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A94Y_diagnosis","not reported",17465,"dead","8070/3",144,NA,"f646e7a7-1e78-5190-856f-6dc051807a1f","c53.9",-17465,"TCGA-VS-A94Y_treatment","cb73e3fa-ec50-5acd-8166-a43ef883f4da","01","false","TCGA-VS-A94Y-01A",NA,"f97be3a0-362e-4093-9895-a383ea1399a8",FALSE,"CBBFD564-A58A-42D3-89B8-682858D13B50","Primary Tumor",NA,1306,40,NA,1389830400,"11",30,"TCGA-VS-A94Y-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T12:40:54.717999-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"b16e545e-da53-4a05-aa65-18007f04f10d",NA,"TCGA-VS-A94Y-01A-01-TS1",NA,80,NA,"a5796618-7b30-464a-a4c2-8d629a2308ac","RNA","TCGA-VS-A94Y-01A-11R","2b3328b7-ac02-49c4-88ef-d300dff88741",1.87,0.17,"UV Spec","R","23","TCGA-VS-A94Y-01A-11R-A38B-07","b52d5d7a-3104-4d2a-a36b-aa9ac75e341d",0.17,0.0547945205479452,44,18.5528756957328,154,"a5191a3e-dece-5dad-87fb-df7d6d6814e9","TCGA-VS-A94Y_exposure","UNCID_2553074.b52d5d7a-3104-4d2a-a36b-aa9ac75e341d.140521_UNC11-SN627_0359_BC4E01ACXX_8_GTGGCC.tar.gz","2014-07-30T17:07:05.000Z","2014-07-30T17:25:21.000Z","8629100C-E39A-4523-B758-328BCD6130C6","F97BE3A0-362E-4093-9895-A383EA1399A8","Unaligned reads",3546498572,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B52D5D7A-3104-4D2A-A36B-AA9AC75E341D","University of North Carolina","564a3d03e4b09c884b24da37","0E7F79CD-D188-42EA-BF96-4BA9E9B8606B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A5796618-7B30-464A-A4C2-8D629A2308AC","2014-07-30T17:25:22.000Z","2B3328B7-AC02-49C4-88EF-D300DFF88741","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1306,"A5796618-7B30-464A-A4C2-8D629A2308AC",NA,"VS","CACTI_p_TCGAb_392_393_394_NSP_GenomeWideSNP_6_G06_1473984.tangent.copynumber.data.txt",40,"TCGA-VS-A94Y-01A",NA,"6D107EBB-1755-4A7C-9A3A-21A49777DDFB","TCGA",2010,"TCGA-VS-A94Y_NTE-1","Progressive Disease","WITH TUMOR","F97BE3A0-362E-4093-9895-A383EA1399A8",47,"nationwidechildrens.org_clinical.TCGA-VS-A94Y.xml","Dead",144,"TCGA-VS-A94Y",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",394,NA,"FB46420F-6375-437E-B620-1B0324E5445C","WHITE",NA,11,30,"B16E545E-DA53-4A05-AA65-18007F04F10D","57C9BE0D-F31E-4FC1-BD98-A7076974092C","UNCID_2506861.b52d5d7a-3104-4d2a-a36b-aa9ac75e341d.sorted_genome_alignments.bam","TCGA-VS-A94Y-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-VS-A94Y-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A94Y-D62789","TCGA-VS-A94Y-R62788","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A94Y",NA,"VS","A94Y","YES","C53.9","8070/3","C53.9","NO","YES",-17465,"FEMALE","WHITE",NA,"No","No","Dead",NA,144,NA,NA,"WITH TUMOR","YES",27,5,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2010,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,2,NA,1,NA,"Progressive Disease","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
140073168,127475349,6073258777,"5B1839C4-549D-41D1-B559-3C6D2A1528CE.bw","0f18ef74-019b-478d-aecd-60cc715bfdb7","5b1839c4-549d-41d1-b559-3c6d2a1528ce","2016-08-25T06:31:39.167338-05:00","UNCID_2449528.be979660-2d11-4707-9c74-b1222c7cb56e.140312_UNC11-SN627_0348_AC3KRYACXX_4_TGACCA.tar.gz","6a1a729b-4144-418d-a618-7d6c7e5f8fe6",5909259511,"Illumina HiSeq","a929405b7cd0bc5cb3471210de720b13","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:36.284160-05:00","2016-05-03T11:44:58.595380-05:00","6a1a729b-4144-418d-a618-7d6c7e5f8fe6_analysis.xml","c3ab08a691dda275fc03b98ef61aabe3","7e9c7fd4-a223-43f9-877e-01b6b17b494f",2124,"2016-09-29T20:33:51.177886-05:00","6a1a729b-4144-418d-a618-7d6c7e5f8fe6_experiment.xml","65ae0a0a87163e270cd73bca18d945ac","71a5361c-c851-495b-a698-74827d36c961",2628,"2016-09-29T20:54:22.839062-05:00","6a1a729b-4144-418d-a618-7d6c7e5f8fe6_run.xml","7f6774272d87af7e4914b9863fc5763f","7e7a4cd6-813e-4ab5-9f26-217321662b7f",354,"2016-09-08T12:26:32.699791-05:00","TCGA-UC-A7PD","2016-09-02T19:00:57.346397-05:00","female","TCGA-UC-A7PD_demographic",1976,"american indian or alaska native","bb3b882b-a620-5052-a314-2d2217a3c07e","not reported",1997,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","UC","5f4f7a1f-2e8a-5fac-ad28-5f6f1142d6e1","University of Washington","not reported","c53.9","TCGA-UC-A7PD_diagnosis","not reported",7855,"dead","8071/3",355,NA,"bee365c6-ba56-5a09-98a8-6da5e45653aa","c53.9",-7855,"TCGA-UC-A7PD_treatment","f61d3274-55e8-5c5d-b1ac-99eb072b9e0d","01","true","TCGA-UC-A7PD-01A",NA,"d3290464-56eb-49fa-bb05-3ce45978929d",FALSE,"E48CD4E1-FBC6-48AB-BACD-26AA3BC252D9","Primary Tumor",NA,6036,40,NA,1379894400,"11",30,"TCGA-UC-A7PD-01A-11",85,NA,0,NA,5,NA,10,NA,"2016-09-08T12:26:32.699791-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"62adb342-94c1-4120-addf-eed8059e9283",NA,"TCGA-UC-A7PD-01A-01-TS1",NA,85,NA,"da943ac8-f25a-4995-bca9-63757aa27d05","RNA","TCGA-UC-A7PD-01A-11R","bdfdc736-d277-44e3-a54d-52dfc652ff54",1.84,0.15,"UV Spec","R","23","TCGA-UC-A7PD-01A-11R-A352-07","be979660-2d11-4707-9c74-b1222c7cb56e",0.15,0.0958904109589041,NA,NA,NA,"78ff6bc7-267a-51f3-8027-429a6a1d4dd0","TCGA-UC-A7PD_exposure","UNCID_2449528.be979660-2d11-4707-9c74-b1222c7cb56e.140312_UNC11-SN627_0348_AC3KRYACXX_4_TGACCA.tar.gz","2014-05-09T09:33:04.000Z","2014-05-09T10:03:02.000Z","6A1A729B-4144-418D-A618-7D6C7E5F8FE6","D3290464-56EB-49FA-BB05-3CE45978929D","Unaligned reads",5909259511,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","BE979660-2D11-4707-9C74-B1222C7CB56E","University of North Carolina","56607450e4b016715ab6737a","0F18EF74-019B-478D-AECD-60CC715BFDB7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DA943AC8-F25A-4995-BCA9-63757AA27D05","2014-05-09T10:03:02.000Z","BDFDC736-D277-44E3-A54D-52DFC652FF54","United States","NO",1,NA,"Primary Tumor","University of Washington",6036,"DA943AC8-F25A-4995-BCA9-63757AA27D05",NA,"UC","TCGA-UC-A7PD-01A-11R-A358-13_mirna.bam.bai",40,"TCGA-UC-A7PD-01A",NA,NA,"TCGA",1997,"TCGA-UC-A7PD_NTE-1","Complete Remission/Response","WITH TUMOR","D3290464-56EB-49FA-BB05-3CE45978929D",21,"nationwidechildrens.org_clinical.TCGA-UC-A7PD.xml","Dead",355,"TCGA-UC-A7PD",NA,NA,"YES",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b","8071/3","FEMALE","C53.9",361,NA,"4404C793-63DD-43BE-9FA4-B3F6DA90FB00","AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"62ADB342-94C1-4120-ADDF-EED8059E9283","E37192B2-065F-4D9A-8A88-FA6361AADBB8","TCGA-UC-A7PD-01A-11R-A358-13_mirna.bam.bai","TCGA-UC-A7PD-01A-11",85,5,0,2,10,"TOP",0,0,"TCGA-UC-A7PD-01A-01-TS1",85,NA,NA,NA,"TCGA-UC-A7PD-R56386","Internal","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-UC-A7PD",NA,"UC","A7PD","YES","C53.9","8071/3","C53.9","NO","YES",-7855,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE",NA,"No","No","Dead",NA,355,NA,NA,"WITH TUMOR","YES",4,2,2014,"NO","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,21,1997,"Other method, specify:","YES",11,0,"G2",NA,2,NA,1.75,NA,"Complete Remission/Response","1995",6,NA,"T1bN0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
180163748,177773816,8461410973,"A0DF05EB-DC44-4492-9A8A-F278F7B0C266.bw","0fec73a1-8d3a-495b-8008-c52f190f4270","a0df05eb-dc44-4492-9a8a-f278f7b0c266","2016-08-09T13:57:44.685615-05:00","UNCID_2187309.f301f3e6-eaec-4d35-b8c0-b0eb6acd2847.120917_UNC11-SN627_0251_AC119PACXX_6_AGTTCC.tar.gz","1133bc9d-61e2-420d-a4e6-8c3b61154303",7877959279,"Illumina HiSeq","4a7fa54f4f5f5fbefdfb24a01e15f905","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:42.086280-05:00","2016-05-03T11:02:00.425419-05:00","1133bc9d-61e2-420d-a4e6-8c3b61154303_analysis.xml","00d83248f08c005095662ccb243b1a93","31c91c82-82eb-4658-a5cd-b660fdb728d4",2124,"2016-08-30T08:22:39.734708-05:00","1133bc9d-61e2-420d-a4e6-8c3b61154303_experiment.xml","958b94fd83ab36f7b1280bb7b7e1347b","1c0f52f8-19ec-4202-8362-794b03f14972",2431,"2016-09-30T00:13:23.589856-05:00","1133bc9d-61e2-420d-a4e6-8c3b61154303_run.xml","0edc749de6be974bbb466593a7ef9afc","f9d60905-1b61-48ea-a60e-985df8d644e9",354,"2016-09-08T12:03:05.127124-05:00","TCGA-C5-A1M5","2016-09-02T18:56:46.778650-05:00","female","TCGA-C5-A1M5_demographic",1943,"white","289b1b16-57c2-581f-9df2-e941448be123","not hispanic or latino",2001,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1M5_diagnosis","not reported",19672,"dead","8070/3",2052,NA,"c7ef817a-050b-57dc-b503-435be153c332","c53.9",-19672,"TCGA-C5-A1M5_treatment","a85cce8f-4c50-5029-a8cd-f02251e8ad38","01","true","TCGA-C5-A1M5-01A",NA,"2091ea13-7864-462a-8e96-c59e50ede1c0",FALSE,"B7A07894-8654-49F3-9583-7AD930443F08","Primary Tumor",NA,5395,190,NA,1300924800,"11",30,"TCGA-C5-A1M5-01A-11",90,NA,2,NA,0,NA,10,NA,"2016-09-08T12:03:05.127124-05:00",NA,60,NA,3,NA,"TOP",NA,0,NA,"84a53153-cef3-4b07-aa7b-71bd8af04cd5",NA,"TCGA-C5-A1M5-01A-01-TSA",NA,90,NA,"f2eae255-892d-4d61-8ed4-325716d2f8c2","RNA","TCGA-C5-A1M5-01A-11R","ed286d53-062f-4c1d-9242-42b2d92781fa",1.77,0.15,"UV Spec","R","23","TCGA-C5-A1M5-01A-11R-A13Y-07","f301f3e6-eaec-4d35-b8c0-b0eb6acd2847",0.15,NA,70,NA,NA,"481edc86-0193-5e75-af6b-26d1681f915e","TCGA-C5-A1M5_exposure","UNCID_2187309.f301f3e6-eaec-4d35-b8c0-b0eb6acd2847.120917_UNC11-SN627_0251_AC119PACXX_6_AGTTCC.tar.gz","2013-09-17T07:16:05.000Z","2013-09-17T07:33:02.000Z","1133BC9D-61E2-420D-A4E6-8C3B61154303","2091EA13-7864-462A-8E96-C59E50EDE1C0","Unaligned reads",7877959279,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F301F3E6-EAEC-4D35-B8C0-B0EB6ACD2847","University of North Carolina","564a39b5e4b0ef121819e713","0FEC73A1-8D3A-495B-8008-C52F190F4270","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F2EAE255-892D-4D61-8ED4-325716D2F8C2","2013-09-17T07:33:02.000Z","ED286D53-062F-4C1D-9242-42B2D92781FA","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",5395,"F2EAE255-892D-4D61-8ED4-325716D2F8C2",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.36EF8DA6-EB98-460D-B983-553061F6C566.txt",190,"TCGA-C5-A1M5-01A",NA,NA,"TCGA",1996,NA,NA,"WITH TUMOR","4666F9BF-C9EF-44CD-A84A-C652051ABDBA",53,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.36EF8DA6-EB98-460D-B983-553061F6C566.txt","Dead",2052,"TCGA-C5-A1M5","NOT HISPANIC OR LATINO","F3E33A52-90DA-4FFB-A199-4082716E66C7",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",114,NA,"5B7F18C9-326F-486E-A153-D91C4709038E","WHITE",NA,11,30,"84A53153-CEF3-4B07-AA7B-71BD8AF04CD5","5D891F1C-4138-4579-8F16-A25BBC8DE408","UNCID_1661626.f301f3e6-eaec-4d35-b8c0-b0eb6acd2847.sorted_genome_alignments.bam.bai","TCGA-C5-A1M5-01A-11",90,0,2,60,10,"TOP",0,3,"TCGA-C5-A1M5-01A-01-TSA",90,NA,NA,NA,"TCGA-C5-A1M5-R29078","COMBINATION","Local Recurrence",NA,"YES",NA,"WITH TUMOR","Dead",2052,"TCGA-C5-A1M5-F29081","TCGA-C5-A1M5",NA,"C5","A1M5","YES","C53.9","8070/3","C53.9","NO","YES",-19672,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,2052,NA,NA,"WITH TUMOR","NO",19,9,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,1996,"Biopsy (cervical / CT-guided / Other)","YES",59,0,"G2",NA,1,NA,NA,NA,NA,"1995",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
195313702,192995706,9208332758,"B5182F49-70F2-45B7-82DE-C6DA68145EEA.bw","110cd100-5730-4873-9fab-2ae6c8732062","b5182f49-70f2-45b7-82de-c6da68145eea","2016-08-09T13:56:40.973839-05:00","UNCID_2186997.a4de3863-03d5-44b0-b711-87aadcb29008.121001_UNC13-SN749_0196_AD140CACXX_2_CGATGT.tar.gz","11727cc2-e425-46b2-91db-e46f97a6551a",8827798578,"Illumina HiSeq","05f3599f0abda60045a5cbbb468de59b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:53:01.452883-05:00","2016-05-03T11:02:00.402341-05:00","11727cc2-e425-46b2-91db-e46f97a6551a_analysis.xml","17bd4dfc70c7e4a5956b6addc9e5260f","7d9fd50f-40f4-44fd-af6e-09a6f7eeb1a0",2122,"2016-08-28T22:19:51.278599-05:00","11727cc2-e425-46b2-91db-e46f97a6551a_experiment.xml","ec96ef838fa5638b9eab3c20d7bc684e","cd78eb62-ff5a-4653-b204-84f170ca6019",2431,"2016-09-29T22:30:08.820142-05:00","11727cc2-e425-46b2-91db-e46f97a6551a_run.xml","22be1aa3279f5111134ba9af5faf0bb1","b9d4383a-411d-4831-ba36-8e2fa0d9b197",354,"2016-09-08T11:29:06.915781-05:00","TCGA-C5-A1M8","2016-09-02T18:56:49.139633-05:00","female","TCGA-C5-A1M8_demographic",1958,"white","bf9900af-1e16-5fc2-9f7f-e3a25f7ff16e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1M8_diagnosis","not reported",15848,"alive","8070/3",NA,919,"6acdbb35-adb2-570e-a84d-b809c27387a3","c53.9",-15848,"TCGA-C5-A1M8_treatment","3bebced7-6b4d-54bb-a5e6-6d6253010d94","01","true","TCGA-C5-A1M8-01A",NA,"72ff7605-0905-4829-8b54-b76b45fbb0df",FALSE,"7EC6DEFF-B0FC-45FF-9B45-92714D5EDBEB","Primary Tumor",NA,3397,100,NA,1300924800,"21",30,"TCGA-C5-A1M8-01A-21",85,NA,2,NA,0,NA,15,NA,"2016-09-08T11:29:06.915781-05:00",NA,5,NA,3,NA,"TOP",NA,2,NA,"103b8b84-15d6-472c-940f-eaac6aa74c75",NA,"TCGA-C5-A1M8-01A-02-TSB",NA,83,NA,"da282a75-7c99-45a0-8094-a9930309b83b","RNA","TCGA-C5-A1M8-01A-21R","46eadddc-2e4d-4911-81b1-56d6f6629272",1.75,0.15,"UV Spec","R","23","TCGA-C5-A1M8-01A-21R-A13Y-07","a4de3863-03d5-44b0-b711-87aadcb29008",0.15,NA,75,28.2283864654296,163,"bc016ca2-df7a-589a-adef-4f9c007fdbf4","TCGA-C5-A1M8_exposure","UNCID_2186997.a4de3863-03d5-44b0-b711-87aadcb29008.121001_UNC13-SN749_0196_AD140CACXX_2_CGATGT.tar.gz","2013-09-16T21:16:03.000Z","2013-09-16T21:47:01.000Z","11727CC2-E425-46B2-91DB-E46F97A6551A","72FF7605-0905-4829-8B54-B76B45FBB0DF","Unaligned reads",8827798578,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A4DE3863-03D5-44B0-B711-87AADCB29008","University of North Carolina","564a3aa1e4b0298dd2c82879","110CD100-5730-4873-9FAB-2AE6C8732062","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DA282A75-7C99-45A0-8094-A9930309B83B","2013-09-16T21:47:01.000Z","46EADDDC-2E4D-4911-81B1-56D6F6629272","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3397,"DA282A75-7C99-45A0-8094-A9930309B83B",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.11C08BC4-2E3E-47BB-80F7-4758587F2EF6.txt",100,"TCGA-C5-A1M8-01A",NA,NA,"TCGA",2001,NA,NA,"TUMOR FREE","D551F7B2-6778-4983-A8BE-D101EB7E5C26",43,"d4504d39c63605431fff1046c6900dda.bam","Alive",NA,"TCGA-C5-A1M8","NOT HISPANIC OR LATINO","642CB91E-1C75-4197-B8E5-3BE96EC03A35",NA,919,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b","8070/3","FEMALE","C53.9",114,NA,"1624463C-089A-41DB-8F72-C7324BCBD47B","WHITE",NA,21,30,"103B8B84-15D6-472C-940F-EAAC6AA74C75","149BBE65-3B8E-4262-A34E-C7FD8EFAA16D","UNCID_1653956.a4de3863-03d5-44b0-b711-87aadcb29008.sorted_genome_alignments.bam.bai","TCGA-C5-A1M8-01A-21",85,0,2,5,15,"TOP",2,3,"TCGA-C5-A1M8-01A-02-TSB",83,NA,NA,NA,"TCGA-C5-A1M8-R29228","EXTERNAL BEAM","Primary Tumor Field","TCGA-C5-A1M8-F57891_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A1M8-F57891","TCGA-C5-A1M8",NA,"C5","A1M8","YES","C53.9","8070/3","C53.9","NO","YES",-15848,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",919,NA,NA,NA,"TUMOR FREE","NO",19,9,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2001,"Cone Biopsy / LEEP","YES",13,0,"G2",NA,1,NA,NA,NA,NA,"1995",7,NA,"T1bN0MX",NA,NA,NA,NA,NA,"Indeterminate (neither Pre or Postmenopausal)",NA,NA,NA,NA,NA,NA
152410312,150739069,7201507691,"C204D355-B876-4341-A111-36D48CBDD2A8.bw","12427b02-6e3f-461c-b271-6ab230f628e7","c204d355-b876-4341-a111-36d48cbdd2a8","2016-08-08T17:33:16.459508-05:00","UNCID_2186816.cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d.121009_UNC16-SN851_0187_AD15RRACXX_5_GGCTAC.tar.gz","9886ab40-93d0-4de9-b4b6-267e32900179",6697629156,"Illumina HiSeq","5b008eafdaaca96817751e2615733386","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:59:27.507349-05:00","2016-05-03T11:01:14.469334-05:00","9886ab40-93d0-4de9-b4b6-267e32900179_analysis.xml","a502ad072e6214b08aeb867a2dc74337","f156203e-63ab-4f06-86d0-79911f15ce00",2124,"2016-09-29T21:26:55.207739-05:00","9886ab40-93d0-4de9-b4b6-267e32900179_experiment.xml","7e78f2451a70c162ff49ea0f4e17d4ab","92dc14ed-5227-4d90-8ae0-ead7132be45b",2431,"2016-09-29T18:25:54.176450-05:00","9886ab40-93d0-4de9-b4b6-267e32900179_run.xml","1e20449eec4dc9ea45a2dba1c9d699f8","2210f095-1fd4-410f-afb5-c51ce1aa262c",354,"2016-09-08T11:40:15.648478-05:00","TCGA-C5-A3HD","2016-09-02T18:58:40.530961-05:00","female","TCGA-C5-A3HD_demographic",1953,"white","1ddb5020-b87b-5c1b-ba3b-d2711bc27224","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A3HD_diagnosis","not reported",18690,"alive","8070/3",NA,1582,"5b9cfa92-3e8c-5848-8129-616232134d99","c53.9",-18690,"TCGA-C5-A3HD_treatment","4f112671-c34e-52ea-9a41-3db98bfe6586","01","true","TCGA-C5-A3HD-01B",NA,"56aa88c8-af6d-42be-8672-074476f6575a",FALSE,"FF901048-0C46-4347-8826-ADEB000EC270","Primary Tumor",NA,2848,70,NA,1323734400,"11",30,"TCGA-C5-A3HD-01B-11",80,NA,0,NA,0,NA,10,NA,"2016-09-08T11:40:15.648478-05:00",NA,30,NA,10,NA,"TOP",NA,10,NA,"7b4a8611-4cf9-4fdd-b9b6-df2b01e307c8",NA,"TCGA-C5-A3HD-01B-01-TSA",NA,80,NA,"3738859e-4143-4844-a0ef-f615b865804e","RNA","TCGA-C5-A3HD-01B-11R","00a15bc8-22ba-4ccd-b698-a8e948355948",1.81,0.18,"UV Spec","R","23","TCGA-C5-A3HD-01B-11R-A213-07","cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d",0.18,1.47945205479452,83,28.719723183391,170,"445a333e-1fa8-5a59-ac40-8fdf9bc9f8c3","TCGA-C5-A3HD_exposure","UNCID_2186816.cbf9a913-bf0f-41cf-b7c5-048b72bbbb5d.121009_UNC16-SN851_0187_AD15RRACXX_5_GGCTAC.tar.gz","2013-09-16T15:13:03.000Z","2013-09-16T15:36:01.000Z","9886AB40-93D0-4DE9-B4B6-267E32900179","56AA88C8-AF6D-42BE-8672-074476F6575A","Unaligned reads",6697629156,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CBF9A913-BF0F-41CF-B7C5-048B72BBBB5D","University of North Carolina","564a3d5ce4b093830b69e582","12427B02-6E3F-461C-B271-6AB230F628E7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3738859E-4143-4844-A0EF-F615B865804E","2013-09-16T15:36:01.000Z","00A15BC8-22BA-4CCD-B698-A8E948355948","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2848,"3738859E-4143-4844-A0EF-F615B865804E",NA,"C5","jhu-usc.edu_CESC.HumanMethylation450.6.lvl-3.TCGA-C5-A3HD-01B-11D-A212-05.txt",70,"TCGA-C5-A3HD-01B",NA,"C267EDF4-0C73-4C1D-96C6-355B2287ADA9","TCGA",2004,NA,NA,"TUMOR FREE","BA733B4B-CB5F-4AB7-BAA9-3A30605E5EF9",51,"nationwidechildrens.org_clinical.TCGA-C5-A3HD.xml","Alive",NA,"TCGA-C5-A3HD","NOT HISPANIC OR LATINO","D0271336-A856-4CC2-9BB5-439CAA421A6D",NA,1582,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIB",NA,NA,NA,"8070/3","FEMALE","C53.9",200,NA,"385A69DB-EAE9-43CC-AC53-8BD88BAD1E04","WHITE",NA,11,30,"7B4A8611-4CF9-4FDD-B9B6-DF2B01E307C8","5B6EFA20-82C4-4B0C-AB1C-80C7285EF9DA","jhu-usc.edu_CESC.HumanMethylation450.6.lvl-3.TCGA-C5-A3HD-01B-11D-A212-05.txt","TCGA-C5-A3HD-01B-11",80,0,0,30,10,"TOP",10,10,"TCGA-C5-A3HD-01B-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-C5-A3HD-D30835","TCGA-C5-A3HD-R30837","COMBINATION","Primary Tumor Field",NA,"NO",1582,"TUMOR FREE","Alive",NA,"TCGA-C5-A3HD-F30834","TCGA-C5-A3HD",NA,"C5","A3HD","YES","C53.9","8070/3","C53.9","NO","YES",-18690,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1582,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2004,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,1995,27,NA,NA,"1995",13,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
108346416,102586675,4890674960,"7B070AAA-EF97-4D3B-AA19-EEC170C7927D.bw","128fd280-9a04-4038-9269-9a945b9a4dc9","7b070aaa-ef97-4d3b-aa19-eec170c7927d","2016-08-25T19:40:12.257132-05:00","UNCID_2358718.75aa1caf-bfa3-4365-a066-31a968ad3d9b.140107_UNC11-SN627_0341_BC38NLACXX_5_GTTTCG.tar.gz","f9426ad3-bded-465f-b840-ee33b48a420d",5217244122,"Illumina HiSeq","acaa0a914e05fbfeb6ad397364d3cea4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:14:42.656311-05:00","2016-05-03T11:37:12.425298-05:00","f9426ad3-bded-465f-b840-ee33b48a420d_analysis.xml","9d657f26d7063df3f015731fe25d2530","8b456b86-a260-4ec7-a85b-7a4d5bb6bea6",2124,"2016-08-27T02:27:22.836520-05:00","f9426ad3-bded-465f-b840-ee33b48a420d_experiment.xml","197c7589590e01d6012e0a88500569c0","a5daaf00-0d0e-4b01-82e9-67151ebf69a6",2628,"2016-09-29T20:39:14.282219-05:00","f9426ad3-bded-465f-b840-ee33b48a420d_run.xml","9f7db1e5dea565abd899954d391487b7","7506449d-1221-4673-8bec-eb1283c19cc0",354,"2016-09-08T11:24:40.087195-05:00","TCGA-FU-A770","2016-09-02T19:00:13.395225-05:00","female","TCGA-FU-A770_demographic",1980,"white","9701f436-bdec-5abe-a27e-0f2b0d6fbdc3","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A770_diagnosis","not reported",12248,"alive","8384/3",NA,34,"5497c4fd-5f14-5a2b-9b8f-aa35afb4c70b","c53.9",-12248,"TCGA-FU-A770_treatment","60106f8d-ecf0-5c25-92a0-c141a58b6189","01","true","TCGA-FU-A770-01A",NA,"9eeca3d2-aded-4f64-93c8-77c4ad4d87c0",FALSE,"23DD976D-0D35-4BFF-89FF-94D9160F2228","Primary Tumor",NA,139,40,NA,1377129600,"11",30,"TCGA-FU-A770-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:24:40.087195-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"b20241f7-233c-4bd5-baa7-ca7aadb5d837",NA,"TCGA-FU-A770-01A-01-TS1",NA,80,NA,"8eb72a66-60a2-4c31-a97b-9834d77cd68d","RNA","TCGA-FU-A770-01A-11R","1c3c6ede-57fb-48f0-86d3-982add63b15d",1.87,0.17,"UV Spec","R","23","TCGA-FU-A770-01A-11R-A33Z-07","75aa1caf-bfa3-4365-a066-31a968ad3d9b",0.17,0.383561643835616,67,21.8775510204082,175,"6ba3cd7d-f730-58df-82b3-d7d10187335b","TCGA-FU-A770_exposure","UNCID_2358718.75aa1caf-bfa3-4365-a066-31a968ad3d9b.140107_UNC11-SN627_0341_BC38NLACXX_5_GTTTCG.tar.gz","2014-02-25T18:03:04.000Z","2014-02-25T18:25:01.000Z","F9426AD3-BDED-465F-B840-EE33B48A420D","9EECA3D2-ADED-4F64-93C8-77C4AD4D87C0","Unaligned reads",5217244122,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","75AA1CAF-BFA3-4365-A066-31A968AD3D9B","University of North Carolina","566077a5e4b0ca319164e720","128FD280-9A04-4038-9269-9A945B9A4DC9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8EB72A66-60A2-4C31-A97B-9834D77CD68D","2014-02-25T18:25:01.000Z","1C3C6EDE-57FB-48F0-86D3-982ADD63B15D","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",139,"8EB72A66-60A2-4C31-A97B-9834D77CD68D",NA,"FU","UNCID_2358718.75aa1caf-bfa3-4365-a066-31a968ad3d9b.140107_UNC11-SN627_0341_BC38NLACXX_5_GTTTCG.tar.gz",40,"TCGA-FU-A770-01A",NA,NA,"TCGA",2013,"TCGA-FU-A770_NTE-1",NA,"TUMOR FREE","F5E6FE54-D348-4E90-9C59-A1A08A43798D",33,"nationwidechildrens.org_clinical.TCGA-FU-A770.xml","Alive",NA,"TCGA-FU-A770","NOT HISPANIC OR LATINO",NA,"NO",34,"No","Cervix","C53.9","N1","Endocervical Adenocarcinoma of the Usual Type",1,"Preoperative","Stage IIIB",NA,NA,"T2a2","8384/3","FEMALE","C53.9",350,NA,NA,"WHITE",NA,11,30,"B20241F7-233C-4BD5-BAA7-CA7AADB5D837","FBE00748-A0D1-4B8B-AAB9-6A2D53C7644E","UNCID_2358718.75aa1caf-bfa3-4365-a066-31a968ad3d9b.140107_UNC11-SN627_0341_BC38NLACXX_5_GTTTCG.tar.gz","TCGA-FU-A770-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-FU-A770-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-FU-A770",NA,"FU","A770","YES","C53.9","8384/3","C53.9","YES","NO",-12248,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",34,NA,NA,NA,"TUMOR FREE","YES",26,2,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,33,2013,"Other method, specify:","YES",10,1,"G2",NA,2,NA,7,NA,NA,"2009",16,NA,"T2a2N1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
124201242,121481221,5795270998,"05A8A881-F8EE-48A2-B11C-A08D7D80CE18.bw","1399d31d-9d5e-441a-b400-8b8a92a6ff8b","05a8a881-f8ee-48a2-b11c-a08d7d80ce18","2016-08-04T23:02:23.479180-05:00","UNCID_2168995.7db85d66-16a3-4062-b98f-1ebe628d2b13.130611_UNC15-SN850_0312_BC265JACXX_4_AGTCAA.tar.gz","0d21bf61-94c0-4449-9145-130e26392812",5537672025,"Illumina HiSeq","4a27e19be2b988adba8678061f1ad881","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:08:41.923646-05:00","2016-05-03T11:06:28.634130-05:00","0d21bf61-94c0-4449-9145-130e26392812_analysis.xml","babdb1e56cef6ac1957e820dbdb2e63c","f6e446c8-83e1-41d5-82d6-4b47fe58a9a0",2123,"2016-09-29T18:05:10.085936-05:00","0d21bf61-94c0-4449-9145-130e26392812_experiment.xml","ec5743fcbf6e049325a8ff20ffbc1567","1546a49a-8449-4cf9-8bfe-118d9a4f1fcc",2431,"2016-09-29T21:36:58.626588-05:00","0d21bf61-94c0-4449-9145-130e26392812_run.xml","7e78a9f902131992caaa3a732f88f483","990159b4-e527-4294-8ffe-47f09be771ea",354,"2016-09-08T11:55:12.575041-05:00","TCGA-LP-A5U3","2016-09-02T19:00:07.791223-05:00","female","TCGA-LP-A5U3_demographic",1972,"asian","f588c0b2-9f5f-569c-be30-dfdbcc578fa8","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A5U3_diagnosis","not reported",14698,"alive","8072/3",NA,25,"79a87d97-814f-5cd1-8109-236da38024c9","c53.9",-14698,"TCGA-LP-A5U3_treatment","2afec7aa-fb19-5c5a-8ab0-9d30c054f141","01","true","TCGA-LP-A5U3-01A",NA,"d314fb5f-fab3-4bc8-b294-217ba6e73cb1",FALSE,"153C30F0-1533-4056-9E90-F1568B8130D9","Primary Tumor",NA,168,520,NA,1362096000,"11",30,"TCGA-LP-A5U3-01A-11",70,NA,20,NA,0,NA,30,NA,"2016-09-08T11:55:12.575041-05:00",NA,20,NA,40,NA,"TOP",NA,0,NA,"6160b977-50ae-49ea-9f30-67c6c8566607",NA,"TCGA-LP-A5U3-01A-01-TSA",NA,70,NA,"544477b7-83b7-4998-8f1c-113d689f526f","RNA","TCGA-LP-A5U3-01A-11R","c3eb4cb1-cf9e-415a-9497-b186b1943aaf",1.94,0.16,"UV Spec","R","23","TCGA-LP-A5U3-01A-11R-A28H-07","7db85d66-16a3-4062-b98f-1ebe628d2b13",0.16,NA,50,19.53125,160,"63bbf126-af00-5aab-a5c8-6f6caba52d6e","TCGA-LP-A5U3_exposure","UNCID_2168995.7db85d66-16a3-4062-b98f-1ebe628d2b13.130611_UNC15-SN850_0312_BC265JACXX_4_AGTCAA.tar.gz","2013-09-20T05:26:04.000Z","2013-09-20T05:40:01.000Z","0D21BF61-94C0-4449-9145-130E26392812","D314FB5F-FAB3-4BC8-B294-217BA6E73CB1","Unaligned reads",5537672025,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7DB85D66-16A3-4062-B98F-1EBE628D2B13","University of North Carolina","564a3c3de4b08c5d8691c749","1399D31D-9D5E-441A-B400-8B8A92A6FF8B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","544477B7-83B7-4998-8F1C-113D689F526F","2013-09-20T05:40:01.000Z","C3EB4CB1-CF9E-415A-9497-B186B1943AAF","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",168,"544477B7-83B7-4998-8F1C-113D689F526F",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D4F30F80-47CD-44E7-A1C9-419484388AF4.txt",520,"TCGA-LP-A5U3-01A",NA,NA,"TCGA",2012,"TCGA-LP-A5U3_NTE-1","Complete Remission/Response","TUMOR FREE","7F1B3A4E-C07F-4D59-8122-922B1D49046C",40,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D4F30F80-47CD-44E7-A1C9-419484388AF4.txt","Alive",NA,"TCGA-LP-A5U3","NOT HISPANIC OR LATINO",NA,"NO",25,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",297,NA,NA,"ASIAN",NA,11,30,"6160B977-50AE-49EA-9F30-67C6C8566607","D6C9C3F9-CC49-4E11-9EAF-8DE3329DE628","8124cd2d1f63991379ac49f067e2d467.bam","TCGA-LP-A5U3-01A-11",70,0,20,20,30,"TOP",0,40,"TCGA-LP-A5U3-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-LP-A5U3",NA,"LP","A5U3","YES","C53.9","8072/3","C53.9","YES","NO",-14698,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",25,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
82930894,82094490,3921259667,"BA59EF50-CFE9-456D-B1B6-67D0945004F6.bw","13d72130-604c-4d79-95cc-53c2e25d91b0","ba59ef50-cfe9-456d-b1b6-67d0945004f6","2016-08-09T14:40:34.929066-05:00","UNCID_2654372.cc3f9a0e-0984-42dc-82bd-965f0c2b6109.141010_UNC12-SN629_0395_BC5FVEACXX_7_ATCACG.tar.gz","833b6e11-17fe-4a49-aa67-00bad2ed7048",3010758403,"Illumina HiSeq","54f409483332db713cde434cb65b4a19","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:53:08.887645-05:00","2016-05-03T12:08:10.840569-05:00","833b6e11-17fe-4a49-aa67-00bad2ed7048_analysis.xml","fc832b239e1f00b28a2f1f84898771cd","7db4db43-7e3e-44b2-a431-2f67b309dd24",2124,"2016-09-29T20:47:29.186329-05:00","833b6e11-17fe-4a49-aa67-00bad2ed7048_experiment.xml","17b072b1f4ffc0db2d68ba1d8f4d95fa","7a24486c-c605-44ed-921d-34ce11089d07",2628,"2016-09-29T18:26:27.154414-05:00","833b6e11-17fe-4a49-aa67-00bad2ed7048_run.xml","26c2e2d057531f133dab30dd868dcc64","226d8b4c-fcf9-4c34-b863-9c6680da7e3f",354,"2016-09-08T10:57:09.108534-05:00","TCGA-ZJ-AAX4","2016-09-02T18:54:41.116419-05:00","female","TCGA-ZJ-AAX4_demographic",1923,"white","a4723a5a-502f-5805-86b0-d4b93335f5d0","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAX4_diagnosis","not reported",31258,"alive","8072/3",NA,21,"e9ecc643-a35b-52b1-8126-b2435a502341","c53.9",-31258,"TCGA-ZJ-AAX4_treatment","57f8c3e5-ecb2-5465-bce4-39e32e668c21","01","true","TCGA-ZJ-AAX4-01A",NA,"4590d000-d67d-4a58-9dd4-612dc4dcb9f9",FALSE,"E5FA90F3-A611-4348-BD0F-16A6B97E83FA","Primary Tumor",NA,1997,60,NA,1396396800,"11",30,"TCGA-ZJ-AAX4-01A-11",70,NA,0,NA,5,NA,24,NA,"2016-09-08T10:57:09.108534-05:00",NA,10,NA,0,NA,"TOP",NA,1,NA,"120cdcc0-a47b-4137-9786-454586adb96d",NA,"TCGA-ZJ-AAX4-01A-01-TS1",NA,70,NA,"522f4914-671e-4dc6-a7b2-b1f8ad876cf8","RNA","TCGA-ZJ-AAX4-01A-11R","a7ac4225-a38e-4666-b011-dfd552f44837",1.82,0.18,"UV Spec","R","23","TCGA-ZJ-AAX4-01A-11R-A42T-07","cc3f9a0e-0984-42dc-82bd-965f0c2b6109",0.18,0.0312328767123288,77,26.643598615917,170,"64a098e7-126e-5f18-a4da-c5bef87f2cee","TCGA-ZJ-AAX4_exposure","UNCID_2654372.cc3f9a0e-0984-42dc-82bd-965f0c2b6109.141010_UNC12-SN629_0395_BC5FVEACXX_7_ATCACG.tar.gz","2014-11-06T18:06:04.000Z","2014-11-06T18:22:23.000Z","833B6E11-17FE-4A49-AA67-00BAD2ED7048","4590D000-D67D-4A58-9DD4-612DC4DCB9F9","Unaligned reads",3010758403,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CC3F9A0E-0984-42DC-82BD-965F0C2B6109","University of North Carolina","56607745e4b0ec1099f8cd67","13D72130-604C-4D79-95CC-53C2E25D91B0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","522F4914-671E-4DC6-A7B2-B1F8AD876CF8","2014-11-06T18:22:23.000Z","A7AC4225-A38E-4666-B011-DFD552F44837","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1997,"522F4914-671E-4DC6-A7B2-B1F8AD876CF8",NA,"ZJ","UNCID_2654372.cc3f9a0e-0984-42dc-82bd-965f0c2b6109.141010_UNC12-SN629_0395_BC5FVEACXX_7_ATCACG.tar.gz",60,"TCGA-ZJ-AAX4-01A",NA,NA,"TCGA",2008,"TCGA-ZJ-AAX4_NTE-1",NA,NA,"F55D1776-85F6-43A5-9794-BC096E289873",85,"nationwidechildrens.org_clinical.TCGA-ZJ-AAX4.xml","Alive",NA,"TCGA-ZJ-AAX4","NOT HISPANIC OR LATINO",NA,NA,21,"Yes","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage II",NA,NA,"T2","8072/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"120CDCC0-A47B-4137-9786-454586ADB96D","A7AC4225-A38E-4666-B011-DFD552F44837","UNCID_2654372.cc3f9a0e-0984-42dc-82bd-965f0c2b6109.141010_UNC12-SN629_0395_BC5FVEACXX_7_ATCACG.tar.gz","TCGA-ZJ-AAX4-01A-11",70,5,0,10,24,"TOP",1,0,"TCGA-ZJ-AAX4-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAX4",NA,"ZJ","AAX4","YES","C53.9","8072/3","C53.9","NO","YES",-31258,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",21,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,85,2008,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G3",NA,4,1949,0.57,NA,NA,"2009",9,NA,"T2N0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114118350,108715006,5176299691,"AD97B334-E034-4D33-A4D5-48C32D5D521C.bw","1451821e-dd49-41fa-a52e-32f8524ffe82","ad97b334-e034-4d33-a4d5-48c32d5d521c","2016-08-26T03:24:20.476476-05:00","UNCID_2449424.abb75efe-7d8f-4d43-a04b-8a97f2eda7b8.140325_UNC11-SN627_0349_AC3KB8ACXX_1_GATCAG.tar.gz","a0962c9a-425c-4469-884f-4592d086e24e",5023643999,"Illumina HiSeq","b72bc4d73fa3bbfb784ec040b87d27bb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:16:29.258902-05:00","2016-05-03T11:44:58.595380-05:00","a0962c9a-425c-4469-884f-4592d086e24e_analysis.xml","4abf2da7f5dc27b2511d3eb15d15cc08","67144036-a800-4ab4-bcc9-653b4154aa6e",2124,"2016-09-29T21:13:48.260867-05:00","a0962c9a-425c-4469-884f-4592d086e24e_experiment.xml","1803b667c873cdfddf44b5b41c4b5d52","8ab556bf-71f5-4018-a74d-03149e69d80c",2628,"2016-09-29T19:26:52.980595-05:00","a0962c9a-425c-4469-884f-4592d086e24e_run.xml","78ab8dd82b374df747fc775ba04f8823","489f9db9-73ae-4f06-ac25-a1667a45f4ec",354,"2016-09-08T11:57:10.096947-05:00","TCGA-UC-A7PF","2016-09-02T19:00:57.813938-05:00","female","TCGA-UC-A7PF_demographic",1955,"not reported","b7eaaa47-3278-5be8-b7df-decf47e3ccc1","not reported",2006,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","UC","5f4f7a1f-2e8a-5fac-ad28-5f6f1142d6e1","University of Washington","not reported","c53.9","TCGA-UC-A7PF_diagnosis","not reported",16412,"dead","8070/3",2859,NA,"7d80496e-9072-5e5f-83bb-33d67467b4cf","c53.9",-16412,"TCGA-UC-A7PF_treatment","f88823aa-fd6a-579a-9382-abeb6ec2b12e","01","true","TCGA-UC-A7PF-01A",NA,"c0ace01f-ba75-4fcc-a95d-8ed9c24596a8",FALSE,"EF390F2F-A13F-4661-86C6-2679E4FAEE72","Primary Tumor",NA,5050,210,NA,1379894400,"11",30,"TCGA-UC-A7PF-01A-11",60,NA,10,NA,0,NA,30,NA,"2016-09-08T11:57:10.096947-05:00",NA,70,NA,10,NA,"TOP",NA,10,NA,"26149acb-ccfd-4aa5-b66b-2285aeae2b80",NA,"TCGA-UC-A7PF-01A-01-TSA",NA,60,NA,"f14df4bd-dd24-46fa-9a02-8c1463cc035a","RNA","TCGA-UC-A7PF-01A-11R","570f5618-a90f-4c95-ab55-49ce57a9d23c",1.87,0.15,"UV Spec","R","23","TCGA-UC-A7PF-01A-11R-A352-07","abb75efe-7d8f-4d43-a04b-8a97f2eda7b8",0.15,NA,210,NA,NA,"4869085f-3297-5bfb-819e-f11a2a71a86e","TCGA-UC-A7PF_exposure","UNCID_2449424.abb75efe-7d8f-4d43-a04b-8a97f2eda7b8.140325_UNC11-SN627_0349_AC3KB8ACXX_1_GATCAG.tar.gz","2014-05-08T22:33:04.000Z","2014-05-08T23:49:01.000Z","A0962C9A-425C-4469-884F-4592D086E24E","C0ACE01F-BA75-4FCC-A95D-8ED9C24596A8","Unaligned reads",5023643999,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","ABB75EFE-7D8F-4D43-A04B-8A97F2EDA7B8","University of North Carolina","566076dfe4b0b37b3d9908b7","1451821E-DD49-41FA-A52E-32F8524FFE82","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F14DF4BD-DD24-46FA-9A02-8C1463CC035A","2014-05-08T23:49:01.000Z","570F5618-A90F-4C95-AB55-49CE57A9D23C","United States","NO",1,NA,"Primary Tumor","University of Washington",5050,"F14DF4BD-DD24-46FA-9A02-8C1463CC035A",NA,"UC","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1F3D85EE-2B7F-4EDF-B976-4471D4AE5C08.txt",210,"TCGA-UC-A7PF-01A",NA,NA,"TCGA",1999,"TCGA-UC-A7PF_NTE-1",NA,NA,"C0ACE01F-BA75-4FCC-A95D-8ED9C24596A8",44,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1F3D85EE-2B7F-4EDF-B976-4471D4AE5C08.txt","Dead",2859,"TCGA-UC-A7PF",NA,NA,NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",361,NA,NA,NA,NA,11,30,"26149ACB-CCFD-4AA5-B66B-2285AEAE2B80","B66E4D9F-7783-41FA-95A2-9537CC4886FE","UNCID_2449424.abb75efe-7d8f-4d43-a04b-8a97f2eda7b8.140325_UNC11-SN627_0349_AC3KB8ACXX_1_GATCAG.tar.gz","TCGA-UC-A7PF-01A-11",60,0,10,70,30,"TOP",10,10,"TCGA-UC-A7PF-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-UC-A7PF",NA,"UC","A7PF","YES","C53.9","8070/3","C53.9","NO","YES",-16412,"FEMALE",NA,NA,"No","No","Dead",NA,2859,NA,NA,NA,"NO",4,2,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,1999,"Cone Biopsy / LEEP","YES",30,5,"G2",NA,2,NA,NA,NA,NA,"2009",7,NA,"T1b1N1M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
116784232,112044665,5348096749,"51DA2568-32EA-4668-9876-4B6E7CA68860.bw","14c65927-b9dd-4ef6-9917-db7bc431ff2f","51da2568-32ea-4668-9876-4b6e7ca68860","2016-08-05T09:23:14.193807-05:00","UNCID_2187245.edd006f4-1914-48b6-84d9-420a09dd82d1.120921_UNC16-SN851_0181_AD14JFACXX_6_GATCAG.tar.gz","fea6fa88-4ebb-4971-b614-8c1e2eaa24ae",5085452097,"Illumina HiSeq","c2faf4ed034a48319d27f7ed8e619c83","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:04:32.560487-05:00","2016-05-03T11:02:00.403413-05:00","fea6fa88-4ebb-4971-b614-8c1e2eaa24ae_analysis.xml","0169e991903734c7e358596b3e759584","84d365f2-97f2-43b5-a27b-41d14ef48744",2124,"2016-09-29T20:22:15.411308-05:00","fea6fa88-4ebb-4971-b614-8c1e2eaa24ae_experiment.xml","6d367ad672bf40a7bf287bf6f4f3293d","6aa13146-ba3f-45ea-bf54-076893bdbb7d",2431,"2016-09-29T22:49:36.824414-05:00","fea6fa88-4ebb-4971-b614-8c1e2eaa24ae_run.xml","9481410bcbd6a4e84b8135999f0cb63d","c5ef521c-3760-49df-8a34-1319c8140ec0",354,"2016-09-08T11:49:11.683196-05:00","TCGA-C5-A0TN","2016-09-02T18:57:17.167065-05:00","female","TCGA-C5-A0TN_demographic",1976,"black or african american","9363b086-fb01-53d8-99a1-022b62baeb53","not hispanic or latino",1997,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A0TN_diagnosis","not reported",7760,"dead","8071/3",348,NA,"c0c552e7-6e55-515d-bc30-e4c916d0d612","c53.9",-7760,"TCGA-C5-A0TN_treatment","f4a84835-fe88-50f6-9fbb-32c3e482039f","01","true","TCGA-C5-A0TN-01A",NA,"59b0b757-7d08-4b3e-9974-fd02747d3665",FALSE,"33FE7DA3-EDB0-4301-BA6A-C51B75312FCA","Primary Tumor",NA,4740,170,NA,1285200000,"21",20,"TCGA-C5-A0TN-01A-21",95,90,0,10,0,0,5,5,"2016-09-08T11:49:11.683196-05:00","2016-09-08T11:49:11.683196-05:00",30,30,20,20,"BOTTOM","TOP",0,5,"8429aa45-6346-4fed-84d2-eb6b53838997","289949db-b8a0-40ad-9cb2-a131f30f8bea","TCGA-C5-A0TN-01A-02-BSB","TCGA-C5-A0TN-01A-02-MSB",95,90,"aeeae1a9-75b2-4811-a8a4-6f8da3bd887a","RNA","TCGA-C5-A0TN-01A-21R","ae84ced1-3b38-4a1a-ac68-fe4b52c1a864",1.7,0.15,"UV Spec","R","23","TCGA-C5-A0TN-01A-21R-A14Y-07","edd006f4-1914-48b6-84d9-420a09dd82d1",0.15,NA,55,NA,NA,"eaa5f362-04c9-569a-ade8-76f6f4ac1da7","TCGA-C5-A0TN_exposure","UNCID_2187245.edd006f4-1914-48b6-84d9-420a09dd82d1.120921_UNC16-SN851_0181_AD14JFACXX_6_GATCAG.tar.gz","2013-09-17T04:46:04.000Z","2013-09-17T05:08:01.000Z","FEA6FA88-4EBB-4971-B614-8C1E2EAA24AE","59B0B757-7D08-4B3E-9974-FD02747D3665","Unaligned reads",5085452097,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","EDD006F4-1914-48B6-84D9-420A09DD82D1","University of North Carolina","564a3d67e4b0298dd2c90d3f","14C65927-B9DD-4EF6-9917-DB7BC431FF2F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AEEAE1A9-75B2-4811-A8A4-6F8DA3BD887A","2013-09-17T05:08:01.000Z","AE84CED1-3B38-4A1A-AC68-FE4B52C1A864","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4740,"AEEAE1A9-75B2-4811-A8A4-6F8DA3BD887A",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.40F6A1D0-844F-412D-94CF-5F5BA0FD62E5.txt",170,"TCGA-C5-A0TN-01A",NA,"1E4E1C91-1CF4-4AE9-A35F-599B3586D121","TCGA",1997,NA,NA,"WITH TUMOR","59B0B757-7D08-4B3E-9974-FD02747D3665",21,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.40F6A1D0-844F-412D-94CF-5F5BA0FD62E5.txt","Dead",348,"TCGA-C5-A0TN","NOT HISPANIC OR LATINO","580778C0-44D2-4307-B52C-EF7DAEFF20A4",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b","8071/3","FEMALE","C53.9",127,NA,"A6534FAD-4FCB-482A-A830-654FAB429416","BLACK OR AFRICAN AMERICAN",NA,21,20,"8429AA45-6346-4FED-84D2-EB6B53838997","AE84CED1-3B38-4A1A-AC68-FE4B52C1A864","TCGA-C5-A0TN-01A-21R-A14X-13_mirna.bam","TCGA-C5-A0TN-01A-21",95,0,0,30,5,"BOTTOM",0,20,"TCGA-C5-A0TN-01A-02-BSB",95,"Cisplatin","Chemotherapy","TCGA-C5-A0TN-D30749","TCGA-C5-A0TN-R30750","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",348,"TCGA-C5-A0TN-F30748","TCGA-C5-A0TN",NA,"C5","A0TN","YES","C53.9","8071/3","C53.9","NO","YES",-7760,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,348,NA,NA,"WITH TUMOR","NO",23,8,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,21,1997,"Other method, specify:","YES",10,2,"G3",NA,1,NA,NA,NA,NA,"1995",8,NA,"T1bN1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
128447396,126829860,6053046246,"78C26A05-2084-494D-83D3-C52C1B800F4C.bw","1636242c-12da-412e-a362-914a20add708","78c26a05-2084-494d-83d3-c52c1b800f4c","2016-08-09T14:00:59.149971-05:00","UNCID_2169023.9ecc833d-b92d-474a-a981-d6e0c12292e0.130606_UNC9-SN296_0373_BD28T1ACXX_3_CGATGT.tar.gz","899e8094-48b7-4837-9f0a-28ca135d4ef0",6302215191,"Illumina HiSeq","6001382a04297682b0cef5d9c7b02c86","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:43:48.067441-05:00","2016-05-03T11:06:28.633852-05:00","899e8094-48b7-4837-9f0a-28ca135d4ef0_analysis.xml","9dc9b15f74eaf8ccaef1f0a0a076a991","77d738b6-be05-42d9-aa0d-196e166baf2c",2121,"2016-08-13T06:54:15.624791-05:00","899e8094-48b7-4837-9f0a-28ca135d4ef0_experiment.xml","2e368d78711035b1154cb5c38fe92fe8","782b5c8c-5645-496f-805b-e8c4d114fa80",2431,"2016-09-29T20:33:36.690354-05:00","899e8094-48b7-4837-9f0a-28ca135d4ef0_run.xml","3da04557286ef021651b282dccb021d8","71852e5e-1363-4c37-aae1-3b5605b16f95",354,"2016-09-08T12:04:57.360690-05:00","TCGA-EA-A5O9","2016-09-02T18:59:50.798210-05:00","female","TCGA-EA-A5O9_demographic",1973,"white","59bc6c10-b720-5d8f-8e93-28ab1e7b4511","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.1","TCGA-EA-A5O9_diagnosis","not reported",14472,"alive","8070/3",NA,788,"5cd74813-7d92-5609-a4a6-d4aa61a77d85","c53.1",-14472,"TCGA-EA-A5O9_treatment","0a15f41d-449d-5b05-9c3a-698c49b4c241","01","true","TCGA-EA-A5O9-01A",NA,"8e088a1e-d5dd-4b3c-a520-dd7fbc716d00",FALSE,"289C553F-685F-4308-B429-C741585BD25F","Primary Tumor",NA,112,330,NA,1360800000,"11",30,"TCGA-EA-A5O9-01A-11",90,NA,0,NA,0,NA,15,NA,"2016-09-08T12:04:57.360690-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"2926c3d0-689a-446f-b4d3-8d77d4c84416",NA,"TCGA-EA-A5O9-01A-01-TSA",NA,85,NA,"69ac7701-cdb3-4600-a0b7-2ef6a5651c9b","RNA","TCGA-EA-A5O9-01A-11R","195bd23f-2904-4bb9-9d5d-af6efe269264",1.79,0.15,"UV Spec","R","23","TCGA-EA-A5O9-01A-11R-A28H-07","9ecc833d-b92d-474a-a981-d6e0c12292e0",0.15,NA,99,38.671875,160,"d61c8529-a48a-5563-88a7-24867275789d","TCGA-EA-A5O9_exposure","UNCID_2169023.9ecc833d-b92d-474a-a981-d6e0c12292e0.130606_UNC9-SN296_0373_BD28T1ACXX_3_CGATGT.tar.gz","2013-09-20T03:26:05.000Z","2013-09-20T03:40:02.000Z","899E8094-48B7-4837-9F0A-28CA135D4EF0","8E088A1E-D5DD-4B3C-A520-DD7FBC716D00","Unaligned reads",6302215191,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9ECC833D-B92D-474A-A981-D6E0C12292E0","University of North Carolina","564a3a10e4b0ef12181a043d","1636242C-12DA-412E-A362-914A20ADD708","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","69AC7701-CDB3-4600-A0B7-2EF6A5651C9B","2013-09-20T03:40:02.000Z","195BD23F-2904-4BB9-9D5D-AF6EFE269264","Ukraine","NO",1,NA,"Primary Tumor","Asterand",112,"69AC7701-CDB3-4600-A0B7-2EF6A5651C9B",NA,"EA","nationwidechildrens.org_biospecimen.TCGA-EA-A5O9.xml",330,"TCGA-EA-A5O9-01A",NA,NA,"TCGA",2012,"TCGA-EA-A5O9_NTE-1","Complete Remission/Response","TUMOR FREE","8E088A1E-D5DD-4B3C-A520-DD7FBC716D00",39,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.F287E787-B947-4C1D-9B34-66D426732136.txt","Alive",NA,"TCGA-EA-A5O9","NOT HISPANIC OR LATINO","B65064F9-7541-43D5-8F63-D1FF7DE466F1","NO",27,"No","Cervix","C53.1","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.1",297,NA,"B8E32CDA-72B6-4792-8A67-AD9EE06DAAEB","WHITE",NA,11,30,"2926C3D0-689A-446F-B4D3-8D77D4C84416","24440A2B-3846-4B55-AC8F-9048DE193CC9","TCGA-EA-A5O9-01A-11R-A28L-13_mirna.bam","TCGA-EA-A5O9-01A-11",90,0,0,0,15,"TOP",0,0,"TCGA-EA-A5O9-01A-01-TSA",85,NA,NA,NA,"TCGA-EA-A5O9-R56060","External","Primary Tumor Field","TCGA-EA-A5O9-F68730_NTE-1","NO",788,"TUMOR FREE","Alive",NA,"TCGA-EA-A5O9-F68730","TCGA-EA-A5O9",NA,"EA","A5O9","YES","C53.1","8070/3","C53.1","YES","NO",-14472,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",27,NA,NA,NA,"TUMOR FREE","YES",22,5,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,39,2012,"Biopsy (cervical / CT-guided / Other)","YES",10,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
109452816,108666368,5191106064,"2B5DD791-7692-4721-9519-7D7D49B52570.bw","173174f8-9d95-40b0-9f88-a4bf4ccb521b","2b5dd791-7692-4721-9519-7d7d49b52570","2016-08-09T14:40:46.727501-05:00","UNCID_2654379.be0d33e0-2aa6-48bb-b8e3-69259e28f8e3.140908_UNC11-SN627_0381_BC5DEKACXX_8_ATTCCT.tar.gz","219e50f9-9a26-4fcf-8560-326015b37b56",4392721382,"Illumina HiSeq","342d45809d0dc556e07ab4d3437744cf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:06:03.099612-05:00","2016-05-03T12:08:10.830175-05:00","219e50f9-9a26-4fcf-8560-326015b37b56_analysis.xml","f619fa9e17342e8b2d2f4ae548c4a32c","ab1a3f81-6ba9-446d-b463-2fd1e1544ef7",2124,"2016-09-29T18:15:36.022568-05:00","219e50f9-9a26-4fcf-8560-326015b37b56_experiment.xml","15183487a9c12d76985edec421cffca6","1ba87f25-5bc6-4832-a92d-ab22b2cc2b52",2628,"2016-09-29T22:15:38.406841-05:00","219e50f9-9a26-4fcf-8560-326015b37b56_run.xml","e04d5c0114e407f4049f45077af8b54e","b0ecafb1-230d-4f5f-8abd-31b26e8a5c8c",354,"2016-09-08T11:14:15.980807-05:00","TCGA-VS-AA62","2016-09-02T18:54:40.383203-05:00","female","TCGA-VS-AA62_demographic",1958,"white","9aa890fb-3711-5bff-9568-a429bd870b26","not reported",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-AA62_diagnosis","not reported",18792,"dead","8070/3",469,NA,"5df12ec1-0ea0-5c40-8617-8b1d716abbd7","c53.9",-18792,"TCGA-VS-AA62_treatment","71f33a99-891f-5294-958b-f9a45421bc0a","01","true","TCGA-VS-AA62-01A",NA,"2cbea378-8e25-4497-92e7-1230d90bfc70",FALSE,"33FDBF1D-90D6-4D05-9AC9-9983421A4CAF","Primary Tumor",NA,1608,60,NA,1394409600,"11",30,"TCGA-VS-AA62-01A-11",75,NA,20,NA,0,NA,20,NA,"2016-09-08T11:14:15.980807-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"596fb6d9-2cab-437d-91c8-8b6a541c3761",NA,"TCGA-VS-AA62-01A-01-TS1",NA,75,NA,"a81aa17c-7d82-43f6-b744-0f4a66ff32a4","RNA","TCGA-VS-AA62-01A-11R","dc44b792-6202-4a6b-9dea-c0c79e13d1c1",1.89,0.17,"UV Spec","R","23","TCGA-VS-AA62-01A-11R-A42T-07","be0d33e0-2aa6-48bb-b8e3-69259e28f8e3",0.17,NA,67,27.5312294543064,156,"a2c3d4dc-e727-5dca-b0dc-1620598e7bb3","TCGA-VS-AA62_exposure","UNCID_2654379.be0d33e0-2aa6-48bb-b8e3-69259e28f8e3.140908_UNC11-SN627_0381_BC5DEKACXX_8_ATTCCT.tar.gz","2014-11-05T05:47:03.000Z","2014-11-05T06:00:06.000Z","219E50F9-9A26-4FCF-8560-326015B37B56","2CBEA378-8E25-4497-92E7-1230D90BFC70","Unaligned reads",4392721382,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","BE0D33E0-2AA6-48BB-B8E3-69259E28F8E3","University of North Carolina","564a3a48e4b093830b68e8e3","173174F8-9D95-40B0-9F88-A4BF4CCB521B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A81AA17C-7D82-43F6-B744-0F4A66FF32A4","2014-11-05T06:00:06.000Z","DC44B792-6202-4A6B-9DEA-C0C79E13D1C1","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1608,"A81AA17C-7D82-43F6-B744-0F4A66FF32A4",NA,"VS","fae32cdfcd82b2e8dc7b0e0a68c6e7e1.bam.bai",60,"TCGA-VS-AA62-01A",NA,"98AE48EA-B27C-4014-8A6C-E1759052C4A4","TCGA",2009,"TCGA-VS-AA62_NTE-1","Progressive Disease","WITH TUMOR","36425D33-2055-4F43-BBEC-D8F22CE31AAC",51,"TCGA-VS-AA62-01A-11R-A42V-13_mirna.bam","Dead",469,"TCGA-VS-AA62",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"FA3EE9E0-6608-4FA3-8CD4-8FE22B9C249B","WHITE",NA,11,30,"596FB6D9-2CAB-437D-91C8-8B6A541C3761","DC44B792-6202-4A6B-9DEA-C0C79E13D1C1","fae32cdfcd82b2e8dc7b0e0a68c6e7e1.bam.bai","TCGA-VS-AA62-01A-11",75,0,20,40,20,"TOP",5,20,"TCGA-VS-AA62-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-VS-AA62-D68117","TCGA-VS-AA62-R68118","Internal","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-AA62",NA,"VS","AA62","YES","C53.9","8070/3","C53.9","NO","YES",-18792,"FEMALE","WHITE",NA,"No","No","Dead",NA,469,NA,NA,"WITH TUMOR","YES",13,11,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Progressive Disease","2009",13,NA,"T2bNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
151001352,148496011,7085371362,"C0BBE26A-79C8-4392-9978-7C420B3786B5.bw","183e8d87-3476-46bc-a989-ed4b09809227","c0bbe26a-79c8-4392-9978-7c420b3786b5","2016-08-26T10:52:09.318252-05:00","UNCID_2553111.ea9fda3a-9efa-4847-aea0-d85f22ab14ca.140404_UNC11-SN627_0350_BC3K66ACXX_4_GCCAAT.tar.gz","d7a1cf5b-7fbe-4eb3-b5b5-b48760fee7db",6355996405,"Illumina HiSeq","e61282ceb5ef7ce3e473040dc0c5cf87","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:40:42.351911-05:00","2016-05-03T11:54:19.908545-05:00","d7a1cf5b-7fbe-4eb3-b5b5-b48760fee7db_analysis.xml","9e525cf9b1cbae3dddaeab0d9249a049","05aa5a8f-10b2-4e87-a3c3-e042625eef88",2124,"2016-09-29T22:47:34.339855-05:00","d7a1cf5b-7fbe-4eb3-b5b5-b48760fee7db_experiment.xml","f187dc9da2ded610db777268f58e8f3d","c4b0eccd-ce22-450d-bcfa-fc1abf5e1e1f",2628,"2016-09-29T18:43:29.904138-05:00","d7a1cf5b-7fbe-4eb3-b5b5-b48760fee7db_run.xml","164adead1089b7a3d453c055ae9a2e61","2d3fc155-f72d-4b65-a505-b90ffd2b5b7c",354,"2016-09-08T11:47:19.902708-05:00","TCGA-C5-A8XH","2016-09-02T19:01:07.042368-05:00","female","TCGA-C5-A8XH_demographic",1968,"white","e02bfaec-c36f-5e7c-bf2c-a6c5b150e4d2","not hispanic or latino",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8XH_diagnosis","not reported",14444,"dead","8070/3",1394,NA,"ab2938e5-b8f5-52d9-b5ba-02b6f469e239","c53.9",-14444,"TCGA-C5-A8XH_treatment","49d064c7-280a-58e6-98c4-d750b1d9e3e2","01","true","TCGA-C5-A8XH-01A",NA,"009db85b-200f-4b6c-a5aa-330f9eba2ae1",FALSE,"3902118B-D919-41B7-99D1-0D5140967526","Primary Tumor",NA,2396,40,NA,1387238400,"11",20,"TCGA-C5-A8XH-01A-11",80,NA,0,NA,5,NA,15,NA,"2016-09-08T11:47:19.902708-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"c25d3022-c205-4b5f-83ed-b448b9d30f27",NA,"TCGA-C5-A8XH-01A-01-TS1",NA,80,NA,"3655a005-728e-47ab-acd7-c3493623ef72","RNA","TCGA-C5-A8XH-01A-11R","ca775763-0937-44f0-aae8-31daf602be34",1.78,0.18,"UV Spec","R","23","TCGA-C5-A8XH-01A-11R-A37O-07","ea9fda3a-9efa-4847-aea0-d85f22ab14ca",0.18,1.0958904109589,60,22.5827091723437,163,"aba63e0d-b514-50dc-92b4-e15e056bfeb0","TCGA-C5-A8XH_exposure","UNCID_2553111.ea9fda3a-9efa-4847-aea0-d85f22ab14ca.140404_UNC11-SN627_0350_BC3K66ACXX_4_GCCAAT.tar.gz","2014-07-31T01:06:04.000Z","2014-07-31T01:27:43.000Z","D7A1CF5B-7FBE-4EB3-B5B5-B48760FEE7DB","009DB85B-200F-4B6C-A5AA-330F9EBA2AE1","Unaligned reads",6355996405,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","EA9FDA3A-9EFA-4847-AEA0-D85F22AB14CA","University of North Carolina","564a3f51e4b09c884b258aea","183E8D87-3476-46BC-A989-ED4B09809227","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3655A005-728E-47AB-ACD7-C3493623EF72","2014-07-31T01:27:43.000Z","CA775763-0937-44F0-AAE8-31DAF602BE34","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2396,"3655A005-728E-47AB-ACD7-C3493623EF72",NA,"C5","2d4b4e590f0423cda9c91ca7440f72ec.bam",40,"TCGA-C5-A8XH-01A",NA,NA,"TCGA",2007,"TCGA-C5-A8XH_NTE-1",NA,"TUMOR FREE","DD752DCE-0439-4C6D-A343-F0CCCF46BBE1",39,"nationwidechildrens.org_clinical.TCGA-C5-A8XH.xml","Dead",1394,"TCGA-C5-A8XH","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",380,NA,NA,"WHITE",NA,11,20,"C25D3022-C205-4B5F-83ED-B448B9D30F27","4B930528-2507-425C-BDB9-12F5376BC6AC","2d4b4e590f0423cda9c91ca7440f72ec.bam","TCGA-C5-A8XH-01A-11",80,5,0,10,15,"TOP",0,0,"TCGA-C5-A8XH-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A8XH",NA,"C5","A8XH","YES","C53.9","8070/3","C53.9","NO","YES",-14444,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1394,NA,NA,"TUMOR FREE","YES",17,4,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,39,2007,"Biopsy (cervical / CT-guided / Other)","YES",33,0,NA,NA,4,2007,20,NA,NA,"2009",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
127365682,124787937,5961399885,"F35A8359-3A7A-414F-8A5C-D278F3B45387.bw","185e1520-92ee-4af5-af15-fbeefb352c99","f35a8359-3a7a-414f-8a5c-d278f3b45387","2016-08-05T05:47:09.803527-05:00","UNCID_2186508.06121F93-9719-4D96-94E1-5B8AFCC347A7.121015_UNC11-SN627_0256_AD15B2ACXX_1_TAGCTT.tar.gz","d4b48d92-9c67-4311-afa7-b59e3abc9cd3",5194319843,"Illumina HiSeq","c0a048341a1e30705c0c107329dc76be","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:23.259463-05:00","2016-05-03T11:00:24.467483-05:00","d4b48d92-9c67-4311-afa7-b59e3abc9cd3_analysis.xml","252faf7a307a9777fc5e620378f5ba31","5df318ef-d307-4aaa-ab0d-d7dd641ea136",2124,"2016-10-07T16:03:21.744151-05:00","d4b48d92-9c67-4311-afa7-b59e3abc9cd3_experiment.xml","c73603499ca8aa9e1d4a3b3b084271c8","db4ffa0c-b250-4748-895c-9cc398b47648",2431,"2016-09-29T22:13:12.059804-05:00","d4b48d92-9c67-4311-afa7-b59e3abc9cd3_run.xml","41acfee754cebc32012294d90a46e6a7","af65086e-6262-4484-9dc4-21c151f2751b",354,"2016-09-08T11:20:54.947031-05:00","TCGA-C5-A2LS","2016-09-02T18:59:25.983032-05:00","female","TCGA-C5-A2LS_demographic",1968,"white","e0b1e1c6-3ca9-5976-baef-06676aec0e9c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LS_diagnosis","not reported",13857,"alive","8380/3",NA,1345,"a7af268e-f1e1-519d-b5f3-0eb5f1b379ae","c53.9",-13857,"TCGA-C5-A2LS_treatment","11f29caf-caab-5ac7-a46d-83c94adca1c2","01","false","TCGA-C5-A2LS-01A",NA,"79248694-77e1-4fbe-8c94-64a308fc982d",FALSE,"0D3F75AE-DFF5-47DB-A875-78D35DE393E0","Primary Tumor",NA,2199,220,NA,1336608000,"22",30,"TCGA-C5-A2LS-01A-22",65,NA,0,NA,0,NA,0,NA,"2016-09-08T11:20:54.947031-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"b33ee8e8-fc69-42d3-b925-ba0b97823798",NA,"TCGA-C5-A2LS-01A-02-TS2",NA,100,NA,"b317d5ab-d499-4f68-b513-da9898d92db3","RNA","TCGA-C5-A2LS-01A-22R","788d1403-1f91-4f5b-85f6-9af2f3192b0f",1.84,0.16,"UV Spec","R","23","TCGA-C5-A2LS-01A-22R-A22U-07","06121f93-9719-4d96-94e1-5b8afcc347a7",0.16,0.602739726027397,92,30.7394166193324,173,"20c81054-0d26-5c87-a5e2-b78abac76ba9","TCGA-C5-A2LS_exposure","UNCID_2186508.06121F93-9719-4D96-94E1-5B8AFCC347A7.121015_UNC11-SN627_0256_AD15B2ACXX_1_TAGCTT.tar.gz","2013-09-16T10:16:04.000Z","2013-09-16T10:48:01.000Z","D4B48D92-9C67-4311-AFA7-B59E3ABC9CD3","79248694-77E1-4FBE-8C94-64A308FC982D","Unaligned reads",5194319843,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","06121F93-9719-4D96-94E1-5B8AFCC347A7","University of North Carolina","564a3a05e4b0ef12181a008f","185E1520-92EE-4AF5-AF15-FBEEFB352C99","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B317D5AB-D499-4F68-B513-DA9898D92DB3","2013-09-16T10:48:01.000Z","788D1403-1F91-4F5B-85F6-9AF2F3192B0F","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2199,"B317D5AB-D499-4F68-B513-DA9898D92DB3",NA,"C5","TCGA-C5-A2LS-01A-22R-A22V-13_mirna.bam",220,"TCGA-C5-A2LS-01A",NA,NA,"TCGA",2005,"TCGA-C5-A2LS_NTE-1","Complete Remission/Response","TUMOR FREE","82D8E275-5D14-4CB5-9C88-2D0E3F863A27",37,"nationwidechildrens.org_clinical.TCGA-C5-A2LS.xml","Alive",NA,"TCGA-C5-A2LS","NOT HISPANIC OR LATINO","779A6701-1102-4C7F-9234-AB794E114F68","NO",1345,"No","Cervix","C53.9","N0","Endocervical Adenocarcinoma of the Usual Type",NA,NA,"Stage IB2",NA,NA,"T1b2","8380/3","FEMALE","C53.9",236,NA,NA,"WHITE",NA,22,30,"B33EE8E8-FC69-42D3-B925-BA0B97823798","943D9038-9E6A-4BB5-B07E-FB4958C45745","TCGA-C5-A2LS-01A-22R-A22V-13_mirna.bam","TCGA-C5-A2LS-01A-22",65,0,0,0,0,"TOP",0,0,"TCGA-C5-A2LS-01A-02-TS2",100,NA,NA,NA,NA,NA,NA,"TCGA-C5-A2LS-F55254_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A2LS-F55254","TCGA-C5-A2LS",NA,"C5","A2LS","YES","C53.9","8380/3","C53.9","NO","YES",-13857,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1345,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,37,2005,"Biopsy (cervical / CT-guided / Other)","YES",41,0,"G1",NA,2,NA,11,NA,"Complete Remission/Response","1995",8,NA,"T1b2N0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120348074,117924954,5624840157,"8C9BA49C-1270-491D-A234-AE1B1C0609BA.bw","1a3d5555-7013-4f06-878a-98944f075b63","8c9ba49c-1270-491d-a234-ae1b1c0609ba","2016-08-25T13:02:05.302636-05:00","UNCID_2553093.ca559bd7-454b-463c-9751-1f772f738599.140416_UNC11-SN627_0353_BC42B0ACXX_1_GTGAAA.tar.gz","32911f44-d9f3-4e72-8f60-a9ab31b51ed4",5391970211,"Illumina HiSeq","a135526ce1d812fcfab67d4f418c875a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:02:45.974738-05:00","2016-05-03T11:54:19.885282-05:00","32911f44-d9f3-4e72-8f60-a9ab31b51ed4_analysis.xml","a33b81540a6737b87618ea6f18e121b4","f350fc35-1ce1-45b4-850f-59de48272d8a",2124,"2016-08-27T02:29:25.299115-05:00","32911f44-d9f3-4e72-8f60-a9ab31b51ed4_experiment.xml","ed2b639da0e6c3ca1fbf71a0255c439e","015312d0-ff67-48ad-a59e-3d78b259aded",2628,"2016-09-29T17:54:04.403534-05:00","32911f44-d9f3-4e72-8f60-a9ab31b51ed4_run.xml","8dbefd7a9753a8eae1eecfa8b5d6bfe5","0e3754be-2508-4bf3-a7b7-a0c6cff2e2ce",354,"2016-09-08T11:51:01.457762-05:00","TCGA-VS-A8QA","2016-09-02T19:01:19.747917-05:00","female","TCGA-VS-A8QA_demographic",1967,"not reported","26b27bad-6565-503d-b320-bf3e4aa1a844","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8QA_diagnosis","not reported",16072,"alive","8070/3",NA,1099,"c20e9cbe-7f07-57b8-a9c2-26915acbe276","c53.9",-16072,"TCGA-VS-A8QA_treatment","df1262c3-4da3-5544-ae90-ac171ce76f24","01","false","TCGA-VS-A8QA-01A",NA,"383da56f-6642-433e-aa69-5c88f105e836",FALSE,"EECF9BD1-22C3-41FC-8357-8ABB54515DE6","Primary Tumor",NA,757,70,NA,1386806400,"11",30,"TCGA-VS-A8QA-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:51:01.457762-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"7c973f56-1915-404b-8ff7-3482308e72df",NA,"TCGA-VS-A8QA-01A-01-TS1",NA,70,NA,"d404ca31-1d28-4f34-8fbb-177db48ae517","RNA","TCGA-VS-A8QA-01A-11R","75d51f4e-aa50-4ec4-8c87-b34a8a8cfd9d",1.92,0.18,"UV Spec","R","23","TCGA-VS-A8QA-01A-11R-A37O-07","ca559bd7-454b-463c-9751-1f772f738599",0.18,NA,67,26.171875,160,"9ed661df-aeec-5175-ba9b-74d241a06672","TCGA-VS-A8QA_exposure","UNCID_2553093.ca559bd7-454b-463c-9751-1f772f738599.140416_UNC11-SN627_0353_BC42B0ACXX_1_GTGAAA.tar.gz","2014-07-30T21:21:04.000Z","2014-07-30T21:46:59.000Z","32911F44-D9F3-4E72-8F60-A9AB31B51ED4","383DA56F-6642-433E-AA69-5C88F105E836","Unaligned reads",5391970211,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CA559BD7-454B-463C-9751-1F772F738599","University of North Carolina","564a3990e4b0ef121819db22","1A3D5555-7013-4F06-878A-98944F075B63","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D404CA31-1D28-4F34-8FBB-177DB48AE517","2014-07-30T21:46:59.000Z","75D51F4E-AA50-4EC4-8C87-B34A8A8CFD9D","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",757,"D404CA31-1D28-4F34-8FBB-177DB48AE517",NA,"VS","TCGA-VS-A8QA-01A-11R-A37P-13_mirna.bam",70,"TCGA-VS-A8QA-01A",NA,NA,"TCGA",2011,"TCGA-VS-A8QA_NTE-1","Complete Remission/Response","TUMOR FREE","652B235D-0463-42A9-A650-011FD2568E5E",44,"nationwidechildrens.org_clinical.TCGA-VS-A8QA.xml","Alive",NA,"TCGA-VS-A8QA",NA,"445DE3B3-4D85-4603-840C-8FA190404E07","NO",708,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",380,NA,"B0D9DCA4-0F41-44A5-8B66-1C702A70C6DB",NA,NA,11,30,"7C973F56-1915-404B-8FF7-3482308E72DF","75D51F4E-AA50-4EC4-8C87-B34A8A8CFD9D","TCGA-VS-A8QA-01A-11R-A37P-13_mirna.bam","TCGA-VS-A8QA-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-VS-A8QA-01A-01-TS1",70,NA,NA,NA,"TCGA-VS-A8QA-R61993","External","Regional site","TCGA-VS-A8QA-F67672_NTE-1","NO",1099,"TUMOR FREE","Alive",NA,"TCGA-VS-A8QA-F67672","TCGA-VS-A8QA",NA,"VS","A8QA","YES","C53.9","8070/3","C53.9","NO","YES",-16072,"FEMALE",NA,NA,"No","No","Alive",708,NA,NA,NA,"TUMOR FREE","YES",30,3,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2011,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,0,"Preoperative",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
105527326,104628074,5000317059,"CA104B57-B160-4148-8A0A-D34BB3E8D88A.bw","1c0b5c18-8760-4483-a88c-1d1d89f61998","ca104b57-b160-4148-8a0a-d34bb3e8d88a","2016-08-26T11:09:54.458644-05:00","UNCID_2553081.ab32f0f9-4327-4189-9dd7-6951531c6e16.140603_UNC15-SN850_0368_AC4GHHACXX_3_ACAGTG.tar.gz","05a0f9fb-4a88-4450-96ef-d3e9a31ccf32",4406345226,"Illumina HiSeq","fdda7a94ca688205dbffa9a7f4d0795d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:00:26.567435-05:00","2016-05-03T11:54:19.885282-05:00","05a0f9fb-4a88-4450-96ef-d3e9a31ccf32_analysis.xml","a8d8215da7af2b11848ead969db3ea66","f1e77614-7c47-4989-8be0-79337876db56",2124,"2016-09-29T22:03:14.176013-05:00","05a0f9fb-4a88-4450-96ef-d3e9a31ccf32_experiment.xml","81d0f80e43f5e4c417c731119d5775d0","a959b5c8-db28-44ff-910e-a932b8940a21",2628,"2016-09-29T22:26:29.647815-05:00","05a0f9fb-4a88-4450-96ef-d3e9a31ccf32_run.xml","d21dbe11c1c16281bee56ae4060eb3e3","b785e501-6dd4-4f57-9495-173100ab3cb7",354,"2016-09-08T11:34:46.695332-05:00","TCGA-JW-AAVH","2016-09-02T18:54:01.897463-05:00","female","TCGA-JW-AAVH_demographic",1967,"white","f18ed299-3db6-595c-957e-150eea02ab25","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-AAVH_diagnosis","not reported",16894,"alive","8072/3",NA,552,"367ababd-2ddf-535f-bdf3-ecb633d04fe2","c53.9",-16894,"TCGA-JW-AAVH_treatment","bdbda90c-b22b-53d9-b1af-d5fd4e3db615","01","true","TCGA-JW-AAVH-01A",NA,"f5a7f638-f35d-46a2-af49-3ffef7cbec47",FALSE,"DDB7F46F-ABEE-4B05-9993-96E68774AB40","Primary Tumor",NA,104,30,NA,1391644800,"11",25,"TCGA-JW-AAVH-01A-11",85,NA,0,NA,5,NA,5,NA,"2016-09-08T11:34:46.695332-05:00",NA,3,NA,2,NA,"TOP",NA,5,NA,"17b1c8c0-762d-4d74-8a19-6a79e8e890e3",NA,"TCGA-JW-AAVH-01A-01-TS1",NA,85,NA,"30a685ef-33d1-42cb-ab52-b11842501db4","RNA","TCGA-JW-AAVH-01A-11R","823b33c7-2277-45e0-a3e2-63ffa22c6671",1.84,0.18,"UV Spec","R","23","TCGA-JW-AAVH-01A-11R-A38B-07","ab32f0f9-4327-4189-9dd7-6951531c6e16",0.18,1.0958904109589,165,68.678459937565,155,"8635be20-7b44-5bb7-a6d4-217201deab51","TCGA-JW-AAVH_exposure","UNCID_2553081.ab32f0f9-4327-4189-9dd7-6951531c6e16.140603_UNC15-SN850_0368_AC4GHHACXX_3_ACAGTG.tar.gz","2014-07-30T18:06:04.000Z","2014-07-30T18:22:24.000Z","05A0F9FB-4A88-4450-96EF-D3E9A31CCF32","F5A7F638-F35D-46A2-AF49-3FFEF7CBEC47","Unaligned reads",4406345226,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AB32F0F9-4327-4189-9DD7-6951531C6E16","University of North Carolina","564a3a53e4b0ef12181a192b","1C0B5C18-8760-4483-A88C-1D1D89F61998","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","30A685EF-33D1-42CB-AB52-B11842501DB4","2014-07-30T18:22:24.000Z","823B33C7-2277-45E0-A3E2-63FFA22C6671","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",104,"30A685EF-33D1-42CB-AB52-B11842501DB4",NA,"JW","CACTI_p_TCGAb_392_393_394_NSP_GenomeWideSNP_6_G08_1473880.birdseed.data.txt",30,"TCGA-JW-AAVH-01A",NA,NA,"TCGA",2013,"TCGA-JW-AAVH_NTE-1",NA,"TUMOR FREE","F5A7F638-F35D-46A2-AF49-3FFEF7CBEC47",46,"nationwidechildrens.org_clinical.TCGA-JW-AAVH.xml","Alive",NA,"TCGA-JW-AAVH","HISPANIC OR LATINO","66142FA6-FB51-4DA0-981D-74148E3C1E2A","NO",204,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",2,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,25,"17B1C8C0-762D-4D74-8A19-6A79E8E890E3","FED62F90-0151-4C26-B062-F0EA39794AB8","CACTI_p_TCGAb_392_393_394_NSP_GenomeWideSNP_6_G08_1473880.raw.copynumber.data.txt","TCGA-JW-AAVH-01A-11",85,5,0,3,5,"TOP",5,2,"TCGA-JW-AAVH-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,"TCGA-JW-AAVH-F70299_NTE-1","NO",552,"TUMOR FREE","Alive",NA,"TCGA-JW-AAVH-F70299","TCGA-JW-AAVH",NA,"JW","AAVH","YES","C53.9","8072/3","C53.9","YES","NO",-16894,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",204,NA,NA,NA,"TUMOR FREE","YES",3,4,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2013,"Biopsy (cervical / CT-guided / Other)","YES",15,0,"G2",NA,2,NA,20,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,2,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
158440118,156909711,7494700303,"877E18A5-6A7A-4E29-9871-DC7EA14A5F27.bw","1c48393e-7de9-42f6-a6f0-2cbfb8359316","877e18a5-6a7a-4e29-9871-dc7ea14a5f27","2016-08-26T00:17:00.972558-05:00","UNCID_2326834.5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb.131015_UNC11-SN627_0328_BC2NN6ACXX_6_GGCTAC.tar.gz","0519be44-6143-4738-b404-c5d8b6f08ea8",7079078140,"Illumina HiSeq","ddd29eabf7f8bced1d3884b643ac6646","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:16:31.451233-05:00","2016-05-03T11:30:43.411663-05:00","0519be44-6143-4738-b404-c5d8b6f08ea8_analysis.xml","891e196d44a9d269bf0c5270376c7018","d69689ff-6da3-4ed0-9810-fe1088b87c7b",2124,"2016-08-28T15:59:22.669666-05:00","0519be44-6143-4738-b404-c5d8b6f08ea8_experiment.xml","ea59bf1027af0159ed350d4be462baec","f221b78a-4bb2-4138-a031-17ed5a3130a2",2628,"2016-09-29T17:47:57.671486-05:00","0519be44-6143-4738-b404-c5d8b6f08ea8_run.xml","acaf06159a333ab6d91f816e17816207","0a5d7947-1bc3-4ee2-9b42-95da0840936a",354,"2016-09-08T11:35:24.096066-05:00","TCGA-C5-A7CK","2016-09-02T19:00:21.192521-05:00","female","TCGA-C5-A7CK_demographic",1943,"white","326038bc-37b9-5283-a28e-407912e0f5c9","not reported",2012,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CK_diagnosis","not reported",21520,"dead","8070/3",4086,NA,"8e4f7587-e404-5512-98bc-41b6305b7eb8","c53.9",-21520,"TCGA-C5-A7CK_treatment","34c453d9-27dd-50fa-a499-97e6751bb1c1","01","true","TCGA-C5-A7CK-01A",NA,"b770fe62-36a7-4a89-8091-2fdd7af44dad",FALSE,"6E6806E3-7BAD-48EB-AAE9-9C15DAC56B2E","Primary Tumor",NA,4483,130,NA,1377820800,"11",30,"TCGA-C5-A7CK-01A-11",60,NA,0,NA,0,NA,0,NA,"2016-09-08T11:35:24.096066-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"742acb2d-5f8c-4769-82d2-d31e20de4242",NA,"TCGA-C5-A7CK-01A-01-TS1",NA,100,NA,"abc5d03d-1e52-4000-8eca-8bd81223f541","RNA","TCGA-C5-A7CK-01A-11R","a804a79b-d2a0-4d1d-90eb-aa6623d3a3ea",1.91,0.15,"UV Spec","R","23","TCGA-C5-A7CK-01A-11R-A32P-07","5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb",0.15,2.19178082191781,55,20.2020202020202,165,"2b98f934-c104-5924-becb-601cb45ecef2","TCGA-C5-A7CK_exposure","UNCID_2326834.5e38ec7f-6d2a-4e9c-98ee-fc00832d2aeb.131015_UNC11-SN627_0328_BC2NN6ACXX_6_GGCTAC.tar.gz","2014-01-22T08:01:03.000Z","2014-01-22T08:34:01.000Z","0519BE44-6143-4738-B404-C5D8B6F08EA8","B770FE62-36A7-4A89-8091-2FDD7AF44DAD","Unaligned reads",7079078140,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5E38EC7F-6D2A-4E9C-98EE-FC00832D2AEB","University of North Carolina","564a3c5ce4b0298dd2c8b6d4","1C48393E-7DE9-42F6-A6F0-2CBFB8359316","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","ABC5D03D-1E52-4000-8ECA-8BD81223F541","2014-01-22T08:34:01.000Z","A804A79B-D2A0-4D1D-90EB-AA6623D3A3EA","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4483,"ABC5D03D-1E52-4000-8ECA-8BD81223F541",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.6BA5E751-37D0-493C-B9C6-69062263C497.txt",130,"TCGA-C5-A7CK-01A",NA,"BFECC70B-9153-4C18-94FB-E3CC92E38501","TCGA",2001,"TCGA-C5-A7CK_NTE-1",NA,"TUMOR FREE","B770FE62-36A7-4A89-8091-2FDD7AF44DAD",58,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.6BA5E751-37D0-493C-B9C6-69062263C497.txt","Dead",4086,"TCGA-C5-A7CK",NA,NA,"NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IVA",NA,NA,NA,"8070/3","FEMALE","C53.9",335,NA,"127EA116-7E46-4CAF-8797-28761E0A975B","WHITE",NA,11,30,"742ACB2D-5F8C-4769-82D2-D31E20DE4242","EFD3D0A4-D74A-4A10-B9C3-66B910B546AE","TCGA-C5-A7CK-01A-11R-A32K-13.isoform.quantification.txt","TCGA-C5-A7CK-01A-11",60,0,0,5,0,"TOP",0,0,"TCGA-C5-A7CK-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-C5-A7CK-D56517","TCGA-C5-A7CK-R56627","External",NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7CK",NA,"C5","A7CK","YES","C53.9","8070/3","C53.9","NO","YES",-21520,"FEMALE","WHITE",NA,"No","No","Dead",NA,4086,NA,NA,"TUMOR FREE","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,58,2001,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,5,NA,40,NA,NA,"1995",17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
78572614,78048960,3728142870,"904EDF2E-411E-43BD-901D-46129AFA283A.bw","1cb1d2ca-dfa6-4c42-9da9-c711dc5aab5d","904edf2e-411e-43bd-901d-46129afa283a","2016-08-09T14:41:33.728813-05:00","UNCID_2654376.11c5127d-0115-4149-8304-1556e175d0ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GGCTAC.tar.gz","9fe2d9a0-2099-4003-9d2e-97267689d668",2989952095,"Illumina HiSeq","3ccacf6622cd6403c5cc286e1d8aac71","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:14:52.275600-05:00","2016-05-03T12:08:10.830175-05:00","9fe2d9a0-2099-4003-9d2e-97267689d668_analysis.xml","fd62c066287401b7e515adad2e821843","8b60f5f8-535f-4166-bf0b-d8d4bc4320ea",2124,"2016-09-29T21:02:39.724365-05:00","9fe2d9a0-2099-4003-9d2e-97267689d668_experiment.xml","474ebd586b5be91ce417f9385f656cb6","8398d6be-c611-403e-909f-59a9e7cb00c4",2628,"2016-09-29T19:11:58.495506-05:00","9fe2d9a0-2099-4003-9d2e-97267689d668_run.xml","7ec3cb748df1ef66b85e07583ec31de6","3f3362f0-1e97-4e18-9c12-0c8403b0b7d9",354,"2016-09-08T11:19:16.600211-05:00","TCGA-VS-A9V3","2016-09-02T18:54:38.663755-05:00","female","TCGA-VS-A9V3_demographic",1951,"white","a80810c8-8e64-57c2-ba0e-a3b3d52e7d6b","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V3_diagnosis","not reported",22990,"alive","8070/3",NA,540,"abe81e19-b6be-53b7-bfa1-c01a252fbeb8","c53.9",-22990,"TCGA-VS-A9V3_treatment","1633b2c1-86b4-5566-b81d-52d6241bc1be","01","false","TCGA-VS-A9V3-01A",NA,"2ac95c68-40d1-4b92-82dd-23a02e51d65a",FALSE,"DCCE7881-D3D1-4DCF-875F-94E83F51D5E2","Primary Tumor",NA,125,70,NA,1390953600,"11",30,"TCGA-VS-A9V3-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:19:16.600211-05:00",NA,3,NA,0,NA,"TOP",NA,3,NA,"61c1b03c-3012-4d58-8658-94eeb6a772ab",NA,"TCGA-VS-A9V3-01A-01-TS1",NA,97,NA,"099a3eeb-2ff5-40b8-b3a1-52c91fb7bef7","RNA","TCGA-VS-A9V3-01A-11R","1280aaa3-a44a-4412-995c-efca9e910b56",1.9,0.17,"UV Spec","R","23","TCGA-VS-A9V3-01A-11R-A42T-07","11c5127d-0115-4149-8304-1556e175d0ba",0.17,NA,60,22.3081499107674,164,"1fb80d45-8356-588a-b3e2-0e06ca748aad","TCGA-VS-A9V3_exposure","UNCID_2654376.11c5127d-0115-4149-8304-1556e175d0ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GGCTAC.tar.gz","2014-11-05T04:47:04.000Z","2014-11-05T04:58:34.000Z","9FE2D9A0-2099-4003-9D2E-97267689D668","2AC95C68-40D1-4B92-82DD-23A02E51D65A","Unaligned reads",2989952095,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","11C5127D-0115-4149-8304-1556E175D0BA","University of North Carolina","564a3ee3e4b0298dd2c98659","1CB1D2CA-DFA6-4C42-9DA9-C711DC5AAB5D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","099A3EEB-2FF5-40B8-B3A1-52C91FB7BEF7","2014-11-05T04:58:34.000Z","1280AAA3-A44A-4412-995C-EFCA9E910B56","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",125,"099A3EEB-2FF5-40B8-B3A1-52C91FB7BEF7",NA,"VS","TCGA-VS-A9V3-01A-11R-A42V-13_mirna.bam",70,"TCGA-VS-A9V3-01A",NA,"BA99CD4B-A6DE-4981-A47C-FB8A203105F1","TCGA",2013,"TCGA-VS-A9V3_NTE-1","Complete Remission/Response","TUMOR FREE","44353B5E-6724-469C-BD25-BC1FBFE634DD",62,"nationwidechildrens.org_clinical.TCGA-VS-A9V3.xml","Alive",NA,"TCGA-VS-A9V3",NA,"C5843EDB-3898-4CA0-BF15-44DDE0979554","NO",253,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IVB",NA,NA,"T4","8070/3","FEMALE","C53.9",420,NA,"6F39D980-D181-472D-8C7E-C51AB4BF511F","WHITE",NA,11,30,"61C1B03C-3012-4D58-8658-94EEB6A772AB","B45739C9-A337-4F29-97FD-C5767D6B2F9F","TCGA-VS-A9V3-01A-11R-A42V-13_mirna.bam","TCGA-VS-A9V3-01A-11",80,0,0,3,0,"TOP",3,0,"TCGA-VS-A9V3-01A-01-TS1",97,"Cisplatin","Chemotherapy","TCGA-VS-A9V3-D63454","TCGA-VS-A9V3-R63452","External","Regional site","TCGA-VS-A9V3-F70883_NTE-1","YES",540,"WITH TUMOR","Alive",NA,"TCGA-VS-A9V3-F70883","TCGA-VS-A9V3",NA,"VS","A9V3","YES","C53.9","8070/3","C53.9","NO","YES",-22990,"FEMALE","WHITE",NA,"No","No","Alive",253,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,62,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",18,NA,"T4NXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
137607046,134915615,6440466273,"FD9F5A9B-2BEB-4D31-9A2D-8D4B4ECBB478.bw","1d730565-ffa9-4cc7-a713-c4b5b7bbb29f","fd9f5a9b-2beb-4d31-9a2d-8d4b4ecbb478","2016-08-27T07:07:40.979394-05:00","UNCID_2520200.78fd9869-2ed5-40a6-a846-07d5089dd810.140424_UNC13-SN749_0344_AC3WUKACXX_3_ATTCCT.tar.gz","f9add60c-cb58-4018-92f3-59cb1864c871",6093358640,"Illumina HiSeq","75529f7afa557336be1c35fe6cd82eed","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:43:14.529831-05:00","2016-05-03T11:51:27.506016-05:00","f9add60c-cb58-4018-92f3-59cb1864c871_analysis.xml","aa9e2dfbab7401a84dd25a076c461ddc","e74917cd-2912-4dcc-b4aa-6927855c2849",2124,"2016-08-27T12:52:32.078318-05:00","f9add60c-cb58-4018-92f3-59cb1864c871_experiment.xml","be4869474d1b7b0e1271a65a0ce0b64b","4fe2fb28-47ad-47c7-921e-b38d1b878423",2628,"2016-09-29T19:22:49.142023-05:00","f9add60c-cb58-4018-92f3-59cb1864c871_run.xml","7f58817e5fc2f5053dd2a1d8ce3bc2a9","4612d6c4-de64-4271-b4f9-b58aebca3165",354,"2016-09-08T11:37:25.226073-05:00","TCGA-MU-A8JM","2016-09-02T19:01:02.118420-05:00","female","TCGA-MU-A8JM_demographic",1967,"white","2b301f37-9add-566c-946a-0ab065fdfc30","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MU","1ae3c544-7f5e-51e8-b9c7-c8b8d809f268","University of Minnesota","not reported","c53.9","TCGA-MU-A8JM_diagnosis","not reported",17156,"alive","8072/3",NA,607,"1041438d-8b5a-5e7b-bf0b-d0c3e1ebc211","c53.9",-17156,"TCGA-MU-A8JM_treatment","15e0e655-5df6-544e-9c1b-212e69e8d7c4","01","true","TCGA-MU-A8JM-01A",NA,"916c873b-3eca-4ef1-b211-5c953dedcaab",FALSE,"A70CA320-58BF-4165-BD92-D791A4385247","Primary Tumor",NA,278,210,NA,1385510400,"11",30,"TCGA-MU-A8JM-01A-11",70,NA,0,NA,10,NA,20,NA,"2016-09-08T11:37:25.226073-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"23ed4e9f-6e81-4873-b66f-8ac5c025d466",NA,"TCGA-MU-A8JM-01A-01-TSA",NA,70,NA,"2f9d2d2b-32e2-446e-88d5-7391f8c0e1f6","RNA","TCGA-MU-A8JM-01A-11R","56ba4cf7-b76d-43a4-858e-dc2d1abbd66f",1.8,0.16,"UV Spec","R","23","TCGA-MU-A8JM-01A-11R-A36F-07","78fd9869-2ed5-40a6-a846-07d5089dd810",0.16,1.64383561643836,86,31.5886134067952,165,"52de56ef-bee9-53ea-ab18-094ef12ecb73","TCGA-MU-A8JM_exposure","UNCID_2520200.78fd9869-2ed5-40a6-a846-07d5089dd810.140424_UNC13-SN749_0344_AC3WUKACXX_3_ATTCCT.tar.gz","2014-07-09T07:36:04.000Z","2014-07-09T20:12:15.000Z","F9ADD60C-CB58-4018-92F3-59CB1864C871","916C873B-3ECA-4EF1-B211-5C953DEDCAAB","Unaligned reads",6093358640,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","78FD9869-2ED5-40A6-A846-07D5089DD810","University of North Carolina","56607505e4b0ca319164cbeb","1D730565-FFA9-4CC7-A713-C4B5B7BBB29F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2F9D2D2B-32E2-446E-88D5-7391F8C0E1F6","2014-07-09T20:12:15.000Z","56BA4CF7-B76D-43A4-858E-DC2D1ABBD66F","United States","NO",1,NA,"Primary Tumor","University of Minnesota",278,"2F9D2D2B-32E2-446E-88D5-7391F8C0E1F6",NA,"MU","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6DEA112A-68FE-4D44-A1D3-94F52FA9D333.txt",210,"TCGA-MU-A8JM-01A",NA,NA,"TCGA",2013,"TCGA-MU-A8JM_NTE-1","Complete Remission/Response","TUMOR FREE","E6A85874-42CE-42EB-B289-4EECB7ACC87E",46,"nationwidechildrens.org_clinical.TCGA-MU-A8JM.xml","Alive",NA,"TCGA-MU-A8JM","NOT HISPANIC OR LATINO","42B2E724-26D3-4C4F-8403-DF2DE074F4F9","NO",165,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Other","Stage IB1",NA,NA,"T1b","8072/3","FEMALE","C53.9",373,NA,NA,"WHITE",NA,11,30,"23ED4E9F-6E81-4873-B66F-8AC5C025D466","B2179483-F353-4953-BB34-2CC404E6F23C","UNCID_2520200.78fd9869-2ed5-40a6-a846-07d5089dd810.140424_UNC13-SN749_0344_AC3WUKACXX_3_ATTCCT.tar.gz","TCGA-MU-A8JM-01A-11",70,10,0,10,20,"TOP",0,0,"TCGA-MU-A8JM-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-MU-A8JM-F69302_NTE-1","NO",607,"TUMOR FREE","Alive",NA,"TCGA-MU-A8JM-F69302","TCGA-MU-A8JM",NA,"MU","A8JM","YES","C53.9","8072/3","C53.9","YES","NO",-17156,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",165,NA,NA,NA,"TUMOR FREE","YES",9,10,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2013,"Cone Biopsy / LEEP","YES",29,0,"G2",NA,4,2012,30,NA,"Complete Remission/Response","2009",7,NA,"T1bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132449126,126371986,6016776635,"2E206314-9928-456E-B7C6-893DC0E3C7C2.bw","1dfb4565-81e1-4a1b-bb59-9b5629d6c447","2e206314-9928-456e-b7c6-893dc0e3c7c2","2016-08-25T11:43:26.502612-05:00","UNCID_2553101.1c3b1633-b318-486c-9d82-101c4a0364cd.140408_UNC11-SN627_0351_AC3KY3ACXX_4_GTCCGC.tar.gz","d9bfd873-c3e0-485f-8668-41d98ccf0627",5710482678,"Illumina HiSeq","ca4dfa60c06ebcfbe61648ff1d44ae7e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:22:31.964005-05:00","2016-05-03T11:54:19.885282-05:00","d9bfd873-c3e0-485f-8668-41d98ccf0627_analysis.xml","9be09179e6f08198013a1e198ece7429","b50daac8-89b2-4c73-9bf5-4c2f2b3cea42",2124,"2016-09-29T17:51:42.224836-05:00","d9bfd873-c3e0-485f-8668-41d98ccf0627_experiment.xml","0962e0c1432de58fc3c3a357e814411b","0cc03002-5af3-4181-9c26-25363cef3b22",2628,"2016-09-29T17:46:05.056727-05:00","d9bfd873-c3e0-485f-8668-41d98ccf0627_run.xml","819884d794b8712ee2f6f5b89cb4327d","0935642b-63b3-482e-8d50-ce0f65ee0d42",354,"2016-09-08T12:12:58.405928-05:00","TCGA-EX-A8YF","2016-09-02T19:01:14.349662-05:00","female","TCGA-EX-A8YF_demographic",1969,"white","550a58d2-9d33-545a-a34a-38beaa3d5619","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A8YF_diagnosis","not reported",16258,"alive","8070/3",NA,473,"80832949-3e35-5040-8b9d-de0adc9cf015","c53.9",-16258,"TCGA-EX-A8YF_treatment","c2653a87-e7b2-57f6-a69f-25153d0eb8a1","01","false","TCGA-EX-A8YF-01A",NA,"c13258f7-5fc4-4710-b328-baf3d9014038",FALSE,"AD08339B-E984-4E09-A8BF-C9FFE92E83F2","Primary Tumor",NA,111,950,NA,1387756800,"11",30,"TCGA-EX-A8YF-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T12:12:58.405928-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"03f53af8-eef6-42d3-b0b3-3b09100bc8b1",NA,"TCGA-EX-A8YF-01A-01-TS1",NA,80,NA,"c6232e54-325e-419a-b449-5cc37271dc4b","RNA","TCGA-EX-A8YF-01A-11R","e70cf602-9a56-450b-b08d-bee7661c76b3",1.94,0.18,"UV Spec","R","23","TCGA-EX-A8YF-01A-11R-A37O-07","1c3b1633-b318-486c-9d82-101c4a0364cd",0.18,NA,57,20.1955782312925,168,"ce78e396-b64a-55fa-b0a7-d401e43728a7","TCGA-EX-A8YF_exposure","UNCID_2553101.1c3b1633-b318-486c-9d82-101c4a0364cd.140408_UNC11-SN627_0351_AC3KY3ACXX_4_GTCCGC.tar.gz","2014-07-30T22:51:04.000Z","2014-07-30T23:17:22.000Z","D9BFD873-C3E0-485F-8668-41D98CCF0627","C13258F7-5FC4-4710-B328-BAF3D9014038","Unaligned reads",5710482678,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1C3B1633-B318-486C-9D82-101C4A0364CD","University of North Carolina","564a3bf6e4b08c5d8691b016","1DFB4565-81E1-4A1B-BB59-9B5629D6C447","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C6232E54-325E-419A-B449-5CC37271DC4B","2014-07-30T23:17:22.000Z","E70CF602-9A56-450B-B08D-BEE7661C76B3","United States","NO",1,NA,"Primary Tumor","University of North Carolina",111,"C6232E54-325E-419A-B449-5CC37271DC4B",NA,"EX","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.25907BD2-AF9F-4497-8B88-8E0E47BC3C33.txt",950,"TCGA-EX-A8YF-01A",NA,NA,"TCGA",2013,"TCGA-EX-A8YF_NTE-1","Complete Remission/Response","TUMOR FREE","C13258F7-5FC4-4710-B328-BAF3D9014038",44,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.25907BD2-AF9F-4497-8B88-8E0E47BC3C33.txt","Alive",NA,"TCGA-EX-A8YF",NA,"8A3DEA2B-F772-4AC8-898E-2729ADE517C9","NO",144,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T2a1","8070/3","FEMALE","C53.9",380,NA,"5F422E11-2128-49FA-907E-653C39B645E1","WHITE",NA,11,30,"03F53AF8-EEF6-42D3-B0B3-3B09100BC8B1","E70CF602-9A56-450B-B08D-BEE7661C76B3","TCGA-EX-A8YF-01A-11R-A37P-13.mirna.quantification.txt","TCGA-EX-A8YF-01A-11",80,0,0,10,20,"TOP",0,0,"TCGA-EX-A8YF-01A-01-TS1",80,NA,NA,NA,"TCGA-EX-A8YF-R57521","External",NA,"TCGA-EX-A8YF-F68767_NTE-2","YES",473,"WITH TUMOR","Alive",NA,"TCGA-EX-A8YF-F68767","TCGA-EX-A8YF",NA,"EX","A8YF","YES","C53.9","8070/3","C53.9","YES","NO",-16258,"FEMALE","WHITE",NA,"No","No","Alive",144,NA,NA,NA,"TUMOR FREE","YES",13,3,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2013,"Biopsy (cervical / CT-guided / Other)","YES",37,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T2a1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
127500764,123122770,5873777804,"913DB655-2C7F-4369-83DE-9257F04CF39B.bw","1e4d7755-b971-4c6e-a2b9-dd83d92bc4c9","913db655-2c7f-4369-83de-9257f04cf39b","2016-08-25T14:46:22.003887-05:00","UNCID_2326784.81417e28-9132-4081-a85f-ed63396427c3.131015_UNC11-SN627_0327_AC2ND3ACXX_4_ACTTGA.tar.gz","44e249fb-7a64-4155-b2e6-51844669f36e",5837959329,"Illumina HiSeq","b7ccd37082238646f50010645f42e7ef","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:55:49.513893-05:00","2016-05-03T11:30:43.413000-05:00","44e249fb-7a64-4155-b2e6-51844669f36e_analysis.xml","adb469c2d33c845cb045d4542208e496","a4c957d5-63c1-4995-be5f-32ae4a33ace0",2124,"2016-09-29T23:09:16.232249-05:00","44e249fb-7a64-4155-b2e6-51844669f36e_experiment.xml","135677aa6b5298a2542734ca4da2fa3f","d224d981-db7f-423c-9902-855138554c8b",2628,"2016-09-29T22:48:14.353626-05:00","44e249fb-7a64-4155-b2e6-51844669f36e_run.xml","1030cb179a3a418a4bf4f9ed7861baf4","c520c1b9-b11a-4745-8618-e231588ff878",354,"2016-09-08T11:23:23.880800-05:00","TCGA-EX-A69M","2016-09-02T19:00:24.054193-05:00","female","TCGA-EX-A69M_demographic",1950,"white","18dbd69c-3af1-5df6-8bbb-aa46c6a48e2c","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A69M_diagnosis","not reported",22917,"dead","8072/3",253,186,"21557294-5830-5db1-a20b-684597a29e8b","c53.9",-22917,"TCGA-EX-A69M_treatment","02b7cc32-0854-5b60-ab3c-45cb4a018fc5","01","false","TCGA-EX-A69M-01A",NA,"be647e6a-0068-40d5-9649-a08c7ad849a1",FALSE,"808A38A8-4E74-42A4-8258-C883A7F6CA0C","Primary Tumor",NA,148,690,NA,1367971200,"11",30,"TCGA-EX-A69M-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:23:23.880800-05:00",NA,5,NA,1,NA,"TOP",NA,1,NA,"89eaff1f-2328-448b-8b2e-31546d069da0",NA,"TCGA-EX-A69M-01A-01-TS1",NA,99,NA,"56454fbd-85fb-4931-a93c-d96c06275a28","RNA","TCGA-EX-A69M-01A-11R","4c513198-5e4f-4fab-b1ca-5d7b3f692491",1.86,0.17,"UV Spec","R","23","TCGA-EX-A69M-01A-11R-A32P-07","81417e28-9132-4081-a85f-ed63396427c3",0.17,NA,58,23.2334561768947,158,"2349e5a5-8aa7-5fbd-9823-cd6bc1cd6c89","TCGA-EX-A69M_exposure","UNCID_2326784.81417e28-9132-4081-a85f-ed63396427c3.131015_UNC11-SN627_0327_AC2ND3ACXX_4_ACTTGA.tar.gz","2014-01-19T07:48:38.000Z","2014-01-19T08:39:02.000Z","44E249FB-7A64-4155-B2E6-51844669F36E","BE647E6A-0068-40D5-9649-A08C7AD849A1","Unaligned reads",5837959329,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","81417E28-9132-4081-A85F-ED63396427C3","University of North Carolina","564a4114e4b0ef12181c455d","1E4D7755-B971-4C6E-A2B9-DD83D92BC4C9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","56454FBD-85FB-4931-A93C-D96C06275A28","2014-01-19T08:39:02.000Z","4C513198-5E4F-4FAB-B1CA-5D7B3F692491","United States","NO",1,NA,"Primary Tumor","University of North Carolina",148,"56454FBD-85FB-4931-A93C-D96C06275A28",NA,"EX","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E473C4E8-6073-41A2-9ABD-7E02564303CB.txt",690,"TCGA-EX-A69M-01A",NA,NA,"TCGA",2012,"TCGA-EX-A69M_NTE-1","Complete Remission/Response","TUMOR FREE","BE647E6A-0068-40D5-9649-A08C7AD849A1",62,"THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_C02_1367134.hg19.seg.txt","Alive",NA,"TCGA-EX-A69M",NA,"3E98B27E-ED50-4CB9-B639-FDBE296C901A","YES",186,"Yes","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB2",NA,NA,"T1b2","8072/3","FEMALE","C53.9",335,NA,NA,"WHITE",NA,11,30,"89EAFF1F-2328-448B-8B2E-31546D069DA0","2CEBC15B-C088-47A0-99D7-5359E158F4C5","TCGA-EX-A69M-01A-11R-A32K-13_mirna.bam","TCGA-EX-A69M-01A-11",75,0,0,5,0,"TOP",1,1,"TCGA-EX-A69M-01A-01-TS1",99,NA,NA,NA,NA,NA,NA,"TCGA-EX-A69M-F59393_NTE-1","YES",NA,"TUMOR FREE","Dead",253,"TCGA-EX-A69M-F59393","TCGA-EX-A69M",NA,"EX","A69M","YES","C53.9","8072/3","C53.9","YES","NO",-22917,"FEMALE","WHITE",NA,"Yes","No","Alive",186,NA,NA,NA,"TUMOR FREE","YES",19,6,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,62,2012,"Cytology (e.g. Peritoneal or pleural fluid)","YES",11,0,"G3",NA,4,2012,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
128850420,127391624,6082896583,"72B5B724-FEB5-43BD-83F6-2E2152DDD800.bw","1ef20703-3684-4b43-a31f-892073208377","72b5b724-feb5-43bd-83f6-2e2152ddd800","2016-08-09T14:00:45.468006-05:00","UNCID_2168996.2953ceed-8418-4c63-b260-307aea1d9e63.130611_UNC15-SN850_0312_BC265JACXX_4_CAGATC.tar.gz","d530bf5c-44d2-4f0b-a545-fde98f4f3849",5755755570,"Illumina HiSeq","6c1a17bfeb3eaa086edff09c39649a9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:01:31.994862-05:00","2016-05-03T11:06:28.634130-05:00","d530bf5c-44d2-4f0b-a545-fde98f4f3849_analysis.xml","0215966a62ba76591b46074ae95a3b0b","82f1199f-4535-4a48-ae56-b5938f70fdaf",2123,"2016-09-29T19:35:58.896387-05:00","d530bf5c-44d2-4f0b-a545-fde98f4f3849_experiment.xml","e0ec7391321454d4682508bd620f8bd0","4e37bcf2-6cf6-423c-acd5-2a74d29a3496",2431,"2016-09-29T18:55:47.718848-05:00","d530bf5c-44d2-4f0b-a545-fde98f4f3849_run.xml","0796e536a493f851c0a96982982063d0","350773c6-8e13-4ebb-9a4c-a361348bcf84",354,"2016-09-08T11:25:36.681040-05:00","TCGA-LP-A5U2","2016-09-02T19:00:05.336578-05:00","female","TCGA-LP-A5U2_demographic",1982,"asian","9a6479d5-36c1-5fff-ad26-997ae3e24ff2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A5U2_diagnosis","not reported",11049,"alive","8384/3",NA,9,"3433c4c3-d1d9-5b7e-9a1d-25fca1e8f6c2","c53.9",-11049,"TCGA-LP-A5U2_treatment","e733767f-4b03-5e5e-b639-61f1ed8f5e96","01","true","TCGA-LP-A5U2-01A",NA,"cbdbe0d3-b3b3-4990-be3a-9af8360889d8",FALSE,"21CF3259-2E5C-48A6-B6BC-094001C4DB87","Primary Tumor",NA,226,550,NA,1362096000,"11",30,"TCGA-LP-A5U2-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:25:36.681040-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"7cb276fa-8c95-4fe8-9397-ec895c9172c8",NA,"TCGA-LP-A5U2-01A-01-TSA",NA,80,NA,"40546b08-5276-4985-b5a9-98ded368b7fb","RNA","TCGA-LP-A5U2-01A-11R","ec556c3b-7adc-44cc-941f-d9a286514440",1.96,0.17,"UV Spec","R","23","TCGA-LP-A5U2-01A-11R-A28H-07","2953ceed-8418-4c63-b260-307aea1d9e63",0.17,NA,51,19.921875,160,"4060f230-2964-50b8-b78b-ff22b9328273","TCGA-LP-A5U2_exposure","UNCID_2168996.2953ceed-8418-4c63-b260-307aea1d9e63.130611_UNC15-SN850_0312_BC265JACXX_4_CAGATC.tar.gz","2013-09-20T05:16:04.000Z","2013-09-20T05:29:01.000Z","D530BF5C-44D2-4F0B-A545-FDE98F4F3849","CBDBE0D3-B3B3-4990-BE3A-9AF8360889D8","Unaligned reads",5755755570,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2953CEED-8418-4C63-B260-307AEA1D9E63","University of North Carolina","5660761ee4b0b37b3d990105","1EF20703-3684-4B43-A31F-892073208377","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","40546B08-5276-4985-B5A9-98DED368B7FB","2013-09-20T05:29:01.000Z","EC556C3B-7ADC-44CC-941F-D9A286514440","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",226,"40546B08-5276-4985-B5A9-98DED368B7FB",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.094DF0CC-0C59-4855-B581-56FB17D71468.txt",550,"TCGA-LP-A5U2-01A",NA,NA,"TCGA",2012,"TCGA-LP-A5U2_NTE-1","Complete Remission/Response","TUMOR FREE","CBDBE0D3-B3B3-4990-BE3A-9AF8360889D8",30,"d04422483048b9012d4b819dc5547cc0.bam.bai","Alive",NA,"TCGA-LP-A5U2","NOT HISPANIC OR LATINO",NA,"NO",9,"No","Cervix","C53.9","N1","Endocervical Adenocarcinoma of the Usual Type",1,"Preoperative","Stage IIIB",NA,NA,"T2a","8384/3","FEMALE","C53.9",297,NA,NA,"ASIAN",NA,11,30,"7CB276FA-8C95-4FE8-9397-EC895C9172C8","A03531DA-1F5D-4C0D-9FBD-7B5ACEDB0C03","TCGA-LP-A5U2-01A-11R-A28L-13_mirna.bam","TCGA-LP-A5U2-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-LP-A5U2-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-LP-A5U2",NA,"LP","A5U2","YES","C53.9","8384/3","C53.9","YES","NO",-11049,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",9,NA,NA,NA,"TUMOR FREE","YES",3,7,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,30,2012,"Biopsy (cervical / CT-guided / Other)","YES",7,2,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",16,NA,"T2aN1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
173654858,166780423,7949906162,"920B547C-6898-446C-AAAF-F4ED96E40AAB.bw","1fe594d9-4240-49ee-8afd-c7d16a377181","920b547c-6898-446c-aaaf-f4ed96e40aab","2016-08-09T13:09:56.998878-05:00","UNCID_2186327.7FB5882C-6F15-462F-83E6-8BFF997BF16D.121102_UNC12-SN629_0235_AC13F5ACXX_6_CAGATC.tar.gz","cfd104d7-ee8e-4e3c-94cc-d53308d78410",7771708527,"Illumina HiSeq","abd35c024d4f323db1d8b57ab50a2a89","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:32:19.571549-05:00","2016-05-03T11:00:24.459758-05:00","cfd104d7-ee8e-4e3c-94cc-d53308d78410_analysis.xml","cb96e4d368856bc584b1faaf589365f7","e07f703c-2c3a-4cfd-87f0-70ff35d8bb7f",2124,"2016-10-07T16:46:16.042613-05:00","cfd104d7-ee8e-4e3c-94cc-d53308d78410_experiment.xml","788344753551614e7af50c2146574514","0f4157ce-0411-4352-bda5-27988d2ce1fc",2431,"2016-09-29T21:51:43.278973-05:00","cfd104d7-ee8e-4e3c-94cc-d53308d78410_run.xml","cadb816dc7b876ec719988c5665094ae","a22d6a9c-2958-4b2d-b28f-3c7279ed84e1",354,"2016-09-08T11:57:08.263020-05:00","TCGA-EX-A1H6","2016-09-02T18:59:29.355278-05:00","female","TCGA-EX-A1H6_demographic",1971,"white","bef5bfd4-49ad-5eb6-94eb-f9c75f7ace25","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A1H6_diagnosis","not reported",14214,"alive","8140/3",NA,241,"42677760-b744-5c28-99ca-4d96ebb7c382","c53.9",-14214,"TCGA-EX-A1H6_treatment","49ee273e-68b9-5042-93c0-c341939563d7","01","false","TCGA-EX-A1H6-01B",NA,"fe018d31-eee8-4335-96a1-95eceabfadf1",FALSE,"C0A44D8D-EE10-45EF-8B23-23A2E793E5D5","Primary Tumor",NA,576,50,NA,1333584000,"11",20,"TCGA-EX-A1H6-01B-11",80,NA,10,NA,0,NA,10,NA,"2016-09-08T11:57:08.263020-05:00",NA,60,NA,20,NA,"TOP",NA,10,NA,"ebf03824-0781-4c6a-a824-cb960965c9ee",NA,"TCGA-EX-A1H6-01B-01-MSA",NA,80,NA,"b8bd4b30-e3f0-4a4c-9505-b400c85984c2","RNA","TCGA-EX-A1H6-01B-11R","e9908545-0f35-4f88-8323-5af8fa671492",1.86,0.17,"UV Spec","R","23","TCGA-EX-A1H6-01B-11R-A22U-07","7fb5882c-6f15-462f-83e6-8bff997bf16d",0.17,NA,74,29.6426854670726,158,"ca17f30f-750d-5e10-8141-9ac83b73d65e","TCGA-EX-A1H6_exposure","UNCID_2186327.7FB5882C-6F15-462F-83E6-8BFF997BF16D.121102_UNC12-SN629_0235_AC13F5ACXX_6_CAGATC.tar.gz","2013-09-16T05:46:06.000Z","2013-09-16T09:02:01.000Z","CFD104D7-EE8E-4E3C-94CC-D53308D78410","FE018D31-EEE8-4335-96A1-95ECEABFADF1","Unaligned reads",7771708527,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7FB5882C-6F15-462F-83E6-8BFF997BF16D","University of North Carolina","564a3e16e4b093830b6a201e","1FE594D9-4240-49EE-8AFD-C7D16A377181","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B8BD4B30-E3F0-4A4C-9505-B400C85984C2","2013-09-16T09:02:01.000Z","E9908545-0F35-4F88-8323-5AF8FA671492","United States","NO",1,NA,"Primary Tumor","University of North Carolina",576,"B8BD4B30-E3F0-4A4C-9505-B400C85984C2",NA,"EX","7796806055_R02C02_Red.idat",50,"TCGA-EX-A1H6-01B",NA,NA,"TCGA",2009,"TCGA-EX-A1H6_NTE-1","Complete Remission/Response","TUMOR FREE","FE018D31-EEE8-4335-96A1-95ECEABFADF1",38,"nationwidechildrens.org_clinical.TCGA-EX-A1H6.xml","Alive",NA,"TCGA-EX-A1H6",NA,"F9390D9E-9E74-4F92-A6D4-36D291AE25BE","NO",241,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8140/3","FEMALE","C53.9",236,NA,NA,"WHITE",NA,11,20,"EBF03824-0781-4C6A-A824-CB960965C9EE","E9908545-0F35-4F88-8323-5AF8FA671492","7796806055_R02C02_Red.idat","TCGA-EX-A1H6-01B-11",80,0,10,60,10,"TOP",10,20,"TCGA-EX-A1H6-01B-01-MSA",80,NA,NA,NA,NA,NA,NA,"TCGA-EX-A1H6-F38911_NTE-1",NA,NA,NA,NA,NA,"TCGA-EX-A1H6-F38911","TCGA-EX-A1H6",NA,"EX","A1H6","YES","C53.9","8140/3","C53.9","NO","YES",-14214,"FEMALE","WHITE",NA,"No","No","Alive",241,NA,NA,NA,"TUMOR FREE","YES",25,6,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,38,2009,"Cone Biopsy / LEEP","YES",20,0,"G1",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
137832850,136077912,6493494496,"847F796A-8CD6-4013-A0FB-26F4FC3EAF0D.bw","20280122-a66a-4c83-8f25-0b9d97558dc2","847f796a-8cd6-4013-a0fb-26f4fc3eaf0d","2016-08-25T23:13:14.096080-05:00","UNCID_2278254.f5380a4f-3678-45b2-bfc2-5b3c0d346dcd.131021_UNC9-SN296_0409_BC2M6NACXX_3_GGCTAC.tar.gz","7ea45803-92c5-482c-8381-f86adad9d4de",6750911114,"Illumina HiSeq","bc3c337e06ebb3ea3d636f3677f77c4e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:38:48.807020-05:00","2016-05-03T11:24:56.858865-05:00","7ea45803-92c5-482c-8381-f86adad9d4de_analysis.xml","9e5e95e3fb0d766c5b93ed5be22cd867","e475f7e2-5f7c-4bf3-b24c-57f8b61e620d",2121,"2016-09-29T20:35:50.412067-05:00","7ea45803-92c5-482c-8381-f86adad9d4de_experiment.xml","f2ff30c309f4574477709c4088e8ae7e","72e10745-5223-487b-a18d-352e058b2c1e",2431,"2016-09-29T22:33:12.384460-05:00","7ea45803-92c5-482c-8381-f86adad9d4de_run.xml","55bccce05254a9d5f4e6d9469d60e096","bbbd59e9-97b2-41b4-9f8e-4cd2f9ffc338",354,"2016-09-08T11:34:31.434483-05:00","TCGA-JX-A3Q0","2016-09-02T18:59:24.766504-05:00","female","TCGA-JX-A3Q0_demographic",1934,"black or african american","fdc10190-4d0a-5448-b7d4-ff8ff3a95040","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JX","6d97b3ee-83c4-5be1-9919-0fdd90c1bb19","Washington University","not reported","c53.9","TCGA-JX-A3Q0_diagnosis","not reported",23313,"alive","8070/3",NA,6375,"951179f2-1bc3-5b92-8c66-c57a12749c59","c53.9",-23313,"TCGA-JX-A3Q0_treatment","9c96361f-7569-500a-b6a2-5f74d4e8d05c","01","true","TCGA-JX-A3Q0-01A",NA,"04ffdfc0-a73f-47ae-9014-73870b69ad91",FALSE,"3CE379FF-5E2B-4DE5-BBD8-51D70E6EFF73","Primary Tumor",NA,5251,170,NA,1330473600,"11",30,"TCGA-JX-A3Q0-01A-11",70,NA,0,NA,0,NA,10,NA,"2016-09-08T11:34:31.434483-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"8cbd79a1-626a-42f4-8535-b4649d5c56d5",NA,"TCGA-JX-A3Q0-01A-01-TS1",NA,80,NA,"729b0720-9e8c-4a4d-ad77-48d7c211ebec","RNA","TCGA-JX-A3Q0-01A-11R","0f5bf34f-dc6e-4c45-9170-de0f752d6324",1.92,0.16,"UV Spec","R","23","TCGA-JX-A3Q0-01A-11R-A32Y-07","f5380a4f-3678-45b2-bfc2-5b3c0d346dcd",0.16,1.0958904109589,57,20.6851502395123,166,"4b264b64-9f31-5d1c-a83c-df5ef848c485","TCGA-JX-A3Q0_exposure","UNCID_2278254.f5380a4f-3678-45b2-bfc2-5b3c0d346dcd.131021_UNC9-SN296_0409_BC2M6NACXX_3_GGCTAC.tar.gz","2013-11-22T07:21:04.000Z","2013-11-22T07:42:02.000Z","7EA45803-92C5-482C-8381-F86ADAD9D4DE","04FFDFC0-A73F-47AE-9014-73870B69AD91","Unaligned reads",6750911114,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F5380A4F-3678-45B2-BFC2-5B3C0D346DCD","University of North Carolina","564a3f37e4b09c884b258390","20280122-A66A-4C83-8F25-0B9D97558DC2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","729B0720-9E8C-4A4D-AD77-48D7C211EBEC","2013-11-22T07:42:02.000Z","0F5BF34F-DC6E-4C45-9170-DE0F752D6324","United States","NO",1,NA,"Primary Tumor","Washington University",5251,"729B0720-9E8C-4A4D-AD77-48D7C211EBEC",NA,"JX","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1DDEE185-E1DE-44AE-AD36-FFCC69B5EE84.txt",170,"TCGA-JX-A3Q0-01A",NA,NA,"TCGA",1997,"TCGA-JX-A3Q0_NTE-1","Complete Remission/Response","TUMOR FREE","3E3551F6-66DC-4F55-97C4-A7741E412CEA",63,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1DDEE185-E1DE-44AE-AD36-FFCC69B5EE84.txt","Alive",NA,"TCGA-JX-A3Q0","NOT HISPANIC OR LATINO","F90B111D-4073-4206-92D4-529E0FB35A19","NO",5957,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage III",NA,NA,"T3","8070/3","FEMALE","C53.9",217,NA,"BDA2FC44-EB35-41EC-BC97-15EA7AFB8665","BLACK OR AFRICAN AMERICAN",NA,11,30,"8CBD79A1-626A-42F4-8535-B4649D5C56D5","CE0E7455-77A3-4AE5-9E05-3D76BBDAE268","UNCID_2266683.f5380a4f-3678-45b2-bfc2-5b3c0d346dcd.sorted_genome_alignments.bam.bai","TCGA-JX-A3Q0-01A-11",70,0,0,0,10,"TOP",10,0,"TCGA-JX-A3Q0-01A-01-TS1",80,NA,NA,NA,"TCGA-JX-A3Q0-R63619","External","Primary Tumor Field","TCGA-JX-A3Q0-F71655_NTE-1","NO",6375,"TUMOR FREE","Alive",NA,"TCGA-JX-A3Q0-F71655","TCGA-JX-A3Q0",NA,"JX","A3Q0","YES","C53.9","8070/3","C53.9","NO","YES",-23313,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",5957,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,63,1997,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,4,1997,20,NA,"Complete Remission/Response","1995",14,NA,"T3N0M0",NA,NA,1,"Post-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
127744744,124166581,5924522485,"C4D64E7A-33F7-4CFC-9FD3-D6AA3D8EFAA7.bw","21254cb0-68f3-4ecc-8d9a-73fb0e994c5b","c4d64e7a-33f7-4cfc-9fd3-d6aa3d8efaa7","2016-08-26T09:13:33.781175-05:00","UNCID_2553116.151ea5c1-80f3-473f-af58-f43df84879f2.140403_UNC15-SN850_0359_BC41CEACXX_8_GAGTGG.tar.gz","6ad0aa60-d594-48f1-9592-06d07c688e97",5712472778,"Illumina HiSeq","35581ed5fca547b58b23bec324b07de1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:29:21.730290-05:00","2016-05-03T11:54:19.908545-05:00","6ad0aa60-d594-48f1-9592-06d07c688e97_analysis.xml","7a2ba84a6deda4743c23b08ccbafc4fe","9468493f-470e-409c-b4a6-4bd5eed2a8e8",2124,"2016-09-29T23:01:06.729527-05:00","6ad0aa60-d594-48f1-9592-06d07c688e97_experiment.xml","80141e726a54ac0242d94924f23d3466","cce6fabf-aaea-474d-a7e3-8834f451bc58",2628,"2016-09-29T17:58:03.279617-05:00","6ad0aa60-d594-48f1-9592-06d07c688e97_run.xml","d5c240620eeed348a3642fb29ec8138e","10b89718-4982-4dff-a42d-861acba331da",354,"2016-09-08T11:58:36.754620-05:00","TCGA-VS-A8QF","2016-09-02T19:01:20.915747-05:00","female","TCGA-VS-A8QF_demographic",1968,"white","d603f46b-2d2c-5ff3-9153-d0b1a6f3cd17","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8QF_diagnosis","not reported",15374,"alive","8070/3",NA,1800,"986a30d9-d6f2-5d87-af56-a5eef32fdc10","c53.9",-15374,"TCGA-VS-A8QF_treatment","3212a9d2-3526-59e3-b89f-fff3b21b1245","01","false","TCGA-VS-A8QF-01A",NA,"9d1990fc-1a2e-4193-8eee-f46e93f4469b",FALSE,"9E014162-B8BD-4DDD-9E8C-A1D18A6A8A7A","Primary Tumor",NA,1399,160,NA,1386806400,"21",30,"TCGA-VS-A8QF-01A-21",80,NA,0,NA,10,NA,10,NA,"2016-09-08T11:58:36.754620-05:00",NA,5,NA,2,NA,"TOP",NA,0,NA,"35b485c6-1b76-4a2b-9ac6-129e9eb54eb4",NA,"TCGA-VS-A8QF-01A-02-TS2",NA,80,NA,"e34cd26a-6bd8-4bf3-be70-a9656e763ca1","RNA","TCGA-VS-A8QF-01A-21R","170f7d4b-eda6-469d-b0d1-6d20226b1280",1.92,0.18,"UV Spec","R","23","TCGA-VS-A8QF-01A-21R-A37O-07","151ea5c1-80f3-473f-af58-f43df84879f2",0.18,NA,68,26.897670187097,159,"aaad7d79-0955-526d-b616-ebc38ee811c4","TCGA-VS-A8QF_exposure","UNCID_2553116.151ea5c1-80f3-473f-af58-f43df84879f2.140403_UNC15-SN850_0359_BC41CEACXX_8_GAGTGG.tar.gz","2014-07-31T02:06:05.000Z","2014-07-31T02:27:35.000Z","6AD0AA60-D594-48F1-9592-06D07C688E97","9D1990FC-1A2E-4193-8EEE-F46E93F4469B","Unaligned reads",5712472778,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","151EA5C1-80F3-473F-AF58-F43DF84879F2","University of North Carolina","564a404ce4b0298dd2c9fa75","21254CB0-68F3-4ECC-8D9A-73FB0E994C5B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E34CD26A-6BD8-4BF3-BE70-A9656E763CA1","2014-07-31T02:27:35.000Z","170F7D4B-EDA6-469D-B0D1-6D20226B1280","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1399,"E34CD26A-6BD8-4BF3-BE70-A9656E763CA1",NA,"VS","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.AFE9BCB4-EE5E-426D-87FF-0F823DDF7351.txt",160,"TCGA-VS-A8QF-01A",NA,"E09A597F-8072-47C3-BAA2-520E63D22AAA","TCGA",2010,"TCGA-VS-A8QF_NTE-1","Complete Remission/Response","TUMOR FREE","FC7E94EF-9DAE-4E71-9673-63B8CF8919A4",42,"nationwidechildrens.org_clinical.TCGA-VS-A8QF.xml","Alive",NA,"TCGA-VS-A8QF",NA,"E805D1F7-0135-49E3-8BC5-596C11F7F450","NO",1507,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"TX","8070/3","FEMALE","C53.9",380,NA,"6E859F03-4394-4ECD-9BA8-E2B414A4B46D","WHITE",NA,21,30,"35B485C6-1B76-4A2B-9AC6-129E9EB54EB4","77ED8D04-CDAA-4AE0-903B-59C1C6CBF8C9","UNCID_2408029.151ea5c1-80f3-473f-af58-f43df84879f2.sorted_genome_alignments.bam","TCGA-VS-A8QF-01A-21",80,10,0,5,10,"TOP",0,2,"TCGA-VS-A8QF-01A-02-TS2",80,"Cisplatin","Chemotherapy","TCGA-VS-A8QF-D62000","TCGA-VS-A8QF-R61997","External","Regional site","TCGA-VS-A8QF-F68175_NTE-1","NO",1762,"TUMOR FREE","Alive",NA,"TCGA-VS-A8QF-F68175","TCGA-VS-A8QF",NA,"VS","A8QF","YES","C53.9","8070/3","C53.9","NO","YES",-15374,"FEMALE","WHITE",NA,"No","No","Alive",1507,NA,NA,NA,"TUMOR FREE","YES",30,3,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,2010,NA,NA,"Complete Remission/Response","2009",13,NA,"TXNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
192245014,187065872,8936220448,"EABA0B17-8E19-48C5-BF62-2A45C9632807.bw","23f011e2-c025-4494-8016-2140cc8d4bce","eaba0b17-8e19-48c5-bf62-2a45c9632807","2016-08-09T13:56:01.702682-05:00","UNCID_2187261.45ce60c9-d18f-43a2-b240-8dc7d854cd27.120921_UNC16-SN851_0181_AD14JFACXX_4_ACAGTG.tar.gz","d29104cf-e2b3-4392-b4c7-560ff1c1e815",8112423147,"Illumina HiSeq","08d289715af067160468d9ae897060e0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:34.731556-05:00","2016-05-03T11:02:00.408696-05:00","d29104cf-e2b3-4392-b4c7-560ff1c1e815_analysis.xml","b1f7b0aeb4cb16245c78d3562ed82fe9","79029d38-eb36-4e61-8ada-fc04aa7924bb",2124,"2016-08-28T12:31:38.440366-05:00","d29104cf-e2b3-4392-b4c7-560ff1c1e815_experiment.xml","5cd5d1c89abdd338d7442fb85ab264a2","2bd83264-3007-4702-a738-16397767d1bc",2431,"2016-09-29T20:26:29.244899-05:00","d29104cf-e2b3-4392-b4c7-560ff1c1e815_run.xml","17be493157f16cb64df0cb396876d7a3","6d4a2c64-06bc-45de-9198-6c75fef1cee1",354,"2016-09-08T12:14:15.682976-05:00","TCGA-C5-A1MJ","2016-09-02T18:57:19.288378-05:00","female","TCGA-C5-A1MJ_demographic",1944,"white","580050df-2725-5a89-afc4-1cf428581b1d","not reported",2005,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MJ_diagnosis","not reported",22308,"dead","8140/3",14,NA,"d65fb355-dcdc-5416-a870-19af404dfed7","c53.9",-22308,"TCGA-C5-A1MJ_treatment","89380a5e-a715-5162-86f8-ab5405ec09e1","01","true","TCGA-C5-A1MJ-01A",NA,"dd926c69-675a-49f7-9494-d85a489b8982",FALSE,"A0D7B6A3-BE64-4736-894D-AF69320180AC","Primary Tumor",NA,2234,100,NA,1301356800,"11",30,"TCGA-C5-A1MJ-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:14:15.682976-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"bb5a2aaa-9669-4e4a-bcd1-116fb912f871",NA,"TCGA-C5-A1MJ-01A-01-TSA",NA,70,NA,"600a3b8c-2f0d-49fa-88e9-ab135d2986aa","RNA","TCGA-C5-A1MJ-01A-11R","72915706-2164-4dfe-b6d1-d8e5fbb811d2",1.81,0.17,"UV Spec","R","23","TCGA-C5-A1MJ-01A-11R-A14Y-07","45ce60c9-d18f-43a2-b240-8dc7d854cd27",0.17,NA,75,27.5482093663912,165,"e60ab63b-ce81-525c-bb99-bd94f8193b7d","TCGA-C5-A1MJ_exposure","UNCID_2187261.45ce60c9-d18f-43a2-b240-8dc7d854cd27.120921_UNC16-SN851_0181_AD14JFACXX_4_ACAGTG.tar.gz","2013-09-17T05:46:04.000Z","2013-09-17T06:16:01.000Z","D29104CF-E2B3-4392-B4C7-560FF1C1E815","DD926C69-675A-49F7-9494-D85A489B8982","Unaligned reads",8112423147,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","45CE60C9-D18F-43A2-B240-8DC7D854CD27","University of North Carolina","564a3cebe4b0298dd2c8e4eb","23F011E2-C025-4494-8016-2140CC8D4BCE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","600A3B8C-2F0D-49FA-88E9-AB135D2986AA","2013-09-17T06:16:01.000Z","72915706-2164-4DFE-B6D1-D8E5FBB811D2","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2234,"600A3B8C-2F0D-49FA-88E9-AB135D2986AA",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A0036B29-51AD-4A3B-A405-7929D1A483E1.txt",100,"TCGA-C5-A1MJ-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","DD926C69-675A-49F7-9494-D85A489B8982",61,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A0036B29-51AD-4A3B-A405-7929D1A483E1.txt","Dead",14,"TCGA-C5-A1MJ",NA,"569ED21E-64AD-42A5-9E3F-33449E692460",NA,NA,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b1","8140/3","FEMALE","C53.9",127,NA,NA,"WHITE",NA,11,30,"BB5A2AAA-9669-4E4A-BCD1-116FB912F871","B9729108-9A28-4CB2-BDB5-31455E0FB8F3","TCGA-C5-A1MJ-01A-11R-A14X-13_mirna.bam.bai","TCGA-C5-A1MJ-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-C5-A1MJ-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TUMOR FREE","Dead",14,"TCGA-C5-A1MJ-F29745","TCGA-C5-A1MJ",NA,"C5","A1MJ","YES","C53.9","8140/3","C53.9","NO","YES",-22308,"FEMALE","WHITE",NA,"No","No","Dead",NA,14,NA,NA,"TUMOR FREE","NO",21,9,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,61,2005,"Biopsy (cervical / CT-guided / Other)","YES",18,0,"G2",NA,1,NA,NA,NA,NA,"1995",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
116455646,115380330,5513250510,"7263CBA8-CE37-4531-A795-9324C6D2A672.bw","240ef385-decc-48f7-a798-a81b4ab0410e","7263cba8-ce37-4531-a795-9324c6d2a672","2016-08-25T16:06:44.301653-05:00","UNCID_2553075.7626194c-9fc3-4b7f-a759-2834583f3890.140521_UNC11-SN627_0359_BC4E01ACXX_5_CAGATC.tar.gz","ca675e90-9d83-4cd4-8e8a-9c6b7a7ba1e6",4687400474,"Illumina HiSeq","a916848f549b6e816f10784e64ceedb0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:52:41.387548-05:00","2016-05-03T11:54:19.885282-05:00","ca675e90-9d83-4cd4-8e8a-9c6b7a7ba1e6_analysis.xml","8fc75d883198d4d0bc8932730022ea6a","ed23f9fe-61c7-4d74-be4f-9ac39d857921",2124,"2016-09-29T17:57:15.693153-05:00","ca675e90-9d83-4cd4-8e8a-9c6b7a7ba1e6_experiment.xml","5365b4451738ba494ddaba4ce4352186","10382c61-cc02-4eeb-8f73-08ccc29d0643",2628,"2016-09-29T22:42:39.837496-05:00","ca675e90-9d83-4cd4-8e8a-9c6b7a7ba1e6_run.xml","c5268825cccfca242439db5e03d8247f","c1a44d1d-3223-41e7-80bf-cab5c65cec29",354,"2016-09-08T12:44:20.665852-05:00","TCGA-VS-A94X","2016-09-02T18:54:06.823390-05:00","female","TCGA-VS-A94X_demographic",1970,"black or african american","7dd2e1d9-ab6a-5aa2-ac34-c4d1d00b08aa","not reported",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A94X_diagnosis","not reported",14955,"dead","8070/3",506,NA,"843e6a7a-c200-5d3d-b305-18fa5f9c6be9","c53.9",-14955,"TCGA-VS-A94X_treatment","c26033aa-1a0a-57a9-bd03-2a3d42b1dc84","01","false","TCGA-VS-A94X-01A",NA,"b3edbb18-0b82-4a64-9b5a-6ef83590317b",FALSE,"434AA106-443D-4A8E-93AD-14DFFD8A2B76","Primary Tumor",NA,1281,140,NA,1389830400,"11",30,"TCGA-VS-A94X-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:44:20.665852-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"1290e0b8-db23-4d16-be86-307b7fd0240f",NA,"TCGA-VS-A94X-01A-01-TS1",NA,70,NA,"618f6fa5-e8b7-444f-8ead-2efea633cc48","RNA","TCGA-VS-A94X-01A-11R","e5f58bca-f077-4967-96f3-f280648f2d2f",1.92,0.16,"UV Spec","R","23","TCGA-VS-A94X-01A-11R-A38B-07","7626194c-9fc3-4b7f-a759-2834583f3890",0.16,NA,42,16.8242268867169,158,"f7b6eb79-c606-5f50-8912-56193f37f3be","TCGA-VS-A94X_exposure","UNCID_2553075.7626194c-9fc3-4b7f-a759-2834583f3890.140521_UNC11-SN627_0359_BC4E01ACXX_5_CAGATC.tar.gz","2014-07-30T16:51:05.000Z","2014-07-30T17:09:44.000Z","CA675E90-9D83-4CD4-8E8A-9C6B7A7BA1E6","B3EDBB18-0B82-4A64-9B5A-6EF83590317B","Unaligned reads",4687400474,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7626194C-9FC3-4B7F-A759-2834583F3890","University of North Carolina","564a3b69e4b093830b694633","240EF385-DECC-48F7-A798-A81B4AB0410E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","618F6FA5-E8B7-444F-8EAD-2EFEA633CC48","2014-07-30T17:09:44.000Z","E5F58BCA-F077-4967-96F3-F280648F2D2F","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1281,"618F6FA5-E8B7-444F-8EAD-2EFEA633CC48",NA,"VS","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.94F1E446-754F-4DBB-A416-2551278C763F.txt",140,"TCGA-VS-A94X-01A",NA,"85118345-207B-43EC-A69C-E16BD65A1EA5","TCGA",2010,"TCGA-VS-A94X_NTE-1","Partial Remission/Response","WITH TUMOR","B3EDBB18-0B82-4A64-9B5A-6EF83590317B",40,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.94F1E446-754F-4DBB-A416-2551278C763F.txt","Dead",506,"TCGA-VS-A94X",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",394,NA,"6434B557-529A-443B-BB52-0389C645DBBE","BLACK OR AFRICAN AMERICAN",NA,11,30,"1290E0B8-DB23-4D16-BE86-307B7FD0240F","E5F58BCA-F077-4967-96F3-F280648F2D2F","f29994b324b2e89e34cf340092698857.bam","TCGA-VS-A94X-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-VS-A94X-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-VS-A94X-D62787","TCGA-VS-A94X-R62786","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A94X",NA,"VS","A94X","YES","C53.9","8070/3","C53.9","NO","YES",-14955,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,506,NA,NA,"WITH TUMOR","YES",21,5,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2010,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Partial Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
167779210,163626017,7812649466,"6D3CC3AC-618B-414A-B640-169C735A6568.bw","262311a0-7a10-4934-8fba-11ee581ad738","6d3cc3ac-618b-414a-b640-169c735a6568","2016-08-05T00:34:56.231067-05:00","UNCID_2187211.5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc.120920_UNC13-SN749_0194_AD15C3ACXX_2_TTAGGC.tar.gz","58625357-a105-4552-a484-b43b379b5561",7572933472,"Illumina HiSeq","c94d6fd4971f9f79b97dcc0068bc4df9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:23:42.451639-05:00","2016-05-03T11:02:00.403413-05:00","58625357-a105-4552-a484-b43b379b5561_analysis.xml","4df2d324448bf3cb642ddc0ef0847b2e","dafa370f-5231-4c60-bfc7-c152a40a98e3",2122,"2016-09-29T19:49:05.583397-05:00","58625357-a105-4552-a484-b43b379b5561_experiment.xml","aa2c303a1718aa07b42f5402cb05dbba","5660568f-24ba-4ed8-b008-0b0619d1ea98",2431,"2016-09-29T21:11:20.854800-05:00","58625357-a105-4552-a484-b43b379b5561_run.xml","d2b00e70949895520ea7cea519453157","89303fd9-e848-424a-95e5-32ca43544bb0",354,"2016-09-08T11:53:00.844514-05:00","TCGA-C5-A1BF","2016-09-02T18:56:42.869661-05:00","female","TCGA-C5-A1BF_demographic",1951,"white","270f7b8f-498d-59f2-8bd0-4c9c89555ffc","not reported",1998,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BF_diagnosis","not reported",16975,"dead","8070/3",570,NA,"ba9bd1b4-2fc2-5fdf-aa46-fef875291760","c53.9",-16975,"TCGA-C5-A1BF_treatment","c82a27a2-97a1-59d8-8378-02262897fe53","01","true","TCGA-C5-A1BF-01B",NA,"37670db3-74d9-4176-bc34-65d2e062d1cb",FALSE,"45EC2A51-EDE1-44E9-8756-A094B998A68B","Primary Tumor",NA,4992,60,NA,1297728000,"11",30,"TCGA-C5-A1BF-01B-11",70,NA,1,NA,0,NA,30,NA,"2016-09-08T11:53:00.844514-05:00",NA,15,NA,3,NA,"TOP",NA,5,NA,"4465e875-37c6-4e90-9be8-2ae85ca8c451",NA,"TCGA-C5-A1BF-01B-01-TS1",NA,65,NA,"b0330d42-86ef-4329-b6f8-e8a4624b735d","RNA","TCGA-C5-A1BF-01B-11R","eb0639d5-571f-47a7-afbc-028472cee2e9",1.8,0.16,"UV Spec","R","23","TCGA-C5-A1BF-01B-11R-A13Y-07","5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc",0.16,1.64383561643836,76,NA,NA,"62f7dc11-671f-55f8-8d7a-8aa9047aa825","TCGA-C5-A1BF_exposure","UNCID_2187211.5b31fb5f-9321-43d8-9b5f-600e8ba2f6cc.120920_UNC13-SN749_0194_AD15C3ACXX_2_TTAGGC.tar.gz","2013-09-17T04:01:04.000Z","2013-09-17T04:24:02.000Z","58625357-A105-4552-A484-B43B379B5561","37670DB3-74D9-4176-BC34-65D2E062D1CB","Unaligned reads",7572933472,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5B31FB5F-9321-43D8-9B5F-600E8BA2F6CC","University of North Carolina","564a3b48e4b0298dd2c85e66","262311A0-7A10-4934-8FBA-11EE581AD738","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B0330D42-86EF-4329-B6F8-E8A4624B735D","2013-09-17T04:24:02.000Z","EB0639D5-571F-47A7-AFBC-028472CEE2E9","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4992,"B0330D42-86EF-4329-B6F8-E8A4624B735D",NA,"C5","STOPS_p_TCGA_b101_114_SNP_N_GenomeWideSNP_6_F04_771836.nocnv_hg19.seg.txt",60,"TCGA-C5-A1BF-01B",NA,"484070B1-FD8E-46A3-B031-DA66D5641485","TCGA",1997,NA,NA,"WITH TUMOR","D7002BAA-1A99-441D-8D83-D146DC49B78F",46,"nationwidechildrens.org_clinical.TCGA-C5-A1BF.xml","Dead",570,"TCGA-C5-A1BF",NA,"A728C808-CE08-48FA-8887-CCEEE2FD28C9",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"TX","8070/3","FEMALE","C53.9",114,NA,"F9D73AD1-B58E-415A-9566-A867B6ABD221","WHITE",NA,11,30,"4465E875-37C6-4E90-9BE8-2AE85CA8C451","75A289FD-911B-4766-B07E-CCCB217DDE6A","STOPS_p_TCGA_b101_114_SNP_N_GenomeWideSNP_6_F04_771836.nocnv_hg19.seg.txt","TCGA-C5-A1BF-01B-11",70,0,1,15,30,"TOP",5,3,"TCGA-C5-A1BF-01B-01-TS1",65,"Cisplatin","Chemotherapy","TCGA-C5-A1BF-D30724","TCGA-C5-A1BF-R30732","EXTERNAL BEAM","Distant Recurrence",NA,"YES",NA,"WITH TUMOR","Dead",570,"TCGA-C5-A1BF-F30729","TCGA-C5-A1BF",NA,"C5","A1BF","YES","C53.9","8070/3","C53.9","NO","YES",-16975,"FEMALE","WHITE",NA,"No","No","Dead",NA,570,NA,NA,"WITH TUMOR","NO",12,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,1997,"Biopsy (cervical / CT-guided / Other)","YES",33,0,"G1",NA,2,NA,30,NA,NA,"1995",6,NA,"TXN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
133576342,128126998,6098462769,"710C05C7-F9CE-45FA-A8CC-29DE2903E04F.bw","27d2b645-f1bf-4486-b0b5-273681b58625","710c05c7-f9ce-45fa-a8cc-29de2903e04f","2016-08-25T15:37:53.236543-05:00","UNCID_2561267.babc730d-6170-4503-8502-d794575fe993.140416_UNC11-SN627_0353_BC42B0ACXX_2_GATCAG.tar.gz","0dba1601-598f-4583-bc3a-71d64299763b",5827998376,"Illumina HiSeq","48f0e5d292f24beebe12d88bd7a35229","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:59:24.487209-05:00","2016-05-03T11:54:19.897074-05:00","0dba1601-598f-4583-bc3a-71d64299763b_analysis.xml","65450268826371e7d689acc5de569bb8","119a3af9-2e7c-4c00-8f24-14e4d325991c",2124,"2016-09-29T20:02:14.871175-05:00","0dba1601-598f-4583-bc3a-71d64299763b_experiment.xml","57d31b4dc34654b2bb3cc329a85a8299","5e7c752e-554e-4bd0-a5cb-496b00737682",2628,"2016-09-29T19:36:07.816151-05:00","0dba1601-598f-4583-bc3a-71d64299763b_run.xml","d452518edd0536a6d626851b0e885baa","4e521b6c-4b64-47fb-b546-ffec5bf4f79d",354,"2016-09-08T11:32:22.413570-05:00","TCGA-VS-A8QM","2016-09-02T19:01:22.169738-05:00","female","TCGA-VS-A8QM_demographic",1962,"not reported","b1b5ee33-28f4-507a-9fc3-f3051386c179","not reported",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8QM_diagnosis","not reported",17168,"dead","8070/3",951,NA,"c3bce7d1-d7e5-537b-b279-e5a6c026a9c4","c53.9",-17168,"TCGA-VS-A8QM_treatment","2fcb4788-0299-50b8-9c1e-93d563ac23e4","01","false","TCGA-VS-A8QM-01A",NA,"9992b93e-8ec5-4f2b-9930-cd82c14f5569",FALSE,"83522ECF-2552-4708-9311-A15C53D436C9","Primary Tumor",NA,1422,90,NA,1386806400,"11",30,"TCGA-VS-A8QM-01A-11",60,NA,1,NA,15,NA,20,NA,"2016-09-08T11:32:22.413570-05:00",NA,8,NA,2,NA,"TOP",NA,5,NA,"420dd287-4f1f-41d2-8f0f-5595da4ae046",NA,"TCGA-VS-A8QM-01A-01-TS1",NA,60,NA,"bc8fbfd5-074a-402f-a768-beab9d66ac90","RNA","TCGA-VS-A8QM-01A-11R","439678ec-43a8-4652-9224-c64dca5cab34",1.84,0.16,"UV Spec","R","23","TCGA-VS-A8QM-01A-11R-A37O-07","babc730d-6170-4503-8502-d794575fe993",0.16,0.876712328767123,53,19.9480597689036,163,"b33e86d2-e785-5d0e-a6b1-444dac557891","TCGA-VS-A8QM_exposure","UNCID_2561267.babc730d-6170-4503-8502-d794575fe993.140416_UNC11-SN627_0353_BC42B0ACXX_2_GATCAG.tar.gz","2014-08-02T16:51:04.000Z","2014-08-02T17:18:14.000Z","0DBA1601-598F-4583-BC3A-71D64299763B","9992B93E-8EC5-4F2B-9930-CD82C14F5569","Unaligned reads",5827998376,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","BABC730D-6170-4503-8502-D794575FE993","University of North Carolina","564a4124e4b0298dd2ca409b","27D2B645-F1BF-4486-B0B5-273681B58625","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BC8FBFD5-074A-402F-A768-BEAB9D66AC90","2014-08-02T17:18:14.000Z","439678EC-43A8-4652-9224-C64DCA5CAB34","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1422,"BC8FBFD5-074A-402F-A768-BEAB9D66AC90",NA,"VS","ce0120949220cac24c911d7662f0be92.bam",90,"TCGA-VS-A8QM-01A",NA,"5079FF1A-2F4B-4088-8168-7A3A3042489A","TCGA",2009,"TCGA-VS-A8QM_NTE-1","Progressive Disease","WITH TUMOR","9B5595F3-61E0-4D0A-B9A2-CCE5DAC511CB",47,"nationwidechildrens.org_clinical.TCGA-VS-A8QM.xml","Dead",951,"TCGA-VS-A8QM",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IVB",NA,NA,"TX","8070/3","FEMALE","C53.9",380,NA,"7575157D-56C4-455B-85A0-E91C7CB39B21",NA,NA,11,30,"420DD287-4F1F-41D2-8F0F-5595DA4AE046","F288292A-022B-4676-B410-D48C15454175","ce0120949220cac24c911d7662f0be92.bam","TCGA-VS-A8QM-01A-11",60,15,1,8,20,"TOP",5,2,"TCGA-VS-A8QM-01A-01-TS1",60,"Cisplatin","Chemotherapy","TCGA-VS-A8QM-D61947","TCGA-VS-A8QM-R61946","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8QM",NA,"VS","A8QM","YES","C53.9","8070/3","C53.9","NO","YES",-17168,"FEMALE",NA,NA,"No","No","Dead",NA,951,NA,NA,"WITH TUMOR","YES",1,4,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,2,NA,16,NA,"Progressive Disease","2009",18,NA,"TXNXM1",NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
138072458,131961633,6301319335,"3D631A56-2C55-48EA-A667-BA46023C9D50.bw","287ce10e-31c8-4b10-9858-6e45451dfbe4","3d631a56-2c55-48ea-a667-ba46023c9d50","2016-08-05T00:11:59.691997-05:00","UNCID_2187239.029c4ec1-b4a1-4aea-a126-aceadb8ab52a.120921_UNC16-SN851_0181_AD14JFACXX_8_AGTCAA.tar.gz","38aded46-2287-4f50-aa08-532526552cfb",5868030929,"Illumina HiSeq","1fcd0a7f5524e0932d5f8e1efff1e570","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:37:54.561225-05:00","2016-05-03T11:02:00.403413-05:00","38aded46-2287-4f50-aa08-532526552cfb_analysis.xml","4d8f94b698347cf181e0415b9b9fc425","742b3d0f-c488-486c-ad20-709506ca684d",2124,"2016-09-29T19:08:08.017084-05:00","38aded46-2287-4f50-aa08-532526552cfb_experiment.xml","c7c27b4ba90996d3fb4017e496d6afee","3cc5d96c-de1a-419b-b02e-c4f214d8150a",2431,"2016-09-29T21:31:35.438839-05:00","38aded46-2287-4f50-aa08-532526552cfb_run.xml","b6ad4d3bc93eec4b823eff613f6fcb35","95b64a8a-7656-4b0c-9597-9c1183ae9531",354,"2016-09-08T11:32:06.418217-05:00","TCGA-C5-A1MN","2016-09-02T18:57:21.163367-05:00","female","TCGA-C5-A1MN_demographic",1965,"white","df713a31-dbca-5682-93e5-4508ad70198a","not hispanic or latino",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MN_diagnosis","not reported",15499,"dead","8070/3",1245,NA,"b41dd1a7-96d2-55ab-8f08-b75920d5dfdb","c53.9",-15499,"TCGA-C5-A1MN_treatment","0ccc0e21-6ebe-5b4b-8e02-ca859b566285","01","true","TCGA-C5-A1MN-01A",NA,"6bad5bce-c734-47eb-85f0-d804022578ce",FALSE,"8C677406-F68A-429E-BC9A-9AE26928D226","Primary Tumor",NA,1441,110,NA,1301356800,"11",30,"TCGA-C5-A1MN-01A-11",85,NA,20,NA,0,NA,10,NA,"2016-09-08T11:32:06.418217-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"5bae5fe9-33fd-4f5d-bc95-a6415c54ef89",NA,"TCGA-C5-A1MN-01A-01-TSA",NA,85,NA,"af3301d4-f696-4d67-afdc-e12afd6c006b","RNA","TCGA-C5-A1MN-01A-11R","06eb0f64-22c8-4572-9791-7da83ddfd27e",1.75,0.16,"UV Spec","R","23","TCGA-C5-A1MN-01A-11R-A14Y-07","029c4ec1-b4a1-4aea-a126-aceadb8ab52a",0.16,1.36986301369863,64,23.5078053259871,165,"8c445831-a118-571e-bf05-741c7a8d0586","TCGA-C5-A1MN_exposure","UNCID_2187239.029c4ec1-b4a1-4aea-a126-aceadb8ab52a.120921_UNC16-SN851_0181_AD14JFACXX_8_AGTCAA.tar.gz","2013-09-17T04:43:04.000Z","2013-09-17T05:07:02.000Z","38ADED46-2287-4F50-AA08-532526552CFB","6BAD5BCE-C734-47EB-85F0-D804022578CE","Unaligned reads",5868030929,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","029C4EC1-B4A1-4AEA-A126-ACEADB8AB52A","University of North Carolina","566075fde4b0ec1099f8c054","287CE10E-31C8-4B10-9858-6E45451DFBE4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AF3301D4-F696-4D67-AFDC-E12AFD6C006B","2013-09-17T05:07:02.000Z","06EB0F64-22C8-4572-9791-7DA83DDFD27E","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1441,"AF3301D4-F696-4D67-AFDC-E12AFD6C006B",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.FCCC4EAA-62B7-4005-887C-716C7FB52D63.txt",110,"TCGA-C5-A1MN-01A",NA,"7B3A715D-196B-44E7-9A3B-BD3C3DA17A09","TCGA",2007,NA,NA,"TUMOR FREE","D3EDD964-C993-4E10-B3B1-06E01B3190CC",42,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.FCCC4EAA-62B7-4005-887C-716C7FB52D63.txt","Dead",1245,"TCGA-C5-A1MN","NOT HISPANIC OR LATINO","B0B5B13E-05AA-432E-A673-026541938F57",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",127,NA,"2505CCB6-FF3E-4433-8489-8871CCCFE10D","WHITE",NA,11,30,"5BAE5FE9-33FD-4F5D-BC95-A6415C54EF89","B66B6926-1BB5-4C16-BE5C-37AB24EF4D5D","TCGA-C5-A1MN-01A-11R-A14X-13_mirna.bam","TCGA-C5-A1MN-01A-11",85,0,20,40,10,"TOP",5,20,"TCGA-C5-A1MN-01A-01-TSA",85,"Cisplatin","Chemotherapy","TCGA-C5-A1MN-D30193","TCGA-C5-A1MN-R30194","COMBINATION","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",1245,"TCGA-C5-A1MN-F30192","TCGA-C5-A1MN",NA,"C5","A1MN","YES","C53.9","8070/3","C53.9","NO","YES",-15499,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1245,NA,NA,"TUMOR FREE","NO",21,10,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2007,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,25,NA,NA,"1995",16,NA,NA,NA,NA,1,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
176774446,171821411,8204229333,"F1C65F64-AF05-4875-B7E4-60FFF56A3F46.bw","29a48c93-bade-4346-a901-de35a6537337","f1c65f64-af05-4875-b7e4-60fff56a3f46","2016-08-09T13:55:59.361293-05:00","UNCID_2187257.aabf5831-8886-4570-9266-00cd858ba17b.120921_UNC16-SN851_0181_AD14JFACXX_8_AGTTCC.tar.gz","3f987b69-8fe1-486a-9e2d-e2bffff9cde1",7509450584,"Illumina HiSeq","89d4138c32c8326ce7b4a13e717fc361","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:04:30.336890-05:00","2016-05-03T11:02:00.403413-05:00","3f987b69-8fe1-486a-9e2d-e2bffff9cde1_analysis.xml","4d6a52a1c488d517a158fcc5864d9b75","f458aec2-d95b-4a47-a8cd-ca277aef85b4",2124,"2016-09-29T18:15:21.651105-05:00","3f987b69-8fe1-486a-9e2d-e2bffff9cde1_experiment.xml","c0ed03269c0de6ada69019a280d44b75","1b80e213-9037-4b3e-9715-3168a01d50e3",2431,"2016-09-29T20:02:26.256401-05:00","3f987b69-8fe1-486a-9e2d-e2bffff9cde1_run.xml","4877cb770b766028e606ceefd0af682f","5e9740f8-1822-47bb-b7a2-dec8b2aaee20",354,"2016-09-08T12:15:09.905472-05:00","TCGA-DS-A1OB","2016-09-02T18:57:27.195263-05:00","female","TCGA-DS-A1OB_demographic",1962,"white","938c935d-7511-5831-92a2-1bfc14ea4589","not hispanic or latino",2009,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A1OB_diagnosis","not reported",16685,"dead","8070/3",861,NA,"fdbb87ec-0231-55c8-a140-edc78db0b558","c53.9",-16685,"TCGA-DS-A1OB_treatment","f51f5417-5b8f-56be-9171-cf51f07d0486","01","true","TCGA-DS-A1OB-01A",NA,"d664c261-6c5f-454d-b908-334dc2683a2b",FALSE,"65C2A525-AEE4-48E9-83F3-CFBADAF161C1","Primary Tumor",NA,1199,150,NA,1302480000,"11",30,"TCGA-DS-A1OB-01A-11",80,NA,5,NA,0,NA,10,NA,"2016-09-08T12:15:09.905472-05:00",NA,50,NA,30,NA,"TOP",NA,10,NA,"dced2292-a317-40af-b7fc-c19ac5067d5b",NA,"TCGA-DS-A1OB-01A-01-TSA",NA,80,NA,"92d0ea47-2131-4cf5-995a-10de1fb79352","RNA","TCGA-DS-A1OB-01A-11R","c73d67d9-e2b9-4c25-b376-c78a4a6976ec",1.81,0.15,"UV Spec","R","23","TCGA-DS-A1OB-01A-11R-A14Y-07","aabf5831-8886-4570-9266-00cd858ba17b",0.15,NA,72,31.1634349030471,152,"d06069de-4dd5-5285-bd92-2ebc66d337e0","TCGA-DS-A1OB_exposure","UNCID_2187257.aabf5831-8886-4570-9266-00cd858ba17b.120921_UNC16-SN851_0181_AD14JFACXX_8_AGTTCC.tar.gz","2013-09-17T05:16:04.000Z","2013-09-17T05:39:01.000Z","3F987B69-8FE1-486A-9E2D-E2BFFFF9CDE1","D664C261-6C5F-454D-B908-334DC2683A2B","Unaligned reads",7509450584,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AABF5831-8886-4570-9266-00CD858BA17B","University of North Carolina","564a3f02e4b093830b6a6b4d","29A48C93-BADE-4346-A901-DE35A6537337","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","92D0EA47-2131-4CF5-995A-10DE1FB79352","2013-09-17T05:39:01.000Z","C73D67D9-E2B9-4C25-B376-C78A4A6976EC","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",1199,"92D0EA47-2131-4CF5-995A-10DE1FB79352",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6F74B999-D13D-458C-90F2-30D59F8D9B54.txt",150,"TCGA-DS-A1OB-01A",NA,"EB18139A-43D7-4750-A63E-307C69FB7F89","TCGA",2007,NA,NA,"WITH TUMOR","D664C261-6C5F-454D-B908-334DC2683A2B",45,"jhu-usc.edu_CESC.HumanMethylation450.2.lvl-3.TCGA-DS-A1OB-01A-11D-A14Z-05.txt","Dead",861,"TCGA-DS-A1OB","NOT HISPANIC OR LATINO","EC3961B6-4727-43CC-B85C-6E816B3B80FC",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b2","8070/3","FEMALE","C53.9",127,NA,"E616CE5E-3EF9-4FDC-AF2B-842FBACEB2D5","WHITE",NA,11,30,"DCED2292-A317-40AF-B7FC-C19AC5067D5B","C73D67D9-E2B9-4C25-B376-C78A4A6976EC","C501.TCGA-DS-A1OB-01A-11D-A16Y-08.4.bam","TCGA-DS-A1OB-01A-11",80,0,5,50,10,"TOP",10,30,"TCGA-DS-A1OB-01A-01-TSA",80,"Gemzar","Chemotherapy","TCGA-DS-A1OB-D20937","TCGA-DS-A1OB-R19931","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",861,"TCGA-DS-A1OB-F19926","TCGA-DS-A1OB",NA,"DS","A1OB","YES","C53.9","8070/3","C53.9","NO","YES",-16685,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,861,NA,NA,"WITH TUMOR","NO",4,1,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2007,"Biopsy (cervical / CT-guided / Other)","YES",31,16,"G2",NA,NA,NA,NA,NA,NA,"1995",6,NA,"T1b2N1M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
172988926,171381306,8178406427,"E5DF76E7-A765-4E07-B87A-06168BF66C5F.bw","2b6d2c15-8bcc-41ab-84d6-601442f4378b","e5df76e7-a765-4e07-b87a-06168bf66c5f","2016-08-25T16:05:14.742089-05:00","UNCID_2187208.8b82c786-64be-410a-89bf-d28dc8d7c4e9.120920_UNC13-SN749_0194_AD15C3ACXX_1_ATCACG.tar.gz","746bc41d-985c-4e16-84b2-68cf230223dd",7768645978,"Illumina HiSeq","8dcba75d1068bea6f421bca5113b7b54","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:01.267527-05:00","2016-05-03T11:02:00.403413-05:00","746bc41d-985c-4e16-84b2-68cf230223dd_analysis.xml","b068eaae8b8e28e135582dfbaeab0cf6","7bbdc213-4f29-428a-8860-e84e58415b98",2123,"2016-08-30T05:24:39.583736-05:00","746bc41d-985c-4e16-84b2-68cf230223dd_experiment.xml","0fded8dd97d8a0bd770ebe67ae5933ee","7495f0e4-294f-4020-aee3-ebf17dca2a3b",2431,"2016-09-29T20:50:42.914670-05:00","746bc41d-985c-4e16-84b2-68cf230223dd_run.xml","29eb1f96871434ad8a35bc93aba27ffc","7c30d62b-082e-4515-ad71-7db191ac675e",354,"2016-09-08T11:54:45.003831-05:00","TCGA-C5-A1BE","2016-09-02T18:56:41.991488-05:00","female","TCGA-C5-A1BE_demographic",1936,"white","aebd6fe8-449f-50c3-945e-d6df755ccfdb","not reported",2005,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BE_diagnosis","not reported",23727,"dead","8072/3",2094,NA,"a812324a-1738-54a4-80f8-2fdb546d0fc9","c53.9",-23727,"TCGA-C5-A1BE_treatment","dd9b56d6-cc51-55d7-973e-9af1f89f5893","01","true","TCGA-C5-A1BE-01B",NA,"7088f4cf-bab7-481e-a0ec-759124ef80ff",FALSE,"0A21AE44-27DF-4F41-BAB5-209A25087C0A","Primary Tumor",NA,3839,40,NA,1297728000,"11",30,"TCGA-C5-A1BE-01B-11",60,NA,0,NA,0,NA,40,NA,"2016-09-08T11:54:45.003831-05:00",NA,15,NA,1,NA,"TOP",NA,0,NA,"9640d8ae-ed1a-4ae7-9cf4-5506303b88e1",NA,"TCGA-C5-A1BE-01B-01-TSA",NA,60,NA,"93d56d90-5b45-4b1a-94a4-bf3df3e4cc9d","RNA","TCGA-C5-A1BE-01B-11R","0b36362b-9a79-4c3d-8f1b-6b5713f97de9",1.74,0.16,"UV Spec","R","23","TCGA-C5-A1BE-01B-11R-A13Y-07","8b82c786-64be-410a-89bf-d28dc8d7c4e9",0.16,NA,76,34.2326922210711,149,"75407f80-5d7e-5153-b130-cc071e6af8c1","TCGA-C5-A1BE_exposure","UNCID_2187208.8b82c786-64be-410a-89bf-d28dc8d7c4e9.120920_UNC13-SN749_0194_AD15C3ACXX_1_ATCACG.tar.gz","2013-09-17T03:46:04.000Z","2013-09-17T04:09:02.000Z","746BC41D-985C-4E16-84B2-68CF230223DD","7088F4CF-BAB7-481E-A0EC-759124EF80FF","Unaligned reads",7768645978,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8B82C786-64BE-410A-89BF-D28DC8D7C4E9","University of North Carolina","564a3dcde4b08c5d869246cc","2B6D2C15-8BCC-41AB-84D6-601442F4378B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","93D56D90-5B45-4B1A-94A4-BF3DF3E4CC9D","2013-09-17T04:09:02.000Z","0B36362B-9A79-4C3D-8F1B-6B5713F97DE9","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3839,"93D56D90-5B45-4B1A-94A4-BF3DF3E4CC9D",NA,"C5","C501.TCGA-C5-A1BE-01B-11D-A13W-08.2.bam",40,"TCGA-C5-A1BE-01B",NA,"A715C97A-30BE-41EA-8E32-FC40D47180B1","TCGA",2000,NA,NA,"WITH TUMOR","F87D9890-19A7-4A67-A4BA-159047E11C1E",64,"nationwidechildrens.org_clinical.TCGA-C5-A1BE.xml","Dead",2094,"TCGA-C5-A1BE",NA,"CF4EB184-9FB1-4CD1-A898-455B33D22B14",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b","8072/3","FEMALE","C53.9",114,NA,"8835917E-89C9-4295-B37C-4B2568E94D31","WHITE",NA,11,30,"9640D8AE-ED1A-4AE7-9CF4-5506303B88E1","87823F7F-A60D-4796-8B9A-597F69117E6D","C501.TCGA-C5-A1BE-01B-11D-A13W-08.2.bam","TCGA-C5-A1BE-01B-11",60,0,0,15,40,"TOP",0,1,"TCGA-C5-A1BE-01B-01-TSA",60,"Cisplatin","Chemotherapy","TCGA-C5-A1BE-D30508","TCGA-C5-A1BE-R30506","COMBINATION","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",2094,"TCGA-C5-A1BE-F30504","TCGA-C5-A1BE",NA,"C5","A1BE","YES","C53.9","8072/3","C53.9","NO","YES",-23727,"FEMALE","WHITE",NA,"No","No","Dead",NA,2094,NA,NA,"WITH TUMOR","NO",12,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2000,"Cone Biopsy / LEEP","YES",38,2,"G2",NA,3,NA,NA,NA,NA,"1995",8,NA,"T1bN1MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
107402002,106399598,5084851924,"5C8C8A6E-40D4-4F82-AC3D-90CFDEE15C0A.bw","2c600a58-98ed-4572-9b6f-edba2719790c","5c8c8a6e-40d4-4f82-ac3d-90cfdee15c0a","2016-08-09T14:41:51.567868-05:00","UNCID_2654371.57955c20-b0c4-4d4c-aea6-cee9179a4118.141010_UNC12-SN629_0394_AC5FTUACXX_2_TAGCTT.tar.gz","de8ad0c8-7f0a-4cdf-939c-56ef500ec5ac",4459724025,"Illumina HiSeq","e0ce3a760c8eb228a5d49db26ae09cb1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:19:48.115857-05:00","2016-05-03T12:08:10.829131-05:00","de8ad0c8-7f0a-4cdf-939c-56ef500ec5ac_analysis.xml","29a792b6a21c745384bd631d8b3955a2","691624dc-8992-4f81-bf60-a6d67cf04077",2124,"2016-08-27T23:13:07.884459-05:00","de8ad0c8-7f0a-4cdf-939c-56ef500ec5ac_experiment.xml","f2c70c47d4c8e270b22ce4b009aec9df","f3ff6530-8bd2-40b0-83b8-575b4d2e7f38",2628,"2016-09-29T19:14:57.345589-05:00","de8ad0c8-7f0a-4cdf-939c-56ef500ec5ac_run.xml","31205b5c38e9c6aee57b6173d816e577","411815a3-9e7c-4b40-aabd-12076cba0e0e",354,"2016-09-08T12:12:49.307472-05:00","TCGA-VS-A9UQ","2016-09-02T18:54:30.538129-05:00","female","TCGA-VS-A9UQ_demographic",1979,"not reported","df3f5556-c904-536f-a7b0-318a46be53d0","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UQ_diagnosis","not reported",11853,"alive","8482/3",NA,1263,"7cff7656-a001-5ac5-9bc5-e78b0235e4f3","c53.9",-11853,"TCGA-VS-A9UQ_treatment","c6c8adb6-665b-5d51-8f4b-367498310625","01","false","TCGA-VS-A9UQ-01A",NA,"4b9dfe4e-b74c-4eb8-82a6-1cf044bafa1f",FALSE,"AF3A1FB4-1FC6-4CB7-93EF-0E3E2FEE3E8B","Primary Tumor",NA,771,130,NA,1391040000,"21",30,"TCGA-VS-A9UQ-01A-21",70,NA,20,NA,0,NA,30,NA,"2016-09-08T12:12:49.307472-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"ed2a9870-3532-41dd-bf08-6d099ce97f77",NA,"TCGA-VS-A9UQ-01A-02-TSB",NA,70,NA,"4584c603-0e3f-48e7-ad19-97dadc5ff04b","RNA","TCGA-VS-A9UQ-01A-21R","82657c74-990d-4cbc-b1f9-5ba18e0b6638",1.87,0.18,"UV Spec","R","23","TCGA-VS-A9UQ-01A-21R-A42T-07","57955c20-b0c4-4d4c-aea6-cee9179a4118",0.18,NA,72,28.125,160,"9a13ba69-699e-5201-96eb-850921e3f016","TCGA-VS-A9UQ_exposure","UNCID_2654371.57955c20-b0c4-4d4c-aea6-cee9179a4118.141010_UNC12-SN629_0394_AC5FTUACXX_2_TAGCTT.tar.gz","2014-11-05T02:27:04.000Z","2014-11-05T02:41:33.000Z","DE8AD0C8-7F0A-4CDF-939C-56EF500EC5AC","4B9DFE4E-B74C-4EB8-82A6-1CF044BAFA1F","Unaligned reads",4459724025,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","57955C20-B0C4-4D4C-AEA6-CEE9179A4118","University of North Carolina","564a3b9ae4b093830b6955f0","2C600A58-98ED-4572-9B6F-EDBA2719790C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4584C603-0E3F-48E7-AD19-97DADC5FF04B","2014-11-05T02:41:33.000Z","82657C74-990D-4CBC-B1F9-5BA18E0B6638","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",771,"4584C603-0E3F-48E7-AD19-97DADC5FF04B",NA,"VS","TCGA-VS-A9UQ-01A-21R-A42V-13.isoform.quantification.txt",130,"TCGA-VS-A9UQ-01A",NA,NA,"TCGA",2011,"TCGA-VS-A9UQ_NTE-1","Complete Remission/Response","TUMOR FREE","F8E3B30A-9755-43DD-98CC-180AEBEEB984",32,"nationwidechildrens.org_clinical.TCGA-VS-A9UQ.xml","Alive",NA,"TCGA-VS-A9UQ",NA,"8358CE9C-A187-49F4-9DA0-3A88CE73A887","YES",920,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",1,"Other","Stage IB",NA,NA,"T1b","8482/3","FEMALE","C53.9",420,NA,"F695D9CA-26D0-4A3F-8A03-B38756A05CBC",NA,NA,21,30,"ED2A9870-3532-41DD-BF08-6D099CE97F77","A0737F25-1642-4FB1-9163-54AB6261CD1E","TCGA-VS-A9UQ-01A-21R-A42V-13_mirna.bam.bai","TCGA-VS-A9UQ-01A-21",70,0,20,40,30,"TOP",0,20,"TCGA-VS-A9UQ-01A-02-TSB",70,NA,NA,NA,"TCGA-VS-A9UQ-R63449","External","Regional site","TCGA-VS-A9UQ-F72068_NTE-1","NO",1204,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UQ-F72068","TCGA-VS-A9UQ",NA,"VS","A9UQ","YES","C53.9","8482/3","C53.9","NO","YES",-11853,"FEMALE",NA,NA,"No","No","Alive",920,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,32,2011,"Biopsy (cervical / CT-guided / Other)","YES",22,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",6,NA,"T1bN0MX",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
129865718,128354126,6134939260,"0117CBB9-1BF9-48B1-BE6E-A9A770FF8721.bw","2c736c5c-9d32-4522-acfd-6620bc291ace","0117cbb9-1bf9-48b1-be6e-a9a770ff8721","2016-08-24T12:56:18.796273-05:00","UNCID_2520189.69e3b16b-5515-416b-808a-0321a107e5c0.140508_UNC11-SN627_0356_AC3UKNACXX_6_CAGATC.tar.gz","9629ffd9-9a7f-49c4-8b62-361bfe3944ec",5675843159,"Illumina HiSeq","c5ee31a0fce8928e0f688caee6714855","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:22:06.960110-05:00","2016-05-03T11:51:27.506016-05:00","9629ffd9-9a7f-49c4-8b62-361bfe3944ec_analysis.xml","558d099ea1dc028331432d32ab27a590","8fd6d4b8-248c-46e9-85bd-71fa9f9759f6",2124,"2016-09-29T19:02:39.693406-05:00","9629ffd9-9a7f-49c4-8b62-361bfe3944ec_experiment.xml","d704baa4718fc9fde6aa36ebc94e7ee0","395c5032-e397-49f3-8731-8374e4dbfd99",2628,"2016-09-29T19:38:05.798179-05:00","9629ffd9-9a7f-49c4-8b62-361bfe3944ec_run.xml","be70ac733dcc217d1dedd7746a57d03b","4f88a20f-2287-4c35-abc1-f79448586be0",354,"2016-09-08T11:49:23.865437-05:00","TCGA-VS-A8EB","2016-09-02T19:01:03.381444-05:00","female","TCGA-VS-A8EB_demographic",1969,"white","80d0067a-6058-5bac-852e-f8a41886e313","not reported",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EB_diagnosis","not reported",15215,"dead","8070/3",305,NA,"6fd5eb41-b3bc-59e7-b758-914a8184dc1a","c53.9",-15215,"TCGA-VS-A8EB_treatment","fab66df8-06a1-55af-b199-d544cd36e201","01","false","TCGA-VS-A8EB-01A",NA,"c5d3ab5d-8863-4c98-993e-c63a32921a28",FALSE,"ED146C1D-315F-4628-A529-62D235938DFF","Primary Tumor",NA,1189,50,NA,1384819200,"11",30,"TCGA-VS-A8EB-01A-11",80,NA,0,NA,10,NA,10,NA,"2016-09-08T11:49:23.865437-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"5f71eae8-e06f-4d4b-9003-52c3e4008c8a",NA,"TCGA-VS-A8EB-01A-01-TS1",NA,80,NA,"057319ad-cf27-4ade-9f20-bad953640050","RNA","TCGA-VS-A8EB-01A-11R","f19e3f2f-0e8e-4a0c-8e2b-f59fb062de23",1.9,0.17,"UV Spec","R","23","TCGA-VS-A8EB-01A-11R-A36F-07","69e3b16b-5515-416b-808a-0321a107e5c0",0.17,NA,64,27.3399119996583,153,"5ac44ae1-5cdc-512d-bba5-b996f9e369c7","TCGA-VS-A8EB_exposure","UNCID_2520189.69e3b16b-5515-416b-808a-0321a107e5c0.140508_UNC11-SN627_0356_AC3UKNACXX_6_CAGATC.tar.gz","2014-07-09T17:04:59.000Z","2014-07-09T17:33:20.000Z","9629FFD9-9A7F-49C4-8B62-361BFE3944EC","C5D3AB5D-8863-4C98-993E-C63A32921A28","Unaligned reads",5675843159,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","69E3B16B-5515-416B-808A-0321A107E5C0","University of North Carolina","564a4090e4b09c884b25e769","2C736C5C-9D32-4522-ACFD-6620BC291ACE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","057319AD-CF27-4ADE-9F20-BAD953640050","2014-07-09T17:33:20.000Z","F19E3F2F-0E8E-4A0C-8E2B-F59FB062DE23","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1189,"057319AD-CF27-4ADE-9F20-BAD953640050",NA,"VS","d704a3b054d00663c0bf5b5867b95d4f.bam",50,"TCGA-VS-A8EB-01A",NA,NA,"TCGA",2010,"TCGA-VS-A8EB_NTE-1","Progressive Disease","WITH TUMOR","C5D3AB5D-8863-4C98-993E-C63A32921A28",41,"nationwidechildrens.org_clinical.TCGA-VS-A8EB.xml","Dead",305,"TCGA-VS-A8EB",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",373,NA,"99BE0B65-9928-4DB6-92FF-8B12330D72DF","WHITE",NA,11,30,"5F71EAE8-E06F-4D4B-9003-52C3E4008C8A","A484604C-B6D8-498B-81D4-1404123D4C41","d704a3b054d00663c0bf5b5867b95d4f.bam","TCGA-VS-A8EB-01A-11",80,10,0,5,10,"TOP",0,0,"TCGA-VS-A8EB-01A-01-TS1",80,NA,NA,NA,"TCGA-VS-A8EB-R61978","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8EB",NA,"VS","A8EB","YES","C53.9","8070/3","C53.9","NO","YES",-15215,"FEMALE","WHITE",NA,"No","No","Dead",NA,305,NA,NA,"WITH TUMOR","YES",22,4,2014,"NO","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,41,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,2,NA,NA,NA,"Progressive Disease","2009",16,NA,"T3bNXM1",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
118533046,113796920,5400424948,"31EF66E5-419A-44C3-BB2A-B69B52FFCECC.bw","2d34e9a3-298c-4365-b7a1-a507c7f069cd","31ef66e5-419a-44c3-bb2a-b69b52ffcecc","2016-08-09T14:04:05.217822-05:00","UNCID_2169703.0dadcb32-0c50-4d9b-8112-d4e533e789d6.130530_UNC9-SN296_0371_BC2528ACXX_4_GTTTCG.tar.gz","ca9740fc-eaf8-417e-8490-37a4231926db",5751856480,"Illumina HiSeq","c381142aea15ef2ab21dadc7367b3844","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:29:30.828361-05:00","2016-05-03T11:05:42.727154-05:00","ca9740fc-eaf8-417e-8490-37a4231926db_analysis.xml","acd8b306623a0a17d8af9ce121fa4155","6f1a72d7-0985-4280-ae9e-dbdef5bd1d63",2121,"2016-09-29T23:34:02.841162-05:00","ca9740fc-eaf8-417e-8490-37a4231926db_experiment.xml","da2e37866a0fc2ba7eb8f43a46cc1d2b","e18b3700-7ab8-4c28-8910-6e31dd16f3b0",2431,"2016-09-29T20:41:51.295563-05:00","ca9740fc-eaf8-417e-8490-37a4231926db_run.xml","95df63fcba3a41cd587dddf43d3ee699","76a507db-4e3f-46fa-b94c-040cbb41cb76",354,"2016-09-08T12:04:31.708890-05:00","TCGA-EA-A556","2016-09-02T18:59:45.297638-05:00","female","TCGA-EA-A556_demographic",1974,"white","aac2f8e9-8ce1-51c8-9bda-12b435c8ac1f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A556_diagnosis","not reported",13988,"alive","8380/3",NA,453,"6acfa460-0de1-5a13-b50a-0f99b49d491a","c53.9",-13988,"TCGA-EA-A556_treatment","aa2f3f22-fe1d-5c78-8c0b-53e00caa669d","01","true","TCGA-EA-A556-01A",NA,"2cae861c-a035-49e8-9dc9-977f2da23137",FALSE,"EDEF2B45-54BF-4329-B7ED-FBF59E13B438","Primary Tumor",NA,119,360,NA,1354838400,"11",30,"TCGA-EA-A556-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T12:04:31.708890-05:00",NA,2,NA,0,NA,"TOP",NA,3,NA,"371798df-872a-4aa0-9894-7db2f16cd3da",NA,"TCGA-EA-A556-01A-01-TSA",NA,97,NA,"88f8c3ef-ff7c-40cb-8cea-5dbf02752593","RNA","TCGA-EA-A556-01A-11R","c0c29404-02a8-4c30-9cbc-234c5a9403b9",1.83,0.17,"UV Spec","R","23","TCGA-EA-A556-01A-11R-A26T-07","0dadcb32-0c50-4d9b-8112-d4e533e789d6",0.17,1.0958904109589,62,24.21875,160,"a86c9695-0a1d-5f9b-b7f4-a1cabbb7ce0f","TCGA-EA-A556_exposure","UNCID_2169703.0dadcb32-0c50-4d9b-8112-d4e533e789d6.130530_UNC9-SN296_0371_BC2528ACXX_4_GTTTCG.tar.gz","2013-09-19T22:37:03.000Z","2013-09-19T22:58:01.000Z","CA9740FC-EAF8-417E-8490-37A4231926DB","2CAE861C-A035-49E8-9DC9-977F2DA23137","Unaligned reads",5751856480,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0DADCB32-0C50-4D9B-8112-D4E533E789D6","University of North Carolina","564a3eb0e4b093830b6a5083","2D34E9A3-298C-4365-B7A1-A507C7F069CD","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","88F8C3EF-FF7C-40CB-8CEA-5DBF02752593","2013-09-19T22:58:01.000Z","C0C29404-02A8-4C30-9CBC-234C5A9403B9","Russia","NO",1,NA,"Primary Tumor","Asterand",119,"88F8C3EF-FF7C-40CB-8CEA-5DBF02752593",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DE361C5C-452A-4E8B-AC77-E037AC111087.txt",360,"TCGA-EA-A556-01A",NA,NA,"TCGA",2012,"TCGA-EA-A556_NTE-1",NA,"TUMOR FREE","40608785-EE17-4A6A-8F61-F83B4A69EA7F",38,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DE361C5C-452A-4E8B-AC77-E037AC111087.txt","Alive",NA,"TCGA-EA-A556","NOT HISPANIC OR LATINO","14840F83-5A91-4CC5-A94A-D778D9E00784","NO",0,"No","Cervix","C53.9","N0","Endometrioid Adenocarcinoma of Endocervix",1,"Other","Stage IB1",NA,NA,"T1b1","8380/3","FEMALE","C53.9",280,NA,NA,"WHITE",NA,11,30,"371798DF-872A-4AA0-9894-7DB2F16CD3DA","FDF1430C-D4A7-4F7D-8068-0A6D0EB542C4","TCGA-EA-A556-01A-11R-A26X-13_mirna.bam.bai","TCGA-EA-A556-01A-11",75,0,0,2,0,"TOP",3,0,"TCGA-EA-A556-01A-01-TSA",97,NA,NA,NA,NA,NA,NA,"TCGA-EA-A556-F53440_NTE-1","NO",453,"TUMOR FREE","Alive",NA,"TCGA-EA-A556-F53440","TCGA-EA-A556",NA,"EA","A556","YES","C53.9","8380/3","C53.9","YES","NO",-13988,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,"TUMOR FREE","YES",22,4,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Endometrioid Adenocarcinoma of Endocervix",NA,0,38,2012,"Cytology (e.g. Peritoneal or pleural fluid)","YES",7,0,"G3",NA,2,NA,20,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
171143958,168827956,8049283147,"C149CEF5-61F3-4B53-B8A9-8244B673EBD0.bw","2da977fc-8b46-4c40-9636-b12fd36a98e4","c149cef5-61f3-4b53-b8a9-8244b673ebd0","2016-08-09T13:12:11.288949-05:00","UNCID_2186291.b107d3e2-8d45-425c-9aa7-0293463b6d66.121102_UNC15-SN850_0240_BD148CACXX_4_ACTTGA.tar.gz","59ae5f8e-d108-4126-a965-e4ae4b401ad8",7762642630,"Illumina HiSeq","71fa8be31ff842ccd7bedcdbdcfbf1e2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:15:32.821338-05:00","2016-05-03T11:00:24.448573-05:00","59ae5f8e-d108-4126-a965-e4ae4b401ad8_analysis.xml","7ee9d5f2f64ed73ed3ac22887bdd8087","fb330869-4912-4434-bd12-7d56408f27ba",2124,"2016-09-29T21:09:50.533178-05:00","59ae5f8e-d108-4126-a965-e4ae4b401ad8_experiment.xml","01014ea05d921ba8081fa91225084c41","88386222-a836-4755-8694-67c5bd23df59",2431,"2016-09-29T19:30:33.999293-05:00","59ae5f8e-d108-4126-a965-e4ae4b401ad8_run.xml","ff0fc4c2f8b44beddbf4fde311496f8d","4af693eb-0184-4c46-81dc-e906af7a9f33",354,"2016-09-08T11:44:51.438136-05:00","TCGA-DG-A2KL","2016-09-02T18:57:46.015537-05:00","female","TCGA-DG-A2KL_demographic",NA,"not reported","ee3b2bcc-ca39-5f38-b1d3-a02f05b79c99","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DG","fa63e449-4302-5d16-bd2c-76f031746194","Ontario Institute for Cancer Research","not reported","c53.9","TCGA-DG-A2KL_diagnosis","not reported",19539,"alive","8071/3",NA,1367,"ab86894a-32fc-50bf-953f-da5ad8ae615f","c53.9",-19539,"TCGA-DG-A2KL_treatment","bfe29d97-2d21-59b4-8fa2-e066506c1349","01","false","TCGA-DG-A2KL-01A",NA,"569883d5-68c2-42f1-b6b1-25d12f99cb65",FALSE,"A0EED671-A0A6-4F3E-86B2-AB8277B134ED","Primary Tumor",NA,NA,380,NA,1313712000,"11",30,"TCGA-DG-A2KL-01A-11",70,NA,10,NA,0,NA,25,NA,"2016-09-08T11:44:51.438136-05:00",NA,60,NA,20,NA,"TOP",NA,5,NA,"25380e85-100b-46a4-950f-52d6d1b110f8",NA,"TCGA-DG-A2KL-01A-01-TS1",NA,70,NA,"17b6c603-21cb-4b39-8aec-1615f96aaa60","RNA","TCGA-DG-A2KL-01A-11R","a0baae8b-190c-4231-8308-a0b050cf70d4",1.83,0.15,"UV Spec","R","23","TCGA-DG-A2KL-01A-11R-A180-07","b107d3e2-8d45-425c-9aa7-0293463b6d66",0.15,1.36986301369863,75,31.2174817898023,155,"ebafb3e9-77b7-5fe7-8cc4-5554c0a18a04","TCGA-DG-A2KL_exposure","UNCID_2186291.b107d3e2-8d45-425c-9aa7-0293463b6d66.121102_UNC15-SN850_0240_BD148CACXX_4_ACTTGA.tar.gz","2013-09-16T04:13:08.000Z","2013-09-16T05:35:01.000Z","59AE5F8E-D108-4126-A965-E4AE4B401AD8","569883D5-68C2-42F1-B6B1-25D12F99CB65","Unaligned reads",7762642630,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B107D3E2-8D45-425C-9AA7-0293463B6D66","University of North Carolina","56607606e4b0ca319164d840","2DA977FC-8B46-4C40-9636-B12FD36A98E4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","17B6C603-21CB-4B39-8AEC-1615F96AAA60","2013-09-16T05:35:01.000Z","A0BAAE8B-190C-4231-8308-A0B050CF70D4","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"17B6C603-21CB-4B39-8AEC-1615F96AAA60",NA,"DG","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.5BF84867-52E7-4E3A-9B13-944FA8E8EAC4.txt",380,"TCGA-DG-A2KL-01A",NA,"DE7C7E8A-DFA5-4D71-9D40-1A65B07AA599","TCGA",NA,"TCGA-DG-A2KL_NTE-1","Complete Remission/Response","TUMOR FREE","569883D5-68C2-42F1-B6B1-25D12F99CB65",53,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.5BF84867-52E7-4E3A-9B13-944FA8E8EAC4.txt","Alive",NA,"TCGA-DG-A2KL",NA,"FC03DED3-A59E-4CB3-B908-C7D3666867A7","NO",1367,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIA",NA,NA,"T2a","8071/3","FEMALE","C53.9",169,NA,"DF3402EA-6D5C-4315-92EB-FFEFD702A50F",NA,NA,11,30,"25380E85-100B-46A4-950F-52D6D1B110F8","BB0EC291-8197-4954-8954-D2B9AB77B76D","TCGA-DG-A2KL-01A-11R-A17X-13_mirna.bam","TCGA-DG-A2KL-01A-11",70,0,10,60,25,"TOP",5,20,"TCGA-DG-A2KL-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-DG-A2KL-D61036","TCGA-DG-A2KL-R61034","External","Regional site","TCGA-DG-A2KL-F61032_NTE-1","NO",1367,"TUMOR FREE","Alive",NA,"TCGA-DG-A2KL-F61032","TCGA-DG-A2KL",NA,"DG","A2KL","YES","C53.9","8071/3","C53.9","NO","YES",-19539,"FEMALE",NA,NA,"No","No","Alive",1367,NA,NA,NA,"TUMOR FREE","YES",20,6,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,NA,"Other method, specify:","YES",8,0,"G1",NA,2,NA,25,NA,"Complete Remission/Response","1995",10,NA,"T2aN0M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
113231446,111072263,5299877714,"0AF351D0-4EC5-4275-AA0A-4FA2AF8A9C85.bw","2e08a89e-4035-4782-b54f-f98eef5db80d","0af351d0-4ec5-4275-aa0a-4fa2af8a9c85","2016-08-24T15:49:02.991534-05:00","UNCID_2553115.fc6c05b9-e904-4c4e-b26a-65b4ac455cf1.140403_UNC15-SN850_0359_BC41CEACXX_6_GGCTAC.tar.gz","44bd75e1-966d-416a-9e75-238b16bd1342",4862267655,"Illumina HiSeq","db0eff84d22601ee053a0ea4b541919e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:18:01.967943-05:00","2016-05-03T11:54:19.908545-05:00","44bd75e1-966d-416a-9e75-238b16bd1342_analysis.xml","46b8738a790965c0a631ca02b396d169","67fbbab2-5699-4df8-a9f5-a10dc1718d4f",2124,"2016-09-29T19:50:24.644977-05:00","44bd75e1-966d-416a-9e75-238b16bd1342_experiment.xml","b4884f33e4eeacda674e8037d514fe87","573fd52d-7e4b-4477-91cc-802ff1171e1d",2628,"2016-09-29T23:10:31.989119-05:00","44bd75e1-966d-416a-9e75-238b16bd1342_run.xml","3f090f33f8f1236bcfb51a171de7f399","d2f6f2e7-5829-4ee6-b163-01126221103f",354,"2016-09-08T11:51:12.051830-05:00","TCGA-VS-A8EJ","2016-09-02T19:01:16.646221-05:00","female","TCGA-VS-A8EJ_demographic",1948,"white","f75864cd-add9-5601-adfd-8069d8f7f4ec","not reported",2009,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EJ_diagnosis","not reported",22000,"dead","8070/3",607,NA,"472efab0-bc00-56f5-9eec-ea9b7f1ae6b5","c53.9",-22000,"TCGA-VS-A8EJ_treatment","15e939b3-e03c-59dc-bb32-bc7611667731","01","false","TCGA-VS-A8EJ-01A",NA,"97bd18f4-cee8-417f-8fe2-ce55e4a761d6",FALSE,"92D067E8-1E5A-46B6-90BD-4DF9782CCA32","Primary Tumor",NA,1771,60,NA,1384732800,"11",30,"TCGA-VS-A8EJ-01A-11",70,NA,20,NA,0,NA,10,NA,"2016-09-08T11:51:12.051830-05:00",NA,20,NA,40,NA,"TOP",NA,20,NA,"06eaf8f3-2a82-493e-9557-f29733942de1",NA,"TCGA-VS-A8EJ-01A-01-TS1",NA,70,NA,"0f38ffcb-8f37-440d-8d02-1681d0691a4d","RNA","TCGA-VS-A8EJ-01A-11R","6d09d927-6647-4e1b-8018-bce1fd54bca7",1.92,0.18,"UV Spec","R","23","TCGA-VS-A8EJ-01A-11R-A37O-07","fc6c05b9-e904-4c4e-b26a-65b4ac455cf1",0.18,NA,113,40.5177668614866,167,"aacfc46c-bfd6-53b3-873e-bfef0e2acd4e","TCGA-VS-A8EJ_exposure","UNCID_2553115.fc6c05b9-e904-4c4e-b26a-65b4ac455cf1.140403_UNC15-SN850_0359_BC41CEACXX_6_GGCTAC.tar.gz","2014-07-31T01:51:04.000Z","2014-07-31T02:07:22.000Z","44BD75E1-966D-416A-9E75-238B16BD1342","97BD18F4-CEE8-417F-8FE2-CE55E4A761D6","Unaligned reads",4862267655,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FC6C05B9-E904-4C4E-B26A-65B4AC455CF1","University of North Carolina","564a3baae4b093830b695b3a","2E08A89E-4035-4782-B54F-F98EEF5DB80D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0F38FFCB-8F37-440D-8D02-1681D0691A4D","2014-07-31T02:07:22.000Z","6D09D927-6647-4E1B-8018-BCE1FD54BCA7","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1771,"0F38FFCB-8F37-440D-8D02-1681D0691A4D",NA,"VS","UNCID_2553115.fc6c05b9-e904-4c4e-b26a-65b4ac455cf1.140403_UNC15-SN850_0359_BC41CEACXX_6_GGCTAC.tar.gz",60,"TCGA-VS-A8EJ-01A",NA,"D2D50CB6-E465-45B9-A255-2178CEC9FE12","TCGA",2008,"TCGA-VS-A8EJ_NTE-1","Progressive Disease","WITH TUMOR","97BD18F4-CEE8-417F-8FE2-CE55E4A761D6",60,"nationwidechildrens.org_clinical.TCGA-VS-A8EJ.xml","Dead",607,"TCGA-VS-A8EJ",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",380,NA,"0CDBB9A8-E1AD-44FB-B68B-5E39F7F417BE","WHITE",NA,11,30,"06EAF8F3-2A82-493E-9557-F29733942DE1","6D09D927-6647-4E1B-8018-BCE1FD54BCA7","TCGA-VS-A8EJ-01A-11R-A37P-13_mirna.bam","TCGA-VS-A8EJ-01A-11",70,0,20,20,10,"TOP",20,40,"TCGA-VS-A8EJ-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-VS-A8EJ-D62776","TCGA-VS-A8EJ-R61944","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8EJ",NA,"VS","A8EJ","YES","C53.9","8070/3","C53.9","NO","YES",-22000,"FEMALE","WHITE",NA,"No","No","Dead",NA,607,NA,NA,"WITH TUMOR","YES",22,4,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,60,2008,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Progressive Disease","2009",13,NA,"T2bNXM1",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
143754708,139838167,6673645323,"B507E82F-6680-497B-A014-033EDD7A2E03.bw","2f261704-d600-4226-90d5-d51ba416b55c","b507e82f-6680-497b-a014-033edd7a2e03","2016-08-26T06:03:44.885843-05:00","UNCID_2553086.32de6610-4b6b-443f-bd20-f67d97558cbd.140513_UNC15-SN850_0364_AC4DVGACXX_8_CAGATC.tar.gz","a98f37dd-8754-4f14-bd87-77dad834b785",6220529688,"Illumina HiSeq","fb6a1ef5bfdd84a857c4a6441fc5761c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:05:01.553323-05:00","2016-05-03T11:54:19.885282-05:00","a98f37dd-8754-4f14-bd87-77dad834b785_analysis.xml","bfaed0d848ca36fb68d1a5c9066682e6","152ff16d-bc4a-476d-aa67-b17b8079eaea",2124,"2016-09-29T23:22:15.023996-05:00","a98f37dd-8754-4f14-bd87-77dad834b785_experiment.xml","4020dd7463999df30dd8ecc06e409bc1","da121f36-be6d-443a-b4a1-3496988f3cae",2628,"2016-09-29T19:44:25.692286-05:00","a98f37dd-8754-4f14-bd87-77dad834b785_run.xml","f78da2a2acc338ca9995b4da7b73f5df","537805f1-ea0c-43c5-8e4c-d72620d8453b",354,"2016-09-08T10:38:28.258005-05:00","TCGA-MA-AA3Y","2016-09-02T18:54:03.902144-05:00","female","TCGA-MA-AA3Y_demographic",1964,"white","7733f744-f790-5190-b612-105a83684d27","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA3Y_diagnosis","not reported",17795,"alive","8071/3",NA,542,"d3ada6c6-4052-5417-82cb-e1594a29858b","c53.9",-17795,"TCGA-MA-AA3Y_treatment","7b7f5ee1-a617-5dde-b4b6-16a0506139ac","01","false","TCGA-MA-AA3Y-01A",NA,"73b25bce-60f8-4f6a-8a23-24191ce2d64e",FALSE,"AA310801-F827-47D4-9A53-9C63D65F12C8","Primary Tumor",NA,478,250,NA,1393200000,"11",30,"TCGA-MA-AA3Y-01A-11",60,NA,0,NA,10,NA,20,NA,"2016-09-08T10:38:28.258005-05:00",NA,10,NA,0,NA,"TOP",NA,10,NA,"0f944a51-69a9-4460-94c0-c2aa2d4e92aa",NA,"TCGA-MA-AA3Y-01A-01-TSA",NA,60,NA,"4714ddd1-9f68-4ae7-aaaa-98a2f070d37e","RNA","TCGA-MA-AA3Y-01A-11R","b84f1375-cda3-4a50-ab8e-a3877a9438aa",1.86,0.17,"UV Spec","R","23","TCGA-MA-AA3Y-01A-11R-A38B-07","32de6610-4b6b-443f-bd20-f67d97558cbd",0.17,NA,65,26.7094017094017,156,"3e4506f1-8344-53bf-bb05-65c63fcdc071","TCGA-MA-AA3Y_exposure","UNCID_2553086.32de6610-4b6b-443f-bd20-f67d97558cbd.140513_UNC15-SN850_0364_AC4DVGACXX_8_CAGATC.tar.gz","2014-07-30T07:36:06.000Z","2014-07-30T20:01:12.000Z","A98F37DD-8754-4F14-BD87-77DAD834B785","73B25BCE-60F8-4F6A-8A23-24191CE2D64E","Unaligned reads",6220529688,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","32DE6610-4B6B-443F-BD20-F67D97558CBD","University of North Carolina","5660775de4b0b37b3d990d61","2F261704-D600-4226-90D5-D51BA416B55C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4714DDD1-9F68-4AE7-AAAA-98A2F070D37E","2014-07-30T20:01:12.000Z","B84F1375-CDA3-4A50-AB8E-A3877A9438AA","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",478,"4714DDD1-9F68-4AE7-AAAA-98A2F070D37E",NA,"MA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D9039497-FD01-4832-966C-FCE8F17A7971.txt",250,"TCGA-MA-AA3Y-01A",NA,NA,"TCGA",2012,"TCGA-MA-AA3Y_NTE-1","Complete Remission/Response","TUMOR FREE","73B25BCE-60F8-4F6A-8A23-24191CE2D64E",48,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D9039497-FD01-4832-966C-FCE8F17A7971.txt","Alive",NA,"TCGA-MA-AA3Y","HISPANIC OR LATINO","65856116-9078-4757-947F-702B972C56BF","NO",542,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Other","Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"0F944A51-69A9-4460-94C0-C2AA2D4E92AA","D3F1A230-8ABC-4273-9F57-205543E93FE8","f89d3e0a2e2f1fdab582a1b68ce5899f.bam","TCGA-MA-AA3Y-01A-11",60,10,0,10,20,"TOP",10,0,"TCGA-MA-AA3Y-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-MA-AA3Y-F65479_NTE-1","NO",542,"TUMOR FREE","Alive",NA,"TCGA-MA-AA3Y-F65479","TCGA-MA-AA3Y",NA,"MA","AA3Y","YES","C53.9","8071/3","C53.9","YES","NO",-17795,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",542,NA,NA,NA,"TUMOR FREE","YES",16,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2012,"Biopsy (cervical / CT-guided / Other)","YES",29,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
135509386,132413401,6311389339,"F941890E-AB33-478F-8C97-1C785DD9428F.bw","2f6a0e87-1e6c-41f3-93e0-3e505fa654b0","f941890e-ab33-478f-8c97-1c785dd9428f","2016-08-27T05:29:24.372602-05:00","UNCID_2561268.f99240d0-32ea-438a-b350-862202b18a30.140416_UNC11-SN627_0353_BC42B0ACXX_2_CAGATC.tar.gz","b1addd82-2719-4caf-af67-6d034c052fc9",5962151128,"Illumina HiSeq","57507f4d23422ea272d411a7b9c3504c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:11:42.623945-05:00","2016-05-03T11:54:19.897074-05:00","b1addd82-2719-4caf-af67-6d034c052fc9_analysis.xml","45d3fc477289b2bfe80cfc95e45c6a7d","f8c2f9ad-b171-46b5-a90d-e16d40a8e7da",2124,"2016-09-29T21:36:57.198661-05:00","b1addd82-2719-4caf-af67-6d034c052fc9_experiment.xml","68eff51ffb45882fe90ed53ae29c75f7","98fc6609-930e-4560-86f4-b7ed144ed785",2628,"2016-09-29T21:16:59.689764-05:00","b1addd82-2719-4caf-af67-6d034c052fc9_run.xml","73597303a39562b80d4a1f1c6cbc1923","8caabfcb-3667-4629-9e57-926c39197fc1",354,"2016-09-08T11:27:37.154467-05:00","TCGA-VS-A94W","2016-09-02T19:01:22.660532-05:00","female","TCGA-VS-A94W_demographic",1972,"white","b6ac0a6d-44b1-5c30-ae22-384fe09446cb","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A94W_diagnosis","not reported",14399,"alive","8070/3",NA,1243,"37c79e70-b93d-5139-aa3b-7bfb87a4f0d4","c53.9",-14399,"TCGA-VS-A94W_treatment","d4342706-0a01-5616-ba97-e02ab9c5fe9e","01","false","TCGA-VS-A94W-01A",NA,"2fbfb3cc-7cd7-41ce-81f4-4a4645840629",FALSE,"D7BD2CF8-068E-4D77-B4C3-8C51BD7A71CE","Primary Tumor",NA,864,80,NA,1389830400,"12",30,"TCGA-VS-A94W-01A-12",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:27:37.154467-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"66d5535f-85c4-4cf1-beca-59a6f5759649",NA,"TCGA-VS-A94W-01A-01-TS1",NA,80,NA,"bef43f04-488e-47bb-bcd9-c7126b0a7dcf","RNA","TCGA-VS-A94W-01A-12R","5df37b64-1d29-466d-8338-51750765a1a8",1.9,0.17,"UV Spec","R","23","TCGA-VS-A94W-01A-12R-A37O-07","f99240d0-32ea-438a-b350-862202b18a30",0.17,NA,79,32.4621959237344,156,"5aeee907-2e14-5b49-b1db-5fc053b63f0d","TCGA-VS-A94W_exposure","UNCID_2561268.f99240d0-32ea-438a-b350-862202b18a30.140416_UNC11-SN627_0353_BC42B0ACXX_2_CAGATC.tar.gz","2014-08-02T17:06:04.000Z","2014-08-02T17:31:39.000Z","B1ADDD82-2719-4CAF-AF67-6D034C052FC9","2FBFB3CC-7CD7-41CE-81F4-4A4645840629","Unaligned reads",5962151128,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F99240D0-32EA-438A-B350-862202B18A30","University of North Carolina","564a3a86e4b093830b68fbe8","2F6A0E87-1E6C-41F3-93E0-3E505FA654B0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BEF43F04-488E-47BB-BCD9-C7126B0A7DCF","2014-08-02T17:31:39.000Z","5DF37B64-1D29-466D-8338-51750765A1A8","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",864,"BEF43F04-488E-47BB-BCD9-C7126B0A7DCF",NA,"VS","UNCID_2561268.f99240d0-32ea-438a-b350-862202b18a30.140416_UNC11-SN627_0353_BC42B0ACXX_2_CAGATC.tar.gz",80,"TCGA-VS-A94W-01A",NA,"D1241E75-98C5-4EE9-AC69-D282F12CAE1D","TCGA",2011,"TCGA-VS-A94W_NTE-1","Complete Remission/Response","TUMOR FREE","58A2BEC9-D928-45B5-9207-FE19EE9FCA35",39,"nationwidechildrens.org_clinical.TCGA-VS-A94W.xml","Alive",NA,"TCGA-VS-A94W",NA,"D2694F1F-E912-416A-B8AE-FA65F3D3A195","NO",879,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Other","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",380,NA,"6CF4FD72-8D28-4222-A718-BE9C47DF43E4","WHITE",NA,12,30,"66D5535F-85C4-4CF1-BECA-59A6F5759649","5DF37B64-1D29-466D-8338-51750765A1A8","UNCID_2561268.f99240d0-32ea-438a-b350-862202b18a30.140416_UNC11-SN627_0353_BC42B0ACXX_2_CAGATC.tar.gz","TCGA-VS-A94W-01A-12",80,0,20,40,15,"TOP",5,20,"TCGA-VS-A94W-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A94W-D70275","TCGA-VS-A94W-R70277","External","Regional site","TCGA-VS-A94W-F67673_NTE-1","NO",1103,"TUMOR FREE","Alive",NA,"TCGA-VS-A94W-F67673","TCGA-VS-A94W",NA,"VS","A94W","YES","C53.9","8070/3","C53.9","NO","YES",-14399,"FEMALE","WHITE",NA,"No","No","Alive",879,NA,NA,NA,"TUMOR FREE","YES",17,10,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,39,2011,"Biopsy (cervical / CT-guided / Other)","YES",47,1,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bN1MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
173349244,167811096,8010717726,"7987E019-8FED-469B-A6C1-34EE430A60C3.bw","3143822c-66c4-4b58-8d29-e92d065ff049","7987e019-8fed-469b-a6c1-34ee430a60c3","2016-08-09T13:56:13.923239-05:00","UNCID_2187265.7a1f4f51-4bea-4e5f-b59a-02fb223d2965.120921_UNC16-SN851_0181_AD14JFACXX_2_CCGTCC.tar.gz","3574e95a-e3f7-4cd9-adb4-4c7636676003",7165749000,"Illumina HiSeq","bc9b9aea98e1c1174f53b0f7156d15c2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:38:24.401755-05:00","2016-05-03T11:02:00.408696-05:00","3574e95a-e3f7-4cd9-adb4-4c7636676003_analysis.xml","344d83075a950ae19eb6ef042ff13f41","befa0bfc-6cbc-4286-9828-9c53a47a1547",2124,"2016-08-26T02:08:17.216369-05:00","3574e95a-e3f7-4cd9-adb4-4c7636676003_experiment.xml","418cd6d178d79a13b2ce0ddc43cb275d","503e8e11-48c4-4eee-a5f0-7460052f15ec",2431,"2016-09-29T21:56:00.734827-05:00","3574e95a-e3f7-4cd9-adb4-4c7636676003_run.xml","254e7c8d8f22e5d31a7e900345d91e60","a4e361b9-7213-497f-b734-8663c9812f96",354,"2016-09-08T13:07:24.775732-05:00","TCGA-C5-A1MH","2016-09-02T18:57:18.155294-05:00","female","TCGA-C5-A1MH_demographic",1933,"white","1ab790de-3147-5c92-9d37-89f923f55d61","not hispanic or latino",2007,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MH_diagnosis","not reported",26234,"dead","8070/3",1186,NA,"55a44618-0a66-554c-8ad4-5413aedb117f","c53.9",-26234,"TCGA-C5-A1MH_treatment","23e2007d-942a-5724-9572-e60e1dd54812","01","true","TCGA-C5-A1MH-01A",NA,"a2c048b4-f95b-4b43-b9f1-b42bb48e5875",FALSE,"4FDCED4B-0729-4B37-8EA7-F66293680952","Primary Tumor",NA,2417,80,NA,1301356800,"11",30,"TCGA-C5-A1MH-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T13:07:24.775732-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"8d15f03c-4eda-4dae-bea9-4d14ebbf2e6c",NA,"TCGA-C5-A1MH-01A-01-TSA",NA,60,NA,"87e36ade-24fa-432f-95fe-adf3162ebc9c","RNA","TCGA-C5-A1MH-01A-11R","bea9033d-7702-41cf-8def-1734f52aa8fe",1.75,0.17,"UV Spec","R","23","TCGA-C5-A1MH-01A-11R-A14Y-07","7a1f4f51-4bea-4e5f-b59a-02fb223d2965",0.17,0.821917808219178,NA,NA,NA,"145b67c3-e9ac-5315-b80e-4d637cb0b273","TCGA-C5-A1MH_exposure","UNCID_2187265.7a1f4f51-4bea-4e5f-b59a-02fb223d2965.120921_UNC16-SN851_0181_AD14JFACXX_2_CCGTCC.tar.gz","2013-09-17T06:16:03.000Z","2013-09-17T06:33:01.000Z","3574E95A-E3F7-4CD9-ADB4-4C7636676003","A2C048B4-F95B-4B43-B9F1-B42BB48E5875","Unaligned reads",7165749000,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7A1F4F51-4BEA-4E5F-B59A-02FB223D2965","University of North Carolina","564a3a3ee4b09c884b24024b","3143822C-66C4-4B58-8D29-E92D065FF049","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","87E36ADE-24FA-432F-95FE-ADF3162EBC9C","2013-09-17T06:33:01.000Z","BEA9033D-7702-41CF-8DEF-1734F52AA8FE","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2417,"87E36ADE-24FA-432F-95FE-ADF3162EBC9C",NA,"C5","BLATE_p_TCGA_b127_wSarc_SNP_N_GenomeWideSNP_6_A12_805422.tangent.copynumber.data.txt",80,"TCGA-C5-A1MH-01A",NA,"DEB8FE59-1B43-48EE-AD48-8F8D46FC5F71","TCGA",2004,NA,NA,"WITH TUMOR","D0B4917B-351F-41AB-A340-3122115C8E62",71,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.4790E476-B3DE-4E7A-AFB1-03842F146150.txt","Dead",1186,"TCGA-C5-A1MH","NOT HISPANIC OR LATINO","D94180C5-06D9-49C6-AA86-3CB531275AD3",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",127,NA,"C22870A8-BB88-472A-87BE-7E4F4A0328D2","WHITE",NA,11,30,"8D15F03C-4EDA-4DAE-BEA9-4D14EBBF2E6C","D33D0277-F2F3-4E19-8403-76B232D7B07E","C501.TCGA-C5-A1MH-01A-11D-A14W-08.3.bam","TCGA-C5-A1MH-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-C5-A1MH-01A-01-TSA",60,"Cisplatin","Chemotherapy","TCGA-C5-A1MH-D29287","TCGA-C5-A1MH-R29286","COMBINATION","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",1186,"TCGA-C5-A1MH-F29283","TCGA-C5-A1MH",NA,"C5","A1MH","YES","C53.9","8070/3","C53.9","NO","YES",-26234,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1186,NA,NA,"WITH TUMOR","NO",19,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,71,2004,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,3,2003,15,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
99635454,98460313,4702518618,"76084AA6-19BF-4605-B6A1-73F1D4BADAF9.bw","3223fec6-1d35-419a-8ee9-7c5885b8be1e","76084aa6-19bf-4605-b6a1-73f1d4badaf9","2016-08-25T17:25:52.001910-05:00","UNCID_2278280.f7e2e36f-3018-4570-9ed2-f256048a9427.130805_UNC9-SN296_0389_AC2AVJACXX_8_ACTGAT.tar.gz","6ebb5516-00d4-4ded-9c47-e3cf355adec8",4679044096,"Illumina HiSeq","6f8cfa9b8738e4f57cbb6173c68e6773","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:18:36.277292-05:00","2016-05-03T11:24:56.858865-05:00","6ebb5516-00d4-4ded-9c47-e3cf355adec8_analysis.xml","f0340faa2ea6aec81ad74bb7cbbca1c0","4360804c-a203-4954-9c85-879ecb258d9e",2122,"2016-10-07T16:50:12.850035-05:00","6ebb5516-00d4-4ded-9c47-e3cf355adec8_experiment.xml","72bc014ce8db9f7a5588a36d137370cc","40072da9-8dae-4874-863c-1eee95b0093d",2431,"2016-09-29T22:32:44.223304-05:00","6ebb5516-00d4-4ded-9c47-e3cf355adec8_run.xml","7acd9b23e848e081238c3b3518bdf3d7","bb6f7965-f75f-4c62-9b65-adbd85541b4c",354,"2016-09-08T12:13:13.451271-05:00","TCGA-LP-A4AX","2016-09-02T18:59:41.969235-05:00","female","TCGA-LP-A4AX_demographic",1966,"asian","08a37b23-2b54-5217-8ee4-ab3bad6261d2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A4AX_diagnosis","not reported",16544,"alive","8070/3",NA,380,"1adf8388-27ff-5000-8c0a-07013fe8482d","c53.9",-16544,"TCGA-LP-A4AX_treatment","b99b9367-dc3d-5d7f-b60d-9bdcd331ca98","01","true","TCGA-LP-A4AX-01A",NA,"067a2e35-52e4-42e2-9c22-db555589c0cf",FALSE,"06D6C5C2-EE8F-40DF-9F99-05E9DA394840","Primary Tumor",NA,263,240,NA,1348185600,"12",20,"TCGA-LP-A4AX-01A-12",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:13:13.451271-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"0c9c3f0a-10ab-4efe-be38-ed8eada35c8f",NA,"TCGA-LP-A4AX-01A-01-TSA",NA,100,NA,"ff6f84a6-e1a0-478e-9a7b-83b4412c838f","RNA","TCGA-LP-A4AX-01A-12R","b863603e-7593-4ac3-a6a9-fc9780ea9dfa",1.83,0.17,"UV Spec","R","23","TCGA-LP-A4AX-01A-12R-A24H-07","f7e2e36f-3018-4570-9ed2-f256048a9427",0.17,NA,NA,NA,NA,"cc68f654-3255-543d-a164-edc8358c4dd9","TCGA-LP-A4AX_exposure","UNCID_2278280.f7e2e36f-3018-4570-9ed2-f256048a9427.130805_UNC9-SN296_0389_AC2AVJACXX_8_ACTGAT.tar.gz","2013-11-22T08:51:03.000Z","2013-11-22T09:11:01.000Z","6EBB5516-00D4-4DED-9C47-E3CF355ADEC8","067A2E35-52E4-42E2-9C22-DB555589C0CF","Unaligned reads",4679044096,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F7E2E36F-3018-4570-9ED2-F256048A9427","University of North Carolina","566076b3e4b016715ab69133","3223FEC6-1D35-419A-8EE9-7C5885B8BE1E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FF6F84A6-E1A0-478E-9A7B-83B4412C838F","2013-11-22T09:11:01.000Z","B863603E-7593-4AC3-A6A9-FC9780EA9DFA","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",263,"FF6F84A6-E1A0-478E-9A7B-83B4412C838F",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D61E568A-FB64-4C66-A46D-B835AB2B7F46.txt",240,"TCGA-LP-A4AX-01A",NA,NA,"TCGA",2011,"TCGA-LP-A4AX_NTE-1",NA,"TUMOR FREE","AA734CF9-0C3C-4CE2-9C1E-3E3F9866C6D1",45,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D61E568A-FB64-4C66-A46D-B835AB2B7F46.txt","Alive",NA,"TCGA-LP-A4AX","NOT HISPANIC OR LATINO","4C42B9D9-6C2F-4B0C-BB5C-97D25DDB8355","NO",2,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",256,NA,"74D7D053-F9AE-4CB3-B6BF-B00EBA95FF72","ASIAN",NA,12,20,"0C9C3F0A-10AB-4EFE-BE38-ED8EADA35C8F","B863603E-7593-4AC3-A6A9-FC9780EA9DFA","UNCID_2278280.f7e2e36f-3018-4570-9ed2-f256048a9427.130805_UNC9-SN296_0389_AC2AVJACXX_8_ACTGAT.tar.gz","TCGA-LP-A4AX-01A-12",80,0,0,2,0,"TOP",0,0,"TCGA-LP-A4AX-01A-01-TSA",100,NA,NA,NA,"TCGA-LP-A4AX-R69767","External","Regional site","TCGA-LP-A4AX-F69765_NTE-1","NO",380,"TUMOR FREE","Alive",NA,"TCGA-LP-A4AX-F69765","TCGA-LP-A4AX",NA,"LP","A4AX","YES","C53.9","8070/3","C53.9","YES","NO",-16544,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",2,NA,NA,NA,"TUMOR FREE","YES",12,3,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2011,"Biopsy (cervical / CT-guided / Other)","YES",2,0,"G3",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
94731752,93134620,4439662132,"329807F7-E0D4-4F53-94E8-E4080E90CB47.bw","3265f9c1-7242-4c7d-b4ad-b6519ee94f84","329807f7-e0d4-4f53-94e8-e4080e90cb47","2016-08-25T13:39:34.054103-05:00","UNCID_2278274.05dbcfac-b558-4621-bc29-30d46658a121.131016_UNC10-SN254_0498_BC2KTUACXX_3_GTTTCG.tar.gz","348ee7eb-e5cf-4625-99cd-b1113d033b5a",4588107738,"Illumina HiSeq","c3da9fe5e86d7292ee422ff4c74d1cc4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:07:06.055867-05:00","2016-05-03T11:24:56.858865-05:00","348ee7eb-e5cf-4625-99cd-b1113d033b5a_analysis.xml","eb1c414482e1a9bc6a11657b405cebc0","86833b9b-884b-4bb7-8d87-78f5194ab30e",2124,"2016-09-29T21:06:54.190894-05:00","348ee7eb-e5cf-4625-99cd-b1113d033b5a_experiment.xml","ed62b2f34fd2a81be88975196492fa30","86651228-39c2-4dae-b9b6-8ff91e60c9d2",2431,"2016-09-29T22:55:27.603896-05:00","348ee7eb-e5cf-4625-99cd-b1113d033b5a_run.xml","1093d8939a62cae38a1d0fa8522edf63","c9867cb0-a1fc-49a0-8bba-3dd8dab1aec7",354,"2016-09-08T11:55:54.841379-05:00","TCGA-EA-A43B","2016-09-02T18:59:37.309203-05:00","female","TCGA-EA-A43B_demographic",1969,"white","f4a4e37a-3a80-5dfb-902e-710e9ca92278","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A43B_diagnosis","not reported",15871,"alive","8071/3",NA,791,"cc463255-08ad-5f5d-bab4-b664cbf0e5d5","c53.9",-15871,"TCGA-EA-A43B_treatment","cc3081d7-208c-5bce-ab1d-4f137da7ae1b","01","true","TCGA-EA-A43B-01A",NA,"82d18b6c-2fb8-4d20-8c5c-6e7528c88cb5",FALSE,"D2D8553E-1C68-4ADC-9D3E-024D04E948C1","Primary Tumor",NA,196,540,NA,1349654400,"81",30,"TCGA-EA-A43B-01A-81",70,NA,3,NA,0,NA,30,NA,"2016-09-08T11:55:54.841379-05:00",NA,10,NA,0,NA,"TOP",NA,5,NA,"ded6acb8-7726-439e-96bc-17fc5c8c52d4",NA,"TCGA-EA-A43B-01A-08-TSH",NA,65,NA,"194d3eaf-f06e-4597-81cb-89717c57ac2a","RNA","TCGA-EA-A43B-01A-81R","add9bc36-7452-470f-8ae0-c9495242ffa6",1.85,0.17,"UV Spec","R","23","TCGA-EA-A43B-01A-81R-A32Y-07","05dbcfac-b558-4621-bc29-30d46658a121",0.17,NA,72,26.7697798929209,164,"748346b8-68bd-54bd-be48-fff6e10e5a72","TCGA-EA-A43B_exposure","UNCID_2278274.05dbcfac-b558-4621-bc29-30d46658a121.131016_UNC10-SN254_0498_BC2KTUACXX_3_GTTTCG.tar.gz","2013-11-22T07:51:04.000Z","2013-11-22T08:11:02.000Z","348EE7EB-E5CF-4625-99CD-B1113D033B5A","82D18B6C-2FB8-4D20-8C5C-6E7528C88CB5","Unaligned reads",4588107738,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","05DBCFAC-B558-4621-BC29-30D46658A121","University of North Carolina","564a3e85e4b0ef12181b6ecd","3265F9C1-7242-4C7D-B4AD-B6519EE94F84","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","194D3EAF-F06E-4597-81CB-89717C57AC2A","2013-11-22T08:11:02.000Z","ADD9BC36-7452-470F-8AE0-C9495242FFA6","Ukraine","NO",1,NA,"Primary Tumor","Asterand",196,"194D3EAF-F06E-4597-81CB-89717C57AC2A",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.485976D3-82C9-44C3-99E9-DC8A454E7225.txt",540,"TCGA-EA-A43B-01A",NA,"BD1405B3-FE04-4F41-8E66-1F933D432F75","TCGA",2012,"TCGA-EA-A43B_NTE-1","Complete Remission/Response","TUMOR FREE","82D18B6C-2FB8-4D20-8C5C-6E7528C88CB5",43,"nationwidechildrens.org_clinical.TCGA-EA-A43B.xml","Alive",NA,"TCGA-EA-A43B","NOT HISPANIC OR LATINO","9506CB3E-973A-42E9-B6C8-3BCA30395F4C","NO",55,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",256,NA,"F86C037E-C3CB-4778-9F00-D133DE88D2FA","WHITE",NA,81,30,"DED6ACB8-7726-439E-96BC-17FC5C8C52D4","15E5D685-8688-4A86-93AF-050E8B56F572","CROZE_p_TCGA_254_256_255_N_GenomeWideSNP_6_E10_1301458.CEL","TCGA-EA-A43B-01A-81",70,0,3,10,30,"TOP",5,0,"TCGA-EA-A43B-01A-08-TSH",65,"5-Fluorouracil","Chemotherapy","TCGA-EA-A43B-D58726","TCGA-EA-A43B-R59524","Internal","Primary Tumor Field","TCGA-EA-A43B-F58719_NTE-1","NO",791,"TUMOR FREE","Alive",NA,"TCGA-EA-A43B-F58719","TCGA-EA-A43B",NA,"EA","A43B","YES","C53.9","8071/3","C53.9","YES","NO",-15871,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",55,NA,NA,NA,"TUMOR FREE","YES",20,11,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2012,"Biopsy (cervical / CT-guided / Other)","YES",24,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
132968336,131468571,6275724480,"1B6505FF-C1A7-4DD0-9827-41A0A3A28F3E.bw","33bc6504-d9ab-4b64-a87c-012915f36644","1b6505ff-c1a7-4dd0-9827-41a0a3a28f3e","2016-08-25T04:41:15.390112-05:00","UNCID_2553112.5f23cd19-f7f0-43e3-961d-0236da5f49ae.140404_UNC11-SN627_0350_BC3K66ACXX_7_GGCTAC.tar.gz","ac35f877-da10-4502-b085-eb7688d4f05d",6130831234,"Illumina HiSeq","442b94a2e8b1945d4a3a4ed51709be1e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:00:06.451979-05:00","2016-05-03T11:54:19.908545-05:00","ac35f877-da10-4502-b085-eb7688d4f05d_analysis.xml","db547d6ca73fa852cf68c6c9d48437f2","8207910e-0bd8-467f-ab83-dee1092fc704",2124,"2016-10-07T16:05:06.898218-05:00","ac35f877-da10-4502-b085-eb7688d4f05d_experiment.xml","fce8d062e8498a1beb54701d7f18dfbd","13d44ac4-eb70-45c2-a91f-dfa99eafb6fe",2628,"2016-09-29T23:56:09.716169-05:00","ac35f877-da10-4502-b085-eb7688d4f05d_run.xml","5cc04ae321c01b0ad561fd045929c6bc","ef4dd356-d704-4600-96c5-02c9647e5d05",354,"2016-09-08T12:16:20.605705-05:00","TCGA-C5-A8ZZ","2016-09-02T19:01:10.732339-05:00","female","TCGA-C5-A8ZZ_demographic",1964,"white","dd831783-2790-50ce-aedc-05c586c56736","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8ZZ_diagnosis","not reported",15262,"alive","8071/3",NA,636,"60bc0aba-8afe-5d4d-ad4c-edb6b11d0b62","c53.9",-15262,"TCGA-C5-A8ZZ_treatment","6f50d225-4885-5f24-9a26-7a7e85f0bd1c","01","false","TCGA-C5-A8ZZ-01A",NA,"2c6dc14f-ed9a-482e-bbe3-fedb9ab65757",FALSE,"38E42051-6D04-4C54-BA9A-8206CC0AFBCB","Primary Tumor",NA,3023,70,NA,1388361600,"11",30,"TCGA-C5-A8ZZ-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:16:20.605705-05:00",NA,60,NA,40,NA,"TOP",NA,10,NA,"e3c4f6c7-7d8e-49ec-a403-0c1ded30e8b5",NA,"TCGA-C5-A8ZZ-01A-01-TS1",NA,70,NA,"a8c025e9-f8db-4ced-8d41-06ecb993fa60","RNA","TCGA-C5-A8ZZ-01A-11R","fffd5b20-9561-4c0a-ad37-0af3590c92ad",1.98,0.17,"UV Spec","R","23","TCGA-C5-A8ZZ-01A-11R-A37O-07","5f23cd19-f7f0-43e3-961d-0236da5f49ae",0.17,1.0958904109589,NA,NA,NA,"141a37c7-31a5-53b9-9ef8-bc70ce57ccef","TCGA-C5-A8ZZ_exposure","UNCID_2553112.5f23cd19-f7f0-43e3-961d-0236da5f49ae.140404_UNC11-SN627_0350_BC3K66ACXX_7_GGCTAC.tar.gz","2014-07-31T01:07:04.000Z","2014-07-31T01:31:06.000Z","AC35F877-DA10-4502-B085-EB7688D4F05D","2C6DC14F-ED9A-482E-BBE3-FEDB9AB65757","Unaligned reads",6130831234,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5F23CD19-F7F0-43E3-961D-0236DA5F49AE","University of North Carolina","564a3c36e4b08c5d8691c49f","33BC6504-D9AB-4B64-A87C-012915F36644","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A8C025E9-F8DB-4CED-8D41-06ECB993FA60","2014-07-31T01:31:06.000Z","FFFD5B20-9561-4C0A-AD37-0AF3590C92AD","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3023,"A8C025E9-F8DB-4CED-8D41-06ECB993FA60",NA,"C5","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E05_1465298.tangent.copynumber.data.txt",70,"TCGA-C5-A8ZZ-01A",NA,"13436EC9-48A3-4CEB-9EFE-93F42CB6EA2D","TCGA",2005,"TCGA-C5-A8ZZ_NTE-1",NA,"TUMOR FREE","9A0BD090-1C58-4A83-82A1-5C6C620752CD",41,"SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E05_1465298.CEL","Alive",NA,"TCGA-C5-A8ZZ","NOT HISPANIC OR LATINO","6FBB6F43-C0DD-4991-8522-0D294CD3FF87","NO",636,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8071/3","FEMALE","C53.9",380,NA,"B7C720D6-84AD-42A0-BE23-35DEF510559F","WHITE",NA,11,30,"E3C4F6C7-7D8E-49EC-A403-0C1DED30E8B5","57C5058D-2176-4E95-8E96-9DC8FAEA40EB","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E05_1465298.tangent.copynumber.data.txt","TCGA-C5-A8ZZ-01A-11",70,0,20,60,20,"TOP",10,40,"TCGA-C5-A8ZZ-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-C5-A8ZZ-D58625","TCGA-C5-A8ZZ-R58627","Internal","Regional site","TCGA-C5-A8ZZ-F66736_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A8ZZ-F66736","TCGA-C5-A8ZZ",NA,"C5","A8ZZ","YES","C53.9","8071/3","C53.9","NO","YES",-15262,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",636,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,41,2005,"Cone Biopsy / LEEP",NA,NA,NA,"G2",NA,2,NA,20,NA,NA,"1995",13,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
149069880,146917706,7011398595,"49778E92-B5D3-4AD9-A1AF-3B722D631B96.bw","34629eb8-0c5e-4910-8e13-bf7d6a1e337f","49778e92-b5d3-4ad9-a1af-3b722d631b96","2016-08-09T13:11:37.919863-05:00","UNCID_2186723.21E92DD7-ADEE-4826-9470-FB7501AD280D.121011_UNC13-SN749_0197_AD16K1ACXX_4_GGCTAC.tar.gz","1fe321c7-767a-45b0-8e3f-95f01a836454",6401274885,"Illumina HiSeq","f25867573b69ff8c750a6222ea500e24","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:22:07.917262-05:00","2016-05-03T11:00:24.467501-05:00","1fe321c7-767a-45b0-8e3f-95f01a836454_analysis.xml","bb498404917cef44f11614ae9235f7f9","ff53baaa-de8a-44a3-a9fc-fef94504e458",2124,"2016-09-29T22:29:32.692900-05:00","1fe321c7-767a-45b0-8e3f-95f01a836454_experiment.xml","4a88b1489ff1343379abf96699542052","b97288dd-fcbb-47d4-8f5d-654c167444f2",2431,"2016-09-29T19:45:16.351605-05:00","1fe321c7-767a-45b0-8e3f-95f01a836454_run.xml","1ef199d840022bbebbb5e7add7bba197","53fceb01-2845-4d14-a9d8-ee5ebfd832bf",354,"2016-09-08T11:44:31.896047-05:00","TCGA-JX-A3Q8","2016-09-02T18:59:25.416763-05:00","female","TCGA-JX-A3Q8_demographic",1971,"asian","491e2fec-a08a-561d-ad0b-06ebe04c0632","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JX","6d97b3ee-83c4-5be1-9919-0fdd90c1bb19","Washington University","not reported","c53.9","TCGA-JX-A3Q8_diagnosis","not reported",14839,"alive","8384/3",NA,1357,"36cf136c-b7f3-5132-a9f7-7efef469c89d","c53.9",-14839,"TCGA-JX-A3Q8_treatment","84c5bbe9-31ed-5dd3-8370-2242ca7f1846","01","true","TCGA-JX-A3Q8-01A",NA,"28954012-3732-40b0-8ea7-f48cbeef4105",FALSE,"0BC4C48F-7EE3-40A4-85AB-44B85DE4EC65","Primary Tumor",NA,252,80,NA,1330473600,"11",30,"TCGA-JX-A3Q8-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T11:44:31.896047-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"717ea52b-7bd9-40f3-ab09-9cc5a999d302",NA,"TCGA-JX-A3Q8-01A-01-TS1",NA,100,NA,"d7ccd019-c80e-4251-a746-38821b1c948b","RNA","TCGA-JX-A3Q8-01A-11R","bb39da47-2b94-4a7b-9ce9-ad45d658d550",1.94,0.16,"UV Spec","R","23","TCGA-JX-A3Q8-01A-11R-A21T-07","21e92dd7-adee-4826-9470-fb7501ad280d",0.16,NA,68,27.2392244832559,158,"5627b288-5b0e-53e6-8ddd-b0ba48ce9a01","TCGA-JX-A3Q8_exposure","UNCID_2186723.21E92DD7-ADEE-4826-9470-FB7501AD280D.121011_UNC13-SN749_0197_AD16K1ACXX_4_GGCTAC.tar.gz","2013-09-16T13:06:05.000Z","2013-09-16T13:45:01.000Z","1FE321C7-767A-45B0-8E3F-95F01A836454","28954012-3732-40B0-8EA7-F48CBEEF4105","Unaligned reads",6401274885,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","21E92DD7-ADEE-4826-9470-FB7501AD280D","University of North Carolina","564a39aae4b0298dd2c7d9e2","34629EB8-0C5E-4910-8E13-BF7D6A1E337F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D7CCD019-C80E-4251-A746-38821B1C948B","2013-09-16T13:45:01.000Z","BB39DA47-2B94-4A7B-9CE9-AD45D658D550","United States","NO",1,NA,"Primary Tumor","Washington University",252,"D7CCD019-C80E-4251-A746-38821B1C948B",NA,"JX","7786923106_R06C02_Grn.idat",80,"TCGA-JX-A3Q8-01A",NA,NA,"TCGA",2011,"TCGA-JX-A3Q8_NTE-1","Complete Remission/Response","TUMOR FREE","A5162279-45AE-4031-B119-71A8C934918F",40,"nationwidechildrens.org_clinical.TCGA-JX-A3Q8.xml","Alive",NA,"TCGA-JX-A3Q8","NOT HISPANIC OR LATINO","8B97CEC3-3A1C-48CD-B059-764085D513B8","NO",922,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",0,"Other","Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",217,NA,NA,"ASIAN",NA,11,30,"717EA52B-7BD9-40F3-AB09-9CC5A999D302","B9F2D309-C9A0-42DB-86C3-BEF1AE7751CF","7786923106_R06C02_Grn.idat","TCGA-JX-A3Q8-01A-11",90,0,0,1,0,"TOP",0,0,"TCGA-JX-A3Q8-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-JX-A3Q8-F60569_NTE-1","NO",922,"TUMOR FREE","Alive",NA,"TCGA-JX-A3Q8-F60569","TCGA-JX-A3Q8",NA,"JX","A3Q8","YES","C53.9","8384/3","C53.9","NO","YES",-14839,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",922,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,40,2011,"Biopsy (cervical / CT-guided / Other)","YES",14,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,0,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
117756132,116019444,5537166288,"A22892DE-0AF4-4B63-9513-1D6825059040.bw","35d677b6-0487-44d3-bbba-651eac7e0635","a22892de-0af4-4b63-9513-1d6825059040","2016-08-09T14:01:18.174933-05:00","UNCID_2169022.8bb52467-45b2-40d5-abd2-69ff0ad83bc5.130606_UNC9-SN296_0373_BD28T1ACXX_3_AGTTCC.tar.gz","37f1db95-cc8b-4857-b950-fe628ad7c4e6",5782977217,"Illumina HiSeq","a3abbc49f5e24ff07760e5fe20318624","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:03:18.739908-05:00","2016-05-03T11:06:28.633852-05:00","37f1db95-cc8b-4857-b950-fe628ad7c4e6_analysis.xml","fefce12c998901864c2bd7c08ab2a1f0","a966e7e8-937c-411a-8908-30b28c481af4",2121,"2016-09-29T19:18:45.495796-05:00","37f1db95-cc8b-4857-b950-fe628ad7c4e6_experiment.xml","7ca85e84a769446db3bff18eb64bf681","4379be38-6f17-41f0-8833-4a7e322a3a62",2431,"2016-09-29T19:19:15.549069-05:00","37f1db95-cc8b-4857-b950-fe628ad7c4e6_run.xml","effe6bafb0947e347e4b2d42aa7a593d","43cf8972-557f-436d-832e-ae75ea6d76ab",354,"2016-09-08T12:07:00.382532-05:00","TCGA-EA-A5ZD","2016-09-02T18:59:51.574681-05:00","female","TCGA-EA-A5ZD_demographic",1972,"asian","15985e73-67bd-5386-9659-8f84026af4f5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A5ZD_diagnosis","not reported",14629,"alive","8070/3",NA,830,"3d3f8851-9dc1-5bad-bdee-fa5754927ba8","c53.9",-14629,"TCGA-EA-A5ZD_treatment","89655a48-c964-590b-8e09-35f31af38fcc","01","true","TCGA-EA-A5ZD-01A",NA,"0add880f-39e7-48ac-94ea-8e15f1ee3d3f",FALSE,"4BB00D13-61EA-409C-AB1D-07DE3B949C85","Primary Tumor",NA,102,2290,NA,1363651200,"11",30,"TCGA-EA-A5ZD-01A-11",60,NA,0,NA,20,NA,20,NA,"2016-09-08T12:07:00.382532-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"10ff27f7-6788-4edd-8020-360beba93c4f",NA,"TCGA-EA-A5ZD-01A-01-TSA",NA,60,NA,"ce482d48-f4f2-4f89-a6ff-a173d4cccd3c","RNA","TCGA-EA-A5ZD-01A-11R","fed6c291-9d50-4246-884e-6c1f46b61821",1.88,0.17,"UV Spec","R","23","TCGA-EA-A5ZD-01A-11R-A28H-07","8bb52467-45b2-40d5-abd2-69ff0ad83bc5",0.17,NA,47,19.8178444931692,154,"5ef13f1b-0571-578c-b3ba-d0d9a5c3a5e3","TCGA-EA-A5ZD_exposure","UNCID_2169022.8bb52467-45b2-40d5-abd2-69ff0ad83bc5.130606_UNC9-SN296_0373_BD28T1ACXX_3_AGTTCC.tar.gz","2013-09-20T03:31:04.000Z","2013-09-20T03:47:02.000Z","37F1DB95-CC8B-4857-B950-FE628AD7C4E6","0ADD880F-39E7-48AC-94EA-8E15F1EE3D3F","Unaligned reads",5782977217,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8BB52467-45B2-40D5-ABD2-69FF0AD83BC5","University of North Carolina","564a40dbe4b0ef12181c32d4","35D677B6-0487-44D3-BBBA-651EAC7E0635","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CE482D48-F4F2-4F89-A6FF-A173D4CCCD3C","2013-09-20T03:47:02.000Z","FED6C291-9D50-4246-884E-6C1F46B61821","Vietnam","NO",1,NA,"Primary Tumor","Asterand",102,"CE482D48-F4F2-4F89-A6FF-A173D4CCCD3C",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C681D567-D4DB-460D-BABE-AD14C6FB9D92.txt",2290,"TCGA-EA-A5ZD-01A",NA,NA,"TCGA",2012,"TCGA-EA-A5ZD_NTE-1",NA,"TUMOR FREE","F5451A26-60A7-4E62-B0A6-8E92CB051662",40,"nationwidechildrens.org_clinical.TCGA-EA-A5ZD.xml","Alive",NA,"TCGA-EA-A5ZD","NOT HISPANIC OR LATINO","C1E006DA-12B0-4913-99C9-C39B133D3104","NO",21,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",297,NA,NA,"ASIAN",NA,11,30,"10FF27F7-6788-4EDD-8020-360BEBA93C4F","B3D098AC-C4EF-41C0-9362-B5314CB918BE","5104268bec67e471523308029855cf7e.bam.bai","TCGA-EA-A5ZD-01A-11",60,20,0,5,20,"TOP",0,0,"TCGA-EA-A5ZD-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-EA-A5ZD-F70877_NTE-1","NO",830,"TUMOR FREE","Alive",NA,"TCGA-EA-A5ZD-F70877","TCGA-EA-A5ZD",NA,"EA","A5ZD","YES","C53.9","8070/3","C53.9","YES","NO",-14629,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",21,NA,NA,NA,"TUMOR FREE","YES",24,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
166048866,163610304,7777903538,"6D77ECAE-A715-4ADD-97D8-A916DC31A4EA.bw","36605f5f-245c-41e5-a9db-705373da7923","6d77ecae-a715-4add-97d8-a916dc31a4ea","2016-08-09T13:57:04.306845-05:00","UNCID_2187359.6252138d-526e-4ed4-8369-7d6e4bde3fbe.120917_UNC11-SN627_0251_AC119PACXX_3_CAGATC.tar.gz","cd7a9842-5a01-40b7-9d6f-f4e504b7fa15",7013207907,"Illumina HiSeq","a75043c5595eb4589e1e91e4eba84b38","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:49:45.642341-05:00","2016-05-03T11:02:40.645042-05:00","cd7a9842-5a01-40b7-9d6f-f4e504b7fa15_analysis.xml","42c9001f8e3ae7e1fae9be8d01dc6e4a","eb4ed97a-6f92-496e-a4f4-5d3a46bb2ea7",2124,"2016-10-07T17:45:48.522727-05:00","cd7a9842-5a01-40b7-9d6f-f4e504b7fa15_experiment.xml","aedbe3a8f1cc48c8e029eaad0df720e9","66e8d076-52c6-4145-a8cd-e36ee040c6be",2431,"2016-09-29T22:30:18.869015-05:00","cd7a9842-5a01-40b7-9d6f-f4e504b7fa15_run.xml","bbca2a39be0aa8870be31086f9a1bdf6","b9f28b63-759b-4fab-b2f3-27c143b22227",354,"2016-09-09T16:39:00.370427-05:00","TCGA-DR-A0ZL","2016-09-02T18:54:37.953332-05:00","female","TCGA-DR-A0ZL_demographic",1951,"asian","76050b82-85d0-57c8-9958-389010b2263f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DR","845c7519-bf45-5d14-a013-eed2831237a8","University of Hawaii","not reported","c53.9","TCGA-DR-A0ZL_diagnosis","not reported",19384,"alive","8070/3",NA,2669,"6dbb4f03-877d-56ba-88ba-164c8b75ba42","c53.9",-19384,"TCGA-DR-A0ZL_treatment","678fb3be-bc70-5074-a3d7-27a850f9e2de","01","false","TCGA-DR-A0ZL-01A",NA,"11a01213-e1c4-4f74-b9c8-736d3e68ee62",FALSE,"6CE9D5FB-FE9B-4727-974E-43691EF974F6","Primary Tumor",NA,2384,80,NA,1291334400,"11",30,"TCGA-DR-A0ZL-01A-11",6,80,1,1,60,0,12,20,"2016-09-09T16:39:00.370427-05:00","2016-09-09T16:39:00.370427-05:00",35,40,40,2,"BOTTOM","TOP",3,0,"ecb807ce-e02a-40c7-a67d-9b615bc41b57","7c80f133-17a4-4577-b191-43bfda9de85b","TCGA-DR-A0ZL-01A-01-MS1","TCGA-DR-A0ZL-01A-01-TS1",25,80,"f043f8e7-10e8-4e79-bfa4-75ac33fd4eb2","RNA","TCGA-DR-A0ZL-01A-11R","281f3230-5413-4a04-82cb-00867ac310d1",1.81,0.16,"UV Spec","R","23","TCGA-DR-A0ZL-01A-11R-A10U-07","6252138d-526e-4ed4-8369-7d6e4bde3fbe",0.16,NA,57,23.7252861602497,155,"0314a27e-9e62-5b7b-9996-2b1a2bea6c50","TCGA-DR-A0ZL_exposure","UNCID_2187359.6252138d-526e-4ed4-8369-7d6e4bde3fbe.120917_UNC11-SN627_0251_AC119PACXX_3_CAGATC.tar.gz","2013-09-17T10:01:03.000Z","2013-09-17T11:47:01.000Z","CD7A9842-5A01-40B7-9D6F-F4E504B7FA15","11A01213-E1C4-4F74-B9C8-736D3E68EE62","Unaligned reads",7013207907,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6252138D-526E-4ED4-8369-7D6E4BDE3FBE","University of North Carolina","564a4068e4b0298dd2ca02f1","36605F5F-245C-41E5-A9DB-705373DA7923","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F043F8E7-10E8-4E79-BFA4-75AC33FD4EB2","2013-09-17T11:47:01.000Z","281F3230-5413-4A04-82CB-00867AC310D1","United States","NO",1,NA,"Primary Tumor","University of Hawaii",2384,"F043F8E7-10E8-4E79-BFA4-75AC33FD4EB2",NA,"DR","C501.TCGA-DR-A0ZL-01A-11D-A10S-08.4.bam",80,"TCGA-DR-A0ZL-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","7ED167E6-07CB-4F06-9936-FAD9F822F65E",53,"nationwidechildrens.org_clinical.TCGA-DR-A0ZL.xml","Alive",NA,"TCGA-DR-A0ZL","NOT HISPANIC OR LATINO","6522F451-A23D-4743-81CE-4ED2142BE30F",NA,2155,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",88,NA,NA,"ASIAN",NA,11,30,"ECB807CE-E02A-40C7-A67D-9B615BC41B57","D50E250F-30D6-4D74-BF96-8C176E4EB47B","C501.TCGA-DR-A0ZL-01A-11D-A10S-08.4.bam","TCGA-DR-A0ZL-01A-11",6,60,1,35,12,"BOTTOM",3,40,"TCGA-DR-A0ZL-01A-01-MS1",25,NA,NA,NA,NA,NA,NA,NA,"NO",2669,"TUMOR FREE","Alive",NA,"TCGA-DR-A0ZL-F17115","TCGA-DR-A0ZL",NA,"DR","A0ZL","YES","C53.9","8070/3","C53.9","NO","YES",-19384,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",2155,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,2004,"Biopsy (cervical / CT-guided / Other)","YES",24,0,"G3",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
100978028,98203748,4688230767,"09758B6F-1B2D-4AED-8913-696097069409.bw","374f614a-bcd1-4283-ac6f-fc27ddc79987","09758b6f-1b2d-4aed-8913-696097069409","2016-08-09T13:57:44.687798-05:00","UNCID_2187256.1f870a12-9d70-4fe4-a176-4cbee06c44e6.120921_UNC16-SN851_0181_AD14JFACXX_2_ATCACG.tar.gz","c92c82df-7583-42f7-b4f5-da7581a43e7d",4156880555,"Illumina HiSeq","3fc21479b6cfe463b2fd0085bd9a5d53","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:57:58.015439-05:00","2016-05-03T11:02:00.403413-05:00","c92c82df-7583-42f7-b4f5-da7581a43e7d_analysis.xml","904fb01a26b1cae37a1759695fc58926","10a93748-8994-48f4-b41c-10c3f6a7ce60",2124,"2016-08-27T04:08:26.083520-05:00","c92c82df-7583-42f7-b4f5-da7581a43e7d_experiment.xml","dd4de5839e37f7b7553ea76f6d9600c0","909e2c3c-fa3b-4343-905b-74dcd47c4f2a",2431,"2016-09-29T21:52:23.072397-05:00","c92c82df-7583-42f7-b4f5-da7581a43e7d_run.xml","9d31ab2a4bd34e9b288a8dfb03bb35e3","a2948a53-11b3-4c46-a25a-e00857f51361",354,"2016-09-08T12:13:49.572404-05:00","TCGA-C5-A1ML","2016-09-02T18:57:20.590634-05:00","female","TCGA-C5-A1ML_demographic",1956,"white","ecc5939e-6502-57b1-9d3d-10e71cc7fb73","not reported",2006,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1ML_diagnosis","not reported",18067,"dead","8070/3",636,NA,"38d5b36a-a1c0-56c6-a0a3-4f8a1d19be82","c53.9",-18067,"TCGA-C5-A1ML_treatment","70905bbb-8f87-5640-8333-f3bfc1dbc9e1","01","true","TCGA-C5-A1ML-01A",NA,"f5495789-2c61-42f2-b6b6-a14e00d2f985",FALSE,"D27AF07C-E69A-46DE-B1E6-4F494E3602B5","Primary Tumor",NA,2037,40,NA,1301356800,"11",30,"TCGA-C5-A1ML-01A-11",90,NA,20,NA,0,NA,10,NA,"2016-09-08T12:13:49.572404-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"a2f6cc77-1b17-4eb9-80f1-545b5656498e",NA,"TCGA-C5-A1ML-01A-01-TSA",NA,90,NA,"fee5b449-4d5c-4c6b-956f-1400e560ea65","RNA","TCGA-C5-A1ML-01A-11R","30a7a107-f0ba-486c-9e30-bf3441026d51",1.98,0.18,"UV Spec","R","23","TCGA-C5-A1ML-01A-11R-A14Y-07","1f870a12-9d70-4fe4-a176-4cbee06c44e6",0.18,2.02739726027397,120,NA,NA,"d6f152cf-d2c2-55e4-acd8-013f30ce3daf","TCGA-C5-A1ML_exposure","UNCID_2187256.1f870a12-9d70-4fe4-a176-4cbee06c44e6.120921_UNC16-SN851_0181_AD14JFACXX_2_ATCACG.tar.gz","2013-09-17T05:13:04.000Z","2013-09-17T05:28:01.000Z","C92C82DF-7583-42F7-B4F5-DA7581A43E7D","F5495789-2C61-42F2-B6B6-A14E00D2F985","Unaligned reads",4156880555,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1F870A12-9D70-4FE4-A176-4CBEE06C44E6","University of North Carolina","56607486e4b018727fe9f3d8","374F614A-BCD1-4283-AC6F-FC27DDC79987","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FEE5B449-4D5C-4C6B-956F-1400E560EA65","2013-09-17T05:28:01.000Z","30A7A107-F0BA-486C-9E30-BF3441026D51","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2037,"FEE5B449-4D5C-4C6B-956F-1400E560EA65",NA,"C5","91d578e349e51da30596c416f3e08405.bam",40,"TCGA-C5-A1ML-01A",NA,NA,"TCGA",2005,NA,NA,"WITH TUMOR","F5495789-2C61-42F2-B6B6-A14E00D2F985",49,"nationwidechildrens.org_clinical.TCGA-C5-A1ML.xml","Dead",636,"TCGA-C5-A1ML",NA,"5576A62C-C406-4C50-B11A-CAAA1901F2D3",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8070/3","FEMALE","C53.9",127,NA,"0E9242BD-B2DB-48D7-859B-7058DA6EB4D8","WHITE",NA,11,30,"A2F6CC77-1B17-4EB9-80F1-545B5656498E","ECCD4C8C-3612-4EC8-8D45-E870008C9141","91d578e349e51da30596c416f3e08405.bam","TCGA-C5-A1ML-01A-11",90,0,20,40,10,"TOP",0,20,"TCGA-C5-A1ML-01A-01-TSA",90,NA,NA,NA,"TCGA-C5-A1ML-R30189","COMBINATION","Primary Tumor Field",NA,"NO",NA,"WITH TUMOR","Dead",636,"TCGA-C5-A1ML-F30188","TCGA-C5-A1ML",NA,"C5","A1ML","YES","C53.9","8070/3","C53.9","NO","YES",-18067,"FEMALE","WHITE",NA,"No","No","Dead",NA,636,NA,NA,"WITH TUMOR","NO",21,10,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2005,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,2,NA,37,NA,NA,"1995",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
213513044,211311946,10027014494,"8B709DB4-0B28-42F1-A7C5-106F5809BEA2.bw","3923a64a-f8d7-4e3e-9218-cee642da21db","8b709db4-0b28-42f1-a7c5-106f5809bea2","2016-08-05T07:11:51.682394-05:00","UNCID_2187326.a57566b4-dd26-46bd-a00f-82136bc2a9be.120917_UNC11-SN627_0251_AC119PACXX_2_GCCAAT.tar.gz","c271f4eb-85bc-46f2-9dc6-27577366d182",9571244142,"Illumina HiSeq","c50eb6a42734e929be0b79a2ac6af6e9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:08:32.562113-05:00","2016-05-03T11:02:00.425419-05:00","c271f4eb-85bc-46f2-9dc6-27577366d182_analysis.xml","cf4f9ed03a17b894b72adc11c746b172","d1aceb9e-24ce-4925-a593-d2039ce3a52d",2124,"2016-09-29T17:41:08.854733-05:00","c271f4eb-85bc-46f2-9dc6-27577366d182_experiment.xml","b3bcf78138351b570ed8c32d4209ef91","05f2f1a2-9827-40bc-ab91-ab3fc61b8bef",2431,"2016-09-29T18:45:39.181138-05:00","c271f4eb-85bc-46f2-9dc6-27577366d182_run.xml","90ab9095c77b12af91376c727db37c65","2e9d237a-0cb1-43d2-8b3c-8739a3c5b8b6",354,"2016-09-08T10:45:50.167313-05:00","TCGA-BI-A0VS","2016-09-02T18:54:53.974740-05:00","female","TCGA-BI-A0VS_demographic",1959,"white","2ddbed5a-9949-553f-81e1-8f239f125270","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","BI","7c1cce46-1302-522c-ad52-74b2655b217c","University of Pittsburgh","not reported","c53.9","TCGA-BI-A0VS_diagnosis","not reported",17839,"alive","8070/3",NA,1735,"34d1d9d4-fc68-557f-9e70-95e6005c4af7","c53.9",-17839,"TCGA-BI-A0VS_treatment","a6c92205-1346-5b65-9ed6-e82f6b0cb826","01","true","TCGA-BI-A0VS-01A",NA,"878cf960-b1a7-427d-bf5c-31f145be4501",FALSE,"5E58A8B7-0F96-4604-9BDE-66A8C2DF7B58","Primary Tumor",NA,1247,60,NA,1287100800,"11",30,"TCGA-BI-A0VS-01A-11",85,60,0,0,0,3,10,37,"2016-09-08T10:45:50.167313-05:00","2016-09-08T10:45:50.167313-05:00",7,20,0,0,"BOTTOM","TOP",5,0,"90872d81-a6f0-471e-9619-5dfdcf7ae448","4036b5d1-141b-474a-82af-f2f9cf05db3d","TCGA-BI-A0VS-01A-01-BS1","TCGA-BI-A0VS-01A-01-TS1",85,60,"6ac86e69-d129-4c9b-a505-e8f57b76dee3","RNA","TCGA-BI-A0VS-01A-11R","66802fab-9a28-4709-bf0a-50fa68b2d8d5",1.89,0.16,"UV Spec","R","23","TCGA-BI-A0VS-01A-11R-A10U-07","a57566b4-dd26-46bd-a00f-82136bc2a9be",0.16,NA,NA,NA,NA,"ab2c2715-a6bb-5c9f-aa48-2b3b7275fd16","TCGA-BI-A0VS_exposure","UNCID_2187326.a57566b4-dd26-46bd-a00f-82136bc2a9be.120917_UNC11-SN627_0251_AC119PACXX_2_GCCAAT.tar.gz","2013-09-17T08:06:03.000Z","2013-09-17T08:29:01.000Z","C271F4EB-85BC-46F2-9DC6-27577366D182","878CF960-B1A7-427D-BF5C-31F145BE4501","Unaligned reads",9571244142,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A57566B4-DD26-46BD-A00F-82136BC2A9BE","University of North Carolina","5660747ae4b018727fe9f333","3923A64A-F8D7-4E3E-9218-CEE642DA21DB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6AC86E69-D129-4C9B-A505-E8F57B76DEE3","2013-09-17T08:29:01.000Z","66802FAB-9A28-4709-BF0A-50FA68B2D8D5","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",1247,"6AC86E69-D129-4C9B-A505-E8F57B76DEE3",NA,"BI","C501.TCGA-BI-A0VS-01A-11D-A10S-08.4.bam",60,"TCGA-BI-A0VS-01A",NA,NA,"TCGA",2007,NA,NA,"TUMOR FREE","878CF960-B1A7-427D-BF5C-31F145BE4501",48,"C501.TCGA-BI-A0VS-10A-01D-A10S-08.4.bam.bai","Alive",NA,"TCGA-BI-A0VS","NOT HISPANIC OR LATINO","AECB6E4A-174A-4D77-8DAA-3DBCD12D01BA",NA,925,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",88,NA,NA,"WHITE",NA,11,30,"90872D81-A6F0-471E-9619-5DFDCF7AE448","66802FAB-9A28-4709-BF0A-50FA68B2D8D5","C501.TCGA-BI-A0VS-01A-11D-A10S-08.4.bam","TCGA-BI-A0VS-01A-11",85,0,0,7,10,"BOTTOM",5,0,"TCGA-BI-A0VS-01A-01-BS1",85,NA,NA,NA,NA,NA,NA,"TCGA-BI-A0VS-F34079_NTE-1","NO",1735,"TUMOR FREE","Alive",NA,"TCGA-BI-A0VS-F34079","TCGA-BI-A0VS",NA,"BI","A0VS","YES","C53.9","8070/3","C53.9","NO","YES",-17839,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",925,NA,NA,NA,"TUMOR FREE","NO",5,4,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2007,"Cytology (e.g. Peritoneal or pleural fluid)",NA,8,0,"G3",NA,2,NA,NA,NA,NA,NA,6,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
185589496,182900078,8672973099,"F2B356FA-79CD-4867-8ABF-84C90A493A75.bw","39a3120c-0889-4a10-816a-e07528a35f7a","f2b356fa-79cd-4867-8abf-84c90a493a75","2016-09-27T17:22:50.083139-05:00","UNCID_2251239.73bf920b-b9dc-4f81-b57a-63ebebccf9cd.120917_UNC11-SN627_0251_AC119PACXX_2_ACAGTG.tar.gz","8d1c95f8-91dd-4898-8027-05e8bf373bd3",8299293671,"Illumina HiSeq","3b70120394383fb7924586043cb706fc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:39.517540-05:00","2016-05-03T11:20:52.084724-05:00","8d1c95f8-91dd-4898-8027-05e8bf373bd3_analysis.xml","16e500675dacdaffbbc47a142d4b6a43","ee6902ee-cd65-4548-8d74-cf969d44b157",2124,"2016-09-29T22:28:38.355108-05:00","8d1c95f8-91dd-4898-8027-05e8bf373bd3_experiment.xml","1d5f29cbfff538cc9b948626ac824987","b8e01ce4-dac5-4885-8fb8-d22ebfb4af44",2431,"2016-09-29T22:06:07.170069-05:00","8d1c95f8-91dd-4898-8027-05e8bf373bd3_run.xml","b10ba5d57578433d6fee2adb2690cf68","ab2305cf-4cfd-4b12-bea9-ac5a2e8dd4b6",354,"2016-09-08T10:41:27.278289-05:00","TCGA-BI-A0VR","2016-09-02T18:54:53.420409-05:00","female","TCGA-BI-A0VR_demographic",1953,"white","ca8d6362-875d-5ce8-b830-2670508908b2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","BI","7c1cce46-1302-522c-ad52-74b2655b217c","University of Pittsburgh","not reported","c53.9","TCGA-BI-A0VR_diagnosis","not reported",19473,"alive","8070/3",NA,1505,"242f9f3b-9085-55d2-82a6-e73c62438fd2","c53.9",-19473,"TCGA-BI-A0VR_treatment","ba1066ea-a43b-5190-a32d-e51da7ed229f","01","true","TCGA-BI-A0VR-01A",NA,"3343f9b1-7dd4-42b7-8d72-518a05d936f4",FALSE,"BA4A1AA9-C1C7-4F84-A375-02B51FB95494","Primary Tumor",NA,1554,100,NA,1287532800,"11",30,"TCGA-BI-A0VR-01A-11",70,70,5,10,0,0,25,20,"2016-09-08T10:41:27.278289-05:00","2016-09-08T10:41:27.278289-05:00",40,60,50,20,"BOTTOM","TOP",5,10,"159d0b81-3d38-4c54-9c00-7e8b2490a0ca","31a885b5-2077-4b6d-b0a8-d9f9b1267d95","TCGA-BI-A0VR-01A-01-BS1","TCGA-BI-A0VR-01A-01-MS1",70,70,"57d99712-a30f-4431-80c7-92b5f028b9b1","RNA","TCGA-BI-A0VR-01A-11R","af7550b9-f68d-4bcb-8981-8622cda60a96",1.87,0.16,"UV Spec","R","23","TCGA-BI-A0VR-01A-11R-A10U-07","73bf920b-b9dc-4f81-b57a-63ebebccf9cd",0.16,1.0958904109589,NA,NA,NA,"953a4f1e-bae9-52cb-9e18-2585c5368b2f","TCGA-BI-A0VR_exposure","UNCID_2251239.73bf920b-b9dc-4f81-b57a-63ebebccf9cd.120917_UNC11-SN627_0251_AC119PACXX_2_ACAGTG.tar.gz","2013-10-26T21:21:04.000Z","2013-10-26T21:44:02.000Z","8D1C95F8-91DD-4898-8027-05E8BF373BD3","3343F9B1-7DD4-42B7-8D72-518A05D936F4","Unaligned reads",8299293671,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","73BF920B-B9DC-4F81-B57A-63EBEBCCF9CD","University of North Carolina","564a3fc4e4b08c5d8692e73c","39A3120C-0889-4A10-816A-E07528A35F7A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","57D99712-A30F-4431-80C7-92B5F028B9B1","2013-10-26T21:44:02.000Z","AF7550B9-F68D-4BCB-8981-8622CDA60A96","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",1554,"57D99712-A30F-4431-80C7-92B5F028B9B1",NA,"BI","C501.TCGA-BI-A0VR-01A-11D-A10S-08.5.bam.bai",100,"TCGA-BI-A0VR-01A",NA,NA,"TCGA",2006,NA,NA,"TUMOR FREE","F978EDD5-23A2-416A-B87F-B1CF6DA45CEB",53,"nationwidechildrens.org_clinical.TCGA-BI-A0VR.xml","Alive",NA,"TCGA-BI-A0VR","NOT HISPANIC OR LATINO","6A8F1959-567A-4D04-94D5-2ECEC883AAFA",NA,1505,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",88,NA,NA,"WHITE",NA,11,30,"31A885B5-2077-4B6D-B0A8-D9F9B1267D95","AF7550B9-F68D-4BCB-8981-8622CDA60A96","C501.TCGA-BI-A0VR-01A-11D-A10S-08.5.bam.bai","TCGA-BI-A0VR-01A-11",70,0,10,60,20,"TOP",10,20,"TCGA-BI-A0VR-01A-01-MS1",70,NA,NA,NA,NA,NA,NA,"TCGA-BI-A0VR-F34080_NTE-1","NO",1505,"TUMOR FREE","Alive",NA,"TCGA-BI-A0VR-F34080","TCGA-BI-A0VR",NA,"BI","A0VR","YES","C53.9","8070/3","C53.9","NO","YES",-19473,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1505,NA,NA,NA,"TUMOR FREE","NO",1,4,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,2006,"Cytology (e.g. Peritoneal or pleural fluid)",NA,43,1,"G3",NA,4,1995,20,NA,NA,NA,16,NA,"T2bN1M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122749276,120934759,5774758814,"131213AD-0313-4DF1-B013-CE67ED262C37.bw","3a3a9b5e-12a1-41f5-a54c-d4c1e0eccb9e","131213ad-0313-4df1-b013-ce67ed262c37","2016-09-29T18:01:41.808314-05:00","UNCID_2332249.265dd9bb-8b5e-4cad-a43e-f21ae0953f22.131016_UNC15-SN850_0333_AC2MBAACXX_3_GTCCGC.tar.gz","a58aeaa6-ad83-4115-893f-0c07fd2f8a9b",5672872048,"Illumina HiSeq","f8044caf4097f062ad3e8b54a95d9fcc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:22:52.949928-05:00","2016-05-03T11:35:41.353993-05:00","a58aeaa6-ad83-4115-893f-0c07fd2f8a9b_analysis.xml","1fa674190d317a0c2c57165e40f620d8","da7e0f74-c993-41a5-a870-6a2cdda7e8bf",2124,"2016-09-29T19:47:53.849752-05:00","a58aeaa6-ad83-4115-893f-0c07fd2f8a9b_experiment.xml","60006d5b1c0763c353413fa2c421fb9c","55982574-0c4f-4fb7-b58d-e62c50b045ba",2628,"2016-09-29T18:39:15.621256-05:00","a58aeaa6-ad83-4115-893f-0c07fd2f8a9b_run.xml","dfe3589f619246fe8b46ec48d2d892e2","2a8149ca-8399-4827-8638-2f957aca1c49",354,"2016-09-08T12:10:24.382957-05:00","TCGA-Q1-A73P","2016-09-02T19:00:53.021357-05:00","female","TCGA-Q1-A73P_demographic",1968,"white","c71ca30b-ae92-573c-9b39-5c289df74074","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A73P_diagnosis","not reported",16450,"alive","8384/3",NA,483,"0f2efbf4-6eb9-5d77-ba9a-49b147d05270","c53.9",-16450,"TCGA-Q1-A73P_treatment","e020d86e-3dbb-5392-9bce-f3516f0580b7","01","true","TCGA-Q1-A73P-01A",NA,"b0377dfd-622e-4d65-b2da-2499f3c8e5c8",FALSE,"5269DE35-6DEC-417C-B618-6F7717FFA55A","Primary Tumor",NA,92,110,NA,1375920000,"11",30,"TCGA-Q1-A73P-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:10:24.382957-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"326b8e8e-150d-4ff8-9dde-c1ec7a269d00",NA,"TCGA-Q1-A73P-01A-01-TSA",NA,70,NA,"1d2066c7-92d0-409a-860a-ee4561260a06","RNA","TCGA-Q1-A73P-01A-11R","f5198aca-6b5b-4722-b5e8-a2e0389f11b4",1.92,0.18,"UV Spec","R","23","TCGA-Q1-A73P-01A-11R-A32P-07","265dd9bb-8b5e-4cad-a43e-f21ae0953f22",0.18,NA,82,27.3981756824485,173,"e832ada2-6470-5209-b227-1d393e6159a3","TCGA-Q1-A73P_exposure","UNCID_2332249.265dd9bb-8b5e-4cad-a43e-f21ae0953f22.131016_UNC15-SN850_0333_AC2MBAACXX_3_GTCCGC.tar.gz","2014-01-28T21:37:05.000Z","2014-01-28T21:51:01.000Z","A58AEAA6-AD83-4115-893F-0C07FD2F8A9B","B0377DFD-622E-4D65-B2DA-2499F3C8E5C8","Unaligned reads",5672872048,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","265DD9BB-8B5E-4CAD-A43E-F21AE0953F22","University of North Carolina","564a3d8be4b0298dd2c917e2","3A3A9B5E-12A1-41F5-A54C-D4C1E0ECCB9E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","1D2066C7-92D0-409A-860A-EE4561260A06","2014-01-28T21:51:01.000Z","F5198ACA-6B5B-4722-B5E8-A2E0389F11B4","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",92,"1D2066C7-92D0-409A-860A-EE4561260A06",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.0095AB4C-70E1-460B-AFEB-74AAB65D1E95.txt",110,"TCGA-Q1-A73P-01A",NA,NA,"TCGA",2013,"TCGA-Q1-A73P_NTE-1",NA,NA,"B0377DFD-622E-4D65-B2DA-2499F3C8E5C8",45,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.0095AB4C-70E1-460B-AFEB-74AAB65D1E95.txt","Alive",NA,"TCGA-Q1-A73P","NOT HISPANIC OR LATINO","0E6D79E8-4E08-4F5B-8FA1-DE962881BC67","NO",146,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",0,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b","8384/3","FEMALE","C53.9",335,NA,NA,"WHITE",NA,11,30,"326B8E8E-150D-4FF8-9DDE-C1EC7A269D00","A429D795-91C9-4C6A-8C39-EBFE73FF8342","THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_D03_1367080.CEL","TCGA-Q1-A73P-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-Q1-A73P-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-Q1-A73P-F62731_NTE-1","NO",483,"TUMOR FREE","Alive",NA,"TCGA-Q1-A73P-F62731","TCGA-Q1-A73P",NA,"Q1","A73P","YES","C53.9","8384/3","C53.9","YES","NO",-16450,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",146,NA,NA,NA,NA,"YES",31,10,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,45,2013,"Biopsy (cervical / CT-guided / Other)","YES",17,0,"G1",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1bN0MX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
183627576,181937408,8684341579,"D94F7E81-0F60-473B-AD4A-0AC13508BDE2.bw","3ac62513-b5f4-4063-aabd-dad08a1f56fb","d94f7e81-0f60-473b-ad4a-0ac13508bde2","2016-08-05T03:45:00.265527-05:00","UNCID_2185454.6171e1c5-1243-4fde-8964-7d1a4d387a86.130129_UNC13-SN749_0217_BD1MTTACXX_5_GCCAAT.tar.gz","af576cb3-bdf5-4e74-8121-7b8d35eddf6b",8541581683,"Illumina HiSeq","a73ab6b6a4f1f10ea8321b75de4142c9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:10:44.479931-05:00","2016-05-03T10:58:56.648400-05:00","af576cb3-bdf5-4e74-8121-7b8d35eddf6b_analysis.xml","39ce046d8dff74a05bb7e360093861ce","3e6ef001-4bd3-4ef8-b5c0-e175c8c65963",2122,"2016-09-29T20:28:43.986433-05:00","af576cb3-bdf5-4e74-8121-7b8d35eddf6b_experiment.xml","93b69bc80c2d1665c64e76dc22e6beb1","6ea3bce4-a8b4-49fe-b8bd-d0bc35c1ca6f",2431,"2016-09-29T20:23:56.779074-05:00","af576cb3-bdf5-4e74-8121-7b8d35eddf6b_run.xml","e4e72f7da2966b9607a9051699749cc1","6bb2fe02-478d-4d9b-8a10-4b7e02de489a",354,"2016-09-08T11:50:37.208076-05:00","TCGA-EA-A3Y4","2016-09-02T18:59:34.482940-05:00","female","TCGA-EA-A3Y4_demographic",1972,"white","306b1aca-7e34-59df-8162-25dc522efe8e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3Y4_diagnosis","not reported",14706,"alive","8070/3",NA,1122,"f12846f7-92ae-5ab6-a1e0-1232513a4e69","c53.9",-14706,"TCGA-EA-A3Y4_treatment","95697147-cc19-53fd-8d16-a71835c3ccea","01","true","TCGA-EA-A3Y4-01A",NA,"ff97c148-76ba-480e-9456-5dd7d7238373",FALSE,"D0A5BC9D-D39C-4A0D-9832-E062AA024D17","Primary Tumor",NA,146,1310,NA,1344902400,"51",30,"TCGA-EA-A3Y4-01A-51",60,NA,0,NA,0,NA,15,NA,"2016-09-08T11:50:37.208076-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"0233a47b-7148-4a49-8c31-e388f03c040c",NA,"TCGA-EA-A3Y4-01A-05-TS5",NA,85,NA,"db6d92ad-10ed-4bc1-8216-16b081eb8d6f","RNA","TCGA-EA-A3Y4-01A-51R","8a88ee5a-a8a6-4492-8fd8-2dde6d93dbfb",1.81,0.18,"UV Spec","R","23","TCGA-EA-A3Y4-01A-51R-A24H-07","6171e1c5-1243-4fde-8964-7d1a4d387a86",0.18,NA,99,35.4978665423644,167,"3b311b2e-4687-520a-ab31-c109350ae45e","TCGA-EA-A3Y4_exposure","UNCID_2185454.6171e1c5-1243-4fde-8964-7d1a4d387a86.130129_UNC13-SN749_0217_BD1MTTACXX_5_GCCAAT.tar.gz","2013-09-14T20:16:05.000Z","2013-09-14T20:39:01.000Z","AF576CB3-BDF5-4E74-8121-7B8D35EDDF6B","FF97C148-76BA-480E-9456-5DD7D7238373","Unaligned reads",8541581683,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6171E1C5-1243-4FDE-8964-7D1A4D387A86","University of North Carolina","564a3fece4b093830b6ab87a","3AC62513-B5F4-4063-AABD-DAD08A1F56FB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DB6D92AD-10ED-4BC1-8216-16B081EB8D6F","2013-09-14T20:39:01.000Z","8A88EE5A-A8A6-4492-8FD8-2DDE6D93DBFB","Ukraine","NO",1,NA,"Primary Tumor","Asterand",146,"DB6D92AD-10ED-4BC1-8216-16B081EB8D6F",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.5D8CB763-CC51-417E-B960-560E5C59938A.txt",1310,"TCGA-EA-A3Y4-01A",NA,NA,"TCGA",2012,"TCGA-EA-A3Y4_NTE-1","Complete Remission/Response","TUMOR FREE","FF97C148-76BA-480E-9456-5DD7D7238373",40,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.5D8CB763-CC51-417E-B960-560E5C59938A.txt","Alive",NA,"TCGA-EA-A3Y4","NOT HISPANIC OR LATINO","BA304B70-77A4-413B-B7CE-6F760907A33F","NO",35,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",256,NA,"C3FB48BA-55AD-45AE-9514-15E5E9C61531","WHITE",NA,51,30,"0233A47B-7148-4A49-8C31-E388F03C040C","CA887868-9DC7-4FC3-92DC-F697C0A1E6A4","UNCID_2185454.6171e1c5-1243-4fde-8964-7d1a4d387a86.130129_UNC13-SN749_0217_BD1MTTACXX_5_GCCAAT.tar.gz","TCGA-EA-A3Y4-01A-51",60,0,0,0,15,"TOP",0,0,"TCGA-EA-A3Y4-01A-05-TS5",85,NA,NA,NA,"TCGA-EA-A3Y4-R46398","External","Primary Tumor Field","TCGA-EA-A3Y4-F46396_NTE-1","NO",441,"TUMOR FREE","Alive",NA,"TCGA-EA-A3Y4-F46396","TCGA-EA-A3Y4",NA,"EA","A3Y4","YES","C53.9","8070/3","C53.9","YES","NO",-14706,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",35,NA,NA,NA,"TUMOR FREE","YES",24,9,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2012,"Biopsy (cervical / CT-guided / Other)","YES",12,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",6,NA,"T1bN0M0",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
188388036,183354701,8755651174,"29C17355-D646-48DA-9E54-7B6DD85DD610.bw","3c5b2452-014b-495f-b86a-f522ed84bc3b","29c17355-d646-48da-9e54-7b6dd85dd610","2016-08-31T10:45:02.760767-05:00","UNCID_2186722.6CF5747F-22B4-498F-B8CE-13E4A2741883.121011_UNC13-SN749_0197_AD16K1ACXX_7_CGATGT.tar.gz","a2fac0a2-15e3-4881-a340-e3ba4425c50a",8338629875,"Illumina HiSeq","46d693b3307990bc5a976b8dc52e3b0f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:05:49.022529-05:00","2016-05-03T11:00:24.467501-05:00","a2fac0a2-15e3-4881-a340-e3ba4425c50a_analysis.xml","1d673fa1aab48aec684d4d5fe34d7e4f","aaf43ecb-f3fe-4212-878d-cf7c864108ee",2124,"2016-10-07T16:54:26.611136-05:00","a2fac0a2-15e3-4881-a340-e3ba4425c50a_experiment.xml","ab55782d0cbe962d7d6c698b0c3c5271","f7d59f08-3e64-4b1c-b530-3de4c602be26",2431,"2016-09-29T23:37:37.782504-05:00","a2fac0a2-15e3-4881-a340-e3ba4425c50a_run.xml","63a537ce5036f1e60920b6839858b5d3","e3cf4380-d455-4b24-986e-ff188ada421f",354,"2016-09-08T12:39:18.153675-05:00","TCGA-EA-A3HT","2016-09-02T18:59:01.800730-05:00","female","TCGA-EA-A3HT_demographic",1943,"white","95a1dccc-39a7-5ce0-97f5-fc50aca7f411","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3HT_diagnosis","not reported",25138,"alive","8070/3",NA,954,"cbf0a5f9-2d47-5e29-bbeb-18bb81059885","c53.9",-25138,"TCGA-EA-A3HT_treatment","1ccec477-6b05-5930-9b26-fe6232c12071","01","true","TCGA-EA-A3HT-01A",NA,"8460c1e5-0029-4d66-af11-373324347800",FALSE,"ADE9CA35-C9F2-417E-8B27-59ACC7E1AE32","Primary Tumor",NA,198,1,NA,1327536000,"61",30,"TCGA-EA-A3HT-01A-61",85,NA,0,NA,5,NA,0,NA,"2016-09-08T12:39:18.153675-05:00",NA,7,NA,0,NA,"TOP",NA,0,NA,"e0252dec-7ed8-467f-b719-79f823345eaf",NA,"TCGA-EA-A3HT-01A-06-TSF",NA,95,NA,"81b06e60-da92-42ed-99e3-1e74355069f3","RNA","TCGA-EA-A3HT-01A-61R","25af3b39-6bb6-4dc7-8af3-4dd515209de9",2.02,0.17,"UV Spec","R","23","TCGA-EA-A3HT-01A-61R-A21T-07","6cf5747f-22b4-498f-b8ce-13e4a2741883",0.17,NA,83,31.2394143550755,163,"8d926bd6-1753-5e4f-9ddf-fe42bf45bb91","TCGA-EA-A3HT_exposure","UNCID_2186722.6CF5747F-22B4-498F-B8CE-13E4A2741883.121011_UNC13-SN749_0197_AD16K1ACXX_7_CGATGT.tar.gz","2013-09-16T12:56:04.000Z","2013-09-16T13:41:01.000Z","A2FAC0A2-15E3-4881-A340-E3BA4425C50A","8460C1E5-0029-4D66-AF11-373324347800","Unaligned reads",8338629875,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6CF5747F-22B4-498F-B8CE-13E4A2741883","University of North Carolina","564a3da4e4b0ef12181b271b","3C5B2452-014B-495F-B86A-F522ED84BC3B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","81B06E60-DA92-42ED-99E3-1E74355069F3","2013-09-16T13:41:01.000Z","25AF3B39-6BB6-4DC7-8AF3-4DD515209DE9","Russia","NO",1,NA,"Primary Tumor","Asterand",198,"81B06E60-DA92-42ED-99E3-1E74355069F3",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F2BA7AA4-9BFA-463E-A2A8-EC141BC66ACA.txt",1,"TCGA-EA-A3HT-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","89EF7B55-AFE7-4EAC-84E3-B0DF9ECF4B67",68,"TCGA-EA-A3HT-01A-61R-A21U-13_mirna.bam.bai","Alive",NA,"TCGA-EA-A3HT","NOT HISPANIC OR LATINO","A8B887B0-1A67-4630-82D0-75E0FDE37471",NA,19,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",217,NA,NA,"WHITE",NA,61,30,"E0252DEC-7ED8-467F-B719-79F823345EAF","914A2B40-6515-41B1-8F2F-12BC2C3CDF37","UNCID_1667494.6CF5747F-22B4-498F-B8CE-13E4A2741883.sorted_genome_alignments.bam","TCGA-EA-A3HT-01A-61",85,5,0,7,0,"TOP",0,0,"TCGA-EA-A3HT-01A-06-TSF",95,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3HT-F66111_NTE-1","NO",954,"TUMOR FREE","Alive",NA,"TCGA-EA-A3HT-F66111","TCGA-EA-A3HT",NA,"EA","A3HT","YES","C53.9","8070/3","C53.9","YES","NO",-25138,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",19,NA,NA,NA,"TUMOR FREE","NO",20,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,68,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",9,0,"G1",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101552934,100330313,4793811103,"B8BD866A-2A7C-45C3-96BB-9AB892D26AE5.bw","3d190f07-2f79-4ee6-9f63-0b563dc05c74","b8bd866a-2a7c-45c3-96bb-9ab892d26ae5","2016-08-05T14:29:14.686440-05:00","UNCID_2654389.1560b26a-bc8d-4bdd-b317-f04b66c2ce5b.141006_UNC15-SN850_0395_AC5FH9ACXX_2_ACTTGA.tar.gz","04de2728-df54-4601-8656-4a7b4d55eca1",4305579750,"Illumina HiSeq","1197146c023231e85f188a9695effdfe","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:44:42.469851-05:00","2016-05-03T12:08:10.830175-05:00","04de2728-df54-4601-8656-4a7b4d55eca1_analysis.xml","cfc95096c07a7111842d38b411753db1","539f9342-601c-4aad-ba0e-044dc869c4ee",2124,"2016-09-29T18:06:30.984297-05:00","04de2728-df54-4601-8656-4a7b4d55eca1_experiment.xml","ae5624a2aa970880035686f9109a2b62","1626fdf8-8106-4a8d-80a1-183880b22a37",2628,"2016-09-29T21:20:54.227865-05:00","04de2728-df54-4601-8656-4a7b4d55eca1_run.xml","05affa03f70b558bd7a453301f6dea60","8f20938d-0535-4a37-92c8-a5156e27aa02",354,"2016-09-09T16:00:36.003233-05:00","TCGA-VS-A950","2016-09-02T18:54:14.767389-05:00","female","TCGA-VS-A950_demographic",1969,"not reported","518b4d43-18b2-56a3-a1f4-d908f50d0403","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A950_diagnosis","not reported",15365,"alive","8070/3",NA,1221,"5965e9ba-463f-5114-884e-ac50e84fde4c","c53.9",-15365,"TCGA-VS-A950_treatment","cdd9c79c-75a6-5280-8464-bce7d1b1f009","01","false","TCGA-VS-A950-01A",NA,"6ae47534-32ce-47f1-9536-8774c525c226",FALSE,"F095B0C9-4855-495D-89C9-B303D7756BFB","Primary Tumor",NA,874,60,NA,1389830400,"11",30,"TCGA-VS-A950-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-09T16:00:36.003233-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"5a3987bd-6994-4aa8-a4c8-58644ff23138",NA,"TCGA-VS-A950-01A-01-TS1",NA,70,NA,"a916b725-277d-4e41-a490-1b26927cdfa2","RNA","TCGA-VS-A950-01A-11R","b0fa3900-6c8c-44dc-8a02-c0b24963ca2c",1.85,0.18,"UV Spec","R","23","TCGA-VS-A950-01A-11R-A42T-07","1560b26a-bc8d-4bdd-b317-f04b66c2ce5b",0.18,NA,57,20.9366391184573,165,"76bae099-462c-5676-a5ee-334f7ff20a58","TCGA-VS-A950_exposure","UNCID_2654389.1560b26a-bc8d-4bdd-b317-f04b66c2ce5b.141006_UNC15-SN850_0395_AC5FH9ACXX_2_ACTTGA.tar.gz","2014-11-05T09:27:04.000Z","2014-11-05T09:39:28.000Z","04DE2728-DF54-4601-8656-4A7B4D55ECA1","6AE47534-32CE-47F1-9536-8774C525C226","Unaligned reads",4305579750,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1560B26A-BC8D-4BDD-B317-F04B66C2CE5B","University of North Carolina","564a3b8ce4b0298dd2c8733c","3D190F07-2F79-4EE6-9F63-0B563DC05C74","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A916B725-277D-4E41-A490-1B26927CDFA2","2014-11-05T09:39:28.000Z","B0FA3900-6C8C-44DC-8A02-C0B24963CA2C","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",874,"A916B725-277D-4E41-A490-1B26927CDFA2",NA,"VS","3999510100_R06C02_Red.idat",60,"TCGA-VS-A950-01A",NA,NA,"TCGA",2011,"TCGA-VS-A950_NTE-1","Partial Remission/Response","WITH TUMOR","6AE47534-32CE-47F1-9536-8774C525C226",42,"nationwidechildrens.org_clinical.TCGA-VS-A950.xml","Alive",NA,"TCGA-VS-A950",NA,"E1E10220-9345-4289-B7F7-2CF51BFF5C29","NO",967,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIIA",NA,NA,"T3a","8070/3","FEMALE","C53.9",420,NA,"E1C2B852-A584-4BAC-BAC4-C10525F42C25",NA,NA,11,30,"5A3987BD-6994-4AA8-A4C8-58644FF23138","F92B7100-0317-48EC-8C1A-A7F8231BA357","3999510100_R06C02_Red.idat","TCGA-VS-A950-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-VS-A950-01A-01-TS1",70,NA,NA,NA,"TCGA-VS-A950-R65891","External","Regional site","TCGA-VS-A950-F67689_NTE-1","NO",1210,"WITH TUMOR","Alive",NA,"TCGA-VS-A950-F67689","TCGA-VS-A950",NA,"VS","A950","YES","C53.9","8070/3","C53.9","NO","YES",-15365,"FEMALE",NA,NA,"No","No","Alive",967,NA,NA,NA,"WITH TUMOR","YES",1,10,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Partial Remission/Response","2009",15,NA,"T3aNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
138677222,136792817,6527805336,"13EFD045-AD61-41EE-9896-67BFA4FC8C09.bw","3df6abe2-2123-4bfa-a4e4-88df5f940c04","13efd045-ad61-41ee-9896-67bfa4fc8c09","2016-08-25T01:59:07.006638-05:00","UNCID_2278252.e2dbf718-1895-4749-b0aa-5fd8acc2f9bc.131021_UNC9-SN296_0409_BC2M6NACXX_3_TAGCTT.tar.gz","82db1a0e-2e8f-4e9a-b5cb-6cde9049a89d",6763841727,"Illumina HiSeq","b57c0b5492e13a700c1c2e521cce0df8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:33:48.590177-05:00","2016-05-03T11:24:56.858865-05:00","82db1a0e-2e8f-4e9a-b5cb-6cde9049a89d_analysis.xml","40f4705c9ebb57c4a72e5cfb290dde87","e164ff63-98b5-497a-ada8-d53f0065c7a9",2122,"2016-09-29T18:26:32.249297-05:00","82db1a0e-2e8f-4e9a-b5cb-6cde9049a89d_experiment.xml","21142a493637a66b03ab966c1ffa6d8a","22780d4e-303d-4c90-916e-a4a1064e2c2e",2431,"2016-09-29T23:42:56.587341-05:00","82db1a0e-2e8f-4e9a-b5cb-6cde9049a89d_run.xml","5a40ce0928c81ced987527efd5bb2bc1","e71c96c8-281b-4e20-9b11-b7885748032c",354,"2016-09-08T11:35:58.462301-05:00","TCGA-JX-A3PZ","2016-09-02T18:59:23.533786-05:00","female","TCGA-JX-A3PZ_demographic",1970,"white","c9b65d17-c488-5ec3-9273-d0d3ae4806a8","not reported",1996,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JX","6d97b3ee-83c4-5be1-9919-0fdd90c1bb19","Washington University","not reported","c53.9","TCGA-JX-A3PZ_diagnosis","not reported",9303,"dead","8071/3",642,NA,"608cfc39-2ce6-5edf-bbbe-aec0c6b7c9e5","c53.9",-9303,"TCGA-JX-A3PZ_treatment","1cdc0374-8b32-57bf-b149-c058969b4413","01","true","TCGA-JX-A3PZ-01A",NA,"bd39c4c4-a4dd-4b2d-9f3c-608ca8708958",FALSE,"BE580A02-1AD8-4526-A0FF-042D4AAB6E15","Primary Tumor",NA,5922,210,NA,1330473600,"11",30,"TCGA-JX-A3PZ-01A-11",90,NA,1,NA,0,NA,0,NA,"2016-09-08T11:35:58.462301-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"2292b59c-ad4c-4c26-aefa-dcbd7be42934",NA,"TCGA-JX-A3PZ-01A-01-TSA",NA,95,NA,"2da4162a-c87f-4a92-8a22-b3d9074636db","RNA","TCGA-JX-A3PZ-01A-11R","b518c9ce-904f-4115-8db8-ea03c99a60fa",1.92,0.18,"UV Spec","R","23","TCGA-JX-A3PZ-01A-11R-A32Y-07","e2dbf718-1895-4749-b0aa-5fd8acc2f9bc",0.18,NA,58,18.9387755102041,175,"1faea39d-ca46-56f2-adb1-825da0e2b9ff","TCGA-JX-A3PZ_exposure","UNCID_2278252.e2dbf718-1895-4749-b0aa-5fd8acc2f9bc.131021_UNC9-SN296_0409_BC2M6NACXX_3_TAGCTT.tar.gz","2013-11-22T06:51:04.000Z","2013-11-22T07:12:03.000Z","82DB1A0E-2E8F-4E9A-B5CB-6CDE9049A89D","BD39C4C4-A4DD-4B2D-9F3C-608CA8708958","Unaligned reads",6763841727,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E2DBF718-1895-4749-B0AA-5FD8ACC2F9BC","University of North Carolina","5660752de4b0b37b3d98f4f4","3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2DA4162A-C87F-4A92-8A22-B3D9074636DB","2013-11-22T07:12:03.000Z","B518C9CE-904F-4115-8DB8-EA03C99A60FA","United States","NO",1,NA,"Primary Tumor","Washington University",5922,"2DA4162A-C87F-4A92-8A22-B3D9074636DB",NA,"JX","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E8E61B42-4CF6-470E-8067-18CC5A90FDF4.txt",210,"TCGA-JX-A3PZ-01A",NA,NA,"TCGA",1995,"TCGA-JX-A3PZ_NTE-4","Complete Remission/Response","WITH TUMOR","BFDA8AD6-DEAE-44DD-BAFE-BA82787B90B2",25,"nationwidechildrens.org_clinical.TCGA-JX-A3PZ.xml","Dead",642,"TCGA-JX-A3PZ",NA,NA,"YES",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB",NA,NA,"T1b","8071/3","FEMALE","C53.9",217,NA,NA,"WHITE",NA,11,30,"2292B59C-AD4C-4C26-AEFA-DCBD7BE42934","B518C9CE-904F-4115-8DB8-EA03C99A60FA","UNCID_2278252.e2dbf718-1895-4749-b0aa-5fd8acc2f9bc.131021_UNC9-SN296_0409_BC2M6NACXX_3_TAGCTT.tar.gz","TCGA-JX-A3PZ-01A-11",90,0,1,1,0,"TOP",5,0,"TCGA-JX-A3PZ-01A-01-TSA",95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-JX-A3PZ",NA,"JX","A3PZ","YES","C53.9","8071/3","C53.9","NO","YES",-9303,"FEMALE","WHITE",NA,"No","No","Dead",NA,642,NA,NA,"WITH TUMOR","YES",17,4,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,25,1995,"Biopsy (cervical / CT-guided / Other)","YES",22,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","1995",6,NA,"T1bN0M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
223993818,221528437,10575096477,"2655F609-B3BB-4D01-B421-D5F4B1232EC8.bw","3edb62c1-25ad-4deb-a005-e881a887d06a","2655f609-b3bb-4d01-b421-d5f4b1232ec8","2016-08-09T12:23:30.379369-05:00","UNCID_2185452.f930146b-0cec-4630-8f79-0e233c238b15.130129_UNC13-SN749_0217_BD1MTTACXX_6_TTAGGC.tar.gz","a9d80e09-37c1-4778-9118-196a2667465e",10330512986,"Illumina HiSeq","3d7331e5607c21ee6a5b58430b3b577f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:53.085926-05:00","2016-05-03T10:58:56.648400-05:00","a9d80e09-37c1-4778-9118-196a2667465e_analysis.xml","dbaa9c61c68dce66519569d8db830a8a","74cd02de-dc0d-490e-a635-be1224598856",2123,"2016-10-07T17:26:24.016723-05:00","a9d80e09-37c1-4778-9118-196a2667465e_experiment.xml","4a6c058c81042a4a187600e4f39fad27","52caf0e9-7019-420f-817e-10c9ffb3b8e8",2431,"2016-09-29T21:50:57.994478-05:00","a9d80e09-37c1-4778-9118-196a2667465e_run.xml","1bd0b3b5779c38105c4eea599e0dc977","a1ad4492-9c92-4ca9-b2ad-792af8426b84",354,"2016-09-08T11:58:38.767575-05:00","TCGA-EA-A439","2016-09-02T18:59:36.179866-05:00","female","TCGA-EA-A439_demographic",1962,"asian","2c2b075d-335c-5beb-98f2-ae16cfe4919f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A439_diagnosis","not reported",18529,"alive","8070/3",NA,965,"eef0e0dc-a410-5def-a1a9-8e56733b7064","c53.9",-18529,"TCGA-EA-A439_treatment","9ea23ce6-79b0-518c-a3bc-7d35d5de5ab8","01","true","TCGA-EA-A439-01A",NA,"388c8abb-83cb-4999-ae5a-b146438274a7",FALSE,"15BB85F2-5EF6-4569-B354-D543A0466983","Primary Tumor",NA,98,500,NA,1344470400,"11",30,"TCGA-EA-A439-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T11:58:38.767575-05:00",NA,5,NA,0,NA,"TOP",NA,5,NA,"59c107b5-93cc-475d-960f-c0a2df1f3049",NA,"TCGA-EA-A439-01A-01-TSA",NA,95,NA,"5a6ea646-a747-43b7-909a-1ddc5550f0d2","RNA","TCGA-EA-A439-01A-11R","4d3c828e-1edd-40f0-b326-963caa018cac",1.83,0.15,"UV Spec","R","23","TCGA-EA-A439-01A-11R-A24H-07","f930146b-0cec-4630-8f79-0e233c238b15",0.15,NA,47,18.359375,160,"09e010b7-2a01-5a73-802c-ffb3dc843834","TCGA-EA-A439_exposure","UNCID_2185452.f930146b-0cec-4630-8f79-0e233c238b15.130129_UNC13-SN749_0217_BD1MTTACXX_6_TTAGGC.tar.gz","2013-09-14T20:13:06.000Z","2013-09-14T20:40:01.000Z","A9D80E09-37C1-4778-9118-196A2667465E","388C8ABB-83CB-4999-AE5A-B146438274A7","Unaligned reads",10330512986,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F930146B-0CEC-4630-8F79-0E233C238B15","University of North Carolina","564a3ec5e4b0298dd2c97baf","3EDB62C1-25AD-4DEB-A005-E881A887D06A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5A6EA646-A747-43B7-909A-1DDC5550F0D2","2013-09-14T20:40:01.000Z","4D3C828E-1EDD-40F0-B326-963CAA018CAC","Vietnam","NO",1,NA,"Primary Tumor","Asterand",98,"5A6EA646-A747-43B7-909A-1DDC5550F0D2",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.6614076A-C936-48EA-97E2-3A12301EDC8A.txt",500,"TCGA-EA-A439-01A",NA,NA,"TCGA",2012,"TCGA-EA-A439_NTE-1","Complete Remission/Response","TUMOR FREE","C45D416F-8F6C-4845-9030-4019C4120BC8",50,"CROZE_p_TCGA_254_256_255_N_GenomeWideSNP_6_F04_1301350.raw.copynumber.data.txt","Alive",NA,"TCGA-EA-A439","NOT HISPANIC OR LATINO","7AB5807B-E29E-41C3-9576-44C2FF3E8C79","NO",20,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIA1",NA,NA,"T2a1","8070/3","FEMALE","C53.9",256,NA,"3CD9595F-69FF-48B5-BDE5-0F9BDE711BD5","ASIAN",NA,11,30,"59C107B5-93CC-475D-960F-C0A2DF1F3049","4D3C828E-1EDD-40F0-B326-963CAA018CAC","TCGA-EA-A439-01A-11R-A24J-13_mirna.bam.bai","TCGA-EA-A439-01A-11",65,0,0,5,0,"TOP",5,0,"TCGA-EA-A439-01A-01-TSA",95,NA,NA,NA,"TCGA-EA-A439-R69589","Internal","Primary Tumor Field","TCGA-EA-A439-F68884_NTE-1","NO",965,"TUMOR FREE","Alive",NA,"TCGA-EA-A439-F68884","TCGA-EA-A439",NA,"EA","A439","YES","C53.9","8070/3","C53.9","YES","NO",-18529,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",20,NA,NA,NA,"TUMOR FREE","YES",20,11,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,50,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",11,NA,"T2a1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
102396968,100726983,4811338962,"04BC7A52-C67F-42CB-8672-D3C51A20F2BA.bw","40a86987-e77f-4977-92b1-8217796e1938","04bc7a52-c67f-42cb-8672-d3c51a20f2ba","2016-08-09T14:42:53.474100-05:00","UNCID_2664311.7819e7d1-5b57-4a61-9eee-6aa31876e78b.141031_UNC11-SN627_0387_AC5FAKACXX_8_ATTCCT.tar.gz","b77222ff-49b1-402c-8872-e185589f0f78",4079696006,"Illumina HiSeq","22a7024fdf1b7a025f72fc152eb40857","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:25:13.720965-05:00","2016-06-22T11:17:34.741668-05:00","b77222ff-49b1-402c-8872-e185589f0f78_analysis.xml","e0fea103e73c1314e5d6c74da74879a1","b6b8c9ac-902f-4686-bf3b-387f32bb1a3d",2124,"2016-08-29T18:29:43.746470-05:00","b77222ff-49b1-402c-8872-e185589f0f78_experiment.xml","9079378b0296b20e511b8618a96ad0c9","27672bc9-35d8-42a5-9e18-10030936b31f",2628,"2016-09-29T23:12:28.861847-05:00","b77222ff-49b1-402c-8872-e185589f0f78_run.xml","f0b4e3928595cfbd0764cac1d9445a5c","d42f3ed7-a287-4a23-8975-7f1fd324b5e5",354,"2016-09-08T10:49:04.349425-05:00","TCGA-ZJ-AAXI","2016-09-02T18:54:44.898574-05:00","female","TCGA-ZJ-AAXI_demographic",1943,"not reported","faafc7a5-4b1a-57ba-8f23-a1dc0cd79783","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXI_diagnosis","not reported",24497,"alive","8072/3",NA,0,"e79361d4-02d1-5440-aa50-977effed840e","c53.9",-24497,"TCGA-ZJ-AAXI_treatment","8bf93110-c86c-5df7-bfcd-316e8fa6f7e5","01","true","TCGA-ZJ-AAXI-01A",NA,"6748a073-7a01-44ca-9f9c-fb69b157ace0",FALSE,"D446A3B4-E137-4A6C-9C17-FEED0163DAED","Primary Tumor",NA,1332,80,NA,1395878400,"11",30,"TCGA-ZJ-AAXI-01A-11",90,NA,0,NA,5,NA,5,NA,"2016-09-08T10:49:04.349425-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"0ad58542-6e72-442d-9ead-0db24c07d312",NA,"TCGA-ZJ-AAXI-01A-01-TS1",NA,90,NA,"2ce12755-3cdf-4da8-9c31-80470180d6ce","RNA","TCGA-ZJ-AAXI-01A-11R","e3feb6cc-d245-42a3-8e39-3f3d692a40c4",1.84,0.16,"UV Spec","R","23","TCGA-ZJ-AAXI-01A-11R-A42T-07","7819e7d1-5b57-4a61-9eee-6aa31876e78b",0.16,NA,NA,NA,NA,"40d5cf54-8ea5-55e2-8f1b-aff268c74193","TCGA-ZJ-AAXI_exposure","UNCID_2664311.7819e7d1-5b57-4a61-9eee-6aa31876e78b.141031_UNC11-SN627_0387_AC5FAKACXX_8_ATTCCT.tar.gz","2014-12-10T01:27:04.000Z","2014-12-10T01:52:26.000Z","B77222FF-49B1-402C-8872-E185589F0F78","6748A073-7A01-44CA-9F9C-FB69B157ACE0","Unaligned reads",4079696006,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7819E7D1-5B57-4A61-9EEE-6AA31876E78B","University of North Carolina","56607516e4b0ec1099f8b4e4","40A86987-E77F-4977-92B1-8217796E1938","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2CE12755-3CDF-4DA8-9C31-80470180D6CE","2014-12-10T01:52:26.000Z","E3FEB6CC-D245-42A3-8E39-3F3D692A40C4","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1332,"2CE12755-3CDF-4DA8-9C31-80470180D6CE",NA,"ZJ","UNCID_2664311.7819e7d1-5b57-4a61-9eee-6aa31876e78b.141031_UNC11-SN627_0387_AC5FAKACXX_8_ATTCCT.tar.gz",80,"TCGA-ZJ-AAXI-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXI_NTE-1",NA,NA,"6748A073-7A01-44CA-9F9C-FB69B157ACE0",67,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXI.xml","Alive",NA,"TCGA-ZJ-AAXI",NA,NA,NA,0,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8072/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"0AD58542-6E72-442D-9EAD-0DB24C07D312","E3FEB6CC-D245-42A3-8E39-3F3D692A40C4","UNCID_2664311.7819e7d1-5b57-4a61-9eee-6aa31876e78b.141031_UNC11-SN627_0387_AC5FAKACXX_8_ATTCCT.tar.gz","TCGA-ZJ-AAXI-01A-11",90,5,0,5,5,"TOP",0,0,"TCGA-ZJ-AAXI-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXI",NA,"ZJ","AAXI","YES","C53.9","8072/3","C53.9","NO","YES",-24497,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",31,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,67,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",13,NA,"T2bNXM0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
102293976,97723846,4664438493,"45472BD4-DBDB-41FE-B0E3-2440880E1DE6.bw","45cadcf3-ea98-4063-9255-5c18d6a5cbab","45472bd4-dbdb-41fe-b0e3-2440880e1de6","2016-08-09T13:12:24.898691-05:00","UNCID_2186962.550b677c-c33a-499c-95dc-68250384b6a8.121002_UNC11-SN627_0254_AC0WP5ACXX_5_GTTTCG.tar.gz","f536df29-341a-47c1-bd58-c53540a73b9a",4223419203,"Illumina HiSeq","b2424d00a0aa494d2f602c3430450b1f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:37:27.426231-05:00","2016-05-03T11:00:24.457874-05:00","f536df29-341a-47c1-bd58-c53540a73b9a_analysis.xml","a09be69b01e915ee774b9c0403fd60ee","29600be0-c1f0-457e-9305-1c69b2920bee",2124,"2016-10-07T16:10:58.910986-05:00","f536df29-341a-47c1-bd58-c53540a73b9a_experiment.xml","43ce38ae236af70674cce281bcfa334d","f3750e00-eaf9-4ad1-bb43-c32a6e900e52",2431,"2016-09-29T18:01:21.798042-05:00","f536df29-341a-47c1-bd58-c53540a73b9a_run.xml","a636929f83b7255bcd540eefb30e48b6","12d84a27-9e97-4acc-b34c-103a98a59eb0",354,"2016-09-08T12:04:09.194230-05:00","TCGA-EK-A2PL","2016-09-02T18:58:22.756414-05:00","female","TCGA-EK-A2PL_demographic",1972,"white","8b1dbfec-0f6e-5fbf-9142-22cbc13bea65","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2PL_diagnosis","not reported",13384,"alive","8072/3",NA,13,"d561fa7a-c45d-50a9-911e-108f18515b5c","c53.9",-13384,"TCGA-EK-A2PL_treatment","281cc737-93ad-51e9-8f02-c067f754ee36","01","false","TCGA-EK-A2PL-01A",NA,"6ee33187-69a7-4328-9521-173cfcde7a1b",FALSE,"B51554EF-AA39-4A99-BC15-A80EC759316E","Primary Tumor",NA,1181,130,NA,1314144000,"11",30,"TCGA-EK-A2PL-01A-11",80,NA,0,NA,7,NA,12,NA,"2016-09-08T12:04:09.194230-05:00",NA,10,NA,0,NA,"TOP",NA,1,NA,"2a3e42ce-bffe-4761-90f2-6aa1772b9d73",NA,"TCGA-EK-A2PL-01A-01-TS1",NA,80,NA,"3beb6b77-c7c3-4efb-8234-2caad683d225","RNA","TCGA-EK-A2PL-01A-11R","62190b9b-8948-49a1-a18c-e6a7cde65ffb",1.82,0.16,"UV Spec","R","23","TCGA-EK-A2PL-01A-11R-A18M-07","550b677c-c33a-499c-95dc-68250384b6a8",0.16,NA,113,40.5177668614866,167,"194984c0-be20-580f-b3db-0f8320ea2f56","TCGA-EK-A2PL_exposure","UNCID_2186962.550b677c-c33a-499c-95dc-68250384b6a8.121002_UNC11-SN627_0254_AC0WP5ACXX_5_GTTTCG.tar.gz","2013-09-16T07:06:04.000Z","2013-09-16T07:42:01.000Z","F536DF29-341A-47C1-BD58-C53540A73B9A","6EE33187-69A7-4328-9521-173CFCDE7A1B","Unaligned reads",4223419203,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","550B677C-C33A-499C-95DC-68250384B6A8","University of North Carolina","564a3d1ae4b093830b69cfd8","45CADCF3-EA98-4063-9255-5C18D6A5CBAB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3BEB6B77-C7C3-4EFB-8234-2CAAD683D225","2013-09-16T07:42:01.000Z","62190B9B-8948-49A1-A18C-E6A7CDE65FFB","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1181,"3BEB6B77-C7C3-4EFB-8234-2CAAD683D225",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.338F2045-F35A-402B-A07C-83AFC37DB6E4.txt",130,"TCGA-EK-A2PL-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","6EE33187-69A7-4328-9521-173CFCDE7A1B",36,"CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_C07_871072.hg18.seg.txt","Alive",NA,"TCGA-EK-A2PL",NA,"929E0F41-6CB6-4AB8-856E-541C2FD52601",NA,0,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIIB",NA,NA,NA,"8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"2A3E42CE-BFFE-4761-90F2-6AA1772B9D73","ED69D583-F6CA-41FC-A3A7-8B4F382799CE","TCGA-EK-A2PL-01A-11R-A18L-13_mirna.bam","TCGA-EK-A2PL-01A-11",80,7,0,10,12,"TOP",1,0,"TCGA-EK-A2PL-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2PL-F58252_NTE-1",NA,13,NA,"Alive",NA,"TCGA-EK-A2PL-F58252","TCGA-EK-A2PL",NA,"EK","A2PL","YES","C53.9","8072/3","C53.9","NO","YES",-13384,"FEMALE","WHITE",NA,"No","No","Alive",0,NA,NA,NA,"WITH TUMOR","NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,36,2008,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
109662466,108067653,5160589360,"B87FFFCD-CB57-4ACD-9C74-AB188984BBB2.bw","46adfbbe-3add-41cd-a388-b1ee0790bf62","b87fffcd-cb57-4acd-9c74-ab188984bbb2","2016-08-26T07:28:16.647652-05:00","UNCID_2332251.a11fe2cb-92b2-463c-873c-b179e1d352cd.131016_UNC15-SN850_0333_AC2MBAACXX_2_CTTGTA.tar.gz","b0a5c28c-4bc4-4c52-8937-fcf7d081e398",5075153350,"Illumina HiSeq","6a3cda47bc6149837cd33e3ae983bee9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:12:42.411962-05:00","2016-05-03T11:35:41.353993-05:00","b0a5c28c-4bc4-4c52-8937-fcf7d081e398_analysis.xml","40712bf3ddcd56d23bbc87d473c65b48","64d207eb-1d2d-497c-87c0-25f9a632701d",2124,"2016-09-29T19:46:15.681897-05:00","b0a5c28c-4bc4-4c52-8937-fcf7d081e398_experiment.xml","08261087c2b06c48bdef219c80c45c6f","549eb2c7-ed6a-429e-af51-d16caeb4f3de",2628,"2016-09-30T00:06:00.212965-05:00","b0a5c28c-4bc4-4c52-8937-fcf7d081e398_run.xml","80004e1a2f6b49feca9ee38cc2473f83","f53cc3d4-13cf-4bca-9994-b96af607d7da",354,"2016-09-08T11:58:34.995678-05:00","TCGA-Q1-A6DT","2016-09-02T19:00:37.727793-05:00","female","TCGA-Q1-A6DT_demographic",1958,"white","06d781e0-1b5e-57ca-babe-1d1f5e1ec80b","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A6DT_diagnosis","not reported",20286,"dead","8072/3",275,103,"a23a22c4-b532-596a-9bdd-789e87d54da1","c53.9",-20286,"TCGA-Q1-A6DT_treatment","0a76f05b-4055-5c27-91be-2f8e307f3e30","01","true","TCGA-Q1-A6DT-01A",NA,"badb7296-d012-4c93-9952-dc53f8e2bbd1",FALSE,"1EB62CB3-7D11-4C4D-B893-5E9B2146C4D3","Primary Tumor",NA,47,50,NA,1369872000,"11",30,"TCGA-Q1-A6DT-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T11:58:34.995678-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e0119239-55ae-49ea-8dd1-cd8371fb95f4",NA,"TCGA-Q1-A6DT-01A-01-TS1",NA,80,NA,"a4080828-e2c2-4df1-ba7f-7e9f25f24e24","RNA","TCGA-Q1-A6DT-01A-11R","3ad436dd-0f0a-4a66-87b3-e72a3c987f31",1.92,0.16,"UV Spec","R","23","TCGA-Q1-A6DT-01A-11R-A32P-07","a11fe2cb-92b2-463c-873c-b179e1d352cd",0.16,NA,NA,NA,NA,"2e1d5f7b-d0f1-5c57-87c6-7bae70cfcf72","TCGA-Q1-A6DT_exposure","UNCID_2332251.a11fe2cb-92b2-463c-873c-b179e1d352cd.131016_UNC15-SN850_0333_AC2MBAACXX_2_CTTGTA.tar.gz","2014-01-28T22:07:03.000Z","2014-01-28T22:22:01.000Z","B0A5C28C-4BC4-4C52-8937-FCF7D081E398","BADB7296-D012-4C93-9952-DC53F8E2BBD1","Unaligned reads",5075153350,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A11FE2CB-92B2-463C-873C-B179E1D352CD","University of North Carolina","564a411be4b0298dd2ca3d24","46ADFBBE-3ADD-41CD-A388-B1EE0790BF62","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A4080828-E2C2-4DF1-BA7F-7E9F25F24E24","2014-01-28T22:22:01.000Z","3AD436DD-0F0A-4A66-87B3-E72A3C987F31","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",47,"A4080828-E2C2-4DF1-BA7F-7E9F25F24E24",NA,"Q1","UNCID_2245145.a11fe2cb-92b2-463c-873c-b179e1d352cd.sorted_genome_alignments.bam",50,"TCGA-Q1-A6DT-01A",NA,NA,"TCGA",2013,"TCGA-Q1-A6DT_NTE-1",NA,"WITH TUMOR","BADB7296-D012-4C93-9952-DC53F8E2BBD1",55,"nationwidechildrens.org_clinical.TCGA-Q1-A6DT.xml","Alive",NA,"TCGA-Q1-A6DT","NOT HISPANIC OR LATINO","8368B9C4-A20D-4CD3-820E-3E0147E2AED9","NO",103,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",NA,NA,"Stage I",NA,NA,"TX","8072/3","FEMALE","C53.9",335,NA,NA,"WHITE",NA,11,30,"E0119239-55AE-49EA-8DD1-CD8371FB95F4","3AD436DD-0F0A-4A66-87B3-E72A3C987F31","THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_C07_1367096.nocnv_hg18.seg.txt","TCGA-Q1-A6DT-01A-11",80,0,0,0,20,"TOP",0,0,"TCGA-Q1-A6DT-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-Q1-A6DT-F62826_NTE-1","NO",NA,"WITH TUMOR","Dead",275,"TCGA-Q1-A6DT-F62826","TCGA-Q1-A6DT",NA,"Q1","A6DT","YES","C53.9","8072/3","C53.9","YES","NO",-20286,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",103,NA,NA,NA,"WITH TUMOR","YES",20,8,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,1,NA,NA,NA,NA,"2009",2,NA,"TXNXMX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
154986580,149540967,7138350082,"5271374C-13CD-4BFE-AC6D-C95AFE491322.bw","46c67dd6-8e66-411d-ad05-95daa9005eb2","5271374c-13cd-4bfe-ac6d-c95afe491322","2016-08-05T11:49:48.797324-05:00","UNCID_2654410.656bb2ee-b7f9-4cee-a694-1217fecf25a7.120921_UNC16-SN851_0181_AD14JFACXX_7_CTTGTA.tar.gz","bec1ea44-1407-454b-b4d3-726d4e4bfaef",6441075695,"Illumina HiSeq","a4a169ae8e7226484d6f063ccb4249a5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:14:01.984330-05:00","2016-05-03T12:08:10.840133-05:00","bec1ea44-1407-454b-b4d3-726d4e4bfaef_analysis.xml","62a7104ed1ea4727da1eb735c2a621a3","fa395623-f458-492a-a3a5-06b7edc78533",2124,"2016-09-29T18:43:52.248739-05:00","bec1ea44-1407-454b-b4d3-726d4e4bfaef_experiment.xml","2a5c1344367e180f80dbb98a8f154d73","2d7c63ea-43ff-48c5-a6c8-eea2d2e83dda",2628,"2016-09-29T22:26:10.040246-05:00","bec1ea44-1407-454b-b4d3-726d4e4bfaef_run.xml","cb07ccfcae103a527f07fd50c548ae17","b74d7179-36c2-48db-8a75-78912a574b33",354,"2016-09-08T12:15:14.824839-05:00","TCGA-DS-A1OA","2016-09-02T18:57:25.752350-05:00","female","TCGA-DS-A1OA_demographic",1924,"asian","bd45e92e-257e-50ca-be64-f2269b1a9796","not hispanic or latino",2003,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A1OA_diagnosis","not reported",28160,"dead","8070/3",879,879,"7b975c32-5836-50d8-8d87-c11f320a84b4","c53.9",-28160,"TCGA-DS-A1OA_treatment","7b1daa9d-6c45-58ad-8eaf-a5fa420678da","01","true","TCGA-DS-A1OA-01A",NA,"a43a5600-8d5d-445c-9f52-a6d994f86ecb",FALSE,"A2FAE559-D2B2-4132-9B16-37E677C1B09A","Primary Tumor",NA,3621,150,NA,1302220800,"11",30,"TCGA-DS-A1OA-01A-11",70,NA,10,NA,0,NA,20,NA,"2016-09-08T12:15:14.824839-05:00",NA,40,NA,40,NA,"TOP",NA,10,NA,"36e29ed6-b98a-4db7-beb7-a1f1e95960ab",NA,"TCGA-DS-A1OA-01A-01-TSA",NA,70,NA,"45d472c9-5489-4723-bb72-1b1b2a98e7bd","RNA","TCGA-DS-A1OA-01A-11R","387ac118-03b4-4c5f-864d-352a3ba3dc3b",1.9,0.17,"UV Spec","R","23","TCGA-DS-A1OA-01A-11R-A14Y-07","656bb2ee-b7f9-4cee-a694-1217fecf25a7",0.17,NA,51,19.921875,160,"11b4b1c5-e260-5866-b98f-0de5ad3b6724","TCGA-DS-A1OA_exposure","UNCID_2654410.656bb2ee-b7f9-4cee-a694-1217fecf25a7.120921_UNC16-SN851_0181_AD14JFACXX_7_CTTGTA.tar.gz","2014-11-05T16:47:04.000Z","2014-11-05T17:07:04.000Z","BEC1EA44-1407-454B-B4D3-726D4E4BFAEF","A43A5600-8D5D-445C-9F52-A6D994F86ECB","Unaligned reads",6441075695,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","656BB2EE-B7F9-4CEE-A694-1217FECF25A7","University of North Carolina","564a40f6e4b0ef12181c3bfa","46C67DD6-8E66-411D-AD05-95DAA9005EB2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","45D472C9-5489-4723-BB72-1B1B2A98E7BD","2014-11-05T17:07:04.000Z","387AC118-03B4-4C5F-864D-352A3BA3DC3B","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",3621,"45D472C9-5489-4723-BB72-1B1B2A98E7BD",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C1F108EE-1D61-4EC1-9F0E-A85272154696.txt",150,"TCGA-DS-A1OA-01A",NA,"F3F96461-3EEB-4FE9-9B1A-7B6C71D1D4CB","TCGA",2001,NA,NA,"WITH TUMOR","A43A5600-8D5D-445C-9F52-A6D994F86ECB",77,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C1F108EE-1D61-4EC1-9F0E-A85272154696.txt","Dead",879,"TCGA-DS-A1OA","NOT HISPANIC OR LATINO","66FCAD69-679F-4F12-ACD1-2DA70AB8CF8E",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",127,NA,"A6EFD717-21AE-419E-8884-8B19320B406F","ASIAN",NA,11,30,"36E29ED6-B98A-4DB7-BEB7-A1F1E95960AB","387AC118-03B4-4C5F-864D-352A3BA3DC3B","C501.TCGA-DS-A1OA-01A-11D-A16Y-08.5.bam.bai","TCGA-DS-A1OA-01A-11",70,0,10,40,20,"TOP",10,40,"TCGA-DS-A1OA-01A-01-TSA",70,"Vinorelbine","Chemotherapy","TCGA-DS-A1OA-D15181","TCGA-DS-A1OA-R15178","IMPLANTS","Primary Tumor Field",NA,"YES",879,"WITH TUMOR","Dead",879,"TCGA-DS-A1OA-F15176","TCGA-DS-A1OA",NA,"DS","A1OA","YES","C53.9","8070/3","C53.9","NO","YES",-28160,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,879,NA,NA,"WITH TUMOR","NO",12,8,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,77,2001,"Biopsy (cervical / CT-guided / Other)","YES",8,8,"G3",NA,1,NA,NA,NA,NA,"1995",6,NA,"T1b1N1M0",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
70545566,68808449,3287343240,"E3372ACE-C7C8-43E5-B30A-1F2D662D8170.bw","4756acc0-4e96-44d4-b359-04d64dc7eb84","e3372ace-c7c8-43e5-b30a-1f2d662d8170","2016-08-09T14:42:09.213417-05:00","UNCID_2654397.212eae3c-4ad5-48e0-90af-b6fe1dfc5554.141010_UNC12-SN629_0395_BC5FVEACXX_3_AGTCAA.tar.gz","d0bbb62d-2314-454a-a2f4-0f8bb0853b06",2719817063,"Illumina HiSeq","1d2cba11fffcb612f3ababa062304229","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:01:42.683402-05:00","2016-05-03T12:08:10.830175-05:00","d0bbb62d-2314-454a-a2f4-0f8bb0853b06_analysis.xml","3718086de6475cb61a7e655bdf92ef23","13153d2b-fc05-4bcd-a3b8-4df813eb5e4c",2124,"2016-09-29T19:58:51.031482-05:00","d0bbb62d-2314-454a-a2f4-0f8bb0853b06_experiment.xml","cec63e7c865932f41cdce21dcf99c9b0","5c6bbd90-20cb-4f5a-a245-e89312f32af2",2628,"2016-09-29T18:41:55.846437-05:00","d0bbb62d-2314-454a-a2f4-0f8bb0853b06_run.xml","270f39d22218ded5e921f957c08e4c39","2c3f5a84-2845-4159-8f7e-6eb8d17e11b2",354,"2016-09-08T11:07:43.793542-05:00","TCGA-ZX-AA5X","2016-09-02T18:54:49.785443-05:00","female","TCGA-ZX-AA5X_demographic",1949,"white","e6a88077-891b-5836-9581-e2e11561a1c9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZX","d37465ab-1aff-541e-bc29-69a4dbf2c3fe","University of Alabama","not reported","c53.9","TCGA-ZX-AA5X_diagnosis","not reported",23440,"alive","8070/3",NA,119,"f0e33d8a-9360-5523-b728-49ea6559c483","c53.9",-23440,"TCGA-ZX-AA5X_treatment","21ddb1e6-ff4d-53d4-a195-60d805680d13","01","true","TCGA-ZX-AA5X-01A",NA,"01bd30a6-0600-4e53-8ef0-bfb5f09fc88d",FALSE,"AFCAEB29-0F3E-48E6-8F0D-92860BCF0640","Primary Tumor",NA,46,70,NA,1394755200,"11",30,"TCGA-ZX-AA5X-01A-11",60,NA,0,NA,10,NA,30,NA,"2016-09-08T11:07:43.793542-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"5c3debea-4e6d-4de5-928f-99520791f78d",NA,"TCGA-ZX-AA5X-01A-01-TS1",NA,60,NA,"48587c3c-d93b-4ac7-8373-caf866b6d681","RNA","TCGA-ZX-AA5X-01A-11R","81be5425-0eba-4744-b231-ae6a9dfa43a1",1.83,0.17,"UV Spec","R","23","TCGA-ZX-AA5X-01A-11R-A42T-07","212eae3c-4ad5-48e0-90af-b6fe1dfc5554",0.17,NA,56,22.7189744005842,157,"98f2ebc7-463b-5be3-898f-c197f21bbf53","TCGA-ZX-AA5X_exposure","UNCID_2654397.212eae3c-4ad5-48e0-90af-b6fe1dfc5554.141010_UNC12-SN629_0395_BC5FVEACXX_3_AGTCAA.tar.gz","2014-11-05T11:47:03.000Z","2014-11-05T11:59:07.000Z","D0BBB62D-2314-454A-A2F4-0F8BB0853B06","01BD30A6-0600-4E53-8EF0-BFB5F09FC88D","Unaligned reads",2719817063,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","212EAE3C-4AD5-48E0-90AF-B6FE1DFC5554","University of North Carolina","564a3d81e4b0298dd2c91580","4756ACC0-4E96-44D4-B359-04D64DC7EB84","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","48587C3C-D93B-4AC7-8373-CAF866B6D681","2014-11-05T11:59:07.000Z","81BE5425-0EBA-4744-B231-AE6A9DFA43A1","United States","NO",1,NA,"Primary Tumor","University of Alabama",46,"48587C3C-D93B-4AC7-8373-CAF866B6D681",NA,"ZX","TCGA-ZX-AA5X-01A-11R-A42V-13_mirna.bam.bai",70,"TCGA-ZX-AA5X-01A",NA,NA,"TCGA",2013,"TCGA-ZX-AA5X_NTE-1",NA,"WITH TUMOR","876EA63D-4FE3-4E7B-A066-E9D29976AB7A",64,"nationwidechildrens.org_clinical.TCGA-ZX-AA5X.xml","Alive",NA,"TCGA-ZX-AA5X","NOT HISPANIC OR LATINO","123886C1-D172-45B4-BD3A-6FF205BA4FF4",NA,119,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"TX","8070/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"5C3DEBEA-4E6D-4DE5-928F-99520791F78D","F8B432B4-7DFD-4F73-B89C-D140FEC5B08B","TCGA-ZX-AA5X-01A-11R-A42V-13_mirna.bam.bai","TCGA-ZX-AA5X-01A-11",60,10,0,10,30,"TOP",0,0,"TCGA-ZX-AA5X-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-ZX-AA5X-F69357_NTE-1",NA,119,"WITH TUMOR","Alive",NA,"TCGA-ZX-AA5X-F69357","TCGA-ZX-AA5X",NA,"ZX","AA5X","YES","C53.9","8070/3","C53.9","YES","NO",-23440,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",119,NA,NA,NA,"WITH TUMOR","NO",24,11,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,NA,"2009",16,NA,"TXNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
70382098,69564591,3322350100,"B08DF564-E4D0-4540-8160-93B3981DF1D8.bw","4770ec81-9174-4d2a-af54-70c00696fb0b","b08df564-e4d0-4540-8160-93b3981df1d8","2016-08-09T14:40:58.962236-05:00","UNCID_2654373.ab8b70eb-04a6-4c52-8301-fa904fa5870a.141010_UNC12-SN629_0395_BC5FVEACXX_6_GAGTGG.tar.gz","e8f984c7-8606-4a3d-982d-fd93a03dd412",2591926408,"Illumina HiSeq","3dcfce678aef3e6d8916d1fd1f8c4f64","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:25:45.225990-05:00","2016-05-03T12:08:10.830175-05:00","e8f984c7-8606-4a3d-982d-fd93a03dd412_analysis.xml","fbf51d37ed94859ab7fb630583e95b5a","b70734bb-a3c7-4eb5-af71-07bdd48c1a81",2124,"2016-10-07T17:33:25.238665-05:00","e8f984c7-8606-4a3d-982d-fd93a03dd412_experiment.xml","bd8c3078521bda255fb69ea9a088fabe","6ccd6561-e45a-4e28-b446-66555515eff2",2628,"2016-09-29T20:19:57.789136-05:00","e8f984c7-8606-4a3d-982d-fd93a03dd412_run.xml","8355557ff209d07c91a13ddddc950db9","692eacd1-45d5-47da-9f7f-b9d7dad4c6de",354,"2016-09-08T11:29:32.863689-05:00","TCGA-VS-A9UU","2016-09-02T18:54:32.163702-05:00","female","TCGA-VS-A9UU_demographic",1971,"not reported","95017f78-3d89-5dc9-b72c-9da6c6180ab9","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UU_diagnosis","not reported",15534,"alive","8070/3",NA,442,"401adf3a-9e5d-557b-897b-3c9a1e7866b5","c53.9",-15534,"TCGA-VS-A9UU_treatment","876e0e20-56ef-5a47-9454-6de8d9969e87","01","false","TCGA-VS-A9UU-01A",NA,"ba357d05-8eb5-4a58-9ef4-4720cfbc1868",FALSE,"D1243906-0895-4A53-B484-7317F7D834D0","Primary Tumor",NA,208,40,NA,1391040000,"11",30,"TCGA-VS-A9UU-01A-11",60,NA,10,NA,0,NA,40,NA,"2016-09-08T11:29:32.863689-05:00",NA,60,NA,20,NA,"TOP",NA,0,NA,"7abff029-6063-4bea-aa73-79ae9a331529",NA,"TCGA-VS-A9UU-01A-01-TS1",NA,60,NA,"afbf594e-70d2-4d31-bcb5-dc0e077e445f","RNA","TCGA-VS-A9UU-01A-11R","0d5acab1-bd8e-4f6b-ab3a-69a10b87a2ae",1.87,0.17,"UV Spec","R","23","TCGA-VS-A9UU-01A-11R-A42T-07","ab8b70eb-04a6-4c52-8301-fa904fa5870a",0.17,0.10958904109589,67,25.5296448712087,162,"140ae0d3-2991-5a22-941e-e01269eeafcb","TCGA-VS-A9UU_exposure","UNCID_2654373.ab8b70eb-04a6-4c52-8301-fa904fa5870a.141010_UNC12-SN629_0395_BC5FVEACXX_6_GAGTGG.tar.gz","2014-11-05T03:27:05.000Z","2014-11-05T03:38:38.000Z","E8F984C7-8606-4A3D-982D-FD93A03DD412","BA357D05-8EB5-4A58-9EF4-4720CFBC1868","Unaligned reads",2591926408,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AB8B70EB-04A6-4C52-8301-FA904FA5870A","University of North Carolina","564a40c3e4b093830b6afdf9","4770EC81-9174-4D2A-AF54-70C00696FB0B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AFBF594E-70D2-4D31-BCB5-DC0E077E445F","2014-11-05T03:38:38.000Z","0D5ACAB1-BD8E-4F6B-AB3A-69A10B87A2AE","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",208,"AFBF594E-70D2-4D31-BCB5-DC0E077E445F",NA,"VS","UNCID_2654373.ab8b70eb-04a6-4c52-8301-fa904fa5870a.141010_UNC12-SN629_0395_BC5FVEACXX_6_GAGTGG.tar.gz",40,"TCGA-VS-A9UU-01A",NA,"96F43D49-0111-4847-BC76-553F3DD390C3","TCGA",2013,"TCGA-VS-A9UU_NTE-1","Complete Remission/Response","TUMOR FREE","BA357D05-8EB5-4A58-9EF4-4720CFBC1868",42,"TCGA-VS-A9UU-01A-11R-A42V-13_mirna.bam","Alive",NA,"TCGA-VS-A9UU",NA,"9685B0F5-A99F-45B8-9A14-93EC32C1AFBE","NO",442,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"474577FA-95A7-4F7F-A9D5-8038B5F40AFB",NA,NA,11,30,"7ABFF029-6063-4BEA-AA73-79AE9A331529","39446E63-3029-466C-B00E-81C5F81D8E79","UNCID_2654373.ab8b70eb-04a6-4c52-8301-fa904fa5870a.141010_UNC12-SN629_0395_BC5FVEACXX_6_GAGTGG.tar.gz","TCGA-VS-A9UU-01A-11",60,0,10,60,40,"TOP",0,20,"TCGA-VS-A9UU-01A-01-TS1",60,"Cisplatin","Chemotherapy","TCGA-VS-A9UU-D65893","TCGA-VS-A9UU-R65895","External","Regional site","TCGA-VS-A9UU-F67691_NTE-1","NO",442,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UU-F67691","TCGA-VS-A9UU",NA,"VS","A9UU","YES","C53.9","8070/3","C53.9","NO","YES",-15534,"FEMALE",NA,NA,"No","No","Alive",442,NA,NA,NA,"TUMOR FREE","YES",1,10,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G1",NA,2,NA,2,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
105467198,103117822,4919530838,"61A7D1B9-FC5A-4B9C-989F-936CDA948C27.bw","48d81b1e-cd75-4b55-a0b2-c331be2a88ae","61a7d1b9-fc5a-4b9c-989f-936cda948c27","2016-08-25T09:11:49.788436-05:00","UNCID_2449517.0d138b3f-4212-47cf-a65e-fc1cbf618e99.140312_UNC15-SN850_0357_AC3M7FACXX_2_CCGTCC.tar.gz","84fd565e-65a5-4b52-b6fa-fe01e87b952f",4627157000,"Illumina HiSeq","5b91644564f0213f9cd813a44f3b6854","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:32:42.494355-05:00","2016-05-03T11:44:58.595380-05:00","84fd565e-65a5-4b52-b6fa-fe01e87b952f_analysis.xml","de000336c155a5d5ea0d2be90d295452","4c40a9a2-20ac-43fd-964e-12daef64d957",2124,"2016-09-29T22:07:38.525900-05:00","84fd565e-65a5-4b52-b6fa-fe01e87b952f_experiment.xml","931de5d8e3cbef8d980b82b8cdda01a4","ac098157-9128-49ac-8ae5-0398b3c03d81",2628,"2016-09-29T18:46:51.802966-05:00","84fd565e-65a5-4b52-b6fa-fe01e87b952f_run.xml","694776589776756f587030443b6573e1","2f67d29d-8b8f-46e9-a6e9-abf1bcd5ff84",354,"2016-09-08T12:26:37.648526-05:00","TCGA-WL-A834","2016-09-02T19:00:58.433196-05:00","female","TCGA-WL-A834_demographic",1955,"white","a2cf59f5-1b94-5238-9644-05fc5487cee9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","WL","fa833218-6b91-5446-9b55-cd513a1d3adf","University of Kansas","not reported","c53.9","TCGA-WL-A834_diagnosis","not reported",NA,"alive","8070/3",NA,791,"aefe9e69-256e-5b83-8ad6-d5d4adb42b16","c53.9",NA,"TCGA-WL-A834_treatment","9c7e46bc-1206-5a04-872a-1e826e4bef80","01","false","TCGA-WL-A834-01A",NA,"dbfbcf94-84bb-47f3-8373-96fadb932d3f",FALSE,"BADCCC27-5838-469E-97AC-FADBE3757376","Primary Tumor",NA,414,120,NA,1382659200,"11",30,"TCGA-WL-A834-01A-11",80,NA,5,NA,0,NA,20,NA,"2016-09-08T12:26:37.648526-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"73797a78-4f66-4fcd-9038-c6fdcdbfabd9",NA,"TCGA-WL-A834-01A-01-TS1",NA,80,NA,"e54d80c0-4293-4a4b-b064-fdbee63b4a18","RNA","TCGA-WL-A834-01A-11R","6c39ec29-bbcd-4e85-9f30-bc3ba2480cb3",1.94,0.18,"UV Spec","R","23","TCGA-WL-A834-01A-11R-A352-07","0d138b3f-4212-47cf-a65e-fc1cbf618e99",0.18,0.356164383561644,79,30.1021185794848,162,"a477c88d-6aa6-5211-b2be-1d4b82ac4ea1","TCGA-WL-A834_exposure","UNCID_2449517.0d138b3f-4212-47cf-a65e-fc1cbf618e99.140312_UNC15-SN850_0357_AC3M7FACXX_2_CCGTCC.tar.gz","2014-05-09T05:33:23.000Z","2014-05-09T06:25:01.000Z","84FD565E-65A5-4B52-B6FA-FE01E87B952F","DBFBCF94-84BB-47F3-8373-96FADB932D3F","Unaligned reads",4627157000,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0D138B3F-4212-47CF-A65E-FC1CBF618E99","University of North Carolina","566075a7e4b0b37b3d98fb6d","48D81B1E-CD75-4B55-A0B2-C331BE2A88AE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E54D80C0-4293-4A4B-B064-FDBEE63B4A18","2014-05-09T06:25:01.000Z","6C39EC29-BBCD-4E85-9F30-BC3BA2480CB3","United States","NO",1,NA,"Primary Tumor","University of Kansas",414,"E54D80C0-4293-4A4B-B064-FDBEE63B4A18",NA,"WL","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.D8E06BD2-30E2-48A5-B1CD-4F056E6CB193.txt",120,"TCGA-WL-A834-01A",NA,"F7763EE1-727F-4DC9-815E-8C90D2949DD2","TCGA",2012,"TCGA-WL-A834_NTE-1",NA,"TUMOR FREE","DBFBCF94-84BB-47F3-8373-96FADB932D3F",57,"nationwidechildrens.org_clinical.TCGA-WL-A834.xml","Alive",NA,"TCGA-WL-A834","NOT HISPANIC OR LATINO","DBBEC886-B242-46E1-9979-250C7CF7AA51","NO",549,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy",NA,NA,NA,"T1b1","8070/3","FEMALE","C53.9",361,NA,"653A4F63-7BE3-46DA-B0D9-16E3FAB675CF","WHITE",NA,11,30,"73797A78-4F66-4FCD-9038-C6FDCDBFABD9","06BE967E-CC48-4C48-8AD9-9AAD70155A53","STOPE_p_TCGAb3_58_59_60_61_62_N_GenomeWideSNP_6_G06_1388100.raw.copynumber.data.txt","TCGA-WL-A834-01A-11",80,0,5,5,20,"TOP",0,0,"TCGA-WL-A834-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-WL-A834-D59852","TCGA-WL-A834-R66386","Internal","Primary Tumor Field","TCGA-WL-A834-F66179_NTE-1","NO",791,"TUMOR FREE","Alive",NA,"TCGA-WL-A834-F66179","TCGA-WL-A834",NA,"WL","A834","YES","C53.9","8070/3","C53.9","NO","YES",NA,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",549,NA,NA,NA,"TUMOR FREE","YES",6,3,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,57,2012,"Biopsy (cervical / CT-guided / Other)","YES",28,4,"G3",NA,4,2012,6.5,NA,NA,NA,1,NA,"T1b1N1",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
192695356,191359234,9144873624,"74E768C1-8766-46AC-AAB4-D79E5049F76A.bw","4da121da-9193-4ac5-8206-03cb1f7c2c14","74e768c1-8766-46ac-aab4-d79e5049f76a","2016-08-05T02:32:01.114151-05:00","UNCID_2654366.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.141006_UNC15-SN850_0395_AC5FH9ACXX_2_TAGCTT.tar.gz","3395dc27-629d-49b4-b422-8caf9e0a572a",8128036414,"Illumina HiSeq","ac2ee8900bd3925848e11f5695ac66b2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:01:03.201263-05:00","2016-05-03T12:08:10.829131-05:00","3395dc27-629d-49b4-b422-8caf9e0a572a_analysis.xml","ec29ab4750f8a1654fe1435be006d467","f2463afd-b125-4176-84cf-267239fd6aa8",2124,"2016-09-29T20:14:45.051415-05:00","3395dc27-629d-49b4-b422-8caf9e0a572a_experiment.xml","f0065fc93dc19138ce290047fab85f65","660d2e8a-5937-4a18-bbea-1770a12713a8",2628,"2016-09-29T20:34:04.913610-05:00","3395dc27-629d-49b4-b422-8caf9e0a572a_run.xml","67dbb0cf355220b358efe6772547868b","71c6a35c-f8bd-40ab-96fa-0e55598a0e3b",354,"2016-09-08T10:27:47.979142-05:00","TCGA-VS-A9UO","2016-09-02T18:54:29.311146-05:00","female","TCGA-VS-A9UO_demographic",1968,"white","6fa9e1c3-4e9b-5845-bd78-20688746fe18","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UO_diagnosis","not reported",15813,"alive","8482/3",NA,1456,"969f51cc-7c78-5ba8-9d70-f67f580c28a8","c53.9",-15813,"TCGA-VS-A9UO_treatment","532d966e-aaae-5b3d-a7dd-6cb3bf77512c","01","false","TCGA-VS-A9UO-01A",NA,"729b1d94-980f-4c94-a154-64283241fff5",FALSE,"53DDB03D-73DC-4496-AF47-2C03D329DDF9","Primary Tumor",NA,1036,60,NA,1391040000,"11",30,"TCGA-VS-A9UO-01A-11",70,NA,5,NA,10,NA,20,NA,"2016-09-08T10:27:47.979142-05:00",NA,5,NA,5,NA,"TOP",NA,0,NA,"1121bba2-6ffe-40a9-a1f8-d5911473db5a",NA,"TCGA-VS-A9UO-01A-01-TS1",NA,70,NA,"8b6a1250-60f4-4eae-b7b7-a73990e89162","RNA","TCGA-VS-A9UO-01A-11R","6895fde5-0069-4836-a3ed-dd74d5780c47",1.89,0.18,"UV Spec","R","23","TCGA-VS-A9UO-01A-11R-A42T-07","b4df19ac-b93c-4de6-b0f6-823bca30b1d7",0.18,NA,40,15.8221589335865,159,"a1da5e69-fb68-5ea1-af63-c24ed4609a5b","TCGA-VS-A9UO_exposure","UNCID_2654366.b4df19ac-b93c-4de6-b0f6-823bca30b1d7.141006_UNC15-SN850_0395_AC5FH9ACXX_2_TAGCTT.tar.gz","2014-11-05T00:27:03.000Z","2014-11-05T00:47:25.000Z","3395DC27-629D-49B4-B422-8CAF9E0A572A","729B1D94-980F-4C94-A154-64283241FFF5","Unaligned reads",8128036414,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B4DF19AC-B93C-4DE6-B0F6-823BCA30B1D7","University of North Carolina","564a3c53e4b0298dd2c8b40e","4DA121DA-9193-4AC5-8206-03CB1F7C2C14","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8B6A1250-60F4-4EAE-B7B7-A73990E89162","2014-11-05T00:47:25.000Z","6895FDE5-0069-4836-A3ED-DD74D5780C47","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1036,"8B6A1250-60F4-4EAE-B7B7-A73990E89162",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_F06_1524102.byallele.copynumber.data.txt",60,"TCGA-VS-A9UO-01A",NA,"7DF378B9-E2A9-41C7-BCF8-FFE5A356565D","TCGA",2011,"TCGA-VS-A9UO_NTE-1","Complete Remission/Response","TUMOR FREE","729B1D94-980F-4C94-A154-64283241FFF5",43,"3999510081_R06C01_Grn.idat","Alive",NA,"TCGA-VS-A9UO",NA,"3DB9D479-A2AA-416C-AC1C-0AC3BED90647","NO",1080,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",1,"Preoperative","Stage IIB",NA,NA,"T2b","8482/3","FEMALE","C53.9",420,NA,"33D580A0-D636-487D-9F03-B6F95BFCB812","WHITE",NA,11,30,"1121BBA2-6FFE-40A9-A1F8-D5911473DB5A","7822E653-417E-445E-85FF-1525A1273335","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_F06_1524102.byallele.copynumber.data.txt","TCGA-VS-A9UO-01A-11",70,10,5,5,20,"TOP",0,5,"TCGA-VS-A9UO-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-VS-A9UO-D63484","TCGA-VS-A9UO-R63485","Internal","Primary Tumor Field","TCGA-VS-A9UO-F67681_NTE-1","NO",1260,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UO-F67681","TCGA-VS-A9UO",NA,"VS","A9UO","YES","C53.9","8482/3","C53.9","NO","YES",-15813,"FEMALE","WHITE",NA,"No","No","Alive",1080,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,43,2011,"Biopsy (cervical / CT-guided / Other)","YES",45,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bN0MX",NA,NA,1,"Preoperative",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
112079078,107274294,5107343947,"0CEA28F0-D7F0-4EB7-A23F-0C5CA6245971.bw","4ed1616e-8c62-4104-bcbe-26d7059f04d0","0cea28f0-d7f0-4eb7-a23f-0c5ca6245971","2016-08-24T18:19:23.450345-05:00","UNCID_2449530.fb4a5161-67f4-4679-8d85-bb1843f3b897.140304_UNC14-SN744_0400_AC3LWGACXX_4_ATTCCT.tar.gz","6390a2ee-2c74-4ee5-a687-bb5a7f9f0fc7",4695017221,"Illumina HiSeq","8eee56829f69c69918659034cd9bf32f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:04:47.652742-05:00","2016-05-03T11:44:58.595380-05:00","6390a2ee-2c74-4ee5-a687-bb5a7f9f0fc7_analysis.xml","f7f2757ea3239f3834cea110aaee1f3e","f47ee001-e700-40c4-b540-065382d2207f",2124,"2016-09-29T17:39:38.035651-05:00","6390a2ee-2c74-4ee5-a687-bb5a7f9f0fc7_experiment.xml","bc991a5f2b60cd42431fa9cac6c35d81","04f05c79-a6a5-4040-a609-0d0ade445c89",2628,"2016-09-29T18:41:46.859036-05:00","6390a2ee-2c74-4ee5-a687-bb5a7f9f0fc7_run.xml","291ae6a5ddfb27db5ac4e1c22b4894b9","2c2589b3-9c59-4772-b5f5-7478a52a31a9",354,"2016-09-08T12:08:22.454290-05:00","TCGA-C5-A7X3","2016-09-02T19:00:19.586913-05:00","female","TCGA-C5-A7X3_demographic",1927,"white","a0b80daf-52d2-579f-8be7-2d50f68a1628","not hispanic or latino",1997,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7X3_diagnosis","not reported",25665,"dead","8072/3",284,NA,"bc7f45e4-83b2-5f67-8b9f-94e281d92ff5","c53.9",-25665,"TCGA-C5-A7X3_treatment","077a4f61-d7e8-5961-96af-0a3b86c88597","01","true","TCGA-C5-A7X3-01A",NA,"5530afa4-aa4b-45dc-8c6b-c83e570096a6",FALSE,"34E0772A-D90C-48BE-86CF-E7968CADDFD7","Primary Tumor",NA,5915,110,NA,1383091200,"11",30,"TCGA-C5-A7X3-01A-11",60,NA,5,NA,0,NA,39,NA,"2016-09-08T12:08:22.454290-05:00",NA,10,NA,5,NA,"TOP",NA,1,NA,"cead427d-3e63-4ada-a9a0-7778a9074552",NA,"TCGA-C5-A7X3-01A-01-TS1",NA,60,NA,"1af15211-78bb-485a-9161-1421f393582f","RNA","TCGA-C5-A7X3-01A-11R","91d19f11-70f9-4d20-a335-9c854a60e2a6",1.81,0.18,"UV Spec","R","23","TCGA-C5-A7X3-01A-11R-A352-07","fb4a5161-67f4-4679-8d85-bb1843f3b897",0.18,NA,79,30.859375,160,"6e08b802-6fee-52b8-8ffa-037a049e5976","TCGA-C5-A7X3_exposure","UNCID_2449530.fb4a5161-67f4-4679-8d85-bb1843f3b897.140304_UNC14-SN744_0400_AC3LWGACXX_4_ATTCCT.tar.gz","2014-05-09T10:33:04.000Z","2014-05-09T10:57:02.000Z","6390A2EE-2C74-4EE5-A687-BB5A7F9F0FC7","5530AFA4-AA4B-45DC-8C6B-C83E570096A6","Unaligned reads",4695017221,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FB4A5161-67F4-4679-8D85-BB1843F3B897","University of North Carolina","566073e4e4b0b37b3d98e39a","4ED1616E-8C62-4104-BCBE-26D7059F04D0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","1AF15211-78BB-485A-9161-1421F393582F","2014-05-09T10:57:02.000Z","91D19F11-70F9-4D20-A335-9C854A60E2A6","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",5915,"1AF15211-78BB-485A-9161-1421F393582F",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.BB6C8BE2-DCC9-43E3-A15F-19252A08BBA9.txt",110,"TCGA-C5-A7X3-01A",NA,"C7862EF2-080F-499E-92D3-840E034090A5","TCGA",1997,"TCGA-C5-A7X3_NTE-1",NA,"TUMOR FREE","8F76D057-71DC-4AE8-BEB6-FB3FC6881258",70,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.BB6C8BE2-DCC9-43E3-A15F-19252A08BBA9.txt","Dead",284,"TCGA-C5-A7X3","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8072/3","FEMALE","C53.9",361,NA,"75AF9EFD-3EAE-4901-9686-2C867D1A0CC6","WHITE",NA,11,30,"CEAD427D-3E63-4ADA-A9A0-7778A9074552","9C27ACF9-F769-4208-80EA-883EDE13D55A","UNCID_2449530.fb4a5161-67f4-4679-8d85-bb1843f3b897.140304_UNC14-SN744_0400_AC3LWGACXX_4_ATTCCT.tar.gz","TCGA-C5-A7X3-01A-11",60,0,5,10,39,"TOP",1,5,"TCGA-C5-A7X3-01A-01-TS1",60,"Cisplatinum","Chemotherapy","TCGA-C5-A7X3-D56994","TCGA-C5-A7X3-R56997","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7X3",NA,"C5","A7X3","YES","C53.9","8072/3","C53.9","NO","YES",-25665,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,284,NA,NA,"TUMOR FREE","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,70,1997,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
114257434,110477292,5265821111,"95C4EFF6-147C-48EC-A2C1-16B8F12AEEF2.bw","4f4e8834-a716-42e6-bd51-60d80a619202","95c4eff6-147c-48ec-a2c1-16b8f12aeef2","2016-08-09T14:01:06.418334-05:00","UNCID_2169208.ea52408f-b5e1-4a15-80bc-945cc74135e4.130606_UNC9-SN296_0372_AC277JACXX_4_TAGCTT.tar.gz","95ed248c-a08a-4523-81a6-37ad2504b485",5509208367,"Illumina HiSeq","9a0184dc14d7f31e4394c4a134742b1d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:54:17.445267-05:00","2016-05-03T11:05:42.727154-05:00","95ed248c-a08a-4523-81a6-37ad2504b485_analysis.xml","7e97bcbb346dc2c1bebd2a247f554354","a3c91b59-8df7-4148-b950-36956a4a3074",2121,"2016-08-13T04:35:28.616707-05:00","95ed248c-a08a-4523-81a6-37ad2504b485_experiment.xml","e4999d2fe2774f3312086ad626d5fb81","78a95268-8c71-4b8a-9e13-3801f4c31c45",2431,"2016-09-29T22:38:17.628332-05:00","95ed248c-a08a-4523-81a6-37ad2504b485_run.xml","7fd061fc90f63d3c8346d21804f7966d","bee8849f-147a-4016-8481-5c2fc55f0224",354,"2016-09-08T12:18:41.791514-05:00","TCGA-MY-A5BF","2016-09-02T18:59:48.933032-05:00","female","TCGA-MY-A5BF_demographic",1944,"white","857ea558-57cf-5d39-8bfa-7a3e7a547f6d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MY","06424429-c5cd-5c57-9e26-68966e407b26","Montefiore Medical Center","not reported","c53.9","TCGA-MY-A5BF_diagnosis","not reported",25082,"alive","8071/3",NA,634,"32c1cd18-3d1a-57e5-98d6-a5cbf37ead46","c53.9",-25082,"TCGA-MY-A5BF_treatment","9e304c46-0e2b-5dcc-9740-a50b57824698","11","true","TCGA-MY-A5BF-11A",NA,"25a7f991-7dc2-4d3f-ac77-7676dd071977",FALSE,NA,"Solid Tissue Normal",NA,97,220,NA,1356566400,"11",30,"TCGA-MY-A5BF-11A-11",0,NA,0,NA,100,NA,0,NA,"2016-09-08T12:18:41.791514-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"566b4c64-64c8-4849-a166-5b64637798d1",NA,"TCGA-MY-A5BF-11A-01-TSA",NA,0,NA,"5d73e616-0157-4569-be47-dba5c4daa8fd","RNA","TCGA-MY-A5BF-11A-11R","61635452-bed9-4baf-a3c1-40362cf8ce11",1.85,0.15,"UV Spec","R","23","TCGA-MY-A5BF-11A-11R-A26T-07","ea52408f-b5e1-4a15-80bc-945cc74135e4",0.15,NA,74,25.6055363321799,170,"1804a719-bb66-5384-8914-0c26caa45a4d","TCGA-MY-A5BF_exposure","UNCID_2169208.ea52408f-b5e1-4a15-80bc-945cc74135e4.130606_UNC9-SN296_0372_AC277JACXX_4_TAGCTT.tar.gz","2013-09-19T23:06:04.000Z","2013-09-19T23:20:01.000Z","95ED248C-A08A-4523-81A6-37AD2504B485","25A7F991-7DC2-4D3F-AC77-7676DD071977","Unaligned reads",5509208367,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","EA52408F-B5E1-4A15-80BC-945CC74135E4","University of North Carolina","564a3d30e4b09c884b24e73c","4F4E8834-A716-42E6-BD51-60D80A619202","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5D73E616-0157-4569-BE47-DBA5C4DAA8FD","2013-09-19T23:20:01.000Z","61635452-BED9-4BAF-A3C1-40362CF8CE11","United States","NO",11,NA,"Solid Tissue Normal","Montefiore Medical Center",97,"5D73E616-0157-4569-BE47-DBA5C4DAA8FD",NA,"MY","UNCID_2058987.ea52408f-b5e1-4a15-80bc-945cc74135e4.sorted_genome_alignments.bam.bai",220,"TCGA-MY-A5BF-11A",NA,"F8BD8AE2-4E5B-4FC7-895D-D907C6A45730","TCGA",2012,"TCGA-MY-A5BF_NTE-1",NA,"TUMOR FREE","9B53A9BB-C0F4-4B11-93B1-04EA84B8F1B1",68,"cc2993e90031bc524da2f058c80eefd2.bam.bai","Alive",NA,"TCGA-MY-A5BF","NOT HISPANIC OR LATINO","687A0961-9280-4D80-B16E-1B0ADC441AB0","NO",132,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIA2",NA,NA,"T2a2","8071/3","FEMALE","C53.9",280,NA,"DF8515B5-83C5-4328-AD33-0B7F7F0E1942","WHITE",NA,11,30,"566B4C64-64C8-4849-A166-5B64637798D1","61635452-BED9-4BAF-A3C1-40362CF8CE11","UNCID_2058987.ea52408f-b5e1-4a15-80bc-945cc74135e4.sorted_genome_alignments.bam.bai","TCGA-MY-A5BF-11A-11",0,100,0,1,0,"TOP",0,0,"TCGA-MY-A5BF-11A-01-TSA",0,"Cisplatin","Chemotherapy","TCGA-MY-A5BF-D67173","TCGA-MY-A5BF-R67174","External","Regional site","TCGA-MY-A5BF-F67160_NTE-1","NO",634,"TUMOR FREE","Alive",NA,"TCGA-MY-A5BF-F67160","TCGA-MY-A5BF",NA,"MY","A5BF","YES","C53.9","8071/3","C53.9","YES","NO",-25082,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",132,NA,NA,NA,"TUMOR FREE","YES",20,5,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,68,2012,"Lymph node sampling or dissection","YES",6,0,"G1",NA,1,NA,NA,NA,NA,"2009",12,NA,"T2a2N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
117702814,115222492,5496400373,"C9A78BEA-D455-4F5E-8B7B-19BCB42887E7.bw","4f4e8834-a716-42e6-bd51-60d80a619202","c9a78bea-d455-4f5e-8b7b-19bcb42887e7","2016-08-07T16:39:00.112586-05:00","UNCID_2169526.77019674-09ef-416d-a02a-8135b048af91.130606_UNC9-SN296_0372_AC277JACXX_3_GTGGCC.tar.gz","0fc72f8f-14a4-4589-9cd0-c4e788b972db",5679995844,"Illumina HiSeq","c9f86df63427061da7624f4619c674f4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:34:30.195650-05:00","2016-05-03T11:05:42.727154-05:00","0fc72f8f-14a4-4589-9cd0-c4e788b972db_analysis.xml","68947123d2fc92eefa102a432c438b5d","bc824c6f-2f0e-4202-a655-ff10c7b54577",2121,"2016-10-07T16:54:48.678619-05:00","0fc72f8f-14a4-4589-9cd0-c4e788b972db_experiment.xml","7edef2152bb3c10512f318cb4ba60cf9","d0717cc2-214e-484a-94ee-da852f9e2884",2431,"2016-09-29T21:07:06.573364-05:00","0fc72f8f-14a4-4589-9cd0-c4e788b972db_run.xml","8dde826519f10d5df1dfd4f60d09bc9f","8684cd16-72aa-487d-b633-db65822f575b",354,"2016-09-08T12:18:41.791514-05:00","TCGA-MY-A5BF","2016-09-02T18:59:48.933032-05:00","female","TCGA-MY-A5BF_demographic",1944,"white","857ea558-57cf-5d39-8bfa-7a3e7a547f6d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MY","06424429-c5cd-5c57-9e26-68966e407b26","Montefiore Medical Center","not reported","c53.9","TCGA-MY-A5BF_diagnosis","not reported",25082,"alive","8071/3",NA,634,"32c1cd18-3d1a-57e5-98d6-a5cbf37ead46","c53.9",-25082,"TCGA-MY-A5BF_treatment","9e304c46-0e2b-5dcc-9740-a50b57824698","01","true","TCGA-MY-A5BF-01A",NA,"73a23ceb-31f6-46b5-8007-8462f17e2780",FALSE,"1BFC6DC1-D8FF-4C55-8925-BA52DEB3ECD3","Primary Tumor",NA,97,190,NA,1356566400,"11",30,"TCGA-MY-A5BF-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:18:41.791514-05:00",NA,3,NA,0,NA,"TOP",NA,2,NA,"9ff67562-2ece-43da-b714-075f5f3b8c3f",NA,"TCGA-MY-A5BF-01A-01-TSA",NA,98,NA,"5d360f97-df53-4135-a001-3a4f9a3a599b","RNA","TCGA-MY-A5BF-01A-11R","028b6764-5d85-418d-a631-b8e8f9d7dce5",1.82,0.17,"UV Spec","R","23","TCGA-MY-A5BF-01A-11R-A26T-07","77019674-09ef-416d-a02a-8135b048af91",0.17,NA,74,25.6055363321799,170,"1804a719-bb66-5384-8914-0c26caa45a4d","TCGA-MY-A5BF_exposure","UNCID_2169526.77019674-09ef-416d-a02a-8135b048af91.130606_UNC9-SN296_0372_AC277JACXX_3_GTGGCC.tar.gz","2013-09-19T22:46:05.000Z","2013-09-19T23:00:02.000Z","0FC72F8F-14A4-4589-9CD0-C4E788B972DB","73A23CEB-31F6-46B5-8007-8462F17E2780","Unaligned reads",5679995844,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","77019674-09EF-416D-A02A-8135B048AF91","University of North Carolina","564a3d2fe4b09c884b24e72c","4F4E8834-A716-42E6-BD51-60D80A619202","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5D360F97-DF53-4135-A001-3A4F9A3A599B","2013-09-19T23:00:02.000Z","028B6764-5D85-418D-A631-B8E8F9D7DCE5","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",97,"5D360F97-DF53-4135-A001-3A4F9A3A599B",NA,"MY","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C4584FD2-F3A6-4475-96F1-7897310781FA.txt",190,"TCGA-MY-A5BF-01A",NA,"F8BD8AE2-4E5B-4FC7-895D-D907C6A45730","TCGA",2012,"TCGA-MY-A5BF_NTE-1",NA,"TUMOR FREE","9B53A9BB-C0F4-4B11-93B1-04EA84B8F1B1",68,"cc2993e90031bc524da2f058c80eefd2.bam.bai","Alive",NA,"TCGA-MY-A5BF","NOT HISPANIC OR LATINO","687A0961-9280-4D80-B16E-1B0ADC441AB0","NO",132,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIA2",NA,NA,"T2a2","8071/3","FEMALE","C53.9",280,NA,"DF8515B5-83C5-4328-AD33-0B7F7F0E1942","WHITE",NA,11,30,"9FF67562-2ECE-43DA-B714-075F5F3B8C3F","D0946A12-FE97-4322-B6A9-0C10371329DD","UNCID_2059074.77019674-09ef-416d-a02a-8135b048af91.sorted_genome_alignments.bam","TCGA-MY-A5BF-01A-11",80,0,0,3,0,"TOP",2,0,"TCGA-MY-A5BF-01A-01-TSA",98,"Cisplatin","Chemotherapy","TCGA-MY-A5BF-D67173","TCGA-MY-A5BF-R67174","External","Regional site","TCGA-MY-A5BF-F67160_NTE-1","NO",634,"TUMOR FREE","Alive",NA,"TCGA-MY-A5BF-F67160","TCGA-MY-A5BF",NA,"MY","A5BF","YES","C53.9","8071/3","C53.9","YES","NO",-25082,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",132,NA,NA,NA,"TUMOR FREE","YES",20,5,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,68,2012,"Lymph node sampling or dissection","YES",6,0,"G1",NA,1,NA,NA,NA,NA,"2009",12,NA,"T2a2N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
146262734,143735153,6830862734,"DB970740-9AC1-4C10-9658-8A77B1C390DD.bw","4f514ed4-3be6-44bc-a531-210027846459","db970740-9ac1-4c10-9658-8a77b1c390dd","2016-08-05T05:10:00.164107-05:00","UNCID_2187310.70b5a53a-d822-4634-b181-79fef68346c0.120917_UNC11-SN627_0251_AC119PACXX_5_CTTGTA.tar.gz","104d6821-57e4-484b-a2d0-239a8cef8084",5945386406,"Illumina HiSeq","c1c1f1aeb695a261ecd9b526ef128684","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:08:13.648688-05:00","2016-05-03T11:02:00.425419-05:00","104d6821-57e4-484b-a2d0-239a8cef8084_analysis.xml","8ef5f6fa23a5661c6579a592b4abf638","173096e6-b032-41fb-a721-ef32e24abf65",2123,"2016-08-13T06:50:04.282787-05:00","104d6821-57e4-484b-a2d0-239a8cef8084_experiment.xml","ea1fc24c153ccdb0cd43fddea1cf91b4","cf1489cd-049a-445a-9898-e14320c89a27",2431,"2016-09-29T17:40:41.380144-05:00","104d6821-57e4-484b-a2d0-239a8cef8084_run.xml","b01fcb069d2147664688357b06d4eb91","05a786c9-313e-4dfe-8b50-087533dbff6c",354,"2016-09-08T11:19:39.076517-05:00","TCGA-C5-A1MF","2016-09-02T18:56:52.496268-05:00","female","TCGA-C5-A1MF_demographic",1955,"white","480dbc48-1f46-593f-9877-bead38061ad9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MF_diagnosis","not reported",17911,"alive","8070/3",NA,1617,"235cc568-7d7f-598c-bf53-192abe3622c4","c53.9",-17911,"TCGA-C5-A1MF_treatment","5feffdd4-a5a9-573d-96ec-99b92f9a3fec","01","true","TCGA-C5-A1MF-01A",NA,"6a7206dd-eb30-4f05-b944-2e5529607d21",FALSE,"1FEEF445-9E69-4AAB-A336-C688BA807CDA","Primary Tumor",NA,2591,130,NA,1300924800,"11",30,"TCGA-C5-A1MF-01A-11",80,NA,10,NA,0,NA,20,NA,"2016-09-08T11:19:39.076517-05:00",NA,30,NA,3,NA,"TOP",NA,2,NA,"00db3a5b-baf4-499e-9abb-53106c56f810",NA,"TCGA-C5-A1MF-01A-01-TSA",NA,78,NA,"725c2602-c0ce-42c7-87f0-07b93c49537c","RNA","TCGA-C5-A1MF-01A-11R","9f6066c6-3b10-4ccc-b5fb-e21ee35d9f8d",1.76,0.18,"UV Spec","R","23","TCGA-C5-A1MF-01A-11R-A13Y-07","70b5a53a-d822-4634-b181-79fef68346c0",0.18,0.547945205479452,70,26.346494034401,163,"1be8d4b7-e715-5268-8c2c-e4c067ff06bb","TCGA-C5-A1MF_exposure","UNCID_2187310.70b5a53a-d822-4634-b181-79fef68346c0.120917_UNC11-SN627_0251_AC119PACXX_5_CTTGTA.tar.gz","2013-09-17T07:16:04.000Z","2013-09-17T07:35:01.000Z","104D6821-57E4-484B-A2D0-239A8CEF8084","6A7206DD-EB30-4F05-B944-2E5529607D21","Unaligned reads",5945386406,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","70B5A53A-D822-4634-B181-79FEF68346C0","University of North Carolina","566074ede4b0ec1099f8b302","4F514ED4-3BE6-44BC-A531-210027846459","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","725C2602-C0CE-42C7-87F0-07B93C49537C","2013-09-17T07:35:01.000Z","9F6066C6-3B10-4CCC-B5FB-E21EE35D9F8D","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2591,"725C2602-C0CE-42C7-87F0-07B93C49537C",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.AE69D647-895F-4476-873B-18BA147D1489.txt",130,"TCGA-C5-A1MF-01A",NA,NA,"TCGA",2004,NA,NA,"TUMOR FREE","6BA81700-3259-45BE-9265-991CBEF21970",49,"nationwidechildrens.org_clinical.TCGA-C5-A1MF.xml","Alive",NA,"TCGA-C5-A1MF","NOT HISPANIC OR LATINO","BAA0B122-260B-4EB3-93A9-FD52D70CFE96",NA,1617,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",114,NA,"86805415-A64D-4D0B-A114-39CEFAA2AE0C","WHITE",NA,11,30,"00DB3A5B-BAF4-499E-9ABB-53106C56F810","0BA220C1-20F7-4C23-9128-59ACF3B49D09","C501.TCGA-C5-A1MF-01A-11D-A13W-08.2.bam","TCGA-C5-A1MF-01A-11",80,0,10,30,20,"TOP",2,3,"TCGA-C5-A1MF-01A-01-TSA",78,NA,NA,NA,"TCGA-C5-A1MF-R21309","COMBINATION","Primary Tumor Field",NA,"NO",1617,"TUMOR FREE","Alive",NA,"TCGA-C5-A1MF-F20976","TCGA-C5-A1MF",NA,"C5","A1MF","YES","C53.9","8070/3","C53.9","NO","YES",-17911,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1617,NA,NA,NA,"TUMOR FREE","NO",25,1,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2004,"Biopsy (cervical / CT-guided / Other)","YES",40,0,"G2",NA,4,1995,10,NA,NA,"1995",8,NA,"T1b2N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
172483142,149675232,7129769227,"883FBD37-0CA0-4562-8925-72ACC1EE93D9.bw","5194a247-cfee-4c11-9475-cf5521a8c6e3","883fbd37-0ca0-4562-8925-72acc1ee93d9","2016-08-09T13:56:24.177778-05:00","UNCID_2186972.9f86c904-9c2f-4413-a5ad-95a6fd65cb71.121002_UNC11-SN627_0254_AC0WP5ACXX_3_AGTTCC.tar.gz","09e23937-972a-4272-b502-177d1461156f",7306983766,"Illumina HiSeq","a54a69fa69c154aeda6fc9406fcb8fd2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:39:43.284220-05:00","2016-05-03T11:01:14.488541-05:00","09e23937-972a-4272-b502-177d1461156f_analysis.xml","ba020c7b732c3c79d35cd112d3b6b7cf","508557e7-b72f-45e2-8a69-0cdb300bd9e7",2124,"2016-09-29T19:24:30.050064-05:00","09e23937-972a-4272-b502-177d1461156f_experiment.xml","718602c658da1a369c8a5c3616ab7b21","471de58c-8508-49a5-bb3a-38f1860ebf51",2431,"2016-09-29T18:01:49.767155-05:00","09e23937-972a-4272-b502-177d1461156f_run.xml","b5aeb9b830568c14386618ca7f4217de","13255fd2-9f38-468b-85c4-e4a97b658532",354,"2016-09-08T12:14:18.508535-05:00","TCGA-EK-A2PG","2016-09-02T18:58:16.469195-05:00","female","TCGA-EK-A2PG_demographic",1917,"black or african american","48ba09dc-9a17-5732-8458-0a6e3ee8dd3e","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2PG_diagnosis","not reported",32500,"alive","8070/3",NA,46,"ff7c754d-e7f0-5355-9c5d-abee151d65d4","c53.9",-32500,"TCGA-EK-A2PG_treatment","02d33168-8201-5a10-9eb8-e7e4277dabe6","01","false","TCGA-EK-A2PG-01A",NA,"b36b549d-2031-47b5-ba70-a3ea88fd5c39",FALSE,"373213AD-4641-426B-AD9F-6C868CAE2868","Primary Tumor",NA,2165,40,NA,1314144000,"11",30,"TCGA-EK-A2PG-01A-11",60,NA,0,NA,29,NA,20,NA,"2016-09-08T12:14:18.508535-05:00",NA,15,NA,0,NA,"TOP",NA,1,NA,"947e376d-3124-456d-9ca3-0074d9a30492",NA,"TCGA-EK-A2PG-01A-01-TS1",NA,50,NA,"4680989a-9c75-4569-ab7f-91fa7656cb6b","RNA","TCGA-EK-A2PG-01A-11R","dbe7357e-774f-4649-ba4c-3a85b063a3e0",1.83,0.17,"UV Spec","R","23","TCGA-EK-A2PG-01A-11R-A18M-07","9f86c904-9c2f-4413-a5ad-95a6fd65cb71",0.17,NA,55,22.8928199791883,155,"70dc2460-9e49-5bca-9f1e-3d7dea436ab7","TCGA-EK-A2PG_exposure","UNCID_2186972.9f86c904-9c2f-4413-a5ad-95a6fd65cb71.121002_UNC11-SN627_0254_AC0WP5ACXX_3_AGTTCC.tar.gz","2013-09-16T07:46:04.000Z","2013-09-16T20:28:01.000Z","09E23937-972A-4272-B502-177D1461156F","B36B549D-2031-47B5-BA70-A3EA88FD5C39","Unaligned reads",7306983766,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9F86C904-9C2F-4413-A5AD-95A6FD65CB71","University of North Carolina","566076efe4b018727fea101d","5194A247-CFEE-4C11-9475-CF5521A8C6E3","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4680989A-9C75-4569-AB7F-91FA7656CB6B","2013-09-16T20:28:01.000Z","DBE7357E-774F-4649-BA4C-3A85B063A3E0","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2165,"4680989A-9C75-4569-AB7F-91FA7656CB6B",NA,"EK","561f94fac36f7b09d9dd70290f9558ca.bam.bai",40,"TCGA-EK-A2PG-01A",NA,NA,"TCGA",2005,NA,NA,NA,"B36B549D-2031-47B5-BA70-A3EA88FD5C39",88,"nationwidechildrens.org_clinical.TCGA-EK-A2PG.xml","Alive",NA,"TCGA-EK-A2PG",NA,"C06D1BDE-AEAB-40CB-A6B3-E6CD12D22DF6",NA,16,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",4,"Preoperative",NA,NA,NA,NA,"8070/3","FEMALE","C53.9",179,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"947E376D-3124-456D-9CA3-0074D9A30492","DBE7357E-774F-4649-BA4C-3A85B063A3E0","561f94fac36f7b09d9dd70290f9558ca.bam.bai","TCGA-EK-A2PG-01A-11",60,29,0,15,20,"TOP",1,0,"TCGA-EK-A2PG-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2PG-F58223_NTE-1",NA,46,NA,"Alive",NA,"TCGA-EK-A2PG-F58223","TCGA-EK-A2PG",NA,"EK","A2PG","YES","C53.9","8070/3","C53.9","NO","YES",-32500,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",16,NA,NA,NA,NA,"NO",12,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,88,2005,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",1,NA,NA,NA,NA,4,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
134624262,128867975,6143025606,"9FE1D006-49F2-471E-91E6-AF0414C24479.bw","53d99a89-6ebd-4637-91db-7ce43ebc6b8b","9fe1d006-49f2-471e-91e6-af0414c24479","2016-08-09T14:41:58.144673-05:00","UNCID_2654406.13b94e1c-6bd0-420f-bf57-c14c91e8f28e.140815_UNC11-SN627_0374_AC5FPLACXX_8_GATCAG.tar.gz","28654806-3d21-44f6-afc7-19ceec7136c1",6028358407,"Illumina HiSeq","31015ecf3290d466fec356c91d46ac6b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:17:14.583778-05:00","2016-05-03T12:08:10.840133-05:00","28654806-3d21-44f6-afc7-19ceec7136c1_analysis.xml","0cc757425020460947ad8394765830d6","67844810-4d99-44d5-affd-9a4aa1ae42bb",2123,"2016-08-13T09:28:45.910973-05:00","28654806-3d21-44f6-afc7-19ceec7136c1_experiment.xml","f7cfec955f9d96a9d2a7f4aa5577dbaf","67ebd145-5a2f-4a9e-9138-d780e51d22b5",2628,"2016-09-29T23:14:58.384554-05:00","28654806-3d21-44f6-afc7-19ceec7136c1_run.xml","9c560e720e82399ddc69d667e5d9f5f2","d5bb6958-db70-429e-a088-5c86ee1e6de2",354,"2016-09-08T11:33:53.789996-05:00","TCGA-UC-A7PG","2016-09-02T18:54:12.850711-05:00","female","TCGA-UC-A7PG_demographic",1959,"white","b177fd00-6eac-526b-9082-8163b69bfb75","not reported",2004,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","UC","5f4f7a1f-2e8a-5fac-ad28-5f6f1142d6e1","University of Washington","not reported","c53.9","TCGA-UC-A7PG_diagnosis","not reported",16231,"dead","8070/3",370,NA,"2089fcfe-ac45-5e35-b3a3-1e870d5a048f","c53.9",-16231,"TCGA-UC-A7PG_treatment","d4beb286-e715-5d3c-a7b9-5e949447604b","01","true","TCGA-UC-A7PG-01A",NA,"15f86bec-a427-40f4-af72-9a61bfa4e445",FALSE,"AB821E7F-7CED-4191-A82D-B411A7C1AA45","Primary Tumor",NA,3610,20,NA,1379894400,"11",30,"TCGA-UC-A7PG-01A-11",60,NA,20,NA,20,NA,20,NA,"2016-09-08T11:33:53.789996-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"821d1470-616d-4efb-ad27-ec2eec0a5373",NA,"TCGA-UC-A7PG-01A-01-TS1",NA,60,NA,"2e42c02c-853a-4296-a4dd-500ba71f9869","RNA","TCGA-UC-A7PG-01A-11R","2414fcf7-4504-4f24-9edb-aa7f659258da",1.86,0.17,"UV Spec","R","23","TCGA-UC-A7PG-01A-11R-A42S-07","13b94e1c-6bd0-420f-bf57-c14c91e8f28e",0.17,2.84931506849315,82,NA,NA,"f352e3ec-dd40-59e3-b9b7-cf12cc0a98bc","TCGA-UC-A7PG_exposure","UNCID_2654406.13b94e1c-6bd0-420f-bf57-c14c91e8f28e.140815_UNC11-SN627_0374_AC5FPLACXX_8_GATCAG.tar.gz","2014-11-05T15:47:04.000Z","2014-11-05T16:02:23.000Z","28654806-3D21-44F6-AFC7-19CEEC7136C1","15F86BEC-A427-40F4-AF72-9A61BFA4E445","Unaligned reads",6028358407,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","13B94E1C-6BD0-420F-BF57-C14C91E8F28E","University of North Carolina","564a3b72e4b09c884b245f4d","53D99A89-6EBD-4637-91DB-7CE43EBC6B8B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2E42C02C-853A-4296-A4DD-500BA71F9869","2014-11-05T16:02:23.000Z","2414FCF7-4504-4F24-9EDB-AA7F659258DA","United States","NO",1,NA,"Primary Tumor","University of Washington",3610,"2E42C02C-853A-4296-A4DD-500BA71F9869",NA,"UC","c89c41ad364442929dba79a0508def59.bam.bai",20,"TCGA-UC-A7PG-01A",NA,"DB97B514-17D5-4D9A-9C22-0896A63486ED","TCGA",2003,"TCGA-UC-A7PG_NTE-1","Progressive Disease","WITH TUMOR","952E4A17-F891-46B8-AC16-8D6C0751FB1A",44,"nationwidechildrens.org_clinical.TCGA-UC-A7PG.xml","Dead",370,"TCGA-UC-A7PG",NA,NA,"NO",NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,"FFFA2557-E8F4-4B02-9AE1-A2868CE0CADE","WHITE",NA,11,30,"821D1470-616D-4EFB-AD27-EC2EEC0A5373","F6BC936D-9D86-4A97-BB90-3AB5956CDAE9","3999510090_R05C02_Red.idat","TCGA-UC-A7PG-01A-11",60,20,20,40,20,"TOP",0,20,"TCGA-UC-A7PG-01A-01-TS1",60,"cisplatin","Chemotherapy","TCGA-UC-A7PG-D61868","TCGA-UC-A7PG-R61864","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-UC-A7PG",NA,"UC","A7PG","YES","C53.9","8070/3","C53.9","NO","YES",-16231,"FEMALE","WHITE",NA,"No","No","Dead",NA,370,NA,NA,"WITH TUMOR","YES",17,7,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2003,"Biopsy (cervical / CT-guided / Other)","YES",9,8,"G1",NA,2,NA,52,NA,"Progressive Disease","1995",16,NA,"T3bN1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
147918784,136546093,6505268151,"11816CC6-8C8B-49C0-99EE-896377BCFCCD.bw","53d99a89-6ebd-4637-91db-7ce43ebc6b8b","11816cc6-8c8b-49c0-99ee-896377bcfccd","2016-08-09T14:40:44.541444-05:00","UNCID_2654408.22727b4c-d2ab-4ebf-a681-d2dd20eb4f43.140808_UNC12-SN629_0386_BC5AB0ACXX_6_TGACCA.tar.gz","ec8e1bb3-d01d-48fa-8006-8d6932d5f773",6478232558,"Illumina HiSeq","3e0b8ea963f7a393415270222eb2763d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:56.368173-05:00","2016-05-03T12:08:10.840133-05:00","ec8e1bb3-d01d-48fa-8006-8d6932d5f773_analysis.xml","093391a9ea8a951695d4e02d8a1d395b","0482ae79-bfbf-4736-9912-79b73d3aa628",2124,"2016-08-13T03:57:21.983931-05:00","ec8e1bb3-d01d-48fa-8006-8d6932d5f773_experiment.xml","4c70a1477c1e2256f8ac92bf538fbf7a","cbeed2ad-f610-40a6-802f-9c658c06be9a",2628,"2016-09-29T18:39:12.282921-05:00","ec8e1bb3-d01d-48fa-8006-8d6932d5f773_run.xml","46358fdf15b0fad8bec2b0b66702fd93","2a777ad7-57fc-445d-a2fc-bde5e373957b",354,"2016-09-08T11:33:53.789996-05:00","TCGA-UC-A7PG","2016-09-02T18:54:12.850711-05:00","female","TCGA-UC-A7PG_demographic",1959,"white","b177fd00-6eac-526b-9082-8163b69bfb75","not reported",2004,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","UC","5f4f7a1f-2e8a-5fac-ad28-5f6f1142d6e1","University of Washington","not reported","c53.9","TCGA-UC-A7PG_diagnosis","not reported",16231,"dead","8070/3",370,NA,"2089fcfe-ac45-5e35-b3a3-1e870d5a048f","c53.9",-16231,"TCGA-UC-A7PG_treatment","d4beb286-e715-5d3c-a7b9-5e949447604b","06","true","TCGA-UC-A7PG-06A",NA,"952e4a17-f891-46b8-ac16-8d6c0751fb1a",FALSE,"3B9B2CF0-2BFB-45D2-BAB8-7DC83277ACCE","Metastatic",NA,3610,40,NA,1379894400,"11",30,"TCGA-UC-A7PG-06A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:33:53.789996-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"babb2d6c-ae59-4dc5-a0bb-81f2b3ce6352",NA,"TCGA-UC-A7PG-06A-01-TS1",NA,80,NA,"ae5a264f-642a-41ae-976c-bd8da513612e","RNA","TCGA-UC-A7PG-06A-11R","645245d8-dc8b-41e6-ba1c-c933646aa30d",1.87,0.17,"UV Spec","R","23","TCGA-UC-A7PG-06A-11R-A42S-07","22727b4c-d2ab-4ebf-a681-d2dd20eb4f43",0.17,2.84931506849315,82,NA,NA,"f352e3ec-dd40-59e3-b9b7-cf12cc0a98bc","TCGA-UC-A7PG_exposure","UNCID_2654408.22727b4c-d2ab-4ebf-a681-d2dd20eb4f43.140808_UNC12-SN629_0386_BC5AB0ACXX_6_TGACCA.tar.gz","2014-11-05T16:27:03.000Z","2014-11-05T16:42:23.000Z","EC8E1BB3-D01D-48FA-8006-8D6932D5F773","952E4A17-F891-46B8-AC16-8D6C0751FB1A","Unaligned reads",6478232558,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","22727B4C-D2AB-4EBF-A681-D2DD20EB4F43","University of North Carolina","566074fee4b0b37b3d98f285","53D99A89-6EBD-4637-91DB-7CE43EBC6B8B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AE5A264F-642A-41AE-976C-BD8DA513612E","2014-11-05T16:42:23.000Z","645245D8-DC8B-41E6-BA1C-C933646AA30D","United States","NO",6,NA,"Metastatic","University of Washington",3610,"AE5A264F-642A-41AE-976C-BD8DA513612E",NA,"UC","TCGA-UC-A7PG-06A-11R-A42U-13_mirna.bam.bai",40,"TCGA-UC-A7PG-06A",NA,"DB97B514-17D5-4D9A-9C22-0896A63486ED","TCGA",2003,"TCGA-UC-A7PG_NTE-1","Progressive Disease","WITH TUMOR","952E4A17-F891-46B8-AC16-8D6C0751FB1A",44,"nationwidechildrens.org_clinical.TCGA-UC-A7PG.xml","Dead",370,"TCGA-UC-A7PG",NA,NA,"NO",NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,"FFFA2557-E8F4-4B02-9AE1-A2868CE0CADE","WHITE",NA,11,30,"BABB2D6C-AE59-4DC5-A0BB-81F2B3CE6352","C75B7C34-81C1-4954-B1A2-84707E7AE827","TCGA-UC-A7PG-06A-11R-A42U-13_mirna.bam.bai","TCGA-UC-A7PG-06A-11",80,0,20,40,20,"TOP",0,20,"TCGA-UC-A7PG-06A-01-TS1",80,"cisplatin","Chemotherapy","TCGA-UC-A7PG-D61868","TCGA-UC-A7PG-R61864","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-UC-A7PG",NA,"UC","A7PG","YES","C53.9","8070/3","C53.9","NO","YES",-16231,"FEMALE","WHITE",NA,"No","No","Dead",NA,370,NA,NA,"WITH TUMOR","YES",17,7,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2003,"Biopsy (cervical / CT-guided / Other)","YES",9,8,"G1",NA,2,NA,52,NA,"Progressive Disease","1995",16,NA,"T3bN1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
110121082,109024702,5207548248,"063FC5C8-4318-4ECC-9CA0-1976CBC8ACB6.bw","53eac147-7eb8-4c54-a982-5e058d6749f8","063fc5c8-4318-4ecc-9ca0-1976cbc8acb6","2016-08-24T08:04:15.271324-05:00","UNCID_2553084.9d09804a-304a-4f05-af84-af513c97f3ed.140513_UNC15-SN850_0365_BC4BYLACXX_4_GTGAAA.tar.gz","f94b9315-fbbb-45b5-a63d-cc98f7317870",4658713514,"Illumina HiSeq","b8f803a6c340b1cae2546fa8341e827f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:19.826655-05:00","2016-05-03T11:54:19.885282-05:00","f94b9315-fbbb-45b5-a63d-cc98f7317870_analysis.xml","61d285c3030ed91bf1995f50a3dfbf0f","080ab017-7202-4646-94a8-222f975cb305",2123,"2016-10-07T17:29:24.528595-05:00","f94b9315-fbbb-45b5-a63d-cc98f7317870_experiment.xml","1ae4bd4e081feca71a2b1dff183e8462","5b65379d-a74e-409c-8f95-46cdb5b6bd85",2628,"2016-09-29T19:05:19.342208-05:00","f94b9315-fbbb-45b5-a63d-cc98f7317870_run.xml","80e940f6f3112ca634995ee8b63f3055","3b07cba9-221f-4a89-9eb0-8987c4641219",354,"2016-09-08T10:38:24.516767-05:00","TCGA-4J-AA1J","2016-09-02T18:54:00.059282-05:00","female","TCGA-4J-AA1J_demographic",1982,"white","1c2c712d-0a6c-5b52-a4b0-8e1d61256f6c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","4J","e6eb6dfc-087e-5212-93c3-a547e627e868","Proteogenex, Inc.","not reported","c53.9","TCGA-4J-AA1J_diagnosis","not reported",11611,"alive","8070/3",NA,542,"20b61f8a-5efb-5bcc-aaad-5f79cd8ff313","c53.9",-11611,"TCGA-4J-AA1J_treatment","f68ae36d-85e6-558c-91a7-f5b69b9dde19","01","false","TCGA-4J-AA1J-01A",NA,"189e0024-c636-48cb-b423-3b3d6bd0caaa",FALSE,"A052742F-3CD5-4881-B004-A7E13ECDC9C2","Primary Tumor",NA,80,590,NA,1393286400,"21",30,"TCGA-4J-AA1J-01A-21",70,NA,0,NA,5,NA,20,NA,"2016-09-08T10:38:24.516767-05:00",NA,5,NA,0,NA,"TOP",NA,5,NA,"2191fb69-62cf-4b52-a989-0ce3423a610e",NA,"TCGA-4J-AA1J-01A-02-TS2",NA,70,NA,"2f82f092-b0b1-458e-b8ec-e2121e799b65","RNA","TCGA-4J-AA1J-01A-21R","d1ce5dee-7aab-4dbb-af7b-bff36e653c2a",1.82,0.16,"UV Spec","R","23","TCGA-4J-AA1J-01A-21R-A38B-07","9d09804a-304a-4f05-af84-af513c97f3ed",0.16,NA,48,17.6308539944904,165,"93ddbaf1-67b9-59a9-8a04-ef00db42fd54","TCGA-4J-AA1J_exposure","UNCID_2553084.9d09804a-304a-4f05-af84-af513c97f3ed.140513_UNC15-SN850_0365_BC4BYLACXX_4_GTGAAA.tar.gz","2014-07-30T07:06:05.000Z","2014-07-30T07:27:14.000Z","F94B9315-FBBB-45B5-A63D-CC98F7317870","189E0024-C636-48CB-B423-3B3D6BD0CAAA","Unaligned reads",4658713514,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9D09804A-304A-4F05-AF84-AF513C97F3ED","University of North Carolina","564a4016e4b09c884b25c28f","53EAC147-7EB8-4C54-A982-5E058D6749F8","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2F82F092-B0B1-458E-B8EC-E2121E799B65","2014-07-30T07:27:14.000Z","D1CE5DEE-7AAB-4DBB-AF7B-BFF36E653C2A","Russia","NO",1,NA,"Primary Tumor","Proteogenex, Inc.",80,"2F82F092-B0B1-458E-B8EC-E2121E799B65",NA,"4J","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.4EE077A4-25B8-4C6B-B0D3-06301827E402.txt",590,"TCGA-4J-AA1J-01A",NA,NA,"TCGA",2013,"TCGA-4J-AA1J_NTE-1","Complete Remission/Response","TUMOR FREE","BF18171E-7ADC-4A36-8435-E033620E7F8D",31,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.4EE077A4-25B8-4C6B-B0D3-06301827E402.txt","Alive",NA,"TCGA-4J-AA1J","NOT HISPANIC OR LATINO","FEDDE494-6ACC-4A28-8626-56B94DB2CA42","NO",226,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",394,NA,"8B8EAD60-859F-4817-B3FE-E7DF78875C73","WHITE",NA,21,30,"2191FB69-62CF-4B52-A989-0CE3423A610E","DC56CEF9-DCC6-47C6-8814-504D5A4ACBEF","UNCID_2553084.9d09804a-304a-4f05-af84-af513c97f3ed.140513_UNC15-SN850_0365_BC4BYLACXX_4_GTGAAA.tar.gz","TCGA-4J-AA1J-01A-21",70,5,0,5,20,"TOP",5,0,"TCGA-4J-AA1J-01A-02-TS2",70,NA,NA,NA,"TCGA-4J-AA1J-R68104","Internal","Primary Tumor Field","TCGA-4J-AA1J-F72061_NTE-1","NO",542,"TUMOR FREE","Alive",NA,"TCGA-4J-AA1J-F72061","TCGA-4J-AA1J",NA,"4J","AA1J","YES","C53.9","8070/3","C53.9","YES","NO",-11611,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",226,NA,NA,NA,"TUMOR FREE","YES",13,11,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,31,2013,"Cytology (e.g. Peritoneal or pleural fluid)","YES",15,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
129985936,128353639,6126127295,"E0F085CC-B90D-4FDE-B60E-C613971BAA00.bw","53eb4c4e-0719-476f-9b2b-279d438d7710","e0f085cc-b90d-4fde-b60e-c613971baa00","2016-08-09T14:00:46.322506-05:00","UNCID_2169001.e5bafefb-df41-4686-9bbe-b176f954d131.130611_UNC15-SN850_0312_BC265JACXX_2_CAGATC.tar.gz","d263e577-c733-45b5-a5e5-af02e9b8c896",5902995006,"Illumina HiSeq","1456887e2368f9e0f6fb08971f0be460","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:54:43.779827-05:00","2016-05-03T11:06:28.634130-05:00","d263e577-c733-45b5-a5e5-af02e9b8c896_analysis.xml","2b1ed09d4621c6155095555ed6a638ac","a40ffd06-139e-4706-85b8-4163edce127a",2123,"2016-10-07T15:51:38.834296-05:00","d263e577-c733-45b5-a5e5-af02e9b8c896_experiment.xml","bda26bc8393b4793b315783c3d2ecb3b","3262e64a-256b-429d-a31a-3eb1fdca1d06",2431,"2016-09-29T21:41:08.801046-05:00","d263e577-c733-45b5-a5e5-af02e9b8c896_run.xml","825cf87f8d9572a6c02da2630e57ea60","9b8831a6-0d06-4f54-b4ed-bab1154319b8",354,"2016-09-08T12:15:13.975663-05:00","TCGA-JW-A5VI","2016-09-02T19:00:02.277369-05:00","female","TCGA-JW-A5VI_demographic",1967,"american indian or alaska native","1e454755-7f2a-53fa-84e2-14e7649ac26c","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VI_diagnosis","not reported",16444,"alive","8072/3",NA,747,"6840e835-f144-5022-9c31-d4100be6d85a","c53.9",-16444,"TCGA-JW-A5VI_treatment","b14c3b1f-2836-5001-8c85-003ae72f6873","01","false","TCGA-JW-A5VI-01A",NA,"79205cbb-4cd4-4061-8313-898ecadb9f11",FALSE,"4ADC462C-2D78-4CAA-B865-5D954A080801","Primary Tumor",NA,406,70,NA,1362528000,"11",30,"TCGA-JW-A5VI-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T12:15:13.975663-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"a61cf116-0bcd-4987-a4e6-d9243319862b",NA,"TCGA-JW-A5VI-01A-01-TS1",NA,90,NA,"051e4bd1-8271-466f-a5d3-6582e3364d17","RNA","TCGA-JW-A5VI-01A-11R","7f252231-33bb-41b2-a0da-cb40db1bc284",1.94,0.16,"UV Spec","R","23","TCGA-JW-A5VI-01A-11R-A28H-07","e5bafefb-df41-4686-9bbe-b176f954d131",0.16,0.547945205479452,59,23.6340330075308,158,"2cb8f448-22c0-5f5f-bc8d-a1e5c16d8e46","TCGA-JW-A5VI_exposure","UNCID_2169001.e5bafefb-df41-4686-9bbe-b176f954d131.130611_UNC15-SN850_0312_BC265JACXX_2_CAGATC.tar.gz","2013-09-20T05:01:03.000Z","2013-09-20T05:23:02.000Z","D263E577-C733-45B5-A5E5-AF02E9B8C896","79205CBB-4CD4-4061-8313-898ECADB9F11","Unaligned reads",5902995006,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E5BAFEFB-DF41-4686-9BBE-B176F954D131","University of North Carolina","566073c8e4b0ca319164ba4c","53EB4C4E-0719-476F-9B2B-279D438D7710","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","051E4BD1-8271-466F-A5D3-6582E3364D17","2013-09-20T05:23:02.000Z","7F252231-33BB-41B2-A0DA-CB40DB1BC284","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",406,"051E4BD1-8271-466F-A5D3-6582E3364D17",NA,"JW","UNCID_2169001.e5bafefb-df41-4686-9bbe-b176f954d131.130611_UNC15-SN850_0312_BC265JACXX_2_CAGATC.tar.gz",70,"TCGA-JW-A5VI-01A",NA,"C5AD3DD1-DB8E-4106-97BE-4CA01A2B0480","TCGA",2012,"TCGA-JW-A5VI_NTE-1","Complete Remission/Response","WITH TUMOR","79205CBB-4CD4-4061-8313-898ECADB9F11",45,"nationwidechildrens.org_clinical.TCGA-JW-A5VI.xml","Alive",NA,"TCGA-JW-A5VI","HISPANIC OR LATINO","5E07D81C-5522-4731-9C8A-82BAB9D34D6C","NO",506,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8072/3","FEMALE","C53.9",297,NA,"C5E09278-557A-432F-B083-9581A6E071CC","AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"A61CF116-0BCD-4987-A4E6-D9243319862B","7F252231-33BB-41B2-A0DA-CB40DB1BC284","UNCID_2169001.e5bafefb-df41-4686-9bbe-b176f954d131.130611_UNC15-SN850_0312_BC265JACXX_2_CAGATC.tar.gz","TCGA-JW-A5VI-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-JW-A5VI-01A-01-TS1",90,"Topotecan","Chemotherapy","TCGA-JW-A5VI-D45006","TCGA-JW-A5VI-R45008","External","Primary Tumor Field","TCGA-JW-A5VI-F58233_NTE-1","YES",747,"WITH TUMOR","Alive",NA,"TCGA-JW-A5VI-F58233","TCGA-JW-A5VI",NA,"JW","A5VI","YES","C53.9","8072/3","C53.9","NO","YES",-16444,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Alive",506,NA,NA,NA,"WITH TUMOR","YES",3,6,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,2,NA,10,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,1,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
112728056,109735358,5238696894,"62361DA2-E4EE-46DA-BB1F-C51DCA9307CC.bw","55add854-e63f-4335-bea9-23c3eb1e766a","62361da2-e4ee-46da-bb1f-c51dca9307cc","2016-08-25T09:28:49.623984-05:00","UNCID_2520192.fa2cdebd-8b7c-452a-8191-994ceeb1e763.140508_UNC11-SN627_0356_AC3UKNACXX_2_CGTACG.tar.gz","48783b9c-0e69-441e-ab88-a6afdc961be9",4637389556,"Illumina HiSeq","0cdbb12da5b0daae986188331797eabf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:24:07.205797-05:00","2016-05-03T11:51:27.506016-05:00","48783b9c-0e69-441e-ab88-a6afdc961be9_analysis.xml","306ceb3a6ac19a064d4b6ca7c6a49901","911aabcc-fc36-4f1d-9cab-54e9d931cdfe",2124,"2016-09-30T00:00:23.482881-05:00","48783b9c-0e69-441e-ab88-a6afdc961be9_experiment.xml","d708dd37982df23d348a4b56d4cc28e1","f1deb61a-9b76-4a67-b80b-e159959950c0",2628,"2016-09-29T23:32:39.520262-05:00","48783b9c-0e69-441e-ab88-a6afdc961be9_run.xml","22929653d019f140166717c3ca6145bf","e0b8046a-b815-47c3-a490-8e105fbd0097",354,"2016-09-08T12:08:44.075599-05:00","TCGA-PN-A8MA","2016-09-02T19:01:02.747252-05:00","female","TCGA-PN-A8MA_demographic",1970,"black or african american","ec52fe2a-bb8a-5ea9-8929-bf0a79f93faa","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","PN","6b3d3dce-d902-59cd-aeef-4631774c3035","Institute of Human Virology Nigeria","not reported","c53.9","TCGA-PN-A8MA_diagnosis","not reported",15918,"alive","8072/3",NA,90,"2cbf8337-531c-566f-96c0-44c889246b0b","c53.9",-15918,"TCGA-PN-A8MA_treatment","173679e2-265d-527d-85c1-d8cf0a782f1f","01","false","TCGA-PN-A8MA-01A",NA,"681a4ab9-daed-498b-9bd2-7ab2ee04dc37",FALSE,"A124C1F0-5522-4A98-8A3D-6A8E6A919102","Primary Tumor",NA,227,80,NA,1385942400,"11",30,"TCGA-PN-A8MA-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T12:08:44.075599-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"978164eb-6260-45ba-a874-fc795b72fa8c",NA,"TCGA-PN-A8MA-01A-01-DX1",NA,80,NA,"03c34405-33cd-4b38-ac38-8b0bd4fedd4c","RNA","TCGA-PN-A8MA-01A-11R","01b377dc-4435-4a22-9d7c-092c016a5855",1.84,0.16,"UV Spec","R","23","TCGA-PN-A8MA-01A-11R-A36F-07","fa2cdebd-8b7c-452a-8191-994ceeb1e763",0.16,NA,71,25.4580659041199,167,"59e3198a-c90e-5e8f-8256-ff55d984054b","TCGA-PN-A8MA_exposure","UNCID_2520192.fa2cdebd-8b7c-452a-8191-994ceeb1e763.140508_UNC11-SN627_0356_AC3UKNACXX_2_CGTACG.tar.gz","2014-07-09T17:36:04.000Z","2014-07-09T18:01:12.000Z","48783B9C-0E69-441E-AB88-A6AFDC961BE9","681A4AB9-DAED-498B-9BD2-7AB2EE04DC37","Unaligned reads",4637389556,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FA2CDEBD-8B7C-452A-8191-994CEEB1E763","University of North Carolina","564a3cf7e4b08c5d8692020f","55ADD854-E63F-4335-BEA9-23C3EB1E766A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","03C34405-33CD-4B38-AC38-8B0BD4FEDD4C","2014-07-09T18:01:12.000Z","01B377DC-4435-4A22-9D7C-092C016A5855","Nigeria","NO",1,NA,"Primary Tumor","Institute of Human Virology Nigeria",227,"03C34405-33CD-4B38-AC38-8B0BD4FEDD4C",NA,"PN","UNCID_2520192.fa2cdebd-8b7c-452a-8191-994ceeb1e763.140508_UNC11-SN627_0356_AC3UKNACXX_2_CGTACG.tar.gz",80,"TCGA-PN-A8MA-01A",NA,"0BA1607D-3682-49B1-A7AB-F5CF48525262","TCGA",2013,"TCGA-PN-A8MA_NTE-1","Stable Disease","WITH TUMOR","EF45C474-EF46-4408-AF46-0DBD7C71D7F4",43,"nationwidechildrens.org_clinical.TCGA-PN-A8MA.xml","Alive",NA,"TCGA-PN-A8MA","NOT HISPANIC OR LATINO","CA0DB769-E918-43C2-8318-352C13AC26EE",NA,90,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Other","Stage IIB",NA,NA,"T2b","8072/3","FEMALE","C53.9",373,NA,"CA6BD07F-2B17-4D19-9C70-DEEAE4442A9B","BLACK OR AFRICAN AMERICAN",NA,11,30,"978164EB-6260-45BA-A874-FC795B72FA8C","01B377DC-4435-4A22-9D7C-092C016A5855","UNCID_2520192.fa2cdebd-8b7c-452a-8191-994ceeb1e763.140508_UNC11-SN627_0356_AC3UKNACXX_2_CGTACG.tar.gz","TCGA-PN-A8MA-01A-11",80,0,0,0,20,"TOP",0,0,"TCGA-PN-A8MA-01A-01-DX1",80,"Cisplatin","Chemotherapy","TCGA-PN-A8MA-D57802","TCGA-PN-A8MA-R57803","External","Regional site","TCGA-PN-A8MA-F64853_NTE-1",NA,90,"WITH TUMOR","Alive",NA,"TCGA-PN-A8MA-F64853","TCGA-PN-A8MA",NA,"PN","A8MA","YES","C53.9","8072/3","C53.9","YES","NO",-15918,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",90,NA,NA,NA,"WITH TUMOR","NO",25,3,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,NA,NA,NA,NA,"Stable Disease","2009",13,NA,"T2bN0M0",NA,NA,1,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
115659860,111336479,5308638866,"1BA16D48-B09E-4699-A1AD-2FFECE4F3CDB.bw","57902b91-be42-441d-8807-a5ea9c21b214","1ba16d48-b09e-4699-a1ad-2ffece4f3cdb","2016-08-25T04:49:13.925087-05:00","UNCID_2520217.7a835fc9-6dfb-464a-bbe0-d42782abab4c.140417_UNC13-SN749_0343_BC41HBACXX_8_AGTCAA.tar.gz","7c78fe68-4e87-47c9-94d1-d5623d327d47",5014778648,"Illumina HiSeq","5672a347147c017a767272d747d4e48c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:44:43.845661-05:00","2016-05-03T11:51:27.516015-05:00","7c78fe68-4e87-47c9-94d1-d5623d327d47_analysis.xml","cfe2cc7e0ca0568b5364b312b0aeb4a6","53a3dc8b-6353-4356-9bc9-448f1a636223",2124,"2016-09-29T19:22:01.676140-05:00","7c78fe68-4e87-47c9-94d1-d5623d327d47_experiment.xml","a3dca0e2ca42fc05b201538e121c7c2c","45929708-04be-4d62-9a83-8663af4795be",2628,"2016-09-29T21:28:20.645564-05:00","7c78fe68-4e87-47c9-94d1-d5623d327d47_run.xml","13f42ffc5462a5e102f54600fa8018fe","93c014a0-53c7-464a-a44a-8712dbeed0cc",354,"2016-09-08T11:46:21.000383-05:00","TCGA-C5-A7X8","2016-09-02T19:01:01.535448-05:00","female","TCGA-C5-A7X8_demographic",1968,"white","9668aefc-c91a-5798-b8bf-5b926ff25f62","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7X8_diagnosis","not reported",12977,"alive","8482/3",NA,83,"2871c4eb-ec82-5012-9e5f-7beb01f223ac","c53.9",-12977,"TCGA-C5-A7X8_treatment","df848d88-e06a-52b4-b6b2-cd5064a80717","01","true","TCGA-C5-A7X8-01A",NA,"76f12767-3e6b-4a8a-a6b2-6bd80889fefb",FALSE,"06979EDA-C06B-46E7-A4B0-C20D1E340F4B","Primary Tumor",NA,3868,70,NA,1383091200,"11",30,"TCGA-C5-A7X8-01A-11",80,NA,0,NA,15,NA,5,NA,"2016-09-08T11:46:21.000383-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"61f50d06-2a15-41b6-b370-c3448fdc1199",NA,"TCGA-C5-A7X8-01A-01-TS1",NA,80,NA,"a247b3e9-11ea-4135-aea8-fc0fa8e1701a","RNA","TCGA-C5-A7X8-01A-11R","7af131bf-fb4c-41eb-8db0-dc7f2d3f3dec",1.83,0.17,"UV Spec","R","23","TCGA-C5-A7X8-01A-11R-A36F-07","7a835fc9-6dfb-464a-bbe0-d42782abab4c",0.17,0.273972602739726,74,25.6055363321799,170,"83625b55-4648-5042-ab02-c77f8bb013ca","TCGA-C5-A7X8_exposure","UNCID_2520217.7a835fc9-6dfb-464a-bbe0-d42782abab4c.140417_UNC13-SN749_0343_BC41HBACXX_8_AGTCAA.tar.gz","2014-07-09T23:21:05.000Z","2014-07-09T23:38:16.000Z","7C78FE68-4E87-47C9-94D1-D5623D327D47","76F12767-3E6B-4A8A-A6B2-6BD80889FEFB","Unaligned reads",5014778648,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7A835FC9-6DFB-464A-BBE0-D42782ABAB4C","University of North Carolina","5660751be4b018727fe9fba2","57902B91-BE42-441D-8807-A5EA9C21B214","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A247B3E9-11EA-4135-AEA8-FC0FA8E1701A","2014-07-09T23:38:17.000Z","7AF131BF-FB4C-41EB-8DB0-DC7F2D3F3DEC","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3868,"A247B3E9-11EA-4135-AEA8-FC0FA8E1701A",NA,"C5","UNCID_2434189.7a835fc9-6dfb-464a-bbe0-d42782abab4c.sorted_genome_alignments.bam.bai",70,"TCGA-C5-A7X8-01A",NA,"5D6C5633-842A-4C8C-9FC6-7C9489484FEA","TCGA",2003,"TCGA-C5-A7X8_NTE-1",NA,"TUMOR FREE","76F12767-3E6B-4A8A-A6B2-6BD80889FEFB",35,"nationwidechildrens.org_clinical.TCGA-C5-A7X8.xml","Alive",NA,"TCGA-C5-A7X8","NOT HISPANIC OR LATINO",NA,"NO",83,"No","Cervix","C53.9","N1","Mucinous Adenocarcinoma of Endocervical Type",NA,NA,"Stage IB1",NA,NA,"T2a","8482/3","FEMALE","C53.9",373,NA,"379FBCE0-0222-4170-A3E4-B9C173A48989","WHITE",NA,11,30,"61F50D06-2A15-41B6-B370-C3448FDC1199","B84660F5-0D6B-4185-91DF-07351C038DE6","UNCID_2434189.7a835fc9-6dfb-464a-bbe0-d42782abab4c.sorted_genome_alignments.bam.bai","TCGA-C5-A7X8-01A-11",80,15,0,2,5,"TOP",0,0,"TCGA-C5-A7X8-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-C5-A7X8-D57044","TCGA-C5-A7X8-R57045","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7X8",NA,"C5","A7X8","YES","C53.9","8482/3","C53.9","NO","YES",-12977,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",83,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,35,2003,"Biopsy (cervical / CT-guided / Other)","YES",27,1,"G2",NA,2,NA,5,NA,NA,"1995",7,NA,"T2aN1M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
126512642,123312778,5880388595,"3E4F14E9-60AE-4F17-9BA7-2A02E908204A.bw","5798d741-c198-4c14-bcc2-e3b17caf1be3","3e4f14e9-60ae-4f17-9ba7-2a02e908204a","2016-08-25T19:07:41.851795-05:00","UNCID_2553095.c43ed784-3bfe-4485-8dd9-cee08f8c0fa8.140416_UNC11-SN627_0353_BC42B0ACXX_1_CGATGT.tar.gz","c499a927-f57b-4005-a4a1-0d0d0bb7896a",5665022697,"Illumina HiSeq","20f899fb62b5242768d48ebac5cfd7e1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:26:37.899061-05:00","2016-05-03T11:54:19.885282-05:00","c499a927-f57b-4005-a4a1-0d0d0bb7896a_analysis.xml","8d002704823e21a5cf915c2a80254b28","b7992db9-d0a0-43f5-9400-b7cd5fdc8b78",2124,"2016-08-27T14:40:56.805405-05:00","c499a927-f57b-4005-a4a1-0d0d0bb7896a_experiment.xml","d36c437932444dfbe79d6950872c56fc","2708b9b9-ccfd-47ba-a244-d9c958eb0bf9",2628,"2016-09-29T18:32:28.430459-05:00","c499a927-f57b-4005-a4a1-0d0d0bb7896a_run.xml","ec768f0f761ff547f4990743cab7f32b","2617b410-ae08-463f-9dd7-1124c2413553",354,"2016-09-08T11:48:38.641051-05:00","TCGA-VS-A8Q9","2016-09-02T19:01:18.938800-05:00","female","TCGA-VS-A8Q9_demographic",1931,"white","a4a61e29-050a-5d6f-86e9-da815ff1b5c3","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8Q9_diagnosis","not reported",28881,"alive","8070/3",NA,1630,"e0670ad1-4871-5da4-9d95-5eaf0930021f","c53.9",-28881,"TCGA-VS-A8Q9_treatment","bdee3fdb-3d65-596b-97ea-a74ebc0a81a7","01","false","TCGA-VS-A8Q9-01A",NA,"a6ade763-6274-43d0-aab5-ae6eef582fdd",FALSE,"9431BD74-BB03-4F47-A135-2FCCF9BAA226","Primary Tumor",NA,1274,50,NA,1386806400,"12",10,"TCGA-VS-A8Q9-01A-12",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:48:38.641051-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"45286f27-7801-4804-a9f8-6ea2cb5e42bd",NA,"TCGA-VS-A8Q9-01A-01-TS1",NA,80,NA,"c8e66d3a-8a13-410e-a898-21b2027c5772","RNA","TCGA-VS-A8Q9-01A-12R","9754d202-b4d9-4e6d-afb3-63836e7fd1b2",1.91,0.18,"UV Spec","R","23","TCGA-VS-A8Q9-01A-12R-A37O-07","c43ed784-3bfe-4485-8dd9-cee08f8c0fa8",0.18,NA,49,21.7777777777778,150,"35be622d-250d-51d0-bb52-fd472be6bbcf","TCGA-VS-A8Q9_exposure","UNCID_2553095.c43ed784-3bfe-4485-8dd9-cee08f8c0fa8.140416_UNC11-SN627_0353_BC42B0ACXX_1_CGATGT.tar.gz","2014-07-30T21:36:05.000Z","2014-07-30T22:02:08.000Z","C499A927-F57B-4005-A4A1-0D0D0BB7896A","A6ADE763-6274-43D0-AAB5-AE6EEF582FDD","Unaligned reads",5665022697,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C43ED784-3BFE-4485-8DD9-CEE08F8C0FA8","University of North Carolina","564a3982e4b0ef121819d717","5798D741-C198-4C14-BCC2-E3B17CAF1BE3","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C8E66D3A-8A13-410E-A898-21B2027C5772","2014-07-30T22:02:08.000Z","9754D202-B4D9-4E6D-AFB3-63836E7FD1B2","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1274,"C8E66D3A-8A13-410E-A898-21B2027C5772",NA,"VS","UNCID_2441400.c43ed784-3bfe-4485-8dd9-cee08f8c0fa8.sorted_genome_alignments.bam.bai",50,"TCGA-VS-A8Q9-01A",NA,NA,"TCGA",2010,"TCGA-VS-A8Q9_NTE-1","Complete Remission/Response","TUMOR FREE","A6ADE763-6274-43D0-AAB5-AE6EEF582FDD",79,"nationwidechildrens.org_clinical.TCGA-VS-A8Q9.xml","Alive",NA,"TCGA-VS-A8Q9",NA,"5A6EDEEE-06D1-4DEC-833E-9C2D9C44A2E6","NO",1400,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"TX","8070/3","FEMALE","C53.9",380,NA,"D47A0DC6-C250-4800-A3B3-B22276DFAE84","WHITE",NA,12,10,"45286F27-7801-4804-A9F8-6EA2CB5E42BD","9754D202-B4D9-4E6D-AFB3-63836E7FD1B2","UNCID_2441400.c43ed784-3bfe-4485-8dd9-cee08f8c0fa8.sorted_genome_alignments.bam.bai","TCGA-VS-A8Q9-01A-12",80,0,20,40,15,"TOP",5,20,"TCGA-VS-A8Q9-01A-01-TS1",80,NA,NA,NA,"TCGA-VS-A8Q9-R61992","Internal","Primary Tumor Field","TCGA-VS-A8Q9-F68140_NTE-1","NO",1630,"TUMOR FREE","Alive",NA,"TCGA-VS-A8Q9-F68140","TCGA-VS-A8Q9",NA,"VS","A8Q9","YES","C53.9","8070/3","C53.9","NO","YES",-28881,"FEMALE","WHITE",NA,"No","No","Alive",1400,NA,NA,NA,"TUMOR FREE","YES",30,3,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,79,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"TXNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
184144666,172258730,8203960785,"79226DD7-BC85-4B8E-BFF8-B1E073129D34.bw","58bdcace-0047-456e-a225-68953edafe5e","79226dd7-bc85-4b8e-bff8-b1e073129d34","2016-08-09T13:56:09.911892-05:00","UNCID_2186750.50b34335-7e00-417a-8e0d-c50a4384b4c9.121011_UNC13-SN749_0197_AD16K1ACXX_1_TTAGGC.tar.gz","9ba079b4-56eb-48f4-bf4a-322b0d156199",8110224108,"Illumina HiSeq","04df8b99bbdf352caaa228d0d2f7ddf5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:32:21.779138-05:00","2016-05-03T11:01:14.486033-05:00","9ba079b4-56eb-48f4-bf4a-322b0d156199_analysis.xml","e18f4918cc8be2ca8eb769c6cacc5479","26059eb9-51f6-4a1e-97f3-878687623a83",2124,"2016-09-29T23:10:21.947791-05:00","9ba079b4-56eb-48f4-bf4a-322b0d156199_experiment.xml","a65fbceb70f915fd3cc52523ca18f687","d2d9dabc-2286-44ac-b004-2775889b34aa",2431,"2016-09-29T23:11:16.783984-05:00","9ba079b4-56eb-48f4-bf4a-322b0d156199_run.xml","98bb1a76d7608cc2243fe8e94cbeb873","d371c855-fae7-4295-8d7b-2cbbb78c2fba",354,"2016-09-08T12:05:21.372778-05:00","TCGA-IR-A3LC","2016-09-02T18:58:52.401220-05:00","female","TCGA-IR-A3LC_demographic",1963,"white","f7a30070-ecb2-56e3-b092-cf68ddd7f4a0","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LC_diagnosis","not reported",14697,"alive","8070/3",NA,3935,"08fbc8f7-4bb5-5e36-9d30-199135402ec4","c53.9",-14697,"TCGA-IR-A3LC_treatment","6eac7cf0-372f-5b75-b7b3-89c17910e166","01","true","TCGA-IR-A3LC-01A",NA,"ac6d15a0-67cf-42aa-97dc-ba50d0e9f409",FALSE,"97FF892D-6CAD-4376-BB48-082EC5BC4C39","Primary Tumor",NA,3214,140,NA,1324598400,"11",30,"TCGA-IR-A3LC-01A-11",85,NA,0,NA,0,NA,0,NA,"2016-09-08T12:05:21.372778-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"49a45946-570c-4347-9a7a-21df966db3cd",NA,"TCGA-IR-A3LC-01A-01-TS1",NA,100,NA,"13428591-c29d-44d9-91a7-00e63970c8c9","RNA","TCGA-IR-A3LC-01A-11R","2ddea9ca-bc6b-4ab7-8729-b0df3276d405",1.77,0.16,"UV Spec","R","23","TCGA-IR-A3LC-01A-11R-A213-07","50b34335-7e00-417a-8e0d-c50a4384b4c9",0.16,NA,64,25,160,"c4a14b3e-cf30-5fa2-b809-b2a97a544995","TCGA-IR-A3LC_exposure","UNCID_2186750.50b34335-7e00-417a-8e0d-c50a4384b4c9.121011_UNC13-SN749_0197_AD16K1ACXX_1_TTAGGC.tar.gz","2013-09-16T20:07:05.000Z","2013-09-16T20:42:01.000Z","9BA079B4-56EB-48F4-BF4A-322B0D156199","AC6D15A0-67CF-42AA-97DC-BA50D0E9F409","Unaligned reads",8110224108,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","50B34335-7E00-417A-8E0D-C50A4384B4C9","University of North Carolina","56607460e4b0ca319164c318","58BDCACE-0047-456E-A225-68953EDAFE5E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","13428591-C29D-44D9-91A7-00E63970C8C9","2013-09-16T20:42:01.000Z","2DDEA9CA-BC6B-4AB7-8729-B0DF3276D405","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",3214,"13428591-C29D-44D9-91A7-00E63970C8C9",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.ED5836F8-2919-4EC1-85ED-0859F071B5A9.txt",140,"TCGA-IR-A3LC-01A",NA,"A95DAC18-6883-4A30-9E1E-27551C9445B7","TCGA",2003,NA,NA,"TUMOR FREE","CA909A69-58FA-4EB0-A013-FC6EB99ED794",40,"nationwidechildrens.org_clinical.TCGA-IR-A3LC.xml","Alive",NA,"TCGA-IR-A3LC",NA,"A0D9023E-0D50-4CE6-8614-691535719F14",NA,3333,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",200,NA,"5388A3E1-6ACC-4CCB-B603-6F1F52810383","WHITE",NA,11,30,"49A45946-570C-4347-9A7A-21DF966DB3CD","F7A856D6-F92C-431F-8B82-3DA8C73EECB7","UNCID_2186750.50b34335-7e00-417a-8e0d-c50a4384b4c9.121011_UNC13-SN749_0197_AD16K1ACXX_1_TTAGGC.tar.gz","TCGA-IR-A3LC-01A-11",85,0,0,5,0,"TOP",0,0,"TCGA-IR-A3LC-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-IR-A3LC-D38296","TCGA-IR-A3LC-R38292","External","Primary Tumor Field","TCGA-IR-A3LC-F38289_NTE-1","NO",3571,"TUMOR FREE","Alive",NA,"TCGA-IR-A3LC-F38289","TCGA-IR-A3LC",NA,"IR","A3LC","YES","C53.9","8070/3","C53.9","NO","YES",-14697,"FEMALE","WHITE",NA,"No","No","Alive",3333,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2003,"Biopsy (cervical / CT-guided / Other)","YES",48,0,"G3",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
127555260,126368904,6038260171,"D47D0936-826F-4D54-9225-F71B95357438.bw","5916af71-0262-42cf-af4b-eac830a8b419","d47d0936-826f-4d54-9225-f71b95357438","2016-08-05T01:54:57.398416-05:00","UNCID_2654387.2e6fd34c-eccc-42a2-a806-bf69f55c0b27.141006_UNC15-SN850_0395_AC5FH9ACXX_3_AGTCAA.tar.gz","d107eb1b-0a61-44ba-9ec1-0ea0f38d257c",5226588006,"Illumina HiSeq","642eebc8072d5ca11fc85bfcdc8a1c8c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:49:26.235117-05:00","2016-05-03T12:08:10.830175-05:00","d107eb1b-0a61-44ba-9ec1-0ea0f38d257c_analysis.xml","a94ff9284536f8c93018c5e621dbde54","a0a809cb-b3b7-44a9-aa5a-22b0a9b83660",2124,"2016-10-07T15:51:06.929187-05:00","d107eb1b-0a61-44ba-9ec1-0ea0f38d257c_experiment.xml","f9d79914cefb5482e5528dd5bda54cc2","ba5b125e-8bed-4afc-9dc9-0f766bd3e06b",2628,"2016-09-29T21:41:34.738252-05:00","d107eb1b-0a61-44ba-9ec1-0ea0f38d257c_run.xml","bb82a670e06a317b105f23cf10c8b556","9bcaf3ca-e5b6-4247-8a27-28aa6ce0e87a",354,"2016-09-08T10:56:14.300979-05:00","TCGA-ZJ-AAXT","2016-09-02T18:54:46.729514-05:00","female","TCGA-ZJ-AAXT_demographic",1955,"white","f85d3e6f-39e1-5470-af85-9e20628db267","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXT_diagnosis","not reported",19847,"alive","8072/3",NA,0,"8f3f006a-a795-5445-a306-26620ff1daf2","c53.9",-19847,"TCGA-ZJ-AAXT_treatment","8baffd22-e707-5f83-bdfb-8ccc4e2b588c","01","true","TCGA-ZJ-AAXT-01A",NA,"e9030cf0-3baf-4658-8d88-a1d458589c4b",FALSE,"963154F2-CBB5-4556-B94D-3E2977CBB3D7","Primary Tumor",NA,1571,90,NA,1396224000,"11",30,"TCGA-ZJ-AAXT-01A-11",90,NA,0,NA,0,NA,20,NA,"2016-09-08T10:56:14.300979-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"f70090c4-0bb8-4db7-8830-e78f84740b5d",NA,"TCGA-ZJ-AAXT-01A-01-TS1",NA,80,NA,"3aa5a490-e3d8-42cf-bd14-0e85bbd55180","RNA","TCGA-ZJ-AAXT-01A-11R","9ad71b0c-8429-4b4d-9327-92f712603ddd",1.83,0.17,"UV Spec","R","23","TCGA-ZJ-AAXT-01A-11R-A42T-07","2e6fd34c-eccc-42a2-a806-bf69f55c0b27",0.17,0.010958904109589,76,27.9155188246097,165,"74ae80ed-937d-5391-ba49-9214ba65a792","TCGA-ZJ-AAXT_exposure","UNCID_2654387.2e6fd34c-eccc-42a2-a806-bf69f55c0b27.141006_UNC15-SN850_0395_AC5FH9ACXX_3_AGTCAA.tar.gz","2014-11-05T08:47:05.000Z","2014-11-05T09:00:19.000Z","D107EB1B-0A61-44BA-9EC1-0EA0F38D257C","E9030CF0-3BAF-4658-8D88-A1D458589C4B","Unaligned reads",5226588006,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2E6FD34C-ECCC-42A2-A806-BF69F55C0B27","University of North Carolina","564a3f0ce4b0ef12181b9b7c","5916AF71-0262-42CF-AF4B-EAC830A8B419","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3AA5A490-E3D8-42CF-BD14-0E85BBD55180","2014-11-05T09:00:19.000Z","9AD71B0C-8429-4B4D-9327-92F712603DDD","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1571,"3AA5A490-E3D8-42CF-BD14-0E85BBD55180",NA,"ZJ","81b203b30b98899ae1decf51a58ed64f.bam.bai",90,"TCGA-ZJ-AAXT-01A",NA,NA,"TCGA",2009,"TCGA-ZJ-AAXT_NTE-1",NA,NA,"E9030CF0-3BAF-4658-8D88-A1D458589C4B",54,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXT.xml","Alive",NA,"TCGA-ZJ-AAXT","NOT HISPANIC OR LATINO",NA,NA,0,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T3b","8072/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"F70090C4-0BB8-4DB7-8830-E78F84740B5D","9AD71B0C-8429-4B4D-9327-92F712603DDD","81b203b30b98899ae1decf51a58ed64f.bam.bai","TCGA-ZJ-AAXT-01A-11",90,0,0,0,20,"TOP",0,0,"TCGA-ZJ-AAXT-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXT",NA,"ZJ","AAXT","YES","C53.9","8072/3","C53.9","NO","YES",-19847,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",31,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,1982,0.2,NA,NA,"2009",16,NA,"T3bN1M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
131365902,127412595,6073676679,"0AE02B91-574C-4165-BA39-E9D7C1A870A2.bw","5aeac31a-176a-4f93-a376-a93a670821bb","0ae02b91-574c-4165-ba39-e9d7c1a870a2","2016-08-24T15:47:40.988204-05:00","UNCID_2553114.3be9f1e8-94ae-476e-b146-38385d130f38.140404_UNC11-SN627_0350_BC3K66ACXX_3_GATCAG.tar.gz","9c585f3d-b332-4546-b1b5-126afd82cfb1",5727520393,"Illumina HiSeq","a54b5df92a2923fc19b60cd6f8d55372","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:23:24.974064-05:00","2016-05-03T11:54:19.908545-05:00","9c585f3d-b332-4546-b1b5-126afd82cfb1_analysis.xml","6451e4d253a678f09c8fe7733c6d904a","46711b49-3164-459f-bd97-70fff5eb1614",2124,"2016-09-29T19:25:57.288260-05:00","9c585f3d-b332-4546-b1b5-126afd82cfb1_experiment.xml","1e967c5aaa555236e72d728fdc6a2050","48075fa1-1bb6-4bf8-8edf-6d2cd6133cf8",2628,"2016-09-29T17:33:50.001499-05:00","9c585f3d-b332-4546-b1b5-126afd82cfb1_run.xml","28ff2239ccca86aed0cbecb4261a662b","0152cd59-6e54-4901-aad6-b1af58c04f32",354,"2016-09-08T11:22:48.173826-05:00","TCGA-2W-A8YY","2016-09-02T19:01:06.324486-05:00","female","TCGA-2W-A8YY_demographic",1962,"white","b89e4409-f7c6-53f2-a85f-31448e2ae1f6","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","2W","5a269b4a-f311-5611-bc51-b078e2a1f319","University of New Mexico","not reported","c53.9","TCGA-2W-A8YY_diagnosis","not reported",18886,"alive","8560/3",NA,533,"908ee155-bfca-5240-b78b-6b82f565aedd","c53.9",-18886,"TCGA-2W-A8YY_treatment","026fa545-ac02-5915-ac23-5984d67a75f8","01","true","TCGA-2W-A8YY-01A",NA,"c9afd150-ea3a-4219-b634-6e097c3b2a4f",FALSE,"C24A4F00-23CD-44A4-B8B3-580A9CEAB16A","Primary Tumor",NA,93,120,NA,1387324800,"11",30,"TCGA-2W-A8YY-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:22:48.173826-05:00",NA,30,NA,30,NA,"TOP",NA,10,NA,"e5237533-ab19-41fb-84d5-80c3ff6d30ef",NA,"TCGA-2W-A8YY-01A-01-TSA",NA,70,NA,"ec4cb27f-2a57-43b7-a735-ba01c2b15b47","RNA","TCGA-2W-A8YY-01A-11R","5c262ac0-3afa-44a5-9d74-f96310b98b18",1.83,0.17,"UV Spec","R","23","TCGA-2W-A8YY-01A-11R-A37O-07","3be9f1e8-94ae-476e-b146-38385d130f38",0.17,NA,42,16.40625,160,"67aa3949-ad62-5f81-ad08-e8e295f84cfb","TCGA-2W-A8YY_exposure","UNCID_2553114.3be9f1e8-94ae-476e-b146-38385d130f38.140404_UNC11-SN627_0350_BC3K66ACXX_3_GATCAG.tar.gz","2014-07-31T01:36:05.000Z","2014-07-31T01:57:44.000Z","9C585F3D-B332-4546-B1B5-126AFD82CFB1","C9AFD150-EA3A-4219-B634-6E097C3B2A4F","Unaligned reads",5727520393,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3BE9F1E8-94AE-476E-B146-38385D130F38","University of North Carolina","564a3ba6e4b09c884b246e75","5AEAC31A-176A-4F93-A376-A93A670821BB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","EC4CB27F-2A57-43B7-A735-BA01C2B15B47","2014-07-31T01:57:44.000Z","5C262AC0-3AFA-44A5-9D74-F96310B98B18","United States","NO",1,NA,"Primary Tumor","University of New Mexico",93,"EC4CB27F-2A57-43B7-A735-BA01C2B15B47",NA,"2W","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C29F674F-5572-4F11-9AA4-8D7F7464BE44.txt",120,"TCGA-2W-A8YY-01A",NA,"14ACEFE0-DDC0-4A31-B354-D0A304A6C773","TCGA",2013,"TCGA-2W-A8YY_NTE-1","Complete Remission/Response","TUMOR FREE","C9AFD150-EA3A-4219-B634-6E097C3B2A4F",51,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C29F674F-5572-4F11-9AA4-8D7F7464BE44.txt","Alive",NA,"TCGA-2W-A8YY","NOT HISPANIC OR LATINO","B00C7A3F-75A6-4B30-B06E-E56DD131B750","NO",148,"No","Cervix","C53.9","N0","Adenosquamous",1,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T2a2","8560/3","FEMALE","C53.9",380,NA,"92D36651-ADD4-4EDD-BF5E-F78C04A8349B","WHITE",NA,11,30,"E5237533-AB19-41FB-84D5-80C3FF6D30EF","C04A4336-A044-4C00-A44E-DBBC79513BCA","191e1f11c562128d1f2afb31f50e73b5.bam.bai","TCGA-2W-A8YY-01A-11",70,0,20,30,20,"TOP",10,30,"TCGA-2W-A8YY-01A-01-TSA",70,"Cisplatin","Chemotherapy","TCGA-2W-A8YY-D58309","TCGA-2W-A8YY-R58310","External","Primary Tumor Field","TCGA-2W-A8YY-F66376_NTE-1","NO",533,"TUMOR FREE","Alive",NA,"TCGA-2W-A8YY-F66376","TCGA-2W-A8YY",NA,"2W","A8YY","YES","C53.9","8560/3","C53.9","YES","NO",-18886,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",148,NA,NA,NA,"TUMOR FREE","YES",15,5,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Adenosquamous",NA,0,51,2013,"Biopsy (cervical / CT-guided / Other)","YES",18,0,"G3",NA,4,2000,NA,NA,"Complete Remission/Response","2009",8,NA,"T2a2N0M0",NA,NA,1,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
126035380,123089685,5872851182,"DED8E9DF-CEFE-45ED-9374-EF9925A135C4.bw","5c326e9b-85e2-4673-9033-c11827467e1a","ded8e9df-cefe-45ed-9374-ef9925a135c4","2016-09-29T23:29:48.053182-05:00","UNCID_2449429.4dfd8634-77b6-40c5-9b01-e9e4e354be1e.140318_UNC12-SN629_0354_AC3K7VACXX_8_CAGATC.tar.gz","2b517a10-1b3b-45b6-a650-118a334a9753",5578777368,"Illumina HiSeq","8c14feeea3face8a19746575e39ce8f0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:06:44.792843-05:00","2016-05-03T11:44:58.602747-05:00","2b517a10-1b3b-45b6-a650-118a334a9753_analysis.xml","832956fd1e96fdbc1c75e7300622037a","d0903c24-4c20-432e-bfb0-5f19765e5649",2124,"2016-08-29T23:10:49.881067-05:00","2b517a10-1b3b-45b6-a650-118a334a9753_experiment.xml","cf1eeaf777a4bd29d85053ad1fda5fb7","16fb65ff-a52d-48e0-8ce9-e8b13e0f0e53",2628,"2016-09-29T20:58:18.252093-05:00","2b517a10-1b3b-45b6-a650-118a334a9753_run.xml","6d2b800cb1ab40ace747e26120eb66c4","80f0a3d6-bbe4-4656-a59d-057d074ebc3a",354,"2016-09-08T11:28:19.033243-05:00","TCGA-C5-A7UC","2016-09-02T19:00:18.410647-05:00","female","TCGA-C5-A7UC_demographic",1954,"white","bd77892a-2f4e-5d50-968d-01dafd6a6fbb","not reported",2003,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7UC_diagnosis","not reported",17765,"dead","8072/3",523,NA,"b1daf894-221b-573f-b4b7-63d967597aa4","c53.9",-17765,"TCGA-C5-A7UC_treatment","82a92a61-6ec1-5e3c-aae1-ad2826eec2c5","01","true","TCGA-C5-A7UC-01A",NA,"531d7816-8606-4415-bca8-3b332f9de720",FALSE,"C9E3A2CF-96E4-4DB5-A47B-9CADB3555A61","Primary Tumor",NA,3993,20,NA,1381363200,"11",10,"TCGA-C5-A7UC-01A-11",95,NA,0,NA,0,NA,20,NA,"2016-09-08T11:28:19.033243-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"97bc1786-96f8-4fe4-b257-07e541760afd",NA,"TCGA-C5-A7UC-01A-01-TS1",NA,80,NA,"6e1d1989-5f7b-44d1-be45-9fa6c2fc311e","RNA","TCGA-C5-A7UC-01A-11R","a0cc8b96-4df9-4317-baba-73224968f575",1.8,0.16,"UV Spec","R","23","TCGA-C5-A7UC-01A-11R-A352-07","4dfd8634-77b6-40c5-9b01-e9e4e354be1e",0.16,NA,NA,NA,NA,"29f7de39-b8bc-54ca-8de6-3df8a3f6ffba","TCGA-C5-A7UC_exposure","UNCID_2449429.4dfd8634-77b6-40c5-9b01-e9e4e354be1e.140318_UNC12-SN629_0354_AC3K7VACXX_8_CAGATC.tar.gz","2014-05-08T23:33:04.000Z","2014-05-14T11:41:01.000Z","2B517A10-1B3B-45B6-A650-118A334A9753","531D7816-8606-4415-BCA8-3B332F9DE720","Unaligned reads",5578777368,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4DFD8634-77B6-40C5-9B01-E9E4E354BE1E","University of North Carolina","564a3af7e4b0ef12181a4e29","5C326E9B-85E2-4673-9033-C11827467E1A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6E1D1989-5F7B-44D1-BE45-9FA6C2FC311E","2014-05-14T11:41:01.000Z","A0CC8B96-4DF9-4317-BABA-73224968F575","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3993,"6E1D1989-5F7B-44D1-BE45-9FA6C2FC311E",NA,"C5","TCGA-C5-A7UC-01A-11R-A358-13_mirna.bam",20,"TCGA-C5-A7UC-01A",NA,NA,"TCGA",2002,"TCGA-C5-A7UC_NTE-1",NA,"TUMOR FREE","531D7816-8606-4415-BCA8-3B332F9DE720",48,"nationwidechildrens.org_clinical.TCGA-C5-A7UC.xml","Dead",523,"TCGA-C5-A7UC",NA,NA,NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8072/3","FEMALE","C53.9",361,NA,NA,"WHITE",NA,11,10,"97BC1786-96F8-4FE4-B257-07E541760AFD","CE8D2BBD-8046-47DC-9BC1-59BE8CA8CBE3","TCGA-C5-A7UC-01A-11R-A358-13_mirna.bam","TCGA-C5-A7UC-01A-11",95,0,0,0,20,"TOP",0,0,"TCGA-C5-A7UC-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7UC",NA,"C5","A7UC","YES","C53.9","8072/3","C53.9","NO","YES",-17765,"FEMALE","WHITE",NA,"No","No","Dead",NA,523,NA,NA,"TUMOR FREE","NO",3,1,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2002,NA,"YES",27,0,"G3",NA,NA,NA,NA,NA,NA,"1995",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
120950762,112006072,5337100376,"D587A993-3C47-4D4C-B744-59169D4F7451.bw","5c72bda2-2ec0-455f-ab27-7247fd5ffff9","d587a993-3c47-4d4c-b744-59169d4f7451","2016-09-29T23:14:37.626720-05:00","UNCID_2332229.c7f8cb76-3d15-41f0-8217-908db558eedc.131016_UNC15-SN850_0333_AC2MBAACXX_3_ATGTCA.tar.gz","8d6a7193-a751-42da-8b5c-05dd7e7c7a56",5459196252,"Illumina HiSeq","6fcbf9852746c5bb4e0a626b7c14ee3c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:11:42.628377-05:00","2016-05-03T11:35:41.353993-05:00","8d6a7193-a751-42da-8b5c-05dd7e7c7a56_analysis.xml","8f21ba9ce690890fdb013450116de325","8960cb5a-4e69-49f7-996a-504691b1acf5",2124,"2016-10-07T16:26:03.157136-05:00","8d6a7193-a751-42da-8b5c-05dd7e7c7a56_experiment.xml","3d93b863f87a95f4c9a372eaddccad6f","f4ed03c7-5f57-4fae-8d56-70ae5b51d25e",2628,"2016-09-29T22:30:49.337881-05:00","8d6a7193-a751-42da-8b5c-05dd7e7c7a56_run.xml","45c151e744e85acd16e720beadcd3f97","ba4342cc-7d9f-430c-b66a-c3411f326547",354,"2016-09-08T12:11:54.058527-05:00","TCGA-Q1-A73Q","2016-09-02T19:00:53.643691-05:00","female","TCGA-Q1-A73Q_demographic",1967,"white","6b8d9592-43a8-5eab-95d3-3a20f1fd460e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A73Q_diagnosis","not reported",16851,"alive","8071/3",NA,284,"dd148765-f6d2-5df0-b121-1e2278a495d8","c53.9",-16851,"TCGA-Q1-A73Q_treatment","17cf75fd-f459-576d-846c-f12eb8a56383","01","true","TCGA-Q1-A73Q-01A",NA,"c7eae01c-cb80-4eaf-b0a4-93a40632f6c6",FALSE,"C29EC084-5A50-4007-B281-391965A67F43","Primary Tumor",NA,96,1260,NA,1375920000,"21",30,"TCGA-Q1-A73Q-01A-21",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:11:54.058527-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"b92d7ec4-4aee-4454-ad34-8ae7d9993af4",NA,"TCGA-Q1-A73Q-01A-02-TSB",NA,70,NA,"8e45e21d-d730-4255-83a9-3885647646de","RNA","TCGA-Q1-A73Q-01A-21R","49fab356-5e7d-4c38-8841-b19332f4b8b7",1.96,0.17,"UV Spec","R","23","TCGA-Q1-A73Q-01A-21R-A32P-07","c7f8cb76-3d15-41f0-8217-908db558eedc",0.17,0.180821917808219,87,34.8501842653421,158,"234f50ab-bed6-51db-a60c-f9c85927138c","TCGA-Q1-A73Q_exposure","UNCID_2332229.c7f8cb76-3d15-41f0-8217-908db558eedc.131016_UNC15-SN850_0333_AC2MBAACXX_3_ATGTCA.tar.gz","2014-01-28T21:07:03.000Z","2014-01-28T21:21:02.000Z","8D6A7193-A751-42DA-8B5C-05DD7E7C7A56","C7EAE01C-CB80-4EAF-B0A4-93A40632F6C6","Unaligned reads",5459196252,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C7F8CB76-3D15-41F0-8217-908DB558EEDC","University of North Carolina","566077a9e4b0ec1099f8d020","5C72BDA2-2EC0-455F-AB27-7247FD5FFFF9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8E45E21D-D730-4255-83A9-3885647646DE","2014-01-28T21:21:02.000Z","49FAB356-5E7D-4C38-8841-B19332F4B8B7","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",96,"8E45E21D-D730-4255-83A9-3885647646DE",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E7F7A921-F39C-4DB0-AC65-0A6AE9578FC6.txt",1260,"TCGA-Q1-A73Q-01A",NA,"9AAD51FE-13BD-4BFC-BE91-D2006570638D","TCGA",2013,"TCGA-Q1-A73Q_NTE-1",NA,NA,"C7EAE01C-CB80-4EAF-B0A4-93A40632F6C6",46,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E7F7A921-F39C-4DB0-AC65-0A6AE9578FC6.txt","Alive",NA,"TCGA-Q1-A73Q","NOT HISPANIC OR LATINO","CB7257C3-4DC4-4278-9424-03E780517625","NO",179,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage I",NA,NA,"TX","8071/3","FEMALE","C53.9",335,NA,"2FCE251E-CEFF-4560-9EFB-22742B60BDB8","WHITE",NA,21,30,"B92D7EC4-4AEE-4454-AD34-8AE7D9993AF4","49FAB356-5E7D-4C38-8841-B19332F4B8B7","34fdadd32d331e59c4cf59d4b9e31257.bam.bai","TCGA-Q1-A73Q-01A-21",70,0,20,40,20,"TOP",10,20,"TCGA-Q1-A73Q-01A-02-TSB",70,"Cisplatin","Chemotherapy","TCGA-Q1-A73Q-D50823","TCGA-Q1-A73Q-R50824","External","Primary Tumor Field","TCGA-Q1-A73Q-F62730_NTE-1","NO",284,"WITH TUMOR","Alive",NA,"TCGA-Q1-A73Q-F62730","TCGA-Q1-A73Q",NA,"Q1","A73Q","YES","C53.9","8071/3","C53.9","YES","NO",-16851,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",179,NA,NA,NA,NA,"YES",31,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,2,NA,3.3,NA,NA,"2009",2,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
130034222,128613874,6140528013,"6BCA24E6-440F-42C5-ABE5-66C37B713A39.bw","5dbd5436-696e-40fa-881b-c2386573ac68","6bca24e6-440f-42c5-abe5-66c37b713a39","2016-08-25T13:26:27.282777-05:00","UNCID_2332317.c564836c-e7fd-48cc-8896-7d18028039f7.131016_UNC15-SN850_0333_AC2MBAACXX_2_CCGTCC.tar.gz","9abbe14c-6294-43b7-b062-899f4af2b49e",6073181301,"Illumina HiSeq","c2b6f7e27a88983c2922f3fe178b1031","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:34:56.659944-05:00","2016-05-03T11:35:41.346304-05:00","9abbe14c-6294-43b7-b062-899f4af2b49e_analysis.xml","75e4608288cb9927681ba8ef4fbb27b4","bccfc05a-0d1d-4a35-8aeb-800efd7f5d1c",2124,"2016-09-30T00:04:31.293834-05:00","9abbe14c-6294-43b7-b062-899f4af2b49e_experiment.xml","cd0c604d92f85e3893b90393193d761c","f45ac4c0-0a4a-4603-a7a4-f3319e8a6086",2628,"2016-09-29T22:32:16.208486-05:00","9abbe14c-6294-43b7-b062-899f4af2b49e_run.xml","c052bb06577b1cae20c6dd9cd18bc95d","bb27e444-bbe0-4193-9f89-859096e9cc96",354,"2016-09-08T12:13:01.631551-05:00","TCGA-Q1-A6DW","2016-09-02T19:00:38.837566-05:00","female","TCGA-Q1-A6DW_demographic",1969,"white","c22b449a-8729-5b93-9b03-0ea84a6f4999","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A6DW_diagnosis","not reported",16200,"alive","8072/3",NA,534,"b3312aee-d34f-5d8d-8fa7-1ac6be7548cb","c53.9",-16200,"TCGA-Q1-A6DW_treatment","6b4b98a5-b7d2-5f2c-8de2-ae5dea985911","01","true","TCGA-Q1-A6DW-01A",NA,"984fc14d-24ee-429e-8172-996c0060aaf0",FALSE,"5C7158E0-E120-4D7C-A68D-FA3853507A83","Primary Tumor",NA,100,120,NA,1369872000,"11",30,"TCGA-Q1-A6DW-01A-11",60,NA,5,NA,0,NA,35,NA,"2016-09-08T12:13:01.631551-05:00",NA,5,NA,5,NA,"TOP",NA,5,NA,"58191c9e-2b8c-4f05-8ddd-4bff73193c5b",NA,"TCGA-Q1-A6DW-01A-01-TSA",NA,60,NA,"73596297-8b29-465e-893f-2cd7d1f4b367","RNA","TCGA-Q1-A6DW-01A-11R","cede7e20-a083-47ec-8477-f9c3064ab3bd",1.89,0.18,"UV Spec","R","23","TCGA-Q1-A6DW-01A-11R-A32P-07","c564836c-e7fd-48cc-8896-7d18028039f7",0.18,0.136986301369863,62,24.21875,160,"e48b32fe-1675-52fc-920d-228dd9d20050","TCGA-Q1-A6DW_exposure","UNCID_2332317.c564836c-e7fd-48cc-8896-7d18028039f7.131016_UNC15-SN850_0333_AC2MBAACXX_2_CCGTCC.tar.gz","2014-01-28T23:07:04.000Z","2014-01-28T23:23:02.000Z","9ABBE14C-6294-43B7-B062-899F4AF2B49E","984FC14D-24EE-429E-8172-996C0060AAF0","Unaligned reads",6073181301,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C564836C-E7FD-48CC-8896-7D18028039F7","University of North Carolina","564a3d3de4b093830b69db6c","5DBD5436-696E-40FA-881B-C2386573AC68","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","73596297-8B29-465E-893F-2CD7D1F4B367","2014-01-28T23:23:02.000Z","CEDE7E20-A083-47EC-8477-F9C3064AB3BD","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",100,"73596297-8B29-465E-893F-2CD7D1F4B367",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D724F57C-3058-4E1F-9B5F-F899F7388CF2.txt",120,"TCGA-Q1-A6DW-01A",NA,"B5C77B18-F27A-4CC5-9CF8-6107E83AAFDB","TCGA",2013,"TCGA-Q1-A6DW_NTE-1",NA,NA,"FF1F9B5B-93ED-4EB0-81F0-AC9BF6DB3767",44,"unc.edu.c564836c-e7fd-48cc-8896-7d18028039f7.2244940.junction_quantification.txt","Alive",NA,"TCGA-Q1-A6DW","NOT HISPANIC OR LATINO","B94C443F-87F8-4E11-868F-9D0584DA11C0","NO",175,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage I",NA,NA,"TX","8072/3","FEMALE","C53.9",335,NA,"688D49E9-6824-4101-9373-9A790A2915D1","WHITE",NA,11,30,"58191C9E-2B8C-4F05-8DDD-4BFF73193C5B","308CE4DD-650D-46B6-8E2B-2ABF411F4EC0","UNCID_2244903.c564836c-e7fd-48cc-8896-7d18028039f7.sorted_genome_alignments.bam","TCGA-Q1-A6DW-01A-11",60,0,5,5,35,"TOP",5,5,"TCGA-Q1-A6DW-01A-01-TSA",60,"Cisplatin","Chemotherapy","TCGA-Q1-A6DW-D46940","TCGA-Q1-A6DW-R46939","Internal","Primary Tumor Field","TCGA-Q1-A6DW-F62829_NTE-1","NO",534,NA,"Alive",NA,"TCGA-Q1-A6DW-F62829","TCGA-Q1-A6DW",NA,"Q1","A6DW","YES","C53.9","8072/3","C53.9","YES","NO",-16200,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",175,NA,NA,NA,NA,"YES",20,8,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,4,2009,2.5,NA,NA,"2009",2,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
117664606,115935503,5531314908,"86A5EDFB-9D06-4FED-BF57-F8D74A68E156.bw","5e39485a-ac6b-496d-9984-2ea8075f6a9b","86a5edfb-9d06-4fed-bf57-f8d74a68e156","2016-08-09T14:01:13.859865-05:00","UNCID_2169019.0ec8f213-1b87-4c8e-86b8-90362601df4a.130606_UNC9-SN296_0373_BD28T1ACXX_4_ACAGTG.tar.gz","f24286ef-a57e-4624-aa8c-c05ec9ab3d19",5736613123,"Illumina HiSeq","08598b6bfdc63695442c82615579df4a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:13:54.890850-05:00","2016-05-03T11:06:28.633852-05:00","f24286ef-a57e-4624-aa8c-c05ec9ab3d19_analysis.xml","ca69ac1fae9c29e65e2fa26040f012ea","d51999b9-9643-4f46-9ddc-9ed95979a677",2121,"2016-09-29T23:42:40.404634-05:00","f24286ef-a57e-4624-aa8c-c05ec9ab3d19_experiment.xml","f7fd4a6962c07b71139b54273158de89","e6f11afb-edcd-435b-972e-47e6afb28461",2431,"2016-09-29T21:24:32.533469-05:00","f24286ef-a57e-4624-aa8c-c05ec9ab3d19_run.xml","a86e2d1a13e78af608d5813da92b8445","915b4b0a-53fc-4cde-949c-cfe259a9ff1a",354,"2016-09-08T12:24:48.509604-05:00","TCGA-EA-A5ZE","2016-09-02T18:59:52.177107-05:00","female","TCGA-EA-A5ZE_demographic",1958,"asian","7e893582-d9d3-5334-b7dc-a8c06afd3abb","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A5ZE_diagnosis","not reported",19868,"alive","8070/3",NA,829,"e4be5f92-7db2-555c-b808-d88d76d15627","c53.9",-19868,"TCGA-EA-A5ZE_treatment","fe8867bf-08f0-594c-9467-023829fafc37","01","true","TCGA-EA-A5ZE-01A",NA,"9baa2c92-0111-4399-ad08-8f6169081ae8",FALSE,"316CE4CE-B951-4DFA-B2CC-B0512AA86871","Primary Tumor",NA,101,2320,NA,1363651200,"11",30,"TCGA-EA-A5ZE-01A-11",70,NA,0,NA,30,NA,10,NA,"2016-09-08T12:24:48.509604-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"4d91c3f4-dfc0-49a3-b0ad-046617b97a6f",NA,"TCGA-EA-A5ZE-01A-01-TSA",NA,60,NA,"b305ef6b-600e-4a7d-84c0-f24313346ae7","RNA","TCGA-EA-A5ZE-01A-11R","71f42f75-8c7e-42a2-aed4-dd064962d7f6",1.87,0.17,"UV Spec","R","23","TCGA-EA-A5ZE-01A-11R-A28H-07","0ec8f213-1b87-4c8e-86b8-90362601df4a",0.17,NA,55,23.4952368747063,153,"1146a0f1-091d-5053-bef4-47ef1a3d9cb2","TCGA-EA-A5ZE_exposure","UNCID_2169019.0ec8f213-1b87-4c8e-86b8-90362601df4a.130606_UNC9-SN296_0373_BD28T1ACXX_4_ACAGTG.tar.gz","2013-09-20T03:43:04.000Z","2013-09-20T03:58:02.000Z","F24286EF-A57E-4624-AA8C-C05EC9AB3D19","9BAA2C92-0111-4399-AD08-8F6169081AE8","Unaligned reads",5736613123,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0EC8F213-1B87-4C8E-86B8-90362601DF4A","University of North Carolina","5660755be4b0ca319164d05a","5E39485A-AC6B-496D-9984-2EA8075F6A9B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B305EF6B-600E-4A7D-84C0-F24313346AE7","2013-09-20T03:58:02.000Z","71F42F75-8C7E-42A2-AED4-DD064962D7F6","Vietnam","NO",1,NA,"Primary Tumor","Asterand",101,"B305EF6B-600E-4A7D-84C0-F24313346AE7",NA,"EA","32abf93283596ca89616f2d4da149a95.bam.bai",2320,"TCGA-EA-A5ZE-01A",NA,NA,"TCGA",2012,"TCGA-EA-A5ZE_NTE-1","Complete Remission/Response","TUMOR FREE","9BAA2C92-0111-4399-AD08-8F6169081AE8",54,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.07182B36-7B4A-4EE6-9A92-E922AC718242.txt","Alive",NA,"TCGA-EA-A5ZE","NOT HISPANIC OR LATINO","BAAFF3CC-EBA5-42F4-A37C-7B888D7C3504","NO",22,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",297,NA,NA,"ASIAN",NA,11,30,"4D91C3F4-DFC0-49A3-B0AD-046617B97A6F","5C3F07CF-CC75-41A2-BDA3-15F498976565","TCGA-EA-A5ZE-01A-11R-A28L-13_mirna.bam.bai","TCGA-EA-A5ZE-01A-11",70,30,0,0,10,"TOP",0,0,"TCGA-EA-A5ZE-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-EA-A5ZE-F57092_NTE-1","YES",456,"TUMOR FREE","Alive",NA,"TCGA-EA-A5ZE-F57092","TCGA-EA-A5ZE",NA,"EA","A5ZE","YES","C53.9","8070/3","C53.9","YES","NO",-19868,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",22,NA,NA,NA,"TUMOR FREE","YES",24,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
120810588,119420210,5702183810,"B9BD5134-2F6A-4454-8F83-69B63F9AE114.bw","5e972e96-7271-439a-905c-6e308c1ef29e","b9bd5134-2f6a-4454-8f83-69b63f9ae114","2016-08-26T07:55:40.419871-05:00","UNCID_2332363.736a30f9-fb53-422d-b66e-1af964011d15.131016_UNC15-SN850_0333_AC2MBAACXX_1_GTGAAA.tar.gz","3e95b7f8-51f4-41d2-82d8-ec64d8282059",5606152225,"Illumina HiSeq","69cf64133164899e00a33699c1cc802b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:14:52.317396-05:00","2016-05-03T11:35:41.346304-05:00","3e95b7f8-51f4-41d2-82d8-ec64d8282059_analysis.xml","53036b180205e1e3c5ae4cfb97c0092a","661f3629-85b8-4c74-8aed-85c8800c344b",2124,"2016-09-29T21:41:40.650448-05:00","3e95b7f8-51f4-41d2-82d8-ec64d8282059_experiment.xml","3a1be40140f6a613645ffa3d4d476291","9bd85876-e3fd-441d-9bb5-080477aef741",2628,"2016-09-29T18:36:07.293424-05:00","3e95b7f8-51f4-41d2-82d8-ec64d8282059_run.xml","b9faecd714ae17d8e8f77b7b363be29c","2877abab-3696-41be-a9fc-6110bf7ee8ef",354,"2016-09-08T11:42:21.690959-05:00","TCGA-MU-A5YI","2016-09-02T19:00:37.241191-05:00","female","TCGA-MU-A5YI_demographic",1951,"black or african american","8148ec81-6ebc-5e8c-849b-4097707dd702","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MU","1ae3c544-7f5e-51e8-b9c7-c8b8d809f268","University of Minnesota","not reported","c53.9","TCGA-MU-A5YI_diagnosis","not reported",21927,"alive","8070/3",NA,1053,"dc9128c1-f070-5b41-b5c0-14b7075aefe3","c53.9",-21927,"TCGA-MU-A5YI_treatment","97e988a4-d35f-52c4-9de0-8659b878be1f","01","true","TCGA-MU-A5YI-01A",NA,"2f247fcf-363e-4d72-97f7-68765989ff05",FALSE,"A762F957-1504-4FD5-9862-D7C8DD94A693","Primary Tumor",NA,593,150,NA,1363305600,"11",30,"TCGA-MU-A5YI-01A-11",70,NA,20,NA,0,NA,30,NA,"2016-09-08T11:42:21.690959-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"dfa60131-08f4-4e23-a5cf-3aa2ba62db2d",NA,"TCGA-MU-A5YI-01A-01-TSA",NA,70,NA,"02434b79-c056-479d-a648-141c9f3ac40d","RNA","TCGA-MU-A5YI-01A-11R","35ee7bd6-3b69-4622-9c71-4c25a11d6c84",1.87,0.18,"UV Spec","R","23","TCGA-MU-A5YI-01A-11R-A32P-07","736a30f9-fb53-422d-b66e-1af964011d15",0.18,0.547945205479452,101,32.9795918367347,175,"fbc244a2-7350-51cd-b422-3b83f041c292","TCGA-MU-A5YI_exposure","UNCID_2332363.736a30f9-fb53-422d-b66e-1af964011d15.131016_UNC15-SN850_0333_AC2MBAACXX_1_GTGAAA.tar.gz","2014-01-28T23:37:04.000Z","2014-01-28T23:52:02.000Z","3E95B7F8-51F4-41D2-82D8-EC64D8282059","2F247FCF-363E-4D72-97F7-68765989FF05","Unaligned reads",5606152225,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","736A30F9-FB53-422D-B66E-1AF964011D15","University of North Carolina","56607585e4b0b37b3d98f9a5","5E972E96-7271-439A-905C-6E308C1EF29E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","02434B79-C056-479D-A648-141C9F3AC40D","2014-01-28T23:52:02.000Z","35EE7BD6-3B69-4622-9C71-4C25A11D6C84","United States","NO",1,NA,"Primary Tumor","University of Minnesota",593,"02434B79-C056-479D-A648-141C9F3AC40D",NA,"MU","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.2A20CB75-42F9-4895-B3DC-9A6FBC9A1E59.txt",150,"TCGA-MU-A5YI-01A",NA,NA,"TCGA",2011,"TCGA-MU-A5YI_NTE-1",NA,"TUMOR FREE","935A0C11-F6BB-4F54-8635-944BA33ADF82",60,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.2A20CB75-42F9-4895-B3DC-9A6FBC9A1E59.txt","Alive",NA,"TCGA-MU-A5YI","NOT HISPANIC OR LATINO","8F97ECC2-B865-4097-8AC4-6606C889AFC1","NO",1,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Post-Adjuvant Therapy","Stage IA1",NA,NA,"T1a1","8070/3","FEMALE","C53.9",335,NA,"9532A85E-BA35-45D2-9789-5BABA2DB41C4","BLACK OR AFRICAN AMERICAN",NA,11,30,"DFA60131-08F4-4E23-A5CF-3AA2BA62DB2D","35EE7BD6-3B69-4622-9C71-4C25A11D6C84","UNCID_2332363.736a30f9-fb53-422d-b66e-1af964011d15.131016_UNC15-SN850_0333_AC2MBAACXX_1_GTGAAA.tar.gz","TCGA-MU-A5YI-01A-11",70,0,20,40,30,"TOP",0,20,"TCGA-MU-A5YI-01A-01-TSA",70,NA,NA,NA,"TCGA-MU-A5YI-R66327","External","Primary Tumor Field","TCGA-MU-A5YI-F60258_NTE-1","YES",1053,"WITH TUMOR","Alive",NA,"TCGA-MU-A5YI-F60258","TCGA-MU-A5YI",NA,"MU","A5YI","YES","C53.9","8070/3","C53.9","YES","NO",-21927,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",1,NA,NA,NA,"TUMOR FREE","YES",23,5,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,60,2011,"Other method, specify:","YES",18,0,"G2",NA,3,1991,10,NA,NA,"2009",4,NA,"T1a1NXMX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
198944394,197354043,9428431103,"082DA9E1-A40D-482B-8E21-A93BA97185F0.bw","5ed3c95a-10d0-4cd5-a54d-523e81587fb1","082da9e1-a40d-482b-8e21-a93ba97185f0","2016-08-05T09:14:56.094594-05:00","UNCID_2187264.7e67a342-4e90-47f9-9c95-03d32009e858.120917_UNC10-SN254_0380_AD1AV3ACXX_8_ATCACG.tar.gz","a2a2c0d2-e594-4893-bdcd-e25c076fb232",8963956502,"Illumina HiSeq","3919de5dbcb1ca92b91f3104295f0adc","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:16:37.393443-05:00","2016-05-03T11:02:00.408696-05:00","a2a2c0d2-e594-4893-bdcd-e25c076fb232_analysis.xml","15edd15e2d6d5690c223b59e57943e86","67266139-987c-44c9-ae0d-de7cfc8eab2b",2124,"2016-10-07T15:43:56.517744-05:00","a2a2c0d2-e594-4893-bdcd-e25c076fb232_experiment.xml","73fb2228fb00599977b8361614e04efd","f8c1269d-292e-49a3-884a-593635ebcfd3",2431,"2016-09-29T21:06:47.928763-05:00","a2a2c0d2-e594-4893-bdcd-e25c076fb232_run.xml","f9ba8b748cf6c843c965a65ba91a7b2a","86568e3b-c9c1-45e5-88eb-1b81a633865f",354,"2016-09-08T11:06:46.307327-05:00","TCGA-DS-A0VK","2016-09-02T18:54:40.173797-05:00","female","TCGA-DS-A0VK_demographic",1951,"white","7ea14920-4497-5668-90c7-b84fbb68f539","not hispanic or latino",1999,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A0VK_diagnosis","not reported",16792,"dead","8070/3",1118,NA,"f1e25836-e798-5ecd-901b-6bd87da9bd19","c53.9",-16792,"TCGA-DS-A0VK_treatment","d13c6b78-09fb-5df5-8b92-fb13e609a34d","01","true","TCGA-DS-A0VK-01A",NA,"0cdaf7e3-1b47-46cb-aff3-5e6762e8f094",FALSE,"0E3B9035-0498-4DDB-B2CD-12C823C5521B","Primary Tumor",NA,5025,210,NA,1291334400,"21",30,"TCGA-DS-A0VK-01A-21",70,60,0,0,0,35,20,10,"2016-09-08T11:06:46.307327-05:00","2016-09-08T11:06:46.307327-05:00",0,12,0,1,"BOTTOM","TOP",0,5,"b9e15339-8bdb-4c38-beaf-bd74fb53695b","2bdf09f2-14c9-4b13-9dd1-4038675bebc3","TCGA-DS-A0VK-01A-02-BSB","TCGA-DS-A0VK-01A-02-MSB",80,50,"1454a90d-7cde-4ec5-a29d-9b5b915c8676","RNA","TCGA-DS-A0VK-01A-21R","6b07dba7-8d7d-4ffe-8d51-b03d1b18c599",1.78,0.16,"UV Spec","R","23","TCGA-DS-A0VK-01A-21R-A10U-07","7e67a342-4e90-47f9-9c95-03d32009e858",0.16,NA,52,19.1000918273646,165,"aa2c9c99-6e1c-56f9-88d2-0044659cec2d","TCGA-DS-A0VK_exposure","UNCID_2187264.7e67a342-4e90-47f9-9c95-03d32009e858.120917_UNC10-SN254_0380_AD1AV3ACXX_8_ATCACG.tar.gz","2013-09-17T06:06:03.000Z","2013-09-17T06:29:01.000Z","A2A2C0D2-E594-4893-BDCD-E25C076FB232","0CDAF7E3-1B47-46CB-AFF3-5E6762E8F094","Unaligned reads",8963956502,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7E67A342-4E90-47F9-9C95-03D32009E858","University of North Carolina","564a3ecee4b0ef12181b85fb","5ED3C95A-10D0-4CD5-A54D-523E81587FB1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","1454A90D-7CDE-4EC5-A29D-9B5B915C8676","2013-09-17T06:29:01.000Z","6B07DBA7-8D7D-4FFE-8D51-B03D1B18C599","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",5025,"1454A90D-7CDE-4EC5-A29D-9B5B915C8676",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.4FB37041-5A5A-492B-B730-CE4D9D0839F7.txt",210,"TCGA-DS-A0VK-01A",NA,"E74BDCD2-CCDE-4FFD-96F8-9707F96B17C4","TCGA",1996,NA,NA,"WITH TUMOR","CE68EA9A-1DE5-4120-909C-5E4330B61FEC",45,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.4FB37041-5A5A-492B-B730-CE4D9D0839F7.txt","Dead",1118,"TCGA-DS-A0VK","NOT HISPANIC OR LATINO","C02BBDD4-D2D7-49F5-B308-24B974932404",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",88,NA,"D370E1F5-D2FF-4717-A8B3-91C9BEAC7470","WHITE",NA,21,30,"B9E15339-8BDB-4C38-BEAF-BD74FB53695B","7A330836-E254-4912-B199-5549E404979A","TCGA-DS-A0VK-01A-21R-A10V-13.mirna.quantification.txt","TCGA-DS-A0VK-01A-21",60,35,0,12,10,"TOP",5,1,"TCGA-DS-A0VK-01A-02-MSB",50,"Carboplatin","Chemotherapy","TCGA-DS-A0VK-D8640","TCGA-DS-A0VK-R8641","EXTERNAL BEAM","Local Recurrence","TCGA-DS-A0VK-F71138_NTE-1","YES",NA,"WITH TUMOR","Dead",1118,"TCGA-DS-A0VK-F71138","TCGA-DS-A0VK",NA,"DS","A0VK","YES","C53.9","8070/3","C53.9","NO","YES",-16792,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1118,NA,NA,"WITH TUMOR","NO",3,2,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,1996,"Other method, specify:",NA,16,1,"G3",NA,4,NA,NA,NA,NA,NA,6,NA,"T1b1N1M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
231572368,227040790,10835914255,"16A8343A-1203-44FB-9F03-05CC7C71B4CC.bw","5f22e050-c172-4f2d-a1f9-6cb749b6ef98","16a8343a-1203-44fb-9f03-05cc7c71b4cc","2016-08-09T14:40:48.764541-05:00","UNCID_2654402.878b8551-fb42-48bc-9403-178c568372cd.140924_UNC15-SN850_0394_AC5DG0ACXX_6_ATCACG.tar.gz","be886884-8449-4ffe-b0bc-76e4b038e543",11032621568,"Illumina HiSeq","d72a362979a9840a35928de0d1a6c5bb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:34:02.616434-05:00","2016-05-03T12:08:10.840133-05:00","be886884-8449-4ffe-b0bc-76e4b038e543_analysis.xml","0ccbb49278e796829d51ddbbf81a854e","2711d32a-330c-45f3-993b-31b5bd02c96a",2124,"2016-08-30T07:08:24.195310-05:00","be886884-8449-4ffe-b0bc-76e4b038e543_experiment.xml","fe887bdd9bc39b9f05cfe9e311247965","fd2354bc-ef35-4e94-bb46-a3cf78db8005",2628,"2016-09-29T21:06:02.307356-05:00","be886884-8449-4ffe-b0bc-76e4b038e543_run.xml","2a8655694487df28e7fdf2971aca471f","85d32181-9050-4804-9896-0427e6002279",354,"2016-09-08T11:14:00.404330-05:00","TCGA-ZJ-AAXN","2016-09-02T18:54:46.093032-05:00","female","TCGA-ZJ-AAXN_demographic",1976,"white","bab1fa1e-2c4e-5de5-9bae-6a9744b6c1c2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXN_diagnosis","not reported",12701,"alive","8072/3",NA,0,"6fbb0e59-acad-5a63-ac6e-c6eee1f9f56b","c53.9",-12701,"TCGA-ZJ-AAXN_treatment","131b4321-74a4-5b58-9ce1-2659e5068321","01","true","TCGA-ZJ-AAXN-01A",NA,"019e7aee-73c9-4330-b4d0-493a97d654b0",FALSE,"33662E91-6459-47D9-858A-243D8E54EB63","Primary Tumor",NA,1190,250,NA,1396224000,"11",30,"TCGA-ZJ-AAXN-01A-11",95,NA,0,NA,0,NA,10,NA,"2016-09-08T11:14:00.404330-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"dbbe7777-b156-4c26-bf98-d8f499a59306",NA,"TCGA-ZJ-AAXN-01A-01-TSA",NA,90,NA,"c0de2c0e-86be-4afb-a302-998759f160ad","RNA","TCGA-ZJ-AAXN-01A-11R","8caa4ab0-9364-47ff-93fc-fbde4765ffad",1.86,0.16,"UV Spec","R","23","TCGA-ZJ-AAXN-01A-11R-A42T-07","878b8551-fb42-48bc-9403-178c568372cd",0.16,0.115068493150685,59,19.7133215276154,173,"0feb190e-fa6c-564e-9cb1-423d5c284b2a","TCGA-ZJ-AAXN_exposure","UNCID_2654402.878b8551-fb42-48bc-9403-178c568372cd.140924_UNC15-SN850_0394_AC5DG0ACXX_6_ATCACG.tar.gz","2014-11-05T14:27:03.000Z","2014-11-05T14:50:22.000Z","BE886884-8449-4FFE-B0BC-76E4B038E543","019E7AEE-73C9-4330-B4D0-493A97D654B0","Unaligned reads",11032621568,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","878B8551-FB42-48BC-9403-178C568372CD","University of North Carolina","564a3e49e4b08c5d86926cb7","5F22E050-C172-4F2D-A1F9-6CB749B6EF98","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C0DE2C0E-86BE-4AFB-A302-998759F160AD","2014-11-05T14:50:22.000Z","8CAA4AB0-9364-47FF-93FC-FBDE4765FFAD","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1190,"C0DE2C0E-86BE-4AFB-A302-998759F160AD",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.41D2098E-6DAA-424E-9FFB-24A6C1D89A13.txt",250,"TCGA-ZJ-AAXN-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXN_NTE-1",NA,NA,"019E7AEE-73C9-4330-B4D0-493A97D654B0",34,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.41D2098E-6DAA-424E-9FFB-24A6C1D89A13.txt","Alive",NA,"TCGA-ZJ-AAXN","NOT HISPANIC OR LATINO",NA,NA,0,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8072/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"DBBE7777-B156-4C26-BF98-D8F499A59306","8CAA4AB0-9364-47FF-93FC-FBDE4765FFAD","SPRAY_p_TCGAb_420_430_NSP_GenomeWideSNP_6_A08_1524430.CEL","TCGA-ZJ-AAXN-01A-11",95,0,0,0,10,"TOP",0,0,"TCGA-ZJ-AAXN-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXN",NA,"ZJ","AAXN","YES","C53.9","8072/3","C53.9","NO","YES",-12701,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",31,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,34,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,NA,NA,2,NA,2.1,NA,NA,"2009",8,NA,"T1b2N1M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
60257468,59445077,2839492733,"00439565-02CE-4BF5-956D-7078B51C0947.bw","60cfa29f-4770-4ee4-aa37-787f53155662","00439565-02ce-4bf5-956d-7078b51c0947","2016-08-05T02:50:30.341545-05:00","UNCID_2654395.c518438f-04e1-4330-b440-4046002d10b8.141010_UNC12-SN629_0394_AC5FTUACXX_2_GATCAG.tar.gz","022ea997-f464-46d0-90ea-768101fb8191",2506773096,"Illumina HiSeq","83e5a7b66af5de7a47519d2c4e0c78f3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:30:47.241863-05:00","2016-05-03T12:08:10.830175-05:00","022ea997-f464-46d0-90ea-768101fb8191_analysis.xml","3bcd264620af13ec9a8aa0675a90b536","9539cac0-c290-4c54-8163-3eeb05d8eef1",2123,"2016-09-29T21:26:12.278527-05:00","022ea997-f464-46d0-90ea-768101fb8191_experiment.xml","b94621d65b1c75a7440eac666aa6018f","925e1e95-788b-4a21-8ac3-5b5d1f633193",2628,"2016-09-29T19:53:56.084888-05:00","022ea997-f464-46d0-90ea-768101fb8191_run.xml","5a76bd9bfa625de85adf857284d99535","596e6b5f-1dc0-486d-931f-4a196a6185f3",354,"2016-09-08T11:21:13.678107-05:00","TCGA-VS-A9UD","2016-09-02T18:54:22.315026-05:00","female","TCGA-VS-A9UD_demographic",1940,"white","b9248212-3410-5c7e-a888-9ef9ebc858f4","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UD_diagnosis","not reported",26815,"alive","8070/3",NA,739,"37e59238-1894-5418-86b2-efb8bb4d356a","c53.9",-26815,"TCGA-VS-A9UD_treatment","484d06b2-3dd5-5347-8545-6aa884969b54","01","false","TCGA-VS-A9UD-01A",NA,"0297296c-67da-430d-bb1d-6c21435e37c1",FALSE,"D0920498-DCB8-454A-A294-204A280D4129","Primary Tumor",NA,327,160,NA,1390953600,"11",30,"TCGA-VS-A9UD-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T11:21:13.678107-05:00",NA,30,NA,70,NA,"TOP",NA,0,NA,"7445bb75-de05-4763-88a0-3184440169ba",NA,"TCGA-VS-A9UD-01A-01-TSA",NA,80,NA,"6c744b85-28fb-4cb1-b157-893517afe1b7","RNA","TCGA-VS-A9UD-01A-11R","45a5dd9f-e342-4e23-bc57-3aba67c09226",1.85,0.17,"UV Spec","R","23","TCGA-VS-A9UD-01A-11R-A42T-07","c518438f-04e1-4330-b440-4046002d10b8",0.17,NA,64,24.6904054627522,161,"c2875b7a-cdff-5bae-997d-44afb38aa8f8","TCGA-VS-A9UD_exposure","UNCID_2654395.c518438f-04e1-4330-b440-4046002d10b8.141010_UNC12-SN629_0394_AC5FTUACXX_2_GATCAG.tar.gz","2014-11-05T11:06:04.000Z","2014-11-05T11:17:35.000Z","022EA997-F464-46D0-90EA-768101FB8191","0297296C-67DA-430D-BB1D-6C21435E37C1","Unaligned reads",2506773096,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C518438F-04E1-4330-B440-4046002D10B8","University of North Carolina","56607715e4b0ca319164e2e3","60CFA29F-4770-4EE4-AA37-787F53155662","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6C744B85-28FB-4CB1-B157-893517AFE1B7","2014-11-05T11:17:35.000Z","45A5DD9F-E342-4E23-BC57-3ABA67C09226","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",327,"6C744B85-28FB-4CB1-B157-893517AFE1B7",NA,"VS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BF375F3D-D2CF-49AB-BD47-43A4062F0781.txt",160,"TCGA-VS-A9UD-01A",NA,"535F5BEE-B950-4EE1-89A0-C45F7565B1B7","TCGA",2013,"TCGA-VS-A9UD_NTE-1","Complete Remission/Response","TUMOR FREE","F73E6812-7F22-4EB3-964B-0F30619BEC67",73,"WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_C08_1524118.nocnv_hg19.seg.txt","Alive",NA,"TCGA-VS-A9UD",NA,"62DE1494-3440-4432-AE5D-534F48BBF283","NO",417,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIIA",NA,NA,"T3a","8070/3","FEMALE","C53.9",420,NA,"8402AECA-469A-47A6-B9BD-327FEAD5BF75","WHITE",NA,11,30,"7445BB75-DE05-4763-88A0-3184440169BA","B73E1370-8E04-4B8B-834D-BE2C9C7A676A","989fbb8c5efe92035c76d9762e820e63.bam.bai","TCGA-VS-A9UD-01A-11",80,0,0,30,20,"TOP",0,70,"TCGA-VS-A9UD-01A-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-VS-A9UD-D63434","TCGA-VS-A9UD-R63433","Internal","Primary Tumor Field","TCGA-VS-A9UD-F67685_NTE-1","NO",599,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UD-F67685","TCGA-VS-A9UD",NA,"VS","A9UD","YES","C53.9","8070/3","C53.9","NO","YES",-26815,"FEMALE","WHITE",NA,"No","No","Alive",417,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,73,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",15,NA,"T3aNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
202624576,193865895,9248199844,"7B2BD361-2BF1-4E97-BC08-457F5A9C2682.bw","61eb08d0-ea01-45e7-884b-ac3d6070172a","7b2bd361-2bf1-4e97-bc08-457f5a9c2682","2016-08-09T13:56:05.661656-05:00","UNCID_2186969.0e842eda-bb7f-4f4a-b1bc-9d6dcf563125.121002_UNC11-SN627_0254_AC0WP5ACXX_4_GTGAAA.tar.gz","003de740-7ed3-4a65-b742-3cb1762dcd0d",8517604547,"Illumina HiSeq","ff9a91a6b88875c985233b27d51589c6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:21:51.314443-05:00","2016-05-03T11:01:14.488541-05:00","003de740-7ed3-4a65-b742-3cb1762dcd0d_analysis.xml","c0a83530416b9cdfd47a01b59150922d","6a60db06-71f5-4fa4-8c88-759d7df1bd88",2124,"2016-09-29T19:08:12.915207-05:00","003de740-7ed3-4a65-b742-3cb1762dcd0d_experiment.xml","ee100f998b499b14f7aec1e96c61be37","3cd476d2-3298-42a4-934b-1e9157a448e9",2431,"2016-09-29T22:57:57.727523-05:00","003de740-7ed3-4a65-b742-3cb1762dcd0d_run.xml","5209d06d75aad821b2e0ae2b06563ce0","cb106231-4483-443c-8299-4b13451e047a",354,"2016-09-08T11:35:18.229935-05:00","TCGA-EK-A2RL","2016-09-02T18:58:29.469820-05:00","female","TCGA-EK-A2RL_demographic",1977,"black or african american","4bfd21b8-c2f3-5938-99ea-52321bc20aaa","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RL_diagnosis","not reported",12047,"dead","8384/3",1453,721,"aed6398a-ac07-597a-8659-0c096a357476","c53.9",-12047,"TCGA-EK-A2RL_treatment","4526c2e6-f732-5e88-a5fd-b6f0c264e7c4","01","false","TCGA-EK-A2RL-01A",NA,"dd3e80d9-0321-40ad-b963-25e2c94c6092",FALSE,"7AE4CF2E-602B-4860-8919-095EA5378504","Primary Tumor",NA,723,140,NA,1315785600,"11",30,"TCGA-EK-A2RL-01A-11",70,NA,1,NA,0,NA,25,NA,"2016-09-08T11:35:18.229935-05:00",NA,3,NA,20,NA,"TOP",NA,2,NA,"f2cd492a-f4d7-4939-bfbc-25ca2ed7868b",NA,"TCGA-EK-A2RL-01A-01-TS1",NA,73,NA,"483698bc-a9f3-4172-a95b-b9ba77779e94","RNA","TCGA-EK-A2RL-01A-11R","d8cc11d9-9099-44fb-a342-98134d4a16f1",1.79,0.15,"UV Spec","R","23","TCGA-EK-A2RL-01A-11R-A18M-07","0e842eda-bb7f-4f4a-b1bc-9d6dcf563125",0.15,NA,89,37.5274076572778,154,"21dd309e-4031-56c4-a907-e4294565e743","TCGA-EK-A2RL_exposure","UNCID_2186969.0e842eda-bb7f-4f4a-b1bc-9d6dcf563125.121002_UNC11-SN627_0254_AC0WP5ACXX_4_GTGAAA.tar.gz","2013-09-16T07:36:03.000Z","2013-09-16T20:25:01.000Z","003DE740-7ED3-4A65-B742-3CB1762DCD0D","DD3E80D9-0321-40AD-B963-25E2C94C6092","Unaligned reads",8517604547,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0E842EDA-BB7F-4F4A-B1BC-9D6DCF563125","University of North Carolina","564a40cfe4b093830b6b01b8","61EB08D0-EA01-45E7-884B-AC3D6070172A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","483698BC-A9F3-4172-A95B-B9BA77779E94","2013-09-16T20:25:01.000Z","D8CC11D9-9099-44FB-A342-98134D4A16F1","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",723,"483698BC-A9F3-4172-A95B-B9BA77779E94",NA,"EK","5db04494568d95a5c0bc4e382c4d5954.bam.bai",140,"TCGA-EK-A2RL-01A",NA,NA,"TCGA",2009,NA,NA,"TUMOR FREE","DD3E80D9-0321-40AD-B963-25E2C94C6092",32,"CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_B06_871060.ismpolish.data.txt","Alive",NA,"TCGA-EK-A2RL","NOT HISPANIC OR LATINO","2581A1BD-9D81-4102-9D22-BC4A42C3056A",NA,721,"No","Cervix","C53.9","N1","Endocervical Type of Adenocarcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b1","8384/3","FEMALE","C53.9",179,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"F2CD492A-F4D7-4939-BFBC-25CA2ED7868B","A01D8DB2-7B37-4140-84BB-106987F04ABE","5db04494568d95a5c0bc4e382c4d5954.bam","TCGA-EK-A2RL-01A-11",70,0,1,3,25,"TOP",2,20,"TCGA-EK-A2RL-01A-01-TS1",73,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RL-F58210_NTE-1","YES",NA,"WITH TUMOR","Dead",1453,"TCGA-EK-A2RL-F58210","TCGA-EK-A2RL",NA,"EK","A2RL","YES","C53.9","8384/3","C53.9","NO","YES",-12047,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",721,NA,NA,NA,"TUMOR FREE","NO",1,12,2011,"YES","YES","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,32,2009,"Other method, specify:","YES",33,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",6,NA,"T1b1N1MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
190670394,186872823,8931037692,"C1D8439A-D527-47F6-ADC1-25867B65DA21.bw","6248f2a3-0da9-419f-ab77-c3f6f4353eb5","c1d8439a-d527-47f6-adc1-25867b65da21","2016-08-05T04:03:55.561744-05:00","UNCID_2186568.A5793D2B-3DEC-477F-B29B-163D235431AC.121015_UNC11-SN627_0256_AD15B2ACXX_2_AGTCAA.tar.gz","d835e685-0dd2-4379-a9df-d6865788864d",8324145632,"Illumina HiSeq","9b43fc823fb398fdb73132a32be119f2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:32:14.422474-05:00","2016-05-03T11:01:14.497317-05:00","d835e685-0dd2-4379-a9df-d6865788864d_analysis.xml","6b71f9973beadd136d6f07368cb9bc1a","96193abe-90ae-4869-bcd0-a30c0df3bee4",2124,"2016-09-29T20:58:06.526983-05:00","d835e685-0dd2-4379-a9df-d6865788864d_experiment.xml","87618daa1923bc4150f3156d715cf3b8","80cdbcce-dfc9-469d-8978-36f9c816c17e",2431,"2016-09-29T18:57:44.550746-05:00","d835e685-0dd2-4379-a9df-d6865788864d_run.xml","eff61b14830332da2c3f989de2817c14","36438928-6cc7-45b0-b960-0f44b327440d",354,"2016-09-08T11:36:23.594560-05:00","TCGA-DG-A2KH","2016-09-02T18:59:27.402097-05:00","female","TCGA-DG-A2KH_demographic",NA,"not reported","3abbdcb8-493d-5f6d-891c-9197eab6e0ec","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DG","fa63e449-4302-5d16-bd2c-76f031746194","Ontario Institute for Cancer Research","not reported","c53.9","TCGA-DG-A2KH_diagnosis","not reported",9209,"alive","8140/3",NA,34,"5dd75709-7047-52bd-9631-f683d084d78b","c53.9",-9209,"TCGA-DG-A2KH_treatment","5995bd91-d57c-5762-b0b5-4e9559723257","01","false","TCGA-DG-A2KH-01A",NA,"6f0c0187-4fc7-492c-bb0d-535e0f9976c4",FALSE,"E92814BB-F3A7-45E6-9F18-B775CD53693F","Primary Tumor",NA,NA,120,NA,1333497600,"21",30,"TCGA-DG-A2KH-01A-21",80,NA,10,NA,0,NA,10,NA,"2016-09-08T11:36:23.594560-05:00",NA,40,NA,30,NA,"TOP",NA,10,NA,"2e262317-ee18-48e9-a922-1ec92f75c77e",NA,"TCGA-DG-A2KH-01A-02-MSB",NA,80,NA,"114ee137-a85c-4f02-a7d4-a69738b54bed","RNA","TCGA-DG-A2KH-01A-21R","250872b4-dea8-4831-95c1-f0ecba0236ae",1.83,0.15,"UV Spec","R","23","TCGA-DG-A2KH-01A-21R-A22U-07","a5793d2b-3dec-477f-b29b-163d235431ac",0.15,NA,NA,NA,NA,"b2f4df5a-dbd1-513b-a88d-d98ff45e735d","TCGA-DG-A2KH_exposure","UNCID_2186568.A5793D2B-3DEC-477F-B29B-163D235431AC.121015_UNC11-SN627_0256_AD15B2ACXX_2_AGTCAA.tar.gz","2013-09-16T20:46:05.000Z","2013-09-16T21:14:02.000Z","D835E685-0DD2-4379-A9DF-D6865788864D","6F0C0187-4FC7-492C-BB0D-535E0F9976C4","Unaligned reads",8324145632,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A5793D2B-3DEC-477F-B29B-163D235431AC","University of North Carolina","56607713e4b018727fea115e","6248F2A3-0DA9-419F-AB77-C3F6F4353EB5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","114EE137-A85C-4F02-A7D4-A69738B54BED","2013-09-16T21:14:02.000Z","250872B4-DEA8-4831-95C1-F0ECBA0236AE","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"114EE137-A85C-4F02-A7D4-A69738B54BED",NA,"DG","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.857EBB46-CE0C-4F46-80F5-DFDD54ECC704.txt",120,"TCGA-DG-A2KH-01A",NA,NA,"TCGA",NA,"TCGA-DG-A2KH_NTE-1",NA,NA,"800667FD-7E05-4A1F-9C22-A7BCFF0AA630",25,"nationwidechildrens.org_clinical.TCGA-DG-A2KH.xml","Alive",NA,"TCGA-DG-A2KH",NA,"D6D4D2CC-35F3-435C-8DFF-F764574A1CA4",NA,34,"No","Cervix","C53.9","N0","Adenosquamous",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8140/3","FEMALE","C53.9",236,NA,NA,NA,NA,21,30,"2E262317-EE18-48E9-A922-1EC92F75C77E","E93D41EA-5BE5-4995-9454-E9939B211050","8894ceddbee870f11da6f2ebb9b53edf.bam.bai","TCGA-DG-A2KH-01A-21",80,0,10,40,10,"TOP",10,30,"TCGA-DG-A2KH-01A-02-MSB",80,NA,NA,NA,NA,NA,NA,"TCGA-DG-A2KH-F49830_NTE-1",NA,NA,NA,NA,NA,"TCGA-DG-A2KH-F49830","TCGA-DG-A2KH",NA,"DG","A2KH","YES","C53.9","8140/3","C53.9","NO","YES",-9209,"FEMALE",NA,NA,"No","No","Alive",34,NA,NA,NA,NA,"NO",11,10,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Adenosquamous",NA,0,25,NA,"Biopsy (cervical / CT-guided / Other)","YES",12,0,"GX",NA,4,NA,NA,NA,NA,"1995",7,NA,"T1b1N0M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
199731584,196177228,9359807353,"D9096909-1439-462D-B69C-CAD1BF4F420C.bw","638035f6-2909-4a44-980f-468ac5d74e18","d9096909-1439-462d-b69c-cad1bf4f420c","2016-08-09T13:10:02.093071-05:00","UNCID_2186725.7feffd22-85c5-4bf9-9a41-28a1f4e0586d.121011_UNC13-SN749_0197_AD16K1ACXX_3_CAGATC.tar.gz","e40046eb-22fa-4162-bdac-e93057de7e8b",8918191878,"Illumina HiSeq","d3cb6f15c27c5d23c895890526781f56","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:35.007487-05:00","2016-05-03T11:00:24.467501-05:00","e40046eb-22fa-4162-bdac-e93057de7e8b_analysis.xml","2478c4879a5f4b669b91265e6a83c790","de12a47b-2bf6-4fb8-ac21-0d052a1fa8cf",2124,"2016-09-29T19:31:09.965177-05:00","e40046eb-22fa-4162-bdac-e93057de7e8b_experiment.xml","83cdad50fbcf2401038c6d725d7eba53","4b59db52-36fb-4648-b2ba-8f4b60a0969f",2431,"2016-09-29T23:42:12.019120-05:00","e40046eb-22fa-4162-bdac-e93057de7e8b_run.xml","9d544023c4d9ed30673dcbb81d57f9b2","e6a23dd6-5045-4ce0-bd06-ef8d40574e30",354,"2016-09-08T12:07:53.639257-05:00","TCGA-EA-A3HR","2016-09-02T18:58:42.889882-05:00","female","TCGA-EA-A3HR_demographic",1954,"white","dd8576a8-bd62-55e7-b0df-7233ceded2fb","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3HR_diagnosis","not reported",20980,"alive","8070/3",NA,940,"9f99f63e-b7d7-5fe4-8bd2-29c9d8d56595","c53.9",-20980,"TCGA-EA-A3HR_treatment","753d67cd-f2bc-53cd-8b73-7203478fa6ba","01","true","TCGA-EA-A3HR-01A",NA,"1fbfa952-f272-4531-9f9d-1b8bd1dd0845",FALSE,"BE99BE0C-3FB8-4AE6-B66D-977B858D880E","Primary Tumor",NA,219,1820,NA,1323820800,"11",30,"TCGA-EA-A3HR-01A-11",75,NA,1,NA,20,NA,5,NA,"2016-09-08T12:07:53.639257-05:00",NA,1,NA,0,NA,"TOP",NA,10,NA,"bf26d24d-f4ae-44a7-bed3-16cd77a350cb",NA,"TCGA-EA-A3HR-01A-01-TSA",NA,65,NA,"0bfaff33-8163-4428-a28f-6afa01df51aa","RNA","TCGA-EA-A3HR-01A-11R","d602c332-3581-45e3-94b4-8ccffabbe6d3",1.87,0.18,"UV Spec","R","23","TCGA-EA-A3HR-01A-11R-A213-07","7feffd22-85c5-4bf9-9a41-28a1f4e0586d",0.18,NA,86,40.3452805404391,146,"0e7265ab-bf65-50c7-bf33-96a7ac452d7c","TCGA-EA-A3HR_exposure","UNCID_2186725.7feffd22-85c5-4bf9-9a41-28a1f4e0586d.121011_UNC13-SN749_0197_AD16K1ACXX_3_CAGATC.tar.gz","2013-09-16T13:01:04.000Z","2013-09-16T13:45:01.000Z","E40046EB-22FA-4162-BDAC-E93057DE7E8B","1FBFA952-F272-4531-9F9D-1B8BD1DD0845","Unaligned reads",8918191878,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7FEFFD22-85C5-4BF9-9A41-28A1F4E0586D","University of North Carolina","564a3c92e4b0298dd2c8c7cf","638035F6-2909-4A44-980F-468AC5D74E18","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0BFAFF33-8163-4428-A28F-6AFA01DF51AA","2013-09-16T13:45:01.000Z","D602C332-3581-45E3-94B4-8CCFFABBE6D3","Russia","NO",1,NA,"Primary Tumor","Asterand",219,"0BFAFF33-8163-4428-A28F-6AFA01DF51AA",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1AC7B9FF-7D24-4540-98B2-CAC49BFC4E5C.txt",1820,"TCGA-EA-A3HR-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","1FBFA952-F272-4531-9F9D-1B8BD1DD0845",57,"OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_E11_955308.tangent.copynumber.data.txt","Alive",NA,"TCGA-EA-A3HR","NOT HISPANIC OR LATINO","428B7DEF-957B-4563-B463-3721D9EFAA3E",NA,40,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage II",NA,NA,"T2a","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"BF26D24D-F4AE-44A7-BED3-16CD77A350CB","D602C332-3581-45E3-94B4-8CCFFABBE6D3","dd44d253e61da96546b7c66ba228dc78.bam.bai","TCGA-EA-A3HR-01A-11",75,20,1,1,5,"TOP",10,0,"TCGA-EA-A3HR-01A-01-TSA",65,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3HR-F66108_NTE-1","NO",940,"TUMOR FREE","Alive",NA,"TCGA-EA-A3HR-F66108","TCGA-EA-A3HR",NA,"EA","A3HR","YES","C53.9","8070/3","C53.9","YES","NO",-20980,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"TUMOR FREE","NO",20,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,57,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",11,0,"G2",NA,1,NA,NA,NA,NA,"2009",9,NA,"T2aN0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
179331904,176819558,8440525473,"7822EA86-35A1-4285-9429-2B63111B9885.bw","63bffdb1-bc08-4175-8be7-d7a056d19816","7822ea86-35a1-4285-9429-2b63111b9885","2016-08-09T13:14:00.493887-05:00","UNCID_2186691.6F54279A-F0B1-4E9D-9E71-7F91CEF40BA2.121011_UNC13-SN749_0197_AD16K1ACXX_7_CCGTCC.tar.gz","3ff4f09e-cd41-4e9f-a5c6-bfb6e3eba06d",8007645577,"Illumina HiSeq","abc54af94ce5cd6ae75fe1fa9d6a029d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:04:16.149133-05:00","2016-05-03T11:00:24.467483-05:00","3ff4f09e-cd41-4e9f-a5c6-bfb6e3eba06d_analysis.xml","9c07dbe1316989d915bdff281b233801","14b78a8d-2018-4848-be06-77f6aa429ecc",2124,"2016-10-07T17:25:49.610660-05:00","3ff4f09e-cd41-4e9f-a5c6-bfb6e3eba06d_experiment.xml","9d2b77cdd165aa6a72f1a006d1d4f105","62fb5165-bcbd-43e8-95e1-5bf44a54c54e",2431,"2016-09-30T00:00:42.266007-05:00","3ff4f09e-cd41-4e9f-a5c6-bfb6e3eba06d_run.xml","186369b103a1e62f6e8949d8ada5cb4d","f212fc25-465e-4e07-adeb-ff317a819f2c",354,"2016-09-08T12:01:51.109258-05:00","TCGA-DS-A3LQ","2016-09-02T18:59:01.248624-05:00","female","TCGA-DS-A3LQ_demographic",1965,"not reported","3dec555b-a52c-5de8-a79d-5f66e2131562","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A3LQ_diagnosis","not reported",16861,"alive","8070/3",NA,699,"22768148-8582-55f9-919c-27605d117faf","c53.9",-16861,"TCGA-DS-A3LQ_treatment","eb288707-f190-537f-b0c7-e2b1bdb03855","01","true","TCGA-DS-A3LQ-01A",NA,"0959274f-e74e-4288-8229-4fb1a2bfc185",FALSE,"179CB483-18CC-4770-9C5E-22B5CC1E80C4","Primary Tumor",NA,175,180,NA,1326153600,"21",10,"TCGA-DS-A3LQ-01A-21",75,NA,0,NA,0,NA,20,NA,"2016-09-08T12:01:51.109258-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"85afba0d-9629-4731-9984-f93ccd59bd4d",NA,"TCGA-DS-A3LQ-01A-02-TSB",NA,75,NA,"e0954c78-2e6b-49fc-bad4-9c4cd575c007","RNA","TCGA-DS-A3LQ-01A-21R","5c88e97c-4c01-42b2-8793-65415bb7cab4",1.74,0.17,"UV Spec","R","23","TCGA-DS-A3LQ-01A-21R-A21T-07","6f54279a-f0b1-4e9d-9e71-7f91cef40ba2",0.17,NA,72,27.0992510068124,163,"7169aa94-00e6-50d4-a53c-c5e7e378240e","TCGA-DS-A3LQ_exposure","UNCID_2186691.6F54279A-F0B1-4E9D-9E71-7F91CEF40BA2.121011_UNC13-SN749_0197_AD16K1ACXX_7_CCGTCC.tar.gz","2013-09-16T12:06:04.000Z","2013-09-16T12:32:02.000Z","3FF4F09E-CD41-4E9F-A5C6-BFB6E3EBA06D","0959274F-E74E-4288-8229-4FB1A2BFC185","Unaligned reads",8007645577,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6F54279A-F0B1-4E9D-9E71-7F91CEF40BA2","University of North Carolina","564a3d11e4b08c5d86920a38","63BFFDB1-BC08-4175-8BE7-D7A056D19816","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E0954C78-2E6B-49FC-BAD4-9C4CD575C007","2013-09-16T12:32:02.000Z","5C88E97C-4C01-42B2-8793-65415BB7CAB4","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",175,"E0954C78-2E6B-49FC-BAD4-9C4CD575C007",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8048B959-1198-4626-B674-E34FB36F51CD.txt",180,"TCGA-DS-A3LQ-01A",NA,"64E076D2-EC46-4033-B991-A5716A6D19A7","TCGA",2011,NA,NA,NA,"44F7A662-8B47-4D2E-9F8F-6CEEA06B54FE",46,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8048B959-1198-4626-B674-E34FB36F51CD.txt","Alive",NA,"TCGA-DS-A3LQ",NA,"EF313955-358D-40A1-A039-D40D4199BA5C",NA,183,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",217,NA,"CDA2C507-A9F4-4593-8F5A-C46423C7F228",NA,NA,21,10,"85AFBA0D-9629-4731-9984-F93CCD59BD4D","5C88E97C-4C01-42B2-8793-65415BB7CAB4","CENTS_p_TCGASNP_212_216_217_N_GenomeWideSNP_6_B05_1039510.CEL","TCGA-DS-A3LQ-01A-21",75,0,0,0,20,"TOP",5,0,"TCGA-DS-A3LQ-01A-02-TSB",75,"Cisplatin","Chemotherapy","TCGA-DS-A3LQ-D31100","TCGA-DS-A3LQ-R31101","EXTERNAL BEAM","Primary Tumor Field","TCGA-DS-A3LQ-F51567_NTE-1","NO",699,"TUMOR FREE","Alive",NA,"TCGA-DS-A3LQ-F51567","TCGA-DS-A3LQ",NA,"DS","A3LQ","YES","C53.9","8070/3","C53.9","YES","NO",-16861,"FEMALE",NA,NA,"No","No","Alive",183,NA,NA,NA,NA,"NO",23,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2011,"Cone Biopsy / LEEP","YES",8,1,"G3",NA,3,1978,NA,NA,NA,"2009",16,NA,"T3bN1M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
179750602,177359596,8464207137,"6FD0CFC8-AC8D-4CF1-8C33-833AD98A30EF.bw","63dcfa32-c69e-45ad-bea3-ae672acb11c6","6fd0cfc8-ac8d-4cf1-8c33-833ad98a30ef","2016-08-09T13:19:06.248808-05:00","UNCID_2185449.26cdb816-44f0-4ff6-a674-93ec31d64fed.130129_UNC13-SN749_0217_BD1MTTACXX_6_CGATGT.tar.gz","e4dad31f-3b56-4377-b92b-3e8b184415b0",8299024585,"Illumina HiSeq","87383b3ef9214c9f0bad285a8ebdfd2c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:31:48.077936-05:00","2016-05-03T10:58:56.648400-05:00","e4dad31f-3b56-4377-b92b-3e8b184415b0_analysis.xml","3fe04c46565c06bade2cd2be9d81e223","badb45ab-c141-4d7d-83b3-04587eb704e3",2123,"2016-10-07T16:20:19.937054-05:00","e4dad31f-3b56-4377-b92b-3e8b184415b0_experiment.xml","c037dd7678798828ee9fb543faf598f7","0cad118c-c315-440f-99d6-13ae5a769979",2431,"2016-09-29T20:18:40.054531-05:00","e4dad31f-3b56-4377-b92b-3e8b184415b0_run.xml","c93b0f71a94c7d80d31a9d25c63111c2","685fc4ba-0fda-43b0-8146-798f59dc060d",354,"2016-09-08T12:08:33.409976-05:00","TCGA-FU-A40J","2016-09-02T18:59:38.405528-05:00","female","TCGA-FU-A40J_demographic",1974,"white","2c6d514b-5314-5187-bf75-e08da9c8f869","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A40J_diagnosis","not reported",14182,"alive","8384/3",NA,426,"09692d7a-7372-57d9-9668-270bd2a0c513","c53.9",-14182,"TCGA-FU-A40J_treatment","18dcfa02-a210-560c-aebd-f72345401395","01","false","TCGA-FU-A40J-01A",NA,"79662c1c-ede3-4206-b294-6dd8cd8db438",FALSE,"7C1993F0-1B9B-4C33-B644-ED3FC16F3A7F","Primary Tumor",NA,76,170,NA,1341446400,"11",30,"TCGA-FU-A40J-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T12:08:33.409976-05:00",NA,3,NA,0,NA,"TOP",NA,1,NA,"5c8431ab-0765-4a3f-a990-91bd5d0c0286",NA,"TCGA-FU-A40J-01A-01-TSA",NA,99,NA,"a761298c-25fd-44ad-904a-97cf01a50e18","RNA","TCGA-FU-A40J-01A-11R","aff93160-ba6f-4047-92a1-2699037c5077",1.86,0.16,"UV Spec","R","23","TCGA-FU-A40J-01A-11R-A24H-07","26cdb816-44f0-4ff6-a674-93ec31d64fed",0.16,NA,78,30.46875,160,"d2e01643-0ecc-574b-98e4-43b66314c011","TCGA-FU-A40J_exposure","UNCID_2185449.26cdb816-44f0-4ff6-a674-93ec31d64fed.130129_UNC13-SN749_0217_BD1MTTACXX_6_CGATGT.tar.gz","2013-09-14T20:07:04.000Z","2013-09-14T20:24:01.000Z","E4DAD31F-3B56-4377-B92B-3E8B184415B0","79662C1C-EDE3-4206-B294-6DD8CD8DB438","Unaligned reads",8299024585,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","26CDB816-44F0-4FF6-A674-93EC31D64FED","University of North Carolina","564a3efbe4b093830b6a6914","63DCFA32-C69E-45AD-BEA3-AE672ACB11C6","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A761298C-25FD-44AD-904A-97CF01A50E18","2013-09-14T20:24:01.000Z","AFF93160-BA6F-4047-92A1-2699037C5077","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",76,"A761298C-25FD-44AD-904A-97CF01A50E18",NA,"FU","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.70D677F9-4C07-4C10-BC21-D75784B8AFA4.txt",170,"TCGA-FU-A40J-01A",NA,"CB60C6D5-AFC3-4B83-9DBF-D649951043AF","TCGA",2012,"TCGA-FU-A40J_NTE-1",NA,"TUMOR FREE","A18A106C-712F-4161-9227-A0659D23D648",38,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.70D677F9-4C07-4C10-BC21-D75784B8AFA4.txt","Alive",NA,"TCGA-FU-A40J","NOT HISPANIC OR LATINO","4FB13BD1-679C-46B1-8321-622608B86191","NO",41,"No","Cervix","C53.9","N1","Endocervical Type of Adenocarcinoma",NA,NA,"Stage IIIB",NA,NA,"T2a1","8384/3","FEMALE","C53.9",256,NA,"CDDE50F8-D9A0-4028-BDF7-DDD202A2F2DF","WHITE",NA,11,30,"5C8431AB-0765-4A3F-A990-91BD5D0C0286","AFF93160-BA6F-4047-92A1-2699037C5077","7842fe2c1082f850fed7d28c2fc68434.bam","TCGA-FU-A40J-01A-11",75,0,0,3,0,"TOP",1,0,"TCGA-FU-A40J-01A-01-TSA",99,"Carboplatin","Chemotherapy","TCGA-FU-A40J-D64220","TCGA-FU-A40J-R64214","External","Primary Tumor Field","TCGA-FU-A40J-F64213_NTE-1","NO",426,"TUMOR FREE","Alive",NA,"TCGA-FU-A40J-F64213","TCGA-FU-A40J",NA,"FU","A40J","YES","C53.9","8384/3","C53.9","YES","NO",-14182,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",41,NA,NA,NA,"TUMOR FREE","YES",4,10,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,38,2012,"Biopsy (cervical / CT-guided / Other)","YES",28,4,"G3",NA,1,NA,NA,NA,NA,"2009",16,NA,"T2a1N1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
164042494,161633372,7714024905,"A451F278-5E83-4BC6-9B15-3AA2117B99B6.bw","66229dd6-c771-4455-a90c-c66fb40cf7fe","a451f278-5e83-4bc6-9b15-3aa2117b99b6","2016-08-09T13:12:12.782923-05:00","UNCID_2186779.953f918b-a82a-408f-b080-d0cb4441e1ef.121009_UNC16-SN851_0187_AD15RRACXX_8_CCGTCC.tar.gz","85ad165f-8cfd-4362-a96f-627d629242db",7312290903,"Illumina HiSeq","e60b51f8de165998daeb98ed715b3545","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:23.974229-05:00","2016-05-03T11:01:14.469334-05:00","85ad165f-8cfd-4362-a96f-627d629242db_analysis.xml","b8328941a67d99c42d0894741b94c58a","747d409f-447e-43c8-85da-2c6aeae8b8d3",2124,"2016-09-29T23:31:38.235793-05:00","85ad165f-8cfd-4362-a96f-627d629242db_experiment.xml","7e11c28a93252ec2981ac1fdfcaa4a1a","e010ff7e-6ae1-4ca2-867f-c4062081da5e",2431,"2016-09-29T17:40:31.137467-05:00","85ad165f-8cfd-4362-a96f-627d629242db_run.xml","543cca4f640a75c747dfa2d5089a4aff","058ab224-e041-4985-9583-6d7516c3fd8b",354,"2016-09-08T11:48:48.333251-05:00","TCGA-IR-A3L7","2016-09-02T18:58:50.773185-05:00","female","TCGA-IR-A3L7_demographic",1963,"white","20b5f973-95c0-578d-b758-d74505a83559","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3L7_diagnosis","not reported",13559,"alive","8070/3",NA,4483,"0ffb793e-7ce8-55e5-96e1-00659a634898","c53.9",-13559,"TCGA-IR-A3L7_treatment","4d5f617c-1f0c-515d-ab57-7c291a449896","01","true","TCGA-IR-A3L7-01A",NA,"f571523c-758c-4f34-a44b-f8e6a3eebe0f",FALSE,"411A8FF2-4778-43AD-99F7-FD5BD23559DD","Primary Tumor",NA,4286,110,NA,1325030400,"21",30,"TCGA-IR-A3L7-01A-21",60,NA,0,NA,40,NA,0,NA,"2016-09-08T11:48:48.333251-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"25b99e27-3424-4667-bcb8-72bacbe4640b",NA,"TCGA-IR-A3L7-01A-02-TSB",NA,60,NA,"e21ddbfd-94a9-4da2-9fe8-7f4d8da68198","RNA","TCGA-IR-A3L7-01A-21R","bcc2c03e-e70c-4c48-a13d-93588c8b03f2",1.78,0.15,"UV Spec","R","23","TCGA-IR-A3L7-01A-21R-A213-07","953f918b-a82a-408f-b080-d0cb4441e1ef",0.15,0.547945205479452,89,28.4081841105685,177,"1d3189d4-026e-5010-96c7-4b51462f2022","TCGA-IR-A3L7_exposure","UNCID_2186779.953f918b-a82a-408f-b080-d0cb4441e1ef.121009_UNC16-SN851_0187_AD15RRACXX_8_CCGTCC.tar.gz","2013-09-16T14:43:04.000Z","2013-09-16T15:06:02.000Z","85AD165F-8CFD-4362-A96F-627D629242DB","F571523C-758C-4F34-A44B-F8E6A3EEBE0F","Unaligned reads",7312290903,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","953F918B-A82A-408F-B080-D0CB4441E1EF","University of North Carolina","56607418e4b018727fe9eda5","66229DD6-C771-4455-A90C-C66FB40CF7FE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E21DDBFD-94A9-4DA2-9FE8-7F4D8DA68198","2013-09-16T15:06:02.000Z","BCC2C03E-E70C-4C48-A13D-93588C8B03F2","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",4286,"E21DDBFD-94A9-4DA2-9FE8-7F4D8DA68198",NA,"IR","OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_B08_955480.byallele.copynumber.data.txt",110,"TCGA-IR-A3L7-01A",NA,"99356D52-C28E-407A-A29D-E5A1088525CE","TCGA",2000,NA,NA,"TUMOR FREE","F571523C-758C-4F34-A44B-F8E6A3EEBE0F",37,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.05FAF119-1842-40FE-9B3D-A97D8E6B9662.txt","Alive",NA,"TCGA-IR-A3L7",NA,"05ADF82F-90EF-4187-9AE7-AF755688B2E3",NA,3509,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",200,NA,"5CD0505B-41CD-4BD5-812E-1744FE9A459A","WHITE",NA,21,30,"25B99E27-3424-4667-BCB8-72BACBE4640B","E12BA701-A5C3-4B32-9906-92F467F43618","UNCID_2186779.953f918b-a82a-408f-b080-d0cb4441e1ef.121009_UNC16-SN851_0187_AD15RRACXX_8_CCGTCC.tar.gz","TCGA-IR-A3L7-01A-21",60,40,0,5,0,"TOP",0,0,"TCGA-IR-A3L7-01A-02-TSB",60,"Cisplatin","Chemotherapy","TCGA-IR-A3L7-D38291","TCGA-IR-A3L7-R38290","External","Primary Tumor Field","TCGA-IR-A3L7-F38287_NTE-1","NO",4483,"TUMOR FREE","Alive",NA,"TCGA-IR-A3L7-F38287","TCGA-IR-A3L7",NA,"IR","A3L7","YES","C53.9","8070/3","C53.9","NO","YES",-13559,"FEMALE","WHITE",NA,"No","No","Alive",3509,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,2000,"Cone Biopsy / LEEP","YES",20,0,"G3",NA,4,1990,10,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
135977610,133962619,6388502109,"6EC25686-4547-459C-9E01-7EDF8DAECE35.bw","67195401-9099-4ca9-9790-f42bcb815289","6ec25686-4547-459c-9e01-7edf8daece35","2016-08-25T14:38:28.638195-05:00","UNCID_2553100.6977f6c7-f4cf-4669-81fd-7740fd5e64f1.140408_UNC11-SN627_0351_AC3KY3ACXX_5_CCGTCC.tar.gz","2a937ea6-1021-4c96-8b37-4b8bacf4ac96",5960230112,"Illumina HiSeq","2d594c596a92cfd5c83d3703f6bc53b1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:35:49.179842-05:00","2016-05-03T11:54:19.885282-05:00","2a937ea6-1021-4c96-8b37-4b8bacf4ac96_analysis.xml","49fc366197e47916adfe165ff9d34bcc","28467634-dcd4-44c1-8312-540a0607d127",2124,"2016-10-07T16:34:06.664405-05:00","2a937ea6-1021-4c96-8b37-4b8bacf4ac96_experiment.xml","6463bfc81e93d0e483b22dae5e5a7b31","a680737a-8bc4-47c1-b37f-4e5e1e87e9d4",2628,"2016-09-29T22:52:13.077197-05:00","2a937ea6-1021-4c96-8b37-4b8bacf4ac96_run.xml","726ba4d69c146bb1f1fa312713e3a4e6","c795351c-21d5-4bd9-bec8-c64a207d57eb",354,"2016-09-08T11:40:50.296184-05:00","TCGA-GH-A9DA","2016-09-02T19:01:14.830684-05:00","female","TCGA-GH-A9DA_demographic",1986,"white","39fa202b-83a9-5c73-8ab3-9fd4d3111602","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","GH","cef25aee-c4df-53ce-be92-2e4d89783a43","ABS - IUPUI","not reported","c53.9","TCGA-GH-A9DA_diagnosis","not reported",10160,"alive","8070/3",NA,540,"9811f4cc-d51d-57ff-9266-393081b3eb6e","c53.9",-10160,"TCGA-GH-A9DA_treatment","f026663e-62ff-5f49-b7db-29044afb84ec","01","false","TCGA-GH-A9DA-01A",NA,"bb5ef93f-c950-482b-b77d-4b0974c1b57d",FALSE,"AAB3DEEA-D415-4495-A42E-E9A6B7AD0D33","Primary Tumor",NA,174,230,NA,1389916800,"21",30,"TCGA-GH-A9DA-01A-21",70,NA,0,NA,15,NA,13,NA,"2016-09-08T11:40:50.296184-05:00",NA,10,NA,2,NA,"TOP",NA,2,NA,"a838806b-089e-429b-9db6-1ff579bd40ad",NA,"TCGA-GH-A9DA-01A-02-TS2",NA,70,NA,"4424f3a3-dd7f-432b-957b-5a4e6b4a6186","RNA","TCGA-GH-A9DA-01A-21R","23e095a0-a099-47df-9ae2-4b8b8ff446e5",1.85,0.18,"UV Spec","R","23","TCGA-GH-A9DA-01A-21R-A37O-07","6977f6c7-f4cf-4669-81fd-7740fd5e64f1",0.18,0.356164383561644,NA,NA,170,"6fcc55e6-88c9-55e6-b59b-aa63ce753ce4","TCGA-GH-A9DA_exposure","UNCID_2553100.6977f6c7-f4cf-4669-81fd-7740fd5e64f1.140408_UNC11-SN627_0351_AC3KY3ACXX_5_CCGTCC.tar.gz","2014-07-30T22:36:04.000Z","2014-07-30T23:01:09.000Z","2A937EA6-1021-4C96-8B37-4B8BACF4AC96","BB5EF93F-C950-482B-B77D-4B0974C1B57D","Unaligned reads",5960230112,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6977F6C7-F4CF-4669-81FD-7740FD5E64F1","University of North Carolina","564a3d8fe4b09c884b25050e","67195401-9099-4CA9-9790-F42BCB815289","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4424F3A3-DD7F-432B-957B-5A4E6B4A6186","2014-07-30T23:01:09.000Z","23E095A0-A099-47DF-9AE2-4B8B8FF446E5","United States","NO",1,NA,"Primary Tumor","ABS - IUPUI",174,"4424F3A3-DD7F-432B-957B-5A4E6B4A6186",NA,"GH","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.9D9F055F-E99A-472E-8A9A-660B8BA451D5.txt",230,"TCGA-GH-A9DA-01A",NA,NA,"TCGA",2013,"TCGA-GH-A9DA_NTE-1","Complete Remission/Response","TUMOR FREE","BB5EF93F-C950-482B-B77D-4B0974C1B57D",27,"SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_D06_1465342.hg19.seg.txt","Alive",NA,"TCGA-GH-A9DA","NOT HISPANIC OR LATINO","47A760E4-E796-44B7-95BF-C5549CA49ECF","NO",274,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB1",NA,NA,"T1b","8070/3","FEMALE","C53.9",380,NA,NA,"WHITE",NA,21,30,"A838806B-089E-429B-9DB6-1FF579BD40AD","45118914-5763-41DE-9E13-33E8E77613AD","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_D07_1465218.tangent.copynumber.data.txt","TCGA-GH-A9DA-01A-21",70,15,0,10,13,"TOP",2,2,"TCGA-GH-A9DA-01A-02-TS2",70,NA,NA,NA,NA,NA,NA,"TCGA-GH-A9DA-F71246_NTE-1","NO",540,"TUMOR FREE","Alive",NA,"TCGA-GH-A9DA-F71246","TCGA-GH-A9DA",NA,"GH","A9DA","YES","C53.9","8070/3","C53.9","YES","NO",-10160,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",274,NA,NA,NA,"TUMOR FREE","YES",7,5,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,27,2013,"Biopsy (cervical / CT-guided / Other)","YES",15,0,"G3",NA,2,NA,6.5,NA,"Complete Remission/Response","2009",7,NA,"T1bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
169013538,166379780,7940639426,"5D2F1EEA-2BA8-4C3A-8436-544EE1D23E7E.bw","674e010c-7ad4-4dc2-86b0-284cd4560633","5d2f1eea-2ba8-4c3a-8436-544ee1d23e7e","2016-08-09T13:11:02.932160-05:00","UNCID_2186708.8724D94D-C194-491B-8C0E-38675B59C2E8.121011_UNC13-SN749_0197_AD16K1ACXX_5_CTTGTA.tar.gz","f960bbf4-47f8-4c91-a7c5-51da832f630e",7466183640,"Illumina HiSeq","823c0af72515c5af3bb55d86fbbf294f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:10:03.606262-05:00","2016-05-03T11:00:24.467501-05:00","f960bbf4-47f8-4c91-a7c5-51da832f630e_analysis.xml","3ff3f1880a8f67c558d4711d17ebe2fd","ad793dc4-7647-44f6-962d-ae8b9e1199ae",2124,"2016-09-29T19:12:01.589592-05:00","f960bbf4-47f8-4c91-a7c5-51da832f630e_experiment.xml","82df9f817e8f6e981ba2e061caec0b2f","3f3dce5c-795d-4ead-975a-4e36e411527b",2431,"2016-09-29T19:22:30.223657-05:00","f960bbf4-47f8-4c91-a7c5-51da832f630e_run.xml","6a20a27c0caca12b269bb0354dfc41db","45dd910c-21f8-4a53-86ac-31aa734d0d0c",354,"2016-09-08T11:20:18.095836-05:00","TCGA-FU-A3HY","2016-09-02T18:59:06.741827-05:00","female","TCGA-FU-A3HY_demographic",1964,"white","7eb7502d-7bd5-5d4d-8ecf-ce06f3feaae1","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3HY_diagnosis","not reported",17228,"alive","8072/3",NA,954,"550b741a-8beb-53b2-8d4b-07a1a65078d5","c53.9",-17228,"TCGA-FU-A3HY_treatment","1c2abf8f-9f13-5edf-9f69-cbde4a730451","01","false","TCGA-FU-A3HY-01A",NA,"a5879a60-aa8b-4da0-904a-9ffe2968418c",FALSE,"4048896F-495E-434F-8849-1DA13FD6C2A2","Primary Tumor",NA,77,15,NA,1327449600,"11",15,"TCGA-FU-A3HY-01A-11",75,NA,0,NA,0,NA,15,NA,"2016-09-08T11:20:18.095836-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"2b51c7c4-0aec-4016-bc9f-79ac364bc618",NA,"TCGA-FU-A3HY-01A-01-TS1",NA,NA,NA,"d1a7e15b-5f76-4117-b20b-07708bd3be9f","RNA","TCGA-FU-A3HY-01A-11R","cf7896f7-d462-46b8-ada2-98067da35b30",2.07,0.15,"UV Spec","R","23","TCGA-FU-A3HY-01A-11R-A21T-07","8724d94d-c194-491b-8c0e-38675b59c2e8",0.15,0.273972602739726,74,25.6055363321799,170,"520c89ec-9ce7-5fca-8e27-8a1be6cf36e1","TCGA-FU-A3HY_exposure","UNCID_2186708.8724D94D-C194-491B-8C0E-38675B59C2E8.121011_UNC13-SN749_0197_AD16K1ACXX_5_CTTGTA.tar.gz","2013-09-16T12:26:03.000Z","2013-09-16T12:52:02.000Z","F960BBF4-47F8-4C91-A7C5-51DA832F630E","A5879A60-AA8B-4DA0-904A-9FFE2968418C","Unaligned reads",7466183640,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8724D94D-C194-491B-8C0E-38675B59C2E8","University of North Carolina","564a3ea0e4b09c884b25573b","674E010C-7AD4-4DC2-86B0-284CD4560633","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D1A7E15B-5F76-4117-B20B-07708BD3BE9F","2013-09-16T12:52:02.000Z","CF7896F7-D462-46B8-ADA2-98067DA35B30","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",77,"D1A7E15B-5F76-4117-B20B-07708BD3BE9F",NA,"FU","TCGA-FU-A3HY-01A-11R-A21U-13_mirna.bam.bai",15,"TCGA-FU-A3HY-01A",NA,"6B9972B5-AE6C-4658-BA1B-30CDE0D8C214","TCGA",2011,NA,NA,"TUMOR FREE","CC602955-FCEC-4357-8B7C-31111CDE9A74",47,"nationwidechildrens.org_clinical.TCGA-FU-A3HY.xml","Alive",NA,"TCGA-FU-A3HY","NOT HISPANIC OR LATINO","90A241D4-404D-4072-8DAE-45A7F75BFE56",NA,20,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8072/3","FEMALE","C53.9",217,NA,"F463D0BF-6C78-4B0A-A0FF-8A10494BEFCB","WHITE",NA,11,15,"2B51C7C4-0AEC-4016-BC9F-79AC364BC618","63A04F4A-699C-489B-82AA-E5D58F9F7988","TCGA-FU-A3HY-01A-11R-A21U-13_mirna.bam.bai","TCGA-FU-A3HY-01A-11",75,0,0,0,15,"TOP",5,0,"TCGA-FU-A3HY-01A-01-TS1",NA,"Cisplatin","Chemotherapy","TCGA-FU-A3HY-D64211","TCGA-FU-A3HY-R64208","External","Primary Tumor Field","TCGA-FU-A3HY-F64205_NTE-1","NO",954,"TUMOR FREE","Alive",NA,"TCGA-FU-A3HY-F64205","TCGA-FU-A3HY",NA,"FU","A3HY","YES","C53.9","8072/3","C53.9","YES","NO",-17228,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",20,NA,NA,NA,"TUMOR FREE","NO",16,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2011,"Biopsy (cervical / CT-guided / Other)","YES",39,1,"G2",NA,2,NA,5,NA,NA,"2009",8,NA,"T1b2N1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
125276408,123720842,5905163525,"675A4293-A4CE-4307-B00B-DFC4D44A87C6.bw","6813c53c-b256-4115-ad90-24d75328779e","675a4293-a4ce-4307-b00b-dfc4d44a87c6","2016-08-09T14:00:27.603648-05:00","UNCID_2169002.87bab535-6f15-4b0f-a274-571a4a81d1be.130611_UNC15-SN850_0312_BC265JACXX_2_TGACCA.tar.gz","b9d18a1b-d27b-46b4-a687-82354ab69944",5679947563,"Illumina HiSeq","143b107d9e8e9a4974c05af9efb04116","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:26:45.807483-05:00","2016-05-03T11:06:28.634130-05:00","b9d18a1b-d27b-46b4-a687-82354ab69944_analysis.xml","cde4738724ee899965134ebc5a622e54","92c0e0dc-1c42-4187-9232-086d455491e7",2123,"2016-08-13T03:36:00.641478-05:00","b9d18a1b-d27b-46b4-a687-82354ab69944_experiment.xml","46e9699d22d5ef247da29fae915dd2a2","ceb0edec-eb1b-4996-a59f-444c234b5754",2431,"2016-09-29T19:57:48.954695-05:00","b9d18a1b-d27b-46b4-a687-82354ab69944_run.xml","3e026f93dbeb81bd206284d4ec857fa5","5bcf5814-328f-4ded-a935-3c0217b1d0a3",354,"2016-09-08T13:11:59.230364-05:00","TCGA-JW-A5VH","2016-09-02T19:00:01.632029-05:00","female","TCGA-JW-A5VH_demographic",1959,"american indian or alaska native","2459ade6-3b97-5815-ba5c-7dd3607aa7aa","hispanic or latino",2012,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VH_diagnosis","not reported",19423,"dead","8070/3",100,NA,"8acd6677-5ab3-5ac7-a9f1-18cb88a80285","c53.9",-19423,"TCGA-JW-A5VH_treatment","f6dd2f32-7a9f-5f73-aecb-fefc90580c58","01","false","TCGA-JW-A5VH-01A",NA,"05ef91d4-13b0-48ff-9758-6acc179f9e8e",FALSE,"D5B62718-1D34-45F7-8DDB-B106AC85B102","Primary Tumor",NA,405,30,NA,1362528000,"11",30,"TCGA-JW-A5VH-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T13:11:59.230364-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"3ce30143-3bf3-4d6d-aa36-0a0372038f7e",NA,"TCGA-JW-A5VH-01A-01-TS1",NA,90,NA,"2e21ae70-0bfe-40e8-b9f0-a628dd1466aa","RNA","TCGA-JW-A5VH-01A-11R","e01dff74-3810-48e9-9af7-6889a44fae90",1.84,0.18,"UV Spec","R","23","TCGA-JW-A5VH-01A-11R-A28H-07","87bab535-6f15-4b0f-a274-571a4a81d1be",0.18,NA,80,30.1102788964583,163,"9708cfe5-5819-56a6-8794-6a398f84afb8","TCGA-JW-A5VH_exposure","UNCID_2169002.87bab535-6f15-4b0f-a274-571a4a81d1be.130611_UNC15-SN850_0312_BC265JACXX_2_TGACCA.tar.gz","2013-09-20T04:56:04.000Z","2013-09-20T05:11:01.000Z","B9D18A1B-D27B-46B4-A687-82354AB69944","05EF91D4-13B0-48FF-9758-6ACC179F9E8E","Unaligned reads",5679947563,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","87BAB535-6F15-4B0F-A274-571A4A81D1BE","University of North Carolina","564a3e60e4b0298dd2c95b31","6813C53C-B256-4115-AD90-24D75328779E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2E21AE70-0BFE-40E8-B9F0-A628DD1466AA","2013-09-20T05:11:01.000Z","E01DFF74-3810-48E9-9AF7-6889A44FAE90","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",405,"2E21AE70-0BFE-40E8-B9F0-A628DD1466AA",NA,"JW","UNCID_2061559.87bab535-6f15-4b0f-a274-571a4a81d1be.sorted_genome_alignments.bam.bai",30,"TCGA-JW-A5VH-01A",NA,"1A8782DE-A9E9-4CE0-A472-584BE2B1272C","TCGA",2012,"TCGA-JW-A5VH_NTE-1","Progressive Disease","WITH TUMOR","C122E138-3FD8-4687-89DD-775F5876D07D",53,"nationwidechildrens.org_clinical.TCGA-JW-A5VH.xml","Dead",100,"TCGA-JW-A5VH","HISPANIC OR LATINO","EF326607-5867-4973-BD0D-B7231C1ED63D","YES",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Other","Stage IVB",NA,NA,"T4","8070/3","FEMALE","C53.9",297,NA,"75638237-6786-4852-91D2-E2A9D4BFE755","AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"3CE30143-3BF3-4D6D-AA36-0A0372038F7E","E01DFF74-3810-48E9-9AF7-6889A44FAE90","UNCID_2061559.87bab535-6f15-4b0f-a274-571a4a81d1be.sorted_genome_alignments.bam.bai","TCGA-JW-A5VH-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-JW-A5VH-01A-01-TS1",90,"carboplatinum","Chemotherapy","TCGA-JW-A5VH-D46358","TCGA-JW-A5VH-R58230","External","Regional site","TCGA-JW-A5VH-F69375_NTE-1","YES",NA,"WITH TUMOR","Dead",100,"TCGA-JW-A5VH-F69375","TCGA-JW-A5VH",NA,"JW","A5VH","YES","C53.9","8070/3","C53.9","NO","YES",-19423,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Dead",NA,100,NA,NA,"WITH TUMOR","YES",31,5,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Progressive Disease","2009",18,NA,"T4NXM1",NA,NA,2,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
85327276,84521888,4037877758,"6FBE0AEF-476A-42B2-A857-846CF1ED92B6.bw","6817bb3e-1f8a-457c-9ab0-31ccda8b6868","6fbe0aef-476a-42b2-a857-846cf1ed92b6","2016-08-09T14:41:51.565428-05:00","UNCID_2654363.56ec376d-abc2-4bcd-87d2-cf10141ab979.141006_UNC15-SN850_0395_AC5FH9ACXX_3_GGCTAC.tar.gz","2babb3d6-b5cc-43c6-ab01-79999bc15b35",3510224088,"Illumina HiSeq","2a53bcefbe7dd48a81f3dbe6358fefea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:23.041288-05:00","2016-05-03T12:08:10.829131-05:00","2babb3d6-b5cc-43c6-ab01-79999bc15b35_analysis.xml","2eeb30d606be8f7a5d9f55c58a5860f7","fcead1cc-c0ba-4bab-9b7d-df0a4ac67619",2124,"2016-08-26T02:17:27.863204-05:00","2babb3d6-b5cc-43c6-ab01-79999bc15b35_experiment.xml","4a68cb4a4750a505ca2a4814a09d3f7a","fa8e9eee-67a0-46cb-9f6a-e142531d295c",2628,"2016-09-29T22:43:18.600746-05:00","2babb3d6-b5cc-43c6-ab01-79999bc15b35_run.xml","4c627312674ea44f16667766925321f5","c2035de4-f5ec-4f9b-abd6-98cbb213ebe1",354,"2016-09-08T10:49:13.781601-05:00","TCGA-VS-A9UZ","2016-09-02T18:54:34.888717-05:00","female","TCGA-VS-A9UZ_demographic",1948,"white","e7f0eaa6-93b8-56da-9606-c27834379c54","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UZ_diagnosis","not reported",22344,"alive","8482/3",NA,2044,"6c44d51e-430d-5278-8053-b73146e34090","c53.9",-22344,"TCGA-VS-A9UZ_treatment","d00c8e95-d2b7-5ac6-a450-50935b7dd7cd","01","false","TCGA-VS-A9UZ-01A",NA,"23154bb9-f757-434b-9c4c-43d03e2bf425",FALSE,"F340AC28-F1AC-4AC3-9C7D-CAC4F3EE04E5","Primary Tumor",NA,1723,90,NA,1390953600,"11",30,"TCGA-VS-A9UZ-01A-11",60,NA,2,NA,15,NA,0,NA,"2016-09-08T10:49:13.781601-05:00",NA,10,NA,3,NA,"TOP",NA,0,NA,"97678688-0897-467f-b10c-c714bceb5f63",NA,"TCGA-VS-A9UZ-01A-01-TS1",NA,85,NA,"af4502de-2345-4852-9a49-f409ccd525bb","RNA","TCGA-VS-A9UZ-01A-11R","2bedb304-5363-4ee3-a5bc-567a211d0107",1.89,0.17,"UV Spec","R","23","TCGA-VS-A9UZ-01A-11R-A42T-07","56ec376d-abc2-4bcd-87d2-cf10141ab979",0.17,NA,54,24.3232286833926,149,"82e7ca00-df4d-5948-8dbd-26a268aa9a7a","TCGA-VS-A9UZ_exposure","UNCID_2654363.56ec376d-abc2-4bcd-87d2-cf10141ab979.141006_UNC15-SN850_0395_AC5FH9ACXX_3_GGCTAC.tar.gz","2014-11-04T23:27:03.000Z","2014-11-04T23:39:37.000Z","2BABB3D6-B5CC-43C6-AB01-79999BC15B35","23154BB9-F757-434B-9C4C-43D03E2BF425","Unaligned reads",3510224088,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","56EC376D-ABC2-4BCD-87D2-CF10141AB979","University of North Carolina","564a3c81e4b0ef12181acb02","6817BB3E-1F8A-457C-9AB0-31CCDA8B6868","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AF4502DE-2345-4852-9A49-F409CCD525BB","2014-11-04T23:39:37.000Z","2BEDB304-5363-4EE3-A5BC-567A211D0107","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1723,"AF4502DE-2345-4852-9A49-F409CCD525BB",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_D04_1524138.ismpolish.data.txt",90,"TCGA-VS-A9UZ-01A",NA,NA,"TCGA",2009,"TCGA-VS-A9UZ_NTE-1","Complete Remission/Response","TUMOR FREE","6176B25A-1AB2-4526-A15F-1883585A4D1A",61,"TCGA-VS-A9UZ-01A-11R-A42V-13_mirna.bam","Alive",NA,"TCGA-VS-A9UZ",NA,"2EC2F2ED-57AC-42BE-8AF9-8D2481CE5E8E","NO",1939,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",NA,NA,"Stage IB1",NA,NA,"T1b","8482/3","FEMALE","C53.9",420,NA,"CF8B5425-7534-452A-B764-655E123D1EBB","WHITE",NA,11,30,"97678688-0897-467F-B10C-C714BCEB5F63","2BEDB304-5363-4EE3-A5BC-567A211D0107","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_D04_1524138.ismpolish.data.txt","TCGA-VS-A9UZ-01A-11",60,15,2,10,0,"TOP",0,3,"TCGA-VS-A9UZ-01A-01-TS1",85,NA,NA,NA,"TCGA-VS-A9UZ-R63875","Internal","Primary Tumor Field","TCGA-VS-A9UZ-F68142_NTE-1","NO",2044,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UZ-F68142","TCGA-VS-A9UZ",NA,"VS","A9UZ","YES","C53.9","8482/3","C53.9","NO","YES",-22344,"FEMALE","WHITE",NA,"No","No","Alive",1939,NA,NA,NA,"TUMOR FREE","YES",20,8,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,61,2009,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1bN0MX",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
182747060,179545137,8566401793,"7139D616-1A15-4288-A9AE-411856A4A76D.bw","6868ba1d-b612-454c-8146-74af2f573d76","7139d616-1a15-4288-a9ae-411856a4a76d","2016-08-07T00:21:38.419136-05:00","UNCID_2186133.A1DBD227-73B7-466F-B766-063A3006A206.121102_UNC12-SN629_0235_AC13F5ACXX_7_GATCAG.tar.gz","b04be3e3-fc9e-405b-b6b8-f7dc368777cc",8206531014,"Illumina HiSeq","67d8823b6664e1c02e12815f0805cc34","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:43:34.103053-05:00","2016-05-03T11:00:24.444360-05:00","b04be3e3-fc9e-405b-b6b8-f7dc368777cc_analysis.xml","45e0a1f3027fa246a8c217cdbafba49c","9d0287a8-fd02-4382-8e7b-7a5ef59d90a9",2123,"2016-09-29T22:56:11.435933-05:00","b04be3e3-fc9e-405b-b6b8-f7dc368777cc_experiment.xml","21e35ebc3571f6813a7d097f4a2f6a39","c9f999a3-4a9c-482e-ad9e-7f3a7a012337",2431,"2016-09-29T22:58:48.702977-05:00","b04be3e3-fc9e-405b-b6b8-f7dc368777cc_run.xml","1b22268dc65859bd349613e0293d7d43","cb871f7c-282c-4b41-acc1-b4d563e46dc8",354,"2016-09-08T11:30:43.771386-05:00","TCGA-FU-A3WB","2016-09-02T18:59:31.064104-05:00","female","TCGA-FU-A3WB_demographic",1969,"white","02869092-cfe7-5516-9785-9494cf306721","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3WB_diagnosis","not reported",15833,"alive","8070/3",NA,491,"1ae78284-d06c-50e3-b9b4-5fe4ca4dc8b6","c53.9",-15833,"TCGA-FU-A3WB_treatment","62e5513f-bfee-5f2f-99c9-8429bf864e9f","01","false","TCGA-FU-A3WB-01A",NA,"0334b0b7-115e-40a0-960b-6a3365cda3ad",FALSE,"20136CDC-19AA-480A-B19C-B4EE219D8903","Primary Tumor",NA,66,20,NA,1335744000,"11",20,"TCGA-FU-A3WB-01A-11",75,NA,0,NA,0,NA,15,NA,"2016-09-08T11:30:43.771386-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"eabbc536-5d30-477c-b56d-8120ccea5faf",NA,"TCGA-FU-A3WB-01A-01-TS1",NA,85,NA,"9923577b-12e3-4efc-ada5-e2ad26ee831c","RNA","TCGA-FU-A3WB-01A-11R","d630f1e0-ff35-41a2-954f-5b5c2e5eaad0",1.83,0.17,"UV Spec","R","23","TCGA-FU-A3WB-01A-11R-A22U-07","a1dbd227-73b7-466f-b766-063a3006a206",0.17,1.36986301369863,89,31.9122234572771,167,"04436a27-7a3c-5b45-a3d0-7ebe1bff5b42","TCGA-FU-A3WB_exposure","UNCID_2186133.A1DBD227-73B7-466F-B766-063A3006A206.121102_UNC12-SN629_0235_AC13F5ACXX_7_GATCAG.tar.gz","2013-09-16T01:16:03.000Z","2013-09-16T02:44:02.000Z","B04BE3E3-FC9E-405B-B6B8-F7DC368777CC","0334B0B7-115E-40A0-960B-6A3365CDA3AD","Unaligned reads",8206531014,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A1DBD227-73B7-466F-B766-063A3006A206","University of North Carolina","564a3fd6e4b08c5d8692ed00","6868BA1D-B612-454C-8146-74AF2F573D76","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9923577B-12E3-4EFC-ADA5-E2AD26EE831C","2013-09-16T02:44:02.000Z","D630F1E0-FF35-41A2-954F-5B5C2E5EAAD0","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",66,"9923577B-12E3-4EFC-ADA5-E2AD26EE831C",NA,"FU","UNCID_1724291.A1DBD227-73B7-466F-B766-063A3006A206.sorted_genome_alignments.bam",20,"TCGA-FU-A3WB-01A",NA,"80E759F8-CE9D-4730-A538-D10A3C87F4C7","TCGA",2012,"TCGA-FU-A3WB_NTE-1","Complete Remission/Response","TUMOR FREE","E4D37B4A-2B93-48DC-B8E2-20FD88C0A8D1",43,"nationwidechildrens.org_clinical.TCGA-FU-A3WB.xml","Alive",NA,"TCGA-FU-A3WB","NOT HISPANIC OR LATINO","0CD063B2-65AF-4A92-80C3-243B737D95E3","NO",25,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",2,"Preoperative","Stage IIA2",NA,NA,"T2a2","8070/3","FEMALE","C53.9",236,NA,"F46A5BF5-D3F4-4903-AB63-8DCAA6C2A910","WHITE",NA,11,20,"EABBC536-5D30-477C-B56D-8120CCEA5FAF","DD7A4A9D-B830-4CEF-90F8-7EDE1EA8F5D7","UNCID_1724291.A1DBD227-73B7-466F-B766-063A3006A206.sorted_genome_alignments.bam","TCGA-FU-A3WB-01A-11",75,0,0,0,15,"TOP",0,0,"TCGA-FU-A3WB-01A-01-TS1",85,"Aloxi","Ancillary","TCGA-FU-A3WB-D64236","TCGA-FU-A3WB-R64234","External","Primary Tumor Field","TCGA-FU-A3WB-F64233_NTE-1","NO",491,"TUMOR FREE","Alive",NA,"TCGA-FU-A3WB-F64233","TCGA-FU-A3WB",NA,"FU","A3WB","YES","C53.9","8070/3","C53.9","YES","NO",-15833,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",25,NA,NA,NA,"TUMOR FREE","YES",24,9,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2012,"Other method, specify:","YES",43,0,"G2",NA,4,2012,25,NA,"Complete Remission/Response","2009",12,NA,"T2a2N0MX",NA,NA,2,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
140289936,138895604,6626405679,"46D7F8C1-D5C5-40CC-BEF5-2E590A847BD9.bw","690a7b2a-7dc5-4504-9372-70c8b55e81c7","46d7f8c1-d5c5-40cc-bef5-2e590a847bd9","2016-08-06T22:31:03.682402-05:00","UNCID_2186392.4b80a4f6-c58b-4955-b390-53c9d722ebfa.121102_UNC15-SN850_0240_BD148CACXX_5_GGCTAC.tar.gz","cf37c197-a3eb-40c8-ae80-9460ac51d9dc",6159290796,"Illumina HiSeq","022c0ec093ca466acbf93732e2748ab2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:58:39.142354-05:00","2016-05-03T11:00:24.467483-05:00","cf37c197-a3eb-40c8-ae80-9460ac51d9dc_analysis.xml","329fa1629ac46afc6af1056456df54f0","81280e8b-f062-4080-9251-4378782a505a",2124,"2016-09-29T21:17:00.592917-05:00","cf37c197-a3eb-40c8-ae80-9460ac51d9dc_experiment.xml","d714e48003f8a0023435b4cd1661c4d9","8cacd2fa-78c4-4fa8-a9dd-7d516e73455b",2431,"2016-09-29T21:55:41.334139-05:00","cf37c197-a3eb-40c8-ae80-9460ac51d9dc_run.xml","7c21bebbf1af8c096f49fe21ea06ce95","a4b15db7-2f1d-4918-ac02-811cd9357ae0",354,"2016-09-08T11:54:30.945068-05:00","TCGA-EK-A2H1","2016-09-02T18:57:48.142728-05:00","female","TCGA-EK-A2H1_demographic",1987,"white","d26d9381-81c4-5866-bcc9-e6b213d3a442","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2H1_diagnosis","not reported",7649,"alive","8072/3",NA,799,"2f263df0-3f79-57d9-90cc-87fb89a40397","c53.9",-7649,"TCGA-EK-A2H1_treatment","2c58d590-13fb-5872-b14e-3779ec5a839b","01","false","TCGA-EK-A2H1-01A",NA,"14fa244b-e920-46bd-8df0-849846c88344",FALSE,"90313D4A-1DB7-42E5-8778-2CB92794B05D","Primary Tumor",NA,1319,140,NA,1308182400,"11",30,"TCGA-EK-A2H1-01A-11",70,NA,0,NA,2,NA,15,NA,"2016-09-08T11:54:30.945068-05:00",NA,20,NA,0,NA,"TOP",NA,3,NA,"b0ea350d-b3ca-482f-ac0f-32dcb8ff8db5",NA,"TCGA-EK-A2H1-01A-01-TSA",NA,80,NA,"e1a1ba1d-e7e3-465e-8e3c-314d2720dac2","RNA","TCGA-EK-A2H1-01A-11R","5dcc544b-0418-4b39-84d5-50dcb300685e",1.88,0.17,"UV Spec","R","23","TCGA-EK-A2H1-01A-11R-A180-07","4b80a4f6-c58b-4955-b390-53c9d722ebfa",0.17,NA,62,24.21875,160,"12a1faf1-0886-5cf4-abd4-5dfdf263952c","TCGA-EK-A2H1_exposure","UNCID_2186392.4b80a4f6-c58b-4955-b390-53c9d722ebfa.121102_UNC15-SN850_0240_BD148CACXX_5_GGCTAC.tar.gz","2013-09-16T08:31:04.000Z","2013-09-16T09:52:01.000Z","CF37C197-A3EB-40C8-AE80-9460AC51D9DC","14FA244B-E920-46BD-8DF0-849846C88344","Unaligned reads",6159290796,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4B80A4F6-C58B-4955-B390-53C9D722EBFA","University of North Carolina","564a3a52e4b0298dd2c80f44","690A7B2A-7DC5-4504-9372-70C8B55E81C7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E1A1BA1D-E7E3-465E-8E3C-314D2720DAC2","2013-09-16T09:52:01.000Z","5DCC544B-0418-4B39-84D5-50DCB300685E","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1319,"E1A1BA1D-E7E3-465E-8E3C-314D2720DAC2",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.FDBD4A06-DE72-4AB2-9949-A4929D93B712.txt",140,"TCGA-EK-A2H1-01A",NA,"47D3FA29-395F-42C6-9004-5FE997C50FD9","TCGA",2007,NA,NA,"TUMOR FREE","3B7ECDE9-CCC2-455F-A935-A12895CDA0FD",20,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.FDBD4A06-DE72-4AB2-9949-A4929D93B712.txt","Alive",NA,"TCGA-EK-A2H1",NA,"6CFC3772-C9D7-4B67-BFDE-EB01348E205E",NA,799,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB2",NA,NA,NA,"8072/3","FEMALE","C53.9",169,NA,"0553564C-5A5C-4B16-A08C-A1B80C999CD1","WHITE",NA,11,30,"B0EA350D-B3CA-482F-AC0F-32DCB8FF8DB5","E80A664A-7944-453A-BE25-40B34205904F","jhu-usc.edu_CESC.HumanMethylation450.4.lvl-3.TCGA-EK-A2H1-01A-11D-A17Z-05.txt","TCGA-EK-A2H1-01A-11",70,2,0,20,15,"TOP",3,0,"TCGA-EK-A2H1-01A-01-TSA",80,"Cetuximab","Chemotherapy","TCGA-EK-A2H1-D21355","TCGA-EK-A2H1-R21356",NA,NA,NA,"NO",799,NA,"Alive",NA,"TCGA-EK-A2H1-F21350","TCGA-EK-A2H1",NA,"EK","A2H1","YES","C53.9","8072/3","C53.9","NO","YES",-7649,"FEMALE","WHITE",NA,"No","No","Alive",799,NA,NA,NA,"TUMOR FREE","NO",3,11,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,20,2007,"Other method, specify:",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1995",8,NA,NA,NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
103443422,101770193,4855546603,"984C44D3-4F5F-44C9-BCD9-C991EBC1FCB8.bw","6949c03e-067a-49a5-b48d-e9380a1b0b27","984c44d3-4f5f-44c9-bcd9-c991ebc1fcb8","2016-08-09T14:41:44.580215-05:00","UNCID_2654391.2410b783-e6c3-4c07-b944-8818d0b0cacb.141010_UNC12-SN629_0394_AC5FTUACXX_6_CGTACG.tar.gz","e7894d6f-9b88-44e1-9dda-026cab70f573",4368724722,"Illumina HiSeq","48fe545a46e8f0b6b26e628143be1a54","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:24:20.450347-05:00","2016-05-03T12:08:10.830175-05:00","e7894d6f-9b88-44e1-9dda-026cab70f573_analysis.xml","98d0aa1a1d657d890bd43aced37236bf","db62cd5e-f8c5-4f79-adda-29c6526dda82",2124,"2016-09-29T20:09:31.508871-05:00","e7894d6f-9b88-44e1-9dda-026cab70f573_experiment.xml","43f65244728f617345b1cb7024817329","62dd63b2-04cc-48e6-a1f6-30c37989e34a",2628,"2016-09-29T19:41:16.308781-05:00","e7894d6f-9b88-44e1-9dda-026cab70f573_run.xml","48c9eff91202a6baa2bdf8f9b7b4f663","5181ad39-2ffa-4142-92c7-342404ecec5a",354,"2016-09-08T10:25:30.441317-05:00","TCGA-VS-A9UH","2016-09-02T18:54:22.926419-05:00","female","TCGA-VS-A9UH_demographic",1957,"black or african american","2cac87eb-d2cb-5e0f-9452-d374ebfe5047","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UH_diagnosis","not reported",19454,"alive","8070/3",NA,1427,"16262964-139e-58a5-98d4-64bb1f49467d","c53.9",-19454,"TCGA-VS-A9UH_treatment","4c68625e-b532-59e0-bcca-6b38e40485d0","01","false","TCGA-VS-A9UH-01A",NA,"ffe75deb-19ce-4bc9-8d1d-252c1917ddfc",FALSE,"0A4B7512-EA49-4210-B588-939F58D602FE","Primary Tumor",NA,1098,70,NA,1390953600,"11",30,"TCGA-VS-A9UH-01A-11",90,NA,0,NA,0,NA,25,NA,"2016-09-08T10:25:30.441317-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"6542fc69-d7bc-4e7c-88fc-c008401ed840",NA,"TCGA-VS-A9UH-01A-01-TS1",NA,75,NA,"e5b01b57-e69d-462f-ac89-5502431e8e63","RNA","TCGA-VS-A9UH-01A-11R","d5d85593-526b-4d66-ab1c-ed5f549d8e77",1.83,0.17,"UV Spec","R","23","TCGA-VS-A9UH-01A-11R-A42T-07","2410b783-e6c3-4c07-b944-8818d0b0cacb",0.17,NA,NA,NA,NA,"639db322-6fd2-59ce-88ff-ae1787399455","TCGA-VS-A9UH_exposure","UNCID_2654391.2410b783-e6c3-4c07-b944-8818d0b0cacb.141010_UNC12-SN629_0394_AC5FTUACXX_6_CGTACG.tar.gz","2014-11-05T10:06:04.000Z","2014-11-05T10:19:09.000Z","E7894D6F-9B88-44E1-9DDA-026CAB70F573","FFE75DEB-19CE-4BC9-8D1D-252C1917DDFC","Unaligned reads",4368724722,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2410B783-E6C3-4C07-B944-8818D0B0CACB","University of North Carolina","566076a8e4b016715ab690ca","6949C03E-067A-49A5-B48D-E9380A1B0B27","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E5B01B57-E69D-462F-AC89-5502431E8E63","2014-11-05T10:19:09.000Z","D5D85593-526B-4D66-AB1C-ED5F549D8E77","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1098,"E5B01B57-E69D-462F-AC89-5502431E8E63",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_H10_1524074.tangent.copynumber.data.txt",70,"TCGA-VS-A9UH-01A",NA,"5ECDA20A-D998-4660-A6B2-F178C7B054EE","TCGA",2010,"TCGA-VS-A9UH_NTE-1","Complete Remission/Response","TUMOR FREE","FFE75DEB-19CE-4BC9-8D1D-252C1917DDFC",53,"nationwidechildrens.org_clinical.TCGA-VS-A9UH.xml","Alive",NA,"TCGA-VS-A9UH",NA,"AC89FC95-D632-406F-853D-1076576B05F7","NO",1120,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Pre-Adjuvant Therapy","Stage IVA",NA,NA,"T4","8070/3","FEMALE","C53.9",420,NA,"29065FD8-D8F9-4241-B700-7DE74A76F9E0","BLACK OR AFRICAN AMERICAN",NA,11,30,"6542FC69-D7BC-4E7C-88FC-C008401ED840","EC9A2A6C-DB65-45E6-907E-867BF9061E6B","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_H10_1524074.nocnv_hg18.seg.txt","TCGA-VS-A9UH-01A-11",90,0,0,0,25,"TOP",0,0,"TCGA-VS-A9UH-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-VS-A9UH-D63870","TCGA-VS-A9UH-R63871","External","Regional site","TCGA-VS-A9UH-F68149_NTE-1","NO",1427,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UH-F68149","TCGA-VS-A9UH",NA,"VS","A9UH","YES","C53.9","8070/3","C53.9","NO","YES",-19454,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1120,NA,NA,NA,"TUMOR FREE","YES",20,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,53,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",17,NA,"T4NXMX",NA,NA,2,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
119824846,118875557,5679767864,"83FE52E0-2DC2-4580-8BB2-FBCBEE4AC240.bw","69baba9f-19c2-4947-95dc-0dd3412929ba","83fe52e0-2dc2-4580-8bb2-fbcbee4ac240","2016-08-25T22:57:07.199673-05:00","UNCID_2553079.c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4.140603_UNC15-SN850_0368_AC4GHHACXX_4_GCCAAT.tar.gz","4233832f-3d66-456a-817e-8118fce265ff",5017457964,"Illumina HiSeq","765d6b3dfb03937a18d7613d20eea9e5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:58:56.656719-05:00","2016-05-03T11:54:19.885282-05:00","4233832f-3d66-456a-817e-8118fce265ff_analysis.xml","9f51608301d6dd82cc7dfcfa0ce8b3b6","5c7c5554-c92a-4310-8a76-424101955bfb",2124,"2016-09-29T22:39:44.510945-05:00","4233832f-3d66-456a-817e-8118fce265ff_experiment.xml","6ff73cc67012129e4f4048afea514b39","bfd4bc7e-02db-4dc1-ae75-b9961346a5c3",2628,"2016-09-29T19:46:10.006110-05:00","4233832f-3d66-456a-817e-8118fce265ff_run.xml","49e5f8e028b8d291cd098b8f3dddbb1d","548e415c-0251-416b-a327-ea31f8ca02ff",354,"2016-09-08T11:24:11.420987-05:00","TCGA-VS-A94Z","2016-09-02T18:54:07.924394-05:00","female","TCGA-VS-A94Z_demographic",1974,"white","689bc8c4-3ecb-5b77-828d-ea0e0ddbf835","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A94Z_diagnosis","not reported",14046,"alive","8070/3",NA,1015,"119d48f2-a5cc-5bf4-8e03-c58d0683c3f6","c53.9",-14046,"TCGA-VS-A94Z_treatment","fbcb45b9-f9da-5b13-904b-512ae059c50f","01","false","TCGA-VS-A94Z-01A",NA,"2d8a0204-0bb7-4691-9732-dca1dc2048b8",FALSE,"8B8D851A-EF25-4052-9BD7-95248B923C6C","Primary Tumor",NA,553,50,NA,1389830400,"11",30,"TCGA-VS-A94Z-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:24:11.420987-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"546bedd2-88ef-4fdf-967a-508be616bda4",NA,"TCGA-VS-A94Z-01A-01-TS1",NA,80,NA,"c1eea786-125d-4ab2-b659-4c4f06f95f67","RNA","TCGA-VS-A94Z-01A-11R","6dfc7f2a-eec7-4bab-933a-8f7ecee2080e",1.89,0.18,"UV Spec","R","23","TCGA-VS-A94Z-01A-11R-A38B-07","c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4",0.18,0.10958904109589,96,36.5797896662094,162,"02bb0908-a7b4-5b8d-8975-23099c404cdd","TCGA-VS-A94Z_exposure","UNCID_2553079.c2ce929e-e3a1-4a3a-b09e-9aff5bfd95f4.140603_UNC15-SN850_0368_AC4GHHACXX_4_GCCAAT.tar.gz","2014-07-30T17:51:06.000Z","2014-07-30T18:11:14.000Z","4233832F-3D66-456A-817E-8118FCE265FF","2D8A0204-0BB7-4691-9732-DCA1DC2048B8","Unaligned reads",5017457964,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C2CE929E-E3A1-4A3A-B09E-9AFF5BFD95F4","University of North Carolina","564a3d25e4b0ef12181afdf6","69BABA9F-19C2-4947-95DC-0DD3412929BA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C1EEA786-125D-4AB2-B659-4C4F06F95F67","2014-07-30T18:11:14.000Z","6DFC7F2A-EEC7-4BAB-933A-8F7ECEE2080E","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",553,"C1EEA786-125D-4AB2-B659-4C4F06F95F67",NA,"VS","ENATE_p_TCGAb_394_395_396_NSP_GenomeWideSNP_6_A07_1474140.hg18.seg.txt",50,"TCGA-VS-A94Z-01A",NA,"138D8801-6CD9-43F9-B8D3-1FB6FB9BF29A","TCGA",2012,"TCGA-VS-A94Z_NTE-1","Complete Remission/Response","TUMOR FREE","F324A954-6590-44E9-B799-690910E82FB2",38,"nationwidechildrens.org_clinical.TCGA-VS-A94Z.xml","Alive",NA,"TCGA-VS-A94Z",NA,"5BEF7B2D-BEDE-46D6-98DE-0C30F1489169","NO",707,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",394,NA,"DFB29CEE-AAD9-43F1-A14C-27BFF3844CFC","WHITE",NA,11,30,"546BEDD2-88EF-4FDF-967A-508BE616BDA4","E6FFAC10-97CF-474F-A4F1-89EE8B3C90E0","TCGA-VS-A94Z-01A-11R-A38M-13.mirna.quantification.txt","TCGA-VS-A94Z-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-VS-A94Z-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A94Z-D62793","TCGA-VS-A94Z-R62791","Internal","Primary Tumor Field","TCGA-VS-A94Z-F67676_NTE-1","NO",742,"TUMOR FREE","Alive",NA,"TCGA-VS-A94Z-F67676","TCGA-VS-A94Z",NA,"VS","A94Z","YES","C53.9","8070/3","C53.9","NO","YES",-14046,"FEMALE","WHITE",NA,"No","No","Alive",707,NA,NA,NA,"TUMOR FREE","YES",21,5,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,4,2010,2,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
119383610,116894375,5541186895,"0923F9CB-DF6F-4BAA-A5F8-0F83CE60D1ED.bw","6a18d184-d3a2-49c2-bd4b-9c18f91b98c7","0923f9cb-df6f-4baa-a5f8-0f83ce60d1ed","2016-08-04T19:11:49.070466-05:00","UNCID_2169827.6b9951d1-1bae-4c66-acad-c6c618d5387d.130530_UNC9-SN296_0371_BC2528ACXX_3_GGCTAC.tar.gz","5f3d4284-9281-4daa-a781-523d1537cb68",5841968491,"Illumina HiSeq","10723266bf0feba970ca8ab96b7878d0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:08:48.465603-05:00","2016-05-03T11:05:42.727154-05:00","5f3d4284-9281-4daa-a781-523d1537cb68_analysis.xml","9cde456631e5fe75bf62b792ded333ac","f6f1fdaa-d6cf-4752-9a5d-b2545f03e758",2121,"2016-09-29T17:57:56.412084-05:00","5f3d4284-9281-4daa-a781-523d1537cb68_experiment.xml","26b3e6bc003e9398db6be59ee43e4966","10a4797d-f0b5-4eff-90f7-9e7b5b2bb00f",2431,"2016-09-29T20:18:19.292692-05:00","5f3d4284-9281-4daa-a781-523d1537cb68_run.xml","c64842587f223dc71742b0ff5a41d7b8","682586c0-f100-4c59-8334-90a40b732500",354,"2016-09-08T12:06:09.043674-05:00","TCGA-EA-A50E","2016-09-02T18:59:44.708137-05:00","female","TCGA-EA-A50E_demographic",1967,"asian","1e0e54df-211e-5fe3-bcc3-59abc4acdfa2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A50E_diagnosis","not reported",16609,"dead","8072/3",227,8,"ef477de9-166b-59e2-be73-c948dafddbf9","c53.9",-16609,"TCGA-EA-A50E_treatment","abbfe29a-fd37-5403-b895-d432e251b19c","01","true","TCGA-EA-A50E-01A",NA,"cc589e45-a94f-4065-a705-8110f7de68cb",FALSE,"9AF109CD-57A9-4560-8B36-9977F208AEE1","Primary Tumor",NA,142,1520,NA,1353456000,"21",30,"TCGA-EA-A50E-01A-21",60,NA,20,NA,0,NA,30,NA,"2016-09-08T12:06:09.043674-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"3db47b8c-2257-49da-8cbb-1dcc2a7270b4",NA,"TCGA-EA-A50E-01A-02-TSB",NA,60,NA,"229ac369-89e2-4d2f-b9d4-6860510662eb","RNA","TCGA-EA-A50E-01A-21R","6ab84799-701f-402e-9255-e51f8b98dadb",1.85,0.17,"UV Spec","R","23","TCGA-EA-A50E-01A-21R-A26T-07","6b9951d1-1bae-4c66-acad-c6c618d5387d",0.17,NA,45,19.4771468144044,152,"38d408b7-ef13-5d87-a82f-1e91399e6760","TCGA-EA-A50E_exposure","UNCID_2169827.6b9951d1-1bae-4c66-acad-c6c618d5387d.130530_UNC9-SN296_0371_BC2528ACXX_3_GGCTAC.tar.gz","2013-09-19T22:36:04.000Z","2013-09-19T22:52:02.000Z","5F3D4284-9281-4DAA-A781-523D1537CB68","CC589E45-A94F-4065-A705-8110F7DE68CB","Unaligned reads",5841968491,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6B9951D1-1BAE-4C66-ACAD-C6C618D5387D","University of North Carolina","564a3f2be4b09c884b25805e","6A18D184-D3A2-49C2-BD4B-9C18F91B98C7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","229AC369-89E2-4D2F-B9D4-6860510662EB","2013-09-19T22:52:02.000Z","6AB84799-701F-402E-9255-E51F8B98DADB","Vietnam","NO",1,NA,"Primary Tumor","Asterand",142,"229AC369-89E2-4D2F-B9D4-6860510662EB",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F6177AB7-60E5-414C-87A0-80D3AA346E5D.txt",1520,"TCGA-EA-A50E-01A",NA,NA,"TCGA",2012,"TCGA-EA-A50E_NTE-1",NA,"WITH TUMOR","CC589E45-A94F-4065-A705-8110F7DE68CB",45,"ENDUE_p_TCGA_271_76_79_280_81_N_GenomeWideSNP_6_E09_1346738.byallele.copynumber.data.txt","Alive",NA,"TCGA-EA-A50E","NOT HISPANIC OR LATINO","CBA7D148-F0A5-473A-9EF4-D93261D05FF6","NO",8,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IVA",NA,NA,"T4","8072/3","FEMALE","C53.9",280,NA,NA,"ASIAN",NA,21,30,"3DB47B8C-2257-49DA-8CBB-1DCC2A7270B4","8FF53E58-D99E-49BA-9B1E-58B92FB5421B","ENDUE_p_TCGA_271_76_79_280_81_N_GenomeWideSNP_6_E09_1346738.ismpolish.data.txt","TCGA-EA-A50E-01A-21",60,0,20,40,30,"TOP",10,20,"TCGA-EA-A50E-01A-02-TSB",60,NA,NA,NA,NA,NA,NA,"TCGA-EA-A50E-F45973_NTE-1","YES",NA,"WITH TUMOR","Dead",227,"TCGA-EA-A50E-F45973","TCGA-EA-A50E",NA,"EA","A50E","YES","C53.9","8072/3","C53.9","YES","NO",-16609,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",8,NA,NA,NA,"WITH TUMOR","YES",27,2,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2012,"Biopsy (cervical / CT-guided / Other)","YES",6,6,"G2",NA,1,NA,NA,NA,NA,"2009",17,NA,"T4N1M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
94526746,93049381,4448359303,"1DEB5206-78CC-4EB5-BCD5-85A6A5B4E273.bw","6b60bf8e-29a1-4c6b-9ead-aea4ddc99064","1deb5206-78cc-4eb5-bcd5-85a6a5b4e273","2016-08-05T05:10:12.922860-05:00","UNCID_2654401.ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4.140908_UNC11-SN627_0381_BC5DEKACXX_5_AGTCAA.tar.gz","53fe0cd5-464f-4eef-a706-2edf9a1578ba",3698061393,"Illumina HiSeq","cb065879813f74c90053256c794540ee","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:06:16.097064-05:00","2016-05-03T12:08:10.840133-05:00","53fe0cd5-464f-4eef-a706-2edf9a1578ba_analysis.xml","05811901a28b5de398d3a3595ade2b21","f565fd16-7516-4ff3-a7d3-5a745f706826",2124,"2016-09-29T18:36:33.234772-05:00","53fe0cd5-464f-4eef-a706-2edf9a1578ba_experiment.xml","a978b35a973f29cf46ae11b95b17a174","28bf9a60-e104-4bdb-b3da-685047eee996",2628,"2016-09-29T23:35:47.436703-05:00","53fe0cd5-464f-4eef-a706-2edf9a1578ba_run.xml","960b92a1bfca00ce821f8f68f7739158","e29ef9fb-b5d8-4f9a-a555-f350975e017a",354,"2016-09-08T12:00:33.027977-05:00","TCGA-ZJ-AAXJ","2016-09-02T18:54:45.475002-05:00","female","TCGA-ZJ-AAXJ_demographic",1967,"not reported","f66d4e97-8bb5-5029-8fc3-9375096b07ff","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXJ_diagnosis","not reported",16007,"alive","8071/3",NA,0,"4f6626e2-4c0a-51cf-8221-5060c6facfe6","c53.9",-16007,"TCGA-ZJ-AAXJ_treatment","23501c28-9db7-52c0-8d19-e37fd2d44f73","01","true","TCGA-ZJ-AAXJ-01A",NA,"3037a277-8907-4058-81d8-a4a09f8a2b14",FALSE,"0C3B91DD-9AA5-4D08-8B07-2E6DFA0E51A3","Primary Tumor",NA,1276,60,NA,1395878400,"11",30,"TCGA-ZJ-AAXJ-01A-11",60,NA,0,NA,15,NA,15,NA,"2016-09-08T12:00:33.027977-05:00",NA,10,NA,2,NA,"TOP",NA,10,NA,"f5ffa91a-63b8-48b8-a3ca-a9f6ee718432",NA,"TCGA-ZJ-AAXJ-01A-01-TS1",NA,60,NA,"7dcba97b-057b-4527-bccb-586dae8a345a","RNA","TCGA-ZJ-AAXJ-01A-11R","6ddbb2e2-6e46-40ac-99fe-0901bbb771c0",1.85,0.17,"UV Spec","R","23","TCGA-ZJ-AAXJ-01A-11R-A42T-07","ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4",0.17,NA,NA,NA,NA,"5208cd75-76bd-55ca-9f54-84ccbedfbb87","TCGA-ZJ-AAXJ_exposure","UNCID_2654401.ab18089c-9cb7-4e3a-8b4a-b1391b89d1b4.140908_UNC11-SN627_0381_BC5DEKACXX_5_AGTCAA.tar.gz","2014-11-05T13:47:04.000Z","2014-11-05T13:59:29.000Z","53FE0CD5-464F-4EEF-A706-2EDF9A1578BA","3037A277-8907-4058-81D8-A4A09F8A2B14","Unaligned reads",3698061393,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AB18089C-9CB7-4E3A-8B4A-B1391B89D1B4","University of North Carolina","564a3fa5e4b08c5d8692ddf8","6B60BF8E-29A1-4C6B-9EAD-AEA4DDC99064","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7DCBA97B-057B-4527-BCCB-586DAE8A345A","2014-11-05T13:59:29.000Z","6DDBB2E2-6E46-40AC-99FE-0901BBB771C0","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1276,"7DCBA97B-057B-4527-BCCB-586DAE8A345A",NA,"ZJ","1aa0eb146fbd8f2829c69f151471c130.bam",60,"TCGA-ZJ-AAXJ-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXJ_NTE-1",NA,NA,"BFF8B8C1-BEA4-462B-BEBA-FBD679F192CC",43,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXJ.xml","Alive",NA,"TCGA-ZJ-AAXJ",NA,NA,NA,0,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8071/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"F5FFA91A-63B8-48B8-A3CA-A9F6EE718432","6DDBB2E2-6E46-40AC-99FE-0901BBB771C0","1aa0eb146fbd8f2829c69f151471c130.bam","TCGA-ZJ-AAXJ-01A-11",60,15,0,10,15,"TOP",10,2,"TCGA-ZJ-AAXJ-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXJ",NA,"ZJ","AAXJ","YES","C53.9","8071/3","C53.9","NO","YES",-16007,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",31,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"2009",13,NA,"T2bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167756340,166027378,7925461107,"E4DB18DA-EB0C-4B2F-9566-7F72222B16D4.bw","6b74c07a-9932-4a80-8296-9db08d0c6964","e4db18da-eb0c-4b2f-9566-7f72222b16d4","2016-08-05T11:35:52.422845-05:00","UNCID_2187201.6a65b2f5-ebe5-4974-9ca6-7e824e7ca087.120920_UNC13-SN749_0194_AD15C3ACXX_3_ACAGTG.tar.gz","a4c92b8a-f41b-411a-80a0-1fa6da81d221",7338838088,"Illumina HiSeq","ae517e0a9170ea6e78814c7d38f07ae6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:57:17.803881-05:00","2016-05-03T11:02:00.403413-05:00","a4c92b8a-f41b-411a-80a0-1fa6da81d221_analysis.xml","56bc444e41f5eb7736723568d0195c30","36047c35-c84d-4410-b474-01e83708cf90",2124,"2016-09-30T00:11:34.315992-05:00","a4c92b8a-f41b-411a-80a0-1fa6da81d221_experiment.xml","62e25766fca152d71b2c6fcb21b3f457","f8ac57ce-6cb8-4194-9aec-89bb16991432",2431,"2016-09-29T22:52:13.473724-05:00","a4c92b8a-f41b-411a-80a0-1fa6da81d221_run.xml","b92210e017ca75f8502367bc61521744","c795d55a-fbe3-489d-b140-7dadcb690e53",354,"2016-09-08T12:00:21.333654-05:00","TCGA-EX-A1H5","2016-09-02T18:56:53.518651-05:00","female","TCGA-EX-A1H5_demographic",1952,"black or african american","c63ffc70-4877-5932-a62d-8619ef2f7fc6","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A1H5_diagnosis","not reported",21338,"alive","8070/3",NA,619,"43d9d3aa-07ef-5e2e-959d-ad71d53d73a0","c53.9",-21338,"TCGA-EX-A1H5_treatment","7c40049d-d593-5177-8bba-4047b1902a35","01","false","TCGA-EX-A1H5-01A",NA,"85452b47-1cdd-42fd-8802-0fd2e6f51a4d",FALSE,"C596A314-A98F-4E6C-92FA-017BDF820E88","Primary Tumor",NA,163,220,NA,1298246400,"31",30,"TCGA-EX-A1H5-01A-31",60,NA,10,NA,0,NA,35,NA,"2016-09-08T12:00:21.333654-05:00",NA,40,NA,30,NA,"TOP",NA,5,NA,"96a16586-3f69-4cdb-8026-0badf38a484b",NA,"TCGA-EX-A1H5-01A-03-TSC",NA,60,NA,"ddaba32e-e7d5-44d9-bd6d-4a38c4ae83cd","RNA","TCGA-EX-A1H5-01A-31R","6561ba08-e8ab-4aea-9306-efb0c37dd5ee",1.7,0.16,"UV Spec","R","23","TCGA-EX-A1H5-01A-31R-A13Y-07","6a65b2f5-ebe5-4974-9ca6-7e824e7ca087",0.16,0.657534246575342,67,24.023808670085,167,"da9261e7-1986-56ca-929e-859c36e4d52c","TCGA-EX-A1H5_exposure","UNCID_2187201.6a65b2f5-ebe5-4974-9ca6-7e824e7ca087.120920_UNC13-SN749_0194_AD15C3ACXX_3_ACAGTG.tar.gz","2013-09-17T03:46:04.000Z","2013-09-17T04:07:02.000Z","A4C92B8A-F41B-411A-80A0-1FA6DA81D221","85452B47-1CDD-42FD-8802-0FD2E6F51A4D","Unaligned reads",7338838088,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6A65B2F5-EBE5-4974-9CA6-7E824E7CA087","University of North Carolina","564a3bbee4b0ef12181a8d9d","6B74C07A-9932-4A80-8296-9DB08D0C6964","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DDABA32E-E7D5-44D9-BD6D-4A38C4AE83CD","2013-09-17T04:07:02.000Z","6561BA08-E8AB-4AEA-9306-EFB0C37DD5EE","United States","NO",1,NA,"Primary Tumor","University of North Carolina",163,"DDABA32E-E7D5-44D9-BD6D-4A38C4AE83CD",NA,"EX","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.05E67180-E51A-488E-BD2D-BD24DA4F2D38.txt",220,"TCGA-EX-A1H5-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","85452B47-1CDD-42FD-8802-0FD2E6F51A4D",58,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.05E67180-E51A-488E-BD2D-BD24DA4F2D38.txt","Alive",NA,"TCGA-EX-A1H5","NOT HISPANIC OR LATINO","DF3C8B2C-5F1D-4CCC-879F-1B6CEA7481AB",NA,178,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",114,NA,"2A62AD4E-6D75-43C6-9504-E9DA0652A430","BLACK OR AFRICAN AMERICAN",NA,31,30,"96A16586-3F69-4CDB-8026-0BADF38A484B","FF133FEF-4A19-44B6-B7D0-723855A37314","TCGA-EX-A1H5-01A-31R-A13X-13_mirna.bam","TCGA-EX-A1H5-01A-31",60,0,10,40,35,"TOP",5,30,"TCGA-EX-A1H5-01A-03-TSC",60,NA,NA,NA,"TCGA-EX-A1H5-R12368",NA,NA,"TCGA-EX-A1H5-F50657_NTE-1","NO",619,"TUMOR FREE","Alive",NA,"TCGA-EX-A1H5-F50657","TCGA-EX-A1H5",NA,"EX","A1H5","YES","C53.9","8070/3","C53.9","YES","NO",-21338,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",178,NA,NA,NA,"TUMOR FREE","NO",21,4,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,58,2010,"Cone Biopsy / LEEP","YES",21,4,"G3",NA,2,NA,12,NA,NA,"2009",13,NA,"T2bN1MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
121622128,119878073,5720642541,"F7456312-1309-4B2F-875D-0F90CDF3EC35.bw","6bcf8b41-7abc-4b6f-899a-1f67b4ada765","f7456312-1309-4b2f-875d-0f90cdf3ec35","2016-08-09T13:14:22.795143-05:00","UNCID_2170076.a27551cc-4bbf-495c-9fc2-7cf6108ed1bf.130517_UNC9-SN296_0366_BD250HACXX_5_GTGGCC.tar.gz","218f3dff-33b2-4197-9ba5-2c3b28810682",5928448938,"Illumina HiSeq","de200206f3b0d6ee239c66883439f611","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:18:52.513442-05:00","2016-05-03T10:55:55.597306-05:00","218f3dff-33b2-4197-9ba5-2c3b28810682_analysis.xml","27b76d17f534814981aedb844d504758","d7eb71c6-6374-4a57-8fa3-a494a7e11fce",2127,"2016-09-29T19:48:13.866604-05:00","218f3dff-33b2-4197-9ba5-2c3b28810682_experiment.xml","0fd0a307a077a8cb7603b0d1bbe6aa44","55d17b9c-7f83-4b59-8260-6f8eb3351a06",2600,"2016-09-29T22:47:10.999531-05:00","218f3dff-33b2-4197-9ba5-2c3b28810682_run.xml","da1398856be292d7f7dda140714011e3","c475c118-b89a-48aa-8558-823b5b917f0e",343,"2016-09-08T12:05:40.081976-05:00","TCGA-HM-A4S6","2016-09-02T18:59:46.603062-05:00","female","TCGA-HM-A4S6_demographic",1961,"white","57f6785a-1c90-5203-a5b6-971a09e3caaa","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c53.9","TCGA-HM-A4S6_diagnosis","not reported",18903,"alive","8070/3",NA,454,"b39ecc59-786b-5dce-97ef-8e02e6d62d8d","c53.9",-18903,"TCGA-HM-A4S6_treatment","0b09ddcf-688d-5ff0-9071-c3a151c275ff","01","false","TCGA-HM-A4S6-01A",NA,"eb4db5b8-1f9f-479a-aa47-36cf387b2571",FALSE,"B4118FB2-3A61-44B4-BC2F-020EB53542A1","Primary Tumor",NA,117,390,NA,1352419200,"11",30,"TCGA-HM-A4S6-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T12:05:40.081976-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"53a6bf9a-1262-4c09-9f79-bb19eeb6458c",NA,"TCGA-HM-A4S6-01A-01-TS1",NA,100,NA,"ae5592a5-8964-45fc-b752-096984c9ac0b","RNA","TCGA-HM-A4S6-01A-11R","33c51f6d-936e-4fcb-a9f2-a843f7a6bd2b",1.91,0.18,"UV Spec","R","23","TCGA-HM-A4S6-01A-11R-A26T-07","a27551cc-4bbf-495c-9fc2-7cf6108ed1bf",0.18,0.547945205479452,101,43.7153739612188,152,"724327ae-e878-586e-9991-50946ad3a822","TCGA-HM-A4S6_exposure","UNCID_2170076.a27551cc-4bbf-495c-9fc2-7cf6108ed1bf.130517_UNC9-SN296_0366_BD250HACXX_5_GTGGCC.tar.gz","2013-09-06T02:50:00.000Z","2013-09-06T03:05:02.000Z","218F3DFF-33B2-4197-9BA5-2C3B28810682","EB4DB5B8-1F9F-479A-AA47-36CF387B2571","Unaligned reads",5928448938,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A27551CC-4BBF-495C-9FC2-7CF6108ED1BF","University of North Carolina","564a3cbfe4b08c5d8691f149","6BCF8B41-7ABC-4B6F-899A-1F67B4ADA765","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AE5592A5-8964-45FC-B752-096984C9AC0B","2013-09-06T03:05:02.000Z","33C51F6D-936E-4FCB-A9F2-A843F7A6BD2B","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",117,"AE5592A5-8964-45FC-B752-096984C9AC0B",NA,"HM","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.0BB4A1E7-3861-4E40-895F-0C25B47E8E57.txt",390,"TCGA-HM-A4S6-01A",NA,"D3B2B9D8-5887-4271-8C20-F368C42E0097","TCGA",2012,"TCGA-HM-A4S6_NTE-1",NA,"TUMOR FREE","EB4DB5B8-1F9F-479A-AA47-36CF387B2571",51,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.0BB4A1E7-3861-4E40-895F-0C25B47E8E57.txt","Alive",NA,"TCGA-HM-A4S6","NOT HISPANIC OR LATINO","D00AFDDF-47EC-4FE8-9332-9AA23C446A7A","NO",244,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIIB",NA,NA,"T1b2","8070/3","FEMALE","C53.9",280,NA,"07AD45EB-B34E-4B03-B41F-AE34B51B9B3E","WHITE",NA,11,30,"53A6BF9A-1262-4C09-9F79-BB19EEB6458C","AB3E70B1-B9C5-414F-A8AB-86CE7FF3C015","UNCID_2028226.a27551cc-4bbf-495c-9fc2-7cf6108ed1bf.sorted_genome_alignments.bam","TCGA-HM-A4S6-01A-11",75,0,0,3,0,"TOP",0,0,"TCGA-HM-A4S6-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-HM-A4S6-D42760","TCGA-HM-A4S6-R42787","External","Primary Tumor Field","TCGA-HM-A4S6-F49848_NTE-1","NO",454,"TUMOR FREE","Alive",NA,"TCGA-HM-A4S6-F49848","TCGA-HM-A4S6",NA,"HM","A4S6","YES","C53.9","8070/3","C53.9","YES","NO",-18903,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",244,NA,NA,NA,"TUMOR FREE","YES",27,2,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2012,"Other method, specify:","YES",13,2,"G3",NA,3,1995,10,NA,NA,"2009",16,NA,"T1b2N1MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
219433742,214399670,10228717242,"9A25E5D8-0706-4960-A76B-BCD0AC93E4FA.bw","6bf00b63-89f8-420c-8d36-f680fb0908b1","9a25e5d8-0706-4960-a76b-bcd0ac93e4fa","2016-08-09T13:10:07.142639-05:00","UNCID_2186745.886e8f4f-107d-4ebd-a312-7cdbacabd35e.121011_UNC13-SN749_0197_AD16K1ACXX_2_TGACCA.tar.gz","e6e48229-674b-4d39-b44d-358c4f888497",9977960391,"Illumina HiSeq","7d34d3902c95aed51f6686ae247d074a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:05.456654-05:00","2016-05-03T11:01:14.469334-05:00","e6e48229-674b-4d39-b44d-358c4f888497_analysis.xml","aeeea40b76bfc4035d1eba1ec7525d30","7e4e0961-e230-4e12-a434-ba83adcdbda1",2124,"2016-09-29T19:48:22.488379-05:00","e6e48229-674b-4d39-b44d-358c4f888497_experiment.xml","88ad6a6fdd15d31c306f72d5cbc89d5f","55e5c4b4-390f-49e4-8487-860b87ee426c",2431,"2016-09-29T19:37:40.902304-05:00","e6e48229-674b-4d39-b44d-358c4f888497_run.xml","e900c92435a34c8af8a314b9472e33c6","4f487822-0b26-405d-9025-9dc6b3f60013",354,"2016-09-08T12:02:59.475644-05:00","TCGA-EA-A3HQ","2016-09-02T18:58:42.405720-05:00","female","TCGA-EA-A3HQ_demographic",1951,"white","952514f4-471a-5f40-b7f2-3a8698b2f917","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3HQ_diagnosis","not reported",21966,"alive","8070/3",NA,1136,"f182162c-5779-5069-8024-009802e5fa90","c53.9",-21966,"TCGA-EA-A3HQ_treatment","00874826-6049-5e2c-998d-8296fc5ee9aa","01","true","TCGA-EA-A3HQ-01A",NA,"e4b391d9-2f3e-474c-afa0-fdf4fd11fdf9",FALSE,"868FEAAA-6A22-47A9-A309-49119D36E75E","Primary Tumor",NA,244,1360,NA,1323820800,"11",30,"TCGA-EA-A3HQ-01A-11",80,NA,0,NA,25,NA,0,NA,"2016-09-08T12:02:59.475644-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"1faa34ad-88f7-49a1-bb86-085c92bdf4c1",NA,"TCGA-EA-A3HQ-01A-01-TSA",NA,75,NA,"55ec8ef0-474f-4fe8-bcde-1f722e8496c0","RNA","TCGA-EA-A3HQ-01A-11R","8297502b-d172-477f-ac67-68173eb34413",1.75,0.16,"UV Spec","R","23","TCGA-EA-A3HQ-01A-11R-A213-07","886e8f4f-107d-4ebd-a312-7cdbacabd35e",0.16,NA,88,34.375,160,"da4c3940-59d4-5882-b13c-802b7e241f2a","TCGA-EA-A3HQ_exposure","UNCID_2186745.886e8f4f-107d-4ebd-a312-7cdbacabd35e.121011_UNC13-SN749_0197_AD16K1ACXX_2_TGACCA.tar.gz","2013-09-16T13:43:10.000Z","2013-09-16T14:17:01.000Z","E6E48229-674B-4D39-B44D-358C4F888497","E4B391D9-2F3E-474C-AFA0-FDF4FD11FDF9","Unaligned reads",9977960391,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","886E8F4F-107D-4EBD-A312-7CDBACABD35E","University of North Carolina","56607408e4b016715ab66f72","6BF00B63-89F8-420C-8D36-F680FB0908B1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","55EC8EF0-474F-4FE8-BCDE-1F722E8496C0","2013-09-16T14:17:01.000Z","8297502B-D172-477F-AC67-68173EB34413","Russia","NO",1,NA,"Primary Tumor","Asterand",244,"55EC8EF0-474F-4FE8-BCDE-1F722E8496C0",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C8052E35-8571-457C-8A92-A7806AB50F69.txt",1360,"TCGA-EA-A3HQ-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","E4B391D9-2F3E-474C-AFA0-FDF4FD11FDF9",60,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C8052E35-8571-457C-8A92-A7806AB50F69.txt","Alive",NA,"TCGA-EA-A3HQ","NOT HISPANIC OR LATINO","8C3E59CF-540E-4096-B7EE-E522C000F765",NA,65,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage II",NA,NA,"T2a","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"1FAA34AD-88F7-49A1-BB86-085C92BDF4C1","8297502B-D172-477F-AC67-68173EB34413","jhu-usc.edu_CESC.HumanMethylation450.6.lvl-3.TCGA-EA-A3HQ-01A-11D-A212-05.txt","TCGA-EA-A3HQ-01A-11",80,25,0,4,0,"TOP",0,0,"TCGA-EA-A3HQ-01A-01-TSA",75,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3HQ-F66107_NTE-1","NO",1136,"TUMOR FREE","Alive",NA,"TCGA-EA-A3HQ-F66107","TCGA-EA-A3HQ",NA,"EA","A3HQ","YES","C53.9","8070/3","C53.9","YES","NO",-21966,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",65,NA,NA,NA,"TUMOR FREE","NO",17,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,60,2011,"Biopsy (cervical / CT-guided / Other)","YES",13,0,"G2",NA,1,NA,NA,NA,NA,"2009",9,NA,"T2aN0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
112666812,107040840,5098549501,"5A41FE8F-FFB3-4B87-BF11-A570C184096D.bw","6c3c8219-74ab-4e54-81f5-84d4d5884252","5a41fe8f-ffb3-4b87-bf11-a570c184096d","2016-08-25T06:05:27.906165-05:00","UNCID_2553098.4601c9ab-da58-46f4-a875-5ef03727b756.140408_UNC11-SN627_0351_AC3KY3ACXX_6_TTAGGC.tar.gz","a5ae9948-ebb4-4244-bee9-19e4ef3e64ab",4912193316,"Illumina HiSeq","cbe835020a4bace1fa2f982882cf983a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:06:48.564675-05:00","2016-05-03T11:54:19.885282-05:00","a5ae9948-ebb4-4244-bee9-19e4ef3e64ab_analysis.xml","c53aeab73048eca10d830620cbcc746f","ab81f92e-7de9-496f-903f-9b9eed728261",2123,"2016-10-07T16:13:30.664024-05:00","a5ae9948-ebb4-4244-bee9-19e4ef3e64ab_experiment.xml","538f18ebdcbdddaef571f7badf428dc1","ac5b4155-f161-4476-afe9-f964ae65407d",2628,"2016-09-29T18:03:38.073308-05:00","a5ae9948-ebb4-4244-bee9-19e4ef3e64ab_run.xml","286eae63d1ac6022f1736db407df31c6","144b0b07-4fdd-4f6d-a6e4-b7beb5fe97e3",354,"2016-09-08T12:15:17.537421-05:00","TCGA-VS-A8Q8","2016-09-02T19:01:18.416964-05:00","female","TCGA-VS-A8Q8_demographic",1984,"white","bb2b4e02-2ed8-5f96-a7d5-5efaf5f8e571","not reported",2012,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8Q8_diagnosis","not reported",9571,"dead","8070/3",978,NA,"23a9033f-b7a4-5968-8d48-8766ba3c762f","c53.9",-9571,"TCGA-VS-A8Q8_treatment","d7304ff6-ec8b-5bb6-bcef-4d14748a20cd","01","false","TCGA-VS-A8Q8-01A",NA,"9fc25b2b-56b2-44d9-8be2-5510c06b8d33",FALSE,"DF0B7CA7-20B3-45CE-A25D-D4F622AF9C9B","Primary Tumor",NA,1348,60,NA,1386806400,"11",30,"TCGA-VS-A8Q8-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T12:15:17.537421-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"dbd30e0d-f410-448f-b18b-12473d550cb6",NA,"TCGA-VS-A8Q8-01A-01-TS1",NA,70,NA,"f63cdc4b-f3a8-40a4-bb28-8c8b8355600f","RNA","TCGA-VS-A8Q8-01A-11R","7d93341e-4dbc-41a1-babb-de1751d25475",1.92,0.16,"UV Spec","R","23","TCGA-VS-A8Q8-01A-11R-A37O-07","4601c9ab-da58-46f4-a875-5ef03727b756",0.16,NA,92,33.386558281318,166,"30aef91e-6f62-51f3-a4ae-3a2a0a2de529","TCGA-VS-A8Q8_exposure","UNCID_2553098.4601c9ab-da58-46f4-a875-5ef03727b756.140408_UNC11-SN627_0351_AC3KY3ACXX_6_TTAGGC.tar.gz","2014-07-30T22:21:04.000Z","2014-07-30T22:40:14.000Z","A5AE9948-EBB4-4244-BEE9-19E4EF3E64AB","9FC25B2B-56B2-44D9-8BE2-5510C06B8D33","Unaligned reads",4912193316,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4601C9AB-DA58-46F4-A875-5EF03727B756","University of North Carolina","564a3c01e4b093830b6976d9","6C3C8219-74AB-4E54-81F5-84D4D5884252","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F63CDC4B-F3A8-40A4-BB28-8C8B8355600F","2014-07-30T22:40:14.000Z","7D93341E-4DBC-41A1-BABB-DE1751D25475","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1348,"F63CDC4B-F3A8-40A4-BB28-8C8B8355600F",NA,"VS","9828653022_R03C01_Grn.idat",60,"TCGA-VS-A8Q8-01A",NA,NA,"TCGA",2010,"TCGA-VS-A8Q8_NTE-2","Progressive Disease","WITH TUMOR","9FC25B2B-56B2-44D9-8BE2-5510C06B8D33",26,"nationwidechildrens.org_clinical.TCGA-VS-A8Q8.xml","Dead",978,"TCGA-VS-A8Q8",NA,NA,"YES",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",380,NA,"45B2DC77-5D9D-47D5-97C2-8D848FBC675F","WHITE",NA,11,30,"DBD30E0D-F410-448F-B18B-12473D550CB6","1CB46866-4259-44DC-B263-6AAFB1BAB16A","9828653022_R03C01_Grn.idat","TCGA-VS-A8Q8-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-VS-A8Q8-01A-01-TS1",70,NA,NA,NA,"TCGA-VS-A8Q8-R61990","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8Q8",NA,"VS","A8Q8","YES","C53.9","8070/3","C53.9","NO","YES",-9571,"FEMALE","WHITE",NA,"No","No","Dead",NA,978,NA,NA,"WITH TUMOR","YES",31,3,2014,"NO","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,26,2010,"Other method, specify:","YES",11,0,"G2",NA,1,NA,NA,NA,"Progressive Disease","2009",6,NA,"T1bN0MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
185944176,184700071,8832041650,"33F84E63-3F6C-4867-ADB1-A0DF39F1295B.bw","6d01421e-d533-4967-8422-97fbc0fb0895","33f84e63-3f6c-4867-adb1-a0df39f1295b","2016-08-09T14:42:00.510057-05:00","UNCID_2654404.78f72cda-30eb-41f6-8713-795ced251abb.140908_UNC11-SN627_0381_BC5DEKACXX_4_GATCAG.tar.gz","e18ae413-c0ea-40cb-8f31-9bf4e1b08dd3",7632275402,"Illumina HiSeq","91e211bfe07ae97395ff34ccd1b57977","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:34:32.324881-05:00","2016-05-03T12:08:10.840133-05:00","e18ae413-c0ea-40cb-8f31-9bf4e1b08dd3_analysis.xml","05c19e447917d6cf99a8a91b694ee86c","bc88c09d-7c3a-484f-825d-4772a731ff27",2124,"2016-09-29T19:48:46.855540-05:00","e18ae413-c0ea-40cb-8f31-9bf4e1b08dd3_experiment.xml","07d5a3d02187f2347ca158f2f50dd8c4","562fec46-53bb-4322-87cf-b02b92eaa7b4",2628,"2016-09-29T19:39:51.411225-05:00","e18ae413-c0ea-40cb-8f31-9bf4e1b08dd3_run.xml","201c77add71cde1f3f97f96520eba7bb","509c90f1-df77-434a-a939-dcb9c062881c",354,"2016-09-08T10:42:19.112022-05:00","TCGA-VS-A9U7","2016-09-02T18:54:18.445579-05:00","female","TCGA-VS-A9U7_demographic",1981,"white","0225aa8d-a882-5b0f-881a-1fdd2298192e","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9U7_diagnosis","not reported",11210,"alive","8070/3",NA,1472,"1ad508ca-9244-5f51-a3af-0a52bd372d43","c53.9",-11210,"TCGA-VS-A9U7_treatment","0e0bc8b0-bdcb-58e5-b08c-b03fc4283c18","01","false","TCGA-VS-A9U7-01A",NA,"e56a6902-4a2d-4768-b030-afa41212646a",FALSE,"3FB4D6F8-6625-49A7-AA2C-533FB9EC9310","Primary Tumor",NA,1029,90,NA,1390953600,"11",30,"TCGA-VS-A9U7-01A-11",90,NA,0,NA,5,NA,5,NA,"2016-09-08T10:42:19.112022-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"4c1e05f5-75d1-4602-87c0-e2ba3dcff87a",NA,"TCGA-VS-A9U7-01A-01-TS1",NA,90,NA,"65817706-73b9-409b-b4eb-1c52f41cd86a","RNA","TCGA-VS-A9U7-01A-11R","eebbbf45-ba0b-4039-bcf9-9723347cd06a",1.8,0.17,"UV Spec","R","23","TCGA-VS-A9U7-01A-11R-A42T-07","78f72cda-30eb-41f6-8713-795ced251abb",0.17,NA,82,33.2670696579983,157,"f19523f1-c29c-52d7-8c3f-25c0d432761e","TCGA-VS-A9U7_exposure","UNCID_2654404.78f72cda-30eb-41f6-8713-795ced251abb.140908_UNC11-SN627_0381_BC5DEKACXX_4_GATCAG.tar.gz","2014-11-05T14:47:03.000Z","2014-11-05T15:03:24.000Z","E18AE413-C0EA-40CB-8F31-9BF4E1B08DD3","E56A6902-4A2D-4768-B030-AFA41212646A","Unaligned reads",7632275402,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","78F72CDA-30EB-41F6-8713-795CED251ABB","University of North Carolina","564a4001e4b09c884b25bd38","6D01421E-D533-4967-8422-97FBC0FB0895","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","65817706-73B9-409B-B4EB-1C52F41CD86A","2014-11-05T15:03:24.000Z","EEBBBF45-BA0B-4039-BCF9-9723347CD06A","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1029,"65817706-73B9-409B-B4EB-1C52F41CD86A",NA,"VS","TCGA-VS-A9U7-01A-11R-A42V-13_mirna.bam.bai",90,"TCGA-VS-A9U7-01A",NA,"188BFB3C-D196-47B2-9C99-4FACCD06ADE7","TCGA",2011,"TCGA-VS-A9U7_NTE-1","Complete Remission/Response","TUMOR FREE","E56A6902-4A2D-4768-B030-AFA41212646A",30,"nationwidechildrens.org_clinical.TCGA-VS-A9U7.xml","Alive",NA,"TCGA-VS-A9U7",NA,"8BA6A375-77C1-4162-93E1-9E1C482BAEF0","NO",1108,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b","8070/3","FEMALE","C53.9",420,NA,"D39D51C6-DADA-409F-B2A0-884F714B1F55","WHITE",NA,11,30,"4C1E05F5-75D1-4602-87C0-E2BA3DCFF87A","89C90458-674C-45EE-8E93-14E695547A7C","TCGA-VS-A9U7-01A-11R-A42V-13_mirna.bam.bai","TCGA-VS-A9U7-01A-11",90,5,0,5,5,"TOP",0,0,"TCGA-VS-A9U7-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-VS-A9U7-D63460","TCGA-VS-A9U7-R63461","Internal","Primary Tumor Field","TCGA-VS-A9U7-F70919_NTE-1","NO",1472,"TUMOR FREE","Alive",NA,"TCGA-VS-A9U7-F70919","TCGA-VS-A9U7",NA,"VS","A9U7","YES","C53.9","8070/3","C53.9","NO","YES",-11210,"FEMALE","WHITE",NA,"No","No","Alive",1108,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,30,2011,"Biopsy (cervical / CT-guided / Other)","YES",18,3,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1bN1M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
123837620,121506892,5798110871,"D6A644F5-D1D0-4A8D-94C4-EE6C3ECE7430.bw","6dca2a6f-7f2c-4524-b528-396a889b2a3f","d6a644f5-d1d0-4a8d-94c4-ee6c3ece7430","2016-10-19T10:03:54.214751-05:00","UNCID_2326802.c51e3133-d702-41cd-af51-094a31f449d4.131015_UNC11-SN627_0327_AC2ND3ACXX_4_GAGTGG.tar.gz","4f12bed7-28a2-4baa-93eb-637f13513164",5678933140,"Illumina HiSeq","544cef9522d269e72a5b6c13f50c9441","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:00:04.707284-05:00","2016-05-03T11:30:43.413000-05:00","4f12bed7-28a2-4baa-93eb-637f13513164_analysis.xml","61fb805b74a169469da99e40f5589d54","11ff460a-0b7b-4bf9-9758-96054286711d",2124,"2016-09-29T18:54:26.886387-05:00","4f12bed7-28a2-4baa-93eb-637f13513164_experiment.xml","c458affb39e9d8710dcbf94bbe9b8616","3423c8f6-81af-445e-8597-4eb3e2646286",2628,"2016-09-29T22:56:40.273811-05:00","4f12bed7-28a2-4baa-93eb-637f13513164_run.xml","418cfff8b8855903d4fe7d2886ecb95f","ca4f7798-847c-455b-b478-6ad4c69e5c99",354,"2016-09-08T11:58:38.934538-05:00","TCGA-EX-A69L","2016-09-02T19:00:23.485964-05:00","female","TCGA-EX-A69L_demographic",1971,"asian","f781c04b-4878-593e-aff0-723100dcd243","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A69L_diagnosis","not reported",15121,"alive","8072/3",NA,602,"c09b16c5-5bc9-58c9-aad5-2778030d2135","c53.9",-15121,"TCGA-EX-A69L_treatment","143cea79-c7fc-5d01-a61f-94c536521340","01","false","TCGA-EX-A69L-01A",NA,"a48eee9d-68c6-4675-96ed-c860139d779c",FALSE,"6B157876-04F4-49D6-BACB-87F8E2B921CE","Primary Tumor",NA,148,530,NA,1367971200,"11",30,"TCGA-EX-A69L-01A-11",70,NA,0,NA,0,NA,0,NA,"2016-09-08T11:58:38.934538-05:00",NA,10,NA,1,NA,"TOP",NA,0,NA,"e006a1cb-1d56-4b3c-ab83-efa6db55a3dd",NA,"TCGA-EX-A69L-01A-01-TS1",NA,100,NA,"7344d4f5-4b23-4250-9459-9ac4eff71b9b","RNA","TCGA-EX-A69L-01A-11R","21901a49-33e2-466e-9bac-3bac3f20c870",1.89,0.17,"UV Spec","R","23","TCGA-EX-A69L-01A-11R-A32P-07","c51e3133-d702-41cd-af51-094a31f449d4",0.17,NA,73,27.4756294930182,163,"b3228816-b74f-5b8e-afab-7ef6a5366b5e","TCGA-EX-A69L_exposure","UNCID_2326802.c51e3133-d702-41cd-af51-094a31f449d4.131015_UNC11-SN627_0327_AC2ND3ACXX_4_GAGTGG.tar.gz","2014-01-19T10:26:17.000Z","2014-01-19T11:05:02.000Z","4F12BED7-28A2-4BAA-93EB-637F13513164","A48EEE9D-68C6-4675-96ED-C860139D779C","Unaligned reads",5678933140,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C51E3133-D702-41CD-AF51-094A31F449D4","University of North Carolina","56607588e4b0ec1099f8bac9","6DCA2A6F-7F2C-4524-B528-396A889B2A3F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7344D4F5-4B23-4250-9459-9AC4EFF71B9B","2014-01-19T11:05:02.000Z","21901A49-33E2-466E-9BAC-3BAC3F20C870","United States","NO",1,NA,"Primary Tumor","University of North Carolina",148,"7344D4F5-4B23-4250-9459-9AC4EFF71B9B",NA,"EX","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A34C4C91-F909-4102-95A8-2DCE367AEDA8.txt",530,"TCGA-EX-A69L-01A",NA,NA,"TCGA",2012,"TCGA-EX-A69L_NTE-1","Complete Remission/Response","TUMOR FREE","A48EEE9D-68C6-4675-96ED-C860139D779C",41,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A34C4C91-F909-4102-95A8-2DCE367AEDA8.txt","Alive",NA,"TCGA-EX-A69L","NOT HISPANIC OR LATINO","E77C3FA8-D5CA-49E7-BC64-D26186144BE2","NO",136,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",335,NA,NA,"ASIAN",NA,11,30,"E006A1CB-1D56-4B3C-AB83-EFA6DB55A3DD","56829D83-C7AF-4CD9-91B6-74675A203395","THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_B11_1367048.hg19.seg.txt","TCGA-EX-A69L-01A-11",70,0,0,10,0,"TOP",0,1,"TCGA-EX-A69L-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-EX-A69L-F63787_NTE-1","NO",602,"TUMOR FREE","Alive",NA,"TCGA-EX-A69L-F63787","TCGA-EX-A69L",NA,"EX","A69L","YES","C53.9","8072/3","C53.9","YES","NO",-15121,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",136,NA,NA,NA,"TUMOR FREE","YES",19,6,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,41,2012,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
181876636,176810638,8441024064,"2A5848CC-A9A2-4AA8-A752-321273E62CF0.bw","6e01248b-c551-4f52-8066-cb2d26eb6394","2a5848cc-a9a2-4aa8-a752-321273e62cf0","2016-08-09T13:11:26.643937-05:00","UNCID_2186709.622F0488-00C2-4F4F-8D5E-6CC9AB5B0E11.121011_UNC13-SN749_0197_AD16K1ACXX_8_CAGATC.tar.gz","7b2036aa-3e81-4982-8f21-cbd704d50a56",8222170145,"Illumina HiSeq","0c89a527059e3e74290c9edd6af0d489","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:53:29.590035-05:00","2016-05-03T11:00:24.467501-05:00","7b2036aa-3e81-4982-8f21-cbd704d50a56_analysis.xml","1e382ae3c29eb71cce931a864ae82be6","a346a303-f85f-4cf6-91c9-a883d3935434",2124,"2016-09-29T22:38:40.877179-05:00","7b2036aa-3e81-4982-8f21-cbd704d50a56_experiment.xml","4d2d25c0c7905a356269d8e5500c8b52","bf2669af-7a49-48c0-987f-dd78721f67b0",2431,"2016-09-29T23:40:29.902246-05:00","7b2036aa-3e81-4982-8f21-cbd704d50a56_run.xml","abdb782dc727bbd5165571232f82f9e7","e586b851-eb12-4836-98fe-35d5cc4a8fbf",354,"2016-09-08T11:27:28.511215-05:00","TCGA-FU-A3YQ","2016-09-02T18:59:31.898947-05:00","female","TCGA-FU-A3YQ_demographic",1977,"white","9f0afba8-32f4-508e-97c4-e7638a136b50","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3YQ_diagnosis","not reported",12816,"alive","8070/3",NA,861,"de20570f-fbf4-54a2-8a23-25bcb38d84e8","c53.9",-12816,"TCGA-FU-A3YQ_treatment","51037b09-7442-5309-9d3c-15d8d944858e","01","false","TCGA-FU-A3YQ-01A",NA,"84a97589-63ae-4151-89f3-40f5aa9de72e",FALSE,"6BF77930-F8F4-41C5-86EF-EF43157BA6B5","Primary Tumor",NA,139,20,NA,1339027200,"11",20,"TCGA-FU-A3YQ-01A-11",60,NA,0,NA,92,NA,0,NA,"2016-09-08T11:27:28.511215-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"2f915212-79f7-4186-8d33-fc1ff4b0a8dc",NA,"TCGA-FU-A3YQ-01A-01-TS1",NA,NA,NA,"d7b55434-c9b1-423d-b0ad-45a44d4919b8","RNA","TCGA-FU-A3YQ-01A-11R","dbb9fc5d-3e78-47b1-b1e5-fdb3c9ef71d1",1.78,0.15,"UV Spec","R","23","TCGA-FU-A3YQ-01A-11R-A22U-07","622f0488-00c2-4f4f-8d5e-6cc9ab5b0e11",0.15,0.547945205479452,101,39.453125,160,"61021e33-d2e3-5986-b8b3-5aaaf4f81e45","TCGA-FU-A3YQ_exposure","UNCID_2186709.622F0488-00C2-4F4F-8D5E-6CC9AB5B0E11.121011_UNC13-SN749_0197_AD16K1ACXX_8_CAGATC.tar.gz","2013-09-16T12:36:04.000Z","2013-09-16T12:56:02.000Z","7B2036AA-3E81-4982-8F21-CBD704D50A56","84A97589-63AE-4151-89F3-40F5AA9DE72E","Unaligned reads",8222170145,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","622F0488-00C2-4F4F-8D5E-6CC9AB5B0E11","University of North Carolina","564a40c7e4b093830b6affd2","6E01248B-C551-4F52-8066-CB2D26EB6394","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D7B55434-C9B1-423D-B0AD-45A44D4919B8","2013-09-16T12:56:02.000Z","DBB9FC5D-3E78-47B1-B1E5-FDB3C9EF71D1","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",139,"D7B55434-C9B1-423D-B0AD-45A44D4919B8",NA,"FU","TCGA-FU-A3YQ-01A-11R-A22V-13_mirna.bam",20,"TCGA-FU-A3YQ-01A",NA,NA,"TCGA",2012,"TCGA-FU-A3YQ_NTE-1",NA,NA,"F4FBEDEB-D14D-4189-99AF-0F015CFE5AC7",35,"nationwidechildrens.org_clinical.TCGA-FU-A3YQ.xml","Alive",NA,"TCGA-FU-A3YQ","NOT HISPANIC OR LATINO","D1EA4476-03A8-4255-B40B-05F3266BA51F","NO",107,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",236,NA,NA,"WHITE",NA,11,20,"2F915212-79F7-4186-8D33-FC1FF4B0A8DC","DBB9FC5D-3E78-47B1-B1E5-FDB3C9EF71D1","TCGA-FU-A3YQ-01A-11R-A22V-13_mirna.bam","TCGA-FU-A3YQ-01A-11",60,92,0,3,0,"TOP",5,0,"TCGA-FU-A3YQ-01A-01-TS1",NA,NA,NA,NA,NA,NA,NA,"TCGA-FU-A3YQ-F64203_NTE-1","NO",861,"TUMOR FREE","Alive",NA,"TCGA-FU-A3YQ-F64203","TCGA-FU-A3YQ",NA,"FU","A3YQ","YES","C53.9","8070/3","C53.9","YES","NO",-12816,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",107,NA,NA,NA,NA,"YES",4,10,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2012,"Biopsy (cervical / CT-guided / Other)","YES",24,0,"G1",NA,2,NA,10,NA,NA,"2009",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
170857858,168085061,8025563988,"7CA6358B-FC8A-4675-B092-9E061038FC83.bw","6f9d21c0-3b88-450d-a249-3e9bafba2dfa","7ca6358b-fc8a-4675-b092-9e061038fc83","2016-08-09T13:09:55.293691-05:00","UNCID_2186136.88EE3A4F-7688-4247-B03C-73F6E3AF7493.121102_UNC12-SN629_0235_AC13F5ACXX_6_ACTTGA.tar.gz","4408d748-26cd-430a-a91a-3797d792ac33",7713217308,"Illumina HiSeq","012cfb8ce6e70576e6fdad603c78bf09","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:19:50.098947-05:00","2016-05-03T11:00:24.444360-05:00","4408d748-26cd-430a-a91a-3797d792ac33_analysis.xml","84475e12c99c959a41e8f067277ec415","1e3bc355-d53f-4dc4-a93c-443a53dda3f6",2124,"2016-08-28T07:33:42.172702-05:00","4408d748-26cd-430a-a91a-3797d792ac33_experiment.xml","06c9f4ef71ddb911e38f6f671468a3cf","f8a5f64d-6255-415b-af94-e26a8020f44d",2431,"2016-09-29T21:43:21.474547-05:00","4408d748-26cd-430a-a91a-3797d792ac33_run.xml","be166bed982f2a0f1fc6c3fa31f60b13","9ce2f0c9-c3b2-4c36-8e31-1f7f871dd998",354,"2016-09-08T12:14:41.104350-05:00","TCGA-EA-A1QS","2016-09-02T18:59:27.969524-05:00","female","TCGA-EA-A1QS_demographic",1964,"white","99ea5dbc-d2d5-5f92-b2f9-30894624b5e5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A1QS_diagnosis","not reported",16923,"alive","8072/3",NA,1203,"b177ba4d-56dd-597e-a5ee-250411a88a91","c53.9",-16923,"TCGA-EA-A1QS_treatment","e75dc2a7-a62a-5ad4-a67d-2fa3b4ac27f2","01","true","TCGA-EA-A1QS-01A",NA,"8389c79e-164e-4462-adcd-364db3afb463",FALSE,"827FEDD4-5D89-4706-A81D-DAFA017EC7FF","Primary Tumor",NA,80,1240,NA,1333584000,"61",30,"TCGA-EA-A1QS-01A-61",60,NA,10,NA,10,NA,20,NA,"2016-09-08T12:14:41.104350-05:00",NA,60,NA,20,NA,"TOP",NA,10,NA,"35d6c617-ebe9-4146-8e77-ef9553a833b0",NA,"TCGA-EA-A1QS-01A-06-TSF",NA,60,NA,"70ff8458-26c8-42cb-881d-2ea046d6f015","RNA","TCGA-EA-A1QS-01A-61R","2d752742-5865-4406-958d-727d71b01430",1.79,0.16,"UV Spec","R","23","TCGA-EA-A1QS-01A-61R-A22U-07","88ee3a4f-7688-4247-b03c-73f6e3af7493",0.16,NA,60,22.3081499107674,164,"988e3098-ff12-5f00-abd5-0e7da5640641","TCGA-EA-A1QS_exposure","UNCID_2186136.88EE3A4F-7688-4247-B03C-73F6E3AF7493.121102_UNC12-SN629_0235_AC13F5ACXX_6_ACTTGA.tar.gz","2013-09-16T01:13:06.000Z","2013-09-16T02:39:02.000Z","4408D748-26CD-430A-A91A-3797D792AC33","8389C79E-164E-4462-ADCD-364DB3AFB463","Unaligned reads",7713217308,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","88EE3A4F-7688-4247-B03C-73F6E3AF7493","University of North Carolina","564a3e38e4b08c5d869267cd","6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","70FF8458-26C8-42CB-881D-2EA046D6F015","2013-09-16T02:39:02.000Z","2D752742-5865-4406-958D-727D71B01430","Russia","NO",1,NA,"Primary Tumor","Asterand",80,"70FF8458-26C8-42CB-881D-2EA046D6F015",NA,"EA","SHOWS_p_7TCGA_236_238_Mx_N_GenomeWideSNP_6_A12_1244606.hg19.seg.txt",1240,"TCGA-EA-A1QS-01A",NA,NA,"TCGA",2010,"TCGA-EA-A1QS_NTE-1","Complete Remission/Response","TUMOR FREE","DAC3E9E0-2A56-450B-9F7D-81B57BB8607E",46,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A770A8A6-09BA-46E2-B221-3B81ECA16660.txt","Alive",NA,"TCGA-EA-A1QS","NOT HISPANIC OR LATINO","01CA5F75-C68A-49A7-B2F8-1050796C0CAA","NO",40,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",236,NA,NA,"WHITE",NA,61,30,"35D6C617-EBE9-4146-8E77-EF9553A833B0","D3285C6A-D112-4A97-AA43-C77642EF2FAC","jhu-usc.edu_CESC.HumanMethylation450.7.lvl-3.TCGA-EA-A1QS-01A-61D-A230-05.txt","TCGA-EA-A1QS-01A-61",60,10,10,60,20,"TOP",10,20,"TCGA-EA-A1QS-01A-06-TSF",60,NA,NA,NA,NA,NA,NA,"TCGA-EA-A1QS-F66103_NTE-1","NO",1203,"TUMOR FREE","Alive",NA,"TCGA-EA-A1QS-F66103","TCGA-EA-A1QS",NA,"EA","A1QS","YES","C53.9","8072/3","C53.9","YES","NO",-16923,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"TUMOR FREE","YES",6,7,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2010,"Biopsy (cervical / CT-guided / Other)","YES",18,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
94204342,92543255,4418998348,"A4C2F4BC-5C62-4B1F-9AB8-46D9468EF523.bw","6ff12a54-10da-4941-bfea-7b66e19b4be9","a4c2f4bc-5c62-4b1f-9ab8-46d9468ef523","2016-08-09T13:11:16.170461-05:00","UNCID_2186797.a886bebc-9578-424a-910c-43ebff0d5696.121009_UNC16-SN851_0187_AD15RRACXX_5_TAGCTT.tar.gz","f3615c82-70ef-48a9-ba47-edbf08331b93",4149318989,"Illumina HiSeq","0443684ed7541ab8c6dddfa3666ad3a5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:48:07.146277-05:00","2016-05-03T11:01:14.469334-05:00","f3615c82-70ef-48a9-ba47-edbf08331b93_analysis.xml","ec2dc25d09682c8a034e0e0e8a8840dd","55be4d9a-c2b2-40d7-81f4-35f863bd2d29",2123,"2016-09-29T18:28:15.734340-05:00","f3615c82-70ef-48a9-ba47-edbf08331b93_experiment.xml","7b3cde23f43dbfc79fd632b73ed23c8a","239502f7-8dea-4230-8c65-7b384bb331f3",2431,"2016-09-30T00:21:01.839065-05:00","f3615c82-70ef-48a9-ba47-edbf08331b93_run.xml","dfc2afd8f5fab34b80b94142037381ff","fe9ded07-6854-4e43-9fce-d095dd4d57d9",354,"2016-09-08T12:13:08.092922-05:00","TCGA-FU-A3HZ","2016-09-02T18:58:49.649834-05:00","female","TCGA-FU-A3HZ_demographic",1946,"white","3bfceb12-366f-51c4-911b-044df0203eca","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3HZ_diagnosis","not reported",23565,"alive","8072/3",NA,1103,"0e08a620-b1eb-58ae-bd1c-32f51483e116","c53.9",-23565,"TCGA-FU-A3HZ_treatment","3a3ca275-4866-50f8-8155-72d6db83b738","01","false","TCGA-FU-A3HZ-01A",NA,"6408a1f5-f5f7-40c8-a2ee-cb8038c15c95",FALSE,"5A91D73E-6F08-4439-AA0D-E73186C81DCB","Primary Tumor",NA,465,16,NA,1325548800,"11",16,"TCGA-FU-A3HZ-01A-11",80,NA,0,NA,0,NA,15,NA,"2016-09-08T12:13:08.092922-05:00",NA,0,NA,0,NA,"TOP",NA,10,NA,"9232b69b-1524-44d5-b66e-453d9352a297",NA,"TCGA-FU-A3HZ-01A-01-TS1",NA,75,NA,"d8647c91-c8b4-4b58-9194-936955a46830","RNA","TCGA-FU-A3HZ-01A-11R","a470b77b-55c8-4bf0-89ee-a8dcfb1ee60c",1.81,0.18,"UV Spec","R","23","TCGA-FU-A3HZ-01A-11R-A213-07","a886bebc-9578-424a-910c-43ebff0d5696",0.18,NA,66,24.2424242424242,165,"6a3b76f7-ac27-5e61-9425-9d975fc9bf26","TCGA-FU-A3HZ_exposure","UNCID_2186797.a886bebc-9578-424a-910c-43ebff0d5696.121009_UNC16-SN851_0187_AD15RRACXX_5_TAGCTT.tar.gz","2013-09-16T14:56:04.000Z","2013-09-16T15:22:02.000Z","F3615C82-70EF-48A9-BA47-EDBF08331B93","6408A1F5-F5F7-40C8-A2EE-CB8038C15C95","Unaligned reads",4149318989,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A886BEBC-9578-424A-910C-43EBFF0D5696","University of North Carolina","56607758e4b016715ab696ff","6FF12A54-10DA-4941-BFEA-7B66E19B4BE9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D8647C91-C8B4-4B58-9194-936955A46830","2013-09-16T15:22:02.000Z","A470B77B-55C8-4BF0-89EE-A8DCFB1EE60C","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",465,"D8647C91-C8B4-4B58-9194-936955A46830",NA,"FU","UNCID_2186797.a886bebc-9578-424a-910c-43ebff0d5696.121009_UNC16-SN851_0187_AD15RRACXX_5_TAGCTT.tar.gz",16,"TCGA-FU-A3HZ-01A",NA,"11063673-DD72-418C-8090-19921AB04C0C","TCGA",2010,NA,NA,"TUMOR FREE","6408A1F5-F5F7-40C8-A2EE-CB8038C15C95",64,"nationwidechildrens.org_clinical.TCGA-FU-A3HZ.xml","Alive",NA,"TCGA-FU-A3HZ","NOT HISPANIC OR LATINO","AF39509B-766F-4AB4-9356-0DF2E7CF2446",NA,31,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IIA2",NA,NA,"T2a2","8072/3","FEMALE","C53.9",200,NA,"5C1F64F2-6BFD-4551-9EFC-5809590AB300","WHITE",NA,11,16,"9232B69B-1524-44D5-B66E-453D9352A297","0DF41FE8-7FF8-44ED-8E21-CDB96B552D5A","UNCID_2186797.a886bebc-9578-424a-910c-43ebff0d5696.121009_UNC16-SN851_0187_AD15RRACXX_5_TAGCTT.tar.gz","TCGA-FU-A3HZ-01A-11",80,0,0,0,15,"TOP",10,0,"TCGA-FU-A3HZ-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-FU-A3HZ-D64229","TCGA-FU-A3HZ-R64227","External","Primary Tumor Field","TCGA-FU-A3HZ-F64224_NTE-1","NO",1103,"TUMOR FREE","Alive",NA,"TCGA-FU-A3HZ-F64224","TCGA-FU-A3HZ",NA,"FU","A3HZ","YES","C53.9","8072/3","C53.9","NO","YES",-23565,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",31,NA,NA,NA,"TUMOR FREE","NO",16,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2010,"Other method, specify:","YES",9,0,"G3",NA,1,NA,NA,NA,NA,"2009",12,NA,"T2a2N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125535584,121277687,5780268030,"8AF4EB7F-418D-4CC9-A9B8-A93A4C1A173B.bw","7067b7da-fb1b-4827-8fe6-9433ed672d3b","8af4eb7f-418d-4cc9-a9b8-a93a4c1a173b","2016-08-25T12:30:18.361290-05:00","UNCID_2358422.33849579-965e-47e7-8fbe-016db46b3d77.140124_UNC13-SN749_0327_BC36RUACXX_7_GATCAG.tar.gz","6de8c0af-de47-4474-9397-46b4516d4272",5767396473,"Illumina HiSeq","0dd54d91801497f84b5872898ee5ba12","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:02:01.344633-05:00","2016-05-03T11:37:12.420448-05:00","6de8c0af-de47-4474-9397-46b4516d4272_analysis.xml","95d541b4fdff8efa00df28c6dcb445c3","38e4a328-98d7-4d56-98a8-151dce4ddd67",2124,"2016-09-29T18:20:07.783892-05:00","6de8c0af-de47-4474-9397-46b4516d4272_experiment.xml","9eb4609e05caf8f8dc4003e30273f893","1e632760-2232-4df4-80f2-06481a744c08",2628,"2016-09-29T17:58:25.520926-05:00","6de8c0af-de47-4474-9397-46b4516d4272_run.xml","ee39be7415c19232065d5b98a60b42ed","10f34c31-8cbd-43b9-893d-084b9cda22ba",354,"2016-09-08T12:02:15.051804-05:00","TCGA-LP-A7HU","2016-09-02T19:00:14.660539-05:00","female","TCGA-LP-A7HU_demographic",1960,"asian","677df7f1-197c-5d87-b15d-bef8693af51e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A7HU_diagnosis","not reported",19595,"alive","8384/3",NA,406,"bbf7ec89-d7e9-5ae2-a409-27e8f87c14f1","c53.9",-19595,"TCGA-LP-A7HU_treatment","95603db1-5cef-5691-9e67-06dac523ef16","01","true","TCGA-LP-A7HU-01A",NA,"c8e06edc-bf1c-4b84-91bb-582b6c2936e5",FALSE,"73BE0D97-1598-42A4-905B-3E652FF7D295","Primary Tumor",NA,141,250,NA,1379030400,"11",30,"TCGA-LP-A7HU-01A-11",65,NA,1,NA,10,NA,20,NA,"2016-09-08T12:02:15.051804-05:00",NA,4,NA,2,NA,"TOP",NA,5,NA,"4a7a9462-d5f6-4163-9333-fc1beecad2ce",NA,"TCGA-LP-A7HU-01A-01-TS1",NA,65,NA,"665ba065-2687-42fe-9657-9fd5106207e1","RNA","TCGA-LP-A7HU-01A-11R","40fb97b4-1c56-4741-a976-d43b6e6bf05b",1.98,0.18,"UV Spec","R","23","TCGA-LP-A7HU-01A-11R-A33Z-07","33849579-965e-47e7-8fbe-016db46b3d77",0.18,NA,58,24.1415192507804,155,"6606512a-e4da-5354-b873-2baa2fa7e80b","TCGA-LP-A7HU_exposure","UNCID_2358422.33849579-965e-47e7-8fbe-016db46b3d77.140124_UNC13-SN749_0327_BC36RUACXX_7_GATCAG.tar.gz","2014-02-25T13:03:05.000Z","2014-02-25T13:26:01.000Z","6DE8C0AF-DE47-4474-9397-46B4516D4272","C8E06EDC-BF1C-4B84-91BB-582B6C2936E5","Unaligned reads",5767396473,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","33849579-965E-47E7-8FBE-016DB46B3D77","University of North Carolina","564a3e6ce4b0298dd2c95f3a","7067B7DA-FB1B-4827-8FE6-9433ED672D3B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","665BA065-2687-42FE-9657-9FD5106207E1","2014-02-25T13:26:01.000Z","40FB97B4-1C56-4741-A976-D43B6E6BF05B","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",141,"665BA065-2687-42FE-9657-9FD5106207E1",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BCB3CB2B-4807-4B75-BEBA-8B33C4F18C18.txt",250,"TCGA-LP-A7HU-01A",NA,NA,"TCGA",2013,"TCGA-LP-A7HU_NTE-1",NA,"TUMOR FREE","C8E06EDC-BF1C-4B84-91BB-582B6C2936E5",53,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BCB3CB2B-4807-4B75-BEBA-8B33C4F18C18.txt","Alive",NA,"TCGA-LP-A7HU","NOT HISPANIC OR LATINO","CD3416F6-16C9-4E22-9292-CDA1DF92B95E","NO",6,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Post-Adjuvant Therapy","Stage II",NA,NA,"T2","8384/3","FEMALE","C53.9",350,NA,"AFB5434D-33D3-44C3-9E78-55B303B85C89","ASIAN",NA,11,30,"4A7A9462-D5F6-4163-9333-FC1BEECAD2CE","A6E3C7CA-A560-4495-A0F2-7E2B7E7AFF65","UNCID_2349730.33849579-965e-47e7-8fbe-016db46b3d77.sorted_genome_alignments.bam.bai","TCGA-LP-A7HU-01A-11",65,10,1,4,20,"TOP",5,2,"TCGA-LP-A7HU-01A-01-TS1",65,NA,NA,NA,"TCGA-LP-A7HU-R69615","External","Primary Tumor Field","TCGA-LP-A7HU-F69614_NTE-1","NO",406,"TUMOR FREE","Alive",NA,"TCGA-LP-A7HU-F69614","TCGA-LP-A7HU",NA,"LP","A7HU","YES","C53.9","8384/3","C53.9","YES","NO",-19595,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",6,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,53,2013,"Biopsy (cervical / CT-guided / Other)","YES",2,0,"G3",NA,1,NA,NA,NA,NA,"2009",9,NA,"T2N0M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
198778004,194410074,9262417050,"E5048887-70C8-468F-881E-2EC55F6E6F3B.bw","7218aa6f-3345-484f-a329-a3b6169a67c7","e5048887-70c8-468f-881e-2ec55f6e6f3b","2016-08-09T13:15:55.802508-05:00","UNCID_2186269.AAB8AE6F-AE54-4203-B2E6-2B86B9CA0337.121102_UNC12-SN629_0236_BC13E1ACXX_1_AGTCAA.tar.gz","62ce93a6-b617-4c05-b279-2ef3b22c8cdd",8790871330,"Illumina HiSeq","e3d787ab5a32c0aa85d83d3b823bc5aa","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:09:55.919186-05:00","2016-05-03T11:00:24.448573-05:00","62ce93a6-b617-4c05-b279-2ef3b22c8cdd_analysis.xml","daaffcef46a1f6c64dd4c74e4b73193d","8846da44-6f2d-4974-adbf-c3abe80b54b5",2123,"2016-09-29T18:38:22.451124-05:00","62ce93a6-b617-4c05-b279-2ef3b22c8cdd_experiment.xml","02fd5e6a46e9a16d4bf530d64d1f18b8","29f3ea7a-9ede-4883-bd15-05844ccea48a",2431,"2016-09-29T18:24:05.153387-05:00","62ce93a6-b617-4c05-b279-2ef3b22c8cdd_run.xml","6bf028bd99cd77654b34d7b9ca98564b","20f25163-bcdd-458d-bb57-0aae0009c353",354,"2016-09-08T12:13:04.217713-05:00","TCGA-FU-A3TQ","2016-09-02T18:59:29.854267-05:00","female","TCGA-FU-A3TQ_demographic",1955,"white","f4844c60-6db4-5821-ba94-d83ac279ce2d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3TQ_diagnosis","not reported",20302,"alive","8070/3",NA,795,"301f9095-1649-5023-8487-f2ce91ace453","c53.9",-20302,"TCGA-FU-A3TQ_treatment","caedf5fd-3333-5874-ba4f-159e8e8cb92a","01","false","TCGA-FU-A3TQ-01A",NA,"2f3bffb4-2c85-4b72-9af5-4db9dc358ae6",FALSE,"76E32FF4-F62D-4ECD-87DF-5C9D9506B3EC","Primary Tumor",NA,561,200,NA,1334620800,"11",30,"TCGA-FU-A3TQ-01A-11",60,NA,5,NA,0,NA,35,NA,"2016-09-08T12:13:04.217713-05:00",NA,60,NA,20,NA,"TOP",NA,5,NA,"59ba41d2-c4ab-47e8-950d-7cd0ad88a538",NA,"TCGA-FU-A3TQ-01A-01-TSA",NA,60,NA,"907ba1e1-72cc-4fe4-9e5b-3b7388189f0a","RNA","TCGA-FU-A3TQ-01A-11R","b781973c-6ee3-4527-ba76-78e32e72750e",1.86,0.18,"UV Spec","R","23","TCGA-FU-A3TQ-01A-11R-A22U-07","aab8ae6f-ae54-4203-b2e6-2b86b9ca0337",0.18,2.73972602739726,59,25.536703601108,152,"0a0d768a-732f-5c0d-adae-761526af22b1","TCGA-FU-A3TQ_exposure","UNCID_2186269.AAB8AE6F-AE54-4203-B2E6-2B86B9CA0337.121102_UNC12-SN629_0236_BC13E1ACXX_1_AGTCAA.tar.gz","2013-09-16T03:36:03.000Z","2013-09-16T04:06:01.000Z","62CE93A6-B617-4C05-B279-2EF3B22C8CDD","2F3BFFB4-2C85-4B72-9AF5-4DB9DC358AE6","Unaligned reads",8790871330,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AAB8AE6F-AE54-4203-B2E6-2B86B9CA0337","University of North Carolina","566073d2e4b0b37b3d98e278","7218AA6F-3345-484F-A329-A3B6169A67C7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","907BA1E1-72CC-4FE4-9E5B-3B7388189F0A","2013-09-16T04:06:01.000Z","B781973C-6EE3-4527-BA76-78E32E72750E","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",561,"907BA1E1-72CC-4FE4-9E5B-3B7388189F0A",NA,"FU","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.ED4A2082-B683-4D56-A7D3-1136F0F1764F.txt",200,"TCGA-FU-A3TQ-01A",NA,NA,"TCGA",2010,"TCGA-FU-A3TQ_NTE-1",NA,"TUMOR FREE","B76ED8FA-2F4E-489F-AAF7-A69CC535C888",55,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.ED4A2082-B683-4D56-A7D3-1136F0F1764F.txt","Alive",NA,"TCGA-FU-A3TQ","NOT HISPANIC OR LATINO","A8E1920F-2401-4B89-A530-73BE8F08562A",NA,48,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",236,NA,NA,"WHITE",NA,11,30,"59BA41D2-C4AB-47E8-950D-7CD0AD88A538","B781973C-6EE3-4527-BA76-78E32E72750E","TCGA-FU-A3TQ-01A-11R-A22V-13_mirna.bam.bai","TCGA-FU-A3TQ-01A-11",60,0,5,60,35,"TOP",5,20,"TCGA-FU-A3TQ-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-FU-A3TQ-F65841_NTE-1","NO",795,"TUMOR FREE","Alive",NA,"TCGA-FU-A3TQ-F65841","TCGA-FU-A3TQ",NA,"FU","A3TQ","YES","C53.9","8070/3","C53.9","NO","YES",-20302,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",48,NA,NA,NA,"TUMOR FREE","NO",6,8,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,2010,"Cone Biopsy / LEEP","YES",12,2,"G2",NA,2,NA,50,NA,NA,"2009",16,NA,"T2bN1MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
190883788,181445751,8632733003,"1BADCC7C-C4D8-4C34-9534-59D622C7A2A2.bw","73aa428a-4288-45f8-8a53-cec173dcc61f","1badcc7c-c4d8-4c34-9534-59d622c7a2a2","2016-08-09T14:02:37.029412-05:00","UNCID_2168992.2807ba60-128f-49fc-9e15-bb3678c12f56.130611_UNC15-SN850_0312_BC265JACXX_5_ACAGTG.tar.gz","4c781747-daaa-4860-bb8b-34ead081db16",8833787648,"Illumina HiSeq","df6fc5ef94a2374255702fcef3e6ab1a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:20:17.615287-05:00","2016-05-03T11:06:28.634130-05:00","4c781747-daaa-4860-bb8b-34ead081db16_analysis.xml","2168e886863a71f1cdc5465b62bdf525","8ebccb9c-6ff3-4a73-9828-3bbfd46eaf72",2123,"2016-10-07T16:18:19.578529-05:00","4c781747-daaa-4860-bb8b-34ead081db16_experiment.xml","7122d61c5abcefaf2364ed177271e9f3","d4ed6a71-413e-462e-b5d8-3ab781f71339",2431,"2016-09-29T18:20:30.090500-05:00","4c781747-daaa-4860-bb8b-34ead081db16_run.xml","7ca7c74a6c4207adc3d2a9a37a624fdc","1ea1e5b1-948d-46ca-a137-43c4b8749e13",354,"2016-09-08T12:12:45.281338-05:00","TCGA-Q1-A5R3","2016-09-02T19:00:09.921346-05:00","female","TCGA-Q1-A5R3_demographic",1956,"white","aeea26ab-bc76-56b7-ad6b-6a76d812b627","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A5R3_diagnosis","not reported",20574,"alive","8070/3",NA,485,"ae4327d9-b4c8-50fd-9fb7-55d0c86631fc","c53.9",-20574,"TCGA-Q1-A5R3_treatment","2dba8c8f-4822-5233-95d2-727770409443","01","true","TCGA-Q1-A5R3-01A",NA,"3671d7c8-af2d-44a8-a3b1-da74ad6ccda2",FALSE,"1E8B41FC-2317-4EEA-BDD8-40BC40D36BA6","Primary Tumor",NA,115,420,NA,1360800000,"11",30,"TCGA-Q1-A5R3-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:12:45.281338-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"b3969926-346e-4b49-963c-d4fb6c01d045",NA,"TCGA-Q1-A5R3-01A-01-TSA",NA,100,NA,"ca1daa35-bf0b-4269-b447-ea9dbb51da0f","RNA","TCGA-Q1-A5R3-01A-11R","d2f22c4a-a8e2-43da-883a-4393c958a525",1.84,0.16,"UV Spec","R","23","TCGA-Q1-A5R3-01A-11R-A28H-07","2807ba60-128f-49fc-9e15-bb3678c12f56",0.16,NA,50,19.0519737844841,162,"377b4450-d746-5d80-a783-1c1df0fedad5","TCGA-Q1-A5R3_exposure","UNCID_2168992.2807ba60-128f-49fc-9e15-bb3678c12f56.130611_UNC15-SN850_0312_BC265JACXX_5_ACAGTG.tar.gz","2013-09-20T05:37:04.000Z","2013-09-20T06:00:01.000Z","4C781747-DAAA-4860-BB8B-34EAD081DB16","3671D7C8-AF2D-44A8-A3B1-DA74AD6CCDA2","Unaligned reads",8833787648,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2807BA60-128F-49FC-9E15-BB3678C12F56","University of North Carolina","564a3cc9e4b093830b69b718","73AA428A-4288-45F8-8A53-CEC173DCC61F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CA1DAA35-BF0B-4269-B447-EA9DBB51DA0F","2013-09-20T06:00:02.000Z","D2F22C4A-A8E2-43DA-883A-4393C958A525","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",115,"CA1DAA35-BF0B-4269-B447-EA9DBB51DA0F",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.677D93FA-9BC4-4BDC-A8E7-EC89133566BD.txt",420,"TCGA-Q1-A5R3-01A",NA,"C5C29ED4-F72E-4232-ACC3-915430D476E6","TCGA",2012,"TCGA-Q1-A5R3_NTE-1","Complete Remission/Response","TUMOR FREE","D5E8C9B5-3A1B-49AD-9E3C-84C4688264FD",56,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.677D93FA-9BC4-4BDC-A8E7-EC89133566BD.txt","Alive",NA,"TCGA-Q1-A5R3","NOT HISPANIC OR LATINO","94A5F763-7C6E-4DBD-ADE1-59B405CE2B96","NO",178,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy",NA,NA,NA,"TX","8070/3","FEMALE","C53.9",297,NA,"42602371-D418-4494-B07E-CFB77B73B3E4","WHITE",NA,11,30,"B3969926-346E-4B49-963C-D4FB6C01D045","F08E3C85-2D79-4823-B889-CBA3C8D9F63A","BRIAR_p_TCGA_297_298_299_300_S_GenomeWideSNP_6_B11_1362254.hg18.seg.txt","TCGA-Q1-A5R3-01A-11",80,0,0,4,0,"TOP",0,0,"TCGA-Q1-A5R3-01A-01-TSA",100,"Cisplatin","Chemotherapy","TCGA-Q1-A5R3-D48282","TCGA-Q1-A5R3-R48281","External","Primary Tumor Field","TCGA-Q1-A5R3-F56894_NTE-1","NO",485,"TUMOR FREE","Alive",NA,"TCGA-Q1-A5R3-F56894","TCGA-Q1-A5R3",NA,"Q1","A5R3","YES","C53.9","8070/3","C53.9","YES","NO",-20574,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",178,NA,NA,NA,"TUMOR FREE","YES",26,4,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,56,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","7th",1,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
159222338,156929958,7456570774,"02CE7DF7-64BD-4297-A240-A5B9EE8771D3.bw","748aada0-448f-4523-9893-3d9618fdbe18","02ce7df7-64bd-4297-a240-a5b9ee8771d3","2016-08-24T13:38:50.916633-05:00","UNCID_2251238.dfb5da30-7995-4132-8bc9-439b0f4f7c4c.120917_UNC11-SN627_0251_AC119PACXX_3_ACTTGA.tar.gz","c5195ccf-71a4-4816-9848-cc87ff8e8221",6709869282,"Illumina HiSeq","89e9f36e1ad4914a261fa2d362fccb0a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:07:00.405254-05:00","2016-05-03T11:20:52.084724-05:00","c5195ccf-71a4-4816-9848-cc87ff8e8221_analysis.xml","f0ea2f70692c5744124dac88a41b8405","3c250bf7-64c3-4348-83c0-014a0da11aa4",2124,"2016-09-29T19:04:47.913037-05:00","c5195ccf-71a4-4816-9848-cc87ff8e8221_experiment.xml","dd087f1d33d95dd6e7bf9525370f93ca","3ab08b34-99f6-4897-8f1d-495c959d5bc5",2431,"2016-09-30T00:20:41.917985-05:00","c5195ccf-71a4-4816-9848-cc87ff8e8221_run.xml","4541442d907f39fed428d2710860e4bf","fe686a79-9aad-4bc1-8b66-b0d617070afe",354,"2016-09-08T10:38:55.853927-05:00","TCGA-DR-A0ZM","2016-09-02T18:54:39.081986-05:00","female","TCGA-DR-A0ZM_demographic",1945,"white","a23c4fa2-eb45-5171-b6a0-d6cf5d5a16c5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DR","845c7519-bf45-5d14-a013-eed2831237a8","University of Hawaii","not reported","c53.9","TCGA-DR-A0ZM_diagnosis","not reported",22464,"alive","8070/3",NA,1791,"330df9fe-9b00-5942-b503-eb4503ed4afb","c53.9",-22464,"TCGA-DR-A0ZM_treatment","1af1bf75-d964-5892-9516-e3c0924e43f8","01","false","TCGA-DR-A0ZM-01A",NA,"ef1b5ff8-8623-43c7-b3ec-27bf332e11d3",FALSE,"14F05EE0-B739-42F8-99B0-0628ABB1B634","Primary Tumor",NA,1506,90,NA,1291334400,"12",30,"TCGA-DR-A0ZM-01A-12",50,60,0,0,0,0,50,40,"2016-09-08T10:38:55.853927-05:00","2016-09-08T10:38:55.853927-05:00",20,25,3,2,"TOP","BOTTOM",0,0,"469f097b-d96e-4b0b-9128-2d841bf30525","06e4f6ba-ca50-42e7-812d-062e980000b7","TCGA-DR-A0ZM-01A-01-TS1","TCGA-DR-A0ZM-01A-01-BS1",50,60,"9e0a08dc-d2a4-4e33-9ef8-d388b3fc83bf","RNA","TCGA-DR-A0ZM-01A-12R","56f4bf35-7bb3-413d-8385-4d5cbe822333",1.82,0.16,"UV Spec","R","23","TCGA-DR-A0ZM-01A-12R-A10U-07","dfb5da30-7995-4132-8bc9-439b0f4f7c4c",0.16,0.821917808219178,64,25.6369171607114,158,"f2e6eb01-7035-565b-9997-b39f546789d1","TCGA-DR-A0ZM_exposure","UNCID_2251238.dfb5da30-7995-4132-8bc9-439b0f4f7c4c.120917_UNC11-SN627_0251_AC119PACXX_3_ACTTGA.tar.gz","2013-10-26T20:51:04.000Z","2013-10-26T21:12:02.000Z","C5195CCF-71A4-4816-9848-CC87FF8E8221","EF1B5FF8-8623-43C7-B3EC-27BF332E11D3","Unaligned reads",6709869282,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","DFB5DA30-7995-4132-8BC9-439B0F4F7C4C","University of North Carolina","564a3e78e4b0ef12181b6acb","748AADA0-448F-4523-9893-3D9618FDBE18","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9E0A08DC-D2A4-4E33-9EF8-D388B3FC83BF","2013-10-26T21:12:02.000Z","56F4BF35-7BB3-413D-8385-4D5CBE822333","United States","NO",1,NA,"Primary Tumor","University of Hawaii",1506,"9E0A08DC-D2A4-4E33-9EF8-D388B3FC83BF",NA,"DR","UNCID_1662110.dfb5da30-7995-4132-8bc9-439b0f4f7c4c.sorted_genome_alignments.bam.bai",90,"TCGA-DR-A0ZM-01A",NA,"D926B906-4EC1-4D19-974E-E852936E646C","TCGA",2006,NA,NA,"TUMOR FREE","EF1B5FF8-8623-43C7-B3EC-27BF332E11D3",61,"nationwidechildrens.org_clinical.TCGA-DR-A0ZM.xml","Alive",NA,"TCGA-DR-A0ZM","NOT HISPANIC OR LATINO","E8B9EB20-405A-45D8-8B1E-7DF36077563C",NA,1289,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",88,NA,"F431B9D3-1E94-4967-B494-7A56D7D49EAC","WHITE",NA,12,30,"469F097B-D96E-4B0B-9128-2D841BF30525","AE5B1F17-D238-487C-A3BB-7387C3D10E1A","UNCID_1662110.dfb5da30-7995-4132-8bc9-439b0f4f7c4c.sorted_genome_alignments.bam.bai","TCGA-DR-A0ZM-01A-12",50,0,0,20,50,"TOP",0,3,"TCGA-DR-A0ZM-01A-01-TS1",50,"Cisplatin","Chemotherapy","TCGA-DR-A0ZM-D17118","TCGA-DR-A0ZM-R17117","EXTERNAL BEAM","Regional site",NA,"NO",1791,"TUMOR FREE","Alive",NA,"TCGA-DR-A0ZM-F17116","TCGA-DR-A0ZM",NA,"DR","A0ZM","YES","C53.9","8070/3","C53.9","NO","YES",-22464,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1289,NA,NA,NA,"TUMOR FREE","NO",28,3,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,61,2006,"Cone Biopsy / LEEP","YES",58,0,"G2",NA,2,NA,15,NA,NA,"2009",16,NA,"T2bN0M0",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
117476674,116390937,5560785459,"CBF6E96A-F56C-4C87-B851-D319930BAAB8.bw","74e47ded-2c00-4455-aaa6-cd662dfbf05e","cbf6e96a-f56c-4c87-b851-d319930baab8","2016-08-26T11:51:52.574712-05:00","UNCID_2278283.985c5f28-72d3-49f6-bc9b-31e565b2ba7c.130805_UNC9-SN296_0389_AC2AVJACXX_8_ATTCCT.tar.gz","d13bfe61-3a90-4552-91d3-eb713b0a47d0",5534452135,"Illumina HiSeq","19d381e418d2236d78c9ecc676a617e1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:49:04.585651-05:00","2016-05-03T11:24:56.858865-05:00","d13bfe61-3a90-4552-91d3-eb713b0a47d0_analysis.xml","2b881149acafb0f1230ca4d080f0e89d","565c2bf9-9524-4701-b2d3-baa067404889",2122,"2016-08-30T08:25:57.571919-05:00","d13bfe61-3a90-4552-91d3-eb713b0a47d0_experiment.xml","cfd19ec96a7c5bab5738bca586f4c257","843a4b6d-14e6-4f8d-96ac-5509eac9c2d5",2431,"2016-09-29T18:33:48.191363-05:00","d13bfe61-3a90-4552-91d3-eb713b0a47d0_run.xml","354de9226d4166d3d310bc37904a852d","26ec273e-fd5b-4ade-9a5f-83bfa03bc8a2",354,"2016-09-08T12:07:32.546107-05:00","TCGA-LP-A4AW","2016-09-02T18:59:41.235499-05:00","female","TCGA-LP-A4AW_demographic",1959,"asian","47541f99-1b91-5420-a7ae-fee70ac7be96","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A4AW_diagnosis","not reported",19079,"alive","8071/3",NA,27,"77648d51-1705-570f-a4c0-8c916702746f","c53.9",-19079,"TCGA-LP-A4AW_treatment","b611faef-cee8-5cb6-ac82-ea66e3f23eb8","01","true","TCGA-LP-A4AW-01A",NA,"5bdc56a0-0690-484e-b4bd-2f7ff96277ae",FALSE,"6FE2BF04-559B-4650-921B-C1674E76EEEB","Primary Tumor",NA,259,420,NA,1347580800,"11",30,"TCGA-LP-A4AW-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:07:32.546107-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"1ee5af4a-5610-480d-afc8-f028407b9ce6",NA,"TCGA-LP-A4AW-01A-01-TSA",NA,100,NA,"dbb11359-948f-4e7a-b3e7-c3abcf7b3029","RNA","TCGA-LP-A4AW-01A-11R","00f32f93-b5c9-4c64-ac3c-43dbe6863a23",2,0.18,"UV Spec","R","23","TCGA-LP-A4AW-01A-11R-A24H-07","985c5f28-72d3-49f6-bc9b-31e565b2ba7c",0.18,NA,52,20.829995193078,158,"1bcd2b20-1ace-5b73-a88c-d5ab47f09fc0","TCGA-LP-A4AW_exposure","UNCID_2278283.985c5f28-72d3-49f6-bc9b-31e565b2ba7c.130805_UNC9-SN296_0389_AC2AVJACXX_8_ATTCCT.tar.gz","2013-11-22T09:06:04.000Z","2013-11-22T09:20:03.000Z","D13BFE61-3A90-4552-91D3-EB713B0A47D0","5BDC56A0-0690-484E-B4BD-2F7FF96277AE","Unaligned reads",5534452135,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","985C5F28-72D3-49F6-BC9B-31E565B2BA7C","University of North Carolina","564a3aece4b0298dd2c8413e","74E47DED-2C00-4455-AAA6-CD662DFBF05E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DBB11359-948F-4E7A-B3E7-C3ABCF7B3029","2013-11-22T09:20:03.000Z","00F32F93-B5C9-4C64-AC3C-43DBE6863A23","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",259,"DBB11359-948F-4E7A-B3E7-C3ABCF7B3029",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.85E20D48-3D30-4459-BFB5-95F947CED890.txt",420,"TCGA-LP-A4AW-01A",NA,NA,"TCGA",2011,"TCGA-LP-A4AW_NTE-1",NA,"TUMOR FREE","CE324702-D597-49E4-8669-BCF2833C0F28",52,"nationwidechildrens.org_clinical.TCGA-LP-A4AW.xml","Alive",NA,"TCGA-LP-A4AW","NOT HISPANIC OR LATINO",NA,"NO",27,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IA",NA,NA,"T1b","8071/3","FEMALE","C53.9",256,NA,NA,"ASIAN",NA,11,30,"1EE5AF4A-5610-480D-AFC8-F028407B9CE6","A4F46CB9-48B1-452E-A1E4-56BB77729C78","TCGA-LP-A4AW-01A-11R-A24J-13_mirna.bam.bai","TCGA-LP-A4AW-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-LP-A4AW-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-LP-A4AW",NA,"LP","A4AW","YES","C53.9","8071/3","C53.9","YES","NO",-19079,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",27,NA,NA,NA,"TUMOR FREE","YES",12,3,2013,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,52,2011,"Biopsy (cervical / CT-guided / Other)","YES",3,NA,"G1",NA,1,NA,NA,NA,NA,"2009",3,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
178877514,176827230,8438110043,"48F6B774-CFD2-4DDF-B7A2-696596413C3F.bw","753ee373-fbcf-4349-b9b2-5a41936e27e9","48f6b774-cfd2-4ddf-b7a2-696596413c3f","2016-08-31T13:47:19.369986-05:00","UNCID_2186838.833baf21-bec9-4fde-aa6b-fb1b1256ae26.121009_UNC16-SN851_0187_AD15RRACXX_1_ATCACG.tar.gz","b3ab964a-3d34-426b-b8f6-3b7a1402f717",7840499339,"Illumina HiSeq","4c7327ec4af6f58558a1eace2c3cf462","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:15:14.799012-05:00","2016-05-03T11:00:24.456168-05:00","b3ab964a-3d34-426b-b8f6-3b7a1402f717_analysis.xml","c0904ba89dd8122434107657778e78f6","1b6f66b7-6dba-4713-929e-9a8be579c6cb",2124,"2016-08-28T04:08:21.964138-05:00","b3ab964a-3d34-426b-b8f6-3b7a1402f717_experiment.xml","30516ed2d372c71db45a45e98cf7ea92","e820949e-d450-4ed0-bb04-6ff0ffcdbb48",2431,"2016-09-29T23:00:46.066294-05:00","b3ab964a-3d34-426b-b8f6-3b7a1402f717_run.xml","7432ffc03f7571923233bd0ea5523fac","ccac91c4-25aa-49c7-93e5-db93e4f3562c",354,"2016-09-08T11:54:35.763665-05:00","TCGA-EA-A3HS","2016-09-02T18:58:43.417545-05:00","female","TCGA-EA-A3HS_demographic",1976,"white","bac7d816-0e48-5773-9d64-562be5ed6169","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3HS_diagnosis","not reported",13117,"alive","8070/3",NA,959,"709a5ee3-d696-54c9-8472-73f4d0114de5","c53.9",-13117,"TCGA-EA-A3HS_treatment","7bc71074-e99d-591a-8d66-50a19f4385a4","01","true","TCGA-EA-A3HS-01A",NA,"0835fa38-9870-472e-b9a0-2a2652807bc5",FALSE,"103C790B-65FE-4E6A-9CD8-C8B35BB09ABB","Primary Tumor",NA,219,1586,NA,1323820800,"11",30,"TCGA-EA-A3HS-01A-11",90,NA,2,NA,0,NA,0,NA,"2016-09-08T11:54:35.763665-05:00",NA,2,NA,1,NA,"TOP",NA,10,NA,"70c289d1-da4e-4351-af6f-2b3a26401db0",NA,"TCGA-EA-A3HS-01A-01-TSA",NA,90,NA,"22ace016-3d6f-46cc-90da-8f91c1d41597","RNA","TCGA-EA-A3HS-01A-11R","06d9bd2d-be23-4fc0-8135-cd6aa78f3e0a",1.9,0.17,"UV Spec","R","23","TCGA-EA-A3HS-01A-11R-A213-07","833baf21-bec9-4fde-aa6b-fb1b1256ae26",0.17,NA,54,18.9069010188719,169,"d8c3eb88-85c4-5a7a-a7b6-bd3b5ad29493","TCGA-EA-A3HS_exposure","UNCID_2186838.833baf21-bec9-4fde-aa6b-fb1b1256ae26.121009_UNC16-SN851_0187_AD15RRACXX_1_ATCACG.tar.gz","2013-09-16T18:37:05.000Z","2013-09-16T07:09:01.000Z","B3AB964A-3D34-426B-B8F6-3B7A1402F717","0835FA38-9870-472E-B9A0-2A2652807BC5","Unaligned reads",7840499339,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","833BAF21-BEC9-4FDE-AA6B-FB1B1256AE26","University of North Carolina","564a3e2ce4b093830b6a2766","753EE373-FBCF-4349-B9B2-5A41936E27E9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","22ACE016-3D6F-46CC-90DA-8F91C1D41597","2013-09-16T07:09:01.000Z","06D9BD2D-BE23-4FC0-8135-CD6AA78F3E0A","Russia","NO",1,NA,"Primary Tumor","Asterand",219,"22ACE016-3D6F-46CC-90DA-8F91C1D41597",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B8DA1194-2F9C-4792-8B40-B582F8D8B501.txt",1586,"TCGA-EA-A3HS-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","241D9F57-D791-41B8-8450-62543149792B",35,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B8DA1194-2F9C-4792-8B40-B582F8D8B501.txt","Alive",NA,"TCGA-EA-A3HS","NOT HISPANIC OR LATINO","B80D6700-2AF3-412B-BEB6-31FD381D05CF",NA,40,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"70C289D1-DA4E-4351-AF6F-2B3A26401DB0","69E43156-AEEE-49D6-B324-A3210F24BFFF","770158cfc6013ac94fc9f8da9bccadec.bam","TCGA-EA-A3HS-01A-11",90,0,2,2,0,"TOP",10,1,"TCGA-EA-A3HS-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3HS-F66110_NTE-1","NO",959,"TUMOR FREE","Alive",NA,"TCGA-EA-A3HS-F66110","TCGA-EA-A3HS",NA,"EA","A3HS","YES","C53.9","8070/3","C53.9","YES","NO",-13117,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"TUMOR FREE","NO",20,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",10,0,"G1",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
115631380,114036266,5438086415,"41D88C3E-5848-4B09-8A77-EAE6AC4EC6B0.bw","75bc22d8-738d-45f8-b6c0-c664f5fef47c","41d88c3e-5848-4b09-8a77-eae6ac4ec6b0","2016-08-25T20:54:45.802611-05:00","UNCID_2278253.e77c56f5-7575-46f0-9751-723085dbd6fc.131016_UNC10-SN254_0498_BC2KTUACXX_8_GATCAG.tar.gz","e1a43ea4-91b1-4a0a-a1bc-9825026633b1",5474951702,"Illumina HiSeq","5959d7f43b2371674328f1d4984867eb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:21:07.117093-05:00","2016-05-03T11:24:56.858865-05:00","e1a43ea4-91b1-4a0a-a1bc-9825026633b1_analysis.xml","86f1a6dd6ff93b781dd1eef696a9d1b1","69e94970-adff-4e65-96a1-5cd6a6d29555",2124,"2016-09-29T20:11:12.216783-05:00","e1a43ea4-91b1-4a0a-a1bc-9825026633b1_experiment.xml","cb9fb7560ccf0bfbcf35fbcb53ab8339","63e1bc6f-7a6e-493f-a9f1-f4cb58c0ab06",2431,"2016-09-29T19:39:52.317247-05:00","e1a43ea4-91b1-4a0a-a1bc-9825026633b1_run.xml","ade39e296a40b1ac7220cf1e0a415091","509f8bd1-602d-46e2-8f4a-3777c81d0564",354,"2016-09-08T11:23:06.778788-05:00","TCGA-IR-A3LI","2016-09-02T18:58:54.718696-05:00","female","TCGA-IR-A3LI_demographic",1957,"white","4705dad3-a0ff-55ca-b102-43bb46d2d505","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LI_diagnosis","not reported",17741,"alive","8384/3",NA,2493,"d1417d49-d144-5b6a-a88a-a88861be5b64","c53.9",-17741,"TCGA-IR-A3LI_treatment","a442c08d-ae65-52a4-aceb-8661361661af","01","true","TCGA-IR-A3LI-01A",NA,"ebfa4682-49c9-4ac1-8147-e3860d852d28",FALSE,"203CED2B-3E76-4539-9B52-D6F8FBF7E642","Primary Tumor",NA,2326,180,NA,1325721600,"11",30,"TCGA-IR-A3LI-01A-11",95,NA,0,NA,0,NA,0,NA,"2016-09-08T11:23:06.778788-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"85fc9b9b-6ee8-4d3b-82e1-ecaf836aefce",NA,"TCGA-IR-A3LI-01A-01-TSA",NA,100,NA,"e7fffc1d-0356-4d7f-8b04-4b5ae69495ad","RNA","TCGA-IR-A3LI-01A-11R","ccdf0c5b-febe-480d-9143-5edf4ee2d69f",1.75,0.17,"UV Spec","R","23","TCGA-IR-A3LI-01A-11R-A32Y-07","e77c56f5-7575-46f0-9751-723085dbd6fc",0.17,NA,71,24.8590735618501,169,"7093d866-f4bd-5d99-aaf5-a1eb6378aee7","TCGA-IR-A3LI_exposure","UNCID_2278253.e77c56f5-7575-46f0-9751-723085dbd6fc.131016_UNC10-SN254_0498_BC2KTUACXX_8_GATCAG.tar.gz","2013-11-22T07:06:04.000Z","2013-11-22T07:26:02.000Z","E1A43EA4-91B1-4A0A-A1BC-9825026633B1","EBFA4682-49C9-4AC1-8147-E3860D852D28","Unaligned reads",5474951702,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E77C56F5-7575-46F0-9751-723085DBD6FC","University of North Carolina","5660767fe4b018727fea0bf1","75BC22D8-738D-45F8-B6C0-C664F5FEF47C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E7FFFC1D-0356-4D7F-8B04-4B5AE69495AD","2013-11-22T07:26:02.000Z","CCDF0C5B-FEBE-480D-9143-5EDF4EE2D69F","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",2326,"E7FFFC1D-0356-4D7F-8B04-4B5AE69495AD",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.CAC8649C-9172-4F4F-8083-62EFF39FB4D6.txt",180,"TCGA-IR-A3LI-01A",NA,"F1DBA871-99FD-4D4C-AB21-A146ACDE4608","TCGA",2005,NA,NA,"TUMOR FREE","EBFA4682-49C9-4AC1-8147-E3860D852D28",48,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.CAC8649C-9172-4F4F-8083-62EFF39FB4D6.txt","Alive",NA,"TCGA-IR-A3LI",NA,"58746A15-CD77-4542-9F73-496B4ACEC3A9",NA,2445,"No","Cervix","C53.9","N1","Endocervical Type of Adenocarcinoma",NA,NA,"Stage IVB",NA,NA,"T2b","8384/3","FEMALE","C53.9",200,NA,"BEFA8E3B-0722-4DC2-BF91-60882B3F193E","WHITE",NA,11,30,"85FC9B9B-6EE8-4D3B-82E1-ECAF836AEFCE","1BC1F9C2-0695-4FA6-8354-E62283EB2509","UNCID_2278253.e77c56f5-7575-46f0-9751-723085dbd6fc.131016_UNC10-SN254_0498_BC2KTUACXX_8_GATCAG.tar.gz","TCGA-IR-A3LI-01A-11",95,0,0,1,0,"TOP",0,0,"TCGA-IR-A3LI-01A-01-TSA",100,"Topotecan HCl","Chemotherapy","TCGA-IR-A3LI-D38331","TCGA-IR-A3LI-R38328","External","Primary Tumor Field","TCGA-IR-A3LI-F38327_NTE-1","NO",2493,"TUMOR FREE","Alive",NA,"TCGA-IR-A3LI-F38327","TCGA-IR-A3LI",NA,"IR","A3LI","YES","C53.9","8384/3","C53.9","NO","YES",-17741,"FEMALE","WHITE",NA,"No","No","Alive",2445,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,48,2005,"Other method, specify:","YES",25,1,"G2",NA,1,NA,NA,NA,NA,"2009",18,NA,"T2bN1M1",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
162277028,158067911,7538641448,"BDF79CC0-00C7-49C1-900B-AB065A733B17.bw","76b54726-d348-4a1b-ae26-5b08d2effc9d","bdf79cc0-00c7-49c1-900b-ab065a733b17","2016-08-09T13:12:56.312995-05:00","UNCID_2186440.099a51db-4d31-4d90-b9cb-fd482309479a.121102_UNC15-SN850_0240_BD148CACXX_7_AGTTCC.tar.gz","8dd427c7-bc63-4fe8-868d-a86d71c99ded",7204187412,"Illumina HiSeq","9f631f5efcab77969dfa318fd4b9f7ad","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:54:02.309472-05:00","2016-05-03T11:00:24.459758-05:00","8dd427c7-bc63-4fe8-868d-a86d71c99ded_analysis.xml","e3d5c77a6ad0efeae76d815f3b68f70a","7e444432-2966-43d1-8d37-53aa94195bdb",2124,"2016-08-13T04:19:37.264083-05:00","8dd427c7-bc63-4fe8-868d-a86d71c99ded_experiment.xml","bd8ed18388c16faec2074dfd2907d81d","9c068c08-f2e1-404f-b6af-8cac146686fd",2431,"2016-09-29T20:58:13.255312-05:00","8dd427c7-bc63-4fe8-868d-a86d71c99ded_run.xml","9bf71d65ecc76ba3e37e2e2f2a94ad12","80df4635-d492-45b1-87bd-d9ff19efbd2e",354,"2016-09-08T11:46:26.918432-05:00","TCGA-EK-A2IP","2016-09-02T18:57:48.664894-05:00","female","TCGA-EK-A2IP_demographic",1978,"white","7c004d83-d0e9-5872-a6c6-711a3040fe4a","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2IP_diagnosis","not reported",10347,"alive","8072/3",NA,202,"651a2637-28b6-593e-b41b-ac652da3077f","c53.9",-10347,"TCGA-EK-A2IP_treatment","196a9a7a-e309-57c4-933d-8343712158fa","01","false","TCGA-EK-A2IP-01A",NA,"4c3570ef-d869-4ca0-8f8b-ec346e13e10c",FALSE,"973889C0-DC63-43F2-9DF4-CA67AFADFA87","Primary Tumor",NA,1675,110,NA,1310515200,"11",30,"TCGA-EK-A2IP-01A-11",85,NA,0,NA,0,NA,15,NA,"2016-09-08T11:46:26.918432-05:00",NA,2,NA,0,NA,"TOP",NA,1,NA,"1fd86060-24eb-4bbf-ba72-985e186236e8",NA,"TCGA-EK-A2IP-01A-01-TSA",NA,84,NA,"04cf9b0d-b076-4c27-9a49-32c1868cc0e1","RNA","TCGA-EK-A2IP-01A-11R","7941710a-ed2f-44d9-8415-ec20d8b88492",1.85,0.16,"UV Spec","R","23","TCGA-EK-A2IP-01A-11R-A180-07","099a51db-4d31-4d90-b9cb-fd482309479a",0.16,NA,69,24.7409372871024,167,"0d1c3cb4-0294-57e9-ba59-df73ed18771e","TCGA-EK-A2IP_exposure","UNCID_2186440.099a51db-4d31-4d90-b9cb-fd482309479a.121102_UNC15-SN850_0240_BD148CACXX_7_AGTTCC.tar.gz","2013-09-16T09:16:04.000Z","2013-09-16T09:37:01.000Z","8DD427C7-BC63-4FE8-868D-A86D71C99DED","4C3570EF-D869-4CA0-8F8B-EC346E13E10C","Unaligned reads",7204187412,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","099A51DB-4D31-4D90-B9CB-FD482309479A","University of North Carolina","564a3dcae4b08c5d869244ab","76B54726-D348-4A1B-AE26-5B08D2EFFC9D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","04CF9B0D-B076-4C27-9A49-32C1868CC0E1","2013-09-16T09:37:01.000Z","7941710A-ED2F-44D9-8415-EC20D8B88492","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1675,"04CF9B0D-B076-4C27-9A49-32C1868CC0E1",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.939F11BA-747F-4A0A-A885-FCF46C2500F7.txt",110,"TCGA-EK-A2IP-01A",NA,NA,"TCGA",2006,NA,NA,NA,"B7A8B87E-4963-4E23-AFAA-D2E391386BF0",28,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.939F11BA-747F-4A0A-A885-FCF46C2500F7.txt","Alive",NA,"TCGA-EK-A2IP",NA,"D46550E1-8A64-46AC-8133-0DE773DC82BF",NA,202,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",169,NA,NA,"WHITE",NA,11,30,"1FD86060-24EB-4BBF-BA72-985E186236E8","23EE02D9-1256-4EF8-9F28-2B90B8E879DD","TCGA-EK-A2IP-01A-11R-A17X-13_mirna.bam.bai","TCGA-EK-A2IP-01A-11",85,0,0,2,15,"TOP",1,0,"TCGA-EK-A2IP-01A-01-TSA",84,NA,NA,NA,NA,NA,NA,NA,"NO",202,NA,"Alive",NA,"TCGA-EK-A2IP-F21349","TCGA-EK-A2IP",NA,"EK","A2IP","YES","C53.9","8072/3","C53.9","NO","YES",-10347,"FEMALE","WHITE",NA,"No","No","Alive",202,NA,NA,NA,NA,"NO",4,11,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,28,2006,"Biopsy (cervical / CT-guided / Other)","YES",18,NA,"G3",NA,NA,NA,NA,NA,NA,"1995",7,NA,"T1b1N0MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
61724840,61115577,2919723680,"A894D686-BFC7-4AEE-A794-DBE718C6B6F6.bw","778389ba-c2e9-47d4-b133-6f4d0e689b34","a894d686-bfc7-4aee-a794-dbe718c6b6f6","2016-08-09T14:41:14.972552-05:00","UNCID_2654374.a4e4724d-bd99-4c46-9130-e34a89c3ef7b.141010_UNC12-SN629_0395_BC5FVEACXX_6_ACTGAT.tar.gz","f9a98cde-4c94-4b10-b368-03ebb5023037",2271059338,"Illumina HiSeq","9be2dfe2cd64368e56d8e08a9fc1cff0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:21:19.295154-05:00","2016-05-03T12:08:10.830175-05:00","f9a98cde-4c94-4b10-b368-03ebb5023037_analysis.xml","11d28864ec7ae485a270b39eb30015f1","fecfb33a-a0b2-466d-b81f-8a12874588c7",2124,"2016-09-29T19:34:24.606864-05:00","f9a98cde-4c94-4b10-b368-03ebb5023037_experiment.xml","a6aad142f2551ae215b5c34413b0a60b","4d426174-5a74-464a-9d9e-ac34e48cd477",2628,"2016-09-29T20:58:11.687984-05:00","f9a98cde-4c94-4b10-b368-03ebb5023037_run.xml","61230f46f8ae61b20d88b78fec6be787","80db7e24-4d59-4a02-8a0f-d71f9e0a7613",354,"2016-09-08T10:47:37.762714-05:00","TCGA-VS-A9V4","2016-09-02T18:54:39.198594-05:00","female","TCGA-VS-A9V4_demographic",1950,"white","64f97052-c2be-5417-b10a-febf50b8e613","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V4_diagnosis","not reported",23334,"dead","8482/3",132,NA,"fd5d2368-a4ad-5ae8-9280-a9b2ce922da7","c53.9",-23334,"TCGA-VS-A9V4_treatment","c79e40d2-adb2-5c59-aa53-44fcbe802f0a","01","false","TCGA-VS-A9V4-01A",NA,"fe295fcf-e3d5-4121-8833-901dcec5294c",FALSE,"6AB799DF-3327-4AFA-BE86-34C638F027CC","Primary Tumor",NA,216,60,NA,1390953600,"12",20,"TCGA-VS-A9V4-01A-12",60,NA,1,NA,40,NA,0,NA,"2016-09-08T10:47:37.762714-05:00",NA,6,NA,5,NA,"TOP",NA,20,NA,"af83b1e4-e46d-4069-b494-166aaca09ae8",NA,"TCGA-VS-A9V4-01A-01-TS1",NA,40,NA,"dd8d986d-ef6e-4409-a51b-d83c9a8fa939","RNA","TCGA-VS-A9V4-01A-12R","84221cac-7d89-4ffd-9241-8fcf2f8cde4a",1.83,0.17,"UV Spec","R","23","TCGA-VS-A9V4-01A-12R-A42T-07","a4e4724d-bd99-4c46-9130-e34a89c3ef7b",0.17,1.64383561643836,52,20.0609544384862,161,"69ef4bbf-79be-54f1-af9f-4a2b2ad5454f","TCGA-VS-A9V4_exposure","UNCID_2654374.a4e4724d-bd99-4c46-9130-e34a89c3ef7b.141010_UNC12-SN629_0395_BC5FVEACXX_6_ACTGAT.tar.gz","2014-11-05T03:51:03.000Z","2014-11-05T04:02:36.000Z","F9A98CDE-4C94-4B10-B368-03EBB5023037","FE295FCF-E3D5-4121-8833-901DCEC5294C","Unaligned reads",2271059338,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A4E4724D-BD99-4C46-9130-E34A89C3EF7B","University of North Carolina","564a3dd7e4b093830b6a0bda","778389BA-C2E9-47D4-B133-6F4D0E689B34","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DD8D986D-EF6E-4409-A51B-D83C9A8FA939","2014-11-05T04:02:36.000Z","84221CAC-7D89-4FFD-9241-8FCF2F8CDE4A","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",216,"DD8D986D-EF6E-4409-A51B-D83C9A8FA939",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_B06_1524204.hg19.seg.txt",60,"TCGA-VS-A9V4-01A",NA,"DCD18A3F-9FC6-43E2-8376-4A4E7D24C11C","TCGA",2013,"TCGA-VS-A9V4_NTE-1",NA,"WITH TUMOR","FE295FCF-E3D5-4121-8833-901DCEC5294C",63,"nationwidechildrens.org_clinical.TCGA-VS-A9V4.xml","Dead",132,"TCGA-VS-A9V4",NA,NA,"YES",NA,"Yes","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",2,"Pre-Adjuvant Therapy","Stage IVA",NA,NA,"T4","8482/3","FEMALE","C53.9",420,NA,"4C70FDE3-B84A-4F01-B471-252B661F12B1","WHITE",NA,12,20,"AF83B1E4-E46D-4069-B494-166AACA09AE8","84221CAC-7D89-4FFD-9241-8FCF2F8CDE4A","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_B06_1524204.hg19.seg.txt","TCGA-VS-A9V4-01A-12",60,40,1,6,0,"TOP",20,5,"TCGA-VS-A9V4-01A-01-TS1",40,"Cisplatin","Chemotherapy","TCGA-VS-A9V4-D63703","TCGA-VS-A9V4-R65896","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9V4",NA,"VS","A9V4","YES","C53.9","8482/3","C53.9","NO","YES",-23334,"FEMALE","WHITE",NA,"Yes","No","Dead",NA,132,NA,NA,"WITH TUMOR","YES",1,10,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,63,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,2013,30,NA,NA,"2009",17,NA,"T4NXMX",NA,NA,2,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
133945736,131956069,6302598785,"0712029E-3765-4272-BE5B-B6C8BCCC0F0F.bw","77d53d4d-3b07-4c79-86fe-6ac812968f39","0712029e-3765-4272-be5b-b6c8bccc0f0f","2016-08-09T13:56:44.521497-05:00","UNCID_2186973.00471faf-5a40-430a-8555-564fa885f618.121002_UNC11-SN627_0254_AC0WP5ACXX_2_CTTGTA.tar.gz","d582e075-bebc-46fc-83c7-f2091977aec1",5432711845,"Illumina HiSeq","004830eeb0a694380b81b1b845a1b2ae","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:58:24.398732-05:00","2016-05-03T11:01:14.488541-05:00","d582e075-bebc-46fc-83c7-f2091977aec1_analysis.xml","8f86745b7351cf6f1312091751d14fc8","5c2699c0-3466-497b-91d5-5a4e961d38b3",2124,"2016-09-29T22:18:13.277617-05:00","d582e075-bebc-46fc-83c7-f2091977aec1_experiment.xml","03a4848a06a117730589fb4afedf914f","b27e3988-240a-493d-a952-e9ca7cc321bd",2431,"2016-09-29T18:48:21.106523-05:00","d582e075-bebc-46fc-83c7-f2091977aec1_run.xml","97f49cb5feedcf961f7578d0138dc85f","30523a81-a746-4ebb-a83b-870a62fda8b4",354,"2016-09-08T12:27:44.377377-05:00","TCGA-C5-A2M2","2016-09-02T18:57:54.220154-05:00","female","TCGA-C5-A2M2_demographic",1953,"white","f45643ac-7f5e-5c71-82fc-9a50b6efa41c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2M2_diagnosis","not reported",20480,"dead","8140/3",1011,25,"efe9af70-3227-5b92-80b9-f37dcbf32d17","c53.9",-20480,"TCGA-C5-A2M2_treatment","509e6c74-d0b0-5f21-951f-f9820fb155d8","01","false","TCGA-C5-A2M2-01A",NA,"6a0afe74-ca6f-492b-a5a9-5fe5ee939722",FALSE,"716583F1-32F6-4CAC-853F-7A0773BB31F9","Primary Tumor",NA,774,140,NA,1315353600,"21",30,"TCGA-C5-A2M2-01A-21",75,NA,0,NA,0,NA,0,NA,"2016-09-08T12:27:44.377377-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"fd84e2bc-c67d-4f2b-97e0-ea1c137dde07",NA,"TCGA-C5-A2M2-01A-02-TSB",NA,100,NA,"ab749457-4bbc-4f17-a74d-906136e6fb6b","RNA","TCGA-C5-A2M2-01A-21R","8716a0d7-b92b-4ad0-885d-36746bcc3d7a",1.88,0.17,"UV Spec","R","23","TCGA-C5-A2M2-01A-21R-A18M-07","00471faf-5a40-430a-8555-564fa885f618",0.17,0.438356164383562,NA,NA,NA,"24935db2-e250-593e-b60c-c50cb165b7e8","TCGA-C5-A2M2_exposure","UNCID_2186973.00471faf-5a40-430a-8555-564fa885f618.121002_UNC11-SN627_0254_AC0WP5ACXX_2_CTTGTA.tar.gz","2013-09-16T07:43:03.000Z","2013-09-16T20:28:01.000Z","D582E075-BEBC-46FC-83C7-F2091977AEC1","6A0AFE74-CA6F-492B-A5A9-5FE5EE939722","Unaligned reads",5432711845,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","00471FAF-5A40-430A-8555-564FA885F618","University of North Carolina","566077a3e4b0ca319164e70d","77D53D4D-3B07-4C79-86FE-6AC812968F39","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AB749457-4BBC-4F17-A74D-906136E6FB6B","2013-09-16T20:28:01.000Z","8716A0D7-B92B-4AD0-885D-36746BCC3D7A","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",774,"AB749457-4BBC-4F17-A74D-906136E6FB6B",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E8A1C40D-96A1-4505-9E4B-42CC804182E2.txt",140,"TCGA-C5-A2M2-01A",NA,NA,"TCGA",2009,NA,NA,NA,"8B9FC1FB-60A8-4457-BD2D-D993DBF515D1",56,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E8A1C40D-96A1-4505-9E4B-42CC804182E2.txt","Alive",NA,"TCGA-C5-A2M2","NOT HISPANIC OR LATINO","8EB75FD7-24CE-4238-953C-78282DB9E8CD",NA,25,"No","Cervix","C53.9",NA,"Endocervical Type of Adenocarcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8140/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,21,30,"FD84E2BC-C67D-4F2B-97E0-EA1C137DDE07","658B7D86-371D-4EEA-9268-BD3F5E566E0A","TCGA-C5-A2M2-01A-21R-A18L-13_mirna.bam.bai","TCGA-C5-A2M2-01A-21",75,0,0,0,0,"TOP",0,0,"TCGA-C5-A2M2-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,"TCGA-C5-A2M2-F55539_NTE-1",NA,NA,NA,"Dead",1011,"TCGA-C5-A2M2-F55539","TCGA-C5-A2M2",NA,"C5","A2M2","YES","C53.9","8140/3","C53.9","NO","YES",-20480,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",25,NA,NA,NA,NA,"NO",4,4,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,56,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,2003,8,NA,NA,"2009",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
127565570,125543404,5988770554,"7B051855-9B09-4887-9BC0-9F077537938E.bw","77da506b-e726-409f-b3eb-d41242862982","7b051855-9b09-4887-9bc0-9f077537938e","2016-08-09T13:59:33.038871-05:00","UNCID_2170067.e2f4f6ea-e643-421e-96ec-3618bb46b91d.130517_UNC9-SN296_0366_BD250HACXX_8_GTTTCG.tar.gz","b1121abe-46c7-4207-9aec-3f6de10e8cfd",6263446451,"Illumina HiSeq","49f0e657317c092fbba7a7e942ea0a13","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:45:23.376904-05:00","2016-05-03T11:05:42.727154-05:00","b1121abe-46c7-4207-9aec-3f6de10e8cfd_analysis.xml","2ada8a6fa5f2549302230f716829231f","78e22666-febe-4e3b-8b8a-bdb9a87813ce",2121,"2016-08-26T14:33:06.812914-05:00","b1121abe-46c7-4207-9aec-3f6de10e8cfd_experiment.xml","162c6991b38aba10c77287fa4be2b1cb","63ed6713-bfd8-45d4-89f2-11af613fc350",2431,"2016-09-29T17:38:29.010448-05:00","b1121abe-46c7-4207-9aec-3f6de10e8cfd_run.xml","2ed3809f1c1a1029633f4f5c3709d555","0438115e-064c-4efb-b16b-76efdd6cfa50",354,"2016-09-08T12:00:57.141663-05:00","TCGA-MU-A51Y","2016-09-02T18:59:47.210016-05:00","female","TCGA-MU-A51Y_demographic",1985,"white","b0778a84-6a63-5dfe-8772-ee30d5eeed92","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MU","1ae3c544-7f5e-51e8-b9c7-c8b8d809f268","University of Minnesota","not reported","c53.9","TCGA-MU-A51Y_diagnosis","not reported",10199,"alive","8072/3",NA,854,"e5bf67e2-40f0-5334-bc20-1eefa3f137ce","c53.9",-10199,"TCGA-MU-A51Y_treatment","8d26f493-57c9-5068-8b6f-805b7ee7044c","01","true","TCGA-MU-A51Y-01A",NA,"51b871df-0b7b-44fe-b9f0-0e39ae6cb3a0",FALSE,"6E5C4ACB-C01C-4AE3-B060-E354CFEF08A0","Primary Tumor",NA,127,90,NA,1353456000,"11",30,"TCGA-MU-A51Y-01A-11",80,NA,0,NA,0,NA,15,NA,"2016-09-08T12:00:57.141663-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"33620596-e8c1-463c-8421-e69e0d6be327",NA,"TCGA-MU-A51Y-01A-01-TS1",NA,80,NA,"3f650843-7336-439f-bc33-69ae45e49bbd","RNA","TCGA-MU-A51Y-01A-11R","7845a422-086d-4525-8811-ee5ef1655d3f",1.83,0.17,"UV Spec","R","23","TCGA-MU-A51Y-01A-11R-A26T-07","e2f4f6ea-e643-421e-96ec-3618bb46b91d",0.17,NA,31,NA,NA,"09effb40-5d45-5875-9d68-3c07986a0b32","TCGA-MU-A51Y_exposure","UNCID_2170067.e2f4f6ea-e643-421e-96ec-3618bb46b91d.130517_UNC9-SN296_0366_BD250HACXX_8_GTTTCG.tar.gz","2013-09-19T22:07:05.000Z","2013-09-19T22:29:02.000Z","B1121ABE-46C7-4207-9AEC-3F6DE10E8CFD","51B871DF-0B7B-44FE-B9F0-0E39AE6CB3A0","Unaligned reads",6263446451,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E2F4F6EA-E643-421E-96EC-3618BB46B91D","University of North Carolina","5660753be4b0b37b3d98f5ae","77DA506B-E726-409F-B3EB-D41242862982","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3F650843-7336-439F-BC33-69AE45E49BBD","2013-09-19T22:29:02.000Z","7845A422-086D-4525-8811-EE5EF1655D3F","United States","NO",1,NA,"Primary Tumor","University of Minnesota",127,"3F650843-7336-439F-BC33-69AE45E49BBD",NA,"MU","UNCID_2170067.e2f4f6ea-e643-421e-96ec-3618bb46b91d.130517_UNC9-SN296_0366_BD250HACXX_8_GTTTCG.tar.gz",90,"TCGA-MU-A51Y-01A",NA,NA,"TCGA",2012,"TCGA-MU-A51Y_NTE-1","Complete Remission/Response","TUMOR FREE","51B871DF-0B7B-44FE-B9F0-0E39AE6CB3A0",27,"nationwidechildrens.org_clinical.TCGA-MU-A51Y.xml","Alive",NA,"TCGA-MU-A51Y",NA,"152EB6D4-360D-490C-B68B-05325803AB2F","NO",422,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIA1",NA,NA,"T2a1","8072/3","FEMALE","C53.9",280,NA,NA,"WHITE",NA,11,30,"33620596-E8C1-463C-8421-E69E0D6BE327","7845A422-086D-4525-8811-EE5EF1655D3F","9305216159_R04C02_Grn.idat","TCGA-MU-A51Y-01A-11",80,0,0,0,15,"TOP",5,0,"TCGA-MU-A51Y-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-MU-A51Y-F69301_NTE-1","NO",854,"TUMOR FREE","Alive",NA,"TCGA-MU-A51Y-F69301","TCGA-MU-A51Y",NA,"MU","A51Y","YES","C53.9","8072/3","C53.9","YES","NO",-10199,"FEMALE","WHITE",NA,"No","No","Alive",422,NA,NA,NA,"TUMOR FREE","YES",14,9,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,27,2012,"Cone Biopsy / LEEP","YES",17,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",11,NA,"T2a1N0MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
153745238,152027946,7258067415,"EF357C46-5C3C-4F51-9383-FF7694D07B97.bw","785ddea1-399d-47d8-b2b0-39e95eaa24b5","ef357c46-5c3c-4f51-9383-ff7694d07b97","2016-08-09T13:12:37.379328-05:00","UNCID_2186279.851064C8-582A-414A-BFCC-E1042BB9FF7B.121102_UNC12-SN629_0235_AC13F5ACXX_8_GGCTAC.tar.gz","831db65d-9055-4cdf-bec1-0f04cdc0bbaf",6808063683,"Illumina HiSeq","350a67c2d0b16f6c0d12807ff7e5033c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:25:13.939687-05:00","2016-05-03T11:00:24.448573-05:00","831db65d-9055-4cdf-bec1-0f04cdc0bbaf_analysis.xml","3a2b2f9ab93117ad2787443d7e765f3b","b6b907cf-18c9-4718-b7ec-c6df65c1abb5",2123,"2016-09-29T22:04:02.945457-05:00","831db65d-9055-4cdf-bec1-0f04cdc0bbaf_experiment.xml","3d791ca0115023eaec81619a214fc2b5","a9d67b85-fbf1-441d-a48c-3928491d8337",2431,"2016-09-29T21:45:44.979727-05:00","831db65d-9055-4cdf-bec1-0f04cdc0bbaf_run.xml","24c4e48fa9e310d32f767bfdd96c3686","9e643dfa-b7f0-4fe8-a100-50aaac096f5c",354,"2016-09-08T11:46:23.366809-05:00","TCGA-IR-A3LF","2016-09-02T18:59:33.402413-05:00","female","TCGA-IR-A3LF_demographic",1940,"white","5056da80-ff6e-55f4-b23c-55a8a1f07e43","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LF_diagnosis","not reported",23721,"alive","8384/3",NA,2949,"b68cbc6c-d963-5e00-9c85-a0a6db27231f","c53.9",-23721,"TCGA-IR-A3LF_treatment","bdcac9c6-fef6-5f64-bec4-41ce58727321","01","true","TCGA-IR-A3LF-01A",NA,"b6a74a02-cd3b-4f0a-bb2f-f90c1d3f6d14",FALSE,"8F0D0E63-D4E5-49A9-AC56-7D538284E917","Primary Tumor",NA,2814,240,NA,1337040000,"21",30,"TCGA-IR-A3LF-01A-21",60,NA,0,NA,30,NA,0,NA,"2016-09-08T11:46:23.366809-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"f578963e-0316-49ec-9e39-4b2763520a31",NA,"TCGA-IR-A3LF-01A-02-TSB",NA,70,NA,"b0514211-0f3c-4af7-ac95-f4e7d6b2c653","RNA","TCGA-IR-A3LF-01A-21R","070c124b-87fe-4dc3-bd8b-97fcb082211a",1.8,0.16,"UV Spec","R","23","TCGA-IR-A3LF-01A-21R-A22U-07","851064c8-582a-414a-bfcc-e1042bb9ff7b",0.16,NA,86,35.79604578564,155,"57d898c2-f576-53b4-bddf-4e8ace3b7395","TCGA-IR-A3LF_exposure","UNCID_2186279.851064C8-582A-414A-BFCC-E1042BB9FF7B.121102_UNC12-SN629_0235_AC13F5ACXX_8_GGCTAC.tar.gz","2013-09-16T04:46:06.000Z","2013-09-16T05:07:01.000Z","831DB65D-9055-4CDF-BEC1-0F04CDC0BBAF","B6A74A02-CD3B-4F0A-BB2F-F90C1D3F6D14","Unaligned reads",6808063683,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","851064C8-582A-414A-BFCC-E1042BB9FF7B","University of North Carolina","566076e3e4b0ca319164e137","785DDEA1-399D-47D8-B2B0-39E95EAA24B5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B0514211-0F3C-4AF7-AC95-F4E7D6B2C653","2013-09-16T05:07:02.000Z","070C124B-87FE-4DC3-BD8B-97FCB082211A","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",2814,"B0514211-0F3C-4AF7-AC95-F4E7D6B2C653",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.B65F36C5-75E0-45AA-B254-16ABC4C5DF64.txt",240,"TCGA-IR-A3LF-01A",NA,NA,"TCGA",2004,"TCGA-IR-A3LF_NTE-1","Complete Remission/Response","TUMOR FREE","BACC5092-B6AB-4A28-9D55-FA3AD22C3EEF",64,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.B65F36C5-75E0-45AA-B254-16ABC4C5DF64.txt","Alive",NA,"TCGA-IR-A3LF",NA,"70AB0558-49A0-4C31-95A3-CC3E9A040099","NO",2949,"No","Cervix","C53.9","N0","Endocervical Adenocarcinoma of the Usual Type",NA,NA,"Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",236,NA,"3828E7A7-0FB6-484C-A794-E3A615FC1A4F","WHITE",NA,21,30,"F578963E-0316-49EC-9E39-4B2763520A31","070C124B-87FE-4DC3-BD8B-97FCB082211A","UNCID_2186279.851064C8-582A-414A-BFCC-E1042BB9FF7B.121102_UNC12-SN629_0235_AC13F5ACXX_8_GGCTAC.tar.gz","TCGA-IR-A3LF-01A-21",60,30,0,0,0,"TOP",0,0,"TCGA-IR-A3LF-01A-02-TSB",70,NA,NA,NA,"TCGA-IR-A3LF-R39512","External","Primary Tumor Field","TCGA-IR-A3LF-F60818_NTE-1","NO",2949,NA,"Alive",NA,"TCGA-IR-A3LF-F60818","TCGA-IR-A3LF",NA,"IR","A3LF","YES","C53.9","8384/3","C53.9","NO","YES",-23721,"FEMALE","WHITE",NA,"No","No","Alive",2949,NA,NA,NA,"TUMOR FREE","YES",24,1,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,64,2004,"Biopsy (cervical / CT-guided / Other)","YES",16,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
79290766,78378779,3745159770,"9492A322-37CA-4582-AC68-66B5D80778AF.bw","78c62970-4b48-4dc4-9042-5f48f42818ec","9492a322-37ca-4582-ac68-66b5d80778af","2016-08-09T14:40:35.474386-05:00","UNCID_2654396.9817f939-fcd5-4130-986b-95228c78e17d.141010_UNC12-SN629_0395_BC5FVEACXX_6_CGTACG.tar.gz","29d5325b-241a-4a20-92aa-740069d970bc",2928434654,"Illumina HiSeq","e53ceae8df2f8c7376d66598e0274c8b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:44:06.499927-05:00","2016-05-03T12:08:10.830175-05:00","29d5325b-241a-4a20-92aa-740069d970bc_analysis.xml","adb71ae72849a84977f602edeb59871d","e7db9978-264c-4e10-99e4-47cd6346cba0",2123,"2016-08-13T09:09:17.328038-05:00","29d5325b-241a-4a20-92aa-740069d970bc_experiment.xml","cdc114afa479822c415ea1b40e9559c1","608497c4-7963-499a-aa94-3ac8e2eabf3b",2628,"2016-09-29T22:04:21.605584-05:00","29d5325b-241a-4a20-92aa-740069d970bc_run.xml","12c674ac01363fefe30cbc40a489f442","aa09ab9b-f351-4385-a46c-3160ed881062",354,"2016-09-09T16:39:05.630920-05:00","TCGA-VS-A9UJ","2016-09-02T18:54:24.209923-05:00","female","TCGA-VS-A9UJ_demographic",1957,"not reported","9416e81e-4f3e-52b7-a542-b18d4d4a8eff","not reported",2012,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UJ_diagnosis","not reported",20264,"dead","8070/3",52,NA,"8715d117-13b2-5fc0-b55f-febcbbdf8113","c53.9",-20264,"TCGA-VS-A9UJ_treatment","d44a15c0-56d2-5112-899b-f6151b60b1bb","01","false","TCGA-VS-A9UJ-01A",NA,"edb78cb9-e493-40a3-9f9c-9e1f3a88c768",FALSE,"41D3937F-69E0-4C7F-B38D-A5067B2C3C0B","Primary Tumor",NA,538,80,NA,1391040000,"11",30,"TCGA-VS-A9UJ-01A-11",80,NA,0,NA,5,NA,13,NA,"2016-09-09T16:39:05.630920-05:00",NA,5,NA,5,NA,"TOP",NA,2,NA,"80e1d65b-ef00-4152-962e-23beaa55d644",NA,"TCGA-VS-A9UJ-01A-01-TS1",NA,80,NA,"561e44f3-699b-4093-b2dd-59c11da3a709","RNA","TCGA-VS-A9UJ-01A-11R","f23a0d1f-a16d-4829-8ea9-b855af2ae210",1.87,0.17,"UV Spec","R","23","TCGA-VS-A9UJ-01A-11R-A42T-07","9817f939-fcd5-4130-986b-95228c78e17d",0.17,NA,NA,NA,NA,"d027dae3-25ec-59e8-849f-f62aaf67fb28","TCGA-VS-A9UJ_exposure","UNCID_2654396.9817f939-fcd5-4130-986b-95228c78e17d.141010_UNC12-SN629_0395_BC5FVEACXX_6_CGTACG.tar.gz","2014-11-05T12:06:04.000Z","2014-11-05T12:18:23.000Z","29D5325B-241A-4A20-92AA-740069D970BC","EDB78CB9-E493-40A3-9F9C-9E1F3A88C768","Unaligned reads",2928434654,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9817F939-FCD5-4130-986B-95228C78E17D","University of North Carolina","564a3dafe4b093830b6a0056","78C62970-4B48-4DC4-9042-5F48F42818EC","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","561E44F3-699B-4093-B2DD-59C11DA3A709","2014-11-05T12:18:23.000Z","F23A0D1F-A16D-4829-8EA9-B855AF2AE210","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",538,"561E44F3-699B-4093-B2DD-59C11DA3A709",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_H04_1524188.hg18.seg.txt",80,"TCGA-VS-A9UJ-01A",NA,NA,"TCGA",2012,"TCGA-VS-A9UJ_NTE-1",NA,"WITH TUMOR","EDB78CB9-E493-40A3-9F9C-9E1F3A88C768",55,"nationwidechildrens.org_clinical.TCGA-VS-A9UJ.xml","Dead",52,"TCGA-VS-A9UJ",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Other","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"80E1D65B-EF00-4152-962E-23BEAA55D644","F23A0D1F-A16D-4829-8EA9-B855AF2AE210","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_H04_1524188.hg18.seg.txt","TCGA-VS-A9UJ-01A-11",80,5,0,5,13,"TOP",2,5,"TCGA-VS-A9UJ-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UJ",NA,"VS","A9UJ","YES","C53.9","8070/3","C53.9","NO","YES",-20264,"FEMALE",NA,NA,"No","No","Dead",NA,52,NA,NA,"WITH TUMOR","YES",9,9,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,NA,"2009",13,NA,"T2bNXMX",NA,NA,1,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
269369564,264550915,12564156736,"993399A4-1B9F-4258-B2D0-155AD58A2E82.bw","7941d1c7-5319-4e8d-a15f-60b61cb68a9b","993399a4-1b9f-4258-b2d0-155ad58a2e82","2016-08-09T13:11:02.279393-05:00","UNCID_2187327.a1d00776-9535-4361-af77-8896e51465fe.120917_UNC11-SN627_0251_AC119PACXX_4_GATCAG.tar.gz","17b91a89-ce8e-4064-a1d8-9be025393c63",12012678336,"Illumina HiSeq","651fb46efd995ad44ae31f9aa72bce47","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:19:51.355230-05:00","2016-05-03T11:02:00.425419-05:00","17b91a89-ce8e-4064-a1d8-9be025393c63_analysis.xml","4f163f2f7656d34111961c60f6de32bb","fde253fb-ea26-46ab-8c31-f95f1a229f9a",2124,"2016-09-29T22:06:01.750988-05:00","17b91a89-ce8e-4064-a1d8-9be025393c63_experiment.xml","c451f077106765aaa96c0774de29a277","ab15a6b8-4736-464f-b932-580e67ac8267",2431,"2016-09-29T21:54:27.779155-05:00","17b91a89-ce8e-4064-a1d8-9be025393c63_run.xml","10bbe33ec062102c812cbd529fcdb066","a3e24cbc-2d1d-410f-aded-0be98be88298",354,"2016-09-08T12:14:58.616327-05:00","TCGA-C5-A1BJ","2016-09-02T18:56:44.246335-05:00","female","TCGA-C5-A1BJ_demographic",1963,"white","23eead91-6df8-5350-b38f-d4d74d625fd6","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BJ_diagnosis","not reported",12611,"alive","8070/3",NA,4385,"b2bfe1ff-669a-538d-9503-75aa7469d7c1","c53.9",-12611,"TCGA-C5-A1BJ_treatment","fad44661-32d8-5b7a-b7cc-ce347799673d","01","true","TCGA-C5-A1BJ-01A",NA,"c7b95d35-7fe9-4c25-94c6-ae6d7416a5c7",FALSE,"9F012D5B-DF59-43C3-96FC-4E6EE55BDAD6","Primary Tumor",NA,4972,130,NA,1295913600,"11",20,"TCGA-C5-A1BJ-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T12:14:58.616327-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"f24c19a0-b8af-44e5-a88f-a5b8e55aa55b",NA,"TCGA-C5-A1BJ-01A-01-TSA",NA,80,NA,"3c5cf1f9-a6d8-4bab-b41b-3dfa4e0cc054","RNA","TCGA-C5-A1BJ-01A-11R","0c212211-6203-481e-91ed-16ede4196ebe",1.83,0.16,"UV Spec","R","23","TCGA-C5-A1BJ-01A-11R-A13Y-07","a1d00776-9535-4361-af77-8896e51465fe",0.16,0.547945205479452,49,17.156262035643,169,"7d7c29ab-edd3-54d1-95e3-46c3460bf706","TCGA-C5-A1BJ_exposure","UNCID_2187327.a1d00776-9535-4361-af77-8896e51465fe.120917_UNC11-SN627_0251_AC119PACXX_4_GATCAG.tar.gz","2013-09-17T08:16:03.000Z","2013-09-17T08:42:02.000Z","17B91A89-CE8E-4064-A1D8-9BE025393C63","C7B95D35-7FE9-4C25-94C6-AE6D7416A5C7","Unaligned reads",12012678336,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A1D00776-9535-4361-AF77-8896E51465FE","University of North Carolina","56607533e4b018727fe9fccd","7941D1C7-5319-4E8D-A15F-60B61CB68A9B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3C5CF1F9-A6D8-4BAB-B41B-3DFA4E0CC054","2013-09-17T08:42:02.000Z","0C212211-6203-481E-91ED-16EDE4196EBE","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4972,"3C5CF1F9-A6D8-4BAB-B41B-3DFA4E0CC054",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.AD09DC41-D11F-40EC-BEDA-17B761E52DC8.txt",130,"TCGA-C5-A1BJ-01A",NA,NA,"TCGA",1997,NA,NA,"TUMOR FREE","C7B95D35-7FE9-4C25-94C6-AE6D7416A5C7",34,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.AD09DC41-D11F-40EC-BEDA-17B761E52DC8.txt","Alive",NA,"TCGA-C5-A1BJ",NA,"BE89C288-53FC-4C20-90EE-E10246554CCD",NA,4385,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8070/3","FEMALE","C53.9",114,NA,"BBFBA676-87B6-41E6-8133-DD7607402605","WHITE",NA,11,20,"F24C19A0-B8AF-44E5-A88F-A5B8E55AA55B","4B95E170-08D2-4F0C-BD98-FDBBE5FFFA51","C501.TCGA-C5-A1BJ-01A-11D-A13W-08.2.bam.bai","TCGA-C5-A1BJ-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-C5-A1BJ-01A-01-TSA",80,NA,NA,NA,"TCGA-C5-A1BJ-R30723","COMBINATION","Primary Tumor Field",NA,"NO",4385,"TUMOR FREE","Alive",NA,"TCGA-C5-A1BJ-F30721","TCGA-C5-A1BJ",NA,"C5","A1BJ","YES","C53.9","8070/3","C53.9","NO","YES",-12611,"FEMALE","WHITE",NA,"No","No","Alive",4385,NA,NA,NA,"TUMOR FREE","NO",13,9,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,34,1997,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,1997,10,NA,NA,"1995",13,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
109146896,103687452,4946914932,"7B7DC93D-5494-4E69-BE07-2967887182F9.bw","79ae5209-f476-4d65-a6c0-ebc18d7c8942","7b7dc93d-5494-4e69-be07-2967887182f9","2016-08-25T19:50:11.590429-05:00","UNCID_2326806.f96c0c4c-5d06-4606-9c58-aebdc3e2cef4.131015_UNC11-SN627_0328_BC2NN6ACXX_7_CGTACG.tar.gz","26adee65-4243-4eb1-8bbf-247ef8f0d8f4",4983410573,"Illumina HiSeq","feb89d87ea01c2298e001b239047cc9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:38:23.112608-05:00","2016-05-03T11:30:43.413000-05:00","26adee65-4243-4eb1-8bbf-247ef8f0d8f4_analysis.xml","e33e64b7173e7e35112873e9fe2a1643","04264df3-b463-4a73-a596-cdd10f8548c5",2124,"2016-09-29T22:42:12.188744-05:00","26adee65-4243-4eb1-8bbf-247ef8f0d8f4_experiment.xml","3ff7dcc0789f962905935c793c5f5ed9","c159ae27-91da-42e4-bea3-2614d097efa7",2628,"2016-09-29T19:53:57.019129-05:00","26adee65-4243-4eb1-8bbf-247ef8f0d8f4_run.xml","280926d03940bb7ca0934501d18542d2","59715c81-2b61-4ec1-9ad9-1d642c9668fd",354,"2016-09-08T11:47:51.873750-05:00","TCGA-EA-A78R","2016-09-02T19:00:22.545571-05:00","female","TCGA-EA-A78R_demographic",1959,"asian","da7f0042-2d26-56f6-89d2-76971375908e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A78R_diagnosis","not reported",19942,"alive","8070/3",NA,410,"2999be24-c39c-50c7-a029-0f6bf50ec0af","c53.9",-19942,"TCGA-EA-A78R_treatment","6d98ddd6-f16d-584c-900d-f56c4cb6d4e4","01","true","TCGA-EA-A78R-01A",NA,"4e047183-6aff-4211-8bf6-28af7a784b9c",FALSE,"36A90083-5078-435F-B9C2-337B75807716","Primary Tumor",NA,126,890,NA,1377043200,"11",30,"TCGA-EA-A78R-01A-11",60,NA,0,NA,10,NA,25,NA,"2016-09-08T11:47:51.873750-05:00",NA,5,NA,0,NA,"TOP",NA,5,NA,"403183bd-93e1-447f-b556-bfb32c1327fe",NA,"TCGA-EA-A78R-01A-01-TSA",NA,60,NA,"14df3c28-1dd5-4266-b261-04640e9a5a3d","RNA","TCGA-EA-A78R-01A-11R","bfda50ac-4427-4b63-9800-483bfd7bc089",1.84,0.16,"UV Spec","R","23","TCGA-EA-A78R-01A-11R-A32P-07","f96c0c4c-5d06-4606-9c58-aebdc3e2cef4",0.16,NA,63,24.609375,160,"b2856ec4-9abd-54dd-8ff7-8b02a4a0f82a","TCGA-EA-A78R_exposure","UNCID_2326806.f96c0c4c-5d06-4606-9c58-aebdc3e2cef4.131015_UNC11-SN627_0328_BC2NN6ACXX_7_CGTACG.tar.gz","2014-01-19T12:22:01.000Z","2014-01-19T13:05:02.000Z","26ADEE65-4243-4EB1-8BBF-247EF8F0D8F4","4E047183-6AFF-4211-8BF6-28AF7A784B9C","Unaligned reads",4983410573,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F96C0C4C-5D06-4606-9C58-AEBDC3E2CEF4","University of North Carolina","56607690e4b018727fea0caa","79AE5209-F476-4D65-A6C0-EBC18D7C8942","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","14DF3C28-1DD5-4266-B261-04640E9A5A3D","2014-01-19T13:05:02.000Z","BFDA50AC-4427-4B63-9800-483BFD7BC089","Vietnam","NO",1,NA,"Primary Tumor","Asterand",126,"14DF3C28-1DD5-4266-B261-04640E9A5A3D",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6E230015-A5EA-43CD-9BCE-4FB37061E492.txt",890,"TCGA-EA-A78R-01A",NA,NA,"TCGA",2013,"TCGA-EA-A78R_NTE-1",NA,"TUMOR FREE","4E047183-6AFF-4211-8BF6-28AF7A784B9C",54,"nationwidechildrens.org_clinical.TCGA-EA-A78R.xml","Alive",NA,"TCGA-EA-A78R","NOT HISPANIC OR LATINO","DC2E85E1-8E6B-471D-9637-1F6EA7599FB4","NO",12,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",335,NA,NA,"ASIAN",NA,11,30,"403183BD-93E1-447F-B556-BFB32C1327FE","C726A59D-B743-4283-B734-7968D02E6FFD","UNCID_2326806.f96c0c4c-5d06-4606-9c58-aebdc3e2cef4.131015_UNC11-SN627_0328_BC2NN6ACXX_7_CGTACG.tar.gz","TCGA-EA-A78R-01A-11",60,10,0,5,25,"TOP",5,0,"TCGA-EA-A78R-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-EA-A78R-F59968_NTE-1","NO",410,"TUMOR FREE","Alive",NA,"TCGA-EA-A78R-F59968","TCGA-EA-A78R",NA,"EA","A78R","YES","C53.9","8070/3","C53.9","YES","NO",-19942,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",12,NA,NA,NA,"TUMOR FREE","YES",21,11,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1NXM0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
97155898,96583254,4619007239,"29BCBA51-2580-473D-9CF7-BEDBD0DBAD1B.bw","7abaca8f-962e-4f9d-b63f-26c131bf5961","29bcba51-2580-473d-9cf7-bedbd0dbad1b","2016-08-09T14:40:46.704463-05:00","UNCID_2654403.4749bc16-8e1b-4e8e-b975-f07fd2ae885e.140908_UNC11-SN627_0381_BC5DEKACXX_4_TAGCTT.tar.gz","fde147ea-7da7-44e0-b7ef-7d81021ff3a7",4003399434,"Illumina HiSeq","f9b71da24e9af99239f08a60a2952f39","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:41:28.901097-05:00","2016-05-03T12:08:10.840133-05:00","fde147ea-7da7-44e0-b7ef-7d81021ff3a7_analysis.xml","af6f2b533e7e64005db112194fc4dffa","766da7a0-235b-41d5-acde-4886879c0e0f",2124,"2016-08-29T08:35:18.564446-05:00","fde147ea-7da7-44e0-b7ef-7d81021ff3a7_experiment.xml","f5d8862013201124ab340a93365f6f75","41c027fc-6d71-4bc7-968e-4fbbd06ebe10",2628,"2016-09-29T18:58:44.078769-05:00","fde147ea-7da7-44e0-b7ef-7d81021ff3a7_run.xml","bd53743fa16493b6044bbc717153ea7d","36df25d6-114c-4696-8a14-3f20aba6aa01",354,"2016-09-08T11:38:12.656866-05:00","TCGA-VS-A9UL","2016-09-02T18:54:24.900834-05:00","female","TCGA-VS-A9UL_demographic",1931,"white","615c5147-41f7-5be4-88fa-c085695c148e","not reported",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UL_diagnosis","not reported",29033,"dead","8070/3",442,NA,"64d3b1a3-2a38-55d0-b793-a2bac9b70e0b","c53.9",-29033,"TCGA-VS-A9UL_treatment","5bf76491-9b07-5ae8-b46a-3508c88f5ef3","01","false","TCGA-VS-A9UL-01A",NA,"4dd233a8-e3eb-4c14-83e5-fa3229430895",FALSE,"79869158-C990-45B6-B77B-A6CEC4886E5C","Primary Tumor",NA,1126,60,NA,1391040000,"11",30,"TCGA-VS-A9UL-01A-11",80,NA,0,NA,0,NA,15,NA,"2016-09-08T11:38:12.656866-05:00",NA,5,NA,5,NA,"TOP",NA,5,NA,"f2828e0a-b50c-4a49-b32a-2c2800024f14",NA,"TCGA-VS-A9UL-01A-01-TS1",NA,80,NA,"41e021f9-8597-4525-a1c5-7df2422f2125","RNA","TCGA-VS-A9UL-01A-11R","56d62ed9-65d3-4268-8ffe-3f4302131c7c",1.87,0.18,"UV Spec","R","23","TCGA-VS-A9UL-01A-11R-A42T-07","4749bc16-8e1b-4e8e-b975-f07fd2ae885e",0.18,NA,56,25.2240890049998,149,"8fc5eaa2-f7d3-548b-9b27-06c6a7dc25d5","TCGA-VS-A9UL_exposure","UNCID_2654403.4749bc16-8e1b-4e8e-b975-f07fd2ae885e.140908_UNC11-SN627_0381_BC5DEKACXX_4_TAGCTT.tar.gz","2014-11-05T14:06:04.000Z","2014-11-05T14:20:13.000Z","FDE147EA-7DA7-44E0-B7EF-7D81021FF3A7","4DD233A8-E3EB-4C14-83E5-FA3229430895","Unaligned reads",4003399434,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4749BC16-8E1B-4E8E-B975-F07FD2AE885E","University of North Carolina","56607795e4b016715ab69884","7ABACA8F-962E-4F9D-B63F-26C131BF5961","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","41E021F9-8597-4525-A1C5-7DF2422F2125","2014-11-05T14:20:13.000Z","56D62ED9-65D3-4268-8FFE-3F4302131C7C","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1126,"41E021F9-8597-4525-A1C5-7DF2422F2125",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_C10_1524120.byallele.copynumber.data.txt",60,"TCGA-VS-A9UL-01A",NA,NA,"TCGA",2010,"TCGA-VS-A9UL_NTE-1","Progressive Disease","WITH TUMOR","E57D6C1A-8AD6-457C-B56B-CE989B356101",79,"nationwidechildrens.org_clinical.TCGA-VS-A9UL.xml","Dead",442,"TCGA-VS-A9UL",NA,NA,"YES",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,"E35831D3-9600-4C36-8BBA-D26AB15CFDF4","WHITE",NA,11,30,"F2828E0A-B50C-4A49-B32A-2C2800024F14","56D62ED9-65D3-4268-8FFE-3F4302131C7C","TCGA-VS-A9UL-01A-11R-A42V-13_mirna.bam.bai","TCGA-VS-A9UL-01A-11",80,0,0,5,15,"TOP",5,5,"TCGA-VS-A9UL-01A-01-TS1",80,NA,NA,NA,"TCGA-VS-A9UL-R63707","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UL",NA,"VS","A9UL","YES","C53.9","8070/3","C53.9","NO","YES",-29033,"FEMALE","WHITE",NA,"No","No","Dead",NA,442,NA,NA,"WITH TUMOR","YES",5,9,2014,"NO","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,79,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Progressive Disease","2009",16,NA,"T3bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122510556,114712821,5467026777,"40855647-E942-4F32-90B7-BEB921929BFB.bw","7b228c3b-e604-41a1-9b76-8dd3d5a59ffe","40855647-e942-4f32-90b7-beb921929bfb","2016-08-25T20:29:51.131408-05:00","UNCID_2553117.a32d716b-4fc9-4451-9106-b4c7cda9bfc1.140403_UNC15-SN850_0359_BC41CEACXX_6_GTTTCG.tar.gz","6eeada86-bf34-404e-b6b0-763b98dd78eb",5191917700,"Illumina HiSeq","06c4a5765ab1ebbe315cfe3a597bb781","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:28:05.382232-05:00","2016-05-03T11:54:19.897074-05:00","6eeada86-bf34-404e-b6b0-763b98dd78eb_analysis.xml","b0bbbd1aece70263c31ad0aa3555c592","93948893-ebba-4a79-b69c-48dfe04f280d",2124,"2016-09-29T23:27:55.405054-05:00","6eeada86-bf34-404e-b6b0-763b98dd78eb_experiment.xml","76ed830e12ed9297d7c6e2a8ea4dbcef","ddb192bd-776f-468b-8dc9-3d702740f227",2628,"2016-09-30T00:04:18.333905-05:00","6eeada86-bf34-404e-b6b0-763b98dd78eb_run.xml","7c6c5bb0d9b1b6fcbeeedfa9b5e9f8fe","f4454a1a-ceda-40a4-bd46-75dbd40b8b29",354,"2016-09-08T11:27:52.174928-05:00","TCGA-VS-A8EI","2016-09-02T19:01:15.917820-05:00","female","TCGA-VS-A8EI_demographic",1974,"white","63fb64c2-1129-5977-9d35-02933f326720","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EI_diagnosis","not reported",14129,"alive","8070/3",NA,729,"38ca0661-f57c-5b2a-bef6-e37664c0cdf5","c53.9",-14129,"TCGA-VS-A8EI_treatment","07139464-a705-50a2-b594-eedea415edd4","01","false","TCGA-VS-A8EI-01A",NA,"6203a3e4-47b3-4457-b112-56e36b4eac31",FALSE,"B9B4DCAB-A369-496B-B36B-9E16041FD940","Primary Tumor",NA,327,40,NA,1384819200,"11",30,"TCGA-VS-A8EI-01A-11",60,NA,0,NA,5,NA,35,NA,"2016-09-08T11:27:52.174928-05:00",NA,20,NA,0,NA,"TOP",NA,0,NA,"64c2a4bf-ce1b-46cb-ae47-44d4bbf51ed6",NA,"TCGA-VS-A8EI-01A-01-TS1",NA,60,NA,"6dfcbfc3-0b2f-42ec-a603-dd59811eb172","RNA","TCGA-VS-A8EI-01A-11R","97a8352a-ec65-4e83-b092-e5d39b21dcd2",1.92,0.17,"UV Spec","R","23","TCGA-VS-A8EI-01A-11R-A37O-07","a32d716b-4fc9-4451-9106-b4c7cda9bfc1",0.17,NA,58,23.2334561768947,158,"c8bbf373-d433-5981-a0ce-47c05449fa66","TCGA-VS-A8EI_exposure","UNCID_2553117.a32d716b-4fc9-4451-9106-b4c7cda9bfc1.140403_UNC15-SN850_0359_BC41CEACXX_6_GTTTCG.tar.gz","2014-07-31T02:21:05.000Z","2014-07-31T02:43:35.000Z","6EEADA86-BF34-404E-B6B0-763B98DD78EB","6203A3E4-47B3-4457-B112-56E36B4EAC31","Unaligned reads",5191917700,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A32D716B-4FC9-4451-9106-B4C7CDA9BFC1","University of North Carolina","564a4106e4b08c5d8693507b","7B228C3B-E604-41A1-9B76-8DD3D5A59FFE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6DFCBFC3-0B2F-42EC-A603-DD59811EB172","2014-07-31T02:43:35.000Z","97A8352A-EC65-4E83-B092-E5D39B21DCD2","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",327,"6DFCBFC3-0B2F-42EC-A603-DD59811EB172",NA,"VS","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E03_1465288.tangent.copynumber.data.txt",40,"TCGA-VS-A8EI-01A",NA,"9081E806-69F2-43F6-8E10-E6D99C3BACD3","TCGA",2012,"TCGA-VS-A8EI_NTE-1","Complete Remission/Response","TUMOR FREE","6203A3E4-47B3-4457-B112-56E36B4EAC31",38,"SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E03_1465288.birdseed.data.txt","Alive",NA,"TCGA-VS-A8EI",NA,"7976B932-2FF2-4246-9CCD-4F57B94887A3","NO",428,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",380,NA,"C760397C-788E-48CA-83EB-04D4E14B9662","WHITE",NA,11,30,"64C2A4BF-CE1B-46CB-AE47-44D4BBF51ED6","97A8352A-EC65-4E83-B092-E5D39B21DCD2","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E03_1465288.hg18.seg.txt","TCGA-VS-A8EI-01A-11",60,5,0,20,35,"TOP",0,0,"TCGA-VS-A8EI-01A-01-TS1",60,"Cisplatin","Chemotherapy","TCGA-VS-A8EI-D64588","TCGA-VS-A8EI-R61983","External","Regional site","TCGA-VS-A8EI-F70922_NTE-1","NO",729,"TUMOR FREE","Alive",NA,"TCGA-VS-A8EI-F70922","TCGA-VS-A8EI",NA,"VS","A8EI","YES","C53.9","8070/3","C53.9","NO","YES",-14129,"FEMALE","WHITE",NA,"No","No","Alive",428,NA,NA,NA,"TUMOR FREE","YES",22,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T3bNXM0",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
122689004,121614762,5802464788,"0DC723D0-7C68-4495-A4B9-2DF2FF19AB14.bw","7b356c12-b226-4e58-be7f-44e50e3eefbe","0dc723d0-7c68-4495-a4b9-2df2ff19ab14","2016-08-24T19:36:17.554992-05:00","UNCID_2278275.e9e998be-4353-441e-83ec-d8c010b0dc79.131016_UNC10-SN254_0498_BC2KTUACXX_3_ATCACG.tar.gz","474d09a4-6ef6-479f-8857-e320de16be2c",5910956455,"Illumina HiSeq","3c0a05348131f9314e26051e671e2ea7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:55:21.490559-05:00","2016-05-03T11:24:56.858865-05:00","474d09a4-6ef6-479f-8857-e320de16be2c_analysis.xml","ba221468548de293a82d6a0d6d0df706","c97dccca-abf0-41b2-b5db-11f26aba0a04",2124,"2016-08-26T12:46:21.376001-05:00","474d09a4-6ef6-479f-8857-e320de16be2c_experiment.xml","6a489f154274d59f91922792ba4e368f","314f3274-f3e8-4d06-a351-cf6e655f567c",2431,"2016-09-29T23:09:05.109348-05:00","474d09a4-6ef6-479f-8857-e320de16be2c_run.xml","73aeb301671ad28acab6d3622630afed","d2060a3b-4ea1-4d19-87f4-588393b236e8",354,"2016-09-08T12:06:59.888162-05:00","TCGA-EA-A410","2016-09-02T18:59:35.029788-05:00","female","TCGA-EA-A410_demographic",1961,"white","49c4794a-bd06-525d-ae55-b5b7d9611391","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A410_diagnosis","not reported",18720,"alive","8070/3",NA,803,"55807f9c-379d-5a4c-ada4-03504aba2efe","c53.9",-18720,"TCGA-EA-A410_treatment","041fb630-b5db-50fb-9da6-c84541408557","01","true","TCGA-EA-A410-01A",NA,"7396043b-2ba2-474f-95a3-72da70f10e5a",FALSE,"EA3DC9B0-2680-4F3C-B14A-05CB047305BD","Primary Tumor",NA,172,700,NA,1343692800,"11",30,"TCGA-EA-A410-01A-11",75,NA,0,NA,10,NA,0,NA,"2016-09-08T12:06:59.888162-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"c6985c2c-5532-43a0-a910-8171d63a07aa",NA,"TCGA-EA-A410-01A-01-TSA",NA,85,NA,"d1fac28a-e231-49c3-b77d-42da89365c0d","RNA","TCGA-EA-A410-01A-11R","8f6eae07-20a2-484e-8f06-0052f38263eb",1.83,0.15,"UV Spec","R","23","TCGA-EA-A410-01A-11R-A32Y-07","e9e998be-4353-441e-83ec-d8c010b0dc79",0.15,NA,80,31.25,160,"002a2ba8-4d9f-5eaf-892d-d78d6479acc8","TCGA-EA-A410_exposure","UNCID_2278275.e9e998be-4353-441e-83ec-d8c010b0dc79.131016_UNC10-SN254_0498_BC2KTUACXX_3_ATCACG.tar.gz","2013-11-22T08:21:04.000Z","2013-11-22T08:41:02.000Z","474D09A4-6EF6-479F-8857-E320DE16BE2C","7396043B-2BA2-474F-95A3-72DA70F10E5A","Unaligned reads",5910956455,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E9E998BE-4353-441E-83EC-D8C010B0DC79","University of North Carolina","564a3dc0e4b0298dd2c9291a","7B356C12-B226-4E58-BE7F-44E50E3EEFBE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D1FAC28A-E231-49C3-B77D-42DA89365C0D","2013-11-22T08:41:02.000Z","8F6EAE07-20A2-484E-8F06-0052F38263EB","Russia","NO",1,NA,"Primary Tumor","Asterand",172,"D1FAC28A-E231-49C3-B77D-42DA89365C0D",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.5852B79F-E34E-4B67-ADDA-CD19B9FDF975.txt",700,"TCGA-EA-A410-01A",NA,NA,"TCGA",2012,"TCGA-EA-A410_NTE-1","Complete Remission/Response","TUMOR FREE","7522576D-1D75-43A3-9CA4-64D425C4E30D",51,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.5852B79F-E34E-4B67-ADDA-CD19B9FDF975.txt","Alive",NA,"TCGA-EA-A410","NOT HISPANIC OR LATINO","05B7E88C-9451-4560-AB5A-2DC2AFF66F00","NO",56,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IIA2",NA,NA,"T2a2","8070/3","FEMALE","C53.9",256,NA,NA,"WHITE",NA,11,30,"C6985C2C-5532-43A0-A910-8171D63A07AA","4B862614-D939-453F-8616-8D4524D0F794","9a6634616aaf1a4f289986b55cbb3ac2.bam","TCGA-EA-A410-01A-11",75,10,0,2,0,"TOP",5,0,"TCGA-EA-A410-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-EA-A410-F66115_NTE-1","NO",803,"TUMOR FREE","Alive",NA,"TCGA-EA-A410-F66115","TCGA-EA-A410",NA,"EA","A410","YES","C53.9","8070/3","C53.9","YES","NO",-18720,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",56,NA,NA,NA,"TUMOR FREE","YES",24,9,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2012,"Biopsy (cervical / CT-guided / Other)","YES",14,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",12,NA,"T2a2N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
156489958,153869762,7345711107,"7540005F-57E0-4E2E-A8A2-BEF2B0F333B1.bw","7b8c04d7-824d-493d-8f2c-9ed87a907192","7540005f-57e0-4e2e-a8a2-bef2b0f333b1","2016-08-05T11:04:48.396551-05:00","UNCID_2186294.249A179F-25D7-4508-B64C-BE08AAAFC82A.121102_UNC12-SN629_0235_AC13F5ACXX_7_TAGCTT.tar.gz","3bc0d63b-619d-4672-a0b4-3fcb11118179",7031157518,"Illumina HiSeq","6067e4d44e4b7f94dd0689bb1ea9f84a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:00:41.532034-05:00","2016-05-03T11:00:24.448573-05:00","3bc0d63b-619d-4672-a0b4-3fcb11118179_analysis.xml","82035dfed6385b57faed1c369f71d77a","f21136fb-a31d-49e6-a07b-97b1aae1f5a0",2124,"2016-09-29T17:57:08.682399-05:00","3bc0d63b-619d-4672-a0b4-3fcb11118179_experiment.xml","26c03ae240a2269c086ab26922e671c8","1025ab87-f6d4-4298-abe5-ec87dcdd8c60",2431,"2016-09-29T17:32:33.671854-05:00","3bc0d63b-619d-4672-a0b4-3fcb11118179_run.xml","8a6644ac3a6dfcd831d003174d85f2c4","008dd6fd-3c05-4580-9ce0-90f3d43cddfa",354,"2016-09-08T12:07:41.381920-05:00","TCGA-IR-A3LA","2016-09-02T18:59:32.776621-05:00","female","TCGA-IR-A3LA_demographic",1942,"white","2782c32e-98ce-5ffd-88dd-ea21dcd598a8","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LA_diagnosis","not reported",21949,"alive","8384/3",NA,4172,"ef7fa240-1894-5161-ae19-25ddd435e720","c53.9",-21949,"TCGA-IR-A3LA_treatment","b02ddf38-3067-5d72-a723-c5a6f5531ff0","01","true","TCGA-IR-A3LA-01A",NA,"7925ea80-8aae-4d99-afe2-74ad1aae6d9d",FALSE,"65E053F4-BCDB-40E2-A76B-1CA62FD61E1B","Primary Tumor",NA,3401,170,NA,1337040000,"11",30,"TCGA-IR-A3LA-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:07:41.381920-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"987bcdcc-4b6a-4fbc-a25c-8d449ea12390",NA,"TCGA-IR-A3LA-01A-01-TSA",NA,100,NA,"76263947-65f0-4e7b-af00-ddc539b8531f","RNA","TCGA-IR-A3LA-01A-11R","34c8fd0b-9a90-4b2c-ac3c-7d390d05b1f0",1.78,0.16,"UV Spec","R","23","TCGA-IR-A3LA-01A-11R-A22U-07","249a179f-25d7-4508-b64c-be08aaafc82a",0.16,NA,101,40.9752931153394,157,"545601bf-162f-5fec-9844-19ebe4cd1836","TCGA-IR-A3LA_exposure","UNCID_2186294.249A179F-25D7-4508-B64C-BE08AAAFC82A.121102_UNC12-SN629_0235_AC13F5ACXX_7_TAGCTT.tar.gz","2013-09-16T04:36:07.000Z","2013-09-16T04:57:01.000Z","3BC0D63B-619D-4672-A0B4-3FCB11118179","7925EA80-8AAE-4D99-AFE2-74AD1AAE6D9D","Unaligned reads",7031157518,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","249A179F-25D7-4508-B64C-BE08AAAFC82A","University of North Carolina","5660744ce4b018727fe9f09e","7B8C04D7-824D-493D-8F2C-9ED87A907192","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","76263947-65F0-4E7B-AF00-DDC539B8531F","2013-09-16T04:57:01.000Z","34C8FD0B-9A90-4B2C-AC3C-7D390D05B1F0","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",3401,"76263947-65F0-4E7B-AF00-DDC539B8531F",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.23FD746E-B0D7-4779-BF26-BB319461F879.txt",170,"TCGA-IR-A3LA-01A",NA,"B61E901D-3B92-401F-AC6A-999C175C46A5","TCGA",2002,"TCGA-IR-A3LA_NTE-1","Complete Remission/Response","TUMOR FREE","D0EBB92C-01A5-4486-A39F-6C89187AC640",60,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.23FD746E-B0D7-4779-BF26-BB319461F879.txt","Alive",NA,"TCGA-IR-A3LA",NA,"83D414B6-2D49-445D-8803-B212811E8E74","NO",3780,"No","Cervix","C53.9","N0","Endometrioid Adenocarcinoma of Endocervix",NA,NA,"Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",236,NA,"CD1DC818-63E5-4EC8-9ED5-4820E37B8434","WHITE",NA,11,30,"987BCDCC-4B6A-4FBC-A25C-8D449EA12390","A13BECDD-9748-48E7-8B12-108574D8EA18","20e8a3e70f699221fcedcb31818dd250.bam","TCGA-IR-A3LA-01A-11",80,0,0,0,0,"TOP",0,0,"TCGA-IR-A3LA-01A-01-TSA",100,"Cisplatin","Chemotherapy","TCGA-IR-A3LA-D39484","TCGA-IR-A3LA-R39483","External","Primary Tumor Field","TCGA-IR-A3LA-F56115_NTE-1","NO",4172,"TUMOR FREE","Alive",NA,"TCGA-IR-A3LA-F56115","TCGA-IR-A3LA",NA,"IR","A3LA","YES","C53.9","8384/3","C53.9","NO","YES",-21949,"FEMALE","WHITE",NA,"No","No","Alive",3780,NA,NA,NA,"TUMOR FREE","YES",24,1,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Endometrioid Adenocarcinoma of Endocervix",NA,0,60,2002,"Other method, specify:","YES",18,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
170647876,167267659,7982735970,"EB1DDB14-4076-4C2C-B911-390C17C21486.bw","7c4ab1ca-4bdd-4ef7-9a42-f6c0c7136d26","eb1ddb14-4076-4c2c-b911-390c17c21486","2016-08-05T09:19:30.688229-05:00","UNCID_2186825.386fbf20-f41e-41e1-96de-578066c35560.121009_UNC16-SN851_0187_AD15RRACXX_4_CAGATC.tar.gz","f5d3756e-9ef1-4416-be84-426dd610921f",7683324121,"Illumina HiSeq","42c4b0949c205ff068881e29bd33e65f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:42.245536-05:00","2016-05-03T11:01:14.469334-05:00","f5d3756e-9ef1-4416-be84-426dd610921f_analysis.xml","87de087836bc046b260e00522fa449e8","fd1e4a03-b4be-447b-8614-228b96fb1b00",2124,"2016-08-30T00:37:35.256035-05:00","f5d3756e-9ef1-4416-be84-426dd610921f_experiment.xml","3de3de4320ce47f501fbe792ab60b49b","6c93ff13-e98d-400e-89d8-843757c37cc8",2431,"2016-09-29T22:49:09.612618-05:00","f5d3756e-9ef1-4416-be84-426dd610921f_run.xml","825dd97d4521ef2fb8badd420554cc6f","c5a731b8-8801-4ba2-95f0-874a3b9bf372",354,"2016-09-08T11:52:35.776884-05:00","TCGA-IR-A3LL","2016-09-02T18:59:00.527810-05:00","female","TCGA-IR-A3LL_demographic",1950,"white","b3fd04cd-acb7-527a-8804-62f941fb5490","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LL_diagnosis","not reported",22123,"alive","8070/3",NA,1106,"4c081a68-2e79-55ba-9bf1-de5f917de0d7","c53.9",-22123,"TCGA-IR-A3LL_treatment","dd8075a9-53e7-51be-9faf-6110fa9c2af3","01","true","TCGA-IR-A3LL-01A",NA,"a0fb972a-ce8f-441f-8707-c3cc1081dee0",FALSE,"CF29FB41-6E3C-4798-A958-37A1B1F9E7AD","Primary Tumor",NA,614,370,NA,1324598400,"11",30,"TCGA-IR-A3LL-01A-11",90,NA,0,NA,20,NA,0,NA,"2016-09-08T11:52:35.776884-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"05213472-3874-4bf1-afbf-6c01d1c0bf8f",NA,"TCGA-IR-A3LL-01A-01-TSA",NA,80,NA,"27f8a3c6-6823-4a2e-ac8b-c033b44e9eb3","RNA","TCGA-IR-A3LL-01A-11R","475ea66a-8e27-4133-9c92-c2bdbe87ac6b",1.78,0.16,"UV Spec","R","23","TCGA-IR-A3LL-01A-11R-A213-07","386fbf20-f41e-41e1-96de-578066c35560",0.16,NA,92,37.3240293723883,157,"0ba0fc90-b9b5-5b22-b1d8-f527b7bec310","TCGA-IR-A3LL_exposure","UNCID_2186825.386fbf20-f41e-41e1-96de-578066c35560.121009_UNC16-SN851_0187_AD15RRACXX_4_CAGATC.tar.gz","2013-09-16T15:26:06.000Z","2013-09-16T15:46:02.000Z","F5D3756E-9EF1-4416-BE84-426DD610921F","A0FB972A-CE8F-441F-8707-C3CC1081DEE0","Unaligned reads",7683324121,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","386FBF20-F41E-41E1-96DE-578066C35560","University of North Carolina","564a3afce4b0ef12181a4ed3","7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","27F8A3C6-6823-4A2E-AC8B-C033B44E9EB3","2013-09-16T15:46:02.000Z","475EA66A-8E27-4133-9C92-C2BDBE87AC6B","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",614,"27F8A3C6-6823-4A2E-AC8B-C033B44E9EB3",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.4157E44A-BFC9-479E-B2DE-D7B6A8C373B9.txt",370,"TCGA-IR-A3LL-01A",NA,"04E0C6F4-594D-4A80-A45A-F15B5D290A01","TCGA",2010,NA,NA,"TUMOR FREE","C05EAB24-367B-4996-BCE0-6E9B24029287",60,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.4157E44A-BFC9-479E-B2DE-D7B6A8C373B9.txt","Alive",NA,"TCGA-IR-A3LL",NA,"D3D5376B-F8E7-4708-9D81-98543EC09164",NA,720,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",200,NA,"A208B7AB-36CE-4936-8B81-2424F3FD1497","WHITE",NA,11,30,"05213472-3874-4BF1-AFBF-6C01D1C0BF8F","475EA66A-8E27-4133-9C92-C2BDBE87AC6B","TCGA-IR-A3LL-01A-11R-A214-13_mirna.bam","TCGA-IR-A3LL-01A-11",90,20,0,2,0,"TOP",0,0,"TCGA-IR-A3LL-01A-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-IR-A3LL-D38340","TCGA-IR-A3LL-R38339","External","Primary Tumor Field","TCGA-IR-A3LL-F38232_NTE-1","NO",957,"TUMOR FREE","Alive",NA,"TCGA-IR-A3LL-F38232","TCGA-IR-A3LL",NA,"IR","A3LL","YES","C53.9","8070/3","C53.9","NO","YES",-22123,"FEMALE","WHITE",NA,"No","No","Alive",720,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,60,2010,"Biopsy (cervical / CT-guided / Other)","YES",15,0,"G2",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
115799274,113999524,5436650391,"9EA70EC4-8BA0-4E3D-B3CB-A68D19E89868.bw","7c4cd55f-750e-4941-a9f3-0632a75d6531","9ea70ec4-8ba0-4e3d-b3cb-a68d19e89868","2016-08-25T20:27:32.962185-05:00","UNCID_2278265.beb89362-12a9-41bd-a1a2-b597138c16fb.131016_UNC10-SN254_0498_BC2KTUACXX_4_GATCAG.tar.gz","78a3cde2-5f04-4600-84e5-240bab54f11a",5559855539,"Illumina HiSeq","6542e9ce3763920156085908a4d92d16","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:03:55.814195-05:00","2016-05-03T11:24:56.858865-05:00","78a3cde2-5f04-4600-84e5-240bab54f11a_analysis.xml","6232736bef59f725e797903a247302bf","f4098fa9-3a90-4b9c-8379-5602a6d812dc",2124,"2016-09-29T20:33:27.274707-05:00","78a3cde2-5f04-4600-84e5-240bab54f11a_experiment.xml","320cc209791ffdcffd72f96362e1374a","716dd316-6039-4965-9862-b34fafaee462",2431,"2016-09-29T19:49:01.276474-05:00","78a3cde2-5f04-4600-84e5-240bab54f11a_run.xml","0ffa261cb4b7293e9adc72c10b5a2e64","5656ae9b-a152-411d-bddf-34128b74ff71",354,"2016-09-08T11:23:30.377372-05:00","TCGA-HM-A3JK","2016-09-02T18:59:22.959448-05:00","female","TCGA-HM-A3JK_demographic",1947,"white","6f949066-51fd-51d7-a021-7d21ef481aaf","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c53.9","TCGA-HM-A3JK_diagnosis","not reported",23618,"alive","8070/3",NA,632,"3c27ba26-80fc-5f9a-9fec-a60655d62a46","c53.9",-23618,"TCGA-HM-A3JK_treatment","fc33d25f-cfea-5f7a-b76a-e3b82c15d851","01","false","TCGA-HM-A3JK-01A",NA,"88c6e5cb-d33e-4042-be7b-12a081acdafb",FALSE,"4CB35553-A72C-474B-A9EB-27EE44173A84","Primary Tumor",NA,170,220,NA,1327536000,"11",30,"TCGA-HM-A3JK-01A-11",65,NA,0,NA,0,NA,25,NA,"2016-09-08T11:23:30.377372-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ba43bab1-e589-4ad2-a5c0-63be9070a20c",NA,"TCGA-HM-A3JK-01A-01-TS1",NA,75,NA,"30631261-91fa-49e3-9d06-645df0ea75a6","RNA","TCGA-HM-A3JK-01A-11R","b415caf1-6bce-46c6-8c3e-cfcde6c68ba7",1.98,0.15,"UV Spec","R","23","TCGA-HM-A3JK-01A-11R-A32Y-07","beb89362-12a9-41bd-a1a2-b597138c16fb",0.15,NA,94,34.5270890725436,165,"0abd47f2-14cf-5432-95e6-d7194229e2f5","TCGA-HM-A3JK_exposure","UNCID_2278265.beb89362-12a9-41bd-a1a2-b597138c16fb.131016_UNC10-SN254_0498_BC2KTUACXX_4_GATCAG.tar.gz","2013-11-22T07:36:04.000Z","2013-11-22T07:50:02.000Z","78A3CDE2-5F04-4600-84E5-240BAB54F11A","88C6E5CB-D33E-4042-BE7B-12A081ACDAFB","Unaligned reads",5559855539,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","BEB89362-12A9-41BD-A1A2-B597138C16FB","University of North Carolina","564a3c5ae4b09c884b24a669","7C4CD55F-750E-4941-A9F3-0632A75D6531","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","30631261-91FA-49E3-9D06-645DF0EA75A6","2013-11-22T07:50:02.000Z","B415CAF1-6BCE-46C6-8C3E-CFCDE6C68BA7","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",170,"30631261-91FA-49E3-9D06-645DF0EA75A6",NA,"HM","01a1ed50458ce9f1fbc171f0df629291.bam.bai",220,"TCGA-HM-A3JK-01A",NA,"8143DAE6-E257-403E-BB9D-38884E600FF7","TCGA",2011,NA,NA,"TUMOR FREE","88C6E5CB-D33E-4042-BE7B-12A081ACDAFB",64,"nationwidechildrens.org_clinical.TCGA-HM-A3JK.xml","Alive",NA,"TCGA-HM-A3JK","NOT HISPANIC OR LATINO","10C0B738-982C-4C8A-9358-383BD8E6DE7E",NA,168,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIA2",NA,NA,"T2b","8070/3","FEMALE","C53.9",217,NA,"1AD07537-6479-4A45-861A-7303ADEFC69B","WHITE",NA,11,30,"BA43BAB1-E589-4AD2-A5C0-63BE9070A20C","B415CAF1-6BCE-46C6-8C3E-CFCDE6C68BA7","01a1ed50458ce9f1fbc171f0df629291.bam.bai","TCGA-HM-A3JK-01A-11",65,0,0,0,25,"TOP",0,0,"TCGA-HM-A3JK-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-HM-A3JK-D21788","TCGA-HM-A3JK-R21787","EXTERNAL BEAM","Primary Tumor Field","TCGA-HM-A3JK-F33102_NTE-1","NO",351,"TUMOR FREE","Alive",NA,"TCGA-HM-A3JK-F33102","TCGA-HM-A3JK",NA,"HM","A3JK","YES","C53.9","8070/3","C53.9","YES","NO",-23618,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",168,NA,NA,NA,"TUMOR FREE","NO",17,2,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2011,"Biopsy (cervical / CT-guided / Other)","YES",51,1,"G3",NA,4,2008,NA,NA,NA,"2009",12,NA,"T2bN1MX",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
70557280,67576740,3213909892,"B04E2E50-0A6E-4224-A825-1714D12E5669.bw","7c93642d-7e05-40f8-b1ef-a014edcfba42","b04e2e50-0a6e-4224-a825-1714d12e5669","2016-08-26T04:27:09.835355-05:00","UNCID_2278276.c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc.131016_UNC10-SN254_0498_BC2KTUACXX_1_ACTTGA.tar.gz","0ec69bcb-4be7-43d8-868f-3b8ab1e99529",3341552762,"Illumina HiSeq","982d1312ff738be11fe91944bb579e32","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:59:46.698311-05:00","2016-05-03T11:24:56.858865-05:00","0ec69bcb-4be7-43d8-868f-3b8ab1e99529_analysis.xml","faaae6b9e9cb6bc5a8a77853fd89e4af","a73963d6-28ff-4e74-b726-0a822b937b6e",2124,"2016-09-29T18:21:25.397490-05:00","0ec69bcb-4be7-43d8-868f-3b8ab1e99529_experiment.xml","0178f50e3371b8e02038c5ce88cabb3f","1f2d9076-88f3-46ac-8ee4-43e0236608b5",2431,"2016-09-29T18:49:44.813448-05:00","0ec69bcb-4be7-43d8-868f-3b8ab1e99529_run.xml","77599b78b9bd31559eca7bd5b2acb10d","312bfb3c-cbcd-4265-8bc8-25087241b4fb",354,"2016-09-08T12:10:14.802474-05:00","TCGA-DG-A2KJ","2016-09-02T18:57:55.604009-05:00","female","TCGA-DG-A2KJ_demographic",1956,"not reported","680b050a-379d-5e66-9ad6-7e69e84c9e07","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DG","fa63e449-4302-5d16-bd2c-76f031746194","Ontario Institute for Cancer Research","not reported","c53.9","TCGA-DG-A2KJ_diagnosis","not reported",18453,"alive","8072/3",NA,2893,"f667bc63-09a0-5512-8613-54352cd3839f","c53.9",-18453,"TCGA-DG-A2KJ_treatment","456d858e-feed-55b5-b524-50a957508009","01","false","TCGA-DG-A2KJ-01A",NA,"4c1108c0-ed8a-4caf-9417-ddfb6352c61e",FALSE,"F5EBC22F-D2D9-4944-9A24-390811798F5B","Primary Tumor",NA,NA,40,NA,1313712000,"11",30,"TCGA-DG-A2KJ-01A-11",80,NA,10,NA,0,NA,15,NA,"2016-09-08T12:10:14.802474-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"3b6cddb7-58c3-4035-ad14-92542762f96b",NA,"TCGA-DG-A2KJ-01A-01-TS1",NA,80,NA,"fce4e63d-0b6a-415f-8ba5-c4804f22e8e0","RNA","TCGA-DG-A2KJ-01A-11R","b6711b8b-2f11-45da-83fd-aa0d31d3653a",1.8,0.15,"UV Spec","R","23","TCGA-DG-A2KJ-01A-11R-A32Y-07","c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc",0.15,NA,NA,NA,NA,"78e545a5-64af-58a6-99ef-a2db91d02e0c","TCGA-DG-A2KJ_exposure","UNCID_2278276.c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc.131016_UNC10-SN254_0498_BC2KTUACXX_1_ACTTGA.tar.gz","2013-11-22T08:06:04.000Z","2013-11-22T08:25:03.000Z","0EC69BCB-4BE7-43D8-868F-3B8AB1E99529","4C1108C0-ED8A-4CAF-9417-DDFB6352C61E","Unaligned reads",3341552762,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C9E3D4C7-862B-4EF2-9A08-216FC44E0BDC","University of North Carolina","56607673e4b018727fea0b79","7C93642D-7E05-40F8-B1EF-A014EDCFBA42","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FCE4E63D-0B6A-415F-8BA5-C4804F22E8E0","2013-11-22T08:25:03.000Z","B6711B8B-2F11-45DA-83FD-AA0D31D3653A","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"FCE4E63D-0B6A-415F-8BA5-C4804F22E8E0",NA,"DG","ff3fb0e4c8af80ed9c012bf598bca00a.bam",40,"TCGA-DG-A2KJ-01A",NA,"FDC804FE-9CBF-44F9-BAD5-F9056C21DD23","TCGA",2006,"TCGA-DG-A2KJ_NTE-1",NA,"TUMOR FREE","F51E97A5-4844-47E4-B6E9-96AD043E31B5",50,"nationwidechildrens.org_clinical.TCGA-DG-A2KJ.xml","Alive",NA,"TCGA-DG-A2KJ",NA,"C6E947C3-2468-4FC3-ADD2-117BED8E75DA",NA,1791,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T1b","8072/3","FEMALE","C53.9",179,NA,"14667F7F-D488-4C55-8BDE-A25444E95973",NA,NA,11,30,"3B6CDDB7-58C3-4035-AD14-92542762F96B","66F967E8-2F93-40A8-B23A-43EDFE3586D3","ff3fb0e4c8af80ed9c012bf598bca00a.bam","TCGA-DG-A2KJ-01A-11",80,0,10,60,15,"TOP",5,10,"TCGA-DG-A2KJ-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-DG-A2KJ-D58846","TCGA-DG-A2KJ-R58847","External","Regional site","TCGA-DG-A2KJ-F49764_NTE-1","NO",1791,"TUMOR FREE","Alive",NA,"TCGA-DG-A2KJ-F49764","TCGA-DG-A2KJ",NA,"DG","A2KJ","YES","C53.9","8072/3","C53.9","NO","YES",-18453,"FEMALE",NA,NA,"No","No","Alive",1791,NA,NA,NA,"TUMOR FREE","NO",10,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,50,2006,"Other method, specify:","YES",23,1,"G3",NA,NA,NA,NA,NA,NA,"1995",16,NA,"T1bN1M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
107020614,91550726,4354799870,"B0BF5E01-536D-40FF-9C24-CBBD611E2FC2.bw","7cc8f5bd-d2d3-44e9-aff6-fe9c9c805938","b0bf5e01-536d-40ff-9c24-cbbd611e2fc2","2016-08-26T04:35:01.801055-05:00","UNCID_2449529.9795c475-908b-40e2-93d3-f07e5b94b91f.140312_UNC11-SN627_0348_AC3KRYACXX_4_CCGTCC.tar.gz","0952d16d-1c34-4100-83fe-c84d49021c5a",4505498713,"Illumina HiSeq","e9e57a5b7d6fedbbcd723097a8e4c694","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:01.163043-05:00","2016-05-03T11:44:58.595380-05:00","0952d16d-1c34-4100-83fe-c84d49021c5a_analysis.xml","1101feeae33bd0caaf40efc68a7c7e84","315b7dd9-86ef-4c50-860e-979a89580925",2124,"2016-08-13T06:21:34.933014-05:00","0952d16d-1c34-4100-83fe-c84d49021c5a_experiment.xml","4b9ac748091e6849158a430e6c6ef198","b17b7d0d-30a7-434e-a663-6a46cc02b60c",2628,"2016-09-29T18:20:14.326961-05:00","0952d16d-1c34-4100-83fe-c84d49021c5a_run.xml","7a95ce0bde747f979b7e368dc49eb78e","1e76250a-27c7-4cc6-97a3-0fe38ff538a2",354,"2016-09-08T11:21:27.368543-05:00","TCGA-JW-A852","2016-09-02T19:00:56.623337-05:00","female","TCGA-JW-A852_demographic",1971,"white","ec5933f2-7f44-53ec-8087-dbf1b6629c9d","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A852_diagnosis","not reported",15682,"dead","8070/3",252,156,"cbbd1323-2333-5533-8ed5-d32f718afca4","c53.9",-15682,"TCGA-JW-A852_treatment","15be58ca-29fc-5d8d-9c2e-8543beec0c2b","01","true","TCGA-JW-A852-01A",NA,"b3bb3d33-1e7f-4892-a3db-a291108593ce",FALSE,"7333C03D-0CDA-4BDE-A213-6FD7D3ACB382","Primary Tumor",NA,57,90,NA,1383091200,"11",30,"TCGA-JW-A852-01A-11",90,NA,0,NA,5,NA,5,NA,"2016-09-08T11:21:27.368543-05:00",NA,3,NA,1,NA,"TOP",NA,0,NA,"845ff65b-6ecf-4154-ad0c-b3ca0423be0f",NA,"TCGA-JW-A852-01A-01-TS1",NA,90,NA,"667d66da-4e2e-4fb2-b6aa-f7a91be3773e","RNA","TCGA-JW-A852-01A-11R","eb3eb3f9-0837-4948-af69-760da0e8fe6d",1.86,0.17,"UV Spec","R","23","TCGA-JW-A852-01A-11R-A352-07","9795c475-908b-40e2-93d3-f07e5b94b91f",0.17,NA,100,39.0625,160,"5911945d-fc22-5f11-8ceb-1339ef48676f","TCGA-JW-A852_exposure","UNCID_2449529.9795c475-908b-40e2-93d3-f07e5b94b91f.140312_UNC11-SN627_0348_AC3KRYACXX_4_CCGTCC.tar.gz","2014-05-09T08:33:05.000Z","2014-05-09T09:43:02.000Z","0952D16D-1C34-4100-83FE-C84D49021C5A","B3BB3D33-1E7F-4892-A3DB-A291108593CE","Unaligned reads",4505498713,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9795C475-908B-40E2-93D3-F07E5B94B91F","University of North Carolina","564a3c47e4b093830b698cde","7CC8F5BD-D2D3-44E9-AFF6-FE9C9C805938","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","667D66DA-4E2E-4FB2-B6AA-F7A91BE3773E","2014-05-09T09:43:02.000Z","EB3EB3F9-0837-4948-AF69-760DA0E8FE6D","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",57,"667D66DA-4E2E-4FB2-B6AA-F7A91BE3773E",NA,"JW","UNCID_2386059.9795c475-908b-40e2-93d3-f07e5b94b91f.sorted_genome_alignments.bam",90,"TCGA-JW-A852-01A",NA,NA,"TCGA",2013,"TCGA-JW-A852_NTE-1","Complete Remission/Response",NA,"B3BB3D33-1E7F-4892-A3DB-A291108593CE",42,"nationwidechildrens.org_clinical.TCGA-JW-A852.xml","Alive",NA,"TCGA-JW-A852","HISPANIC OR LATINO","9CFF7655-444A-490E-AC40-3D2A4DC2CDFC","YES",156,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",361,NA,NA,"WHITE",NA,11,30,"845FF65B-6ECF-4154-AD0C-B3CA0423BE0F","EB3EB3F9-0837-4948-AF69-760DA0E8FE6D","UNCID_2386059.9795c475-908b-40e2-93d3-f07e5b94b91f.sorted_genome_alignments.bam","TCGA-JW-A852-01A-11",90,5,0,3,5,"TOP",0,1,"TCGA-JW-A852-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-JW-A852-F69374_NTE-1","YES",NA,"WITH TUMOR","Dead",252,"TCGA-JW-A852-F69374","TCGA-JW-A852",NA,"JW","A852","YES","C53.9","8070/3","C53.9","YES","NO",-15682,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",156,NA,NA,NA,NA,"YES",12,2,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bN1MX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
164493332,161942873,7685679178,"7B6B1788-B297-4442-B6BE-B7CE8754491E.bw","7df6c297-f2d6-43ef-973b-1f95676b0cc4","7b6b1788-b297-4442-b6be-b7ce8754491e","2016-08-09T13:56:05.714607-05:00","UNCID_2187305.feb35af1-052d-41a6-9e76-f47b610ab956.120917_UNC11-SN627_0251_AC119PACXX_8_GTCCGC.tar.gz","74a96e3b-e5c8-4986-b5f2-308b64694966",7064975136,"Illumina HiSeq","f8e5bbce912da4959e677f3850fc4bb5","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:07:45.548732-05:00","2016-05-03T11:02:00.425419-05:00","74a96e3b-e5c8-4986-b5f2-308b64694966_analysis.xml","e620ea725b6d36092729887bed34ca34","16e62907-0478-402a-8cef-bb83e30b36e2",2124,"2016-09-29T20:06:41.281122-05:00","74a96e3b-e5c8-4986-b5f2-308b64694966_experiment.xml","e5cca3aa1aedc374363d26436f8c5c71","61284b90-d69c-48b5-87ee-09b1e9421cf6",2431,"2016-09-29T18:38:12.351543-05:00","74a96e3b-e5c8-4986-b5f2-308b64694966_run.xml","13bba08cb8f5bd73be651ba09f483197","29d98d0b-d41c-4502-b18c-0fd5dd78120a",354,"2016-09-08T12:14:00.696332-05:00","TCGA-C5-A1BK","2016-09-02T18:56:44.942247-05:00","female","TCGA-C5-A1BK_demographic",1958,"black or african american","e1d4c132-0847-51a3-a7e0-dc1cb5bdd563","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BK_diagnosis","not reported",13297,"alive","8070/3",NA,5385,"5a7648e9-d450-5a61-bec9-3eba801dc2b1","c53.9",-13297,"TCGA-C5-A1BK_treatment","5cbc09e8-02d7-5429-a9a2-01a8d00e91c5","01","true","TCGA-C5-A1BK-01B",NA,"f23956c1-df69-40a4-bf11-aecba194f78c",FALSE,"E6129BB7-CE4E-400A-B8B9-45DE508C995D","Primary Tumor",NA,5966,80,NA,1297728000,"11",30,"TCGA-C5-A1BK-01B-11",70,NA,0,NA,0,NA,30,NA,"2016-09-08T12:14:00.696332-05:00",NA,50,NA,5,NA,"TOP",NA,0,NA,"86c00487-ef71-4272-96c3-e999c8ff866d",NA,"TCGA-C5-A1BK-01B-01-TS1",NA,70,NA,"5b754db5-206f-4b46-8eb4-9bcae622186c","RNA","TCGA-C5-A1BK-01B-11R","0a92e390-a7de-4f9e-a38c-66ce660ba622",1.83,0.17,"UV Spec","R","23","TCGA-C5-A1BK-01B-11R-A13Y-07","feb35af1-052d-41a6-9e76-f47b610ab956",0.17,NA,82,35.9633349414499,151,"f22bc5f1-de8e-5958-86e6-ed65c0b12aae","TCGA-C5-A1BK_exposure","UNCID_2187305.feb35af1-052d-41a6-9e76-f47b610ab956.120917_UNC11-SN627_0251_AC119PACXX_8_GTCCGC.tar.gz","2013-09-17T07:06:04.000Z","2013-09-17T07:28:01.000Z","74A96E3B-E5C8-4986-B5F2-308B64694966","F23956C1-DF69-40A4-BF11-AECBA194F78C","Unaligned reads",7064975136,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FEB35AF1-052D-41A6-9E76-F47B610AB956","University of North Carolina","56607603e4b018727fea06a7","7DF6C297-F2D6-43EF-973B-1F95676B0CC4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5B754DB5-206F-4B46-8EB4-9BCAE622186C","2013-09-17T07:28:01.000Z","0A92E390-A7DE-4F9E-A38C-66CE660BA622","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",5966,"5B754DB5-206F-4B46-8EB4-9BCAE622186C",NA,"C5","UNCID_2187305.feb35af1-052d-41a6-9e76-f47b610ab956.120917_UNC11-SN627_0251_AC119PACXX_8_GTCCGC.tar.gz",80,"TCGA-C5-A1BK-01B",NA,NA,"TCGA",1994,NA,NA,"TUMOR FREE","F23956C1-DF69-40A4-BF11-AECBA194F78C",36,"nationwidechildrens.org_clinical.TCGA-C5-A1BK.xml","Alive",NA,"TCGA-C5-A1BK","NOT HISPANIC OR LATINO","87B84680-9113-478E-8E40-C95347345EEA",NA,5385,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",114,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"86C00487-EF71-4272-96C3-E999C8FF866D","32C759D2-50CA-4CAF-A00D-6B38ED6CE2EE","UNCID_2187305.feb35af1-052d-41a6-9e76-f47b610ab956.120917_UNC11-SN627_0251_AC119PACXX_8_GTCCGC.tar.gz","TCGA-C5-A1BK-01B-11",70,0,0,50,30,"TOP",0,5,"TCGA-C5-A1BK-01B-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-C5-A1BK-F62484_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A1BK-F62484","TCGA-C5-A1BK",NA,"C5","A1BK","YES","C53.9","8070/3","C53.9","NO","YES",-13297,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",5385,NA,NA,NA,"TUMOR FREE","NO",23,8,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,36,1994,"Other method, specify:","YES",20,0,"G2",NA,1,NA,NA,NA,NA,"1988",6,NA,"T1bN0MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
189022812,186518452,8877620323,"A090D00C-34DF-4906-A517-4803C4C9A332.bw","7fb8e7be-4118-41f8-b785-5cbb0afdb8b7","a090d00c-34df-4906-a517-4803c4c9a332","2016-08-25T21:31:06.125076-05:00","UNCID_2187356.0bb1946f-bc01-47d8-887f-e63f3a16e32d.120917_UNC11-SN627_0251_AC119PACXX_6_AGTCAA.tar.gz","ff683620-4012-4b41-9fba-a1b31ea267b7",8258289204,"Illumina HiSeq","fcd15a1cb3da22510680ccfee83053c9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:31:12.853198-05:00","2016-05-03T11:30:02.972846-05:00","ff683620-4012-4b41-9fba-a1b31ea267b7_analysis.xml","025aa4ce26b2dd416a3bfdc957dafe7c","957b266a-724d-4dae-88f6-42bc48751fb1",2124,"2016-09-30T00:10:51.725974-05:00","ff683620-4012-4b41-9fba-a1b31ea267b7_experiment.xml","6b53407b2ae8c7e99b1f7b54c21b6c3d","f8387ec5-3c00-43d4-a680-c4f9179a1a9a",2431,"2016-09-29T22:13:23.842402-05:00","ff683620-4012-4b41-9fba-a1b31ea267b7_run.xml","a188e8038e2c3784968808372a3cd781","af84b671-7b06-4f29-9ba4-51db88fdafd7",354,"2016-09-08T12:00:55.688886-05:00","TCGA-C5-A1BM","2016-09-02T18:56:46.208747-05:00","female","TCGA-C5-A1BM_demographic",1919,"black or african american","38f570ef-3327-5a93-8033-4bcbf9bef1bc","not reported",2003,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BM_diagnosis","not reported",28815,"dead","8070/3",2520,NA,"dc2dde10-cdf9-5a1f-858f-354c8aaa8ea7","c53.9",-28815,"TCGA-C5-A1BM_treatment","d9d8601a-17b7-5a6b-b004-9633414775e4","01","true","TCGA-C5-A1BM-01A",NA,"57bc4710-6ac5-4279-b233-b65f42999a84",FALSE,"D23DE232-F930-40C8-A560-4B75C41C6115","Primary Tumor",NA,4853,70,NA,1296172800,"11",30,"TCGA-C5-A1BM-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T12:00:55.688886-05:00",NA,50,NA,20,NA,"TOP",NA,10,NA,"61582586-e067-47b9-a74b-ba4f3d1e0675",NA,"TCGA-C5-A1BM-01A-01-TS1",NA,80,NA,"69103abb-07d2-472b-a13b-1467624eb8a4","RNA","TCGA-C5-A1BM-01A-11R","1bfd04fd-da62-476b-9637-85c9f2b46506",1.87,0.16,"UV Spec","R","23","TCGA-C5-A1BM-01A-11R-A13Y-07","0bb1946f-bc01-47d8-887f-e63f3a16e32d",0.16,NA,56,19.1511918197052,171,"3d356e29-cf44-5db1-8f20-433de70f6471","TCGA-C5-A1BM_exposure","UNCID_2187356.0bb1946f-bc01-47d8-887f-e63f3a16e32d.120917_UNC11-SN627_0251_AC119PACXX_6_AGTCAA.tar.gz","2013-09-17T10:07:04.000Z","2014-01-16T02:08:01.000Z","FF683620-4012-4B41-9FBA-A1B31EA267B7","57BC4710-6AC5-4279-B233-B65F42999A84","Unaligned reads",8258289204,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0BB1946F-BC01-47D8-887F-E63F3A16E32D","University of North Carolina","564a40d0e4b0ef12181c2f78","7FB8E7BE-4118-41F8-B785-5CBB0AFDB8B7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","69103ABB-07D2-472B-A13B-1467624EB8A4","2014-01-16T02:08:01.000Z","1BFD04FD-DA62-476B-9637-85C9F2B46506","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4853,"69103ABB-07D2-472B-A13B-1467624EB8A4",NA,"C5","TCGA-C5-A1BM-01A-11R-A13X-13.isoform.quantification.txt",70,"TCGA-C5-A1BM-01A",NA,NA,"TCGA",1997,NA,NA,"TUMOR FREE","79FA29B9-822F-4B0F-9108-50E65CD943CA",78,"nationwidechildrens.org_clinical.TCGA-C5-A1BM.xml","Dead",2520,"TCGA-C5-A1BM",NA,"762A4263-A5CB-4E7B-8502-9E2963A29FE0",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T2","8070/3","FEMALE","C53.9",114,NA,"7FD3BFBF-823C-4A8F-81A1-A8A13B938783","BLACK OR AFRICAN AMERICAN",NA,11,30,"61582586-E067-47B9-A74B-BA4F3D1E0675","55C0E174-8539-45A5-9A6C-EDF2EA9C26F1","TCGA-C5-A1BM-01A-11R-A13X-13.isoform.quantification.txt","TCGA-C5-A1BM-01A-11",80,0,20,50,10,"TOP",10,20,"TCGA-C5-A1BM-01A-01-TS1",80,NA,NA,NA,"TCGA-C5-A1BM-R30746","COMBINATION","Primary Tumor Field",NA,"NO",NA,"TUMOR FREE","Dead",2520,"TCGA-C5-A1BM-F30745","TCGA-C5-A1BM",NA,"C5","A1BM","YES","C53.9","8070/3","C53.9","NO","YES",-28815,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,2520,NA,NA,"TUMOR FREE","NO",21,9,2011,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,78,1997,"Biopsy (cervical / CT-guided / Other)","YES",23,8,"G2",NA,4,NA,NA,NA,NA,"1995",6,NA,"T2N1MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
115431634,112615049,5377012193,"340D44A6-9BEA-412C-9973-D9ABD6692255.bw","81658ce6-d4a9-4ee0-ae8f-cf2fa8485701","340d44a6-9bea-412c-9973-d9abd6692255","2016-08-25T14:12:32.484919-05:00","UNCID_2553082.b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e.140513_UNC15-SN850_0365_BC4BYLACXX_6_CAGATC.tar.gz","d7d8ef0e-1243-4acf-8563-8718fbad04f1",4793097807,"Illumina HiSeq","91195001874cf9105ca427f2d2cbda13","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:42:49.383822-05:00","2016-05-03T11:54:19.885282-05:00","d7d8ef0e-1243-4acf-8563-8718fbad04f1_analysis.xml","37f25cbb86b9c96cef292515a6d217e8","e70c8a2b-8d10-4c4c-aa43-7cc4e14b123a",2124,"2016-09-29T20:34:39.674066-05:00","d7d8ef0e-1243-4acf-8563-8718fbad04f1_experiment.xml","c31680a42e2b501e9ef5fd7ca71fcdef","72250d09-097a-4e6a-89d8-b14e074305d5",2628,"2016-09-29T18:50:58.037258-05:00","d7d8ef0e-1243-4acf-8563-8718fbad04f1_run.xml","f02fbb799265d8def49300249b9f353f","31f7576b-c4c3-4944-a383-eefd7b5c65a0",354,"2016-09-08T10:48:19.784621-05:00","TCGA-MA-AA41","2016-09-02T18:54:05.115740-05:00","female","TCGA-MA-AA41_demographic",1980,"white","e75644aa-0317-5a38-8980-0083a3afe9d9","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA41_diagnosis","not reported",12398,"alive","8070/3",NA,254,"ce23faec-0c9c-5d75-b505-df257cd4cc95","c53.9",-12398,"TCGA-MA-AA41_treatment","9ea68023-26ed-5c0b-9907-80ae15f66638","01","false","TCGA-MA-AA41-01A",NA,"fa033cf0-6015-49c6-8b8a-045d88a21667",FALSE,"3E26B1B5-771B-4F99-BB78-C83C9F6557D2","Primary Tumor",NA,197,340,NA,1392940800,"11",30,"TCGA-MA-AA41-01A-11",75,NA,0,NA,5,NA,20,NA,"2016-09-08T10:48:19.784621-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"4a78b791-7a61-4326-aacd-c4366f22b549",NA,"TCGA-MA-AA41-01A-01-TS1",NA,75,NA,"fa48433f-eb23-4f3b-9387-cb37bcc078e5","RNA","TCGA-MA-AA41-01A-11R","9c125448-7c38-4f1b-bf65-14b8831c7bc5",1.87,0.17,"UV Spec","R","23","TCGA-MA-AA41-01A-11R-A38B-07","b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e",0.17,0.273972602739726,47,18.5910367469641,159,"29296511-402b-5f34-b890-77d0777f7aec","TCGA-MA-AA41_exposure","UNCID_2553082.b2a62b6a-4dd4-463a-8bdb-c9fb6d09f50e.140513_UNC15-SN850_0365_BC4BYLACXX_6_CAGATC.tar.gz","2014-07-30T18:21:05.000Z","2014-07-30T18:47:07.000Z","D7D8EF0E-1243-4ACF-8563-8718FBAD04F1","FA033CF0-6015-49C6-8B8A-045D88A21667","Unaligned reads",4793097807,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B2A62B6A-4DD4-463A-8BDB-C9FB6D09F50E","University of North Carolina","564a3befe4b09c884b2484d6","81658CE6-D4A9-4EE0-AE8F-CF2FA8485701","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FA48433F-EB23-4F3B-9387-CB37BCC078E5","2014-07-30T18:47:07.000Z","9C125448-7C38-4F1B-BF65-14B8831C7BC5","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",197,"FA48433F-EB23-4F3B-9387-CB37BCC078E5",NA,"MA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.EAD0873A-0639-48FC-B340-C009F8FC6984.txt",340,"TCGA-MA-AA41-01A",NA,NA,"TCGA",2013,"TCGA-MA-AA41_NTE-1","Progressive Disease","WITH TUMOR","FA033CF0-6015-49C6-8B8A-045D88A21667",33,"ENATE_p_TCGAb_394_395_396_NSP_GenomeWideSNP_6_A11_1474130.nocnv_hg19.seg.txt","Alive",NA,"TCGA-MA-AA41","HISPANIC OR LATINO","90250EF3-3BE9-4ECB-A234-69D7E898D782","NO",279,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",4,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2","8070/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"4A78B791-7A61-4326-AACD-C4366F22B549","9C125448-7C38-4F1B-BF65-14B8831C7BC5","ENATE_p_TCGAb_394_395_396_NSP_GenomeWideSNP_6_A11_1474130.ismpolish.data.txt","TCGA-MA-AA41-01A-11",75,5,0,5,20,"TOP",0,0,"TCGA-MA-AA41-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-MA-AA41-F65481_NTE-1","NO",254,"WITH TUMOR","Alive",NA,"TCGA-MA-AA41-F65481","TCGA-MA-AA41",NA,"MA","AA41","YES","C53.9","8070/3","C53.9","YES","NO",-12398,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",279,NA,NA,NA,"WITH TUMOR","YES",16,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,33,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,2,NA,5,NA,"Progressive Disease","2009",13,NA,"T2N1M1",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
124340630,123191781,5847566340,"E8D0D1E7-E5A8-4014-80C1-0245F90F4358.bw","825a6fbb-aede-436f-800b-c7f096da0a77","e8d0d1e7-e5a8-4014-80c1-0245f90f4358","2016-08-09T13:56:22.691373-05:00","UNCID_2187321.c4c15b15-8010-47d8-8c6b-3c6b9dae9716.120917_UNC11-SN627_0251_AC119PACXX_7_CCGTCC.tar.gz","c2858bdd-7683-4c59-8e12-7dac8bc2cfb7",5559410767,"Illumina HiSeq","23eac77f8eacf38d9104d5fb0bbb60cd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:47:48.503492-05:00","2016-05-03T11:02:00.425419-05:00","c2858bdd-7683-4c59-8e12-7dac8bc2cfb7_analysis.xml","5418cd8a40e8d607bb6f2151d8470a6e","7a543076-b64d-4a3f-a16e-6138a0208940",2124,"2016-09-29T22:46:27.340527-05:00","c2858bdd-7683-4c59-8e12-7dac8bc2cfb7_experiment.xml","0e09d0087e177e44891df923cbb51a1f","c400875e-3cc4-481a-b883-f3bb6a0dbfa2",2431,"2016-09-29T21:49:25.581454-05:00","c2858bdd-7683-4c59-8e12-7dac8bc2cfb7_run.xml","2a2e78d80190ab488ef1117b65c13f83","a0a5192e-b42d-4538-8e72-be47a10857d1",354,"2016-09-08T12:11:47.828506-05:00","TCGA-C5-A1M6","2016-09-02T18:56:47.370185-05:00","female","TCGA-C5-A1M6_demographic",1943,"white","c8aaadca-705c-5125-9b54-18789b1b1874","not reported",2000,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1M6_diagnosis","not reported",20090,"dead","8070/3",955,NA,"ba32a558-0908-5db7-a1f5-8cd74e4ff7e5","c53.9",-20090,"TCGA-C5-A1M6_treatment","e4946f5b-7052-5132-be81-5db089f37adc","01","true","TCGA-C5-A1M6-01A",NA,"013eeabf-611e-4351-b1a3-c3f172f5e081",FALSE,"849F2BBF-C820-4C31-B213-648545060C3E","Primary Tumor",NA,4668,80,NA,1300924800,"11",30,"TCGA-C5-A1M6-01A-11",95,NA,5,NA,0,NA,5,NA,"2016-09-08T12:11:47.828506-05:00",NA,3,NA,2,NA,"TOP",NA,10,NA,"198f22cc-bfae-465a-a154-c953e0e33b29",NA,"TCGA-C5-A1M6-01A-01-TSA",NA,85,NA,"47129a95-a92c-4549-a840-51c2f74e930b","RNA","TCGA-C5-A1M6-01A-11R","4552de80-a392-4906-b123-217ea423c3db",1.8,0.15,"UV Spec","R","23","TCGA-C5-A1M6-01A-11R-A13Y-07","c4c15b15-8010-47d8-8c6b-3c6b9dae9716",0.15,NA,77,28.2828282828283,165,"8539c9ae-3769-504d-9d78-a2f9be6cb437","TCGA-C5-A1M6_exposure","UNCID_2187321.c4c15b15-8010-47d8-8c6b-3c6b9dae9716.120917_UNC11-SN627_0251_AC119PACXX_7_CCGTCC.tar.gz","2013-09-17T07:43:04.000Z","2013-09-17T08:00:01.000Z","C2858BDD-7683-4C59-8E12-7DAC8BC2CFB7","013EEABF-611E-4351-B1A3-C3F172F5E081","Unaligned reads",5559410767,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C4C15B15-8010-47D8-8C6B-3C6B9DAE9716","University of North Carolina","564a3b86e4b09c884b24657d","825A6FBB-AEDE-436F-800B-C7F096DA0A77","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","47129A95-A92C-4549-A840-51C2F74E930B","2013-09-17T08:00:01.000Z","4552DE80-A392-4906-B123-217EA423C3DB","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4668,"47129A95-A92C-4549-A840-51C2F74E930B",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.1F43A50D-9930-4F21-8EF8-1A09A5DABDF4.txt",80,"TCGA-C5-A1M6-01A",NA,"C82C2709-144B-4A16-A2AB-5A74C1C6427D","TCGA",1998,NA,NA,"WITH TUMOR","60991A31-58A8-422A-8E4A-EA01EBE43311",55,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.1F43A50D-9930-4F21-8EF8-1A09A5DABDF4.txt","Dead",955,"TCGA-C5-A1M6",NA,"325B5E5D-07BB-4334-9AB0-0BAE75F21CE9",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIB",NA,NA,NA,"8070/3","FEMALE","C53.9",114,NA,"5372C829-641C-41EE-B038-A44B7323AC65","WHITE",NA,11,30,"198F22CC-BFAE-465A-A154-C953E0E33B29","87D24FF1-33DE-4576-98B7-615FDF4A8CF1","UNCID_2187321.c4c15b15-8010-47d8-8c6b-3c6b9dae9716.120917_UNC11-SN627_0251_AC119PACXX_7_CCGTCC.tar.gz","TCGA-C5-A1M6-01A-11",95,0,5,3,5,"TOP",10,2,"TCGA-C5-A1M6-01A-01-TSA",85,"Cisplatinum","Chemotherapy","TCGA-C5-A1M6-D29218","TCGA-C5-A1M6-R29221","COMBINATION","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",955,"TCGA-C5-A1M6-F29215","TCGA-C5-A1M6",NA,"C5","A1M6","YES","C53.9","8070/3","C53.9","NO","YES",-20090,"FEMALE","WHITE",NA,"No","No","Dead",NA,955,NA,NA,"WITH TUMOR","NO",21,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,1998,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,NA,"1995",13,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
130018114,127098448,6061553946,"19EA1494-8572-40E1-B9BB-3739F47B607D.bw","8328925e-3324-4188-85f1-6ffbf819d9e7","19ea1494-8572-40e1-b9bb-3739f47b607d","2016-08-25T04:12:44.909884-05:00","UNCID_2449535.1bf205a9-a7fb-4a53-8b3d-9943b91481c2.140304_UNC14-SN744_0400_AC3LWGACXX_1_AGTTCC.tar.gz","1f10a8ab-a4a2-48c0-ac00-8fb2d241120f",5732474978,"Illumina HiSeq","bb14837519d622f359bec2e8329f232c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:24.414195-05:00","2016-05-03T11:44:58.595833-05:00","1f10a8ab-a4a2-48c0-ac00-8fb2d241120f_analysis.xml","e3a078ae159d241edbf1e92a2222b05d","5df71f30-5c0e-4b66-8f40-fd8b43013903",2124,"2016-09-29T19:46:17.088461-05:00","1f10a8ab-a4a2-48c0-ac00-8fb2d241120f_experiment.xml","32a5f1893e848941f6031823e536a4aa","54a22fbc-f3c0-4497-a18c-926a9ee1e30d",2628,"2016-09-29T23:05:25.900789-05:00","1f10a8ab-a4a2-48c0-ac00-8fb2d241120f_run.xml","d496a83da548173d9e9caabab8e237c6","cfb4ca57-d442-4f32-b035-a9b677598a02",354,"2016-09-08T11:38:53.563020-05:00","TCGA-C5-A7UH","2016-09-02T19:00:18.916815-05:00","female","TCGA-C5-A7UH_demographic",1948,"white","be6a63a1-cae8-523c-8072-035c95fbfc14","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7UH_diagnosis","not reported",20189,"alive","8070/3",NA,3988,"3b044d9b-77d8-598d-b50f-25f62818264a","c53.9",-20189,"TCGA-C5-A7UH_treatment","a9b06be8-27dd-5527-a1d2-f2911dbf63dc","01","true","TCGA-C5-A7UH-01A",NA,"e7e2ed15-f966-4177-b02b-76ae2a31fc5e",FALSE,"5D5876DB-6A68-4862-8982-8E15F26C9BF9","Primary Tumor",NA,3604,10,NA,1381363200,"11",10,"TCGA-C5-A7UH-01A-11",95,NA,0,NA,0,NA,20,NA,"2016-09-08T11:38:53.563020-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"71838ae8-d7f1-42aa-a07e-29c807bd20c1",NA,"TCGA-C5-A7UH-01A-01-TS1",NA,80,NA,"72eb46d1-2fc6-46b2-80e6-44cbed3bfc30","RNA","TCGA-C5-A7UH-01A-11R","d7d45ec1-3c5d-44f7-8c6d-8aaa4b476d10",1.8,0.16,"UV Spec","R","23","TCGA-C5-A7UH-01A-11R-A352-07","1bf205a9-a7fb-4a53-8b3d-9943b91481c2",0.16,NA,56,21.0771952275208,163,"05c73bbb-6425-5192-a521-ccdc996acbea","TCGA-C5-A7UH_exposure","UNCID_2449535.1bf205a9-a7fb-4a53-8b3d-9943b91481c2.140304_UNC14-SN744_0400_AC3LWGACXX_1_AGTTCC.tar.gz","2014-05-09T14:33:03.000Z","2014-05-09T15:31:02.000Z","1F10A8AB-A4A2-48C0-AC00-8FB2D241120F","E7E2ED15-F966-4177-B02B-76AE2A31FC5E","Unaligned reads",5732474978,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1BF205A9-A7FB-4A53-8B3D-9943B91481C2","University of North Carolina","566076ebe4b0b37b3d99092b","8328925E-3324-4188-85F1-6FFBF819D9E7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","72EB46D1-2FC6-46B2-80E6-44CBED3BFC30","2014-05-09T15:31:02.000Z","D7D45EC1-3C5D-44F7-8C6D-8AAA4B476D10","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3604,"72EB46D1-2FC6-46B2-80E6-44CBED3BFC30",NA,"C5","d403f4842fb79683464b18379bfa09b3.bam.bai",10,"TCGA-C5-A7UH-01A",NA,"984C0FC8-5951-46F4-AF25-B8163F38204D","TCGA",2003,"TCGA-C5-A7UH_NTE-1",NA,"TUMOR FREE","E7E2ED15-F966-4177-B02B-76AE2A31FC5E",55,"nationwidechildrens.org_clinical.TCGA-C5-A7UH.xml","Alive",NA,"TCGA-C5-A7UH","NOT HISPANIC OR LATINO","DCB04753-169E-4034-8C9E-D7254D9C6A3B","NO",1846,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",361,NA,"F68974B3-7827-48CC-9179-7C87895E3D99","WHITE",NA,11,10,"71838AE8-D7F1-42AA-A07E-29C807BD20C1","D7D45EC1-3C5D-44F7-8C6D-8AAA4B476D10","d403f4842fb79683464b18379bfa09b3.bam.bai","TCGA-C5-A7UH-01A-11",95,0,0,0,20,"TOP",0,0,"TCGA-C5-A7UH-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-C5-A7UH-D57021","TCGA-C5-A7UH-R57024","External","Regional site","TCGA-C5-A7UH-F66737_NTE-1","NO",3988,"TUMOR FREE","Alive",NA,"TCGA-C5-A7UH-F66737","TCGA-C5-A7UH",NA,"C5","A7UH","YES","C53.9","8070/3","C53.9","NO","YES",-20189,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1846,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,2003,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
213112768,210509609,10047785593,"1C1B4793-8DAF-4763-BA4D-C4E869A4ED35.bw","84cb84d0-7c7e-453c-8cc5-65b5af941028","1c1b4793-8daf-4763-ba4d-c4e869a4ed35","2016-08-05T11:33:55.999343-05:00","UNCID_2234677.27e35f6c-7d6c-46e8-844d-e08a5920af3e.130129_UNC13-SN749_0217_BD1MTTACXX_5_TGACCA.tar.gz","46b9148d-f0b3-4992-862f-9e7e164775df",9886123874,"Illumina HiSeq","17fa4b22e405f516bb7c1fd8841624a1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:23:06.941863-05:00","2016-05-03T11:20:13.161874-05:00","46b9148d-f0b3-4992-862f-9e7e164775df_analysis.xml","f601069e415039c111580eae4c2f698b","fff30e38-4c75-44a8-a4c6-24b5cd119d78",2124,"2016-08-26T12:45:59.957194-05:00","46b9148d-f0b3-4992-862f-9e7e164775df_experiment.xml","7b971c03a5b3a10554fd8660a185f77c","e7a8bcb3-628d-425e-a51c-f174b9490320",2431,"2016-09-29T21:21:48.378626-05:00","46b9148d-f0b3-4992-862f-9e7e164775df_run.xml","f71a1c8a02a75cfeeebf1011777692e2","8fa2a4a2-f91e-4904-86ef-e412b4287544",354,"2016-09-08T11:39:03.684388-05:00","TCGA-EA-A411","2016-09-02T18:59:35.683429-05:00","female","TCGA-EA-A411_demographic",1962,"white","0afd3141-02fd-5b97-9e30-499c918f53c7","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A411_diagnosis","not reported",18561,"alive","8070/3",NA,747,"6542ae1d-60c1-5a0e-aae5-8ac18c0120ee","c53.9",-18561,"TCGA-EA-A411_treatment","9602da0f-98d3-5971-b11c-45158b0c2609","01","true","TCGA-EA-A411-01A",NA,"a6a6864d-e479-41e1-9cb5-64c7f25cacd5",FALSE,"A7CCC7A3-CF3C-4722-B1F5-890B3A4D9A6D","Primary Tumor",NA,100,740,NA,1343692800,"11",30,"TCGA-EA-A411-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T11:39:03.684388-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"d1336e0f-201e-4ad2-bf6d-98543b601206",NA,"TCGA-EA-A411-01A-01-TSA",NA,100,NA,"607261b5-a1db-4751-84d5-96e3546fa119","RNA","TCGA-EA-A411-01A-11R","9d0fbdf2-2732-4ba4-984a-3f5cbf329da5",1.81,0.17,"UV Spec","R","23","TCGA-EA-A411-01A-11R-A24H-07","27e35f6c-7d6c-46e8-844d-e08a5920af3e",0.17,NA,74,23.8894628099174,176,"8ddc2ed1-39b0-567d-a4ca-2ff0fb554a53","TCGA-EA-A411_exposure","UNCID_2234677.27e35f6c-7d6c-46e8-844d-e08a5920af3e.130129_UNC13-SN749_0217_BD1MTTACXX_5_TGACCA.tar.gz","2013-10-19T00:06:06.000Z","2013-10-19T00:30:02.000Z","46B9148D-F0B3-4992-862F-9E7E164775DF","A6A6864D-E479-41E1-9CB5-64C7F25CACD5","Unaligned reads",9886123874,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","27E35F6C-7D6C-46E8-844D-E08A5920AF3E","University of North Carolina","56607456e4b018727fe9f12a","84CB84D0-7C7E-453C-8CC5-65B5AF941028","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","607261B5-A1DB-4751-84D5-96E3546FA119","2013-10-19T00:30:02.000Z","9D0FBDF2-2732-4BA4-984A-3F5CBF329DA5","Russia","NO",1,NA,"Primary Tumor","Asterand",100,"607261B5-A1DB-4751-84D5-96E3546FA119",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A92FDF5F-D4BE-4084-B677-6AAB64AD1342.txt",740,"TCGA-EA-A411-01A",NA,NA,"TCGA",2012,"TCGA-EA-A411_NTE-1","Complete Remission/Response","TUMOR FREE","CB601AF7-B63C-4FA2-B8F0-256002E19007",50,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A92FDF5F-D4BE-4084-B677-6AAB64AD1342.txt","Alive",NA,"TCGA-EA-A411","NOT HISPANIC OR LATINO","6AD213C2-7C8C-4591-9D86-D91B358F56DC","NO",41,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",256,NA,NA,"WHITE",NA,11,30,"D1336E0F-201E-4AD2-BF6D-98543B601206","E127B552-FD94-4535-9396-E39C552900F2","CROZE_p_TCGA_254_256_255_N_GenomeWideSNP_6_F06_1301336.ismpolish.data.txt","TCGA-EA-A411-01A-11",65,0,0,2,0,"TOP",0,0,"TCGA-EA-A411-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,"TCGA-EA-A411-F66116_NTE-1","NO",747,"TUMOR FREE","Alive",NA,"TCGA-EA-A411-F66116","TCGA-EA-A411",NA,"EA","A411","YES","C53.9","8070/3","C53.9","YES","NO",-18561,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",41,NA,NA,NA,"TUMOR FREE","YES",24,9,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,50,2012,"Cytology (e.g. Peritoneal or pleural fluid)","YES",13,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
170111686,166828659,7949010773,"45BF59B3-95BD-4196-ABAA-4C4F0DB38572.bw","85abfd69-cf72-43f6-a7dd-97056f22c91b","45bf59b3-95bd-4196-abaa-4c4f0db38572","2016-08-05T10:55:52.875162-05:00","UNCID_2186293.0375a538-64dc-4f7b-807e-d765c8d88c23.121102_UNC15-SN850_0240_BD148CACXX_3_GCCAAT.tar.gz","44843334-81c0-40f2-a5d1-5d522669b08d",7559797360,"Illumina HiSeq","bcc20d8130bacd9ee927c27a09db81e3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:32:20.116035-05:00","2016-05-03T11:00:24.448573-05:00","44843334-81c0-40f2-a5d1-5d522669b08d_analysis.xml","777ede70825ca158b291ca841ec3d4d5","70c2c5b4-da68-4104-a5d9-88e39d7fecd4",2124,"2016-09-29T18:51:14.692507-05:00","44843334-81c0-40f2-a5d1-5d522669b08d_experiment.xml","97b43103a176f15768744e5f831ab0a3","3228090a-5671-4cd6-9bd3-2cd2f41f6315",2431,"2016-09-29T22:59:57.792986-05:00","44843334-81c0-40f2-a5d1-5d522669b08d_run.xml","abc356e6988f48a33f216e6fb3d6deb9","cc2f8367-182a-4582-ac4d-a3abe4160c79",354,"2016-09-08T11:30:05.170705-05:00","TCGA-FU-A23K","2016-09-02T18:57:41.400574-05:00","female","TCGA-FU-A23K_demographic",1982,"white","5b1195bb-6463-53aa-8327-5f2c0e35f1c8","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A23K_diagnosis","not reported",10551,"alive","8083/3",NA,372,"8b8b468b-ff10-5ccc-aa9c-a66ab5b9dc0c","c53.9",-10551,"TCGA-FU-A23K_treatment","47fcb118-5a8d-59bd-98af-91acebfd2e8d","01","false","TCGA-FU-A23K-01A",NA,"7fe455c5-b312-4f45-be86-294262e0ae7a",FALSE,"D5E65FAE-5BC9-43A9-89D0-AA7D266F3C06","Primary Tumor",NA,192,100,NA,1303862400,"11",30,"TCGA-FU-A23K-01A-11",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:30:05.170705-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"a8ce9441-420a-4116-8a7d-d52ef404a51d",NA,"TCGA-FU-A23K-01A-01-TSA",NA,80,NA,"31bd2ee1-11bd-4d7f-a6e0-137bb24fcde1","RNA","TCGA-FU-A23K-01A-11R","a502271d-5243-485b-bd6b-90846dd5ff11",1.83,0.17,"UV Spec","R","23","TCGA-FU-A23K-01A-11R-A16R-07","0375a538-64dc-4f7b-807e-d765c8d88c23",0.17,NA,91,33.425160697888,165,"9c739a89-559a-5315-a188-eba3a89e9783","TCGA-FU-A23K_exposure","UNCID_2186293.0375a538-64dc-4f7b-807e-d765c8d88c23.121102_UNC15-SN850_0240_BD148CACXX_3_GCCAAT.tar.gz","2013-09-16T04:26:05.000Z","2013-09-16T04:47:01.000Z","44843334-81C0-40F2-A5D1-5D522669B08D","7FE455C5-B312-4F45-BE86-294262E0AE7A","Unaligned reads",7559797360,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0375A538-64DC-4F7B-807E-D765C8D88C23","University of North Carolina","564a3e01e4b0298dd2c93d04","85ABFD69-CF72-43F6-A7DD-97056F22C91B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","31BD2EE1-11BD-4D7F-A6E0-137BB24FCDE1","2013-09-16T04:47:01.000Z","A502271D-5243-485B-BD6B-90846DD5FF11","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",192,"31BD2EE1-11BD-4D7F-A6E0-137BB24FCDE1",NA,"FU","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1533008F-A3B8-4B50-A280-0A1C1FFACEFD.txt",100,"TCGA-FU-A23K-01A",NA,NA,"TCGA",2010,NA,NA,NA,"AD2CEE65-CA6B-46F5-A145-227A18211B02",28,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.1533008F-A3B8-4B50-A280-0A1C1FFACEFD.txt","Alive",NA,"TCGA-FU-A23K",NA,NA,NA,37,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T1b1","8083/3","FEMALE","C53.9",148,NA,NA,"WHITE",NA,11,30,"A8CE9441-420A-4116-8A7D-D52EF404A51D","ADC0D6F1-8E26-4269-A818-71A1D3458CAA","C501.TCGA-FU-A23K-01A-11D-A16O-08.2.bam.bai","TCGA-FU-A23K-01A-11",80,0,20,40,15,"TOP",5,20,"TCGA-FU-A23K-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-FU-A23K",NA,"FU","A23K","YES","C53.9","8083/3","C53.9","NO","YES",-10551,"FEMALE","WHITE",NA,"No","No","Alive",37,NA,NA,NA,"TUMOR FREE","NO",18,7,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,28,2010,"Biopsy (cervical / CT-guided / Other)","YES",24,1,"G3",NA,1,NA,NA,NA,NA,"2009",16,NA,"T1b1N1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
197976316,193998977,9249841206,"47B5A2A7-7E13-4558-99D2-067F5075C6A4.bw","86731af9-2d33-4521-9cf9-5f6152ca15d7","47b5a2a7-7e13-4558-99d2-067f5075c6a4","2016-08-05T11:55:02.006965-05:00","UNCID_2186497.58ccb54d-2d23-4bce-b05d-02e543d83306.121102_UNC15-SN850_0240_BD148CACXX_4_CAGATC.tar.gz","7d2868c0-0781-4676-985c-e70f1e5b1d16",8964446697,"Illumina HiSeq","5770b7ecceb041a2572f6afa2f5c1949","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:48:57.019892-05:00","2016-05-03T11:05:42.712110-05:00","7d2868c0-0781-4676-985c-e70f1e5b1d16_analysis.xml","1df2d9efb26d4c5de6cc721d34bf3080","30b49e22-ac9b-4ae8-abb9-b2c3a1971907",2124,"2016-09-29T18:45:02.052260-05:00","7d2868c0-0781-4676-985c-e70f1e5b1d16_experiment.xml","2d3401622d9eb13598c6794b92004836","2e37aafc-b254-4472-8b95-7cb7d15686e5",2431,"2016-09-29T19:44:04.968393-05:00","7d2868c0-0781-4676-985c-e70f1e5b1d16_run.xml","76a4bad24a229927daa342c7afca443d","53429426-972e-4e65-9a91-cef770e8d19f",354,"2016-09-08T12:11:13.377887-05:00","TCGA-FU-A23L","2016-09-02T18:57:42.792617-05:00","female","TCGA-FU-A23L_demographic",1950,"white","4aba7602-64cb-5a00-bfbb-dc52280402df","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A23L_diagnosis","not reported",21962,"alive","8070/3",NA,725,"b4e1f5b6-9295-51e8-b4c3-e6776e859e8e","c53.9",-21962,"TCGA-FU-A23L_treatment","ce2479ed-b355-5538-9bb4-e931ae3ee3a5","01","false","TCGA-FU-A23L-01A",NA,"7748115f-bce5-4932-8bbb-ae0d96725f37",FALSE,"717358E4-EB69-4232-B0AE-36C7058531A9","Primary Tumor",NA,165,150,NA,1303862400,"11",30,"TCGA-FU-A23L-01A-11",90,NA,20,NA,0,NA,10,NA,"2016-09-08T12:11:13.377887-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"bdefc9ea-b25b-4e8d-a1ac-ca13d3ab59b8",NA,"TCGA-FU-A23L-01A-01-TSA",NA,90,NA,"c1dd4292-9610-4cb2-bb9d-60fd2759e2fc","RNA","TCGA-FU-A23L-01A-11R","72430cb6-928f-4fbc-b5bc-79ed3e1d01da",1.86,0.17,"UV Spec","R","23","TCGA-FU-A23L-01A-11R-A16R-07","58ccb54d-2d23-4bce-b05d-02e543d83306",0.17,NA,56,21.0771952275208,163,"74678de7-dd95-5238-a871-becf1ab1907f","TCGA-FU-A23L_exposure","UNCID_2186497.58ccb54d-2d23-4bce-b05d-02e543d83306.121102_UNC15-SN850_0240_BD148CACXX_4_CAGATC.tar.gz","2013-09-19T07:13:06.000Z","2013-09-19T07:37:02.000Z","7D2868C0-0781-4676-985C-E70F1E5B1D16","7748115F-BCE5-4932-8BBB-AE0D96725F37","Unaligned reads",8964446697,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","58CCB54D-2D23-4BCE-B05D-02E543D83306","University of North Carolina","564a3f61e4b093830b6a8a04","86731AF9-2D33-4521-9CF9-5F6152CA15D7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C1DD4292-9610-4CB2-BB9D-60FD2759E2FC","2013-09-19T07:37:02.000Z","72430CB6-928F-4FBC-B5BC-79ED3E1D01DA","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",165,"C1DD4292-9610-4CB2-BB9D-60FD2759E2FC",NA,"FU","TCGA-FU-A23L-01A-11R-A16Q-13_mirna.bam.bai",150,"TCGA-FU-A23L-01A",NA,"74452C14-7355-4AD6-958B-BCB5BF4E44E9","TCGA",2010,NA,NA,NA,"7748115F-BCE5-4932-8BBB-AE0D96725F37",60,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.179BC59D-8509-4989-8D44-D7C6EB2CCF8B.txt","Alive",NA,"TCGA-FU-A23L",NA,"80146D90-A1A8-4BD2-99A7-EF5F8FF73CAE",NA,37,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIA1",NA,NA,"T2a1","8070/3","FEMALE","C53.9",148,NA,"ADD8CB4B-F58C-441D-90AD-E37F0F85104F","WHITE",NA,11,30,"BDEFC9EA-B25B-4E8D-A1AC-CA13D3AB59B8","F287CFD5-E8D7-4295-99B2-F7AC9EC3C849","C501.TCGA-FU-A23L-01A-11D-A16O-08.2.bam","TCGA-FU-A23L-01A-11",90,0,20,40,10,"TOP",0,20,"TCGA-FU-A23L-01A-01-TSA",90,"Cisplatin","Chemotherapy","TCGA-FU-A23L-D56155","TCGA-FU-A23L-R56153","External","Primary Tumor Field","TCGA-FU-A23L-F56151_NTE-1","NO",725,"TUMOR FREE","Alive",NA,"TCGA-FU-A23L-F56151","TCGA-FU-A23L",NA,"FU","A23L","YES","C53.9","8070/3","C53.9","NO","YES",-21962,"FEMALE","WHITE",NA,"No","No","Alive",37,NA,NA,NA,NA,"NO",18,7,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,60,2010,"Biopsy (cervical / CT-guided / Other)","YES",11,0,"G3",NA,1,NA,NA,NA,NA,"2009",11,NA,"T2a1N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
101353314,100353898,4796058500,"E94638E8-CB51-4FBB-8BCB-4BFD7A812291.bw","87e701ab-acfd-45f2-a12e-323c94e5f3d5","e94638e8-cb51-4fbb-8bcb-4bfd7a812291","2016-08-26T22:54:25.784752-05:00","UNCID_2553077.05293acf-1896-4a84-af90-0fe7483bdb66.140521_UNC11-SN627_0359_BC4E01ACXX_3_GTGAAA.tar.gz","b3c6e60e-5df3-4ff1-9380-13842547ff81",4094851722,"Illumina HiSeq","5002e4d4f528f375c73ac2bc3e4d5eb7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:20:39.667831-05:00","2016-05-03T11:54:19.885282-05:00","b3c6e60e-5df3-4ff1-9380-13842547ff81_analysis.xml","6acdbaaa5fadd9ba3ad654375357cf02","1eb99e89-0e1f-49ed-98f4-e6d09baa650f",2123,"2016-09-30T00:13:47.418799-05:00","b3c6e60e-5df3-4ff1-9380-13842547ff81_experiment.xml","ae15a356dacb619c219f85b371bb7390","fa155698-fe62-4e59-80a3-8bbf69b7448a",2628,"2016-09-29T19:11:54.091616-05:00","b3c6e60e-5df3-4ff1-9380-13842547ff81_run.xml","bcb3d3d6ec05950cf52fe564a1e45720","3f2b4553-3fd9-49f9-9c19-481b768f7202",354,"2016-09-08T10:31:46.611048-05:00","TCGA-EA-A97N","2016-09-02T18:54:01.179653-05:00","female","TCGA-EA-A97N_demographic",1975,"white","2dc3760c-bd9a-5b11-8931-bb9ab4ab14c3","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A97N_diagnosis","not reported",13984,"alive","8070/3",NA,11,"4188fc79-04c4-52d2-be66-f794b9c861c0","c53.9",-13984,"TCGA-EA-A97N_treatment","c6ed529b-607a-56ca-be6b-7ea56e893dbd","01","true","TCGA-EA-A97N-01A",NA,"b7ca7bff-a333-4996-bbf0-74063d1e0472",FALSE,"23982BB4-8B3A-4F8B-98EE-11E63B92FA17","Primary Tumor",NA,83,630,NA,1389225600,"11",30,"TCGA-EA-A97N-01A-11",60,NA,20,NA,0,NA,30,NA,"2016-09-08T10:31:46.611048-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"bb1c30a3-ac41-49ab-a77d-32b2e00118bf",NA,"TCGA-EA-A97N-01A-01-TSA",NA,60,NA,"21361d0b-1fc0-4f39-85e5-bb63340044f7","RNA","TCGA-EA-A97N-01A-11R","e4c3195b-8955-444d-8f48-cb31c5eac466",1.9,0.17,"UV Spec","R","23","TCGA-EA-A97N-01A-11R-A38B-07","05293acf-1896-4a84-af90-0fe7483bdb66",0.17,NA,60,23.4375,160,"299a5074-5b03-5a0b-b706-d2c5eb51336d","TCGA-EA-A97N_exposure","UNCID_2553077.05293acf-1896-4a84-af90-0fe7483bdb66.140521_UNC11-SN627_0359_BC4E01ACXX_3_GTGAAA.tar.gz","2014-07-30T17:21:04.000Z","2014-07-30T17:37:03.000Z","B3C6E60E-5DF3-4FF1-9380-13842547FF81","B7CA7BFF-A333-4996-BBF0-74063D1E0472","Unaligned reads",4094851722,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","05293ACF-1896-4A84-AF90-0FE7483BDB66","University of North Carolina","564a3d1ee4b09c884b24e2fa","87E701AB-ACFD-45F2-A12E-323C94E5F3D5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","21361D0B-1FC0-4F39-85E5-BB63340044F7","2014-07-30T17:37:03.000Z","E4C3195B-8955-444D-8F48-CB31C5EAC466","Ukraine","NO",1,NA,"Primary Tumor","Asterand",83,"21361D0B-1FC0-4F39-85E5-BB63340044F7",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DA5131EF-4E20-4519-BE27-4C016B087F14.txt",630,"TCGA-EA-A97N-01A",NA,NA,"TCGA",2013,"TCGA-EA-A97N_NTE-1","Complete Remission/Response","TUMOR FREE","B7CA7BFF-A333-4996-BBF0-74063D1E0472",38,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DA5131EF-4E20-4519-BE27-4C016B087F14.txt","Alive",NA,"TCGA-EA-A97N","NOT HISPANIC OR LATINO","285ADF1C-6702-41D7-9F9F-04207AAC5D20","NO",11,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"BB1C30A3-AC41-49AB-A77D-32B2E00118BF","E4C3195B-8955-444D-8F48-CB31C5EAC466","TCGA-EA-A97N-01A-11R-A38M-13_mirna.bam.bai","TCGA-EA-A97N-01A-11",60,0,20,40,30,"TOP",10,20,"TCGA-EA-A97N-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-EA-A97N-F68492","TCGA-EA-A97N",NA,"EA","A97N","YES","C53.9","8070/3","C53.9","YES","NO",-13984,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",11,NA,NA,NA,"TUMOR FREE","YES",18,4,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2013,"Biopsy (cervical / CT-guided / Other)","YES",10,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
53110604,52552326,2511296917,"A17352A8-0D3C-4545-8136-7DAE2FB0E102.bw","88f0aa4a-6bfd-4573-b136-58f84f867f10","a17352a8-0d3c-4545-8136-7dae2fb0e102","2016-08-09T14:40:37.225835-05:00","UNCID_2654369.aa304440-f222-41d7-8ced-7387a8ac4ea3.141010_UNC12-SN629_0394_AC5FTUACXX_3_CTTGTA.tar.gz","06e66d05-c710-4d62-baa4-115577e310e3",2141895330,"Illumina HiSeq","2d39923e36591118842d20d6a2effd88","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:03:40.834041-05:00","2016-05-03T12:08:10.829131-05:00","06e66d05-c710-4d62-baa4-115577e310e3_analysis.xml","4e1506e051db981bbe165d2c4a929ca6","3a035edc-ffc9-4520-ad62-6740bf20f9e3",2124,"2016-10-07T16:35:21.064748-05:00","06e66d05-c710-4d62-baa4-115577e310e3_experiment.xml","bd5566d978e471180081482c85e462bb","ce94f3a9-b43f-4376-89e4-02e11e4f36e5",2628,"2016-09-29T21:32:34.645052-05:00","06e66d05-c710-4d62-baa4-115577e310e3_run.xml","4918bd9f17cb2b2dff11a14e232d8c71","964d0bd3-b0a5-4753-885b-a38bf52020ef",354,"2016-09-08T11:29:20.322888-05:00","TCGA-ZJ-AAXB","2016-09-02T18:54:43.356442-05:00","female","TCGA-ZJ-AAXB_demographic",1967,"white","50a695b2-2130-5c22-8d39-419b36f9bf5b","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXB_diagnosis","not reported",15492,"alive","8384/3",NA,0,"ad66d87b-2c22-5d68-8c47-d6745c41c80f","c53.9",-15492,"TCGA-ZJ-AAXB_treatment","0419f52f-3e72-51ab-a72a-463a0b4ad20c","01","true","TCGA-ZJ-AAXB-01A",NA,"65cf8a15-a1f6-4e86-b42f-3e52296d169f",FALSE,"AB550C0A-6FE6-4D92-A5E3-A7141A32CC26","Primary Tumor",NA,1591,140,NA,1395878400,"11",30,"TCGA-ZJ-AAXB-01A-11",85,NA,0,NA,0,NA,25,NA,"2016-09-08T11:29:20.322888-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"ae149d7f-1291-4809-a2a8-ef41f5c5fecb",NA,"TCGA-ZJ-AAXB-01A-01-TSA",NA,75,NA,"12f38519-1f3e-4aaf-977e-cb50e4d1fab6","RNA","TCGA-ZJ-AAXB-01A-11R","4cab968b-d98e-45e7-bf8c-2137713603ba",1.88,0.16,"UV Spec","R","23","TCGA-ZJ-AAXB-01A-11R-A42T-07","aa304440-f222-41d7-8ced-7387a8ac4ea3",0.16,NA,97,36.5087131619557,163,"03d0acd3-2d50-59a4-9bbb-5b4f5d8dfb18","TCGA-ZJ-AAXB_exposure","UNCID_2654369.aa304440-f222-41d7-8ced-7387a8ac4ea3.141010_UNC12-SN629_0394_AC5FTUACXX_3_CTTGTA.tar.gz","2014-11-05T01:27:04.000Z","2014-11-05T01:39:08.000Z","06E66D05-C710-4D62-BAA4-115577E310E3","65CF8A15-A1F6-4E86-B42F-3E52296D169F","Unaligned reads",2141895330,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AA304440-F222-41D7-8CED-7387A8AC4EA3","University of North Carolina","56607704e4b0ca319164e25d","88F0AA4A-6BFD-4573-B136-58F84F867F10","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","12F38519-1F3E-4AAF-977E-CB50E4D1FAB6","2014-11-05T01:39:08.000Z","4CAB968B-D98E-45E7-BF8C-2137713603BA","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1591,"12F38519-1F3E-4AAF-977E-CB50E4D1FAB6",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BE8443E8-A912-4790-A922-DE3D5D97B398.txt",140,"TCGA-ZJ-AAXB-01A",NA,NA,"TCGA",2009,"TCGA-ZJ-AAXB_NTE-1",NA,NA,"65CF8A15-A1F6-4E86-B42F-3E52296D169F",42,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.BE8443E8-A912-4790-A922-DE3D5D97B398.txt","Alive",NA,"TCGA-ZJ-AAXB","NOT HISPANIC OR LATINO",NA,NA,0,"No","Cervix","C53.9","N0","Endocervical Adenocarcinoma of the Usual Type",NA,NA,"Stage IB2",NA,NA,"T1b2","8384/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"AE149D7F-1291-4809-A2A8-EF41F5C5FECB","979850B6-64E8-4C76-AE5B-27FE4CFC1453","TCGA-ZJ-AAXB-01A-11R-A42V-13_mirna.bam.bai","TCGA-ZJ-AAXB-01A-11",85,0,0,0,25,"TOP",0,0,"TCGA-ZJ-AAXB-01A-01-TSA",75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXB",NA,"ZJ","AAXB","YES","C53.9","8384/3","C53.9","NO","YES",-15492,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",31,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,42,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,NA,"2009",8,NA,"T1b2N0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
241042170,237709148,11341000937,"B18A6F95-D4ED-416B-B5A1-9A4934865D0D.bw","8911c80c-c903-48e4-af5b-ffedef9abc47","b18a6f95-d4ed-416b-b5a1-9a4934865d0d","2016-08-09T13:59:33.402042-05:00","UNCID_2186370.5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8.121102_UNC12-SN629_0235_AC13F5ACXX_4_ATTCCT.tar.gz","d9529824-6898-43c8-9c3e-67ec1b289001",11061649860,"Illumina HiSeq","6ec25c1b15aa981ab85fe411b3d464d8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:05:48.994496-05:00","2016-05-03T11:05:42.730061-05:00","d9529824-6898-43c8-9c3e-67ec1b289001_analysis.xml","3282931834aec5915ee054b57938f657","85aaa567-5983-44e8-9525-bcb137db9764",2124,"2016-09-29T17:54:49.599561-05:00","d9529824-6898-43c8-9c3e-67ec1b289001_experiment.xml","f9e6aaaa5f23982c01262c3d1ab19244","0ea8e809-1790-4452-9d96-e28ee791f519",2431,"2016-09-29T18:54:09.551080-05:00","d9529824-6898-43c8-9c3e-67ec1b289001_run.xml","08b00c95758072f99e984878fe76b285","33f632ff-a898-4588-b103-b602569c3f8f",354,"2016-09-08T12:44:02.016316-05:00","TCGA-C5-A2M1","2016-09-02T18:57:53.482966-05:00","female","TCGA-C5-A2M1_demographic",1968,"white","ea0b63da-a2c9-588c-8a9b-293b2adf766d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2M1_diagnosis","not reported",13835,"alive","8384/3",NA,1169,"bc8810f9-b161-54b4-8c12-52b4ddd960a1","c53.9",-13835,"TCGA-C5-A2M1_treatment","3af7a5a4-bf3c-5272-93dd-37f01abc00d4","01","false","TCGA-C5-A2M1-01A",NA,"065bb06f-5bb7-4f79-b374-97a3011f22ae",FALSE,"13B5E17B-0613-4A86-8DB5-1DD3B5AF7A23","Primary Tumor",NA,2275,30,NA,1315353600,"11",20,"TCGA-C5-A2M1-01A-11",70,NA,0,NA,0,NA,0,NA,"2016-09-08T12:44:02.016316-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e81db716-e520-473e-aa02-583722682bdc",NA,"TCGA-C5-A2M1-01A-01-TS1",NA,100,NA,"46992335-f031-4d85-9cdc-5836eb6e55e7","RNA","TCGA-C5-A2M1-01A-11R","faad3499-08b7-401b-8fbb-f157c02807c0",1.82,0.18,"UV Spec","R","23","TCGA-C5-A2M1-01A-11R-A18M-07","5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8",0.18,NA,76,26.9274376417234,168,"9a3b4007-b196-5ba6-bbdd-73a2a5357e53","TCGA-C5-A2M1_exposure","UNCID_2186370.5c5d18f0-dc25-4d65-9ea7-f90d69db0ce8.121102_UNC12-SN629_0235_AC13F5ACXX_4_ATTCCT.tar.gz","2013-09-19T07:36:07.000Z","2013-09-19T20:01:02.000Z","D9529824-6898-43C8-9C3E-67EC1B289001","065BB06F-5BB7-4F79-B374-97A3011F22AE","Unaligned reads",11061649860,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5C5D18F0-DC25-4D65-9EA7-F90D69DB0CE8","University of North Carolina","564a4039e4b0ef12181bfd58","8911C80C-C903-48E4-AF5B-FFEDEF9ABC47","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","46992335-F031-4D85-9CDC-5836EB6E55E7","2013-09-19T20:01:02.000Z","FAAD3499-08B7-401B-8FBB-F157C02807C0","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2275,"46992335-F031-4D85-9CDC-5836EB6E55E7",NA,"C5","TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.bam",30,"TCGA-C5-A2M1-01A",NA,NA,"TCGA",2005,NA,NA,"TUMOR FREE","D54090CA-8F9B-4F5E-BA79-92CADB9BD6A7",37,"nationwidechildrens.org_clinical.TCGA-C5-A2M1.xml","Alive",NA,"TCGA-C5-A2M1","NOT HISPANIC OR LATINO","DA3BA7B8-18F0-49AA-BB2E-AD4EA476B3A3",NA,1169,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,20,"E81DB716-E520-473E-AA02-583722682BDC","FAAD3499-08B7-401B-8FBB-F157C02807C0","98fc2f7cb337eb55aa2a74d33b736b84.bam","TCGA-C5-A2M1-01A-11",70,0,0,0,0,"TOP",0,0,"TCGA-C5-A2M1-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-C5-A2M1-F63928_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A2M1-F63928","TCGA-C5-A2M1",NA,"C5","A2M1","YES","C53.9","8384/3","C53.9","NO","YES",-13835,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1169,NA,NA,NA,"TUMOR FREE","NO",8,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,37,2005,"Biopsy (cervical / CT-guided / Other)","YES",31,0,"G2",NA,1,NA,NA,NA,NA,"1995",7,NA,"T1b1N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
154285800,144739366,6904014419,"33E92C5F-0C42-4549-AD5B-0A064182A272.bw","8a4da4f0-30f2-497e-8a7c-988fd6b813cb","33e92c5f-0c42-4549-ad5b-0a064182a272","2016-08-31T13:47:17.607195-05:00","UNCID_2234913.3f679347-cd3b-4711-aa6c-e5d87fa93052.121001_UNC13-SN749_0196_AD140CACXX_1_ATGTCA.tar.gz","cba7f034-6498-43cc-a261-7040de9a85ef",6952002961,"Illumina HiSeq","70587f545d9e458fa81fe332fb06a761","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:52:31.194832-05:00","2016-05-03T11:20:13.161874-05:00","cba7f034-6498-43cc-a261-7040de9a85ef_analysis.xml","7281d818a9ac01df5b224e06e22f9601","c7ca5c57-22af-435e-98fa-257db4f81637",2123,"2016-08-13T07:32:53.642468-05:00","cba7f034-6498-43cc-a261-7040de9a85ef_experiment.xml","ac88d776b09d72b2bcc7cd18c91331c6","8e60c63b-2718-4ae5-b18c-5909a7dd522d",2431,"2016-09-29T17:52:04.311417-05:00","cba7f034-6498-43cc-a261-7040de9a85ef_run.xml","371702c4a8217ca3f83cdc568c6899ef","0cfbbc5f-c1ea-4471-b091-a4c2026d5182",354,"2016-09-08T12:04:23.596958-05:00","TCGA-C5-A1BN","2016-09-02T18:57:17.659084-05:00","female","TCGA-C5-A1BN_demographic",1981,"white","a36116b1-2582-5dd4-830a-a0a062466646","not hispanic or latino",2007,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BN_diagnosis","not reported",9783,"dead","8070/3",166,NA,"e90b2f98-703e-5913-bff6-973be8159415","c53.9",-9783,"TCGA-C5-A1BN_treatment","7ffa196a-69f6-59be-b124-136b981c05d5","01","true","TCGA-C5-A1BN-01B",NA,"dd05713e-6d6d-4876-89df-69a905d24500",FALSE,"541610BD-6ACC-4EE7-8942-8524C8BE0515","Primary Tumor",NA,1253,30,NA,1297728000,"11",30,"TCGA-C5-A1BN-01B-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T12:04:23.596958-05:00",NA,25,NA,8,NA,"TOP",NA,0,NA,"3f65a165-c26e-4b29-8959-2d2e1f3b7b1e",NA,"TCGA-C5-A1BN-01B-01-TSA",NA,80,NA,"45bd1718-ea55-4617-b042-5276d7f01e5a","RNA","TCGA-C5-A1BN-01B-11R","c41d1411-86d3-4797-857f-195867486a84",1.7,0.17,"UV Spec","R","23","TCGA-C5-A1BN-01B-11R-A14Y-07","3f679347-cd3b-4711-aa6c-e5d87fa93052",0.17,0.602739726027397,68,25.5937370619895,163,"e221739f-59e3-5b1f-9091-92494a26712f","TCGA-C5-A1BN_exposure","UNCID_2234913.3f679347-cd3b-4711-aa6c-e5d87fa93052.121001_UNC13-SN749_0196_AD140CACXX_1_ATGTCA.tar.gz","2013-10-19T02:06:04.000Z","2013-10-19T02:27:02.000Z","CBA7F034-6498-43CC-A261-7040DE9A85EF","DD05713E-6D6D-4876-89DF-69A905D24500","Unaligned reads",6952002961,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3F679347-CD3B-4711-AA6C-E5D87FA93052","University of North Carolina","56607779e4b0b37b3d990e07","8A4DA4F0-30F2-497E-8A7C-988FD6B813CB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","45BD1718-EA55-4617-B042-5276D7F01E5A","2013-10-19T02:27:02.000Z","C41D1411-86D3-4797-857F-195867486A84","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1253,"45BD1718-EA55-4617-B042-5276D7F01E5A",NA,"C5","TCGA-C5-A1BN-01B-11R-A14X-13_mirna.bam.bai",30,"TCGA-C5-A1BN-01B",NA,"79519932-2069-4484-8A3C-2B29A74C417D","TCGA",2007,NA,NA,"WITH TUMOR","DD05713E-6D6D-4876-89DF-69A905D24500",26,"nationwidechildrens.org_clinical.TCGA-C5-A1BN.xml","Dead",166,"TCGA-C5-A1BN","NOT HISPANIC OR LATINO","9D32A61A-665C-48D1-86C4-F9B065E1CE19",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8070/3","FEMALE","C53.9",127,NA,"20B79403-3BCB-42A7-9354-FE7E59DC987E","WHITE",NA,11,30,"3F65A165-C26E-4B29-8959-2D2E1F3B7B1E","C41D1411-86D3-4797-857F-195867486A84","unc.edu.3f679347-cd3b-4711-aa6c-e5d87fa93052.1746758.bt.exon_quantification.txt","TCGA-C5-A1BN-01B-11",80,0,0,25,20,"TOP",0,8,"TCGA-C5-A1BN-01B-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-C5-A1BN-D30415","TCGA-C5-A1BN-R30416","COMBINATION","Primary Tumor Field",NA,"NO",NA,"WITH TUMOR","Dead",166,"TCGA-C5-A1BN-F30414","TCGA-C5-A1BN",NA,"C5","A1BN","YES","C53.9","8070/3","C53.9","NO","YES",-9783,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,166,NA,NA,"WITH TUMOR","NO",21,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,26,2007,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,2,NA,11,NA,NA,"1995",8,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
122116342,118524393,5651263147,"E041B375-3E60-4F18-A6EF-D1C249E3B8EE.bw","8ac819b3-4227-4eae-be03-8760b197df9a","e041b375-3e60-4f18-a6ef-d1c249e3b8ee","2016-08-26T19:35:13.688504-05:00","UNCID_2553108.94f22e5d-e471-4add-9291-27bc5c96a519.140408_UNC11-SN627_0351_AC3KY3ACXX_1_GTCCGC.tar.gz","435d9bd5-3e13-40bf-b797-5bc0c4dcca38",5380795868,"Illumina HiSeq","1f7180c384d26d1b9d76a0af440cd029","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:21:51.717595-05:00","2016-05-03T11:54:19.908545-05:00","435d9bd5-3e13-40bf-b797-5bc0c4dcca38_analysis.xml","89424ab22ec8ec71df5f973e97901278","4577e946-2e9e-4227-b0e6-29196ce4d89d",2124,"2016-08-13T08:31:07.761198-05:00","435d9bd5-3e13-40bf-b797-5bc0c4dcca38_experiment.xml","1c4e75a28c2db8fd6e0707b2be1baf03","5cd1d46f-d65e-4d26-9383-043bdfd994d0",2628,"2016-09-29T22:22:20.218376-05:00","435d9bd5-3e13-40bf-b797-5bc0c4dcca38_run.xml","3ef1ab4a9eb23ac3191c534ff6381ea7","b4ed78c3-3aee-42fa-ba96-fcb700b2a7e7",354,"2016-09-08T11:32:45.048472-05:00","TCGA-C5-A8XK","2016-09-02T19:01:08.560663-05:00","female","TCGA-C5-A8XK_demographic",1970,"black or african american","b29878cc-c12d-56bd-bf8a-cec857a45a03","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8XK_diagnosis","not reported",11268,"alive","8070/3",NA,3039,"aaff3b75-c9bf-5bbc-9dec-f33a6cd5946e","c53.9",-11268,"TCGA-C5-A8XK_treatment","31a6cd43-8aa5-5c7a-91cc-ae05df24ead1","01","true","TCGA-C5-A8XK-01A",NA,"edbcf0c7-e8c8-40e9-8170-bf91de078f5f",FALSE,"1F6ED6D4-2EF5-4F87-8F4E-08CD7834A2E5","Primary Tumor",NA,4840,20,NA,1387238400,"11",25,"TCGA-C5-A8XK-01A-11",85,NA,3,NA,0,NA,15,NA,"2016-09-08T11:32:45.048472-05:00",NA,3,NA,3,NA,"TOP",NA,0,NA,"93bd39b9-fd5e-4b30-aebb-fd1c70b06056",NA,"TCGA-C5-A8XK-01A-01-TS1",NA,85,NA,"3320d5f5-0c62-4eac-ad90-49eca55dfdf1","RNA","TCGA-C5-A8XK-01A-11R","b18e8d03-1cbf-4e7e-b3b0-a94a50aefdd9",1.84,0.18,"UV Spec","R","23","TCGA-C5-A8XK-01A-11R-A37O-07","94f22e5d-e471-4add-9291-27bc5c96a519",0.18,NA,NA,NA,NA,"dcd66aa3-dac0-5b43-a62a-179e3e22e52b","TCGA-C5-A8XK_exposure","UNCID_2553108.94f22e5d-e471-4add-9291-27bc5c96a519.140408_UNC11-SN627_0351_AC3KY3ACXX_1_GTCCGC.tar.gz","2014-07-31T00:36:05.000Z","2014-07-31T00:57:42.000Z","435D9BD5-3E13-40BF-B797-5BC0C4DCCA38","EDBCF0C7-E8C8-40E9-8170-BF91DE078F5F","Unaligned reads",5380795868,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","94F22E5D-E471-4ADD-9291-27BC5C96A519","University of North Carolina","564a3bd2e4b0ef12181a9385","8AC819B3-4227-4EAE-BE03-8760B197DF9A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3320D5F5-0C62-4EAC-AD90-49ECA55DFDF1","2014-07-31T00:57:42.000Z","B18E8D03-1CBF-4E7E-B3B0-A94A50AEFDD9","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4840,"3320D5F5-0C62-4EAC-AD90-49ECA55DFDF1",NA,"C5","TCGA-C5-A8XK-01A-11R-A37P-13_mirna.bam.bai",20,"TCGA-C5-A8XK-01A",NA,"3690C830-6E5E-4FA9-8B13-65AB49B74002","TCGA",2000,"TCGA-C5-A8XK_NTE-1",NA,"TUMOR FREE","EDBCF0C7-E8C8-40E9-8170-BF91DE078F5F",30,"nationwidechildrens.org_clinical.TCGA-C5-A8XK.xml","Alive",NA,"TCGA-C5-A8XK",NA,"2746912D-FE59-4613-8FFE-0ECB75303A6F","NO",3039,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,NA,NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"97BA0371-8182-4011-BE8E-A55A68CA2C44","BLACK OR AFRICAN AMERICAN",NA,11,25,"93BD39B9-FD5E-4B30-AEBB-FD1C70B06056","B18E8D03-1CBF-4E7E-B3B0-A94A50AEFDD9","TCGA-C5-A8XK-01A-11R-A37P-13_mirna.bam.bai","TCGA-C5-A8XK-01A-11",85,0,3,3,15,"TOP",0,3,"TCGA-C5-A8XK-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-C5-A8XK-D58139","TCGA-C5-A8XK-R58141","External","Regional site","TCGA-C5-A8XK-F66732_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A8XK-F66732","TCGA-C5-A8XK",NA,"C5","A8XK","YES","C53.9","8070/3","C53.9","NO","YES",-11268,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",3039,NA,NA,NA,"TUMOR FREE","YES",1,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,30,2000,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
165519920,162703708,7761138845,"EDF90AF6-6C64-4BD2-AADF-8D7D188650B2.bw","8dbcb17d-0396-4faa-9b32-8e2566424bff","edf90af6-6c64-4bd2-aadf-8d7d188650b2","2016-08-27T01:01:42.480754-05:00","UNCID_2278282.b58a46e6-797d-4f88-88ef-932d0d2a6f6e.130909_UNC15-SN850_0327_BD2DT1ACXX_5_CGATGT.tar.gz","5c58e2d7-55a1-4058-bcd2-48c4dc957221",7591500377,"Illumina HiSeq","9273982b001b6581dac6d18be87c62de","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:55:37.314192-05:00","2016-05-03T11:24:56.858865-05:00","5c58e2d7-55a1-4058-bcd2-48c4dc957221_analysis.xml","41d9745fb91fff94670c69ac51787db5","eefcef38-5383-4a20-96bb-6345f44168e2",2124,"2016-09-29T19:44:24.833438-05:00","5c58e2d7-55a1-4058-bcd2-48c4dc957221_experiment.xml","2dc51915847d6c73e6330d518012a5ef","53758d39-7732-488e-b6c0-564112ce898d",2431,"2016-09-29T22:48:04.534716-05:00","5c58e2d7-55a1-4058-bcd2-48c4dc957221_run.xml","53bd2c5ac3a868de9bb477595abde5f2","c5038da0-5331-420a-8ebb-d0b99ba9666b",354,"2016-09-08T12:09:36.007608-05:00","TCGA-DG-A2KK","2016-09-02T18:57:45.498104-05:00","female","TCGA-DG-A2KK_demographic",1956,"not reported","78b6d217-8694-5500-b7c5-bb48ae7a8c03","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DG","fa63e449-4302-5d16-bd2c-76f031746194","Ontario Institute for Cancer Research","not reported","c53.9","TCGA-DG-A2KK_diagnosis","not reported",18834,"alive","8140/3",NA,2496,"78089068-3097-5b54-8da1-4e5e2328732e","c53.9",-18834,"TCGA-DG-A2KK_treatment","4f68ec24-bb0c-5fa5-ab4d-47c4828ca58a","01","false","TCGA-DG-A2KK-01A",NA,"9c102289-0fac-4646-b2ec-ac1037e54536",FALSE,"D01A3CDE-6669-434E-800D-3344E2A5FA48","Primary Tumor",NA,NA,280,NA,1313712000,"11",30,"TCGA-DG-A2KK-01A-11",70,NA,10,NA,0,NA,25,NA,"2016-09-08T12:09:36.007608-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"dc65e5bb-771d-45a9-8b7a-27397de8c04d",NA,"TCGA-DG-A2KK-01A-01-TS1",NA,70,NA,"d713c4d5-bb4b-40b2-9ca0-94ab1b9d7a00","RNA","TCGA-DG-A2KK-01A-11R","3ffb4fee-3688-4ea3-8c39-aff9b5f7d5fa",1.9,0.15,"UV Spec","R","23","TCGA-DG-A2KK-01A-11R-A180-07","b58a46e6-797d-4f88-88ef-932d0d2a6f6e",0.15,1.36986301369863,64,25.9645421720962,157,"07d82a28-08d3-5305-800d-dee7d00692e5","TCGA-DG-A2KK_exposure","UNCID_2278282.b58a46e6-797d-4f88-88ef-932d0d2a6f6e.130909_UNC15-SN850_0327_BD2DT1ACXX_5_CGATGT.tar.gz","2013-11-22T09:21:03.000Z","2013-11-22T09:42:02.000Z","5C58E2D7-55A1-4058-BCD2-48C4DC957221","9C102289-0FAC-4646-B2EC-AC1037E54536","Unaligned reads",7591500377,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B58A46E6-797D-4F88-88EF-932D0D2A6F6E","University of North Carolina","564a40e4e4b0ef12181c35fa","8DBCB17D-0396-4FAA-9B32-8E2566424BFF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D713C4D5-BB4B-40B2-9CA0-94AB1B9D7A00","2013-11-22T09:42:02.000Z","3FFB4FEE-3688-4EA3-8C39-AFF9B5F7D5FA","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"D713C4D5-BB4B-40B2-9CA0-94AB1B9D7A00",NA,"DG","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E86D642C-A5D4-4D95-9BD0-16FEB48F2960.txt",280,"TCGA-DG-A2KK-01A",NA,"C7F19426-0D49-41B9-AF8D-EBE3FA652802","TCGA",2007,"TCGA-DG-A2KK_NTE-1","Complete Remission/Response","TUMOR FREE","9C102289-0FAC-4646-B2EC-AC1037E54536",51,"WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_F10_845268.hg19.seg.txt","Alive",NA,"TCGA-DG-A2KK",NA,"DA39DECB-A19D-435E-9463-5F35AAFC9924","NO",1544,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T1b1","8140/3","FEMALE","C53.9",169,NA,"FEDBEFBD-DF56-419E-8AB1-BB0B0D612089",NA,NA,11,30,"DC65E5BB-771D-45A9-8B7A-27397DE8C04D","3FFB4FEE-3688-4EA3-8C39-AFF9B5F7D5FA","TCGA-DG-A2KK-01A-11R-A17X-13_mirna.bam.bai","TCGA-DG-A2KK-01A-11",70,0,10,60,25,"TOP",5,10,"TCGA-DG-A2KK-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-DG-A2KK-D49823","TCGA-DG-A2KK-R49822","External","Regional site","TCGA-DG-A2KK-F65463_NTE-1",NA,2496,NA,"Alive",NA,"TCGA-DG-A2KK-F65463","TCGA-DG-A2KK",NA,"DG","A2KK","YES","C53.9","8140/3","C53.9","NO","YES",-18834,"FEMALE",NA,NA,"No","No","Alive",1544,NA,NA,NA,"TUMOR FREE","YES",11,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2007,"Biopsy (cervical / CT-guided / Other)","YES",28,2,"G3",NA,4,2007,25,NA,"Complete Remission/Response","1995",16,NA,"T1b1N1M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
224577562,219969423,10435735833,"569320D2-316C-4E2D-B7B3-D7D5C4DAD42D.bw","91310434-2a99-4e1d-81e6-3d58d097089f","569320d2-316c-4e2d-b7b3-d7d5c4dad42d","2016-08-09T13:56:59.232207-05:00","UNCID_2187315.cde3fda7-c23f-480b-bc20-ac27bcfe4536.120917_UNC11-SN627_0251_AC119PACXX_7_ATGTCA.tar.gz","441136cd-051f-4887-ae99-87e30f4e8c71",9942907399,"Illumina HiSeq","2146abfa67c2b80d3f98964fe09a6831","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:49:43.851000-05:00","2016-05-03T11:02:00.425419-05:00","441136cd-051f-4887-ae99-87e30f4e8c71_analysis.xml","77d6f5699655d33060a46197d6b16b86","7b8d1fbe-3197-4ac3-9a40-589a7d6c7b42",2124,"2016-09-30T00:20:58.624012-05:00","441136cd-051f-4887-ae99-87e30f4e8c71_experiment.xml","f7c3d1eb49f8f98928de67eec7537cc2","fe934d7d-b1c9-4270-a8cc-3fa72a6c1182",2431,"2016-09-29T19:02:15.617889-05:00","441136cd-051f-4887-ae99-87e30f4e8c71_run.xml","267496947aac449e93adbf9707b5c523","391230f5-d823-4b83-9283-387c8201b280",354,"2016-09-08T11:42:45.131671-05:00","TCGA-C5-A1BI","2016-09-02T18:56:43.582563-05:00","female","TCGA-C5-A1BI_demographic",1970,"white","559078b9-18df-5977-845d-51ff9ebd82b5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BI_diagnosis","not reported",11564,"alive","8070/3",NA,1112,"2804cc72-d52f-5af0-ad71-6b147f134ad2","c53.9",-11564,"TCGA-C5-A1BI_treatment","ec69785b-e8ef-5f0d-b92d-9fd6945f3af8","01","true","TCGA-C5-A1BI-01B",NA,"e75716d2-39cb-41d4-9e14-3718e9639c96",FALSE,"25B6B201-ECCC-44F5-82AF-B9DC7848A117","Primary Tumor",NA,3550,30,NA,1297728000,"11",30,"TCGA-C5-A1BI-01B-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:42:45.131671-05:00",NA,45,NA,5,NA,"TOP",NA,0,NA,"a76122f3-1373-40d0-8e2e-bb56f1b4d5d8",NA,"TCGA-C5-A1BI-01B-01-TSA",NA,90,NA,"9ddf0cca-8747-4b3e-bc2c-442b34483109","RNA","TCGA-C5-A1BI-01B-11R","0932cf25-642d-45e9-9955-13d8bc449f6c",1.86,0.17,"UV Spec","R","23","TCGA-C5-A1BI-01B-11R-A13Y-07","cde3fda7-c23f-480b-bc20-ac27bcfe4536",0.17,0.821917808219178,59,23.9360623149012,157,"9adcea93-b087-558f-b494-712d2dd3d802","TCGA-C5-A1BI_exposure","UNCID_2187315.cde3fda7-c23f-480b-bc20-ac27bcfe4536.120917_UNC11-SN627_0251_AC119PACXX_7_ATGTCA.tar.gz","2013-09-17T07:36:04.000Z","2013-09-17T08:02:01.000Z","441136CD-051F-4887-AE99-87E30F4E8C71","E75716D2-39CB-41D4-9E14-3718E9639C96","Unaligned reads",9942907399,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CDE3FDA7-C23F-480B-BC20-AC27BCFE4536","University of North Carolina","564a3f43e4b08c5d8692bdc2","91310434-2A99-4E1D-81E6-3D58D097089F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9DDF0CCA-8747-4B3E-BC2C-442B34483109","2013-09-17T08:02:01.000Z","0932CF25-642D-45E9-9955-13D8BC449F6C","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3550,"9DDF0CCA-8747-4B3E-BC2C-442B34483109",NA,"C5","UNCID_2187315.cde3fda7-c23f-480b-bc20-ac27bcfe4536.120917_UNC11-SN627_0251_AC119PACXX_7_ATGTCA.tar.gz",30,"TCGA-C5-A1BI-01B",NA,"CD5F4D29-A387-4D5D-AC20-A519665F404D","TCGA",2001,NA,NA,"TUMOR FREE","E75716D2-39CB-41D4-9E14-3718E9639C96",31,"nationwidechildrens.org_clinical.TCGA-C5-A1BI.xml","Alive",NA,"TCGA-C5-A1BI","NOT HISPANIC OR LATINO","C617492C-0F13-4017-B918-651A9131C72D",NA,1112,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",114,NA,"39962F26-55DD-4F8A-A47E-216B7B36EE89","WHITE",NA,11,30,"A76122F3-1373-40D0-8E2E-BB56F1B4D5D8","87DADF0E-6A81-498A-9CC6-14C54EE82328","UNCID_2187315.cde3fda7-c23f-480b-bc20-ac27bcfe4536.120917_UNC11-SN627_0251_AC119PACXX_7_ATGTCA.tar.gz","TCGA-C5-A1BI-01B-11",90,0,0,45,10,"TOP",0,5,"TCGA-C5-A1BI-01B-01-TSA",90,"Cisplatin","Chemotherapy","TCGA-C5-A1BI-D30513","TCGA-C5-A1BI-R30514","COMBINATION","Primary Tumor Field","TCGA-C5-A1BI-F57886_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A1BI-F57886","TCGA-C5-A1BI",NA,"C5","A1BI","YES","C53.9","8070/3","C53.9","NO","YES",-11564,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1112,NA,NA,NA,"TUMOR FREE","NO",12,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,31,2001,"Other method, specify:","YES",NA,NA,"G2",NA,2,NA,15,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
134397052,129916384,6191490828,"AFFB223D-DAE9-4567-9EF2-8E4DF9D8782D.bw","929505f7-0270-475e-a9d6-00bf38dc78ba","affb223d-dae9-4567-9ef2-8e4df9d8782d","2016-08-26T04:18:46.147695-05:00","UNCID_2358600.459f5e07-fffc-4f47-904b-3c51367c83f1.140107_UNC11-SN627_0341_BC38NLACXX_6_GTTTCG.tar.gz","b0fcb148-fc05-45b5-ba51-be2922f94143",6237532196,"Illumina HiSeq","da30b9d646ee4f9f26745de089be2996","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:27:23.882012-05:00","2016-05-03T11:37:12.425298-05:00","b0fcb148-fc05-45b5-ba51-be2922f94143_analysis.xml","8a4776c55773cae908967ddaef79b35f","9324cafc-e57d-4a65-ba6c-b85fef65c5b6",2124,"2016-09-29T20:30:20.238660-05:00","b0fcb148-fc05-45b5-ba51-be2922f94143_experiment.xml","bad8bd231a4770605cace39056e80fb8","6f9c1420-3320-48af-82b1-2abe2f8247e3",2628,"2016-09-30T00:18:12.292339-05:00","b0fcb148-fc05-45b5-ba51-be2922f94143_run.xml","da08660e13bfc8cd11f07164f7cc98f9","fccab36b-e857-47e2-b5f0-913cef6559da",354,"2016-09-08T12:01:15.043723-05:00","TCGA-HM-A6W2","2016-09-02T19:00:13.934453-05:00","female","TCGA-HM-A6W2_demographic",1979,"black or african american","b97698f5-8c16-5d6d-9e3c-fe21ed9e066a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c56.9","TCGA-HM-A6W2_diagnosis","not reported",12775,"alive","8070/3",NA,287,"7540a8b1-0caa-56bf-a37b-2c89d924d117","c56.9",-12775,"TCGA-HM-A6W2_treatment","25319593-bd2c-5cfe-a35a-630667dda41f","01","false","TCGA-HM-A6W2-01A",NA,"f403db48-de4c-4b7e-a786-0b7ce0116f80",FALSE,"611A1962-1D19-48DF-B086-4FBA139822FF","Primary Tumor",NA,51,1280,NA,1377475200,"21",30,"TCGA-HM-A6W2-01A-21",80,NA,1,NA,10,NA,5,NA,"2016-09-08T12:01:15.043723-05:00",NA,4,NA,0,NA,"TOP",NA,5,NA,"4749d541-0bb8-49f1-8c7b-d8dec8e491b8",NA,"TCGA-HM-A6W2-01A-02-TS2",NA,80,NA,"9ebc81c6-39e3-4a94-a01b-ce638445f778","RNA","TCGA-HM-A6W2-01A-21R","81fb2705-89f4-4a1e-9c0e-a3fc20459ef4",1.91,0.18,"UV Spec","R","23","TCGA-HM-A6W2-01A-21R-A33Z-07","459f5e07-fffc-4f47-904b-3c51367c83f1",0.18,0.438356164383562,89,34.765625,160,"d240824a-8d5c-5ff8-81c4-641306ffb200","TCGA-HM-A6W2_exposure","UNCID_2358600.459f5e07-fffc-4f47-904b-3c51367c83f1.140107_UNC11-SN627_0341_BC38NLACXX_6_GTTTCG.tar.gz","2014-02-25T16:03:04.000Z","2014-02-25T16:26:01.000Z","B0FCB148-FC05-45B5-BA51-BE2922F94143","F403DB48-DE4C-4B7E-A786-0B7CE0116F80","Unaligned reads",6237532196,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","459F5E07-FFFC-4F47-904B-3C51367C83F1","University of North Carolina","564a3a77e4b0298dd2c81bf1","929505F7-0270-475E-A9D6-00BF38DC78BA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9EBC81C6-39E3-4A94-A01B-CE638445F778","2014-02-25T16:26:01.000Z","81FB2705-89F4-4A1E-9C0E-A3FC20459EF4","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",51,"9EBC81C6-39E3-4A94-A01B-CE638445F778",NA,"HM","TCGA-HM-A6W2-01A-21R-A342-13_mirna.bam.bai",1280,"TCGA-HM-A6W2-01A",NA,"B41660FF-ED31-4FF2-B0DD-57253CB818F8","TCGA",2013,"TCGA-HM-A6W2_NTE-1",NA,NA,"F403DB48-DE4C-4B7E-A786-0B7CE0116F80",34,"nationwidechildrens.org_clinical.TCGA-HM-A6W2.xml","Alive",NA,"TCGA-HM-A6W2","NOT HISPANIC OR LATINO","2CA7F0EA-2468-4124-BCD3-62803F6E98A4","NO",125,"No","Cervix","C56.9","N0","Adenosquamous",0,"Preoperative","Stage IVB",NA,NA,"T2a","8070/3","FEMALE","C56.9",350,NA,"AB51DD7E-13F7-4844-A0D8-DF864A85481E","BLACK OR AFRICAN AMERICAN",NA,21,30,"4749D541-0BB8-49F1-8C7B-D8DEC8E491B8","81FB2705-89F4-4A1E-9C0E-A3FC20459EF4","UNCID_2324601.459f5e07-fffc-4f47-904b-3c51367c83f1.sorted_genome_alignments.bam.bai","TCGA-HM-A6W2-01A-21",80,10,1,4,5,"TOP",5,0,"TCGA-HM-A6W2-01A-02-TS2",80,"Cisplatin","Chemotherapy","TCGA-HM-A6W2-D50249","TCGA-HM-A6W2-R50248","External","Primary Tumor Field","TCGA-HM-A6W2-F57139_NTE-1","NO",287,"TUMOR FREE","Alive",NA,"TCGA-HM-A6W2-F57139","TCGA-HM-A6W2",NA,"HM","A6W2","YES","C56.9","8070/3","C56.9","YES","NO",-12775,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",125,NA,NA,NA,NA,"YES",18,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Adenosquamous",NA,0,34,2013,"Biopsy (cervical / CT-guided / Other)","YES",7,NA,"G3",NA,2,NA,8,NA,NA,"2009",18,NA,"T2aN0M1",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
94516180,91029170,4339989879,"56FC9454-0A6A-4CC3-95C4-BE0E0D0BAFCE.bw","929505f7-0270-475e-a9d6-00bf38dc78ba","56fc9454-0a6a-4cc3-95c4-be0e0d0bafce","2016-08-25T04:45:18.770919-05:00","UNCID_2358476.386214f6-caab-4e0f-b3ed-e6103110c3bb.140114_UNC13-SN749_0325_AC339CACXX_3_GTTTCG.tar.gz","f2f5b17f-35d2-4390-b883-5bdc5593622a",4630296843,"Illumina HiSeq","2b002ec4377401e7925b28eade23671d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:12:32.749159-05:00","2016-05-03T11:37:12.420448-05:00","f2f5b17f-35d2-4390-b883-5bdc5593622a_analysis.xml","a6885ad11600d056147c5ce8ebae3e80","3f91bf30-3b1c-488d-9dae-cacee9a01254",2124,"2016-09-29T23:16:59.042167-05:00","f2f5b17f-35d2-4390-b883-5bdc5593622a_experiment.xml","7f4f1c47aefbbabe27ebe1481c01c482","d6d9c247-938f-47d9-a4ba-1260c36bbd5c",2628,"2016-09-29T22:20:28.679922-05:00","f2f5b17f-35d2-4390-b883-5bdc5593622a_run.xml","f60e9997eebbb9df934268bcae5e482c","b3c0cd66-4ee7-4379-ab89-20bc5950a4fa",354,"2016-09-08T12:01:15.043723-05:00","TCGA-HM-A6W2","2016-09-02T19:00:13.934453-05:00","female","TCGA-HM-A6W2_demographic",1979,"black or african american","b97698f5-8c16-5d6d-9e3c-fe21ed9e066a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c56.9","TCGA-HM-A6W2_diagnosis","not reported",12775,"alive","8070/3",NA,287,"7540a8b1-0caa-56bf-a37b-2c89d924d117","c56.9",-12775,"TCGA-HM-A6W2_treatment","25319593-bd2c-5cfe-a35a-630667dda41f","06","false","TCGA-HM-A6W2-06A",NA,"cb0ce562-7679-4843-9b4a-fb245280a45b",FALSE,"FD13C302-78F0-4FEE-B90A-95A10C236CE9","Metastatic",NA,51,1340,NA,1374537600,"22",10,"TCGA-HM-A6W2-06A-22",60,NA,2,NA,15,NA,20,NA,"2016-09-08T12:01:15.043723-05:00",NA,5,NA,2,NA,"TOP",NA,5,NA,"f08cab91-2e8a-42a9-b40b-509e03d9bbd4",NA,"TCGA-HM-A6W2-06A-02-TS2",NA,60,NA,"968b6c38-2925-4e2f-84e5-1a6e38e701cf","RNA","TCGA-HM-A6W2-06A-22R","3014f64a-0256-4754-a4d2-701f3db98b41",1.91,0.18,"UV Spec","R","23","TCGA-HM-A6W2-06A-22R-A33Z-07","386214f6-caab-4e0f-b3ed-e6103110c3bb",0.18,0.438356164383562,89,34.765625,160,"d240824a-8d5c-5ff8-81c4-641306ffb200","TCGA-HM-A6W2_exposure","UNCID_2358476.386214f6-caab-4e0f-b3ed-e6103110c3bb.140114_UNC13-SN749_0325_AC339CACXX_3_GTTTCG.tar.gz","2014-02-25T14:03:05.000Z","2014-02-25T14:26:01.000Z","F2F5B17F-35D2-4390-B883-5BDC5593622A","CB0CE562-7679-4843-9B4A-FB245280A45B","Unaligned reads",4630296843,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","386214F6-CAAB-4E0F-B3ED-E6103110C3BB","University of North Carolina","564a3a77e4b0ef12181a24e5","929505F7-0270-475E-A9D6-00BF38DC78BA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","968B6C38-2925-4E2F-84E5-1A6E38E701CF","2014-02-25T14:26:01.000Z","3014F64A-0256-4754-A4D2-701F3DB98B41","United States","NO",6,NA,"Metastatic","Christiana Healthcare",51,"968B6C38-2925-4E2F-84E5-1A6E38E701CF",NA,"HM","DIODE_p_TCGAb3_47_48_49_50_NSP_GenomeWideSNP_6_G05_1373226.ismpolish.data.txt",1340,"TCGA-HM-A6W2-06A",NA,"B41660FF-ED31-4FF2-B0DD-57253CB818F8","TCGA",2013,"TCGA-HM-A6W2_NTE-1",NA,NA,"F403DB48-DE4C-4B7E-A786-0B7CE0116F80",34,"nationwidechildrens.org_clinical.TCGA-HM-A6W2.xml","Alive",NA,"TCGA-HM-A6W2","NOT HISPANIC OR LATINO","2CA7F0EA-2468-4124-BCD3-62803F6E98A4","NO",125,"No","Cervix","C56.9","N0","Adenosquamous",0,"Preoperative","Stage IVB",NA,NA,"T2a","8070/3","FEMALE","C56.9",350,NA,"AB51DD7E-13F7-4844-A0D8-DF864A85481E","BLACK OR AFRICAN AMERICAN",NA,22,10,"F08CAB91-2E8A-42A9-B40B-509E03D9BBD4","E72531DB-0C8C-4056-B053-514DB044DC78","DIODE_p_TCGAb3_47_48_49_50_NSP_GenomeWideSNP_6_G05_1373226.ismpolish.data.txt","TCGA-HM-A6W2-06A-22",60,15,2,5,20,"TOP",5,2,"TCGA-HM-A6W2-06A-02-TS2",60,"Cisplatin","Chemotherapy","TCGA-HM-A6W2-D50249","TCGA-HM-A6W2-R50248","External","Primary Tumor Field","TCGA-HM-A6W2-F57139_NTE-1","NO",287,"TUMOR FREE","Alive",NA,"TCGA-HM-A6W2-F57139","TCGA-HM-A6W2",NA,"HM","A6W2","YES","C56.9","8070/3","C56.9","YES","NO",-12775,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",125,NA,NA,NA,NA,"YES",18,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Adenosquamous",NA,0,34,2013,"Biopsy (cervical / CT-guided / Other)","YES",7,NA,"G3",NA,2,NA,8,NA,NA,"2009",18,NA,"T2aN0M1",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
68701186,67750510,3235337694,"43226365-FAEF-46C5-AF1B-5C6C2BED84FF.bw","939abca1-8bd0-4271-9a9b-666764eeb3b6","43226365-faef-46c5-af1b-5c6c2bed84ff","2016-08-09T14:41:22.007654-05:00","UNCID_2654399.e5241411-aec5-4822-8522-8e74c51a0d79.141010_UNC12-SN629_0395_BC5FVEACXX_1_ACTTGA.tar.gz","11d26703-6707-4dc2-b13b-f7dbf214c295",2874156660,"Illumina HiSeq","47b1ac32b99389d80545f33e37acfcf0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:29:03.656074-05:00","2016-05-03T12:08:10.830175-05:00","11d26703-6707-4dc2-b13b-f7dbf214c295_analysis.xml","7d240e5be61057b71fcf86487dd4acb9","24180e1e-64cc-40d9-92c1-5ebc1a8da8c3",2124,"2016-09-29T18:55:14.271137-05:00","11d26703-6707-4dc2-b13b-f7dbf214c295_experiment.xml","4f03b7f35b1473bc29b2f7874d5053f9","34ad0978-a2bc-450c-8165-04cd427f8d21",2628,"2016-09-29T22:03:53.442009-05:00","11d26703-6707-4dc2-b13b-f7dbf214c295_run.xml","d0d442c30b70ec696e02fd7b367f14b8","a9c04e7f-3077-453d-8544-7db2494c4de0",354,"2016-09-08T10:44:34.732194-05:00","TCGA-VS-A9U5","2016-09-02T18:54:17.250536-05:00","female","TCGA-VS-A9U5_demographic",1953,"white","1c4feb39-fce0-5bbf-a050-25531fefc016","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9U5_diagnosis","not reported",21149,"alive","8070/3",NA,1535,"ff31b9f3-635b-594f-933e-7b180ea1ed35","c53.9",-21149,"TCGA-VS-A9U5_treatment","c8b58d23-5cb8-5166-9177-11ca5cb2bb48","01","false","TCGA-VS-A9U5-01A",NA,"cab5da46-f163-42eb-8ba8-43ed69e8e518",FALSE,"4DCCBB92-3E31-4B62-8F8E-00264488ADD0","Primary Tumor",NA,1114,300,NA,1390867200,"11",30,"TCGA-VS-A9U5-01A-11",60,NA,0,NA,35,NA,5,NA,"2016-09-08T10:44:34.732194-05:00",NA,35,NA,0,NA,"TOP",NA,0,NA,"81635967-4f4a-4691-937c-76b2f8624e7e",NA,"TCGA-VS-A9U5-01A-01-TS1",NA,60,NA,"89774af5-656c-4f35-924f-d47fa0e076bd","RNA","TCGA-VS-A9U5-01A-11R","ac1db7ae-464a-448b-9ad7-d82ab1c4047f",1.85,0.16,"UV Spec","R","23","TCGA-VS-A9U5-01A-11R-A42T-07","e5241411-aec5-4822-8522-8e74c51a0d79",0.16,NA,74,28.1969212010364,162,"a2977b9a-4ce1-5a7b-9553-1c8aa2d156ee","TCGA-VS-A9U5_exposure","UNCID_2654399.e5241411-aec5-4822-8522-8e74c51a0d79.141010_UNC12-SN629_0395_BC5FVEACXX_1_ACTTGA.tar.gz","2014-11-05T12:27:04.000Z","2014-11-05T12:39:23.000Z","11D26703-6707-4DC2-B13B-F7DBF214C295","CAB5DA46-F163-42EB-8BA8-43ED69E8E518","Unaligned reads",2874156660,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E5241411-AEC5-4822-8522-8E74C51A0D79","University of North Carolina","5660758ce4b016715ab6843b","939ABCA1-8BD0-4271-9A9B-666764EEB3B6","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","89774AF5-656C-4F35-924F-D47FA0E076BD","2014-11-05T12:39:23.000Z","AC1DB7AE-464A-448B-9AD7-D82AB1C4047F","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1114,"89774AF5-656C-4F35-924F-D47FA0E076BD",NA,"VS","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.FF774297-756E-40BC-910D-6702417510C2.txt",300,"TCGA-VS-A9U5-01A",NA,"EF658883-3A46-4E6C-8256-6A45287BD55E","TCGA",2010,"TCGA-VS-A9U5_NTE-1","Complete Remission/Response","TUMOR FREE","CAB5DA46-F163-42EB-8BA8-43ED69E8E518",57,"UNCID_2646747.e5241411-aec5-4822-8522-8e74c51a0d79.sorted_genome_alignments.bam.bai","Alive",NA,"TCGA-VS-A9U5",NA,"C77D4FAC-452C-4ECB-BCC9-C6CF2EB23444","NO",1185,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"33C219CA-7D2D-4F53-8B02-F15DEF82BFE2","WHITE",NA,11,30,"81635967-4F4A-4691-937C-76B2F8624E7E","AC1DB7AE-464A-448B-9AD7-D82AB1C4047F","UNCID_2654399.e5241411-aec5-4822-8522-8e74c51a0d79.141010_UNC12-SN629_0395_BC5FVEACXX_1_ACTTGA.tar.gz","TCGA-VS-A9U5-01A-11",60,35,0,35,5,"TOP",0,0,"TCGA-VS-A9U5-01A-01-TS1",60,"Cisplatin","Chemotherapy","TCGA-VS-A9U5-D63439","TCGA-VS-A9U5-R63438","External","Regional site","TCGA-VS-A9U5-F67679_NTE-1","NO",1367,"TUMOR FREE","Alive",NA,"TCGA-VS-A9U5-F67679","TCGA-VS-A9U5",NA,"VS","A9U5","YES","C53.9","8070/3","C53.9","NO","YES",-21149,"FEMALE","WHITE",NA,"No","No","Alive",1185,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,57,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
201152538,196668156,9394724174,"1536110A-B42A-4A84-9474-9895321FDCE9.bw","941f75a1-fea4-4539-ba69-60bb11608f6d","1536110a-b42a-4a84-9474-9895321fdce9","2016-08-09T13:56:41.926208-05:00","UNCID_2187263.e5452386-f28c-450f-b13b-4b1ef4713fa1.120921_UNC16-SN851_0181_AD14JFACXX_3_TTAGGC.tar.gz","34b035ca-d024-4556-931b-02fcbd0ee18e",8788905658,"Illumina HiSeq","f26987d727f007e129a69d6a903e7bea","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:14:11.085226-05:00","2016-05-03T11:02:00.408696-05:00","34b035ca-d024-4556-931b-02fcbd0ee18e_analysis.xml","52460e425d24eeec49d71927498534b3","1accc9ae-fa00-4c61-830d-f2a120b3b66b",2124,"2016-09-29T22:32:09.508344-05:00","34b035ca-d024-4556-931b-02fcbd0ee18e_experiment.xml","de4ed820ffab71a67d4f741e51245938","bb169438-627b-4b1e-b307-c582472d4a5c",2431,"2016-09-29T19:42:09.067831-05:00","34b035ca-d024-4556-931b-02fcbd0ee18e_run.xml","d0c67cc08baae6d67eb162e659a2e1c6","521146ac-9464-4949-8b61-3797ca3559cc",354,"2016-09-08T11:29:17.160055-05:00","TCGA-C5-A1MI","2016-09-02T18:57:18.749619-05:00","female","TCGA-C5-A1MI_demographic",1954,"white","46252144-807c-52b1-9bcf-001f5ce149df","not hispanic or latino",2006,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MI_diagnosis","not reported",18336,"dead","8070/3",1083,NA,"8204a2f2-e766-546d-838e-8c84018e05bc","c53.9",-18336,"TCGA-C5-A1MI_treatment","704f70ed-d2c4-5117-82f1-3e6efff7536a","01","true","TCGA-C5-A1MI-01A",NA,"a753bcf7-82d6-4fb1-af0d-641898bbff9c",FALSE,"FD31F805-C852-467E-9708-7D00339944B5","Primary Tumor",NA,2346,50,NA,1301356800,"11",30,"TCGA-C5-A1MI-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:29:17.160055-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"b31684b1-8b01-4c30-902f-bf1c973fb226",NA,"TCGA-C5-A1MI-01A-01-TSA",NA,80,NA,"08d9cfc0-21c3-4be6-bd0f-676953df8f30","RNA","TCGA-C5-A1MI-01A-11R","08e7dd2a-f287-416f-a722-f6448380cb14",1.83,0.17,"UV Spec","R","23","TCGA-C5-A1MI-01A-11R-A14Y-07","e5452386-f28c-450f-b13b-4b1ef4713fa1",0.17,1.91780821917808,77,NA,NA,"3f44627e-2b2d-5ee7-868a-6be32be5d476","TCGA-C5-A1MI_exposure","UNCID_2187263.e5452386-f28c-450f-b13b-4b1ef4713fa1.120921_UNC16-SN851_0181_AD14JFACXX_3_TTAGGC.tar.gz","2013-09-17T06:16:04.000Z","2013-09-17T06:39:01.000Z","34B035CA-D024-4556-931B-02FCBD0EE18E","A753BCF7-82D6-4FB1-AF0D-641898BBFF9C","Unaligned reads",8788905658,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E5452386-F28C-450F-B13B-4B1EF4713FA1","University of North Carolina","564a3f93e4b09c884b259da0","941F75A1-FEA4-4539-BA69-60BB11608F6D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","08D9CFC0-21C3-4BE6-BD0F-676953DF8F30","2013-09-17T06:39:01.000Z","08E7DD2A-F287-416F-A722-F6448380CB14","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2346,"08D9CFC0-21C3-4BE6-BD0F-676953DF8F30",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6424B36F-37F0-4816-8964-D1DB61A06F63.txt",50,"TCGA-C5-A1MI-01A",NA,"DFEB8D3B-38B3-424F-B0C9-9586D927E8D1","TCGA",2004,NA,NA,"WITH TUMOR","B9B8F225-DF87-48BD-BB39-E049F8BB2C0F",50,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6424B36F-37F0-4816-8964-D1DB61A06F63.txt","Dead",1083,"TCGA-C5-A1MI","NOT HISPANIC OR LATINO","4BC060E1-9276-4927-B7A8-AC303EEA0DF9",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",127,NA,"034E2EB2-AE1A-434C-9368-40C04BCA883B","WHITE",NA,11,30,"B31684B1-8B01-4C30-902F-BF1C973FB226","8F79EEBC-A05C-4ECF-AC14-24F80823F948","TCGA-C5-A1MI-01A-11R-A14X-13_mirna.bam.bai","TCGA-C5-A1MI-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-C5-A1MI-01A-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-C5-A1MI-D29734","TCGA-C5-A1MI-R29736","COMBINATION","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",1083,"TCGA-C5-A1MI-F29733","TCGA-C5-A1MI",NA,"C5","A1MI","YES","C53.9","8070/3","C53.9","NO","YES",-18336,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1083,NA,NA,"WITH TUMOR","NO",19,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,50,2004,"Biopsy (cervical / CT-guided / Other)","YES",17,1,"G2",NA,2,NA,35,NA,NA,"1995",7,NA,"T1b1N1M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
142047960,135627523,6457116608,"812255DD-536B-4216-90B1-27D5AB339BE2.bw","959fe574-054a-4fef-9cbe-a801a9a355de","812255dd-536b-4216-90b1-27d5ab339be2","2016-08-25T22:01:09.640717-05:00","UNCID_2553090.d1d352f8-4919-4288-8e6a-bbf550a7236b.140416_UNC11-SN627_0352_AC3M6RACXX_8_TTAGGC.tar.gz","4f91a282-108c-4f67-9bc4-f500548401c1",6232824850,"Illumina HiSeq","39b1f63e3e4dd08df7dc58fe48fd503f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:43:21.082021-05:00","2016-05-03T11:54:19.885282-05:00","4f91a282-108c-4f67-9bc4-f500548401c1_analysis.xml","36c139db1cba42fc2b86e7a6788c47bd","e75c52da-e00b-4aa7-8ef3-e9f7c936efde",2124,"2016-10-07T16:56:39.333159-05:00","4f91a282-108c-4f67-9bc4-f500548401c1_experiment.xml","6ee02ca280a50da1b65b679393e2c3f8","3048796c-3f94-4a2c-9072-c98cf9fc6025",2628,"2016-09-29T22:50:01.712181-05:00","4f91a282-108c-4f67-9bc4-f500548401c1_run.xml","719e7f73a72f7506047661b0dbbfad28","c63000cf-7ace-453d-a21e-c52e89bcb6c7",354,"2016-09-08T11:20:59.678485-05:00","TCGA-C5-A8XI","2016-09-02T19:01:07.592947-05:00","female","TCGA-C5-A8XI_demographic",1939,"black or african american","49876dc7-3f9b-5c7b-bd47-b99a6c91e126","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8XI_diagnosis","not reported",25220,"alive","8070/3",NA,254,"c200a131-65be-5860-85c7-e9bda51a5a13","c53.9",-25220,"TCGA-C5-A8XI_treatment","b24d80b3-4b49-5bf8-8268-0c46a9cbbe62","01","true","TCGA-C5-A8XI-01A",NA,"a69e5235-b458-457c-807a-1cf5e907b869",FALSE,"57D0E001-5535-4687-B04D-5CBEF5D6EF6F","Primary Tumor",NA,2069,130,NA,1387238400,"11",30,"TCGA-C5-A8XI-01A-11",85,NA,0,NA,0,NA,15,NA,"2016-09-08T11:20:59.678485-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"eacd14b1-df98-40c8-b38c-33301aaafe03",NA,"TCGA-C5-A8XI-01A-01-TS1",NA,85,NA,"7d6bbe26-896b-48cd-8764-4a7e477dd83e","RNA","TCGA-C5-A8XI-01A-11R","1b290476-fa56-4f99-bf34-28327629fc76",1.86,0.18,"UV Spec","R","23","TCGA-C5-A8XI-01A-11R-A37O-07","d1d352f8-4919-4288-8e6a-bbf550a7236b",0.18,3.12328767123288,NA,NA,NA,"839db4a2-8d82-575f-b94c-64d3d3570f5f","TCGA-C5-A8XI_exposure","UNCID_2553090.d1d352f8-4919-4288-8e6a-bbf550a7236b.140416_UNC11-SN627_0352_AC3M6RACXX_8_TTAGGC.tar.gz","2014-07-30T20:36:05.000Z","2014-07-30T21:01:10.000Z","4F91A282-108C-4F67-9BC4-F500548401C1","A69E5235-B458-457C-807A-1CF5E907B869","Unaligned reads",6232824850,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","D1D352F8-4919-4288-8E6A-BBF550A7236B","University of North Carolina","566076cce4b0ca319164e06d","959FE574-054A-4FEF-9CBE-A801A9A355DE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7D6BBE26-896B-48CD-8764-4A7E477DD83E","2014-07-30T21:01:10.000Z","1B290476-FA56-4F99-BF34-28327629FC76","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2069,"7D6BBE26-896B-48CD-8764-4A7E477DD83E",NA,"C5","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_A03_1465376.byallele.copynumber.data.txt",130,"TCGA-C5-A8XI-01A",NA,"BCB7C41F-67F7-4B56-8448-39B7D7C61C9B","TCGA",2008,"TCGA-C5-A8XI_NTE-1",NA,"TUMOR FREE","D257692F-0B8E-4B7B-9F6A-E573D9026911",69,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.49680150-87AC-4D5E-A4CE-CE96E2997D53.txt","Alive",NA,"TCGA-C5-A8XI",NA,"1C75BAD9-CCC6-4FD2-9596-59A1E0E1269D","NO",254,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",380,NA,"DC4AFA65-9A4A-4713-A77A-1612F28E1412","BLACK OR AFRICAN AMERICAN",NA,11,30,"EACD14B1-DF98-40C8-B38C-33301AAAFE03","F7E8AFA8-8B9B-408C-892A-842CC0A9E47F","TCGA-C5-A8XI-01A-11R-A37P-13_mirna.bam.bai","TCGA-C5-A8XI-01A-11",85,0,0,10,15,"TOP",0,0,"TCGA-C5-A8XI-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-C5-A8XI-D58650","TCGA-C5-A8XI-R58651","External","Regional site","TCGA-C5-A8XI-F66724_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A8XI-F66724","TCGA-C5-A8XI",NA,"C5","A8XI","YES","C53.9","8070/3","C53.9","NO","YES",-25220,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",254,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,69,2008,"Biopsy (cervical / CT-guided / Other)","YES",10,0,"G3",NA,2,NA,57,NA,NA,"1995",8,NA,"T1b2N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
121822452,119853634,5695617375,"5D4563D6-68B7-4C9D-A3F4-AA7D45D5112C.bw","968bd652-786c-4ddb-a937-dc480cb821fc","5d4563d6-68b7-4c9d-a3f4-aa7d45d5112c","2016-08-07T01:35:40.796303-05:00","UNCID_2169580.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.130530_UNC9-SN296_0371_BC2528ACXX_6_ATCACG.tar.gz","34e539b4-50b4-4302-bf46-0f2178883448",5904660405,"Illumina HiSeq","758babd8e7a3e8f90f2c62e72eafd17d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:58:05.265611-05:00","2016-05-03T11:05:42.727154-05:00","34e539b4-50b4-4302-bf46-0f2178883448_analysis.xml","49e1d9013a52c0ccbe6269a9b237b8fd","a628c6d4-9d37-4dec-96fc-dcf33b41ab5f",2121,"2016-09-29T18:04:10.340363-05:00","34e539b4-50b4-4302-bf46-0f2178883448_experiment.xml","abf86c73f1a5285dae47bcfc3e99d5ae","14a7f86b-fc42-4010-9ebc-ab7ed802c6df",2431,"2016-09-29T21:26:22.390829-05:00","34e539b4-50b4-4302-bf46-0f2178883448_run.xml","4bc7342be8c9993095192ac0f753b317","927ab9c0-7336-42ea-b33c-9a79e1f0e4e1",354,"2016-09-08T12:13:34.058862-05:00","TCGA-FU-A57G","2016-09-02T18:59:45.930481-05:00","female","TCGA-FU-A57G_demographic",1962,"white","4ae30b56-0b49-5dc4-92fc-6d938a941a0b","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.0","TCGA-FU-A57G_diagnosis","not reported",17905,"alive","8384/3",NA,1078,"c4638e53-8396-5115-891e-01967dae8c1c","c53.0",-17905,"TCGA-FU-A57G_treatment","d0b02fec-2ff8-5cc8-9345-d54f7b951446","01","false","TCGA-FU-A57G-01A",NA,"f91ea887-55a6-47ac-8807-7cd4fb075e14",FALSE,"39B03354-F9B3-4FBA-8D7E-126E3AE752DA","Primary Tumor",NA,684,70,NA,1355356800,"11",30,"TCGA-FU-A57G-01A-11",75,NA,20,NA,0,NA,15,NA,"2016-09-08T12:13:34.058862-05:00",NA,20,NA,40,NA,"TOP",NA,10,NA,"8552f1c4-20c7-4d3f-9451-c2f1881bf8bf",NA,"TCGA-FU-A57G-01A-01-TS1",NA,75,NA,"19cfe8b1-5f13-4497-8ec4-eb56dacfafaf","RNA","TCGA-FU-A57G-01A-11R","f5c890ec-6139-4381-8a30-5cc5d7ad136a",1.81,0.17,"UV Spec","R","23","TCGA-FU-A57G-01A-11R-A26T-07","93bf6de4-c67e-4d0b-8fe6-2431a0e0d342",0.17,NA,57,22.265625,160,"71e7bea8-1ef3-59b4-a68e-06c8d4f13110","TCGA-FU-A57G_exposure","UNCID_2169580.93bf6de4-c67e-4d0b-8fe6-2431a0e0d342.130530_UNC9-SN296_0371_BC2528ACXX_6_ATCACG.tar.gz","2013-09-19T22:43:05.000Z","2013-09-19T23:02:02.000Z","34E539B4-50B4-4302-BF46-0F2178883448","F91EA887-55A6-47AC-8807-7CD4FB075E14","Unaligned reads",5904660405,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","93BF6DE4-C67E-4D0B-8FE6-2431A0E0D342","University of North Carolina","564a3f53e4b093830b6a8627","968BD652-786C-4DDB-A937-DC480CB821FC","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","19CFE8B1-5F13-4497-8EC4-EB56DACFAFAF","2013-09-19T23:02:02.000Z","F5C890EC-6139-4381-8A30-5CC5D7AD136A","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",684,"19CFE8B1-5F13-4497-8EC4-EB56DACFAFAF",NA,"FU","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.03EE5C70-AD05-49F8-83F9-AB7C4A1F323A.txt",70,"TCGA-FU-A57G-01A",NA,NA,"TCGA",2011,"TCGA-FU-A57G_NTE-1",NA,"TUMOR FREE","393EE79B-6710-4C7A-B2FF-9C8FBE04FBAA",49,"nationwidechildrens.org_clinical.TCGA-FU-A57G.xml","Alive",NA,"TCGA-FU-A57G","NOT HISPANIC OR LATINO","579A889E-B348-4E07-B574-54AB09E53033","NO",40,"No","Cervix","C53.0","N0","Endocervical Type of Adenocarcinoma",1,"Preoperative","Stage IB2",NA,NA,"T1b2","8384/3","FEMALE","C53.0",280,NA,NA,"WHITE",NA,11,30,"8552F1C4-20C7-4D3F-9451-C2F1881BF8BF","F5C890EC-6139-4381-8A30-5CC5D7AD136A","a18fae2b151c5f22e63f5de7d8a20114.bam","TCGA-FU-A57G-01A-11",75,0,20,20,15,"TOP",10,40,"TCGA-FU-A57G-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-FU-A57G-F65838_NTE-1","NO",1078,"TUMOR FREE","Alive",NA,"TCGA-FU-A57G-F65838","TCGA-FU-A57G",NA,"FU","A57G","YES","C53.0","8384/3","C53.0","YES","NO",-17905,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"TUMOR FREE","YES",31,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,49,2011,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G2",NA,1,NA,NA,NA,NA,"2009",8,NA,"T1b2N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
220978146,216973458,10354537363,"BAA39781-DB94-473C-98B1-FA6CD3E1C67A.bw","970b619f-2eb5-4557-a7b8-5def35943c58","baa39781-db94-473c-98b1-fa6cd3e1c67a","2016-08-05T09:35:09.129890-05:00","UNCID_2187000.3aab069c-f3e6-4a95-89eb-bf896b36c4b3.121001_UNC13-SN749_0196_AD140CACXX_1_CCGTCC.tar.gz","2fb0dd5a-2c06-4f03-91f5-81c12e71cc81",10035158412,"Illumina HiSeq","af607adce328e523e9557824d8f58b17","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:35:32.408664-05:00","2016-05-03T11:02:00.406437-05:00","2fb0dd5a-2c06-4f03-91f5-81c12e71cc81_analysis.xml","b0e3de60ce5a17a099f15c76a9048405","72af11df-4c99-4524-8d2a-b0295e94707c",2124,"2016-10-07T16:28:19.486984-05:00","2fb0dd5a-2c06-4f03-91f5-81c12e71cc81_experiment.xml","ea27ac608226dfd7895ec9bc1dc00e6f","be0bfba1-eeb9-4639-bcbc-1f43da67c28d",2431,"2016-09-29T19:36:38.064571-05:00","2fb0dd5a-2c06-4f03-91f5-81c12e71cc81_run.xml","55fe5c49b9083b5057f1b166c9a9edec","4e9f003b-0a60-4727-8a36-f72b4199a895",354,"2016-09-08T11:49:28.108436-05:00","TCGA-EA-A1QT","2016-09-02T18:57:44.971669-05:00","female","TCGA-EA-A1QT_demographic",1964,"white","e073d2ef-6720-58d9-abb0-4f0884dbf3f9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A1QT_diagnosis","not reported",17475,"alive","8072/3",NA,1243,"4c6da326-3c2b-579b-9821-b6eb5ace87cd","c53.9",-17475,"TCGA-EA-A1QT_treatment","8bf8ff49-0270-56ec-b9fb-fe2b00128325","01","true","TCGA-EA-A1QT-01A",NA,"f61cfdd1-9055-492b-888b-87b524d3f869",FALSE,"87B05129-51AC-401B-AAEC-CAF13E97061E","Primary Tumor",NA,64,680,NA,1303257600,"11",30,"TCGA-EA-A1QT-01A-11",70,NA,10,NA,0,NA,25,NA,"2016-09-08T11:49:28.108436-05:00",NA,60,NA,20,NA,"TOP",NA,5,NA,"5a517400-267d-4569-9c20-6f00a08e7ed7",NA,"TCGA-EA-A1QT-01A-01-TSA",NA,70,NA,"5bb61183-5a84-4917-a0ba-ec5e634919ef","RNA","TCGA-EA-A1QT-01A-11R","278319fb-dca3-4661-9b00-cf10b3750e7f",1.8,0.16,"UV Spec","R","23","TCGA-EA-A1QT-01A-11R-A14Y-07","3aab069c-f3e6-4a95-89eb-bf896b36c4b3",0.16,NA,68,25.5937370619895,163,"d3d43ed1-6ea3-5d83-b7ba-a0669b45277b","TCGA-EA-A1QT_exposure","UNCID_2187000.3aab069c-f3e6-4a95-89eb-bf896b36c4b3.121001_UNC13-SN749_0196_AD140CACXX_1_CCGTCC.tar.gz","2013-09-16T22:31:04.000Z","2013-09-16T23:33:01.000Z","2FB0DD5A-2C06-4F03-91F5-81C12E71CC81","F61CFDD1-9055-492B-888B-87B524D3F869","Unaligned reads",10035158412,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3AAB069C-F3E6-4A95-89EB-BF896B36C4B3","University of North Carolina","564a3a81e4b0298dd2c81e3d","970B619F-2EB5-4557-A7B8-5DEF35943C58","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5BB61183-5A84-4917-A0BA-EC5E634919EF","2013-09-16T23:33:01.000Z","278319FB-DCA3-4661-9B00-CF10B3750E7F","Russia","NO",1,NA,"Primary Tumor","Asterand",64,"5BB61183-5A84-4917-A0BA-EC5E634919EF",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C7D3A64F-5697-4AE3-A459-947CDE9BBFAF.txt",680,"TCGA-EA-A1QT-01A",NA,NA,"TCGA",2011,NA,NA,NA,"F61CFDD1-9055-492B-888B-87B524D3F869",47,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C7D3A64F-5697-4AE3-A459-947CDE9BBFAF.txt","Alive",NA,"TCGA-EA-A1QT","NOT HISPANIC OR LATINO","DE174934-0AAA-4CE9-90ED-2D5DDDAA39F5",NA,8,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b","8072/3","FEMALE","C53.9",127,NA,NA,"WHITE",NA,11,30,"5A517400-267D-4569-9C20-6F00A08E7ED7","278319FB-DCA3-4661-9B00-CF10B3750E7F","C501.TCGA-EA-A1QT-01A-11D-A14W-08.3.bam","TCGA-EA-A1QT-01A-11",70,0,10,60,25,"TOP",5,20,"TCGA-EA-A1QT-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",376,"TUMOR FREE","Alive",NA,"TCGA-EA-A1QT-F29729","TCGA-EA-A1QT",NA,"EA","A1QT","YES","C53.9","8072/3","C53.9","YES","NO",-17475,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",8,NA,NA,NA,NA,"NO",3,8,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",18,0,"G2",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
89063578,88068704,4207947705,"C1411CDA-814D-4E21-8929-C0F77858828F.bw","97cf3268-9756-4659-9e98-f200f96a91f4","c1411cda-814d-4e21-8929-c0f77858828f","2016-08-09T14:42:21.526894-05:00","UNCID_2654394.5fd1a695-76a4-4ccb-8623-6b1e65e7de3a.141010_UNC12-SN629_0394_AC5FTUACXX_2_ACTTGA.tar.gz","9eee6671-30ac-456f-b499-730f83e5d1ba",3704387448,"Illumina HiSeq","ac170f7e0a1ddfdacb96d89a35b0bedb","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:26:47.968372-05:00","2016-05-03T12:08:10.830175-05:00","9eee6671-30ac-456f-b499-730f83e5d1ba_analysis.xml","6f0462cee80de84c3fa5bb5230d1d5b1","b7b60228-a879-44f3-ad42-c19806169e53",2124,"2016-08-28T19:23:14.592452-05:00","9eee6671-30ac-456f-b499-730f83e5d1ba_experiment.xml","745b8fe89d7b55dd75760bc2017125da","f313bc28-8121-43d5-9b58-33d2a4748944",2628,"2016-09-29T23:38:16.387467-05:00","9eee6671-30ac-456f-b499-730f83e5d1ba_run.xml","196c1af75b450bc9ca385f6898767bef","e4226449-598b-46a1-bdde-1285860b932e",354,"2016-09-08T11:33:54.671362-05:00","TCGA-VS-A958","2016-09-02T18:54:16.114963-05:00","female","TCGA-VS-A958_demographic",1964,"white","b024842a-0f94-506d-866d-04288ffa7f25","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A958_diagnosis","not reported",16905,"alive","8072/3",NA,1525,"4563803b-a367-53be-ab93-7efc87aff88c","c53.9",-16905,"TCGA-VS-A958_treatment","55ec1bac-1e1b-5c24-bd12-80d469dd39af","01","false","TCGA-VS-A958-01A",NA,"8d7ae762-4d4a-4bed-a1f8-331a93c4d89c",FALSE,"643CD93E-47D0-4D40-96C8-DDF836EEF501","Primary Tumor",NA,1189,90,NA,1389830400,"11",30,"TCGA-VS-A958-01A-11",90,NA,0,NA,0,NA,15,NA,"2016-09-08T11:33:54.671362-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"4b7b9a57-e7de-4716-8cc7-1901b8dbdc0f",NA,"TCGA-VS-A958-01A-01-TS1",NA,85,NA,"cf61ef4a-c286-44a2-91b6-5075a873630b","RNA","TCGA-VS-A958-01A-11R","04b2ca00-ec19-4b09-b881-a3107354ec49",1.91,0.18,"UV Spec","R","23","TCGA-VS-A958-01A-11R-A42T-07","5fd1a695-76a4-4ccb-8623-6b1e65e7de3a",0.18,NA,61,26.7532125783957,151,"cb1d5716-1faf-5270-a449-4652cb1f8cd0","TCGA-VS-A958_exposure","UNCID_2654394.5fd1a695-76a4-4ccb-8623-6b1e65e7de3a.141010_UNC12-SN629_0394_AC5FTUACXX_2_ACTTGA.tar.gz","2014-11-05T11:27:04.000Z","2014-11-05T11:39:35.000Z","9EEE6671-30AC-456F-B499-730F83E5D1BA","8D7AE762-4D4A-4BED-A1F8-331A93C4D89C","Unaligned reads",3704387448,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5FD1A695-76A4-4CCB-8623-6B1E65E7DE3A","University of North Carolina","564a3fe9e4b0ef12181be2a9","97CF3268-9756-4659-9E98-F200F96A91F4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CF61EF4A-C286-44A2-91B6-5075A873630B","2014-11-05T11:39:35.000Z","04B2CA00-EC19-4B09-B881-A3107354EC49","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1189,"CF61EF4A-C286-44A2-91B6-5075A873630B",NA,"VS","8214acf922254ac0c437a9a61fb7b7bc.bam",90,"TCGA-VS-A958-01A",NA,"4B8E9E37-3369-4E1F-9D37-45B1B326F4A0","TCGA",2010,"TCGA-VS-A958_NTE-1","Complete Remission/Response","TUMOR FREE","8D7AE762-4D4A-4BED-A1F8-331A93C4D89C",46,"nationwidechildrens.org_clinical.TCGA-VS-A958.xml","Alive",NA,"TCGA-VS-A958",NA,"474A10B1-AA49-45D8-95C1-B0F5B110814B","NO",1333,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8072/3","FEMALE","C53.9",420,NA,"0E594200-A7D3-49BA-B219-A05F3F0934FF","WHITE",NA,11,30,"4B7B9A57-E7DE-4716-8CC7-1901B8DBDC0F","04B2CA00-EC19-4B09-B881-A3107354EC49","8214acf922254ac0c437a9a61fb7b7bc.bam","TCGA-VS-A958-01A-11",90,0,0,0,15,"TOP",0,0,"TCGA-VS-A958-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-VS-A958-D62804","TCGA-VS-A958-R62802","External","Regional site","TCGA-VS-A958-F68144_NTE-1","NO",1525,"TUMOR FREE","Alive",NA,"TCGA-VS-A958-F68144","TCGA-VS-A958",NA,"VS","A958","YES","C53.9","8072/3","C53.9","NO","YES",-16905,"FEMALE","WHITE",NA,"No","No","Alive",1333,NA,NA,NA,"TUMOR FREE","YES",21,5,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
141033252,139967878,6684478478,"EFE2F248-C13E-4E8D-9153-8C903848AC4A.bw","98784bbe-e286-48df-838d-1a88040658bf","efe2f248-c13e-4e8d-9153-8c903848ac4a","2016-08-04T23:36:43.521890-05:00","UNCID_2664303.625af8d9-87a0-4017-833b-962fad1f79e5.141030_UNC15-SN850_0397_AC5F8LACXX_5_GTTTCG.tar.gz","5de8be54-36f8-430c-9989-e347d2857c30",6051678260,"Illumina HiSeq","cac0ef04689a14c40e7e7f6656c5e3f6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:15:50.165691-05:00","2016-06-22T11:17:34.741668-05:00","5de8be54-36f8-430c-9989-e347d2857c30_analysis.xml","fa2dbb50236b977f4d9f9cd95098d29f","d6312e7f-5810-49b0-a9eb-1ec0a7ca8daf",2124,"2016-10-07T17:53:28.097182-05:00","5de8be54-36f8-430c-9989-e347d2857c30_experiment.xml","9f3a522e6c4974cf7f20ef2076a4fb2c","5045e2c5-57bd-4c27-9d5d-43d21c429ac7",2628,"2016-09-29T22:51:20.136142-05:00","5de8be54-36f8-430c-9989-e347d2857c30_run.xml","ca7a1c6d936fda3b68141cec7fd93d1f","c6fee4f9-6b1b-4715-b38a-54fcfef76401",354,"2016-09-08T10:39:07.516189-05:00","TCGA-VS-A9U6","2016-09-02T18:54:17.880523-05:00","female","TCGA-VS-A9U6_demographic",1959,"white","749302a4-1de7-5925-8b8f-ca5b25144cda","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9U6_diagnosis","not reported",19109,"alive","8072/3",NA,1320,"cdb61f46-c303-55ed-b959-66c974b4c0d8","c53.9",-19109,"TCGA-VS-A9U6_treatment","24664aa8-03b5-5f91-b689-d6dda7ed03c2","01","false","TCGA-VS-A9U6-01A",NA,"caab3aab-214b-4ab3-823b-b8fe790514cc",FALSE,"BB78B2C7-E9AF-47D4-AAA2-354D1CFC2F76","Primary Tumor",NA,1058,60,NA,1390953600,"11",30,"TCGA-VS-A9U6-01A-11",80,NA,0,NA,5,NA,15,NA,"2016-09-08T10:39:07.516189-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"4baf5248-ffb5-4a7a-b830-89d6e2ea29db",NA,"TCGA-VS-A9U6-01A-01-TS1",NA,80,NA,"d0520bfd-86be-4d5e-9720-365dbbdf2fd0","RNA","TCGA-VS-A9U6-01A-11R","6daccd52-205b-49ef-99c1-4b6c78452a9d",1.85,0.17,"UV Spec","R","23","TCGA-VS-A9U6-01A-11R-A42T-07","625af8d9-87a0-4017-833b-962fad1f79e5",0.17,NA,66,27.120315581854,156,"b8e20f90-5cb8-5d60-b3c9-597281b20b94","TCGA-VS-A9U6_exposure","UNCID_2664303.625af8d9-87a0-4017-833b-962fad1f79e5.141030_UNC15-SN850_0397_AC5F8LACXX_5_GTTTCG.tar.gz","2014-12-10T00:06:04.000Z","2014-12-10T00:32:23.000Z","5DE8BE54-36F8-430C-9989-E347D2857C30","CAAB3AAB-214B-4AB3-823B-B8FE790514CC","Unaligned reads",6051678260,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","625AF8D9-87A0-4017-833B-962FAD1F79E5","University of North Carolina","566075d8e4b0b37b3d98fdd3","98784BBE-E286-48DF-838D-1A88040658BF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D0520BFD-86BE-4D5E-9720-365DBBDF2FD0","2014-12-10T00:32:23.000Z","6DACCD52-205B-49EF-99C1-4B6C78452A9D","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1058,"D0520BFD-86BE-4D5E-9720-365DBBDF2FD0",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_E10_1524170.tangent.copynumber.data.txt",60,"TCGA-VS-A9U6-01A",NA,"BDE69B17-53CF-4220-96CA-A9006A4A466E","TCGA",2011,"TCGA-VS-A9U6_NTE-1","Stable Disease","WITH TUMOR","CAAB3AAB-214B-4AB3-823B-B8FE790514CC",52,"nationwidechildrens.org_clinical.TCGA-VS-A9U6.xml","Alive",NA,"TCGA-VS-A9U6",NA,"A1A6B1CC-0926-4AE2-89FE-9C299D671B4F","YES",1213,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IVB",NA,NA,"T4","8072/3","FEMALE","C53.9",420,NA,"7CFBCD8F-1211-4E0C-9D0B-C25BE5A84F70","WHITE",NA,11,30,"4BAF5248-FFB5-4A7A-B830-89D6E2EA29DB","6DACCD52-205B-49EF-99C1-4B6C78452A9D","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_E10_1524170.tangent.copynumber.data.txt","TCGA-VS-A9U6-01A-11",80,5,0,2,15,"TOP",0,0,"TCGA-VS-A9U6-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A9U6-D63446","TCGA-VS-A9U6-R63444","External","Regional site","TCGA-VS-A9U6-F68123_NTE-2","YES",1320,"WITH TUMOR","Alive",NA,"TCGA-VS-A9U6-F68123","TCGA-VS-A9U6",NA,"VS","A9U6","YES","C53.9","8072/3","C53.9","NO","YES",-19109,"FEMALE","WHITE",NA,"No","No","Alive",1213,NA,NA,NA,"WITH TUMOR","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,52,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Stable Disease","2009",18,NA,"T4NXM1",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
184450416,181436960,8651600277,"D3939C84-D1D6-4060-9F91-AEB222A9BDD5.bw","9912432e-74bc-4846-93b4-fa2bf8070bd1","d3939c84-d1d6-4060-9f91-aeb222a9bdd5","2016-08-09T13:14:14.496579-05:00","UNCID_2186830.b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91.121009_UNC16-SN851_0187_AD15RRACXX_3_ACAGTG.tar.gz","417412dc-53b1-45ac-afc0-03345325593c",8216876508,"Illumina HiSeq","93b619c51b32eb4101ecb95660c6ee74","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:56:24.615611-05:00","2016-05-03T11:01:14.469334-05:00","417412dc-53b1-45ac-afc0-03345325593c_analysis.xml","a14b41dc9a9869016f8ceaf3f8387b5c","7fbf785b-a49d-4cd3-abcd-aa8a4136f819",2124,"2016-09-29T20:52:17.738045-05:00","417412dc-53b1-45ac-afc0-03345325593c_experiment.xml","d8af700e62c4f3d04d6362d3ade6fcc0","7d332fa2-4105-4998-a9c2-d4d1de3907a0",2431,"2016-09-29T19:36:08.090595-05:00","417412dc-53b1-45ac-afc0-03345325593c_run.xml","7f3bd5c07b8c1175728ee21235fb9f89","4e527632-973e-4cb0-b957-868dbe91272c",354,"2016-09-08T11:38:39.244133-05:00","TCGA-EA-A3HU","2016-09-02T18:58:44.098224-05:00","female","TCGA-EA-A3HU_demographic",1968,"white","14e5039e-ffb4-561e-8b22-d69098307bc5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3HU_diagnosis","not reported",15909,"alive","8070/3",NA,1013,"f5c5f472-aae1-5b43-8931-03284ceefa53","c53.9",-15909,"TCGA-EA-A3HU_treatment","6703910a-9e31-57c8-a64a-6d294b6e6572","01","true","TCGA-EA-A3HU-01A",NA,"05409da8-60dc-4073-91f0-f91832f3a607",FALSE,"3A6FE044-430D-4D43-9365-9FA788758BE5","Primary Tumor",NA,182,1440,NA,1323820800,"11",30,"TCGA-EA-A3HU-01A-11",95,NA,0,NA,0,NA,0,NA,"2016-09-08T11:38:39.244133-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"f3f41100-1218-4843-b4be-a704f672caac",NA,"TCGA-EA-A3HU-01A-01-TSA",NA,100,NA,"7db07e51-724d-4210-a888-a7ea590e9b65","RNA","TCGA-EA-A3HU-01A-11R","0625e560-7c39-4e97-8134-42cbd48cd63f",1.33,0.18,"UV Spec","R","23","TCGA-EA-A3HU-01A-11R-A213-07","b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91",0.18,NA,68,25.9106843468983,162,"6aa15ef6-ce57-599a-b564-4bbace5bb7fb","TCGA-EA-A3HU_exposure","UNCID_2186830.b99c2f7f-3b3c-4ea9-b6b1-84aadaeecd91.121009_UNC16-SN851_0187_AD15RRACXX_3_ACAGTG.tar.gz","2013-09-16T15:46:04.000Z","2013-09-16T16:09:01.000Z","417412DC-53B1-45AC-AFC0-03345325593C","05409DA8-60DC-4073-91F0-F91832F3A607","Unaligned reads",8216876508,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B99C2F7F-3B3C-4EA9-B6B1-84AADAEECD91","University of North Carolina","56607664e4b016715ab68e16","9912432E-74BC-4846-93B4-FA2BF8070BD1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7DB07E51-724D-4210-A888-A7EA590E9B65","2013-09-16T16:09:01.000Z","0625E560-7C39-4E97-8134-42CBD48CD63F","Russia","NO",1,NA,"Primary Tumor","Asterand",182,"7DB07E51-724D-4210-A888-A7EA590E9B65",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.852A3427-BBBC-436E-884F-B58AF5A7ACF3.txt",1440,"TCGA-EA-A3HU-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","AAAB0578-2C13-4ECA-BFD1-06FB6840756E",43,"nationwidechildrens.org_clinical.TCGA-EA-A3HU.xml","Alive",NA,"TCGA-EA-A3HU","NOT HISPANIC OR LATINO","C46E4B85-E63D-4854-8E39-66860981B916",NA,81,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage II",NA,NA,"T2a2","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"F3F41100-1218-4843-B4BE-A704F672CAAC","1C2ECF50-3DCF-4388-980F-86F538B9962D","OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_E01_955426.tangent.copynumber.data.txt","TCGA-EA-A3HU-01A-11",95,0,0,1,0,"TOP",0,0,"TCGA-EA-A3HU-01A-01-TSA",100,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3HU-F66112_NTE-1","NO",1013,"TUMOR FREE","Alive",NA,"TCGA-EA-A3HU-F66112","TCGA-EA-A3HU",NA,"EA","A3HU","YES","C53.9","8070/3","C53.9","YES","NO",-15909,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",81,NA,NA,NA,"TUMOR FREE","NO",17,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",14,0,"G2",NA,1,NA,NA,NA,NA,"2009",9,NA,"T2a2N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
179869516,173186192,8261814573,"EABD2987-8C1E-49E5-94AF-C0BDE5335A48.bw","9aa36ac2-8418-4109-a3c1-63ca8742baab","eabd2987-8c1e-49e5-94af-c0bde5335a48","2016-08-09T13:57:41.618787-05:00","UNCID_2186963.51257d94-f973-4dfd-93d7-72ec4013def7.121002_UNC11-SN627_0254_AC0WP5ACXX_5_CGTACG.tar.gz","2430d07e-6cee-4c99-a423-ed4dfb4b8c5e",7410772801,"Illumina HiSeq","6e196233f6d4f547a16db94a05b607df","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:55:08.313185-05:00","2016-05-03T11:01:14.476120-05:00","2430d07e-6cee-4c99-a423-ed4dfb4b8c5e_analysis.xml","61e98a8a6f16fb8765ef2d1f28abbe6b","7ef6be18-a5ed-4759-8c84-78a4b906e7fd",2124,"2016-09-29T21:36:24.791571-05:00","2430d07e-6cee-4c99-a423-ed4dfb4b8c5e_experiment.xml","adf3f2a852ccd1549cba5e3ebe64d2f1","98a2997e-6ed8-45ca-8cac-449bdd800b30",2431,"2016-09-29T20:13:00.025960-05:00","2430d07e-6cee-4c99-a423-ed4dfb4b8c5e_run.xml","cee51272378babaf6359a74d3f30b3fb","6501566f-c9e7-4a3b-a12d-f28aeab208af",354,"2016-09-08T11:23:11.648481-05:00","TCGA-EK-A2RE","2016-09-02T18:58:27.732372-05:00","female","TCGA-EK-A2RE_demographic",1984,"white","1f2e28b6-22c1-5aff-8007-01e525deede3","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RE_diagnosis","not reported",9743,"alive","8071/3",NA,57,"9570b1ac-0b38-554e-abd0-306c408a2bf6","c53.9",-9743,"TCGA-EK-A2RE_treatment","cd178207-f49d-595b-bb26-047e5aa4f100","01","false","TCGA-EK-A2RE-01A",NA,"7bcf54b6-3ffa-4014-92c6-51a7099e6f02",FALSE,"86AFFE75-2DB8-40E3-9BCA-A2F695173DCC","Primary Tumor",NA,364,120,NA,1315785600,"11",30,"TCGA-EK-A2RE-01A-11",70,NA,0,NA,10,NA,19,NA,"2016-09-08T11:23:11.648481-05:00",NA,20,NA,4,NA,"TOP",NA,1,NA,"6169ccd1-7e88-4a3a-a94e-6b3bfd2161a0",NA,"TCGA-EK-A2RE-01A-01-TS1",NA,70,NA,"aba2732e-be90-4392-b921-45c8012e99d1","RNA","TCGA-EK-A2RE-01A-11R","7be1be20-7412-4a11-a44d-09d3ec803a09",1.88,0.16,"UV Spec","R","23","TCGA-EK-A2RE-01A-11R-A18M-07","51257d94-f973-4dfd-93d7-72ec4013def7",0.16,NA,54,20.8325296091972,161,"cf64d768-2b27-52bc-a716-80b0367967de","TCGA-EK-A2RE_exposure","UNCID_2186963.51257d94-f973-4dfd-93d7-72ec4013def7.121002_UNC11-SN627_0254_AC0WP5ACXX_5_CGTACG.tar.gz","2013-09-16T07:13:08.000Z","2013-09-16T20:05:01.000Z","2430D07E-6CEE-4C99-A423-ED4DFB4B8C5E","7BCF54B6-3FFA-4014-92C6-51A7099E6F02","Unaligned reads",7410772801,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","51257D94-F973-4DFD-93D7-72EC4013DEF7","University of North Carolina","566074b3e4b016715ab678e2","9AA36AC2-8418-4109-A3C1-63CA8742BAAB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","ABA2732E-BE90-4392-B921-45C8012E99D1","2013-09-16T20:05:01.000Z","7BE1BE20-7412-4A11-A44D-09D3EC803A09","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",364,"ABA2732E-BE90-4392-B921-45C8012E99D1",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.CC285FB3-7E31-4A64-BEFF-36F0909E6C8D.txt",120,"TCGA-EK-A2RE-01A",NA,NA,"TCGA",2010,NA,NA,NA,"7BCF54B6-3FFA-4014-92C6-51A7099E6F02",26,"CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_F05_870990.hg19.seg.txt","Alive",NA,"TCGA-EK-A2RE","NOT HISPANIC OR LATINO","140918C4-B42E-4D3F-86DA-72A0BF738DFE",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIA",NA,NA,"T2a2","8071/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"6169CCD1-7E88-4A3A-A94E-6B3BFD2161A0","BB490939-D0AC-4EE1-BF31-C9E95A18FDA2","TCGA-EK-A2RE-01A-11R-A18L-13_mirna.bam","TCGA-EK-A2RE-01A-11",70,10,0,20,19,"TOP",1,4,"TCGA-EK-A2RE-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RE-F58263_NTE-1",NA,NA,NA,"Alive",NA,"TCGA-EK-A2RE-F58263","TCGA-EK-A2RE",NA,"EK","A2RE","YES","C53.9","8071/3","C53.9","NO","YES",-9743,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",57,NA,NA,NA,"TUMOR FREE","NO",5,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,26,2010,"Other method, specify:","YES",21,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",10,NA,"T2a2N0MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
115898050,110778781,5289301488,"F4BE2ABE-2CEB-4A6A-B8EC-0355F8C63B9B.bw","9ba72a77-aef0-4788-8072-60c28902e55d","f4be2abe-2ceb-4a6a-b8ec-0355f8c63b9b","2016-09-30T00:05:14.114308-05:00","UNCID_2553085.01ab5f23-487f-4a57-97b3-6a110a789124.140513_UNC15-SN850_0364_AC4DVGACXX_4_GTTTCG.tar.gz","0b8c3483-9499-48f7-bb5b-e825275051fb",4940804719,"Illumina HiSeq","fc922f10745debd45b30502b2d12023b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:30:14.513505-05:00","2016-05-03T11:54:19.885282-05:00","0b8c3483-9499-48f7-bb5b-e825275051fb_analysis.xml","9021fd611a64c1802285f84c9560ae77","df1fd2c2-0793-4736-8adc-0cbe3a0699f4",2124,"2016-08-29T16:37:01.387571-05:00","0b8c3483-9499-48f7-bb5b-e825275051fb_experiment.xml","bde84d8d77ec212a8533751523f8a623","cfc2692f-ef5e-4c54-93a6-55d2209f7eda",2628,"2016-09-29T22:21:00.890389-05:00","0b8c3483-9499-48f7-bb5b-e825275051fb_run.xml","a8b797af351282153323c6263c2e108c","b41439fd-02a2-4cbf-a47a-c479f6d97831",354,"2016-09-08T11:06:43.997863-05:00","TCGA-VS-A954","2016-09-02T18:54:10.393860-05:00","female","TCGA-VS-A954_demographic",1943,"not reported","7c1932a4-abb7-5995-a30e-0867e67dcc46","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A954_diagnosis","not reported",24498,"alive","8070/3",NA,1714,"0871b589-5ac5-5139-b07a-f50a90934f97","c53.9",-24498,"TCGA-VS-A954_treatment","7fe1640f-2cbe-5168-8da6-2a28c61ba973","01","false","TCGA-VS-A954-01A",NA,"889e4fb2-6cda-4b02-99b8-e2ca03ff01da",FALSE,"5A62ACAB-9170-49CB-AA5A-82E90CA3A200","Primary Tumor",NA,1259,80,NA,1389830400,"11",30,"TCGA-VS-A954-01A-11",90,NA,0,NA,0,NA,15,NA,"2016-09-08T11:06:43.997863-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"33926c20-ea65-4ed1-b9da-dacab54fd8bf",NA,"TCGA-VS-A954-01A-01-TS1",NA,85,NA,"586d5c7f-b34e-4c77-8ebc-576fda5ec5cf","RNA","TCGA-VS-A954-01A-11R","674ccd81-dbc1-416e-b293-a6b9b3f2a9f7",1.89,0.18,"UV Spec","R","23","TCGA-VS-A954-01A-11R-A38B-07","01ab5f23-487f-4a57-97b3-6a110a789124",0.18,NA,58,22.65625,160,"93c1c6cb-8c26-50c8-8036-a2a2ee96bd40","TCGA-VS-A954_exposure","UNCID_2553085.01ab5f23-487f-4a57-97b3-6a110a789124.140513_UNC15-SN850_0364_AC4DVGACXX_4_GTTTCG.tar.gz","2014-07-30T07:21:06.000Z","2014-07-30T07:40:09.000Z","0B8C3483-9499-48F7-BB5B-E825275051FB","889E4FB2-6CDA-4B02-99B8-E2CA03FF01DA","Unaligned reads",4940804719,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","01AB5F23-487F-4A57-97B3-6A110A789124","University of North Carolina","56607731e4b0ec1099f8cca8","9BA72A77-AEF0-4788-8072-60C28902E55D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","586D5C7F-B34E-4C77-8EBC-576FDA5EC5CF","2014-07-30T07:40:09.000Z","674CCD81-DBC1-416E-B293-A6B9B3F2A9F7","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1259,"586D5C7F-B34E-4C77-8EBC-576FDA5EC5CF",NA,"VS","TCGA-VS-A954-01A-11R-A38M-13.mirna.quantification.txt",80,"TCGA-VS-A954-01A",NA,"31C84693-FA3B-435F-8746-78CEA4D4B89F","TCGA",2010,"TCGA-VS-A954_NTE-1","Complete Remission/Response","TUMOR FREE","889E4FB2-6CDA-4B02-99B8-E2CA03FF01DA",67,"nationwidechildrens.org_clinical.TCGA-VS-A954.xml","Alive",NA,"TCGA-VS-A954",NA,"CB50A808-3E20-4D67-BD61-CCE32AA34DF3","NO",1295,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",394,NA,"C18A2AC7-3A17-4CE2-BF84-371E71953308",NA,NA,11,30,"33926C20-EA65-4ED1-B9DA-DACAB54FD8BF","67D865B6-4A77-4567-AB82-B446BDC21302","TCGA-VS-A954-01A-11R-A38M-13.mirna.quantification.txt","TCGA-VS-A954-01A-11",90,0,0,0,15,"TOP",0,0,"TCGA-VS-A954-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-VS-A954-D62797","TCGA-VS-A954-R62796","Internal","Primary Tumor Field","TCGA-VS-A954-F71212_NTE-1","NO",1714,"TUMOR FREE","Alive",NA,"TCGA-VS-A954-F71212","TCGA-VS-A954",NA,"VS","A954","YES","C53.9","8070/3","C53.9","NO","YES",-24498,"FEMALE",NA,NA,"No","No","Alive",1295,NA,NA,NA,"TUMOR FREE","YES",21,5,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,67,2010,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",16,NA,"T3bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
75559928,74451230,3555507395,"627BC251-D217-4955-B718-6B9D6DEA1756.bw","9c516d28-bef2-4334-bdda-97950bd95ac0","627bc251-d217-4955-b718-6b9d6dea1756","2016-08-09T14:41:41.010248-05:00","UNCID_2654398.66a29b88-60e4-4fae-90b3-5c32560dd3ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GATCAG.tar.gz","16e356b1-cdc2-4d9f-a993-9cc8b5102b42",2873523379,"Illumina HiSeq","3af44abfbffe0a2cd24a3fddd33b5684","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:50:41.447306-05:00","2016-05-03T12:08:10.840133-05:00","16e356b1-cdc2-4d9f-a993-9cc8b5102b42_analysis.xml","a5db3c802e956e39da390d40f41769f7","7c2e710b-6d00-4557-bc8f-c323f46e5d5a",2123,"2016-09-30T00:16:52.739127-05:00","16e356b1-cdc2-4d9f-a993-9cc8b5102b42_experiment.xml","eea5028d059d08e8f17ba9088704545c","fbf8b5c4-efda-418c-804f-1f237611f1c8",2628,"2016-09-29T23:28:34.545269-05:00","16e356b1-cdc2-4d9f-a993-9cc8b5102b42_run.xml","c2e396579251b9c5a207a91774925b17","de10d541-7dcc-44ec-a925-d8435e3c2cdc",354,"2016-09-08T10:40:57.730814-05:00","TCGA-VS-A9UI","2016-09-02T18:54:23.605200-05:00","female","TCGA-VS-A9UI_demographic",1935,"white","5fe61eae-cf94-5029-ad73-efd51bcc7189","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UI_diagnosis","not reported",27838,"dead","8070/3",1372,1246,"706b54bd-df93-5618-9049-3c4a01c7ccc6","c53.9",-27838,"TCGA-VS-A9UI_treatment","2ee66a20-2379-582b-8028-4806d3df51a6","01","false","TCGA-VS-A9UI-01A",NA,"59ddf846-c93a-46af-85eb-bdd57bb36aeb",FALSE,"0907F0B0-7E43-40EB-881F-2ED5E39DB600","Primary Tumor",NA,1050,60,NA,1391040000,"11",30,"TCGA-VS-A9UI-01A-11",60,NA,5,NA,0,NA,38,NA,"2016-09-08T10:40:57.730814-05:00",NA,20,NA,5,NA,"TOP",NA,2,NA,"f51c7811-8402-4373-adcd-634ec57cc74d",NA,"TCGA-VS-A9UI-01A-01-TS1",NA,60,NA,"ba65e84b-5b38-4d53-97c7-7fb293fec3aa","RNA","TCGA-VS-A9UI-01A-11R","12199fc3-fb33-4c73-8f4c-984d9b9452e4",1.84,0.18,"UV Spec","R","23","TCGA-VS-A9UI-01A-11R-A42T-07","66a29b88-60e4-4fae-90b3-5c32560dd3ba",0.18,NA,70,NA,NA,"052c8b1f-c0ce-59aa-8c93-4bda093cd3c1","TCGA-VS-A9UI_exposure","UNCID_2654398.66a29b88-60e4-4fae-90b3-5c32560dd3ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GATCAG.tar.gz","2014-11-05T12:47:04.000Z","2014-11-05T12:59:15.000Z","16E356B1-CDC2-4D9F-A993-9CC8B5102B42","59DDF846-C93A-46AF-85EB-BDD57BB36AEB","Unaligned reads",2873523379,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","66A29B88-60E4-4FAE-90B3-5C32560DD3BA","University of North Carolina","5660772ee4b0ec1099f8cc90","9C516D28-BEF2-4334-BDDA-97950BD95AC0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BA65E84B-5B38-4D53-97C7-7FB293FEC3AA","2014-11-05T12:59:15.000Z","12199FC3-FB33-4C73-8F4C-984D9B9452E4","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1050,"BA65E84B-5B38-4D53-97C7-7FB293FEC3AA",NA,"VS","UNCID_2654398.66a29b88-60e4-4fae-90b3-5c32560dd3ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GATCAG.tar.gz",60,"TCGA-VS-A9UI-01A",NA,NA,"TCGA",2011,"TCGA-VS-A9UI_NTE-1","Complete Remission/Response","TUMOR FREE","F6391485-7528-4719-A480-167B1CDB2AE6",76,"nationwidechildrens.org_clinical.TCGA-VS-A9UI.xml","Alive",NA,"TCGA-VS-A9UI",NA,"BF9AFFC9-CEC4-4E37-AB5E-18B68AA4ACE5","NO",953,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"E4EFC749-FA8D-48F8-9188-3A4AD3D03F96","WHITE",NA,11,30,"F51C7811-8402-4373-ADCD-634EC57CC74D","9A324519-C8FA-4C95-BD4E-E67E5A907C73","UNCID_2654398.66a29b88-60e4-4fae-90b3-5c32560dd3ba.141010_UNC12-SN629_0395_BC5FVEACXX_2_GATCAG.tar.gz","TCGA-VS-A9UI-01A-11",60,0,5,20,38,"TOP",2,5,"TCGA-VS-A9UI-01A-01-TS1",60,NA,NA,NA,"TCGA-VS-A9UI-R63490","External","Regional site","TCGA-VS-A9UI-F67686_NTE-1","NO",1246,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UI-F67686","TCGA-VS-A9UI",NA,"VS","A9UI","YES","C53.9","8070/3","C53.9","NO","YES",-27838,"FEMALE","WHITE",NA,"No","No","Alive",953,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,76,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
121981284,120113417,5731585082,"31B54613-A20E-4039-BB8B-9B52104CE418.bw","9dba5a81-3587-4f5a-8d19-e0b0aed0a677","31b54613-a20e-4039-bb8b-9b52104ce418","2016-08-04T20:20:59.049193-05:00","UNCID_2169014.97a13a19-7b9b-4e53-9dfe-6a5836a44510.130606_UNC9-SN296_0373_BD28T1ACXX_6_CTTGTA.tar.gz","b0f33684-061e-4253-8895-e7ee3ca8e9f9",5971417904,"Illumina HiSeq","e1c9ce14af2f2bcdba031d249250d1d6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:59:31.692437-05:00","2016-05-03T11:06:28.633852-05:00","b0f33684-061e-4253-8895-e7ee3ca8e9f9_analysis.xml","f30795c7822f8385a35a4dd1d7763607","37611a5b-6800-43a5-82ad-e3090f23b96f",2121,"2016-09-29T17:51:04.918877-05:00","b0f33684-061e-4253-8895-e7ee3ca8e9f9_experiment.xml","b234754a6efb9739f65e2ff474684399","0c5844d1-e8e3-4d83-bf2f-d6317e5e3624",2431,"2016-09-29T20:05:21.966774-05:00","b0f33684-061e-4253-8895-e7ee3ca8e9f9_run.xml","c62e816b07e7a484c2b8dce4ca537f5c","605d2b3f-c86e-482f-ad7d-594e3775b09b",354,"2016-09-08T12:11:14.540722-05:00","TCGA-FU-A5XV","2016-09-02T19:00:00.322454-05:00","female","TCGA-FU-A5XV_demographic",1980,"white","34d5d1c9-4511-586f-9b82-4a61ca2ba7b2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A5XV_diagnosis","not reported",11692,"alive","8070/3",NA,321,"f53306c7-d030-5c18-b7e3-60be50051413","c53.9",-11692,"TCGA-FU-A5XV_treatment","74686a8c-6262-5ad4-a3d3-60b8c33952b0","01","false","TCGA-FU-A5XV-01A",NA,"8d5976cf-7e2d-420d-ba18-477a43ccec54",FALSE,"650F9C07-D8FB-46BD-8565-D03E83F049D6","Primary Tumor",NA,105,70,NA,1363046400,"11",30,"TCGA-FU-A5XV-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T12:11:14.540722-05:00",NA,80,NA,20,NA,"TOP",NA,0,NA,"65c1837a-5299-4df8-b341-3bd1d950d48f",NA,"TCGA-FU-A5XV-01A-01-TS1",NA,90,NA,"a4e2cfb7-666a-4d9c-9cee-111ec4047c8e","RNA","TCGA-FU-A5XV-01A-11R","5d7b6ab9-5cca-4524-ab6a-1a6c04dd85b6",1.9,0.17,"UV Spec","R","23","TCGA-FU-A5XV-01A-11R-A28H-07","97a13a19-7b9b-4e53-9dfe-6a5836a44510",0.17,0.986301369863014,69,27.9930220292912,157,"9cf3048b-6dcd-5e73-ae42-154bc68c49f3","TCGA-FU-A5XV_exposure","UNCID_2169014.97a13a19-7b9b-4e53-9dfe-6a5836a44510.130606_UNC9-SN296_0373_BD28T1ACXX_6_CTTGTA.tar.gz","2013-09-20T04:06:04.000Z","2013-09-20T04:20:02.000Z","B0F33684-061E-4253-8895-E7EE3CA8E9F9","8D5976CF-7E2D-420D-BA18-477A43CCEC54","Unaligned reads",5971417904,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","97A13A19-7B9B-4E53-9DFE-6A5836A44510","University of North Carolina","564a4034e4b09c884b25cd03","9DBA5A81-3587-4F5A-8D19-E0B0AED0A677","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A4E2CFB7-666A-4D9C-9CEE-111EC4047C8E","2013-09-20T04:20:02.000Z","5D7B6AB9-5CCA-4524-AB6A-1A6C04DD85B6","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",105,"A4E2CFB7-666A-4D9C-9CEE-111EC4047C8E",NA,"FU","jhu-usc.edu_CESC.HumanMethylation450.12.lvl-2.TCGA-FU-A5XV-01A-11D-A28C-05.txt",70,"TCGA-FU-A5XV-01A",NA,NA,"TCGA",2012,"TCGA-FU-A5XV_NTE-1",NA,NA,"8D5976CF-7E2D-420D-BA18-477A43CCEC54",32,"nationwidechildrens.org_clinical.TCGA-FU-A5XV.xml","Alive",NA,"TCGA-FU-A5XV","NOT HISPANIC OR LATINO","E435B69A-2868-48A8-8947-33067F3A471F","NO",60,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"T1b2","8070/3","FEMALE","C53.9",297,NA,"EB8F1F3C-3F18-4F28-907D-D3BDE96F966C","WHITE",NA,11,30,"65C1837A-5299-4DF8-B341-3BD1D950D48F","A2C403F4-A54D-4976-AB00-549F8FEB606A","jhu-usc.edu_CESC.HumanMethylation450.12.lvl-2.TCGA-FU-A5XV-01A-11D-A28C-05.txt","TCGA-FU-A5XV-01A-11",90,0,0,80,10,"TOP",0,20,"TCGA-FU-A5XV-01A-01-TS1",90,NA,NA,NA,"TCGA-FU-A5XV-R66005","External","Primary Tumor Field","TCGA-FU-A5XV-F66004_NTE-1","NO",321,"TUMOR FREE","Alive",NA,"TCGA-FU-A5XV-F66004","TCGA-FU-A5XV",NA,"FU","A5XV","YES","C53.9","8070/3","C53.9","YES","NO",-11692,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",60,NA,NA,NA,NA,"YES",12,7,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,32,2012,"Cone Biopsy / LEEP","YES",63,2,"G3",NA,2,NA,18,NA,NA,"2009",16,NA,"T1b2N1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
151255232,146828832,7004347117,"3F292B7C-A535-4DBD-BC20-CB4F85A1C94B.bw","9e2e29e8-d94a-499f-a98a-5b53b2c38f3b","3f292b7c-a535-4dbd-bc20-cb4f85a1c94b","2016-08-09T13:18:28.037616-05:00","UNCID_2186547.E35790F7-26DF-4D0A-9474-88F13372D606.121015_UNC11-SN627_0256_AD15B2ACXX_1_CTTGTA.tar.gz","ff0c084b-d726-4e4a-a28e-3c7472c45f68",6187035779,"Illumina HiSeq","b5ef8b02cf26f4a662343727960b94ac","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:11:12.004291-05:00","2016-05-03T11:00:24.467483-05:00","ff0c084b-d726-4e4a-a28e-3c7472c45f68_analysis.xml","06fdb3af8a2f882d5262eba1231d0a41","d36277d6-ab53-4a3b-a190-680f17804363",2124,"2016-10-07T16:33:12.454145-05:00","ff0c084b-d726-4e4a-a28e-3c7472c45f68_experiment.xml","6b3ac84db506f17de4c7f56d8dace0e3","970937c4-ff28-474a-ade2-7c9d7715ed4a",2431,"2016-09-29T22:58:56.434011-05:00","ff0c084b-d726-4e4a-a28e-3c7472c45f68_run.xml","3d9f8722b7391e795039446a0c31b8cb","cb9e4db8-3797-4e69-aa00-00f2f19a88b1",354,"2016-09-08T12:06:29.280960-05:00","TCGA-EA-A3QD","2016-09-02T18:59:28.495147-05:00","female","TCGA-EA-A3QD_demographic",1952,"white","568b21ea-7c72-5c94-8cc4-4ef2dfa766ad","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3QD_diagnosis","not reported",21655,"alive","8070/3",NA,397,"ebd7b062-6f3f-5855-b1df-0c3bcf15a4e1","c53.9",-21655,"TCGA-EA-A3QD_treatment","00a8a599-a658-58d1-bbc6-5619082c574c","01","true","TCGA-EA-A3QD-01A",NA,"987e1913-a506-4a06-b247-9ff778ce552b",FALSE,"C5F8BF41-F7A7-4870-890E-861D2DE51DBE","Primary Tumor",NA,146,250,NA,1331251200,"32",20,"TCGA-EA-A3QD-01A-32",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:06:29.280960-05:00",NA,13,NA,0,NA,"TOP",NA,0,NA,"798651ab-06f2-440c-a31c-817126a3ce9d",NA,"TCGA-EA-A3QD-01A-03-TSC",NA,100,NA,"662b857b-17fa-4e1b-af49-558cf29ac960","RNA","TCGA-EA-A3QD-01A-32R","1412cbcd-e0bf-498a-a3b6-8de98445e232",1.83,0.17,"UV Spec","R","23","TCGA-EA-A3QD-01A-32R-A22U-07","e35790f7-26df-4d0a-9474-88f13372d606",0.17,NA,105,39.5197410516015,163,"a4887dd5-f890-5266-a2ad-bc2728dfd017","TCGA-EA-A3QD_exposure","UNCID_2186547.E35790F7-26DF-4D0A-9474-88F13372D606.121015_UNC11-SN627_0256_AD15B2ACXX_1_CTTGTA.tar.gz","2013-09-16T11:16:04.000Z","2013-09-16T11:48:02.000Z","FF0C084B-D726-4E4A-A28E-3C7472C45F68","987E1913-A506-4A06-B247-9FF778CE552B","Unaligned reads",6187035779,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E35790F7-26DF-4D0A-9474-88F13372D606","University of North Carolina","564a3e54e4b0ef12181b5fa3","9E2E29E8-D94A-499F-A98A-5B53B2C38F3B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","662B857B-17FA-4E1B-AF49-558CF29AC960","2013-09-16T11:48:02.000Z","1412CBCD-E0BF-498A-A3B6-8DE98445E232","United States","NO",1,NA,"Primary Tumor","Asterand",146,"662B857B-17FA-4E1B-AF49-558CF29AC960",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C86A293C-53BA-4937-AC97-FF272952998A.txt",250,"TCGA-EA-A3QD-01A",NA,"342CF8C0-1020-45FF-9C5C-D96128CB5368","TCGA",2011,NA,NA,"TUMOR FREE","ECD247FC-70A8-4C1E-BF11-C0DB2FF531A0",59,"TCGA-EA-A3QD-01A-32R-A22V-13_mirna.bam.bai","Alive",NA,"TCGA-EA-A3QD","NOT HISPANIC OR LATINO","72D426D0-11A1-497D-A4DF-747A601BB4B2",NA,33,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",236,NA,"FD295AD4-9D61-4696-A332-639B379F1E45","WHITE",NA,32,20,"798651AB-06F2-440C-A31C-817126A3CE9D","43C7A4CC-ADAE-4F97-983E-EBF66A6E5B95","jhu-usc.edu_CESC.HumanMethylation450.7.lvl-2.TCGA-EA-A3QD-01A-32D-A230-05.txt","TCGA-EA-A3QD-01A-32",80,0,0,13,0,"TOP",0,0,"TCGA-EA-A3QD-01A-03-TSC",100,"Cisplatin","Chemotherapy","TCGA-EA-A3QD-D58164","TCGA-EA-A3QD-R58367","External","Primary Tumor Field","TCGA-EA-A3QD-F58163_NTE-1","NO",397,"TUMOR FREE","Alive",NA,"TCGA-EA-A3QD-F58163","TCGA-EA-A3QD",NA,"EA","A3QD","YES","C53.9","8070/3","C53.9","YES","NO",-21655,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",33,NA,NA,NA,"TUMOR FREE","NO",30,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,59,2011,"Cytology (e.g. Peritoneal or pleural fluid)","YES",6,1,"G3",NA,1,NA,NA,NA,NA,"2009",16,NA,"T1b1N1M0",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
113311950,109141881,5166528617,"BEA2A5EB-EEA9-4F31-AC38-810E04CE124B.bw","9e79059f-3453-4aa6-9849-55a267c711a4","bea2a5eb-eea9-4f31-ac38-810e04ce124b","2016-08-06T07:13:23.561139-05:00","UNCID_2170027.c3db032d-a822-4eca-8891-2c4d13a5866a.130530_UNC9-SN296_0371_BC2528ACXX_3_GATCAG.tar.gz","759ea298-3504-4173-b713-84d1bfb00b7a",5493159290,"Illumina HiSeq","3b800ccc459a66db5aac336814c80909","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:04:31.973656-05:00","2016-05-03T11:05:42.727154-05:00","759ea298-3504-4173-b713-84d1bfb00b7a_analysis.xml","d24ad2c560687060035d556456551cd0","f45be647-8a39-4c74-89a3-15f26184de76",2121,"2016-10-07T15:39:10.661086-05:00","759ea298-3504-4173-b713-84d1bfb00b7a_experiment.xml","f35a61d979c99410c74b3e96a0408d9d","d0aeeec8-cb79-4521-b6c8-9b1792ef39e7",2431,"2016-09-29T18:05:21.299803-05:00","759ea298-3504-4173-b713-84d1bfb00b7a_run.xml","b1ee3a3ee724f66f7b01bc69b06790e0","15630da9-c70a-4aa3-8f4e-b7993c4792ef",354,"2016-09-08T12:30:06.105527-05:00","TCGA-EA-A4BA","2016-09-02T18:59:44.021092-05:00","female","TCGA-EA-A4BA_demographic",1963,"white","80b71141-dcc4-5a39-858b-63e070300bec","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A4BA_diagnosis","not reported",17995,"alive","8384/3",NA,755,"541363d2-d3a6-5946-8f2f-939f5ae977b8","c53.9",-17995,"TCGA-EA-A4BA_treatment","4a7b97aa-23d7-53d6-b69e-72abb1cefe8c","01","true","TCGA-EA-A4BA-01A",NA,"26cf8464-c376-4c53-8e41-35e9ab326f0e",FALSE,"E9335EB7-5DF6-4C05-AC5C-FEEC629ED84E","Primary Tumor",NA,122,400,NA,1351468800,"21",30,"TCGA-EA-A4BA-01A-21",60,NA,3,NA,0,NA,40,NA,"2016-09-08T12:30:06.105527-05:00",NA,5,NA,3,NA,"TOP",NA,5,NA,"46f1826f-5b73-405f-9713-31a3d92982e3",NA,"TCGA-EA-A4BA-01A-02-TSB",NA,55,NA,"30344956-3d41-4160-be19-46ce3404ee5b","RNA","TCGA-EA-A4BA-01A-21R","f0dca84e-7743-4516-b7cb-05583b367e12",1.85,0.17,"UV Spec","R","23","TCGA-EA-A4BA-01A-21R-A26T-07","c3db032d-a822-4eca-8891-2c4d13a5866a",0.17,NA,96,36.5797896662094,162,"d0cf2695-244a-517d-98c3-020a1b998f6b","TCGA-EA-A4BA_exposure","UNCID_2170027.c3db032d-a822-4eca-8891-2c4d13a5866a.130530_UNC9-SN296_0371_BC2528ACXX_3_GATCAG.tar.gz","2013-09-19T22:31:04.000Z","2013-09-19T22:50:01.000Z","759EA298-3504-4173-B713-84D1BFB00B7A","26CF8464-C376-4C53-8E41-35E9AB326F0E","Unaligned reads",5493159290,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C3DB032D-A822-4ECA-8891-2C4D13A5866A","University of North Carolina","564a3eb3e4b09c884b255ce4","9E79059F-3453-4AA6-9849-55A267C711A4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","30344956-3D41-4160-BE19-46CE3404EE5B","2013-09-19T22:50:01.000Z","F0DCA84E-7743-4516-B7CB-05583B367E12","Ukraine","NO",1,NA,"Primary Tumor","Asterand",122,"30344956-3D41-4160-BE19-46CE3404EE5B",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.7F604A99-19D9-42F8-BA04-4E42C885D118.txt",400,"TCGA-EA-A4BA-01A",NA,"B4F30A70-2AB7-4FA1-888B-AC1E7096ACAC","TCGA",2012,"TCGA-EA-A4BA_NTE-1","Complete Remission/Response","TUMOR FREE","C49C9269-AA6B-4E0E-ABAD-0F5E7DF171E0",49,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.7F604A99-19D9-42F8-BA04-4E42C885D118.txt","Alive",NA,"TCGA-EA-A4BA","NOT HISPANIC OR LATINO","F967F126-EB6A-4D79-AF63-7F77756DB164","NO",10,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Preoperative","Stage IB2",NA,NA,"T1b2","8384/3","FEMALE","C53.9",280,NA,"D79220A4-F0AA-4434-B04C-C5030F3A80EB","WHITE",NA,21,30,"46F1826F-5B73-405F-9713-31A3D92982E3","F0DCA84E-7743-4516-B7CB-05583B367E12","9305216159_R05C02_Grn.idat","TCGA-EA-A4BA-01A-21",60,0,3,5,40,"TOP",5,3,"TCGA-EA-A4BA-01A-02-TSB",55,"Carboplatin","Chemotherapy","TCGA-EA-A4BA-D49909","TCGA-EA-A4BA-R50169","External","Primary Tumor Field","TCGA-EA-A4BA-F63128_NTE-1","NO",755,"TUMOR FREE","Alive",NA,"TCGA-EA-A4BA-F63128","TCGA-EA-A4BA",NA,"EA","A4BA","YES","C53.9","8384/3","C53.9","YES","NO",-17995,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",10,NA,NA,NA,"TUMOR FREE","YES",5,2,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,49,2012,"Biopsy (cervical / CT-guided / Other)","YES",10,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
118356982,114009391,5439226767,"99D84D46-19DA-43F1-B639-DCE9953F1529.bw","9fa42fe6-ccd0-4850-b08b-97b20eceb8df","99d84d46-19da-43f1-b639-dce9953f1529","2016-08-25T18:10:20.007310-05:00","UNCID_2553080.01a6c838-ea9c-488c-8dcb-8bac73253a33.140603_UNC15-SN850_0368_AC4GHHACXX_7_GTCCGC.tar.gz","9264b0e1-a154-4604-a1ab-31726e2fe8da",4926082379,"Illumina HiSeq","8ae3bc94fa2d048a7d0d9c82a902048e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:28:35.275183-05:00","2016-05-03T11:54:19.885282-05:00","9264b0e1-a154-4604-a1ab-31726e2fe8da_analysis.xml","29c2be272f35c88ed3947dc1b59d1d54","6e8b0941-4462-4408-be16-fbfcfc94b507",2124,"2016-09-29T20:47:47.197563-05:00","9264b0e1-a154-4604-a1ab-31726e2fe8da_experiment.xml","dd90df8dd6736beb2e04b134d3a2995d","7a50d792-5b1e-4652-a7e3-3ba6ff997115",2628,"2016-09-29T18:40:45.937895-05:00","9264b0e1-a154-4604-a1ab-31726e2fe8da_run.xml","543d29f8a2794580c198b86af84d161e","2b7b9156-5055-4fec-a35d-d7ac61d9aaf8",354,"2016-09-08T11:30:38.659842-05:00","TCGA-VS-A952","2016-09-02T18:54:08.446244-05:00","female","TCGA-VS-A952_demographic",1944,"white","6f9d0826-1159-5cdd-914f-cf2edfe88b1a","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A952_diagnosis","not reported",24345,"alive","8482/3",NA,1778,"242aacb6-ae31-5e9e-91de-bdd2b62b9950","c53.9",-24345,"TCGA-VS-A952_treatment","acf5e3e0-ec81-50b8-9e0b-3d760eac6f91","01","false","TCGA-VS-A952-01A",NA,"ca8fa362-bd1e-4af7-bdb1-d1b2e113b551",FALSE,"B7893751-3A8F-4FD8-996F-D8C93C108336","Primary Tumor",NA,1288,50,NA,1389830400,"11",30,"TCGA-VS-A952-01A-11",70,NA,20,NA,0,NA,30,NA,"2016-09-08T11:30:38.659842-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"e9dfac83-7349-4e9c-bcbf-c52d17622a85",NA,"TCGA-VS-A952-01A-01-TS1",NA,70,NA,"7b58b286-74b9-42b2-8982-2c03bb672514","RNA","TCGA-VS-A952-01A-11R","d613245c-3d2e-40fc-b120-ef634f50cb51",1.89,0.18,"UV Spec","R","23","TCGA-VS-A952-01A-11R-A38B-07","01a6c838-ea9c-488c-8dcb-8bac73253a33",0.18,NA,65,27.0551508844953,155,"f51ed160-fc96-5202-8c1f-3104cf72e797","TCGA-VS-A952_exposure","UNCID_2553080.01a6c838-ea9c-488c-8dcb-8bac73253a33.140603_UNC15-SN850_0368_AC4GHHACXX_7_GTCCGC.tar.gz","2014-07-30T18:07:04.000Z","2014-07-30T18:24:30.000Z","9264B0E1-A154-4604-A1AB-31726E2FE8DA","CA8FA362-BD1E-4AF7-BDB1-D1B2E113B551","Unaligned reads",4926082379,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","01A6C838-EA9C-488C-8DCB-8BAC73253A33","University of North Carolina","56607579e4b018727fea004d","9FA42FE6-CCD0-4850-B08B-97B20ECEB8DF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7B58B286-74B9-42B2-8982-2C03BB672514","2014-07-30T18:24:30.000Z","D613245C-3D2E-40FC-B120-EF634F50CB51","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1288,"7B58B286-74B9-42B2-8982-2C03BB672514",NA,"VS","9829119010_R06C02_Red.idat",50,"TCGA-VS-A952-01A",NA,NA,"TCGA",2010,"TCGA-VS-A952_NTE-1","Complete Remission/Response","TUMOR FREE","DB8E6C68-CF0C-451A-A8C1-FB63A26592C2",66,"nationwidechildrens.org_clinical.TCGA-VS-A952.xml","Alive",NA,"TCGA-VS-A952",NA,"E001B4F1-CAB7-4324-A415-27992C3AF2E9","NO",1365,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",0,"Other","Stage IB1",NA,NA,"T1b","8482/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"E9DFAC83-7349-4E9C-BCBF-C52D17622A85","AE836009-5862-4358-8EBC-ABC1D8CB0CEB","TCGA-VS-A952-01A-11R-A38M-13_mirna.bam.bai","TCGA-VS-A952-01A-11",70,0,20,40,30,"TOP",0,20,"TCGA-VS-A952-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-VS-A952-F72388_NTE-1","NO",1778,"TUMOR FREE","Alive",NA,"TCGA-VS-A952-F72388","TCGA-VS-A952",NA,"VS","A952","YES","C53.9","8482/3","C53.9","NO","YES",-24345,"FEMALE","WHITE",NA,"No","No","Alive",1365,NA,NA,NA,"TUMOR FREE","YES",21,5,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,66,2010,"Biopsy (cervical / CT-guided / Other)","YES",15,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1bN0MX",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
193053782,183830946,8764351672,"4588817E-1068-4A78-86B6-4674A0112DDA.bw","a04cb81e-53bd-4686-9626-52ee87e3e261","4588817e-1068-4a78-86b6-4674a0112dda","2016-08-05T03:55:32.415822-05:00","UNCID_2186274.3c109286-fa30-4f6b-98d1-70cd89f87f31.121102_UNC15-SN850_0240_BD148CACXX_7_ATGTCA.tar.gz","52e3810f-38cc-4053-9e89-5ca8a0aba74d",8540139977,"Illumina HiSeq","210d67a24076201259123e2c8983930c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:18.351744-05:00","2016-05-03T11:00:24.448573-05:00","52e3810f-38cc-4053-9e89-5ca8a0aba74d_analysis.xml","c0b2504269dbbacb515e7896479899e4","fcde38c0-460c-4c0a-a17d-0c572fffb21d",2124,"2016-08-26T10:56:04.186469-05:00","52e3810f-38cc-4053-9e89-5ca8a0aba74d_experiment.xml","5af94f7bb8f1e6c14a5bd9840974e67f","b2eb9ff1-b643-437b-853d-09b989b77197",2431,"2016-09-29T21:47:27.406225-05:00","52e3810f-38cc-4053-9e89-5ca8a0aba74d_run.xml","2e097fd958660e5ef1e84abe8445db94","9f7005f3-2e49-4727-9e34-a6a355b3c9ab",354,"2016-09-08T12:02:12.104651-05:00","TCGA-EK-A2IR","2016-09-02T18:57:49.195168-05:00","female","TCGA-EK-A2IR_demographic",1949,"white","e6187bbc-a0e8-5a96-8520-6b0e23b226c6","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2IR_diagnosis","not reported",17581,"alive","8071/3",NA,3442,"8c0df594-62ba-59a9-9806-683f4ee8e3b3","c53.9",-17581,"TCGA-EK-A2IR_treatment","00297462-e042-5eac-9415-79d3cef720f4","01","false","TCGA-EK-A2IR-01A",NA,"d4e7991a-90ec-4248-8c62-28e816edad48",FALSE,"2A0B2B7B-4EBC-49BC-929C-2E5AED2CCBC5","Primary Tumor",NA,4950,130,NA,1310515200,"11",30,"TCGA-EK-A2IR-01A-11",90,NA,0,NA,0,NA,20,NA,"2016-09-08T12:02:12.104651-05:00",NA,2,NA,0,NA,"TOP",NA,1,NA,"f555e682-07f5-4626-beeb-3ee33df5e6d1",NA,"TCGA-EK-A2IR-01A-01-TSA",NA,79,NA,"42c07afb-0c6f-4d57-aa6e-90fd216239c7","RNA","TCGA-EK-A2IR-01A-11R","7e85fcc3-f290-42f6-9d61-c7281a07de11",1.78,0.16,"UV Spec","R","23","TCGA-EK-A2IR-01A-11R-A180-07","3c109286-fa30-4f6b-98d1-70cd89f87f31",0.16,0.986301369863014,61,23.828125,160,"bcd78814-36fc-5d23-8f80-7b78106b2766","TCGA-EK-A2IR_exposure","UNCID_2186274.3c109286-fa30-4f6b-98d1-70cd89f87f31.121102_UNC15-SN850_0240_BD148CACXX_7_ATGTCA.tar.gz","2013-09-16T03:56:04.000Z","2013-09-16T04:29:01.000Z","52E3810F-38CC-4053-9E89-5CA8A0ABA74D","D4E7991A-90EC-4248-8C62-28E816EDAD48","Unaligned reads",8540139977,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3C109286-FA30-4F6B-98D1-70CD89F87F31","University of North Carolina","564a39fce4b09c884b23ee7c","A04CB81E-53BD-4686-9626-52EE87E3E261","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","42C07AFB-0C6F-4D57-AA6E-90FD216239C7","2013-09-16T04:29:01.000Z","7E85FCC3-F290-42F6-9D61-C7281A07DE11","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",4950,"42C07AFB-0C6F-4D57-AA6E-90FD216239C7",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.4E99977A-5CA0-49FC-A1AC-69B4138A18BF.txt",130,"TCGA-EK-A2IR-01A",NA,NA,"TCGA",1997,NA,NA,"TUMOR FREE","D4E7991A-90EC-4248-8C62-28E816EDAD48",48,"WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_B01_845150.raw.copynumber.data.txt","Alive",NA,"TCGA-EK-A2IR",NA,"E51E74C5-FC7B-4C26-ACFF-57D95AE7C4EE",NA,2679,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB2",NA,NA,"T1b","8071/3","FEMALE","C53.9",169,NA,NA,"WHITE",NA,11,30,"F555E682-07F5-4626-BEEB-3EE33DF5E6D1","7E85FCC3-F290-42F6-9D61-C7281A07DE11","unc.edu.3c109286-fa30-4f6b-98d1-70cd89f87f31.1715687.junction_quantification.txt","TCGA-EK-A2IR-01A-11",90,0,0,2,20,"TOP",1,0,"TCGA-EK-A2IR-01A-01-TSA",79,NA,NA,NA,NA,NA,NA,NA,"NO",3442,"TUMOR FREE","Alive",NA,"TCGA-EK-A2IR-F21345","TCGA-EK-A2IR",NA,"EK","A2IR","YES","C53.9","8071/3","C53.9","NO","YES",-17581,"FEMALE","WHITE",NA,"No","No","Alive",2679,NA,NA,NA,"TUMOR FREE","NO",8,11,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,1997,"Other method, specify:","YES",24,NA,"G3",NA,NA,NA,18,NA,NA,"1995",8,NA,"T1bN0MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
119763670,118161789,5611542886,"6AC633BD-BEC1-4750-94E3-378972DAB6B3.bw","a0598331-79e1-418d-b50c-fd945b843506","6ac633bd-bec1-4750-94e3-378972dab6b3","2016-08-09T13:56:48.221394-05:00","UNCID_2187316.318e2cdd-08c5-4611-913f-7f4a6f49677d.120917_UNC11-SN627_0251_AC119PACXX_4_TAGCTT.tar.gz","9caa56fc-f84f-4119-b28e-9fb7dc5b88ba",5354416159,"Illumina HiSeq","4542d6776c4f2725e2d0386474c4e8d2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:28:01.005947-05:00","2016-05-03T11:02:00.425419-05:00","9caa56fc-f84f-4119-b28e-9fb7dc5b88ba_analysis.xml","7e83a331517de0712fe55f32bbe6f415","49551e19-bbb5-4732-9150-3a017d8d81bc",2124,"2016-10-07T17:44:26.090617-05:00","9caa56fc-f84f-4119-b28e-9fb7dc5b88ba_experiment.xml","885a474cf30098284becd45de4c31c60","66b340f5-cad6-41a1-a28c-c0e3168760d1",2431,"2016-09-30T00:02:25.699594-05:00","9caa56fc-f84f-4119-b28e-9fb7dc5b88ba_run.xml","0542585f72ff66f7e8bd14aac7a9ef7f","f31cd313-6c31-4ebc-88e5-4aa16a83d69e",354,"2016-09-08T12:14:09.770585-05:00","TCGA-C5-A1ME","2016-09-02T18:56:51.455370-05:00","female","TCGA-C5-A1ME_demographic",1963,"white","51720bed-d894-5b9a-bfbf-3ab5597058ae","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1ME_diagnosis","not reported",14970,"alive","8140/3",NA,1756,"3e1c335e-e7d7-56c6-9d2d-0757182c91f7","c53.9",-14970,"TCGA-C5-A1ME_treatment","d0dde06c-3f13-5dc9-8ecf-9225661f648b","01","true","TCGA-C5-A1ME-01A",NA,"663ef1fc-5ac6-4f4d-97f6-485cc0086d7f",FALSE,"00322045-7A7F-44D1-8381-94F027200227","Primary Tumor",NA,2632,60,NA,1300924800,"11",30,"TCGA-C5-A1ME-01A-11",60,NA,0,NA,0,NA,40,NA,"2016-09-08T12:14:09.770585-05:00",NA,15,NA,5,NA,"TOP",NA,0,NA,"c0734684-87df-40aa-8716-7684cec1a041",NA,"TCGA-C5-A1ME-01A-01-TSA",NA,60,NA,"d15c4d11-eae5-4faa-847d-2482e007d7ca","RNA","TCGA-C5-A1ME-01A-11R","a87888f1-0370-4d7d-af8a-5132f829f38e",1.85,0.17,"UV Spec","R","23","TCGA-C5-A1ME-01A-11R-A13Y-07","318e2cdd-08c5-4611-913f-7f4a6f49677d",0.17,1.20547945205479,69,25.3443526170799,165,"230f0907-4854-535e-8788-ec812d309738","TCGA-C5-A1ME_exposure","UNCID_2187316.318e2cdd-08c5-4611-913f-7f4a6f49677d.120917_UNC11-SN627_0251_AC119PACXX_4_TAGCTT.tar.gz","2013-09-17T07:26:03.000Z","2013-09-17T08:03:02.000Z","9CAA56FC-F84F-4119-B28E-9FB7DC5B88BA","663EF1FC-5AC6-4F4D-97F6-485CC0086D7F","Unaligned reads",5354416159,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","318E2CDD-08C5-4611-913F-7F4A6F49677D","University of North Carolina","564a3a6ce4b0ef12181a20c1","A0598331-79E1-418D-B50C-FD945B843506","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D15C4D11-EAE5-4FAA-847D-2482E007D7CA","2013-09-17T08:03:02.000Z","A87888F1-0370-4D7D-AF8A-5132F829F38E","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2632,"D15C4D11-EAE5-4FAA-847D-2482E007D7CA",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B27BC67D-DE4A-4713-A07F-65322FB64A5B.txt",60,"TCGA-C5-A1ME-01A",NA,NA,"TCGA",2003,NA,NA,"TUMOR FREE","999BF71B-3C36-4055-A38A-A5E1E86C458A",40,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B27BC67D-DE4A-4713-A07F-65322FB64A5B.txt","Alive",NA,"TCGA-C5-A1ME","NOT HISPANIC OR LATINO","B23DA17C-E16E-4CD1-8390-28726BB9EBC0",NA,132,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8140/3","FEMALE","C53.9",114,NA,NA,"WHITE",NA,11,30,"C0734684-87DF-40AA-8716-7684CEC1A041","FA176AD3-D877-4A0C-B200-99986FDF7FCD","UNCID_2187316.318e2cdd-08c5-4611-913f-7f4a6f49677d.120917_UNC11-SN627_0251_AC119PACXX_4_TAGCTT.tar.gz","TCGA-C5-A1ME-01A-11",60,0,0,15,40,"TOP",0,5,"TCGA-C5-A1ME-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,NA,"NO",1756,"TUMOR FREE","Alive",NA,"TCGA-C5-A1ME-F29281","TCGA-C5-A1ME",NA,"C5","A1ME","YES","C53.9","8140/3","C53.9","NO","YES",-14970,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",132,NA,NA,NA,"TUMOR FREE","NO",19,9,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,40,2003,"Biopsy (cervical / CT-guided / Other)","YES",27,0,"G1",NA,4,2003,22,NA,NA,"1995",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
109346226,108772418,5199759348,"09E17C6E-7EDE-4DDF-B5ED-2521AF870C9A.bw","a1b99260-8643-4cef-95a0-3853d64762b7","09e17c6e-7ede-4ddf-b5ed-2521af870c9a","2016-08-09T14:40:40.836300-05:00","UNCID_2654378.df428368-b3b0-4e70-b930-2e143645a779.140908_UNC11-SN627_0381_BC5DEKACXX_8_ACTGAT.tar.gz","da9f9cb1-da73-4f07-b03a-fb1d1e41cff4",4375016175,"Illumina HiSeq","fce4971d55f6dc26581943b0120f41f7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:48:21.618976-05:00","2016-05-03T12:08:10.830175-05:00","da9f9cb1-da73-4f07-b03a-fb1d1e41cff4_analysis.xml","647627bd680cd05651caa29278849533","c5353408-1047-47c5-bff6-3f0832d5acb2",2124,"2016-09-29T18:54:28.036216-05:00","da9f9cb1-da73-4f07-b03a-fb1d1e41cff4_experiment.xml","8d641be13b34f275733bf4cc695f894d","3425b23d-4ca1-4ae5-85c4-739ba4539cad",2628,"2016-09-29T18:40:37.408079-05:00","da9f9cb1-da73-4f07-b03a-fb1d1e41cff4_run.xml","3af1e47eb81b2dcfb529f7de6d3593d1","2b635936-8207-436e-82e0-0e9d76ce8a29",354,"2016-09-08T10:29:18.079859-05:00","TCGA-VS-A9UY","2016-09-02T18:54:34.288577-05:00","female","TCGA-VS-A9UY_demographic",1983,"not reported","7b0f68cf-f827-5f1f-8a15-27707f4c2c4a","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UY_diagnosis","not reported",10707,"dead","8070/3",555,NA,"b56488bc-58b9-58c0-81ec-be4ab0bead60","c53.9",-10707,"TCGA-VS-A9UY_treatment","64347676-5ca5-5b6c-a6c3-b7d99607855e","01","false","TCGA-VS-A9UY-01A",NA,"bce456cf-2c7d-4959-84f1-3cc4d69a1291",FALSE,"DDC2DC1F-C4E3-4F51-9F0C-3EE90A7C4819","Primary Tumor",NA,454,90,NA,1390953600,"11",30,"TCGA-VS-A9UY-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T10:29:18.079859-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"b7dd3f28-2610-46cd-ab6c-ad5e9f5d7fcd",NA,"TCGA-VS-A9UY-01A-01-TS1",NA,100,NA,"b9c2f083-db6c-4adf-956c-bac2ca8111ed","RNA","TCGA-VS-A9UY-01A-11R","3e64506c-c9c1-4b7f-95a3-25406886426e",1.89,0.18,"UV Spec","R","23","TCGA-VS-A9UY-01A-11R-A42T-07","df428368-b3b0-4e70-b930-2e143645a779",0.18,NA,46,17.3134103654635,163,"cb30ee56-ea24-5602-80d2-be5170866689","TCGA-VS-A9UY_exposure","UNCID_2654378.df428368-b3b0-4e70-b930-2e143645a779.140908_UNC11-SN627_0381_BC5DEKACXX_8_ACTGAT.tar.gz","2014-11-05T05:27:03.000Z","2014-11-05T05:40:06.000Z","DA9F9CB1-DA73-4F07-B03A-FB1D1E41CFF4","BCE456CF-2C7D-4959-84F1-3CC4D69A1291","Unaligned reads",4375016175,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","DF428368-B3B0-4E70-B930-2E143645A779","University of North Carolina","56607754e4b018727fea13d7","A1B99260-8643-4CEF-95A0-3853D64762B7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B9C2F083-DB6C-4ADF-956C-BAC2CA8111ED","2014-11-05T05:40:06.000Z","3E64506C-C9C1-4B7F-95A3-25406886426E","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",454,"B9C2F083-DB6C-4ADF-956C-BAC2CA8111ED",NA,"VS","UNCID_2654378.df428368-b3b0-4e70-b930-2e143645a779.140908_UNC11-SN627_0381_BC5DEKACXX_8_ACTGAT.tar.gz",90,"TCGA-VS-A9UY-01A",NA,"47D7D03D-BCC9-4123-AE5B-71157465604C","TCGA",2012,"TCGA-VS-A9UY_NTE-1","Progressive Disease","WITH TUMOR","BCE456CF-2C7D-4959-84F1-3CC4D69A1291",29,"nationwidechildrens.org_clinical.TCGA-VS-A9UY.xml","Dead",555,"TCGA-VS-A9UY",NA,NA,"YES",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Pre-Adjuvant Therapy","Stage IVB",NA,NA,"T1b2","8070/3","FEMALE","C53.9",420,NA,"5CCD2C7C-8CF2-43AD-8F06-956C5563043D",NA,NA,11,30,"B7DD3F28-2610-46CD-AB6C-AD5E9F5D7FCD","3E64506C-C9C1-4B7F-95A3-25406886426E","UNCID_2654378.df428368-b3b0-4e70-b930-2e143645a779.140908_UNC11-SN627_0381_BC5DEKACXX_8_ACTGAT.tar.gz","TCGA-VS-A9UY-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-VS-A9UY-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-VS-A9UY-D64585","TCGA-VS-A9UY-R64582","Internal","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UY",NA,"VS","A9UY","YES","C53.9","8070/3","C53.9","NO","YES",-10707,"FEMALE",NA,NA,"No","No","Dead",NA,555,NA,NA,"WITH TUMOR","YES",5,9,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,29,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Progressive Disease","2009",18,NA,"T1b2NXMX",NA,NA,2,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
123972056,119884989,5712756069,"58D9C750-26A2-4B7C-84C4-13D7AFB4C5EA.bw","a300db40-e0b8-4c45-abbd-d7aa06211e9c","58d9c750-26a2-4b7c-84c4-13d7afb4c5ea","2016-08-25T05:44:40.617304-05:00","UNCID_2358744.9ce21675-b3ac-45b0-85c6-f3b2e4188944.140107_UNC11-SN627_0341_BC38NLACXX_3_GTGGCC.tar.gz","b9022f51-19c5-4c20-accb-2c6b2785f705",6006250955,"Illumina HiSeq","75efa06108061db29c04c281fa3db3e6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:30:51.360743-05:00","2016-05-03T11:37:12.425298-05:00","b9022f51-19c5-4c20-accb-2c6b2785f705_analysis.xml","3146d532a80a2c368d3f3c1f90bea83f","ba48bb8e-1985-41e9-902f-0eca85485d84",2124,"2016-09-29T17:36:25.817845-05:00","b9022f51-19c5-4c20-accb-2c6b2785f705_experiment.xml","a185c5416ebb7f8ee5e4f86492e4bd31","02ebc4d6-7dfb-4301-af27-36f74ab8be88",2628,"2016-09-29T19:03:34.170378-05:00","b9022f51-19c5-4c20-accb-2c6b2785f705_run.xml","84ecd6103fe3791c3373b9c92b94efac","39efdfed-d040-4096-9eba-acf2214ffa05",354,"2016-09-08T11:36:32.935819-05:00","TCGA-EA-A6QX","2016-09-02T19:00:12.756854-05:00","female","TCGA-EA-A6QX_demographic",1964,"asian","a39f5a41-917d-5ec5-ada2-d3ce9b11807c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A6QX_diagnosis","not reported",18035,"alive","8070/3",NA,730,"cef39518-bc87-543d-a48b-493fbac11ae1","c53.9",-18035,"TCGA-EA-A6QX_treatment","09c1ea78-5048-5758-bd13-c7509339aa90","01","true","TCGA-EA-A6QX-01A",NA,"1387de0a-aa60-4075-8673-fa3eb9ac45de",FALSE,"84774C0F-D4E4-4BE3-9159-4E932890F7EC","Primary Tumor",NA,99,1260,NA,1375833600,"12",30,"TCGA-EA-A6QX-01A-12",80,NA,1,NA,10,NA,10,NA,"2016-09-08T11:36:32.935819-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"66853f14-1300-4d44-b297-061ffa80102d",NA,"TCGA-EA-A6QX-01A-01-TSA",NA,80,NA,"88bc2058-abee-4a4d-b7bd-7e785b60d3f8","RNA","TCGA-EA-A6QX-01A-12R","315bf251-c70c-45c6-92db-00fef790f3b1",1.88,0.17,"UV Spec","R","23","TCGA-EA-A6QX-01A-12R-A33Z-07","9ce21675-b3ac-45b0-85c6-f3b2e4188944",0.17,NA,49,20.6611570247934,154,"271986f5-5cf8-5b25-97f9-3758256397bf","TCGA-EA-A6QX_exposure","UNCID_2358744.9ce21675-b3ac-45b0-85c6-f3b2e4188944.140107_UNC11-SN627_0341_BC38NLACXX_3_GTGGCC.tar.gz","2014-02-25T19:03:06.000Z","2014-02-25T19:30:01.000Z","B9022F51-19C5-4C20-ACCB-2C6B2785F705","1387DE0A-AA60-4075-8673-FA3EB9AC45DE","Unaligned reads",6006250955,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9CE21675-B3AC-45B0-85C6-F3B2E4188944","University of North Carolina","564a3e0be4b09c884b2528d4","A300DB40-E0B8-4C45-ABBD-D7AA06211E9C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","88BC2058-ABEE-4A4D-B7BD-7E785B60D3F8","2014-02-25T19:30:01.000Z","315BF251-C70C-45C6-92DB-00FEF790F3B1","Vietnam","NO",1,NA,"Primary Tumor","Asterand",99,"88BC2058-ABEE-4A4D-B7BD-7E785B60D3F8",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A8AC0A62-1CC2-43E6-AFC2-6B455B8F5759.txt",1260,"TCGA-EA-A6QX-01A",NA,NA,"TCGA",2013,"TCGA-EA-A6QX_NTE-1",NA,"TUMOR FREE","B4477A58-5B29-408D-8DD5-DC5123FBC390",49,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A8AC0A62-1CC2-43E6-AFC2-6B455B8F5759.txt","Alive",NA,"TCGA-EA-A6QX","NOT HISPANIC OR LATINO","D02F903A-D6CE-4F61-93CB-30FE1A0FB8A7","NO",19,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",350,NA,NA,"ASIAN",NA,12,30,"66853F14-1300-4D44-B297-061FFA80102D","7FCB22F2-6497-4D2A-8CDB-7D14524FE435","88f8212f59e3298c9ab41f74b53f3b0d.bam","TCGA-EA-A6QX-01A-12",80,10,1,1,10,"TOP",0,0,"TCGA-EA-A6QX-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,"TCGA-EA-A6QX-F71637_NTE-1","NO",730,"TUMOR FREE","Alive",NA,"TCGA-EA-A6QX-F71637","TCGA-EA-A6QX",NA,"EA","A6QX","YES","C53.9","8070/3","C53.9","YES","NO",-18035,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",19,NA,NA,NA,"TUMOR FREE","YES",16,10,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2013,"Biopsy (cervical / CT-guided / Other)","YES",3,2,"G3",NA,1,NA,NA,NA,NA,"2009",16,NA,"T1b1N1M0",NA,NA,NA,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
205203686,201602982,9627602689,"DF28E138-E222-4F77-9B61-69E601CA7E60.bw","a3be445a-a592-4073-815b-47ae41f9c4a0","df28e138-e222-4f77-9b61-69e601ca7e60","2016-08-09T13:57:10.018732-05:00","UNCID_2187207.721c59a5-22b6-4388-a47d-d0108ea2c1aa.120920_UNC13-SN749_0194_AD15C3ACXX_2_TGACCA.tar.gz","e8e2acc3-9fcf-4a28-a129-fdfcbd0f7b4e",9204802113,"Illumina HiSeq","1b6d0197bed61ad6054e95a925f1c296","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:12:56.091910-05:00","2016-05-03T11:02:00.403413-05:00","e8e2acc3-9fcf-4a28-a129-fdfcbd0f7b4e_analysis.xml","74b63bb115f4b3429ede4316e24acadd","af38e55a-00f4-42b4-9723-ca30c0cdb5bc",2124,"2016-09-29T20:30:46.241309-05:00","e8e2acc3-9fcf-4a28-a129-fdfcbd0f7b4e_experiment.xml","f355d872adb46072ffc335702de89dd4","6fdbcbb9-f7ac-4e5d-afa2-5f0d752e7f2b",2431,"2016-09-29T23:24:12.784646-05:00","e8e2acc3-9fcf-4a28-a129-fdfcbd0f7b4e_run.xml","45a42544479ad5d90d96a9250530d234","db4cf5d0-60d7-44b3-a26e-fb82a94daa37",354,"2016-09-08T12:16:00.578089-05:00","TCGA-C5-A1M9","2016-09-02T18:56:50.361499-05:00","female","TCGA-C5-A1M9_demographic",1956,"white","0c358cef-5d56-5115-968f-b8a2963b7054","not hispanic or latino",2004,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1M9_diagnosis","not reported",17020,"dead","8140/3",1065,NA,"15933051-2e16-58ca-9c62-15d1f8f44453","c53.9",-17020,"TCGA-C5-A1M9_treatment","3511df24-a1cb-5cef-9efe-3b1c520dad59","01","true","TCGA-C5-A1M9-01A",NA,"577057af-7775-497b-bee9-e04562648509",FALSE,"6D91450A-9499-4B66-90DF-E68B4880E64C","Primary Tumor",NA,3120,160,NA,1300924800,"11",30,"TCGA-C5-A1M9-01A-11",85,NA,10,NA,0,NA,15,NA,"2016-09-08T12:16:00.578089-05:00",NA,8,NA,5,NA,"TOP",NA,10,NA,"16fe8686-5596-4a71-ba2a-6bf0bf24ac3e",NA,"TCGA-C5-A1M9-01A-01-TSA",NA,75,NA,"645abf01-a350-4d00-9c66-157d3045777d","RNA","TCGA-C5-A1M9-01A-11R","ac81b780-5399-484f-8b5d-9a433af61003",1.74,0.16,"UV Spec","R","23","TCGA-C5-A1M9-01A-11R-A13Y-07","721c59a5-22b6-4388-a47d-d0108ea2c1aa",0.16,NA,49,20.3954214360042,155,"2e05ade9-a69d-5c37-a64c-48aae2c988f5","TCGA-C5-A1M9_exposure","UNCID_2187207.721c59a5-22b6-4388-a47d-d0108ea2c1aa.120920_UNC13-SN749_0194_AD15C3ACXX_2_TGACCA.tar.gz","2013-09-17T03:43:05.000Z","2013-09-17T04:08:01.000Z","E8E2ACC3-9FCF-4A28-A129-FDFCBD0F7B4E","577057AF-7775-497B-BEE9-E04562648509","Unaligned reads",9204802113,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","721C59A5-22B6-4388-A47D-D0108EA2C1AA","University of North Carolina","564a3d5ae4b0298dd2c9084b","A3BE445A-A592-4073-815B-47AE41F9C4A0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","645ABF01-A350-4D00-9C66-157D3045777D","2013-09-17T04:08:01.000Z","AC81B780-5399-484F-8B5D-9A433AF61003","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3120,"645ABF01-A350-4D00-9C66-157D3045777D",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.9169E928-8406-4FF7-824A-AA5FA7B3BF5A.txt",160,"TCGA-C5-A1M9-01A",NA,"C5BFBED2-5160-4123-87EF-9FC20F4C7FC1","TCGA",2002,NA,NA,"WITH TUMOR","AE9477F6-7175-41AD-9090-4E61419D9B91",46,"STOPS_p_TCGA_b101_114_SNP_N_GenomeWideSNP_6_F03_771710.CEL","Dead",1065,"TCGA-C5-A1M9","NOT HISPANIC OR LATINO","018631C0-1498-493F-9C17-00F3D103E683",NA,NA,"No","Cervix","C53.9","N1","Endocervical Type of Adenocarcinoma",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T3b","8140/3","FEMALE","C53.9",114,NA,"0580D63F-0356-4009-94FE-BF4C4979DD1A","WHITE",NA,11,30,"16FE8686-5596-4A71-BA2A-6BF0BF24AC3E","FDCC0F7A-CC8F-44C8-8C68-B8D6F87BD252","TCGA-C5-A1M9-01A-11R-A13X-13_mirna.bam","TCGA-C5-A1M9-01A-11",85,0,10,8,15,"TOP",10,5,"TCGA-C5-A1M9-01A-01-TSA",75,"Cisplatin","Chemotherapy","TCGA-C5-A1M9-D29231","TCGA-C5-A1M9-R29232","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",1065,"TCGA-C5-A1M9-F29254","TCGA-C5-A1M9",NA,"C5","A1M9","YES","C53.9","8140/3","C53.9","NO","YES",-17020,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,1065,NA,NA,"WITH TUMOR","NO",19,9,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,46,2002,"Biopsy (cervical / CT-guided / Other)","YES",19,14,"G3",NA,1,NA,NA,NA,NA,"1995",7,NA,"T3bN1M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
210394088,202323618,9659627585,"FEA489A8-E423-4266-AADA-9BAAB29AB94B.bw","a4e444b5-bbca-4ef0-b92f-908d608cbb91","fea489a8-e423-4266-aada-9baab29ab94b","2016-08-05T11:28:41.716038-05:00","UNCID_2186690.6EDC7D3A-9F83-449F-A371-C040D8B5164D.121011_UNC13-SN749_0197_AD16K1ACXX_8_TGACCA.tar.gz","ec334293-c065-4d39-b3a5-963ec6d29616",9473646583,"Illumina HiSeq","b94fd77fad41abc65ff25eedf5b32368","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:59:08.102331-05:00","2016-05-03T11:00:24.467501-05:00","ec334293-c065-4d39-b3a5-963ec6d29616_analysis.xml","8210fd2c750f7941f56104b070a31da8","371aa4c2-fede-4386-9b18-dfab3405002c",2124,"2016-08-26T07:17:51.236180-05:00","ec334293-c065-4d39-b3a5-963ec6d29616_experiment.xml","df5e11705504c52b7012dc769ae12515","ee0ef350-c4af-450d-b877-3baac0f45011",2431,"2016-09-29T21:40:19.479820-05:00","ec334293-c065-4d39-b3a5-963ec6d29616_run.xml","1cfbe486053abd5b8201d1b8c454c5cc","9afd3483-e7ee-49ce-9e3e-9e322a5ef95b",354,"2016-09-08T11:42:40.779202-05:00","TCGA-EA-A3QE","2016-09-02T18:59:03.507790-05:00","female","TCGA-EA-A3QE_demographic",1966,"white","c61be201-5c80-52b5-9da8-fb0961a1e30a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A3QE_diagnosis","not reported",16460,"alive","8072/3",NA,761,"79d41491-bc74-55c8-a4c5-12afd80eb656","c53.9",-16460,"TCGA-EA-A3QE_treatment","18f77fb3-de1f-5d0c-be79-86524b03ffaa","01","true","TCGA-EA-A3QE-01A",NA,"36ffa53d-1404-49c0-b9c1-a3eb1ecbc6b9",FALSE,"E3358197-B104-4672-863F-8BE50488B2D0","Primary Tumor",NA,126,380,NA,1330905600,"21",30,"TCGA-EA-A3QE-01A-21",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:42:40.779202-05:00",NA,15,NA,0,NA,"TOP",NA,0,NA,"5acc89ba-acdf-4324-90fd-efee36fd1648",NA,"TCGA-EA-A3QE-01A-02-TSB",NA,100,NA,"d3eb2c90-e25d-4bc0-8b79-950aa0396967","RNA","TCGA-EA-A3QE-01A-21R","43e90e27-79a0-42d5-adf2-7f560a04f041",1.96,0.16,"UV Spec","R","23","TCGA-EA-A3QE-01A-21R-A21T-07","6edc7d3a-9f83-449f-a371-c040d8b5164d",0.16,NA,73,30.780907404284,154,"772ce939-5840-5aa9-941a-fd7c8feb9b6c","TCGA-EA-A3QE_exposure","UNCID_2186690.6EDC7D3A-9F83-449F-A371-C040D8B5164D.121011_UNC13-SN749_0197_AD16K1ACXX_8_TGACCA.tar.gz","2013-09-16T12:13:04.000Z","2013-09-16T12:53:01.000Z","EC334293-C065-4D39-B3A5-963EC6D29616","36FFA53D-1404-49C0-B9C1-A3EB1ECBC6B9","Unaligned reads",9473646583,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6EDC7D3A-9F83-449F-A371-C040D8B5164D","University of North Carolina","564a3abae4b08c5d86914bd0","A4E444B5-BBCA-4EF0-B92F-908D608CBB91","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D3EB2C90-E25D-4BC0-8B79-950AA0396967","2013-09-16T12:53:01.000Z","43E90E27-79A0-42D5-ADF2-7F560A04F041","Russia","NO",1,NA,"Primary Tumor","Asterand",126,"D3EB2C90-E25D-4BC0-8B79-950AA0396967",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.0C3AE6A1-F10D-4EE1-A357-D2F3E0F217D1.txt",380,"TCGA-EA-A3QE-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","36FFA53D-1404-49C0-B9C1-A3EB1ECBC6B9",45,"nationwidechildrens.org_clinical.TCGA-EA-A3QE.xml","Alive",NA,"TCGA-EA-A3QE","NOT HISPANIC OR LATINO","002DABBC-A0DA-47B4-8D50-08241D99D769",NA,47,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Other","Stage IB",NA,NA,"T1b","8072/3","FEMALE","C53.9",217,NA,NA,"WHITE",NA,21,30,"5ACC89BA-ACDF-4324-90FD-EFEE36FD1648","ADBF1D1C-1572-4D87-A3CA-40E1C205C8AC","949429624627d6c5ccc79d7e705e1c1e.bam.bai","TCGA-EA-A3QE-01A-21",80,0,0,15,0,"TOP",0,0,"TCGA-EA-A3QE-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,"TCGA-EA-A3QE-F66113_NTE-1","NO",761,"TUMOR FREE","Alive",NA,"TCGA-EA-A3QE-F66113","TCGA-EA-A3QE",NA,"EA","A3QE","YES","C53.9","8072/3","C53.9","YES","NO",-16460,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",47,NA,NA,NA,"TUMOR FREE","NO",9,5,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2011,"Biopsy (cervical / CT-guided / Other)","YES",14,NA,"G2",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
97339866,96081309,4587327077,"F3FCC207-15CD-41EA-A3EF-F5D2C12AC373.bw","a4f13656-a941-498a-9ac9-f020ed559b35","f3fcc207-15cd-41ea-a3ef-f5d2c12ac373","2016-08-09T17:03:18.814150-05:00","UNCID_2654390.f77f995c-4e18-4803-a703-8f3aee49837b.141010_UNC12-SN629_0394_AC5FTUACXX_7_ATCACG.tar.gz","8042957d-6726-4388-8f57-08e80050f690",4046843365,"Illumina HiSeq","37a440fccc886321c57d3f64835b7e10","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:30.812584-05:00","2016-05-03T12:08:10.830175-05:00","8042957d-6726-4388-8f57-08e80050f690_analysis.xml","4b75591d54298478df1e9415dbb744f2","ee4ccc4c-47fc-4525-8858-69b475f13cf7",2124,"2016-09-29T20:35:45.125282-05:00","8042957d-6726-4388-8f57-08e80050f690_experiment.xml","c2c988b11417318cfa46f26c2b917393","72ce54aa-4d7e-471c-bc3e-544bb8e6b4e4",2628,"2016-09-29T19:17:16.998463-05:00","8042957d-6726-4388-8f57-08e80050f690_run.xml","8bb7610bd2ce85442a686f2f901d9610","428ec589-f109-49b5-a8e5-12b05bff66af",354,"2016-09-08T11:10:45.255250-05:00","TCGA-ZJ-AB0I","2016-09-02T18:54:49.169051-05:00","female","TCGA-ZJ-AB0I_demographic",1981,"white","0bf8d223-a29d-5a24-9e8b-52b4e060f1b7","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AB0I_diagnosis","not reported",9486,"alive","8071/3",NA,0,"15e39925-8402-5ba8-8673-b779b707f8b5","c53.9",-9486,"TCGA-ZJ-AB0I_treatment","23bbd596-4a31-5533-b7fe-ded3d3186c8f","01","true","TCGA-ZJ-AB0I-01A",NA,"91e7aa6c-3424-4e98-a4cc-8c6d3474ed5d",FALSE,"77538CA6-8ACB-4224-BF03-DC7A4BABCEF7","Primary Tumor",NA,2643,200,NA,1396224000,"11",30,"TCGA-ZJ-AB0I-01A-11",95,NA,0,NA,0,NA,20,NA,"2016-09-08T11:10:45.255250-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"7d72e423-76cd-45b7-b17a-bbf669c80834",NA,"TCGA-ZJ-AB0I-01A-01-TSA",NA,80,NA,"0a9330c5-d469-4240-97a2-d183158184a7","RNA","TCGA-ZJ-AB0I-01A-11R","318ed607-6afa-4daf-b3c3-5b6171c68171",1.82,0.18,"UV Spec","R","23","TCGA-ZJ-AB0I-01A-11R-A42T-07","f77f995c-4e18-4803-a703-8f3aee49837b",0.18,0.712328767123288,78,26.0616793076949,173,"832f0c55-6f50-51ec-a4f8-293479ca113d","TCGA-ZJ-AB0I_exposure","UNCID_2654390.f77f995c-4e18-4803-a703-8f3aee49837b.141010_UNC12-SN629_0394_AC5FTUACXX_7_ATCACG.tar.gz","2014-11-05T09:47:04.000Z","2014-11-05T09:59:27.000Z","8042957D-6726-4388-8F57-08E80050F690","91E7AA6C-3424-4E98-A4CC-8C6D3474ED5D","Unaligned reads",4046843365,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F77F995C-4E18-4803-A703-8F3AEE49837B","University of North Carolina","564a3bbae4b0298dd2c88239","A4F13656-A941-498A-9AC9-F020ED559B35","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0A9330C5-D469-4240-97A2-D183158184A7","2014-11-05T09:59:27.000Z","318ED607-6AFA-4DAF-B3C3-5B6171C68171","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",2643,"0A9330C5-D469-4240-97A2-D183158184A7",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C9EB2866-AF28-4560-95FB-CF546AEDDD83.txt",200,"TCGA-ZJ-AB0I-01A",NA,NA,"TCGA",2006,"TCGA-ZJ-AB0I_NTE-1",NA,NA,"91E7AA6C-3424-4E98-A4CC-8C6D3474ED5D",25,"nationwidechildrens.org_clinical.TCGA-ZJ-AB0I.xml","Alive",NA,"TCGA-ZJ-AB0I","NOT HISPANIC OR LATINO",NA,NA,0,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8071/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"7D72E423-76CD-45B7-B17A-BBF669C80834","318ED607-6AFA-4DAF-B3C3-5B6171C68171","UNCID_2648094.f77f995c-4e18-4803-a703-8f3aee49837b.sorted_genome_alignments.bam.bai","TCGA-ZJ-AB0I-01A-11",95,0,0,0,20,"TOP",0,0,"TCGA-ZJ-AB0I-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AB0I",NA,"ZJ","AB0I","YES","C53.9","8071/3","C53.9","NO","YES",-9486,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,25,2006,"Biopsy (cervical / CT-guided / Other)","YES",NA,NA,NA,NA,4,2006,13,NA,NA,"1995",13,NA,"T2bN1MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
48797598,48487521,2317052807,"53DD7AFB-A258-4643-A501-BACC95D17A50.bw","a5885835-9473-455a-bac0-6fa43fa8a866","53dd7afb-a258-4643-a501-bacc95d17a50","2016-08-05T11:11:56.799133-05:00","UNCID_2654383.b6c90737-2ec8-46e6-801a-7e64ba2b5b0b.141006_UNC15-SN850_0395_AC5FH9ACXX_6_ACTGAT.tar.gz","40c2a8b1-9eb9-4691-9f1a-94271a97e72d",2239062186,"Illumina HiSeq","951e8d67dbae28a6b61a244904f11405","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:31:46.293614-05:00","2016-05-03T12:08:10.830175-05:00","40c2a8b1-9eb9-4691-9f1a-94271a97e72d_analysis.xml","eb0b53696bbb52b3ecd8db67b9879b3b","000d60f9-6d95-4e54-a306-869f0efe8d4a",2123,"2016-09-29T18:55:43.864044-05:00","40c2a8b1-9eb9-4691-9f1a-94271a97e72d_experiment.xml","006b0c632b5fddfc670286a3627c9c51","34fb3335-0971-4bf4-96cb-31f537750be8",2628,"2016-09-29T20:29:14.743046-05:00","40c2a8b1-9eb9-4691-9f1a-94271a97e72d_run.xml","8738d6ea4925cb08054afe028c1dd927","6eedb86e-c766-4eb2-a3a6-1679973cfe2e",354,"2016-09-08T11:41:54.892391-05:00","TCGA-VS-A9V0","2016-09-02T18:54:35.770990-05:00","female","TCGA-VS-A9V0_demographic",1955,"not reported","a894f7b7-8563-5f6c-b54f-611c8a25ef35","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V0_diagnosis","not reported",21215,"alive","8482/3",NA,573,"e4307750-9b81-515e-b335-d5c78aeb0b95","c53.9",-21215,"TCGA-VS-A9V0_treatment","300f3619-42df-5aa8-a86f-432c2057d7c9","01","false","TCGA-VS-A9V0-01A",NA,"07a9ae9e-fce3-4975-8726-a3b5e9c2ff71",FALSE,"98E32BD3-DB7B-4E70-B254-19A5CC29B4D3","Primary Tumor",NA,264,140,NA,1390953600,"11",30,"TCGA-VS-A9V0-01A-11",65,NA,1,NA,0,NA,0,NA,"2016-09-08T11:41:54.892391-05:00",NA,8,NA,2,NA,"TOP",NA,0,NA,"be4b2bd0-7eb0-4f7f-953c-0e097be13dd7",NA,"TCGA-VS-A9V0-01A-01-TSA",NA,100,NA,"994e0fb2-6fbd-487c-90db-a16755585e0d","RNA","TCGA-VS-A9V0-01A-11R","08ff7873-f284-4efe-b8b1-6199149d4cab",1.85,0.17,"UV Spec","R","23","TCGA-VS-A9V0-01A-11R-A42T-07","b6c90737-2ec8-46e6-801a-7e64ba2b5b0b",0.17,0.246575342465753,76,30.4438391283448,158,"bee337c2-26ca-5a55-99c9-d26cce8324a6","TCGA-VS-A9V0_exposure","UNCID_2654383.b6c90737-2ec8-46e6-801a-7e64ba2b5b0b.141006_UNC15-SN850_0395_AC5FH9ACXX_6_ACTGAT.tar.gz","2014-11-05T07:27:05.000Z","2014-11-05T07:39:11.000Z","40C2A8B1-9EB9-4691-9F1A-94271A97E72D","07A9AE9E-FCE3-4975-8726-A3B5E9C2FF71","Unaligned reads",2239062186,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B6C90737-2EC8-46E6-801A-7E64BA2B5B0B","University of North Carolina","564a3e02e4b0298dd2c93d8e","A5885835-9473-455A-BAC0-6FA43FA8A866","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","994E0FB2-6FBD-487C-90DB-A16755585E0D","2014-11-05T07:39:11.000Z","08FF7873-F284-4EFE-B8B1-6199149D4CAB","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",264,"994E0FB2-6FBD-487C-90DB-A16755585E0D",NA,"VS","SPRAY_p_TCGAb_420_430_NSP_GenomeWideSNP_6_A04_1524282.nocnv_hg19.seg.txt",140,"TCGA-VS-A9V0-01A",NA,"F3AA1D6F-478C-4EAB-A251-42884E286649","TCGA",2013,"TCGA-VS-A9V0_NTE-1","Complete Remission/Response","WITH TUMOR","EFE38C7C-556C-4A15-BA78-0505E35872F0",58,"nationwidechildrens.org_clinical.TCGA-VS-A9V0.xml","Alive",NA,"TCGA-VS-A9V0",NA,"3F9C4FC7-3654-4899-8283-9F5A367023BB","YES",529,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",1,"Other","Stage IB",NA,NA,"T1b","8482/3","FEMALE","C53.9",420,NA,"11C10893-DDA5-4FD2-84A2-76371809E434",NA,NA,11,30,"BE4B2BD0-7EB0-4F7F-953C-0E097BE13DD7","955A7C09-376E-44C2-81F8-125BBE26E2B6","SPRAY_p_TCGAb_420_430_NSP_GenomeWideSNP_6_A04_1524282.ismpolish.data.txt","TCGA-VS-A9V0-01A-11",65,0,1,8,0,"TOP",0,2,"TCGA-VS-A9V0-01A-01-TSA",100,"Cisplatin","Chemotherapy","TCGA-VS-A9V0-D65886","TCGA-VS-A9V0-R65885","Internal","Primary Tumor Field","TCGA-VS-A9V0-F67690_NTE-1","NO",573,"WITH TUMOR","Alive",NA,"TCGA-VS-A9V0-F67690","TCGA-VS-A9V0",NA,"VS","A9V0","YES","C53.9","8482/3","C53.9","NO","YES",-21215,"FEMALE",NA,NA,"No","No","Alive",529,NA,NA,NA,"WITH TUMOR","YES",1,10,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,58,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,4,2012,4.5,NA,"Complete Remission/Response","2009",6,NA,"T1bNXMX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
74049578,73326165,3503593082,"D850B2A1-1F8A-4A44-A0CF-8D9DD4A1889A.bw","a6a07bc7-ab1b-429d-81ed-d7a890c88e51","d850b2a1-1f8a-4a44-a0cf-8d9dd4a1889a","2016-08-09T14:41:47.954299-05:00","UNCID_2654370.7d481f46-fd01-47ce-b321-39240129af48.141010_UNC12-SN629_0394_AC5FTUACXX_3_GGCTAC.tar.gz","cf8cdc74-e66a-4070-b43a-f0f867873bdd",3017699439,"Illumina HiSeq","a811eb27e7efffa3b916f3e437e2991c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:09:03.054291-05:00","2016-05-03T12:08:10.829131-05:00","cf8cdc74-e66a-4070-b43a-f0f867873bdd_analysis.xml","3a68aca1942dfd6ec64a4e79fc285545","6297c14a-8737-4b9b-aa39-0ba87219c0bc",2124,"2016-08-13T02:26:30.504236-05:00","cf8cdc74-e66a-4070-b43a-f0f867873bdd_experiment.xml","6fd287a088ee46fdc580e97d12030ecd","365023db-ab48-4c84-8f72-9f4738a9ca28",2628,"2016-09-29T21:43:05.109149-05:00","cf8cdc74-e66a-4070-b43a-f0f867873bdd_run.xml","ff4aae5d9f1dff06400f31baa67a3fee","9cba0342-6f10-4d9e-a13c-31a1626e2058",354,"2016-09-08T10:39:29.966197-05:00","TCGA-VS-A9V1","2016-09-02T18:54:36.532744-05:00","female","TCGA-VS-A9V1_demographic",1967,"white","66a61ca7-9c3a-52d5-9f9d-d864b073bd31","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V1_diagnosis","not reported",17001,"dead","8482/3",157,NA,"5d451923-0249-52d4-ad32-f2c7447cffd5","c53.9",-17001,"TCGA-VS-A9V1_treatment","c5e6be9a-7d07-5e48-b142-e1e2310e29df","01","false","TCGA-VS-A9V1-01A",NA,"457c7d04-b8ca-4478-9a41-d086261150aa",FALSE,"BC3B49BB-004C-4079-B1A2-97B74891BFD6","Primary Tumor",NA,217,60,NA,1390953600,"11",30,"TCGA-VS-A9V1-01A-11",60,NA,1,NA,0,NA,0,NA,"2016-09-08T10:39:29.966197-05:00",NA,10,NA,1,NA,"TOP",NA,0,NA,"3bfc4dc9-4133-4a5f-808b-9f7706324b53",NA,"TCGA-VS-A9V1-01A-01-TS1",NA,100,NA,"bbf51a46-5b9e-4459-a8f4-1a78178f90ea","RNA","TCGA-VS-A9V1-01A-11R","ffea5cdf-5617-4305-a142-42f303944e7e",1.86,0.17,"UV Spec","R","23","TCGA-VS-A9V1-01A-11R-A42T-07","7d481f46-fd01-47ce-b321-39240129af48",0.17,0.131506849315068,45,18.7304890738814,155,"46c564a9-85d3-5fcf-a0f8-d19d38ee952f","TCGA-VS-A9V1_exposure","UNCID_2654370.7d481f46-fd01-47ce-b321-39240129af48.141010_UNC12-SN629_0394_AC5FTUACXX_3_GGCTAC.tar.gz","2014-11-05T02:06:04.000Z","2014-11-05T02:18:13.000Z","CF8CDC74-E66A-4070-B43A-F0F867873BDD","457C7D04-B8CA-4478-9A41-D086261150AA","Unaligned reads",3017699439,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7D481F46-FD01-47CE-B321-39240129AF48","University of North Carolina","564a3c2be4b0298dd2c8a6e1","A6A07BC7-AB1B-429D-81ED-D7A890C88E51","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BBF51A46-5B9E-4459-A8F4-1A78178F90EA","2014-11-05T02:18:13.000Z","FFEA5CDF-5617-4305-A142-42F303944E7E","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",217,"BBF51A46-5B9E-4459-A8F4-1A78178F90EA",NA,"VS","UNCID_2654370.7d481f46-fd01-47ce-b321-39240129af48.141010_UNC12-SN629_0394_AC5FTUACXX_3_GGCTAC.tar.gz",60,"TCGA-VS-A9V1-01A",NA,"70591F56-179A-43E5-BC9C-587884B78384","TCGA",2013,"TCGA-VS-A9V1_NTE-1","Progressive Disease","WITH TUMOR","F9668BE8-B3D5-4251-8415-379E52818238",46,"nationwidechildrens.org_clinical.TCGA-VS-A9V1.xml","Dead",157,"TCGA-VS-A9V1",NA,NA,"YES",NA,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",NA,NA,"Stage IVB",NA,NA,"T3b","8482/3","FEMALE","C53.9",420,NA,"05F87958-0746-4CAF-9AF2-C28A02340E27","WHITE",NA,11,30,"3BFC4DC9-4133-4A5F-808B-9F7706324B53","FFEA5CDF-5617-4305-A142-42F303944E7E","UNCID_2654370.7d481f46-fd01-47ce-b321-39240129af48.141010_UNC12-SN629_0394_AC5FTUACXX_3_GGCTAC.tar.gz","TCGA-VS-A9V1-01A-11",60,0,1,10,0,"TOP",0,1,"TCGA-VS-A9V1-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-VS-A9V1-D64593","TCGA-VS-A9V1-R64592","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9V1",NA,"VS","A9V1","YES","C53.9","8482/3","C53.9","NO","YES",-17001,"FEMALE","WHITE",NA,"No","No","Dead",NA,157,NA,NA,"WITH TUMOR","YES",5,9,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,46,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,2.4,NA,"Progressive Disease","2009",18,NA,"T3bNXMX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
87823052,86630761,4129092194,"B3F746DC-E487-4305-9F30-825D1520E8FD.bw","a945fd96-ffb3-4787-bacd-60da4560c8a5","b3f746dc-e487-4305-9f30-825d1520e8fd","2016-08-09T14:40:57.254983-05:00","UNCID_2654377.541b5a26-2819-4cab-bbc7-e88df4999681.141010_UNC12-SN629_0395_BC5FVEACXX_2_TAGCTT.tar.gz","9bebfd3c-9403-46bb-8452-f933950b32ad",3306564235,"Illumina HiSeq","bf808ab783db042f156394fd7f001d9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:15:54.108324-05:00","2016-05-03T12:08:10.830175-05:00","9bebfd3c-9403-46bb-8452-f933950b32ad_analysis.xml","e81def5a631e62eee998c72e09922173","66c0826b-c319-4ecc-9a6a-18e010017533",2124,"2016-09-29T19:53:34.958039-05:00","9bebfd3c-9403-46bb-8452-f933950b32ad_experiment.xml","90cf1a4071f2638133d772b176bc2dca","5935668f-6474-45b3-8a4b-ed20a82b775d",2628,"2016-09-29T18:26:43.094291-05:00","9bebfd3c-9403-46bb-8452-f933950b32ad_run.xml","36dbe86e3e6e4b24a4e98d5fbf11b283","22970b52-d648-496c-ae72-5f10e8fb8356",354,"2016-09-08T11:23:27.266025-05:00","TCGA-VS-A9UT","2016-09-02T18:54:31.569668-05:00","female","TCGA-VS-A9UT_demographic",1941,"asian","795382eb-8837-519f-8788-68a9eecf6081","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UT_diagnosis","not reported",26603,"alive","8482/3",NA,482,"c48f03c0-bae4-593f-9e47-08b982d6aa7a","c53.9",-26603,"TCGA-VS-A9UT_treatment","de4fc764-0ccc-5818-a48c-605452a9b5c3","01","false","TCGA-VS-A9UT-01A",NA,"c772bc85-f358-450a-8693-899eac419271",FALSE,"2CBE50B6-D35F-495B-AF90-7536DBA459D0","Primary Tumor",NA,210,50,NA,1391040000,"11",30,"TCGA-VS-A9UT-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:23:27.266025-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"bb64b2d0-4d40-4aba-a0a3-5fda7a19d6ca",NA,"TCGA-VS-A9UT-01A-01-TS1",NA,80,NA,"27c2ce4e-aa5f-4acd-a1bf-0deb7975b29d","RNA","TCGA-VS-A9UT-01A-11R","671a3720-2731-4023-858b-0fc0b72e9061",1.89,0.18,"UV Spec","R","23","TCGA-VS-A9UT-01A-11R-A42T-07","541b5a26-2819-4cab-bbc7-e88df4999681",0.18,NA,42,20.2546296296296,144,"123edc46-d4af-532d-ba8a-7348331c957b","TCGA-VS-A9UT_exposure","UNCID_2654377.541b5a26-2819-4cab-bbc7-e88df4999681.141010_UNC12-SN629_0395_BC5FVEACXX_2_TAGCTT.tar.gz","2014-11-05T05:06:04.000Z","2014-11-05T05:18:31.000Z","9BEBFD3C-9403-46BB-8452-F933950B32AD","C772BC85-F358-450A-8693-899EAC419271","Unaligned reads",3306564235,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","541B5A26-2819-4CAB-BBC7-E88DF4999681","University of North Carolina","56607536e4b0ec1099f8b6a1","A945FD96-FFB3-4787-BACD-60DA4560C8A5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","27C2CE4E-AA5F-4ACD-A1BF-0DEB7975B29D","2014-11-05T05:18:31.000Z","671A3720-2731-4023-858B-0FC0B72E9061","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",210,"27C2CE4E-AA5F-4ACD-A1BF-0DEB7975B29D",NA,"VS","UNCID_2654377.541b5a26-2819-4cab-bbc7-e88df4999681.141010_UNC12-SN629_0395_BC5FVEACXX_2_TAGCTT.tar.gz",50,"TCGA-VS-A9UT-01A",NA,NA,"TCGA",2013,"TCGA-VS-A9UT_NTE-1","Complete Remission/Response","TUMOR FREE","C772BC85-F358-450A-8693-899EAC419271",72,"nationwidechildrens.org_clinical.TCGA-VS-A9UT.xml","Alive",NA,"TCGA-VS-A9UT",NA,"95A662B8-1508-4BA1-B0D0-F9FDBBA4DCC4","NO",104,"No","Cervix","C53.9","N1","Mucinous Adenocarcinoma of Endocervical Type",1,"Pre-Adjuvant Therapy","Stage IB",NA,NA,"T1b1","8482/3","FEMALE","C53.9",420,NA,NA,"ASIAN",NA,11,30,"BB64B2D0-4D40-4ABA-A0A3-5FDA7A19D6CA","671A3720-2731-4023-858B-0FC0B72E9061","UNCID_2654377.541b5a26-2819-4cab-bbc7-e88df4999681.141010_UNC12-SN629_0395_BC5FVEACXX_2_TAGCTT.tar.gz","TCGA-VS-A9UT-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-VS-A9UT-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UT-F68155_NTE-1","NO",482,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UT-F68155","TCGA-VS-A9UT",NA,"VS","A9UT","YES","C53.9","8482/3","C53.9","NO","YES",-26603,"FEMALE","ASIAN",NA,"No","No","Alive",104,NA,NA,NA,"TUMOR FREE","YES",1,10,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,72,2013,"Biopsy (cervical / CT-guided / Other)","YES",14,1,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",6,NA,"T1b1N1MX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
145809076,143253184,6837878286,"BE38240A-F7C2-439F-9AAE-51C8A340F310.bw","ac0ae100-8072-47cc-81d9-8b52b1bf9236","be38240a-f7c2-439f-9aae-51c8a340f310","2016-08-06T19:55:09.504068-05:00","UNCID_2186959.fa8d81bb-a026-426c-8e24-2c8ca93007c4.121002_UNC11-SN627_0254_AC0WP5ACXX_7_ATTCCT.tar.gz","61c2ccb9-fe27-4768-abff-e9ed523431ca",6122304525,"Illumina HiSeq","75910e7385eff9b5661a762e7db4c69e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:29:24.538524-05:00","2016-05-03T11:00:24.457874-05:00","61c2ccb9-fe27-4768-abff-e9ed523431ca_analysis.xml","ed7c1be8ad2297d01952bf63c5164954","4a38d506-b032-4780-a67e-226db93dae3c",2124,"2016-09-29T18:17:34.857880-05:00","61c2ccb9-fe27-4768-abff-e9ed523431ca_experiment.xml","72178173917d5c15ed3081c73663b549","1cee5f13-dcdb-414e-8f92-bd69b7dc66bb",2431,"2016-09-30T00:12:45.099933-05:00","61c2ccb9-fe27-4768-abff-e9ed523431ca_run.xml","3699d09368140279e3ecc487fa258db2","f96ad27a-73dc-4973-80a5-32b639c29c94",354,"2016-09-08T11:43:31.466901-05:00","TCGA-EK-A2RC","2016-09-02T18:58:27.099701-05:00","female","TCGA-EK-A2RC_demographic",1976,"not reported","d8c5cc9f-73ea-56bc-8df0-39e309b0637b","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RC_diagnosis","not reported",12353,"alive","8070/3",NA,129,"c0f44d03-3ae1-50d5-9e8a-094eabdb9f90","c53.9",-12353,"TCGA-EK-A2RC_treatment","6880ed6f-c9e2-5b26-b4d8-05650f6ad532","01","false","TCGA-EK-A2RC-01A",NA,"0e8c70c9-1e73-4173-b82f-e5df1cae8bc2",FALSE,"1FBD6F5F-52DB-4DA3-AB1D-BB81200A032B","Primary Tumor",NA,786,100,NA,1315785600,"11",30,"TCGA-EK-A2RC-01A-11",92,NA,0,NA,5,NA,10,NA,"2016-09-08T11:43:31.466901-05:00",NA,2,NA,0,NA,"TOP",NA,1,NA,"11838234-0c42-4636-a22f-be2e0cecfc72",NA,"TCGA-EK-A2RC-01A-01-TS1",NA,84,NA,"0f05ea48-12a9-4002-a7a2-64ed04879d5b","RNA","TCGA-EK-A2RC-01A-11R","bba6c827-6580-47dd-a833-84d133b58be5",1.86,0.16,"UV Spec","R","23","TCGA-EK-A2RC-01A-11R-A18M-07","fa8d81bb-a026-426c-8e24-2c8ca93007c4",0.16,NA,72,24.9134948096886,170,"659dee9c-0c5f-5a60-98f4-c9571bd2ebc9","TCGA-EK-A2RC_exposure","UNCID_2186959.fa8d81bb-a026-426c-8e24-2c8ca93007c4.121002_UNC11-SN627_0254_AC0WP5ACXX_7_ATTCCT.tar.gz","2013-09-16T07:07:04.000Z","2013-09-16T07:45:01.000Z","61C2CCB9-FE27-4768-ABFF-E9ED523431CA","0E8C70C9-1E73-4173-B82F-E5DF1CAE8BC2","Unaligned reads",6122304525,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FA8D81BB-A026-426C-8E24-2C8CA93007C4","University of North Carolina","56607477e4b016715ab67587","AC0AE100-8072-47CC-81D9-8B52B1BF9236","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0F05EA48-12A9-4002-A7A2-64ED04879D5B","2013-09-16T07:45:01.000Z","BBA6C827-6580-47DD-A833-84D133B58BE5","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",786,"0F05EA48-12A9-4002-A7A2-64ED04879D5B",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.272D7304-B95D-43A9-B70C-20E37C81082C.txt",100,"TCGA-EK-A2RC-01A",NA,NA,"TCGA",2009,NA,NA,NA,"7515ED16-1CF5-4CF0-BC49-7F1885346EDA",33,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.272D7304-B95D-43A9-B70C-20E37C81082C.txt","Alive",NA,"TCGA-EK-A2RC",NA,"1AAF985E-FB66-409A-AB1F-10C81A5AA92C",NA,131,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,NA,"8070/3","FEMALE","C53.9",179,NA,NA,NA,NA,11,30,"11838234-0C42-4636-A22F-BE2E0CECFC72","9C10E05E-4C6B-4B84-B91E-0173FFED9ACB","UNCID_2186959.fa8d81bb-a026-426c-8e24-2c8ca93007c4.121002_UNC11-SN627_0254_AC0WP5ACXX_7_ATTCCT.tar.gz","TCGA-EK-A2RC-01A-11",92,5,0,2,10,"TOP",1,0,"TCGA-EK-A2RC-01A-01-TS1",84,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RC-F58260_NTE-1",NA,131,NA,"Alive",NA,"TCGA-EK-A2RC-F58260","TCGA-EK-A2RC",NA,"EK","A2RC","YES","C53.9","8070/3","C53.9","NO","YES",-12353,"FEMALE",NA,NA,"No","No","Alive",129,NA,NA,NA,"TUMOR FREE","NO",7,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,33,2009,"Other method, specify:","YES",16,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
176351472,172573293,8231437165,"A9022D9E-1D30-49EE-8552-1364A8027F34.bw","acbfeb99-2b6b-4232-9ab5-a58549c6bc3a","a9022d9e-1d30-49ee-8552-1364a8027f34","2016-08-09T13:39:52.706600-05:00","UNCID_2186432.2713b35a-f04a-4078-85c6-34140350398f.121102_UNC15-SN850_0240_BD148CACXX_8_CCGTCC.tar.gz","f082bf26-9ee0-4d08-bab9-c318e7fbfb95",7902714693,"Illumina HiSeq","24594445741b4f03cd4a7cb42ed30345","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:45:08.254168-05:00","2016-05-03T11:00:24.467483-05:00","f082bf26-9ee0-4d08-bab9-c318e7fbfb95_analysis.xml","a74770424a10bdd127138b7dcf206454","e8848ee0-282d-4655-86b2-2e11b38bcaa1",2124,"2016-09-29T22:04:29.021351-05:00","f082bf26-9ee0-4d08-bab9-c318e7fbfb95_experiment.xml","77ba97ec0591cd041e3ad372a5640176","aa1d410a-f3f8-4e90-ba11-e0126bf94290",2431,"2016-09-29T17:53:17.851656-05:00","f082bf26-9ee0-4d08-bab9-c318e7fbfb95_run.xml","183d6520f7f0e246cc8426120c606c54","0dc2d544-8d70-45fe-83c8-f9439206bd80",354,"2016-09-08T12:02:20.751399-05:00","TCGA-EK-A2RK","2016-09-02T18:58:28.717184-05:00","female","TCGA-EK-A2RK_demographic",1942,"white","5fe8d63d-9a1a-5968-a6f3-92764a3af197","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RK_diagnosis","not reported",24541,"alive","8072/3",NA,13,"d4054349-3e1d-5019-bf6e-38dbbf020722","c53.9",-24541,"TCGA-EK-A2RK_treatment","fa23e784-15a2-5ae0-a3ae-8477da35f808","01","false","TCGA-EK-A2RK-01A",NA,"b51d8c9b-f387-4e28-a592-b53fe6c2fd8b",FALSE,"53039912-13F8-4EB8-B8DD-39B39F2AE486","Primary Tumor",NA,709,120,NA,1315785600,"11",30,"TCGA-EK-A2RK-01A-11",70,NA,0,NA,37,NA,10,NA,"2016-09-08T12:02:20.751399-05:00",NA,10,NA,0,NA,"TOP",NA,3,NA,"e459116a-acaf-4139-83b4-cb2f99b5722c",NA,"TCGA-EK-A2RK-01A-01-TS1",NA,50,NA,"2eba3f8b-11ac-4f75-b837-5d209ff9a504","RNA","TCGA-EK-A2RK-01A-11R","5ac9dc8e-e02e-4a7e-8027-dd1d61800860",1.78,0.17,"UV Spec","R","23","TCGA-EK-A2RK-01A-11R-A18M-07","2713b35a-f04a-4078-85c6-34140350398f",0.17,NA,101,37.0982552800735,165,"349da671-cff1-5660-8b2c-ae3ba265042b","TCGA-EK-A2RK_exposure","UNCID_2186432.2713b35a-f04a-4078-85c6-34140350398f.121102_UNC15-SN850_0240_BD148CACXX_8_CCGTCC.tar.gz","2013-09-16T09:16:05.000Z","2013-09-16T10:43:01.000Z","F082BF26-9EE0-4D08-BAB9-C318E7FBFB95","B51D8C9B-F387-4E28-A592-B53FE6C2FD8B","Unaligned reads",7902714693,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2713B35A-F04A-4078-85C6-34140350398F","University of North Carolina","564a3f80e4b08c5d8692d0f1","ACBFEB99-2B6B-4232-9AB5-A58549C6BC3A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2EBA3F8B-11AC-4F75-B837-5D209FF9A504","2013-09-16T10:43:01.000Z","5AC9DC8E-E02E-4A7E-8027-DD1D61800860","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",709,"2EBA3F8B-11AC-4F75-B837-5D209FF9A504",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8946907D-9AB9-4A3F-80CD-5689DAAB4556.txt",120,"TCGA-EK-A2RK-01A",NA,NA,"TCGA",2009,NA,NA,NA,"EFFC7CC4-57CB-46E5-AA64-FF8BB19D6BF3",67,"nationwidechildrens.org_clinical.TCGA-EK-A2RK.xml","Alive",NA,"TCGA-EK-A2RK","NOT HISPANIC OR LATINO","F2FF4121-2857-47A6-A8C4-FA6F3ECA9EC5",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,NA,"Stage IA2",NA,NA,"T1b1","8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"E459116A-ACAF-4139-83B4-CB2F99B5722C","EBDCDC14-EDB8-4E9E-97F9-7CEB2B44CEF6","93b883f5ac9ee78df800c56af53c57a1.bam","TCGA-EK-A2RK-01A-11",70,37,0,10,10,"TOP",3,0,"TCGA-EK-A2RK-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RK-F58268_NTE-1",NA,13,NA,"Alive",NA,"TCGA-EK-A2RK-F58268","TCGA-EK-A2RK",NA,"EK","A2RK","YES","C53.9","8072/3","C53.9","NO","YES",-24541,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",13,NA,NA,NA,NA,"NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,67,2009,"Other method, specify:","YES",27,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",5,NA,"T1b1N0MX",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125022170,122473516,5843273651,"0E8A56EE-D9A2-48A5-B793-A358BE1E4EFA.bw","acf5cbf3-09ca-4f4d-a44e-1792613190fc","0e8a56ee-d9a2-48a5-b793-a358be1e4efa","2016-08-05T06:00:07.479640-05:00","UNCID_2168997.5005b96a-a215-43a0-8b55-f212891bca11.130611_UNC15-SN850_0312_BC265JACXX_3_AGTTCC.tar.gz","4963a442-5789-4cb9-9267-5879a54e3473",5604076316,"Illumina HiSeq","0dc9397babdfbce0ef5321f5395948c7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:40:38.981450-05:00","2016-05-03T11:06:28.634130-05:00","4963a442-5789-4cb9-9267-5879a54e3473_analysis.xml","5c9a4c2d563390f95e113ae404085d0e","75e53b53-a24e-4b1e-a838-ac5e3b639c64",2123,"2016-09-29T18:59:15.751154-05:00","4963a442-5789-4cb9-9267-5879a54e3473_experiment.xml","052a66e4be63a12f7eaaf5357a14996c","3734b4d5-d784-404e-b8ae-decb5b4356e5",2431,"2016-09-29T19:55:12.827104-05:00","4963a442-5789-4cb9-9267-5879a54e3473_run.xml","6f242730d9c43f1fbbef1fcd8c01cf82","5a3864d4-2cc5-421c-b274-75453b2b26a9",354,"2016-09-08T12:05:14.891571-05:00","TCGA-JX-A5QV","2016-09-02T19:00:04.799482-05:00","female","TCGA-JX-A5QV_demographic",1975,"white","dd1d8d29-dffa-5481-8e33-51f75b8771b6","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JX","6d97b3ee-83c4-5be1-9919-0fdd90c1bb19","Washington University","not reported","c53.9","TCGA-JX-A5QV_diagnosis","not reported",13667,"alive","8071/3",NA,636,"db38b6bb-5109-57f6-be56-aebd386d50fb","c53.9",-13667,"TCGA-JX-A5QV_treatment","aa935361-04fa-55c0-9a23-fee7be633bfa","01","true","TCGA-JX-A5QV-01A",NA,"dbf0af15-1463-4884-94d9-959ea3cabb67",FALSE,"6C4DBD4D-8F4E-4680-AE60-1AFE2BF72732","Primary Tumor",NA,147,120,NA,1361232000,"22",20,"TCGA-JX-A5QV-01A-22",60,NA,0,NA,20,NA,20,NA,"2016-09-08T12:05:14.891571-05:00",NA,5,NA,5,NA,"TOP",NA,0,NA,"dead6c31-a859-4fe6-a7ba-8f1a7993d622",NA,"TCGA-JX-A5QV-01A-02-TSB",NA,60,NA,"433b6b45-111f-4b1d-b0c3-60ccf65f8aa8","RNA","TCGA-JX-A5QV-01A-22R","feda871d-42ae-4347-820e-bcbdf0746c92",1.88,0.17,"UV Spec","R","23","TCGA-JX-A5QV-01A-22R-A28H-07","5005b96a-a215-43a0-8b55-f212891bca11",0.17,NA,61,22.4058769513315,165,"c78fcf57-bbea-52f7-9bfc-70aec6f91578","TCGA-JX-A5QV_exposure","UNCID_2168997.5005b96a-a215-43a0-8b55-f212891bca11.130611_UNC15-SN850_0312_BC265JACXX_3_AGTTCC.tar.gz","2013-09-20T05:16:05.000Z","2013-09-20T05:46:01.000Z","4963A442-5789-4CB9-9267-5879A54E3473","DBF0AF15-1463-4884-94D9-959EA3CABB67","Unaligned reads",5604076316,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5005B96A-A215-43A0-8B55-F212891BCA11","University of North Carolina","564a3a3be4b09c884b240075","ACF5CBF3-09CA-4F4D-A44E-1792613190FC","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","433B6B45-111F-4B1D-B0C3-60CCF65F8AA8","2013-09-20T05:46:01.000Z","FEDA871D-42AE-4347-820E-BCBDF0746C92","United States","NO",1,NA,"Primary Tumor","Washington University",147,"433B6B45-111F-4B1D-B0C3-60CCF65F8AA8",NA,"JX","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F32F346E-9E0B-4EDA-AB4D-09FCC54BED28.txt",120,"TCGA-JX-A5QV-01A",NA,NA,"TCGA",2012,"TCGA-JX-A5QV_NTE-1","Complete Remission/Response","TUMOR FREE","DBF0AF15-1463-4884-94D9-959EA3CABB67",37,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F32F346E-9E0B-4EDA-AB4D-09FCC54BED28.txt","Alive",NA,"TCGA-JX-A5QV","NOT HISPANIC OR LATINO","E43ED47D-9FCF-4089-9098-1FB49E4D48FD","NO",243,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",297,NA,"6F46A440-07E9-474B-AF81-CE435012F81D","WHITE",NA,22,20,"DEAD6C31-A859-4FE6-A7BA-8F1A7993D622","FEDA871D-42AE-4347-820E-BCBDF0746C92","UNCID_2061440.5005b96a-a215-43a0-8b55-f212891bca11.sorted_genome_alignments.bam","TCGA-JX-A5QV-01A-22",60,20,0,5,20,"TOP",0,5,"TCGA-JX-A5QV-01A-02-TSB",60,NA,NA,NA,"TCGA-JX-A5QV-R63623","Internal","Primary Tumor Field","TCGA-JX-A5QV-F71657_NTE-1","NO",636,"TUMOR FREE","Alive",NA,"TCGA-JX-A5QV-F71657","TCGA-JX-A5QV",NA,"JX","A5QV","YES","C53.9","8071/3","C53.9","NO","YES",-13667,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",243,NA,NA,NA,"TUMOR FREE","YES",11,6,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,2012,"Biopsy (cervical / CT-guided / Other)","YES",13,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
178992420,176355924,8415828404,"51667574-318E-4BDB-8F42-8512A4C1B84F.bw","ada77320-fd05-4e43-be72-864391044b35","51667574-318e-4bdb-8f42-8512a4c1b84f","2016-08-08T18:47:17.716905-05:00","UNCID_2186167.95a815e7-101e-416c-90b0-5c6c568ab897.121102_UNC12-SN629_0235_AC13F5ACXX_3_ACTGAT.tar.gz","4e63eef5-0eb5-4e5d-8d5c-0a960710bcbc",8068426521,"Illumina HiSeq","850b937e09bad8c884d8cd6ba6e8e9c6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:17:13.665807-05:00","2016-05-03T11:00:24.444360-05:00","4e63eef5-0eb5-4e5d-8d5c-0a960710bcbc_analysis.xml","06d5e21795346cba6609b7c6745b0b03","1cb6adb0-dcb9-42db-b2c5-b1e4598efa06",2124,"2016-08-26T16:18:32.413585-05:00","4e63eef5-0eb5-4e5d-8d5c-0a960710bcbc_experiment.xml","2c31a1bea3fed165d0d73059c0a3ddb2","2e138b0f-73e0-455d-87a4-8fb982fd85f3",2431,"2016-09-29T19:54:11.595095-05:00","4e63eef5-0eb5-4e5d-8d5c-0a960710bcbc_run.xml","3e9a7e51cd61cd8798ca9ba76dcf5c02","5993dc5b-7e71-47cf-aeb3-9e0c53eee4b2",354,"2016-09-08T12:15:40.300992-05:00","TCGA-EK-A2RA","2016-09-02T18:58:25.651370-05:00","female","TCGA-EK-A2RA_demographic",1937,"not reported","5bd84de1-fb17-529d-8c85-5d2aadacbbc8","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RA_diagnosis","not reported",27209,"alive","8072/3",NA,1246,"ef58ae33-d162-56a3-b9da-a88b0f11f63c","c53.9",-27209,"TCGA-EK-A2RA_treatment","c37e14ad-0072-5c63-811c-66d0b34d4398","01","false","TCGA-EK-A2RA-01A",NA,"cf39d26f-ae75-40ee-a809-3f48e2558e54",FALSE,"4BF58062-E21B-4C5E-91D3-8AB242D8D62E","Primary Tumor",NA,232,130,NA,1315785600,"11",30,"TCGA-EK-A2RA-01A-11",65,NA,0,NA,15,NA,22,NA,"2016-09-08T12:15:40.300992-05:00",NA,25,NA,0,NA,"TOP",NA,3,NA,"81460008-abf6-4d9f-87a9-6f85a4d310c3",NA,"TCGA-EK-A2RA-01A-01-TS1",NA,60,NA,"82453af1-579d-4e1b-af1e-593a50290680","RNA","TCGA-EK-A2RA-01A-11R","59a368bd-1d4e-49e1-bb6f-83aa4a7765c7",1.9,0.17,"UV Spec","R","23","TCGA-EK-A2RA-01A-11R-A18M-07","95a815e7-101e-416c-90b0-5c6c568ab897",0.17,NA,72,28.125,160,"1a4f5a92-4830-52fe-afba-fa296ab3eb26","TCGA-EK-A2RA_exposure","UNCID_2186167.95a815e7-101e-416c-90b0-5c6c568ab897.121102_UNC12-SN629_0235_AC13F5ACXX_3_ACTGAT.tar.gz","2013-09-16T01:45:20.000Z","2013-09-16T02:08:01.000Z","4E63EEF5-0EB5-4E5D-8D5C-0A960710BCBC","CF39D26F-AE75-40EE-A809-3F48E2558E54","Unaligned reads",8068426521,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","95A815E7-101E-416C-90B0-5C6C568AB897","University of North Carolina","56607466e4b0ca319164c365","ADA77320-FD05-4E43-BE72-864391044B35","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","82453AF1-579D-4E1B-AF1E-593A50290680","2013-09-16T02:08:01.000Z","59A368BD-1D4E-49E1-BB6F-83AA4A7765C7","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",232,"82453AF1-579D-4E1B-AF1E-593A50290680",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A6DF7C14-361B-4DFF-B886-9EE48F169CD4.txt",130,"TCGA-EK-A2RA-01A",NA,NA,"TCGA",2011,NA,NA,"WITH TUMOR","CF39D26F-AE75-40EE-A809-3F48E2558E54",74,"nationwidechildrens.org_clinical.TCGA-EK-A2RA.xml","Alive",NA,"TCGA-EK-A2RA","HISPANIC OR LATINO","63BA1DDB-BC51-49A6-B0E7-2E73A933A114",NA,302,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIA2",NA,NA,"T2a2","8072/3","FEMALE","C53.9",179,NA,NA,NA,NA,11,30,"81460008-ABF6-4D9F-87A9-6F85A4D310C3","6F2EEB73-A08A-4130-9703-D6E8ED5E615A","UNCID_1726632.95a815e7-101e-416c-90b0-5c6c568ab897.sorted_genome_alignments.bam.bai","TCGA-EK-A2RA-01A-11",65,15,0,25,22,"TOP",3,0,"TCGA-EK-A2RA-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RA-F58256_NTE-1","NO",489,"WITH TUMOR","Alive",NA,"TCGA-EK-A2RA-F58256","TCGA-EK-A2RA",NA,"EK","A2RA","YES","C53.9","8072/3","C53.9","NO","YES",-27209,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",302,NA,NA,NA,"WITH TUMOR","NO",4,1,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,74,2011,"Other method, specify:","YES",32,0,"G3",NA,4,2010,NA,NA,NA,"2009",12,NA,"T2a2N0MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
116832774,111034031,5295373301,"B0A442C9-67E4-4534-8A5C-D6D73F42358C.bw","adb7c5c8-4afd-40dc-89f1-571fbd88e4f9","b0a442c9-67e4-4534-8a5c-d6d73f42358c","2016-08-09T14:41:07.697386-05:00","UNCID_2654407.476a57b4-654c-48b3-929b-37996cd93f45.140815_UNC11-SN627_0374_AC5FPLACXX_7_GCCAAT.tar.gz","33bb9817-0262-423d-84c2-071153b0e2bc",5122639691,"Illumina HiSeq","36f22fd876a5f6612b630d213cffca79","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:04:49.423619-05:00","2016-05-03T12:08:10.840133-05:00","33bb9817-0262-423d-84c2-071153b0e2bc_analysis.xml","974326b7363428631588a670b44f825f","aa556cb2-487c-4684-87a5-1edff145e814",2124,"2016-09-29T19:20:02.180942-05:00","33bb9817-0262-423d-84c2-071153b0e2bc_experiment.xml","282d332950d39d205b41d260d9bfedbc","444dd5ab-e122-434f-afbe-f5fa0bcc1a18",2628,"2016-09-29T22:43:37.682493-05:00","33bb9817-0262-423d-84c2-071153b0e2bc_run.xml","7b5373ffdeb5a30a06aaac06635f9d4f","c23499a3-df8b-4237-88be-380038fca18e",354,"2016-09-08T10:26:44.620002-05:00","TCGA-MA-AA3X","2016-09-02T18:54:11.578944-05:00","female","TCGA-MA-AA3X_demographic",1962,"black or african american","008191e0-bcae-5349-89e1-8b1cf0fd8799","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA3X_diagnosis","not reported",18412,"alive","8070/3",NA,595,"cdade31a-0b6c-587c-ac9f-963fd5aafc3d","c53.9",-18412,"TCGA-MA-AA3X_treatment","08fb9ba2-a2c2-5764-b730-98a7a5a614c0","01","false","TCGA-MA-AA3X-01A",NA,"8fc32f98-8bd2-4f9d-9039-c6092145d1d3",FALSE,"FE614842-9700-472D-B1D8-F2DFF940D489","Primary Tumor",NA,471,130,NA,1393200000,"22",10,"TCGA-MA-AA3X-01A-22",80,NA,0,NA,0,NA,18,NA,"2016-09-08T10:26:44.620002-05:00",NA,10,NA,0,NA,"TOP",NA,2,NA,"137eda04-da64-42b4-a7a6-bfa7100a0478",NA,"TCGA-MA-AA3X-01A-02-TSB",NA,80,NA,"e49f4d42-eac4-473a-99df-cddf94f2f296","RNA","TCGA-MA-AA3X-01A-22R","3d6679f9-2d93-4656-aa8c-71c547e71c61",1.8,0.15,"UV Spec","R","23","TCGA-MA-AA3X-01A-22R-A42S-07","476a57b4-654c-48b3-929b-37996cd93f45",0.15,0.520547945205479,73,25.2595155709343,170,"9e3360e6-f610-50e4-b59d-8d6e433aefc3","TCGA-MA-AA3X_exposure","UNCID_2654407.476a57b4-654c-48b3-929b-37996cd93f45.140815_UNC11-SN627_0374_AC5FPLACXX_7_GCCAAT.tar.gz","2014-11-05T15:27:04.000Z","2014-11-05T15:46:13.000Z","33BB9817-0262-423D-84C2-071153B0E2BC","8FC32F98-8BD2-4F9D-9039-C6092145D1D3","Unaligned reads",5122639691,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","476A57B4-654C-48B3-929B-37996CD93F45","University of North Carolina","564a4056e4b09c884b25d66d","ADB7C5C8-4AFD-40DC-89F1-571FBD88E4F9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E49F4D42-EAC4-473A-99DF-CDDF94F2F296","2014-11-05T15:46:13.000Z","3D6679F9-2D93-4656-AA8C-71C547E71C61","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",471,"E49F4D42-EAC4-473A-99DF-CDDF94F2F296",NA,"MA","UNCID_2654407.476a57b4-654c-48b3-929b-37996cd93f45.140815_UNC11-SN627_0374_AC5FPLACXX_7_GCCAAT.tar.gz",130,"TCGA-MA-AA3X-01A",NA,"10F27E3D-3267-4B36-A08A-A46F8A6D8FD0","TCGA",2012,"TCGA-MA-AA3X_NTE-1","Complete Remission/Response","TUMOR FREE","8FC32F98-8BD2-4F9D-9039-C6092145D1D3",50,"WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_G10_1524124.nocnv_hg19.seg.txt","Alive",NA,"TCGA-MA-AA3X","NOT HISPANIC OR LATINO","05FBA44C-3968-4E81-A1E3-DD0A815C11DC","NO",617,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,"0B1E56C2-01B9-4ED5-85E2-6298F03082A2","BLACK OR AFRICAN AMERICAN",NA,22,10,"137EDA04-DA64-42B4-A7A6-BFA7100A0478","3D6679F9-2D93-4656-AA8C-71C547E71C61","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_G10_1524124.CEL","TCGA-MA-AA3X-01A-22",80,0,0,10,18,"TOP",2,0,"TCGA-MA-AA3X-01A-02-TSB",80,"Cisplatin","Chemotherapy","TCGA-MA-AA3X-D64892","TCGA-MA-AA3X-R64893","External","Primary Tumor Field","TCGA-MA-AA3X-F65478_NTE-1","NO",595,"TUMOR FREE","Alive",NA,"TCGA-MA-AA3X-F65478","TCGA-MA-AA3X",NA,"MA","AA3X","YES","C53.9","8070/3","C53.9","YES","NO",-18412,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",617,NA,NA,NA,"TUMOR FREE","YES",15,7,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,50,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,2,NA,9.5,NA,"Complete Remission/Response","2009",16,NA,"T3bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
98132098,97243786,4645723954,"25A5BC09-0D88-4385-87AF-997F9018522D.bw","adc60720-ac20-4e73-9c37-3ad3119c07d6","25a5bc09-0d88-4385-87af-997f9018522d","2016-08-09T14:40:50.664459-05:00","UNCID_2654368.c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a.141010_UNC12-SN629_0394_AC5FTUACXX_5_GAGTGG.tar.gz","04f53df2-4a04-4358-893d-b01c8073f0a1",4089764107,"Illumina HiSeq","8d0cea34e1eb2ca054c588647c7de79b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:41:54.564365-05:00","2016-05-03T12:08:10.829131-05:00","04f53df2-4a04-4358-893d-b01c8073f0a1_analysis.xml","5cca5f8bd4046f2d40e5764d7abd7a6a","c12c4a80-7c7b-4ace-8c9e-b632da8088f2",2124,"2016-08-13T08:18:37.754443-05:00","04f53df2-4a04-4358-893d-b01c8073f0a1_experiment.xml","7f7018c719f1b3c68a3bc3435554b367","04b831d3-73ee-4f79-9660-dc48653ad3b5",2628,"2016-09-29T20:15:52.361988-05:00","04f53df2-4a04-4358-893d-b01c8073f0a1_run.xml","4e8d38c6b0fd0c4b061d52eb909c13da","66bacf13-d1ab-4871-bded-9cea182eaed8",354,"2016-09-08T11:47:18.369632-05:00","TCGA-VS-A9UR","2016-09-02T18:54:31.076343-05:00","female","TCGA-VS-A9UR_demographic",1960,"white","41c2f061-47c8-5db8-8740-42ecfce5ba0b","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UR_diagnosis","not reported",19688,"alive","8482/3",NA,793,"9251545a-4b97-5a1c-8d0e-6887cb8f85a6","c53.9",-19688,"TCGA-VS-A9UR_treatment","f041e46b-b938-581b-a904-c24b39318d1d","01","false","TCGA-VS-A9UR-01A",NA,"5a8cd4a4-4a2f-4765-a2c9-9b362c867822",FALSE,"BD8A6A1F-9210-4A69-AB09-EDCFC5F28482","Primary Tumor",NA,323,80,NA,1391040000,"11",30,"TCGA-VS-A9UR-01A-11",80,NA,20,NA,0,NA,20,NA,"2016-09-08T11:47:18.369632-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"329f5e80-edfb-4c90-8374-06019a949e26",NA,"TCGA-VS-A9UR-01A-01-TS1",NA,80,NA,"2069a6ee-bbe8-4493-bcf4-9a2f0a5b1f42","RNA","TCGA-VS-A9UR-01A-11R","d122b2d9-b6a4-4979-a528-3194a8e057a7",1.91,0.18,"UV Spec","R","23","TCGA-VS-A9UR-01A-11R-A42T-07","c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a",0.18,NA,64,24.6904054627522,161,"2180a263-3509-500b-889c-2675109759f1","TCGA-VS-A9UR_exposure","UNCID_2654368.c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a.141010_UNC12-SN629_0394_AC5FTUACXX_5_GAGTGG.tar.gz","2014-11-05T01:47:04.000Z","2014-11-05T02:00:03.000Z","04F53DF2-4A04-4358-893D-B01C8073F0A1","5A8CD4A4-4A2F-4765-A2C9-9B362C867822","Unaligned reads",4089764107,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C4FFA8AE-421E-4259-B3EC-EE69FC94FC1A","University of North Carolina","566076e5e4b0b37b3d9908f5","ADC60720-AC20-4E73-9C37-3AD3119C07D6","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2069A6EE-BBE8-4493-BCF4-9A2F0A5B1F42","2014-11-05T02:00:03.000Z","D122B2D9-B6A4-4979-A528-3194A8E057A7","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",323,"2069A6EE-BBE8-4493-BCF4-9A2F0A5B1F42",NA,"VS","86d98de0fdf53c1684641472388d8f99.bam",80,"TCGA-VS-A9UR-01A",NA,"5160FB3B-17E6-47A9-B589-32D895E197B2","TCGA",2013,"TCGA-VS-A9UR_NTE-1","Complete Remission/Response","TUMOR FREE","67211D18-7858-4234-9AF6-AC99136DE6C9",53,"UNCID_2654368.c4ffa8ae-421e-4259-b3ec-ee69fc94fc1a.141010_UNC12-SN629_0394_AC5FTUACXX_5_GAGTGG.tar.gz","Alive",NA,"TCGA-VS-A9UR",NA,"7DAABB56-D4E2-49D7-95DC-42116E9B527B","NO",455,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",1,"Pre-Adjuvant Therapy","Stage IIA",NA,NA,"T2a","8482/3","FEMALE","C53.9",420,NA,"DC4C2E2D-7373-4754-B7F7-7D881203103C","WHITE",NA,11,30,"329F5E80-EDFB-4C90-8374-06019A949E26","18D692C7-7674-4D9E-9DF6-5E52EF1C3A56","86d98de0fdf53c1684641472388d8f99.bam","TCGA-VS-A9UR-01A-11",80,0,20,40,20,"TOP",0,20,"TCGA-VS-A9UR-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A9UR-D63470","TCGA-VS-A9UR-R63468","External","Regional site","TCGA-VS-A9UR-F72067_NTE-1","YES",793,"WITH TUMOR","Alive",NA,"TCGA-VS-A9UR-F72067","TCGA-VS-A9UR",NA,"VS","A9UR","YES","C53.9","8482/3","C53.9","NO","YES",-19688,"FEMALE","WHITE",NA,"No","No","Alive",455,NA,NA,NA,"TUMOR FREE","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,53,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",10,NA,"T2aNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
142266780,139712074,6672014493,"344B9631-AAA5-4302-8747-D584345D9131.bw","aed93a3a-7dcb-4ba9-84c0-bc735cbd545f","344b9631-aaa5-4302-8747-d584345d9131","2016-08-25T14:36:03.128201-05:00","UNCID_2520219.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.140417_UNC13-SN749_0343_BC41HBACXX_6_CGATGT.tar.gz","2fa97376-5d29-40e6-93ec-af33935deef0",6336870103,"Illumina HiSeq","e721967176895e99074e6b343b6c870f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:38.744927-05:00","2016-05-03T11:51:27.516015-05:00","2fa97376-5d29-40e6-93ec-af33935deef0_analysis.xml","008354144a83d5a990ae2ff218a3a63a","0846aee4-c9d1-425a-ac10-5659a146af02",2124,"2016-09-29T18:41:44.188609-05:00","2fa97376-5d29-40e6-93ec-af33935deef0_experiment.xml","79efc4b1dde8731407cb2e2cf7f4705d","2c1d2ac9-a820-41bc-a636-56dfa9b948d1",2628,"2016-09-30T00:18:41.427776-05:00","2fa97376-5d29-40e6-93ec-af33935deef0_run.xml","29c888407b15648d4e138ab296ee9f5c","fd1b9bd9-2b0b-4262-a878-dea1d8191333",354,"2016-09-08T11:31:24.407625-05:00","TCGA-C5-A7X5","2016-09-02T19:00:59.716664-05:00","female","TCGA-C5-A7X5_demographic",1931,"black or african american","5b3cbe5a-de8f-591b-b503-607f675d5c01","not hispanic or latino",2004,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7X5_diagnosis","not reported",26542,"dead","8071/3",414,NA,"68ee052e-ce25-524d-92bd-ffe6370d9abf","c53.9",-26542,"TCGA-C5-A7X5_treatment","ad9da948-9e5a-57b1-b1ac-30fed26efe9f","01","true","TCGA-C5-A7X5-01A",NA,"39b3dd96-515b-42b1-ac56-66602e0cf8fe",FALSE,"0807894B-043D-4074-85C4-6C7BFB2C8C54","Primary Tumor",NA,3836,90,NA,1383091200,"11",30,"TCGA-C5-A7X5-01A-11",80,NA,3,NA,0,NA,20,NA,"2016-09-08T11:31:24.407625-05:00",NA,5,NA,2,NA,"TOP",NA,0,NA,"5a6b701f-fd8b-41d5-8327-a4d4f355fd5d",NA,"TCGA-C5-A7X5-01A-01-TS1",NA,80,NA,"fbd256c2-816a-4dfd-bd9e-c607917f9459","RNA","TCGA-C5-A7X5-01A-11R","45729d4f-3f2e-46e8-a575-181875b6886e",1.84,0.18,"UV Spec","R","23","TCGA-C5-A7X5-01A-11R-A36F-07","39d645d6-f7ca-4a01-a3b0-5ae3754c8a68",0.18,NA,59,22.206330686138,163,"fb57f4bb-9867-550e-a875-aad43cf6aa12","TCGA-C5-A7X5_exposure","UNCID_2520219.39d645d6-f7ca-4a01-a3b0-5ae3754c8a68.140417_UNC13-SN749_0343_BC41HBACXX_6_CGATGT.tar.gz","2014-07-10T00:06:06.000Z","2014-07-10T00:24:06.000Z","2FA97376-5D29-40E6-93EC-AF33935DEEF0","39B3DD96-515B-42B1-AC56-66602E0CF8FE","Unaligned reads",6336870103,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","39D645D6-F7CA-4A01-A3B0-5AE3754C8A68","University of North Carolina","56607608e4b016715ab68a1e","AED93A3A-7DCB-4BA9-84C0-BC735CBD545F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FBD256C2-816A-4DFD-BD9E-C607917F9459","2014-07-10T00:24:06.000Z","45729D4F-3F2E-46E8-A575-181875B6886E","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3836,"FBD256C2-816A-4DFD-BD9E-C607917F9459",NA,"C5","TCGA-C5-A7X5-01A-11R-A36A-13_mirna.bam.bai",90,"TCGA-C5-A7X5-01A",NA,"07EDF1F2-521E-473D-B227-ED8038C74D39","TCGA",2003,"TCGA-C5-A7X5_NTE-1",NA,"WITH TUMOR","52AE8FBB-6130-4C9B-B484-E8E6401A46DC",72,"nationwidechildrens.org_clinical.TCGA-C5-A7X5.xml","Dead",414,"TCGA-C5-A7X5","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IVB",NA,NA,NA,"8071/3","FEMALE","C53.9",373,NA,"F5932A55-7523-41D1-8F00-3B6441C8DCEB","BLACK OR AFRICAN AMERICAN",NA,11,30,"5A6B701F-FD8B-41D5-8327-A4D4F355FD5D","EEADE226-2BFC-4EE6-B123-38B90C25B123","DEVEL_p_TCGAb3_73_74_75_76_NSP_GenomeWideSNP_6_D05_1438338.raw.copynumber.data.txt","TCGA-C5-A7X5-01A-11",80,0,3,5,20,"TOP",0,2,"TCGA-C5-A7X5-01A-01-TS1",80,"Taxol","Chemotherapy","TCGA-C5-A7X5-D56989","TCGA-C5-A7X5-R56991","Internal","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7X5",NA,"C5","A7X5","YES","C53.9","8071/3","C53.9","NO","YES",-26542,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,414,NA,NA,"WITH TUMOR","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,72,2003,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1995",18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
57587892,57001560,2724519589,"1C3795AD-6306-4892-95F5-92DF3375D46A.bw","af33df2e-9737-4f63-952c-858a70aa589c","1c3795ad-6306-4892-95f5-92df3375d46a","2016-08-09T14:42:27.784117-05:00","UNCID_2654365.fc9e612c-8909-47de-b6f0-8691d5bc67c5.141010_UNC12-SN629_0394_AC5FTUACXX_7_ATTCCT.tar.gz","bde3c334-5df5-47cb-bd20-c4867a1da1d7",2395342935,"Illumina HiSeq","e5bb33caa5dda8b4474ff424e0c25763","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:01:26.820384-05:00","2016-05-03T12:08:10.829131-05:00","bde3c334-5df5-47cb-bd20-c4867a1da1d7_analysis.xml","3aa0ef302131e25c425e84a80f41944d","a836c2e1-0041-4c9e-8112-739dde5cb042",2124,"2016-09-29T21:47:18.354445-05:00","bde3c334-5df5-47cb-bd20-c4867a1da1d7_experiment.xml","25335dbdfc07117b61f21e7fe86e5d47","9f5cbce5-c8da-4054-9c9a-45f7b9ab1e39",2628,"2016-09-29T21:50:18.158358-05:00","bde3c334-5df5-47cb-bd20-c4867a1da1d7_run.xml","b1abaf507d66b8f0478527aacbca71e6","a13b4dc1-450f-4f8e-be55-624c08c7de6f",354,"2016-09-08T11:08:09.625669-05:00","TCGA-ZJ-AAXD","2016-09-02T18:54:43.810231-05:00","female","TCGA-ZJ-AAXD_demographic",1975,"not reported","c8e598b1-682c-5e58-9bdc-aa1f15e9a40c","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXD_diagnosis","not reported",12968,"alive","8072/3",NA,0,"543738b7-f615-5e76-821b-005c9b38ef7b","c53.9",-12968,"TCGA-ZJ-AAXD_treatment","3024ac1e-50c8-5257-bab2-f781591a4bda","01","true","TCGA-ZJ-AAXD-01A",NA,"5f1cad28-473f-414c-b72c-c93707300e57",FALSE,"AAEBC293-E409-4B14-9310-6820BA844EE6","Primary Tumor",NA,1164,130,NA,1395878400,"21",30,"TCGA-ZJ-AAXD-01A-21",70,NA,0,NA,0,NA,40,NA,"2016-09-08T11:08:09.625669-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"106c313d-d753-4c59-96b0-2667879a85c7",NA,"TCGA-ZJ-AAXD-01A-02-TS2",NA,60,NA,"37f634c8-4d7c-4171-b98e-d79f1f6150fd","RNA","TCGA-ZJ-AAXD-01A-21R","d0c75e5b-80ff-47cd-a38d-5244319cbfa9",1.86,0.17,"UV Spec","R","23","TCGA-ZJ-AAXD-01A-21R-A42T-07","fc9e612c-8909-47de-b6f0-8691d5bc67c5",0.17,NA,NA,NA,NA,"0616db00-32c1-5215-882b-afccfa10f160","TCGA-ZJ-AAXD_exposure","UNCID_2654365.fc9e612c-8909-47de-b6f0-8691d5bc67c5.141010_UNC12-SN629_0394_AC5FTUACXX_7_ATTCCT.tar.gz","2014-11-05T00:06:04.000Z","2014-11-05T00:17:29.000Z","BDE3C334-5DF5-47CB-BD20-C4867A1DA1D7","5F1CAD28-473F-414C-B72C-C93707300E57","Unaligned reads",2395342935,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FC9E612C-8909-47DE-B6F0-8691D5BC67C5","University of North Carolina","564a3c4fe4b093830b698f26","AF33DF2E-9737-4F63-952C-858A70AA589C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","37F634C8-4D7C-4171-B98E-D79F1F6150FD","2014-11-05T00:17:30.000Z","D0C75E5B-80FF-47CD-A38D-5244319CBFA9","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1164,"37F634C8-4D7C-4171-B98E-D79F1F6150FD",NA,"ZJ","UNCID_2647863.fc9e612c-8909-47de-b6f0-8691d5bc67c5.sorted_genome_alignments.bam",130,"TCGA-ZJ-AAXD-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXD_NTE-1",NA,NA,"5F1CAD28-473F-414C-B72C-C93707300E57",35,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXD.xml","Alive",NA,"TCGA-ZJ-AAXD",NA,NA,NA,0,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T3b","8072/3","FEMALE","C53.9",420,NA,NA,NA,NA,21,30,"106C313D-D753-4C59-96B0-2667879A85C7","D0C75E5B-80FF-47CD-A38D-5244319CBFA9","UNCID_2647863.fc9e612c-8909-47de-b6f0-8691d5bc67c5.sorted_genome_alignments.bam","TCGA-ZJ-AAXD-01A-21",70,0,0,0,40,"TOP",0,0,"TCGA-ZJ-AAXD-01A-02-TS2",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXD",NA,"ZJ","AAXD","YES","C53.9","8072/3","C53.9","NO","YES",-12968,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",30,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",16,NA,"T3bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121247134,119221181,5691840713,"17BB221D-8BF9-4391-83DD-423AE1E03651.bw","afb5442e-0249-475b-8f82-cae4e0268ad1","17bb221d-8bf9-4391-83dd-423ae1e03651","2016-08-25T03:24:17.851808-05:00","UNCID_2520212.f00b3401-8432-4748-8d19-267e945cd3c0.140417_UNC13-SN749_0342_AC41N6ACXX_6_ACAGTG.tar.gz","f3a90896-508b-44f0-abc6-de257a7f14af",5437949198,"Illumina HiSeq","dab04dcecd1599a6489c83c5240b3d02","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:43:55.133828-05:00","2016-05-03T11:52:18.424197-05:00","f3a90896-508b-44f0-abc6-de257a7f14af_analysis.xml","422fd3fa3764fc648d05fd353bd4a44c","77ee0071-e2d0-4d5b-8e1a-da9ae5febe73",2124,"2016-10-07T16:03:44.588185-05:00","f3a90896-508b-44f0-abc6-de257a7f14af_experiment.xml","7862c8ea1054e2b4bd3ae4d7a3dcc891","23530183-8231-42cb-ae6b-7a52848bbec2",2628,"2016-09-29T23:53:15.084225-05:00","f3a90896-508b-44f0-abc6-de257a7f14af_run.xml","97ee59840b6770bc4c4ce0cfc2449372","ed83c1b3-357f-46b3-9b27-60dfaffe9334",354,"2016-09-08T11:30:38.874872-05:00","TCGA-VS-A8EC","2016-09-02T19:01:04.018382-05:00","female","TCGA-VS-A8EC_demographic",1956,"white","b9115183-f263-5c46-be2e-8656e987d2e0","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EC_diagnosis","not reported",20286,"alive","8070/3",NA,1415,"e8f5ded4-e9dd-5a9b-8de9-2d5b6310b160","c53.9",-20286,"TCGA-VS-A8EC_treatment","99aaf916-670a-52f6-8356-fe8cc9959f44","01","false","TCGA-VS-A8EC-01A",NA,"1c1d6cac-62d8-4477-9469-25973f9f27ee",FALSE,"5D347DA8-4A0A-4E09-BCF3-DDD115D741C6","Primary Tumor",NA,1015,60,NA,1384819200,"11",30,"TCGA-VS-A8EC-01A-11",80,NA,0,NA,5,NA,10,NA,"2016-09-08T11:30:38.874872-05:00",NA,5,NA,5,NA,"TOP",NA,5,NA,"a7457e86-58e0-4387-8b81-35e5f10f6af5",NA,"TCGA-VS-A8EC-01A-01-TS1",NA,80,NA,"7be07efa-720f-4e06-b89c-e913898b5f64","RNA","TCGA-VS-A8EC-01A-11R","a7769593-0fed-478c-a11a-f87c3cd247c6",1.88,0.17,"UV Spec","R","23","TCGA-VS-A8EC-01A-11R-A36F-07","f00b3401-8432-4748-8d19-267e945cd3c0",0.17,NA,46,19.3961882273571,154,"c14e7fc1-d741-5100-a75b-926daaab19df","TCGA-VS-A8EC_exposure","UNCID_2520212.f00b3401-8432-4748-8d19-267e945cd3c0.140417_UNC13-SN749_0342_AC41N6ACXX_6_ACAGTG.tar.gz","2014-07-09T22:21:04.000Z","2014-07-12T04:30:30.000Z","F3A90896-508B-44F0-ABC6-DE257A7F14AF","1C1D6CAC-62D8-4477-9469-25973F9F27EE","Unaligned reads",5437949198,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F00B3401-8432-4748-8D19-267E945CD3C0","University of North Carolina","564a3ff3e4b08c5d8692f63c","AFB5442E-0249-475B-8F82-CAE4E0268AD1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7BE07EFA-720F-4E06-B89C-E913898B5F64","2014-07-09T22:46:11.000Z","A7769593-0FED-478C-A11A-F87C3CD247C6","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1015,"7BE07EFA-720F-4E06-B89C-E913898B5F64",NA,"VS","UNCID_2439686.f00b3401-8432-4748-8d19-267e945cd3c0.sorted_genome_alignments.bam",60,"TCGA-VS-A8EC-01A",NA,"E92C9CD5-FA20-429C-9D02-ED80C876D1CB","TCGA",2011,"TCGA-VS-A8EC_NTE-1","Complete Remission/Response","TUMOR FREE","664A6344-8CB7-4BC8-A0CA-CB6A8E6DF6B6",55,"nationwidechildrens.org_clinical.TCGA-VS-A8EC.xml","Alive",NA,"TCGA-VS-A8EC",NA,"DCC7226E-2391-42E7-B6EC-8FB484330A56","NO",1050,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,NA,"Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",373,NA,"D9E5B933-D2E5-48C3-9373-09C029A0C434","WHITE",NA,11,30,"A7457E86-58E0-4387-8B81-35E5F10F6AF5","A7769593-0FED-478C-A11A-F87C3CD247C6","UNCID_2439686.f00b3401-8432-4748-8d19-267e945cd3c0.sorted_genome_alignments.bam","TCGA-VS-A8EC-01A-11",80,5,0,5,10,"TOP",5,5,"TCGA-VS-A8EC-01A-01-TS1",80,"Carboplatin","Chemotherapy","TCGA-VS-A8EC-D61977","TCGA-VS-A8EC-R61975","External","Regional site","TCGA-VS-A8EC-F67671_NTE-1","NO",1232,"TUMOR FREE","Alive",NA,"TCGA-VS-A8EC-F67671","TCGA-VS-A8EC",NA,"VS","A8EC","YES","C53.9","8070/3","C53.9","NO","YES",-20286,"FEMALE","WHITE",NA,"No","No","Alive",1050,NA,NA,NA,"TUMOR FREE","YES",22,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,"Complete Remission/Response","2009",16,NA,"T3bNXM0",NA,NA,1,NA,NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
171113516,166595012,7951137931,"297611E9-9555-4BCA-A723-02E846ACC23A.bw","b0b293c1-bd7e-4ba8-9f44-47398488ef2c","297611e9-9555-4bca-a723-02e846acc23a","2016-08-25T09:54:29.511970-05:00","UNCID_2520224.aa91c19b-008d-497a-8121-a06cf9dc7b29.140417_UNC13-SN749_0343_BC41HBACXX_2_CCGTCC.tar.gz","83d1bdd9-74cc-40d1-8a41-4885297e4fe5",7708302638,"Illumina HiSeq","f446cf9ab1ff96d756554440ebfad205","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:36:57.021245-05:00","2016-05-03T11:51:27.516015-05:00","83d1bdd9-74cc-40d1-8a41-4885297e4fe5_analysis.xml","e78e23b295e22da7d670ea3ea32d62ec","98fbd551-b9bb-4dc2-a6f0-94277040d488",2124,"2016-08-26T12:49:05.688380-05:00","83d1bdd9-74cc-40d1-8a41-4885297e4fe5_experiment.xml","f8de6b7fdf79d61b32b5d7edb8175f52","0f19ff3d-563d-466e-b748-0df157c0fc10",2628,"2016-09-29T21:16:05.331040-05:00","83d1bdd9-74cc-40d1-8a41-4885297e4fe5_run.xml","69167fdf3dbee11eec329e23c14f403c","8c181f44-3b5a-4927-89c8-0b5ab36cd956",354,"2016-09-08T11:43:52.155143-05:00","TCGA-VS-A8EG","2016-09-02T19:01:04.548910-05:00","female","TCGA-VS-A8EG_demographic",1975,"not reported","05e90e3e-1231-5e3c-8e2d-a499d67cb897","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EG_diagnosis","not reported",13166,"alive","8070/3",NA,1386,"7202777f-8840-516f-9af7-9395ce210eef","c53.9",-13166,"TCGA-VS-A8EG_treatment","27052a22-6dba-5274-a2f2-a126a63bccac","01","false","TCGA-VS-A8EG-01A",NA,"2d433014-1b56-4790-8c83-6ffa37040d9c",FALSE,"96C32FDF-692D-4709-B1A7-E5B22318E683","Primary Tumor",NA,846,60,NA,1384819200,"11",30,"TCGA-VS-A8EG-01A-11",80,NA,0,NA,20,NA,0,NA,"2016-09-08T11:43:52.155143-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"a8e77b95-b665-42ef-9a34-78954a47edac",NA,"TCGA-VS-A8EG-01A-01-TS1",NA,80,NA,"208a936d-009e-447a-824f-e4dadc1fae52","RNA","TCGA-VS-A8EG-01A-11R","a5318d9c-c683-470f-8784-9db6611caa28",1.94,0.17,"UV Spec","R","23","TCGA-VS-A8EG-01A-11R-A36F-07","aa91c19b-008d-497a-8121-a06cf9dc7b29",0.17,NA,66,25.78125,160,"e00f203c-493c-5ce0-afca-c9f265d3a33d","TCGA-VS-A8EG_exposure","UNCID_2520224.aa91c19b-008d-497a-8121-a06cf9dc7b29.140417_UNC13-SN749_0343_BC41HBACXX_2_CCGTCC.tar.gz","2014-07-10T01:06:04.000Z","2014-07-10T01:33:27.000Z","83D1BDD9-74CC-40D1-8A41-4885297E4FE5","2D433014-1B56-4790-8C83-6FFA37040D9C","Unaligned reads",7708302638,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AA91C19B-008D-497A-8121-A06CF9DC7B29","University of North Carolina","564a40f1e4b09c884b26036d","B0B293C1-BD7E-4BA8-9F44-47398488EF2C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","208A936D-009E-447A-824F-E4DADC1FAE52","2014-07-10T01:33:27.000Z","A5318D9C-C683-470F-8784-9DB6611CAA28","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",846,"208A936D-009E-447A-824F-E4DADC1FAE52",NA,"VS","UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments.bam",60,"TCGA-VS-A8EG-01A",NA,NA,"TCGA",2011,"TCGA-VS-A8EG_NTE-1","Complete Remission/Response","TUMOR FREE","9BCAF270-A900-4E58-AC21-73FEE4CE2317",36,"nationwidechildrens.org_clinical.TCGA-VS-A8EG.xml","Alive",NA,"TCGA-VS-A8EG",NA,"C275017C-D8AC-49A3-AEB7-1BDB7C7C3E54","NO",883,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",373,NA,"B9890A64-DD34-420D-9822-386D04D42922",NA,NA,11,30,"A8E77B95-B665-42EF-9A34-78954A47EDAC","D4A22B4A-772E-403F-91F2-43F5A50ABBE8","UNCID_2434464.aa91c19b-008d-497a-8121-a06cf9dc7b29.sorted_genome_alignments.bam","TCGA-VS-A8EG-01A-11",80,20,0,5,0,"TOP",0,0,"TCGA-VS-A8EG-01A-01-TS1",80,NA,NA,NA,"TCGA-VS-A8EG-R62008","External","Regional site","TCGA-VS-A8EG-F67670_NTE-1","NO",1149,"TUMOR FREE","Alive",NA,"TCGA-VS-A8EG-F67670","TCGA-VS-A8EG",NA,"VS","A8EG","YES","C53.9","8070/3","C53.9","NO","YES",-13166,"FEMALE",NA,NA,"No","No","Alive",883,NA,NA,NA,"TUMOR FREE","YES",22,4,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,36,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1NXM0",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
99980890,93481205,4453448289,"AD7FF180-1EAC-4783-8A62-E9626B96DD9F.bw","b0f63819-fc86-4981-9d92-0115c6de3bce","ad7ff180-1eac-4783-8a62-e9626b96dd9f","2016-08-26T03:21:36.201662-05:00","UNCID_2358658.22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20.140107_UNC11-SN627_0341_BC38NLACXX_6_CGTACG.tar.gz","4eaff607-1a36-4e6f-96a0-6c67a5b51609",4621296141,"Illumina HiSeq","2eb93164a8da6996dcce2ab291e8a782","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:08:58.899802-05:00","2016-05-03T11:37:12.425298-05:00","4eaff607-1a36-4e6f-96a0-6c67a5b51609_analysis.xml","ebd462ceb056f6b69cf37be5c9599f6e","acce1590-aa17-4058-8565-2deab705fd71",2124,"2016-08-26T14:40:57.285997-05:00","4eaff607-1a36-4e6f-96a0-6c67a5b51609_experiment.xml","68709e4dec4ff773c2cc33b145ef4f90","d116a774-4dcf-4639-b021-be3497b80cff",2628,"2016-09-29T17:33:09.041008-05:00","4eaff607-1a36-4e6f-96a0-6c67a5b51609_run.xml","e9ebe1641392798017a3830e4efe0314","00e70449-38ac-4496-be49-261a58962a8f",354,"2016-09-08T11:19:32.959001-05:00","TCGA-Q1-A73S","2016-09-02T19:00:16.574092-05:00","female","TCGA-Q1-A73S_demographic",1979,"white","89479242-1912-5c5c-9672-4f230e66dd06","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A73S_diagnosis","not reported",12229,"alive","8560/3",NA,688,"91026da8-e32c-53fc-9bda-c9c0d37e6357","c53.9",-12229,"TCGA-Q1-A73S_treatment","29204d72-76b6-531a-b386-4af0cac9b041","01","true","TCGA-Q1-A73S-01A",NA,"f2d717d6-a3ae-4595-91b2-73215abc71f9",FALSE,"264F3D75-C462-4904-8AFB-2D18B0A59CB7","Primary Tumor",NA,232,490,NA,1376006400,"11",30,"TCGA-Q1-A73S-01A-11",80,NA,1,NA,0,NA,15,NA,"2016-09-08T11:19:32.959001-05:00",NA,1,NA,1,NA,"TOP",NA,5,NA,"7cfa5fbf-5ed8-4169-9ffa-5b3676c0d802",NA,"TCGA-Q1-A73S-01A-01-TSA",NA,80,NA,"f374d44c-805e-4d8f-bf3b-ada5776bfdf1","RNA","TCGA-Q1-A73S-01A-11R","b4179ff8-a66a-48de-bd63-4550667b0535",1.92,0.18,"UV Spec","R","23","TCGA-Q1-A73S-01A-11R-A33Z-07","22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20",0.18,0.410958904109589,68,26.5625,160,"73abcf6d-e5d9-5c23-8032-e3c62fcf1975","TCGA-Q1-A73S_exposure","UNCID_2358658.22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20.140107_UNC11-SN627_0341_BC38NLACXX_6_CGTACG.tar.gz","2014-02-25T17:03:04.000Z","2014-02-25T17:25:02.000Z","4EAFF607-1A36-4E6F-96A0-6C67A5B51609","F2D717D6-A3AE-4595-91B2-73215ABC71F9","Unaligned reads",4621296141,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","22CC3EDE-A5D9-4AC0-9C4D-0A7F12D6BC20","University of North Carolina","566073c0e4b0b37b3d98e188","B0F63819-FC86-4981-9D92-0115C6DE3BCE","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F374D44C-805E-4D8F-BF3B-ADA5776BFDF1","2014-02-25T17:25:02.000Z","B4179FF8-A66A-48DE-BD63-4550667B0535","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",232,"F374D44C-805E-4D8F-BF3B-ADA5776BFDF1",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8338B88E-C70C-435A-B4A1-F7D869485F60.txt",490,"TCGA-Q1-A73S-01A",NA,"5017EAAD-0177-496C-A6DB-E916EE13386D","TCGA",2012,"TCGA-Q1-A73S_NTE-1",NA,NA,"F2D717D6-A3AE-4595-91B2-73215ABC71F9",33,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8338B88E-C70C-435A-B4A1-F7D869485F60.txt","Alive",NA,"TCGA-Q1-A73S","NOT HISPANIC OR LATINO","398788E9-83BE-41CB-A3BA-1B6FDEB5500A","NO",316,"No","Cervix","C53.9","N1","Adenosquamous",0,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8560/3","FEMALE","C53.9",350,NA,"A0B54EF3-0D50-4835-A7B2-B6A2FB11725D","WHITE",NA,11,30,"7CFA5FBF-5ED8-4169-9FFA-5B3676C0D802","B4179FF8-A66A-48DE-BD63-4550667B0535","UNCID_2358658.22cc3ede-a5d9-4ac0-9c4d-0a7f12d6bc20.140107_UNC11-SN627_0341_BC38NLACXX_6_CGTACG.tar.gz","TCGA-Q1-A73S-01A-11",80,0,1,1,15,"TOP",5,1,"TCGA-Q1-A73S-01A-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-Q1-A73S-D50813","TCGA-Q1-A73S-R50812","External","Primary Tumor Field","TCGA-Q1-A73S-F62725_NTE-1","NO",688,"TUMOR FREE","Alive",NA,"TCGA-Q1-A73S-F62725","TCGA-Q1-A73S",NA,"Q1","A73S","YES","C53.9","8560/3","C53.9","YES","NO",-12229,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",316,NA,NA,NA,NA,"YES",31,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Adenosquamous",NA,0,33,2012,"Other method, specify:","YES",18,2,"G2",NA,4,2012,7.5,NA,NA,"2009",7,NA,"T1b1N1MX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
133976616,128651282,6123739986,"FD544083-9BD5-4036-BD81-0352B67CC45C.bw","b12deb95-6aa1-49cb-a3c5-a711d42d6fb9","fd544083-9bd5-4036-bd81-0352b67cc45c","2016-09-30T00:19:00.825835-05:00","UNCID_2553092.aefd1510-484d-43c7-ab67-931b1e7406fa.140416_UNC11-SN627_0353_BC42B0ACXX_3_TGACCA.tar.gz","11d75b0d-866c-479a-b8bd-01be5cd1c41a",5808320171,"Illumina HiSeq","261800a1653bd3bd12dafaf8a5c27700","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:47:05.906877-05:00","2016-05-03T11:54:19.885282-05:00","11d75b0d-866c-479a-b8bd-01be5cd1c41a_analysis.xml","ff9fff25659cfa99bae5db0921ce140b","2f8e0be2-921f-4ff7-8800-e4691c6d40ab",2124,"2016-09-29T22:52:01.390939-05:00","11d75b0d-866c-479a-b8bd-01be5cd1c41a_experiment.xml","7ab3544dbafa75902b76da86a456d592","c7775188-b3db-4dd3-979a-607e0ef46c99",2628,"2016-09-29T18:33:57.609312-05:00","11d75b0d-866c-479a-b8bd-01be5cd1c41a_run.xml","3687a5f2b926afa25084b80d52976b9a","27012ba1-9736-404b-828f-47df52a32087",354,"2016-09-08T11:27:24.101089-05:00","TCGA-ZJ-A8QQ","2016-09-02T19:01:23.757518-05:00","female","TCGA-ZJ-A8QQ_demographic",1983,"white","ab0e2e6f-c8fb-5361-840e-7260c5ce8baa","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-A8QQ_diagnosis","not reported",8918,"alive","8072/3",NA,2056,"03f20fbc-805f-55c2-9e99-6f2960b7b816","c53.9",-8918,"TCGA-ZJ-A8QQ_treatment","6b787520-e13e-5ddd-8892-74f1b34b1844","01","true","TCGA-ZJ-A8QQ-01A",NA,"a29fddb5-b032-43eb-a56c-a736f25596cc",FALSE,"C27506F6-D35D-4A7A-8BDA-AC3F72432DAF","Primary Tumor",NA,2165,30,NA,1386288000,"11",30,"TCGA-ZJ-A8QQ-01A-11",80,NA,2,NA,5,NA,10,NA,"2016-09-08T11:27:24.101089-05:00",NA,2,NA,2,NA,"TOP",NA,5,NA,"d42303c1-ed1e-4a24-883e-7576d367858b",NA,"TCGA-ZJ-A8QQ-01A-01-TS1",NA,80,NA,"cf1be58f-b360-4206-9944-207de30a2e14","RNA","TCGA-ZJ-A8QQ-01A-11R","d4d1f05c-0603-4efe-85f1-3a0619899eba",1.79,0.15,"UV Spec","R","23","TCGA-ZJ-A8QQ-01A-11R-A37O-07","aefd1510-484d-43c7-ab67-931b1e7406fa",0.15,1.0958904109589,71,28.4409549751642,158,"5d0bfdce-6a79-5edc-ab98-0caa13266ccb","TCGA-ZJ-A8QQ_exposure","UNCID_2553092.aefd1510-484d-43c7-ab67-931b1e7406fa.140416_UNC11-SN627_0353_BC42B0ACXX_3_TGACCA.tar.gz","2014-07-30T21:06:04.000Z","2014-07-30T21:25:17.000Z","11D75B0D-866C-479A-B8BD-01BE5CD1C41A","A29FDDB5-B032-43EB-A56C-A736F25596CC","Unaligned reads",5808320171,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AEFD1510-484D-43C7-AB67-931B1E7406FA","University of North Carolina","56607496e4b0ca319164c61d","B12DEB95-6AA1-49CB-A3C5-A711D42D6FB9","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CF1BE58F-B360-4206-9944-207DE30A2E14","2014-07-30T21:25:17.000Z","D4D1F05C-0603-4EFE-85F1-3A0619899EBA","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",2165,"CF1BE58F-B360-4206-9944-207DE30A2E14",NA,"ZJ","UNCID_2553092.aefd1510-484d-43c7-ab67-931b1e7406fa.140416_UNC11-SN627_0353_BC42B0ACXX_3_TGACCA.tar.gz",30,"TCGA-ZJ-A8QQ-01A",NA,"D9393162-CBD7-4C44-926C-6511920A4C85","TCGA",2007,"TCGA-ZJ-A8QQ_NTE-1","Complete Remission/Response","TUMOR FREE","A29FDDB5-B032-43EB-A56C-A736F25596CC",24,"nationwidechildrens.org_clinical.TCGA-ZJ-A8QQ.xml","Alive",NA,"TCGA-ZJ-A8QQ","NOT HISPANIC OR LATINO",NA,"NO",2056,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIB",NA,NA,"T1b2","8072/3","FEMALE","C53.9",380,NA,"B88ED042-AC57-4287-A19D-4AE529F3502E","WHITE",NA,11,30,"D42303C1-ED1E-4A24-883E-7576D367858B","0EC0BA28-8FAF-43F0-8FA0-1856782A15D4","UNCID_2553092.aefd1510-484d-43c7-ab67-931b1e7406fa.140416_UNC11-SN627_0353_BC42B0ACXX_3_TGACCA.tar.gz","TCGA-ZJ-A8QQ-01A-11",80,5,2,2,10,"TOP",5,2,"TCGA-ZJ-A8QQ-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-ZJ-A8QQ-D56891","TCGA-ZJ-A8QQ-R56892","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-A8QQ",NA,"ZJ","A8QQ","YES","C53.9","8072/3","C53.9","NO","YES",-8918,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2056,NA,NA,NA,"TUMOR FREE","YES",25,2,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,24,2007,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,2,NA,20,NA,"Complete Remission/Response","1995",13,NA,"T1b2N0M0",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
114479366,112884708,5386089319,"879A74D5-5B29-418D-A0F4-8E88D6384008.bw","b16469af-a721-43e9-a4d7-c39b94d1139f","879a74d5-5b29-418d-a0f4-8e88d6384008","2016-08-05T08:28:59.449350-05:00","UNCID_2169024.80241bee-c4e9-4ce7-a920-022f8b00e21d.130606_UNC9-SN296_0373_BD28T1ACXX_2_GCCAAT.tar.gz","6bcc7b64-2e3b-4256-99ae-de57c0b4ea71",5673737544,"Illumina HiSeq","981a5fedb2ce5dba626097fc1cd65075","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:01:11.779311-05:00","2016-05-03T11:06:28.633852-05:00","6bcc7b64-2e3b-4256-99ae-de57c0b4ea71_analysis.xml","66feb94ebfe7d632448989fd7a097cf7","12bd3bdc-d169-416d-828f-ab94ca3bebd6",2121,"2016-10-07T15:43:31.693546-05:00","6bcc7b64-2e3b-4256-99ae-de57c0b4ea71_experiment.xml","1ea841f8d3c29d8c20829e252d21702d","f8bd005e-4878-4254-959a-ee4582b68080",2431,"2016-09-30T00:15:13.742888-05:00","6bcc7b64-2e3b-4256-99ae-de57c0b4ea71_run.xml","fff7fe705e5d7fbbb09d322fee700896","faff1299-9e0c-47f4-b095-d2d27dacfecb",354,"2016-09-08T12:56:06.734456-05:00","TCGA-DS-A5RQ","2016-09-02T18:59:49.488252-05:00","female","TCGA-DS-A5RQ_demographic",1932,"white","1dd28120-25b1-57b0-a027-a652c0541438","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A5RQ_diagnosis","not reported",29526,"alive","8070/3",NA,512,"15679ba1-8fc4-514e-97a6-c8261c70a805","c53.9",-29526,"TCGA-DS-A5RQ_treatment","16e6a7fb-b4a7-5478-a43c-17e30fe7fa24","01","true","TCGA-DS-A5RQ-01A",NA,"1c93033c-aa43-4f75-b299-7c5daafd226f",FALSE,"DE25B703-53D6-488B-AFAF-BFA8DA52FF62","Primary Tumor",NA,203,220,NA,1360800000,"11",30,"TCGA-DS-A5RQ-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T12:56:06.734456-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"d345e9c7-4ac9-4d19-b4b1-db08af41d024",NA,"TCGA-DS-A5RQ-01A-01-TSA",NA,100,NA,"c76d2065-f56d-4169-a341-3309b0ba085a","RNA","TCGA-DS-A5RQ-01A-11R","eb669f28-cc81-4773-9563-f068050997cf",1.89,0.18,"UV Spec","R","23","TCGA-DS-A5RQ-01A-11R-A28H-07","80241bee-c4e9-4ce7-a920-022f8b00e21d",0.18,1.91780821917808,61,27.8487947406866,148,"6c5347ed-a81b-5b2e-a99d-3675e9a03883","TCGA-DS-A5RQ_exposure","UNCID_2169024.80241bee-c4e9-4ce7-a920-022f8b00e21d.130606_UNC9-SN296_0373_BD28T1ACXX_2_GCCAAT.tar.gz","2013-09-20T03:16:05.000Z","2013-09-20T03:36:02.000Z","6BCC7B64-2E3B-4256-99AE-DE57C0B4EA71","1C93033C-AA43-4F75-B299-7C5DAAFD226F","Unaligned reads",5673737544,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","80241BEE-C4E9-4CE7-A920-022F8B00E21D","University of North Carolina","564a3f5ee4b093830b6a8850","B16469AF-A721-43E9-A4D7-C39B94D1139F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C76D2065-F56D-4169-A341-3309B0BA085A","2013-09-20T03:36:02.000Z","EB669F28-CC81-4773-9563-F068050997CF","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",203,"C76D2065-F56D-4169-A341-3309B0BA085A",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.D4ECE36C-3B7F-467F-AB01-BFA1F7DE7684.txt",220,"TCGA-DS-A5RQ-01A",NA,"20A70A61-B65B-4EE9-BA68-1B3738C291A3","TCGA",2012,"TCGA-DS-A5RQ_NTE-1","Complete Remission/Response","TUMOR FREE","F35BFA2E-F04B-47A7-9D5B-DBA97C937BE7",80,"DRIPS_p_TCGA_295_296_297_N_GenomeWideSNP_6_D04_1343790.CEL","Alive",NA,"TCGA-DS-A5RQ","NOT HISPANIC OR LATINO","968C0997-3D1A-42D0-803C-2C145FA8C622","NO",208,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",297,NA,"78B0CB54-8D7A-4A44-941C-EF102F4B60A6","WHITE",NA,11,30,"D345E9C7-4AC9-4D19-B4B1-DB08AF41D024","EB669F28-CC81-4773-9563-F068050997CF","UNCID_2169024.80241bee-c4e9-4ce7-a920-022f8b00e21d.130606_UNC9-SN296_0373_BD28T1ACXX_2_GCCAAT.tar.gz","TCGA-DS-A5RQ-01A-11",75,0,0,3,0,"TOP",0,0,"TCGA-DS-A5RQ-01A-01-TSA",100,"Cisplatin","Chemotherapy","TCGA-DS-A5RQ-D43181","TCGA-DS-A5RQ-R43183","External","Primary Tumor Field","TCGA-DS-A5RQ-F43182_NTE-1","NO",208,"TUMOR FREE","Alive",NA,"TCGA-DS-A5RQ-F43182","TCGA-DS-A5RQ",NA,"DS","A5RQ","YES","C53.9","8070/3","C53.9","YES","NO",-29526,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",208,NA,NA,NA,"TUMOR FREE","YES",15,5,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,80,2012,"Biopsy (cervical / CT-guided / Other)","YES",42,0,"G2",NA,2,NA,35,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
128494006,127404913,6088396079,"43CD982C-13C0-4A52-803A-9A3A3FAE09BC.bw","b5f0e361-d67d-4fa9-9916-43623dafb10f","43cd982c-13c0-4a52-803a-9a3a3fae09bc","2016-08-07T00:15:52.070371-05:00","UNCID_2654364.1f431436-f6bd-4f64-81ad-820e11385e94.141006_UNC15-SN850_0395_AC5FH9ACXX_3_CTTGTA.tar.gz","11b24242-46e6-4be7-8826-b886064133ea",5248421368,"Illumina HiSeq","99909ef8a4be29a0cedfbc6f5f1ffcc6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:02:25.902837-05:00","2016-05-03T12:08:10.829131-05:00","11b24242-46e6-4be7-8826-b886064133ea_analysis.xml","da4a0ed335a659f1ed006537449722d8","a8ddc9fe-c923-44ff-8223-5cda33133d42",2123,"2016-09-29T19:56:20.478999-05:00","11b24242-46e6-4be7-8826-b886064133ea_experiment.xml","c733b56145846ddb95fb1fdff99bf752","5aeac4a1-35d4-43cd-bb83-7a21d1370b79",2628,"2016-09-29T21:04:14.120294-05:00","11b24242-46e6-4be7-8826-b886064133ea_run.xml","179577f191adde866f7bcbe35b6539d2","849bd7a8-426a-464f-9938-fa9fd21eedac",354,"2016-09-08T11:04:45.672121-05:00","TCGA-ZJ-AAX8","2016-09-02T18:54:41.800105-05:00","female","TCGA-ZJ-AAX8_demographic",1951,"not reported","2599ef60-6105-5a75-9fe8-b158d487577e","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAX8_diagnosis","not reported",21481,"alive","8072/3",NA,0,"2e7e53ab-96f8-57e7-ba94-d1a43c0a74ee","c53.9",-21481,"TCGA-ZJ-AAX8_treatment","e9a010cd-dd6b-54a7-930b-c780615ab929","01","true","TCGA-ZJ-AAX8-01A",NA,"a6024a4a-245d-4d7e-9fee-96dcb3fea807",FALSE,"8CCFD872-3834-4769-A6C6-809E77108BE5","Primary Tumor",NA,1789,170,NA,1396569600,"11",30,"TCGA-ZJ-AAX8-01A-11",70,NA,5,NA,0,NA,25,NA,"2016-09-08T11:04:45.672121-05:00",NA,10,NA,5,NA,"TOP",NA,5,NA,"e74f44e7-2872-4ab0-8afe-91cf009b6e3e",NA,"TCGA-ZJ-AAX8-01A-01-TS1",NA,70,NA,"daed24f0-0ef3-4be2-b2b4-1f41d2282bbe","RNA","TCGA-ZJ-AAX8-01A-11R","2124aeaa-2d18-4bf5-974a-6ff8cc946164",1.86,0.17,"UV Spec","R","23","TCGA-ZJ-AAX8-01A-11R-A42T-07","1f431436-f6bd-4f64-81ad-820e11385e94",0.17,NA,NA,NA,NA,"259b76c4-892b-5fcc-9cd8-8617b07a6720","TCGA-ZJ-AAX8_exposure","UNCID_2654364.1f431436-f6bd-4f64-81ad-820e11385e94.141006_UNC15-SN850_0395_AC5FH9ACXX_3_CTTGTA.tar.gz","2014-11-04T23:51:03.000Z","2014-11-05T00:04:37.000Z","11B24242-46E6-4BE7-8826-B886064133EA","A6024A4A-245D-4D7E-9FEE-96DCB3FEA807","Unaligned reads",5248421368,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1F431436-F6BD-4F64-81AD-820E11385E94","University of North Carolina","566074f7e4b016715ab67c51","B5F0E361-D67D-4FA9-9916-43623DAFB10F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DAED24F0-0EF3-4BE2-B2B4-1F41D2282BBE","2014-11-05T00:04:37.000Z","2124AEAA-2D18-4BF5-974A-6FF8CC946164","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1789,"DAED24F0-0EF3-4BE2-B2B4-1F41D2282BBE",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.41ECD370-91AA-4D24-BF11-EE3BD9A84619.txt",170,"TCGA-ZJ-AAX8-01A",NA,NA,"TCGA",2009,"TCGA-ZJ-AAX8_NTE-1",NA,NA,"F6F8FBC3-CB20-4001-AF37-825A73B19941",58,"unc.edu.1f431436-f6bd-4f64-81ad-820e11385e94.2651018.junction_quantification.txt","Alive",NA,"TCGA-ZJ-AAX8",NA,NA,NA,0,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T3b","8072/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"E74F44E7-2872-4AB0-8AFE-91CF009B6E3E","1636730E-A00D-4BCD-BA15-30F2E1962238","3999510081_R03C01_Grn.idat","TCGA-ZJ-AAX8-01A-11",70,0,5,10,25,"TOP",5,5,"TCGA-ZJ-AAX8-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAX8",NA,"ZJ","AAX8","YES","C53.9","8072/3","C53.9","NO","YES",-21481,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,58,2009,"Biopsy (cervical / CT-guided / Other)","YES",NA,NA,"G2",NA,NA,NA,NA,NA,NA,"2009",16,NA,"T3bN1M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
164630764,156550158,7464477487,"DCD0313D-5206-4111-8743-A8A0227257D9.bw","b610d391-0c9d-4114-94d6-5e4aa4270122","dcd0313d-5206-4111-8743-a8a0227257d9","2016-08-09T13:14:59.660201-05:00","UNCID_2186808.f1f0a4e6-8757-43f2-96c5-5b6bae173590.121009_UNC16-SN851_0187_AD15RRACXX_6_CTTGTA.tar.gz","a6dbb41a-af9e-474b-aaf7-f522db88541a",7189108081,"Illumina HiSeq","65d05558a5e85d8e98bf349b555b630c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:49:25.976562-05:00","2016-05-03T11:01:14.469334-05:00","a6dbb41a-af9e-474b-aaf7-f522db88541a_analysis.xml","5fb1a3974d5b39ad7b8e7f21106808c1","c5cf6450-88dc-466c-b928-3e7d31490f6a",2123,"2016-08-25T22:29:09.170413-05:00","a6dbb41a-af9e-474b-aaf7-f522db88541a_experiment.xml","7156c5c55e6f434317b8904e932e2f97","63fe6f84-fdd8-4332-af5c-84493b0c9b97",2431,"2016-09-29T18:57:00.006169-05:00","a6dbb41a-af9e-474b-aaf7-f522db88541a_run.xml","15c3807484aa2fc8a273773f1e248da7","35d2cd73-406d-433e-849e-e8aec6d8432e",354,"2016-09-08T11:23:07.126680-05:00","TCGA-EK-A2RN","2016-09-02T18:58:45.154139-05:00","female","TCGA-EK-A2RN_demographic",1964,"white","cb34bd07-c1de-54fc-aaaf-3b6e47b22d7e","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RN_diagnosis","not reported",16487,"alive","8071/3",NA,71,"ad67a812-cdc9-5443-bc48-c833348ccec1","c53.9",-16487,"TCGA-EK-A2RN_treatment","4098ee03-db5e-561a-b26b-602b9cdf87e7","01","false","TCGA-EK-A2RN-01A",NA,"24bacabf-8c6f-416a-b1f3-b0baaa2f0ad9",FALSE,"5B78C1A5-1A21-4970-8CB9-54B6D7C5F672","Primary Tumor",NA,756,60,NA,1315785600,"12",20,"TCGA-EK-A2RN-01A-12",98,NA,0,NA,0,NA,0,NA,"2016-09-08T11:23:07.126680-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"64df7972-c0e7-4c0a-ac48-2065773aaf92",NA,"TCGA-EK-A2RN-01A-01-TS1",NA,95,NA,"6f238c3e-60a9-41bd-b516-6ed2bd61abea","RNA","TCGA-EK-A2RN-01A-12R","3c6c421e-b515-4c82-a74e-666c0cdafd5b",1.92,0.16,"UV Spec","R","23","TCGA-EK-A2RN-01A-12R-A213-07","f1f0a4e6-8757-43f2-96c5-5b6bae173590",0.16,NA,68,21.952479338843,176,"c5605bf1-5e86-57c9-9f8c-f961f4500228","TCGA-EK-A2RN_exposure","UNCID_2186808.f1f0a4e6-8757-43f2-96c5-5b6bae173590.121009_UNC16-SN851_0187_AD15RRACXX_6_CTTGTA.tar.gz","2013-09-16T15:01:03.000Z","2013-09-16T15:24:01.000Z","A6DBB41A-AF9E-474B-AAF7-F522DB88541A","24BACABF-8C6F-416A-B1F3-B0BAAA2F0AD9","Unaligned reads",7189108081,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F1F0A4E6-8757-43F2-96C5-5B6BAE173590","University of North Carolina","5660772be4b018727fea1248","B610D391-0C9D-4114-94D6-5E4AA4270122","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6F238C3E-60A9-41BD-B516-6ED2BD61ABEA","2013-09-16T15:24:01.000Z","3C6C421E-B515-4C82-A74E-666C0CDAFD5B","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",756,"6F238C3E-60A9-41BD-B516-6ED2BD61ABEA",NA,"EK","6929793021_R01C02_Grn.idat",60,"TCGA-EK-A2RN-01A",NA,NA,"TCGA",2009,NA,NA,NA,"C44B832D-9F76-4EA3-9CB8-9F51465D605A",45,"nationwidechildrens.org_clinical.TCGA-EK-A2RN.xml","Alive",NA,"TCGA-EK-A2RN",NA,"7437CFD5-BE42-4891-970B-763B90241D2A",NA,3,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T2b","8071/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,12,20,"64DF7972-C0E7-4C0A-AC48-2065773AAF92","415D1C62-091C-4D13-B448-382218595D7C","UNCID_2186808.f1f0a4e6-8757-43f2-96c5-5b6bae173590.121009_UNC16-SN851_0187_AD15RRACXX_6_CTTGTA.tar.gz","TCGA-EK-A2RN-01A-12",98,0,0,0,0,"TOP",5,0,"TCGA-EK-A2RN-01A-01-TS1",95,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RN-F58269_NTE-1",NA,16,NA,"Alive",NA,"TCGA-EK-A2RN-F58269","TCGA-EK-A2RN",NA,"EK","A2RN","YES","C53.9","8071/3","C53.9","NO","YES",-16487,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",71,NA,NA,NA,"WITH TUMOR","NO",5,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2009,"Cone Biopsy / LEEP","YES",15,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",7,NA,"T2bN1MX",NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
145861940,142095962,6789229173,"331A9160-D730-45DD-A985-C6CAC03035ED.bw","b726f18b-b996-4978-9f27-b3a540e06270","331a9160-d730-45dd-a985-c6cac03035ed","2016-08-09T13:56:46.725337-05:00","UNCID_2187258.174159b7-d7a4-43d5-8c04-7f62f8d0db14.120921_UNC16-SN851_0181_AD14JFACXX_5_CAGATC.tar.gz","21e2f20a-365c-46a5-8d0c-98c2d825c880",6484510621,"Illumina HiSeq","43764378681e3b1c9f1a487c51e1cea7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:52:06.576918-05:00","2016-05-03T11:02:00.408696-05:00","21e2f20a-365c-46a5-8d0c-98c2d825c880_analysis.xml","c7633bf527594f2ebc6479093bf434ad","7d0f7bef-df87-456e-a9eb-2b83cfc460eb",2124,"2016-08-13T06:32:54.888536-05:00","21e2f20a-365c-46a5-8d0c-98c2d825c880_experiment.xml","533814bf0f5fafbc416f5be5e7816c47","e9ddaf12-dd80-4be9-a760-9c00975bbece",2431,"2016-09-29T23:42:05.157403-05:00","21e2f20a-365c-46a5-8d0c-98c2d825c880_run.xml","faf0ee09ba15a1459209273f6365c094","e69176d9-303c-4c9c-9f92-b72b382db788",354,"2016-09-08T11:55:39.793786-05:00","TCGA-C5-A1MK","2016-09-02T18:57:20.053702-05:00","female","TCGA-C5-A1MK_demographic",1926,"white","8a519342-7f06-5de8-8207-a0221c418d8c","not hispanic or latino",2005,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MK_diagnosis","not reported",28939,"dead","8070/3",74,NA,"d408c7f0-4ee7-5e37-8ad6-a48d10fac0e8","c53.9",-28939,"TCGA-C5-A1MK_treatment","62c2f859-298b-5514-89b4-79793d3c1815","01","true","TCGA-C5-A1MK-01A",NA,"4b90c14d-cafd-4b28-8494-85c2f5d8e80c",FALSE,"75B6D26C-3C3C-4D2E-BFDD-C9CB81AE3793","Primary Tumor",NA,2052,50,NA,1301356800,"11",30,"TCGA-C5-A1MK-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:55:39.793786-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"9cd20864-a2d8-42c6-b409-1da20cc58c9a",NA,"TCGA-C5-A1MK-01A-01-TSA",NA,80,NA,"40322ef5-2302-4e7f-85e6-5023e9176842","RNA","TCGA-C5-A1MK-01A-11R","01756ebd-6506-4052-a9ec-b931416f0a90",1.88,0.17,"UV Spec","R","23","TCGA-C5-A1MK-01A-11R-A14Y-07","174159b7-d7a4-43d5-8c04-7f62f8d0db14",0.17,NA,63,26.2226847034339,155,"aa9d63be-edf9-581f-8e3e-e7cf08e6c38b","TCGA-C5-A1MK_exposure","UNCID_2187258.174159b7-d7a4-43d5-8c04-7f62f8d0db14.120921_UNC16-SN851_0181_AD14JFACXX_5_CAGATC.tar.gz","2013-09-17T05:26:03.000Z","2013-09-17T05:46:01.000Z","21E2F20A-365C-46A5-8D0C-98C2D825C880","4B90C14D-CAFD-4B28-8494-85C2F5D8E80C","Unaligned reads",6484510621,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","174159B7-D7A4-43D5-8C04-7F62F8D0DB14","University of North Carolina","5660774ae4b018727fea1381","B726F18B-B996-4978-9F27-B3A540E06270","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","40322EF5-2302-4E7F-85E6-5023E9176842","2013-09-17T05:46:01.000Z","01756EBD-6506-4052-A9EC-B931416F0A90","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2052,"40322EF5-2302-4E7F-85E6-5023E9176842",NA,"C5","TCGA-C5-A1MK-01A-11R-A14X-13_mirna.bam",50,"TCGA-C5-A1MK-01A",NA,"2B5D6306-B757-4481-AAFD-9C8DBDBBECFB","TCGA",2005,NA,NA,"WITH TUMOR","BBA1013B-00CB-4AB8-9621-00D31E6176D0",79,"nationwidechildrens.org_clinical.TCGA-C5-A1MK.xml","Dead",74,"TCGA-C5-A1MK","NOT HISPANIC OR LATINO","0665FA73-B8EF-4766-9686-34C75DBA21C9",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",127,NA,"2C339BD1-F900-4BBC-98A6-149D92140C32","WHITE",NA,11,30,"9CD20864-A2D8-42C6-B409-1DA20CC58C9A","01756EBD-6506-4052-A9EC-B931416F0A90","TCGA-C5-A1MK-01A-11R-A14X-13_mirna.bam","TCGA-C5-A1MK-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-C5-A1MK-01A-01-TSA",80,"Carboplatin","Chemotherapy","TCGA-C5-A1MK-D30184","TCGA-C5-A1MK-R30185","COMBINATION","Primary Tumor Field",NA,"NO",NA,"WITH TUMOR","Dead",74,"TCGA-C5-A1MK-F30183","TCGA-C5-A1MK",NA,"C5","A1MK","YES","C53.9","8070/3","C53.9","NO","YES",-28939,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,74,NA,NA,"WITH TUMOR","NO",21,10,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,79,2005,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
186706050,185136622,8851486281,"9EEECA0E-530D-4724-B016-A716F0782148.bw","b75644c2-b515-41ce-9b03-842ef5208a17","9eeeca0e-530d-4724-b016-a716f0782148","2016-08-05T07:18:20.872978-05:00","UNCID_2186509.D1F596D6-1F2C-4728-BE8C-0EF9CC402F88.121015_UNC11-SN627_0256_AD15B2ACXX_2_CCGTCC.tar.gz","2774cc5e-5655-401d-88e7-3aaba05dee1b",8215137639,"Illumina HiSeq","837c4a0e607546e30b40e6cbfd99b518","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:38:03.324108-05:00","2016-05-03T11:00:24.467483-05:00","2774cc5e-5655-401d-88e7-3aaba05dee1b_analysis.xml","a38d3144383f5b9dd96496831d0eb096","7442c92d-48ae-4a8c-bb6e-61ec95ad17ed",2124,"2016-09-29T23:28:03.578756-05:00","2774cc5e-5655-401d-88e7-3aaba05dee1b_experiment.xml","26c99a445d585c64029f4c265a6bfb3f","ddc350fc-e903-4a1b-8ff6-bc6e26a8ca0f",2431,"2016-09-29T23:16:01.756547-05:00","2774cc5e-5655-401d-88e7-3aaba05dee1b_run.xml","59b344a7e06f01c214edcfbc4b22748f","d64ba52c-b034-4b56-a8cd-401e547709cc",354,"2016-09-08T11:35:18.915905-05:00","TCGA-FU-A3TX","2016-09-02T18:59:30.422690-05:00","female","TCGA-FU-A3TX_demographic",1934,"not reported","d44cb975-85d2-5377-bb6f-799d3098549e","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3TX_diagnosis","not reported",28825,"alive","8070/3",NA,45,"920e65dd-2b2b-5f10-81ad-852b371bce1f","c53.9",-28825,"TCGA-FU-A3TX_treatment","b2d5432c-e036-544a-991c-02f98add656c","01","false","TCGA-FU-A3TX-01A",NA,"d9146847-1e6a-4963-9bc2-c2041b36a84c",FALSE,"8206742A-1778-4B5F-AD56-32D9501EDA3C","Primary Tumor",NA,78,140,NA,1334620800,"11",30,"TCGA-FU-A3TX-01A-11",70,NA,10,NA,0,NA,25,NA,"2016-09-08T11:35:18.915905-05:00",NA,60,NA,10,NA,"TOP",NA,5,NA,"ecebf2b3-c3e6-4a20-bc02-4760df8c19ac",NA,"TCGA-FU-A3TX-01A-01-TSA",NA,70,NA,"cb7e9146-d0d3-4c65-9206-a2481214d18e","RNA","TCGA-FU-A3TX-01A-11R","5addd07b-9f6f-4c9d-9627-c1e42c13bfa8",1.85,0.15,"UV Spec","R","23","TCGA-FU-A3TX-01A-11R-A22U-07","d1f596d6-1f2c-4728-be8c-0ef9cc402f88",0.15,NA,67,NA,NA,"0585da6c-d3c2-5d57-b08c-f7360996a463","TCGA-FU-A3TX_exposure","UNCID_2186509.D1F596D6-1F2C-4728-BE8C-0EF9CC402F88.121015_UNC11-SN627_0256_AD15B2ACXX_2_CCGTCC.tar.gz","2013-09-16T10:26:04.000Z","2013-09-16T11:11:02.000Z","2774CC5E-5655-401D-88E7-3AABA05DEE1B","D9146847-1E6A-4963-9BC2-C2041B36A84C","Unaligned reads",8215137639,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","D1F596D6-1F2C-4728-BE8C-0EF9CC402F88","University of North Carolina","564a3c64e4b0ef12181ac09e","B75644C2-B515-41CE-9B03-842EF5208A17","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CB7E9146-D0D3-4C65-9206-A2481214D18E","2013-09-16T11:11:02.000Z","5ADDD07B-9F6F-4C9D-9627-C1E42C13BFA8","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",78,"CB7E9146-D0D3-4C65-9206-A2481214D18E",NA,"FU","TCGA-FU-A3TX-01A-11R-A22V-13_mirna.bam",140,"TCGA-FU-A3TX-01A",NA,NA,"TCGA",2012,"TCGA-FU-A3TX_NTE-1",NA,NA,"D9146847-1E6A-4963-9BC2-C2041B36A84C",78,"TCGA-FU-A3TX-01A-11R-A22V-13_mirna.bam","Alive",NA,"TCGA-FU-A3TX",NA,NA,"NO",45,"Yes","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",236,NA,NA,NA,NA,11,30,"ECEBF2B3-C3E6-4A20-BC02-4760DF8C19AC","B9065598-BF5D-4486-AD8A-4BB2114F60B3","UNCID_1673940.D1F596D6-1F2C-4728-BE8C-0EF9CC402F88.sorted_genome_alignments.bam","TCGA-FU-A3TX-01A-11",70,0,10,60,25,"TOP",5,10,"TCGA-FU-A3TX-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-FU-A3TX",NA,"FU","A3TX","YES","C53.9","8070/3","C53.9","YES","NO",-28825,"FEMALE",NA,NA,"Yes","No","Alive",45,NA,NA,NA,NA,"YES",6,8,2012,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,78,2012,"Cytology (e.g. Peritoneal or pleural fluid)","YES",30,0,"G3",NA,4,1993,NA,NA,NA,"2009",8,NA,"T1b2N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
160627918,153917701,7340061331,"B3073976-CA3F-4115-9243-8C2D9E1B975D.bw","b79558c5-1db2-4b1e-a7b8-efbd19aa855e","b3073976-ca3f-4115-9243-8c2d9e1b975d","2016-08-09T13:56:27.631382-05:00","UNCID_2186837.9fd5309d-03cc-4123-8bc8-d7dfba4955d2.121009_UNC16-SN851_0187_AD15RRACXX_2_TTAGGC.tar.gz","9709e64c-0a33-4bf7-8a33-703a3d973d66",7234527299,"Illumina HiSeq","9c40b8d33d6be6cddf6939b148e6dd9b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:38:20.842440-05:00","2016-05-03T11:01:14.488541-05:00","9709e64c-0a33-4bf7-8a33-703a3d973d66_analysis.xml","08cc88d50be32f122fd3170ea893876a","4fb0e85e-c413-4ae9-97b2-b2f7653da1ac",2124,"2016-10-07T17:22:51.681960-05:00","9709e64c-0a33-4bf7-8a33-703a3d973d66_experiment.xml","6b1239a9178fd88de0d33cbf3366813b","6a928754-9be3-4a13-85f7-c48cb3fede70",2431,"2016-09-29T22:31:05.977732-05:00","9709e64c-0a33-4bf7-8a33-703a3d973d66_run.xml","0d8210a48a0e544186145ae4c565b01a","ba6ec628-9a13-47d2-baec-ceae5fc91095",354,"2016-09-08T12:15:38.320425-05:00","TCGA-IR-A3LK","2016-09-02T18:58:59.982359-05:00","female","TCGA-IR-A3LK_demographic",1940,"white","d7614098-62e5-5315-a1c0-d847d6d24062","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LK_diagnosis","not reported",25440,"dead","8070/3",908,808,"e6ab025f-a26c-5a4d-90a7-c8069253a3c4","c53.9",-25440,"TCGA-IR-A3LK_treatment","b1754ff4-8169-572f-bd2a-2d020afef309","01","true","TCGA-IR-A3LK-01A",NA,"dca9ff1f-dd32-43dd-8fd4-446d014f5db8",FALSE,"3AE8F93E-83B7-4501-B916-EC4EA9959F99","Primary Tumor",NA,779,110,NA,1324598400,"12",30,"TCGA-IR-A3LK-01A-12",90,NA,0,NA,0,NA,0,NA,"2016-09-08T12:15:38.320425-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"32adc40a-c10c-42cb-a014-c41ce398342e",NA,"TCGA-IR-A3LK-01A-01-TS1",NA,100,NA,"9b178cb9-38b8-420e-96e5-d26ffa64c69d","RNA","TCGA-IR-A3LK-01A-12R","334385e0-ee8d-47b8-937a-7938b1d17fe1",1.77,0.16,"UV Spec","R","23","TCGA-IR-A3LK-01A-12R-A213-07","9fd5309d-03cc-4123-8bc8-d7dfba4955d2",0.16,NA,96,35.2617079889807,165,"5ac97f5d-c4e5-5844-8c22-9d73aa93f213","TCGA-IR-A3LK_exposure","UNCID_2186837.9fd5309d-03cc-4123-8bc8-d7dfba4955d2.121009_UNC16-SN851_0187_AD15RRACXX_2_TTAGGC.tar.gz","2013-09-16T07:37:04.000Z","2013-09-16T20:25:01.000Z","9709E64C-0A33-4BF7-8A33-703A3D973D66","DCA9FF1F-DD32-43DD-8FD4-446D014F5DB8","Unaligned reads",7234527299,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9FD5309D-03CC-4123-8BC8-D7DFBA4955D2","University of North Carolina","564a3a64e4b0ef12181a1e9e","B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9B178CB9-38B8-420E-96E5-D26FFA64C69D","2013-09-16T20:25:01.000Z","334385E0-EE8D-47B8-937A-7938B1D17FE1","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",779,"9B178CB9-38B8-420E-96E5-D26FFA64C69D",NA,"IR","jhu-usc.edu_CESC.HumanMethylation450.6.lvl-2.TCGA-IR-A3LK-01A-12D-A212-05.txt",110,"TCGA-IR-A3LK-01A",NA,"E502C966-183F-4170-A354-B67DE0DE5D91","TCGA",2009,NA,NA,"WITH TUMOR","DD471C07-B1BC-441E-8FEE-8DF228EBA7B3",69,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.9F4623A9-D7C2-4EB5-8CA9-6F0C67828AEB.txt","Alive",NA,"TCGA-IR-A3LK",NA,"3A108750-52F1-4F7D-8792-26882DD1D8FC",NA,808,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",200,NA,"F0EBAD73-8386-4A60-841C-7B2090ED13C2","WHITE",NA,12,30,"32ADC40A-C10C-42CB-A014-C41CE398342E","D2AC0F28-C930-4D80-AD4D-45C3A47FAEC0","b757e4a6dd764dcc27c60bf847ab9c9e.bam","TCGA-IR-A3LK-01A-12",90,0,0,2,0,"TOP",0,0,"TCGA-IR-A3LK-01A-01-TS1",100,"Carboplatin","Chemotherapy","TCGA-IR-A3LK-D38336","TCGA-IR-A3LK-R38334","External","Primary Tumor Field","TCGA-IR-A3LK-F38333_NTE-2","YES",NA,"WITH TUMOR","Dead",908,"TCGA-IR-A3LK-F38333","TCGA-IR-A3LK",NA,"IR","A3LK","YES","C53.9","8070/3","C53.9","NO","YES",-25440,"FEMALE","WHITE",NA,"No","No","Alive",808,NA,NA,NA,"WITH TUMOR","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,69,2009,"Biopsy (cervical / CT-guided / Other)","YES",17,0,"G3",NA,1,NA,NA,NA,NA,"2009",8,NA,"T1b2N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
125290464,114021456,5418432139,"77B3C9B4-1A7F-41BB-A37D-01EF80E933CC.bw","b7f2958f-256e-4c30-9c61-11e76ddb36ba","77b3c9b4-1a7f-41bb-a37d-01ef80e933cc","2016-08-05T05:49:52.766042-05:00","UNCID_2186831.d7954ccb-a03f-45cb-a059-88fc217cb753.121009_UNC16-SN851_0187_AD15RRACXX_1_CGATGT.tar.gz","de2bc7b0-32a8-452b-9fca-0d16982bed4e",5358585750,"Illumina HiSeq","5194eddc838a071875d44bb8e33c18ab","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:40:50.359433-05:00","2016-05-03T11:01:14.469334-05:00","de2bc7b0-32a8-452b-9fca-0d16982bed4e_analysis.xml","1ba4b4d45bc587cca0c2959bebeb87f8","9b53365d-19bb-496e-83e1-ca4c499121d5",2124,"2016-08-13T06:21:22.320602-05:00","de2bc7b0-32a8-452b-9fca-0d16982bed4e_experiment.xml","73e71e62dfbcca1dcaf47d424ed10224","feaddd87-20f8-4523-a484-9d6c1ae50f59",2431,"2016-09-29T23:22:09.665371-05:00","de2bc7b0-32a8-452b-9fca-0d16982bed4e_run.xml","5a48d762496d0e1add19514c842d2ea3","da07c0d3-d3e1-422a-895f-ae8a0cd038e6",354,"2016-09-08T12:14:15.480642-05:00","TCGA-FU-A3EO","2016-09-02T18:58:48.973918-05:00","female","TCGA-FU-A3EO_demographic",1956,"white","4b53cf7d-3b93-508c-b31b-345cefe1836a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3EO_diagnosis","not reported",20207,"alive","8140/3",NA,490,"974f5fd6-2f98-5091-acf2-e4a82759d69e","c53.9",-20207,"TCGA-FU-A3EO_treatment","9e1d4012-b026-5b5c-9084-2398e334f6e6","01","false","TCGA-FU-A3EO-01A",NA,"59f1684e-5631-4e1e-a1dc-91739f7c159c",FALSE,"FA82B92B-202A-44B2-B186-F38F2C33E062","Primary Tumor",NA,137,20,NA,1320105600,"11",20,"TCGA-FU-A3EO-01A-11",60,NA,0,NA,0,NA,25,NA,"2016-09-08T12:14:15.480642-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"d73f916a-4bdd-49e8-af6c-216e0cea2996",NA,"TCGA-FU-A3EO-01A-01-TS1",NA,75,NA,"e02441e0-7d41-4703-8449-b9cd9998c881","RNA","TCGA-FU-A3EO-01A-11R","aaa5d835-ad39-4dc1-a085-dd33c5061557",1.72,0.15,"UV Spec","R","23","TCGA-FU-A3EO-01A-11R-A213-07","d7954ccb-a03f-45cb-a059-88fc217cb753",0.15,2.19178082191781,64,23.5078053259871,165,"8fca997a-0bda-54c4-9d7e-43f7504cf768","TCGA-FU-A3EO_exposure","UNCID_2186831.d7954ccb-a03f-45cb-a059-88fc217cb753.121009_UNC16-SN851_0187_AD15RRACXX_1_CGATGT.tar.gz","2013-09-16T15:43:04.000Z","2013-09-16T16:05:01.000Z","DE2BC7B0-32A8-452B-9FCA-0D16982BED4E","59F1684E-5631-4E1E-A1DC-91739F7C159C","Unaligned reads",5358585750,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","D7954CCB-A03F-45CB-A059-88FC217CB753","University of North Carolina","566075c3e4b016715ab686f5","B7F2958F-256E-4C30-9C61-11E76DDB36BA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E02441E0-7D41-4703-8449-B9CD9998C881","2013-09-16T16:05:01.000Z","AAA5D835-AD39-4DC1-A085-DD33C5061557","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",137,"E02441E0-7D41-4703-8449-B9CD9998C881",NA,"FU","TCGA-FU-A3EO-01A-11R-A214-13_mirna.bam.bai",20,"TCGA-FU-A3EO-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","B4C02B0C-1ABE-4C3F-BE7C-5DE397EFAC95",55,"nationwidechildrens.org_clinical.TCGA-FU-A3EO.xml","Alive",NA,"TCGA-FU-A3EO","NOT HISPANIC OR LATINO","1E9AA2FE-4C00-468E-A062-DCCC9228652E",NA,66,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8140/3","FEMALE","C53.9",200,NA,"F3D2E004-8EF0-4BDA-8BA1-5FA95BB07132","WHITE",NA,11,20,"D73F916A-4BDD-49E8-AF6C-216E0CEA2996","AAA5D835-AD39-4DC1-A085-DD33C5061557","TCGA-FU-A3EO-01A-11R-A214-13_mirna.bam.bai","TCGA-FU-A3EO-01A-11",60,0,0,0,25,"TOP",0,0,"TCGA-FU-A3EO-01A-01-TS1",75,NA,NA,NA,"TCGA-FU-A3EO-R44094","Internal","Primary Tumor Field","TCGA-FU-A3EO-F44091_NTE-1","NO",490,"TUMOR FREE","Alive",NA,"TCGA-FU-A3EO-F44091","TCGA-FU-A3EO",NA,"FU","A3EO","YES","C53.9","8140/3","C53.9","YES","NO",-20207,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",66,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,55,2011,"Biopsy (cervical / CT-guided / Other)","YES",23,0,"G2",NA,2,NA,40,NA,NA,"2009",13,NA,"T2bN0MX",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
153566040,151969444,7254989627,"C0C26822-2E9F-4FB0-81D4-575027C8B71C.bw","b7f2958f-256e-4c30-9c61-11e76ddb36ba","c0c26822-2e9f-4fb0-81d4-575027c8b71c","2016-08-05T08:17:46.721678-05:00","UNCID_2186827.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.121009_UNC16-SN851_0187_AD15RRACXX_3_GCCAAT.tar.gz","c88cec49-d1f4-470f-b34b-bd011984a910",6862457191,"Illumina HiSeq","9dc7ed2b34eb53893ed8e601d97bfc3d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:17:59.212625-05:00","2016-05-03T11:01:14.469334-05:00","c88cec49-d1f4-470f-b34b-bd011984a910_analysis.xml","ea24178f08868dd832865afe96712c16","4304e56c-3682-4019-ae1f-3025b69c1049",2124,"2016-09-29T19:10:38.637244-05:00","c88cec49-d1f4-470f-b34b-bd011984a910_experiment.xml","b8248952c943eec23881ba5bcdbe079e","3e61834c-862d-4483-bf34-3a43a4dd68d9",2431,"2016-09-30T00:01:53.758633-05:00","c88cec49-d1f4-470f-b34b-bd011984a910_run.xml","08e25490be78f29836865af1ea56aae3","f2c927f1-4c54-4be7-a59f-785c7615e860",354,"2016-09-08T12:14:15.480642-05:00","TCGA-FU-A3EO","2016-09-02T18:58:48.973918-05:00","female","TCGA-FU-A3EO_demographic",1956,"white","4b53cf7d-3b93-508c-b31b-345cefe1836a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3EO_diagnosis","not reported",20207,"alive","8140/3",NA,490,"974f5fd6-2f98-5091-acf2-e4a82759d69e","c53.9",-20207,"TCGA-FU-A3EO_treatment","9e1d4012-b026-5b5c-9084-2398e334f6e6","11","false","TCGA-FU-A3EO-11A",NA,"b4c02b0c-1abe-4c3f-be7c-5de397efac95",FALSE,NA,"Solid Tissue Normal",NA,137,80,NA,1320710400,"13",20,"TCGA-FU-A3EO-11A-13",0,NA,0,NA,100,NA,0,NA,"2016-09-08T12:14:15.480642-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"5b853927-fc9b-4ba0-b9b7-b4bc8fe5259f",NA,"TCGA-FU-A3EO-11A-01-TS1",NA,0,NA,"434559ff-acf5-4552-9a09-cfb9a35d747f","RNA","TCGA-FU-A3EO-11A-13R","7944063e-2256-4c51-a47a-12046c672cc0",1.48,0.18,"UV Spec","R","23","TCGA-FU-A3EO-11A-13R-A213-07","3349e197-7ef8-4cfd-b365-1dbf5c7db58d",0.18,2.19178082191781,64,23.5078053259871,165,"8fca997a-0bda-54c4-9d7e-43f7504cf768","TCGA-FU-A3EO_exposure","UNCID_2186827.3349e197-7ef8-4cfd-b365-1dbf5c7db58d.121009_UNC16-SN851_0187_AD15RRACXX_3_GCCAAT.tar.gz","2013-09-16T15:36:04.000Z","2013-09-16T15:57:01.000Z","C88CEC49-D1F4-470F-B34B-BD011984A910","B4C02B0C-1ABE-4C3F-BE7C-5DE397EFAC95","Unaligned reads",6862457191,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3349E197-7EF8-4CFD-B365-1DBF5C7DB58D","University of North Carolina","564a3b2ce4b093830b693217","B7F2958F-256E-4C30-9C61-11E76DDB36BA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","434559FF-ACF5-4552-9A09-CFB9A35D747F","2013-09-16T15:57:01.000Z","7944063E-2256-4C51-A47A-12046C672CC0","United States","NO",11,NA,"Solid Tissue Normal","International Genomics Consortium",137,"434559FF-ACF5-4552-9A09-CFB9A35D747F",NA,"FU","TCGA-FU-A3EO-11A-13R-A214-13_mirna.bam.bai",80,"TCGA-FU-A3EO-11A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","B4C02B0C-1ABE-4C3F-BE7C-5DE397EFAC95",55,"nationwidechildrens.org_clinical.TCGA-FU-A3EO.xml","Alive",NA,"TCGA-FU-A3EO","NOT HISPANIC OR LATINO","1E9AA2FE-4C00-468E-A062-DCCC9228652E",NA,66,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",1,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8140/3","FEMALE","C53.9",200,NA,"F3D2E004-8EF0-4BDA-8BA1-5FA95BB07132","WHITE",NA,13,20,"5B853927-FC9B-4BA0-B9B7-B4BC8FE5259F","E89D09D9-0C00-41AF-AF97-3C9B8DCFB652","TCGA-FU-A3EO-11A-13R-A214-13_mirna.bam.bai","TCGA-FU-A3EO-11A-13",0,100,0,0,0,"TOP",0,0,"TCGA-FU-A3EO-11A-01-TS1",0,NA,NA,NA,"TCGA-FU-A3EO-R44094","Internal","Primary Tumor Field","TCGA-FU-A3EO-F44091_NTE-1","NO",490,"TUMOR FREE","Alive",NA,"TCGA-FU-A3EO-F44091","TCGA-FU-A3EO",NA,"FU","A3EO","YES","C53.9","8140/3","C53.9","YES","NO",-20207,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",66,NA,NA,NA,"TUMOR FREE","NO",15,2,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,55,2011,"Biopsy (cervical / CT-guided / Other)","YES",23,0,"G2",NA,2,NA,40,NA,NA,"2009",13,NA,"T2bN0MX",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
177957202,167561179,7985992387,"F1FCE328-2B3B-499A-888D-0E66A017E8B0.bw","b82f4c6d-530f-4b0e-8f33-995633cb254a","f1fce328-2b3b-499a-888d-0e66a017e8b0","2016-08-09T13:11:08.915850-05:00","UNCID_2186180.c188647f-7c72-4228-acd8-de6e5892f7fe.121102_UNC12-SN629_0235_AC13F5ACXX_2_CGTACG.tar.gz","39814526-af0f-4187-a38c-b68f62716b2f",7967597977,"Illumina HiSeq","168acfed3e41819d1712b4572debdfad","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:54:01.572313-05:00","2016-05-03T11:00:24.444360-05:00","39814526-af0f-4187-a38c-b68f62716b2f_analysis.xml","ede524c9612b84ac4b3ed61d1d023c5c","edf9ba96-4826-43a4-86c1-78b22c15805d",2124,"2016-08-26T14:32:22.571795-05:00","39814526-af0f-4187-a38c-b68f62716b2f_experiment.xml","0b81673c7e150fc6c8604caacba72683","ab625c25-d93c-4471-a4ac-f976717441c4",2431,"2016-09-29T18:13:24.762697-05:00","39814526-af0f-4187-a38c-b68f62716b2f_run.xml","5515275fe4fac96311d6cbbd150393d1","1a5c4d35-70c7-49f5-8762-96bce1bd7c03",354,"2016-09-08T12:13:44.075482-05:00","TCGA-C5-A2LX","2016-09-02T18:57:50.964260-05:00","female","TCGA-C5-A2LX_demographic",1953,"white","21ac1193-d164-5d9c-acb4-bd18d489f4c6","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LX_diagnosis","not reported",20070,"alive","8070/3",NA,2526,"3f8c1bd4-f3ce-5d47-a6a7-b40b753f9fd5","c53.9",-20070,"TCGA-C5-A2LX_treatment","92f0ef41-5754-55a2-9055-66881c6acaab","01","false","TCGA-C5-A2LX-01A",NA,"41bebea3-11c2-4748-8e60-082cfb8e0251",FALSE,"CF12FC3E-41CA-48EE-AF88-15ACA2C0067D","Primary Tumor",NA,1583,160,NA,1314144000,"11",30,"TCGA-C5-A2LX-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T12:13:44.075482-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"fc092561-6c07-4bba-aa01-c8fbf8cf2fc5",NA,"TCGA-C5-A2LX-01A-01-TSA",NA,100,NA,"67878353-460a-41e6-a83c-7b93b06c4a2e","RNA","TCGA-C5-A2LX-01A-11R","c56a871b-7559-47af-b006-706d68466057",1.84,0.16,"UV Spec","R","23","TCGA-C5-A2LX-01A-11R-A18M-07","c188647f-7c72-4228-acd8-de6e5892f7fe",0.16,1.91780821917808,65,23.8751147842057,165,"5f149724-05b1-5462-97df-5478653fd239","TCGA-C5-A2LX_exposure","UNCID_2186180.c188647f-7c72-4228-acd8-de6e5892f7fe.121102_UNC12-SN629_0235_AC13F5ACXX_2_CGTACG.tar.gz","2013-09-16T01:56:04.000Z","2013-09-16T02:19:02.000Z","39814526-AF0F-4187-A38C-B68F62716B2F","41BEBEA3-11C2-4748-8E60-082CFB8E0251","Unaligned reads",7967597977,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C188647F-7C72-4228-ACD8-DE6E5892F7FE","University of North Carolina","566074b9e4b0ec1099f8b066","B82F4C6D-530F-4B0E-8F33-995633CB254A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","67878353-460A-41E6-A83C-7B93B06C4A2E","2013-09-16T02:19:02.000Z","C56A871B-7559-47AF-B006-706D68466057","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1583,"67878353-460A-41E6-A83C-7B93B06C4A2E",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.48EC2082-9A47-44FB-9E0E-19120B7365A7.txt",160,"TCGA-C5-A2LX-01A",NA,"85A0C61D-EA35-4F65-96E7-BA0F109F33E8","TCGA",2007,NA,NA,"TUMOR FREE","9D41477D-8B08-46BA-ABDD-865BBAAD1F81",54,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.48EC2082-9A47-44FB-9E0E-19120B7365A7.txt","Alive",NA,"TCGA-C5-A2LX","NOT HISPANIC OR LATINO","D773F4CA-F971-475C-BFCD-1D415C0212BD",NA,491,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T2","8070/3","FEMALE","C53.9",179,NA,"CE937AB7-D24C-409F-BB01-2B70D49B83CE","WHITE",NA,11,30,"FC092561-6C07-4BBA-AA01-C8FBF8CF2FC5","C56A871B-7559-47AF-B006-706D68466057","UNCID_2186180.c188647f-7c72-4228-acd8-de6e5892f7fe.121102_UNC12-SN629_0235_AC13F5ACXX_2_CGTACG.tar.gz","TCGA-C5-A2LX-01A-11",90,0,0,0,0,"TOP",0,0,"TCGA-C5-A2LX-01A-01-TSA",100,"Cisplatin","Chemotherapy","TCGA-C5-A2LX-D21317","TCGA-C5-A2LX-R21319","COMBINATION","Primary Tumor Field",NA,"NO",491,"TUMOR FREE","Alive",NA,"TCGA-C5-A2LX-F21316","TCGA-C5-A2LX",NA,"C5","A2LX","YES","C53.9","8070/3","C53.9","NO","YES",-20070,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",491,NA,NA,NA,"TUMOR FREE","NO",8,2,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2007,"Biopsy (cervical / CT-guided / Other)","YES",39,3,"G2",NA,2,NA,35,NA,NA,"1995",7,NA,"T2N1MX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
227113924,221925194,10598342354,"F069DAD6-F1EB-42F7-8252-F3F6EC46CC3E.bw","b8eae533-2ad6-4dcf-98af-0fe7ff23a879","f069dad6-f1eb-42f7-8252-f3f6ec46cc3e","2016-08-05T10:32:09.737123-05:00","UNCID_2654411.4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0.120921_UNC16-SN851_0181_AD14JFACXX_6_TAGCTT.tar.gz","eb32c33e-41cb-40c7-949c-048cdd8311d7",9852373338,"Illumina HiSeq","f3e6990d193c0cd6b47771049492c589","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:01:00.287085-05:00","2016-05-03T12:08:10.840133-05:00","eb32c33e-41cb-40c7-949c-048cdd8311d7_analysis.xml","71345a00fa779e6c7e401b7f1522db47","a7f2c3df-44d2-4a92-b12a-0e2715140b84",2124,"2016-09-29T23:28:41.566245-05:00","eb32c33e-41cb-40c7-949c-048cdd8311d7_experiment.xml","41616e5852575b432ca879044b4994e8","de22899f-973f-4814-8469-9e2f7871e89f",2628,"2016-09-29T19:06:21.875550-05:00","eb32c33e-41cb-40c7-949c-048cdd8311d7_run.xml","9a2323a14a4d2a5b30ae8bc1c94ea922","3bb9ec10-5757-4eec-b58b-46bf0fabc9e2",354,"2016-09-08T11:25:51.789162-05:00","TCGA-DS-A1O9","2016-09-02T18:57:24.507609-05:00","female","TCGA-DS-A1O9_demographic",1924,"white","5e25866a-ae60-5092-8c76-3b40dd6bf109","not hispanic or latino",1999,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A1O9_diagnosis","not reported",27433,"dead","8070/3",266,266,"0a1821f5-1f70-56e2-9ebd-3722cb8269f5","c53.9",-27433,"TCGA-DS-A1O9_treatment","e8fe7da6-a1b4-5616-a047-ca4b14f1dc78","01","true","TCGA-DS-A1O9-01A",NA,"78782d7d-faa0-43ee-beb7-3a19f1187fd6",FALSE,"DDC9EA73-6412-4D20-A422-0F57A8925536","Primary Tumor",NA,4152,210,NA,1302220800,"11",30,"TCGA-DS-A1O9-01A-11",70,NA,10,NA,0,NA,25,NA,"2016-09-08T11:25:51.789162-05:00",NA,40,NA,30,NA,"TOP",NA,5,NA,"25092dd1-39a8-418c-a424-79a53834fdc2",NA,"TCGA-DS-A1O9-01A-01-TSA",NA,70,NA,"46c6a9d2-0ede-4b38-b29a-4c0b224781b7","RNA","TCGA-DS-A1O9-01A-11R","01e29ac3-4da6-4b78-86c7-53a7ed3122e3",1.81,0.17,"UV Spec","R","23","TCGA-DS-A1O9-01A-11R-A14Y-07","4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0",0.17,NA,32,18.3654729109275,132,"78bf3ac1-9aab-5309-a84f-4d18799b9fae","TCGA-DS-A1O9_exposure","UNCID_2654411.4eadb0cd-c88e-4f3e-b3a1-d76d3b16aba0.120921_UNC16-SN851_0181_AD14JFACXX_6_TAGCTT.tar.gz","2014-11-05T17:27:05.000Z","2014-11-05T17:48:25.000Z","EB32C33E-41CB-40C7-949C-048CDD8311D7","78782D7D-FAA0-43EE-BEB7-3A19F1187FD6","Unaligned reads",9852373338,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4EADB0CD-C88E-4F3E-B3A1-D76D3B16ABA0","University of North Carolina","564a3fb3e4b0298dd2c9c9ef","B8EAE533-2AD6-4DCF-98AF-0FE7FF23A879","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","46C6A9D2-0EDE-4B38-B29A-4C0B224781B7","2014-11-05T17:48:25.000Z","01E29AC3-4DA6-4B78-86C7-53A7ED3122E3","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",4152,"46C6A9D2-0EDE-4B38-B29A-4C0B224781B7",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.3B37639D-EC0D-426D-ABC5-9243B346F13D.txt",210,"TCGA-DS-A1O9-01A",NA,NA,"TCGA",1999,NA,NA,"WITH TUMOR","E74F027E-B512-46A1-8DE2-B7DC6C266AF1",75,"nationwidechildrens.org_clinical.TCGA-DS-A1O9.xml","Dead",266,"TCGA-DS-A1O9","NOT HISPANIC OR LATINO","28BF1FA0-4650-45CB-91D2-9D7106C45522",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IVA",NA,NA,"T4","8070/3","FEMALE","C53.9",127,NA,NA,"WHITE",NA,11,30,"25092DD1-39A8-418C-A424-79A53834FDC2","8DDFD8FC-3F04-487D-8BC6-BA726CCE0E6C","TCGA-DS-A1O9-01A-11R-A14X-13.mirna.quantification.txt","TCGA-DS-A1O9-01A-11",70,0,10,40,25,"TOP",5,30,"TCGA-DS-A1O9-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,NA,"NO",266,"WITH TUMOR","Dead",266,"TCGA-DS-A1O9-F15174","TCGA-DS-A1O9",NA,"DS","A1O9","YES","C53.9","8070/3","C53.9","NO","YES",-27433,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,266,NA,NA,"WITH TUMOR","NO",12,8,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,75,1999,"Biopsy (cervical / CT-guided / Other)","YES",19,0,"G3",NA,2,NA,NA,NA,NA,"2009",17,NA,"T4N0M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
131426104,127679399,6092485058,"99CC822E-8C98-4EEC-BB58-AEF76A0B5332.bw","bae2af5e-484a-44f7-ad6b-66137cdae300","99cc822e-8c98-4eec-bb58-aef76a0b5332","2016-08-25T17:54:51.789019-05:00","UNCID_2326833.131525c8-7f24-48c3-bef9-cc9414e793b8.131015_UNC11-SN627_0328_BC2NN6ACXX_6_AGTCAA.tar.gz","882d44e0-8bf5-4604-8307-300126c250f7",5830757210,"Illumina HiSeq","3a4e2383ee81fe177a1a390ae0a0a6f9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:31:11.148970-05:00","2016-05-03T11:30:43.411663-05:00","882d44e0-8bf5-4604-8307-300126c250f7_analysis.xml","7b1dfd7c5ddaea264f2b453fc0f8d4ab","ba7c0c91-1cee-47b3-9d58-a328d94a8915",2124,"2016-08-29T08:32:49.519388-05:00","882d44e0-8bf5-4604-8307-300126c250f7_experiment.xml","c79ea04c6d95086e92b42416e26d20c7","12fb8422-8de1-40d5-bd1e-31d54f31619a",2628,"2016-09-29T22:35:47.974907-05:00","882d44e0-8bf5-4604-8307-300126c250f7_run.xml","676ff529ef188f031faa7922071ad240","bd51e1d4-74d3-4eeb-998f-8fdf351ae82a",354,"2016-09-08T11:41:15.124788-05:00","TCGA-C5-A7CL","2016-09-02T19:00:21.736010-05:00","female","TCGA-C5-A7CL_demographic",1954,"white","1bd2fea1-eac2-57a0-a541-89567294e488","not reported",2003,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CL_diagnosis","not reported",17869,"dead","8070/3",471,NA,"ea476aca-080c-55cc-9634-37ea5f073a5a","c53.9",-17869,"TCGA-C5-A7CL_treatment","525004cc-f6c3-57fe-86c1-3cf3d8cfb506","01","true","TCGA-C5-A7CL-01A",NA,"695043a5-66da-4b86-8540-6aca605aec86",FALSE,"8AC84EA1-1A57-4263-9AA1-832DFAABBA08","Primary Tumor",NA,4090,60,NA,1377820800,"11",30,"TCGA-C5-A7CL-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:41:15.124788-05:00",NA,5,NA,0,NA,"TOP",NA,15,NA,"321370cf-a5ab-4a67-b90f-8bc92506a3bb",NA,"TCGA-C5-A7CL-01A-01-TS1",NA,85,NA,"046ca62e-aadf-4a3f-bd98-d469b455feb9","RNA","TCGA-C5-A7CL-01A-11R","e2677c26-b71f-4b71-802d-b5c7e56af43b",1.98,0.18,"UV Spec","R","23","TCGA-C5-A7CL-01A-11R-A32P-07","131525c8-7f24-48c3-bef9-cc9414e793b8",0.18,1.0958904109589,103,38.76698407919,163,"658190b4-48af-5b72-b063-38a3f75572f6","TCGA-C5-A7CL_exposure","UNCID_2326833.131525c8-7f24-48c3-bef9-cc9414e793b8.131015_UNC11-SN627_0328_BC2NN6ACXX_6_AGTCAA.tar.gz","2014-01-22T19:46:05.000Z","2014-01-22T08:10:02.000Z","882D44E0-8BF5-4604-8307-300126C250F7","695043A5-66DA-4B86-8540-6ACA605AEC86","Unaligned reads",5830757210,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","131525C8-7F24-48C3-BEF9-CC9414E793B8","University of North Carolina","564a405de4b0ef12181c08d5","BAE2AF5E-484A-44F7-AD6B-66137CDAE300","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","046CA62E-AADF-4A3F-BD98-D469B455FEB9","2014-01-22T08:10:02.000Z","E2677C26-B71F-4B71-802D-B5C7E56AF43B","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4090,"046CA62E-AADF-4A3F-BD98-D469B455FEB9",NA,"C5","THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_B07_1367084.byallele.copynumber.data.txt",60,"TCGA-C5-A7CL-01A",NA,"271171D5-3179-4158-AE53-56A570CA3C73","TCGA",2002,"TCGA-C5-A7CL_NTE-1",NA,"WITH TUMOR","695043A5-66DA-4B86-8540-6ACA605AEC86",48,"nationwidechildrens.org_clinical.TCGA-C5-A7CL.xml","Dead",471,"TCGA-C5-A7CL",NA,NA,"NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",335,NA,"10FAC1CA-0C59-4184-9FFA-3BFC8B3099FC","WHITE",NA,11,30,"321370CF-A5AB-4A67-B90F-8BC92506A3BB","0930DB81-23C9-4BFD-BE2F-46EB2A60732D","TCGA-C5-A7CL-01A-11R-A32K-13_mirna.bam","TCGA-C5-A7CL-01A-11",75,0,0,5,0,"TOP",15,0,"TCGA-C5-A7CL-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-C5-A7CL-D56981","TCGA-C5-A7CL-R56983","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7CL",NA,"C5","A7CL","YES","C53.9","8070/3","C53.9","NO","YES",-17869,"FEMALE","WHITE",NA,"No","No","Dead",NA,471,NA,NA,"WITH TUMOR","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2002,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,20,NA,NA,"1995",16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
130562068,128379828,6132549635,"C86EBD08-53F2-4972-801A-74970FDD6A62.bw","bbb96b5a-80e8-4542-80b4-2444cf1fe51e","c86ebd08-53f2-4972-801a-74970fdd6a62","2016-08-09T14:01:32.135130-05:00","UNCID_2168999.d8e69719-3717-4c5d-8928-6b921d6ac187.130611_UNC15-SN850_0312_BC265JACXX_3_TGACCA.tar.gz","59310a88-16e9-40e8-9297-6802908ce5d1",5860827578,"Illumina HiSeq","262c1b1e40c29c4f42d32ad91976a057","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:53:07.044510-05:00","2016-05-03T11:06:28.634130-05:00","59310a88-16e9-40e8-9297-6802908ce5d1_analysis.xml","07e23e06c00b3ed5ba6cc30c053846ce","7db04c6d-876c-4478-aedb-840168cbf5f8",2123,"2016-10-07T17:55:58.001571-05:00","59310a88-16e9-40e8-9297-6802908ce5d1_experiment.xml","8a66c3775e6a7ef7ce716309f1cacb7c","6905c31c-e338-42f9-b957-1c729697c39c",2431,"2016-09-29T19:58:10.902987-05:00","59310a88-16e9-40e8-9297-6802908ce5d1_run.xml","2759510ac05b78601e2b05369c47106b","5c049478-ecf3-4152-9649-64a054e9fb6f",354,"2016-09-08T11:35:55.735511-05:00","TCGA-JW-A5VK","2016-09-02T19:00:03.336766-05:00","female","TCGA-JW-A5VK_demographic",1969,"black or african american","11dde3ef-29b1-5fcc-ba6f-e7914b8713ee","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VK_diagnosis","not reported",15965,"alive","8052/3",NA,623,"a4d5300b-8741-58f2-90fd-7367a4ca754a","c53.9",-15965,"TCGA-JW-A5VK_treatment","51839976-5a22-5842-aad0-f8659a293dc7","01","false","TCGA-JW-A5VK-01A",NA,"3f2e0ac8-13aa-4fc1-a08b-ac22c19d5164",FALSE,"00E96283-50FE-4604-A268-FF2A65B58B7F","Primary Tumor",NA,219,80,NA,1362528000,"11",30,"TCGA-JW-A5VK-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:35:55.735511-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"ae698ccb-ec05-4da4-9998-d111d0afa8ae",NA,"TCGA-JW-A5VK-01A-01-TS1",NA,90,NA,"50548ca4-7e61-49aa-8d03-1374186cd637","RNA","TCGA-JW-A5VK-01A-11R","4ac5b517-ef93-48f8-b347-b83f322505df",1.94,0.16,"UV Spec","R","23","TCGA-JW-A5VK-01A-11R-A28H-07","d8e69719-3717-4c5d-8928-6b921d6ac187",0.16,0.0547945205479452,68,27.2392244832559,158,"31db2279-cae2-5c14-947b-d649ea534540","TCGA-JW-A5VK_exposure","UNCID_2168999.d8e69719-3717-4c5d-8928-6b921d6ac187.130611_UNC15-SN850_0312_BC265JACXX_3_TGACCA.tar.gz","2013-09-20T05:07:03.000Z","2013-09-20T05:21:01.000Z","59310A88-16E9-40E8-9297-6802908CE5D1","3F2E0AC8-13AA-4FC1-A08B-AC22C19D5164","Unaligned reads",5860827578,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","D8E69719-3717-4C5D-8928-6B921D6AC187","University of North Carolina","564a3e94e4b09c884b25535b","BBB96B5A-80E8-4542-80B4-2444CF1FE51E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","50548CA4-7E61-49AA-8D03-1374186CD637","2013-09-20T05:21:01.000Z","4AC5B517-EF93-48F8-B347-B83F322505DF","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",219,"50548CA4-7E61-49AA-8D03-1374186CD637",NA,"JW","UNCID_2061542.d8e69719-3717-4c5d-8928-6b921d6ac187.sorted_genome_alignments.bam.bai",80,"TCGA-JW-A5VK-01A",NA,NA,"TCGA",2012,"TCGA-JW-A5VK_NTE-1","Complete Remission/Response","TUMOR FREE","686B057C-0F8B-4123-836A-AACDB07F2883",43,"nationwidechildrens.org_clinical.TCGA-JW-A5VK.xml","Alive",NA,"TCGA-JW-A5VK","NOT HISPANIC OR LATINO","07AAB628-7634-4ECF-B75F-496129738625","NO",198,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8052/3","FEMALE","C53.9",297,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"AE698CCB-EC05-4DA4-9998-D111D0AFA8AE","767D2144-43F6-4AC6-86C5-A1A34F7CDB74","DRIPS_p_TCGA_295_296_297_N_GenomeWideSNP_6_F10_1343896.byallele.copynumber.data.txt","TCGA-JW-A5VK-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-JW-A5VK-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-JW-A5VK-F58232_NTE-1","NO",623,NA,"Alive",NA,"TCGA-JW-A5VK-F58232","TCGA-JW-A5VK",NA,"JW","A5VK","YES","C53.9","8052/3","C53.9","YES","NO",-15965,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",198,NA,NA,NA,"TUMOR FREE","YES",31,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,3,NA,1,NA,"Complete Remission/Response","2009",8,NA,"T1b2NXMX",NA,NA,1,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
96642696,95443770,4558220424,"F07326F2-C1D6-4D5A-9693-25C3A04B0EC2.bw","bc2003b9-d489-4559-8672-d9fd2d82f2e8","f07326f2-c1d6-4d5a-9693-25c3a04b0ec2","2016-08-09T14:31:46.152284-05:00","UNCID_2553087.cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8.140513_UNC15-SN850_0364_AC4DVGACXX_3_GTGGCC.tar.gz","c6b4e22b-114a-4cac-a76f-472cfe5c909a",4112444855,"Illumina HiSeq","cf4247e583d613d7b9854d844e4b731d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:58:32.141101-05:00","2016-05-03T11:54:19.885282-05:00","c6b4e22b-114a-4cac-a76f-472cfe5c909a_analysis.xml","a702e6c4f0d7400c988177d057d1d086","5c39583b-fb91-473d-8ed7-d0cf429b8f68",2124,"2016-09-29T20:29:42.405067-05:00","c6b4e22b-114a-4cac-a76f-472cfe5c909a_experiment.xml","9331c2c33a174b52f38b9a2340891ba5","6f398709-013b-48c6-a98b-8d66ee2ea6c9",2628,"2016-09-29T23:05:23.616887-05:00","c6b4e22b-114a-4cac-a76f-472cfe5c909a_run.xml","3fc361d10525bff7397a8278d27650a5","cfaf4e57-b3ee-4a56-a35a-28736b0eec48",354,"2016-09-08T10:46:39.885460-05:00","TCGA-MA-AA3Z","2016-09-02T18:54:04.536946-05:00","female","TCGA-MA-AA3Z_demographic",1970,"white","4ce0315e-56e0-5bef-b0cd-2c0cda0c79b4","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA3Z_diagnosis","not reported",15762,"alive","8070/3",NA,595,"0177944d-c31c-5462-93e8-c7e013bee33b","c53.9",-15762,"TCGA-MA-AA3Z_treatment","2ab822f7-4530-5f81-9e8e-23662fcee4c1","01","false","TCGA-MA-AA3Z-01A",NA,"ea75c7f0-6bba-42f8-8d0a-5a592a7d5298",FALSE,"9CE46816-BE2F-46EA-880C-709BE2D40A1A","Primary Tumor",NA,352,230,NA,1393200000,"11",30,"TCGA-MA-AA3Z-01A-11",80,NA,0,NA,0,NA,20,NA,"2016-09-08T10:46:39.885460-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"0dccd4bf-d922-4713-b595-9c847def56e0",NA,"TCGA-MA-AA3Z-01A-01-TS1",NA,80,NA,"a8995783-edb4-4316-b866-57adaaf305a4","RNA","TCGA-MA-AA3Z-01A-11R","70e765c1-2ce2-40c7-b16a-9e5352fd037d",1.87,0.17,"UV Spec","R","23","TCGA-MA-AA3Z-01A-11R-A38B-07","cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8",0.17,NA,84,32.8125,160,"9aa4e670-d40d-5d68-8d66-5d4942460c51","TCGA-MA-AA3Z_exposure","UNCID_2553087.cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8.140513_UNC15-SN850_0364_AC4DVGACXX_3_GTGGCC.tar.gz","2014-07-30T07:51:05.000Z","2014-07-30T20:06:21.000Z","C6B4E22B-114A-4CAC-A76F-472CFE5C909A","EA75C7F0-6BBA-42F8-8D0A-5A592A7D5298","Unaligned reads",4112444855,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CD04AD05-2CC4-490D-B4FA-D9C5E5A118E8","University of North Carolina","564a3db3e4b0ef12181b2bf0","BC2003B9-D489-4559-8672-D9FD2D82F2E8","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A8995783-EDB4-4316-B866-57ADAAF305A4","2014-07-30T20:06:21.000Z","70E765C1-2CE2-40C7-B16A-9E5352FD037D","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",352,"A8995783-EDB4-4316-B866-57ADAAF305A4",NA,"MA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.58DA0BF4-6F81-404C-B348-29BDA4104BAE.txt",230,"TCGA-MA-AA3Z-01A",NA,NA,"TCGA",2013,"TCGA-MA-AA3Z_NTE-1","Complete Remission/Response","TUMOR FREE","EA75C7F0-6BBA-42F8-8D0A-5A592A7D5298",43,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.58DA0BF4-6F81-404C-B348-29BDA4104BAE.txt","Alive",NA,"TCGA-MA-AA3Z","HISPANIC OR LATINO","090D11DA-8960-4B1E-AD24-8D32535CDAF5","NO",469,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"0DCCD4BF-D922-4713-B595-9C847DEF56E0","7A45BE26-D250-4726-849B-99CF8F24E20C","UNCID_2553087.cd04ad05-2cc4-490d-b4fa-d9c5e5a118e8.140513_UNC15-SN850_0364_AC4DVGACXX_3_GTGGCC.tar.gz","TCGA-MA-AA3Z-01A-11",80,0,0,10,20,"TOP",0,0,"TCGA-MA-AA3Z-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-MA-AA3Z-F65480_NTE-1","NO",595,"TUMOR FREE","Alive",NA,"TCGA-MA-AA3Z-F65480","TCGA-MA-AA3Z",NA,"MA","AA3Z","YES","C53.9","8070/3","C53.9","YES","NO",-15762,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",469,NA,NA,NA,"TUMOR FREE","YES",16,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2N0M0",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
165779472,161220913,7690804644,"8ACBD428-7713-48D9-810A-43C9CD191A73.bw","bc63dd2a-b8f6-4b30-a8d7-ce193bcd17f1","8acbd428-7713-48d9-810a-43c9cd191a73","2016-08-02T11:24:46.901112-05:00","UNCID_2186118.E26F5A99-6A8D-429E-8849-8A9B5680D466.121102_UNC12-SN629_0235_AC13F5ACXX_8_CTTGTA.tar.gz","55843900-f416-4ec1-bbcb-2b008ecca4fb",7333829629,"Illumina HiSeq","40dbafc767581d2bed13b13631add52d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:52:00.361390-05:00","2016-05-03T11:00:24.444360-05:00","55843900-f416-4ec1-bbcb-2b008ecca4fb_analysis.xml","1eaa02b82ae1f41fae3377061b10a11f","7d010849-4f8b-406a-9bef-7cea86d11497",2123,"2016-08-28T02:27:12.847642-05:00","55843900-f416-4ec1-bbcb-2b008ecca4fb_experiment.xml","6aad69849fef44888617bf9882cde03c","54700e77-1834-4e68-a666-fbeb046f7a3d",2431,"2016-09-29T18:36:37.010534-05:00","55843900-f416-4ec1-bbcb-2b008ecca4fb_run.xml","530047b194fcdf40a89389fc5961db56","28cbf5c6-a375-48f0-9e12-6fcdca948863",354,"2016-09-08T12:06:54.636956-05:00","TCGA-C5-A3HE","2016-09-02T18:59:26.779581-05:00","female","TCGA-C5-A3HE_demographic",1962,"white","510e317a-7fbe-50c2-a9a5-75e200893257","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A3HE_diagnosis","not reported",16139,"alive","8070/3",NA,548,"9ac1b6b5-780c-5697-9954-c205fd7572b0","c53.9",-16139,"TCGA-C5-A3HE_treatment","5c9e48b6-895e-57d9-8c5e-eb71808fb9ac","01","true","TCGA-C5-A3HE-01A",NA,"506d8b22-ee8d-4fb3-bb57-5ca79d6f5637",FALSE,"8D7665DB-F820-4545-81C8-233A3AE3F9C9","Primary Tumor",NA,1801,220,NA,1335744000,"21",30,"TCGA-C5-A3HE-01A-21",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:06:54.636956-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"80a2bb87-c6cd-4ad7-95c3-50814e0537e5",NA,"TCGA-C5-A3HE-01A-02-MS2",NA,100,NA,"ff2a6496-eb2a-42e2-824f-5be4ccda8013","RNA","TCGA-C5-A3HE-01A-21R","171b3936-6ad3-40d0-b0f6-d0b1a941b298",1.88,0.17,"UV Spec","R","23","TCGA-C5-A3HE-01A-21R-A22U-07","e26f5a99-6a8d-429e-8849-8a9b5680d466",0.17,NA,NA,NA,NA,"eb226895-4ffb-5d07-b2f3-099eeaedd626","TCGA-C5-A3HE_exposure","UNCID_2186118.E26F5A99-6A8D-429E-8849-8A9B5680D466.121102_UNC12-SN629_0235_AC13F5ACXX_8_CTTGTA.tar.gz","2013-09-16T00:56:04.000Z","2013-09-16T01:23:02.000Z","55843900-F416-4EC1-BBCB-2B008ECCA4FB","506D8B22-EE8D-4FB3-BB57-5CA79D6F5637","Unaligned reads",7333829629,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E26F5A99-6A8D-429E-8849-8A9B5680D466","University of North Carolina","566074d2e4b018727fe9f7bd","BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FF2A6496-EB2A-42E2-824F-5BE4CCDA8013","2013-09-16T01:23:02.000Z","171B3936-6AD3-40D0-B0F6-D0B1A941B298","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1801,"FF2A6496-EB2A-42E2-824F-5BE4CCDA8013",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8AD07B41-00BD-4A85-84CA-F529626BF6C3.txt",220,"TCGA-C5-A3HE-01A",NA,NA,"TCGA",2006,"TCGA-C5-A3HE_NTE-1",NA,NA,"58E4B79D-744E-45FE-9836-91D2B2E2C19E",44,"nationwidechildrens.org_clinical.TCGA-C5-A3HE.xml","Alive",NA,"TCGA-C5-A3HE","NOT HISPANIC OR LATINO","B756F543-72E1-431A-B4B4-AFA174CD9396","YES",548,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",236,NA,"B2DDDD94-15B1-4C65-B8C8-2E8D6B4EE0C1","WHITE",NA,21,30,"80A2BB87-C6CD-4AD7-95C3-50814E0537E5","B8B27F7C-3C1E-44F2-B191-4DF876290E3A","UNCID_2186118.E26F5A99-6A8D-429E-8849-8A9B5680D466.121102_UNC12-SN629_0235_AC13F5ACXX_8_CTTGTA.tar.gz","TCGA-C5-A3HE-01A-21",80,0,0,0,0,"TOP",0,0,"TCGA-C5-A3HE-01A-02-MS2",100,NA,NA,NA,"TCGA-C5-A3HE-R55256","External","Primary Tumor Field","TCGA-C5-A3HE-F55255_NTE-1",NA,NA,NA,"Alive",NA,"TCGA-C5-A3HE-F55255","TCGA-C5-A3HE",NA,"C5","A3HE","YES","C53.9","8070/3","C53.9","NO","YES",-16139,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",548,NA,NA,NA,NA,"YES",3,1,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2006,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,NA,"1995",8,NA,"T1b2N0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
107668188,96891884,4610238569,"3D3501B4-1A43-4FA7-90A2-CCEBF66BFD4A.bw","bdad2f13-ede2-4aad-91a4-bf60f8888bf2","3d3501b4-1a43-4fa7-90a2-ccebf66bfd4a","2016-09-29T19:08:48.540477-05:00","UNCID_2358580.58e01e27-fe36-4ee7-9560-f668bf6dcb48.140107_UNC11-SN627_0341_BC38NLACXX_7_CGTACG.tar.gz","8afc19ab-ad5e-4b25-8dab-a1c9b18d3a9f",5020046099,"Illumina HiSeq","d92cd24093cda5f05a30c507ffed24da","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:27:01.730419-05:00","2016-05-03T11:37:12.420448-05:00","8afc19ab-ad5e-4b25-8dab-a1c9b18d3a9f_analysis.xml","f6fab644a24d0c9fdf5bf324ea4a8b48","92ed8e95-08b8-47ec-8a19-75a753dd15c9",2124,"2016-09-29T20:20:56.761888-05:00","8afc19ab-ad5e-4b25-8dab-a1c9b18d3a9f_experiment.xml","4cbcf095631f4d5fda71b13d78900d36","69cceff9-9f97-47fa-a2a1-c0b045c9c097",2628,"2016-09-29T18:42:38.793345-05:00","8afc19ab-ad5e-4b25-8dab-a1c9b18d3a9f_run.xml","5e043ea996e850356ff3867792e976d0","2cb26159-20da-44de-b257-416268509460",354,"2016-09-08T11:59:26.901191-05:00","TCGA-RA-A741","2016-09-02T19:00:17.251988-05:00","female","TCGA-RA-A741_demographic",1979,"white","53b3a11d-9ce6-58e4-b2b5-41f208acb11b","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","RA","9492f86d-fb58-52dd-8393-27972b17577a","Candler","not reported","c53.9","TCGA-RA-A741_diagnosis","not reported",12607,"alive","8070/3",NA,444,"6f2cabbd-a1ef-59df-99f2-6f681d681d6d","c53.9",-12607,"TCGA-RA-A741_treatment","7d81b12f-b16f-5652-88ca-fd29adb46996","01","false","TCGA-RA-A741-01A",NA,"84ca6bcf-2a51-44d4-9c5f-1edaf9a076af",FALSE,"4CC49B26-FA09-4B3C-BB2F-236914852C7A","Primary Tumor",NA,22,180,NA,1376006400,"11",30,"TCGA-RA-A741-01A-11",85,NA,20,NA,0,NA,5,NA,"2016-09-08T11:59:26.901191-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"9f942a46-f417-4e77-9b91-7908f6febb35",NA,"TCGA-RA-A741-01A-01-TS1",NA,85,NA,"29e5eb17-66dc-4e3c-a0ab-7fcdaeed631d","RNA","TCGA-RA-A741-01A-11R","bae84f13-e0b4-4fe7-8758-76ffa4cd931f",1.92,0.16,"UV Spec","R","23","TCGA-RA-A741-01A-11R-A33Z-07","58e01e27-fe36-4ee7-9560-f668bf6dcb48",0.16,0.547945205479452,86,31.5886134067952,165,"d61ae52b-db40-53cb-abc9-f59de58396eb","TCGA-RA-A741_exposure","UNCID_2358580.58e01e27-fe36-4ee7-9560-f668bf6dcb48.140107_UNC11-SN627_0341_BC38NLACXX_7_CGTACG.tar.gz","2014-02-25T15:03:05.000Z","2014-02-25T15:25:02.000Z","8AFC19AB-AD5E-4B25-8DAB-A1C9B18D3A9F","84CA6BCF-2A51-44D4-9C5F-1EDAF9A076AF","Unaligned reads",5020046099,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","58E01E27-FE36-4EE7-9560-F668BF6DCB48","University of North Carolina","5660745be4b0ca319164c2c2","BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","29E5EB17-66DC-4E3C-A0AB-7FCDAEED631D","2014-02-25T15:25:02.000Z","BAE84F13-E0B4-4FE7-8758-76FFA4CD931F","United States","NO",1,NA,"Primary Tumor","Candler",22,"29E5EB17-66DC-4E3C-A0AB-7FCDAEED631D",NA,"RA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.B1B3C261-B418-4B28-AAEA-749C4370A347.txt",180,"TCGA-RA-A741-01A",NA,"E0AD8182-60F5-46E5-8B7E-C8623125249C","TCGA",2013,"TCGA-RA-A741_NTE-1",NA,NA,"C44B1B40-1A10-43C4-B0B8-D3C26108CAB3",34,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.B1B3C261-B418-4B28-AAEA-749C4370A347.txt","Alive",NA,"TCGA-RA-A741","NOT HISPANIC OR LATINO","F1336B1B-5842-41DE-BC42-3ECD4B484E01","NO",118,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIB",NA,NA,NA,"8070/3","FEMALE","C53.9",350,NA,"D9BFAB19-4E70-4099-82CF-B2BFBC11BB07","WHITE",NA,11,30,"9F942A46-F417-4E77-9B91-7908F6FEBB35","BAC10992-0FE1-40EF-9768-7EEAC54F8FB9","UNCID_2358580.58e01e27-fe36-4ee7-9560-f668bf6dcb48.140107_UNC11-SN627_0341_BC38NLACXX_7_CGTACG.tar.gz","TCGA-RA-A741-01A-11",85,0,20,40,5,"TOP",10,20,"TCGA-RA-A741-01A-01-TS1",85,"avastin","Chemotherapy","TCGA-RA-A741-D66182","TCGA-RA-A741-R51264","External","Primary Tumor Field","TCGA-RA-A741-F66178_NTE-1","NO",444,"TUMOR FREE","Alive",NA,"TCGA-RA-A741-F66178","TCGA-RA-A741",NA,"RA","A741","YES","C53.9","8070/3","C53.9","YES","NO",-12607,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",118,NA,NA,NA,NA,"YES",13,11,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,34,2013,"Biopsy (cervical / CT-guided / Other)","YES",4,0,"GX",NA,4,2013,10,NA,NA,"2009",13,NA,NA,NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
110167904,106099889,5060865932,"DD51C17C-300F-44A4-955A-C9BC85417842.bw","be8b1c78-8cb1-4bff-b1fe-71ecdc454c94","dd51c17c-300f-44a4-955a-c9bc85417842","2016-08-26T18:23:19.362321-05:00","UNCID_2553106.073d66b5-917e-45e3-8104-b8d4dfa28e6b.140408_UNC11-SN627_0351_AC3KY3ACXX_2_AGTTCC.tar.gz","714b07bc-9d93-462a-9950-723c40a755a3",4842925868,"Illumina HiSeq","0bf65d80d42d3f4429860ffdd23bf455","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:40:44.232754-05:00","2016-05-03T11:54:19.908545-05:00","714b07bc-9d93-462a-9950-723c40a755a3_analysis.xml","79dbf55110a74c8a68915ec0542cdd8e","9b432fcf-5b66-4da6-847d-99ba501d1e1a",2124,"2016-10-07T16:31:19.693216-05:00","714b07bc-9d93-462a-9950-723c40a755a3_experiment.xml","cd5807a57060bb74270256def30bcf71","2e127d89-eb43-4c86-bd30-9aa1f8ea7c5f",2628,"2016-09-29T23:48:17.758633-05:00","714b07bc-9d93-462a-9950-723c40a755a3_run.xml","24a87a608765a5f5d08bd740bc776e00","ea6709e9-d75f-4978-9300-d5f4627c50c7",354,"2016-09-08T12:13:11.817660-05:00","TCGA-C5-A8YR","2016-09-02T19:01:09.598930-05:00","female","TCGA-C5-A8YR_demographic",1938,"white","d1769e7f-0fa2-5522-af26-71e6325f0e40","not hispanic or latino",1996,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8YR_diagnosis","not reported",20672,"dead","8072/3",837,NA,"ce9249f9-b3b1-5633-a8ba-2583c03c83a9","c53.9",-20672,"TCGA-C5-A8YR_treatment","7014ad11-37a6-55ef-91f2-4435d138eef5","01","true","TCGA-C5-A8YR-01A",NA,"f6f42f6c-a61e-466c-8658-fe77ccbdb3f2",FALSE,"C808B5E4-A426-4E68-9BFE-A98533562FD4","Primary Tumor",NA,7049,50,NA,1387324800,"12",10,"TCGA-C5-A8YR-01A-12",60,NA,0,NA,15,NA,25,NA,"2016-09-08T12:13:11.817660-05:00",NA,10,NA,2,NA,"TOP",NA,0,NA,"02c74258-23fa-46d1-8fab-7f7b8899984c",NA,"TCGA-C5-A8YR-01A-01-TS1",NA,60,NA,"0394e749-36c2-4242-b0d4-01090dd4c916","RNA","TCGA-C5-A8YR-01A-12R","3467062b-da2c-4176-b83a-f42a176c669d",1.83,0.17,"UV Spec","R","23","TCGA-C5-A8YR-01A-12R-A37O-07","073d66b5-917e-45e3-8104-b8d4dfa28e6b",0.17,NA,80,NA,NA,"e542d3a2-479c-5c48-8c10-3cb08bfdcdd6","TCGA-C5-A8YR_exposure","UNCID_2553106.073d66b5-917e-45e3-8104-b8d4dfa28e6b.140408_UNC11-SN627_0351_AC3KY3ACXX_2_AGTTCC.tar.gz","2014-07-31T00:06:04.000Z","2014-07-31T00:27:20.000Z","714B07BC-9D93-462A-9950-723C40A755A3","F6F42F6C-A61E-466C-8658-FE77CCBDB3F2","Unaligned reads",4842925868,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","073D66B5-917E-45E3-8104-B8D4DFA28E6B","University of North Carolina","564a3efbe4b0ef12181b960b","BE8B1C78-8CB1-4BFF-B1FE-71ECDC454C94","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0394E749-36C2-4242-B0D4-01090DD4C916","2014-07-31T00:27:20.000Z","3467062B-DA2C-4176-B83A-F42A176C669D","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",7049,"0394E749-36C2-4242-B0D4-01090DD4C916",NA,"C5","3f02733722fc08b708d447abf2aed9d9.bam",50,"TCGA-C5-A8YR-01A",NA,NA,"TCGA",1994,"TCGA-C5-A8YR_NTE-1",NA,NA,"F6F42F6C-A61E-466C-8658-FE77CCBDB3F2",56,"nationwidechildrens.org_clinical.TCGA-C5-A8YR.xml","Dead",837,"TCGA-C5-A8YR","NOT HISPANIC OR LATINO",NA,"YES",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8072/3","FEMALE","C53.9",380,NA,NA,"WHITE",NA,12,10,"02C74258-23FA-46D1-8FAB-7F7B8899984C","41774D54-14FC-42EC-A0CB-6095DCCA10F7","3f02733722fc08b708d447abf2aed9d9.bam","TCGA-C5-A8YR-01A-12",60,15,0,10,25,"TOP",0,2,"TCGA-C5-A8YR-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A8YR",NA,"C5","A8YR","YES","C53.9","8072/3","C53.9","NO","YES",-20672,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,837,NA,NA,NA,"YES",1,4,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,56,1994,"Biopsy (cervical / CT-guided / Other)","YES",29,0,"G3",NA,1,NA,NA,NA,NA,"1988",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
158132126,155937610,7442089179,"58FF391C-1D83-426C-8F92-C15F78F56C95.bw","be8fa67d-c2d3-4fff-82fe-a46ba1fa8df0","58ff391c-1d83-426c-8f92-c15f78f56c95","2016-08-09T13:13:57.077436-05:00","UNCID_2186826.93810b75-cbbb-4dbb-bbe1-efb66d19516d.121009_UNC16-SN851_0187_AD15RRACXX_4_ACTTGA.tar.gz","10e96630-c663-4d71-828d-78344cf05d82",7150766057,"Illumina HiSeq","7870a0052074730892697dad2e33dd1d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:17:05.286704-05:00","2016-05-03T11:01:14.469334-05:00","10e96630-c663-4d71-828d-78344cf05d82_analysis.xml","a1a1c66bca7e3f23bcfd52ec0b8aed69","1ca42a17-43cb-404a-a8cb-cb8bc231b236",2124,"2016-08-27T12:46:47.487877-05:00","10e96630-c663-4d71-828d-78344cf05d82_experiment.xml","d6e7ada24a25422c9ef5646067e333e8","e1e62a7f-c256-493b-950c-f7db60e9f518",2431,"2016-09-29T20:21:30.128402-05:00","10e96630-c663-4d71-828d-78344cf05d82_run.xml","637ec4ac44346d94b49a7d67ebae3253","6a28f2cb-050e-4f4d-9739-7e5b5b0fe969",354,"2016-09-08T12:10:48.693837-05:00","TCGA-C5-A2LZ","2016-09-02T18:58:39.884990-05:00","female","TCGA-C5-A2LZ_demographic",1933,"white","b044dc61-89d3-5b2c-a61b-ee492f95e43b","not hispanic or latino",2006,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LZ_diagnosis","not reported",24059,"dead","8070/3",3046,NA,"5b796ac1-a564-5295-b009-4623eaba680f","c53.9",-24059,"TCGA-C5-A2LZ_treatment","d697bba5-72d4-5252-9764-421d0e2ee769","01","false","TCGA-C5-A2LZ-01A",NA,"6b9f4254-dbd3-4d82-bae8-d43a4915a7cd",FALSE,"EF2D354D-F959-45B3-AA5C-170E00AF3F45","Primary Tumor",NA,4886,80,NA,1314144000,"11",30,"TCGA-C5-A2LZ-01A-11",65,NA,0,NA,0,NA,30,NA,"2016-09-08T12:10:48.693837-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"92539bbb-3b5d-4721-bdf9-297260b1ec70",NA,"TCGA-C5-A2LZ-01A-01-TSA",NA,70,NA,"8be3f0e0-6179-4692-901e-07b38df53508","RNA","TCGA-C5-A2LZ-01A-11R","cd3cc2a2-ae25-461f-908a-e15dc6727478",1.86,0.17,"UV Spec","R","23","TCGA-C5-A2LZ-01A-11R-A213-07","93810b75-cbbb-4dbb-bbe1-efb66d19516d",0.17,2.73972602739726,85,31.9921713274869,163,"e3db852c-42cb-5aa6-b8ce-a1efe275b501","TCGA-C5-A2LZ_exposure","UNCID_2186826.93810b75-cbbb-4dbb-bbe1-efb66d19516d.121009_UNC16-SN851_0187_AD15RRACXX_4_ACTTGA.tar.gz","2013-09-16T15:31:05.000Z","2013-09-16T15:54:02.000Z","10E96630-C663-4D71-828D-78344CF05D82","6B9F4254-DBD3-4D82-BAE8-D43A4915A7CD","Unaligned reads",7150766057,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","93810B75-CBBB-4DBB-BBE1-EFB66D19516D","University of North Carolina","5660757ee4b018727fea00a0","BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8BE3F0E0-6179-4692-901E-07B38DF53508","2013-09-16T15:54:02.000Z","CD3CC2A2-AE25-461F-908A-E15DC6727478","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4886,"8BE3F0E0-6179-4692-901E-07B38DF53508",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.11B6B548-475A-4F7F-A3F1-DBFC8B2BDE6F.txt",80,"TCGA-C5-A2LZ-01A",NA,NA,"TCGA",1998,"TCGA-C5-A2LZ_NTE-1","Complete Remission/Response","WITH TUMOR","6B9F4254-DBD3-4D82-BAE8-D43A4915A7CD",65,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.11B6B548-475A-4F7F-A3F1-DBFC8B2BDE6F.txt","Dead",3046,"TCGA-C5-A2LZ","NOT HISPANIC OR LATINO","1E30F6A6-F672-4B24-8113-9A237BA43709","YES",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",200,NA,"F2E7AFCB-4077-4208-8E9A-87AB06FF294F","WHITE",NA,11,30,"92539BBB-3B5D-4721-BDF9-297260B1EC70","CD3CC2A2-AE25-461F-908A-E15DC6727478","TCGA-C5-A2LZ-01A-11R-A214-13_mirna.bam","TCGA-C5-A2LZ-01A-11",65,0,0,0,30,"TOP",0,0,"TCGA-C5-A2LZ-01A-01-TSA",70,NA,NA,NA,"TCGA-C5-A2LZ-R33612","Internal","Primary Tumor Field","TCGA-C5-A2LZ-F33609_NTE-1","YES",NA,"WITH TUMOR","Dead",3046,"TCGA-C5-A2LZ-F33609","TCGA-C5-A2LZ",NA,"C5","A2LZ","YES","C53.9","8070/3","C53.9","NO","YES",-24059,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,3046,NA,NA,"WITH TUMOR","YES",10,7,2012,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,65,1998,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,50,NA,"Complete Remission/Response","1995",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
172409678,170067930,8122022904,"ACE65C6E-2B10-4972-91B4-9199DD4B179D.bw","bfd82578-8b60-4c23-85a1-fc14a1cf5f12","ace65c6e-2b10-4972-91b4-9199dd4b179d","2016-08-09T13:57:59.535594-05:00","UNCID_2186975.689fb0d6-789a-45c2-8f2f-12cc3a2ea553.121002_UNC11-SN627_0254_AC0WP5ACXX_1_TAGCTT.tar.gz","1c34c1e7-b4bf-481a-a2c4-eb985f0df166",7145980812,"Illumina HiSeq","4c875c6d1804f538c685538d65518538","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:15:55.163848-05:00","2016-05-03T11:01:14.486033-05:00","1c34c1e7-b4bf-481a-a2c4-eb985f0df166_analysis.xml","965b8fc6ec68bf5728784a77d40cf473","41af9722-5c7d-47c4-a16a-afe306fe29e6",2124,"2016-09-29T21:27:07.799568-05:00","1c34c1e7-b4bf-481a-a2c4-eb985f0df166_experiment.xml","cc4a731544d29658ea483375ed960beb","92fe95c5-f956-47c7-be0b-6a5fde0d7a55",2431,"2016-09-29T20:09:33.483432-05:00","1c34c1e7-b4bf-481a-a2c4-eb985f0df166_run.xml","de77309b6f19967cf6fdf13f65d33685","62e1d4eb-b2b9-4ba2-8a7d-5f220546bd8b",354,"2016-09-08T12:05:49.168783-05:00","TCGA-EK-A2PI","2016-09-02T18:58:17.002310-05:00","female","TCGA-EK-A2PI_demographic",1965,"white","265589c3-58f6-5ec3-9f86-cdcbc5c9efd2","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2PI_diagnosis","not reported",16324,"alive","8072/3",NA,586,"3a5e1166-557f-5435-adb5-1acf80226eb7","c53.9",-16324,"TCGA-EK-A2PI_treatment","0d0e79bb-bd8d-5a64-b385-137c65c06803","01","false","TCGA-EK-A2PI-01A",NA,"e42a980a-8189-41ad-b5ff-10181229f8b2",FALSE,"1DA80321-4DC2-4BEF-B932-1B38B6BEDB24","Primary Tumor",NA,881,50,NA,1314144000,"11",30,"TCGA-EK-A2PI-01A-11",68,NA,0,NA,30,NA,18,NA,"2016-09-08T12:05:49.168783-05:00",NA,10,NA,0,NA,"TOP",NA,2,NA,"b85ef208-7541-45f3-a5b4-6acf3a1124a3",NA,"TCGA-EK-A2PI-01A-01-TS1",NA,50,NA,"833e61cc-04d5-4f89-a4c7-a33ffbc9011a","RNA","TCGA-EK-A2PI-01A-11R","e5e9cc1a-c822-4bcb-9b16-56ec61d03aaf",1.86,0.17,"UV Spec","R","23","TCGA-EK-A2PI-01A-11R-A18M-07","689fb0d6-789a-45c2-8f2f-12cc3a2ea553",0.17,NA,53,20.1950922115531,162,"8f4971f8-5eea-5246-9a10-472691a34012","TCGA-EK-A2PI_exposure","UNCID_2186975.689fb0d6-789a-45c2-8f2f-12cc3a2ea553.121002_UNC11-SN627_0254_AC0WP5ACXX_1_TAGCTT.tar.gz","2013-09-16T07:56:04.000Z","2013-09-16T20:41:01.000Z","1C34C1E7-B4BF-481A-A2C4-EB985F0DF166","E42A980A-8189-41AD-B5FF-10181229F8B2","Unaligned reads",7145980812,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","689FB0D6-789A-45C2-8F2F-12CC3A2EA553","University of North Carolina","5660765ce4b0ec1099f8c48e","BFD82578-8B60-4C23-85A1-FC14A1CF5F12","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","833E61CC-04D5-4F89-A4C7-A33FFBC9011A","2013-09-16T20:41:01.000Z","E5E9CC1A-C822-4BCB-9B16-56EC61D03AAF","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",881,"833E61CC-04D5-4F89-A4C7-A33FFBC9011A",NA,"EK","20efd5a82fa9bb931ef431c1fd6aa4d4.bam",50,"TCGA-EK-A2PI-01A",NA,NA,"TCGA",2009,NA,NA,"WITH TUMOR","E7434C63-5EB7-4F98-8483-2F77634DD1FB",44,"UNCID_2186975.689fb0d6-789a-45c2-8f2f-12cc3a2ea553.121002_UNC11-SN627_0254_AC0WP5ACXX_1_TAGCTT.tar.gz","Alive",NA,"TCGA-EK-A2PI",NA,"FA9BAF59-91C3-4E9F-828A-DAB9BA64182A",NA,0,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIIB",NA,NA,NA,"8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"B85EF208-7541-45F3-A5B4-6ACF3A1124A3","FEC0686B-6144-4EFC-A0D1-5616F5882F1F","20efd5a82fa9bb931ef431c1fd6aa4d4.bam","TCGA-EK-A2PI-01A-11",68,30,0,10,18,"TOP",2,0,"TCGA-EK-A2PI-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2PI-F58244_NTE-1",NA,42,NA,"Alive",NA,"TCGA-EK-A2PI-F58244","TCGA-EK-A2PI",NA,"EK","A2PI","YES","C53.9","8072/3","C53.9","NO","YES",-16324,"FEMALE","WHITE",NA,"No","No","Alive",0,NA,NA,NA,"WITH TUMOR","NO",1,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,NA,"1988",16,NA,NA,NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
132638992,131276982,6270885592,"B2088466-FA5D-491C-9982-99B33683E66F.bw","c13215d9-26a8-4c8b-b4fe-5da6aa3222af","b2088466-fa5d-491c-9982-99b33683e66f","2016-08-09T13:56:41.298855-05:00","UNCID_2186974.1a6ee24e-975c-4ba8-8cc3-666555fb89d6.121002_UNC11-SN627_0254_AC0WP5ACXX_1_GGCTAC.tar.gz","b3c836f9-f04f-4403-827c-908f60d56cb4",5515913517,"Illumina HiSeq","4dfd75992427d80a6c69bb4409a1a7ae","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:36:44.001489-05:00","2016-05-03T11:01:14.488026-05:00","b3c836f9-f04f-4403-827c-908f60d56cb4_analysis.xml","a6d8bea29179d7eef88b114b3059cb3a","98d526a1-1a1e-4743-83b0-34ec19bad6ea",2124,"2016-10-07T16:13:58.425925-05:00","b3c836f9-f04f-4403-827c-908f60d56cb4_experiment.xml","29fd45cb504d7a9859b86deef8227e9f","0406df9d-24b5-4040-84a9-1d1cc47c6701",2431,"2016-09-29T19:05:32.626258-05:00","b3c836f9-f04f-4403-827c-908f60d56cb4_run.xml","8a623a5b7389ae8775b4606de166abf5","3b2f7a3e-bb57-4925-a815-8ed0946417fd",354,"2016-09-08T11:35:06.761100-05:00","TCGA-EK-A2RM","2016-09-02T18:58:30.279159-05:00","female","TCGA-EK-A2RM_demographic",1969,"white","90203209-d8d4-5d71-baed-ff4269484fff","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RM_diagnosis","not reported",14842,"alive","8070/3",NA,50,"81f67ae3-6a61-5d10-9649-83006baffa08","c53.9",-14842,"TCGA-EK-A2RM_treatment","159ea24a-dfa8-58a6-aa79-6d5176ee4880","01","false","TCGA-EK-A2RM-01A",NA,"f0ca60fb-bd45-4f15-a791-0c5b1218d8ef",FALSE,"3810E8FD-27A9-4E65-9BD2-BFA5594813B8","Primary Tumor",NA,778,100,NA,1315785600,"21",30,"TCGA-EK-A2RM-01A-21",95,NA,0,NA,0,NA,20,NA,"2016-09-08T11:35:06.761100-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"557023ec-3e2c-493e-9f23-4aa0da611608",NA,"TCGA-EK-A2RM-01A-02-TS2",NA,75,NA,"b958874a-66ce-40e7-a1c5-82c199d322ba","RNA","TCGA-EK-A2RM-01A-21R","27d0f268-e47d-4d99-b121-5546669000ac",1.82,0.17,"UV Spec","R","23","TCGA-EK-A2RM-01A-21R-A18M-07","1a6ee24e-975c-4ba8-8cc3-666555fb89d6",0.17,NA,105,37.6492523934168,167,"84ad40e3-e385-55d3-915f-1da3b30f9091","TCGA-EK-A2RM_exposure","UNCID_2186974.1a6ee24e-975c-4ba8-8cc3-666555fb89d6.121002_UNC11-SN627_0254_AC0WP5ACXX_1_GGCTAC.tar.gz","2013-09-16T20:37:05.000Z","2013-09-16T20:58:02.000Z","B3C836F9-F04F-4403-827C-908F60D56CB4","F0CA60FB-BD45-4F15-A791-0C5B1218D8EF","Unaligned reads",5515913517,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1A6EE24E-975C-4BA8-8CC3-666555FB89D6","University of North Carolina","564a401ae4b093830b6ac745","C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B958874A-66CE-40E7-A1C5-82C199D322BA","2013-09-16T20:58:02.000Z","27D0F268-E47D-4D99-B121-5546669000AC","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",778,"B958874A-66CE-40E7-A1C5-82C199D322BA",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.8E91B507-4AF4-432F-9A6A-1B07118A6AE2.txt",100,"TCGA-EK-A2RM-01A",NA,NA,"TCGA",2009,NA,NA,"WITH TUMOR","FE891CD9-AE0A-4242-8A56-B5D6D2B85B43",40,"TCGA-EK-A2RM-01A-21R-A18L-13.isoform.quantification.txt","Alive",NA,"TCGA-EK-A2RM","NOT HISPANIC OR LATINO","DA301AF1-443A-4FFD-B742-E36232444EBE",NA,NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",1,NA,"Stage IB",NA,NA,NA,"8070/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,21,30,"557023EC-3E2C-493E-9F23-4AA0DA611608","E68063EA-CDBF-46A3-8AEA-7C1DDC592D10","CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_B10_871080.nocnv_hg18.seg.txt","TCGA-EK-A2RM-01A-21",95,0,0,1,20,"TOP",5,0,"TCGA-EK-A2RM-01A-02-TS2",75,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RM-F58215_NTE-1",NA,NA,NA,"Alive",NA,"TCGA-EK-A2RM-F58215","TCGA-EK-A2RM",NA,"EK","A2RM","YES","C53.9","8070/3","C53.9","NO","YES",-14842,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",50,NA,NA,NA,"WITH TUMOR","NO",1,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2009,"Other method, specify:","YES",36,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",6,NA,NA,NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
118038208,112453171,5361751488,"D47AF416-1687-4FE0-A235-8815B6E8EB0B.bw","c14468eb-e725-4029-96cc-75bb9ebd9def","d47af416-1687-4fe0-a235-8815b6e8eb0b","2016-08-26T15:03:14.138288-05:00","UNCID_2449456.fcbdaa46-c576-42e9-ac1f-0ba553247f4f.140312_UNC15-SN850_0357_AC3M7FACXX_5_CAGATC.tar.gz","4c09f62c-3e61-4134-896f-adc030dba13b",5192092542,"Illumina HiSeq","21e0d51227aae4ce5bacc04692f14a64","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:17:10.775599-05:00","2016-05-03T11:44:58.595380-05:00","4c09f62c-3e61-4134-896f-adc030dba13b_analysis.xml","30b5446a17267f1d3f2639a7a824b879","d6f4111d-5830-4c51-8065-0dfad4d3ba77",2124,"2016-09-29T18:43:27.173471-05:00","4c09f62c-3e61-4134-896f-adc030dba13b_experiment.xml","5fbc7a101aa97e97d0eec2d47d708870","2d3862d3-71ed-4030-a89c-21a9862b8b7e",2628,"2016-09-29T23:39:28.677125-05:00","4c09f62c-3e61-4134-896f-adc030dba13b_run.xml","9c9d16d7a3fd147d387d87163fe37b71","e4e6e0e0-b0e6-4af7-83d4-11e8c7cb2c11",354,"2016-09-08T11:41:00.317451-05:00","TCGA-DS-A7WI","2016-09-02T19:00:55.855285-05:00","female","TCGA-DS-A7WI_demographic",1970,"white","dbe51ba0-4095-53e8-aa24-50372b733a87","not hispanic or latino",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A7WI_diagnosis","not reported",15970,"dead","8072/3",252,NA,"34ba9a61-0df7-5f4c-9aca-e3973883a902","c53.9",-15970,"TCGA-DS-A7WI_treatment","0b842bfc-08f9-5f65-9032-b9704f0bf1ed","01","true","TCGA-DS-A7WI-01A",NA,"062963b0-87d9-4d01-907f-ce9eaa7bf1c5",FALSE,"4538B5EA-E6C8-4EEA-8387-A1E3C5A754F9","Primary Tumor",NA,222,160,NA,1381449600,"12",30,"TCGA-DS-A7WI-01A-12",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:41:00.317451-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"013bb459-c1bf-4f49-908f-e5eb2db644a9",NA,"TCGA-DS-A7WI-01A-01-TS1",NA,80,NA,"e775ca9d-abdf-4077-98af-cb4fdbc57246","RNA","TCGA-DS-A7WI-01A-12R","526df179-ec3e-4dae-b421-6c57936aab62",1.87,0.18,"UV Spec","R","23","TCGA-DS-A7WI-01A-12R-A352-07","fcbdaa46-c576-42e9-ac1f-0ba553247f4f",0.18,NA,57,20.9366391184573,165,"eaa7ec1c-ea7c-5e47-9562-5aae3cc3da33","TCGA-DS-A7WI_exposure","UNCID_2449456.fcbdaa46-c576-42e9-ac1f-0ba553247f4f.140312_UNC15-SN850_0357_AC3M7FACXX_5_CAGATC.tar.gz","2014-05-09T02:33:04.000Z","2014-05-09T03:03:02.000Z","4C09F62C-3E61-4134-896F-ADC030DBA13B","062963B0-87D9-4D01-907F-CE9EAA7BF1C5","Unaligned reads",5192092542,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FCBDAA46-C576-42E9-AC1F-0BA553247F4F","University of North Carolina","564a4095e4b0ef12181c1be2","C14468EB-E725-4029-96CC-75BB9EBD9DEF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E775CA9D-ABDF-4077-98AF-CB4FDBC57246","2014-05-09T03:03:02.000Z","526DF179-EC3E-4DAE-B421-6C57936AAB62","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",222,"E775CA9D-ABDF-4077-98AF-CB4FDBC57246",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.817F7D56-55EA-4F67-999F-5E94870D3AAB.txt",160,"TCGA-DS-A7WI-01A",NA,"7D8F75F1-23CB-44C0-B948-3494D6D754CE","TCGA",2013,"TCGA-DS-A7WI_NTE-1","Complete Remission/Response","WITH TUMOR","E85A47AF-011A-44BE-A8BE-1F7A6736C903",43,"nationwidechildrens.org_clinical.TCGA-DS-A7WI.xml","Dead",252,"TCGA-DS-A7WI","NOT HISPANIC OR LATINO","52E1E93F-25AB-4B77-A402-01A0FF532F19","YES",NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIA2",NA,NA,"T2a2","8072/3","FEMALE","C53.9",361,NA,"48E93AD6-5B6C-405C-8889-BDBDA79CDE58","WHITE",NA,12,30,"013BB459-C1BF-4F49-908F-E5EB2DB644A9","A840D979-932D-47C1-90AF-B840F60E6FFF","UNCID_2388732.fcbdaa46-c576-42e9-ac1f-0ba553247f4f.sorted_genome_alignments.bam.bai","TCGA-DS-A7WI-01A-12",80,0,20,40,10,"TOP",10,20,"TCGA-DS-A7WI-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-DS-A7WI-D54772","TCGA-DS-A7WI-R54773","External","Primary Tumor Field","TCGA-DS-A7WI-F54771_NTE-1","YES",NA,"WITH TUMOR","Dead",252,"TCGA-DS-A7WI-F54771","TCGA-DS-A7WI",NA,"DS","A7WI","YES","C53.9","8072/3","C53.9","YES","NO",-15970,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,252,NA,NA,"WITH TUMOR","YES",23,12,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2013,"Biopsy (cervical / CT-guided / Other)","YES",15,1,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",12,NA,"T2a2N1MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
117544734,112624254,5371590782,"4DCAD07F-CC43-46F6-B2F3-EDBF3EDD1045.bw","c4f61715-ee58-4799-a5f4-0f5e27c4093d","4dcad07f-cc43-46f6-b2f3-edbf3edd1045","2016-08-25T01:34:21.139594-05:00","UNCID_2553113.b21b7604-5292-4f80-b0d9-8a99b9c0c1a6.140403_UNC15-SN850_0359_BC41CEACXX_8_GTTTCG.tar.gz","a9a1a7a6-7b16-4e54-86d7-09820f7388b8",5273815393,"Illumina HiSeq","584eaec46e3da069784b7e2368c63a7d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:59:12.490489-05:00","2016-05-03T11:54:19.908545-05:00","a9a1a7a6-7b16-4e54-86d7-09820f7388b8_analysis.xml","b0f0e17a360458052f0963c2e26333b1","cbc594d6-52ab-4b83-b6f9-836d5749d52f",2124,"2016-10-07T16:38:46.130191-05:00","a9a1a7a6-7b16-4e54-86d7-09820f7388b8_experiment.xml","eb817206502f1d4993b27afeef7a92e2","aebe7682-d312-43d5-b44d-dc4cb1347fc9",2628,"2016-09-29T17:44:53.395527-05:00","a9a1a7a6-7b16-4e54-86d7-09820f7388b8_run.xml","70f621503448d72436e2482a2caade2b","08751aff-143c-450e-a18c-b20f0fb6c919",354,"2016-09-08T11:57:15.272493-05:00","TCGA-VS-A8QH","2016-09-02T19:01:21.629747-05:00","female","TCGA-VS-A8QH_demographic",1934,"white","08720afb-060f-56b5-bae4-64c6fe5242c2","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8QH_diagnosis","not reported",27909,"dead","8482/3",1210,NA,"d0a62eb6-7320-5ff9-aeff-f303588f947a","c53.9",-27909,"TCGA-VS-A8QH_treatment","8f8fb55a-dd19-5003-b677-0ce9416fe40b","01","false","TCGA-VS-A8QH-01A",NA,"400eedf2-5115-4771-b7f4-e82ace6d31be",FALSE,"9123109C-CD5E-4E0B-8920-3A81C41B0E76","Primary Tumor",NA,1369,40,NA,1386806400,"11",30,"TCGA-VS-A8QH-01A-11",90,NA,1,NA,5,NA,5,NA,"2016-09-08T11:57:15.272493-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"1cf0d092-db02-4ec1-92ae-6cb64416484e",NA,"TCGA-VS-A8QH-01A-01-TS1",NA,90,NA,"776e2868-e7c0-4dd2-8658-6eabd65094f1","RNA","TCGA-VS-A8QH-01A-11R","adecea79-05cc-45c4-91a8-f2a4bf94d103",1.92,0.16,"UV Spec","R","23","TCGA-VS-A8QH-01A-11R-A37O-07","b21b7604-5292-4f80-b0d9-8a99b9c0c1a6",0.16,NA,73,28.8754400537953,159,"d20f057f-21fb-5fc8-87dc-69a34d601274","TCGA-VS-A8QH_exposure","UNCID_2553113.b21b7604-5292-4f80-b0d9-8a99b9c0c1a6.140403_UNC15-SN850_0359_BC41CEACXX_8_GTTTCG.tar.gz","2014-07-31T01:21:05.000Z","2014-07-31T01:43:35.000Z","A9A1A7A6-7B16-4E54-86D7-09820F7388B8","400EEDF2-5115-4771-B7F4-E82ACE6D31BE","Unaligned reads",5273815393,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B21B7604-5292-4F80-B0D9-8A99B9C0C1A6","University of North Carolina","566074c0e4b018727fe9f6dc","C4F61715-EE58-4799-A5F4-0F5E27C4093D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","776E2868-E7C0-4DD2-8658-6EABD65094F1","2014-07-31T01:43:35.000Z","ADECEA79-05CC-45C4-91A8-F2A4BF94D103","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1369,"776E2868-E7C0-4DD2-8658-6EABD65094F1",NA,"VS","TCGA-VS-A8QH-01A-11R-A37P-13_mirna.bam",40,"TCGA-VS-A8QH-01A",NA,"D1392037-BB2A-4CF5-8421-BE274E5395F2","TCGA",2010,"TCGA-VS-A8QH_NTE-1","Partial Remission/Response","WITH TUMOR","4512FA54-E68B-4418-B79A-7A38B5CB8435",76,"nationwidechildrens.org_clinical.TCGA-VS-A8QH.xml","Dead",1210,"TCGA-VS-A8QH",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"TX","8482/3","FEMALE","C53.9",380,NA,"9F3D3BCE-937A-4B10-A1BA-6D3D0EAFCEC5","WHITE",NA,11,30,"1CF0D092-DB02-4EC1-92AE-6CB64416484E","ADECEA79-05CC-45C4-91A8-F2A4BF94D103","TCGA-VS-A8QH-01A-11R-A37P-13_mirna.bam","TCGA-VS-A8QH-01A-11",90,5,1,4,5,"TOP",0,0,"TCGA-VS-A8QH-01A-01-TS1",90,"Gemcitabine","Chemotherapy","TCGA-VS-A8QH-D62005","TCGA-VS-A8QH-R62002","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8QH",NA,"VS","A8QH","YES","C53.9","8482/3","C53.9","NO","YES",-27909,"FEMALE","WHITE",NA,"No","No","Dead",NA,1210,NA,NA,"WITH TUMOR","YES",30,3,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,76,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Partial Remission/Response","2009",7,NA,"TXNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
135580420,128648182,6131443260,"AAAE0BD9-63FC-4A0E-A27E-447B634BAD99.bw","c659f1c9-f3b4-4cfe-8627-2bb716c62b96","aaae0bd9-63fc-4a0e-a27e-447b634bad99","2016-08-07T17:30:31.591799-05:00","UNCID_2654405.110bcd0d-95b5-4387-bfa3-837fbde32085.140815_UNC11-SN627_0374_AC5FPLACXX_8_GTCCGC.tar.gz","a83153d6-5384-485c-9209-065ef7489862",6088073334,"Illumina HiSeq","214d1df722569a0f293780190cd52002","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:51:29.039434-05:00","2016-05-03T12:08:10.840133-05:00","a83153d6-5384-485c-9209-065ef7489862_analysis.xml","14c9da7d29046844c56c47075372ad42","a20378dd-dbc1-4ecc-ad87-efcf59425b48",2123,"2016-09-29T23:32:41.492091-05:00","a83153d6-5384-485c-9209-065ef7489862_experiment.xml","56b14e14abe58e80b447a3e41c630fc2","e0bb15fd-b31b-4e72-8f7f-5dba4329f68d",2628,"2016-09-29T18:12:22.869905-05:00","a83153d6-5384-485c-9209-065ef7489862_run.xml","bb098b8377224161a7dba165b45adf4c","19bf10b6-72d8-4217-b401-0c61a6f6494d",354,"2016-09-08T11:03:47.675513-05:00","TCGA-UC-A7PI","2016-09-02T18:54:14.134682-05:00","female","TCGA-UC-A7PI_demographic",1965,"white","b02c1476-13a3-5a76-bedb-1b913fd8768d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","UC","5f4f7a1f-2e8a-5fac-ad28-5f6f1142d6e1","University of Washington","not reported","c53.0","TCGA-UC-A7PI_diagnosis","not reported",16427,"alive","8380/3",NA,2114,"46c35806-59e3-5c71-8fd9-acfc0d07599b","c53.0",-16427,"TCGA-UC-A7PI_treatment","da14bbcd-b69b-5c99-a4f9-43beb5ef2faf","01","true","TCGA-UC-A7PI-01A",NA,"243df871-b041-450f-88a4-bc5174a73601",FALSE,"9FA775F9-4A52-498E-93B3-BAEE344324CC","Primary Tumor",NA,1647,30,NA,1379894400,"11",30,"TCGA-UC-A7PI-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T11:03:47.675513-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"6f21db1a-7a68-427d-bec0-30640fdce3d8",NA,"TCGA-UC-A7PI-01A-01-TS1",NA,100,NA,"ba451dcd-6a68-44bd-b779-a70a70b50e74","RNA","TCGA-UC-A7PI-01A-11R","082efb20-50be-438c-af8d-73bb07b69dba",1.9,0.17,"UV Spec","R","23","TCGA-UC-A7PI-01A-11R-A42S-07","110bcd0d-95b5-4387-bfa3-837fbde32085",0.17,NA,64,NA,NA,"3775e5be-f295-517b-a0ae-dd0802e1a84c","TCGA-UC-A7PI_exposure","UNCID_2654405.110bcd0d-95b5-4387-bfa3-837fbde32085.140815_UNC11-SN627_0374_AC5FPLACXX_8_GTCCGC.tar.gz","2014-11-05T15:06:04.000Z","2014-11-05T15:25:24.000Z","A83153D6-5384-485C-9209-065EF7489862","243DF871-B041-450F-88A4-BC5174A73601","Unaligned reads",6088073334,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","110BCD0D-95B5-4387-BFA3-837FBDE32085","University of North Carolina","5660774fe4b0ca319164e4ed","C659F1C9-F3B4-4CFE-8627-2BB716C62B96","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BA451DCD-6A68-44BD-B779-A70A70B50E74","2014-11-05T15:25:24.000Z","082EFB20-50BE-438C-AF8D-73BB07B69DBA","United States","NO",1,NA,"Primary Tumor","University of Washington",1647,"BA451DCD-6A68-44BD-B779-A70A70B50E74",NA,"UC","b3cf4864641cbad52d3817e8c41c01c0.bam",30,"TCGA-UC-A7PI-01A",NA,NA,"TCGA",2009,"TCGA-UC-A7PI_NTE-2","Complete Remission/Response","TUMOR FREE","9F25259C-40ED-459C-B84D-82C025BFC999",44,"nationwidechildrens.org_clinical.TCGA-UC-A7PI.xml","Alive",NA,"TCGA-UC-A7PI","NOT HISPANIC OR LATINO","D068B38E-F895-439B-8E12-084A0287800C","YES",1905,"No","Cervix","C53.0","N0","Endometrioid Adenocarcinoma of Endocervix",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8380/3","FEMALE","C53.0",420,NA,NA,"WHITE",NA,11,30,"6F21DB1A-7A68-427D-BEC0-30640FDCE3D8","2CFFB49C-E16F-4327-9275-DE3EF921EA2C","b3cf4864641cbad52d3817e8c41c01c0.bam","TCGA-UC-A7PI-01A-11",65,0,0,3,0,"TOP",0,0,"TCGA-UC-A7PI-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-UC-A7PI-F72053_NTE-2","YES",2114,"TUMOR FREE","Alive",NA,"TCGA-UC-A7PI-F72053","TCGA-UC-A7PI",NA,"UC","A7PI","YES","C53.0","8380/3","C53.0","NO","YES",-16427,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1905,NA,NA,NA,"TUMOR FREE","YES",17,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Endometrioid Adenocarcinoma of Endocervix",NA,0,44,2009,"Biopsy (cervical / CT-guided / Other)","YES",47,0,"G1",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
128187402,124952235,5961561371,"BC471AA1-52CF-4CEE-9866-34CE91404F45.bw","c80f777e-d150-40f3-9fa9-02ef9a6d7692","bc471aa1-52cf-4cee-9866-34ce91404f45","2016-08-26T09:03:53.228681-05:00","UNCID_2332278.432d3081-de85-448f-8499-2446b25af20c.131016_UNC15-SN850_0333_AC2MBAACXX_2_AGTTCC.tar.gz","35eb93af-acfb-4676-b109-10de0d6e8cf0",5930976835,"Illumina HiSeq","23778312c7a704eacbe265b08a9a76c4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:24:58.334855-05:00","2016-05-03T11:35:41.346304-05:00","35eb93af-acfb-4676-b109-10de0d6e8cf0_analysis.xml","f40f91a258244bef2c4394f744ade3c7","919b6431-34ea-434c-bcab-d67775a308b7",2124,"2016-10-07T16:31:10.521867-05:00","35eb93af-acfb-4676-b109-10de0d6e8cf0_experiment.xml","296d43fca5af47753abdd415be948a1e","2e124129-766c-4a79-8901-a1d80bd64fe5",2628,"2016-09-29T18:14:55.131292-05:00","35eb93af-acfb-4676-b109-10de0d6e8cf0_run.xml","cd0b34ef44adb30d8cb786d414348fb7","1b3d9fd4-aa5b-42f1-b514-c92af29620a0",354,"2016-09-08T11:33:46.547351-05:00","TCGA-Q1-A6DV","2016-09-02T19:00:38.331077-05:00","female","TCGA-Q1-A6DV_demographic",1977,"asian","7651b33d-7e23-50b4-a6d5-e55b561095c9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.0","TCGA-Q1-A6DV_diagnosis","not reported",13166,"alive","8482/3",NA,491,"1e111997-87a3-5c5e-93bc-5280af5ac8d2","c53.0",-13166,"TCGA-Q1-A6DV_treatment","20733606-1ec8-57a5-8700-33dbbb309389","01","true","TCGA-Q1-A6DV-01A",NA,"f717f1ad-0582-47e3-a337-c39e0d837f4d",FALSE,"B42DEC07-001A-4766-BFD6-DE67D04ABA65","Primary Tumor",NA,79,80,NA,1369872000,"11",30,"TCGA-Q1-A6DV-01A-11",60,NA,5,NA,10,NA,30,NA,"2016-09-08T11:33:46.547351-05:00",NA,15,NA,5,NA,"TOP",NA,0,NA,"b6d29039-9f8c-4cce-93d6-47e304e4b3bb",NA,"TCGA-Q1-A6DV-01A-01-TS1",NA,60,NA,"7e3c4fe3-f377-4a2d-9fbf-2b6637c0e050","RNA","TCGA-Q1-A6DV-01A-11R","09c87cea-8131-4acb-ab96-1ee16aeae60c",1.88,0.16,"UV Spec","R","23","TCGA-Q1-A6DV-01A-11R-A32P-07","432d3081-de85-448f-8499-2446b25af20c",0.16,NA,60,25.9695290858726,152,"5b988df9-d500-52bb-ac91-e6db1cb7b563","TCGA-Q1-A6DV_exposure","UNCID_2332278.432d3081-de85-448f-8499-2446b25af20c.131016_UNC15-SN850_0333_AC2MBAACXX_2_AGTTCC.tar.gz","2014-01-28T22:37:05.000Z","2014-01-28T22:53:02.000Z","35EB93AF-ACFB-4676-B109-10DE0D6E8CF0","F717F1AD-0582-47E3-A337-C39E0D837F4D","Unaligned reads",5930976835,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","432D3081-DE85-448F-8499-2446B25AF20C","University of North Carolina","5660762fe4b0ca319164da13","C80F777E-D150-40F3-9FA9-02EF9A6D7692","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7E3C4FE3-F377-4A2D-9FBF-2B6637C0E050","2014-01-28T22:53:02.000Z","09C87CEA-8131-4ACB-AB96-1EE16AEAE60C","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",79,"7E3C4FE3-F377-4A2D-9FBF-2B6637C0E050",NA,"Q1","UNCID_2332278.432d3081-de85-448f-8499-2446b25af20c.131016_UNC15-SN850_0333_AC2MBAACXX_2_AGTTCC.tar.gz",80,"TCGA-Q1-A6DV-01A",NA,NA,"TCGA",2013,"TCGA-Q1-A6DV_NTE-1",NA,NA,"F717F1AD-0582-47E3-A337-C39E0D837F4D",36,"nationwidechildrens.org_clinical.TCGA-Q1-A6DV.xml","Alive",NA,"TCGA-Q1-A6DV","NOT HISPANIC OR LATINO","A674FEB3-996A-4AC8-B6E5-072DC84A12B1","NO",113,"No","Cervix","C53.0","N0","Mucinous Adenocarcinoma of Endocervical Type",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8482/3","FEMALE","C53.0",335,NA,NA,"ASIAN",NA,11,30,"B6D29039-9F8C-4CCE-93D6-47E304E4B3BB","7518DECB-8219-4485-AAF6-9456210D7154","UNCID_2332278.432d3081-de85-448f-8499-2446b25af20c.131016_UNC15-SN850_0333_AC2MBAACXX_2_AGTTCC.tar.gz","TCGA-Q1-A6DV-01A-11",60,10,5,15,30,"TOP",0,5,"TCGA-Q1-A6DV-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-Q1-A6DV-F62827_NTE-1","NO",491,"TUMOR FREE","Alive",NA,"TCGA-Q1-A6DV-F62827","TCGA-Q1-A6DV",NA,"Q1","A6DV","YES","C53.0","8482/3","C53.0","YES","NO",-13166,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",113,NA,NA,NA,NA,"YES",20,8,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,36,2013,"Other method, specify:","YES",2,0,"G2",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
165262444,162878212,7769511669,"81D3EE3F-AC11-404F-8092-307F0DC12198.bw","c83c52f4-3815-4f49-8218-cf80aaa62e2f","81d3ee3f-ac11-404f-8092-307f0dc12198","2016-08-04T21:12:13.762773-05:00","UNCID_2186449.c59486e3-0de6-4fd2-adef-b3b369d41e7c.121102_UNC15-SN850_0240_BD148CACXX_6_CTTGTA.tar.gz","d47f4a33-83bc-416f-bd00-18f79f204606",7413344137,"Illumina HiSeq","afe463d27be0705598ee1a48c25acc06","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:59:03.948113-05:00","2016-05-03T11:00:24.467483-05:00","d47f4a33-83bc-416f-bd00-18f79f204606_analysis.xml","4dbddb7d0e1c4d61ba3df5c5cd577854","5c8ee5db-664d-4f33-af47-04f48ac97f4f",2124,"2016-09-30T00:07:17.643677-05:00","d47f4a33-83bc-416f-bd00-18f79f204606_experiment.xml","475e655b0f7d267064742aa6fc790f7c","f60925a5-16a3-4736-9d32-58642efb1758",2431,"2016-09-29T18:19:50.889749-05:00","d47f4a33-83bc-416f-bd00-18f79f204606_run.xml","ce10e0e70625b1a4aedc1e34caf42ff4","1e3dfb31-4688-4bbf-9acf-2ded4ace7982",354,"2016-09-08T12:30:54.739104-05:00","TCGA-EK-A2H0","2016-09-02T18:57:47.540823-05:00","female","TCGA-EK-A2H0_demographic",1983,"white","027453cb-ae74-534e-aa1d-59e35e1a046e","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2H0_diagnosis","not reported",8918,"alive","8071/3",NA,1847,"5a2fca0b-a0e9-5fb5-9f0c-3a1d22a4d196","c53.9",-8918,"TCGA-EK-A2H0_treatment","4236e9a8-5996-5a89-8791-635b6f5c1a4b","01","false","TCGA-EK-A2H0-01A",NA,"cee04dec-391c-4c22-bc7d-d3dd36380db3",FALSE,"AEDD5CA3-2E0A-414F-AA38-CCF5229EC7F2","Primary Tumor",NA,1268,160,NA,1308182400,"11",30,"TCGA-EK-A2H0-01A-11",94,NA,0,NA,0,NA,10,NA,"2016-09-08T12:30:54.739104-05:00",NA,2,NA,0,NA,"TOP",NA,5,NA,"1f5a10e3-2c42-4623-9ad5-725673b25fa4",NA,"TCGA-EK-A2H0-01A-01-TSA",NA,85,NA,"49eef2f2-e077-4929-9773-6cd9c5164a9b","RNA","TCGA-EK-A2H0-01A-11R","f383880b-7f7f-4443-b877-14e82903b465",1.88,0.18,"UV Spec","R","23","TCGA-EK-A2H0-01A-11R-A180-07","c59486e3-0de6-4fd2-adef-b3b369d41e7c",0.18,NA,88,36.1604207758054,156,"01e41584-f250-586a-a762-00cc4aaf5d61","TCGA-EK-A2H0_exposure","UNCID_2186449.c59486e3-0de6-4fd2-adef-b3b369d41e7c.121102_UNC15-SN850_0240_BD148CACXX_6_CTTGTA.tar.gz","2013-09-16T09:01:04.000Z","2013-09-16T10:28:01.000Z","D47F4A33-83BC-416F-BD00-18F79F204606","CEE04DEC-391C-4C22-BC7D-D3DD36380DB3","Unaligned reads",7413344137,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C59486E3-0DE6-4FD2-ADEF-B3B369D41E7C","University of North Carolina","566073b5e4b0b37b3d98e0ea","C83C52F4-3815-4F49-8218-CF80AAA62E2F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","49EEF2F2-E077-4929-9773-6CD9C5164A9B","2013-09-16T10:28:01.000Z","F383880B-7F7F-4443-B877-14E82903B465","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1268,"49EEF2F2-E077-4929-9773-6CD9C5164A9B",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A420B883-B083-453C-BF60-128E2737BBE3.txt",160,"TCGA-EK-A2H0-01A",NA,"3CF33478-3029-494E-AE79-DF669875863C","TCGA",2007,NA,NA,"TUMOR FREE","CEE04DEC-391C-4C22-BC7D-D3DD36380DB3",24,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A420B883-B083-453C-BF60-128E2737BBE3.txt","Alive",NA,"TCGA-EK-A2H0",NA,"695F359E-7C62-4EC8-BB17-F4F7DEFA1822",NA,1398,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIB",NA,NA,NA,"8071/3","FEMALE","C53.9",169,NA,"49E947F8-C3A4-4F86-A74D-3CCA3E73DFC6","WHITE",NA,11,30,"1F5A10E3-2C42-4623-9AD5-725673B25FA4","FBCC007F-9203-42F3-BBC5-A10E789C41CE","TCGA-EK-A2H0-01A-11R-A17X-13_mirna.bam","TCGA-EK-A2H0-01A-11",94,0,0,2,10,"TOP",5,0,"TCGA-EK-A2H0-01A-01-TSA",85,"Cisplatin","Chemotherapy","TCGA-EK-A2H0-D31970","TCGA-EK-A2H0-R31973","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",1398,"TUMOR FREE","Alive",NA,"TCGA-EK-A2H0-F31965","TCGA-EK-A2H0",NA,"EK","A2H0","YES","C53.9","8071/3","C53.9","NO","YES",-8918,"FEMALE","WHITE",NA,"No","No","Alive",1398,NA,NA,NA,"TUMOR FREE","NO",3,11,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,24,2007,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1995",13,NA,NA,NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
112676244,110392987,5264631202,"8C02026C-C25E-406B-B8B8-A1A82362AE79.bw","c92696ba-f549-480d-8d4a-5f23b27aa336","8c02026c-c25e-406b-b8b8-a1a82362ae79","2016-08-25T12:53:22.245232-05:00","UNCID_2553103.13b52657-459f-45f6-a4ce-a2da459104ac.140408_UNC11-SN627_0351_AC3KY3ACXX_3_ATCACG.tar.gz","a268002e-fe56-4994-9976-d3dcde6f16db",4921656579,"Illumina HiSeq","6916250cab69e7cb1082e3e61ed5c08e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:47:06.179373-05:00","2016-05-03T11:54:19.885282-05:00","a268002e-fe56-4994-9976-d3dcde6f16db_analysis.xml","3e8dfc6e53313550a2a5d539835f0e11","9f3d00c0-28b1-4c18-8f05-483cb67e43d3",2124,"2016-09-30T00:12:31.485031-05:00","a268002e-fe56-4994-9976-d3dcde6f16db_experiment.xml","505dd3b7f2b9b7fdfe1c96e08be75094","f943b369-0342-49e2-9a59-c9da41da4bd0",2628,"2016-09-29T22:33:38.959180-05:00","a268002e-fe56-4994-9976-d3dcde6f16db_run.xml","1898329fec4b9ab88df4ee75bd422ee2","bc030ea5-2b4a-4390-8174-7cf7c0fc7148",354,"2016-09-08T11:21:39.278040-05:00","TCGA-C5-A907","2016-09-02T19:01:13.590911-05:00","female","TCGA-C5-A907_demographic",1966,"white","0c3da3e8-e1c3-5e79-9b6f-cc3b90ba3550","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A907_diagnosis","not reported",17304,"alive","8070/3",NA,448,"0d3943fe-1c44-5daf-9c83-6b833fdbe10b","c53.9",-17304,"TCGA-C5-A907_treatment","c013e48f-a73e-5582-8d66-606ff62936f2","01","false","TCGA-C5-A907-01A",NA,"b5495329-a954-4bee-ae9c-9bc909acd1c1",FALSE,"6AC8C0C6-A43A-427E-90D3-6584FC2F723E","Primary Tumor",NA,48,100,NA,1388361600,"11",30,"TCGA-C5-A907-01A-11",70,NA,1,NA,10,NA,15,NA,"2016-09-08T11:21:39.278040-05:00",NA,8,NA,1,NA,"TOP",NA,5,NA,"e0d13713-6294-47d5-9d0b-21d233ef4977",NA,"TCGA-C5-A907-01A-01-TS1",NA,70,NA,"5bbd5ffe-fd71-4d4d-a3fe-407935aca829","RNA","TCGA-C5-A907-01A-11R","c573c63e-df7d-430a-925f-0efa33bbec37",1.8,0.17,"UV Spec","R","23","TCGA-C5-A907-01A-11R-A37O-07","13b52657-459f-45f6-a4ce-a2da459104ac",0.17,NA,95,35.7559561895442,163,"3284806a-6e05-55c2-8729-42da19c232e9","TCGA-C5-A907_exposure","UNCID_2553103.13b52657-459f-45f6-a4ce-a2da459104ac.140408_UNC11-SN627_0351_AC3KY3ACXX_3_ATCACG.tar.gz","2014-07-30T23:06:07.000Z","2014-07-30T23:32:08.000Z","A268002E-FE56-4994-9976-D3DCDE6F16DB","B5495329-A954-4BEE-AE9C-9BC909ACD1C1","Unaligned reads",4921656579,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","13B52657-459F-45F6-A4CE-A2DA459104AC","University of North Carolina","564a3af4e4b08c5d86915dd7","C92696BA-F549-480D-8D4A-5F23B27AA336","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5BBD5FFE-FD71-4D4D-A3FE-407935ACA829","2014-07-30T23:32:08.000Z","C573C63E-DF7D-430A-925F-0EFA33BBEC37","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",48,"5BBD5FFE-FD71-4D4D-A3FE-407935ACA829",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.2396FB56-1204-4736-8BD4-7C40A569A39E.txt",100,"TCGA-C5-A907-01A",NA,"A838B6D3-A560-4453-A856-6B9D1170211F","TCGA",2013,"TCGA-C5-A907_NTE-1",NA,"TUMOR FREE","B5495329-A954-4BEE-AE9C-9BC909ACD1C1",47,"nationwidechildrens.org_clinical.TCGA-C5-A907.xml","Alive",NA,"TCGA-C5-A907","NOT HISPANIC OR LATINO","E26C070D-0CCD-4372-B6E8-1F36A2DA120C","NO",136,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"538BADFC-CA28-462D-8620-E816DFAAED5B","WHITE",NA,11,30,"E0D13713-6294-47D5-9D0B-21D233EF4977","D11FF77B-9523-4C20-8C8E-5417DECE1FB5","UNCID_2553103.13b52657-459f-45f6-a4ce-a2da459104ac.140408_UNC11-SN627_0351_AC3KY3ACXX_3_ATCACG.tar.gz","TCGA-C5-A907-01A-11",70,10,1,8,15,"TOP",5,1,"TCGA-C5-A907-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-C5-A907-D58147","TCGA-C5-A907-R58149","Internal","Primary Tumor Field","TCGA-C5-A907-F66735_NTE-1","NO",361,"TUMOR FREE","Alive",NA,"TCGA-C5-A907-F66735","TCGA-C5-A907",NA,"C5","A907","YES","C53.9","8070/3","C53.9","NO","YES",-17304,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",136,NA,NA,NA,"TUMOR FREE","YES",1,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G2",NA,4,2006,NA,NA,NA,"2009",8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121208882,118664351,5662299506,"6A005F2A-A0C1-4CA4-B15B-96B08F013874.bw","c996cffb-8132-4973-987d-143274b6a081","6a005f2a-a0c1-4ca4-b15b-96b08f013874","2016-08-09T13:14:11.069717-05:00","UNCID_2186139.6c6c44ac-3626-482e-8d33-adbd122f8352.121102_UNC12-SN629_0235_AC13F5ACXX_4_ATCACG.tar.gz","05e4441f-d0b9-4934-9c6c-2eacfcc3e12a",5590935437,"Illumina HiSeq","b8541ca084126cc8759e4fa10d9f0ef7","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:40:47.568069-05:00","2016-05-03T11:00:24.444360-05:00","05e4441f-d0b9-4934-9c6c-2eacfcc3e12a_analysis.xml","9b2bf1cb9a452e059a7f474045df2146","e5b87e47-f60b-42c9-86f0-de8201e9a440",2124,"2016-09-29T19:37:33.915916-05:00","05e4441f-d0b9-4934-9c6c-2eacfcc3e12a_experiment.xml","df776a383d6e2cce91ac32f0bb20e148","4f3696d1-ac8d-4bd5-921f-c85404dc8ea7",2431,"2016-09-29T21:18:54.988485-05:00","05e4441f-d0b9-4934-9c6c-2eacfcc3e12a_run.xml","5b400dab66f703d4fe9ce49626d2e97f","8de66695-0a03-4acb-82b0-64953a232e7a",354,"2016-09-08T11:47:35.463530-05:00","TCGA-EK-A2RO","2016-09-02T18:58:30.860984-05:00","female","TCGA-EK-A2RO_demographic",1951,"american indian or alaska native","1992f764-40d3-516f-880c-ca3ab588a776","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RO_diagnosis","not reported",21844,"alive","8072/3",NA,2,"21e90e58-53d8-5aee-b6a7-246edefe98d1","c53.9",-21844,"TCGA-EK-A2RO_treatment","33e9d746-c90a-5063-8f2a-68f2be3bc437","01","false","TCGA-EK-A2RO-01A",NA,"31ea30da-ab0d-48af-bb1c-58f99ab033a9",FALSE,"49E0E89E-7DB0-4FFD-8246-1EF8E4308829","Primary Tumor",NA,409,90,NA,1315785600,"11",30,"TCGA-EK-A2RO-01A-11",65,NA,1,NA,0,NA,48,NA,"2016-09-08T11:47:35.463530-05:00",NA,5,NA,0,NA,"TOP",NA,2,NA,"795824ef-504b-401d-bcf4-21d84544dec3",NA,"TCGA-EK-A2RO-01A-01-TS1",NA,50,NA,"14e7a79b-e95b-43b0-9c2e-eeb485440943","RNA","TCGA-EK-A2RO-01A-11R","c7199856-48b9-4991-9e40-19541ea8bc3b",1.82,0.18,"UV Spec","R","23","TCGA-EK-A2RO-01A-11R-A18M-07","6c6c44ac-3626-482e-8d33-adbd122f8352",0.18,NA,77,27.281746031746,168,"e02b34ea-7214-5429-af5d-afc24c3f7c44","TCGA-EK-A2RO_exposure","UNCID_2186139.6c6c44ac-3626-482e-8d33-adbd122f8352.121102_UNC12-SN629_0235_AC13F5ACXX_4_ATCACG.tar.gz","2013-09-16T01:26:04.000Z","2013-09-16T01:40:02.000Z","05E4441F-D0B9-4934-9C6C-2EACFCC3E12A","31EA30DA-AB0D-48AF-BB1C-58F99AB033A9","Unaligned reads",5590935437,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6C6C44AC-3626-482E-8D33-ADBD122F8352","University of North Carolina","566075dbe4b0b37b3d98fdfb","C996CFFB-8132-4973-987D-143274B6A081","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","14E7A79B-E95B-43B0-9C2E-EEB485440943","2013-09-16T01:40:02.000Z","C7199856-48B9-4991-9E40-19541EA8BC3B","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",409,"14E7A79B-E95B-43B0-9C2E-EEB485440943",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.33DF4CED-0F6D-4E70-BD3F-D21D94310B95.txt",90,"TCGA-EK-A2RO-01A",NA,NA,"TCGA",2010,NA,NA,NA,"31EA30DA-AB0D-48AF-BB1C-58F99AB033A9",59,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.33DF4CED-0F6D-4E70-BD3F-D21D94310B95.txt","Alive",NA,"TCGA-EK-A2RO","HISPANIC OR LATINO","B306158B-7F22-48F5-B1E0-1A41E1EA9DC4",NA,2,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIB",NA,NA,NA,"8072/3","FEMALE","C53.9",179,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"795824EF-504B-401D-BCF4-21D84544DEC3","6B8601B7-C57C-44A2-9168-FCD0A9E136C3","6929718044_R04C02_Red.idat","TCGA-EK-A2RO-01A-11",65,0,1,5,48,"TOP",2,0,"TCGA-EK-A2RO-01A-01-TS1",50,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RO-F58270_NTE-1",NA,-4,NA,"Alive",NA,"TCGA-EK-A2RO-F58270","TCGA-EK-A2RO",NA,"EK","A2RO","YES","C53.9","8072/3","C53.9","NO","YES",-21844,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Alive",2,NA,NA,NA,"WITH TUMOR","NO",5,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,59,2010,"Lymph node sampling or dissection","YES",32,0,"G1",NA,NA,NA,NA,NA,NA,"1988",13,NA,NA,NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
138351226,134022741,6389567904,"B55743F2-4D63-4375-85D3-F58281CFD852.bw","c99f476b-e8b1-4cdd-9164-0da450064886","b55743f2-4d63-4375-85d3-f58281cfd852","2016-08-26T06:08:59.297517-05:00","UNCID_2553104.729d243c-73f2-42d2-8737-55275a062a8f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_TTAGGC.tar.gz","522f15a9-57c1-421a-90d6-ebde6543738d",6019308963,"Illumina HiSeq","623afbc40c9a348b204ce07f67e8f4e0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:28:49.093346-05:00","2016-05-03T11:54:19.885282-05:00","522f15a9-57c1-421a-90d6-ebde6543738d_analysis.xml","8729c7022fc924464a7f4a061a98835d","23f52e61-1f4d-495d-936f-a939281570fe",2124,"2016-09-29T23:47:23.630548-05:00","522f15a9-57c1-421a-90d6-ebde6543738d_experiment.xml","15993eeb8d44be7cbc99a7257a471e6c","e9e3acb4-13bb-4fc5-ae27-2eba05265286",2628,"2016-09-29T17:57:09.440967-05:00","522f15a9-57c1-421a-90d6-ebde6543738d_run.xml","74b99f77f38d107e00def6962a033149","1027e6a9-2c95-4723-9f52-89b9e98ad0f3",354,"2016-09-08T11:44:01.718862-05:00","TCGA-C5-A905","2016-09-02T19:01:12.895400-05:00","female","TCGA-C5-A905_demographic",1957,"black or african american","09e78095-44ef-5ede-88fe-20dab56ea56c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A905_diagnosis","not reported",13584,"alive","8070/3",NA,4879,"2e5b3d1e-416e-5f31-9169-add89f4c8e4c","c53.9",-13584,"TCGA-C5-A905_treatment","f09854b3-df82-52e2-ac11-3e32c44be244","01","false","TCGA-C5-A905-01A",NA,"ae60de0b-6db7-4fb1-a335-e4e7babd251b",FALSE,"A2899C0E-696C-4613-8443-35FDC795CD01","Primary Tumor",NA,7129,40,NA,1388361600,"11",20,"TCGA-C5-A905-01A-11",75,NA,0,NA,5,NA,15,NA,"2016-09-08T11:44:01.718862-05:00",NA,4,NA,1,NA,"TOP",NA,5,NA,"944a1eab-290d-437a-b025-5fc0b0c8c048",NA,"TCGA-C5-A905-01A-01-TS1",NA,75,NA,"2831001c-9f06-41d5-adc3-7567842d6875","RNA","TCGA-C5-A905-01A-11R","0534f29c-e24c-478c-a138-ff8586702782",1.93,0.18,"UV Spec","R","23","TCGA-C5-A905-01A-11R-A37O-07","729d243c-73f2-42d2-8737-55275a062a8f",0.18,NA,73,NA,NA,"808b817a-7abe-50a7-8886-8818905586bd","TCGA-C5-A905_exposure","UNCID_2553104.729d243c-73f2-42d2-8737-55275a062a8f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_TTAGGC.tar.gz","2014-07-30T23:21:05.000Z","2014-07-30T23:42:04.000Z","522F15A9-57C1-421A-90D6-EBDE6543738D","AE60DE0B-6DB7-4FB1-A335-E4E7BABD251B","Unaligned reads",6019308963,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","729D243C-73F2-42D2-8737-55275A062A8F","University of North Carolina","56607549e4b0b37b3d98f67b","C99F476B-E8B1-4CDD-9164-0DA450064886","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2831001C-9F06-41D5-ADC3-7567842D6875","2014-07-30T23:42:04.000Z","0534F29C-E24C-478C-A138-FF8586702782","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",7129,"2831001C-9F06-41D5-ADC3-7567842D6875",NA,"C5","UNCID_2553104.729d243c-73f2-42d2-8737-55275a062a8f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_TTAGGC.tar.gz",40,"TCGA-C5-A905-01A",NA,NA,"TCGA",1994,"TCGA-C5-A905_NTE-1",NA,"TUMOR FREE","B7D145D4-5CDA-4455-903D-B0C216726FF6",37,"nationwidechildrens.org_clinical.TCGA-C5-A905.xml","Alive",NA,"TCGA-C5-A905","NOT HISPANIC OR LATINO","1065AB31-DFD9-4FDA-BF9B-E86489E570BE","NO",4879,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",380,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,20,"944A1EAB-290D-437A-B025-5FC0B0C8C048","C7DA5339-385E-47F9-906B-D94A839CB2A6","UNCID_2553104.729d243c-73f2-42d2-8737-55275a062a8f.140408_UNC11-SN627_0351_AC3KY3ACXX_3_TTAGGC.tar.gz","TCGA-C5-A905-01A-11",75,5,0,4,15,"TOP",5,1,"TCGA-C5-A905-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-C5-A905-F66740_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A905-F66740","TCGA-C5-A905",NA,"C5","A905","YES","C53.9","8070/3","C53.9","NO","YES",-13584,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",4879,NA,NA,NA,"TUMOR FREE","YES",1,4,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,1994,"Biopsy (cervical / CT-guided / Other)","YES",33,0,"G2",NA,NA,NA,NA,NA,NA,"1988",6,NA,"T1bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
87931656,87415608,4180938277,"24F98393-C817-4D0E-A7DB-05D2B5C71F40.bw","c9e4bac6-0cac-4fca-a548-527deac5b880","24f98393-c817-4d0e-a7db-05d2b5c71f40","2016-08-06T23:31:37.080385-05:00","UNCID_2654382.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.140908_UNC11-SN627_0381_BC5DEKACXX_4_GGCTAC.tar.gz","5816317d-0582-4af1-8327-d8305ab7724f",3639888301,"Illumina HiSeq","8778a51fe4e19554bae6d8244f676b8f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:10:16.638662-05:00","2016-05-03T12:08:10.830175-05:00","5816317d-0582-4af1-8327-d8305ab7724f_analysis.xml","4de7d13cdba93841e2ad74477c37bc20","f7dbc1ed-18fd-4e73-af3d-fc94ad241024",2124,"2016-09-29T23:20:06.067434-05:00","5816317d-0582-4af1-8327-d8305ab7724f_experiment.xml","b1eb2c6b45870c96bdad27282ded48d4","d8b467a6-fb39-499f-9274-c7a87923acfa",2628,"2016-09-29T22:52:33.058944-05:00","5816317d-0582-4af1-8327-d8305ab7724f_run.xml","672d544350c115da8ba23c116b302e26","c7cf4b04-65c9-46e6-a893-2b34e56c4b42",354,"2016-09-08T11:19:41.725645-05:00","TCGA-VS-A9UV","2016-09-02T18:54:32.732380-05:00","female","TCGA-VS-A9UV_demographic",1939,"not reported","0f632bfe-afec-502a-994f-d95d8fdfaaad","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UV_diagnosis","not reported",27348,"dead","8070/3",104,NA,"9fae3e5c-a10c-546a-a04a-acafde5bd8fb","c53.9",-27348,"TCGA-VS-A9UV_treatment","236b2b4d-f6e2-5434-906e-ba91e6f7b4f9","01","false","TCGA-VS-A9UV-01A",NA,"60817f05-7c77-4631-a77e-d7a018aa1a23",FALSE,"EAF200A1-9A0C-4A51-A241-14173B4F323E","Primary Tumor",NA,125,50,NA,1391040000,"11",30,"TCGA-VS-A9UV-01A-11",70,NA,20,NA,0,NA,30,NA,"2016-09-08T11:19:41.725645-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"66c12cd5-d0be-42e7-9e45-4d2e9d56a38f",NA,"TCGA-VS-A9UV-01A-01-TS1",NA,70,NA,"66d938cc-a1ed-4480-bb20-f690b65911f2","RNA","TCGA-VS-A9UV-01A-11R","0a925d74-7dc4-4cf8-806e-fe885ddbf4fa",1.91,0.18,"UV Spec","R","23","TCGA-VS-A9UV-01A-11R-A42T-07","2f48ea8f-6e03-4f00-acc5-e9bc491ad673",0.18,NA,31,13.4175900277008,152,"42df624e-859c-58e4-afe8-dba94204cdaf","TCGA-VS-A9UV_exposure","UNCID_2654382.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.140908_UNC11-SN627_0381_BC5DEKACXX_4_GGCTAC.tar.gz","2014-11-05T06:47:04.000Z","2014-11-05T06:59:33.000Z","5816317D-0582-4AF1-8327-D8305AB7724F","60817F05-7C77-4631-A77E-D7A018AA1A23","Unaligned reads",3639888301,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2F48EA8F-6E03-4F00-ACC5-E9BC491AD673","University of North Carolina","56607591e4b016715ab68479","C9E4BAC6-0CAC-4FCA-A548-527DEAC5B880","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","66D938CC-A1ED-4480-BB20-F690B65911F2","2014-11-05T06:59:33.000Z","0A925D74-7DC4-4CF8-806E-FE885DDBF4FA","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",125,"66D938CC-A1ED-4480-BB20-F690B65911F2",NA,"VS","UNCID_2654382.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.140908_UNC11-SN627_0381_BC5DEKACXX_4_GGCTAC.tar.gz",50,"TCGA-VS-A9UV-01A",NA,NA,"TCGA",2013,"TCGA-VS-A9UV_NTE-1",NA,"WITH TUMOR","60817F05-7C77-4631-A77E-D7A018AA1A23",74,"nationwidechildrens.org_clinical.TCGA-VS-A9UV.xml","Dead",104,"TCGA-VS-A9UV",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Other","Stage IVA",NA,NA,"T4","8070/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"66C12CD5-D0BE-42E7-9E45-4D2E9D56A38F","1ACB5E66-8806-4DA0-A13C-7B4FA3A863E2","UNCID_2654382.2f48ea8f-6e03-4f00-acc5-e9bc491ad673.140908_UNC11-SN627_0381_BC5DEKACXX_4_GGCTAC.tar.gz","TCGA-VS-A9UV-01A-11",70,0,20,40,30,"TOP",0,20,"TCGA-VS-A9UV-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UV",NA,"VS","A9UV","YES","C53.9","8070/3","C53.9","NO","YES",-27348,"FEMALE",NA,NA,"No","No","Dead",NA,104,NA,NA,"WITH TUMOR","YES",11,8,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,74,2013,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,NA,"2009",17,NA,"T4NXMX",NA,NA,1,"Other",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
142733356,140452217,6697712328,"2C2AEF1D-4112-4EC7-9027-5E3FD26E8802.bw","c9f519b6-73f1-4737-83cb-f5ef208592cd","2c2aef1d-4112-4ec7-9027-5e3fd26e8802","2016-08-31T13:40:18.807691-05:00","UNCID_2553099.4b1da384-ab8a-4c6f-a76a-54ddc5314594.140408_UNC11-SN627_0351_AC3KY3ACXX_7_AGTTCC.tar.gz","e962fe60-72e6-47a9-9a9b-8e048321c494",6397051677,"Illumina HiSeq","c3cf37fadb4e10b2bc70fd29626a6661","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:14:53.069263-05:00","2016-05-03T11:54:19.885282-05:00","e962fe60-72e6-47a9-9a9b-8e048321c494_analysis.xml","4d4fb3ede2f6fff9a35e3c3e32013ba7","b076667f-1d3b-4af1-a4b4-23c99ca9041e",2124,"2016-08-13T01:54:49.243283-05:00","e962fe60-72e6-47a9-9a9b-8e048321c494_experiment.xml","103846832f254b255541dfade76f0994","297c3482-d893-4f60-963b-ccbdd236be0f",2628,"2016-09-29T17:43:18.810696-05:00","e962fe60-72e6-47a9-9a9b-8e048321c494_run.xml","c12191633de5eb9163f4df9005678509","075b86c1-7538-492a-b75f-e5e6da1a674b",354,"2016-09-08T12:14:11.648838-05:00","TCGA-MY-A913","2016-09-02T19:01:15.337811-05:00","female","TCGA-MY-A913_demographic",1985,"black or african american","0aa45086-f9f1-5c36-9bcd-fe995ae75cc5","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MY","06424429-c5cd-5c57-9e26-68966e407b26","Montefiore Medical Center","not reported","c53.9","TCGA-MY-A913_diagnosis","not reported",10379,"alive","8070/3",NA,524,"0d3d1359-d5b7-561d-ab9b-495816641b9e","c53.9",-10379,"TCGA-MY-A913_treatment","71aefdca-fe22-537a-9a9a-de6645aa84ce","01","true","TCGA-MY-A913-01A",NA,"76cf81fb-771b-43cf-9aa5-8342fd133626",FALSE,"E17EECA7-26DE-4456-94B2-6B5A9F4931AD","Primary Tumor",NA,107,210,NA,1388361600,"11",30,"TCGA-MY-A913-01A-11",70,NA,0,NA,10,NA,10,NA,"2016-09-08T12:14:11.648838-05:00",NA,10,NA,0,NA,"TOP",NA,10,NA,"cef0df69-5d80-42d0-9d54-752f0dab83d5",NA,"TCGA-MY-A913-01A-01-TSA",NA,70,NA,"aa71a8ee-7ee7-4484-9abd-3bf8510365cd","RNA","TCGA-MY-A913-01A-11R","161f9afa-0c10-4dc5-8d6d-902f957223e2",1.85,0.17,"UV Spec","R","23","TCGA-MY-A913-01A-11R-A37O-07","4b1da384-ab8a-4c6f-a76a-54ddc5314594",0.17,NA,76,28.6047649516354,163,"8e520b54-c77c-5a11-a5ce-2bba0d0d36fd","TCGA-MY-A913_exposure","UNCID_2553099.4b1da384-ab8a-4c6f-a76a-54ddc5314594.140408_UNC11-SN627_0351_AC3KY3ACXX_7_AGTTCC.tar.gz","2014-07-30T22:37:04.000Z","2014-07-30T23:07:12.000Z","E962FE60-72E6-47A9-9A9B-8E048321C494","76CF81FB-771B-43CF-9AA5-8342FD133626","Unaligned reads",6397051677,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4B1DA384-AB8A-4C6F-A76A-54DDC5314594","University of North Carolina","564a3b38e4b0ef12181a620f","C9F519B6-73F1-4737-83CB-F5EF208592CD","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AA71A8EE-7EE7-4484-9ABD-3BF8510365CD","2014-07-30T23:07:12.000Z","161F9AFA-0C10-4DC5-8D6D-902F957223E2","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",107,"AA71A8EE-7EE7-4484-9ABD-3BF8510365CD",NA,"MY","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.263D2292-E1D0-4937-90C2-C733495AFF02.txt",210,"TCGA-MY-A913-01A",NA,"6CFF5264-76FD-43DC-87CB-9C01433D42E3","TCGA",2013,"TCGA-MY-A913_NTE-1","Complete Remission/Response","TUMOR FREE","76CF81FB-771B-43CF-9AA5-8342FD133626",28,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.263D2292-E1D0-4937-90C2-C733495AFF02.txt","Alive",NA,"TCGA-MY-A913","HISPANIC OR LATINO","2AF15E75-7DCC-4C3B-8308-CE67192BFBC5","NO",167,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIA",NA,NA,"Tis","8070/3","FEMALE","C53.9",380,NA,"40D24AF3-A51A-412A-9D75-ABAC9509BAB0","BLACK OR AFRICAN AMERICAN",NA,11,30,"CEF0DF69-5D80-42D0-9D54-752F0DAB83D5","F4B06F52-F22C-422A-830C-F015422DB860","UNCID_2415121.4b1da384-ab8a-4c6f-a76a-54ddc5314594.sorted_genome_alignments.bam","TCGA-MY-A913-01A-11",70,10,0,10,10,"TOP",10,0,"TCGA-MY-A913-01A-01-TSA",70,"Cisplatin","Chemotherapy","TCGA-MY-A913-D59733","TCGA-MY-A913-R58806","Internal","Primary Tumor Field","TCGA-MY-A913-F71177_NTE-1","NO",524,"TUMOR FREE","Alive",NA,"TCGA-MY-A913-F71177","TCGA-MY-A913",NA,"MY","A913","YES","C53.9","8070/3","C53.9","YES","NO",-10379,"FEMALE","BLACK OR AFRICAN AMERICAN","HISPANIC OR LATINO","No","No","Alive",167,NA,NA,NA,"TUMOR FREE","YES",23,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,28,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,5,NA,NA,NA,"Complete Remission/Response","2009",10,NA,"TisN0M1",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
79378434,78727198,3762788589,"8BAC3CB5-2987-4349-8AE8-B83DDD16CA3C.bw","ca242b4c-b879-4e13-a1e7-84c984067189","8bac3cb5-2987-4349-8ae8-b83ddd16ca3c","2016-08-05T08:52:44.463555-05:00","UNCID_2654388.389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a.141006_UNC15-SN850_0395_AC5FH9ACXX_2_GATCAG.tar.gz","1c0727df-7dd3-4b09-9b85-01167af2b75a",3370353495,"Illumina HiSeq","af6859e4272ca772edcb2f259a63e819","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:20:56.393322-05:00","2016-05-03T12:08:10.830175-05:00","1c0727df-7dd3-4b09-9b85-01167af2b75a_analysis.xml","18bfe2ee13e7ebc88c55c4d9df36795c","1ee4e90c-d638-49db-b603-482b7d8144e7",2124,"2016-09-29T21:34:00.235235-05:00","1c0727df-7dd3-4b09-9b85-01167af2b75a_experiment.xml","2672c26a99f9c1e143edd00dc5fd686f","972ab4d7-7a60-48d4-9a91-e950e5712413",2628,"2016-09-29T19:44:20.474110-05:00","1c0727df-7dd3-4b09-9b85-01167af2b75a_run.xml","8ae229e2d813f04256b3bbcbd57d28c8","5369c66b-a2c6-4ff6-8172-576192362f23",354,"2016-09-08T12:13:18.402553-05:00","TCGA-VS-A9UB","2016-09-02T18:54:20.220564-05:00","female","TCGA-VS-A9UB_demographic",1958,"not reported","51df48c6-e344-5b89-9180-2392e0071609","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UB_diagnosis","not reported",19737,"alive","8070/3",NA,911,"26cf6fa6-8396-5650-9817-5b26af95aab9","c53.9",-19737,"TCGA-VS-A9UB_treatment","3191169b-8cf9-5fd7-b75f-2e5eac418d4b","01","false","TCGA-VS-A9UB-01A",NA,"720645a9-7408-4cd2-a6f2-de9dd694cf3a",FALSE,"73D61A64-9435-4E72-898C-3A4E7C109CF3","Primary Tumor",NA,435,140,NA,1390953600,"22",10,"TCGA-VS-A9UB-01A-22",70,NA,0,NA,0,NA,10,NA,"2016-09-08T12:13:18.402553-05:00",NA,30,NA,70,NA,"TOP",NA,20,NA,"085dfb18-a511-4bf3-8733-846251ddd882",NA,"TCGA-VS-A9UB-01A-02-TSB",NA,70,NA,"5a010cc8-7016-41a6-8b73-31b637d4d0f7","RNA","TCGA-VS-A9UB-01A-22R","49cadaee-b767-4127-9d60-36d6b040f561",1.87,0.17,"UV Spec","R","23","TCGA-VS-A9UB-01A-22R-A42T-07","389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a",0.17,NA,79,28.6688924372188,166,"4dccd752-35f7-59f9-9445-f3e6c5d905d9","TCGA-VS-A9UB_exposure","UNCID_2654388.389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a.141006_UNC15-SN850_0395_AC5FH9ACXX_2_GATCAG.tar.gz","2014-11-05T09:06:04.000Z","2014-11-05T09:18:26.000Z","1C0727DF-7DD3-4B09-9B85-01167AF2B75A","720645A9-7408-4CD2-A6F2-DE9DD694CF3A","Unaligned reads",3370353495,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","389EB99B-53C7-41DD-8CE3-F3D8D70A1E7A","University of North Carolina","564a3b7ae4b09c884b246175","CA242B4C-B879-4E13-A1E7-84C984067189","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","5A010CC8-7016-41A6-8B73-31B637D4D0F7","2014-11-05T09:18:26.000Z","49CADAEE-B767-4127-9D60-36D6B040F561","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",435,"5A010CC8-7016-41A6-8B73-31B637D4D0F7",NA,"VS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F54758E3-15BA-49F2-8F6A-B68B540D499C.txt",140,"TCGA-VS-A9UB-01A",NA,"107F4992-511B-4946-8096-D16382E92606","TCGA",2012,"TCGA-VS-A9UB_NTE-1","Complete Remission/Response","TUMOR FREE","75B41B7D-BE0E-4DEF-96C7-C83937111D5B",54,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.F54758E3-15BA-49F2-8F6A-B68B540D499C.txt","Alive",NA,"TCGA-VS-A9UB",NA,"E4EFBA87-40B5-49DF-AD2D-3073562550B1","NO",562,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",2,"Other","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"D92AA023-7CFD-42A6-8B87-84A557CC578B",NA,NA,22,10,"085DFB18-A511-4BF3-8733-846251DDD882","B79CA5DF-595C-4979-809E-F8AC313697D8","UNCID_2650894.389eb99b-53c7-41dd-8ce3-f3d8d70a1e7a.sorted_genome_alignments.bam.bai","TCGA-VS-A9UB-01A-22",70,0,0,30,10,"TOP",20,70,"TCGA-VS-A9UB-01A-02-TSB",70,"Cisplatin","Chemotherapy","TCGA-VS-A9UB-D65878","TCGA-VS-A9UB-R65876","Internal","Primary Tumor Field","TCGA-VS-A9UB-F67692_NTE-1","NO",648,"TUMOR FREE","Alive",NA,"TCGA-VS-A9UB-F67692","TCGA-VS-A9UB",NA,"VS","A9UB","YES","C53.9","8070/3","C53.9","NO","YES",-19737,"FEMALE",NA,NA,"No","No","Alive",562,NA,NA,NA,"TUMOR FREE","YES",1,10,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2012,"Biopsy (cervical / CT-guided / Other)","YES",51,0,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bN0MX",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
47901864,47454010,2266880171,"ED9C74E6-92FC-4E58-8FCE-1761DEA0C977.bw","cb31b3ce-8595-4d75-9436-bb59e95c3a19","ed9c74e6-92fc-4e58-8fce-1761dea0c977","2016-08-09T14:41:06.787837-05:00","UNCID_2654384.78879d70-1eb8-4677-869c-a4c51e537062.141006_UNC15-SN850_0395_AC5FH9ACXX_6_GTTTCG.tar.gz","9f9d21ba-eb92-4bcd-ba9a-73e73616d3fd",2204502456,"Illumina HiSeq","abce9c92ec8aeb4575bb7dfc214c3bf4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:56:16.721105-05:00","2016-05-03T12:08:10.830175-05:00","9f9d21ba-eb92-4bcd-ba9a-73e73616d3fd_analysis.xml","f05fc6e3eb2fd78cc8b8541ddeaae109","ca061d65-60fb-4e8b-874f-76097b2570b2",2124,"2016-10-07T16:44:35.594182-05:00","9f9d21ba-eb92-4bcd-ba9a-73e73616d3fd_experiment.xml","f5b750f1e68e81a675057cd0689a9266","fe82f3be-c597-4611-a9ba-7461b6fb632c",2628,"2016-09-29T17:58:11.621716-05:00","9f9d21ba-eb92-4bcd-ba9a-73e73616d3fd_run.xml","5061e34f2c88129afdce5578215f5848","10cdae4b-0bf8-4428-a422-f01dd8c2fcaf",354,"2016-09-08T11:22:13.632478-05:00","TCGA-VS-A957","2016-09-02T18:54:15.351477-05:00","female","TCGA-VS-A957_demographic",1946,"white","4544d810-07d0-512b-8d28-89b88c81ac28","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A957_diagnosis","not reported",23585,"alive","8070/3",NA,1688,"9dc9b068-a5ae-55d3-91ad-f1bc861d7109","c53.9",-23585,"TCGA-VS-A957_treatment","471a7b1f-28f7-5fc0-bbef-8ac4dde2bcd1","01","false","TCGA-VS-A957-01A",NA,"afb4994a-f250-4a04-a918-9f32afa7044c",FALSE,"A1599777-E100-4429-8872-764AE82C9258","Primary Tumor",NA,1210,90,NA,1389830400,"11",30,"TCGA-VS-A957-01A-11",90,NA,0,NA,0,NA,15,NA,"2016-09-08T11:22:13.632478-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"778fa248-cb1b-4c79-b787-4d59e54d148f",NA,"TCGA-VS-A957-01A-01-TS1",NA,85,NA,"6dedb19f-df88-4482-92e1-7835317d0040","RNA","TCGA-VS-A957-01A-11R","88220c8f-a219-4109-9bb2-a98e0156485b",1.89,0.18,"UV Spec","R","23","TCGA-VS-A957-01A-11R-A42T-07","78879d70-1eb8-4677-869c-a4c51e537062",0.18,NA,91,37.3931623931624,156,"9c5b0835-ba7e-59a0-99fd-be2f303800d5","TCGA-VS-A957_exposure","UNCID_2654384.78879d70-1eb8-4677-869c-a4c51e537062.141006_UNC15-SN850_0395_AC5FH9ACXX_6_GTTTCG.tar.gz","2014-11-05T07:47:04.000Z","2014-11-05T07:59:07.000Z","9F9D21BA-EB92-4BCD-BA9A-73E73616D3FD","AFB4994A-F250-4A04-A918-9F32AFA7044C","Unaligned reads",2204502456,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","78879D70-1EB8-4677-869C-A4C51E537062","University of North Carolina","566073e1e4b0b37b3d98e35e","CB31B3CE-8595-4D75-9436-BB59E95C3A19","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6DEDB19F-DF88-4482-92E1-7835317D0040","2014-11-05T07:59:07.000Z","88220C8F-A219-4109-9BB2-A98E0156485B","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1210,"6DEDB19F-DF88-4482-92E1-7835317D0040",NA,"VS","UNCID_2654384.78879d70-1eb8-4677-869c-a4c51e537062.141006_UNC15-SN850_0395_AC5FH9ACXX_6_GTTTCG.tar.gz",90,"TCGA-VS-A957-01A",NA,"FE43C9DF-DCCC-4A9A-B4E6-05BD6260167D","TCGA",2010,"TCGA-VS-A957_NTE-1","Complete Remission/Response","TUMOR FREE","805CFF10-F34C-4E66-8AAE-2539AE4C5BD1",64,"nationwidechildrens.org_clinical.TCGA-VS-A957.xml","Alive",NA,"TCGA-VS-A957",NA,"79448B6A-ED3E-4C33-9A11-31A00A661151","NO",1280,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",420,NA,"D57AC135-AF2C-4BE8-B846-A30F9C9D0B2C","WHITE",NA,11,30,"778FA248-CB1B-4C79-B787-4D59E54D148F","CA32E56C-6475-44A7-84EC-2814DB814403","UNCID_2654384.78879d70-1eb8-4677-869c-a4c51e537062.141006_UNC15-SN850_0395_AC5FH9ACXX_6_GTTTCG.tar.gz","TCGA-VS-A957-01A-11",90,0,0,0,15,"TOP",0,0,"TCGA-VS-A957-01A-01-TS1",85,"Cisplatin","Chemotherapy","TCGA-VS-A957-D62800","TCGA-VS-A957-R62798","External","Regional site","TCGA-VS-A957-F72066_NTE-1","NO",1688,"TUMOR FREE","Alive",NA,"TCGA-VS-A957-F72066","TCGA-VS-A957",NA,"VS","A957","YES","C53.9","8070/3","C53.9","NO","YES",-23585,"FEMALE","WHITE",NA,"No","No","Alive",1280,NA,NA,NA,"TUMOR FREE","YES",27,5,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1NXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
138262090,135101446,6441314564,"BA732ED4-F6BA-404E-BA3C-CA558FAD866A.bw","cb695fdd-381e-4c00-836e-0ba27e32176b","ba732ed4-f6ba-404e-ba3c-ca558fad866a","2016-08-26T08:20:23.572984-05:00","UNCID_2553094.cad09fcd-1d43-4fb4-8d65-6f52c9a17d86.140416_UNC11-SN627_0353_BC42B0ACXX_2_CCGTCC.tar.gz","433ab0ee-fd95-4cfc-8ceb-c948ebdc4567",6118834611,"Illumina HiSeq","1b6c6313f2ec424fe97d733c221f425f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:48:00.384074-05:00","2016-05-03T11:54:19.885282-05:00","433ab0ee-fd95-4cfc-8ceb-c948ebdc4567_analysis.xml","a590a4e2164a9dd50602ec9736286557","7a73568c-8bf2-4cde-8137-884ad76fe0f8",2124,"2016-09-30T00:18:57.098088-05:00","433ab0ee-fd95-4cfc-8ceb-c948ebdc4567_experiment.xml","43f5e492c2a645da5939bd9a84abc7ac","fd471a85-f1ab-496b-be57-4a231ee3c655",2628,"2016-09-29T20:51:19.608290-05:00","433ab0ee-fd95-4cfc-8ceb-c948ebdc4567_run.xml","dbc6e34f08a35e7d195685428ca4fee5","7c8dada1-0d04-4d2b-aefa-7c7813d86a86",354,"2016-09-08T12:00:15.267431-05:00","TCGA-VS-A8QC","2016-09-02T19:01:20.373232-05:00","female","TCGA-VS-A8QC_demographic",1958,"white","e8410601-eed3-52e6-85f4-45d6740da62c","not reported",2009,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8QC_diagnosis","not reported",18743,"dead","8070/3",350,NA,"a57539d7-8aaa-5163-8415-bd5380bbea70","c53.9",-18743,"TCGA-VS-A8QC_treatment","ccd0b36d-287b-51ba-a3ab-9f99fb9040ab","01","false","TCGA-VS-A8QC-01A",NA,"047b9b65-ae3a-47a9-9cd5-3bbe05471c8f",FALSE,"2A1AB5DB-9963-41C6-B28F-1A26D149930C","Primary Tumor",NA,1768,40,NA,1386806400,"11",30,"TCGA-VS-A8QC-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T12:00:15.267431-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"783955bd-fe3f-4432-842f-b24d870d1b6c",NA,"TCGA-VS-A8QC-01A-01-TS1",NA,70,NA,"695634e6-17cb-41ce-8719-58a031f95744","RNA","TCGA-VS-A8QC-01A-11R","09e82beb-71c1-4175-9193-930da581b5f7",1.9,0.17,"UV Spec","R","23","TCGA-VS-A8QC-01A-11R-A37O-07","cad09fcd-1d43-4fb4-8d65-6f52c9a17d86",0.17,NA,90,38.9542936288089,152,"77eb4a62-d11f-5392-a371-9145f74dedfb","TCGA-VS-A8QC_exposure","UNCID_2553094.cad09fcd-1d43-4fb4-8d65-6f52c9a17d86.140416_UNC11-SN627_0353_BC42B0ACXX_2_CCGTCC.tar.gz","2014-07-30T21:37:04.000Z","2014-07-30T22:05:13.000Z","433AB0EE-FD95-4CFC-8CEB-C948EBDC4567","047B9B65-AE3A-47A9-9CD5-3BBE05471C8F","Unaligned reads",6118834611,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CAD09FCD-1D43-4FB4-8D65-6F52C9A17D86","University of North Carolina","564a3ca0e4b09c884b24bb84","CB695FDD-381E-4C00-836E-0BA27E32176B","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","695634E6-17CB-41CE-8719-58A031F95744","2014-07-30T22:05:13.000Z","09E82BEB-71C1-4175-9193-930DA581B5F7","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1768,"695634E6-17CB-41CE-8719-58A031F95744",NA,"VS","TCGA-VS-A8QC-01A-11R-A37P-13_mirna.bam.bai",40,"TCGA-VS-A8QC-01A",NA,"31286449-EDE9-4BC3-ADA7-30943A71494A","TCGA",2009,"TCGA-VS-A8QC_NTE-1","Progressive Disease","WITH TUMOR","6BCD780E-FF97-49FB-9084-287C61DB05E5",51,"nationwidechildrens.org_clinical.TCGA-VS-A8QC.xml","Dead",350,"TCGA-VS-A8QC",NA,NA,"YES",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Pre-Adjuvant Therapy","Stage IVA",NA,NA,"TX","8070/3","FEMALE","C53.9",380,NA,"B286FE72-2A2C-4C9C-9539-6C42D19FAF82","WHITE",NA,11,30,"783955BD-FE3F-4432-842F-B24D870D1B6C","30669DD2-76E2-4EFE-B39B-D91A458C37BB","TCGA-VS-A8QC-01A-11R-A37P-13_mirna.bam.bai","TCGA-VS-A8QC-01A-11",70,0,20,40,25,"TOP",5,20,"TCGA-VS-A8QC-01A-01-TS1",70,"Paclitaxel","Chemotherapy","TCGA-VS-A8QC-D61994","TCGA-VS-A8QC-R61995","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8QC",NA,"VS","A8QC","YES","C53.9","8070/3","C53.9","NO","YES",-18743,"FEMALE","WHITE",NA,"No","No","Dead",NA,350,NA,NA,"WITH TUMOR","YES",30,3,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,NA,NA,"Progressive Disease","2009",17,NA,"TXNXMX",NA,NA,2,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
186122872,182215319,8691535686,"E750385A-12D9-4A88-B4DF-C1306B5EF3B7.bw","cb780c10-8810-4384-b829-954aab1c16c8","e750385a-12d9-4a88-b4df-c1306b5ef3b7","2016-08-04T23:58:56.914511-05:00","UNCID_2186730.8bae571a-8285-48dd-aea3-9eb002c0610b.121011_UNC13-SN749_0197_AD16K1ACXX_2_ACAGTG.tar.gz","91442b11-9ff6-4a46-838f-0a60347d27a0",8447176788,"Illumina HiSeq","0e5d5488f01acb5eb1a12eec021fcf81","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:46:44.020237-05:00","2016-05-03T11:00:24.467501-05:00","91442b11-9ff6-4a46-838f-0a60347d27a0_analysis.xml","c63345861f416fc8623571690808ea4a","099f8caf-dfcc-4a11-b8fd-596ea2f594f2",2124,"2016-09-29T20:58:26.788560-05:00","91442b11-9ff6-4a46-838f-0a60347d27a0_experiment.xml","079c72cba60d2d635dd480e7403577ef","810820dd-fdbd-4ee8-8be8-c46853c3910f",2431,"2016-09-29T22:29:35.863939-05:00","91442b11-9ff6-4a46-838f-0a60347d27a0_run.xml","b7a09ac1e5710f95430ff677a0062899","b97b1d02-d3b4-43bb-bfd2-fa3ae14f8302",354,"2016-09-08T11:30:41.014259-05:00","TCGA-EK-A3GM","2016-09-02T18:58:47.676908-05:00","female","TCGA-EK-A3GM_demographic",1941,"white","967abeed-c34d-587b-89c9-db223e8ca613","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A3GM_diagnosis","not reported",23879,"alive","8384/3",NA,0,"5720155f-abe5-56cb-af42-d789f161aebc","c53.9",-23879,"TCGA-EK-A3GM_treatment","618b3ede-107c-5cff-81cb-eec04ffadbb6","01","false","TCGA-EK-A3GM-01A",NA,"a4b92b76-ff87-475e-924b-840f652fc019",FALSE,"15E809A3-4A09-426E-B816-C31246ECCCA4","Primary Tumor",NA,2122,120,NA,1323043200,"11",30,"TCGA-EK-A3GM-01A-11",97,NA,0,NA,0,NA,10,NA,"2016-09-08T11:30:41.014259-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"e9da4ebc-25d6-4839-ab0a-9310d0d17c29",NA,"TCGA-EK-A3GM-01A-01-TSA",NA,85,NA,"cc098412-5b8d-4cd4-8f08-f06502e4cc67","RNA","TCGA-EK-A3GM-01A-11R","fb76eda3-7adf-4c3e-98ac-7c13d52b6a51",1.87,0.17,"UV Spec","R","23","TCGA-EK-A3GM-01A-11R-A213-07","8bae571a-8285-48dd-aea3-9eb002c0610b",0.17,NA,83,36.8888888888889,150,"2a20f6d9-036a-53a1-ac1b-fda94eceebbc","TCGA-EK-A3GM_exposure","UNCID_2186730.8bae571a-8285-48dd-aea3-9eb002c0610b.121011_UNC13-SN749_0197_AD16K1ACXX_2_ACAGTG.tar.gz","2013-09-16T13:13:04.000Z","2013-09-16T14:01:01.000Z","91442B11-9FF6-4A46-838F-0A60347D27A0","A4B92B76-FF87-475E-924B-840F652FC019","Unaligned reads",8447176788,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8BAE571A-8285-48DD-AEA3-9EB002C0610B","University of North Carolina","566075bae4b0ec1099f8bd44","CB780C10-8810-4384-B829-954AAB1C16C8","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CC098412-5B8D-4CD4-8F08-F06502E4CC67","2013-09-16T14:01:01.000Z","FB76EDA3-7ADF-4C3E-98AC-7C13D52B6A51","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2122,"CC098412-5B8D-4CD4-8F08-F06502E4CC67",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E932E7D1-9C9C-446B-B772-CAA451D3A27E.txt",120,"TCGA-EK-A3GM-01A",NA,NA,"TCGA",2006,NA,NA,NA,"A4B92B76-FF87-475E-924B-840F652FC019",65,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.E932E7D1-9C9C-446B-B772-CAA451D3A27E.txt","Alive",NA,"TCGA-EK-A3GM","HISPANIC OR LATINO","6D10BF75-97D0-40DE-9D5D-D640E6F35A4A",NA,0,"No","Cervix","C53.9",NA,"Endocervical Type of Adenocarcinoma",0,"Preoperative","Stage IIA",NA,NA,NA,"8384/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"E9DA4EBC-25D6-4839-AB0A-9310D0D17C29","BEA28482-84A2-4BE1-B0F1-0556794BFB88","UNCID_2186730.8bae571a-8285-48dd-aea3-9eb002c0610b.121011_UNC13-SN749_0197_AD16K1ACXX_2_ACAGTG.tar.gz","TCGA-EK-A3GM-01A-11",97,0,0,1,10,"TOP",5,0,"TCGA-EK-A3GM-01A-01-TSA",85,NA,NA,NA,NA,NA,NA,"TCGA-EK-A3GM-F58222_NTE-1",NA,23,NA,"Alive",NA,"TCGA-EK-A3GM-F58222","TCGA-EK-A3GM",NA,"EK","A3GM","YES","C53.9","8384/3","C53.9","NO","YES",-23879,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,NA,"NO",2,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,65,2006,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,NA,"1988",10,NA,NA,NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
120945668,119688428,5716760864,"6B1DC5E4-5F82-4395-913F-6AEDB5B63188.bw","cca23650-1b06-4977-91e8-f35e73e70c48","6b1dc5e4-5f82-4395-913f-6aedb5b63188","2016-08-09T14:41:13.116931-05:00","UNCID_2654386.c9b500aa-3196-4dc2-8580-8696b6c52c4d.141006_UNC15-SN850_0395_AC5FH9ACXX_5_CGTACG.tar.gz","fe0040ec-568e-4713-afbd-d24fb9d2b273",4982481762,"Illumina HiSeq","40021286c964df3aea1c07fce7d8828b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:58:00.301855-05:00","2016-05-03T12:08:10.830175-05:00","fe0040ec-568e-4713-afbd-d24fb9d2b273_analysis.xml","581e2240372ec2f1bd21d0f1804d9236","cb17f3fb-fd45-4abb-97c8-1ac5c08da887",2123,"2016-09-29T18:19:02.736439-05:00","fe0040ec-568e-4713-afbd-d24fb9d2b273_experiment.xml","c4b0dbc731aaddab66c216302e42f15d","1dc17302-3e9c-4d0b-926d-a4b1d3ca5b5f",2628,"2016-09-30T00:06:44.128068-05:00","fe0040ec-568e-4713-afbd-d24fb9d2b273_run.xml","8379fdcf487b85e8898955548b3be18e","f5b3b802-919e-4adb-a886-ce74e30e404c",354,"2016-09-08T11:16:38.411740-05:00","TCGA-VS-A9UC","2016-09-02T18:54:20.734816-05:00","female","TCGA-VS-A9UC_demographic",1980,"not reported","fa8e4308-9991-5085-962c-6100ba9f2579","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UC_diagnosis","not reported",11790,"alive","8070/3",NA,825,"d040cf91-15be-5132-9d40-942e67fb9c14","c53.9",-11790,"TCGA-VS-A9UC_treatment","3afb4bbb-5e2f-5967-a692-6707e1a9ad3a","01","false","TCGA-VS-A9UC-01A",NA,"a771eae0-b985-413e-a509-83c9593537b2",FALSE,"F7CE1EAA-6332-4A64-88C8-3BB5905380AA","Primary Tumor",NA,370,80,NA,1390953600,"11",30,"TCGA-VS-A9UC-01A-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:16:38.411740-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e06a7ab6-584d-49c5-b5e3-34e9efc94379",NA,"TCGA-VS-A9UC-01A-01-TS1",NA,90,NA,"7d4c069d-53b8-4f4c-9e84-3abc27ec32aa","RNA","TCGA-VS-A9UC-01A-11R","5861ef93-1800-4992-8082-b63689d0e145",1.85,0.17,"UV Spec","R","23","TCGA-VS-A9UC-01A-11R-A42T-07","c9b500aa-3196-4dc2-8580-8696b6c52c4d",0.17,NA,76,32.4661454995942,153,"f99d0058-cb9c-59c2-aaea-38fa6d2529f8","TCGA-VS-A9UC_exposure","UNCID_2654386.c9b500aa-3196-4dc2-8580-8696b6c52c4d.141006_UNC15-SN850_0395_AC5FH9ACXX_5_CGTACG.tar.gz","2014-11-05T08:27:03.000Z","2014-11-05T08:40:16.000Z","FE0040EC-568E-4713-AFBD-D24FB9D2B273","A771EAE0-B985-413E-A509-83C9593537B2","Unaligned reads",4982481762,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","C9B500AA-3196-4DC2-8580-8696B6C52C4D","University of North Carolina","564a40ece4b093830b6b0c7c","CCA23650-1B06-4977-91E8-F35E73E70C48","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7D4C069D-53B8-4F4C-9E84-3ABC27EC32AA","2014-11-05T08:40:16.000Z","5861EF93-1800-4992-8082-B63689D0E145","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",370,"7D4C069D-53B8-4F4C-9E84-3ABC27EC32AA",NA,"VS","UNCID_2650830.c9b500aa-3196-4dc2-8580-8696b6c52c4d.sorted_genome_alignments.bam.bai",80,"TCGA-VS-A9UC-01A",NA,"C0D9120A-6CA4-4746-997B-0B828C421848","TCGA",2012,"TCGA-VS-A9UC_NTE-1","Stable Disease","WITH TUMOR","A771EAE0-B985-413E-A509-83C9593537B2",32,"nationwidechildrens.org_clinical.TCGA-VS-A9UC.xml","Alive",NA,"TCGA-VS-A9UC",NA,"30AE72CB-4D04-42ED-B21A-1FFE6EBC7C09","NO",511,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"F632EE3A-AF6E-442C-9E1A-4A780707202F",NA,NA,11,30,"E06A7AB6-584D-49C5-B5E3-34E9EFC94379","57E2D762-2900-4695-AA67-C51A3AE6BF6F","UNCID_2650830.c9b500aa-3196-4dc2-8580-8696b6c52c4d.sorted_genome_alignments.bam.bai","TCGA-VS-A9UC-01A-11",90,0,0,0,10,"TOP",0,0,"TCGA-VS-A9UC-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-VS-A9UC-D63478","TCGA-VS-A9UC-R63472","External","Regional site","TCGA-VS-A9UC-F68147_NTE-1","NO",691,"WITH TUMOR","Alive",NA,"TCGA-VS-A9UC-F68147","TCGA-VS-A9UC",NA,"VS","A9UC","YES","C53.9","8070/3","C53.9","NO","YES",-11790,"FEMALE",NA,NA,"No","No","Alive",511,NA,NA,NA,"WITH TUMOR","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,32,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Stable Disease","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
170026798,167058261,7972166310,"A7C12D37-FD50-4674-A054-1774F4E5C3B3.bw","ccd569e9-dcbe-4280-8c21-6bfe4ce60d7a","a7c12d37-fd50-4674-a054-1774f4e5c3b3","2016-08-05T00:29:49.907147-05:00","UNCID_2186359.48ee0be7-9c0f-4e6d-81cf-638c52beef8b.121102_UNC12-SN629_0235_AC13F5ACXX_3_GAGTGG.tar.gz","bdfd84be-3fe1-4471-aae0-16c73ab88cf4",7677723449,"Illumina HiSeq","6c9f851939f40f908cdbd67b9fa2bf06","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:38.490380-05:00","2016-05-03T11:05:42.712110-05:00","bdfd84be-3fe1-4471-aae0-16c73ab88cf4_analysis.xml","d51ff0f87f7a81737f3595dbcbab9b36","de1afa3f-7014-49ba-a859-2a0f5457a340",2124,"2016-09-29T19:57:15.299000-05:00","bdfd84be-3fe1-4471-aae0-16c73ab88cf4_experiment.xml","09ad3b249203e40429b6993e2a2142a0","5b7bd7a4-7bb3-45d0-960b-39e423eef391",2431,"2016-09-29T20:23:24.775907-05:00","bdfd84be-3fe1-4471-aae0-16c73ab88cf4_run.xml","3e433455fb7e09a8d45a15d6f0632613","6b59138f-aab5-40f4-9937-a4c4bd9360bc",354,"2016-09-08T11:59:43.062477-05:00","TCGA-EK-A2RJ","2016-09-02T18:58:28.173749-05:00","female","TCGA-EK-A2RJ_demographic",1958,"white","80da4f82-ed9b-5d26-85cf-2287e1005d2a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RJ_diagnosis","not reported",18664,"alive","8070/3",NA,53,"d364884d-dc93-5cb3-8f0a-9231aa73f157","c53.9",-18664,"TCGA-EK-A2RJ_treatment","1857ae6d-20ec-53a2-ab2d-17aa74259b73","01","false","TCGA-EK-A2RJ-01A",NA,"9492d265-9f48-4b2f-9344-a0604939b23c",FALSE,"6761746F-0149-4AE4-840F-D99B8FCEF6F5","Primary Tumor",NA,714,130,NA,1315785600,"11",30,"TCGA-EK-A2RJ-01A-11",70,NA,0,NA,0,NA,2,NA,"2016-09-08T11:59:43.062477-05:00",NA,20,NA,5,NA,"TOP",NA,12,NA,"e2452d4d-be00-4930-a06d-568ee8e34502",NA,"TCGA-EK-A2RJ-01A-01-TS1",NA,86,NA,"b946f3de-0f4a-4d7a-bc3b-6909ad5b7b1f","RNA","TCGA-EK-A2RJ-01A-11R","f1cddfcd-b1d7-472c-be14-c283515ff011",1.74,0.18,"UV Spec","R","23","TCGA-EK-A2RJ-01A-11R-A18M-07","48ee0be7-9c0f-4e6d-81cf-638c52beef8b",0.18,NA,85,32.3883554336229,162,"3b378038-ed27-5dfb-8447-1b1096a6e7ac","TCGA-EK-A2RJ_exposure","UNCID_2186359.48ee0be7-9c0f-4e6d-81cf-638c52beef8b.121102_UNC12-SN629_0235_AC13F5ACXX_3_GAGTGG.tar.gz","2013-09-19T07:26:04.000Z","2013-09-19T07:47:01.000Z","BDFD84BE-3FE1-4471-AAE0-16C73AB88CF4","9492D265-9F48-4B2F-9344-A0604939B23C","Unaligned reads",7677723449,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","48EE0BE7-9C0F-4E6D-81CF-638C52BEEF8B","University of North Carolina","564a3fb2e4b0298dd2c9c932","CCD569E9-DCBE-4280-8C21-6BFE4CE60D7A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B946F3DE-0F4A-4D7A-BC3B-6909AD5B7B1F","2013-09-19T07:47:01.000Z","F1CDDFCD-B1D7-472C-BE14-C283515FF011","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",714,"B946F3DE-0F4A-4D7A-BC3B-6909AD5B7B1F",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.23F28333-7FA9-41C6-8039-57739EC99A30.txt",130,"TCGA-EK-A2RJ-01A",NA,NA,"TCGA",2009,NA,NA,NA,"9492D265-9F48-4B2F-9344-A0604939B23C",51,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.23F28333-7FA9-41C6-8039-57739EC99A30.txt","Alive",NA,"TCGA-EK-A2RJ","NOT HISPANIC OR LATINO","3F70386C-1795-4493-89F1-E35A0B23CB94",NA,NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"E2452D4D-BE00-4930-A06D-568EE8E34502","F1CDDFCD-B1D7-472C-BE14-C283515FF011","889a1fa97c05824c916621c92b1ffb36.bam.bai","TCGA-EK-A2RJ-01A-11",70,0,0,20,2,"TOP",12,5,"TCGA-EK-A2RJ-01A-01-TS1",86,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RJ-F58265_NTE-1",NA,NA,NA,"Alive",NA,"TCGA-EK-A2RJ-F58265","TCGA-EK-A2RJ",NA,"EK","A2RJ","YES","C53.9","8070/3","C53.9","NO","YES",-18664,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",53,NA,NA,NA,"TUMOR FREE","NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2009,"Biopsy (cervical / CT-guided / Other)","YES",22,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",8,NA,"T1b2N0MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
120459186,94037934,4443557653,"2155C764-2063-4D9C-9ACD-96AA73475F5E.bw","ce5765fb-5221-4cbf-aa76-bb863803df57","2155c764-2063-4d9c-9acd-96aa73475f5e","2016-08-25T06:56:36.357271-05:00","UNCID_2520210.01d666b4-9605-422a-bfba-231b0d6ef20f.140417_UNC13-SN749_0342_AC41N6ACXX_8_ATGTCA.tar.gz","bf2f7756-9821-4069-bd44-6e46b78e92d2",4778582367,"Illumina HiSeq","1f65dff2f610ce0acdc7791e4fa97224","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:49:06.762307-05:00","2016-05-03T11:51:27.506016-05:00","bf2f7756-9821-4069-bd44-6e46b78e92d2_analysis.xml","231f156c2e6dca1e3b90941bbdce01c8","30ce47e2-5137-44bd-95b7-e94074e679ae",2124,"2016-09-29T21:05:40.528312-05:00","bf2f7756-9821-4069-bd44-6e46b78e92d2_experiment.xml","890971b4150e65b1992cffe25fb951be","85916edb-41ea-43d9-aadc-0a69f8df95c4",2628,"2016-09-29T19:15:48.826092-05:00","bf2f7756-9821-4069-bd44-6e46b78e92d2_run.xml","24fe551c4ca0b8eb7120fc0b2c1ad459","41a25209-835c-4de9-b010-13367fd39800",354,"2016-09-08T12:10:19.274244-05:00","TCGA-C5-A7UI","2016-09-02T19:00:59.189965-05:00","female","TCGA-C5-A7UI_demographic",1962,"black or african american","552b8b51-bc06-5c36-ba18-02db1c1c8389","not hispanic or latino",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7UI_diagnosis","not reported",15349,"dead","8072/3",2888,NA,"728414b3-3e02-5872-b2a5-fb0e4173861a","c53.9",-15349,"TCGA-C5-A7UI_treatment","47188a5e-f1a6-5d53-9be9-438c7c3c427b","01","true","TCGA-C5-A7UI-01A",NA,"24ea2d5e-66d2-479b-8be6-ae59336876df",FALSE,"A07E7AF1-55EA-4EA1-A5DA-A54E17771CA9","Primary Tumor",NA,3221,20,NA,1381363200,"11",20,"TCGA-C5-A7UI-01A-11",95,NA,0,NA,0,NA,15,NA,"2016-09-08T12:10:19.274244-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"1562cd02-e256-4a05-823f-d7aed1b882eb",NA,"TCGA-C5-A7UI-01A-01-TS1",NA,80,NA,"b7489af5-7dc1-480c-abdc-726b11ee7075","RNA","TCGA-C5-A7UI-01A-11R","b1bd32d7-a81d-440e-82cf-e4d276cdb3ec",1.83,0.17,"UV Spec","R","23","TCGA-C5-A7UI-01A-11R-A36F-07","01d666b4-9605-422a-bfba-231b0d6ef20f",0.17,0.657534246575342,86,NA,NA,"8bf97167-5a93-5b66-ad14-94fec284564e","TCGA-C5-A7UI_exposure","UNCID_2520210.01d666b4-9605-422a-bfba-231b0d6ef20f.140417_UNC13-SN749_0342_AC41N6ACXX_8_ATGTCA.tar.gz","2014-07-09T22:06:04.000Z","2014-07-09T22:29:07.000Z","BF2F7756-9821-4069-BD44-6E46B78E92D2","24EA2D5E-66D2-479B-8BE6-AE59336876DF","Unaligned reads",4778582367,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","01D666B4-9605-422A-BFBA-231B0D6EF20F","University of North Carolina","5660765ae4b0b37b3d99039f","CE5765FB-5221-4CBF-AA76-BB863803DF57","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B7489AF5-7DC1-480C-ABDC-726B11EE7075","2014-07-09T22:29:07.000Z","B1BD32D7-A81D-440E-82CF-E4D276CDB3EC","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3221,"B7489AF5-7DC1-480C-ABDC-726B11EE7075",NA,"C5","TCGA-C5-A7UI-01A-11R-A36A-13_mirna.bam",20,"TCGA-C5-A7UI-01A",NA,NA,"TCGA",2004,"TCGA-C5-A7UI_NTE-1",NA,"TUMOR FREE","60420A95-E90B-4441-9E9C-0F3F7DF129BD",42,"nationwidechildrens.org_clinical.TCGA-C5-A7UI.xml","Dead",2888,"TCGA-C5-A7UI","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",373,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,20,"1562CD02-E256-4A05-823F-D7AED1B882EB","B25A0337-A4FA-475E-B645-A68F0BBAB97F","TCGA-C5-A7UI-01A-11R-A36A-13_mirna.bam","TCGA-C5-A7UI-01A-11",95,0,0,0,15,"TOP",5,0,"TCGA-C5-A7UI-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7UI",NA,"C5","A7UI","YES","C53.9","8072/3","C53.9","NO","YES",-15349,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,2888,NA,NA,"TUMOR FREE","YES",1,4,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2004,"Biopsy (cervical / CT-guided / Other)","YES",24,0,"G3",NA,2,NA,12,NA,NA,"1995",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132283382,130178361,6213149833,"DE23CC15-A95E-4119-9B3C-8EEC45900D11.bw","cecaecb4-51ef-407d-a882-0e4b444b0a77","de23cc15-a95e-4119-9b3c-8eec45900d11","2016-09-29T23:28:41.896671-05:00","UNCID_2553105.6cec0faf-100b-48b0-9221-fb1be7ff8597.140408_UNC11-SN627_0351_AC3KY3ACXX_2_CTTGTA.tar.gz","a365f46e-389f-4449-9302-1fb594dae64d",5820619434,"Illumina HiSeq","3caafd53c70a33eff3b45023c5c6379f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:33:57.131377-05:00","2016-05-03T11:54:19.908545-05:00","a365f46e-389f-4449-9302-1fb594dae64d_analysis.xml","53d5c0e617b6ba330317bc4c814204bd","01699182-a425-4c0c-8b00-0fe805e933d8",2124,"2016-09-29T20:49:02.643365-05:00","a365f46e-389f-4449-9302-1fb594dae64d_experiment.xml","aef8c81821ce33e5df5e7e4e92b1c1d7","7b1cf515-4044-43ae-82c1-6443caa3ee57",2628,"2016-09-29T21:28:30.287904-05:00","a365f46e-389f-4449-9302-1fb594dae64d_run.xml","2c9f1ba1e9d52742bee0d434fd0c3cb4","93da8814-dbce-4ab0-a2a6-a8ccdd147b7b",354,"2016-09-08T12:20:01.871886-05:00","TCGA-C5-A8YT","2016-09-02T19:01:10.177160-05:00","female","TCGA-C5-A8YT_demographic",1972,"white","6526c401-17b9-5ab2-9cc1-b80a60a96166","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8YT_diagnosis","not reported",13253,"dead","8070/3",633,186,"6277c2b7-0ad0-5736-b86f-c97111087da6","c53.9",-13253,"TCGA-C5-A8YT_treatment","cb328b4c-cbf0-5847-9d28-ae3679c21998","01","true","TCGA-C5-A8YT-01A",NA,"289e659b-b352-49e5-ae7c-02f5914e8876",FALSE,"78E3AF70-E5A9-4A7F-ABD1-4E08238EAB9D","Primary Tumor",NA,1939,50,NA,1387411200,"11",30,"TCGA-C5-A8YT-01A-11",75,NA,1,NA,10,NA,15,NA,"2016-09-08T12:20:01.871886-05:00",NA,5,NA,1,NA,"TOP",NA,0,NA,"2790a50c-9192-4018-833e-01d2e8f8cf83",NA,"TCGA-C5-A8YT-01A-01-TS1",NA,75,NA,"33098fb4-e556-4e2f-b82a-be703680a8c1","RNA","TCGA-C5-A8YT-01A-11R","716461f3-8e8d-4df5-a6dc-9d7e77f4510d",1.84,0.18,"UV Spec","R","23","TCGA-C5-A8YT-01A-11R-A37O-07","6cec0faf-100b-48b0-9221-fb1be7ff8597",0.18,1.0958904109589,NA,NA,NA,"ea25cbfa-69e7-55bd-98bd-103f5a7e1971","TCGA-C5-A8YT_exposure","UNCID_2553105.6cec0faf-100b-48b0-9221-fb1be7ff8597.140408_UNC11-SN627_0351_AC3KY3ACXX_2_CTTGTA.tar.gz","2014-07-30T23:36:04.000Z","2014-07-30T23:59:07.000Z","A365F46E-389F-4449-9302-1FB594DAE64D","289E659B-B352-49E5-AE7C-02F5914E8876","Unaligned reads",5820619434,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6CEC0FAF-100B-48B0-9221-FB1BE7FF8597","University of North Carolina","56607632e4b018727fea08d7","CECAECB4-51EF-407D-A882-0E4B444B0A77","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","33098FB4-E556-4E2F-B82A-BE703680A8C1","2014-07-30T23:59:07.000Z","716461F3-8E8D-4DF5-A6DC-9D7E77F4510D","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",1939,"33098FB4-E556-4E2F-B82A-BE703680A8C1",NA,"C5","TCGA-C5-A8YT-01A-11R-A37P-13_mirna.bam",50,"TCGA-C5-A8YT-01A",NA,"023568BE-29CA-47DC-A39F-9E562969725B","TCGA",2008,"TCGA-C5-A8YT_NTE-1",NA,"WITH TUMOR","575DF574-6342-4C62-933F-BC44BE4A0633",36,"nationwidechildrens.org_clinical.TCGA-C5-A8YT.xml","Alive",NA,"TCGA-C5-A8YT","NOT HISPANIC OR LATINO","9883E718-B278-4F06-ACF6-5DDCFD26F1DD","NO",186,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"BE6A194A-440E-4C26-AE60-168DE9ABC978","WHITE",NA,11,30,"2790A50C-9192-4018-833E-01D2E8F8CF83","B509923C-2C5B-46C8-A45A-F20B5D8EE3B1","TCGA-C5-A8YT-01A-11R-A37P-13_mirna.bam","TCGA-C5-A8YT-01A-11",75,10,1,5,15,"TOP",0,1,"TCGA-C5-A8YT-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-C5-A8YT-D58633","TCGA-C5-A8YT-R58635","External","Regional site","TCGA-C5-A8YT-F66723_NTE-1",NA,NA,"WITH TUMOR","Dead",633,"TCGA-C5-A8YT-F66723","TCGA-C5-A8YT",NA,"C5","A8YT","YES","C53.9","8070/3","C53.9","NO","YES",-13253,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",186,NA,NA,NA,"WITH TUMOR","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,36,2008,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,2,NA,20,NA,NA,"1995",7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
110735410,108947009,5195594219,"5DB1DCAD-638E-48A4-9F40-3D6268FDEC33.bw","cef2efb2-93cc-4bdf-a343-9965e7e0432c","5db1dcad-638e-48a4-9f40-3d6268fdec33","2016-08-05T11:10:32.401059-05:00","UNCID_2169265.6cf2bd67-93bd-449e-9204-5ac5f75cbfd1.130606_UNC9-SN296_0372_AC277JACXX_3_ATCACG.tar.gz","21a0d80b-8516-45a6-a325-4dc215782310",5347588510,"Illumina HiSeq","96a455071f9a612502eba2625db9aa77","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:47.419435-05:00","2016-05-03T11:05:42.727154-05:00","21a0d80b-8516-45a6-a325-4dc215782310_analysis.xml","c32416782da9cf821a1874c42ec75fa2","31d83f22-bf6d-47ff-a5d3-1022753ecbce",2121,"2016-09-29T21:25:24.778721-05:00","21a0d80b-8516-45a6-a325-4dc215782310_experiment.xml","5fecf6ab74d1042a0e4ff43ec0793ec7","91dd7291-bff2-46d5-b8be-6f41896e8a21",2431,"2016-09-29T23:34:14.507212-05:00","21a0d80b-8516-45a6-a325-4dc215782310_run.xml","0791fdbd92611dd1ddeea961e6fd49b4","e1a55a87-f35c-43da-8aae-d5e2c245a73e",354,"2016-09-08T11:31:45.971161-05:00","TCGA-MY-A5BD","2016-09-02T18:59:47.708484-05:00","female","TCGA-MY-A5BD_demographic",1948,"white","41a40228-9d9f-589a-87c2-062494ddce34","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MY","06424429-c5cd-5c57-9e26-68966e407b26","Montefiore Medical Center","not reported","c53.9","TCGA-MY-A5BD_diagnosis","not reported",22901,"alive","8070/3",NA,1667,"a6af7911-c1a7-5417-9bda-d7e512f87a15","c53.9",-22901,"TCGA-MY-A5BD_treatment","e0250bfc-a01c-51ee-8841-85a8df999630","01","true","TCGA-MY-A5BD-01A",NA,"e182da4d-0421-44d4-b954-7b616b84762a",FALSE,"4BCA8C55-997E-4700-A12C-B520575C3608","Primary Tumor",NA,983,10,NA,1356566400,"11",10,"TCGA-MY-A5BD-01A-11",90,NA,10,NA,0,NA,10,NA,"2016-09-08T11:31:45.971161-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"98dbe7d7-9aa8-4626-9262-9e743c4c73ac",NA,"TCGA-MY-A5BD-01A-01-TS1",NA,90,NA,"c9aa79ca-6d00-4ff9-baea-9c8a9b409495","RNA","TCGA-MY-A5BD-01A-11R","9eaa4641-97e9-47c4-bf03-eced5d60930b",1.83,0.17,"UV Spec","R","23","TCGA-MY-A5BD-01A-11R-A26T-07","6cf2bd67-93bd-449e-9204-5ac5f75cbfd1",0.17,NA,91,36.9183334009493,157,"ed757411-2187-5dbc-8c1c-9e0a89832b97","TCGA-MY-A5BD_exposure","UNCID_2169265.6cf2bd67-93bd-449e-9204-5ac5f75cbfd1.130606_UNC9-SN296_0372_AC277JACXX_3_ATCACG.tar.gz","2013-09-19T23:01:04.000Z","2013-09-19T23:17:02.000Z","21A0D80B-8516-45A6-A325-4DC215782310","E182DA4D-0421-44D4-B954-7B616B84762A","Unaligned reads",5347588510,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6CF2BD67-93BD-449E-9204-5AC5F75CBFD1","University of North Carolina","566073a7e4b0b37b3d98e01e","CEF2EFB2-93CC-4BDF-A343-9965E7E0432C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C9AA79CA-6D00-4FF9-BAEA-9C8A9B409495","2013-09-19T23:17:02.000Z","9EAA4641-97E9-47C4-BF03-ECED5D60930B","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",983,"C9AA79CA-6D00-4FF9-BAEA-9C8A9B409495",NA,"MY","7c40e34864e2b2d13177e80096f38143.bam.bai",10,"TCGA-MY-A5BD-01A",NA,"6E4581C1-EB5C-493C-8EEC-E6B8ECE74BB5","TCGA",2010,"TCGA-MY-A5BD_NTE-1",NA,"TUMOR FREE","E182DA4D-0421-44D4-B954-7B616B84762A",62,"nationwidechildrens.org_clinical.TCGA-MY-A5BD.xml","Alive",NA,"TCGA-MY-A5BD","HISPANIC OR LATINO","E8AC2DF3-EC67-44C8-BD56-D7B26ECA878B","NO",904,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",280,NA,"0EA875DA-9A41-4E7C-8DFA-A146245D620B","WHITE",NA,11,10,"98DBE7D7-9AA8-4626-9262-9E743C4C73AC","9EAA4641-97E9-47C4-BF03-ECED5D60930B","7c40e34864e2b2d13177e80096f38143.bam.bai","TCGA-MY-A5BD-01A-11",90,0,10,40,10,"TOP",0,20,"TCGA-MY-A5BD-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-MY-A5BD-D67175","TCGA-MY-A5BD-R67176","External","Primary Tumor Field","TCGA-MY-A5BD-F67085_NTE-1","NO",1667,"TUMOR FREE","Alive",NA,"TCGA-MY-A5BD-F67085","TCGA-MY-A5BD",NA,"MY","A5BD","YES","C53.9","8070/3","C53.9","NO","YES",-22901,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",904,NA,NA,NA,"TUMOR FREE","YES",20,5,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,62,2010,"Biopsy (cervical / CT-guided / Other)","YES",26,0,"G1",NA,1,NA,NA,NA,NA,"2009",13,NA,"T2bN0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
134164504,131350919,6224544543,"34AF0341-73D7-4080-AAEB-4C1541C2569F.bw","cfb61fd8-0bca-40b4-878c-cc914a289792","34af0341-73d7-4080-aaeb-4c1541c2569f","2016-08-05T23:40:59.346339-05:00","UNCID_2170056.41c1975d-219d-4131-a77e-e70224ed6c41.130530_UNC9-SN296_0371_BC2528ACXX_3_TTAGGC.tar.gz","d9706838-1a8b-4421-ba43-f2a4c563ebe8",6554845312,"Illumina HiSeq","620d0b42c61f23da266f5da84b24a613","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:18:38.645319-05:00","2016-05-03T11:05:42.727154-05:00","d9706838-1a8b-4421-ba43-f2a4c563ebe8_analysis.xml","8a542f931feacd12f096ec82d13a2e99","4366c472-88b7-45ed-908d-923ec88ac12b",2121,"2016-08-13T04:18:11.472192-05:00","d9706838-1a8b-4421-ba43-f2a4c563ebe8_experiment.xml","2a846892bd58159c4bbd10957725f222","d411f840-a0fa-469c-8852-7c093a63fffb",2431,"2016-09-29T21:25:30.684818-05:00","d9706838-1a8b-4421-ba43-f2a4c563ebe8_run.xml","db005dc54eaa40aa0129432d86cb380d","91ea581d-35cc-42e9-853b-c52e019fa65f",354,"2016-09-08T11:26:56.409277-05:00","TCGA-EA-A44S","2016-09-02T18:59:42.592037-05:00","female","TCGA-EA-A44S_demographic",1981,"white","08df13dd-bfa3-5adc-94ed-c8e977a5a7eb","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A44S_diagnosis","not reported",11621,"alive","8070/3",NA,369,"7fddcb2f-2f7f-5ad0-b352-a1b6c7965e5d","c53.9",-11621,"TCGA-EA-A44S_treatment","03e7f850-3262-5670-8710-2d2a35edb2d8","01","true","TCGA-EA-A44S-01A",NA,"0d96e0b0-5abd-4528-a733-354308e0cfef",FALSE,"25D56763-173A-4F45-AA4E-118382CD2296","Primary Tumor",NA,120,1200,NA,1346803200,"12",30,"TCGA-EA-A44S-01A-12",70,NA,5,NA,10,NA,0,NA,"2016-09-08T11:26:56.409277-05:00",NA,5,NA,1,NA,"TOP",NA,0,NA,"f4411c4a-b100-48f8-a94b-ceb2c137dd7d",NA,"TCGA-EA-A44S-01A-01-TSA",NA,90,NA,"7922d888-777c-4337-85a6-82a10e0a12b5","RNA","TCGA-EA-A44S-01A-12R","e1e13880-c5de-4388-95c6-d0135e21c9d9",1.81,0.18,"UV Spec","R","23","TCGA-EA-A44S-01A-12R-A26T-07","41c1975d-219d-4131-a77e-e70224ed6c41",0.18,NA,83,25.0573602221954,182,"53055aa0-8518-58be-b063-739e77c7893b","TCGA-EA-A44S_exposure","UNCID_2170056.41c1975d-219d-4131-a77e-e70224ed6c41.130530_UNC9-SN296_0371_BC2528ACXX_3_TTAGGC.tar.gz","2013-09-19T22:26:06.000Z","2013-09-19T22:49:02.000Z","D9706838-1A8B-4421-BA43-F2A4C563EBE8","0D96E0B0-5ABD-4528-A733-354308E0CFEF","Unaligned reads",6554845312,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","41C1975D-219D-4131-A77E-E70224ED6C41","University of North Carolina","564a3ae8e4b0ef12181a480d","CFB61FD8-0BCA-40B4-878C-CC914A289792","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7922D888-777C-4337-85A6-82A10E0A12B5","2013-09-19T22:49:02.000Z","E1E13880-C5DE-4388-95C6-D0135E21C9D9","Ukraine","NO",1,NA,"Primary Tumor","Asterand",120,"7922D888-777C-4337-85A6-82A10E0A12B5",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DA2D285B-32D4-475C-8195-DCEF5563578C.txt",1200,"TCGA-EA-A44S-01A",NA,"D4AEB293-B03B-47C2-A043-2EF0415A0447","TCGA",2012,"TCGA-EA-A44S_NTE-1",NA,"TUMOR FREE","110B220D-ED23-483D-9F5A-EB6401BC78E7",31,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.DA2D285B-32D4-475C-8195-DCEF5563578C.txt","Alive",NA,"TCGA-EA-A44S","NOT HISPANIC OR LATINO",NA,"NO",9,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"T2a2","8070/3","FEMALE","C53.9",280,NA,"A7674A6E-6C1A-42FC-88F0-4E9DF994CC18","WHITE",NA,12,30,"F4411C4A-B100-48F8-A94B-CEB2C137DD7D","E1E13880-C5DE-4388-95C6-D0135E21C9D9","ENDUE_p_TCGA_271_76_79_280_81_N_GenomeWideSNP_6_H06_1346848.hg18.seg.txt","TCGA-EA-A44S-01A-12",70,10,5,5,0,"TOP",0,1,"TCGA-EA-A44S-01A-01-TSA",90,"Doxorubicin","Chemotherapy","TCGA-EA-A44S-D49905","TCGA-EA-A44S-R49900","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-EA-A44S",NA,"EA","A44S","YES","C53.9","8070/3","C53.9","YES","NO",-11621,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",9,NA,NA,NA,"TUMOR FREE","YES",19,12,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,31,2012,"Biopsy (cervical / CT-guided / Other)","YES",10,4,"G2",NA,1,NA,NA,NA,NA,"2009",16,NA,"T2a2N1M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
137415934,133766245,6377987221,"B60D4235-44AF-4BA4-98C0-BCCDC28E90B9.bw","d02ffaa9-0403-4a89-be01-cce35c80dd69","b60d4235-44af-4ba4-98c0-bccdc28e90b9","2016-08-26T06:23:36.105083-05:00","UNCID_2449532.5f6b58e1-df96-4c94-aa88-e4f23339794c.140304_UNC14-SN744_0400_AC3LWGACXX_2_ATGTCA.tar.gz","f157608c-b95d-4e37-9257-a1574c65a8f4",6065998394,"Illumina HiSeq","b6f16facde951370d023b07901aa6709","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:21:19.982025-05:00","2016-05-03T11:44:58.595833-05:00","f157608c-b95d-4e37-9257-a1574c65a8f4_analysis.xml","1d8a4f6823a7edecf38ac7e31ef2db17","1f210084-365b-4e26-9816-2cd6d86af7f7",2124,"2016-09-29T18:49:05.876192-05:00","f157608c-b95d-4e37-9257-a1574c65a8f4_experiment.xml","0c3cf846261bb81f405dd9940890c2a4","30cbb5ef-e1d8-4c35-8146-dfd417f414db",2628,"2016-09-29T23:32:24.659741-05:00","f157608c-b95d-4e37-9257-a1574c65a8f4_run.xml","f6562a64333d7943ff8726f36c1586e4","e08dc7d9-76fc-4fc9-bbb5-3b2a11c1cce2",354,"2016-09-08T11:22:22.303249-05:00","TCGA-DS-A7WF","2016-09-02T19:00:54.787163-05:00","female","TCGA-DS-A7WF_demographic",1965,"not reported","992b032a-e1b4-5551-a8ce-e937f78d0a9d","hispanic or latino",2007,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A7WF_diagnosis","not reported",15319,"dead","8560/3",492,NA,"2d18d71e-5945-5438-9f15-999d81b2b6bb","c53.9",-15319,"TCGA-DS-A7WF_treatment","9e1dfd7f-8ad5-52a7-90b4-0aff097a7a81","01","true","TCGA-DS-A7WF-01A",NA,"14c03e34-5e97-42f5-9789-2a92fb8bbcf3",FALSE,"0C2D7B64-5F80-4F95-BCFC-D550A9674A2E","Primary Tumor",NA,2483,230,NA,1381449600,"11",30,"TCGA-DS-A7WF-01A-11",90,NA,20,NA,0,NA,10,NA,"2016-09-08T11:22:22.303249-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"3e5926d1-9d6f-46f1-a68d-098e238ab580",NA,"TCGA-DS-A7WF-01A-01-TSA",NA,90,NA,"09fcf82b-8d9d-449d-8370-f79727848344","RNA","TCGA-DS-A7WF-01A-11R","b5228ecb-4a46-42c7-94b2-8d651092f1ac",1.9,0.17,"UV Spec","R","23","TCGA-DS-A7WF-01A-11R-A352-07","5f6b58e1-df96-4c94-aa88-e4f23339794c",0.17,0.383561643835616,63,24.609375,160,"6f6d1283-bef5-5ea3-b267-1d9a59dcc61f","TCGA-DS-A7WF_exposure","UNCID_2449532.5f6b58e1-df96-4c94-aa88-e4f23339794c.140304_UNC14-SN744_0400_AC3LWGACXX_2_ATGTCA.tar.gz","2014-05-09T11:33:03.000Z","2014-05-09T12:13:01.000Z","F157608C-B95D-4E37-9257-A1574C65A8F4","14C03E34-5E97-42F5-9789-2A92FB8BBCF3","Unaligned reads",6065998394,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5F6B58E1-DF96-4C94-AA88-E4F23339794C","University of North Carolina","564a3beee4b093830b697049","D02FFAA9-0403-4A89-BE01-CCE35C80DD69","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","09FCF82B-8D9D-449D-8370-F79727848344","2014-05-09T12:13:01.000Z","B5228ECB-4A46-42C7-94B2-8D651092F1AC","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",2483,"09FCF82B-8D9D-449D-8370-F79727848344",NA,"DS","UNCID_2396519.5f6b58e1-df96-4c94-aa88-e4f23339794c.sorted_genome_alignments.bam.bai",230,"TCGA-DS-A7WF-01A",NA,"6BBFFE71-CD5D-4340-89B0-709C35F6FA63","TCGA",2006,"TCGA-DS-A7WF_NTE-3","Partial Remission/Response","WITH TUMOR","2D83B77B-9140-4554-A436-E43C1F36DC98",41,"nationwidechildrens.org_clinical.TCGA-DS-A7WF.xml","Dead",492,"TCGA-DS-A7WF","HISPANIC OR LATINO","DAF85478-51B5-40D7-BF0B-2B8C95C588B2","YES",NA,"No","Cervix","C53.9","N0","Adenosquamous",1,"Preoperative","Stage IB2",NA,NA,"T1b2","8560/3","FEMALE","C53.9",361,NA,"251B0201-5008-4AD0-8B75-62A6B717952A",NA,NA,11,30,"3E5926D1-9D6F-46F1-A68D-098E238AB580","EC2A7860-CB10-4476-AD00-1395D874120E","UNCID_2396519.5f6b58e1-df96-4c94-aa88-e4f23339794c.sorted_genome_alignments.bam.bai","TCGA-DS-A7WF-01A-11",90,0,20,40,10,"TOP",0,20,"TCGA-DS-A7WF-01A-01-TSA",90,"Cisplatin","Chemotherapy","TCGA-DS-A7WF-D54752","TCGA-DS-A7WF-R54759",NA,"Primary Tumor Field","TCGA-DS-A7WF-F54754_NTE-3","YES",NA,"WITH TUMOR","Dead",492,"TCGA-DS-A7WF-F54754","TCGA-DS-A7WF",NA,"DS","A7WF","YES","C53.9","8560/3","C53.9","NO","YES",-15319,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Dead",NA,492,NA,NA,"WITH TUMOR","YES",23,12,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Adenosquamous",NA,0,41,2006,"Biopsy (cervical / CT-guided / Other)","YES",23,0,"G3",NA,2,NA,7,NA,"Partial Remission/Response","1995",8,NA,"T1b2N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
183379806,179422923,8560126979,"CF463D89-2C9F-4257-BF04-8BC1CD40EA7D.bw","d07d0a56-a25e-426b-8384-9d49e6545527","cf463d89-2c9f-4257-bf04-8bc1cd40ea7d","2016-08-05T10:29:23.765971-05:00","UNCID_2186737.6878010a-30d5-44ef-bd70-99f532a584d5.121011_UNC13-SN749_0197_AD16K1ACXX_1_CGATGT.tar.gz","b2424505-daf1-4d2f-bac9-85505fd4081d",8084940756,"Illumina HiSeq","9a1815a3c71f21f2cbe2b51afde98e65","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:40:53.743775-05:00","2016-05-03T11:00:24.467501-05:00","b2424505-daf1-4d2f-bac9-85505fd4081d_analysis.xml","25845e3d4bcf531e3ca6b56889e1f9d1","05ca73da-10cc-42e3-9ea6-47c440f13d8d",2124,"2016-09-29T21:37:09.607259-05:00","b2424505-daf1-4d2f-bac9-85505fd4081d_experiment.xml","7a00812e3248e95eff8f4064e952be86","991bf829-4760-43a8-a09b-24518ced316c",2431,"2016-09-29T17:39:23.273081-05:00","b2424505-daf1-4d2f-bac9-85505fd4081d_run.xml","a88fa069e89f0edac147e1b32a2de506","04c936ce-99df-43d7-b708-99e0c654c867",354,"2016-09-08T12:45:49.399487-05:00","TCGA-EK-A3GK","2016-09-02T18:58:46.357543-05:00","female","TCGA-EK-A3GK_demographic",1976,"white","e7124302-dec0-5ed2-942d-e266af06dc9d","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A3GK_diagnosis","not reported",12207,"alive","8384/3",NA,15,"81e79cf3-5412-5726-b883-1b3ce6ed1cd0","c53.9",-12207,"TCGA-EK-A3GK_treatment","2fc5c58c-2c6c-5dff-86af-68ee28fa98c1","01","false","TCGA-EK-A3GK-01A",NA,"f9371b06-c6e5-4363-bdaa-bd85f95a01c4",FALSE,"FA43F625-0F3A-4CAD-B55D-A00113DEA927","Primary Tumor",NA,744,90,NA,1323043200,"11",30,"TCGA-EK-A3GK-01A-11",96,NA,0,NA,0,NA,2,NA,"2016-09-08T12:45:49.399487-05:00",NA,1,NA,0,NA,"TOP",NA,2,NA,"1dbdc040-f79f-4892-8a00-6efd60f5f4c2",NA,"TCGA-EK-A3GK-01A-01-TSA",NA,96,NA,"0103f635-0471-48ef-a4a2-964d4789a216","RNA","TCGA-EK-A3GK-01A-11R","c71cb510-1272-4ed4-af40-e0a9e98e4314",1.86,0.18,"UV Spec","R","23","TCGA-EK-A3GK-01A-11R-A213-07","6878010a-30d5-44ef-bd70-99f532a584d5",0.18,NA,73,26.8135904499541,165,"0da6b6fc-cf26-5f33-9776-9d6971effdcb","TCGA-EK-A3GK_exposure","UNCID_2186737.6878010a-30d5-44ef-bd70-99f532a584d5.121011_UNC13-SN749_0197_AD16K1ACXX_1_CGATGT.tar.gz","2013-09-16T13:36:04.000Z","2013-09-16T14:03:02.000Z","B2424505-DAF1-4D2F-BAC9-85505FD4081D","F9371B06-C6E5-4363-BDAA-BD85F95A01C4","Unaligned reads",8084940756,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","6878010A-30D5-44EF-BD70-99F532A584D5","University of North Carolina","564a3f8be4b093830b6a9925","D07D0A56-A25E-426B-8384-9D49E6545527","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0103F635-0471-48EF-A4A2-964D4789A216","2013-09-16T14:03:02.000Z","C71CB510-1272-4ED4-AF40-E0A9E98E4314","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",744,"0103F635-0471-48EF-A4A2-964D4789A216",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.84DFB78B-2D19-4F71-BCB0-F7A141BC6690.txt",90,"TCGA-EK-A3GK-01A",NA,NA,"TCGA",2009,NA,NA,NA,"F9371B06-C6E5-4363-BDAA-BD85F95A01C4",33,"nationwidechildrens.org_clinical.TCGA-EK-A3GK.xml","Alive",NA,"TCGA-EK-A3GK","NOT HISPANIC OR LATINO","42226CB4-3D23-416E-801F-55BDC325783D",NA,3,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"1DBDC040-F79F-4892-8A00-6EFD60F5F4C2","B6C30C68-713F-4E04-AD71-C96F7216FEB5","OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_B12_955422.tangent.copynumber.data.txt","TCGA-EK-A3GK-01A-11",96,0,0,1,2,"TOP",2,0,"TCGA-EK-A3GK-01A-01-TSA",96,NA,NA,NA,NA,NA,NA,"TCGA-EK-A3GK-F58272_NTE-1",NA,15,NA,"Alive",NA,"TCGA-EK-A3GK-F58272","TCGA-EK-A3GK",NA,"EK","A3GK","YES","C53.9","8384/3","C53.9","NO","YES",-12207,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",15,NA,NA,NA,"TUMOR FREE","NO",2,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,33,2009,"Other method, specify:","YES",22,0,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,"T1b1N0MX",NA,NA,0,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
150333512,148557153,7094005694,"EF6C8165-484A-4530-AEDF-93DCC4A8455D.bw","d0cbe668-5c95-4261-a1e8-cef55093a0f7","ef6c8165-484a-4530-aedf-93dcc4a8455d","2016-08-27T01:32:02.884628-05:00","UNCID_2332219.48ad4bbc-d720-43da-98a8-e002c69ff5aa.131016_UNC15-SN850_0333_AC2MBAACXX_3_GTGGCC.tar.gz","00873561-4beb-4396-a2d4-eee6d263f2cc",6898324085,"Illumina HiSeq","4f1333d3e91d946ca7197c019351a9f9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:09:17.875187-05:00","2016-05-03T11:35:41.353993-05:00","00873561-4beb-4396-a2d4-eee6d263f2cc_analysis.xml","b9faf6c690bd73432b240898c0596151","d2289e2b-c685-45ca-9ebd-c1b3ee2db856",2124,"2016-08-25T22:38:06.877451-05:00","00873561-4beb-4396-a2d4-eee6d263f2cc_experiment.xml","8140adbc2ba3e6dc6629de30ef6a6a50","6aad0e7a-934f-4dad-9d09-7bdbe58716c7",2628,"2016-09-29T19:09:06.306504-05:00","00873561-4beb-4396-a2d4-eee6d263f2cc_run.xml","437c517c40d2e5005a8119f828656d40","3d685391-53d1-4cda-ac4b-9456be6427a1",354,"2016-09-08T12:17:00.673062-05:00","TCGA-Q1-A73O","2016-09-02T19:00:52.490076-05:00","female","TCGA-Q1-A73O_demographic",1976,"not reported","127a02eb-ed2a-5540-8fcb-82783f3b993e","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A73O_diagnosis","not reported",13601,"alive","8072/3",NA,428,"ff2b6606-26fb-5275-92a8-7260a88bf419","c53.9",-13601,"TCGA-Q1-A73O_treatment","85cf14c3-6483-5a9e-a7da-94d9ae9fdd42","01","true","TCGA-Q1-A73O-01A",NA,"bc95ea67-748a-4826-9112-8ec1ea2167cf",FALSE,"2D4BBE0A-11E4-46C1-8416-FA0E724B53FC","Primary Tumor",NA,77,90,NA,1375920000,"11",30,"TCGA-Q1-A73O-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T12:17:00.673062-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"3f67768c-5cfb-4694-9399-beae77fb4edd",NA,"TCGA-Q1-A73O-01A-01-TSA",NA,70,NA,"3c8917b9-bdf6-4d51-a7dc-728f2df95a82","RNA","TCGA-Q1-A73O-01A-11R","529911d7-4f41-4c01-a3fc-b7f9f0abdbc4",1.94,0.18,"UV Spec","R","23","TCGA-Q1-A73O-01A-11R-A32P-07","48ad4bbc-d720-43da-98a8-e002c69ff5aa",0.18,NA,76,32.8947368421053,152,"034518e3-79ca-5b0f-8635-7f83fc140647","TCGA-Q1-A73O_exposure","UNCID_2332219.48ad4bbc-d720-43da-98a8-e002c69ff5aa.131016_UNC15-SN850_0333_AC2MBAACXX_3_GTGGCC.tar.gz","2014-01-28T08:37:03.000Z","2014-01-28T08:59:02.000Z","00873561-4BEB-4396-A2D4-EEE6D263F2CC","BC95EA67-748A-4826-9112-8EC1EA2167CF","Unaligned reads",6898324085,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","48AD4BBC-D720-43DA-98A8-E002C69FF5AA","University of North Carolina","566075c9e4b0b37b3d98fd21","D0CBE668-5C95-4261-A1E8-CEF55093A0F7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","3C8917B9-BDF6-4D51-A7DC-728F2DF95A82","2014-01-28T08:59:02.000Z","529911D7-4F41-4C01-A3FC-B7F9F0ABDBC4","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",77,"3C8917B9-BDF6-4D51-A7DC-728F2DF95A82",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.FA37518B-8DC1-4510-8DF4-6E7021ECC8B5.txt",90,"TCGA-Q1-A73O-01A",NA,"0CBEB31F-1EFD-41EB-8D76-26FF440332EA","TCGA",2013,"TCGA-Q1-A73O_NTE-1",NA,NA,"BC95EA67-748A-4826-9112-8EC1EA2167CF",37,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.FA37518B-8DC1-4510-8DF4-6E7021ECC8B5.txt","Alive",NA,"TCGA-Q1-A73O","HISPANIC OR LATINO","50124CF3-240C-4382-AAB5-FF23B783B1F6","NO",146,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"TX","8072/3","FEMALE","C53.9",335,NA,"AB92587C-C118-40D6-A9CF-CB7DC167FC54",NA,NA,11,30,"3F67768C-5CFB-4694-9399-BEAE77FB4EDD","529911D7-4F41-4C01-A3FC-B7F9F0ABDBC4","9422492089_R05C01_Red.idat","TCGA-Q1-A73O-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-Q1-A73O-01A-01-TSA",70,"Cisplatin","Chemotherapy","TCGA-Q1-A73O-D50840","TCGA-Q1-A73O-R50842","External","Primary Tumor Field","TCGA-Q1-A73O-F62831_NTE-1","NO",428,"TUMOR FREE","Alive",NA,"TCGA-Q1-A73O-F62831","TCGA-Q1-A73O",NA,"Q1","A73O","YES","C53.9","8072/3","C53.9","YES","NO",-13601,"FEMALE",NA,"HISPANIC OR LATINO","No","No","Alive",146,NA,NA,NA,NA,"YES",31,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,1,NA,NA,NA,NA,"2009",8,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
135593816,133102255,6354027272,"B9F6B5E4-4D10-49B8-A8FE-8F33C5A62CBF.bw","d1a5b028-ec79-456b-81a1-69838e2922df","b9f6b5e4-4d10-49b8-a8fe-8f33c5a62cbf","2016-08-09T14:00:25.448267-05:00","UNCID_2168998.bd76ebed-0575-46c8-8c8a-f02fdcffc2e9.130611_UNC15-SN850_0312_BC265JACXX_3_GCCAAT.tar.gz","2052c002-19cf-4d8e-aa8a-2a991e3576ba",6093189414,"Illumina HiSeq","e3343d9b217b232ed50db67cd06ac7a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:09:47.930026-05:00","2016-05-03T11:06:28.634130-05:00","2052c002-19cf-4d8e-aa8a-2a991e3576ba_analysis.xml","ef53a08614da55dceac51634992ff84c","ad510cc1-4b26-4317-a892-ea433cd99aad",2123,"2016-08-13T03:37:27.299399-05:00","2052c002-19cf-4d8e-aa8a-2a991e3576ba_experiment.xml","2a188dd2cd7c182fbaf6d452947b5373","cb91316e-9d30-4630-8e90-237092900c05",2431,"2016-09-29T21:33:19.769995-05:00","2052c002-19cf-4d8e-aa8a-2a991e3576ba_run.xml","76e5445b7d5050062d55db09ac833f1e","96c0e86d-693f-456e-9c66-034cae72fb16",354,"2016-09-08T11:34:03.626952-05:00","TCGA-JW-A5VL","2016-09-02T19:00:04.193869-05:00","female","TCGA-JW-A5VL_demographic",1975,"american indian or alaska native","7aa4a2c2-3f7f-5a24-8988-a1860ed5248e","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VL_diagnosis","not reported",13604,"alive","8070/3",NA,474,"3b001e11-1541-501b-8271-8074fd0f7192","c53.9",-13604,"TCGA-JW-A5VL_treatment","d2e2b5f9-ac65-57ab-bc15-c66f3c736b21","01","false","TCGA-JW-A5VL-01A",NA,"ca60fb49-741c-4bf2-b381-5a0be5a0569f",FALSE,"7C385D8F-CFDF-48DC-B421-4B2483CE9B25","Primary Tumor",NA,114,160,NA,1362528000,"11",30,"TCGA-JW-A5VL-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:34:03.626952-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"96cb75bc-bfd0-438f-b1e5-6c2255e69180",NA,"TCGA-JW-A5VL-01A-01-TS1",NA,90,NA,"116a0e3a-4523-478f-bc1b-97ba0f628d6d","RNA","TCGA-JW-A5VL-01A-11R","65452e91-a790-46a1-8fef-259f96fa0fdb",1.9,0.16,"UV Spec","R","23","TCGA-JW-A5VL-01A-11R-A28H-07","bd76ebed-0575-46c8-8c8a-f02fdcffc2e9",0.16,NA,71,27.734375,160,"4019c13a-3a7a-58e5-9853-a41386299edb","TCGA-JW-A5VL_exposure","UNCID_2168998.bd76ebed-0575-46c8-8c8a-f02fdcffc2e9.130611_UNC15-SN850_0312_BC265JACXX_3_GCCAAT.tar.gz","2013-09-20T05:13:05.000Z","2013-09-20T05:29:01.000Z","2052C002-19CF-4D8E-AA8A-2A991E3576BA","CA60FB49-741C-4BF2-B381-5A0BE5A0569F","Unaligned reads",6093189414,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","BD76EBED-0575-46C8-8C8A-F02FDCFFC2E9","University of North Carolina","566077b1e4b0ec1099f8d056","D1A5B028-EC79-456B-81A1-69838E2922DF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","116A0E3A-4523-478F-BC1B-97BA0F628D6D","2013-09-20T05:29:01.000Z","65452E91-A790-46A1-8FEF-259F96FA0FDB","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",114,"116A0E3A-4523-478F-BC1B-97BA0F628D6D",NA,"JW","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.9180D48E-36DA-421A-933F-FD75E6515174.txt",160,"TCGA-JW-A5VL-01A",NA,NA,"TCGA",2012,"TCGA-JW-A5VL_NTE-1","Complete Remission/Response","TUMOR FREE","CA60FB49-741C-4BF2-B381-5A0BE5A0569F",37,"DRIPS_p_TCGA_295_296_297_N_GenomeWideSNP_6_F06_1343810.tangent.copynumber.data.txt","Alive",NA,"TCGA-JW-A5VL","HISPANIC OR LATINO","4D37F72D-5FD1-462F-AD32-91A161F475F7","NO",88,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",297,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"96CB75BC-BFD0-438F-B1E5-6C2255E69180","3AE5A08F-82EE-4607-B838-EF823731568C","UNCID_2168998.bd76ebed-0575-46c8-8c8a-f02fdcffc2e9.130611_UNC15-SN850_0312_BC265JACXX_3_GCCAAT.tar.gz","TCGA-JW-A5VL-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-JW-A5VL-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-JW-A5VL-F58247_NTE-1","NO",474,"TUMOR FREE","Alive",NA,"TCGA-JW-A5VL-F58247","TCGA-JW-A5VL",NA,"JW","A5VL","YES","C53.9","8070/3","C53.9","YES","NO",-13604,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Alive",88,NA,NA,NA,"TUMOR FREE","YES",31,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G1",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2NXMX",NA,NA,1,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
124539504,119437857,5693209292,"CE539000-92D7-4622-9C8D-BC6E01310681.bw","d223ff09-b80b-4368-9d80-a59dfbe4d820","ce539000-92d7-4622-9c8d-bc6e01310681","2016-08-26T12:52:01.443005-05:00","UNCID_2358856.f227e397-0bc7-4e98-a7ea-befd78191cc3.140107_UNC11-SN627_0341_BC38NLACXX_1_GTGGCC.tar.gz","945bcd43-0753-4d3a-a785-931443a17bfd",5748069544,"Illumina HiSeq","54f79198891a8f66118e48f738e3c3e6","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:50:54.881109-05:00","2016-05-03T11:37:12.417456-05:00","945bcd43-0753-4d3a-a785-931443a17bfd_analysis.xml","845f5d604d30b03f437a0c384a4b8f1f","31ed1302-8a07-409e-bc83-63753fd6cd72",2124,"2016-09-29T23:47:42.192252-05:00","945bcd43-0753-4d3a-a785-931443a17bfd_experiment.xml","8e8272ad0a362ee62d659e1868b2dea3","ea0ac46f-df5b-4baa-90ff-d01e8b556750",2628,"2016-09-29T19:32:57.725912-05:00","945bcd43-0753-4d3a-a785-931443a17bfd_run.xml","41016f7416d9080fdba3d6a86af0f47e","4c66652b-aa19-4db6-935d-ca6df0e73b25",354,"2016-09-08T11:20:23.313569-05:00","TCGA-C5-A7CM","2016-09-02T19:00:11.293749-05:00","female","TCGA-C5-A7CM_demographic",1977,"white","b4f23d5e-b849-52ad-9541-5d23e89fec8c","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CM_diagnosis","not reported",12853,"alive","8384/3",NA,619,"e3b10277-a579-5229-a3cc-1fe47e1b8ded","c53.9",-12853,"TCGA-C5-A7CM_treatment","3bfb8f43-79a1-5bbc-bcf1-32181437d6cc","01","true","TCGA-C5-A7CM-01A",NA,"fefa6b4c-243d-4544-accc-11515bbe516e",FALSE,"E9F95E79-28C9-4AA3-B0D7-02B00447B321","Primary Tumor",NA,254,60,NA,1377820800,"11",30,"TCGA-C5-A7CM-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:20:23.313569-05:00",NA,2,NA,0,NA,"TOP",NA,4,NA,"ffbac115-361e-493f-b3f5-bb0e4bcb91bb",NA,"TCGA-C5-A7CM-01A-01-TS1",NA,96,NA,"724e2e68-b3cd-49bf-a1b3-077cd1d80f53","RNA","TCGA-C5-A7CM-01A-11R","faaab8ef-0224-49f4-a78f-5f2f735abef2",1.98,0.18,"UV Spec","R","23","TCGA-C5-A7CM-01A-11R-A33Z-07","f227e397-0bc7-4e98-a7ea-befd78191cc3",0.18,NA,75,26.5731292517007,168,"bd56f13c-319e-55c9-b71a-e7c272d26b7b","TCGA-C5-A7CM_exposure","UNCID_2358856.f227e397-0bc7-4e98-a7ea-befd78191cc3.140107_UNC11-SN627_0341_BC38NLACXX_1_GTGGCC.tar.gz","2014-02-25T08:33:05.000Z","2014-02-25T08:52:01.000Z","945BCD43-0753-4D3A-A785-931443A17BFD","FEFA6B4C-243D-4544-ACCC-11515BBE516E","Unaligned reads",5748069544,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F227E397-0BC7-4E98-A7EA-BEFD78191CC3","University of North Carolina","564a3ff7e4b08c5d8692f877","D223FF09-B80B-4368-9D80-A59DFBE4D820","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","724E2E68-B3CD-49BF-A1B3-077CD1D80F53","2014-02-25T08:52:01.000Z","FAAAB8EF-0224-49F4-A78F-5F2F735ABEF2","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",254,"724E2E68-B3CD-49BF-A1B3-077CD1D80F53",NA,"C5","UNCID_2324277.f227e397-0bc7-4e98-a7ea-befd78191cc3.sorted_genome_alignments.bam.bai",60,"TCGA-C5-A7CM-01A",NA,"CD77064F-E9A7-42BE-B00B-4932416F1705","TCGA",2012,"TCGA-C5-A7CM_NTE-1","Complete Remission/Response","TUMOR FREE","FEFA6B4C-243D-4544-ACCC-11515BBE516E",35,"nationwidechildrens.org_clinical.TCGA-C5-A7CM.xml","Alive",NA,"TCGA-C5-A7CM","HISPANIC OR LATINO","8A143D38-011C-4083-8265-910AD54F15D7","NO",294,"No","Cervix","C53.9",NA,"Endocervical Adenocarcinoma of the Usual Type",0,"Post-Adjuvant Therapy","Stage IB2",NA,NA,NA,"8384/3","FEMALE","C53.9",350,NA,"28A7C62D-54B4-4BAE-A3C7-655C7C9FB4AD","WHITE",NA,11,30,"FFBAC115-361E-493F-B3F5-BB0E4BCB91BB","FAAAB8EF-0224-49F4-A78F-5F2F735ABEF2","UNCID_2324277.f227e397-0bc7-4e98-a7ea-befd78191cc3.sorted_genome_alignments.bam.bai","TCGA-C5-A7CM-01A-11",75,0,0,2,0,"TOP",4,0,"TCGA-C5-A7CM-01A-01-TS1",96,"Cisplatin","Chemotherapy","TCGA-C5-A7CM-D56984","TCGA-C5-A7CM-R57037","Internal","Primary Tumor Field","TCGA-C5-A7CM-F63996_NTE-1","NO",619,"TUMOR FREE","Alive",NA,"TCGA-C5-A7CM-F63996","TCGA-C5-A7CM",NA,"C5","A7CM","YES","C53.9","8384/3","C53.9","NO","YES",-12853,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",294,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Adenocarcinoma of the Usual Type",NA,0,35,2012,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,1997,NA,NA,"Complete Remission/Response","2009",8,NA,NA,NA,NA,0,"Post-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
112531168,111662437,5340856529,"D3BBC405-A22A-4009-ABF6-96FEEE653051.bw","d3ff2aeb-46be-4f54-8a8f-178eb921fbb6","d3bbc405-a22a-4009-abf6-96feee653051","2016-08-09T14:40:42.687736-05:00","UNCID_2654381.288f90b8-5be8-4077-b578-62b80b14f0c0.140908_UNC11-SN627_0381_BC5DEKACXX_5_CTTGTA.tar.gz","c5d3fac7-f437-453b-941f-69ef2492719b",4452820946,"Illumina HiSeq","870cf935c7e54297536fa4372c75ac5e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:08:31.768202-05:00","2016-05-03T12:08:10.830175-05:00","c5d3fac7-f437-453b-941f-69ef2492719b_analysis.xml","12f6cf12cb7f2a2a07ce3a5151462572","17652b7b-f5e8-4060-bd17-94f310bc6b6f",2124,"2016-10-07T17:24:58.462846-05:00","c5d3fac7-f437-453b-941f-69ef2492719b_experiment.xml","c7cbd22d161379dae6941cbf2626ead9","7338889a-0053-4dfc-a409-409c6377d599",2628,"2016-09-29T17:35:08.482431-05:00","c5d3fac7-f437-453b-941f-69ef2492719b_run.xml","cf8276111588b148152b8b6969a2296b","022166aa-6338-44b6-9455-d3f6a72a389a",354,"2016-09-08T10:24:58.083197-05:00","TCGA-VS-A9V5","2016-09-02T18:54:39.875000-05:00","female","TCGA-VS-A9V5_demographic",1961,"white","98120a64-df98-5e43-b5b5-74ee19b40164","not reported",2012,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9V5_diagnosis","not reported",18577,"dead","8482/3",494,NA,"6e0c6323-e04c-5036-a7bf-b01714cc5a58","c53.9",-18577,"TCGA-VS-A9V5_treatment","e1870d1c-d25d-5ece-9f2b-701dc58cdc1c","01","false","TCGA-VS-A9V5-01A",NA,"9e58ab67-62f4-4270-b7d5-3b4ed920defa",FALSE,"3EF810E0-17D2-4D40-9D81-29D896915C92","Primary Tumor",NA,1019,80,NA,1390953600,"11",30,"TCGA-VS-A9V5-01A-11",70,NA,1,NA,0,NA,0,NA,"2016-09-08T10:24:58.083197-05:00",NA,5,NA,2,NA,"TOP",NA,0,NA,"79d7bc1c-57f8-4487-bbbc-b0f29c39832a",NA,"TCGA-VS-A9V5-01A-01-TS1",NA,100,NA,"4edb43b9-993c-4333-b628-9eef6f7e29ce","RNA","TCGA-VS-A9V5-01A-11R","96e567d6-f5db-4d41-a041-125eea76b255",1.92,0.17,"UV Spec","R","23","TCGA-VS-A9V5-01A-11R-A42T-07","288f90b8-5be8-4077-b578-62b80b14f0c0",0.17,NA,98,39.7582052010223,157,"0422cb82-5f81-587e-9dd4-4c908a6503fb","TCGA-VS-A9V5_exposure","UNCID_2654381.288f90b8-5be8-4077-b578-62b80b14f0c0.140908_UNC11-SN627_0381_BC5DEKACXX_5_CTTGTA.tar.gz","2014-11-05T06:27:05.000Z","2014-11-05T06:39:33.000Z","C5D3FAC7-F437-453B-941F-69EF2492719B","9E58AB67-62F4-4270-B7D5-3B4ED920DEFA","Unaligned reads",4452820946,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","288F90B8-5BE8-4077-B578-62B80B14F0C0","University of North Carolina","564a3a32e4b093830b68e0f6","D3FF2AEB-46BE-4F54-8A8F-178EB921FBB6","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4EDB43B9-993C-4333-B628-9EEF6F7E29CE","2014-11-05T06:39:33.000Z","96E567D6-F5DB-4D41-A041-125EEA76B255","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1019,"4EDB43B9-993C-4333-B628-9EEF6F7E29CE",NA,"VS","43f2cd21c8bf106981f52f14e7d55581.bam.bai",80,"TCGA-VS-A9V5-01A",NA,"502961DD-9C7F-4032-BED4-F6E20D29702F","TCGA",2011,"TCGA-VS-A9V5_NTE-1","Progressive Disease","WITH TUMOR","9E58AB67-62F4-4270-B7D5-3B4ED920DEFA",50,"nationwidechildrens.org_clinical.TCGA-VS-A9V5.xml","Dead",494,"TCGA-VS-A9V5",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",1,"Pre-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8482/3","FEMALE","C53.9",420,NA,"ACCE741D-6C77-4244-BF9E-D1259D278133","WHITE",NA,11,30,"79D7BC1C-57F8-4487-BBBC-B0F29C39832A","96E567D6-F5DB-4D41-A041-125EEA76B255","43f2cd21c8bf106981f52f14e7d55581.bam.bai","TCGA-VS-A9V5-01A-11",70,0,1,5,0,"TOP",0,2,"TCGA-VS-A9V5-01A-01-TS1",100,"Carboplatin","Chemotherapy","TCGA-VS-A9V5-D65882","TCGA-VS-A9V5-R65881","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9V5",NA,"VS","A9V5","YES","C53.9","8482/3","C53.9","NO","YES",-18577,"FEMALE","WHITE",NA,"No","No","Dead",NA,494,NA,NA,"WITH TUMOR","YES",1,10,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,50,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Progressive Disease","2009",13,NA,"T2bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
131041726,126411744,6034861022,"0B3C86BD-0D20-4408-9BE3-05658729505F.bw","d4510801-8ce4-4f10-8b31-25c0a39b5135","0b3c86bd-0d20-4408-9be3-05658729505f","2016-08-05T02:07:11.529878-05:00","UNCID_2186968.5ff64ded-bdb0-4125-b1b9-8a3945e82810.121002_UNC11-SN627_0254_AC0WP5ACXX_2_AGTCAA.tar.gz","9cdb7888-221c-4320-b7de-f41c1b17547b",5362264914,"Illumina HiSeq","6daa5ebbe9bdb998d4aa4f05f0c69d2e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:09:59.592594-05:00","2016-05-03T11:01:14.476120-05:00","9cdb7888-221c-4320-b7de-f41c1b17547b_analysis.xml","2c50583960e01a41d602f56bddbed0fd","18426333-5aef-4fd4-8b8e-3d752f402d29",2124,"2016-08-13T10:00:49.870278-05:00","9cdb7888-221c-4320-b7de-f41c1b17547b_experiment.xml","036aeb28ce3f6cecf4ba69501a5d93a6","1dc571b9-e214-4961-8f4d-d056eaf5c804",2431,"2016-09-29T21:11:00.041813-05:00","9cdb7888-221c-4320-b7de-f41c1b17547b_run.xml","8936e4e8d59dbbbb80151f8941ce940c","88f4d4d8-2b55-4046-877b-8ccdc284a4d6",354,"2016-09-08T11:30:03.347842-05:00","TCGA-EK-A2R8","2016-09-02T18:58:24.628278-05:00","female","TCGA-EK-A2R8_demographic",1962,"white","affa87b1-5f11-5a53-be1a-9739ad638ea9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2R8_diagnosis","not reported",17692,"alive","8072/3",NA,44,"ac8ce049-516e-5630-bfe8-10abce402ef2","c53.9",-17692,"TCGA-EK-A2R8_treatment","1936a091-2c57-593e-88e7-7bc73ed15075","01","false","TCGA-EK-A2R8-01A",NA,"6b8e0af3-1632-4fed-9a37-879ea013ae24",FALSE,"7E69142C-4F3A-4F81-9DC8-72C86F689083","Primary Tumor",NA,554,100,NA,1315785600,"21",30,"TCGA-EK-A2R8-01A-21",65,NA,0,NA,2,NA,5,NA,"2016-09-08T11:30:03.347842-05:00",NA,5,NA,25,NA,"TOP",NA,15,NA,"b52e8672-872b-4596-acf9-bc83a37e6b9d",NA,"TCGA-EK-A2R8-01A-02-TS2",NA,78,NA,"2b2e558d-81cf-4e7c-892f-278567149cc5","RNA","TCGA-EK-A2R8-01A-21R","36001c49-75df-4db0-ad78-070e5b57ee12",1.85,0.18,"UV Spec","R","23","TCGA-EK-A2R8-01A-21R-A18M-07","5ff64ded-bdb0-4125-b1b9-8a3945e82810",0.18,NA,75,25.9515570934256,170,"4ddf352c-e59e-5f7a-b977-df3b3aeb5358","TCGA-EK-A2R8_exposure","UNCID_2186968.5ff64ded-bdb0-4125-b1b9-8a3945e82810.121002_UNC11-SN627_0254_AC0WP5ACXX_2_AGTCAA.tar.gz","2013-09-16T07:31:04.000Z","2013-09-16T20:18:02.000Z","9CDB7888-221C-4320-B7DE-F41C1B17547B","6B8E0AF3-1632-4FED-9A37-879EA013AE24","Unaligned reads",5362264914,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5FF64DED-BDB0-4125-B1B9-8A3945E82810","University of North Carolina","564a3bcde4b0ef12181a9189","D4510801-8CE4-4F10-8B31-25C0A39B5135","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2B2E558D-81CF-4E7C-892F-278567149CC5","2013-09-16T20:18:02.000Z","36001C49-75DF-4DB0-AD78-070E5B57EE12","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",554,"2B2E558D-81CF-4E7C-892F-278567149CC5",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.AC94BFF4-8049-498D-987E-297D102E8F1D.txt",100,"TCGA-EK-A2R8-01A",NA,NA,"TCGA",2010,NA,NA,"WITH TUMOR","6B8E0AF3-1632-4FED-9A37-879EA013AE24",48,"nationwidechildrens.org_clinical.TCGA-EK-A2R8.xml","Alive",NA,"TCGA-EK-A2R8","NOT HISPANIC OR LATINO","46F0F3A5-4F9A-4783-9F67-6B4DD3A91A77",NA,40,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB2",NA,NA,"T1b2","8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,21,30,"B52E8672-872B-4596-ACF9-BC83A37E6B9D","36001C49-75DF-4DB0-AD78-070E5B57EE12","6929718044_R04C01_Red.idat","TCGA-EK-A2R8-01A-21",65,2,0,5,5,"TOP",15,25,"TCGA-EK-A2R8-01A-02-TS2",78,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2R8-F58216_NTE-1",NA,44,NA,"Alive",NA,"TCGA-EK-A2R8-F58216","TCGA-EK-A2R8",NA,"EK","A2R8","YES","C53.9","8072/3","C53.9","NO","YES",-17692,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",40,NA,NA,NA,"WITH TUMOR","NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2010,"Biopsy (cervical / CT-guided / Other)","YES",17,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",8,NA,"T1b2N1MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
188482202,185164386,8837801640,"9B9C5071-7C3F-416C-B91C-6F5966747F54.bw","d5d8a818-d689-4c6f-96b0-13f2cb10c3ca","9b9c5071-7c3f-416c-b91c-6f5966747f54","2016-08-09T13:10:08.968178-05:00","UNCID_2186207.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.121102_UNC12-SN629_0235_AC13F5ACXX_1_GTGGCC.tar.gz","034b0035-47ce-42fb-88e3-1aab4aa84234",8698890799,"Illumina HiSeq","5c3ef1c9ee2421192408382ef1cdc34d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:13:12.854051-05:00","2016-05-03T11:00:24.448573-05:00","034b0035-47ce-42fb-88e3-1aab4aa84234_analysis.xml","f8ff495348a76fbc76a13f71251d8a52","1a40b23f-7378-43c3-8167-0acee81b8f8d",2124,"2016-09-29T22:46:26.793871-05:00","034b0035-47ce-42fb-88e3-1aab4aa84234_experiment.xml","0e05bb5244e0455f929f7ba8896d47ee","c3ffb502-f8c5-429b-8633-a6e71b076d2f",2431,"2016-09-29T22:11:34.289696-05:00","034b0035-47ce-42fb-88e3-1aab4aa84234_run.xml","edca78e0f7c76a5e740f8ac4fdd138a7","ae52dc16-ca08-4a67-8bf6-1f677eb3c60a",354,"2016-09-08T11:41:55.503747-05:00","TCGA-FU-A2QG","2016-09-02T18:58:31.371323-05:00","female","TCGA-FU-A2QG_demographic",1982,"white","48dc9c31-e71c-51aa-893d-2e97c12cea81","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A2QG_diagnosis","not reported",10865,"alive","8071/3",NA,579,"3823246f-fe8a-543f-ade9-1803040ef5fd","c53.9",-10865,"TCGA-FU-A2QG_treatment","303c456a-808d-5a35-800d-a73d9810945b","01","false","TCGA-FU-A2QG-01A",NA,"81ae8e2d-e42e-4249-8490-2f36610351cb",FALSE,"9616EC35-D8F6-4EE1-AF0A-BF955C6A4C14","Primary Tumor",NA,77,180,NA,1316563200,"11",20,"TCGA-FU-A2QG-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:41:55.503747-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"493e987e-2773-48c1-b5e0-207d84ae1c59",NA,"TCGA-FU-A2QG-01A-01-TS1",NA,70,NA,"e437fff7-d0c8-4f36-8788-e4858a761ccd","RNA","TCGA-FU-A2QG-01A-11R","3d86477c-4dae-4097-8a99-91a04f0b5b87",1.84,0.16,"UV Spec","R","23","TCGA-FU-A2QG-01A-11R-A18M-07","7e7e0d0f-aa97-4c0d-bffc-7d8977288836",0.16,0.821917808219178,138,47.7508650519031,170,"a2acf419-0384-5246-a789-24ee5f065aec","TCGA-FU-A2QG_exposure","UNCID_2186207.7e7e0d0f-aa97-4c0d-bffc-7d8977288836.121102_UNC12-SN629_0235_AC13F5ACXX_1_GTGGCC.tar.gz","2013-09-16T02:13:17.000Z","2013-09-16T04:30:01.000Z","034B0035-47CE-42FB-88E3-1AAB4AA84234","81AE8E2D-E42E-4249-8490-2F36610351CB","Unaligned reads",8698890799,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7E7E0D0F-AA97-4C0D-BFFC-7D8977288836","University of North Carolina","564a3c7ce4b08c5d8691dabd","D5D8A818-D689-4C6F-96B0-13F2CB10C3CA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E437FFF7-D0C8-4F36-8788-E4858A761CCD","2013-09-16T04:30:01.000Z","3D86477C-4DAE-4097-8A99-91A04F0B5B87","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",77,"E437FFF7-D0C8-4F36-8788-E4858A761CCD",NA,"FU","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.BF0B2734-8B91-46D0-BC54-D21D1EB1C035.txt",180,"TCGA-FU-A2QG-01A",NA,NA,"TCGA",2011,NA,NA,"TUMOR FREE","81AE8E2D-E42E-4249-8490-2F36610351CB",29,"CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_B03_871082.raw.copynumber.data.txt","Alive",NA,"TCGA-FU-A2QG","NOT HISPANIC OR LATINO","421C33C5-37FD-49D7-A2A9-242B3733FF50",NA,28,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,20,"493E987E-2773-48C1-B5E0-207D84AE1C59","51562CFD-2EE9-4299-8172-6B0F640B3D79","CELLA_p_TCGA_177_179_Esph_SNP_N_GenomeWideSNP_6_B03_871082.hg19.seg.txt","TCGA-FU-A2QG-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-FU-A2QG-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-FU-A2QG-F43199_NTE-1","NO",579,"TUMOR FREE","Alive",NA,"TCGA-FU-A2QG-F43199","TCGA-FU-A2QG",NA,"FU","A2QG","YES","C53.9","8071/3","C53.9","YES","NO",-10865,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",28,NA,NA,NA,"TUMOR FREE","NO",18,10,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,29,2011,"Biopsy (cervical / CT-guided / Other)","YES",32,0,"G2",NA,4,2011,15,NA,NA,"2009",7,NA,"T1b1N0",NA,NA,1,"Preoperative",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
116906114,114594622,5465971622,"A9469A4A-C5F9-4681-A916-A26F0B4307BA.bw","d626a732-af64-4dec-b4bf-3cb761bf4c8d","a9469a4a-c5f9-4681-a916-a26f0b4307ba","2016-08-26T01:48:58.709654-05:00","UNCID_2358891.09f55b71-b6ee-42a5-96eb-6a2929e35bbf.131217_UNC14-SN744_0384_BC32YDACXX_8_CTTGTA.tar.gz","1de728b6-2975-4dc7-9f50-6329ccff0d88",5516104880,"Illumina HiSeq","deb8ff901c6a53a499bc5a4b0ff74f36","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:16:03.231822-05:00","2016-05-03T11:37:12.425258-05:00","1de728b6-2975-4dc7-9f50-6329ccff0d88_analysis.xml","b3c2d6721aeaa53a1cfd0ab545703801","66d7d6d4-e598-4e9a-b2d2-49bd14795aa6",2124,"2016-09-29T22:21:55.154001-05:00","1de728b6-2975-4dc7-9f50-6329ccff0d88_experiment.xml","cb217450fcccd4f13c081473605d118c","b4ac19a5-2442-4d88-8463-950191fd56a6",2628,"2016-09-30T00:01:55.868721-05:00","1de728b6-2975-4dc7-9f50-6329ccff0d88_run.xml","6633fe135c1e1a7cae37334df8dd5499","f2cd96d3-eed0-4939-b45a-6df89cbdd46a",354,"2016-09-08T12:05:31.611339-05:00","TCGA-C5-A7CH","2016-09-02T19:00:10.738500-05:00","female","TCGA-C5-A7CH_demographic",1958,"white","e10eb89e-a826-595e-912a-f8b0cc3f9d4a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CH_diagnosis","not reported",15777,"alive","8070/3",NA,4694,"062e3b29-bf0e-5974-b087-2250c4b102fa","c53.9",-15777,"TCGA-C5-A7CH_treatment","b1953aa4-7902-57f8-8ba3-d171f2e9d119","01","true","TCGA-C5-A7CH-01A",NA,"fbf7856e-6330-4033-8b33-d06fc2b99108",FALSE,"68C37151-5277-4370-BEA9-5DBD6429E06F","Primary Tumor",NA,4329,40,NA,1377820800,"11",30,"TCGA-C5-A7CH-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:05:31.611339-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"a84a47ef-ac57-461d-9053-2d850a63da9e",NA,"TCGA-C5-A7CH-01A-01-TS1",NA,100,NA,"ba68b4ae-1e7d-4c6e-96b7-20d98139e33f","RNA","TCGA-C5-A7CH-01A-11R","8b7d6da7-d7f5-4a50-b1bf-9f787f4bf7c1",1.94,0.18,"UV Spec","R","23","TCGA-C5-A7CH-01A-11R-A33Z-07","09f55b71-b6ee-42a5-96eb-6a2929e35bbf",0.18,NA,104,40.1219088769723,161,"31058360-78dd-5a98-9a80-7fe05f5e6a25","TCGA-C5-A7CH_exposure","UNCID_2358891.09f55b71-b6ee-42a5-96eb-6a2929e35bbf.131217_UNC14-SN744_0384_BC32YDACXX_8_CTTGTA.tar.gz","2014-02-26T08:33:04.000Z","2014-02-26T09:03:02.000Z","1DE728B6-2975-4DC7-9F50-6329CCFF0D88","FBF7856E-6330-4033-8B33-D06FC2B99108","Unaligned reads",5516104880,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","09F55B71-B6EE-42A5-96EB-6A2929E35BBF","University of North Carolina","566076a1e4b0b37b3d990679","D626A732-AF64-4DEC-B4BF-3CB761BF4C8D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BA68B4AE-1E7D-4C6E-96B7-20D98139E33F","2014-02-26T09:03:02.000Z","8B7D6DA7-D7F5-4A50-B1BF-9F787F4BF7C1","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4329,"BA68B4AE-1E7D-4C6E-96B7-20D98139E33F",NA,"C5","3a4780910e6b0fba7d8a783c63b0d3af.bam",40,"TCGA-C5-A7CH-01A",NA,"797AE99C-E4D4-4EDE-8E29-0A8F3A1BE314","TCGA",2001,"TCGA-C5-A7CH_NTE-1",NA,NA,"FBF7856E-6330-4033-8B33-D06FC2B99108",43,"nationwidechildrens.org_clinical.TCGA-C5-A7CH.xml","Alive",NA,"TCGA-C5-A7CH","NOT HISPANIC OR LATINO","878E5010-27D3-4ADA-BE19-17F47A02E806",NA,771,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,NA,"8070/3","FEMALE","C53.9",350,NA,"A48DA42C-C02C-4F6A-99A2-ECE67A09B79B","WHITE",NA,11,30,"A84A47EF-AC57-461D-9053-2D850A63DA9E","AB4970CE-3A6E-4E4A-A7C4-C38280E589FA","3a4780910e6b0fba7d8a783c63b0d3af.bam","TCGA-C5-A7CH-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-C5-A7CH-01A-01-TS1",100,NA,NA,"TCGA-C5-A7CH-D56511","TCGA-C5-A7CH-R56512",NA,NA,"TCGA-C5-A7CH-F63994_NTE-1","NO",4694,"TUMOR FREE","Alive",NA,"TCGA-C5-A7CH-F63994","TCGA-C5-A7CH",NA,"C5","A7CH","YES","C53.9","8070/3","C53.9","NO","YES",-15777,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",771,NA,NA,NA,NA,"NO",3,1,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,43,2001,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,NA,"1995",13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
178553622,174750530,8299985433,"A31B57E4-E30B-4A1B-829D-1B47D9CEC041.bw","d7a75bf5-5189-4978-99d9-fcef91c9fbd2","a31b57e4-e30b-4a1b-829d-1b47d9cec041","2016-08-09T13:57:26.756813-05:00","UNCID_2187002.ebe70126-032b-4f1e-9d89-1e0bd2f05907.121003_UNC15-SN850_0237_AC0WRBACXX_8_GATCAG.tar.gz","49d96658-423e-4b27-837f-f9350b2f18cd",7872263216,"Illumina HiSeq","73b764b76d2226bf56d095fe851a511d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:28:39.979975-05:00","2016-05-03T11:02:00.405063-05:00","49d96658-423e-4b27-837f-f9350b2f18cd_analysis.xml","f6a860a6539e07cb39a64189ff6429b3","6e999de5-6516-42d5-a81a-d5b06fcd7703",2124,"2016-08-28T05:50:11.535128-05:00","49d96658-423e-4b27-837f-f9350b2f18cd_experiment.xml","2c7d24896e2ba3279cdecedb06564ef5","5fa41098-fbe9-4c10-8463-33eeb8fb2095",2431,"2016-09-29T20:27:06.032938-05:00","49d96658-423e-4b27-837f-f9350b2f18cd_run.xml","862f3b1348df4e230729b41898f52c91","6daa8e31-5b26-4753-a70f-e4bc6c0e7f1f",354,"2016-09-08T11:46:38.809536-05:00","TCGA-EK-A2R7","2016-09-02T18:58:24.000969-05:00","female","TCGA-EK-A2R7_demographic",1965,"white","c72a45fc-702d-5edd-a3e8-0432a7a36686","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2R7_diagnosis","not reported",16487,"alive","8072/3",NA,27,"e024490f-90ca-553e-a1c5-a4350cb6cccb","c53.9",-16487,"TCGA-EK-A2R7_treatment","70feb8b9-a655-59da-b58a-79a883af5105","01","false","TCGA-EK-A2R7-01A",NA,"ee9a22df-8612-4b71-af3a-6b16c73197ea",FALSE,"5EE5A64B-9025-4C3E-8CD8-8293515BC1F8","Primary Tumor",NA,546,100,NA,1315785600,"11",30,"TCGA-EK-A2R7-01A-11",88,NA,0,NA,19,NA,5,NA,"2016-09-08T11:46:38.809536-05:00",NA,6,NA,0,NA,"TOP",NA,1,NA,"5c28740a-66c5-4a8a-b0c3-813b0aafd2ec",NA,"TCGA-EK-A2R7-01A-01-TS1",NA,75,NA,"9ff04aac-76ba-4510-a094-543963dba685","RNA","TCGA-EK-A2R7-01A-11R","645364ef-d390-4270-b81e-7dad55bb129d",1.88,0.16,"UV Spec","R","23","TCGA-EK-A2R7-01A-11R-A18M-07","ebe70126-032b-4f1e-9d89-1e0bd2f05907",0.16,NA,75,27.5482093663912,165,"a7f21188-7f74-505f-89a7-efa0ea8df656","TCGA-EK-A2R7_exposure","UNCID_2187002.ebe70126-032b-4f1e-9d89-1e0bd2f05907.121003_UNC15-SN850_0237_AC0WRBACXX_8_GATCAG.tar.gz","2013-09-16T21:46:04.000Z","2013-09-16T22:09:01.000Z","49D96658-423E-4B27-837F-F9350B2F18CD","EE9A22DF-8612-4B71-AF3A-6B16C73197EA","Unaligned reads",7872263216,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","EBE70126-032B-4F1E-9D89-1E0BD2F05907","University of North Carolina","564a3edde4b09c884b2568d8","D7A75BF5-5189-4978-99D9-FCEF91C9FBD2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9FF04AAC-76BA-4510-A094-543963DBA685","2013-09-16T22:09:01.000Z","645364EF-D390-4270-B81E-7DAD55BB129D","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",546,"9FF04AAC-76BA-4510-A094-543963DBA685",NA,"EK","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.5084B39A-9371-4D27-9812-371724EED76C.txt",100,"TCGA-EK-A2R7-01A",NA,NA,"TCGA",2010,NA,NA,NA,"EE9A22DF-8612-4B71-AF3A-6B16C73197EA",45,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.5084B39A-9371-4D27-9812-371724EED76C.txt","Alive",NA,"TCGA-EK-A2R7","NOT HISPANIC OR LATINO","B56ACFCB-32D4-4E0A-AE66-4A3AF16C62E6",NA,11,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB",NA,NA,"T1b1","8072/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"5C28740A-66C5-4A8A-B0C3-813B0AAFD2EC","EC06F33F-9FC2-4BAE-BE35-B685BC12429B","UNCID_1649852.ebe70126-032b-4f1e-9d89-1e0bd2f05907.sorted_genome_alignments.bam","TCGA-EK-A2R7-01A-11",88,19,0,6,5,"TOP",1,0,"TCGA-EK-A2R7-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2R7-F58254_NTE-1",NA,11,NA,"Alive",NA,"TCGA-EK-A2R7-F58254","TCGA-EK-A2R7",NA,"EK","A2R7","YES","C53.9","8072/3","C53.9","NO","YES",-16487,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",27,NA,NA,NA,"TUMOR FREE","NO",2,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2010,"Biopsy (cervical / CT-guided / Other)","YES",21,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",6,NA,"T1b1N1M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
193948022,189253748,9025120677,"647255CE-F84A-4070-B3FD-D8ACA32C4D09.bw","d7f07485-522a-49d9-b105-5a9a51aca8f7","647255ce-f84a-4070-b3fd-d8aca32c4d09","2016-08-01T22:29:10.922149-05:00","UNCID_2186278.76e090d4-d2c2-4918-97d8-4dd1dbea5452.121102_UNC15-SN850_0240_BD148CACXX_6_AGTCAA.tar.gz","a36e185e-d0b1-42b9-a324-ca8032f78abc",8692261402,"Illumina HiSeq","229dc3affc5b88a200f619730bec1921","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:55.830957-05:00","2016-05-03T11:00:24.448573-05:00","a36e185e-d0b1-42b9-a324-ca8032f78abc_analysis.xml","93e185fcece53b718f4bfe6f2279e07d","de4d1ca4-e440-4ba8-b006-da3c68de3e6f",2124,"2016-09-29T17:52:17.985001-05:00","a36e185e-d0b1-42b9-a324-ca8032f78abc_experiment.xml","6a1123c8e7c744604a240369baa4c1ae","0d212401-4873-49f8-8600-1e33f81385ea",2431,"2016-09-29T22:04:44.465802-05:00","a36e185e-d0b1-42b9-a324-ca8032f78abc_run.xml","2497b1df07c3a8268cf13cdd2352575c","aa48ace2-ae01-437f-a86c-57dc26848c9a",354,"2016-09-08T12:16:53.908542-05:00","TCGA-EK-A2GZ","2016-09-02T18:57:47.022474-05:00","female","TCGA-EK-A2GZ_demographic",1944,"black or african american","ece04bce-8e8f-5579-943d-f6f15c4d40b2","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2GZ_diagnosis","not reported",23599,"alive","8070/3",NA,383,"5370dcdb-7e11-5b23-b861-78ed3bad748a","c53.9",-23599,"TCGA-EK-A2GZ_treatment","88c7ed19-532a-531a-8fb4-9b64c9ffb1bc","01","false","TCGA-EK-A2GZ-01A",NA,"5686f844-be97-472d-8564-a35c3a3ebac2",FALSE,"793DCC7F-E9F9-4A23-A5C3-2738AD4E0091","Primary Tumor",NA,1099,40,NA,1308182400,"11",30,"TCGA-EK-A2GZ-01A-11",98,NA,0,NA,0,NA,65,NA,"2016-09-08T12:16:53.908542-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"1518ac4a-4b26-4f18-a6f7-573bf84884d9",NA,"TCGA-EK-A2GZ-01A-01-TSA",NA,30,NA,"6469b5ba-c242-4ba3-8ac8-ee28ef3c4cbf","RNA","TCGA-EK-A2GZ-01A-11R","67782850-673a-4668-b8d2-f74de4a9faa0",2.04,0.15,"UV Spec","R","23","TCGA-EK-A2GZ-01A-11R-A180-07","76e090d4-d2c2-4918-97d8-4dd1dbea5452",0.15,NA,64,25,160,"fad6b9bd-2fbf-5cf1-a3cd-0902494d4649","TCGA-EK-A2GZ_exposure","UNCID_2186278.76e090d4-d2c2-4918-97d8-4dd1dbea5452.121102_UNC15-SN850_0240_BD148CACXX_6_AGTCAA.tar.gz","2013-09-16T04:06:05.000Z","2013-09-16T04:41:02.000Z","A36E185E-D0B1-42B9-A324-CA8032F78ABC","5686F844-BE97-472D-8564-A35C3A3EBAC2","Unaligned reads",8692261402,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","76E090D4-D2C2-4918-97D8-4DD1DBEA5452","University of North Carolina","564a3cbce4b0298dd2c8d4d0","D7F07485-522A-49D9-B105-5A9A51ACA8F7","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","6469B5BA-C242-4BA3-8AC8-EE28EF3C4CBF","2013-09-16T04:41:02.000Z","67782850-673A-4668-B8D2-F74DE4A9FAA0","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",1099,"6469B5BA-C242-4BA3-8AC8-EE28EF3C4CBF",NA,"EK","UNCID_1712116.76e090d4-d2c2-4918-97d8-4dd1dbea5452.sorted_genome_alignments.bam",40,"TCGA-EK-A2GZ-01A",NA,NA,"TCGA",2008,NA,NA,"WITH TUMOR","FB6D3454-EFC5-4E2F-89FA-70AA6114527D",64,"nationwidechildrens.org_clinical.TCGA-EK-A2GZ.xml","Alive",NA,"TCGA-EK-A2GZ","NOT HISPANIC OR LATINO","2A5B41D9-F23F-415F-B0F3-878278C4A055",NA,383,"Yes","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IIIB",NA,NA,NA,"8070/3","FEMALE","C53.9",169,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,11,30,"1518AC4A-4B26-4F18-A6F7-573BF84884D9","80585518-A8E7-4D62-925F-7A9FBD2B528D","unc.edu.76e090d4-d2c2-4918-97d8-4dd1dbea5452.1712287.junction_quantification.txt","TCGA-EK-A2GZ-01A-11",98,0,0,1,65,"TOP",5,0,"TCGA-EK-A2GZ-01A-01-TSA",30,NA,NA,NA,NA,NA,NA,NA,"NO",383,"WITH TUMOR","Alive",NA,"TCGA-EK-A2GZ-F31876","TCGA-EK-A2GZ",NA,"EK","A2GZ","YES","C53.9","8070/3","C53.9","NO","YES",-23599,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","Yes","No","Alive",383,NA,NA,NA,"WITH TUMOR","NO",8,11,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2008,"Biopsy (cervical / CT-guided / Other)","YES",14,NA,"G2",NA,NA,NA,NA,NA,NA,"1995",16,NA,NA,NA,NA,0,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
182850320,178639959,8519266897,"8F5E9F02-51D7-410E-B8B7-22737F2F095A.bw","d9b0ac5a-811d-4305-bb1c-a965bd389ce4","8f5e9f02-51d7-410e-b8b7-22737f2f095a","2016-08-25T14:03:35.214763-05:00","UNCID_2358885.a661f07b-e207-4221-b9f2-a5704be3650b.140102_UNC15-SN850_0344_AC384WACXX_3_AGTTCC.tar.gz","6e64d57b-e686-4c54-86d2-28e47541fd37",8506028159,"Illumina HiSeq","8463ccd0f7fe88f46c541ae2db3bec7e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:14:02.894258-05:00","2016-05-03T11:37:12.425258-05:00","6e64d57b-e686-4c54-86d2-28e47541fd37_analysis.xml","1c72f823abc27444b620c9c7e153ea9f","659c7467-e95c-427c-b402-39e7e8b2d15c",2124,"2016-09-29T21:25:24.655799-05:00","6e64d57b-e686-4c54-86d2-28e47541fd37_experiment.xml","bc29911ce9fac1ce9104d04f3e81be5e","91dcf2cb-b99c-4874-b4a8-73e6d7d9c799",2628,"2016-09-30T00:12:58.272734-05:00","6e64d57b-e686-4c54-86d2-28e47541fd37_run.xml","17f7258e2d54d95d3c7ea51a41aa003f","f98c73ef-926d-4d39-a9bd-1a6e8ed5346a",354,"2016-09-08T11:35:57.336354-05:00","TCGA-Q1-A73R","2016-09-02T19:00:15.320397-05:00","female","TCGA-Q1-A73R_demographic",1968,"white","126a10d7-bbd1-571e-86a0-0d0cf1096f7d","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A73R_diagnosis","not reported",16701,"alive","8384/3",NA,567,"f74718c5-4aee-5c8a-95b5-8262fb8ef037","c53.9",-16701,"TCGA-Q1-A73R_treatment","62d65c9b-7544-59f9-b7d0-6defe4135ca0","01","true","TCGA-Q1-A73R-01A",NA,"52ffbe32-0018-4f2b-95f7-fad8c331d863",FALSE,"2294E1F2-FA18-4E80-A7C8-F7089B24298A","Primary Tumor",NA,118,580,NA,1376006400,"11",30,"TCGA-Q1-A73R-01A-11",60,NA,1,NA,20,NA,15,NA,"2016-09-08T11:35:57.336354-05:00",NA,1,NA,1,NA,"TOP",NA,5,NA,"7c84a4f4-6f30-4420-abbb-b5d39557763c",NA,"TCGA-Q1-A73R-01A-01-TSA",NA,60,NA,"fd41dfe9-f977-44a7-9144-271d2e5544e8","RNA","TCGA-Q1-A73R-01A-11R","e3a4d845-1457-4c55-8422-f9bf30411f81",1.92,0.17,"UV Spec","R","23","TCGA-Q1-A73R-01A-11R-A33Z-07","a661f07b-e207-4221-b9f2-a5704be3650b",0.17,NA,95,39.5421436004162,155,"7144242d-7c93-5586-b27d-d497317ef7ec","TCGA-Q1-A73R_exposure","UNCID_2358885.a661f07b-e207-4221-b9f2-a5704be3650b.140102_UNC15-SN850_0344_AC384WACXX_3_AGTTCC.tar.gz","2014-02-26T02:33:03.000Z","2014-02-26T02:58:01.000Z","6E64D57B-E686-4C54-86D2-28E47541FD37","52FFBE32-0018-4F2B-95F7-FAD8C331D863","Unaligned reads",8506028159,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A661F07B-E207-4221-B9F2-A5704BE3650B","University of North Carolina","5660749ce4b016715ab677b0","D9B0AC5A-811D-4305-BB1C-A965BD389CE4","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FD41DFE9-F977-44A7-9144-271D2E5544E8","2014-02-26T02:58:01.000Z","E3A4D845-1457-4C55-8422-F9BF30411F81","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",118,"FD41DFE9-F977-44A7-9144-271D2E5544E8",NA,"Q1","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.6922055B-2C39-4A60-80D9-ADF3269CD2DB.txt",580,"TCGA-Q1-A73R-01A",NA,NA,"TCGA",2013,"TCGA-Q1-A73R_NTE-1",NA,NA,"52FFBE32-0018-4F2B-95F7-FAD8C331D863",45,"nationwidechildrens.org_clinical.TCGA-Q1-A73R.xml","Alive",NA,"TCGA-Q1-A73R",NA,"147BEDE9-35B4-4ACA-A782-36ECCEB7177E","NO",190,"No","Cervix","C53.9","NX","Endocervical Type of Adenocarcinoma",0,"Post-Adjuvant Therapy","Stage I",NA,NA,"TX","8384/3","FEMALE","C53.9",350,NA,NA,"WHITE",NA,11,30,"7C84A4F4-6F30-4420-ABBB-B5D39557763C","E3A4D845-1457-4C55-8422-F9BF30411F81","UNCID_2358885.a661f07b-e207-4221-b9f2-a5704be3650b.140102_UNC15-SN850_0344_AC384WACXX_3_AGTTCC.tar.gz","TCGA-Q1-A73R-01A-11",60,20,1,1,15,"TOP",5,1,"TCGA-Q1-A73R-01A-01-TSA",60,NA,NA,NA,NA,NA,NA,"TCGA-Q1-A73R-F62729_NTE-1","NO",567,"TUMOR FREE","Alive",NA,"TCGA-Q1-A73R-F62729","TCGA-Q1-A73R",NA,"Q1","A73R","YES","C53.9","8384/3","C53.9","YES","NO",-16701,"FEMALE","WHITE",NA,"No","No","Alive",190,NA,NA,NA,NA,"YES",31,10,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,45,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,1,NA,NA,NA,NA,"2009",2,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
129584270,126323130,6023682071,"8074A7F6-2FDE-4578-B71C-01C542D468FE.bw","d9c2ca21-f1a6-4cf4-be28-6c2492dd38e5","8074a7f6-2fde-4578-b71c-01c542d468fe","2016-08-25T21:37:24.949279-05:00","UNCID_2553096.8d5e2fac-878b-440c-a19b-09c972b840ac.140408_UNC11-SN627_0351_AC3KY3ACXX_8_CAGATC.tar.gz","f7095c66-4085-4960-b92c-b2c119ff1eb7",5590250376,"Illumina HiSeq","c6e123796ac9ffa32f4f348821d152a1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:34:47.917439-05:00","2016-05-03T11:54:19.885282-05:00","f7095c66-4085-4960-b92c-b2c119ff1eb7_analysis.xml","0dc26876ca223897a88550f335615d73","723cda55-837d-409f-97d4-e6ce336c83f0",2124,"2016-09-29T23:37:04.614053-05:00","f7095c66-4085-4960-b92c-b2c119ff1eb7_experiment.xml","c4b78d3f43984cfdcb70dcf51b92c00f","e371aee0-72d0-44df-9dee-f0900ba62a04",2628,"2016-09-29T19:27:46.480217-05:00","f7095c66-4085-4960-b92c-b2c119ff1eb7_run.xml","45cd2e3705de8318e75772c8f2c55431","492e8068-663a-48df-9f1a-b77d3244442e",354,"2016-09-08T11:23:30.785236-05:00","TCGA-VS-A8EK","2016-09-02T19:01:17.298150-05:00","female","TCGA-VS-A8EK_demographic",1943,"white","4d54678c-a545-5708-beee-8173b8e14a44","not reported",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EK_diagnosis","not reported",23817,"dead","8070/3",829,NA,"af3d1a02-7242-5056-9c3a-6c4a73482a3d","c53.9",-23817,"TCGA-VS-A8EK_treatment","97197dbe-69a7-505d-9dce-75ae2fb325fe","01","false","TCGA-VS-A8EK-01A",NA,"f6eb459e-98b3-437a-963f-cdb4a6bb2528",FALSE,"C5B99AC6-E318-4608-8E70-96176F97EF90","Primary Tumor",NA,1784,160,NA,1384732800,"12",30,"TCGA-VS-A8EK-01A-12",60,NA,20,NA,0,NA,30,NA,"2016-09-08T11:23:30.785236-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"0bc2f4b4-1f8c-4384-9f0f-bcb6cc5be294",NA,"TCGA-VS-A8EK-01A-01-TS1",NA,60,NA,"79fca340-8b94-497c-942e-43b9372bd803","RNA","TCGA-VS-A8EK-01A-12R","a969a1f8-9b03-42cd-8eec-31a16e6a957b",1.83,0.17,"UV Spec","R","23","TCGA-VS-A8EK-01A-12R-A37O-07","8d5e2fac-878b-440c-a19b-09c972b840ac",0.17,NA,50,21.359306249733,153,"61dacf91-1bf2-5efc-ac21-3ec0c588c6d5","TCGA-VS-A8EK_exposure","UNCID_2553096.8d5e2fac-878b-440c-a19b-09c972b840ac.140408_UNC11-SN627_0351_AC3KY3ACXX_8_CAGATC.tar.gz","2014-07-30T21:51:04.000Z","2014-07-30T22:10:15.000Z","F7095C66-4085-4960-B92C-B2C119FF1EB7","F6EB459E-98B3-437A-963F-CDB4A6BB2528","Unaligned reads",5590250376,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8D5E2FAC-878B-440C-A19B-09C972B840AC","University of North Carolina","566077abe4b0b37b3d990f4e","D9C2CA21-F1A6-4CF4-BE28-6C2492DD38E5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","79FCA340-8B94-497C-942E-43B9372BD803","2014-07-30T22:10:15.000Z","A969A1F8-9B03-42CD-8EEC-31A16E6A957B","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1784,"79FCA340-8B94-497C-942E-43B9372BD803",NA,"VS","TCGA-VS-A8EK-01A-12R-A37P-13.mirna.quantification.txt",160,"TCGA-VS-A8EK-01A",NA,"4608A3B1-2585-4E69-8194-33D9CA824C35","TCGA",2008,"TCGA-VS-A8EK_NTE-1","Partial Remission/Response","WITH TUMOR","F6EB459E-98B3-437A-963F-CDB4A6BB2528",65,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.18D2E64E-B473-4594-BECE-25C028266FA4.txt","Dead",829,"TCGA-VS-A8EK",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IVA",NA,NA,"T4","8070/3","FEMALE","C53.9",380,NA,"6CEF663F-8D0D-45A0-B1BF-1080E350C15D","WHITE",NA,12,30,"0BC2F4B4-1F8C-4384-9F0F-BCB6CC5BE294","2ECB1A1F-AA84-4DC8-902C-B75F9D43110A","UNCID_2553096.8d5e2fac-878b-440c-a19b-09c972b840ac.140408_UNC11-SN627_0351_AC3KY3ACXX_8_CAGATC.tar.gz","TCGA-VS-A8EK-01A-12",60,0,20,40,30,"TOP",10,20,"TCGA-VS-A8EK-01A-01-TS1",60,"Cisplatin","Chemotherapy","TCGA-VS-A8EK-D62778","TCGA-VS-A8EK-R61985","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A8EK",NA,"VS","A8EK","YES","C53.9","8070/3","C53.9","NO","YES",-23817,"FEMALE","WHITE",NA,"No","No","Dead",NA,829,NA,NA,"WITH TUMOR","YES",22,4,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,65,2008,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,NA,NA,NA,NA,"Partial Remission/Response","2009",17,NA,"T4NXM0",NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
108673304,101135126,4817287438,"2A946F17-F245-409E-A019-C60CDA18DC7D.bw","da30a845-c4d3-4c78-b8b0-210239224f8f","2a946f17-f245-409e-a019-c60cda18dc7d","2016-08-25T10:11:22.570234-05:00","UNCID_2358798.41a6b734-2741-4d93-8813-ed27b21c81c0.140107_UNC11-SN627_0341_BC38NLACXX_2_GTGGCC.tar.gz","607b7ef6-bee7-4669-a50d-cff4779c90e9",5016578548,"Illumina HiSeq","76845f021cd2e814b0243c28779eecd3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:45:56.703415-05:00","2016-05-03T11:37:12.425298-05:00","607b7ef6-bee7-4669-a50d-cff4779c90e9_analysis.xml","88f13d00e48521cc76e1e537d5f70182","9e8185f8-e6b7-487e-a3e1-c825d43e92c8",2124,"2016-10-07T16:55:00.242015-05:00","607b7ef6-bee7-4669-a50d-cff4779c90e9_experiment.xml","f17dea68d223a7e2fb534824d76c86ca","c0d00063-9a49-45be-9bb7-ac3e365c9171",2628,"2016-09-29T21:27:44.007989-05:00","607b7ef6-bee7-4669-a50d-cff4779c90e9_run.xml","7ef2011c6b567433c8f6338eb01107e4","935dd79a-ddca-43a6-bc7a-1b7f824b6620",354,"2016-09-08T11:26:49.803507-05:00","TCGA-C5-A7UE","2016-09-02T19:00:12.144917-05:00","female","TCGA-C5-A7UE_demographic",1956,"white","6deac872-62d5-5e0d-adcf-f240b0fc3e09","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7UE_diagnosis","not reported",16473,"alive","8070/3",NA,4738,"e71805d0-bc14-5266-966c-cc100db62cda","c53.9",-16473,"TCGA-C5-A7UE_treatment","92a0deb7-7a5e-5ef4-8e3f-f98254f6925d","01","true","TCGA-C5-A7UE-01A",NA,"48ecab30-cf47-43a8-af5c-026140a53ef8",FALSE,"445F27B0-FFBC-474E-A750-04052A852FB2","Primary Tumor",NA,4375,30,NA,1381363200,"11",20,"TCGA-C5-A7UE-01A-11",95,NA,0,NA,0,NA,10,NA,"2016-09-08T11:26:49.803507-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"06533cea-5037-4dd5-8978-23b69d39f938",NA,"TCGA-C5-A7UE-01A-01-TS1",NA,90,NA,"8d17ac02-aa76-4698-aae1-7b2ce2ce4f45","RNA","TCGA-C5-A7UE-01A-11R","346f7d0c-7452-4330-bc11-e21526e629d5",1.8,0.17,"UV Spec","R","23","TCGA-C5-A7UE-01A-11R-A33Z-07","41a6b734-2741-4d93-8813-ed27b21c81c0",0.17,1.91780821917808,63,24.609375,160,"67d8f830-6119-5ad5-ad17-8c6c568106b5","TCGA-C5-A7UE_exposure","UNCID_2358798.41a6b734-2741-4d93-8813-ed27b21c81c0.140107_UNC11-SN627_0341_BC38NLACXX_2_GTGGCC.tar.gz","2014-02-25T19:24:10.000Z","2014-02-25T19:50:02.000Z","607B7EF6-BEE7-4669-A50D-CFF4779C90E9","48ECAB30-CF47-43A8-AF5C-026140A53EF8","Unaligned reads",5016578548,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","41A6B734-2741-4D93-8813-ED27B21C81C0","University of North Carolina","564a3ac3e4b093830b691002","DA30A845-C4D3-4C78-B8B0-210239224F8F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8D17AC02-AA76-4698-AAE1-7B2CE2CE4F45","2014-02-25T19:50:02.000Z","346F7D0C-7452-4330-BC11-E21526E629D5","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4375,"8D17AC02-AA76-4698-AAE1-7B2CE2CE4F45",NA,"C5","UNCID_2324650.41a6b734-2741-4d93-8813-ed27b21c81c0.sorted_genome_alignments.bam.bai",30,"TCGA-C5-A7UE-01A",NA,"F8C24E83-C9C1-48FC-B371-0CCDD3B809F0","TCGA",2001,"TCGA-C5-A7UE_NTE-1",NA,"TUMOR FREE","48ECAB30-CF47-43A8-AF5C-026140A53EF8",45,"nationwidechildrens.org_clinical.TCGA-C5-A7UE.xml","Alive",NA,"TCGA-C5-A7UE",NA,"CADE137A-46A4-4D33-8D24-7BA59B0D3F84","NO",2602,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,NA,"8070/3","FEMALE","C53.9",350,NA,"3DC3C8CB-121F-42F9-B772-C94F2C879BC2","WHITE",NA,11,20,"06533CEA-5037-4DD5-8978-23B69D39F938","346F7D0C-7452-4330-BC11-E21526E629D5","UNCID_2324650.41a6b734-2741-4d93-8813-ed27b21c81c0.sorted_genome_alignments.bam.bai","TCGA-C5-A7UE-01A-11",95,0,0,0,10,"TOP",0,0,"TCGA-C5-A7UE-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-C5-A7UE-D57027","TCGA-C5-A7UE-R57028","External","Regional site","TCGA-C5-A7UE-F66716_NTE-1","YES",4738,"TUMOR FREE","Alive",NA,"TCGA-C5-A7UE-F66716","TCGA-C5-A7UE",NA,"C5","A7UE","YES","C53.9","8070/3","C53.9","NO","YES",-16473,"FEMALE","WHITE",NA,"No","No","Alive",2602,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2001,"Biopsy (cervical / CT-guided / Other)","YES",23,1,"G2",NA,2,NA,35,NA,NA,"1995",7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
107310162,104832225,5005487975,"0878C381-47F9-4786-82C2-94AC840BEDCB.bw","da5fcb99-16b4-4f9e-8602-d6a6192875ef","0878c381-47f9-4786-82c2-94ac840bedcb","2016-08-24T10:49:48.195202-05:00","UNCID_2553083.4523956c-5427-45e0-a640-cc5ce875b022.140513_UNC15-SN850_0365_BC4BYLACXX_2_GTGGCC.tar.gz","f4b2997f-3441-4de9-bb34-db5581c8e36c",4574515031,"Illumina HiSeq","821496eb8f2768e53b16c2e3613ed8c4","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:54:09.233475-05:00","2016-05-03T11:54:19.885282-05:00","f4b2997f-3441-4de9-bb34-db5581c8e36c_analysis.xml","eaf41e38c62d7f323e207fab3b22936c","c8c54408-7714-4a58-a573-25b7e05c0c78",2124,"2016-09-29T19:46:43.241408-05:00","f4b2997f-3441-4de9-bb34-db5581c8e36c_experiment.xml","e0bf1242ad8a292b784b98d634aa5199","54e5f0c3-126b-4087-bd7f-b64805fc77cb",2628,"2016-09-29T21:49:29.761456-05:00","f4b2997f-3441-4de9-bb34-db5581c8e36c_run.xml","3065957a79077721f50984a0cb470b2f","a0b3471f-3db5-4679-924b-438ff9fe1c4a",354,"2016-09-08T11:36:04.994811-05:00","TCGA-MA-AA42","2016-09-02T18:54:06.169602-05:00","female","TCGA-MA-AA42_demographic",1938,"white","26900c1e-e43c-5a4b-895d-1528bcd332a5","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA42_diagnosis","not reported",27460,"alive","8070/3",NA,259,"f22e34ed-080e-5238-8c6a-3a02a0a0b27a","c53.9",-27460,"TCGA-MA-AA42_treatment","4f27fa22-b4eb-5769-8509-83483b6ab17d","01","false","TCGA-MA-AA42-01A",NA,"778cfc29-210b-455e-8130-85094940d628",FALSE,"62F4EBB5-6F2F-4D4C-817E-88EEF577BF1C","Primary Tumor",NA,57,170,NA,1393200000,"12",30,"TCGA-MA-AA42-01A-12",75,NA,0,NA,5,NA,2,NA,"2016-09-08T11:36:04.994811-05:00",NA,3,NA,2,NA,"TOP",NA,18,NA,"110eede3-0dea-42ea-a0ad-e2fd80c40b8d",NA,"TCGA-MA-AA42-01A-01-TS1",NA,75,NA,"bb19c932-0905-4dfc-b873-85f75dd945ca","RNA","TCGA-MA-AA42-01A-12R","f9e9c871-9456-4661-8a36-d1cae5663636",1.87,0.17,"UV Spec","R","23","TCGA-MA-AA42-01A-12R-A38B-07","4523956c-5427-45e0-a640-cc5ce875b022",0.17,NA,63,32.1428571428571,140,"a56bdb90-11d8-57c8-8ee3-faf33cdd6ceb","TCGA-MA-AA42_exposure","UNCID_2553083.4523956c-5427-45e0-a640-cc5ce875b022.140513_UNC15-SN850_0365_BC4BYLACXX_2_GTGGCC.tar.gz","2014-07-30T18:51:04.000Z","2014-07-30T07:09:48.000Z","F4B2997F-3441-4DE9-BB34-DB5581C8E36C","778CFC29-210B-455E-8130-85094940D628","Unaligned reads",4574515031,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4523956C-5427-45E0-A640-CC5CE875B022","University of North Carolina","564a4073e4b08c5d86931fbe","DA5FCB99-16B4-4F9E-8602-D6A6192875EF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BB19C932-0905-4DFC-B873-85F75DD945CA","2014-07-30T07:09:48.000Z","F9E9C871-9456-4661-8A36-D1CAE5663636","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",57,"BB19C932-0905-4DFC-B873-85F75DD945CA",NA,"MA","nationwidechildrens.org_biospecimen.TCGA-MA-AA42.xml",170,"TCGA-MA-AA42-01A",NA,NA,"TCGA",2013,"TCGA-MA-AA42_NTE-1","Complete Remission/Response","TUMOR FREE","A3B5BB67-E320-4BB0-B694-3EEDE4BAB9E6",75,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.8C54A0B1-1E91-40CE-8BC8-2CC140B4310C.txt","Alive",NA,"TCGA-MA-AA42","HISPANIC OR LATINO","5E31E84E-DB8A-47B3-944F-37FFF1EE966E","NO",168,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,12,30,"110EEDE3-0DEA-42EA-A0AD-E2FD80C40B8D","EC3A3F4C-4B63-42F4-9A7A-3D2BC2493B48","aac021ebb11b4a0e893c1c60a5aa39bf.bam.bai","TCGA-MA-AA42-01A-12",75,5,0,3,2,"TOP",18,2,"TCGA-MA-AA42-01A-01-TS1",75,NA,NA,NA,NA,NA,NA,"TCGA-MA-AA42-F65482_NTE-1","NO",259,"TUMOR FREE","Alive",NA,"TCGA-MA-AA42-F65482","TCGA-MA-AA42",NA,"MA","AA42","YES","C53.9","8070/3","C53.9","YES","NO",-27460,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",168,NA,NA,NA,"TUMOR FREE","YES",22,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,75,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bN0M0",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
161618170,158292816,7560550415,"54504893-92C5-4328-85A8-2A882680B5E0.bw","da901e97-3a1d-4952-8254-9c4e60d2812c","54504893-92c5-4328-85a8-2a882680b5e0","2016-08-25T03:48:10.921106-05:00","UNCID_2553088.1893be96-6727-4bfa-aa28-2a2df326c464.140513_UNC15-SN850_0364_AC4DVGACXX_3_ACTTGA.tar.gz","c4448638-55eb-40f9-a941-597e41830db2",6847344473,"Illumina HiSeq","f3b69ba734b6ee02b00db34cbf5463fd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:17:40.940464-05:00","2016-05-03T11:54:19.885282-05:00","c4448638-55eb-40f9-a941-597e41830db2_analysis.xml","ac9b947aa0b0f6dd9d5d0e2dccee4477","d7408aa2-176c-4e7f-b098-93804ac1adfa",2124,"2016-08-13T08:26:25.964555-05:00","c4448638-55eb-40f9-a941-597e41830db2_experiment.xml","d877f48da4052b16c0e0853c80d019da","2f38289f-a4dc-479e-9577-1d8fbfdc311a",2628,"2016-09-29T18:46:37.202309-05:00","c4448638-55eb-40f9-a941-597e41830db2_run.xml","820eec7176a153250690a59193bca901","2f3b0163-8786-4398-86e9-3f5cfaa061b7",354,"2016-09-08T11:34:54.118159-05:00","TCGA-VS-A953","2016-09-02T18:54:09.165025-05:00","female","TCGA-VS-A953_demographic",1947,"not reported","6b8b6227-a231-53aa-9ce0-38e8fb2c76f6","not reported",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A953_diagnosis","not reported",23277,"dead","8070/3",477,NA,"9799686d-8739-51ee-be9e-8bf1ca8f82d4","c53.9",-23277,"TCGA-VS-A953_treatment","2a12d4b6-4d3f-59b6-9790-c9fd84757e3d","01","false","TCGA-VS-A953-01A",NA,"65730227-e033-445e-aba7-6dfd3ef9df32",FALSE,"C5CCCB76-671A-4498-BA9F-A5D5AF6DD215","Primary Tumor",NA,1274,50,NA,1390435200,"11",30,"TCGA-VS-A953-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T11:34:54.118159-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"ab0b895d-ee0c-4851-ab48-e4db45cb438b",NA,"TCGA-VS-A953-01A-01-TS1",NA,80,NA,"be277047-a80f-4a5f-b00d-2a23035b1d00","RNA","TCGA-VS-A953-01A-11R","0dd0574d-787b-48de-b0ae-876d41665ec1",1.94,0.16,"UV Spec","R","23","TCGA-VS-A953-01A-11R-A38B-07","1893be96-6727-4bfa-aa28-2a2df326c464",0.16,NA,47,19.5629552549428,155,"14ec524f-7984-5be1-8206-f27395e39fa5","TCGA-VS-A953_exposure","UNCID_2553088.1893be96-6727-4bfa-aa28-2a2df326c464.140513_UNC15-SN850_0364_AC4DVGACXX_3_ACTTGA.tar.gz","2014-07-30T20:06:06.000Z","2014-07-30T20:31:07.000Z","C4448638-55EB-40F9-A941-597E41830DB2","65730227-E033-445E-ABA7-6DFD3EF9DF32","Unaligned reads",6847344473,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1893BE96-6727-4BFA-AA28-2A2DF326C464","University of North Carolina","564a40f6e4b093830b6b0eed","DA901E97-3A1D-4952-8254-9C4E60D2812C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","BE277047-A80F-4A5F-B00D-2A23035B1D00","2014-07-30T20:31:07.000Z","0DD0574D-787B-48DE-B0AE-876D41665EC1","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1274,"BE277047-A80F-4A5F-B00D-2A23035B1D00",NA,"VS","ENATE_p_TCGAb_394_395_396_NSP_GenomeWideSNP_6_B09_1474074.byallele.copynumber.data.txt",50,"TCGA-VS-A953-01A",NA,NA,"TCGA",2010,"TCGA-VS-A953_NTE-1","Partial Remission/Response","WITH TUMOR","65730227-E033-445E-ABA7-6DFD3EF9DF32",63,"nationwidechildrens.org_clinical.TCGA-VS-A953.xml","Dead",477,"TCGA-VS-A953",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IVA",NA,NA,"T4","8070/3","FEMALE","C53.9",394,NA,NA,NA,NA,11,30,"AB0B895D-EE0C-4851-AB48-E4DB45CB438B","3B6F488B-6580-440B-9F11-DDC4CB8A715F","ENATE_p_TCGAb_394_395_396_NSP_GenomeWideSNP_6_B09_1474074.byallele.copynumber.data.txt","TCGA-VS-A953-01A-11",80,0,20,40,10,"TOP",10,20,"TCGA-VS-A953-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A953",NA,"VS","A953","YES","C53.9","8070/3","C53.9","NO","YES",-23277,"FEMALE",NA,NA,"No","No","Dead",NA,477,NA,NA,"WITH TUMOR","YES",17,10,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,63,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"GX",NA,1,NA,NA,NA,"Partial Remission/Response","2009",17,NA,"T4NXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
197807388,194016287,9258611984,"0A27D1BE-E5DD-459A-A51F-6D8AAF7CFEB4.bw","dac27c24-cdbf-4527-9214-178fde3d098a","0a27d1be-e5dd-459a-a51f-6d8aaf7cfeb4","2016-08-09T13:11:17.781420-05:00","UNCID_2186710.38948BD8-BC9A-4E38-9F7A-F72D3531050E.121011_UNC13-SN749_0197_AD16K1ACXX_5_AGTCAA.tar.gz","2135e24c-94a8-4b92-9604-281ae35fa455",8759617985,"Illumina HiSeq","0b08b5c5514f794b3c2f242a467cd21b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:11:00.359703-05:00","2016-05-03T11:00:24.467501-05:00","2135e24c-94a8-4b92-9604-281ae35fa455_analysis.xml","303558df3d632dd15e21cfef291336a2","18e10bac-4420-4858-bf04-c78c76309679",2123,"2016-08-28T22:15:41.915289-05:00","2135e24c-94a8-4b92-9604-281ae35fa455_experiment.xml","a26a18a1d30e4dc89ce95310d74f1052","7c434f34-dc50-43ac-ad71-341497418e08",2431,"2016-09-29T21:42:16.745504-05:00","2135e24c-94a8-4b92-9604-281ae35fa455_run.xml","70adef20361902a7a46f309fce0f2946","9c394ded-bdc5-4a31-9603-bb8292b4e876",354,"2016-09-08T11:29:47.890409-05:00","TCGA-FU-A3NI","2016-09-02T18:59:08.590361-05:00","female","TCGA-FU-A3NI_demographic",1965,"white","c83f0273-bfbf-5c28-b76c-f918391f39d5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","FU","e5cd6166-769e-57d4-8432-fd38cc4a95b1","International Genomics Consortium","not reported","c53.9","TCGA-FU-A3NI_diagnosis","not reported",16533,"dead","8071/3",638,44,"6be26424-9402-5055-998d-71d72bfc5b00","c53.9",-16533,"TCGA-FU-A3NI_treatment","9201a09a-3f37-54dd-9eec-37a07814405f","01","false","TCGA-FU-A3NI-01A",NA,"c75c6fd3-79ef-48b8-b3bd-d097ef2a73ad",FALSE,"3FD96F22-8669-4908-8DEC-9B9A82A8D5D5","Primary Tumor",NA,466,70,NA,1327449600,"11",30,"TCGA-FU-A3NI-01A-11",80,NA,0,NA,0,NA,5,NA,"2016-09-08T11:29:47.890409-05:00",NA,0,NA,0,NA,"TOP",NA,5,NA,"7998b249-1ceb-4739-a059-8a2a5c8c2c02",NA,"TCGA-FU-A3NI-01A-01-TS1",NA,90,NA,"18ad2a70-c891-4054-80f5-d21d9951a0d8","RNA","TCGA-FU-A3NI-01A-11R","c636d847-d8ea-4739-b84f-732ff85c6c5e",2.04,0.16,"UV Spec","R","23","TCGA-FU-A3NI-01A-11R-A21T-07","38948bd8-bc9a-4e38-9f7a-f72d3531050e",0.16,NA,57,21.7192501143118,162,"5b294eb9-3e60-5445-9b92-dd9e700176b3","TCGA-FU-A3NI_exposure","UNCID_2186710.38948BD8-BC9A-4E38-9F7A-F72D3531050E.121011_UNC13-SN749_0197_AD16K1ACXX_5_AGTCAA.tar.gz","2013-09-16T12:43:06.000Z","2013-09-16T13:51:01.000Z","2135E24C-94A8-4B92-9604-281AE35FA455","C75C6FD3-79EF-48B8-B3BD-D097EF2A73AD","Unaligned reads",8759617985,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","38948BD8-BC9A-4E38-9F7A-F72D3531050E","University of North Carolina","564a40dde4b0ef12181c342c","DAC27C24-CDBF-4527-9214-178FDE3D098A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","18AD2A70-C891-4054-80F5-D21D9951A0D8","2013-09-16T13:51:01.000Z","C636D847-D8EA-4739-B84F-732FF85C6C5E","United States","NO",1,NA,"Primary Tumor","International Genomics Consortium",466,"18AD2A70-C891-4054-80F5-D21D9951A0D8",NA,"FU","TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam.bai",70,"TCGA-FU-A3NI-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","E949DB99-6FE2-48F2-9D45-469A7909BA87",45,"90aa78928fed2a8621713b0442500687.bam","Alive",NA,"TCGA-FU-A3NI","NOT HISPANIC OR LATINO","57AAFF5F-2A05-4F2C-AF93-9256F68E63FD",NA,44,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",217,NA,NA,"WHITE",NA,11,30,"7998B249-1CEB-4739-A059-8A2A5C8C2C02","E42FB3FA-D943-4BF4-87CD-8910E398DB65","TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam.bai","TCGA-FU-A3NI-01A-11",80,0,0,0,5,"TOP",5,0,"TCGA-FU-A3NI-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-FU-A3NI-F65839_NTE-1",NA,NA,NA,"Dead",638,"TCGA-FU-A3NI-F65839","TCGA-FU-A3NI",NA,"FU","A3NI","YES","C53.9","8071/3","C53.9","NO","YES",-16533,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",44,NA,NA,NA,"TUMOR FREE","NO",17,4,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,45,2010,"Biopsy (cervical / CT-guided / Other)","YES",29,2,"G2",NA,2,NA,NA,NA,NA,"2009",7,NA,"T1b1N1MX",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
126702404,122297383,5835224139,"89ED5A3E-CAC0-4AB4-B858-A3CD8F34DBD5.bw","dadcf6d5-03eb-4090-bcc3-b9e9dc3c7e08","89ed5a3e-cac0-4ab4-b858-a3cd8f34dbd5","2016-08-25T12:09:29.826131-05:00","UNCID_2449457.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.140312_UNC15-SN850_0357_AC3M7FACXX_5_GTCCGC.tar.gz","ead45280-daea-4e05-bde4-eec8e56d8c68",5606439803,"Illumina HiSeq","eaccf3be25a0b2e2ae2e8ca2cee0b53e","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:18:30.378416-05:00","2016-05-03T11:44:58.595380-05:00","ead45280-daea-4e05-bde4-eec8e56d8c68_analysis.xml","c77a6c92df6b64087029b182beb54bc6","fcfe2744-860d-4331-9ad2-8d594834917c",2123,"2016-09-29T22:13:56.861471-05:00","ead45280-daea-4e05-bde4-eec8e56d8c68_experiment.xml","2413793153b2084ee7fccab3e50146b4","afd9af8b-653c-4c4e-984a-7908f696fe5f",2628,"2016-09-29T20:22:19.555159-05:00","ead45280-daea-4e05-bde4-eec8e56d8c68_run.xml","857bd021eb602c343745c6a8ae08c898","6aacab2a-a205-461c-a834-6099d2f00762",354,"2016-09-08T12:19:08.950768-05:00","TCGA-DS-A7WH","2016-09-02T19:00:55.327452-05:00","female","TCGA-DS-A7WH_demographic",1979,"white","bab1ea56-abe0-5370-ae4b-5eb4cdf0e455","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A7WH_diagnosis","not reported",12644,"alive","8480/3",NA,533,"97438538-885f-535e-ac20-485924dc8168","c53.9",-12644,"TCGA-DS-A7WH_treatment","ce8fe03f-f012-5817-b573-99d22384946b","01","true","TCGA-DS-A7WH-01A",NA,"b742714f-55c2-48b7-9d4b-667f82056f68",FALSE,"069FDE0B-57A4-4398-856D-F3FE511F89B4","Primary Tumor",NA,230,200,NA,1381449600,"22",20,"TCGA-DS-A7WH-01A-22",60,NA,20,NA,0,NA,30,NA,"2016-09-08T12:19:08.950768-05:00",NA,20,NA,40,NA,"TOP",NA,10,NA,"d101d4a9-11bc-4ae5-8ed8-fa7c0d97c1e0",NA,"TCGA-DS-A7WH-01A-02-TSB",NA,60,NA,"9644208d-baed-47c4-b912-507a7e1d6282","RNA","TCGA-DS-A7WH-01A-22R","3892819f-36df-4cbc-8948-bd7305cac68e",1.83,0.17,"UV Spec","R","23","TCGA-DS-A7WH-01A-22R-A352-07","3380e6d8-52a0-4b19-acb1-2fb686cbd5df",0.17,NA,50,17.7154195011338,168,"ff9eeed1-dbb0-5690-a3e1-c330d8ca69f4","TCGA-DS-A7WH_exposure","UNCID_2449457.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.140312_UNC15-SN850_0357_AC3M7FACXX_5_GTCCGC.tar.gz","2014-05-09T01:33:03.000Z","2014-05-09T02:23:03.000Z","EAD45280-DAEA-4E05-BDE4-EEC8E56D8C68","B742714F-55C2-48B7-9D4B-667F82056F68","Unaligned reads",5606439803,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3380E6D8-52A0-4B19-ACB1-2FB686CBD5DF","University of North Carolina","566076d4e4b018727fea0f1b","DADCF6D5-03EB-4090-BCC3-B9E9DC3C7E08","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9644208D-BAED-47C4-B912-507A7E1D6282","2014-05-09T02:23:03.000Z","3892819F-36DF-4CBC-8948-BD7305CAC68E","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",230,"9644208D-BAED-47C4-B912-507A7E1D6282",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.BB0D8B6B-4065-4562-A677-A92977A81BC9.txt",200,"TCGA-DS-A7WH-01A",NA,"77253106-F449-4E19-800E-3EB594A38AD4","TCGA",2013,"TCGA-DS-A7WH_NTE-1","Complete Remission/Response","TUMOR FREE","B742714F-55C2-48B7-9D4B-667F82056F68",34,"UNCID_2388836.3380e6d8-52a0-4b19-acb1-2fb686cbd5df.sorted_genome_alignments.bam","Alive",NA,"TCGA-DS-A7WH","NOT HISPANIC OR LATINO","1FCCC802-98A3-4BF1-B63C-B1F2734D4603","NO",223,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",0,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8480/3","FEMALE","C53.9",361,NA,"43CF1C5A-D41C-41D6-AC75-DD5D28489291","WHITE",NA,22,20,"D101D4A9-11BC-4AE5-8ED8-FA7C0D97C1E0","E52B432F-C458-47C0-BE74-81C3A837123F","TCGA-DS-A7WH-01A-22R-A358-13_mirna.bam","TCGA-DS-A7WH-01A-22",60,0,20,20,30,"TOP",10,40,"TCGA-DS-A7WH-01A-02-TSB",60,"Cisplatin","Chemotherapy","TCGA-DS-A7WH-D54774","TCGA-DS-A7WH-R54775","External","Primary Tumor Field","TCGA-DS-A7WH-F63889_NTE-1","NO",533,"TUMOR FREE","Alive",NA,"TCGA-DS-A7WH-F63889","TCGA-DS-A7WH",NA,"DS","A7WH","YES","C53.9","8480/3","C53.9","YES","NO",-12644,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",223,NA,NA,NA,"TUMOR FREE","YES",23,12,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,34,2013,"Biopsy (cervical / CT-guided / Other)","YES",22,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
106049716,103523046,4935773415,"ACEEB0A5-AADB-4EF9-8710-4BAF95522CEA.bw","db44488e-4ed0-4082-bca0-bbfd22ff0537","aceeb0a5-aadb-4ef9-8710-4baf95522cea","2016-08-26T03:10:45.596110-05:00","UNCID_2553089.5ad0c6f5-9be9-46f2-a705-fb9c616464ae.140416_UNC11-SN627_0353_BC42B0ACXX_4_CGATGT.tar.gz","c92927b2-b89f-4984-9001-eb53b80e2bd0",4888445039,"Illumina HiSeq","4b9fbbfea7255a4e60640495b3f17e28","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:26:21.498862-05:00","2016-05-03T11:54:19.885282-05:00","c92927b2-b89f-4984-9001-eb53b80e2bd0_analysis.xml","8ecf6b7cd74f03dce06cfadbe30d3547","4846d838-b5b3-4593-8494-ba4d42d71693",2123,"2016-08-13T04:53:30.900468-05:00","c92927b2-b89f-4984-9001-eb53b80e2bd0_experiment.xml","cd5c44b6ab23e4dcc96eefd6d6777f09","c9f2e598-cf87-4661-a019-bd76e12441d5",2628,"2016-09-29T23:33:49.503103-05:00","c92927b2-b89f-4984-9001-eb53b80e2bd0_run.xml","085e40534334c978377712a8203dd7b6","e167a49e-01fb-4540-860f-337354f705fc",354,"2016-09-08T11:37:08.484791-05:00","TCGA-ZJ-A8QR","2016-09-02T19:01:24.335632-05:00","female","TCGA-ZJ-A8QR_demographic",1969,"native hawaiian or other pacific islander","2557e337-b0fe-505f-ac1c-8fa04ccdc656","not hispanic or latino",2008,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-A8QR_diagnosis","not reported",14225,"dead","8071/3",582,NA,"501ae23f-c169-5331-9041-2a1294b6c6ac","c53.9",-14225,"TCGA-ZJ-A8QR_treatment","f23baf05-7771-5e7b-b44e-39b224a8c461","01","true","TCGA-ZJ-A8QR-01A",NA,"7f18d32a-281b-472d-ba6b-37458a904f8d",FALSE,"0C8716BD-1A48-4392-9F40-6A5C04FA8004","Primary Tumor",NA,2173,840,NA,1386288000,"11",30,"TCGA-ZJ-A8QR-01A-11",80,NA,0,NA,10,NA,8,NA,"2016-09-08T11:37:08.484791-05:00",NA,2,NA,5,NA,"TOP",NA,2,NA,"2081ccd4-bdf9-4878-be4d-c57131367829",NA,"TCGA-ZJ-A8QR-01A-01-TSA",NA,80,NA,"d5ee9755-8d2f-437b-821c-706bb6bf9b30","RNA","TCGA-ZJ-A8QR-01A-11R","5914d645-693e-4923-9bbd-058e0b273872",1.83,0.15,"UV Spec","R","23","TCGA-ZJ-A8QR-01A-11R-A37O-07","5ad0c6f5-9be9-46f2-a705-fb9c616464ae",0.15,0.0219178082191781,58,NA,NA,"c0b8b193-9c01-5284-b438-36c509f1a5c3","TCGA-ZJ-A8QR_exposure","UNCID_2553089.5ad0c6f5-9be9-46f2-a705-fb9c616464ae.140416_UNC11-SN627_0353_BC42B0ACXX_4_CGATGT.tar.gz","2014-07-30T20:21:05.000Z","2014-07-30T20:45:43.000Z","C92927B2-B89F-4984-9001-EB53B80E2BD0","7F18D32A-281B-472D-BA6B-37458A904F8D","Unaligned reads",4888445039,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5AD0C6F5-9BE9-46F2-A705-FB9C616464AE","University of North Carolina","56607688e4b0b37b3d990586","DB44488E-4ED0-4082-BCA0-BBFD22FF0537","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D5EE9755-8D2F-437B-821C-706BB6BF9B30","2014-07-30T20:45:43.000Z","5914D645-693E-4923-9BBD-058E0B273872","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",2173,"D5EE9755-8D2F-437B-821C-706BB6BF9B30",NA,"ZJ","SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_C11_1465258.raw.copynumber.data.txt",840,"TCGA-ZJ-A8QR-01A",NA,NA,"TCGA",2007,"TCGA-ZJ-A8QR_NTE-1",NA,NA,"7F18D32A-281B-472D-BA6B-37458A904F8D",38,"nationwidechildrens.org_clinical.TCGA-ZJ-A8QR.xml","Dead",582,"TCGA-ZJ-A8QR","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage I",NA,NA,"TX","8071/3","FEMALE","C53.9",380,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,11,30,"2081CCD4-BDF9-4878-BE4D-C57131367829","D74303CC-5D61-4BB3-B0F1-43CB436B96B9","UNCID_2553089.5ad0c6f5-9be9-46f2-a705-fb9c616464ae.140416_UNC11-SN627_0353_BC42B0ACXX_4_CGATGT.tar.gz","TCGA-ZJ-A8QR-01A-11",80,10,0,2,8,"TOP",2,5,"TCGA-ZJ-A8QR-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-A8QR",NA,"ZJ","A8QR","YES","C53.9","8071/3","C53.9","NO","YES",-14225,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER","NOT HISPANIC OR LATINO","No","No","Dead",NA,582,NA,NA,NA,"YES",25,2,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2007,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,2,2009,0.4,NA,NA,"2009",2,NA,"TXNXMX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
190453134,188344463,8996161108,"02C74D81-5976-4252-BC6C-B10E934DECA2.bw","ddd4b6d2-5be0-4edd-977a-a795eea3c738","02c74d81-5976-4252-bc6c-b10e934deca2","2016-08-09T14:41:35.970270-05:00","UNCID_2654385.39dc6ace-24eb-499b-ad94-64cf08849087.141006_UNC15-SN850_0395_AC5FH9ACXX_7_ATCACG.tar.gz","a41e6939-ae45-4c25-93ad-aa0070645f6e",7775238400,"Illumina HiSeq","40cbb7d5359791b5787b6d22a29d0681","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:33.930709-05:00","2016-05-03T12:08:10.830175-05:00","a41e6939-ae45-4c25-93ad-aa0070645f6e_analysis.xml","151c7fce86a7c6ad8735f54fba9d9bad","0836bcd7-33ec-4ec1-acf6-fd83bb941310",2124,"2016-09-29T20:37:39.239622-05:00","a41e6939-ae45-4c25-93ad-aa0070645f6e_experiment.xml","84b09b7b17681c370edb2a83eade8619","7401b9e2-25c3-454e-a16b-ba5c9e2726d3",2628,"2016-09-29T20:34:06.848291-05:00","a41e6939-ae45-4c25-93ad-aa0070645f6e_run.xml","0e64f68872a02ef9b35ab9e817b582ab","71c9c02c-f165-4869-93c9-6f94a266e79a",354,"2016-09-08T12:14:13.848617-05:00","TCGA-ZJ-AAXU","2016-09-02T18:54:47.755391-05:00","female","TCGA-ZJ-AAXU_demographic",1959,"white","5be10f7f-4bef-5411-b6c6-95968f2c5df9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXU_diagnosis","not reported",18773,"alive","8072/3",NA,5,"8360549d-a7c2-5a6d-ab08-2400bd029021","c53.9",-18773,"TCGA-ZJ-AAXU_treatment","b504fb7a-8c54-52be-8a06-c190ab54f8c8","01","true","TCGA-ZJ-AAXU-01A",NA,"4ea52eea-1ff8-4b69-ab97-caaadf915136",FALSE,"6A8C28EF-7774-492D-99D0-C197662699AE","Primary Tumor",NA,1437,80,NA,1396224000,"11",30,"TCGA-ZJ-AAXU-01A-11",95,NA,0,NA,0,NA,15,NA,"2016-09-08T12:14:13.848617-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"354ee38b-9e42-41c5-8a6f-00d9aaf741c7",NA,"TCGA-ZJ-AAXU-01A-01-TS1",NA,85,NA,"1e0fcbb5-bd1e-43ba-94b1-9678dfeb0e31","RNA","TCGA-ZJ-AAXU-01A-11R","f966eca3-1414-45dc-94ae-4c5d2fe52139",1.85,0.16,"UV Spec","R","23","TCGA-ZJ-AAXU-01A-11R-A42T-07","39dc6ace-24eb-499b-ad94-64cf08849087",0.16,2.89643835616438,70,25.7116620752984,165,"137507a8-6db0-564d-9073-fad75a2e9622","TCGA-ZJ-AAXU_exposure","UNCID_2654385.39dc6ace-24eb-499b-ad94-64cf08849087.141006_UNC15-SN850_0395_AC5FH9ACXX_7_ATCACG.tar.gz","2014-11-05T08:06:04.000Z","2014-11-05T08:26:26.000Z","A41E6939-AE45-4C25-93AD-AA0070645F6E","4EA52EEA-1FF8-4B69-AB97-CAAADF915136","Unaligned reads",7775238400,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","39DC6ACE-24EB-499B-AD94-64CF08849087","University of North Carolina","566075ade4b016715ab685e3","DDD4B6D2-5BE0-4EDD-977A-A795EEA3C738","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","1E0FCBB5-BD1E-43BA-94B1-9678DFEB0E31","2014-11-05T08:26:26.000Z","F966ECA3-1414-45DC-94AE-4C5D2FE52139","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1437,"1E0FCBB5-BD1E-43BA-94B1-9678DFEB0E31",NA,"ZJ","UNCID_2654385.39dc6ace-24eb-499b-ad94-64cf08849087.141006_UNC15-SN850_0395_AC5FH9ACXX_7_ATCACG.tar.gz",80,"TCGA-ZJ-AAXU-01A",NA,NA,"TCGA",2010,"TCGA-ZJ-AAXU_NTE-1",NA,NA,"FD8C46B4-623F-49B6-A413-094BC9CDB053",51,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXU.xml","Alive",NA,"TCGA-ZJ-AAXU","NOT HISPANIC OR LATINO",NA,NA,5,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8072/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"354EE38B-9E42-41C5-8A6F-00D9AAF741C7","F966ECA3-1414-45DC-94AE-4C5D2FE52139","UNCID_2654385.39dc6ace-24eb-499b-ad94-64cf08849087.141006_UNC15-SN850_0395_AC5FH9ACXX_7_ATCACG.tar.gz","TCGA-ZJ-AAXU-01A-11",95,0,0,0,15,"TOP",0,0,"TCGA-ZJ-AAXU-01A-01-TS1",85,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXU",NA,"ZJ","AAXU","YES","C53.9","8072/3","C53.9","NO","YES",-18773,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",5,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,2,NA,52.86,NA,NA,"2009",13,NA,"T2bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
132578268,127351747,6068196622,"D365A238-4739-4B54-9608-DC548F21C04E.bw","de3cfb81-25c3-4137-8f24-ad8aa607c158","d365a238-4739-4b54-9608-dc548f21c04e","2016-09-29T23:11:13.182480-05:00","UNCID_2553109.f11b075c-7ada-4945-b3a2-2eee097c077d.140408_UNC11-SN627_0351_AC3KY3ACXX_1_ATGTCA.tar.gz","ade3f8e2-fd0f-4bc5-a600-e10e6f907136",5790295663,"Illumina HiSeq","6241ee85c9c7ad49f15b984d84f30e02","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:14:18.811016-05:00","2016-05-03T11:54:19.908545-05:00","ade3f8e2-fd0f-4bc5-a600-e10e6f907136_analysis.xml","271358a773b33e351c955d4442d944d0","8b0586f9-6ab9-4f95-87f8-35e1c51fdc1d",2124,"2016-08-13T06:50:54.757834-05:00","ade3f8e2-fd0f-4bc5-a600-e10e6f907136_experiment.xml","eb1b1e678795ba7b478c1195ae2bc4b8","1c07b6ee-8359-4ff6-bfe4-d0269095e03f",2628,"2016-09-29T21:40:17.012296-05:00","ade3f8e2-fd0f-4bc5-a600-e10e6f907136_run.xml","5eb05f1b9b053b4d5bde432311e3b490","9af5497a-f0e4-42eb-b998-2c5bfa13bda2",354,"2016-09-08T11:30:53.855429-05:00","TCGA-C5-A8YQ","2016-09-02T19:01:09.065483-05:00","female","TCGA-C5-A8YQ_demographic",1927,"white","deb93226-4ffd-5a5f-9ba9-d9a55d1d4132","not hispanic or latino",2007,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8YQ_diagnosis","not reported",28873,"dead","8070/3",715,NA,"6cffd619-5e13-559a-b25d-b0294896507b","c53.9",-28873,"TCGA-C5-A8YQ_treatment","150b3eb3-563b-596f-8c97-52233c6c8764","01","true","TCGA-C5-A8YQ-01A",NA,"08d61f68-2182-4f72-9850-8f1abbf3c4b0",FALSE,"BF1A25FA-5A13-4C4B-8686-342B180FD72F","Primary Tumor",NA,2673,50,NA,1387324800,"11",30,"TCGA-C5-A8YQ-01A-11",90,NA,0,NA,2,NA,8,NA,"2016-09-08T11:30:53.855429-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"602f8be7-4bbf-46db-a38a-e56f8f27749a",NA,"TCGA-C5-A8YQ-01A-01-TS1",NA,90,NA,"1167514b-a118-4c20-b315-d6c4b25afd8d","RNA","TCGA-C5-A8YQ-01A-11R","c9bc4e8e-733f-42ed-b254-47c92186e1cc",1.81,0.15,"UV Spec","R","23","TCGA-C5-A8YQ-01A-11R-A37O-07","f11b075c-7ada-4945-b3a2-2eee097c077d",0.15,3.06849315068493,70,25.7116620752984,165,"b9ecc51d-5732-5ec1-992c-56bad539ef08","TCGA-C5-A8YQ_exposure","UNCID_2553109.f11b075c-7ada-4945-b3a2-2eee097c077d.140408_UNC11-SN627_0351_AC3KY3ACXX_1_ATGTCA.tar.gz","2014-07-31T00:21:06.000Z","2014-07-31T00:43:39.000Z","ADE3F8E2-FD0F-4BC5-A600-E10E6F907136","08D61F68-2182-4F72-9850-8F1ABBF3C4B0","Unaligned reads",5790295663,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","F11B075C-7ADA-4945-B3A2-2EEE097C077D","University of North Carolina","56607500e4b018727fe9fa39","DE3CFB81-25C3-4137-8F24-AD8AA607C158","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","1167514B-A118-4C20-B315-D6C4B25AFD8D","2014-07-31T00:43:39.000Z","C9BC4E8E-733F-42ED-B254-47C92186E1CC","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",2673,"1167514B-A118-4C20-B315-D6C4B25AFD8D",NA,"C5","UNCID_2414924.f11b075c-7ada-4945-b3a2-2eee097c077d.sorted_genome_alignments.bam",50,"TCGA-C5-A8YQ-01A",NA,"ED687F1B-1E47-4D1B-AF20-7C902B7766E3","TCGA",2006,"TCGA-C5-A8YQ_NTE-1",NA,"WITH TUMOR","787995C1-79BA-4FB5-95A7-B6DF8C92C7D7",79,"nationwidechildrens.org_clinical.TCGA-C5-A8YQ.xml","Dead",715,"TCGA-C5-A8YQ","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"B4D5BA3A-A2E3-4B48-8530-6AE2FA51CA93","WHITE",NA,11,30,"602F8BE7-4BBF-46DB-A38A-E56F8F27749A","FEED9C7A-7041-4221-A882-A2C79CD13FA7","UNCID_2414924.f11b075c-7ada-4945-b3a2-2eee097c077d.sorted_genome_alignments.bam","TCGA-C5-A8YQ-01A-11",90,2,0,2,8,"TOP",0,0,"TCGA-C5-A8YQ-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-C5-A8YQ-D58639","TCGA-C5-A8YQ-R58640","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A8YQ",NA,"C5","A8YQ","YES","C53.9","8070/3","C53.9","NO","YES",-28873,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,715,NA,NA,"WITH TUMOR","YES",17,4,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,79,2006,"Biopsy (cervical / CT-guided / Other)","YES",23,3,"G2",NA,2,NA,56,NA,NA,"1995",7,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
167718684,159752736,7621163395,"F70F7ED5-A3B7-4210-95AD-DEFA0A565F06.bw","deda68dd-e9ad-45cc-9dbb-1c5836ef6519","f70f7ed5-a3b7-4210-95ad-defa0a565f06","2016-08-09T13:10:54.115007-05:00","UNCID_2186790.1dbe0951-14cc-4489-aaf2-f3592be05f07.121009_UNC16-SN851_0187_AD15RRACXX_7_ATGTCA.tar.gz","30a32ec4-e251-4b53-b52c-d406c8ad0dc7",7383373207,"Illumina HiSeq","ff5b4803d8f62b798fb2fccd9cbb46f0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:20:48.553728-05:00","2016-05-03T11:01:14.469334-05:00","30a32ec4-e251-4b53-b52c-d406c8ad0dc7_analysis.xml","4a7d039a6d5146c46de5e741fb81f0e8","b3f65938-285a-4df1-a538-95c25ee05c51",2124,"2016-09-29T20:55:31.835932-05:00","30a32ec4-e251-4b53-b52c-d406c8ad0dc7_experiment.xml","90875619bd8d786331d5068f7ebbae90","7f33ebee-fc36-49ac-b66a-774d38f1ef05",2431,"2016-09-29T23:08:58.706592-05:00","30a32ec4-e251-4b53-b52c-d406c8ad0dc7_run.xml","67931767da68c7fb0ec4858bd9d82f46","d1f6011b-fbf6-4b2c-a93a-3ce67a56091a",354,"2016-09-08T12:19:36.166588-05:00","TCGA-EK-A3GJ","2016-09-02T18:58:45.793527-05:00","female","TCGA-EK-A3GJ_demographic",1959,"native hawaiian or other pacific islander","4cb00d40-2fa4-5a1c-8fdf-46a4c703069a","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A3GJ_diagnosis","not reported",18630,"alive","8071/3",NA,3,"fdb28d94-691f-5666-bb31-b80160a1851d","c53.9",-18630,"TCGA-EK-A3GJ_treatment","149b70cc-ae0e-5583-be9a-0168ec6ed77f","01","false","TCGA-EK-A3GJ-01A",NA,"93ab0265-4851-4a8e-bee3-496ea8de56f7",FALSE,"45318527-2DCC-472C-8712-8639CCF4931D","Primary Tumor",NA,407,90,NA,1325808000,"21",30,"TCGA-EK-A3GJ-01A-21",85,NA,1,NA,0,NA,10,NA,"2016-09-08T12:19:36.166588-05:00",NA,8,NA,1,NA,"TOP",NA,5,NA,"09969184-6d2b-4c28-aff6-ab0fa8812483",NA,"TCGA-EK-A3GJ-01A-02-TSB",NA,75,NA,"ac52ccca-9f7e-4697-846f-3238546dba80","RNA","TCGA-EK-A3GJ-01A-21R","0887d254-b9cc-406b-ab7f-7bacad7f7273",1.76,0.17,"UV Spec","R","23","TCGA-EK-A3GJ-01A-21R-A213-07","1dbe0951-14cc-4489-aaf2-f3592be05f07",0.17,NA,96,32.8306145480661,171,"d321eea8-eab4-51e1-a510-667376f6faa0","TCGA-EK-A3GJ_exposure","UNCID_2186790.1dbe0951-14cc-4489-aaf2-f3592be05f07.121009_UNC16-SN851_0187_AD15RRACXX_7_ATGTCA.tar.gz","2013-09-16T15:06:04.000Z","2013-09-16T15:26:02.000Z","30A32EC4-E251-4B53-B52C-D406C8AD0DC7","93AB0265-4851-4A8E-BEE3-496EA8DE56F7","Unaligned reads",7383373207,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1DBE0951-14CC-4489-AAF2-F3592BE05F07","University of North Carolina","566074e0e4b0ec1099f8b24b","DEDA68DD-E9AD-45CC-9DBB-1C5836EF6519","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","AC52CCCA-9F7E-4697-846F-3238546DBA80","2013-09-16T15:26:02.000Z","0887D254-B9CC-406B-AB7F-7BACAD7F7273","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",407,"AC52CCCA-9F7E-4697-846F-3238546DBA80",NA,"EK","TCGA-EK-A3GJ-01A-21R-A214-13_mirna.bam",90,"TCGA-EK-A3GJ-01A",NA,NA,"TCGA",2010,NA,NA,NA,"D21C9094-664F-49DC-8768-178D56256B45",51,"OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_B04_955446.byallele.copynumber.data.txt","Alive",NA,"TCGA-EK-A3GJ",NA,"E17BEEB6-96C2-49FA-BC0A-E375EAEBC545",NA,3,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b1","8071/3","FEMALE","C53.9",200,NA,NA,"NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,21,30,"09969184-6D2B-4C28-AFF6-AB0FA8812483","A039CD9B-650B-4928-9648-304B3EA7BB0C","TCGA-EK-A3GJ-01A-21R-A214-13_mirna.bam","TCGA-EK-A3GJ-01A-21",85,0,1,8,10,"TOP",5,1,"TCGA-EK-A3GJ-01A-02-TSB",75,NA,NA,NA,NA,NA,NA,"TCGA-EK-A3GJ-F58271_NTE-1",NA,3,NA,"Alive",NA,"TCGA-EK-A3GJ-F58271","TCGA-EK-A3GJ",NA,"EK","A3GJ","YES","C53.9","8071/3","C53.9","NO","YES",-18630,"FEMALE","NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER",NA,"No","No","Alive",3,NA,NA,NA,NA,"NO",3,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2010,"Other method, specify:","YES",24,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",7,NA,"T1b1N0",NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
105632188,104404095,4978115097,"A92C23A9-BC25-4025-9501-6D5FF8E2A502.bw","dedfd5fb-3c72-40f9-a7ef-52c2176bf662","a92c23a9-bc25-4025-9501-6d5ff8e2a502","2016-08-26T01:50:02.056068-05:00","UNCID_2553076.8130cfd8-49c8-429d-b559-7ff8f1d359fa.140521_UNC11-SN627_0359_BC4E01ACXX_4_GCCAAT.tar.gz","87e3ebd0-bceb-42b5-a223-9bd4201f3ef9",4254576000,"Illumina HiSeq","099f712cecfd8c04df2df58c8fb8e4f3","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:08:57.457936-05:00","2016-05-03T11:54:19.885282-05:00","87e3ebd0-bceb-42b5-a223-9bd4201f3ef9_analysis.xml","cdd89f5a9a974811f31d4ca5a773d145","d1f1dd0d-60d4-4932-9341-e26b4100c52b",2124,"2016-09-29T18:42:51.177013-05:00","87e3ebd0-bceb-42b5-a223-9bd4201f3ef9_experiment.xml","3f4972bbff590b61a4cda5f0beb669cd","2cd48c0d-4aae-4c2f-a295-d512ed70636d",2628,"2016-09-29T23:40:17.429935-05:00","87e3ebd0-bceb-42b5-a223-9bd4201f3ef9_run.xml","b665784eafbe8cea68306993212eac87","e567b39c-067a-4e5e-8a5f-1b2091ec8b11",354,"2016-09-08T10:48:14.983748-05:00","TCGA-C5-A7XC","2016-09-02T18:54:00.587434-05:00","female","TCGA-C5-A7XC_demographic",1978,"white","c69aa0dc-0450-5987-9da9-5d9c5fec3087","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7XC_diagnosis","not reported",9776,"alive","8070/3",NA,1551,"b73ec19b-525c-5412-85e5-389607d3cafa","c53.9",-9776,"TCGA-C5-A7XC_treatment","7e681fb6-3a96-5864-a01e-eb6d36a99ae2","01","true","TCGA-C5-A7XC-01A",NA,"e8355ff6-e927-4a35-a9c1-512442279a10",FALSE,"5BE71CCD-AA13-4B9E-BD99-2122F9A00B3A","Primary Tumor",NA,3358,30,NA,1391472000,"11",30,"TCGA-C5-A7XC-01A-11",60,NA,0,NA,0,NA,40,NA,"2016-09-08T10:48:14.983748-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"50d083cf-f080-4275-ae93-82e7272d9bc7",NA,"TCGA-C5-A7XC-01A-01-TS1",NA,60,NA,"9b5fc9fd-be10-4c73-865f-3de1ab2881d8","RNA","TCGA-C5-A7XC-01A-11R","be52bcab-9883-4a76-9edd-5c1c7d73d00e",1.92,0.17,"UV Spec","R","23","TCGA-C5-A7XC-01A-11R-A38B-07","8130cfd8-49c8-429d-b559-7ff8f1d359fa",0.17,0.273972602739726,53,NA,NA,"a94ef0c5-97a7-5cbf-8c2c-436ea375b016","TCGA-C5-A7XC_exposure","UNCID_2553076.8130cfd8-49c8-429d-b559-7ff8f1d359fa.140521_UNC11-SN627_0359_BC4E01ACXX_4_GCCAAT.tar.gz","2014-07-30T17:06:04.000Z","2014-07-30T17:29:13.000Z","87E3EBD0-BCEB-42B5-A223-9BD4201F3EF9","E8355FF6-E927-4A35-A9C1-512442279A10","Unaligned reads",4254576000,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8130CFD8-49C8-429D-B559-7FF8F1D359FA","University of North Carolina","564a3c1ae4b0ef12181aa999","DEDFD5FB-3C72-40F9-A7EF-52C2176BF662","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","9B5FC9FD-BE10-4C73-865F-3DE1AB2881D8","2014-07-30T17:29:13.000Z","BE52BCAB-9883-4A76-9EDD-5C1C7D73D00E","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3358,"9B5FC9FD-BE10-4C73-865F-3DE1AB2881D8",NA,"C5","faf0f8178c3c4154121f9c673ce81eb7.bam.bai",30,"TCGA-C5-A7XC-01A",NA,NA,"TCGA",2004,"TCGA-C5-A7XC_NTE-1",NA,"TUMOR FREE","E8355FF6-E927-4A35-A9C1-512442279A10",26,"nationwidechildrens.org_clinical.TCGA-C5-A7XC.xml","Alive",NA,"TCGA-C5-A7XC","NOT HISPANIC OR LATINO","597F6C96-2533-4EFD-879F-DF699D912814","NO",1551,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b","8070/3","FEMALE","C53.9",394,NA,NA,"WHITE",NA,11,30,"50D083CF-F080-4275-AE93-82E7272D9BC7","BE52BCAB-9883-4A76-9EDD-5C1C7D73D00E","faf0f8178c3c4154121f9c673ce81eb7.bam.bai","TCGA-C5-A7XC-01A-11",60,0,0,0,40,"TOP",0,0,"TCGA-C5-A7XC-01A-01-TS1",60,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7XC-F66722_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A7XC-F66722","TCGA-C5-A7XC",NA,"C5","A7XC","YES","C53.9","8070/3","C53.9","NO","YES",-9776,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1551,NA,NA,NA,"TUMOR FREE","YES",7,5,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,26,2004,"Biopsy (cervical / CT-guided / Other)","YES",42,0,"G2",NA,2,NA,5,NA,NA,"1995",7,NA,"T1bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
167589344,165790531,7875003313,"ECE9BBF4-840E-47A6-8378-0B6C4A2369D3.bw","dfd30f94-19e3-4838-95df-14a3763419af","ece9bbf4-840e-47a6-8378-0b6c4a2369d3","2016-08-27T00:38:11.566625-05:00","UNCID_2251240.b9e35423-81e4-4ffe-b08a-4bb93b3cf976.120917_UNC11-SN627_0251_AC119PACXX_1_CGATGT.tar.gz","d8124e5e-6b08-408f-bc62-b2a62752212e",7330330324,"Illumina HiSeq","68f2b74fb3f5d689c1420b42bb414d9a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:22:43.879151-05:00","2016-05-03T11:20:52.084724-05:00","d8124e5e-6b08-408f-bc62-b2a62752212e_analysis.xml","dd4d783e7bb27e8fd8d8bed5cc01a28b","903c16db-218d-4678-afe5-9ff75456bd12",2124,"2016-08-13T04:02:11.332581-05:00","d8124e5e-6b08-408f-bc62-b2a62752212e_experiment.xml","ab006e8c448b8b6c6a67a9bbd25bb8eb","031bef02-6e7d-4e20-901b-19a9c1d7584e",2431,"2016-09-29T20:17:53.161843-05:00","d8124e5e-6b08-408f-bc62-b2a62752212e_run.xml","dcf48610727c55e975984cfc05a638b7","67e1a58e-3e14-47de-a4f4-0e0b927791a7",354,"2016-09-08T12:03:15.135973-05:00","TCGA-DS-A0VL","2016-09-02T18:54:40.791919-05:00","female","TCGA-DS-A0VL_demographic",1976,"white","ea6d52e6-870b-5111-8e12-de787e0db13a","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A0VL_diagnosis","not reported",9186,"alive","8070/3",1692,81,"61224064-9396-51f3-a627-bbbbb2c903de","c53.9",-9186,"TCGA-DS-A0VL_treatment","2c513170-2a8e-5db5-a038-51c4cc48e3f1","01","true","TCGA-DS-A0VL-01A",NA,"cdf4ab19-f243-4efc-a5dc-8253cbe48845",FALSE,"89391955-6647-4F46-969D-9AC4205B2D9C","Primary Tumor",NA,3243,120,NA,1286841600,"21",30,"TCGA-DS-A0VL-01A-21",75,75,0,0,0,0,0,0,"2016-09-08T12:03:15.135973-05:00","2016-09-08T12:03:15.135973-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"c43390c6-200f-458e-8246-07743da5a426","89278db4-383b-40b1-88b1-4caa54ce377c","TCGA-DS-A0VL-01A-02-BSB","TCGA-DS-A0VL-01A-02-TSB",100,100,"0570d958-fdc4-4381-9abc-7493712be245","RNA","TCGA-DS-A0VL-01A-21R","dec71493-560e-463a-963b-5bfb7e96ff19",1.89,0.17,"UV Spec","R","23","TCGA-DS-A0VL-01A-21R-A10U-07","b9e35423-81e4-4ffe-b08a-4bb93b3cf976",0.17,NA,86,29.757785467128,170,"dd79bef4-1f86-5074-b7d5-4c4294405d9f","TCGA-DS-A0VL_exposure","UNCID_2251240.b9e35423-81e4-4ffe-b08a-4bb93b3cf976.120917_UNC11-SN627_0251_AC119PACXX_1_CGATGT.tar.gz","2013-10-26T22:21:04.000Z","2013-10-26T23:02:01.000Z","D8124E5E-6B08-408F-BC62-B2A62752212E","CDF4AB19-F243-4EFC-A5DC-8253CBE48845","Unaligned reads",7330330324,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B9E35423-81E4-4FFE-B08A-4BB93B3CF976","University of North Carolina","5660743ce4b0ca319164c0f1","DFD30F94-19E3-4838-95DF-14A3763419AF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0570D958-FDC4-4381-9ABC-7493712BE245","2013-10-26T23:02:01.000Z","DEC71493-560E-463A-963B-5BFB7E96FF19","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",3243,"0570D958-FDC4-4381-9ABC-7493712BE245",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.8B8C4526-49B9-4DF0-9298-772F08C6CC21.txt",120,"TCGA-DS-A0VL-01A",NA,NA,"TCGA",2001,NA,NA,"TUMOR FREE","CDF4AB19-F243-4EFC-A5DC-8253CBE48845",25,"AMAZE_p_TCGASNP_b86_87_88_N_GenomeWideSNP_6_E02_735550.hg18.seg.txt","Alive",NA,"TCGA-DS-A0VL",NA,"126FEA22-F84C-4738-AF33-D7CE6B31FFFE",NA,81,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",88,NA,NA,"WHITE",NA,21,30,"C43390C6-200F-458E-8246-07743DA5A426","DEC71493-560E-463A-963B-5BFB7E96FF19","UNCID_2251240.b9e35423-81e4-4ffe-b08a-4bb93b3cf976.120917_UNC11-SN627_0251_AC119PACXX_1_CGATGT.tar.gz","TCGA-DS-A0VL-01A-21",75,0,0,0,0,"TOP",0,0,"TCGA-DS-A0VL-01A-02-TSB",100,NA,NA,NA,NA,NA,NA,"TCGA-DS-A0VL-F71085_NTE-1",NA,81,"TUMOR FREE","Alive",NA,"TCGA-DS-A0VL-F71085","TCGA-DS-A0VL",NA,"DS","A0VL","YES","C53.9","8070/3","C53.9","NO","YES",-9186,"FEMALE","WHITE",NA,"No","No","Alive",81,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,25,2001,"Biopsy (cervical / CT-guided / Other)",NA,8,0,"G2",NA,1,NA,NA,NA,NA,NA,6,NA,"T1b1N0M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
139424686,136667668,6517603984,"38749490-0FCF-4B33-9EBC-8F86C2D9E4AF.bw","e0a5d99b-b58b-4301-b2dc-a767d90059b1","38749490-0fcf-4b33-9ebc-8f86c2d9e4af","2016-08-25T16:02:44.609071-05:00","UNCID_2553097.79a31785-793f-4878-8c09-64c8fb0c53e3.140408_UNC11-SN627_0351_AC3KY3ACXX_8_ACAGTG.tar.gz","374319fc-8430-47af-9778-6e6f813c8e27",6000105415,"Illumina HiSeq","a64c90d269fff3963850f3c56c8dc76f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:57:53.863610-05:00","2016-05-03T11:54:19.885282-05:00","374319fc-8430-47af-9778-6e6f813c8e27_analysis.xml","5f20b72bff114567476ae667d8cc8087","80aaa69d-f69e-4be0-af5c-dda4639fad0b",2124,"2016-09-29T22:11:38.129388-05:00","374319fc-8430-47af-9778-6e6f813c8e27_experiment.xml","44109bf6e5c4515bd71d693ecafa3b65","ae5e76b3-91f3-475d-8b52-ad5d2a9bf19d",2628,"2016-09-29T21:21:48.789439-05:00","374319fc-8430-47af-9778-6e6f813c8e27_run.xml","d52e2774bf97d49cf460757e2d709eb7","8fa4f6f9-bf7e-42b4-abad-986a2e69ffdd",354,"2016-09-08T12:14:26.175955-05:00","TCGA-VS-A8EL","2016-09-02T19:01:17.929391-05:00","female","TCGA-VS-A8EL_demographic",1971,"black or african american","bbb2c806-a430-534a-8659-5a920b56eebc","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A8EL_diagnosis","not reported",14162,"alive","8070/3",NA,1992,"5d164433-d20b-517d-9ff4-76fadcbf6ee9","c53.9",-14162,"TCGA-VS-A8EL_treatment","c5fe1940-719c-5458-8661-5a72d2115d47","01","false","TCGA-VS-A8EL-01A",NA,"9e2b9edd-5fed-4283-a46f-a8185a911e94",FALSE,"14765542-0003-41A9-8863-BDC90E87594D","Primary Tumor",NA,1589,60,NA,1384732800,"11",30,"TCGA-VS-A8EL-01A-11",80,NA,20,NA,0,NA,10,NA,"2016-09-08T12:14:26.175955-05:00",NA,20,NA,40,NA,"TOP",NA,10,NA,"7d51bd19-79a8-4afe-96bf-f6e36b02bb62",NA,"TCGA-VS-A8EL-01A-01-TS1",NA,80,NA,"e34d561a-0bd4-4fc1-bf05-f6cd5d3669c3","RNA","TCGA-VS-A8EL-01A-11R","df4e681a-348c-4795-aa07-8e0da005c796",2.02,0.15,"UV Spec","R","23","TCGA-VS-A8EL-01A-11R-A37O-07","79a31785-793f-4878-8c09-64c8fb0c53e3",0.15,NA,78,28.3059950645957,166,"c71c93ac-c4cc-5f2a-b800-bd21e94feaa8","TCGA-VS-A8EL_exposure","UNCID_2553097.79a31785-793f-4878-8c09-64c8fb0c53e3.140408_UNC11-SN627_0351_AC3KY3ACXX_8_ACAGTG.tar.gz","2014-07-30T22:06:04.000Z","2014-07-30T22:32:21.000Z","374319FC-8430-47AF-9778-6E6F813C8E27","9E2B9EDD-5FED-4283-A46F-A8185A911E94","Unaligned reads",6000105415,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","79A31785-793F-4878-8C09-64C8FB0C53E3","University of North Carolina","566075bde4b016715ab686a9","E0A5D99B-B58B-4301-B2DC-A767D90059B1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","E34D561A-0BD4-4FC1-BF05-F6CD5D3669C3","2014-07-30T22:32:22.000Z","DF4E681A-348C-4795-AA07-8E0DA005C796","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1589,"E34D561A-0BD4-4FC1-BF05-F6CD5D3669C3",NA,"VS","TCGA-VS-A8EL-01A-11R-A37P-13_mirna.bam.bai",60,"TCGA-VS-A8EL-01A",NA,"B38CCD33-80D7-4EDA-B3C7-28F024DC880D","TCGA",2009,"TCGA-VS-A8EL_NTE-1","Complete Remission/Response","TUMOR FREE","9E2B9EDD-5FED-4283-A46F-A8185A911E94",38,"nationwidechildrens.org_clinical.TCGA-VS-A8EL.xml","Alive",NA,"TCGA-VS-A8EL",NA,"610391F8-F961-4C1A-8B2B-973601BA9E65","NO",1628,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",380,NA,"C071FCDE-F24A-4383-BA80-62368BE4AF60","BLACK OR AFRICAN AMERICAN",NA,11,30,"7D51BD19-79A8-4AFE-96BF-F6E36B02BB62","DF4E681A-348C-4795-AA07-8E0DA005C796","9828653016_R05C02_Red.idat","TCGA-VS-A8EL-01A-11",80,0,20,20,10,"TOP",10,40,"TCGA-VS-A8EL-01A-01-TS1",80,"Cisplatin","Chemotherapy","TCGA-VS-A8EL-D64589","TCGA-VS-A8EL-R61987","External","Regional site","TCGA-VS-A8EL-F71214_NTE-1","NO",1992,"TUMOR FREE","Alive",NA,"TCGA-VS-A8EL-F71214","TCGA-VS-A8EL",NA,"VS","A8EL","YES","C53.9","8070/3","C53.9","NO","YES",-14162,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",1628,NA,NA,NA,"TUMOR FREE","YES",22,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2009,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bNXM0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
144145962,141703799,6761328475,"02ABB64E-768B-4999-A899-EEE573D5F186.bw","e15d92a1-6925-4b58-a494-d6f665f67b83","02abb64e-768b-4999-a899-eee573d5f186","2016-08-24T13:36:27.598186-05:00","UNCID_2278251.9f1118f7-2469-4161-9930-58af9b633b66.131021_UNC9-SN296_0409_BC2M6NACXX_4_TTAGGC.tar.gz","8491d5e8-7a7b-4176-b470-d3394c7b3a36",7129532704,"Illumina HiSeq","c39f969465655ca421d4c1254308822a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:10:16.706843-05:00","2016-05-03T11:24:56.858865-05:00","8491d5e8-7a7b-4176-b470-d3394c7b3a36_analysis.xml","2661bbaee4ecfbc5458b5bc578519e66","186d6a42-eccb-48f1-b8f7-9d900b5bf90d",2122,"2016-09-29T23:46:07.150581-05:00","8491d5e8-7a7b-4176-b470-d3394c7b3a36_experiment.xml","523cd5090aa8e118cb27cf262994d97f","e918d4b7-ec84-409d-97ec-484bfb089e3a",2431,"2016-09-29T23:35:21.952754-05:00","8491d5e8-7a7b-4176-b470-d3394c7b3a36_run.xml","2642d0f901c340370e02b68c24c0447e","e2596529-4125-4c53-bd14-b57d895d3a20",354,"2016-09-08T11:22:24.757601-05:00","TCGA-LP-A4AU","2016-09-02T18:59:39.940759-05:00","female","TCGA-LP-A4AU_demographic",1976,"asian","ed9e8dd1-53a6-5216-9310-b92dc0041625","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A4AU_diagnosis","not reported",13074,"alive","8070/3",NA,343,"d71b670f-6307-523c-ae36-d203d512a7a8","c53.9",-13074,"TCGA-LP-A4AU_treatment","265013a0-daa6-5075-bcf1-c7d7dbc4bdab","01","true","TCGA-LP-A4AU-01A",NA,"0eeab2b9-8e74-4d25-841f-38634d580a69",FALSE,"A929AD30-1751-4BEB-BB5C-B5D191565385","Primary Tumor",NA,272,500,NA,1348531200,"32",20,"TCGA-LP-A4AU-01A-32",80,NA,0,NA,3,NA,0,NA,"2016-09-08T11:22:24.757601-05:00",NA,2,NA,0,NA,"TOP",NA,2,NA,"57b55507-7d7b-4e61-b0a2-a776e58fcc90",NA,"TCGA-LP-A4AU-01A-03-TSC",NA,95,NA,"8b24f9bd-b44c-4161-a357-d85fedebdb58","RNA","TCGA-LP-A4AU-01A-32R","b25637ed-bb6f-4e1c-bad8-f89655da07d2",1.77,0.16,"UV Spec","R","23","TCGA-LP-A4AU-01A-32R-A32Y-07","9f1118f7-2469-4161-9930-58af9b633b66",0.16,NA,49,20.9321201247383,153,"b0795695-3c22-5150-b5f8-c051dec9be23","TCGA-LP-A4AU_exposure","UNCID_2278251.9f1118f7-2469-4161-9930-58af9b633b66.131021_UNC9-SN296_0409_BC2M6NACXX_4_TTAGGC.tar.gz","2013-11-22T06:36:04.000Z","2013-11-22T07:03:02.000Z","8491D5E8-7A7B-4176-B470-D3394C7B3A36","0EEAB2B9-8E74-4D25-841F-38634D580A69","Unaligned reads",7129532704,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","9F1118F7-2469-4161-9930-58AF9B633B66","University of North Carolina","56607490e4b018727fe9f45d","E15D92A1-6925-4B58-A494-D6F665F67B83","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8B24F9BD-B44C-4161-A357-D85FEDEBDB58","2013-11-22T07:03:02.000Z","B25637ED-BB6F-4E1C-BAD8-F89655DA07D2","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",272,"8B24F9BD-B44C-4161-A357-D85FEDEBDB58",NA,"LP","TCGA-LP-A4AU-01A-32R-A24J-13_mirna.bam",500,"TCGA-LP-A4AU-01A",NA,"36DCFD67-54B3-451B-BF22-25FE9393781B","TCGA",2011,"TCGA-LP-A4AU_NTE-1",NA,"TUMOR FREE","183CD482-306B-4989-81C2-97A1EC2AFFE2",35,"nationwidechildrens.org_clinical.TCGA-LP-A4AU.xml","Alive",NA,"TCGA-LP-A4AU","NOT HISPANIC OR LATINO","0DEC8F9D-F9CC-45C9-892A-1CE7F40CF7E7","NO",3,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",3,"Other","Stage IIIB",NA,NA,"T2","8070/3","FEMALE","C53.9",256,NA,"16B40533-1E57-49D9-9A3E-10A1BDA3567A","ASIAN",NA,32,20,"57B55507-7D7B-4E61-B0A2-A776E58FCC90","319817AE-9AB9-41EC-A431-09C4C256CBDB","13d92ef76d5e23806b6781720a6c7703.bam.bai","TCGA-LP-A4AU-01A-32",80,3,0,2,0,"TOP",2,0,"TCGA-LP-A4AU-01A-03-TSC",95,"5FU","Chemotherapy","TCGA-LP-A4AU-D58087","TCGA-LP-A4AU-R60812","External","Primary Tumor Field","TCGA-LP-A4AU-F58081_NTE-1","NO",343,"TUMOR FREE","Alive",NA,"TCGA-LP-A4AU-F58081","TCGA-LP-A4AU",NA,"LP","A4AU","YES","C53.9","8070/3","C53.9","YES","NO",-13074,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",3,NA,NA,NA,"TUMOR FREE","YES",12,3,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2011,"Biopsy (cervical / CT-guided / Other)","YES",NA,NA,"G3",NA,1,NA,NA,NA,NA,"2009",16,NA,"T2N1M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
186139964,182947481,8737018248,"C1C467A8-18B1-4C3F-AC45-33359ED6FDC4.bw","e2ff7cfd-a101-45b9-895f-26f403e7bdfb","c1c467a8-18b1-4c3f-ac45-33359ed6fdc4","2016-08-09T13:12:42.369416-05:00","UNCID_2186820.cf0a3802-710c-4ec7-9778-2d8150656ab7.121009_UNC16-SN851_0187_AD15RRACXX_6_AGTCAA.tar.gz","5c656e79-8b31-42fd-a0f1-e40d9aba8112",8338900871,"Illumina HiSeq","39131fe298f1699be8f1dbb12287df7f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:25:22.203302-05:00","2016-05-03T11:01:14.469334-05:00","5c656e79-8b31-42fd-a0f1-e40d9aba8112_analysis.xml","0cb0feb00dcd721407af1b34b5f517d0","47a540d1-9bb6-4cfd-a81d-427fcde8b569",2124,"2016-09-29T23:17:35.336822-05:00","5c656e79-8b31-42fd-a0f1-e40d9aba8112_experiment.xml","030366c9e4aab47b6c16dbb21a94085e","d730a8d8-b936-4042-ab3c-16e508b026f8",2431,"2016-09-29T21:59:09.528607-05:00","5c656e79-8b31-42fd-a0f1-e40d9aba8112_run.xml","6ab134204a9540be43cc9017e3cc0c4d","a6d4cc32-1120-4938-9a0b-9023fed4ee38",354,"2016-09-08T11:48:03.454693-05:00","TCGA-HG-A2PA","2016-09-02T18:58:50.199488-05:00","female","TCGA-HG-A2PA_demographic",1971,"white","f7df9b45-facb-5e46-ab9c-b1d270339e7a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HG","5135fe92-5d80-5d69-871b-2d9cc5c630b5","Roswell Park","not reported","c53.9","TCGA-HG-A2PA_diagnosis","not reported",14025,"dead","8070/3",773,773,"1b061704-d810-54e5-b56e-be1789721be8","c53.9",-14025,"TCGA-HG-A2PA_treatment","9cffb20f-d798-502e-aa61-4c32511d852c","01","true","TCGA-HG-A2PA-01A",NA,"235dbd13-5052-4e19-9c1c-a72a1a9a79ce",FALSE,"63D65B11-EE47-4B19-A811-56D61DB0D7EC","Primary Tumor",NA,729,180,NA,1314316800,"11",30,"TCGA-HG-A2PA-01A-11",90,NA,1,NA,15,NA,4,NA,"2016-09-08T11:48:03.454693-05:00",NA,7,NA,0,NA,"TOP",NA,1,NA,"3d436789-2d90-41f3-82cc-a4dcfa1985ca",NA,"TCGA-HG-A2PA-01A-01-TSA",NA,80,NA,"828389b6-9ec3-4887-ba37-3fa8a8a40f6e","RNA","TCGA-HG-A2PA-01A-11R","ef633001-5c97-4003-b8c6-d591354c548e",1.85,0.16,"UV Spec","R","23","TCGA-HG-A2PA-01A-11R-A213-07","cf0a3802-710c-4ec7-9778-2d8150656ab7",0.16,NA,95,35.3212373587151,164,"b7e9c982-965a-52fb-add9-e5dcdde49d56","TCGA-HG-A2PA_exposure","UNCID_2186820.cf0a3802-710c-4ec7-9778-2d8150656ab7.121009_UNC16-SN851_0187_AD15RRACXX_6_AGTCAA.tar.gz","2013-09-16T15:16:05.000Z","2013-09-16T15:51:01.000Z","5C656E79-8B31-42FD-A0F1-E40D9ABA8112","235DBD13-5052-4E19-9C1C-A72A1A9A79CE","Unaligned reads",8338900871,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CF0A3802-710C-4EC7-9778-2D8150656AB7","University of North Carolina","564a3b15e4b0ef12181a5775","E2FF7CFD-A101-45B9-895F-26F403E7BDFB","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","828389B6-9EC3-4887-BA37-3FA8A8A40F6E","2013-09-16T15:51:01.000Z","EF633001-5C97-4003-B8C6-D591354C548E","United States","NO",1,NA,"Primary Tumor","Roswell Park",729,"828389B6-9EC3-4887-BA37-3FA8A8A40F6E",NA,"HG","6929793021_R02C01_Grn.idat",180,"TCGA-HG-A2PA-01A",NA,"EE17B0E2-CE3E-43C0-80C9-57134F94BA7C","TCGA",2009,NA,NA,"WITH TUMOR","6BF28F80-8EB4-48E6-B63C-6FD68F41F42F",38,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.265071B8-67FE-4D9C-BA29-34AF6E92F53D.txt","Alive",NA,"TCGA-HG-A2PA","NOT HISPANIC OR LATINO","231EFDE1-8D48-4D3E-AA49-90D0C9399DC8",NA,773,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB2",NA,NA,"T1b2","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"3D436789-2D90-41F3-82CC-A4DCFA1985CA","F0FACA71-C52E-4028-85F7-2CF0D8B9F4BC","TCGA-HG-A2PA-01A-11R-A214-13_mirna.bam.bai","TCGA-HG-A2PA-01A-11",90,15,1,7,4,"TOP",1,0,"TCGA-HG-A2PA-01A-01-TSA",80,"Taxol","Chemotherapy","TCGA-HG-A2PA-D33512",NA,NA,NA,"TCGA-HG-A2PA-F33511_NTE-1","YES",NA,"WITH TUMOR","Dead",773,"TCGA-HG-A2PA-F33511","TCGA-HG-A2PA",NA,"HG","A2PA","YES","C53.9","8070/3","C53.9","NO","YES",-14025,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",773,NA,NA,NA,"WITH TUMOR","NO",23,12,2011,"YES","YES","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2009,"Biopsy (cervical / CT-guided / Other)","YES",30,0,"G2",NA,2,NA,NA,NA,NA,"2009",8,NA,"T1b2N0M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
119425746,117075131,5591316104,"78B2E4A1-9DAE-404F-AB47-1896450EF254.bw","e711b88e-fa0e-4781-8549-7a53ed3a13a1","78b2e4a1-9dae-404f-ab47-1896450ef254","2016-08-05T11:57:17.863288-05:00","UNCID_2187255.694a3bf4-f789-4aef-9dc8-13f4f8ae0283.120921_UNC16-SN851_0181_AD14JFACXX_4_GCCAAT.tar.gz","3d81b2a6-91e2-4de3-bfb3-2e32bc1f1898",5078521978,"Illumina HiSeq","53dd3c7873aeca5d2054ac3cb4f7f5fd","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:45:59.921556-05:00","2016-05-03T11:02:00.403413-05:00","3d81b2a6-91e2-4de3-bfb3-2e32bc1f1898_analysis.xml","a980672ad7a187af43c844da293ee1a4","9e8b3b56-5fbe-4463-8096-89176c11378c",2124,"2016-09-29T23:23:33.221076-05:00","3d81b2a6-91e2-4de3-bfb3-2e32bc1f1898_experiment.xml","e285733992295fe73f379fe37f491884","dae06c57-350a-4ee2-973e-d00682d433eb",2431,"2016-09-29T20:35:54.272956-05:00","3d81b2a6-91e2-4de3-bfb3-2e32bc1f1898_run.xml","51c0884788388da479f47ec066d5722d","72ecfede-b10b-49ee-ad27-9b038c64e662",354,"2016-09-08T13:30:47.220790-05:00","TCGA-DS-A1OC","2016-09-02T18:57:43.585905-05:00","female","TCGA-DS-A1OC_demographic",1963,"white","8cfb2e51-546c-5789-b478-7829f5e9474c","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A1OC_diagnosis","not reported",17357,"alive","8070/3",NA,376,"8797991c-c912-55d5-861c-adc162915a6d","c53.9",-17357,"TCGA-DS-A1OC_treatment","1852b30e-56bc-5a22-a64b-c6fb69bb1936","01","true","TCGA-DS-A1OC-01A",NA,"3b3d08f6-0463-4647-87cb-86f64509e3cd",FALSE,"8E48E714-87FA-4B0A-86DB-75E58784AA2C","Primary Tumor",NA,378,190,NA,1302480000,"11",30,"TCGA-DS-A1OC-01A-11",80,NA,5,NA,0,NA,15,NA,"2016-09-08T13:30:47.220790-05:00",NA,40,NA,30,NA,"TOP",NA,5,NA,"7aea5d60-7b9b-4641-8ee3-74f7f062cd98",NA,"TCGA-DS-A1OC-01A-01-TSA",NA,80,NA,"b7c17afb-1b4b-434c-bd22-6603ded9a2c0","RNA","TCGA-DS-A1OC-01A-11R","a698a974-4765-4689-a2f9-fbaaa77a659a",1.92,0.16,"UV Spec","R","23","TCGA-DS-A1OC-01A-11R-A14Y-07","694a3bf4-f789-4aef-9dc8-13f4f8ae0283",0.16,NA,78,39.7959183673469,140,"49fbeed7-e424-544f-9f83-3af19a67984f","TCGA-DS-A1OC_exposure","UNCID_2187255.694a3bf4-f789-4aef-9dc8-13f4f8ae0283.120921_UNC16-SN851_0181_AD14JFACXX_4_GCCAAT.tar.gz","2013-09-17T05:16:04.000Z","2013-09-17T05:31:01.000Z","3D81B2A6-91E2-4DE3-BFB3-2E32BC1F1898","3B3D08F6-0463-4647-87CB-86F64509E3CD","Unaligned reads",5078521978,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","694A3BF4-F789-4AEF-9DC8-13F4F8AE0283","University of North Carolina","56607677e4b016715ab68ee7","E711B88E-FA0E-4781-8549-7A53ED3A13A1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B7C17AFB-1B4B-434C-BD22-6603DED9A2C0","2013-09-17T05:31:01.000Z","A698A974-4765-4689-A2F9-FBAAA77A659A","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",378,"B7C17AFB-1B4B-434C-BD22-6603DED9A2C0",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.53BE8C06-2C3C-42EF-A4B8-202A39B34E36.txt",190,"TCGA-DS-A1OC-01A",NA,"98AB3883-AF06-4239-BC79-D7D1BC76FBD7","TCGA",2010,NA,NA,"TUMOR FREE","9F3D6908-B1C1-4B0C-94C8-6FF459D689CC",47,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.53BE8C06-2C3C-42EF-A4B8-202A39B34E36.txt","Alive",NA,"TCGA-DS-A1OC","HISPANIC OR LATINO","DFC8B6C2-1077-4131-B99C-1BFB21836B09",NA,376,"Yes","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",127,NA,"A95697FD-5421-4DE3-84A2-3571920993EE","WHITE",NA,11,30,"7AEA5D60-7B9B-4641-8EE3-74F7F062CD98","F8CE9700-775F-4094-8F17-F3AFF3576315","UNCID_1658077.694a3bf4-f789-4aef-9dc8-13f4f8ae0283.sorted_genome_alignments.bam","TCGA-DS-A1OC-01A-11",80,0,5,40,15,"TOP",5,30,"TCGA-DS-A1OC-01A-01-TSA",80,"Gemzar","Chemotherapy","TCGA-DS-A1OC-D15191","TCGA-DS-A1OC-R15189","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",376,"TUMOR FREE","Alive",NA,"TCGA-DS-A1OC-F15188","TCGA-DS-A1OC",NA,"DS","A1OC","YES","C53.9","8070/3","C53.9","NO","YES",-17357,"FEMALE","WHITE","HISPANIC OR LATINO","Yes","No","Alive",376,NA,NA,NA,"TUMOR FREE","NO",12,8,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2010,"Biopsy (cervical / CT-guided / Other)","YES",19,2,"G2",NA,4,NA,NA,NA,NA,"2009",6,NA,"T1b1N1M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
109124246,103481829,4935328922,"CCDB0290-91DA-4089-84A6-4434BA028D30.bw","e733f289-a0ec-478c-aad9-1378ad26ddfa","ccdb0290-91da-4089-84a6-4434ba028d30","2016-08-05T06:12:10.108328-05:00","UNCID_2234793.0046fef7-052b-4d4e-b264-b3bf2e2699b1.121002_UNC11-SN627_0254_AC0WP5ACXX_4_GTGGCC.tar.gz","e0b337ce-8e93-4a17-9097-0d8929153394",4601927470,"Illumina HiSeq","0ba8d3c3df6a25c60d150f927fc6bbd0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:59:38.748358-05:00","2016-05-03T11:20:13.161874-05:00","e0b337ce-8e93-4a17-9097-0d8929153394_analysis.xml","339ddafdb3b9c371593bab1b3fbed570","11bf5e98-58bc-4620-8e3e-9f731665978f",2124,"2016-09-29T19:35:04.326574-05:00","e0b337ce-8e93-4a17-9097-0d8929153394_experiment.xml","05c23f3ec175b01d7e43d4e901e7d26c","4dab4b5d-64d4-4b86-b67b-28fb0a94effe",2431,"2016-09-29T23:31:30.648191-05:00","e0b337ce-8e93-4a17-9097-0d8929153394_run.xml","32e2ece5559bceab3bc70da8597f7874","dffa1178-cee5-4e8f-b01e-cebf34eabb59",354,"2016-09-08T11:40:15.113181-05:00","TCGA-C5-A2LY","2016-09-02T18:57:51.479353-05:00","female","TCGA-C5-A2LY_demographic",1972,"white","42974369-f1be-57e7-9098-4ec86e8d0ecd","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LY_diagnosis","not reported",11018,"alive","8070/3",NA,2383,"511d17ea-4467-5651-9706-d85be4c9d00b","c53.9",-11018,"TCGA-C5-A2LY_treatment","3c410351-0b58-59d5-b520-a0bc9a8a1bf3","01","false","TCGA-C5-A2LY-01A",NA,"298b78b6-2508-4247-a4e9-aee460786f98",FALSE,"BA97051E-10A1-46D8-B5EF-D8163C5430D9","Primary Tumor",NA,3169,220,NA,1314662400,"31",30,"TCGA-C5-A2LY-01A-31",80,NA,20,NA,0,NA,15,NA,"2016-09-08T11:40:15.113181-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"11eb5f7e-74f5-4227-a5bd-d5947cf630a7",NA,"TCGA-C5-A2LY-01A-03-TSC",NA,80,NA,"2861ea6c-76c2-4bb8-b746-f52a2e8b8e27","RNA","TCGA-C5-A2LY-01A-31R","e3f3d54f-6138-4858-9c63-08afdbc36497",1.87,0.17,"UV Spec","R","23","TCGA-C5-A2LY-01A-31R-A18M-07","0046fef7-052b-4d4e-b264-b3bf2e2699b1",0.17,NA,88,34.375,160,"e9caf22a-57c8-5d9e-ad4a-e1bc12ab9e3d","TCGA-C5-A2LY_exposure","UNCID_2234793.0046fef7-052b-4d4e-b264-b3bf2e2699b1.121002_UNC11-SN627_0254_AC0WP5ACXX_4_GTGGCC.tar.gz","2013-10-19T00:51:05.000Z","2013-10-19T01:07:02.000Z","E0B337CE-8E93-4A17-9097-0D8929153394","298B78B6-2508-4247-A4E9-AEE460786F98","Unaligned reads",4601927470,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0046FEF7-052B-4D4E-B264-B3BF2E2699B1","University of North Carolina","566074e6e4b018727fe9f8e0","E733F289-A0EC-478C-AAD9-1378AD26DDFA","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2861EA6C-76C2-4BB8-B746-F52A2E8B8E27","2013-10-19T01:07:02.000Z","E3F3D54F-6138-4858-9C63-08AFDBC36497","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3169,"2861EA6C-76C2-4BB8-B746-F52A2E8B8E27",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.C159F07D-C0B9-450E-BC7D-777552F38ADD.txt",220,"TCGA-C5-A2LY-01A",NA,"9DC32BEE-25A6-48D6-A582-A6E165A5813B","TCGA",2002,NA,NA,"TUMOR FREE","80879749-FD29-4988-A078-CD34D4745453",30,"79336789b2b54dd5a911c6a486795271.bam.bai","Alive",NA,"TCGA-C5-A2LY","NOT HISPANIC OR LATINO","711C6875-24AC-43F0-8A0C-04FB1AA8307E",NA,2383,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",179,NA,"396BAC85-FCF8-492B-B9BE-0883FDC45685","WHITE",NA,31,30,"11EB5F7E-74F5-4227-A5BD-D5947CF630A7","C316791D-3BAB-4898-8A9A-450812E52EE0","TCGA-C5-A2LY-01A-31R-A18L-13_mirna.bam.bai","TCGA-C5-A2LY-01A-31",80,0,20,40,15,"TOP",5,20,"TCGA-C5-A2LY-01A-03-TSC",80,"Cisplatin","Chemotherapy","TCGA-C5-A2LY-D21305","TCGA-C5-A2LY-R21307","COMBINATION","Primary Tumor Field",NA,"NO",2383,"TUMOR FREE","Alive",NA,"TCGA-C5-A2LY-F20978","TCGA-C5-A2LY",NA,"C5","A2LY","YES","C53.9","8070/3","C53.9","NO","YES",-11018,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2383,NA,NA,NA,"TUMOR FREE","NO",25,1,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,30,2002,"Biopsy (cervical / CT-guided / Other)","YES",8,0,"G2",NA,1,NA,NA,NA,NA,"1995",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
190791424,184649210,8801598853,"D5041E80-20A0-4C1A-9AC1-2394F6DB6E92.bw","e77c3f70-08d1-40d3-b038-f09a519423cc","d5041e80-20a0-4c1a-9ac1-2394f6db6e92","2016-08-06T23:34:39.349643-05:00","UNCID_2186834.ab31f363-93f1-4ef9-a47a-731657fdf534.121009_UNC16-SN851_0187_AD15RRACXX_2_TGACCA.tar.gz","b3aa5676-4409-442b-bd49-c9fdc3768ea5",8578326373,"Illumina HiSeq","ff3b7a914b1852e5eec712e8949dfe61","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:53:27.445788-05:00","2016-05-03T11:00:24.456168-05:00","b3aa5676-4409-442b-bd49-c9fdc3768ea5_analysis.xml","3debdf1e4bb31e9d44280a28547114a4","c85d49c6-bb7a-4b6c-9f08-25fd8c20cf1b",2124,"2016-08-13T05:54:31.095149-05:00","b3aa5676-4409-442b-bd49-c9fdc3768ea5_experiment.xml","b8ce3602701ac480ab425a4a3feed61f","5015aa2b-5e18-4e8f-b884-ac79d521d832",2431,"2016-09-29T22:46:48.513719-05:00","b3aa5676-4409-442b-bd49-c9fdc3768ea5_run.xml","2330ba064bae388abbf80f05024f3a8d","c437bb94-7475-4432-bfd4-96cd99d49e61",354,"2016-09-08T11:41:30.435346-05:00","TCGA-C5-A1BQ","2016-09-02T18:58:39.023605-05:00","female","TCGA-C5-A1BQ_demographic",1937,"white","be578d3f-a3cc-5b26-82e6-8d8e0bed0125","not hispanic or latino",2003,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1BQ_diagnosis","not reported",24018,"dead","8071/3",604,NA,"c0cfa558-d4e0-5c06-816c-fb7905359b12","c53.9",-24018,"TCGA-C5-A1BQ_treatment","d91edc7a-a9bb-5754-96f4-f436ce2cd0b5","01","true","TCGA-C5-A1BQ-01C",NA,"6ef38e19-07ac-4032-8fb4-59129a126d3f",FALSE,"567FBF76-C88B-4D5A-804F-D93C536B2CAC","Primary Tumor",NA,3311,40,NA,1323734400,"11",30,"TCGA-C5-A1BQ-01C-11",90,NA,0,NA,0,NA,10,NA,"2016-09-08T11:41:30.435346-05:00",NA,10,NA,10,NA,"TOP",NA,20,NA,"98edb638-ed5e-47fb-833e-7d762b7f4550",NA,"TCGA-C5-A1BQ-01C-01-TS1",NA,70,NA,"70d8178b-b378-48bf-a0af-e783d1bc0bc6","RNA","TCGA-C5-A1BQ-01C-11R","f8140824-3ff1-4911-9298-252392cd18f4",1.8,0.16,"UV Spec","R","23","TCGA-C5-A1BQ-01C-11R-A213-07","ab31f363-93f1-4ef9-a47a-731657fdf534",0.16,1.36986301369863,69,31.9311398028599,147,"7b1df006-311d-5300-be55-79b8cd9a1761","TCGA-C5-A1BQ_exposure","UNCID_2186834.ab31f363-93f1-4ef9-a47a-731657fdf534.121009_UNC16-SN851_0187_AD15RRACXX_2_TGACCA.tar.gz","2013-09-16T18:46:04.000Z","2013-09-16T07:18:01.000Z","B3AA5676-4409-442B-BD49-C9FDC3768EA5","6EF38E19-07AC-4032-8FB4-59129A126D3F","Unaligned reads",8578326373,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AB31F363-93F1-4EF9-A47A-731657FDF534","University of North Carolina","564a3f9ce4b0ef12181bc98c","E77C3F70-08D1-40D3-B038-F09A519423CC","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","70D8178B-B378-48BF-A0AF-E783D1BC0BC6","2013-09-16T07:18:01.000Z","F8140824-3FF1-4911-9298-252392CD18F4","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3311,"70D8178B-B378-48BF-A0AF-E783D1BC0BC6",NA,"C5","TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.bam",40,"TCGA-C5-A1BQ-01C",NA,"A9F43408-7749-4CDF-9C60-6D3B1C4AE50F","TCGA",2002,"TCGA-C5-A1BQ_NTE-1","Partial Remission/Response","TUMOR FREE","6EF38E19-07AC-4032-8FB4-59129A126D3F",65,"nationwidechildrens.org_clinical.TCGA-C5-A1BQ.xml","Dead",604,"TCGA-C5-A1BQ","NOT HISPANIC OR LATINO","B04B5A51-6D6D-48AF-A668-732CD51F1A07","NO",NA,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,NA,"8071/3","FEMALE","C53.9",200,NA,"ACE47F29-9561-4D9D-BC3C-DB41E3203DC7","WHITE",NA,11,30,"98EDB638-ED5E-47FB-833E-7D762B7F4550","FA519E8E-D068-47D4-A4BB-69D4145A1C4C","UNCID_1664776.ab31f363-93f1-4ef9-a47a-731657fdf534.sorted_genome_alignments.bam.bai","TCGA-C5-A1BQ-01C-11",90,0,0,10,10,"TOP",20,10,"TCGA-C5-A1BQ-01C-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-C5-A1BQ-D34132","TCGA-C5-A1BQ-R34133","External","Primary Tumor Field","TCGA-C5-A1BQ-F34245_NTE-1","NO",NA,"TUMOR FREE","Dead",604,"TCGA-C5-A1BQ-F34245","TCGA-C5-A1BQ",NA,"C5","A1BQ","YES","C53.9","8071/3","C53.9","NO","YES",-24018,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,604,NA,NA,"TUMOR FREE","YES",7,8,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,65,2002,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,4,1999,25,NA,"Partial Remission/Response","1995",16,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
214474466,212501131,10144158150,"20EB9CC6-EABB-438A-9030-E766459996D1.bw","e7c7783c-1d0f-4f42-a4cf-518825e91d91","20eb9cc6-eabb-438a-9030-e766459996d1","2016-08-09T13:09:52.104391-05:00","UNCID_2185450.135d2983-9bfc-476a-8313-661f8bde6d06.130129_UNC13-SN749_0217_BD1MTTACXX_7_ATCACG.tar.gz","0e559835-8a90-4345-890b-1aa57dd122a8",9272860390,"Illumina HiSeq","e2b41342b666a314a450d748e8a22e6c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:32:05.434668-05:00","2016-05-03T10:58:56.648400-05:00","0e559835-8a90-4345-890b-1aa57dd122a8_analysis.xml","9f0eebad9788c06d80f3fba28b48028e","e0565714-c73f-42f5-b41c-7b00e2a5362c",2123,"2016-09-29T17:47:31.868676-05:00","0e559835-8a90-4345-890b-1aa57dd122a8_experiment.xml","d22e577105a8a465f00c8088b45b3545","0a1c4c96-48f5-4a0f-b3c9-1f69079a070a",2431,"2016-09-29T23:39:07.912788-05:00","0e559835-8a90-4345-890b-1aa57dd122a8_run.xml","41603a046d1e98b557ab10b23eb511a0","e4af41ed-e21a-47da-b57e-0079fc9252d7",354,"2016-09-08T12:13:27.282917-05:00","TCGA-IR-A3LB","2016-09-02T18:59:39.313294-05:00","female","TCGA-IR-A3LB_demographic",1949,"white","020494ec-2818-50fa-a424-368275a91fa1","not hispanic or latino",2007,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LB_diagnosis","not reported",19374,"dead","8384/3",2032,NA,"18736943-2ef5-5bd3-bb41-b5375114c136","c53.9",-19374,"TCGA-IR-A3LB_treatment","c102d4f5-e876-5ff8-ad1c-100390a96e6b","01","true","TCGA-IR-A3LB-01A",NA,"a753b6cc-2ffc-4480-a6c8-178780ae8be5",FALSE,"8E99E100-EB4F-472A-BB28-36592B1AA26E","Primary Tumor",NA,3385,180,NA,1340841600,"11",30,"TCGA-IR-A3LB-01A-11",90,NA,0,NA,0,NA,0,NA,"2016-09-08T12:13:27.282917-05:00",NA,1,NA,0,NA,"TOP",NA,1,NA,"84023a76-1b8b-42f2-9079-e508dfc0643d",NA,"TCGA-IR-A3LB-01A-01-TSA",NA,99,NA,"d9f6011c-c264-4afa-b850-b58f3a8a33d7","RNA","TCGA-IR-A3LB-01A-11R","48f9b338-1ca3-4854-8e07-9665ca84bdcf",1.82,0.16,"UV Spec","R","23","TCGA-IR-A3LB-01A-11R-A24H-07","135d2983-9bfc-476a-8313-661f8bde6d06",0.16,0.136986301369863,94,33.3049886621315,168,"b68773d9-6676-5654-a61b-4924877e8c0f","TCGA-IR-A3LB_exposure","UNCID_2185450.135d2983-9bfc-476a-8313-661f8bde6d06.130129_UNC13-SN749_0217_BD1MTTACXX_7_ATCACG.tar.gz","2013-09-14T20:46:04.000Z","2013-09-14T21:14:01.000Z","0E559835-8A90-4345-890B-1AA57DD122A8","A753B6CC-2FFC-4480-A6C8-178780AE8BE5","Unaligned reads",9272860390,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","135D2983-9BFC-476A-8313-661F8BDE6D06","University of North Carolina","564a3d15e4b08c5d86920c93","E7C7783C-1D0F-4F42-A4CF-518825E91D91","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D9F6011C-C264-4AFA-B850-B58F3A8A33D7","2013-09-14T21:14:01.000Z","48F9B338-1CA3-4854-8E07-9665CA84BDCF","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",3385,"D9F6011C-C264-4AFA-B850-B58F3A8A33D7",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.512D1B08-402F-433F-974C-B134628CBA33.txt",180,"TCGA-IR-A3LB-01A",NA,"F04625F9-2C4F-4B6F-944D-C730D8BB68AC","TCGA",2002,"TCGA-IR-A3LB_NTE-1","Complete Remission/Response","WITH TUMOR","BA226DE0-7A7C-42DC-84A4-10C0CF798244",53,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.512D1B08-402F-433F-974C-B134628CBA33.txt","Dead",2032,"TCGA-IR-A3LB","NOT HISPANIC OR LATINO",NA,"YES",NA,"No","Cervix","C53.9","N0","Endocervical Type of Adenocarcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8384/3","FEMALE","C53.9",256,NA,"D80114DF-760E-41E8-8B3B-C47DAA42DE50","WHITE",NA,11,30,"84023A76-1B8B-42F2-9079-E508DFC0643D","78424DD4-6A9F-4601-BAB2-67EBEC47C8EF","CROZE_p_TCGA_254_256_255_N_GenomeWideSNP_6_G01_1301450.birdseed.data.txt","TCGA-IR-A3LB-01A-11",90,0,0,1,0,"TOP",1,0,"TCGA-IR-A3LB-01A-01-TSA",99,"Carboplatin","Chemotherapy","TCGA-IR-A3LB-D39505","TCGA-IR-A3LB-R39500","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-IR-A3LB",NA,"IR","A3LB","YES","C53.9","8384/3","C53.9","NO","YES",-19374,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,2032,NA,NA,"WITH TUMOR","YES",24,1,2013,"NO","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,53,2002,"Biopsy (cervical / CT-guided / Other)","YES",29,0,"G3",NA,3,1972,2.5,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
200834926,197389995,9402895611,"73E99110-9A7C-4F73-98C5-79D22CB06230.bw","e87fadbe-c58c-41d1-b413-8cf6ce70ce94","73e99110-9a7c-4f73-98c5-79d22cb06230","2016-08-07T01:15:44.730894-05:00","UNCID_2186288.04bf866a-cb97-4e47-a3dd-2fe2e0c5d123.121102_UNC15-SN850_0240_BD148CACXX_5_TAGCTT.tar.gz","8761f4e7-8b3b-42b5-b3d7-dbb90c01671e",8768885695,"Illumina HiSeq","14e5271c006e0eedf6ccce49e009bab8","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:47:58.959803-05:00","2016-05-03T11:00:24.448573-05:00","8761f4e7-8b3b-42b5-b3d7-dbb90c01671e_analysis.xml","ad19a1e4a8590caa2a4fda4e2136fa18","7a6f7446-eaa5-4614-bb8b-21faa90fbfe3",2124,"2016-10-07T17:38:22.814767-05:00","8761f4e7-8b3b-42b5-b3d7-dbb90c01671e_experiment.xml","947fd785a918be29d38bb7efda3c0c5c","6ddbb659-073c-4102-a34c-0983cf49184f",2431,"2016-09-29T21:27:04.920165-05:00","8761f4e7-8b3b-42b5-b3d7-dbb90c01671e_run.xml","513d93b4ecfc6234336fc936fc19c846","92f6eb61-c48b-4ccb-8c00-a8844de65d48",354,"2016-09-08T11:24:09.781999-05:00","TCGA-DG-A2KM","2016-09-02T18:57:46.507270-05:00","female","TCGA-DG-A2KM_demographic",1962,"not reported","a00f3f01-0869-5c7b-91d3-10620eeb4cff","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DG","fa63e449-4302-5d16-bd2c-76f031746194","Ontario Institute for Cancer Research","not reported","c53.9","TCGA-DG-A2KM_diagnosis","not reported",16808,"alive","8070/3",NA,1946,"d884e4d5-9128-5279-8eda-cfa8b1d5ba85","c53.9",-16808,"TCGA-DG-A2KM_treatment","1b4c3b3f-d238-5571-aa33-f9f2b25fbfeb","01","false","TCGA-DG-A2KM-01A",NA,"1b6919ff-16c7-4986-a7fc-af7900a52909",FALSE,"CDF128FF-AEED-450F-B882-09A020F3DB36","Primary Tumor",NA,NA,170,NA,1313712000,"11",30,"TCGA-DG-A2KM-01A-11",90,NA,10,NA,0,NA,10,NA,"2016-09-08T11:24:09.781999-05:00",NA,60,NA,10,NA,"TOP",NA,0,NA,"a102ce58-d0a8-454d-a6f2-7ec9b3acb71f",NA,"TCGA-DG-A2KM-01A-01-TS1",NA,90,NA,"08dba69b-4382-4f3e-9015-b363ac558924","RNA","TCGA-DG-A2KM-01A-11R","060ec8d5-ac0b-4ffb-946b-cb591bc5c4be",1.86,0.16,"UV Spec","R","23","TCGA-DG-A2KM-01A-11R-A180-07","04bf866a-cb97-4e47-a3dd-2fe2e0c5d123",0.16,NA,NA,NA,169,"339d6f57-a1b4-5344-99ff-b72edb542b65","TCGA-DG-A2KM_exposure","UNCID_2186288.04bf866a-cb97-4e47-a3dd-2fe2e0c5d123.121102_UNC15-SN850_0240_BD148CACXX_5_TAGCTT.tar.gz","2013-09-16T04:16:06.000Z","2013-09-16T04:51:02.000Z","8761F4E7-8B3B-42B5-B3D7-DBB90C01671E","1B6919FF-16C7-4986-A7FC-AF7900A52909","Unaligned reads",8768885695,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","04BF866A-CB97-4E47-A3DD-2FE2E0C5D123","University of North Carolina","564a3be7e4b0ef12181a9a05","E87FADBE-C58C-41D1-B413-8CF6CE70CE94","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","08DBA69B-4382-4F3E-9015-B363AC558924","2013-09-16T04:51:02.000Z","060EC8D5-AC0B-4FFB-946B-CB591BC5C4BE","Canada","NO",1,NA,"Primary Tumor","Ontario Institute for Cancer Research",NA,"08DBA69B-4382-4F3E-9015-B363AC558924",NA,"DG","WHIRR_p_TCGA_168_169_170_redo_N_GenomeWideSNP_6_F11_845228.CEL",170,"TCGA-DG-A2KM-01A",NA,"EA657419-8880-44EF-9936-5476962614BA","TCGA",2008,"TCGA-DG-A2KM_NTE-1","Complete Remission/Response","TUMOR FREE","F7DF9CC3-F41F-4042-861B-F7D7F2FE50C0",46,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.655D5978-8AF4-42DB-9ADB-801D8ACEDFB8.txt","Alive",NA,"TCGA-DG-A2KM",NA,"6E50CF35-4A25-4C31-B0E3-EB264A9D288C","NO",1218,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",169,NA,"9EFDB63A-590E-4251-BBD9-08F9E8E2BF6F",NA,NA,11,30,"A102CE58-D0A8-454D-A6F2-7EC9B3ACB71F","AE3C346C-68B6-498F-8C86-F92395287DC3","TCGA-DG-A2KM-01A-11R-A17X-13_mirna.bam","TCGA-DG-A2KM-01A-11",90,0,10,60,10,"TOP",0,10,"TCGA-DG-A2KM-01A-01-TS1",90,"Cisplatin","Chemotherapy","TCGA-DG-A2KM-D49780","TCGA-DG-A2KM-R49778","External","Regional site","TCGA-DG-A2KM-F68502_NTE-1","NO",1946,"TUMOR FREE","Alive",NA,"TCGA-DG-A2KM-F68502","TCGA-DG-A2KM",NA,"DG","A2KM","YES","C53.9","8070/3","C53.9","NO","YES",-16808,"FEMALE",NA,NA,"No","No","Alive",1218,NA,NA,NA,"TUMOR FREE","YES",10,10,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,46,2008,"Biopsy (cervical / CT-guided / Other)","YES",9,4,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","1995",7,NA,"T1b1N1M0",NA,NA,0,"Pre-Adjuvant Therapy",NA,NA,NA,NA,NA,NA,NA,NA
125118432,123388266,5884911816,"FAD8A464-9BC3-4ED9-9517-B18D36514325.bw","e89d0cb1-6ec2-43ee-a6d9-b922b680af34","fad8a464-9bc3-4ed9-9517-b18d36514325","2016-08-27T06:04:45.350526-05:00","UNCID_2553102.971dec7f-6cb5-4575-85f7-be59097ae606.140408_UNC11-SN627_0351_AC3KY3ACXX_4_ATCACG.tar.gz","f151c63f-0815-468f-8499-68ff12be6759",5405051524,"Illumina HiSeq","f4a6b454d676754fb19ea47a96306432","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:12:40.291124-05:00","2016-05-03T11:54:19.885282-05:00","f151c63f-0815-468f-8499-68ff12be6759_analysis.xml","ba1cf9d7b5a463011a91a5e7228b36b2","f95cf73d-35d4-4254-9930-57bea0351d44",2124,"2016-10-07T16:03:43.833035-05:00","f151c63f-0815-468f-8499-68ff12be6759_experiment.xml","3522a07b9f27a63dc5e1233638ca1045","338cb28e-94aa-49bf-a0bd-eb902a8a37d3",2628,"2016-09-29T19:09:08.861691-05:00","f151c63f-0815-468f-8499-68ff12be6759_run.xml","6a5869e4b080a4cc18aee9e58d8d13f4","3d6e2275-7f34-4803-a5de-e40a2ba32eaa",354,"2016-09-08T12:14:34.741507-05:00","TCGA-C5-A8XJ","2016-09-02T19:01:08.075644-05:00","female","TCGA-C5-A8XJ_demographic",1928,"white","7125f9a0-cf7a-5e7c-90aa-af854f7f2337","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A8XJ_diagnosis","not reported",27087,"alive","8070/3",NA,4467,"0ccde1ca-936d-596d-aeec-caf6b542db68","c53.9",-27087,"TCGA-C5-A8XJ_treatment","dbf87643-004f-56bb-8dc1-270b5bfdcbd8","01","true","TCGA-C5-A8XJ-01A",NA,"17e11d4a-17c9-4f67-b1c6-bb715bd79859",FALSE,"0758C57C-F182-48E1-BEA7-27C5B9206FB9","Primary Tumor",NA,4175,100,NA,1387238400,"11",30,"TCGA-C5-A8XJ-01A-11",70,NA,0,NA,15,NA,15,NA,"2016-09-08T12:14:34.741507-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"7000c592-81cb-4a18-8bc7-909ff983c835",NA,"TCGA-C5-A8XJ-01A-01-TS1",NA,70,NA,"d6bbcfe3-7fd9-4399-acb6-80be481c9b70","RNA","TCGA-C5-A8XJ-01A-11R","5847466d-adab-429c-8e56-41eb2afc1a81",1.8,0.16,"UV Spec","R","23","TCGA-C5-A8XJ-01A-11R-A37O-07","971dec7f-6cb5-4575-85f7-be59097ae606",0.16,NA,114,44.53125,160,"5efe4715-df86-5f33-abf6-de68211be590","TCGA-C5-A8XJ_exposure","UNCID_2553102.971dec7f-6cb5-4575-85f7-be59097ae606.140408_UNC11-SN627_0351_AC3KY3ACXX_4_ATCACG.tar.gz","2014-07-30T23:07:04.000Z","2014-07-30T23:32:07.000Z","F151C63F-0815-468F-8499-68FF12BE6759","17E11D4A-17C9-4F67-B1C6-BB715BD79859","Unaligned reads",5405051524,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","971DEC7F-6CB5-4575-85F7-BE59097AE606","University of North Carolina","564a3e58e4b08c5d86927200","E89D0CB1-6EC2-43EE-A6D9-B922B680AF34","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D6BBCFE3-7FD9-4399-ACB6-80BE481C9B70","2014-07-30T23:32:07.000Z","5847466D-ADAB-429C-8E56-41EB2AFC1A81","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4175,"D6BBCFE3-7FD9-4399-ACB6-80BE481C9B70",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E396C1F2-2B80-413F-822F-056FA27A5C88.txt",100,"TCGA-C5-A8XJ-01A",NA,"3FCF68B3-E355-4DA0-9C94-B6149603DF9A","TCGA",2002,"TCGA-C5-A8XJ_NTE-1",NA,"TUMOR FREE","3CF4CA4A-C992-4A2D-B8B4-8B6BC1B83004",74,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E396C1F2-2B80-413F-822F-056FA27A5C88.txt","Alive",NA,"TCGA-C5-A8XJ","NOT HISPANIC OR LATINO","1C09EDD6-08C3-4436-A080-FBA75F7FDE18","NO",2305,"Yes","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,NA,"8070/3","FEMALE","C53.9",380,NA,"DE52AD8A-FFAC-4A67-9540-1552C80DE3AC","WHITE",NA,11,30,"7000C592-81CB-4A18-8BC7-909FF983C835","6DCE22F2-7A12-4424-86F3-EB62AC06A145","UNCID_2414607.971dec7f-6cb5-4575-85f7-be59097ae606.sorted_genome_alignments.bam","TCGA-C5-A8XJ-01A-11",70,15,0,5,15,"TOP",0,0,"TCGA-C5-A8XJ-01A-01-TS1",70,"Cisplatinum","Chemotherapy","TCGA-C5-A8XJ-D58645","TCGA-C5-A8XJ-R58647","Internal","Primary Tumor Field","TCGA-C5-A8XJ-F66731_NTE-1","NO",4467,"TUMOR FREE","Alive",NA,"TCGA-C5-A8XJ-F66731","TCGA-C5-A8XJ",NA,"C5","A8XJ","YES","C53.9","8070/3","C53.9","NO","YES",-27087,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",2305,NA,NA,NA,"TUMOR FREE","YES",17,4,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,74,2002,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,NA,NA,1,NA,NA,NA,NA,"1995",6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
255335268,253261564,12101198483,"9AF0E82E-E621-437A-8D19-700532B95090.bw","e8de2228-3aaa-48ad-a2e4-2940280af6fd","9af0e82e-e621-437a-8d19-700532b95090","2016-08-09T14:41:16.319995-05:00","UNCID_2654362.38d23f3a-0380-4759-930f-bdcb89a4eafe.141006_UNC15-SN850_0395_AC5FH9ACXX_6_ATTCCT.tar.gz","1591c9e3-10cf-4cc9-9735-28e63e1c74a3",11602234603,"Illumina HiSeq","43233db61547df2970b6afb8b5809613","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:48:18.591308-05:00","2016-05-03T12:08:10.830175-05:00","1591c9e3-10cf-4cc9-9735-28e63e1c74a3_analysis.xml","48cca81b240ce9408cc262a6ce500560","c52c45d4-2384-466d-95ce-18f051c6906c",2120,"2016-08-26T12:50:27.368025-05:00","1591c9e3-10cf-4cc9-9735-28e63e1c74a3_experiment.xml","3dcae4bb62742c87ae83425b34785eb9","e6f0b03b-5dba-4146-9bdf-9b740793392a",2628,"2016-09-29T19:48:11.437835-05:00","1591c9e3-10cf-4cc9-9735-28e63e1c74a3_run.xml","641e368c46fb763e72d4f99068aa277a","55cba4b8-fef3-459f-b11b-c84d6c285560",354,"2016-09-08T11:13:51.554109-05:00","TCGA-ZJ-AAXA","2016-09-02T18:54:42.376592-05:00","female","TCGA-ZJ-AAXA_demographic",1945,"white","5e5f7ee7-4f28-561c-9c79-aafe49d01517","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AAXA_diagnosis","not reported",23603,"alive","8072/3",NA,43,"2f57f63e-f8b0-5f3e-bd5c-c17d7a2c2c20","c53.9",-23603,"TCGA-ZJ-AAXA_treatment","4487c22d-546f-58af-ab4c-0b4e4cc0de57","01","true","TCGA-ZJ-AAXA-01A",NA,"444cded8-685b-4f74-a8b2-9c4b5f777c1d",FALSE,"01EB0759-6676-494E-9044-263629A7BD93","Primary Tumor",NA,1479,140,NA,1395878400,"11",30,"TCGA-ZJ-AAXA-01A-11",90,NA,0,NA,10,NA,10,NA,"2016-09-08T11:13:51.554109-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"e56e4061-5619-4b25-8b72-77d5a5cd7c67",NA,"TCGA-ZJ-AAXA-01A-01-TSA",NA,80,NA,"ff874226-61b5-4495-802e-e24ea0781402","RNA","TCGA-ZJ-AAXA-01A-11R","7abb04e8-e2bc-4218-8c70-3ac1bed723d0",1.88,0.16,"UV Spec","R","23","TCGA-ZJ-AAXA-01A-11R-A42T-07","38d23f3a-0380-4759-930f-bdcb89a4eafe",0.16,1.42465753424658,78,32.4661810613944,155,"f5e7b645-b64f-5f29-8001-8fe4899dff00","TCGA-ZJ-AAXA_exposure","UNCID_2654362.38d23f3a-0380-4759-930f-bdcb89a4eafe.141006_UNC15-SN850_0395_AC5FH9ACXX_6_ATTCCT.tar.gz","2014-11-05T02:47:04.000Z","2014-11-05T03:11:29.000Z","1591C9E3-10CF-4CC9-9735-28E63E1C74A3","444CDED8-685B-4F74-A8B2-9C4B5F777C1D","Unaligned reads",11602234603,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","38D23F3A-0380-4759-930F-BDCB89A4EAFE","University of North Carolina","56607528e4b0ec1099f8b5d2","E8DE2228-3AAA-48AD-A2E4-2940280AF6FD","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FF874226-61B5-4495-802E-E24EA0781402","2014-11-05T03:11:29.000Z","7ABB04E8-E2BC-4218-8C70-3AC1BED723D0","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",1479,"FF874226-61B5-4495-802E-E24EA0781402",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.6EE028AB-9CE6-46AD-8B4E-488E38706EDF.txt",140,"TCGA-ZJ-AAXA-01A",NA,NA,"TCGA",2009,"TCGA-ZJ-AAXA_NTE-1",NA,NA,"95ECEE61-57CA-46E5-9042-F304549BBA71",64,"nationwidechildrens.org_clinical.TCGA-ZJ-AAXA.xml","Alive",NA,"TCGA-ZJ-AAXA","NOT HISPANIC OR LATINO",NA,NA,43,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b","8072/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"E56E4061-5619-4B25-8B72-77D5A5CD7C67","C0847300-6F00-4131-A567-61843BCA4E1B","UNCID_2654362.38d23f3a-0380-4759-930f-bdcb89a4eafe.141006_UNC15-SN850_0395_AC5FH9ACXX_6_ATTCCT.tar.gz","TCGA-ZJ-AAXA-01A-11",90,10,0,0,10,"TOP",0,0,"TCGA-ZJ-AAXA-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AAXA",NA,"ZJ","AAXA","YES","C53.9","8072/3","C53.9","NO","YES",-23603,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",43,NA,NA,NA,NA,"NO",30,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2009,"Cone Biopsy / LEEP",NA,NA,NA,"G2",NA,3,1989,26,NA,NA,"2009",7,NA,"T1bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
195128558,192476148,9185381835,"27DA48F3-4FC1-41A3-8E49-5B25F1CCFF07.bw","e8e16aaf-3621-4ce8-b02a-7893dd656e4d","27da48f3-4fc1-41a3-8e49-5b25f1ccff07","2016-08-08T00:57:58.621578-05:00","UNCID_2187097.a8717ede-a85b-4133-bafc-48abd7892f71.120920_UNC13-SN749_0194_AD15C3ACXX_1_GTGAAA.tar.gz","48377897-c81b-434e-b2bc-64155038be96",8725220892,"Illumina HiSeq","82c3dc884e9c4f827bdac40c5e36b9c1","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:57:11.029736-05:00","2016-05-03T11:02:00.406437-05:00","48377897-c81b-434e-b2bc-64155038be96_analysis.xml","63d0c81b9c7056c497f7e6389515ed5f","803bf628-4b24-4760-99af-38a56dbde4b9",2124,"2016-09-29T20:40:13.157519-05:00","48377897-c81b-434e-b2bc-64155038be96_experiment.xml","3e674dfd24560219f6a24b22d4658ca2","75a3992e-b03e-45b7-8c47-1d5e648c1b4f",2431,"2016-09-29T20:58:24.960208-05:00","48377897-c81b-434e-b2bc-64155038be96_run.xml","927b6a84a0d93ef517e22d820df7fbd4","8103685b-75f8-4c46-99e8-c2193bad8c95",354,"2016-09-08T12:16:34.325146-05:00","TCGA-C5-A1M7","2016-09-02T18:56:48.008854-05:00","female","TCGA-C5-A1M7_demographic",1962,"white","1b5ffa0d-eb0f-55c0-a42d-ea72a71462b4","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1M7_diagnosis","not reported",13808,"alive","8070/3",NA,1409,"8a2100cd-1eb9-5b7a-a2dc-4009a17da4c4","c53.9",-13808,"TCGA-C5-A1M7_treatment","a813b03a-8ac2-58f4-9b01-832f51a4e07e","01","true","TCGA-C5-A1M7-01A",NA,"77c5348b-8327-4851-98c1-2f6bcd0682f9",FALSE,"ABC2B2A7-E5EE-4198-80E0-E64A6305B47A","Primary Tumor",NA,4265,90,NA,1300924800,"11",30,"TCGA-C5-A1M7-01A-11",60,NA,5,NA,0,NA,40,NA,"2016-09-08T12:16:34.325146-05:00",NA,75,NA,5,NA,"TOP",NA,2,NA,"88069886-0813-4f04-9479-d30ce98eadd5",NA,"TCGA-C5-A1M7-01A-01-TS1",NA,58,NA,"8c27b16c-b99b-49da-97b7-848e54ff6f67","RNA","TCGA-C5-A1M7-01A-11R","494690ca-a599-4fee-94cc-612f9a9f53ef",1.77,0.16,"UV Spec","R","23","TCGA-C5-A1M7-01A-11R-A13Y-07","a8717ede-a85b-4133-bafc-48abd7892f71",0.16,1.42465753424658,69,25.3443526170799,165,"98670887-2a1b-5d42-b5fd-ed5c548ccaf8","TCGA-C5-A1M7_exposure","UNCID_2187097.a8717ede-a85b-4133-bafc-48abd7892f71.120920_UNC13-SN749_0194_AD15C3ACXX_1_GTGAAA.tar.gz","2013-09-16T23:36:05.000Z","2013-09-16T23:58:02.000Z","48377897-C81B-434E-B2BC-64155038BE96","77C5348B-8327-4851-98C1-2F6BCD0682F9","Unaligned reads",8725220892,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","A8717EDE-A85B-4133-BAFC-48ABD7892F71","University of North Carolina","564a3a98e4b09c884b241d27","E8E16AAF-3621-4CE8-B02A-7893DD656E4D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","8C27B16C-B99B-49DA-97B7-848E54FF6F67","2013-09-16T23:58:02.000Z","494690CA-A599-4FEE-94CC-612F9A9F53EF","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4265,"8C27B16C-B99B-49DA-97B7-848E54FF6F67",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.FC4D06F1-DFC3-4660-A049-EDED1CF39AE4.txt",90,"TCGA-C5-A1M7-01A",NA,NA,"TCGA",1999,NA,NA,"TUMOR FREE","77C5348B-8327-4851-98C1-2F6BCD0682F9",37,"nationwidechildrens.org_clinical.TCGA-C5-A1M7.xml","Alive",NA,"TCGA-C5-A1M7","NOT HISPANIC OR LATINO","C5F8DD5F-5904-4119-A0AE-6441FA7B8031",NA,1409,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",114,NA,NA,"WHITE",NA,11,30,"88069886-0813-4F04-9479-D30CE98EADD5","EED320D1-D434-424A-A884-C49E1B55E54C","STOPS_p_TCGA_b101_114_SNP_N_GenomeWideSNP_6_G06_771696.tangent.copynumber.data.txt","TCGA-C5-A1M7-01A-11",60,0,5,75,40,"TOP",2,5,"TCGA-C5-A1M7-01A-01-TS1",58,NA,NA,NA,NA,NA,NA,"TCGA-C5-A1M7-F57890_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A1M7-F57890","TCGA-C5-A1M7",NA,"C5","A1M7","YES","C53.9","8070/3","C53.9","NO","YES",-13808,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1409,NA,NA,NA,"TUMOR FREE","NO",24,1,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,37,1999,"Other method, specify:","YES",30,0,"G2",NA,2,NA,26,NA,NA,"1995",6,NA,"T1bN0MX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
142060616,139419377,6650358840,"EFE5A302-D138-4044-A301-5C5FD1C24836.bw","e8f07d20-d043-4c69-8898-87d0f0fc5a9a","efe5a302-d138-4044-a301-5c5fd1c24836","2016-08-27T01:41:18.045303-05:00","UNCID_2553110.8f532265-5436-4bd8-9766-4b768c84514a.140404_UNC11-SN627_0350_BC3K66ACXX_7_GATCAG.tar.gz","235cad44-6128-4c85-8bfe-738045080db1",6533087022,"Illumina HiSeq","eadd8ecc28a78712f7b2e86eb85a347b","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:00:26.913899-05:00","2016-05-03T11:54:19.908545-05:00","235cad44-6128-4c85-8bfe-738045080db1_analysis.xml","aae4fce00ce27c25c0dbcb700b103532","a79e1463-cc33-4cfa-9ccc-e79609163bfd",2124,"2016-08-29T00:18:14.807108-05:00","235cad44-6128-4c85-8bfe-738045080db1_experiment.xml","651f7cdd3dcb3f23ad25ba15151eccbd","48228106-5f06-433d-bb2a-ff1b6f3b124e",2628,"2016-09-29T18:13:37.389721-05:00","235cad44-6128-4c85-8bfe-738045080db1_run.xml","bbf8577a44f99898e906d4eaf0213516","1a75b646-4272-4b2c-b8b3-8afec7cc88e2",354,"2016-09-08T11:34:06.669491-05:00","TCGA-C5-A901","2016-09-02T19:01:11.630750-05:00","female","TCGA-C5-A901_demographic",1956,"white","522d1be0-78ba-5a5c-98c3-9304882d6673","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A901_diagnosis","not reported",16186,"alive","8071/3",NA,518,"f01a94a2-6094-5c0a-a475-eaa4004f08e4","c53.9",-16186,"TCGA-C5-A901_treatment","1cf9aca4-4d5d-5209-bef0-c40a02ec8123","01","false","TCGA-C5-A901-01A",NA,"030fa1d2-6da0-4f33-9574-f2d703751d1b",FALSE,"5190FB9E-E28B-4CAB-9FB1-9DF839F2D977","Primary Tumor",NA,4811,20,NA,1388448000,"11",20,"TCGA-C5-A901-01A-11",70,NA,20,NA,0,NA,20,NA,"2016-09-08T11:34:06.669491-05:00",NA,40,NA,20,NA,"TOP",NA,10,NA,"27fda5e0-e09f-4688-a36f-665532e93d58",NA,"TCGA-C5-A901-01A-01-TS1",NA,70,NA,"eb3287ef-1254-4447-8fc5-ef17c5a125ab","RNA","TCGA-C5-A901-01A-11R","baa1cf70-6558-4961-9304-fd40052b28b0",1.98,0.18,"UV Spec","R","23","TCGA-C5-A901-01A-11R-A37O-07","8f532265-5436-4bd8-9766-4b768c84514a",0.18,0.10958904109589,54,19.5964581216432,166,"a863b466-e5ce-591b-b755-f861527317cf","TCGA-C5-A901_exposure","UNCID_2553110.8f532265-5436-4bd8-9766-4b768c84514a.140404_UNC11-SN627_0350_BC3K66ACXX_7_GATCAG.tar.gz","2014-07-31T00:51:04.000Z","2014-07-31T01:15:19.000Z","235CAD44-6128-4C85-8BFE-738045080DB1","030FA1D2-6DA0-4F33-9574-F2D703751D1B","Unaligned reads",6533087022,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8F532265-5436-4BD8-9766-4B768C84514A","University of North Carolina","564a3b08e4b0298dd2c84902","E8F07D20-D043-4C69-8898-87D0F0FC5A9A","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","EB3287EF-1254-4447-8FC5-EF17C5A125AB","2014-07-31T01:15:19.000Z","BAA1CF70-6558-4961-9304-FD40052B28B0","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4811,"EB3287EF-1254-4447-8FC5-EF17C5A125AB",NA,"C5","UNCID_2411740.8f532265-5436-4bd8-9766-4b768c84514a.sorted_genome_alignments.bam.bai",20,"TCGA-C5-A901-01A",NA,NA,"TCGA",2000,"TCGA-C5-A901_NTE-1",NA,"TUMOR FREE","2D8BD645-6DCE-4A03-AF87-C91132A013AD",44,"SPAED_p_TCGAb_380_381_NSP_GenomeWideSNP_6_E12_1465276.birdseed.data.txt","Alive",NA,"TCGA-C5-A901",NA,"8135C852-8BB5-4B95-9180-607DBD4C7745","NO",518,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,NA,NA,NA,"TX","8071/3","FEMALE","C53.9",380,NA,NA,"WHITE",NA,11,20,"27FDA5E0-E09F-4688-A36F-665532E93D58","BAA1CF70-6558-4961-9304-FD40052B28B0","TCGA-C5-A901-01A-11R-A37P-13_mirna.bam.bai","TCGA-C5-A901-01A-11",70,0,20,40,20,"TOP",10,20,"TCGA-C5-A901-01A-01-TS1",70,NA,NA,NA,NA,NA,NA,"TCGA-C5-A901-F66739_NTE-1",NA,NA,NA,NA,NA,"TCGA-C5-A901-F66739","TCGA-C5-A901",NA,"C5","A901","YES","C53.9","8071/3","C53.9","NO","YES",-16186,"FEMALE","WHITE",NA,"No","No","Alive",518,NA,NA,NA,"TUMOR FREE","YES",1,4,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,44,2000,"Cytology (e.g. Peritoneal or pleural fluid)","YES",19,2,"G2",NA,5,NA,2,NA,NA,"5th",1,NA,"TXN1MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
128342370,126211349,6018239563,"D3E866AC-D66A-4C07-9F47-89AF460320DE.bw","eb0eb159-732e-43ff-a402-7f2d9f67daa8","d3e866ac-d66a-4c07-9f47-89af460320de","2016-08-26T14:53:28.907278-05:00","UNCID_2278255.028824a6-0890-43c9-a46f-48a23483d205.131016_UNC10-SN254_0498_BC2KTUACXX_5_ACTTGA.tar.gz","b0d61f34-dca0-4840-b7bf-24c388f54d3c",6203709337,"Illumina HiSeq","7b4613927f664bd925ec83cfc10baa7d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:35:56.217223-05:00","2016-05-03T11:24:56.858865-05:00","b0d61f34-dca0-4840-b7bf-24c388f54d3c_analysis.xml","899355577600f4f3a07eecbcd086a98f","72ef6cc6-22c0-4a64-8e2d-dc710336911f",2124,"2016-09-29T21:58:50.800490-05:00","b0d61f34-dca0-4840-b7bf-24c388f54d3c_experiment.xml","53fabc9a0cd6304bca3e24ec4272db4d","a6a0b7b1-6e78-4801-8e9e-8ad227c0f3b5",2431,"2016-09-29T21:03:55.066348-05:00","b0d61f34-dca0-4840-b7bf-24c388f54d3c_run.xml","e0447dafa72785468c080da40d452153","846699dd-a080-4968-b9bc-85f114f66456",354,"2016-09-08T12:03:46.191294-05:00","TCGA-EX-A449","2016-09-02T18:59:37.815392-05:00","female","TCGA-EX-A449_demographic",1970,"white","da569c95-fd9b-5c09-8fe9-d0590d2cbb8a","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A449_diagnosis","not reported",15559,"alive","8384/3",NA,447,"0982425c-0e61-55da-bf94-ac6952378c84","c53.9",-15559,"TCGA-EX-A449_treatment","84b1f9fb-b8cf-57db-b0c2-8cb7fc1b9516","01","false","TCGA-EX-A449-01A",NA,"ef0ae9ca-356d-4f5b-8f1d-acf8c02670bb",FALSE,"C758E08B-3903-4C72-8F2D-5B064F24BCC1","Primary Tumor",NA,79,360,NA,1348617600,"11",30,"TCGA-EX-A449-01A-11",80,NA,1,NA,0,NA,0,NA,"2016-09-08T12:03:46.191294-05:00",NA,2,NA,0,NA,"TOP",NA,10,NA,"1d648516-faa9-4435-946d-dcf63c45a8d4",NA,"TCGA-EX-A449-01A-01-TS1",NA,90,NA,"dff163e3-b6d3-408f-9bae-5c215fb8e9c4","RNA","TCGA-EX-A449-01A-11R","ca96ce83-26f0-48f8-a8af-e88f7d8dc2af",1.81,0.18,"UV Spec","R","23","TCGA-EX-A449-01A-11R-A32Y-07","028824a6-0890-43c9-a46f-48a23483d205",0.18,NA,107,37.9109977324263,168,"9d161e87-dbb2-5068-9233-faaecc5c18b6","TCGA-EX-A449_exposure","UNCID_2278255.028824a6-0890-43c9-a46f-48a23483d205.131016_UNC10-SN254_0498_BC2KTUACXX_5_ACTTGA.tar.gz","2013-11-22T08:36:04.000Z","2013-11-22T08:57:02.000Z","B0D61F34-DCA0-4840-B7BF-24C388F54D3C","EF0AE9CA-356D-4F5B-8F1D-ACF8C02670BB","Unaligned reads",6203709337,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","028824A6-0890-43C9-A46F-48A23483D205","University of North Carolina","566074a9e4b0ca319164c70e","EB0EB159-732E-43FF-A402-7F2D9F67DAA8","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","DFF163E3-B6D3-408F-9BAE-5C215FB8E9C4","2013-11-22T08:57:02.000Z","CA96CE83-26F0-48F8-A8AF-E88F7D8DC2AF","United States","NO",1,NA,"Primary Tumor","University of North Carolina",79,"DFF163E3-B6D3-408F-9BAE-5C215FB8E9C4",NA,"EX","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.4F8CD975-7A4D-43CD-A503-7ADE21803B47.txt",360,"TCGA-EX-A449-01A",NA,"F031D1DD-20A0-4CFE-93B8-51E09B7099EC","TCGA",2012,"TCGA-EX-A449_NTE-1",NA,"WITH TUMOR","EF0AE9CA-356D-4F5B-8F1D-ACF8C02670BB",42,"nationwidechildrens.org_clinical.TCGA-EX-A449.xml","Alive",NA,"TCGA-EX-A449","NOT HISPANIC OR LATINO","76415BCE-E8CC-42FB-86F7-0ABC2604D44E",NA,34,"Yes","Cervix","C53.9","NX","Endocervical Type of Adenocarcinoma",NA,NA,"Stage IVB",NA,NA,"T1b1","8384/3","FEMALE","C53.9",256,NA,"40D9C014-C00C-4A9B-8FFE-09DAD4CCE249","WHITE",NA,11,30,"1D648516-FAA9-4435-946D-DCF63C45A8D4","BBBAE3E5-DA51-43DC-99B9-7118F66FEA4E","TCGA-EX-A449-01A-11R-A24J-13_mirna.bam","TCGA-EX-A449-01A-11",80,0,1,2,0,"TOP",10,0,"TCGA-EX-A449-01A-01-TS1",90,"Carboplatin","Chemotherapy","TCGA-EX-A449-D47412","TCGA-EX-A449-R47569","External","Primary Tumor Field","TCGA-EX-A449-F47567_NTE-1","NO",447,"TUMOR FREE","Alive",NA,"TCGA-EX-A449-F47567","TCGA-EX-A449",NA,"EX","A449","YES","C53.9","8384/3","C53.9","YES","NO",-15559,"FEMALE","WHITE","NOT HISPANIC OR LATINO","Yes","No","Alive",34,NA,NA,NA,"WITH TUMOR","NO",1,11,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,42,2012,"Other method, specify:","NO",NA,NA,"G1",NA,NA,NA,NA,NA,NA,"7th",18,NA,"T1b1NXM1",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
141446406,138894628,6621525276,"89C45456-9392-4EB3-9A82-A130B6702AAF.bw","eb3ba1fb-8254-4c02-a982-507f075cbac1","89c45456-9392-4eb3-9a82-a130b6702aaf","2016-08-25T12:08:00.991529-05:00","UNCID_2553091.acb24854-1e1a-4de8-a52f-f0c742cb82a1.140416_UNC11-SN627_0353_BC42B0ACXX_3_ACAGTG.tar.gz","270f2020-6314-4297-bdf5-06415cdeb796",6171492755,"Illumina HiSeq","ee2b37fa864e85063a750a3391f862b0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:19:42.944622-05:00","2016-05-03T11:54:19.885282-05:00","270f2020-6314-4297-bdf5-06415cdeb796_analysis.xml","695fcf36a6dc5f2c00a6abb53b9555fa","fdc85c48-7bbe-464d-ae90-209a2d78c9ed",2124,"2016-08-26T05:40:08.044549-05:00","270f2020-6314-4297-bdf5-06415cdeb796_experiment.xml","ec485887e65548b966a02d6142fcd1a7","10c687e3-ab14-4951-88b8-0877e743ab94",2628,"2016-09-29T19:01:14.869761-05:00","270f2020-6314-4297-bdf5-06415cdeb796_run.xml","7a4fa2d2cac6303487a48004dceec716","3861e4c3-17c8-4354-bc7e-e382392e8da0",354,"2016-09-08T12:53:23.950948-05:00","TCGA-ZJ-A8QO","2016-09-02T19:01:23.233774-05:00","female","TCGA-ZJ-A8QO_demographic",1934,"not reported","a1abbedc-99c9-5ff1-a959-890fd1291926","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-A8QO_diagnosis","not reported",26723,"alive","8072/3",NA,0,"23004784-3472-5986-acbd-d7fe23a93152","c53.9",-26723,"TCGA-ZJ-A8QO_treatment","31c9946b-6fee-5ffb-98b2-5bd3469e602d","01","true","TCGA-ZJ-A8QO-01A",NA,"c65da2a9-b5b3-4e0d-9fa3-f6a17c212ce1",FALSE,"F1113E49-016E-4D32-86C3-2620C9839F2E","Primary Tumor",NA,2261,200,NA,1386288000,"11",30,"TCGA-ZJ-A8QO-01A-11",80,NA,0,NA,5,NA,10,NA,"2016-09-08T12:53:23.950948-05:00",NA,5,NA,0,NA,"TOP",NA,5,NA,"a9d53915-8be2-465d-8767-a9304f5f23af",NA,"TCGA-ZJ-A8QO-01A-01-TSA",NA,80,NA,"33337b5b-787f-4c86-827f-9e706f453135","RNA","TCGA-ZJ-A8QO-01A-11R","9206c3be-b53e-4134-92e5-044ed225b889",1.81,0.15,"UV Spec","R","23","TCGA-ZJ-A8QO-01A-11R-A37O-07","acb24854-1e1a-4de8-a52f-f0c742cb82a1",0.15,NA,NA,NA,NA,"80021b3c-9398-599c-b2e8-92e51f230049","TCGA-ZJ-A8QO_exposure","UNCID_2553091.acb24854-1e1a-4de8-a52f-f0c742cb82a1.140416_UNC11-SN627_0353_BC42B0ACXX_3_ACAGTG.tar.gz","2014-07-30T20:51:06.000Z","2014-07-30T21:16:05.000Z","270F2020-6314-4297-BDF5-06415CDEB796","C65DA2A9-B5B3-4E0D-9FA3-F6A17C212CE1","Unaligned reads",6171492755,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","ACB24854-1E1A-4DE8-A52F-F0C742CB82A1","University of North Carolina","564a3b12e4b08c5d86916825","EB3BA1FB-8254-4C02-A982-507F075CBAC1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","33337B5B-787F-4C86-827F-9E706F453135","2014-07-30T21:16:05.000Z","9206C3BE-B53E-4134-92E5-044ED225B889","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",2261,"33337B5B-787F-4C86-827F-9E706F453135",NA,"ZJ","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.D29EE792-E846-4EF2-A5EB-EB3C44AACD84.txt",200,"TCGA-ZJ-A8QO-01A",NA,NA,"TCGA",2007,"TCGA-ZJ-A8QO_NTE-1",NA,NA,"C65DA2A9-B5B3-4E0D-9FA3-F6A17C212CE1",73,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.D29EE792-E846-4EF2-A5EB-EB3C44AACD84.txt","Alive",NA,"TCGA-ZJ-A8QO",NA,NA,NA,0,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",NA,NA,NA,NA,NA,NA,"8072/3","FEMALE","C53.9",380,NA,NA,NA,NA,11,30,"A9D53915-8BE2-465D-8767-A9304F5F23AF","CCF6EC11-955D-4187-8D83-94C1D9608863","4da93329803ce72a5de740d9f36f87c6.bam","TCGA-ZJ-A8QO-01A-11",80,5,0,5,10,"TOP",5,0,"TCGA-ZJ-A8QO-01A-01-TSA",80,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-A8QO",NA,"ZJ","A8QO","YES","C53.9","8072/3","C53.9","NO","YES",-26723,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,73,2007,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
121910178,116126164,5528345145,"8FF5C8FC-2565-49BE-9EE0-91A84A85AB2A.bw","eb59cf69-1997-41b9-bf69-69ad7da292a1","8ff5c8fc-2565-49be-9ee0-91a84a85ab2a","2016-08-05T11:55:15.969128-05:00","UNCID_2661067.1e7b2ed2-be35-4cce-a613-9c8203c49ebb.130909_UNC15-SN850_0327_BD2DT1ACXX_3_AGTTCC.tar.gz","a5c95229-b9c5-4969-9fb8-9c0bcb313440",5587840589,"Illumina HiSeq","a09df20b16af4d1b8d8320d729dbdc6f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:08:02.475784-05:00","2016-06-22T11:15:44.268337-05:00","a5c95229-b9c5-4969-9fb8-9c0bcb313440_analysis.xml","b81afe88d8a3a74c1d0c7b824bc61822","3cb84668-d60c-43f7-b6b9-78b5f490e178",2124,"2016-09-29T21:28:42.106839-05:00","a5c95229-b9c5-4969-9fb8-9c0bcb313440_experiment.xml","3a775b18c7951783a7af55cd7bc8bad7","93fab1ee-4c54-4f2a-b6be-0e54425187dc",2628,"2016-09-29T17:38:35.431539-05:00","a5c95229-b9c5-4969-9fb8-9c0bcb313440_run.xml","9fdcb02e1adcfbceb8ee96edb1abf54d","0447a81f-9ebd-48f3-a42a-b22667d1b022",354,"2016-09-08T11:48:18.779924-05:00","TCGA-C5-A1MQ","2016-09-02T18:57:23.334613-05:00","female","TCGA-C5-A1MQ_demographic",1974,"white","e39da075-1ad4-578e-a166-ff760f4e4b37","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A1MQ_diagnosis","not reported",12836,"alive","8070/3",NA,1031,"e450a98e-e787-5ced-ba23-f5e6c28d4632","c53.9",-12836,"TCGA-C5-A1MQ_treatment","01cce4d7-7905-5ddd-8d17-5c6e080140bf","01","true","TCGA-C5-A1MQ-01A",NA,"f5fc27d9-4949-43e9-b358-78cb69d87a3c",FALSE,"C77E58E6-6536-4DBE-9703-8EA34A3C908B","Primary Tumor",NA,667,140,NA,1301356800,"11",30,"TCGA-C5-A1MQ-01A-11",90,NA,20,NA,0,NA,5,NA,"2016-09-08T11:48:18.779924-05:00",NA,40,NA,20,NA,"TOP",NA,5,NA,"c9d18386-5204-4df7-86d0-a6c8d9007962",NA,"TCGA-C5-A1MQ-01A-01-TSA",NA,90,NA,"2d692527-11e6-4c79-b307-10faeffbb51c","RNA","TCGA-C5-A1MQ-01A-11R","73475810-8804-4a0d-9132-033605640ed0",1.78,0.2,"UV Spec","R","23","TCGA-C5-A1MQ-01A-11R-A14Y-07","1e7b2ed2-be35-4cce-a613-9c8203c49ebb",0.2,NA,116,37.8775510204082,175,"82977ca5-6c2e-5fa9-a039-86389e28226d","TCGA-C5-A1MQ_exposure","UNCID_2661067.1e7b2ed2-be35-4cce-a613-9c8203c49ebb.130909_UNC15-SN850_0327_BD2DT1ACXX_3_AGTTCC.tar.gz","2014-11-15T18:47:04.000Z","2014-11-15T19:02:30.000Z","A5C95229-B9C5-4969-9FB8-9C0BCB313440","F5FC27D9-4949-43E9-B358-78CB69D87A3C","Unaligned reads",5587840589,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1E7B2ED2-BE35-4CCE-A613-9C8203C49EBB","University of North Carolina","564a39b9e4b09c884b23da4b","EB59CF69-1997-41B9-BF69-69AD7DA292A1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2D692527-11E6-4C79-B307-10FAEFFBB51C","2014-11-15T19:02:30.000Z","73475810-8804-4A0D-9132-033605640ED0","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",667,"2D692527-11E6-4C79-B307-10FAEFFBB51C",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.135CDBF1-DF8E-4F67-A2BF-821C1E48EF15.txt",140,"TCGA-C5-A1MQ-01A",NA,"AA6B4B82-7328-43D8-809B-164E794CE799","TCGA",2009,NA,NA,"TUMOR FREE","F5FC27D9-4949-43E9-B358-78CB69D87A3C",35,"nationwidechildrens.org_clinical.TCGA-C5-A1MQ.xml","Alive",NA,"TCGA-C5-A1MQ","NOT HISPANIC OR LATINO","8747457F-34C4-471D-8AEF-A966CC0FB408",NA,17,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy","Stage IIA",NA,NA,"T2b","8070/3","FEMALE","C53.9",127,NA,"766A0747-65D4-4C44-8595-6B477F47C520","WHITE",NA,11,30,"C9D18386-5204-4DF7-86D0-A6C8D9007962","6A7A50EF-9272-4B08-B6E6-9D7BFA672999","4d55b306c9f948c74d83dd41705f0440.bam","TCGA-C5-A1MQ-01A-11",90,0,20,40,5,"TOP",5,20,"TCGA-C5-A1MQ-01A-01-TSA",90,"Cisplatin","Chemotherapy","TCGA-C5-A1MQ-D31341","TCGA-C5-A1MQ-R31342","COMBINATION","Primary Tumor Field",NA,"NO",1031,"TUMOR FREE","Alive",NA,"TCGA-C5-A1MQ-F31340","TCGA-C5-A1MQ",NA,"C5","A1MQ","YES","C53.9","8070/3","C53.9","NO","YES",-12836,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",17,NA,NA,NA,"TUMOR FREE","NO",21,10,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,35,2009,"Biopsy (cervical / CT-guided / Other)","YES",33,0,"G2",NA,1,NA,NA,NA,NA,"1995",10,NA,"T2bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
225511600,219422966,10478404733,"846DF088-75D5-49CF-BDDC-27E735A08DCA.bw","ec609ebe-2db9-4b95-a154-512fdfa9038f","846df088-75d5-49cf-bddc-27e735a08dca","2016-08-09T13:56:41.772183-05:00","UNCID_2187259.3ed6846b-8a17-4eed-bc64-c28fb9aed192.120921_UNC16-SN851_0181_AD14JFACXX_5_ACTTGA.tar.gz","2265361b-8678-4adb-81fb-9b6172706fae",9979378257,"Illumina HiSeq","57b0f0d915cd0e93850afc38e7e38684","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:42:38.255993-05:00","2016-05-03T11:02:00.408696-05:00","2265361b-8678-4adb-81fb-9b6172706fae_analysis.xml","c21ce83593b7e23968c42290e71f5209","52597b60-023b-485e-8da3-9aeedce9280b",2124,"2016-09-29T18:14:45.997125-05:00","2265361b-8678-4adb-81fb-9b6172706fae_experiment.xml","51e22cab317bb5b7242bd9f362b7f6d0","1b277634-e731-4995-ae53-b73089787d46",2431,"2016-09-29T17:34:33.379286-05:00","2265361b-8678-4adb-81fb-9b6172706fae_run.xml","568560131fc928c54ace745e985d8468","01c89ee4-e5d3-457a-8645-c158a05da2c1",354,"2016-09-08T13:06:19.007935-05:00","TCGA-DS-A1OD","2016-09-02T18:57:44.413209-05:00","female","TCGA-DS-A1OD_demographic",1954,"white","5265495b-9fa0-5b20-af5d-282eae5f3e93","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A1OD_diagnosis","not reported",17954,"alive","8070/3",NA,3874,"b100a472-04b0-5d73-9999-6ae059559885","c53.9",-17954,"TCGA-DS-A1OD_treatment","95160aa6-89d5-5c99-8903-e181b3d36c34","01","true","TCGA-DS-A1OD-01A",NA,"cc4ca8cd-1292-4e11-9b9a-2b5e1c7ba245",FALSE,"81536C16-0708-483D-AAE9-DD3477D85177","Primary Tumor",NA,2968,110,NA,1302480000,"11",30,"TCGA-DS-A1OD-01A-11",80,NA,5,NA,0,NA,15,NA,"2016-09-08T13:06:19.007935-05:00",NA,40,NA,30,NA,"TOP",NA,5,NA,"71481c09-680d-42ad-a133-989544e1353c",NA,"TCGA-DS-A1OD-01A-01-TSA",NA,80,NA,"a047d36b-7e3f-4df2-bfe1-7077dd74ad6b","RNA","TCGA-DS-A1OD-01A-11R","a9cb669d-b759-4536-a939-ce38514c40b1",1.94,0.16,"UV Spec","R","23","TCGA-DS-A1OD-01A-11R-A14Y-07","3ed6846b-8a17-4eed-bc64-c28fb9aed192",0.16,NA,89,37.044745057232,155,"0da017fa-8753-5400-96a6-326edfdc8e60","TCGA-DS-A1OD_exposure","UNCID_2187259.3ed6846b-8a17-4eed-bc64-c28fb9aed192.120921_UNC16-SN851_0181_AD14JFACXX_5_ACTTGA.tar.gz","2013-09-17T05:31:03.000Z","2013-09-17T05:55:02.000Z","2265361B-8678-4ADB-81FB-9B6172706FAE","CC4CA8CD-1292-4E11-9B9A-2B5E1C7BA245","Unaligned reads",9979378257,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3ED6846B-8A17-4EED-BC64-C28FB9AED192","University of North Carolina","564a3c44e4b09c884b249f10","EC609EBE-2DB9-4B95-A154-512FDFA9038F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A047D36B-7E3F-4DF2-BFE1-7077DD74AD6B","2013-09-17T05:55:02.000Z","A9CB669D-B759-4536-A939-CE38514C40B1","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",2968,"A047D36B-7E3F-4DF2-BFE1-7077DD74AD6B",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.04640F98-D09E-4760-9F47-5E68498D3176.txt",110,"TCGA-DS-A1OD-01A",NA,"5FF927AF-D6B8-41A8-984D-219DC466B2A9","TCGA",2003,NA,NA,"TUMOR FREE","CC4CA8CD-1292-4E11-9B9A-2B5E1C7BA245",49,"nationwidechildrens.org_clinical.TCGA-DS-A1OD.xml","Alive",NA,"TCGA-DS-A1OD","NOT HISPANIC OR LATINO","FA00B4C7-F906-47F6-AF70-A08A4A734B6A",NA,3097,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",127,NA,"9E893DCD-3762-4ED4-972D-49C9E7280DB2","WHITE",NA,11,30,"71481C09-680D-42AD-A133-989544E1353C","A9CB669D-B759-4536-A939-CE38514C40B1","UNCID_1659756.3ed6846b-8a17-4eed-bc64-c28fb9aed192.sorted_genome_alignments.bam","TCGA-DS-A1OD-01A-11",80,0,5,40,15,"TOP",5,30,"TCGA-DS-A1OD-01A-01-TSA",80,"Cisplatin","Chemotherapy","TCGA-DS-A1OD-D15186","TCGA-DS-A1OD-R15185","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",3097,"TUMOR FREE","Alive",NA,"TCGA-DS-A1OD-F15184","TCGA-DS-A1OD",NA,"DS","A1OD","YES","C53.9","8070/3","C53.9","NO","YES",-17954,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",3097,NA,NA,NA,"TUMOR FREE","NO",12,8,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2003,"Biopsy (cervical / CT-guided / Other)","YES",16,0,"G3",NA,4,NA,NA,NA,NA,"1995",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
106251504,104897131,5007606602,"EA3A19E1-7ADE-47B6-A35A-71290967147A.bw","ed17685c-b706-41e4-8a76-11cb0e6700cd","ea3a19e1-7ade-47b6-a35a-71290967147a","2016-08-07T23:03:03.070663-05:00","UNCID_2169021.1ff2db10-00fe-4ddc-98d1-e15ffea42333.130606_UNC9-SN296_0373_BD28T1ACXX_3_CTTGTA.tar.gz","88af5e8c-9db0-4431-9161-066e2cccde13",5207413574,"Illumina HiSeq","6d746cf283a834d2a865a9d12fe6604d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:25:31.646972-05:00","2016-05-03T11:06:28.633852-05:00","88af5e8c-9db0-4431-9161-066e2cccde13_analysis.xml","d93972594f2206f10b81e76724f40442","dc2c8744-55ac-4dd7-8133-e9b7e28bc6dc",2121,"2016-10-07T15:48:44.152952-05:00","88af5e8c-9db0-4431-9161-066e2cccde13_experiment.xml","4b16b16257f5757d42f646d17ce6285c","09b581e4-4c05-4e4c-8bbd-21da4144af60",2431,"2016-09-29T20:26:53.018270-05:00","88af5e8c-9db0-4431-9161-066e2cccde13_run.xml","f0e7bf13060ad32ddfafd26be2e93fa8","6d8877c2-f7c8-4f5e-a7da-17f39e4d4fe1",354,"2016-09-08T11:31:28.296995-05:00","TCGA-EA-A5FO","2016-09-02T18:59:50.104644-05:00","female","TCGA-EA-A5FO_demographic",1953,"white","be62bd91-6fc0-5b2d-b0ba-7dad204b96ce","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EA","ddbd5231-0d72-5408-b91f-cfab9de671fb","Asterand","not reported","c53.9","TCGA-EA-A5FO_diagnosis","not reported",21561,"alive","8070/3",NA,815,"9ca11dd5-2821-55a4-a6ff-624d6e48a8a3","c53.9",-21561,"TCGA-EA-A5FO_treatment","44f5ef91-474b-5b0f-bf1b-eb24c24389bb","01","true","TCGA-EA-A5FO-01A",NA,"bfcb73ba-363b-4dc3-9b36-246043e43f12",FALSE,"4022C7F9-CECA-4C6B-92D5-729518405F30","Primary Tumor",NA,132,570,NA,1360540800,"21",30,"TCGA-EA-A5FO-01A-21",60,NA,0,NA,30,NA,10,NA,"2016-09-08T11:31:28.296995-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"997d2b19-d8ab-476d-8710-f8b6dfcd5d4e",NA,"TCGA-EA-A5FO-01A-02-TSB",NA,60,NA,"58d0b14d-2c8f-4ef9-a408-20ac795b8eac","RNA","TCGA-EA-A5FO-01A-21R","05589395-6bc4-466b-bd28-4e8c5e83876a",1.89,0.15,"UV Spec","R","23","TCGA-EA-A5FO-01A-21R-A28H-07","1ff2db10-00fe-4ddc-98d1-e15ffea42333",0.15,NA,58,22.1002895900015,162,"334ae8f4-caf5-5d0f-ae77-6ed64ebd859a","TCGA-EA-A5FO_exposure","UNCID_2169021.1ff2db10-00fe-4ddc-98d1-e15ffea42333.130606_UNC9-SN296_0373_BD28T1ACXX_3_CTTGTA.tar.gz","2013-09-20T03:36:05.000Z","2013-09-20T03:49:01.000Z","88AF5E8C-9DB0-4431-9161-066E2CCCDE13","BFCB73BA-363B-4DC3-9B36-246043E43F12","Unaligned reads",5207413574,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1FF2DB10-00FE-4DDC-98D1-E15FFEA42333","University of North Carolina","56607649e4b0ca319164db2a","ED17685C-B706-41E4-8A76-11CB0E6700CD","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","58D0B14D-2C8F-4EF9-A408-20AC795B8EAC","2013-09-20T03:49:01.000Z","05589395-6BC4-466B-BD28-4E8C5E83876A","Ukraine","NO",1,NA,"Primary Tumor","Asterand",132,"58D0B14D-2C8F-4EF9-A408-20AC795B8EAC",NA,"EA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.D91C5622-88A7-4D01-ACA5-14A0123D0ADF.txt",570,"TCGA-EA-A5FO-01A",NA,NA,"TCGA",2012,"TCGA-EA-A5FO_NTE-1",NA,"TUMOR FREE","BFCB73BA-363B-4DC3-9B36-246043E43F12",59,"nationwidechildrens.org_clinical.TCGA-EA-A5FO.xml","Alive",NA,"TCGA-EA-A5FO","NOT HISPANIC OR LATINO","D4C21843-1FFF-49B2-9932-ADBE99F2254D","NO",45,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",297,NA,"D3EED5E1-168B-4E40-A537-D5AB08DD7E8F","WHITE",NA,21,30,"997D2B19-D8AB-476D-8710-F8B6DFCD5D4E","ED313DBE-D75D-4E1F-8FB9-FCC43DCE10B0","TCGA-EA-A5FO-01A-21R-A28L-13_mirna.bam","TCGA-EA-A5FO-01A-21",60,30,0,5,10,"TOP",0,0,"TCGA-EA-A5FO-01A-02-TSB",60,NA,NA,NA,"TCGA-EA-A5FO-R59526","External","Regional site","TCGA-EA-A5FO-F58802_NTE-1","NO",427,"TUMOR FREE","Alive",NA,"TCGA-EA-A5FO-F58802","TCGA-EA-A5FO",NA,"EA","A5FO","YES","C53.9","8070/3","C53.9","YES","NO",-21561,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",45,NA,NA,NA,"TUMOR FREE","YES",22,5,2013,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,59,2012,"Biopsy (cervical / CT-guided / Other)","YES",21,0,"G2",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
192550376,189410798,9043586836,"B2C43D0C-732B-4C54-938F-D3C9FDA880DA.bw","ed6d989d-da09-4818-8fed-f33d88b628af","b2c43d0c-732b-4c54-938f-d3c9fda880da","2016-08-09T13:57:27.187631-05:00","UNCID_2187278.16ced370-3e97-40a5-9743-6bdd7bbc37d3.120917_UNC10-SN254_0380_AD1AV3ACXX_8_TTAGGC.tar.gz","61c0bdd9-df13-43f5-8248-326e556d4553",8740667084,"Illumina HiSeq","a3109a90f6f0bc4dedfa6a2418f2b083","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:30:36.671215-05:00","2016-05-03T11:02:00.408696-05:00","61c0bdd9-df13-43f5-8248-326e556d4553_analysis.xml","621d7d92d86d1c10a88daa3db64a8da8","ba2362ac-8915-45d9-8e9a-9c9542885d69",2124,"2016-08-28T17:37:47.257089-05:00","61c0bdd9-df13-43f5-8248-326e556d4553_experiment.xml","10988f84f07c579aac97e3633131dbdb","0c60b91b-494e-409d-8e40-c6415463f81c",2431,"2016-09-29T20:36:47.722123-05:00","61c0bdd9-df13-43f5-8248-326e556d4553_run.xml","564df532182c7156a93d371bd0e3e976","737866e8-13da-4d21-93cb-16240d168015",354,"2016-09-08T11:00:44.911504-05:00","TCGA-DS-A0VM","2016-09-02T18:54:41.350740-05:00","female","TCGA-DS-A0VM_demographic",1952,"white","1cb85425-fcc7-5f49-a441-8c3d2ab914e5","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A0VM_diagnosis","not reported",18839,"alive","8070/3",NA,2128,"f541092f-9922-52ae-8823-402bae68cdfb","c53.9",-18839,"TCGA-DS-A0VM_treatment","e7310ac2-2471-531f-8688-375f01082163","01","true","TCGA-DS-A0VM-01A",NA,"52c90714-b4ed-42fa-8763-914140308ffa",FALSE,"7C9830C1-15CB-4D38-8995-3A061E80741F","Primary Tumor",NA,2813,180,NA,1286841600,"11",30,"TCGA-DS-A0VM-01A-11",75,75,0,0,0,0,20,0,"2016-09-08T11:00:44.911504-05:00","2016-09-08T11:00:44.911504-05:00",0,0,0,0,"BOTTOM","TOP",0,0,"d889b541-31c7-4927-9846-859290c0baf9","b5ccbace-baf7-405e-b3af-533a261ac612","TCGA-DS-A0VM-01A-01-BSA","TCGA-DS-A0VM-01A-01-TSA",80,100,"cf87485b-f1aa-4cdb-9364-4775c0ee8c8f","RNA","TCGA-DS-A0VM-01A-11R","3d6aba1c-2f5b-4b83-967c-5d5e1076f1ed",1.83,0.16,"UV Spec","R","23","TCGA-DS-A0VM-01A-11R-A10U-07","16ced370-3e97-40a5-9743-6bdd7bbc37d3",0.16,NA,69,25.9701155481953,163,"71fa5484-dad4-5f10-b180-991c1a5a9eac","TCGA-DS-A0VM_exposure","UNCID_2187278.16ced370-3e97-40a5-9743-6bdd7bbc37d3.120917_UNC10-SN254_0380_AD1AV3ACXX_8_TTAGGC.tar.gz","2013-09-17T06:37:05.000Z","2013-09-17T07:10:02.000Z","61C0BDD9-DF13-43F5-8248-326E556D4553","52C90714-B4ED-42FA-8763-914140308FFA","Unaligned reads",8740667084,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","16CED370-3E97-40A5-9743-6BDD7BBC37D3","University of North Carolina","566076b0e4b0ca319164df5d","ED6D989D-DA09-4818-8FED-F33D88B628AF","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CF87485B-F1AA-4CDB-9364-4775C0EE8C8F","2013-09-17T07:10:02.000Z","3D6ABA1C-2F5B-4B83-967C-5D5E1076F1ED","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",2813,"CF87485B-F1AA-4CDB-9364-4775C0EE8C8F",NA,"DS","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B2E5BD97-D176-4560-8FC7-B082EF9A66E9.txt",180,"TCGA-DS-A0VM-01A",NA,"1D3DA5D7-7C94-4BA8-961D-D37EC233D318","TCGA",2003,NA,NA,"TUMOR FREE","52C90714-B4ED-42FA-8763-914140308FFA",51,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.B2E5BD97-D176-4560-8FC7-B082EF9A66E9.txt","Alive",NA,"TCGA-DS-A0VM","NOT HISPANIC OR LATINO","0D9FC68A-CE9A-49AD-A038-3ADE324549FF",NA,2128,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b1","8070/3","FEMALE","C53.9",88,NA,NA,"WHITE",NA,11,30,"D889B541-31C7-4927-9846-859290C0BAF9","A5BF1CCC-66BC-4610-8B6E-0EF815412BCB","C501.TCGA-DS-A0VM-01A-11D-A10S-08.4.bam","TCGA-DS-A0VM-01A-11",75,0,0,0,20,"BOTTOM",0,0,"TCGA-DS-A0VM-01A-01-BSA",80,"Cisplatin","Chemotherapy","TCGA-DS-A0VM-D8642",NA,NA,NA,"TCGA-DS-A0VM-F53351_NTE-1","NO",3589,"TUMOR FREE","Alive",NA,"TCGA-DS-A0VM-F53351","TCGA-DS-A0VM",NA,"DS","A0VM","YES","C53.9","8070/3","C53.9","NO","YES",-18839,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2128,NA,NA,NA,"TUMOR FREE","NO",7,1,2011,"YES","YES","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,51,2003,"Biopsy (cervical / CT-guided / Other)",NA,21,1,"G3",NA,1,NA,NA,NA,NA,NA,6,NA,"T1b1N1M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
122571364,121660213,5818714958,"EEC856B5-9B7F-488D-975E-CE2FF7072879.bw","ed74703a-6838-4f4e-9524-d6fb7b208687","eec856b5-9b7f-488d-975e-ce2ff7072879","2016-08-09T14:40:48.598565-05:00","UNCID_2654400.eb0b4f03-9121-4c2a-bc13-4d9109d6b894.140908_UNC11-SN627_0381_BC5DEKACXX_8_GTTTCG.tar.gz","3bf1eebc-3b91-4b9b-8cb0-c5fc5d3be723",4938028924,"Illumina HiSeq","5dd7f71d4d97296d78a101926efe3701","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:51:06.311240-05:00","2016-05-03T12:08:10.840133-05:00","3bf1eebc-3b91-4b9b-8cb0-c5fc5d3be723_analysis.xml","fded34e3224846df1eb213bc4c272fb7","7c6b130a-8c9e-4538-8568-f16d00997bdd",2124,"2016-09-29T18:08:38.255688-05:00","3bf1eebc-3b91-4b9b-8cb0-c5fc5d3be723_experiment.xml","132f623c2e83c38b3fa6c1171e7a1a44","1777a8c3-29cb-43b5-9625-07bbb6bb9614",2628,"2016-09-29T17:40:24.893584-05:00","3bf1eebc-3b91-4b9b-8cb0-c5fc5d3be723_run.xml","42eea665cdd25205e58b4a37e048ea8e","05781471-c5e1-4e28-8521-de92647629af",354,"2016-09-08T11:47:15.610566-05:00","TCGA-MA-AA43","2016-09-02T18:54:12.197771-05:00","female","TCGA-MA-AA43_demographic",1965,"white","7300a6df-8abd-58f2-a05e-0d3e0cf59e33","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA43_diagnosis","not reported",17658,"alive","8070/3",NA,346,"cf9e6447-dc91-5dd7-aaec-e289b40035cb","c53.9",-17658,"TCGA-MA-AA43_treatment","d6f63f8e-d868-5abe-bb26-e368e10ab7dc","01","false","TCGA-MA-AA43-01A",NA,"f8b4a1c7-58aa-4259-b42d-fa7bcce0e463",FALSE,"662EBBFF-1A0B-4217-8E3D-C453AAA4BDAD","Primary Tumor",NA,180,110,NA,1394064000,"11",30,"TCGA-MA-AA43-01A-11",80,NA,0,NA,10,NA,5,NA,"2016-09-08T11:47:15.610566-05:00",NA,4,NA,0,NA,"TOP",NA,5,NA,"bcfab30f-03f4-484c-9df7-2413f987d37d",NA,"TCGA-MA-AA43-01A-01-TS1",NA,80,NA,"b72ef909-6dd2-41d6-bc8f-af2e4e2e3f09","RNA","TCGA-MA-AA43-01A-11R","7d3ff213-c587-4a72-9a48-bd8bc2657f7f",1.89,0.18,"UV Spec","R","23","TCGA-MA-AA43-01A-11R-A42T-07","eb0b4f03-9121-4c2a-bc13-4d9109d6b894",0.18,0.635616438356164,72,31.1634349030471,152,"954204ec-a3fa-5a7a-98ae-858c3f79419a","TCGA-MA-AA43_exposure","UNCID_2654400.eb0b4f03-9121-4c2a-bc13-4d9109d6b894.140908_UNC11-SN627_0381_BC5DEKACXX_8_GTTTCG.tar.gz","2014-11-05T13:27:05.000Z","2014-11-05T13:40:27.000Z","3BF1EEBC-3B91-4B9B-8CB0-C5FC5D3BE723","F8B4A1C7-58AA-4259-B42D-FA7BCCE0E463","Unaligned reads",4938028924,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","EB0B4F03-9121-4C2A-BC13-4D9109D6B894","University of North Carolina","564a3fc9e4b0298dd2c9d0c5","ED74703A-6838-4F4E-9524-D6FB7B208687","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","B72EF909-6DD2-41D6-BC8F-AF2E4E2E3F09","2014-11-05T13:40:27.000Z","7D3FF213-C587-4A72-9A48-BD8BC2657F7F","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",180,"B72EF909-6DD2-41D6-BC8F-AF2E4E2E3F09",NA,"MA","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.030704AA-5162-44EE-B68B-7D35FB6DD2A0.txt",110,"TCGA-MA-AA43-01A",NA,NA,"TCGA",2013,"TCGA-MA-AA43_NTE-1","Complete Remission/Response","TUMOR FREE","F8B4A1C7-58AA-4259-B42D-FA7BCCE0E463",48,"nationwidechildrens.org_clinical.TCGA-MA-AA43.xml","Alive",NA,"TCGA-MA-AA43","HISPANIC OR LATINO","E9D6C13D-CE66-451C-9838-BF61821F5F14","NO",227,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IIIB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,NA,"WHITE",NA,11,30,"BCFAB30F-03F4-484C-9DF7-2413F987D37D","7D3FF213-C587-4A72-9A48-BD8BC2657F7F","UNCID_2633325.eb0b4f03-9121-4c2a-bc13-4d9109d6b894.sorted_genome_alignments.bam.bai","TCGA-MA-AA43-01A-11",80,10,0,4,5,"TOP",5,0,"TCGA-MA-AA43-01A-01-TS1",80,NA,NA,NA,NA,NA,NA,"TCGA-MA-AA43-F65483_NTE-1","NO",346,"TUMOR FREE","Alive",NA,"TCGA-MA-AA43-F65483","TCGA-MA-AA43",NA,"MA","AA43","YES","C53.9","8070/3","C53.9","YES","NO",-17658,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",227,NA,NA,NA,"TUMOR FREE","YES",22,7,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2013,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,4,2013,11.6,NA,"Complete Remission/Response","2009",16,NA,"T3bNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
94688990,94063768,4496530219,"8A68C417-09CC-4FA1-BFEB-EB4B738853A4.bw","ee2c9743-eaa1-4f0d-8d35-e96686ac3913","8a68c417-09cc-4fa1-bfeb-eb4b738853a4","2016-08-09T14:41:17.604826-05:00","UNCID_2654380.d8259ddb-5f41-43ea-889c-1e7dba9d32bc.140908_UNC11-SN627_0381_BC5DEKACXX_7_GAGTGG.tar.gz","72c011eb-c083-4281-af89-2e92712428ee",3768325244,"Illumina HiSeq","6dc1eaee5e0a737a324d8ab3ffb98a3d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:34:55.240584-05:00","2016-05-03T12:08:10.830175-05:00","72c011eb-c083-4281-af89-2e92712428ee_analysis.xml","a76eea81abf36cbf968ee3ddd2ca5a6f","27a91a32-823a-4c20-9259-dab688a096a2",2124,"2016-09-29T22:45:53.158509-05:00","72c011eb-c083-4281-af89-2e92712428ee_experiment.xml","a55cce8b50b2076c937ddb75440d2871","c3a35719-bed4-43e6-b67f-e53c824492e7",2628,"2016-09-29T21:30:34.164736-05:00","72c011eb-c083-4281-af89-2e92712428ee_run.xml","528f6eb08bfc7da22d705703b6d5eaf4","951a9bc7-01d7-41f0-a030-fa1bb6dd410b",354,"2016-09-08T10:51:35.950597-05:00","TCGA-VS-A9UM","2016-09-02T18:54:28.738613-05:00","female","TCGA-VS-A9UM_demographic",1972,"black or african american","640db672-8b7c-5dac-af66-dd0d760c8937","not reported",2013,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UM_diagnosis","not reported",14255,"dead","8070/3",829,NA,"5c2e5094-7f64-5eb7-a160-e690e3c20a6f","c53.9",-14255,"TCGA-VS-A9UM_treatment","993e2e31-9a53-55d5-b49f-15d33e0cfc4d","01","false","TCGA-VS-A9UM-01A",NA,"24825a46-bcf8-4e14-a3a5-e2486c54e247",FALSE,"20927111-D875-4B7E-9E8F-F8EE861600D2","Primary Tumor",NA,1068,80,NA,1391040000,"11",30,"TCGA-VS-A9UM-01A-11",75,NA,0,NA,5,NA,20,NA,"2016-09-08T10:51:35.950597-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"7fdb3611-f30b-4aee-8d99-d63ec97819b7",NA,"TCGA-VS-A9UM-01A-01-TS1",NA,75,NA,"d779b743-63d8-4909-8de1-031f28d35dd9","RNA","TCGA-VS-A9UM-01A-11R","db5c69f5-7759-465e-8075-5f8bfa47fa6e",1.87,0.17,"UV Spec","R","23","TCGA-VS-A9UM-01A-11R-A42T-07","d8259ddb-5f41-43ea-889c-1e7dba9d32bc",0.17,NA,75,29.296875,160,"5c047f38-2557-5304-80ff-78946d0c6240","TCGA-VS-A9UM_exposure","UNCID_2654380.d8259ddb-5f41-43ea-889c-1e7dba9d32bc.140908_UNC11-SN627_0381_BC5DEKACXX_7_GAGTGG.tar.gz","2014-11-05T06:06:04.000Z","2014-11-05T06:18:35.000Z","72C011EB-C083-4281-AF89-2E92712428EE","24825A46-BCF8-4E14-A3A5-E2486C54E247","Unaligned reads",3768325244,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","D8259DDB-5F41-43EA-889C-1E7DBA9D32BC","University of North Carolina","564a3fa3e4b0298dd2c9c410","EE2C9743-EAA1-4F0D-8D35-E96686AC3913","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D779B743-63D8-4909-8DE1-031F28D35DD9","2014-11-05T06:18:35.000Z","DB5C69F5-7759-465E-8075-5F8BFA47FA6E","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1068,"D779B743-63D8-4909-8DE1-031F28D35DD9",NA,"VS","UNCID_2633119.d8259ddb-5f41-43ea-889c-1e7dba9d32bc.sorted_genome_alignments.bam.bai",80,"TCGA-VS-A9UM-01A",NA,"5E4A789E-39EA-4751-A2C1-1CE33311769B","TCGA",2011,"TCGA-VS-A9UM_NTE-1","Complete Remission/Response","TUMOR FREE","3C3C8768-36F7-4611-B6B3-D6B8126F5594",39,"nationwidechildrens.org_clinical.TCGA-VS-A9UM.xml","Dead",829,"TCGA-VS-A9UM",NA,NA,"NO",NA,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Pre-Adjuvant Therapy","Stage IVB",NA,NA,"T3b","8070/3","FEMALE","C53.9",420,NA,"BF25C3A0-C32F-4F2C-8E4F-66CF9D8C690F","BLACK OR AFRICAN AMERICAN",NA,11,30,"7FDB3611-F30B-4AEE-8D99-D63EC97819B7","11F30520-885B-4D55-8E82-98799E88A780","UNCID_2633119.d8259ddb-5f41-43ea-889c-1e7dba9d32bc.sorted_genome_alignments.bam.bai","TCGA-VS-A9UM-01A-11",75,5,0,5,20,"TOP",0,0,"TCGA-VS-A9UM-01A-01-TS1",75,"Cisplatin","Chemotherapy","TCGA-VS-A9UM-D64654","TCGA-VS-A9UM-R64652","External","Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-VS-A9UM",NA,"VS","A9UM","YES","C53.9","8070/3","C53.9","NO","YES",-14255,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Dead",NA,829,NA,NA,"TUMOR FREE","YES",9,9,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,39,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",18,NA,"T3bNXMX",NA,NA,0,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
144224034,142438718,6794580947,"C5DF1A0D-952C-44E2-BF83-ED57177EF60E.bw","f0bb0d18-1190-463d-a0ba-839c2c776794","c5df1a0d-952c-44e2-bf83-ed57177ef60e","2016-08-09T14:01:01.741998-05:00","UNCID_2169000.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.130611_UNC15-SN850_0312_BC265JACXX_2_AGTTCC.tar.gz","db4cc7cb-499b-4d64-8b23-f83bd5128b2b",6543399135,"Illumina HiSeq","831a5ad0b361b713778cec8e6fbe21bf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:24:51.768835-05:00","2016-05-03T11:06:28.634130-05:00","db4cc7cb-499b-4d64-8b23-f83bd5128b2b_analysis.xml","ec5e263651447529ee5204e6d5025912","6c4886c8-c87c-4cf7-ae26-872e616a03a8",2123,"2016-10-07T17:39:11.027289-05:00","db4cc7cb-499b-4d64-8b23-f83bd5128b2b_experiment.xml","cb6c24884244288ba678526acd2d67b1","4d8b3c7d-76b3-4599-a6b1-1bad55d69667",2431,"2016-09-29T17:46:12.105759-05:00","db4cc7cb-499b-4d64-8b23-f83bd5128b2b_run.xml","9bf0c84fc3bc33cc44f5845e11d4c1c8","094af13d-7eef-4a3a-bd2a-83da80388779",354,"2016-09-08T12:12:23.077046-05:00","TCGA-JW-A5VJ","2016-09-02T19:00:02.844150-05:00","female","TCGA-JW-A5VJ_demographic",1956,"american indian or alaska native","0ab5c574-05c5-5fb0-bf70-79525705529f","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A5VJ_diagnosis","not reported",20714,"alive","8070/3",NA,652,"0c50bb2b-f273-567d-a361-e13238e5cad3","c53.9",-20714,"TCGA-JW-A5VJ_treatment","153d4cc8-c19f-5361-89ce-15e01a534c19","01","false","TCGA-JW-A5VJ-01A",NA,"0fc6e478-1fa9-430c-96ea-b14fb2101181",FALSE,"F62BE627-89E6-49C1-88BD-5FAC87777BDB","Primary Tumor",NA,301,60,NA,1362528000,"11",30,"TCGA-JW-A5VJ-01A-11",90,NA,20,NA,0,NA,10,NA,"2016-09-08T12:12:23.077046-05:00",NA,40,NA,20,NA,"TOP",NA,0,NA,"361f37c4-3d55-4484-b4f6-caab18d2a7d9",NA,"TCGA-JW-A5VJ-01A-01-TS1",NA,90,NA,"42ccd200-b700-4f4f-87e6-f521ef254ee5","RNA","TCGA-JW-A5VJ-01A-11R","f89099b1-0698-4e71-a771-533c9ad4fda7",1.92,0.16,"UV Spec","R","23","TCGA-JW-A5VJ-01A-11R-A28H-07","fef94ae2-4cd8-4e24-9220-3fa17ef1230a",0.16,NA,57,23.7252861602497,155,"dec9d1d3-168b-58b6-b759-3f5971bb3958","TCGA-JW-A5VJ_exposure","UNCID_2169000.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.130611_UNC15-SN850_0312_BC265JACXX_2_AGTTCC.tar.gz","2013-09-20T05:06:04.000Z","2013-09-20T05:21:01.000Z","DB4CC7CB-499B-4D64-8B23-F83BD5128B2B","0FC6E478-1FA9-430C-96EA-B14FB2101181","Unaligned reads",6543399135,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","FEF94AE2-4CD8-4E24-9220-3FA17EF1230A","University of North Carolina","564a3bb2e4b093830b695d44","F0BB0D18-1190-463D-A0BA-839C2C776794","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","42CCD200-B700-4F4F-87E6-F521EF254EE5","2013-09-20T05:21:01.000Z","F89099B1-0698-4E71-A771-533C9AD4FDA7","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",301,"42CCD200-B700-4F4F-87E6-F521EF254EE5",NA,"JW","UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments.bam",60,"TCGA-JW-A5VJ-01A",NA,NA,"TCGA",2012,"TCGA-JW-A5VJ_NTE-1","Progressive Disease","WITH TUMOR","AC802945-3208-4D9B-B92A-6E16C64A06C9",56,"nationwidechildrens.org_clinical.TCGA-JW-A5VJ.xml","Alive",NA,"TCGA-JW-A5VJ","HISPANIC OR LATINO","89AF6DF0-4A55-492B-AD18-D8957D7A9421","YES",401,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",2,"Post-Adjuvant Therapy","Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",297,NA,NA,"AMERICAN INDIAN OR ALASKA NATIVE",NA,11,30,"361F37C4-3D55-4484-B4F6-CAAB18D2A7D9","6BCAB7D7-8236-45BE-B27B-C5E91D78B186","UNCID_2061749.fef94ae2-4cd8-4e24-9220-3fa17ef1230a.sorted_genome_alignments.bam","TCGA-JW-A5VJ-01A-11",90,0,20,40,10,"TOP",0,20,"TCGA-JW-A5VJ-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,"TCGA-JW-A5VJ-F61351_NTE-1","NO",652,"WITH TUMOR","Alive",NA,"TCGA-JW-A5VJ-F61351","TCGA-JW-A5VJ",NA,"JW","A5VJ","YES","C53.9","8070/3","C53.9","YES","NO",-20714,"FEMALE","AMERICAN INDIAN OR ALASKA NATIVE","HISPANIC OR LATINO","No","No","Alive",401,NA,NA,NA,"WITH TUMOR","YES",3,6,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,56,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,"Progressive Disease","2009",13,NA,"T2bNXMX",NA,NA,2,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
97015366,96185572,4597763801,"B5C9EA22-F758-4BD2-BD1F-282EC1078AED.bw","f0cfaacc-30e5-4e54-b33a-f0fd5dad620e","b5c9ea22-f758-4bd2-bd1f-282ec1078aed","2016-08-09T14:40:52.760647-05:00","UNCID_2654361.b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd.141006_UNC15-SN850_0395_AC5FH9ACXX_5_GAGTGG.tar.gz","b36f3008-761f-4633-8078-d26cbe66ff5f",3995120378,"Illumina HiSeq","965612642d35457bc0da73cdf6206ead","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:16:39.290002-05:00","2016-05-03T12:08:10.829131-05:00","b36f3008-761f-4633-8078-d26cbe66ff5f_analysis.xml","654a72e7a880bad2a588ac6519b082ae","8c76f6d6-4784-4501-98a4-a3ae04094b80",2124,"2016-09-29T21:22:21.818552-05:00","b36f3008-761f-4633-8078-d26cbe66ff5f_experiment.xml","9e4000ffb5a433db28439b7b820dccb9","9001e43a-1fd0-4a5f-b462-f124f307c41c",2628,"2016-09-29T17:47:31.467201-05:00","b36f3008-761f-4633-8078-d26cbe66ff5f_run.xml","11259bac14eaac8f8d84c232b152b09e","0a1b53ad-0fce-493e-b8fd-1e2c474b3c79",354,"2016-09-08T11:46:00.063133-05:00","TCGA-VS-A9UP","2016-09-02T18:54:29.957010-05:00","female","TCGA-VS-A9UP_demographic",1968,"not reported","be1457d8-926f-5ff5-8c8b-74e50d2e8eab","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A9UP_diagnosis","not reported",15849,"alive","8482/3",NA,1444,"f25ad650-e11d-5e49-b489-c08fc83d85d5","c53.9",-15849,"TCGA-VS-A9UP_treatment","e36fd1b6-3f66-53d9-b65b-a8f14f23a601","01","false","TCGA-VS-A9UP-01A",NA,"04b8f6aa-7f97-4d01-a890-d9e6aa1d45df",FALSE,"CA4BC8DE-D4C5-4B10-AB82-8A0C766C529F","Primary Tumor",NA,993,50,NA,1391040000,"11",30,"TCGA-VS-A9UP-01A-11",70,NA,20,NA,0,NA,25,NA,"2016-09-08T11:46:00.063133-05:00",NA,50,NA,20,NA,"TOP",NA,5,NA,"68e82753-9b6e-4544-b919-efb4c140dcd0",NA,"TCGA-VS-A9UP-01A-01-TS1",NA,70,NA,"c3d5702d-758d-4d4a-ac3a-e9461f1ca16a","RNA","TCGA-VS-A9UP-01A-11R","f65b7599-2967-4e96-99b0-929c5dfcf229",1.82,0.18,"UV Spec","R","23","TCGA-VS-A9UP-01A-11R-A42T-07","b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd",0.18,0.0547945205479452,68,28.3038501560874,155,"7ab533d8-a1ea-540b-adb5-d9688827abe7","TCGA-VS-A9UP_exposure","UNCID_2654361.b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd.141006_UNC15-SN850_0395_AC5FH9ACXX_5_GAGTGG.tar.gz","2014-11-04T23:06:05.000Z","2014-11-04T23:19:04.000Z","B36F3008-761F-4633-8078-D26CBE66FF5F","04B8F6AA-7F97-4D01-A890-D9E6AA1D45DF","Unaligned reads",3995120378,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B1E7DB92-7DD8-4BF1-B6CF-649DF1BB96BD","University of North Carolina","564a4031e4b09c884b25cb22","F0CFAACC-30E5-4E54-B33A-F0FD5DAD620E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C3D5702D-758D-4D4A-AC3A-E9461F1CA16A","2014-11-04T23:19:04.000Z","F65B7599-2967-4E96-99B0-929C5DFCF229","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",993,"C3D5702D-758D-4D4A-AC3A-E9461F1CA16A",NA,"VS","UNCID_2650776.b1e7db92-7dd8-4bf1-b6cf-649df1bb96bd.sorted_genome_alignments.bam",50,"TCGA-VS-A9UP-01A",NA,"82CD6A7E-AD39-4A38-A53F-0AD1EABE3268","TCGA",2011,"TCGA-VS-A9UP_NTE-1","Complete Remission/Response","WITH TUMOR","9CD99F4D-69A5-4685-8720-0484D14F8C6C",43,"nationwidechildrens.org_clinical.TCGA-VS-A9UP.xml","Alive",NA,"TCGA-VS-A9UP",NA,"C345FB70-D1A0-44D1-8679-5ECBEE5C3340","YES",1150,"No","Cervix","C53.9","NX","Mucinous Adenocarcinoma of Endocervical Type",1,"Pre-Adjuvant Therapy","Stage IIA",NA,NA,"T2a","8482/3","FEMALE","C53.9",420,NA,"8533DD0D-C740-484C-9D6E-11D354352A19",NA,NA,11,30,"68E82753-9B6E-4544-B919-EFB4C140DCD0","F65B7599-2967-4E96-99B0-929C5DFCF229","TCGA-VS-A9UP-01A-11R-A42V-13_mirna.bam.bai","TCGA-VS-A9UP-01A-11",70,0,20,50,25,"TOP",5,20,"TCGA-VS-A9UP-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-VS-A9UP-D63458","TCGA-VS-A9UP-R63456","External","Regional site","TCGA-VS-A9UP-F67674_NTE-1","NO",1316,"WITH TUMOR","Alive",NA,"TCGA-VS-A9UP-F67674","TCGA-VS-A9UP",NA,"VS","A9UP","YES","C53.9","8482/3","C53.9","NO","YES",-15849,"FEMALE",NA,NA,"No","No","Alive",1150,NA,NA,NA,"WITH TUMOR","YES",11,8,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,43,2011,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,2,NA,1,NA,"Complete Remission/Response","2009",10,NA,"T2aNXMX",NA,NA,1,"Pre-Adjuvant Therapy",NA,"Peri (6-12 months since last menstrual period)",NA,NA,NA,NA,NA,NA
88497286,87039419,4155687133,"3F08AE92-3EFD-4D7F-8C5C-BFB3621F0CD6.bw","f0daf315-8909-4cda-886d-a2770b08db94","3f08ae92-3efd-4d7f-8c5c-bfb3621f0cd6","2016-08-09T14:40:55.972237-05:00","UNCID_2654393.ad34a739-074f-4463-b053-d1368c4d34db.141010_UNC12-SN629_0394_AC5FTUACXX_3_AGTCAA.tar.gz","52d65013-1a85-4d0f-b54b-17dbad5f7376",3571846950,"Illumina HiSeq","d8f21e1f19477137ae4df395b52ab721","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T22:35:20.277499-05:00","2016-05-03T12:08:10.830175-05:00","52d65013-1a85-4d0f-b54b-17dbad5f7376_analysis.xml","9c9bc7b18ea94b5267bf86ca4753210e","bd101baf-78ca-4a69-bb47-9b688758047c",2124,"2016-08-26T04:03:04.296189-05:00","52d65013-1a85-4d0f-b54b-17dbad5f7376_experiment.xml","e1738111f5c88abbd1d480b2e96cca42","4da3f911-258b-4ec7-967d-3fb3e91549a6",2628,"2016-09-29T20:43:51.484911-05:00","52d65013-1a85-4d0f-b54b-17dbad5f7376_run.xml","77e34f5c77518a0172c8286aa4982937","77e11f00-a394-4b8f-828d-e443332b1b26",354,"2016-09-08T11:36:55.166887-05:00","TCGA-ZJ-AB0H","2016-09-02T18:54:48.681782-05:00","female","TCGA-ZJ-AB0H_demographic",1958,"not reported","4ecce1b4-6b53-5b77-b257-99d8a6c6a894","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","ZJ","d6a28561-6c7f-5bdf-89f3-2fa8e1a7dfed","NCI HRE Branch","not reported","c53.9","TCGA-ZJ-AB0H_diagnosis","not reported",17869,"alive","8072/3",NA,0,"18b38efe-7dbb-52e5-8cf9-c03d70438b1e","c53.9",-17869,"TCGA-ZJ-AB0H_treatment","d70ca058-9705-5054-b81c-7f8e688ae495","01","true","TCGA-ZJ-AB0H-01A",NA,"33ecb03b-be5d-4735-bf25-045c79ae3462",FALSE,"4D5AE266-6C48-44FA-A613-4A8BC9160CBF","Primary Tumor",NA,2619,80,NA,1396224000,"11",30,"TCGA-ZJ-AB0H-01A-11",95,NA,0,NA,0,NA,10,NA,"2016-09-08T11:36:55.166887-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"b8f4f757-7fd9-4244-93d6-532771bdbe4a",NA,"TCGA-ZJ-AB0H-01A-01-TS1",NA,90,NA,"39563905-45c7-4b4c-9ec5-d2249cbc9a05","RNA","TCGA-ZJ-AB0H-01A-11R","8065584c-643f-4b87-87e6-0e5d3bc7b41e",1.83,0.18,"UV Spec","R","23","TCGA-ZJ-AB0H-01A-11R-A42T-07","ad34a739-074f-4463-b053-d1368c4d34db",0.18,NA,NA,NA,NA,"7b9b9218-8f68-5129-9a9f-b521a31b6d3f","TCGA-ZJ-AB0H_exposure","UNCID_2654393.ad34a739-074f-4463-b053-d1368c4d34db.141010_UNC12-SN629_0394_AC5FTUACXX_3_AGTCAA.tar.gz","2014-11-05T10:47:04.000Z","2014-11-05T10:59:32.000Z","52D65013-1A85-4D0F-B54B-17DBAD5F7376","33ECB03B-BE5D-4735-BF25-045C79AE3462","Unaligned reads",3571846950,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","AD34A739-074F-4463-B053-D1368C4D34DB","University of North Carolina","566075f0e4b0b37b3d98feff","F0DAF315-8909-4CDA-886D-A2770B08DB94","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","39563905-45C7-4B4C-9EC5-D2249CBC9A05","2014-11-05T10:59:32.000Z","8065584C-643F-4B87-87E6-0E5D3BC7B41E","United States","NO",1,NA,"Primary Tumor","NCI HRE Branch",2619,"39563905-45C7-4B4C-9EC5-D2249CBC9A05",NA,"ZJ","UNCID_2654393.ad34a739-074f-4463-b053-d1368c4d34db.141010_UNC12-SN629_0394_AC5FTUACXX_3_AGTCAA.tar.gz",80,"TCGA-ZJ-AB0H-01A",NA,NA,"TCGA",2006,"TCGA-ZJ-AB0H_NTE-1",NA,NA,"E2B02B02-860B-485B-99EE-7EC70757D928",48,"WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_A04_1524192.tangent.copynumber.data.txt","Alive",NA,"TCGA-ZJ-AB0H",NA,NA,NA,0,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIIB",NA,NA,"T3b","8072/3","FEMALE","C53.9",420,NA,NA,NA,NA,11,30,"B8F4F757-7FD9-4244-93D6-532771BDBE4A","8065584C-643F-4B87-87E6-0E5D3BC7B41E","UNCID_2654393.ad34a739-074f-4463-b053-d1368c4d34db.141010_UNC12-SN629_0394_AC5FTUACXX_3_AGTCAA.tar.gz","TCGA-ZJ-AB0H-01A-11",95,0,0,0,10,"TOP",0,0,"TCGA-ZJ-AB0H-01A-01-TS1",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-ZJ-AB0H",NA,"ZJ","AB0H","YES","C53.9","8072/3","C53.9","NO","YES",-17869,"FEMALE",NA,NA,"No","No","Alive",0,NA,NA,NA,NA,"NO",19,12,2014,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2006,"Biopsy (cervical / CT-guided / Other)","YES",NA,NA,NA,NA,NA,NA,NA,NA,NA,"2009",16,NA,"T3bN1M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
183700164,176300091,8413731037,"8F0D43F1-2199-4DBB-9B16-1E5F2CED2FEC.bw","f150d999-cdec-427e-b8b2-00731c648989","8f0d43f1-2199-4dbb-9b16-1e5f2ced2fec","2016-08-09T13:51:32.797807-05:00","UNCID_2186728.0A78E78C-F31A-488A-BF37-C47B108954FD.121011_UNC13-SN749_0197_AD16K1ACXX_6_ATGTCA.tar.gz","b9a8a0b8-ce99-485a-849a-76a0343521a4",8110049090,"Illumina HiSeq","9e0fd45e6d78948ff11402d31585b08c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:43:24.797528-05:00","2016-05-03T11:01:14.486033-05:00","b9a8a0b8-ce99-485a-849a-76a0343521a4_analysis.xml","3095625f8668bdeb05b4dfad4af52ffa","9cec7d7a-6133-491d-bed5-2eaf14203f43",2124,"2016-08-30T05:24:42.595870-05:00","b9a8a0b8-ce99-485a-849a-76a0343521a4_experiment.xml","bf875361e7683e992f4bd318551a80e7","7a5f8468-73f5-4cae-b953-feed4ea9393a",2431,"2016-09-29T21:54:30.824918-05:00","b9a8a0b8-ce99-485a-849a-76a0343521a4_run.xml","2c0a15172279936cc476487292ad2cad","a3ec3017-1444-42e2-9da2-a7b93111ec9b",354,"2016-09-08T11:59:00.294659-05:00","TCGA-HM-A3JJ","2016-09-02T18:59:09.668923-05:00","female","TCGA-HM-A3JJ_demographic",1970,"black or african american","662441e5-57ed-53bb-89f2-af562311a56b","not hispanic or latino",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c53.9","TCGA-HM-A3JJ_diagnosis","not reported",14736,"dead","8070/3",659,NA,"ebd7f7a1-5f61-55e1-b2ec-b0a18cfe25c2","c53.9",-14736,"TCGA-HM-A3JJ_treatment","fb281798-cc89-52e1-b8b8-849f928365dd","11","false","TCGA-HM-A3JJ-11A",NA,"3fbfda3f-0286-41df-999c-4ba50429ca60",FALSE,NA,"Solid Tissue Normal",NA,629,950,NA,1324425600,"12",30,"TCGA-HM-A3JJ-11A-12",0,NA,0,NA,100,NA,0,NA,"2016-09-08T11:59:00.294659-05:00",NA,1,NA,0,NA,"TOP",NA,0,NA,"176defe3-92cd-4f70-8b77-362b45c19c2d",NA,"TCGA-HM-A3JJ-11A-01-TS1",NA,0,NA,"0d6deefc-ab9d-4596-bb0c-c85e16b2e15b","RNA","TCGA-HM-A3JJ-11A-12R","eecb0432-3d8d-4adf-812a-4c61a6d2ef6a",1.74,0.17,"UV Spec","R","23","TCGA-HM-A3JJ-11A-12R-A21T-07","0a78e78c-f31a-488a-bf37-c47b108954fd",0.17,NA,72,24.0569347455645,173,"eb5a3a45-6995-52e3-ac36-e8cf65c4f1b4","TCGA-HM-A3JJ_exposure","UNCID_2186728.0A78E78C-F31A-488A-BF37-C47B108954FD.121011_UNC13-SN749_0197_AD16K1ACXX_6_ATGTCA.tar.gz","2013-09-16T20:16:05.000Z","2013-09-16T20:50:01.000Z","B9A8A0B8-CE99-485A-849A-76A0343521A4","3FBFDA3F-0286-41DF-999C-4BA50429CA60","Unaligned reads",8110049090,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0A78E78C-F31A-488A-BF37-C47B108954FD","University of North Carolina","564a397ee4b0298dd2c7cbfc","F150D999-CDEC-427E-B8B2-00731C648989","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","0D6DEEFC-AB9D-4596-BB0C-C85E16B2E15B","2013-09-16T20:50:01.000Z","EECB0432-3D8D-4ADF-812A-4C61A6D2EF6A","United States","NO",11,NA,"Solid Tissue Normal","Christiana Healthcare",629,"0D6DEEFC-AB9D-4596-BB0C-C85E16B2E15B",NA,"HM","CENTS_p_TCGASNP_212_216_217_N_GenomeWideSNP_6_C02_1039542.birdseed.data.txt",950,"TCGA-HM-A3JJ-11A",NA,"801FEF42-121B-46DF-ABD7-6CCECA54F4D8","TCGA",2010,NA,NA,"WITH TUMOR","5CCB1FCE-2ED1-4D92-87D7-B5855275E3BB",40,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.8AE5BF11-9C43-4107-81B3-B4033B96D0F5.txt","Dead",659,"TCGA-HM-A3JJ","NOT HISPANIC OR LATINO","FB92D8C0-4D24-43F4-948D-7982266BBBAA",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",217,NA,"6E60DD71-D115-4A48-8432-9726F4C74A4C","BLACK OR AFRICAN AMERICAN",NA,12,30,"176DEFE3-92CD-4F70-8B77-362B45C19C2D","6493E683-49AF-4C94-9729-056296E1B90B","7786923106_R01C01_Grn.idat","TCGA-HM-A3JJ-11A-12",0,100,0,1,0,"TOP",0,0,"TCGA-HM-A3JJ-11A-01-TS1",0,"Cisplatin","Chemotherapy","TCGA-HM-A3JJ-D29258","TCGA-HM-A3JJ-R29327","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",659,"TCGA-HM-A3JJ-F29259","TCGA-HM-A3JJ",NA,"HM","A3JJ","YES","C53.9","8070/3","C53.9","YES","NO",-14736,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,659,NA,NA,"WITH TUMOR","NO",12,3,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2010,"Cone Biopsy / LEEP","YES",41,4,"G3",NA,NA,NA,NA,NA,NA,"2009",7,NA,"T1b1N1MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
182720030,179345998,8565019738,"54BABD8B-EA9F-4875-8594-2179B38C73BD.bw","f150d999-cdec-427e-b8b2-00731c648989","54babd8b-ea9f-4875-8594-2179b38c73bd","2016-08-05T04:31:58.521405-05:00","UNCID_2186703.4811BA43-5130-4CD4-8317-6D4495144C9E.121011_UNC13-SN749_0197_AD16K1ACXX_6_AGTTCC.tar.gz","187fa4ea-257c-4f9b-9465-a3949b133d58",8082419770,"Illumina HiSeq","71eb4aef5a3d4ec27dd6e7f0ab7f017c","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:13:48.339379-05:00","2016-05-03T11:00:24.467501-05:00","187fa4ea-257c-4f9b-9465-a3949b133d58_analysis.xml","a41af713040941cb9f0cc07d59acc1d0","8ab60e4d-bb2b-4f81-b74f-7eeb196d8481",2124,"2016-10-07T15:49:37.531317-05:00","187fa4ea-257c-4f9b-9465-a3949b133d58_experiment.xml","1c2afd94129479c5998f1f86bbada9b6","c9f9c272-a40b-4bed-9983-52bc7cde9b1f",2431,"2016-09-29T23:18:20.080456-05:00","187fa4ea-257c-4f9b-9465-a3949b133d58_run.xml","dea707f679277cd1a93a9361edebf162","d7a22823-b8df-4619-acc7-f9441a1defe3",354,"2016-09-08T11:59:00.294659-05:00","TCGA-HM-A3JJ","2016-09-02T18:59:09.668923-05:00","female","TCGA-HM-A3JJ_demographic",1970,"black or african american","662441e5-57ed-53bb-89f2-af562311a56b","not hispanic or latino",2011,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","HM","7eba89bc-ed35-5ad6-ab8b-ecd55a02ec77","Christiana Healthcare","not reported","c53.9","TCGA-HM-A3JJ_diagnosis","not reported",14736,"dead","8070/3",659,NA,"ebd7f7a1-5f61-55e1-b2ec-b0a18cfe25c2","c53.9",-14736,"TCGA-HM-A3JJ_treatment","fb281798-cc89-52e1-b8b8-849f928365dd","01","false","TCGA-HM-A3JJ-01A",NA,"5ccb1fce-2ed1-4d92-87d7-b5855275e3bb",FALSE,"5F8358A7-34EB-4DAA-81F0-18B27BDCDF65","Primary Tumor",NA,629,680,NA,1324425600,"21",30,"TCGA-HM-A3JJ-01A-21",60,NA,0,NA,10,NA,10,NA,"2016-09-08T11:59:00.294659-05:00",NA,5,NA,1,NA,"TOP",NA,0,NA,"f03d0fe5-2b4f-4054-831b-e2edb02c4886",NA,"TCGA-HM-A3JJ-01A-02-TS2",NA,80,NA,"798e1c30-3523-4747-b970-6230a4ca1a9d","RNA","TCGA-HM-A3JJ-01A-21R","081cfa07-0340-4e2f-8398-636bbc7e6910",1.78,0.17,"UV Spec","R","23","TCGA-HM-A3JJ-01A-21R-A21T-07","4811ba43-5130-4cd4-8317-6d4495144c9e",0.17,NA,72,24.0569347455645,173,"eb5a3a45-6995-52e3-ac36-e8cf65c4f1b4","TCGA-HM-A3JJ_exposure","UNCID_2186703.4811BA43-5130-4CD4-8317-6D4495144C9E.121011_UNC13-SN749_0197_AD16K1ACXX_6_AGTTCC.tar.gz","2013-09-16T12:16:04.000Z","2013-09-16T12:40:02.000Z","187FA4EA-257C-4F9B-9465-A3949B133D58","5CCB1FCE-2ED1-4D92-87D7-B5855275E3BB","Unaligned reads",8082419770,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","4811BA43-5130-4CD4-8317-6D4495144C9E","University of North Carolina","564a397de4b0ef121819d4d9","F150D999-CDEC-427E-B8B2-00731C648989","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","798E1C30-3523-4747-B970-6230A4CA1A9D","2013-09-16T12:40:02.000Z","081CFA07-0340-4E2F-8398-636BBC7E6910","United States","NO",1,NA,"Primary Tumor","Christiana Healthcare",629,"798E1C30-3523-4747-B970-6230A4CA1A9D",NA,"HM","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.8AE5BF11-9C43-4107-81B3-B4033B96D0F5.txt",680,"TCGA-HM-A3JJ-01A",NA,"801FEF42-121B-46DF-ABD7-6CCECA54F4D8","TCGA",2010,NA,NA,"WITH TUMOR","5CCB1FCE-2ED1-4D92-87D7-B5855275E3BB",40,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.8AE5BF11-9C43-4107-81B3-B4033B96D0F5.txt","Dead",659,"TCGA-HM-A3JJ","NOT HISPANIC OR LATINO","FB92D8C0-4D24-43F4-948D-7982266BBBAA",NA,NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",217,NA,"6E60DD71-D115-4A48-8432-9726F4C74A4C","BLACK OR AFRICAN AMERICAN",NA,21,30,"F03D0FE5-2B4F-4054-831B-E2EDB02C4886","ADB7CD1F-860A-4D9D-8004-092FA9669AD9","TCGA-HM-A3JJ-01A-21R-A21U-13_mirna.bam","TCGA-HM-A3JJ-01A-21",60,10,0,5,10,"TOP",0,1,"TCGA-HM-A3JJ-01A-02-TS2",80,"Cisplatin","Chemotherapy","TCGA-HM-A3JJ-D29258","TCGA-HM-A3JJ-R29327","EXTERNAL BEAM","Primary Tumor Field",NA,"YES",NA,"WITH TUMOR","Dead",659,"TCGA-HM-A3JJ-F29259","TCGA-HM-A3JJ",NA,"HM","A3JJ","YES","C53.9","8070/3","C53.9","YES","NO",-14736,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Dead",NA,659,NA,NA,"WITH TUMOR","NO",12,3,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,40,2010,"Cone Biopsy / LEEP","YES",41,4,"G3",NA,NA,NA,NA,NA,NA,"2009",7,NA,"T1b1N1MX",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
90983618,87294775,4157214683,"C149B6F8-03DC-4907-920A-F3318B8D2A1E.bw","f241d6b1-2c32-4478-8f8d-8c746464f7d1","c149b6f8-03dc-4907-920a-f3318b8d2a1e","2016-08-26T10:55:56.460662-05:00","UNCID_2545270.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.131021_UNC9-SN296_0409_BC2M6NACXX_5_ATCACG.tar.gz","010784df-315c-4308-af6f-15035166459f",4508371860,"Illumina HiSeq","bf6cee4c238d0db03a55ac005ba083e0","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:09:53.733073-05:00","2016-05-03T11:53:03.318295-05:00","010784df-315c-4308-af6f-15035166459f_analysis.xml","4e5bb8fdfeee1eddc45ca2b647f9d5de","d28f6332-325d-45db-9b55-8d5dde60d79f",2122,"2016-10-07T16:13:35.963710-05:00","010784df-315c-4308-af6f-15035166459f_experiment.xml","c121d8ea5191468ef4e99d27e2d53291","cc721b91-767f-4b53-9b60-25e4a756949e",2628,"2016-09-29T17:51:22.625529-05:00","010784df-315c-4308-af6f-15035166459f_run.xml","84ac60b53eca04b8d05ffd02a3e4ff9c","0c8903dc-6faf-4a9f-94f6-fb835257dc9c",354,"2016-09-08T11:20:38.534575-05:00","TCGA-LP-A4AV","2016-09-02T18:59:40.625472-05:00","female","TCGA-LP-A4AV_demographic",1948,"asian","0aee0634-b47a-5986-a90a-bbf0d14cf39c","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","LP","952088ff-1617-513e-9cbb-773239dafad0","ILSBIO","not reported","c53.9","TCGA-LP-A4AV_diagnosis","not reported",NA,"alive","8071/3",NA,0,"49203847-eb85-50c8-bb0b-edcbf33efefb","c53.9",NA,"TCGA-LP-A4AV_treatment","fcb62b0b-84e4-5c9c-93b3-bb212b44344e","01","true","TCGA-LP-A4AV-01A",NA,"522e7c48-5f2c-4fc3-9f3e-23a4347ec4b9",FALSE,"7880E0A0-01B8-4A31-967D-8833B20752BB","Primary Tumor",NA,413,180,NA,1348185600,"11",30,"TCGA-LP-A4AV-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:20:38.534575-05:00",NA,3,NA,0,NA,"TOP",NA,10,NA,"1630edb7-9ced-4a22-9362-2cc05dc6ce4b",NA,"TCGA-LP-A4AV-01A-01-TSA",NA,90,NA,"950d3e61-34cc-43ac-9e1d-091b9e574757","RNA","TCGA-LP-A4AV-01A-11R","dbb317d4-1317-4d40-a8a5-cc2fef94510e",1.87,0.15,"UV Spec","R","23","TCGA-LP-A4AV-01A-11R-A32Y-07","777d3cf0-1f4a-42e9-b88c-cdf2d783b24d",0.15,NA,42,17.9418172497757,153,"527bf9f7-0b7d-5943-91ee-d6d1f2d0620d","TCGA-LP-A4AV_exposure","UNCID_2545270.777d3cf0-1f4a-42e9-b88c-cdf2d783b24d.131021_UNC9-SN296_0409_BC2M6NACXX_5_ATCACG.tar.gz","2014-07-23T00:06:04.000Z","2014-07-23T00:22:20.000Z","010784DF-315C-4308-AF6F-15035166459F","522E7C48-5F2C-4FC3-9F3E-23A4347EC4B9","Unaligned reads",4508371860,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","777D3CF0-1F4A-42E9-B88C-CDF2D783B24D","University of North Carolina","564a3b5ce4b0298dd2c86485","F241D6B1-2C32-4478-8F8D-8C746464F7D1","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","950D3E61-34CC-43AC-9E1D-091B9E574757","2014-07-23T00:22:20.000Z","DBB317D4-1317-4D40-A8A5-CC2FEF94510E","Vietnam","NO",1,NA,"Primary Tumor","ILSBIO",413,"950D3E61-34CC-43AC-9E1D-091B9E574757",NA,"LP","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.41413CCA-EDCB-4BA1-945E-81C34DBFF006.txt",180,"TCGA-LP-A4AV-01A",NA,NA,"TCGA",2011,"TCGA-LP-A4AV_NTE-1",NA,"TUMOR FREE","EC08F8EE-DA6A-4CFA-AEE9-07754224FC58",63,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.41413CCA-EDCB-4BA1-945E-81C34DBFF006.txt","Alive",NA,"TCGA-LP-A4AV","NOT HISPANIC OR LATINO",NA,"NO",0,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8071/3","FEMALE","C53.9",256,NA,NA,"ASIAN",NA,11,30,"1630EDB7-9CED-4A22-9362-2CC05DC6CE4B","DBB317D4-1317-4D40-A8A5-CC2FEF94510E","TCGA-LP-A4AV-01A-11R-A24J-13_mirna.bam.bai","TCGA-LP-A4AV-01A-11",80,0,0,3,0,"TOP",10,0,"TCGA-LP-A4AV-01A-01-TSA",90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-LP-A4AV",NA,"LP","A4AV","YES","C53.9","8071/3","C53.9","YES","NO",NA,"FEMALE","ASIAN","NOT HISPANIC OR LATINO","No","No","Alive",0,NA,NA,NA,"TUMOR FREE","YES",12,3,2013,"NO","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,63,2011,"Biopsy (cervical / CT-guided / Other)","YES",3,NA,"G2",NA,1,NA,NA,NA,NA,"2009",6,NA,"T1bN0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
183089538,180107944,8588115216,"F93D26E2-4B45-495D-BC8E-5B592F8FDABF.bw","f24ed9c0-92bb-4003-86d2-42ab26617a05","f93d26e2-4b45-495d-bc8e-5b592f8fdabf","2016-08-09T13:56:54.112731-05:00","UNCID_2186742.2cdcd676-9056-4b42-8029-5b8dc44d3b57.121011_UNC13-SN749_0197_AD16K1ACXX_3_GCCAAT.tar.gz","978bc198-4912-47dd-ae91-06be6c91c726",8188467333,"Illumina HiSeq","619f4fbabdb112056f73acad7cddfb3d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:48:29.417532-05:00","2016-05-03T11:01:14.486033-05:00","978bc198-4912-47dd-ae91-06be6c91c726_analysis.xml","63de921ab57a9e852f101c46ccdce25e","a016f1bd-b7f7-4e14-9c2a-b772fda60726",2124,"2016-09-29T20:37:32.637908-05:00","978bc198-4912-47dd-ae91-06be6c91c726_experiment.xml","fe5e52291339b4e4686d745d5bcb04bb","73efde24-5f6d-49b7-a72f-81ebb8e73217",2431,"2016-09-29T23:56:37.667345-05:00","978bc198-4912-47dd-ae91-06be6c91c726_run.xml","e36113287ea2980f6f168d1df25908f5","ef95bcaf-d1b3-4e09-b6a4-36597a2f3d32",354,"2016-09-08T11:24:12.202998-05:00","TCGA-IR-A3LH","2016-09-02T18:58:53.531486-05:00","female","TCGA-IR-A3LH_demographic",1956,"black or african american","3cce19cd-d981-52af-9919-dd7bbdf0b3a5","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","IR","e9dfe0cc-e14e-566e-862d-50be5eb18231","Memorial Sloan Kettering","not reported","c53.9","TCGA-IR-A3LH_diagnosis","not reported",18118,"alive","8070/3",NA,2394,"c005e093-c274-5e14-927a-c8e8f6fcc4e1","c53.9",-18118,"TCGA-IR-A3LH_treatment","b63825f3-4462-5406-bb24-9d7a733bccec","01","true","TCGA-IR-A3LH-01A",NA,"d95e5389-dd55-4d55-ab01-6a770c66502f",FALSE,"7204DF29-2167-48A0-AA56-51E9AFFBB0D5","Primary Tumor",NA,2501,340,NA,1324598400,"21",30,"TCGA-IR-A3LH-01A-21",95,NA,1,NA,0,NA,0,NA,"2016-09-08T11:24:12.202998-05:00",NA,1,NA,0,NA,"TOP",NA,5,NA,"c96cfe98-0074-4d99-adc8-ee22c20fa60f",NA,"TCGA-IR-A3LH-01A-02-TSB",NA,95,NA,"a660bd38-24fb-4269-8181-51c8b8a9f405","RNA","TCGA-IR-A3LH-01A-21R","b0b69d7c-8c2c-4538-944c-fea3b1b1893d",1.78,0.16,"UV Spec","R","23","TCGA-IR-A3LH-01A-21R-A213-07","2cdcd676-9056-4b42-8029-5b8dc44d3b57",0.16,1.0958904109589,74,31.2025636700961,154,"ed4ef9ae-9eb0-5e38-943c-ba1afb57b7a5","TCGA-IR-A3LH_exposure","UNCID_2186742.2cdcd676-9056-4b42-8029-5b8dc44d3b57.121011_UNC13-SN749_0197_AD16K1ACXX_3_GCCAAT.tar.gz","2013-09-16T20:16:03.000Z","2013-09-16T20:52:01.000Z","978BC198-4912-47DD-AE91-06BE6C91C726","D95E5389-DD55-4D55-AB01-6A770C66502F","Unaligned reads",8188467333,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","2CDCD676-9056-4B42-8029-5B8DC44D3B57","University of North Carolina","566075e7e4b0b37b3d98fe95","F24ED9C0-92BB-4003-86D2-42AB26617A05","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","A660BD38-24FB-4269-8181-51C8B8A9F405","2013-09-16T20:52:01.000Z","B0B69D7C-8C2C-4538-944C-FEA3B1B1893D","United States","NO",1,NA,"Primary Tumor","Memorial Sloan Kettering",2501,"A660BD38-24FB-4269-8181-51C8B8A9F405",NA,"IR","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.321A85A8-BC4A-4D64-B8E6-89FC29A338CB.txt",340,"TCGA-IR-A3LH-01A",NA,"3D3105F8-BC2E-4485-B58F-96DDF1DB8EE8","TCGA",2005,NA,NA,"TUMOR FREE","D95E5389-DD55-4D55-AB01-6A770C66502F",49,"jhu-usc.edu_CESC.HumanMethylation450.6.lvl-3.TCGA-IR-A3LH-01A-21D-A212-05.txt","Alive",NA,"TCGA-IR-A3LH",NA,"588B37E3-4421-48B1-8E69-8BD9BD851994",NA,2394,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIA1",NA,NA,"T2a1","8070/3","FEMALE","C53.9",200,NA,"0CE9C2F8-E78E-497A-A8B1-BDDEC1A38D07","BLACK OR AFRICAN AMERICAN",NA,21,30,"C96CFE98-0074-4D99-ADC8-EE22C20FA60F","FA4512AA-4BCC-4D60-8E62-FC84739B984C","OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_C01_955338.CEL","TCGA-IR-A3LH-01A-21",95,0,1,1,0,"TOP",5,0,"TCGA-IR-A3LH-01A-02-TSB",95,"Cisplatin","Chemotherapy","TCGA-IR-A3LH-D38301","TCGA-IR-A3LH-R38300","Internal","Primary Tumor Field","TCGA-IR-A3LH-F68422_NTE-1","NO",2394,"TUMOR FREE","Alive",NA,"TCGA-IR-A3LH-F68422","TCGA-IR-A3LH",NA,"IR","A3LH","YES","C53.9","8070/3","C53.9","NO","YES",-18118,"FEMALE","BLACK OR AFRICAN AMERICAN",NA,"No","No","Alive",2394,NA,NA,NA,"TUMOR FREE","NO",13,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2005,"Biopsy (cervical / CT-guided / Other)","YES",40,0,"G4",NA,4,2000,20,NA,NA,"2009",11,NA,"T2a1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
82457646,81311450,3882945162,"C98275CD-C39A-4E14-A731-4F3EB7396665.bw","f2bea37e-0d19-49e1-91a0-a4de4dfa2d35","c98275cd-c39a-4e14-a731-4f3eb7396665","2016-08-09T14:41:48.020917-05:00","UNCID_2654392.33be2852-1252-432d-9f4e-2d0749f2563a.141010_UNC12-SN629_0394_AC5FTUACXX_6_GTTTCG.tar.gz","8b8cf7a2-a4c7-4037-9869-fd8285112aab",3500317732,"Illumina HiSeq","50fc838b4fcf3d13d56d70287031ff72","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:05:07.631791-05:00","2016-05-03T12:08:10.830175-05:00","8b8cf7a2-a4c7-4037-9869-fd8285112aab_analysis.xml","80ed28ca83688600377e36c4ffd48a78","853343b5-81fe-488e-935b-90c80aee3422",2124,"2016-09-29T20:51:36.377798-05:00","8b8cf7a2-a4c7-4037-9869-fd8285112aab_experiment.xml","22e10b39335aee88b89595a2296cbbab","7cbee962-e861-4081-b391-d08267d66fb5",2628,"2016-09-29T22:48:37.971550-05:00","8b8cf7a2-a4c7-4037-9869-fd8285112aab_run.xml","2847bbd8c30b639febe7287fb96c2878","c559d531-e782-4497-b7c6-2b51df8dd836",354,"2016-09-08T10:44:56.021956-05:00","TCGA-VS-A959","2016-09-02T18:54:16.580748-05:00","female","TCGA-VS-A959_demographic",1934,"not reported","70616370-1dfa-51bd-8b2b-bb0020de7562","not reported",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","VS","9bdddb02-0639-5513-acf8-c993f7dcb2e7","Barretos Cancer Hospital","not reported","c53.9","TCGA-VS-A959_diagnosis","not reported",27897,"alive","8070/3",NA,1561,"b50281ab-e6cc-5a03-9c5b-ba7db1b6a5a3","c53.9",-27897,"TCGA-VS-A959_treatment","c388eb5f-fb60-5bb9-a0dc-9ea3e0e4a9f0","01","false","TCGA-VS-A959-01A",NA,"60db8167-4ad6-47df-a9f4-d145195a10bd",FALSE,"10A6CADD-C99B-4A34-9D5D-02AD37C1AB80","Primary Tumor",NA,1181,70,NA,1389830400,"11",30,"TCGA-VS-A959-01A-11",60,NA,0,NA,0,NA,20,NA,"2016-09-08T10:44:56.021956-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"cffaddcc-63d7-4f39-993f-6360f4523abc",NA,"TCGA-VS-A959-01A-01-TS1",NA,80,NA,"eaa840b3-e43a-48cc-9adc-1d0f9a251161","RNA","TCGA-VS-A959-01A-11R","655c20c6-025f-40ae-9865-ce3cd2c62141",1.85,0.17,"UV Spec","R","23","TCGA-VS-A959-01A-11R-A42T-07","33be2852-1252-432d-9f4e-2d0749f2563a",0.17,NA,47,22.3543400713436,145,"2f47c5d2-df1e-50f2-9a21-530b83fe8901","TCGA-VS-A959_exposure","UNCID_2654392.33be2852-1252-432d-9f4e-2d0749f2563a.141010_UNC12-SN629_0394_AC5FTUACXX_6_GTTTCG.tar.gz","2014-11-05T10:27:04.000Z","2014-11-05T10:39:27.000Z","8B8CF7A2-A4C7-4037-9869-FD8285112AAB","60DB8167-4AD6-47DF-A9F4-D145195A10BD","Unaligned reads",3500317732,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","33BE2852-1252-432D-9F4E-2D0749F2563A","University of North Carolina","564a3b44e4b09c884b2450b1","F2BEA37E-0D19-49E1-91A0-A4DE4DFA2D35","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","EAA840B3-E43A-48CC-9ADC-1D0F9A251161","2014-11-05T10:39:27.000Z","655C20C6-025F-40AE-9865-CE3CD2C62141","Brazil","NO",1,NA,"Primary Tumor","Barretos Cancer Hospital",1181,"EAA840B3-E43A-48CC-9ADC-1D0F9A251161",NA,"VS","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_A10_1524190.byallele.copynumber.data.txt",70,"TCGA-VS-A959-01A",NA,NA,"TCGA",2010,"TCGA-VS-A959_NTE-1","Complete Remission/Response","TUMOR FREE","D1894791-E427-4DB9-97B2-A3B73A4E8E30",76,"nationwidechildrens.org_clinical.TCGA-VS-A959.xml","Alive",NA,"TCGA-VS-A959",NA,"F1DD89AC-B98D-4C9A-80D3-081CB7E5B5F8","NO",1197,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIB",NA,NA,"T2b","8070/3","FEMALE","C53.9",420,NA,"A2FE7905-179D-46F5-86EF-50C91BCA091B",NA,NA,11,30,"CFFADDCC-63D7-4F39-993F-6360F4523ABC","CBBCBCD3-A3AD-4BA8-B13C-A23835C1E7F7","WANED_p_TCGAb_113_420_NSP_GenomeWideSNP_6_A10_1524190.byallele.copynumber.data.txt","TCGA-VS-A959-01A-11",60,0,0,0,20,"TOP",0,0,"TCGA-VS-A959-01A-01-TS1",80,NA,NA,NA,"TCGA-VS-A959-R62807","Internal","Primary Tumor Field","TCGA-VS-A959-F70914_NTE-1","NO",1561,"TUMOR FREE","Alive",NA,"TCGA-VS-A959-F70914","TCGA-VS-A959",NA,"VS","A959","YES","C53.9","8070/3","C53.9","NO","YES",-27897,"FEMALE",NA,NA,"No","No","Alive",1197,NA,NA,NA,"TUMOR FREE","YES",27,5,2014,"YES","NO","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,76,2010,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,1,NA,NA,NA,"Complete Remission/Response","2009",13,NA,"T2bNXMX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
134534760,133048004,6352192176,"354DC705-216E-42F0-B29E-C1F8D6C9489A.bw","f2c901d1-2039-4046-89b5-c2d45bcf10c3","354dc705-216e-42f0-b29e-c1f8d6c9489a","2016-08-25T14:44:16.940552-05:00","UNCID_2337786.5abdff9b-a6a9-4564-9ac3-98a563f65fe6.131015_UNC11-SN627_0328_BC2NN6ACXX_5_ACTGAT.tar.gz","dd926c19-8942-4008-b2a2-907989b18637",6091693012,"Illumina HiSeq","fb22d0d5b809248fe7b6402da559b91f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:39:15.840878-05:00","2016-05-03T11:35:41.364651-05:00","dd926c19-8942-4008-b2a2-907989b18637_analysis.xml","c422b68ce0456bea8cda563b377f2569","2a81ccfd-cc3a-44d1-a5f3-d2b5a87ec829",2124,"2016-10-07T15:53:53.881800-05:00","dd926c19-8942-4008-b2a2-907989b18637_experiment.xml","f5b6397e3cf742a1e2474dfa08c5a138","0a381ec5-f034-4b34-9892-a41e48688df6",2628,"2016-09-29T20:47:22.387978-05:00","dd926c19-8942-4008-b2a2-907989b18637_run.xml","f443409a38f21e913012dec07bdaa568","7a11ec94-ca7c-4dbb-ab96-942a9013b0e0",354,"2016-09-08T11:31:56.867689-05:00","TCGA-C5-A7CG","2016-09-02T19:00:20.227683-05:00","female","TCGA-C5-A7CG_demographic",1942,"white","9333d139-0199-5f66-871e-498d666a4939","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CG_diagnosis","not reported",20242,"alive","8070/3",NA,6408,"0bf55cd3-c9f8-5b82-aed0-a765ba635773","c53.9",-20242,"TCGA-C5-A7CG_treatment","6e0832d5-76d3-53f9-965a-2a7af3c6a4da","01","true","TCGA-C5-A7CG-01A",NA,"e88f2479-3e23-43be-8c35-1e9385cbce08",FALSE,"E511E773-AAEF-4685-AC83-3EF5F31C489F","Primary Tumor",NA,6043,150,NA,1377820800,"11",30,"TCGA-C5-A7CG-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:31:56.867689-05:00",NA,4,NA,0,NA,"TOP",NA,3,NA,"4fad64de-43ff-4c08-b9b4-a99db4359559",NA,"TCGA-C5-A7CG-01A-01-TS1",NA,97,NA,"2072e9f7-b474-4bb0-af31-691ca963bf01","RNA","TCGA-C5-A7CG-01A-11R","53496dd2-3e15-4dd1-9d11-c54169883658",1.96,0.18,"UV Spec","R","23","TCGA-C5-A7CG-01A-11R-A32P-07","5abdff9b-a6a9-4564-9ac3-98a563f65fe6",0.18,NA,94,32.9120128847029,169,"32e969ad-b822-5d12-8916-93bb304b968e","TCGA-C5-A7CG_exposure","UNCID_2337786.5abdff9b-a6a9-4564-9ac3-98a563f65fe6.131015_UNC11-SN627_0328_BC2NN6ACXX_5_ACTGAT.tar.gz","2014-02-04T02:07:06.000Z","2014-02-04T02:31:01.000Z","DD926C19-8942-4008-B2A2-907989B18637","E88F2479-3E23-43BE-8C35-1E9385CBCE08","Unaligned reads",6091693012,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5ABDFF9B-A6A9-4564-9AC3-98A563F65FE6","University of North Carolina","564a3985e4b0ef121819d797","F2C901D1-2039-4046-89B5-C2D45BCF10C3","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2072E9F7-B474-4BB0-AF31-691CA963BF01","2014-02-04T02:31:01.000Z","53496DD2-3E15-4DD1-9D11-C54169883658","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",6043,"2072E9F7-B474-4BB0-AF31-691CA963BF01",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.9864C71F-FFC6-4BAD-99FA-EA39BEBD99DC.txt",150,"TCGA-C5-A7CG-01A",NA,NA,"TCGA",1997,"TCGA-C5-A7CG_NTE-1",NA,"TUMOR FREE","E88F2479-3E23-43BE-8C35-1E9385CBCE08",55,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.9864C71F-FFC6-4BAD-99FA-EA39BEBD99DC.txt","Alive",NA,"TCGA-C5-A7CG","NOT HISPANIC OR LATINO","AD654A5B-6601-4D68-A8B7-C112A53C2D8E","NO",5564,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB",NA,NA,"T1b","8070/3","FEMALE","C53.9",335,NA,NA,"WHITE",NA,11,30,"4FAD64DE-43FF-4C08-B9B4-A99DB4359559","DB275096-3046-48DC-858E-73ED40EB8658","970aa77d058b34f6993256b8d659ec34.bam","TCGA-C5-A7CG-01A-11",75,0,0,4,0,"TOP",3,0,"TCGA-C5-A7CG-01A-01-TS1",97,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7CG-F63991_NTE-1","NO",6408,"TUMOR FREE","Alive",NA,"TCGA-C5-A7CG-F63991","TCGA-C5-A7CG",NA,"C5","A7CG","YES","C53.9","8070/3","C53.9","NO","YES",-20242,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",5564,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,55,1997,"Biopsy (cervical / CT-guided / Other)","YES",47,0,"G2",NA,1,NA,NA,NA,NA,"1995",6,NA,"T1bN0MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
129275516,126917667,6059170897,"6752EED9-7990-433F-A206-D5398C396471.bw","f3cbadb3-3b83-47cd-b8a0-b0e10343a295","6752eed9-7990-433f-a206-d5398c396471","2016-08-09T14:01:05.532986-05:00","UNCID_2168994.e0dc1957-256a-4ffe-9521-66dd3970639c.130611_UNC15-SN850_0312_BC265JACXX_4_CGATGT.tar.gz","fc67bf3c-3783-45f7-89a3-168294a367ba",5787211963,"Illumina HiSeq","53d34f660627b1d6f63c73231aac267a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:56:54.580594-05:00","2016-05-03T11:06:28.634130-05:00","fc67bf3c-3783-45f7-89a3-168294a367ba_analysis.xml","870e9b761b355a8a64b73960b1322e4d","35c478b4-40b6-4a9a-882e-4ea6f5d9d637",2123,"2016-10-07T16:36:58.538409-05:00","fc67bf3c-3783-45f7-89a3-168294a367ba_experiment.xml","c39d60302b570878e957d432dc54fa2a","87f96333-4fe5-41cf-9d35-5caab205d0a5",2431,"2016-09-29T18:47:17.118789-05:00","fc67bf3c-3783-45f7-89a3-168294a367ba_run.xml","d4a7871025a63007eed8f83d50b77550","2faa8c33-da8b-4f72-812f-ea7a04f76450",354,"2016-09-08T11:30:48.735728-05:00","TCGA-Q1-A5R2","2016-09-02T19:00:09.279977-05:00","female","TCGA-Q1-A5R2_demographic",1948,"white","1a3b083e-7a64-5579-8523-c2515ae20ea1","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A5R2_diagnosis","not reported",23523,"alive","8070/3",NA,499,"82088496-08f4-5b57-ba4a-830e9b816e67","c53.9",-23523,"TCGA-Q1-A5R2_treatment","ea4a2063-65d9-555a-a4c9-1a31d91cbc5b","01","true","TCGA-Q1-A5R2-01A",NA,"cc7e7631-8c2f-41da-81ac-82073a7ab5d7",FALSE,"D5BD3FE8-6CE0-41A1-A9CB-FE8874C4A16F","Primary Tumor",NA,57,30,NA,1360800000,"11",20,"TCGA-Q1-A5R2-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:30:48.735728-05:00",NA,3,NA,0,NA,"TOP",NA,0,NA,"f9fd798b-6718-4ad6-a99d-2c319a54c5b2",NA,"TCGA-Q1-A5R2-01A-01-TS1",NA,100,NA,"c99ae64e-36fa-4a62-80bb-e5bf457a33d0","RNA","TCGA-Q1-A5R2-01A-11R","1c3e3232-6139-432a-a2b0-a0d136d60251",1.83,0.15,"UV Spec","R","23","TCGA-Q1-A5R2-01A-11R-A28H-07","e0dc1957-256a-4ffe-9521-66dd3970639c",0.15,NA,76,29.6875,160,"818f24bb-1d53-532d-b049-43e808a52b71","TCGA-Q1-A5R2_exposure","UNCID_2168994.e0dc1957-256a-4ffe-9521-66dd3970639c.130611_UNC15-SN850_0312_BC265JACXX_4_CGATGT.tar.gz","2013-09-20T05:31:05.000Z","2013-09-20T05:46:01.000Z","FC67BF3C-3783-45F7-89A3-168294A367BA","CC7E7631-8C2F-41DA-81AC-82073A7AB5D7","Unaligned reads",5787211963,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","E0DC1957-256A-4FFE-9521-66DD3970639C","University of North Carolina","564a3cace4b09c884b24bf66","F3CBADB3-3B83-47CD-B8A0-B0E10343A295","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","C99AE64E-36FA-4A62-80BB-E5BF457A33D0","2013-09-20T05:46:01.000Z","1C3E3232-6139-432A-A2B0-A0D136D60251","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",57,"C99AE64E-36FA-4A62-80BB-E5BF457A33D0",NA,"Q1","UNCID_2061607.e0dc1957-256a-4ffe-9521-66dd3970639c.sorted_genome_alignments.bam",30,"TCGA-Q1-A5R2-01A",NA,"56934D77-B222-4F09-B296-CCA334AAD2D7","TCGA",2012,"TCGA-Q1-A5R2_NTE-1",NA,"WITH TUMOR","CC7E7631-8C2F-41DA-81AC-82073A7AB5D7",64,"nationwidechildrens.org_clinical.TCGA-Q1-A5R2.xml","Alive",NA,"TCGA-Q1-A5R2","NOT HISPANIC OR LATINO","6CF1ABFF-816F-43CB-B856-C2501185B8B0","NO",105,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",0,"Post-Adjuvant Therapy",NA,NA,NA,"TX","8070/3","FEMALE","C53.9",297,NA,"391BD273-80E2-428A-B0B6-657D0F7CACE2","WHITE",NA,11,20,"F9FD798B-6718-4AD6-A99D-2C319A54C5B2","3E5D0D75-F0EC-48F9-BE8F-87AAFB08C42F","UNCID_2061607.e0dc1957-256a-4ffe-9521-66dd3970639c.sorted_genome_alignments.bam","TCGA-Q1-A5R2-01A-11",80,0,0,3,0,"TOP",0,0,"TCGA-Q1-A5R2-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-Q1-A5R2-D48279","TCGA-Q1-A5R2-R48280","External","Primary Tumor Field","TCGA-Q1-A5R2-F56898_NTE-1","NO",499,"TUMOR FREE","Alive",NA,"TCGA-Q1-A5R2-F56898","TCGA-Q1-A5R2",NA,"Q1","A5R2","YES","C53.9","8070/3","C53.9","YES","NO",-23523,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",105,NA,NA,NA,"WITH TUMOR","YES",26,4,2013,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,64,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"G3",NA,1,NA,NA,NA,NA,"7th",1,NA,"TXNXMX",NA,NA,0,"Post-Adjuvant Therapy",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
156561650,151032785,7211566847,"C3E94C5D-68C4-400C-B7CB-38C42E9D5FFF.bw","f40468de-3b86-4922-9951-f8ae28da6af0","c3e94c5d-68c4-400c-b7cb-38c42e9d5fff","2016-08-05T01:06:01.652626-05:00","UNCID_2187260.5015be4c-acad-4536-bb65-59696b168717.120921_UNC16-SN851_0181_AD14JFACXX_3_CGATGT.tar.gz","ae59231d-8ebf-40f1-afe0-53629527df37",6786583627,"Illumina HiSeq","7bf4fd7ef8ddc3ece742c0ca8a71938f","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:22:18.932746-05:00","2016-05-03T11:02:00.408696-05:00","ae59231d-8ebf-40f1-afe0-53629527df37_analysis.xml","394a3ac81467462cdce5639971c9d3bc","8ffcc146-b67f-4354-9591-fee204f977e5",2124,"2016-09-29T20:56:28.391526-05:00","ae59231d-8ebf-40f1-afe0-53629527df37_experiment.xml","b5c744910cd63f59143be9dc1e79fefa","7fcb4a39-06db-4c90-89d9-5dfc092eddfe",2431,"2016-09-29T21:46:17.749450-05:00","ae59231d-8ebf-40f1-afe0-53629527df37_run.xml","f7ecca3e249b80d9cd2d5d2c7d5a4f90","9ebc99fe-6bfd-41d8-a407-cf30b21d721c",354,"2016-09-08T12:00:59.926360-05:00","TCGA-BI-A20A","2016-09-02T18:57:16.690851-05:00","female","TCGA-BI-A20A_demographic",1961,"white","cc0e6c25-eb51-59de-b862-7d317ac27d94","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","BI","7c1cce46-1302-522c-ad52-74b2655b217c","University of Pittsburgh","not reported","c53.9","TCGA-BI-A20A_diagnosis","not reported",18215,"alive","8070/3",NA,720,"f24299a6-f346-5edd-b739-020306a45620","c53.9",-18215,"TCGA-BI-A20A_treatment","a94d7ce7-9f4c-5a08-89b9-fa46c2e972df","01","true","TCGA-BI-A20A-01A",NA,"73bb25ec-bf67-4a93-a159-a4b34e7534de",FALSE,"FA32D74F-9855-489A-8217-F588682F96CE","Primary Tumor",NA,218,60,NA,1302566400,"11",30,"TCGA-BI-A20A-01A-11",70,NA,10,NA,0,NA,20,NA,"2016-09-08T12:00:59.926360-05:00",NA,40,NA,30,NA,"TOP",NA,10,NA,"ccfe4cb7-3ec5-449a-964d-ac737db121ab",NA,"TCGA-BI-A20A-01A-01-TSA",NA,70,NA,"4e6c4ead-59ce-4a35-b5ba-311a1a8fd4fa","RNA","TCGA-BI-A20A-01A-11R","2639b772-e323-4d92-ae27-eb83ecaeea33",1.85,0.16,"UV Spec","R","23","TCGA-BI-A20A-01A-11R-A14Y-07","5015be4c-acad-4536-bb65-59696b168717",0.16,NA,59,21.1552942020151,167,"f3a27346-cd25-5afc-9144-9aaf62ba35bc","TCGA-BI-A20A_exposure","UNCID_2187260.5015be4c-acad-4536-bb65-59696b168717.120921_UNC16-SN851_0181_AD14JFACXX_3_CGATGT.tar.gz","2013-09-17T05:36:05.000Z","2013-09-17T05:57:01.000Z","AE59231D-8EBF-40F1-AFE0-53629527DF37","73BB25EC-BF67-4A93-A159-A4B34E7534DE","Unaligned reads",6786583627,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","5015BE4C-ACAD-4536-BB65-59696B168717","University of North Carolina","564a3aa6e4b0ef12181a3395","F40468DE-3B86-4922-9951-F8AE28DA6AF0","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4E6C4EAD-59CE-4A35-B5BA-311A1A8FD4FA","2013-09-17T05:57:01.000Z","2639B772-E323-4D92-AE27-EB83ECAEEA33","United States","NO",1,NA,"Primary Tumor","University of Pittsburgh",218,"4E6C4EAD-59CE-4A35-B5BA-311A1A8FD4FA",NA,"BI","TCGA-BI-A20A-01A-11R-A14X-13_mirna.bam",60,"TCGA-BI-A20A-01A",NA,NA,"TCGA",2010,NA,NA,"TUMOR FREE","73BB25EC-BF67-4A93-A159-A4B34E7534DE",49,"nationwidechildrens.org_clinical.TCGA-BI-A20A.xml","Alive",NA,"TCGA-BI-A20A","NOT HISPANIC OR LATINO","52901882-F487-474D-9079-85DE04926BAE",NA,72,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",127,NA,NA,"WHITE",NA,11,30,"CCFE4CB7-3EC5-449A-964D-AC737DB121AB","CEAD859F-A211-47AC-8229-C584FED9BF45","TCGA-BI-A20A-01A-11R-A14X-13_mirna.bam","TCGA-BI-A20A-01A-11",70,0,10,40,20,"TOP",10,30,"TCGA-BI-A20A-01A-01-TSA",70,NA,NA,NA,NA,NA,NA,"TCGA-BI-A20A-F39615_NTE-1","NO",462,"TUMOR FREE","Alive",NA,"TCGA-BI-A20A-F39615","TCGA-BI-A20A",NA,"BI","A20A","YES","C53.9","8070/3","C53.9","NO","YES",-18215,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",72,NA,NA,NA,"TUMOR FREE","NO",5,10,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,49,2010,"Cone Biopsy / LEEP","YES",6,0,"G3",NA,NA,NA,NA,NA,NA,"7th",7,NA,"T1b1N0M0",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
148176098,145621889,6948521772,"CE6B6871-3ED3-44DE-A777-7558D4429057.bw","f5d90810-8c4b-4ced-9360-383e42cb54b3","ce6b6871-3ed3-44de-a777-7558d4429057","2016-08-26T13:03:27.754833-05:00","UNCID_2545283.576cc9e7-f32b-4478-a8a6-e77c16a07e35.131021_UNC9-SN296_0409_BC2M6NACXX_5_GTGGCC.tar.gz","bb7c7dc7-3153-4a27-8ee5-87116473aa06",7394767325,"Illumina HiSeq","7bdacd25a79a378c545f716e7a49157a","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:56:43.965319-05:00","2016-05-03T11:53:44.550213-05:00","bb7c7dc7-3153-4a27-8ee5-87116473aa06_analysis.xml","a7131fa8da029468e2a81caec4750d7b","efa8891e-80da-496b-869a-c6837419e85d",2122,"2016-10-07T16:06:14.894573-05:00","bb7c7dc7-3153-4a27-8ee5-87116473aa06_experiment.xml","58f0fc71f679de475ead6d40319c4d14","dba34c77-885e-40e1-b263-cc1c113b90be",2628,"2016-09-29T21:25:16.452433-05:00","bb7c7dc7-3153-4a27-8ee5-87116473aa06_run.xml","2d6d83c039d53ce1a1384788715c015c","91c74004-f251-4668-87e8-602aa3613df5",354,"2016-09-08T11:35:29.209713-05:00","TCGA-EX-A3L1","2016-09-02T18:59:06.202612-05:00","female","TCGA-EX-A3L1_demographic",1979,"white","f2f2da12-d201-5908-b20f-cfa9008b70df","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EX","799c35e8-c06e-55db-a3ec-c5dcd30f2c31","University of North Carolina","not reported","c53.9","TCGA-EX-A3L1_diagnosis","not reported",11943,"alive","8070/3",NA,463,"97fe8a2c-3e03-523e-8e53-20c826150be9","c53.9",-11943,"TCGA-EX-A3L1_treatment","c310d0b5-9257-5e3d-ad59-01ea48b685cc","01","false","TCGA-EX-A3L1-01A",NA,"89ad6395-973b-4011-bfbd-6759209406be",FALSE,"39B5AD4F-9206-4AE5-96EF-AC8E5B2B10E5","Primary Tumor",NA,161,110,NA,1328140800,"11",10,"TCGA-EX-A3L1-01A-11",60,NA,0,NA,0,NA,5,NA,"2016-09-08T11:35:29.209713-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"43539c4c-b8a0-4f39-882e-e496e35b2a09",NA,"TCGA-EX-A3L1-01A-01-TS1",NA,95,NA,"7575324a-5850-4e37-9dbe-6879778ed822","RNA","TCGA-EX-A3L1-01A-11R","3bf0900b-90c7-4c31-9c5b-48ec5c777984",1.89,0.18,"UV Spec","R","23","TCGA-EX-A3L1-01A-11R-A32Y-07","576cc9e7-f32b-4478-a8a6-e77c16a07e35",0.18,NA,57,22.265625,160,"41dd1e14-e7d6-50ff-b3ec-81173c7f3cf9","TCGA-EX-A3L1_exposure","UNCID_2545283.576cc9e7-f32b-4478-a8a6-e77c16a07e35.131021_UNC9-SN296_0409_BC2M6NACXX_5_GTGGCC.tar.gz","2014-07-23T00:37:05.000Z","2014-07-23T01:02:45.000Z","BB7C7DC7-3153-4A27-8EE5-87116473AA06","89AD6395-973B-4011-BFBD-6759209406BE","Unaligned reads",7394767325,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","576CC9E7-F32B-4478-A8A6-E77C16A07E35","University of North Carolina","564a407de4b08c5d86932307","F5D90810-8C4B-4CED-9360-383E42CB54B3","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7575324A-5850-4E37-9DBE-6879778ED822","2014-07-23T01:02:45.000Z","3BF0900B-90C7-4C31-9C5B-48EC5C777984","United States","NO",1,NA,"Primary Tumor","University of North Carolina",161,"7575324A-5850-4E37-9DBE-6879778ED822",NA,"EX","511b37bcb1e1cf5668c1e85b0a0fba96.bam",110,"TCGA-EX-A3L1-01A",NA,"D5445E7B-B1F0-466E-9421-73072DDC7669","TCGA",2011,NA,NA,"TUMOR FREE","92F592AF-39F4-4772-83BA-83D303BD1D60",32,"nationwidechildrens.org_clinical.TCGA-EX-A3L1.xml","Alive",NA,"TCGA-EX-A3L1","NOT HISPANIC OR LATINO","B0AE48F2-2B6A-4AA1-8B25-6C5664A9527D",NA,211,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIA1",NA,NA,"T2a1","8070/3","FEMALE","C53.9",217,NA,"CB690BF4-776F-4608-A783-02F991091941","WHITE",NA,11,10,"43539C4C-B8A0-4F39-882E-E496E35B2A09","B5E8272B-9B70-492F-AF44-23316CE5C1E4","511b37bcb1e1cf5668c1e85b0a0fba96.bam","TCGA-EX-A3L1-01A-11",60,0,0,0,5,"TOP",0,0,"TCGA-EX-A3L1-01A-01-TS1",95,"Cisplatin","Chemotherapy","TCGA-EX-A3L1-D38133","TCGA-EX-A3L1-R38135","External","Primary Tumor Field","TCGA-EX-A3L1-F38130_NTE-1","NO",463,"TUMOR FREE","Alive",NA,"TCGA-EX-A3L1-F38130","TCGA-EX-A3L1",NA,"EX","A3L1","YES","C53.9","8070/3","C53.9","YES","NO",-11943,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",211,NA,NA,NA,"TUMOR FREE","NO",19,4,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,32,2011,"Biopsy (cervical / CT-guided / Other)","YES",22,0,"G3",NA,1,NA,NA,NA,NA,"2009",11,NA,"T2a1N0M0",NA,NA,NA,NA,NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
178293658,174804754,8341126424,"A06E7D1E-E432-4A4C-8BB0-314304F96EDF.bw","f727fcb9-e457-4643-9468-f739133b7e9c","a06e7d1e-e432-4a4c-8bb0-314304f96edf","2016-08-05T08:42:13.342729-05:00","UNCID_2186718.b74c4373-3809-4536-85ef-4c9e651a913e.121011_UNC13-SN749_0197_AD16K1ACXX_4_ACTTGA.tar.gz","7a0cdedd-2d48-4026-a3ab-8585dfec91a6",7646775975,"Illumina HiSeq","4aec17a0adf5ee595e642ec7300d3e9d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:28:41.327051-05:00","2016-05-03T11:00:24.467501-05:00","7a0cdedd-2d48-4026-a3ab-8585dfec91a6_analysis.xml","98f4356f5f675c458f72d07b1873cdb1","de21c077-34e8-45e2-87c6-b3ac3a87aaf1",2124,"2016-09-29T19:41:25.107714-05:00","7a0cdedd-2d48-4026-a3ab-8585dfec91a6_experiment.xml","68c7c6a2e79775522bea9e559c7bf0f8","519cd634-dc07-4dd8-aace-d6518188e196",2431,"2016-09-29T22:04:43.457794-05:00","7a0cdedd-2d48-4026-a3ab-8585dfec91a6_run.xml","7175d9b24af4558d051569ffc7694b4e","aa457713-149b-4584-976b-24ef4cad2081",354,"2016-09-08T11:59:47.644767-05:00","TCGA-EK-A3GN","2016-09-02T18:58:48.499098-05:00","female","TCGA-EK-A3GN_demographic",1958,"white","8f0a2ccd-6caa-5199-9d60-73e4797209fc","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A3GN_diagnosis","not reported",17425,"alive","8070/3",NA,27,"c894b1ec-c2b8-5035-8404-e83b801f8bfa","c53.9",-17425,"TCGA-EK-A3GN_treatment","548cad62-9b9a-5f78-90e0-f70f643f4fc8","01","false","TCGA-EK-A3GN-01A",NA,"eb5034e2-d4a7-48e0-9524-31ddd63c9d94",FALSE,"357A8CB5-F1BF-4BFC-97DF-07CEF0D55026","Primary Tumor",NA,2374,90,NA,1323043200,"11",30,"TCGA-EK-A3GN-01A-11",60,NA,1,NA,30,NA,25,NA,"2016-09-08T11:59:47.644767-05:00",NA,10,NA,0,NA,"TOP",NA,5,NA,"6f36a1a7-a8d7-434d-ac14-7aac3ce45f59",NA,"TCGA-EK-A3GN-01A-01-TS1",NA,40,NA,"fe64f27e-b1a9-4473-83fb-03515444133f","RNA","TCGA-EK-A3GN-01A-11R","26230ca8-f8bc-40b3-a2ba-821d9164f51e",1.84,0.16,"UV Spec","R","23","TCGA-EK-A3GN-01A-11R-A213-07","b74c4373-3809-4536-85ef-4c9e651a913e",0.16,NA,83,32.421875,160,"4370910e-f5b0-5d01-832d-989563db87b0","TCGA-EK-A3GN_exposure","UNCID_2186718.b74c4373-3809-4536-85ef-4c9e651a913e.121011_UNC13-SN749_0197_AD16K1ACXX_4_ACTTGA.tar.gz","2013-09-16T12:46:03.000Z","2013-09-16T13:07:02.000Z","7A0CDEDD-2D48-4026-A3AB-8585DFEC91A6","EB5034E2-D4A7-48E0-9524-31DDD63C9D94","Unaligned reads",7646775975,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","B74C4373-3809-4536-85EF-4C9E651A913E","University of North Carolina","564a3acee4b08c5d86915284","F727FCB9-E457-4643-9468-F739133B7E9C","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","FE64F27E-B1A9-4473-83FB-03515444133F","2013-09-16T13:07:02.000Z","26230CA8-F8BC-40B3-A2BA-821D9164F51E","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",2374,"FE64F27E-B1A9-4473-83FB-03515444133F",NA,"EK","OKRAS_p_TCGA_198_199_200_SNP_N_GenomeWideSNP_6_A07_955328.hg19.seg.txt",90,"TCGA-EK-A3GN-01A",NA,NA,"TCGA",2005,NA,NA,"WITH TUMOR","EB5034E2-D4A7-48E0-9524-31DDD63C9D94",47,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.C68D40B8-F4FA-49CF-A16D-CBA515D9EEC9.txt","Alive",NA,"TCGA-EK-A3GN","NOT HISPANIC OR LATINO",NA,NA,1,"No","Cervix","C53.9","NX","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IIIB",NA,NA,"TX","8070/3","FEMALE","C53.9",200,NA,NA,"WHITE",NA,11,30,"6F36A1A7-A8D7-434D-AC14-7AAC3CE45F59","D8633CDE-C755-4AB0-8ABA-ABB69826359D","UNCID_1669744.b74c4373-3809-4536-85ef-4c9e651a913e.sorted_genome_alignments.bam.bai","TCGA-EK-A3GN-01A-11",60,30,1,10,25,"TOP",5,0,"TCGA-EK-A3GN-01A-01-TS1",40,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"TCGA-EK-A3GN",NA,"EK","A3GN","YES","C53.9","8070/3","C53.9","NO","YES",-17425,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",1,NA,NA,NA,"WITH TUMOR","NO",2,2,2012,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2005,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G3",NA,NA,NA,NA,NA,NA,"1988",16,NA,"TXNX",NA,NA,1,"Preoperative",NA,NA,NA,NA,NA,NA,NA,NA
128034638,124144789,5914478449,"1ABBEF80-508F-4247-B43D-3E549372113B.bw","f8ab17ec-c365-41a6-a4bc-36653e84bce5","1abbef80-508f-4247-b43d-3e549372113b","2016-08-07T22:42:16.391541-05:00","UNCID_2169404.8e7c9d3f-137c-4f4d-829d-76f11c133267.130606_UNC9-SN296_0372_AC277JACXX_3_ACTTGA.tar.gz","3a2c29e0-d614-4be1-bea0-a83f9872da6c",6172618126,"Illumina HiSeq","bf096007b1415dd8545a7dfd7b27ce94","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:19:18.159205-05:00","2016-05-03T11:05:42.727154-05:00","3a2c29e0-d614-4be1-bea0-a83f9872da6c_analysis.xml","586ff21c83b8f07f33657b94353c3fb3","68c71136-a34b-4159-869d-10c20f4ce182",2121,"2016-09-29T22:37:01.252765-05:00","3a2c29e0-d614-4be1-bea0-a83f9872da6c_experiment.xml","b6069e4c928cc478b7c5aeeee8803560","be16709f-3670-465d-a298-e37a043b6b94",2431,"2016-09-29T21:52:21.364097-05:00","3a2c29e0-d614-4be1-bea0-a83f9872da6c_run.xml","06c776f1a7abc1d6671cf25e75c3ce6a","a28f3869-03f6-42dd-9b08-bcc75824b654",354,"2016-09-08T11:31:33.843449-05:00","TCGA-MY-A5BE","2016-09-02T18:59:48.321627-05:00","female","TCGA-MY-A5BE_demographic",1969,"black or african american","9af8c53c-e90d-5f64-9337-6ecbc558be4f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MY","06424429-c5cd-5c57-9e26-68966e407b26","Montefiore Medical Center","not reported","c53.9","TCGA-MY-A5BE_diagnosis","not reported",15466,"alive","8070/3",NA,1066,"a4ce427a-6632-5bd9-8304-b0415d84e8f2","c53.9",-15466,"TCGA-MY-A5BE_treatment","f67a6c0b-fc69-5a3e-8758-5bcee4f0a790","01","true","TCGA-MY-A5BE-01A",NA,"4b0d9159-61fd-44d9-a18b-d0d03def61e1",FALSE,"8D0A3856-45BE-458D-996A-49B5C255296C","Primary Tumor",NA,386,140,NA,1356566400,"21",30,"TCGA-MY-A5BE-01A-21",80,NA,0,NA,0,NA,0,NA,"2016-09-08T11:31:33.843449-05:00",NA,3,NA,0,NA,"TOP",NA,5,NA,"c49b317a-11e2-4bf7-9eff-982d2a15aac5",NA,"TCGA-MY-A5BE-01A-02-TSB",NA,95,NA,"cdfa93fd-b86d-4271-a45b-671bf17773f6","RNA","TCGA-MY-A5BE-01A-21R","fc982e61-ddae-4769-9442-6bcfb61fb00c",1.86,0.17,"UV Spec","R","23","TCGA-MY-A5BE-01A-21R-A26T-07","8e7c9d3f-137c-4f4d-829d-76f11c133267",0.17,NA,84,34.0784616008763,157,"eb3bf49b-e92a-5638-ada1-82902efbd9ff","TCGA-MY-A5BE_exposure","UNCID_2169404.8e7c9d3f-137c-4f4d-829d-76f11c133267.130606_UNC9-SN296_0372_AC277JACXX_3_ACTTGA.tar.gz","2013-09-19T22:56:05.000Z","2013-09-19T23:10:02.000Z","3A2C29E0-D614-4BE1-BEA0-A83F9872DA6C","4B0D9159-61FD-44D9-A18B-D0D03DEF61E1","Unaligned reads",6172618126,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","8E7C9D3F-137C-4F4D-829D-76F11C133267","University of North Carolina","564a3b22e4b0298dd2c85208","F8AB17EC-C365-41A6-A4BC-36653E84BCE5","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","CDFA93FD-B86D-4271-A45B-671BF17773F6","2013-09-19T23:10:02.000Z","FC982E61-DDAE-4769-9442-6BCFB61FB00C","United States","NO",1,NA,"Primary Tumor","Montefiore Medical Center",386,"CDFA93FD-B86D-4271-A45B-671BF17773F6",NA,"MY","TCGA-MY-A5BE-01A-21R-A26X-13_mirna.bam.bai",140,"TCGA-MY-A5BE-01A",NA,NA,"TCGA",2011,"TCGA-MY-A5BE_NTE-1",NA,"TUMOR FREE","751AFF47-42C7-4695-8D49-C8A97BE7A16B",42,"nationwidechildrens.org_clinical.TCGA-MY-A5BE.xml","Alive",NA,"TCGA-MY-A5BE","NOT HISPANIC OR LATINO","4FBAAC0C-7FFA-4469-836A-C67C296B1F05","NO",2,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",280,NA,NA,"BLACK OR AFRICAN AMERICAN",NA,21,30,"C49B317A-11E2-4BF7-9EFF-982D2A15AAC5","FC982E61-DDAE-4769-9442-6BCFB61FB00C","TCGA-MY-A5BE-01A-21R-A26X-13_mirna.bam.bai","TCGA-MY-A5BE-01A-21",80,0,0,3,0,"TOP",5,0,"TCGA-MY-A5BE-01A-02-TSB",95,NA,NA,NA,NA,NA,NA,"TCGA-MY-A5BE-F67177_NTE-1","NO",1066,"TUMOR FREE","Alive",NA,"TCGA-MY-A5BE-F67177","TCGA-MY-A5BE",NA,"MY","A5BE","YES","C53.9","8070/3","C53.9","NO","YES",-15466,"FEMALE","BLACK OR AFRICAN AMERICAN","NOT HISPANIC OR LATINO","No","No","Alive",2,NA,NA,NA,"TUMOR FREE","YES",20,5,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2011,"Biopsy (cervical / CT-guided / Other)","YES",NA,NA,"G3",NA,1,NA,NA,NA,NA,"2009",7,NA,"T1b1N0MX",NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
211369374,208144392,9884175401,"835AAE7F-F873-4D11-8845-232D261A38DF.bw","f8d342f5-9b92-42e1-8b0d-0876cc26965d","835aae7f-f873-4d11-8845-232d261a38df","2016-08-08T04:09:21.570283-05:00","UNCID_2187330.1fc14ee0-e307-4349-a2ac-9e28c31163f2.120917_UNC11-SN627_0251_AC119PACXX_1_TGACCA.tar.gz","5c221eb0-1db3-4b46-9454-ed9759e665da",9260092843,"Illumina HiSeq","08f4c9d6228022c538be6d2cb5765c15","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:47:57.003708-05:00","2016-05-03T11:02:00.425419-05:00","5c221eb0-1db3-4b46-9454-ed9759e665da_analysis.xml","936c295c409298a9b93eb1a978ed1cdd","0a5ba3c3-186e-4dec-a1dc-29e73081c531",2124,"2016-10-07T17:16:59.860258-05:00","5c221eb0-1db3-4b46-9454-ed9759e665da_experiment.xml","3c5f58f196fba6bb728a192fed8dc9e1","51156d31-dc3c-4832-945e-858ed3778b40",2431,"2016-09-29T17:58:40.490707-05:00","5c221eb0-1db3-4b46-9454-ed9759e665da_run.xml","c5d7b80f734a557bc43dba8be7c120ff","111bd66d-4c29-4b23-a644-042758682edd",354,"2016-09-08T12:16:51.787658-05:00","TCGA-DS-A0VN","2016-09-02T18:54:41.890872-05:00","female","TCGA-DS-A0VN_demographic",1955,"white","798012e2-bc1d-51e9-8be8-488352e4ff42","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","DS","7d15717f-b2a0-5017-9968-990f6ed1a25d","Cedars Sinai","not reported","c53.9","TCGA-DS-A0VN_diagnosis","not reported",17433,"alive","8070/3",NA,2910,"6d997db6-32d8-5063-b570-a9c86f8bc7f7","c53.9",-17433,"TCGA-DS-A0VN_treatment","3f9b34a3-3d16-5bae-99ee-ea4ec9c2746d","01","true","TCGA-DS-A0VN-01A",NA,"0bdb7e71-6de9-4949-bf71-abb9c7f5bc45",FALSE,"F98AC018-6C95-44F5-BEF4-4A5C422970C4","Primary Tumor",NA,2831,190,NA,1291334400,"21",30,"TCGA-DS-A0VN-01A-21",45,65,0,0,0,0,20,0,"2016-09-08T12:16:51.787658-05:00","2016-09-08T12:16:51.787658-05:00",0,0,0,0,"TOP","BOTTOM",0,0,"d6361633-27b0-4b65-9d48-839e01435849","b40864dd-f84d-46fb-ba5a-ac68428c2471","TCGA-DS-A0VN-01A-02-TSB","TCGA-DS-A0VN-01A-02-BSB",80,100,"31eeadac-76fd-4236-9230-e8b50e432ade","RNA","TCGA-DS-A0VN-01A-21R","7a373d43-9386-47f2-97db-3216740e6c95",1.89,0.14,"UV Spec","R","23","TCGA-DS-A0VN-01A-21R-A10U-07","1fc14ee0-e307-4349-a2ac-9e28c31163f2",0.14,NA,81,29.7520661157025,165,"38d348a7-0847-557f-84ba-46d41371ed24","TCGA-DS-A0VN_exposure","UNCID_2187330.1fc14ee0-e307-4349-a2ac-9e28c31163f2.120917_UNC11-SN627_0251_AC119PACXX_1_TGACCA.tar.gz","2013-09-17T08:31:04.000Z","2013-09-17T08:57:01.000Z","5C221EB0-1DB3-4B46-9454-ED9759E665DA","0BDB7E71-6DE9-4949-BF71-ABB9C7F5BC45","Unaligned reads",9260092843,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","1FC14EE0-E307-4349-A2AC-9E28C31163F2","University of North Carolina","564a3f26e4b0ef12181ba2ec","F8D342F5-9B92-42E1-8B0D-0876CC26965D","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","31EEADAC-76FD-4236-9230-E8B50E432ADE","2013-09-17T08:57:01.000Z","7A373D43-9386-47F2-97DB-3216740E6C95","United States","NO",1,NA,"Primary Tumor","Cedars Sinai",2831,"31EEADAC-76FD-4236-9230-E8B50E432ADE",NA,"DS","jhu-usc.edu_CESC.HumanMethylation450.9.lvl-3.TCGA-DS-A0VN-01A-21D-A10W-05.txt",190,"TCGA-DS-A0VN-01A",NA,"C2D25FD5-44C6-400A-8857-33092A62271C","TCGA",2002,NA,NA,"TUMOR FREE","B60FA473-3B87-4BE0-8A28-9F0EBB0C25B0",47,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.A833FC95-34C0-4E8B-82C6-BE2E99E23411.txt","Alive",NA,"TCGA-DS-A0VN","NOT HISPANIC OR LATINO","72F5D828-1650-4B50-A706-92F807C4FCAE",NA,2910,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Preoperative","Stage IB",NA,NA,"T1b2","8070/3","FEMALE","C53.9",88,NA,"76BADCEE-D596-4CCF-A333-8FFC963FD834","WHITE",NA,21,30,"D6361633-27B0-4B65-9D48-839E01435849","79806B17-4DA7-4396-AD76-BC9A7501851E","C501.TCGA-DS-A0VN-01A-21D-A10S-08.5.bam","TCGA-DS-A0VN-01A-21",65,0,0,0,0,"BOTTOM",0,0,"TCGA-DS-A0VN-01A-02-BSB",100,"Cisplatin","Chemotherapy","TCGA-DS-A0VN-D8738","TCGA-DS-A0VN-R8739","EXTERNAL BEAM","Primary Tumor Field","TCGA-DS-A0VN-F53350_NTE-1","NO",3609,"TUMOR FREE","Alive",NA,"TCGA-DS-A0VN-F53350","TCGA-DS-A0VN",NA,"DS","A0VN","YES","C53.9","8070/3","C53.9","NO","YES",-17433,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2910,NA,NA,NA,"TUMOR FREE","NO",4,3,2011,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,47,2002,"Biopsy (cervical / CT-guided / Other)",NA,19,0,"G2",NA,1,NA,NA,NA,NA,NA,6,NA,"T1b2N0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
121229332,119330946,5697335110,"E98A0460-6529-4DBA-8542-1B98801D7A7D.bw","f8f470d2-924f-41dd-92c5-516b0bf68e44","e98a0460-6529-4dba-8542-1b98801d7a7d","2016-08-26T23:06:12.601575-05:00","UNCID_2326811.723cafa2-ce72-4c19-954b-9be09a1b08e9.131015_UNC11-SN627_0328_BC2NN6ACXX_6_GATCAG.tar.gz","d3d584f5-0709-4280-a5a7-7ef282da46fa",5398930965,"Illumina HiSeq","7c7b0dfe7876f0003a58da1840dbe21d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-30T00:09:56.334887-05:00","2016-05-03T11:30:43.411663-05:00","d3d584f5-0709-4280-a5a7-7ef282da46fa_analysis.xml","dc14cc72cb795a03165aa2d1501034a5","f7a5e467-7c8f-425a-bd9b-19c4932abff5",2124,"2016-09-29T23:52:01.465809-05:00","d3d584f5-0709-4280-a5a7-7ef282da46fa_experiment.xml","79631b6cf8595557ce89002d3b000e5c","ecb8ba66-e1fb-4323-ac76-ff1f7b3fd316",2628,"2016-09-30T00:11:56.390305-05:00","d3d584f5-0709-4280-a5a7-7ef282da46fa_run.xml","a43d43245c24fb39c71680ccd539df23","f8e7f888-7904-4777-a8be-ba1941dff87f",354,"2016-09-08T12:16:31.618936-05:00","TCGA-C5-A7CJ","2016-09-02T19:00:20.729166-05:00","female","TCGA-C5-A7CJ_demographic",1960,"white","5a846e66-8960-51eb-ad97-51afd0653ff6","not hispanic or latino",2010,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A7CJ_diagnosis","not reported",15652,"dead","8071/3",3097,NA,"2f99e7e2-98ac-5d2c-bb97-dc55a9f20c96","c53.9",-15652,"TCGA-C5-A7CJ_treatment","759379fc-39ab-5283-a43e-4293f247fa0d","01","true","TCGA-C5-A7CJ-01A",NA,"7e1eea3a-3ced-45dc-86e7-43867738bf49",FALSE,"3EA65A3A-81EC-4121-AFA9-620B37BB23A8","Primary Tumor",NA,3977,40,NA,1377820800,"11",30,"TCGA-C5-A7CJ-01A-11",65,NA,0,NA,0,NA,0,NA,"2016-09-08T12:16:31.618936-05:00",NA,5,NA,0,NA,"TOP",NA,0,NA,"f5e60902-b807-484c-a3c8-c44c12e7dacd",NA,"TCGA-C5-A7CJ-01A-01-TS1",NA,100,NA,"f681d72e-c0ee-40e5-b4a4-4d2a6e2541a6","RNA","TCGA-C5-A7CJ-01A-11R","be328443-b1f6-4028-827a-bdd5911ab5fc",2.08,0.18,"UV Spec","R","23","TCGA-C5-A7CJ-01A-11R-A32P-07","723cafa2-ce72-4c19-954b-9be09a1b08e9",0.18,1.64383561643836,60,22.5827091723437,163,"5db878a8-1655-5b52-aef9-09dc48856904","TCGA-C5-A7CJ_exposure","UNCID_2326811.723cafa2-ce72-4c19-954b-9be09a1b08e9.131015_UNC11-SN627_0328_BC2NN6ACXX_6_GATCAG.tar.gz","2014-01-19T16:11:41.000Z","2014-01-22T08:16:02.000Z","D3D584F5-0709-4280-A5A7-7EF282DA46FA","7E1EEA3A-3CED-45DC-86E7-43867738BF49","Unaligned reads",5398930965,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","723CAFA2-CE72-4C19-954B-9BE09A1B08E9","University of North Carolina","564a3d7ce4b093830b69ef94","F8F470D2-924F-41DD-92C5-516B0BF68E44","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F681D72E-C0EE-40E5-B4A4-4D2A6E2541A6","2014-01-22T08:16:02.000Z","BE328443-B1F6-4028-827A-BDD5911AB5FC","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3977,"F681D72E-C0EE-40E5-B4A4-4D2A6E2541A6",NA,"C5","UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments.bam",40,"TCGA-C5-A7CJ-01A",NA,"1AACD955-9EB2-4DFA-BA7A-89FD85626A3E","TCGA",2002,"TCGA-C5-A7CJ_NTE-1",NA,"TUMOR FREE","7E1EEA3A-3CED-45DC-86E7-43867738BF49",42,"THREW_p_TCGAb_329_335_336_NSP_GenomeWideSNP_6_B04_1367070.nocnv_hg19.seg.txt","Dead",3097,"TCGA-C5-A7CJ","NOT HISPANIC OR LATINO",NA,"NO",NA,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",NA,NA,"Stage IIA",NA,NA,"T2a","8071/3","FEMALE","C53.9",335,NA,"9A87C89B-FCF1-4B29-9E79-60476DABF22B","WHITE",NA,11,30,"F5E60902-B807-484C-A3C8-C44C12E7DACD","BE328443-B1F6-4028-827A-BDD5911AB5FC","UNCID_2247103.723cafa2-ce72-4c19-954b-9be09a1b08e9.sorted_genome_alignments.bam","TCGA-C5-A7CJ-01A-11",65,0,0,5,0,"TOP",0,0,"TCGA-C5-A7CJ-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-C5-A7CJ-D56515","TCGA-C5-A7CJ-R56979",NA,"Regional site",NA,NA,NA,NA,NA,NA,NA,"TCGA-C5-A7CJ",NA,"C5","A7CJ","YES","C53.9","8071/3","C53.9","NO","YES",-15652,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Dead",NA,3097,NA,NA,"TUMOR FREE","YES",3,1,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,42,2002,"Biopsy (cervical / CT-guided / Other)","YES",30,2,"G2",NA,2,NA,30,NA,NA,"1995",10,NA,"T2aN1MX",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
162665296,156238125,7453223149,"06A9CBF8-01D0-4720-BCE8-83F0E77C862F.bw","f92a994d-b080-42c9-966f-34c1000865e3","06a9cbf8-01d0-4720-bce8-83f0e77c862f","2016-08-09T14:00:01.747677-05:00","UNCID_2186350.59d21a33-8d29-4c23-95a8-7986d2a3db36.121102_UNC12-SN629_0235_AC13F5ACXX_2_GTTTCG.tar.gz","7cdbe989-d89d-4528-b3ec-5bfef1f7efd5",7299997307,"Illumina HiSeq","5576634e7570d82a9dec851799c97ff9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T17:44:32.372924-05:00","2016-05-03T11:05:42.712110-05:00","7cdbe989-d89d-4528-b3ec-5bfef1f7efd5_analysis.xml","9caf0e32e78979fc7800498055973d47","0830e8d7-b486-4b09-8076-c65a68d35739",2124,"2016-08-27T23:06:07.004999-05:00","7cdbe989-d89d-4528-b3ec-5bfef1f7efd5_experiment.xml","69e2426130b2023e797b6e9e8141257b","46976807-05f3-4ca0-9b2b-642538fd9b56",2431,"2016-09-29T19:29:36.481721-05:00","7cdbe989-d89d-4528-b3ec-5bfef1f7efd5_run.xml","2073275bef5cd0d7209f4a1a3aa785dd","4a5928e6-ee9c-4870-855e-56b181133b32",354,"2016-09-08T12:08:27.173116-05:00","TCGA-EK-A2RB","2016-09-02T18:58:26.320041-05:00","female","TCGA-EK-A2RB_demographic",1963,"white","73550513-7545-5d9b-8e44-eea63d9b29e9","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","EK","79b0b814-da1b-5b92-8267-b86b3332989b","Gynecologic Oncology Group","not reported","c53.9","TCGA-EK-A2RB_diagnosis","not reported",17752,"alive","8070/3",NA,9,"ea4ff224-956c-5f69-a1b7-1419b38b4242","c53.9",-17752,"TCGA-EK-A2RB_treatment","dc0f65f5-c22e-55a6-a9b6-18be43963388","01","false","TCGA-EK-A2RB-01A",NA,"8254cf9e-5176-4649-b8f5-a6f61ead3cd6",FALSE,"F973731C-16D2-4391-ACCF-381C362B8438","Primary Tumor",NA,169,70,NA,1315785600,"11",30,"TCGA-EK-A2RB-01A-11",92,NA,0,NA,0,NA,15,NA,"2016-09-08T12:08:27.173116-05:00",NA,5,NA,0,NA,"TOP",NA,1,NA,"45101b3c-e301-4bd3-b4ef-69428940c0d4",NA,"TCGA-EK-A2RB-01A-01-TS1",NA,84,NA,"72d2d43e-694c-477d-a35d-d761db34670c","RNA","TCGA-EK-A2RB-01A-11R","2b07857b-c52e-448f-8ba4-27b1cdc29464",1.86,0.17,"UV Spec","R","23","TCGA-EK-A2RB-01A-11R-A18M-07","59d21a33-8d29-4c23-95a8-7986d2a3db36",0.17,NA,105,34.2857142857143,175,"368423ed-1d31-54c1-a66d-5e622abea514","TCGA-EK-A2RB_exposure","UNCID_2186350.59d21a33-8d29-4c23-95a8-7986d2a3db36.121102_UNC12-SN629_0235_AC13F5ACXX_2_GTTTCG.tar.gz","2013-09-19T07:16:05.000Z","2013-09-19T07:37:02.000Z","7CDBE989-D89D-4528-B3EC-5BFEF1F7EFD5","8254CF9E-5176-4649-B8F5-A6F61EAD3CD6","Unaligned reads",7299997307,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","59D21A33-8D29-4C23-95A8-7986D2A3DB36","University of North Carolina","564a3b39e4b093830b69369d","F92A994D-B080-42C9-966F-34C1000865E3","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","72D2D43E-694C-477D-A35D-D761DB34670C","2013-09-19T07:37:02.000Z","2B07857B-C52E-448F-8BA4-27B1CDC29464","United States","NO",1,NA,"Primary Tumor","Gynecologic Oncology Group",169,"72D2D43E-694C-477D-A35D-D761DB34670C",NA,"EK","TCGA-EK-A2RB-01A-11R-A18L-13_mirna.bam",70,"TCGA-EK-A2RB-01A",NA,NA,"TCGA",2011,NA,NA,NA,"F062BD00-CB9C-4648-A917-7C7CA0AA17A5",48,"nationwidechildrens.org_clinical.TCGA-EK-A2RB.xml","Alive",NA,"TCGA-EK-A2RB","NOT HISPANIC OR LATINO","96BC3B25-A51B-42C3-A6F8-1B9970506198",NA,-1,"No","Cervix","C53.9",NA,"Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IVB",NA,NA,NA,"8070/3","FEMALE","C53.9",179,NA,NA,"WHITE",NA,11,30,"45101B3C-E301-4BD3-B4EF-69428940C0D4","195A700C-1422-4225-91EA-ADAD33FBFD57","TCGA-EK-A2RB-01A-11R-A18L-13_mirna.bam","TCGA-EK-A2RB-01A-11",92,0,0,5,15,"TOP",1,0,"TCGA-EK-A2RB-01A-01-TS1",84,NA,NA,NA,NA,NA,NA,"TCGA-EK-A2RB-F58259_NTE-1",NA,-1,NA,"Alive",NA,"TCGA-EK-A2RB-F58259","TCGA-EK-A2RB",NA,"EK","A2RB","YES","C53.9","8070/3","C53.9","NO","YES",-17752,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",9,NA,NA,NA,"TUMOR FREE","NO",7,12,2011,"YES","NO","NO",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,48,2011,"Other method, specify:","NO",NA,NA,"G3",NA,2,NA,NA,NA,NA,"1988",18,NA,NA,NA,NA,0,"Other",NA,NA,NA,NA,NA,NA,NA,NA
108964658,106034611,5056149569,"206865A9-A67C-49A6-93AD-55D06E777559.bw","f93ccd2d-3c77-4bd3-8cac-5203bd57735f","206865a9-a67c-49a6-93ad-55d06e777559","2016-08-09T14:01:45.354303-05:00","UNCID_2168993.ca1c37f0-52c9-4702-87ea-1a81a09c12e8.130611_UNC15-SN850_0312_BC265JACXX_5_AGTCAA.tar.gz","f4174bfa-43d8-44ba-9a71-ca5fb63150fc",5096575609,"Illumina HiSeq","784d20601b007b6ed4ec192f1620d030","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:01:28.996549-05:00","2016-05-03T11:06:28.634130-05:00","f4174bfa-43d8-44ba-9a71-ca5fb63150fc_analysis.xml","8b58737e03f87c8d24a03ddd7e890a66","cd224358-6c92-4aa7-898d-9cbc2ee086a4",2123,"2016-09-29T20:00:58.770199-05:00","f4174bfa-43d8-44ba-9a71-ca5fb63150fc_experiment.xml","55e8319e921f7f1e7962f849e59166af","5db57b22-6c5f-449d-9c75-7215bafdbbb2",2431,"2016-09-29T20:47:52.043016-05:00","f4174bfa-43d8-44ba-9a71-ca5fb63150fc_run.xml","51696b028bbbf81e20a1e70b5b866c92","7a5e04b6-6657-4941-bee6-b158729d8395",354,"2016-09-08T11:23:03.260954-05:00","TCGA-Q1-A5R1","2016-09-02T19:00:08.525902-05:00","female","TCGA-Q1-A5R1_demographic",1980,"white","6d4afa0e-b38d-5122-bf8b-b8f97c1effee","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","Q1","c18ae966-fdce-58b7-8573-6259cbf3fb1f","University of Oklahoma HSC","not reported","c53.9","TCGA-Q1-A5R1_diagnosis","not reported",11705,"alive","8482/3",NA,474,"160e78ac-3a17-542d-bd22-77a0f6e9973e","c53.9",-11705,"TCGA-Q1-A5R1_treatment","8d45a93f-a5c8-5f5a-a515-3539ec0c1200","01","true","TCGA-Q1-A5R1-01A",NA,"4913cea2-4243-4cf3-a0a0-b38e92f29ede",FALSE,"2239503A-D9D8-4262-BAF1-1D6F78AA2826","Primary Tumor",NA,127,30,NA,1360800000,"11",20,"TCGA-Q1-A5R1-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:23:03.260954-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"dd4adbfa-3677-4f84-a3a7-5eb2e6408a9d",NA,"TCGA-Q1-A5R1-01A-01-TS1",NA,100,NA,"f7d8007b-9e0c-4d2d-b643-afa6b7367d54","RNA","TCGA-Q1-A5R1-01A-11R","633b263b-ab81-4ab7-b9b6-fc1a478011c4",1.92,0.16,"UV Spec","R","23","TCGA-Q1-A5R1-01A-11R-A28H-07","ca1c37f0-52c9-4702-87ea-1a81a09c12e8",0.16,NA,92,27.4717071277136,183,"7ba9d5c9-ada6-5636-a862-f3e7c851ce42","TCGA-Q1-A5R1_exposure","UNCID_2168993.ca1c37f0-52c9-4702-87ea-1a81a09c12e8.130611_UNC15-SN850_0312_BC265JACXX_5_AGTCAA.tar.gz","2013-09-20T05:36:05.000Z","2013-09-20T05:50:01.000Z","F4174BFA-43D8-44BA-9A71-CA5FB63150FC","4913CEA2-4243-4CF3-A0A0-B38E92F29EDE","Unaligned reads",5096575609,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","CA1C37F0-52C9-4702-87EA-1A81A09C12E8","University of North Carolina","564a3c08e4b0298dd2c89b60","F93CCD2D-3C77-4BD3-8CAC-5203BD57735F","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F7D8007B-9E0C-4D2D-B643-AFA6B7367D54","2013-09-20T05:50:01.000Z","633B263B-AB81-4AB7-B9B6-FC1A478011C4","United States","NO",1,NA,"Primary Tumor","University of Oklahoma HSC",127,"F7D8007B-9E0C-4D2D-B643-AFA6B7367D54",NA,"Q1","UNCID_2061312.ca1c37f0-52c9-4702-87ea-1a81a09c12e8.sorted_genome_alignments.bam.bai",30,"TCGA-Q1-A5R1-01A",NA,NA,"TCGA",2012,"TCGA-Q1-A5R1_NTE-1","Complete Remission/Response","TUMOR FREE","85E88E38-048B-4085-AE0F-328645A5182B",32,"nationwidechildrens.org_clinical.TCGA-Q1-A5R1.xml","Alive",NA,"TCGA-Q1-A5R1","NOT HISPANIC OR LATINO","5E9D3F51-24D0-414E-945A-4720DCC569F5","NO",113,"No","Cervix","C53.9","N0","Mucinous Adenocarcinoma of Endocervical Type",0,"Other","Stage IB1",NA,NA,"T1b1","8482/3","FEMALE","C53.9",297,NA,NA,"WHITE",NA,11,20,"DD4ADBFA-3677-4F84-A3A7-5EB2E6408A9D","A30534DD-92CC-4D2C-986A-B9024F47F12C","BRIAR_p_TCGA_297_298_299_300_S_GenomeWideSNP_6_B05_1362356.ismpolish.data.txt","TCGA-Q1-A5R1-01A-11",75,0,0,4,0,"TOP",0,0,"TCGA-Q1-A5R1-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-Q1-A5R1-F56897_NTE-1","NO",474,"TUMOR FREE","Alive",NA,"TCGA-Q1-A5R1-F56897","TCGA-Q1-A5R1",NA,"Q1","A5R1","YES","C53.9","8482/3","C53.9","YES","NO",-11705,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",113,NA,NA,NA,"TUMOR FREE","YES",26,4,2013,"YES","NO","NO",NA,NA,NA,"Cervical","Mucinous Adenocarcinoma of Endocervical Type",NA,0,32,2012,"Cytology (e.g. Peritoneal or pleural fluid)","YES",4,0,"G2",NA,1,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N0MX",NA,NA,0,"Other",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
169697358,166643876,7957345544,"26DABC83-DB30-452F-9BE2-366760CB138E.bw","fb4af6b2-4bed-4dbe-9309-29f59ed30fb2","26dabc83-db30-452f-9be2-366760cb138e","2016-08-25T08:52:49.519861-05:00","UNCID_2326749.0697ab9a-88cc-4428-b02a-7666f0a772fa.131015_UNC11-SN627_0327_AC2ND3ACXX_8_GTTTCG.tar.gz","fbc86886-f364-4d8a-965d-cf74be3051ca",7800887564,"Illumina HiSeq","1d05786c14abdf0543a73f907581b06d","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T20:01:01.323292-05:00","2016-05-03T11:30:43.413000-05:00","fbc86886-f364-4d8a-965d-cf74be3051ca_analysis.xml","40053c48939e821f9870e38ad34fdde9","5dba8ba2-8e7a-4295-ab65-7cab6094a74f",2124,"2016-09-29T22:20:57.212988-05:00","fbc86886-f364-4d8a-965d-cf74be3051ca_experiment.xml","4e911cde8980e1b74b72c05d4c11aa64","b40bc536-5e29-4e89-b63e-4ce55b135dc2",2628,"2016-09-29T20:56:26.699606-05:00","fbc86886-f364-4d8a-965d-cf74be3051ca_run.xml","63ee4185338263d7213334d711f7c01b","7fc644aa-3582-46a1-b57b-9d8b9e8da765",354,"2016-09-08T12:13:40.503867-05:00","TCGA-JW-A69B","2016-09-02T19:00:36.740993-05:00","female","TCGA-JW-A69B_demographic",1968,"white","daf77b94-517f-5593-86d1-6f3dc8684b97","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","JW","dca0609a-dd66-5416-a451-fc33614d83e4","BLN - Baylor","not reported","c53.9","TCGA-JW-A69B_diagnosis","not reported",16080,"alive","8384/3",NA,863,"a5ca3426-f323-5a9c-a3df-08ad739ae7ee","c53.9",-16080,"TCGA-JW-A69B_treatment","69aa9486-7607-5b6b-bdcd-3603746bed82","01","true","TCGA-JW-A69B-01A",NA,"bdcffdb1-2753-4211-adc2-57a0cb363ca3",FALSE,"5C2BA942-7F36-496E-AB8F-0EF8A5DE9669","Primary Tumor",NA,231,80,NA,1367798400,"11",30,"TCGA-JW-A69B-01A-11",80,NA,0,NA,0,NA,0,NA,"2016-09-08T12:13:40.503867-05:00",NA,2,NA,0,NA,"TOP",NA,0,NA,"d365b80b-7adc-47a1-a27d-2437fb64ec39",NA,"TCGA-JW-A69B-01A-01-TS1",NA,100,NA,"4b609078-d511-49de-a697-fcb2b0c5ca7d","RNA","TCGA-JW-A69B-01A-11R","396e978f-0d64-4851-b037-723d2c5aeb12",2.16,0.17,"UV Spec","R","23","TCGA-JW-A69B-01A-11R-A32P-07","0697ab9a-88cc-4428-b02a-7666f0a772fa",0.17,NA,69,28.7200832466181,155,"795e1ce5-52da-5e2d-addd-367ea06e0bba","TCGA-JW-A69B_exposure","UNCID_2326749.0697ab9a-88cc-4428-b02a-7666f0a772fa.131015_UNC11-SN627_0327_AC2ND3ACXX_8_GTTTCG.tar.gz","2014-01-19T06:21:09.000Z","2014-01-19T07:45:03.000Z","FBC86886-F364-4D8A-965D-CF74BE3051CA","BDCFFDB1-2753-4211-ADC2-57A0CB363CA3","Unaligned reads",7800887564,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","0697AB9A-88CC-4428-B02A-7666F0A772FA","University of North Carolina","564a3d9ae4b0ef12181b2445","FB4AF6B2-4BED-4DBE-9309-29F59ED30FB2","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","4B609078-D511-49DE-A697-FCB2B0C5CA7D","2014-01-19T07:45:03.000Z","396E978F-0D64-4851-B037-723D2C5AEB12","United States","NO",1,NA,"Primary Tumor","BLN - Baylor",231,"4B609078-D511-49DE-A697-FCB2B0C5CA7D",NA,"JW","TCGA-JW-A69B-01A-11R-A32K-13_mirna.bam.bai",80,"TCGA-JW-A69B-01A",NA,NA,"TCGA",2012,"TCGA-JW-A69B_NTE-1","Complete Remission/Response","TUMOR FREE","BDCFFDB1-2753-4211-ADC2-57A0CB363CA3",44,"nationwidechildrens.org_clinical.TCGA-JW-A69B.xml","Alive",NA,"TCGA-JW-A69B","HISPANIC OR LATINO","526F1C65-18FB-46AD-8B93-B28C465C8633","NO",306,"No","Cervix","C53.9","NX","Endocervical Type of Adenocarcinoma",1,"Other","Stage IB2",NA,NA,"T1b2","8384/3","FEMALE","C53.9",335,NA,NA,"WHITE",NA,11,30,"D365B80B-7ADC-47A1-A27D-2437FB64EC39","7CC8E03D-BCD1-4F71-9E5A-4143B6169CA9","TCGA-JW-A69B-01A-11R-A32K-13_mirna.bam.bai","TCGA-JW-A69B-01A-11",80,0,0,2,0,"TOP",0,0,"TCGA-JW-A69B-01A-01-TS1",100,NA,NA,NA,NA,NA,NA,"TCGA-JW-A69B-F69345_NTE-1","NO",863,"TUMOR FREE","Alive",NA,"TCGA-JW-A69B-F69345","TCGA-JW-A69B",NA,"JW","A69B","YES","C53.9","8384/3","C53.9","YES","NO",-16080,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",306,NA,NA,NA,"TUMOR FREE","YES",10,2,2014,"YES","NO","NO",NA,NA,NA,"Cervical","Endocervical Type of Adenocarcinoma",NA,0,44,2012,"Biopsy (cervical / CT-guided / Other)","NO",NA,NA,"GX",NA,1,NA,NA,NA,"Complete Remission/Response","2009",8,NA,"T1b2NXMX",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
158958028,156426908,7469864264,"9DD5272A-2D6E-4774-83E3-0CD761EDE926.bw","fb66b7f5-22ca-4d4d-97c2-30e6edfff781","9dd5272a-2d6e-4774-83e3-0cd761ede926","2016-08-09T13:11:36.529328-05:00","UNCID_2186960.26616de7-08df-4359-9c00-c649409b1480.121002_UNC11-SN627_0254_AC0WP5ACXX_6_GAGTGG.tar.gz","ab5951a5-3906-42af-b873-72b9949cd1fd",6607681578,"Illumina HiSeq","cd152168d1c0e06a868002e529e4c4a9","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T21:59:02.744394-05:00","2016-05-03T11:00:24.457874-05:00","ab5951a5-3906-42af-b873-72b9949cd1fd_analysis.xml","1d2f56feae441523d3d049375c88c722","a6c1819c-d689-4de5-a500-112e38e990f1",2124,"2016-10-07T15:52:51.500083-05:00","ab5951a5-3906-42af-b873-72b9949cd1fd_experiment.xml","814ad33d9c382b1650a3e09e9536af57","1ad1da88-47c6-401e-aeae-60fdfadf5506",2431,"2016-09-29T19:43:50.829507-05:00","ab5951a5-3906-42af-b873-72b9949cd1fd_run.xml","aded73f8c962547ba6250c5c0d96443a","5318e7aa-079a-4307-b6f0-60b341015923",354,"2016-09-08T11:32:13.870466-05:00","TCGA-C5-A2LT","2016-09-02T18:57:49.948025-05:00","female","TCGA-C5-A2LT_demographic",1963,"white","8d29e440-af4d-5585-9e58-2e57be2e813f","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.9","TCGA-C5-A2LT_diagnosis","not reported",13966,"alive","8071/3",NA,2226,"de72accb-699f-51b2-a38d-a38a0866b14c","c53.9",-13966,"TCGA-C5-A2LT_treatment","1eae926e-70c7-54ca-aa49-23f1426a8278","01","false","TCGA-C5-A2LT-01A",NA,"eede6958-96a5-433d-8823-503b58559ed4",FALSE,"C9125C3D-81F0-4E3A-93BB-E2DD191B0B78","Primary Tumor",NA,3715,180,NA,1314144000,"11",30,"TCGA-C5-A2LT-01A-11",65,NA,0,NA,0,NA,25,NA,"2016-09-08T11:32:13.870466-05:00",NA,0,NA,0,NA,"TOP",NA,0,NA,"6e7de933-623c-41f5-8007-4eab8db691b1",NA,"TCGA-C5-A2LT-01A-01-TSA",NA,75,NA,"d6cf05ec-24d8-4468-a7c9-097e8a169aed","RNA","TCGA-C5-A2LT-01A-11R","0560692f-a591-45a3-ac83-3357e3b6a98f",1.83,0.17,"UV Spec","R","23","TCGA-C5-A2LT-01A-11R-A18M-07","26616de7-08df-4359-9c00-c649409b1480",0.17,1.04109589041096,59,22.206330686138,163,"c0cccfe5-ae58-5cdb-9039-733f5936aea0","TCGA-C5-A2LT_exposure","UNCID_2186960.26616de7-08df-4359-9c00-c649409b1480.121002_UNC11-SN627_0254_AC0WP5ACXX_6_GAGTGG.tar.gz","2013-09-16T07:01:05.000Z","2013-09-16T07:35:01.000Z","AB5951A5-3906-42AF-B873-72B9949CD1FD","EEDE6958-96A5-433D-8823-503B58559ED4","Unaligned reads",6607681578,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","26616DE7-08DF-4359-9C00-C649409B1480","University of North Carolina","56607433e4b016715ab671d8","FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","D6CF05EC-24D8-4468-A7C9-097E8A169AED","2013-09-16T07:35:01.000Z","0560692F-A591-45A3-AC83-3357E3B6A98F","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",3715,"D6CF05EC-24D8-4468-A7C9-097E8A169AED",NA,"C5","mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A1308ED2-5DA8-4E39-A1D4-6290246973ED.txt",180,"TCGA-C5-A2LT-01A",NA,"D103CCB4-91ED-4A27-861D-D1AED78A279E","TCGA",2001,NA,NA,"TUMOR FREE","EEDE6958-96A5-433D-8823-503B58559ED4",38,"mdanderson.org_CESC.MDA_RPPA_Core.SuperCurve.Level_2.A1308ED2-5DA8-4E39-A1D4-6290246973ED.txt","Alive",NA,"TCGA-C5-A2LT","NOT HISPANIC OR LATINO","CE5C401A-3BF2-434B-8810-2E8581C00DDF",NA,2226,"No","Cervix","C53.9","N0","Cervical Squamous Cell Carcinoma",1,"Pre-Adjuvant Therapy","Stage IB",NA,NA,"T1b","8071/3","FEMALE","C53.9",179,NA,"35B9F77E-651D-4672-9BAB-BE570501128B","WHITE",NA,11,30,"6E7DE933-623C-41F5-8007-4EAB8DB691B1","D68BE93C-BFDD-4716-AB21-6F621B26AC92","UNCID_2186960.26616de7-08df-4359-9c00-c649409b1480.121002_UNC11-SN627_0254_AC0WP5ACXX_6_GAGTGG.tar.gz","TCGA-C5-A2LT-01A-11",65,0,0,0,25,"TOP",0,0,"TCGA-C5-A2LT-01A-01-TSA",75,"Cisplatin","Chemotherapy","TCGA-C5-A2LT-D21298","TCGA-C5-A2LT-R21299","EXTERNAL BEAM","Primary Tumor Field",NA,"NO",2226,"TUMOR FREE","Alive",NA,"TCGA-C5-A2LT-F20928","TCGA-C5-A2LT",NA,"C5","A2LT","YES","C53.9","8071/3","C53.9","NO","YES",-13966,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2226,NA,NA,NA,"TUMOR FREE","NO",24,1,2012,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,38,2001,"Biopsy (cervical / CT-guided / Other)","YES",31,0,"G3",NA,2,NA,19,NA,NA,"1995",6,NA,"T1bN0M0",NA,NA,1,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
102995270,101413557,4844759625,"4938E366-C740-4C9C-9358-FF37997DC9EF.bw","fc2bce29-4685-49f5-b901-2117bf673bb8","4938e366-c740-4c9c-9358-ff37997dc9ef","2016-08-26T01:07:25.998412-05:00","UNCID_2553078.52041760-a4d7-43e0-b2be-6b7055fe49ed.140603_UNC15-SN850_0368_AC4GHHACXX_8_CCGTCC.tar.gz","38578ead-43aa-4f64-ad0e-5088ab0015ef",4259153267,"Illumina HiSeq","f75c44a15a9b8369ae9ceb848969a554","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T23:43:27.283131-05:00","2016-05-03T11:54:19.885282-05:00","38578ead-43aa-4f64-ad0e-5088ab0015ef_analysis.xml","6e03b07c1e90b41cf062c25b6b9368de","e76a60d2-5723-44e1-afe2-5ed40389d1d5",2124,"2016-09-29T20:17:09.420016-05:00","38578ead-43aa-4f64-ad0e-5088ab0015ef_experiment.xml","95e564b263756a584657e75f5d050c60","6779544d-c6c3-4edf-aac4-6cc149cd3979",2628,"2016-09-29T17:40:34.807554-05:00","38578ead-43aa-4f64-ad0e-5088ab0015ef_run.xml","f8776818cea7687a8ca70c487b194d8d","05945e38-a152-4085-b18c-73556666283c",354,"2016-09-08T12:15:39.660878-05:00","TCGA-MA-AA3W","2016-09-02T18:54:03.187725-05:00","female","TCGA-MA-AA3W_demographic",1958,"white","dc43d9da-89ee-54c9-b9bc-ca7e7978d30f","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","MA","5fe89b89-0806-50b6-8ec5-ac5d25b402e6","MD Anderson Cancer Center","not reported","c53.9","TCGA-MA-AA3W_diagnosis","not reported",20066,"alive","8070/3",NA,685,"7b0e413a-7d9f-5917-93a9-49cb59df9923","c53.9",-20066,"TCGA-MA-AA3W_treatment","3ac75976-1185-5fc6-9835-acad3bf66300","01","false","TCGA-MA-AA3W-01A",NA,"a047fcfb-307f-4548-9ab7-2e2336ed17a2",FALSE,"1C91223A-5529-46CD-AA9C-40A974F1843E","Primary Tumor",NA,512,170,NA,1393200000,"11",30,"TCGA-MA-AA3W-01A-11",70,NA,0,NA,20,NA,10,NA,"2016-09-08T12:15:39.660878-05:00",NA,10,NA,0,NA,"TOP",NA,0,NA,"0c2e52a6-797f-4864-8c5f-419575488f12",NA,"TCGA-MA-AA3W-01A-01-TSA",NA,70,NA,"f587ce44-5bad-416c-8ff9-eb87bf655133","RNA","TCGA-MA-AA3W-01A-11R","ba466c0f-9ad5-46ff-b0a0-035e6e6dd98e",1.87,0.15,"UV Spec","R","23","TCGA-MA-AA3W-01A-11R-A38B-07","52041760-a4d7-43e0-b2be-6b7055fe49ed",0.15,0.312328767123288,84,34.9635796045786,155,"114819e1-9b89-5240-a9e0-86b9820b636f","TCGA-MA-AA3W_exposure","UNCID_2553078.52041760-a4d7-43e0-b2be-6b7055fe49ed.140603_UNC15-SN850_0368_AC4GHHACXX_8_CCGTCC.tar.gz","2014-07-30T17:36:04.000Z","2014-07-30T17:53:12.000Z","38578EAD-43AA-4F64-AD0E-5088AB0015EF","A047FCFB-307F-4548-9AB7-2E2336ED17A2","Unaligned reads",4259153267,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","52041760-A4D7-43E0-B2BE-6B7055FE49ED","University of North Carolina","56607462e4b0ca319164c336","FC2BCE29-4685-49F5-B901-2117BF673BB8","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","F587CE44-5BAD-416C-8FF9-EB87BF655133","2014-07-30T17:53:12.000Z","BA466C0F-9AD5-46FF-B0A0-035E6E6DD98E","United States","NO",1,NA,"Primary Tumor","MD Anderson Cancer Center",512,"F587CE44-5BAD-416C-8FF9-EB87BF655133",NA,"MA","mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E9FE952A-0600-4871-B650-997628E6A1C0.txt",170,"TCGA-MA-AA3W-01A",NA,"DE131EAB-9290-4833-8513-3BA191FBDDDC","TCGA",2012,"TCGA-MA-AA3W_NTE-1","Complete Remission/Response","TUMOR FREE","A047FCFB-307F-4548-9AB7-2E2336ED17A2",54,"mdanderson.org_CESC.MDA_RPPA_Core.protein_expression.Level_3.E9FE952A-0600-4871-B650-997628E6A1C0.txt","Alive",NA,"TCGA-MA-AA3W","HISPANIC OR LATINO","60299942-2D28-4F7E-A6AC-AA817A94562C","NO",503,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",1,"Post-Adjuvant Therapy","Stage IB1",NA,NA,"T1b1","8070/3","FEMALE","C53.9",394,NA,"B85ED5DE-8A84-47F8-B3C8-75497178A3F0","WHITE",NA,11,30,"0C2E52A6-797F-4864-8C5F-419575488F12","BA466C0F-9AD5-46FF-B0A0-035E6E6DD98E","UNCID_2553078.52041760-a4d7-43e0-b2be-6b7055fe49ed.140603_UNC15-SN850_0368_AC4GHHACXX_8_CCGTCC.tar.gz","TCGA-MA-AA3W-01A-11",70,20,0,10,10,"TOP",0,0,"TCGA-MA-AA3W-01A-01-TSA",70,"Cisplatin","Chemotherapy","TCGA-MA-AA3W-D64865","TCGA-MA-AA3W-R64878","External","Primary Tumor Field","TCGA-MA-AA3W-F65477_NTE-1","NO",685,"TUMOR FREE","Alive",NA,"TCGA-MA-AA3W-F65477","TCGA-MA-AA3W",NA,"MA","AA3W","YES","C53.9","8070/3","C53.9","YES","NO",-20066,"FEMALE","WHITE","HISPANIC OR LATINO","No","No","Alive",503,NA,NA,NA,"TUMOR FREE","YES",15,7,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,54,2012,"Biopsy (cervical / CT-guided / Other)","YES",40,1,"G3",NA,2,NA,5.7,NA,"Complete Remission/Response","2009",7,NA,"T1b1N1M0",NA,NA,1,"Preoperative",NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
135471400,132124986,6308681045,"E2DA59C4-A47C-41E3-BC55-2D00C6EC17FB.bw","ff3808e4-eece-4046-819b-fe1019317f8e","e2da59c4-a47c-41e3-bc55-2d00c6ec17fb","2016-08-26T20:33:03.464722-05:00","UNCID_2449497.3292c30c-9fa5-4c11-a6ff-57282c7961fa.140312_UNC15-SN850_0357_AC3M7FACXX_4_CGATGT.tar.gz","455c7a80-360c-4e0e-9303-52500af74659",6124110674,"Illumina HiSeq","3464abe2ea09735bf893476c33208ff2","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T18:18:13.461330-05:00","2016-05-03T11:44:58.602747-05:00","455c7a80-360c-4e0e-9303-52500af74659_analysis.xml","6945f12c3bc36a048302f4344f0ee366","1d53dc21-b98e-4665-bd61-35ed02f3bd0d",2124,"2016-09-29T22:35:58.368275-05:00","455c7a80-360c-4e0e-9303-52500af74659_experiment.xml","eab520449b7c21afd665fef1a4a93a5b","bd719b88-df7b-4326-aec6-7dfbac9ece29",2628,"2016-09-29T20:27:26.610746-05:00","455c7a80-360c-4e0e-9303-52500af74659_run.xml","296bee59e1f326b3240a72d1061fd3d5","6dda24b5-be58-4660-a889-697af85cb0bc",354,"2016-09-08T11:19:27.445487-05:00","TCGA-C5-A7CO","2016-09-02T19:00:17.797901-05:00","female","TCGA-C5-A7CO_demographic",1934,"white","ca1f8381-132a-5a5e-b8a1-54c6da6832cf","not hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","C5","be01935f-aec8-581f-8047-d4334d4e4ee0","Medical College of Wisconsin","not reported","c53.0","TCGA-C5-A7CO_diagnosis","not reported",25045,"alive","8070/3",NA,4482,"abd8641d-74f1-5ef7-8a59-7cd9348cf55f","c53.0",-25045,"TCGA-C5-A7CO_treatment","dee6109e-ef58-5bf5-832a-dd913a3fed30","01","true","TCGA-C5-A7CO-01A",NA,"562dbeca-f85d-4b58-8802-b09d0dd161c1",FALSE,"D677E858-2615-413D-859E-5889286B4398","Primary Tumor",NA,4117,50,NA,1377820800,"11",30,"TCGA-C5-A7CO-01A-11",75,NA,0,NA,0,NA,0,NA,"2016-09-08T11:19:27.445487-05:00",NA,4,NA,0,NA,"TOP",NA,0,NA,"9a1d5d05-1750-488c-8034-c6dd1161c43b",NA,"TCGA-C5-A7CO-01A-01-TS1",NA,100,NA,"7e2ecc20-19ae-4d91-a6bd-7c09ee94414d","RNA","TCGA-C5-A7CO-01A-11R","247c51a9-547d-443d-8787-51490a5d5d29",1.94,0.17,"UV Spec","R","23","TCGA-C5-A7CO-01A-11R-A352-07","3292c30c-9fa5-4c11-a6ff-57282c7961fa",0.17,2.08219178082192,98,39.2565294023394,158,"a887b224-0267-5c3d-9062-8fab85797451","TCGA-C5-A7CO_exposure","UNCID_2449497.3292c30c-9fa5-4c11-a6ff-57282c7961fa.140312_UNC15-SN850_0357_AC3M7FACXX_4_CGATGT.tar.gz","2014-05-14T09:33:04.000Z","2014-05-14T11:52:03.000Z","455C7A80-360C-4E0E-9303-52500AF74659","562DBECA-F85D-4B58-8802-B09D0DD161C1","Unaligned reads",6124110674,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","3292C30C-9FA5-4C11-A6FF-57282C7961FA","University of North Carolina","5660763ee4b018727fea0952","FF3808E4-EECE-4046-819B-FE1019317F8E","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","7E2ECC20-19AE-4D91-A6BD-7C09EE94414D","2014-05-14T11:52:03.000Z","247C51A9-547D-443D-8787-51490A5D5D29","United States","NO",1,NA,"Primary Tumor","Medical College of Wisconsin",4117,"7E2ECC20-19AE-4D91-A6BD-7C09EE94414D",NA,"C5","UNCID_2449497.3292c30c-9fa5-4c11-a6ff-57282c7961fa.140312_UNC15-SN850_0357_AC3M7FACXX_4_CGATGT.tar.gz",50,"TCGA-C5-A7CO-01A",NA,"120E8710-FFBF-48B1-8C5B-676E7B0E3876","TCGA",2002,"TCGA-C5-A7CO_NTE-1",NA,"TUMOR FREE","A398E3A5-CC4A-479C-8393-54A0F74A3395",68,"nationwidechildrens.org_clinical.TCGA-C5-A7CO.xml","Alive",NA,"TCGA-C5-A7CO","NOT HISPANIC OR LATINO","8B026D23-540E-4DEC-AA92-13582026555D","NO",2233,"No","Cervix","C53.0",NA,"Cervical Squamous Cell Carcinoma",NA,NA,"Stage IB2",NA,NA,NA,"8070/3","FEMALE","C53.0",361,NA,"E7D98013-E4CF-413D-A6C9-AFA03DBBD504","WHITE",NA,11,30,"9A1D5D05-1750-488C-8034-C6DD1161C43B","ADEC80E8-8F9B-442A-B73C-FEC5B790D8E8","UNCID_2449497.3292c30c-9fa5-4c11-a6ff-57282c7961fa.140312_UNC15-SN850_0357_AC3M7FACXX_4_CGATGT.tar.gz","TCGA-C5-A7CO-01A-11",75,0,0,4,0,"TOP",0,0,"TCGA-C5-A7CO-01A-01-TS1",100,"Cisplatin","Chemotherapy","TCGA-C5-A7CO-D56985","TCGA-C5-A7CO-R56987","External","Regional site","TCGA-C5-A7CO-F63995_NTE-1","NO",4482,"TUMOR FREE","Alive",NA,"TCGA-C5-A7CO-F63995","TCGA-C5-A7CO",NA,"C5","A7CO","YES","C53.0","8070/3","C53.0","NO","YES",-25045,"FEMALE","WHITE","NOT HISPANIC OR LATINO","No","No","Alive",2233,NA,NA,NA,"TUMOR FREE","YES",3,1,2014,"YES","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,68,2002,"Biopsy (cervical / CT-guided / Other)",NA,NA,NA,"G2",NA,3,1972,38,NA,NA,"1995",8,NA,NA,NA,NA,NA,NA,NA,"Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)",NA,NA,NA,NA,NA,NA
136219000,133430702,6371535553,"37349E62-0BFB-4FEA-81D0-2AB7E7625B0D.bw","ffd8d31f-bc4b-4e19-bbaf-0e26e9f3a107","37349e62-0bfb-4fea-81d0-2ab7e7625b0d","2016-08-25T15:26:23.840899-05:00","UNCID_2546126.7f3a2afd-ef8e-4035-8fec-8dab2b53672c.140417_UNC13-SN749_0343_BC41HBACXX_8_AGTTCC.tar.gz","729df0f1-7140-4512-b681-f5dc998272d9",5908591713,"Illumina HiSeq","401d298a8845108b6dd7552ca2853abf","TARGZ","07","University of North Carolina","UNC","ee7a85b3-8177-5d60-a10c-51180eb9009c","unc.edu","2016-09-29T19:14:15.314481-05:00","2016-05-03T11:53:44.572321-05:00","729df0f1-7140-4512-b681-f5dc998272d9_analysis.xml","58bd4bc44d9a90c092f1f7eb8dbc1bd1","40abf52e-f499-41d6-a208-c5a179ac3a16",2124,"2016-08-13T04:36:59.931045-05:00","729df0f1-7140-4512-b681-f5dc998272d9_experiment.xml","d48ea497faa4e69853cded411fe016c8","911de807-2806-4803-9bb1-7de4e9235fec",2628,"2016-09-29T18:20:11.491362-05:00","729df0f1-7140-4512-b681-f5dc998272d9_run.xml","4c82a44dfd2c0e030af274dda1c6b332","1e6e601f-9ce2-4858-95bf-adb585defe8d",354,"2016-09-08T11:23:59.209362-05:00","TCGA-XS-A8TJ","2016-09-02T19:01:05.808262-05:00","female","TCGA-XS-A8TJ_demographic",1971,"black or african american","5ea9dd35-689f-59a1-ace4-337548b30510","hispanic or latino",NA,"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","Cervix","TCGA-CESC","Cervical squamous cell carcinoma and endocervical adenocarcinoma","NCH","XS","c8f8078b-92e0-5469-b3ff-c308da2bea12","University of Sao Paulo","not reported","c53.9","TCGA-XS-A8TJ_diagnosis","not reported",15298,"alive","8072/3",NA,890,"1fea327a-4e87-506b-aaa6-8e6ee0335d59","c53.9",-15298,"TCGA-XS-A8TJ_treatment","f2d85f3c-5d80-5cd3-9053-ee0981fd689c","01","true","TCGA-XS-A8TJ-01A",NA,"784c1b78-e1bc-4a01-b895-9cc6483436d1",FALSE,"C8BBFFAA-4A45-44D3-921B-6F2BD8DB5B19","Primary Tumor",NA,642,20,NA,1387324800,"11",20,"TCGA-XS-A8TJ-01A-11",70,NA,0,NA,10,NA,20,NA,"2016-09-08T11:23:59.209362-05:00",NA,15,NA,0,NA,"TOP",NA,0,NA,"c3432071-d274-44ab-8d8c-d88f60478cfb",NA,"TCGA-XS-A8TJ-01A-01-TS1",NA,70,NA,"2d522247-2b99-4bbd-b9a7-52f1a3b6e958","RNA","TCGA-XS-A8TJ-01A-11R","24416590-b447-4bcc-9fc5-a27a1f9116e5",1.89,0.17,"UV Spec","R","23","TCGA-XS-A8TJ-01A-11R-A36F-07","7f3a2afd-ef8e-4035-8fec-8dab2b53672c",0.17,NA,51,23.9256896228185,146,"78804f6f-eb3f-553f-a83f-573f01243f2f","TCGA-XS-A8TJ_exposure","UNCID_2546126.7f3a2afd-ef8e-4035-8fec-8dab2b53672c.140417_UNC13-SN749_0343_BC41HBACXX_8_AGTTCC.tar.gz","2014-07-24T07:21:04.000Z","2014-07-24T07:42:22.000Z","729DF0F1-7140-4512-B681-F5DC998272D9","784C1B78-E1BC-4A01-B895-9CC6483436D1","Unaligned reads",5908591713,"Controlled","Illumina HiSeq","TCGA-CESC","RNA-Seq","Raw sequencing data","7F3A2AFD-EF8E-4035-8FEC-8DAB2B53672C","University of North Carolina","56607482e4b0b37b3d98ec4c","FFD8D31F-BC4B-4E19-BBAF-0E26E9F3A107","Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","TARGZ","2D522247-2B99-4BBD-B9A7-52F1A3B6E958","2014-07-24T07:42:22.000Z","24416590-B447-4BCC-9FC5-A27A1F9116E5","Brazil","NO",1,NA,"Primary Tumor","University of Sao Paulo",642,"2D522247-2B99-4BBD-B9A7-52F1A3B6E958",NA,"XS","DEVEL_p_TCGAb3_73_74_75_76_NSP_GenomeWideSNP_6_D11_1438404.birdseed.data.txt",20,"TCGA-XS-A8TJ-01A",NA,"B4F2E7FC-3BE4-456A-9C73-7E967A8E4987","TCGA",2012,"TCGA-XS-A8TJ_NTE-1","Complete Remission/Response","TUMOR FREE","E28C0E2E-DA46-47EB-AE54-494FDF22DC69",41,"nationwidechildrens.org_clinical.TCGA-XS-A8TJ.xml","Alive",NA,"TCGA-XS-A8TJ","HISPANIC OR LATINO",NA,"NO",890,"No","Cervix","C53.9","N1","Cervical Squamous Cell Carcinoma",0,"Preoperative","Stage IB1",NA,NA,"T1b1","8072/3","FEMALE","C53.9",373,NA,"62CC0EDB-0CC0-484C-BFF5-CEB516FB595D","BLACK OR AFRICAN AMERICAN",NA,11,20,"C3432071-D274-44AB-8D8C-D88F60478CFB","60961739-1E4D-4CEA-BA15-B89184A14350","UNCID_2546126.7f3a2afd-ef8e-4035-8fec-8dab2b53672c.140417_UNC13-SN749_0343_BC41HBACXX_8_AGTTCC.tar.gz","TCGA-XS-A8TJ-01A-11",70,10,0,15,20,"TOP",0,0,"TCGA-XS-A8TJ-01A-01-TS1",70,"Cisplatin","Chemotherapy","TCGA-XS-A8TJ-D63711","TCGA-XS-A8TJ-R63706","External","Primary Tumor Field",NA,NA,NA,NA,NA,NA,NA,"TCGA-XS-A8TJ",NA,"XS","A8TJ","YES","C53.9","8072/3","C53.9","YES","NO",-15298,"FEMALE","BLACK OR AFRICAN AMERICAN","HISPANIC OR LATINO","No","No","Alive",890,NA,NA,NA,"TUMOR FREE","YES",28,7,2014,"NO","YES","YES",NA,NA,NA,"Cervical","Cervical Squamous Cell Carcinoma",NA,0,41,2012,"Biopsy (cervical / CT-guided / Other)","YES",20,5,"G2",NA,5,NA,NA,NA,"Complete Remission/Response","2009",7,NA,"T1b1N1M0",NA,NA,0,"Preoperative",NA,"Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)",NA,NA,NA,NA,NA,NA
